Citrus Sinensis ID: 024158

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-
Protein Sequence
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Secondary Structure (PSIPRED)
cccccccccccccccEEEccccccccccccccccEEEEEEcccccEEEEEEEcHHHHHHHHHHHHHHHHHHHHHHcccccEEccccEEEEccEEEEEEEEccccccHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccEEEccccccccccccccEEEccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHccHHHHHHHHHHccccccccccHHHHcccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccHHHEEEEEEEEEcccEEEEEEEEccccEEEEEEEEEHHHHHHcccHHHHHHHHHHHcccccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccEccccEcHHHccHHHHccccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcHHHHHHHHccccccHHHcccHHHHHccccccccccccccccc
Coil and Loop (DISEMBL)
mdtktaerednrkrewslqdfeigrplgkgkfgrVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQsslrhpnilrlygwfhddERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYChenhvihrdikpenllldhegrlkigdfgwsvqsrskrhtmcgtldylapemvenkehdyavdnwtlGILCYEflygappfeaesqkdTFRSISAEAKHLISRLLVKDSSKRLSLQkimehpwiiknanprgtcdi
Flexible Loop (DISEMBL)
mdtktaerednrkrewslqdfeigrplgkgkfGRVYLVReveskhpvalkiiFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDfgwsvqsrskrHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISrllvkdssKRLSlqkimehpwiiknanprgtcdi
Low Complexity Region (SEG)
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Disordered region (IsUnstruct)
*****************LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF***************AKHLISRLLVKD***RLSLQKIMEHPWIIK**********
Disordered Region (DISOPRED)
********************FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP******
Disordered Region (DISEMBL)
*************REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Disordered Region (DISPRO)
**************EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR*****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	271	2.2.26 [Sep-21-2011]
O64629	288	Serine/threonine-protein	yes	no	0.992	0.934	0.749	1e-124
Q9M077	294	Serine/threonine-protein	no	no	0.940	0.867	0.623	2e-99
Q683C9	282	Serine/threonine-protein	no	no	0.963	0.925	0.607	9e-98
Q2TA06	402	Aurora kinase A OS=Bos ta	yes	no	0.948	0.639	0.605	4e-95
P97477	395	Aurora kinase A OS=Mus mu	yes	no	0.944	0.648	0.608	2e-94
P59241	397	Aurora kinase A OS=Rattus	yes	no	0.966	0.659	0.594	1e-93
A5GFW1	402	Aurora kinase A OS=Sus sc	yes	no	0.959	0.646	0.591	2e-93
O14965	403	Aurora kinase A OS=Homo s	yes	no	0.963	0.647	0.589	3e-93
Q91820	407	Aurora kinase A-A OS=Xeno	N/A	no	0.963	0.641	0.586	6e-93
Q91819	408	Aurora kinase A-B OS=Xeno	N/A	no	0.963	0.639	0.586	3e-92

>sp|O64629|AUR3_ARATH Serine/threonine-protein kinase Aurora-3 OS=Arabidopsis thaliana GN=AUR3 PE=2 SV=1

 Score =  444 bits (1141), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 212/283 (74%), Positives = 241/283 (85%), Gaps = 14/283 (4%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------- 226
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+             
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

Phosphorylates in vitro histone H3 at 'Ser-10' and 'Ser-28', but not at 'Thr-3' or 'Thr-11'. Colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M077|AUR1_ARATH Serine/threonine-protein kinase Aurora-1 OS=Arabidopsis thaliana GN=AUR1 PE=1 SV=1

 Score =  362 bits (928), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 167/268 (62%), Positives = 213/268 (79%), Gaps = 13/268 (4%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           ++ W+L DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQLRRE+EI
Sbjct: 23  QKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRREVEI 82

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+F+D +R++LILEYA RGELY++L+K + F+E++AATY+ASL  AL
Sbjct: 83  QSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASLARAL 142

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
            YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL PEMVE+ E
Sbjct: 143 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 202

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------------ISAEAKHLISRL 239
           HD +VD W+LGILCYEFLYG PPFEA    DT+R              ISA AK LIS++
Sbjct: 203 HDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDLISQM 262

Query: 240 LVKDSSKRLSLQKIMEHPWIIKNANPRG 267
           LVK+SS+RL L K++EHPWI++NA+P G
Sbjct: 263 LVKESSQRLPLHKLLEHPWIVQNADPSG 290

Phosphorylates specifically 'Ser-10' of histone H3 in vitro and colocalizes with phosphorylated histone H3 during mitosis. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might also colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs). In contrast with the mammalian B-type Aurora, AUR1 has no kinase activity toward 'Ser-28' of histone H3.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q683C9|AUR2_ARATH Serine/threonine-protein kinase Aurora-2 OS=Arabidopsis thaliana GN=AUR2 PE=2 SV=2

 Score =  356 bits (914), Expect = 9e-98,   Method: Compositional matrix adjust.
 Identities = 167/275 (60%), Positives = 216/275 (78%), Gaps = 14/275 (5%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           A  E  +KR W+  DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQ
Sbjct: 5   AASEAAQKR-WTTSDFDIGKPLGRGKFGHVYLAREKRSDHIVALKVLFKAQLQQSQVEHQ 63

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           LRRE+EIQS LRHPNILRLYG+F+D +R++LILEYA RGELY+EL+K + F+E++AATY+
Sbjct: 64  LRREVEIQSHLRHPNILRLYGYFYDQKRVYLILEYAVRGELYKELQKCKYFSERRAATYV 123

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAP 185
           ASL  AL YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL P
Sbjct: 124 ASLARALIYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPP 183

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEA 232
           EMVE+ EHD +VD W+LGILCYEFLYG PPFEA    +T++ I             S+ A
Sbjct: 184 EMVESVEHDASVDIWSLGILCYEFLYGVPPFEAREHSETYKRIVQVDLKFPPKPIVSSSA 243

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 267
           K LIS++LVK+S++RL+L K++EHPWI++NA+P G
Sbjct: 244 KDLISQMLVKESTQRLALHKLLEHPWIVQNADPSG 278

Phosphorylates specifically 'Ser-10' of histone H3 in vitro. Associates with cytoskeletal structures that are necessary for cytokinesis and with the microtubule spindle. Might colocalize with gamma-tubulin and function in microtubule organizing centers (MTOCs).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2TA06|AURKA_BOVIN Aurora kinase A OS=Bos taurus GN=AURKA PE=2 SV=1

 Score =  347 bits (891), Expect = 4e-95,   Method: Compositional matrix adjust.
 Identities = 163/269 (60%), Positives = 206/269 (76%), Gaps = 12/269 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA++ ++T+R IS             A+ LI
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFPDCVPEGARDLI 360

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           SRLL  + S+R +L++++EHPWII N+ P
Sbjct: 361 SRLLKHNPSQRPTLKEVLEHPWIIANSKP 389

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P97477|AURKA_MOUSE Aurora kinase A OS=Mus musculus GN=Aurka PE=1 SV=1

 Score =  345 bits (886), Expect = 2e-94,   Method: Compositional matrix adjust.
 Identities = 163/268 (60%), Positives = 204/268 (76%), Gaps = 12/268 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ED +KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 112 EDTKKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRR 171

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 172 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 231

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R TMCGTLDYL PEM
Sbjct: 232 ANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEM 291

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS             A+ LI
Sbjct: 292 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 351

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           SRLL  ++S+RL+L +++EHPWI  N++
Sbjct: 352 SRLLKHNASQRLTLAEVLEHPWIKANSS 379

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P59241|AURKA_RAT Aurora kinase A OS=Rattus norvegicus GN=Aurka PE=1 SV=1

 Score =  343 bits (879), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 163/274 (59%), Positives = 206/274 (75%), Gaps = 12/274 (4%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct: 108 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 167

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct: 168 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 227

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
           TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 228 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 287

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------A 230
           Y  PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS            
Sbjct: 288 YQPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTE 347

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
            A+ LISRLL  +SS+RL+L +++EHPWI  N++
Sbjct: 348 GARDLISRLLKHNSSQRLTLAEVLEHPWIKANSS 381

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5GFW1|AURKA_PIG Aurora kinase A OS=Sus scrofa GN=AURKA PE=2 SV=1

 Score =  342 bits (876), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 161/272 (59%), Positives = 204/272 (75%), Gaps = 12/272 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKTQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LI
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVPEGARDLI 360

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 268
           SRLL  + S R +L++++EHPWI  N+ P  +
Sbjct: 361 SRLLKHNPSHRPTLKEVLEHPWITANSKPASS 392

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity (By similarity). Necessary for proper cilia disassembly prior to mitosis.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O14965|AURKA_HUMAN Aurora kinase A OS=Homo sapiens GN=AURKA PE=1 SV=2

 Score =  341 bits (875), Expect = 3e-93,   Method: Compositional matrix adjust.
 Identities = 161/273 (58%), Positives = 204/273 (74%), Gaps = 12/273 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 121 EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 180

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 181 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 240

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 241 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 300

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LI
Sbjct: 301 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 360

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 361 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 393

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Required for initial activation of CDK1 at centrosomes. Phosphorylates numerous target proteins, including ARHGEF2, BORA, BRCA1, CDC25B, DLGP5, HDAC6, KIF2A, LATS2, NDEL1, PARD3, PPP1R2, PLK1, RASSF1, TACC3, p53/TP53 and TPX2. Regulates KIF2A tubulin depolymerase activity. Required for normal axon formation. Plays a role in microtubule remodeling during neurite extension. Important for microtubule formation and/or stabilization. Also acts as a key regulatory component of the p53/TP53 pathway, and particularly the checkpoint-response pathways critical for oncogenic transformation of cells, by phosphorylating and stabilizating p53/TP53. Phosphorylates its own inhibitors, the protein phosphatase type 1 (PP1) isoforms, to inhibit their activity. Necessary for proper cilia disassembly prior to mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91820|AURAA_XENLA Aurora kinase A-A OS=Xenopus laevis GN=aurka-a PE=1 SV=1

 Score =  340 bits (872), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 160/273 (58%), Positives = 203/273 (74%), Gaps = 12/273 (4%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct: 122 TSAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct: 182 EHQLRREVEIQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
            YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 242 MYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA----------- 230
           YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+R IS            
Sbjct: 302 YLPPEMIEGRMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPPYVSE 361

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           EA+ L+S+LL  + + RL L+ ++EHPWIIKN+
Sbjct: 362 EARDLVSKLLKHNPNHRLPLKGVLEHPWIIKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q91819|AURAB_XENLA Aurora kinase A-B OS=Xenopus laevis GN=aurka-b PE=2 SV=3

 Score =  338 bits (866), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 160/273 (58%), Positives = 203/273 (74%), Gaps = 12/273 (4%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
           T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct: 122 TLAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
           +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct: 182 EHQLRREVEIQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
            YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct: 242 LYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA----------- 230
           YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+R IS            
Sbjct: 302 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPPYVSE 361

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           EAK L+S+LL  + + RL L+ ++EHPWI+KN+
Sbjct: 362 EAKDLVSKLLKHNPNHRLPLKGVLEHPWIVKNS 394

Mitotic serine/threonine kinases that contributes to the regulation of cell cycle progression. Associates with the centrosome and the spindle microtubules during mitosis and plays a critical role in various mitotic events including the establishment of mitotic spindle, centrosome duplication, centrosome separation as well as maturation, chromosomal alignment, spindle assembly checkpoint, and cytokinesis. Phosphorylates numerous target proteins. Important for microtubule formation and/or stabilization.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	271
224090609	283	predicted protein [Populus trichocarpa]	0.974	0.932	0.779	1e-127
356545969	332	PREDICTED: serine/threonine-protein kina	0.985	0.804	0.778	1e-126
225453778	281	PREDICTED: serine/threonine-protein kina	0.974	0.939	0.779	1e-125
356506339	276	PREDICTED: serine/threonine-protein kina	0.966	0.949	0.781	1e-125
15225495	288	serine/threonine-protein kinase aurora-3	0.992	0.934	0.749	1e-122
449432227	285	PREDICTED: serine/threonine-protein kina	0.952	0.905	0.763	1e-120
297828267	288	ATAUR3 [Arabidopsis lyrata subsp. lyrata	0.992	0.934	0.742	1e-120
357514781	305	Serine/threonine protein kinase Aurora-3	0.974	0.865	0.687	1e-114
255541356	260	Serine/threonine-protein kinase, putativ	0.830	0.865	0.810	1e-108
147781807	312	hypothetical protein VITISV_011428 [Viti	0.856	0.743	0.759	1e-106

>gi|224090609|ref|XP_002309033.1| predicted protein [Populus trichocarpa] gi|222855009|gb|EEE92556.1| predicted protein [Populus trichocarpa]

 Score =  458 bits (1179), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 216/277 (77%), Positives = 243/277 (87%), Gaps = 13/277 (4%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ++ + R+R WS+ DFEIG+PLG+GKFGRVY+ REV+SK+ VALK+IFKEQI+KY I HQL
Sbjct: 6   KKSEPRRRGWSIADFEIGKPLGRGKFGRVYVAREVKSKYIVALKVIFKEQIDKYNIHHQL 65

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REM+IQ+SL HPNILRLYGWFHDD+R+F+ILEYAH GEL++ELRK    +EQ+AATY+A
Sbjct: 66  KREMDIQTSLSHPNILRLYGWFHDDQRVFMILEYAHGGELFKELRKCGYLSEQKAATYVA 125

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SL NALAYCHE  VIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTLDYLAPE
Sbjct: 126 SLANALAYCHEKDVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTLDYLAPE 185

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAK 233
           MVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ+DTFR I             SAEAK
Sbjct: 186 MVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQRDTFRRIVKVDLTFPSTPPVSAEAK 245

Query: 234 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 270
           +LI+RLLVKDSSKRLSLQKI+EHPWIIKNANP GTCD
Sbjct: 246 NLITRLLVKDSSKRLSLQKILEHPWIIKNANPMGTCD 282

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356545969|ref|XP_003541405.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Glycine max]

 Score =  456 bits (1173), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 218/280 (77%), Positives = 241/280 (86%), Gaps = 13/280 (4%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M ++    E+N KR WSL+DFEIG+PLG+GKFGRVY+ REV+SK  VALK+IFKEQI+KY
Sbjct: 34  MASQNPAEEENSKRHWSLEDFEIGKPLGRGKFGRVYVAREVKSKFVVALKVIFKEQIDKY 93

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           ++ HQLRREMEIQ+SLRH NILRLYGWFHD +R+FLILEYAH+GELY+ELRK    TE+Q
Sbjct: 94  RVHHQLRREMEIQTSLRHANILRLYGWFHDADRVFLILEYAHKGELYKELRKKGHLTEKQ 153

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL 180
           AATYI SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTL
Sbjct: 154 AATYILSLTKALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTL 213

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------S 227
           DYLAPEMVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ DTF+             S
Sbjct: 214 DYLAPEMVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQSDTFKRIMKVDLSFPSTPS 273

Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 267
           +S EAK+LISRLLVKDSS+RLSLQKIMEHPWIIKNA+  G
Sbjct: 274 VSIEAKNLISRLLVKDSSRRLSLQKIMEHPWIIKNADFVG 313

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225453778|ref|XP_002270462.1| PREDICTED: serine/threonine-protein kinase Aurora-3 [Vitis vinifera] gi|296089088|emb|CBI38791.3| unnamed protein product [Vitis vinifera]

 Score =  452 bits (1163), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 216/277 (77%), Positives = 237/277 (85%), Gaps = 13/277 (4%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           E    ++++WSL DFEIG+PLG+GKFGRVYL RE++SK+ VALK+IFK QIEKY++ HQL
Sbjct: 4   EPSQKQQKQWSLDDFEIGKPLGRGKFGRVYLAREIKSKYVVALKVIFKAQIEKYRLHHQL 63

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REMEIQ+SL HPN+LRLYGWFHD ERIFLILEY + GELYRELRK    TE+QAATYIA
Sbjct: 64  KREMEIQTSLCHPNVLRLYGWFHDSERIFLILEYCYGGELYRELRKTGYLTEKQAATYIA 123

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGTLDYLAPE
Sbjct: 124 SLTQALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSTNKRRTMCGTLDYLAPE 183

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAK 233
           MVENK HDYAVDNWTLGILCYEFLYG PPFEAESQ DTF+ I             SAEAK
Sbjct: 184 MVENKAHDYAVDNWTLGILCYEFLYGVPPFEAESQSDTFKRIMKVDLSFPSNPHVSAEAK 243

Query: 234 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 270
           +LISRLLVKDSSKRLSLQKIMEHPWIIKNANP GTC+
Sbjct: 244 NLISRLLVKDSSKRLSLQKIMEHPWIIKNANPTGTCN 280

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356506339|ref|XP_003521942.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Glycine max]

 Score =  452 bits (1162), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 215/275 (78%), Positives = 237/275 (86%), Gaps = 13/275 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           + N KREWSL DFEIG+PLGKGKFGRVY+ REV+SK  VALK+IFKEQ+EKY+I HQLRR
Sbjct: 2   DGNPKREWSLNDFEIGKPLGKGKFGRVYVAREVKSKFVVALKVIFKEQLEKYRIHHQLRR 61

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           EMEIQ SL+H N+LRLYGWFHD ER++LILEYAH GELY+EL K   F E+QAATYI SL
Sbjct: 62  EMEIQFSLQHQNVLRLYGWFHDSERVYLILEYAHNGELYKELSKKGHFNEKQAATYILSL 121

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
           T ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQSRSKRHTMCGTLDYLAPEMV
Sbjct: 122 TKALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSRSKRHTMCGTLDYLAPEMV 181

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------SISAEAKHL 235
           ENK HDYAVDNWTLGILCYEFLYGAPPFEAESQ DTF+             ++S EAK+L
Sbjct: 182 ENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQVDTFKRIMKVDLSFPSTPNVSLEAKNL 241

Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 270
           ISRLLVKDSS+RLSLQ+IMEHPWI KNA+P+G C+
Sbjct: 242 ISRLLVKDSSRRLSLQRIMEHPWITKNADPKGVCN 276

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15225495|ref|NP_182073.1| serine/threonine-protein kinase aurora-3 [Arabidopsis thaliana] gi|75318481|sp|O64629.1|AUR3_ARATH RecName: Full=Serine/threonine-protein kinase Aurora-3; Short=AtAur3; AltName: Full=Aurora-like kinase 3 gi|2979542|gb|AAC06151.1| putative protein kinase [Arabidopsis thaliana] gi|18491289|gb|AAL69469.1| At2g45490/F17K2.2 [Arabidopsis thaliana] gi|55467122|emb|CAH69534.1| aurora-like kinase 3 [Arabidopsis thaliana] gi|67845863|dbj|BAE00021.1| Aurora kinase [Arabidopsis thaliana] gi|330255467|gb|AEC10561.1| serine/threonine-protein kinase aurora-3 [Arabidopsis thaliana]

 Score =  444 bits (1141), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 212/283 (74%), Positives = 241/283 (85%), Gaps = 14/283 (4%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------- 226
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+             
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449432227|ref|XP_004133901.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Cucumis sativus] gi|449519938|ref|XP_004166991.1| PREDICTED: serine/threonine-protein kinase Aurora-3-like [Cucumis sativus]

 Score =  437 bits (1124), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 207/271 (76%), Positives = 233/271 (85%), Gaps = 13/271 (4%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+WSL+DF++G+PLGKGKFGRVYL REV SK+ VALK+IF+EQ++KY I  QL REMEI
Sbjct: 13  KRQWSLKDFDVGKPLGKGKFGRVYLAREVRSKYIVALKVIFREQMKKYGIHRQLMREMEI 72

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           Q+SLRHPNILRLYGWFHD ERIF+ILEYAHRGELYRELRK+   +E+QAATY+ SLT AL
Sbjct: 73  QTSLRHPNILRLYGWFHDAERIFMILEYAHRGELYRELRKNGHLSEKQAATYMLSLTQAL 132

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           AYCHE  VIHRDIKPENLLLDHEGRLKIGDFGW+VQSRSKR+TMCGTLDYLAPEMVENK 
Sbjct: 133 AYCHEKDVIHRDIKPENLLLDHEGRLKIGDFGWAVQSRSKRYTMCGTLDYLAPEMVENKG 192

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------SISAEAKHLISRL 239
           HD+A+DNWT+GILCYEFLYG PPFEAESQ DTF+              IS EA+ LI RL
Sbjct: 193 HDFAIDNWTMGILCYEFLYGVPPFEAESQSDTFQRIRKVELNFPSTPRISTEARDLIGRL 252

Query: 240 LVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 270
           LVKDSSKRLSLQ+I EHPWIIKNA+P G C+
Sbjct: 253 LVKDSSKRLSLQEIEEHPWIIKNADPSGICN 283

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297828267|ref|XP_002882016.1| ATAUR3 [Arabidopsis lyrata subsp. lyrata] gi|297327855|gb|EFH58275.1| ATAUR3 [Arabidopsis lyrata subsp. lyrata]

 Score =  437 bits (1123), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 210/283 (74%), Positives = 238/283 (84%), Gaps = 14/283 (4%)

Query: 1   MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
           M  ++ E +  + +++WSL DFEIG PLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct: 1   MSKRSTESDAGDTEKQWSLADFEIGGPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
           YKI HQLRREMEIQ+SL HPNILRL+GWF DDERIFLILEYAH GELY  L+K+   TEQ
Sbjct: 61  YKIHHQLRREMEIQTSLSHPNILRLFGWFDDDERIFLILEYAHGGELYGVLKKNGHLTEQ 120

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct: 121 QAATYIASLSEALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------- 226
           LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+             
Sbjct: 181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query: 227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           ++S EAK+LIS+LLVKD SKRLSL+KIM+HPWI+KNA+P+G C
Sbjct: 241 NVSEEAKNLISQLLVKDPSKRLSLEKIMQHPWIVKNADPKGVC 283

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357514781|ref|XP_003627679.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|358344449|ref|XP_003636302.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|358345551|ref|XP_003636840.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355502237|gb|AES83440.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355502775|gb|AES83978.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula] gi|355521701|gb|AET02155.1| Serine/threonine protein kinase Aurora-3 [Medicago truncatula]

 Score =  417 bits (1073), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 209/304 (68%), Positives = 232/304 (76%), Gaps = 40/304 (13%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ++   R+ EWS+ DFEIG+PLG+GKFGRVY+ REV+SK+ +ALK+IFKEQ+EKY I HQL
Sbjct: 2   DQNQKREHEWSINDFEIGKPLGRGKFGRVYVAREVKSKYVIALKVIFKEQLEKYNILHQL 61

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--- 123
           RREMEIQ SL+HPNILRLYGWFHD ER++LILEYAH GELY+ELRK   F+E+QAAT   
Sbjct: 62  RREMEIQISLKHPNILRLYGWFHDAERVYLILEYAHNGELYKELRKKGHFSEKQAATIDR 121

Query: 124 ------------------------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK 159
                                   YI SLT ALAYCHE HVIHRDIKPENLLLDHEGRLK
Sbjct: 122 YRERERERERERERERERERDRERYILSLTKALAYCHEKHVIHRDIKPENLLLDHEGRLK 181

Query: 160 IGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           I DFGWSVQS  KR TMCGTLDYLAPEMVENK HDYAVDNWTLGILCYEFLYG PPFEAE
Sbjct: 182 IADFGWSVQSVKKRKTMCGTLDYLAPEMVENKGHDYAVDNWTLGILCYEFLYGVPPFEAE 241

Query: 220 SQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           SQ+DTF+ I             S  AK+LISRLLVKDSSKRL LQKIMEHPWI +NAN  
Sbjct: 242 SQEDTFKRIRDVDLNFPPTPHVSKNAKNLISRLLVKDSSKRLPLQKIMEHPWIKENANHT 301

Query: 267 GTCD 270
           G C+
Sbjct: 302 GVCE 305

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255541356|ref|XP_002511742.1| Serine/threonine-protein kinase, putative [Ricinus communis] gi|223548922|gb|EEF50411.1| Serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  397 bits (1020), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 193/238 (81%), Positives = 209/238 (87%), Gaps = 13/238 (5%)

Query: 43  SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH 102
           SK+ VALK+IFKEQIEKY+I HQL+REMEIQ++L HPN+LRLYGWFHDDERIFLILEYA 
Sbjct: 19  SKYIVALKVIFKEQIEKYRIHHQLKREMEIQTNLCHPNVLRLYGWFHDDERIFLILEYAQ 78

Query: 103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
            GELY+EL+K     E+QAATYIASLTNAL+YCH+  VIHRDIKPENLLLDHEGRLKI D
Sbjct: 79  GGELYKELKKKGFLCEKQAATYIASLTNALSYCHKKDVIHRDIKPENLLLDHEGRLKIAD 138

Query: 163 FGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
           FGWSVQSRSKRHTMCGTLDYLAPEMVENK HDYAVDNWTLGILCYEFLYGAPPFEAESQK
Sbjct: 139 FGWSVQSRSKRHTMCGTLDYLAPEMVENKAHDYAVDNWTLGILCYEFLYGAPPFEAESQK 198

Query: 223 DTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 267
           DTFR I             SAEAK+LI+RLLVKDSSKRLSLQKI+EHPWIIKNA+P G
Sbjct: 199 DTFRRIMKVDLTFPSHPPVSAEAKNLITRLLVKDSSKRLSLQKILEHPWIIKNADPMG 256

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147781807|emb|CAN65449.1| hypothetical protein VITISV_011428 [Vitis vinifera]

 Score =  390 bits (1001), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 186/245 (75%), Positives = 206/245 (84%), Gaps = 13/245 (5%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           E    ++++WSL DFEIG+PLG+GKFGRVYL RE++SK+ VALK+IFK QIEKY++ HQL
Sbjct: 19  EXSQKQQKQWSLDDFEIGKPLGRGKFGRVYLAREIKSKYVVALKVIFKAQIEKYRLHHQL 78

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           +REMEIQ+SL HPN+LRLYGWFHD ERIFLILEY + GELYRELRK    TE+QAATYIA
Sbjct: 79  KREMEIQTSLCHPNVLRLYGWFHDSERIFLILEYCYGGELYRELRKTGYLTEKQAATYIA 138

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           SLT ALAYCHE HVIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGTLDYLAPE
Sbjct: 139 SLTQALAYCHEKHVIHRDIKPENLLLDHEGRLKIADFGWSVQSTNKRRTMCGTLDYLAPE 198

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAK 233
           MVENK HDYAVDNWTLGILCYEFLYG PPFEAESQ DTF+ I             SAEAK
Sbjct: 199 MVENKAHDYAVDNWTLGILCYEFLYGVPPFEAESQSDTFKRIMKVDLSFPSNPHVSAEAK 258

Query: 234 HLISR 238
           +LISR
Sbjct: 259 NLISR 263

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	271
TAIR|locus:2043624	288	AUR3 "ataurora3" [Arabidopsis	0.992	0.934	0.749	8.4e-113
TAIR|locus:2134103	294	AUR1 "ataurora1" [Arabidopsis	0.940	0.867	0.623	4.5e-91
UNIPROTKB|Q2TA06	402	AURKA "Aurora kinase A" [Bos t	0.966	0.651	0.6	2e-86
UNIPROTKB|F1LN52	418	Aurka "Aurora kinase A" [Rattu	0.977	0.633	0.598	3.3e-86
MGI|MGI:894678	395	Aurka "aurora kinase A" [Mus m	0.955	0.655	0.608	5.4e-86
RGD|628895	397	Aurka "aurora kinase A" [Rattu	0.977	0.667	0.594	1.4e-85
UNIPROTKB|O14965	403	AURKA "Aurora kinase A" [Homo	0.970	0.652	0.589	4.9e-85
UNIPROTKB|A5GFW1	402	AURKA "Aurora kinase A" [Sus s	0.955	0.644	0.597	4.9e-85
UNIPROTKB|Q91820	407	aurka-a "Aurora kinase A-A" [X	0.963	0.641	0.586	6.2e-85
UNIPROTKB|Q91819	408	aurka-b "Aurora kinase A-B" [X	0.963	0.639	0.586	2.1e-84

TAIR|locus:2043624 AUR3 "ataurora3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
 Identities = 212/283 (74%), Positives = 241/283 (85%)

Query:     1 MDTKTAERE-DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK 59
             M  K+ E +  N +++WSL DFEIGRPLGKGKFGRVYL RE +SK+ VALK+IFKEQIEK
Sbjct:     1 MSKKSTESDAGNTEKQWSLADFEIGRPLGKGKFGRVYLAREAKSKYIVALKVIFKEQIEK 60

Query:    60 YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             YKI HQLRREMEIQ+SLRHPNILRL+GWFHD+ERIFLILEYAH GELY  L+++   TEQ
Sbjct:    61 YKIHHQLRREMEIQTSLRHPNILRLFGWFHDNERIFLILEYAHGGELYGVLKQNGHLTEQ 120

Query:   120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
             QAATYIASL+ ALAYCH   VIHRDIKPENLLLDHEGRLKI DFGWSVQS +KR TMCGT
Sbjct:   121 QAATYIASLSQALAYCHGKCVIHRDIKPENLLLDHEGRLKIADFGWSVQSSNKRKTMCGT 180

Query:   180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------- 226
             LDYLAPEMVEN++HDYAVDNWTLGILCYEFLYG PPFEAESQKDTF+             
Sbjct:   181 LDYLAPEMVENRDHDYAVDNWTLGILCYEFLYGNPPFEAESQKDTFKRILKIDLSFPLTP 240

Query:   227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
             ++S EAK+LIS+LLVKD SKRLS++KIM+HPWI+KNA+P+G C
Sbjct:   241 NVSEEAKNLISQLLVKDPSKRLSIEKIMQHPWIVKNADPKGVC 283

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000775 "chromosome, centromeric region" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0043987 "histone H3-S10 phosphorylation" evidence=IDA

GO:0043988 "histone H3-S28 phosphorylation" evidence=IDA

GO:0044022 "histone kinase activity (H3-S28 specific)" evidence=IDA

GO:0000226 "microtubule cytoskeleton organization" evidence=RCA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0009640 "photomorphogenesis" evidence=RCA

GO:0010388 "cullin deneddylation" evidence=RCA

GO:0016567 "protein ubiquitination" evidence=RCA

GO:0016571 "histone methylation" evidence=RCA

GO:0016579 "protein deubiquitination" evidence=RCA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

TAIR|locus:2134103 AUR1 "ataurora1" [Arabidopsis thaliana (taxid:3702)]

 Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
 Identities = 167/268 (62%), Positives = 213/268 (79%)

Query:    13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             ++ W+L DF+IG+PLG+GKFG VYL RE  S H VALK++FK Q+++ +++HQLRRE+EI
Sbjct:    23 QKRWTLSDFDIGKPLGRGKFGHVYLAREKRSNHVVALKVLFKSQLQQSQVEHQLRREVEI 82

Query:    73 QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             QS LRHPNILRLYG+F+D +R++LILEYA RGELY++L+K + F+E++AATY+ASL  AL
Sbjct:    83 QSHLRHPNILRLYGYFYDQKRVYLILEYAARGELYKDLQKCKYFSERRAATYVASLARAL 142

Query:   133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
              YCH  HVIHRDIKPENLL+  +G LKI DFGWSV + ++R TMCGTLDYL PEMVE+ E
Sbjct:   143 IYCHGKHVIHRDIKPENLLIGAQGELKIADFGWSVHTFNRRRTMCGTLDYLPPEMVESVE 202

Query:   193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAKHLISRL 239
             HD +VD W+LGILCYEFLYG PPFEA    DT+R I             SA AK LIS++
Sbjct:   203 HDASVDIWSLGILCYEFLYGVPPFEAMEHSDTYRRIVQVDLKFPPKPIISASAKDLISQM 262

Query:   240 LVKDSSKRLSLQKIMEHPWIIKNANPRG 267
             LVK+SS+RL L K++EHPWI++NA+P G
Sbjct:   263 LVKESSQRLPLHKLLEHPWIVQNADPSG 290

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005819 "spindle" evidence=IDA

GO:0016572 "histone phosphorylation" evidence=RCA;IDA

GO:0035175 "histone kinase activity (H3-S10 specific)" evidence=IDA

GO:0005874 "microtubule" evidence=IDA

GO:0009504 "cell plate" evidence=IDA

GO:0000278 "mitotic cell cycle" evidence=RCA

GO:0006342 "chromatin silencing" evidence=RCA

GO:0051567 "histone H3-K9 methylation" evidence=RCA

UNIPROTKB|Q2TA06 AURKA "Aurora kinase A" [Bos taurus (taxid:9913)]

 Score = 864 (309.2 bits), Expect = 2.0e-86, P = 2.0e-86
 Identities = 165/275 (60%), Positives = 210/275 (76%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE----------AKH 234
             EM+E + HD  VD W+LG+LCYEFL G PPFEA++ ++T+R IS  E          A+ 
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEADTYQETYRRISRVEFTFPDCVPEGARD 358

Query:   235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
             LISRLL  + S+R +L++++EHPWII N+ P  +C
Sbjct:   359 LISRLLKHNPSQRPTLKEVLEHPWIIANSKP-SSC 392

GO:0004672 "protein kinase activity" evidence=ISS

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|F1LN52 Aurka "Aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
 Identities = 167/279 (59%), Positives = 210/279 (75%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct:   129 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 188

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct:   189 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 248

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
             TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   249 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 308

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE--------- 231
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS  E         
Sbjct:   309 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTE 368

Query:   232 -AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 267
              A+ LISRLL  +SS+RL+L +++EHPWI  N++  P G
Sbjct:   369 GARDLISRLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 407

GO:0000278 "mitotic cell cycle" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005876 "spindle microtubule" evidence=IEA

GO:0019901 "protein kinase binding" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0031647 "regulation of protein stability" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

MGI|MGI:894678 Aurka "aurora kinase A" [Mus musculus (taxid:10090)]

 Score = 860 (307.8 bits), Expect = 5.4e-86, P = 5.4e-86
 Identities = 166/273 (60%), Positives = 207/273 (75%)

Query:     9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
             ED +KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct:   112 EDTKKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKANVEHQLRR 171

Query:    69 EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
             E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct:   172 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 231

Query:   129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
              NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R TMCGTLDYL PEM
Sbjct:   232 ANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTMCGTLDYLPPEM 291

Query:   188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE----------AKHLI 236
             +E + HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS  E          A+ LI
Sbjct:   292 IEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 351

Query:   237 SRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 267
             SRLL  ++S+RL+L +++EHPWI  N++  P G
Sbjct:   352 SRLLKHNASQRLTLAEVLEHPWIKANSSKPPTG 384

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000278 "mitotic cell cycle" evidence=IMP

GO:0004672 "protein kinase activity" evidence=ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO

GO:0005819 "spindle" evidence=ISO

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0007049 "cell cycle" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

RGD|628895 Aurka "aurora kinase A" [Rattus norvegicus (taxid:10116)]

 Score = 856 (306.4 bits), Expect = 1.4e-85, P = 1.4e-85
 Identities = 166/279 (59%), Positives = 209/279 (74%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T   + ED++KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  +
Sbjct:   108 TSIQKTEDSKKRQWTLEDFDIGRPLGKGKFGNVYLAREKQSKFILALKVLFKVQLEKAGV 167

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ A
Sbjct:   168 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA 227

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
             TYI  L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   228 TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 287

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE--------- 231
             Y  PEM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS  E         
Sbjct:   288 YQPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTE 347

Query:   232 -AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN--PRG 267
              A+ LISRLL  +SS+RL+L +++EHPWI  N++  P G
Sbjct:   348 GARDLISRLLKHNSSQRLTLAEVLEHPWIKANSSKPPTG 386

GO:0000278 "mitotic cell cycle" evidence=ISO

GO:0000922 "spindle pole" evidence=IEA

GO:0004672 "protein kinase activity" evidence=ISO;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0005813 "centrosome" evidence=ISO;IDA

GO:0005819 "spindle" evidence=IDA

GO:0005874 "microtubule" evidence=IEA

GO:0005876 "spindle microtubule" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0007049 "cell cycle" evidence=TAS

GO:0007067 "mitosis" evidence=IEA

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030030 "cell projection organization" evidence=IEA

GO:0031616 "spindle pole centrosome" evidence=ISO

GO:0031625 "ubiquitin protein ligase binding" evidence=ISO

GO:0031647 "regulation of protein stability" evidence=ISO

GO:0032355 "response to estradiol stimulus" evidence=IEP

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0051301 "cell division" evidence=IEA

UNIPROTKB|O14965 AURKA "Aurora kinase A" [Homo sapiens (taxid:9606)]

 Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
 Identities = 162/275 (58%), Positives = 206/275 (74%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE----------AKH 234
             EM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS  E          A+ 
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 358

Query:   235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
             LISRLL  + S+R  L++++EHPWI  N++    C
Sbjct:   359 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 393

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0048015 "phosphatidylinositol-mediated signaling" evidence=NAS

GO:0007051 "spindle organization" evidence=NAS

GO:0007049 "cell cycle" evidence=NAS

GO:0031647 "regulation of protein stability" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0019901 "protein kinase binding" evidence=IPI

GO:0005813 "centrosome" evidence=IDA;TAS

GO:0030496 "midbody" evidence=TAS

GO:0046777 "protein autophosphorylation" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0046605 "regulation of centrosome cycle" evidence=TAS

GO:0045840 "positive regulation of mitosis" evidence=TAS

GO:0005819 "spindle" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0005876 "spindle microtubule" evidence=IDA

GO:0031616 "spindle pole centrosome" evidence=IDA

UNIPROTKB|A5GFW1 AURKA "Aurora kinase A" [Sus scrofa (taxid:9823)]

 Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
 Identities = 162/271 (59%), Positives = 205/271 (75%)

Query:     7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
             + E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQL
Sbjct:   119 KNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKTQLEKAGVEHQL 178

Query:    67 RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             RRE+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI 
Sbjct:   179 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGAVYRELQKLSKFDEQRTATYIT 238

Query:   127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAP 185
              L NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL P
Sbjct:   239 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPP 298

Query:   186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-AE----------AKH 234
             EM+E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS  E          A+ 
Sbjct:   299 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVPEGARD 358

Query:   235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             LISRLL  + S R +L++++EHPWI  N+ P
Sbjct:   359 LISRLLKHNPSHRPTLKEVLEHPWITANSKP 389

GO:0004672 "protein kinase activity" evidence=ISS

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0000922 "spindle pole" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0030030 "cell projection organization" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0005874 "microtubule" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q91820 aurka-a "Aurora kinase A-A" [Xenopus laevis (taxid:8355)]

 Score = 850 (304.3 bits), Expect = 6.2e-85, P = 6.2e-85
 Identities = 160/273 (58%), Positives = 203/273 (74%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct:   122 TSAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct:   182 EHQLRREVEIQSHLRHPNILRLYGYFHDASRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
              YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   242 MYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA----------- 230
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+R IS            
Sbjct:   302 YLPPEMIEGRMHDETVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPPYVSE 361

Query:   231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
             EA+ L+S+LL  + + RL L+ ++EHPWIIKN+
Sbjct:   362 EARDLVSKLLKHNPNHRLPLKGVLEHPWIIKNS 394

GO:0000922 "spindle pole" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005813 "centrosome" evidence=IDA

GO:0005876 "spindle microtubule" evidence=IDA

GO:0008017 "microtubule binding" evidence=IDA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IMP

GO:0019894 "kinesin binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IMP

GO:0090307 "spindle assembly involved in mitosis" evidence=IMP

UNIPROTKB|Q91819 aurka-b "Aurora kinase A-B" [Xenopus laevis (taxid:8355)]

 Score = 845 (302.5 bits), Expect = 2.1e-84, P = 2.1e-84
 Identities = 160/273 (58%), Positives = 203/273 (74%)

Query:     3 TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI 62
             T    +E+ +K++W L+DFEIGRPLGKGKFG VYL RE ESK  +ALK++FK Q+EK  +
Sbjct:   122 TLAVPKEEGKKKQWCLEDFEIGRPLGKGKFGNVYLARERESKFILALKVLFKSQLEKAGV 181

Query:    63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
             +HQLRRE+EIQS LRHPNILRLYG+FHD  R++LIL+YA  GEL+REL+K  RF +Q++A
Sbjct:   182 EHQLRREVEIQSHLRHPNILRLYGYFHDACRVYLILDYAPGGELFRELQKCTRFDDQRSA 241

Query:   123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLD 181
              YI  L  AL YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLD
Sbjct:   242 LYIKQLAEALLYCHSKKVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLD 301

Query:   182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA----------- 230
             YL PEM+E + HD  VD W+LG+LCYEFL G PPFE ++ ++T+R IS            
Sbjct:   302 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFETDTHQETYRRISKVEFQYPPYVSE 361

Query:   231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
             EAK L+S+LL  + + RL L+ ++EHPWI+KN+
Sbjct:   362 EAKDLVSKLLKHNPNHRLPLKGVLEHPWIVKNS 394

GO:0000922 "spindle pole" evidence=ISS

GO:0004672 "protein kinase activity" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0005813 "centrosome" evidence=ISS

GO:0005876 "spindle microtubule" evidence=ISS

GO:0008017 "microtubule binding" evidence=ISS

GO:0018105 "peptidyl-serine phosphorylation" evidence=ISS

GO:0019894 "kinesin binding" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

GO:0090307 "spindle assembly involved in mitosis" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P97477	AURKA_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6082	0.9446	0.6481	yes	no
Q8SRL5	IPL1_ENCCU	2, ., 7, ., 1, 1, ., 1	0.4904	0.9077	0.9044	yes	no
O01427	AIR2_CAEEL	2, ., 7, ., 1, 1, ., 1	0.5330	0.9040	0.8032	yes	no
Q54WX4	AURK_DICDI	2, ., 7, ., 1, 1, ., 1	0.5413	0.9372	0.6614	yes	no
O14965	AURKA_HUMAN	2, ., 7, ., 1, 1, ., 1	0.5897	0.9630	0.6476	yes	no
Q6C3J2	IPL1_YARLI	2, ., 7, ., 1, 1, ., 1	0.5057	0.9151	0.6684	yes	no
A5GFW1	AURKA_PIG	2, ., 7, ., 1, 1, ., 1	0.5919	0.9594	0.6467	yes	no
O59790	ARK1_SCHPO	2, ., 7, ., 1, 1, ., 1	0.5632	0.9151	0.6985	yes	no
P59241	AURKA_RAT	2, ., 7, ., 1, 1, ., 1	0.5948	0.9667	0.6599	yes	no
Q2TA06	AURKA_BOVIN	2, ., 7, ., 1, 1, ., 1	0.6059	0.9483	0.6393	yes	no
Q61XD3	AIR2_CAEBR	2, ., 7, ., 1, 1, ., 1	0.5363	0.9188	0.8245	N/A	no
O64629	AUR3_ARATH	2, ., 7, ., 1, 1, ., 1	0.7491	0.9926	0.9340	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_VI0258 hypothetical protein (283 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	271
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-99
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-85
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-85
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-84
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-77
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-72
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-68
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-66
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-66
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-66
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-66
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-64
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-63
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-62
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-58
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-56
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-55
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-54
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-53
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-53
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-52
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-52
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-52
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-52
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-52
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-51
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-51
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-50
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-50
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-49
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-49
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-48
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-47
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-47
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-47
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-47
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-47
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-46
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-46
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-46
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-45
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-45
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-45
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-44
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-44
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-44
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-44
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-44
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-43
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-43
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-43
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-43
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-42
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-42
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-42
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-42
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-42
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-41
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-41
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-40
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-40
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-40
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-39
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-39
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-39
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-39
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-39
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-38
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-38
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-37
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-37
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-37
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-37
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-37
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-37
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-37
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-36
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-36
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-36
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-36
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-35
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-35
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-34
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-34
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-34
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-34
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-34
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-34
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-34
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-33
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-33
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-33
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	8e-33
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-33
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-32
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-32
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-32
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-32
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-31
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-31
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	9e-31
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-30
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-30
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-30
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-30
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-30
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-29
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-29
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-29
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-29
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-29
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-29
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-29
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-29
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-29
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	7e-29
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-28
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-28
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-28
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-28
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-28
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-28
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-28
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-27
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-27
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-27
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-27
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	7e-27
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	8e-27
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-26
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-26
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-26
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-26
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-26
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-26
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-26
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	6e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-26
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-25
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-25
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-25
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-25
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-25
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-24
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-24
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-24
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-24
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-24
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-23
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-23
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-22
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-22
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-22
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-22
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-21
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	5e-21
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-21
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-20
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-20
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-19
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-19
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-19
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-19
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-18
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-18
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-18
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-18
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	7e-18
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-17
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-17
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-17
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-15
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-15
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-15
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-14
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-12
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-12
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-09
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	6e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	8e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  290 bits (746), Expect = 1e-99
 Identities = 101/256 (39%), Positives = 159/256 (62%), Gaps = 19/256 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +EI   LG+G FG+VYL R+ ++   VA+K+I K++I+K +   ++ RE++I   L+HPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RLY  F D+++++L++EY   G+L+  L+K  R +E +A  Y+  + +AL Y H   +
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +HRD+KPEN+LLD +G +K+ DFG +  +    K  T  GT +Y+APE++  K +  AVD
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVD 178

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISRLLVKD 243
            W+LG++ YE L G PPF  + Q                     IS EAK LI +LLVKD
Sbjct: 179 IWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKD 238

Query: 244 SSKRLSLQKIMEHPWI 259
             KRL+ ++ ++HP+ 
Sbjct: 239 PEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  254 bits (652), Expect = 3e-85
 Identities = 105/249 (42%), Positives = 152/249 (61%), Gaps = 17/249 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG+V LVR+ ++    A+K++ K++I K K       E  I S + HP I++L+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F  +E+++L+LEYA  GEL+  L K  RF+E++A  Y A +  AL Y H   +I+RD+K
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
           PEN+LLD +G +K+ DFG +       S+ +T CGT +YLAPE++  K +  AVD W+LG
Sbjct: 121 PENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLG 180

Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRL---S 249
           +L YE L G PPF AE +K+ +  I           S EA+ LIS LL KD +KRL    
Sbjct: 181 VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240

Query: 250 LQKIMEHPW 258
            ++I  HP+
Sbjct: 241 AEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  255 bits (653), Expect = 6e-85
 Identities = 111/256 (43%), Positives = 147/256 (57%), Gaps = 16/256 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFE  + LG G FGRV LVR   S    ALKI+ K +I K K    +  E  I  S+RH
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P ++ LYG F DD  ++L++EY   GEL+  LRK  RF E  A  Y A +  AL Y H  
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
            +++RD+KPENLLLD +G +KI DFG++ + + + +T+CGT +YLAPE++ +K +  AVD
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVD 180

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKR 247
            W LGIL YE L G PPF  ++    +  I           S +AK LI  LL  D +KR
Sbjct: 181 WWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR 240

Query: 248 LSLQK-----IMEHPW 258
           L   K     I  HPW
Sbjct: 241 LGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  252 bits (646), Expect = 3e-84
 Identities = 99/261 (37%), Positives = 139/261 (53%), Gaps = 23/261 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ R LG G FG VY  +   +   VA+KI+ K   EK K     RRE+ I   L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RL   F D + ++L++EY   G+L+  L +    +E +A      +   L Y H N +
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           IHRD+KPEN+LLD  G +KI DFG + +   S S   T  GT  Y+APE ++    +   
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPK 179

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKD------------------TFRSISAEAKHLISR 238
           VD W+LG++ YE L G PPF  E+  D                   + S S EAK LI +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKK 239

Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
            L KD SKR + ++I++HPW 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  234 bits (599), Expect = 7e-77
 Identities = 92/279 (32%), Positives = 142/279 (50%), Gaps = 39/279 (13%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            DF+ G+ +G+G F  V L +E E+    A+KI+ K Q+ K K    ++ E E+ + L  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP I++LY  F D+E ++ +LEYA  GEL + +RK+    E+    Y A +  AL Y H 
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----------------------QSRSKRH 174
             +IHRD+KPEN+LLD +  +KI DFG +                        ++R +  
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---- 230
           +  GT +Y++PE++  K    + D W LG + Y+ L G PPF   ++  TF+ I      
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS 240

Query: 231 -------EAKHLISRLLVKDSSKRL----SLQKIMEHPW 258
                  +AK LI +LLV D   RL       ++  HP+
Sbjct: 241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  222 bits (568), Expect = 2e-72
 Identities = 99/254 (38%), Positives = 137/254 (53%), Gaps = 22/254 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G FGRV LV+        ALK + K  I +   Q  +  E EI     HP I++LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F D + I++++EY   GEL+  LR    F E  A  YIA +  A  Y H   +I+RD+K
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGI 204
           PENLLLD  G +K+ DFG++  ++S  K  T CGT +Y+APE++ NK +D++VD W+LGI
Sbjct: 121 PENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGI 180

Query: 205 LCYEFLYGAPPF--EAESQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLS 249
           L YE L G PPF  + E   + +  I                AK LI +LL ++  +RL 
Sbjct: 181 LLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG 240

Query: 250 LQK-----IMEHPW 258
             K     I +H W
Sbjct: 241 NLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  210 bits (538), Expect = 5e-68
 Identities = 85/256 (33%), Positives = 135/256 (52%), Gaps = 20/256 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            FEI   +GKG FG VY  R   +   VA+K+I   ++E  + + ++  E++I    +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI---KLESKEKKEKIINEIQILKKCKHP 57

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHEN 138
           NI++ YG +   + +++++E+   G L   L+  ++  TE Q A     L   L Y H N
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            +IHRDIK  N+LL  +G +K+ DFG S Q      R+TM GT  ++APE++  K +DY 
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 197 VDNWTLGILCYEFLYGAPPF-EAESQKD----------TFRSI---SAEAKHLISRLLVK 242
            D W+LGI   E   G PP+ E    K             R+    S E K  + + L K
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237

Query: 243 DSSKRLSLQKIMEHPW 258
           +  KR + +++++HP+
Sbjct: 238 NPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  207 bits (529), Expect = 1e-66
 Identities = 92/260 (35%), Positives = 139/260 (53%), Gaps = 27/260 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           + KG +GRV+L ++  +    A+K+I K  + +     Q+  E +I S  + P +++LY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F   + ++L++EY   G+L   L       E  A  YIA +  AL Y H N +IHRD+K
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 147 PENLLLDHEGRLKIGDFGWS---VQSRSKR--------HTMCGTLDYLAPEMVENKEHDY 195
           P+N+L+D  G LK+ DFG S   +  R             + GT DY+APE++  + H  
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAKHLISRLLVK 242
            VD W+LG + YEFL G PPF  E+ ++ F++I             S EA  LIS+LLV 
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP 240

Query: 243 DSSKRL---SLQKIMEHPWI 259
           D  KRL   S+++I  HP+ 
Sbjct: 241 DPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  205 bits (525), Expect = 1e-66
 Identities = 87/237 (36%), Positives = 129/237 (54%), Gaps = 28/237 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG VYL R+ ++   VA+KII KE         +L RE+EI   L HPNI++LYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F D+  ++L++EY   G L   L+++  + +E +    +  +   L Y H N +IHRD+
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 146 KPENLLLDH-EGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENK-EHDYAVDNW 200
           KPEN+LLD   G++K+ DFG S    S +    T+ GT  Y+APE++  K  +    D W
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIW 178

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
           +LG++ YE                      E K LI ++L KD  KR S ++I+EH 
Sbjct: 179 SLGVILYEL--------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  208 bits (531), Expect = 4e-66
 Identities = 97/260 (37%), Positives = 143/260 (55%), Gaps = 16/260 (6%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
            W L DFE+G  LG G FGRV + +   +    A+K + K +I K K    + +E  I  
Sbjct: 14  SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM 73

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+ +   F D+ R++ +LE+   GEL+  LRK  RF    A  Y A L  A  Y
Sbjct: 74  ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +I+RD+KPENLLLD++G +K+ DFG++ +   +  T+CGT +YLAPE++++K H 
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHG 193

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
            AVD WT+G+L YEF+ G PPF  ++    +  I              A+ L+  LL  D
Sbjct: 194 KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253

Query: 244 SSKRL-----SLQKIMEHPW 258
            +KRL      +  +  HP+
Sbjct: 254 HTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  207 bits (529), Expect = 6e-66
 Identities = 96/291 (32%), Positives = 148/291 (50%), Gaps = 51/291 (17%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F+  + LGKG  GRV+LVR   +    ALK++ K+++ K     ++  E EI ++L H
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
           P +  LY  F  +  + L+++Y   GEL+R L++   +  +E+ A  Y A +  AL Y H
Sbjct: 61  PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-------------------- 176
              +++RD+KPEN+LL   G + + DF  S QS  +   +                    
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET 180

Query: 177 ------------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT 224
                        GT +Y+APE++    H  AVD WTLGIL YE LYG  PF+  ++ +T
Sbjct: 181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240

Query: 225 FRSI-------------SAEAKHLISRLLVKDSSKRLSLQK----IMEHPW 258
           F +I             S+ A+ LI +LLVKD SKRL  ++    I +HP+
Sbjct: 241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  202 bits (515), Expect = 3e-64
 Identities = 100/257 (38%), Positives = 147/257 (57%), Gaps = 18/257 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
            D E  + +G G FGRV+LVR+  S+H  ALK++   E I   + QH +  E  +   + 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH-VHNEKRVLKEVS 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP I+RL+   HD   +++++EY   GEL+  LR   RF+      Y + +  AL Y H 
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
             +++RD+KPEN+LLD EG +K+ DFG++ + R +  T+CGT +YLAPE++++K H+ AV
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAV 179

Query: 198 DNWTLGILCYEFLYGAPPFEAE----------SQKDTF-RSISAEAKHLISRLLVKDSSK 246
           D W LGIL YE L G PPF  +          + K  F R +   AK LI +LLV D ++
Sbjct: 180 DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTR 239

Query: 247 RLSLQK-----IMEHPW 258
           RL   K     +  H W
Sbjct: 240 RLGNMKNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  199 bits (508), Expect = 2e-63
 Identities = 87/261 (33%), Positives = 140/261 (53%), Gaps = 24/261 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLR 77
            +EI + +GKG FG+VYLVR         LK I    +     + +     E++I   L 
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI---DLSNMSEKEREDALNEVKILKKLN 57

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           HPNI++ Y  F +  ++ +++EYA  G+L ++++K ++    F E+Q   +   L  AL 
Sbjct: 58  HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVEN 190
           Y H   ++HRDIKP+N+ L   G +K+GDFG S     +     T+ GT  YL+PE+ +N
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN 177

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISR 238
           K ++Y  D W+LG + YE      PFE E+  +    I            S+E ++L+S 
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSS 237

Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
           LL KD  +R S+ +I++ P+I
Sbjct: 238 LLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  197 bits (502), Expect = 1e-62
 Identities = 86/258 (33%), Positives = 142/258 (55%), Gaps = 20/258 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRHP 79
           FE+ R +GKG FG+V +V++ ++K   A+K + K++ +EK  ++  +  E  I   L HP
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR-NVLNERRILQELNHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            ++ L+  F D+E ++L+++    G+L   L +  +F+E+Q   +I  +  AL Y H   
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           +IHRDIKP+N+LLD +G + I DF  +  V   +   +  GT  Y+APE++  + +  AV
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAV 180

Query: 198 DNWTLGILCYEFLYGAPPFEAESQK--DTFRSI------------SAEAKHLISRLLVKD 243
           D W+LG+  YE L G  P+   S+   D  R+             S EA   I++LL +D
Sbjct: 181 DWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD 240

Query: 244 SSKRLS--LQKIMEHPWI 259
             KRL   L+ +  HP+ 
Sbjct: 241 PQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  185 bits (472), Expect = 5e-58
 Identities = 89/262 (33%), Positives = 129/262 (49%), Gaps = 26/262 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLRH 78
           D E  + LG+G  G VY VR   +    ALK I      E    + QL RE++   S   
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF---RKQLLRELKTLRSCES 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS-LTNALAYCH- 136
           P +++ YG F+ +  I ++LEY   G L   L+K  +  E   A YIA  +   L Y H 
Sbjct: 59  PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA-YIARQILKGLDYLHT 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKEH 193
           + H+IHRDIKP NLL++ +G +KI DFG S     +  + +T  GT+ Y++PE ++ + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY 177

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEAKHLIS 237
            YA D W+LG+   E   G  PF    Q   F                   S E +  IS
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFIS 237

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
             L KD  KR S  ++++HP+I
Sbjct: 238 ACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  180 bits (458), Expect = 6e-56
 Identities = 81/261 (31%), Positives = 133/261 (50%), Gaps = 22/261 (8%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++  G  LG+G FG VYL  + ++   +A+K +      + +++  L RE+ I SSL+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE-ALEREIRILSSLQHP 59

Query: 80  NILRLYGWFHDDERIFL--ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           NI+R YG   D+E+  L   LEY   G L   L+K  +  E     Y   +   LAY H 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG-----WSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           N ++HRDIK  N+L+D +G +K+ DFG       +++     ++ GT  ++APE++  +E
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQ------KDTFRS--------ISAEAKHLISR 238
           +  A D W+LG    E   G PP+           K             +S EAK  + +
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK 239

Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
            L +D  KR +  ++++HP++
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  182 bits (463), Expect = 1e-55
 Identities = 96/288 (33%), Positives = 148/288 (51%), Gaps = 51/288 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRH 78
           DFE+ + +G+G FG V+LVR+ ++    A+K++ K   I++ +I H +R E +I +    
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADS 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I++LY  F D+E ++L++EY   G+L   L +   F E+ A  YIA L  AL   H+ 
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG-----------WSVQSRS---------------- 171
             IHRDIKP+N+L+D +G +K+ DFG               + S                
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 172 -KRHTMC----GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
            +R        GT DY+APE++    +    D W+LG++ YE LYG PPF +++ ++T+ 
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240

Query: 227 SI---------------SAEAKHLISRLLVKDSSKRL-SLQKIMEHPW 258
            I               S EA  LI RLL  D   RL S ++I  HP+
Sbjct: 241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 3e-54
 Identities = 90/255 (35%), Positives = 131/255 (51%), Gaps = 24/255 (9%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQL--RREMEIQSSLRHPNI 81
           +P+ KG FG VYL ++  +    A+K++ K + I K ++ +    R  M IQ     P +
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYV 59

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            +LY  F   + ++L++EY + G+    ++      E  A  YIA +   +   H+  +I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGII 119

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           HRDIKPENLL+D  G LK+ DFG S      +    GT DYLAPE +     D   D W+
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-FVGTPDYLAPETILGVGDDKMSDWWS 178

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDSSK 246
           LG + +EFL+G PPF AE+    F +I               S EA  LI+RLL  D +K
Sbjct: 179 LGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK 238

Query: 247 RLS---LQKIMEHPW 258
           RL     Q+I  HP+
Sbjct: 239 RLGANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  174 bits (443), Expect = 2e-53
 Identities = 100/268 (37%), Positives = 149/268 (55%), Gaps = 29/268 (10%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ R LG G +G+V+LVR+V         A+K++ K  I +K K     R E ++  +
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  D ++ LIL+Y + GEL+  L +   FTE +   YIA +  AL +
Sbjct: 61  VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVEN 190
            H+  +I+RDIK EN+LLD EG + + DFG S     +   + ++ CGT++Y+APE++  
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRSI-----------SAEAK 233
               HD AVD W+LG+L +E L GA PF    E  SQ +  R I           SAEA+
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR 240

Query: 234 HLISRLLVKDSSKRL---SLQKIMEHPW 258
             I +LL KD  KRL      +I  HP+
Sbjct: 241 DFIQKLLEKDPKKRLGANGADEIKNHPF 268

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  175 bits (444), Expect = 4e-53
 Identities = 98/270 (36%), Positives = 144/270 (53%), Gaps = 17/270 (6%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQH 64
           + +E  RK +   +DF   R LG G FGRV L   + E   PVA+K   K +I K K   
Sbjct: 17  STKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
            +  E +I + + HP  + LYG F D+  ++L+LE+   GE +  LR+++RF       Y
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLA 184
            A +     Y    ++++RD+KPENLLLD +G +K+ DFG++    ++ +T+CGT +Y+A
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIA 196

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAK 233
           PE++ N  H  A D WTLGI  YE L G PPF A      ++ I               K
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK 256

Query: 234 HLISRLLVKDSSKRL-----SLQKIMEHPW 258
           HL+ +LL  D +KR        Q + EHPW
Sbjct: 257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  172 bits (438), Expect = 2e-52
 Identities = 79/264 (29%), Positives = 137/264 (51%), Gaps = 24/264 (9%)

Query: 27  LGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           +G+G  G VY   +  +   VA+K +  ++Q ++  I      E+ I    +HPNI+  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-----EILIMKDCKHPNIVDYY 81

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRD 144
             +   + +++++EY   G L   + ++  R  E Q A     +   L Y H  +VIHRD
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRD 141

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+LL  +G +K+ DFG++ Q    +SKR+++ GT  ++APE+++ K++   VD W+
Sbjct: 142 IKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201

Query: 202 LGILCYEFLYGAPPFEAE---------SQKDTFR-----SISAEAKHLISRLLVKDSSKR 247
           LGI+C E   G PP+  E         + K           S E K  +++ LVKD  KR
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR 261

Query: 248 LSLQKIMEHPWIIKNANPRGTCDI 271
            S +++++HP++ K         +
Sbjct: 262 PSAEELLQHPFLKKACPKEEFAPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  170 bits (434), Expect = 2e-52
 Identities = 81/255 (31%), Positives = 137/255 (53%), Gaps = 16/255 (6%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++G  +G+G FG VY    +E+   VA+K I  E+I++  ++  + +E+++  +L+HP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI++  G     + +++ILEYA  G L + ++K   F E   A Y+  +   LAY HE  
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYA 196
           VIHRDIK  N+L   +G +K+ DFG + +         ++ GT  ++APE++E      A
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 197 VDNWTLGILCYEFLYGAPP-FEAESQKDTFR-----------SISAEAKHLISRLLVKDS 244
            D W+LG    E L G PP ++       FR            IS E K  + +   KD 
Sbjct: 180 SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP 239

Query: 245 SKRLSLQKIMEHPWI 259
           + R + +++++HPWI
Sbjct: 240 NLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  172 bits (438), Expect = 3e-52
 Identities = 90/242 (37%), Positives = 139/242 (57%), Gaps = 18/242 (7%)

Query: 25  RPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPN 80
           + LGKG +G+V+ VR+V         A+K++ K  I +  K     + E  I  +++HP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ L   F    +++LILEY   GEL+  L +   F E  A  Y++ ++ AL + H+  +
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           I+RD+KPEN+LLD +G +K+ DFG    S+   +  HT CGT++Y+APE++    H  AV
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAV 181

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSK 246
           D W+LG L Y+ L GAPPF AE++K T   I           + EA+ L+ +LL ++ S 
Sbjct: 182 DWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241

Query: 247 RL 248
           RL
Sbjct: 242 RL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  172 bits (437), Expect = 5e-52
 Identities = 99/252 (39%), Positives = 146/252 (57%), Gaps = 21/252 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H L     +Q++ RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y H   V++RD+
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--- 248
           G++ YE + G  PF  +  +  F           R++S EAK L++ LL KD  +RL   
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 241

Query: 249 --SLQKIMEHPW 258
               ++IMEH +
Sbjct: 242 PEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  172 bits (437), Expect = 6e-52
 Identities = 83/258 (32%), Positives = 138/258 (53%), Gaps = 19/258 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+I   +G+G +G+V+L ++ ++   VALK + K  + K      +  E +I ++ +  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +++L   F DDE ++L +EY   G+    L      +E  A  Y+A +  A+   HE  
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
            IHRD+KPEN L+D  G +K+ DFG S    +  +++ G+ DY+APE++  K +D+ VD 
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDY 181

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRSI-------------------SAEAKHLISRLL 240
           W+LG + YEFL G PPF   +  +T+ ++                   S EA  LI++L+
Sbjct: 182 WSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLI 241

Query: 241 VKDSSKRLSLQKIMEHPW 258
              S +  SL+ I  HP+
Sbjct: 242 NDPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  171 bits (435), Expect = 1e-51
 Identities = 86/251 (34%), Positives = 139/251 (55%), Gaps = 19/251 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ I K K Q  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H  ++I+RD+
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG     ++      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--- 248
           G + YE LYG PPF +    + +            +IS  A+HL+  LL KD +KRL   
Sbjct: 183 GAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242

Query: 249 -SLQKIMEHPW 258
               +I  H +
Sbjct: 243 DDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  170 bits (433), Expect = 2e-51
 Identities = 86/255 (33%), Positives = 134/255 (52%), Gaps = 24/255 (9%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNI 81
           + LGKG FG+V L     +    A+K++ K+ I   +  +     +R + +    +HP +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG--KHPFL 58

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            +L+  F   +R+F ++EY + G+L   +++  RF E +A  Y A +   L + HE  +I
Sbjct: 59  TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +RD+K +N+LLD EG +KI DFG     +       T CGT DY+APE++  + +  AVD
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVD 178

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKR 247
            W LG+L YE L G  PFE + + + F+SI           S EAK ++   L K+  KR
Sbjct: 179 WWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKR 238

Query: 248 LSL-----QKIMEHP 257
           L       Q I  HP
Sbjct: 239 LGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  166 bits (421), Expect = 8e-50
 Identities = 88/256 (34%), Positives = 152/256 (59%), Gaps = 27/256 (10%)

Query: 27  LGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSSLRHPNI 81
           LG+G FG+V+LVR++   ++    A+K++ K  +   K++ ++R +ME  I + + HP I
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL---KVRDRVRTKMERDILAEVNHPFI 60

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           ++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + H   +I
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           +RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + H  + D
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 180

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKR 247
            W+ G+L +E L G+ PF+ + +K+T   I           S EA+ L+  L  ++ + R
Sbjct: 181 WWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANR 240

Query: 248 L-----SLQKIMEHPW 258
           L      +++I  HP+
Sbjct: 241 LGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  167 bits (424), Expect = 9e-50
 Identities = 96/281 (34%), Positives = 136/281 (48%), Gaps = 44/281 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I R LG+G FG VYL R+   +  VALK++ K+   K K   +  RE++I +SL HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 80  -NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
            NI++LY +F D+  ++L++EY   G L   L+K  R    +E +A   +A + +AL Y 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 136 HENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR---------HTMCGTLDYLAP 185
           H   +IHRDIKPEN+LLD +G  +K+ DFG +                 T  GT  Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 186 EMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAES---------------------- 220
           E++          + D W+LGI  YE L G PPFE E                       
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 221 --QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                    IS  A  L+ +LL KD   RLS    + H  +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  165 bits (418), Expect = 3e-49
 Identities = 99/250 (39%), Positives = 146/250 (58%), Gaps = 21/250 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++ RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H   V++RDI
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--- 248
           G++ YE + G  PF  +  +  F           R++S EAK L++ LL KD  +RL   
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGG 241

Query: 249 --SLQKIMEH 256
               +++MEH
Sbjct: 242 PSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  164 bits (416), Expect = 6e-49
 Identities = 84/254 (33%), Positives = 139/254 (54%), Gaps = 22/254 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L     +    A+K++ K+ I +   +   +  +  +  + +HP +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+F ++EY + G+L  ++++ R+F E ++  Y A +T AL + H + VI+RD+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD EG  K+ DFG   +         T CGT DY+APE+++  E+  +VD W L
Sbjct: 123 KLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWAL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSL- 250
           G+L YE + G PPFEA+++ D F SI           S EA  ++   + K+ +KRL   
Sbjct: 183 GVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCV 242

Query: 251 ------QKIMEHPW 258
                   I +HP+
Sbjct: 243 ASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  161 bits (409), Expect = 7e-48
 Identities = 83/257 (32%), Positives = 135/257 (52%), Gaps = 29/257 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALK------IIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG+G FG+V L    ++    A+K      II ++++E    +   +R  E  +S RHP 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE---KRIFETANSERHPF 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ L+  F  ++ +  ++EYA  G+L   +     F+E +A  Y A +   L Y HEN +
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKI 122

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           ++RD+K +NLLLD EG +KI DFG   +      +  T CGT ++LAPE++    +  AV
Sbjct: 123 VYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAV 182

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSK 246
           D W LG+L YE L G  PF  + +++ F SI           S EA  ++ RLL ++  +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242

Query: 247 RL-----SLQKIMEHPW 258
           RL       + + + P+
Sbjct: 243 RLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  159 bits (404), Expect = 1e-47
 Identities = 100/273 (36%), Positives = 152/273 (55%), Gaps = 31/273 (11%)

Query: 20  DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ + LG G +G+V+LVR+V   +S    A+K++ K  I +K K     R E ++   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  D ++ LIL+Y + GEL+  L +  RF EQ+   Y   +  AL +
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVEN 190
            H+  +I+RDIK EN+LLD  G + + DFG S +       + ++ CGT++Y+AP++V  
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPF----EAESQKDTFRSI-----------SAEAK 233
            +  HD AVD W++G+L YE L GA PF    E  SQ +  R I           SA AK
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240

Query: 234 HLISRLLVKDSSKRL-----SLQKIMEHPWIIK 261
            +I RLL+KD  KRL        +I +HP+  K
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  158 bits (403), Expect = 2e-47
 Identities = 83/265 (31%), Positives = 130/265 (49%), Gaps = 28/265 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYKIQHQLRREMEIQS 74
           + F +   +GKG FG VY   +  +   VA+K+I     +++IE       +++E++  S
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIE------DIQQEIQFLS 54

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
             R P I + YG F    ++++I+EY   G    +L K  +  E   A  +  +   L Y
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGKLDETYIAFILREVLLGLEY 113

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENK 191
            HE   IHRDIK  N+LL  EG +K+ DFG S Q   + SKR+T  GT  ++APE+++  
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTF------------RSISAEAKHLISR 238
            +D   D W+LGI   E   G PP  +    +  F               S   K  +S 
Sbjct: 174 GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL 233

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNA 263
            L KD  +R S +++++H + IK A
Sbjct: 234 CLNKDPKERPSAKELLKHKF-IKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  159 bits (404), Expect = 3e-47
 Identities = 98/251 (39%), Positives = 147/251 (58%), Gaps = 22/251 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S RHP +  L 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRD 144
             F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y H E +V++RD
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121

Query: 145 IKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           +K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ ++  AVD W 
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181

Query: 202 LGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL-- 248
           LG++ YE + G  PF  +  +  F           R++S EAK L+S LL KD  +RL  
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGG 241

Query: 249 ---SLQKIMEH 256
                ++IM+H
Sbjct: 242 GPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  159 bits (404), Expect = 3e-47
 Identities = 91/255 (35%), Positives = 141/255 (55%), Gaps = 21/255 (8%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILR 83
           R LGKG FG+V L R  ES    A+K++ K+ I +         E  I S  R HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           LY  F   +R+F ++E+ + G+L   ++K RRF E +A  Y A +T+AL + H+  +I+R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLDHEG  K+ DFG     + +     T CGT DY+APE+++   +  +VD W
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLS 249
            +G+L YE L G  PFEAE++ D F +I           S +A  ++   + K+ + RL 
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG 240

Query: 250 L------QKIMEHPW 258
                  + I+ HP+
Sbjct: 241 SLTLGGEEAILRHPF 255

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  159 bits (404), Expect = 4e-47
 Identities = 97/252 (38%), Positives = 145/252 (57%), Gaps = 21/252 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V LVRE  S    A+KI+ KE I  K ++ H L  E  +  + RHP +  L 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-ESRVLKNTRHPFLTSLK 61

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   +R+  ++EY + GEL+  L + R F+E +   Y A + +AL Y H   +++RD+
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEHDYAVDNWTL 202
           K ENL+LD +G +KI DFG   +  +   TM   CGT +YLAPE++E+ ++  AVD W L
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181

Query: 203 GILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--- 248
           G++ YE + G  PF  +  +  F           R++SA+AK L+S LL+KD +KRL   
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGG 241

Query: 249 --SLQKIMEHPW 258
               ++IM H +
Sbjct: 242 PDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  157 bits (398), Expect = 2e-46
 Identities = 82/237 (34%), Positives = 138/237 (58%), Gaps = 15/237 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L R    +   A+K++ K+ I K K +  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H  ++++RD+
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG    +++      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRL 248
           G + YE LYG PPF + +  + +            +I+  A+HL+  LL KD +KRL
Sbjct: 183 GAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  157 bits (397), Expect = 3e-46
 Identities = 92/250 (36%), Positives = 143/250 (57%), Gaps = 19/250 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           +GKG FG+V  VR+ +++   ALK I K  I  + ++ H L  E  + + +  P I+ L 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++L+L + + GEL+  L++  RF   +A  Y A L  AL   H+ +VI+RD+
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119

Query: 146 KPENLLLDHEGRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD++G + + DFG    +++   K +T CGT +YLAPE++    +  AVD WTL
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSL- 250
           G+L YE L G PPF  E+  + +R I             +AK L+  LL +D ++RL   
Sbjct: 180 GVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYN 239

Query: 251 --QKIMEHPW 258
             Q+I  HP+
Sbjct: 240 GAQEIKNHPF 249

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  154 bits (392), Expect = 6e-46
 Identities = 80/263 (30%), Positives = 127/263 (48%), Gaps = 30/263 (11%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           G  +G G FG+VY    +++   +A+K I + Q    K   ++  EM++   L+HPN+++
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            YG     E++++ +EY   G L   L   R   E     Y   L   LAY H + ++HR
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---------MCGTLDYLAPEMV---ENK 191
           DIKP N+ LDH G +K+GDFG +V  + K +T         + GT  Y+APE++   + K
Sbjct: 124 DIKPANIFLDHNGVIKLGDFGCAV--KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFE------------AESQKDTF---RSISAEAKHLI 236
            H  A D W+LG +  E   G  P+                 K        +S E K  +
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFL 241

Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            R L  D  KR +  ++++HP++
Sbjct: 242 DRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  154 bits (390), Expect = 4e-45
 Identities = 92/269 (34%), Positives = 149/269 (55%), Gaps = 30/269 (11%)

Query: 20  DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           +FE+ + LG G +G+V+LVR+V   ++    A+K++ K  + +K K     R E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 76  LRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +R  P ++ L+  F  + ++ LIL+Y   GE++  L +   F+E +   Y   +  AL +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVEN 190
            H+  +++RDIK EN+LLD EG + + DFG S     + + + ++ CGT++Y+APE++  
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG 180

Query: 191 KE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRS-ISAEAKH 234
           K  H  AVD W+LGIL +E L GA PF  E +++T              F S I  EA+ 
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240

Query: 235 LISRLLVKDSSKRL-----SLQKIMEHPW 258
           L+ +LL KD  KRL        +I EHP+
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  153 bits (388), Expect = 7e-45
 Identities = 83/237 (35%), Positives = 132/237 (55%), Gaps = 15/237 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ I K K Q+ +  E  +   +L+HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++ +L+Y + GEL+  L++ R F E +A  Y A + +A+ Y H  ++I+RD+
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG     V+      T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRL 248
           G + YE LYG PPF +      + +I           +  A  L+  LL KD  +RL
Sbjct: 183 GAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  152 bits (385), Expect = 7e-45
 Identities = 87/258 (33%), Positives = 133/258 (51%), Gaps = 33/258 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRH---PNI 81
           +G+G +G VY  + V +   VALKII       +   IQ    RE+ + S LR    PNI
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ----REVALLSQLRQSQPPNI 64

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
            + YG +    R+++I+EYA  G + R L K     E+  +  I  +  AL Y H+  VI
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVI 123

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV-ENKEHDYAV 197
           HRDIK  N+L+ + G +K+ DFG +    Q+ SKR T  GT  ++APE++ E K +D   
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------SAEAKHLISRLLV 241
           D W+LGI  YE   G PP+   S  D FR++                S   +  ++  L 
Sbjct: 184 DIWSLGITIYEMATGNPPY---SDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240

Query: 242 KDSSKRLSLQKIMEHPWI 259
           ++  +RLS +++++  WI
Sbjct: 241 EEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  153 bits (387), Expect = 1e-44
 Identities = 87/255 (34%), Positives = 144/255 (56%), Gaps = 23/255 (9%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQL-RREMEIQSSLRH-PNILR 83
           +GKG FG+VY VR+ +++   A+K++ K++I  K ++ H +  R + +++ L   P I+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L   F  D  ++L+ +Y   GEL+  L+K  RF+E +A  YIA L  AL + H+  +++R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPE-MVENKEHDYAVDN 199
           D+KPEN+LLD  G + + DFG S  + +     +T CGT +YLAPE +++ K +   VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVKDSSKR 247
           W+LG+L +E   G  PF AE  +  +R+I            S E +  +  LL ++   R
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240

Query: 248 L----SLQKIMEHPW 258
           L       ++ EHP+
Sbjct: 241 LGAHRDAVELKEHPF 255

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  151 bits (384), Expect = 1e-44
 Identities = 77/286 (26%), Positives = 136/286 (47%), Gaps = 51/286 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    LG+G +G VY  R+ ++   VALK I  +  E+  I     RE+ +   L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I++L    H + +++L+ EY    +L + L K     +     + +  L   LAYCH + 
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT---MCGTLDYLAPE-MVENKEH 193
           ++HRD+KP+N+L++ +G LK+ DFG +       + +T   +  TL Y APE ++ +K +
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHY 176

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------- 224
             AVD W++G +  E + G P F  +S+ D                              
Sbjct: 177 STAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236

Query: 225 -----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                         +  E   L+S++L  + +KR+S ++ ++HP+ 
Sbjct: 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  150 bits (380), Expect = 3e-44
 Identities = 80/269 (29%), Positives = 124/269 (46%), Gaps = 33/269 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            D E    LG G  G V  V    +   +A+K I  E      IQ Q+ RE++I      
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNS 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGEL---YRELRKHRRFTEQQAATYIASLTNALAYC 135
           P I+  YG F+++  I + +EY   G L    +E++   R  E+       ++   L Y 
Sbjct: 59  PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG--RIPERILGKIAVAVLKGLTYL 116

Query: 136 HENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEH 193
           HE H +IHRD+KP N+L++  G++K+ DFG S Q   S   T  GT  Y+APE ++  ++
Sbjct: 117 HEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDY 176

Query: 194 DYAVDNWTLGILCYE-----FLYGAP------PFEAESQ----------KDTFRSISAEA 232
               D W+LG+   E     F Y          FE                 F   S + 
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKF---SPDF 233

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
           +  ++  L+KD  +R S ++++EHP+I K
Sbjct: 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  152 bits (387), Expect = 3e-44
 Identities = 94/299 (31%), Positives = 149/299 (49%), Gaps = 62/299 (20%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRH 78
           DFE  + +G+G FG V LV++ ++ H  A+K + K E +EK ++ H +R E +I +   +
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAH-VRAERDILAEADN 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++LY  F D+  ++LI+EY   G++   L K   FTE++   YIA    A+   H+ 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG---------------------------------- 164
             IHRDIKP+NLLLD +G +K+ DFG                                  
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 165 -------WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
                  W    R+  ++  GT DY+APE+     ++   D W+LG++ YE L G PPF 
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Query: 218 AESQKDTFRSI---------------SAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
           +++ ++T+R I               S EAK LI RL   ++ +RL    + +I  HP+
Sbjct: 241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  148 bits (377), Expect = 8e-44
 Identities = 86/267 (32%), Positives = 130/267 (48%), Gaps = 29/267 (10%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRH 78
           D+E+   +GKG FG V  VR       +  K I    + EK K Q  L  E+ I   L+H
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ--LVSEVNILRELKH 58

Query: 79  PNILRLYGWFHD--DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNAL 132
           PNI+R Y    D  ++ +++++EY   G+L + ++K     +   E+     +  L  AL
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 133 AYCH-----ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             CH      N V+HRD+KP N+ LD    +K+GDFG +       S   T  GT  Y++
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFRSI----SAEA 232
           PE + +  +D   D W+LG L YE    +PPF A +Q           FR I    S+E 
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL 238

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWI 259
             +I  +L  D  KR S +++++ P I
Sbjct: 239 NEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  149 bits (378), Expect = 1e-43
 Identities = 82/286 (28%), Positives = 126/286 (44%), Gaps = 49/286 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            ++I   +G+G  G V+  ++ E+   VALK +   ++E   I +Q  RE++   + +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHEN 138
            +++L   F       L++EY     L   LR   R   E Q  +Y+  L   +AY H N
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTM---CGTLDYLAPEMVENKEH- 193
            ++HRD+KP NLL+  +G LKI DFG + + S  +         T  Y APE++      
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQ-------------------------------- 221
           D  VD W +G +  E L G+P F  E+                                 
Sbjct: 179 DPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT 238

Query: 222 ---------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                    ++ F   S EA  L+  LLV D SKRLS  + + HP+
Sbjct: 239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  148 bits (376), Expect = 5e-43
 Identities = 82/261 (31%), Positives = 133/261 (50%), Gaps = 24/261 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSL 76
           DF     LGKG FG+V L     +    A+KI+ K+   Q +  +     +R + +    
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG-- 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P + +L+  F   +R++ ++EY + G+L   +++  +F E  A  Y A +   L + H
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +I+RD+K +N++LD EG +KI DFG    ++       T CGT DY+APE++  + +
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             +VD W  G+L YE L G PPF+ E + + F+SI           S EA  +   LL K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTK 238

Query: 243 DSSKRLSL-----QKIMEHPW 258
             +KRL       + I EH +
Sbjct: 239 HPAKRLGCGPTGERDIREHAF 259

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  146 bits (370), Expect = 7e-43
 Identities = 73/255 (28%), Positives = 121/255 (47%), Gaps = 20/255 (7%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK---IIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           G  LG G FG VY    ++     A+K   +    Q  +  ++ QL +E+ + S L+HPN
Sbjct: 5   GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVK-QLEQEIALLSKLQHPN 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++  G   +++ +++ LE    G L + L+K+  F E     Y   +   L Y H+ + 
Sbjct: 64  IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEMVENK-EHDYAV 197
           +HRDIK  N+L+D  G +K+ DFG + Q           G+  ++APE++  +  +  A 
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAKHLISRLLVKDS 244
           D W+LG    E   G PP+           I             S EAK  I + L +D 
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDP 243

Query: 245 SKRLSLQKIMEHPWI 259
           S R +  +++EHP++
Sbjct: 244 SLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  148 bits (374), Expect = 8e-43
 Identities = 82/248 (33%), Positives = 135/248 (54%), Gaps = 16/248 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L     +    A+K + K+ + E   ++  +     +  +  HP +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++EY + G+L   ++   RF E +A  Y A +   L + H+  +I+RD+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD +G +KI DFG    ++    K  T CGT DY+APE+++ ++++ +VD W+ 
Sbjct: 123 KLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSLQ 251
           G+L YE L G  PF  E + + F SI           S EAK  +S+L  +D +KRL + 
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVD 242

Query: 252 -KIMEHPW 258
             I +HP+
Sbjct: 243 GDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  147 bits (372), Expect = 2e-42
 Identities = 82/251 (32%), Positives = 138/251 (54%), Gaps = 19/251 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLY 85
           +GKG FG+V L +        A+K++ K+ +   K Q  +  E  +   +++HP ++ L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E+++ +L++ + GEL+  L++ R F E +A  Y A + +AL Y H  ++++RD+
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           KPEN+LLD +G + + DFG   +  ++     T CGT +YLAPE++  + +D  VD W L
Sbjct: 123 KPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCL 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSLQ 251
           G + YE LYG PPF      + + +I           S  A  ++  LL KD  +RL  +
Sbjct: 183 GAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242

Query: 252 ----KIMEHPW 258
               +I EHP+
Sbjct: 243 EDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  144 bits (366), Expect = 3e-42
 Identities = 78/264 (29%), Positives = 136/264 (51%), Gaps = 33/264 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
           + F+I   LG+G +G VY     E+   VA+K++  +E ++      ++ +E+ I     
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ------EIIKEISILKQCD 56

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYC 135
            P I++ YG +  +  +++++EY   G +  ++ K  ++  TE++ A  +      L Y 
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGLEYL 115

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKE 192
           H N  IHRDIK  N+LL+ EG+ K+ DFG S Q   + +KR+T+ GT  ++APE+++   
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------------SAEAKHL 235
           ++   D W+LGI   E   G PP+   S     R+I                 S E    
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF 232

Query: 236 ISRLLVKDSSKRLSLQKIMEHPWI 259
           + + LVKD  +R S  ++++HP+I
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  146 bits (371), Expect = 3e-42
 Identities = 78/266 (29%), Positives = 130/266 (48%), Gaps = 27/266 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF++   +G+G FG V +VRE  +    A+K++ K  +   +       E +I S    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
           P I +L   F D + ++L++EY   G+L   L ++  +F E  A  Y+A L  A+   H+
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM----CGTLDYLAPEMVE---- 189
              +HRDIKPEN+L+D  G +K+ DFG + +  + +        GT DY+APE++     
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180

Query: 190 --NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
                +    D W+LG++ YE +YG  PF   +   T+ +I               S++ 
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF 240

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPW 258
             LI  LL     +RL  + +  HP+
Sbjct: 241 LDLIQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 4e-42
 Identities = 86/277 (31%), Positives = 134/277 (48%), Gaps = 45/277 (16%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-- 77
            FE+   +G+G +G+VY  R  ++   VA+KI+   + E+ +I+ +          LR  
Sbjct: 7   IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-------ILRKY 59

Query: 78  --HPNILRLYGWF-------HDDERIFLILEYAHRG---ELYRELRKH-RRFTEQQAATY 124
             HPNI   YG F       +DD+ ++L++E    G   +L + LRK  +R  E+  A  
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLD 181
           +      LAY HEN VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY 178

Query: 182 YLAPEMVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------- 228
           ++APE++   E     +D   D W+LGI   E   G PP            I        
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238

Query: 229 ------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                 S +    IS  L+K+  +R  +++++EHP+I
Sbjct: 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  146 bits (369), Expect = 9e-42
 Identities = 84/293 (28%), Positives = 134/293 (45%), Gaps = 35/293 (11%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
            + ++          SL + E    +G G  G VY V    +    ALK+I+    +   
Sbjct: 57  SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT-- 114

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           ++ Q+ RE+EI   + HPN+++ +  F  +  I ++LE+   G L           EQ  
Sbjct: 115 VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFL 170

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--C-- 177
           A     + + +AY H  H++HRDIKP NLL++    +KI DFG    SR    TM  C  
Sbjct: 171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFG---VSRILAQTMDPCNS 227

Query: 178 --GTLDYLAPEMVENKEHD-----YAVDNWTLGILCYEFLYGAPPFEAESQKD------- 223
             GT+ Y++PE +    +      YA D W+LG+   EF  G  PF    Q D       
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA 287

Query: 224 --------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 268
                      + S E +H IS  L ++ +KR S  ++++HP+I++    +G 
Sbjct: 288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQ 340

Length = 353

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  143 bits (362), Expect = 1e-41
 Identities = 80/255 (31%), Positives = 123/255 (48%), Gaps = 18/255 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF++ + LGKG +G VY V+ +      ALK +        K +     E+ I +S+ HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV-DLGSMSQKEREDAVNEIRILASVNHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYC 135
           NI+     F D  ++ +++EYA  G+L + + K     +   EQ+       L   L   
Sbjct: 60  NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
           HE  ++HRD+K  N+LL     +KIGD G S V  ++   T  GT  Y+APE+ + + + 
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS 179

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFRSI----SAEAKHLISRLLVK 242
           Y  D W+LG L YE    APPFEA S +D         +  I    S + ++ I  +L  
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV 239

Query: 243 DSSKRLSLQKIMEHP 257
               R +  KI+  P
Sbjct: 240 KPKLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  143 bits (362), Expect = 2e-41
 Identities = 78/270 (28%), Positives = 124/270 (45%), Gaps = 34/270 (12%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-HQLRREMEIQSSLRH 78
           D+E+   +G G    VY    + +   VA+K I    +EK +    +LR+E++  S   H
Sbjct: 2   DYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCNH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALAY 134
           PN+++ Y  F   + ++L++ Y   G L  ++ K         E   AT +  +   L Y
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLL-DIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSKRHTMCGTLDYLAPE- 186
            H N  IHRDIK  N+LL  +G +KI DFG S        ++R  R T  GT  ++APE 
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPF--------------EAESQKDTFRSI---S 229
           M +   +D+  D W+ GI   E   GA P+                    +T       S
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS 237

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              + +IS  L KD SKR + +++++H + 
Sbjct: 238 KSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  141 bits (357), Expect = 1e-40
 Identities = 74/267 (27%), Positives = 134/267 (50%), Gaps = 31/267 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-----EIQSSLRHPNI 81
           +G+G  G V +  +  +   VA+K        K  ++ Q RRE+      I    +HPNI
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVK--------KMDLRKQQRRELLFNEVVIMRDYQHPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           + +Y  +   + +++++E+   G L  ++  H R  E+Q AT   ++  AL++ H   VI
Sbjct: 79  VEMYSSYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +++LL  +GR+K+ DFG+  Q      +R ++ GT  ++APE++    +   VD
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E      + I              S   +  + R+LV+D 
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257

Query: 245 SKRLSLQKIMEHPWIIKNANPRGTCDI 271
           ++R +  +++ HP++ K   P     +
Sbjct: 258 AQRATAAELLNHPFLAKAGPPSSIVPL 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  139 bits (353), Expect = 2e-40
 Identities = 85/254 (33%), Positives = 130/254 (51%), Gaps = 18/254 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E  R +G+G FG V+L R    +  V +K I  EQ+ K   +   + E ++   L HPN
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHEN 138
           I+  Y  F +D+ + +++EYA  G L   ++K       E     +   +  AL + H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 139 HVIHRDIKPENLLLD-HEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            ++HRD+K +N+LLD H+  +KIGDFG S  + S+SK +T+ GT  Y++PE+ E K ++ 
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAES--------QKDTFRSI----SAEAKHLISRLLVKD 243
             D W LG + YE       FEA +           TF  I    S + + LI  +L  D
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLD 240

Query: 244 SSKRLSLQKIMEHP 257
            SKR  L +IM  P
Sbjct: 241 PSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  139 bits (352), Expect = 3e-40
 Identities = 80/254 (31%), Positives = 131/254 (51%), Gaps = 26/254 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR----EMEIQSSLRHPN 80
           R LGKG FG   L R  E    V    ++KE +   ++  + RR    E+ I S L+HPN
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLV----VWKE-VNLTRLSEKERRDALNEIVILSLLQHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHEN 138
           I+  Y  F DD  + + +EYA+ G LY ++  +K + F E+    Y+  + +A++Y H+ 
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKEHDY 195
            ++HRDIK  N+ L   G +K+GDFG S    S+     T+ GT  Y++PE+ +  ++++
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVKD 243
             D W LG + YE L     F+A +  +    I            S+E   L+  LL +D
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240

Query: 244 SSKRLSLQKIMEHP 257
             KR +  ++++ P
Sbjct: 241 PEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 1e-39
 Identities = 81/267 (30%), Positives = 133/267 (49%), Gaps = 34/267 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +D+E+ + +G G +G VY  R++ +   VA+K+I  E  + ++I   +++E+ +    R
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI---IQQEISMLKECR 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLT-NALA 133
           HPNI+  +G +   +++++++EY   G   ++Y+  R     +E Q A Y+   T   LA
Sbjct: 59  HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIA-YVCRETLKGLA 115

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV-E 189
           Y HE   IHRDIK  N+LL  +G +K+ DFG S Q   + +KR +  GT  ++APE+   
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 190 NKEHDY--AVDNWTLGILCYEFLYGAPP-----------------FEAESQKDTFRSISA 230
            ++  Y    D W LGI   E     PP                 F     KD  +  S 
Sbjct: 176 ERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK-WSP 234

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHP 257
                I + L KD  KR +  K+++HP
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 1e-39
 Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 20/224 (8%)

Query: 25  RPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           + LG+G FG VY   L  +      VA+K + KE   + + +    +E  +   L HPN+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASE-EERKDFLKEARVMKKLGHPNV 58

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNAL 132
           +RL G   ++E ++L+LEY   G+L   LRK R           + +   ++   +   +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD-----YLAPEM 187
            Y      +HRD+   N L+  +  +KI DFG S       +    T       ++APE 
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPES 178

Query: 188 VENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISA 230
           +++       D W+ G+L +E F  GA P+   S ++    +  
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  139 bits (351), Expect = 2e-39
 Identities = 75/248 (30%), Positives = 136/248 (54%), Gaps = 16/248 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V+L     +    A+K + K+ +     ++  +  +  +  +  HP +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H   +++RD+
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N+LLD +G +KI DFG    ++   +K  T CGT DY+APE++  ++++ +VD W+ 
Sbjct: 123 KLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSLQ 251
           G+L YE L G  PF    +++ F+SI           + EAK ++ +L V++  +RL ++
Sbjct: 183 GVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVK 242

Query: 252 -KIMEHPW 258
             I +HP+
Sbjct: 243 GDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  136 bits (344), Expect = 4e-39
 Identities = 78/256 (30%), Positives = 123/256 (48%), Gaps = 20/256 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFEI   +GKG FG V+ V     K   A+K I   ++ + + + +   E  + + L   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSS 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHE 137
            I+R Y  F D  ++ +++EYA  G+L++ L+    R   E Q   +   +   LA+ H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEH 193
             ++HRDIK  NL LD    +KIGD G     S  +     T+ GT  YL+PE+ E+K +
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN-TIVGTPYYLSPELCEDKPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLV 241
           +   D W LG++ YE   G  PF+A +Q      I            S +   LI + L 
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLT 238

Query: 242 KDSSKRLSLQKIMEHP 257
           KD  +R    +++ +P
Sbjct: 239 KDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  137 bits (346), Expect = 5e-39
 Identities = 85/270 (31%), Positives = 126/270 (46%), Gaps = 37/270 (13%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           E+ R LG+G  G V   R   +    ALK I  +      +Q Q+ RE+EI  S + P I
Sbjct: 5   ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTD--PNPDLQKQILRELEINKSCKSPYI 61

Query: 82  LRLYGWFHDDE--RIFLILEYAHRGEL---YRELRKHRRFTEQQAATYIA-SLTNALAYC 135
           ++ YG F D+    I + +EY   G L   Y++++K      ++    IA S+   L+Y 
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKE 192
           H   +IHRDIKP N+LL  +G++K+ DFG S   V S +   T  GT  Y+APE ++ K 
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTGTSFYMAPERIQGKP 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQK-----------------------DTFRSIS 229
           +    D W+LG+   E      PF  E +                              S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            E K  I + L KD ++R +   ++EHPWI
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  135 bits (341), Expect = 2e-38
 Identities = 73/261 (27%), Positives = 124/261 (47%), Gaps = 24/261 (9%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F+I + +GKG+F  VY    +     VALK +   ++   K +    +E+++   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           HPN+++    F ++  + ++LE A  G+L R + KH     R   E+    Y   L +AL
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
            + H   ++HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE + 
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTFRSI-------------SAEAKH 234
              +++  D W+LG L YE      PF  +        + I             S E + 
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239

Query: 235 LISRLLVKDSSKRLSLQKIME 255
           L+SR +  D  KR  +  +++
Sbjct: 240 LVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  136 bits (344), Expect = 2e-38
 Identities = 81/246 (32%), Positives = 130/246 (52%), Gaps = 19/246 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSL 76
           DF     LGKG FG+V L     +    A+KI+ K+   Q +  +     +R + +Q   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD-- 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P + +L+  F   +R++ ++EY + G+L   +++  +F E QA  Y A ++  L + H
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEH 193
              +I+RD+K +N++LD EG +KI DFG   +         T CGT DY+APE++  + +
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             +VD W  G+L YE L G PPF+ E + + F+SI           S EA  +   L+ K
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK 238

Query: 243 DSSKRL 248
             SKRL
Sbjct: 239 HPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 1e-37
 Identities = 80/265 (30%), Positives = 133/265 (50%), Gaps = 32/265 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A KII    +E++E + +      E++I S  +
Sbjct: 7   WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV------EIDILSECK 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCH 136
           HPNI+ LY  +  + ++++++E+   G L   + +  R  TE Q       +  AL + H
Sbjct: 61  HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMV----- 188
            + VIHRD+K  N+LL  +G +K+ DFG S +++S   KR T  GT  ++APE+V     
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTF---RSISAEAKH 234
           ++  +DY  D W+LGI   E     PP              +S+  T       S+    
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND 240

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
            +   LVKD   R +  ++++HP++
Sbjct: 241 FLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  133 bits (337), Expect = 2e-37
 Identities = 79/244 (32%), Positives = 128/244 (52%), Gaps = 15/244 (6%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQLRREMEIQSSLRH 78
           DF     LGKG FG+V L     +    A+KI+ K+  I+   ++  +  +  +  S + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P + +L+  F   +R++ ++EY + G+L  ++++  RF E  A  Y A +   L + H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +I+RD+K +N++LD EG +KI DFG    ++       T CGT DY+APE++  + +  
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDS 244
           +VD W  G+L YE L G  PFE E + + F+SI           S EA  +   L+ K  
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240

Query: 245 SKRL 248
            KRL
Sbjct: 241 GKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  133 bits (335), Expect = 3e-37
 Identities = 74/257 (28%), Positives = 135/257 (52%), Gaps = 21/257 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V + RE  S   VA+K++    + K + +  L  E+ I    +H N++ +Y 
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   E +++++E+   G L  ++    R  E+Q AT   S+  AL Y H   VIHRDIK
Sbjct: 86  SYLVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    +   VD W+LG
Sbjct: 145 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG 204

Query: 204 ILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+ ++S              +      IS   +  + R+L ++  +R +
Sbjct: 205 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT 264

Query: 250 LQKIMEHPWIIKNANPR 266
            Q++++HP++++   P 
Sbjct: 265 AQELLDHPFLLQTGLPE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 3e-37
 Identities = 74/262 (28%), Positives = 132/262 (50%), Gaps = 31/262 (11%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNI 81
           G+ LG+G FGRVYL  +V++   +A+K +  +       +    L  E+++  +L+H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           ++ YG   DDE + + +EY   G +  +L+ +   TE     Y   +   + Y H N ++
Sbjct: 67  VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HTMC----------GTLDYLAPEMVEN 190
           HRDIK  N+L D  G +K+GDFG      SKR  T+C          GT  +++PE++  
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFG-----ASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFR------------SISAEAKHLIS 237
           + +    D W++G    E L   PP+ E E+    F+             +S +A++ + 
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR 241

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
           R  V+++ KR S ++++ H ++
Sbjct: 242 RTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  133 bits (336), Expect = 4e-37
 Identities = 75/264 (28%), Positives = 139/264 (52%), Gaps = 30/264 (11%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LV   +++   A+K+I KE +   +    ++ E  + +++  HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F  + R+F ++E+   G+L   +++ R+  E+ A  Y A ++ AL + HE  +I+R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++  +++ ++VD W
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEA--------------------ESQKDTFRSISAEAKHLISRLL 240
            LG+L +E + G  PF+                     E Q    RS+S +A  ++   L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL 240

Query: 241 VKDSSKRL------SLQKIMEHPW 258
            KD  +RL        + I  HP+
Sbjct: 241 NKDPKERLGCHPQTGFRDIKSHPF 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 4e-37
 Identities = 81/292 (27%), Positives = 127/292 (43%), Gaps = 58/292 (19%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    +G+G +G+VY  R  ++   VALK I  E  EK        RE+++   LRHPN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPN 59

Query: 81  ILRLYGWFHDDER--IFLILEYA-H--RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           I+RL        +  I+++ EY  H   G L     K   FTE Q   Y+  L   L Y 
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK---FTESQIKCYMKQLLEGLQYL 116

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG---WSVQSRSKRHT--MCGTLDYLAPE-MVE 189
           H N ++HRDIK  N+L++++G LK+ DFG      +  S  +T  +  TL Y  PE ++ 
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---------------------------- 221
              +   VD W++G +  E   G P F+  ++                            
Sbjct: 176 ATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF 235

Query: 222 -------------KDTFRS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                        ++ F+  I   A  L+ +LL  D  KR+S  + ++H + 
Sbjct: 236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  133 bits (337), Expect = 8e-37
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 67/303 (22%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRHP 79
           F   + +G G FG V LVR+V++    A+K + K + + + +  H ++ E +I +   + 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAH-VKAERDILAEADNE 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +++LY  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+  
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFG------W---------------------------- 165
            IHRDIKP+N+L+D +G +K+ DFG      W                            
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 166 -----SVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA 213
                 ++ R KR       H++ GT +Y+APE++    +    D W++G++ YE L G 
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Query: 214 PPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDSSKRL---SLQKIME 255
           PPF A++  +T   +               S EA  LI R L   +  RL      +I  
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 256 HPW 258
           HP+
Sbjct: 301 HPF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  131 bits (331), Expect = 2e-36
 Identities = 74/248 (29%), Positives = 134/248 (54%), Gaps = 24/248 (9%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LVR  +++   A+K++ KE +   +    ++ E  + + +  HP ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y HE  +I+R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  +++ ++VD W
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEA--------------------ESQKDTFRSISAEAKHLISRLL 240
            LG+L +E + G  PF+                     E Q    RS+S +A  ++   L
Sbjct: 181 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL 240

Query: 241 VKDSSKRL 248
            KD  +RL
Sbjct: 241 NKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  129 bits (326), Expect = 4e-36
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 37/270 (13%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ----------LRREMEIQ 73
           G  +GKG +GRVYL   V +   +A+K +   ++                  LR E+E  
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQV---ELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L H NI++  G+   +E + + LEY   G +   LR + RF EQ    +   +   LA
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMV 188
           Y H   ++HRD+K +NLL+D +G  KI DFG S +S       +  +M G++ ++APE++
Sbjct: 123 YLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPP----------FEAESQK-------DTFRSIS 229
            +    Y+  VD W+LG +  E   G  P          F+  +++       D   ++S
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
             A   ++     +   R + +++++HP+I
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  130 bits (328), Expect = 5e-36
 Identities = 73/248 (29%), Positives = 131/248 (52%), Gaps = 16/248 (6%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG+V L          A+K + K+ +     ++  +  +  +  +  +P +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
             F   E +F ++E+ + G+L   ++   RF   +A  Y A +   L + H   +I+RD+
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 146 KPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           K +N++LD +G +KI DFG    +V   ++  T CGT DY+APE+++  ++ ++VD W+ 
Sbjct: 123 KLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSF 182

Query: 203 GILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISRLLVKDSSKRLSLQ 251
           G+L YE L G  PF  + + + F S           I+ E+K ++ +L  +D ++RL + 
Sbjct: 183 GVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVV 242

Query: 252 -KIMEHPW 258
             I  HP+
Sbjct: 243 GNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  129 bits (326), Expect = 8e-36
 Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 49/285 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRH 78
           +E G+ LG+G +  VY  R+ E+   VA+K I   + ++ K  I     RE+++   L+H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHE 137
           PNI+ L   F     I L+ E+    +L + ++ K    T     +Y+      L Y H 
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
           N ++HRD+KP NLL+  +G LK+ DFG +        K      T  Y APE++    H 
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARH- 179

Query: 195 Y--AVDNWTLGILCYEFLYGAP-------------------------------------- 214
           Y   VD W++G +  E L   P                                      
Sbjct: 180 YGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239

Query: 215 -PFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            PF     K  F + S +A  L+ RLL  + +KR++ ++ +EHP+
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  129 bits (326), Expect = 1e-35
 Identities = 72/249 (28%), Positives = 132/249 (53%), Gaps = 22/249 (8%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILR 83
           R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +  +P ++ 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  F    R+FL++EY + G+L   +++ R+  E+ A  Y A +  AL + HE  +I+R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 144 DIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K +N+LLD +G +K+ D+G     +       T CGT +Y+APE++  +E+ ++VD W
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWW 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTF------------------RSISAEAKHLISRLLVK 242
            LG+L +E + G  PF+  +                       R +S +A H++   L K
Sbjct: 181 ALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK 240

Query: 243 DSSKRLSLQ 251
           D  +RL  Q
Sbjct: 241 DPKERLGCQ 249

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  127 bits (322), Expect = 1e-35
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 13/213 (6%)

Query: 22  EIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +G+ LG+G FG VY      +    +  VA+K + KE   + +I+ +  RE  I   L 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIE-EFLREARIMRKLD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYC 135
           HPNI++L G   ++E + +++EY   G+L   LRK+R    +     ++   +   + Y 
Sbjct: 60  HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD----YLAPEMVENK 191
              + IHRD+   N L+     +KI DFG S       +           ++APE ++  
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKD 223
           +     D W+ G+L +E F  G  P+   S  +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE 212

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  129 bits (325), Expect = 3e-35
 Identities = 88/296 (29%), Positives = 142/296 (47%), Gaps = 59/296 (19%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLRH 78
           DFE  + +G+G FG V LV++ ++ H  A+KI+ K + +EK ++ H +R E +I      
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAH-IRAERDILVEADG 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             +++++  F D   ++LI+E+   G++   L K    +E+    YIA    A+   H+ 
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG---------------------------------- 164
             IHRDIKP+NLLLD +G +K+ DFG                                  
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180

Query: 165 ----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
               W    R   ++  GT DY+APE+     ++   D W+LG++ YE L G PPF +E+
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240

Query: 221 QKDTFRS---------------ISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
            ++T+R                IS +AK LI R    DS  R+    +++I  HP+
Sbjct: 241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  129 bits (326), Expect = 3e-35
 Identities = 87/276 (31%), Positives = 136/276 (49%), Gaps = 28/276 (10%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E   K     +DF++ + +G+G FG V LVR   SK   A+K++ K ++ K         
Sbjct: 33  EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E +I +      I++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEV 151

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLA 184
             AL   H    IHRD+KP+N+LLD  G LK+ DFG  ++  +     C    GT DY++
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYIS 211

Query: 185 PEMVENKEHD--YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------- 226
           PE+++++  D  Y    D W++G+  YE L G  PF A+S   T+               
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDD 271

Query: 227 -SISAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
             IS +AK LI   L  D   RL    + +I  HP+
Sbjct: 272 IEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (317), Expect = 6e-35
 Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 12/212 (5%)

Query: 22  EIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +G+ LG+G FG VY      +  + K  VA+K + ++  E+   +    RE  I   L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE--FLREARIMRKLD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           HPN+++L G   ++E +++++EY   G+L   LRK+R + +     ++   +   + Y  
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD----YLAPEMVENKE 192
             + IHRD+   N L+     +KI DFG S       +           ++APE ++  +
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKD 223
                D W+ G+L +E F  G  P+   S ++
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 211

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  126 bits (318), Expect = 1e-34
 Identities = 77/276 (27%), Positives = 131/276 (47%), Gaps = 35/276 (12%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE  + +  G +G VYLVR  E++   A+K I K+ +       Q+  E +I +   +P
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENP 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            ++ ++  F     + +++EY   G+    L+         A  Y A    AL Y H   
Sbjct: 62  FVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG 121

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------------------MCGTLD 181
           ++HRD+KP+NLL+   G +K+ DFG S        T                  +CGT +
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RS 227
           Y+APE++  + +   VD W +GI+ YEFL G  PF  ++ ++ F               +
Sbjct: 182 YIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241

Query: 228 ISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWII 260
           + A+A+ LISRLL ++  +RL      ++ +H + +
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 2e-34
 Identities = 88/272 (32%), Positives = 136/272 (50%), Gaps = 36/272 (13%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  Y+A +  A+   H+
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------WSVQSRSKRHTMCGTLDYLAPEM-- 187
              +HRDIKP+N+LLD  G +++ DFG         +VQS    +   GT DY++PE+  
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS----NVAVGTPDYISPEILQ 176

Query: 188 -VENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
            +E+ +  Y    D W+LG+  YE LYG  PF AES  +T+  I                
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDV 236

Query: 229 SAEAKHLISRLLVKDSSK--RLSLQKIMEHPW 258
           S EAK LI RL+    ++  R  LQ   +HP+
Sbjct: 237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 3e-34
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 48/285 (16%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++    +G+G +G VY  R+  +   VA+K I K + E   I     RE+++   L HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I++L   F     ++L+ E+    +LY+ ++  +R   E    +Y+  L   LA+CH + 
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC---GTLDYLAPE-MVENKEHDY 195
           ++HRD+KPENLL++ EG LK+ DFG +    S          T  Y APE ++ +K +  
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDT------------------------------- 224
            VD W++G +  E L   P F  +S+ D                                
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 225 ----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                     F + S +A  L+S++L  D  KR++ ++ + HP+ 
Sbjct: 239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 4e-34
 Identities = 81/283 (28%), Positives = 135/283 (47%), Gaps = 58/283 (20%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  R+  +   VALK I  E  E   +     RE+ +   L HPNI+RL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHV 140
             H + +++L+ E+     L  +L+K+               +Y+  L   +AYCH + V
Sbjct: 66  VVHSENKLYLVFEF-----LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDY 195
           +HRD+KP+NLL+D EG LK+ DFG    + V  R+  H +  TL Y APE ++ ++++  
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQ----------------------------KDTF-- 225
            VD W++G +  E +   P F  +S+                            K TF  
Sbjct: 180 PVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239

Query: 226 ----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                      ++  +   L+S++LV D +KR+S +  ++HP+
Sbjct: 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  123 bits (311), Expect = 5e-34
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)

Query: 21  FEIGRPLGKGKFGRVYL--VREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            E+G+ LG+G FG VY   ++         VA+K + KE   + + + +   E  I   L
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASE-EEREEFLEEASIMKKL 58

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
            HPNI+RL G     E ++++ EY   G+L   LRKH    T +        +   + Y 
Sbjct: 59  SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD---YLAPEMVEN 190
              + +HRD+   N L+     +KI DFG S  +          G      ++APE +++
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178

Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
            +     D W+ G+L +E F  G  P+   S ++    +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL 217

Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  124 bits (312), Expect = 6e-34
 Identities = 74/256 (28%), Positives = 131/256 (51%), Gaps = 21/256 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R ++ GT  ++APE++    +   VD W+LG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203

Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263

Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 264 AAELLKHPFLAKAGPP 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  123 bits (311), Expect = 8e-34
 Identities = 81/261 (31%), Positives = 130/261 (49%), Gaps = 32/261 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA+K        +  +Q Q ++E+ I   L     +HPNI
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+                     +SA  +  ++R L  D 
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 257

Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++HP+ +K A P
Sbjct: 258 EKRGSAKELLQHPF-LKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  125 bits (315), Expect = 9e-34
 Identities = 81/272 (29%), Positives = 138/272 (50%), Gaps = 26/272 (9%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           RK +   +D+++ + +G+G FG V LVR   S+   A+K++ K ++ K         E +
Sbjct: 36  RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +  A
Sbjct: 96  IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFYTAEVVLA 154

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEM 187
           L   H   +IHRD+KP+N+LLD  G LK+ DFG  ++        C    GT DY++PE+
Sbjct: 155 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214

Query: 188 VENKEHD----YAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SI 228
           ++++  D       D W++G+  +E L G  PF A+S   T+                 I
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI 274

Query: 229 SAEAKHLISRLLVKDSSK--RLSLQKIMEHPW 258
           S  AK+LI   L     +  R  +++I +HP+
Sbjct: 275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  122 bits (308), Expect = 1e-33
 Identities = 72/250 (28%), Positives = 131/250 (52%), Gaps = 18/250 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG+  LV+  E      +K I   ++   K + + R+E+ + S+++HPNI++   
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F ++  ++++++Y   G+LY+++   R   F E Q   +   +  AL + H+  ++HRD
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+ L  +G +K+GDFG +    S      T  GT  YL+PE+ EN+ ++   D W 
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWA 186

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVKDSSKRLS 249
           LG + YE       FEA + K+    I            S + ++L+S+L  ++   R S
Sbjct: 187 LGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPS 246

Query: 250 LQKIMEHPWI 259
           +  I+E  +I
Sbjct: 247 VNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  122 bits (308), Expect = 2e-33
 Identities = 75/255 (29%), Positives = 120/255 (47%), Gaps = 24/255 (9%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   +   +    A K + K++++K K +     E +I   +    I+ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F   + + L++   + G+L   +       F E +A  Y A +   L + H+  +++RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           +KPEN+LLD  G ++I D G +V+     K     GT  Y+APE+++ + +D++VD + L
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFAL 180

Query: 203 GILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDSSKR 247
           G   YE + G  PF    +K     +               S EAK L   LL KD  KR
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR 240

Query: 248 L-----SLQKIMEHP 257
           L     S  ++ EHP
Sbjct: 241 LGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  121 bits (305), Expect = 3e-33
 Identities = 74/258 (28%), Positives = 137/258 (53%), Gaps = 21/258 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI + +G+G FG++YL + + +S+H V  +I   +   K K   +  +E+ + + ++HP
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMKHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHE 137
           NI+  +  F ++ R+F+++EY   G+L + + + R   F+E Q  ++   ++  L + H+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 138 NHVIHRDIKPENLLLDHEGRL-KIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
             ++HRDIK +N+ L   G + K+GDFG + Q   S    +T  GT  YL+PE+ +N+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY 179

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLV 241
           +   D W+LG + YE      PFE  +       I            S + + LIS+L  
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK 239

Query: 242 KDSSKRLSLQKIMEHPWI 259
                R S+  I++ P++
Sbjct: 240 VSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 4e-33
 Identities = 85/309 (27%), Positives = 139/309 (44%), Gaps = 71/309 (22%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLR 77
           +DF   + +GKG FG V LV++ ++    A+K + K E  +K ++ H ++ E ++ +   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
            P ++ LY  F D + ++LI+E+   G+L   L K+  F+E     Y+A    A+   H+
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------------------------------- 164
              IHRDIKP+N+L+D  G +K+ DFG                                 
Sbjct: 120 LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSV 179

Query: 165 -----------------WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCY 207
                            W    R   ++  GT DY+APE+   + +    D W+LG + +
Sbjct: 180 AVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239

Query: 208 EFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDSSKRL---S 249
           E L G PPF +E+  +T+R I               S EA+ LI RL+  ++  RL    
Sbjct: 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298

Query: 250 LQKIMEHPW 258
             +I  HP+
Sbjct: 299 AHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  121 bits (304), Expect = 7e-33
 Identities = 77/256 (30%), Positives = 134/256 (52%), Gaps = 22/256 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +  E  +   VA+K   K  + K + +  L  E+ I     H N++ +Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q AT   S+  AL+Y H   VIHRDIK
Sbjct: 87  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 147 PENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    +   VD W+LG
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG 205

Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      R I              S+  +  +  +LV++ S+R +
Sbjct: 206 IMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT 265

Query: 250 LQKIMEHPWIIKNANP 265
            Q++++HP+ +K A P
Sbjct: 266 AQELLQHPF-LKLAGP 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  122 bits (308), Expect = 8e-33
 Identities = 75/249 (30%), Positives = 125/249 (50%), Gaps = 40/249 (16%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK-EQIEKYKIQHQLRREMEIQSSLR 77
           +DFE  + +G+G FG V LV++ ++ H  A+KI+ K + +EK ++ H +R E +I     
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGH-IRAERDILVEAD 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
              +++++  F D   ++LI+E+   G++   L K    TE++   YIA    A+   H+
Sbjct: 60  SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--------------------------------- 164
              IHRDIKP+NLLLD +G +K+ DFG                                 
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 165 -----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
                W    R    +  GT DY+APE+     ++   D W+LG++ YE L G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 220 SQKDTFRSI 228
           + ++T++ +
Sbjct: 240 TPQETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  122 bits (306), Expect = 8e-33
 Identities = 80/268 (29%), Positives = 135/268 (50%), Gaps = 28/268 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  Y+A +  A+   H+
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVENKE- 192
            H +HRDIKP+N+L+D  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 193 ----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------SAEA 232
               +    D W+LG+  YE LYG  PF AES  +T+  I                S +A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 233 KHLISRLLVKDSSK--RLSLQKIMEHPW 258
           K LI RL+     +  +  ++   +HP+
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPF 268

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  120 bits (302), Expect = 2e-32
 Identities = 87/276 (31%), Positives = 137/276 (49%), Gaps = 46/276 (16%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIE-KYKIQHQLRREMEIQS 74
           +EI   +GKG +G+VY V   +     A+KI+       E+IE +Y I         +QS
Sbjct: 24  WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI---------LQS 74

Query: 75  SLRHPNILRLYGWFHDDER-----IFLILEYAHRG---ELYREL-RKHRRFTEQQAATYI 125
              HPN+++ YG F+  ++     ++L+LE  + G   EL + L    +R  E   +  +
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDY 182
                 L + H N +IHRD+K  N+LL  EG +K+ DFG S Q   +R +R+T  GT  +
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFW 194

Query: 183 LAPEMVE-NKEHDYAVDN----WTLGILCYEFLYGAPP-FEAESQKDTFR---------- 226
           +APE++   +++DY+ D     W+LGI   E   G PP F+    K  F+          
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL 254

Query: 227 ---SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                     H IS+ L+KD   R S+  ++EHP+I
Sbjct: 255 HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  120 bits (302), Expect = 2e-32
 Identities = 79/256 (30%), Positives = 129/256 (50%), Gaps = 22/256 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V+   +V +   VA+K I    ++K   +  +  E+ +   L++PNI+    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            F   + +F+++EY   G L  ++       E Q A        AL + H N VIHRDIK
Sbjct: 84  SFLVGDELFVVMEYLAGGSL-TDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD W+LG
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 204 ILCYEFLYGAPPFEAESQKDTFRSISAEA--------------KHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E+       I+                 +  ++R L  D  KR S
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS 262

Query: 250 LQKIMEHPWIIKNANP 265
            +++++HP+ +K A P
Sbjct: 263 AKELLQHPF-LKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  121 bits (304), Expect = 2e-32
 Identities = 81/248 (32%), Positives = 124/248 (50%), Gaps = 26/248 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E  +  +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   R  E  A  YIA +  A+   H+
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------SAEA 232
                    D W+LG+  YE LYG  PF AES  +T+  I                S EA
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA 240

Query: 233 KHLISRLL 240
           K LI RL+
Sbjct: 241 KDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  122 bits (306), Expect = 2e-32
 Identities = 80/265 (30%), Positives = 133/265 (50%), Gaps = 26/265 (9%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 43  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 195 ----YAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHL 235
                  D W++G+  YE L G  PF A+S   T+                 IS EAK+L
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281

Query: 236 ISRLLVKDSSK--RLSLQKIMEHPW 258
           I   L     +  R  +++I  H +
Sbjct: 282 ICAFLTDREVRLGRNGVEEIKRHLF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  117 bits (295), Expect = 6e-31
 Identities = 65/297 (21%), Positives = 118/297 (39%), Gaps = 66/297 (22%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---R--REMEIQSS 75
           +E+ +P+G G +G V    +  +   VA+K I             +   R  RE+++   
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV------FDDLIDAKRILREIKLLRH 55

Query: 76  LRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           LRH NI+ L              ++++ E     +L++ ++  +  T+     ++  +  
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILR 114

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLA 184
            L Y H  +VIHRD+KP N+L++    LKI DFG +        ++  +     T  Y A
Sbjct: 115 GLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRA 174

Query: 185 PE-MVENKEHDYAVDNWTLG-ILC-------------Y---------------------- 207
           PE ++ +  +  A+D W++G I               Y                      
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234

Query: 208 ------EFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                  +L   P    +     F   S EA  L+ ++LV D  KR++  + + HP+
Sbjct: 235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 8e-31
 Identities = 71/211 (33%), Positives = 107/211 (50%), Gaps = 8/211 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             +E+   +G+G +G V   R   +   VA+K  FKE  +   ++    RE+++   LRH
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRH 59

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA-TYIASLTNALAYCHE 137
            NI+ L   F    R++L+ EY  R  L   L          A  +YI  L  A+AYCH 
Sbjct: 60  ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRH--TMCGTLDYLAPE-MVENKE 192
           +++IHRDIKPEN+L+   G LK+ DFG+  ++++R          T  Y APE +V +  
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           +   VD W +G +  E L G P F  +S  D
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  115 bits (290), Expect = 9e-31
 Identities = 78/261 (29%), Positives = 131/261 (50%), Gaps = 32/261 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   ++ +   VA+K        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVI 137

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 197

Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDV 257

Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            +R S +++++HP+ +K A P
Sbjct: 258 DRRGSAKELLQHPF-LKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  115 bits (289), Expect = 9e-31
 Identities = 65/216 (30%), Positives = 113/216 (52%), Gaps = 11/216 (5%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ---IEKYKIQHQLRREMEIQSSLRHPN 80
           G+ LG G F   Y  R+V++   +A+K +   +    E+ ++   LR+E+ + + L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R+ G   +D    L +E+   G +   L K+  F E     Y   L   L+Y HEN +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 141 IHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSK-------RHTMCGTLDYLAPEMVENKE 192
           IHRD+K  NLL+D  G+ L+I DFG + +  +K       +  + GT+ ++APE++  ++
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           +  + D W++G +  E     PP+ AE   +    I
Sbjct: 185 YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  114 bits (288), Expect = 9e-31
 Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 27/263 (10%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK------IIFKEQIEKYKIQHQLRREMEIQSSLR 77
           G  +G G FG VYL     S   +A+K      +    +  K  +   L RE+ +   L+
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI++  G   D + + + LEY   G +   L  +  F E     ++  +   L Y H 
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMV 188
             +IHRDIK  N+L+D++G +KI DFG S          ++   R ++ G++ ++APE+V
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTFR-----------SISAEAKHLI 236
           +   +    D W+LG L  E L G  PF   +Q +  F+           +IS+EA   +
Sbjct: 185 KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFL 244

Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            +    D +KR +  ++++HP++
Sbjct: 245 EKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  115 bits (288), Expect = 2e-30
 Identities = 81/270 (30%), Positives = 136/270 (50%), Gaps = 32/270 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E++I +S  
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV------EIDILASCD 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L   F+ +  +++++E+   G +    L   R  TE Q          AL Y H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMV----- 188
           EN +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++APE+V     
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTF---RSISAEAKH 234
           +++ +DY  D W+LGI   E     PP             A+S+  T       S+E K 
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
            + + L K+   R +  ++++HP++  N+N
Sbjct: 241 FLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  113 bits (284), Expect = 5e-30
 Identities = 83/262 (31%), Positives = 124/262 (47%), Gaps = 38/262 (14%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSSLRHPNILRLY 85
           LGKG +G VY  R++ ++    ++I  KE  E+     Q L  E+ + S L+H NI++  
Sbjct: 16  LGKGTYGIVYAARDLSTQ----VRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 86  GWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIH 142
           G   ++    + +E    G L   LR      +  EQ    Y   +   L Y H+N ++H
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 143 RDIKPENLLLD-HEGRLKIGDFGWSVQSRSKR--------HTMCGTLDYLAPEMVENKEH 193
           RDIK +N+L++ + G +KI DFG      SKR         T  GTL Y+APE+++    
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFG-----TSKRLAGINPCTETFTGTLQYMAPEVIDKGPR 186

Query: 194 DY--AVDNWTLGILCYEFLYGAPPFE--AESQKDTFR------------SISAEAKHLIS 237
            Y    D W+LG    E   G PPF    E Q   F+            S+SAEAK+ I 
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFIL 246

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
           R    D  KR S   +++ P++
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  113 bits (283), Expect = 5e-30
 Identities = 69/252 (27%), Positives = 123/252 (48%), Gaps = 19/252 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + + R +G+G FGR  LV+ V S    A+K I +       ++   R+E  + + ++HP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEI-RLPKSSSAVEDS-RKEAVLLAKMKHP 58

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCHE 137
           NI+     F  D  +++++EY   G+L ++++  + + F E     +   +   + + HE
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHD 194
             V+HRDIK +N+ L   G++K+GDFG +       +   T  GT  Y+ PE+ EN  ++
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN 178

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVK 242
              D W+LG + YE      PF+A S K+    +            S E + LI ++  +
Sbjct: 179 NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR 238

Query: 243 DSSKRLSLQKIM 254
           +   R S   I+
Sbjct: 239 NPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 6e-30
 Identities = 81/288 (28%), Positives = 130/288 (45%), Gaps = 56/288 (19%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +++ + LG G FG VYL R  E+   VA+K + K    K+    +     E++S  +   
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYR--ELRKHRRFTEQQAATYIASLTNALAYC 135
           HPNI++L   F +++ ++ + EY   G LY+  + RK + F+E    + I  +   LA+ 
Sbjct: 57  HPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HT-MCGTLDYLAPEMV-ENKE 192
           H++   HRD+KPENLL+     +KI DFG + + RS+  +T    T  Y APE++  +  
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 193 HDYAVDNWTLGILCYEFLY-------GA-------------------------------- 213
           +   VD W LG +  E LY       G+                                
Sbjct: 176 YSSPVDIWALGCIMAE-LYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234

Query: 214 ---PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
              P F   S      + S EA  LI  +L  D  KR +  + ++HP+
Sbjct: 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  112 bits (282), Expect = 7e-30
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 7/206 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELR---KHRRFT-EQQAATYIASLTNALA 133
           HPN+++ Y  F +D  + ++LE A  G+L R ++   K +R   E+    Y   L +AL 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
           + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF 216
             +++  D W+LG L YE      PF
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  116 bits (291), Expect = 1e-29
 Identities = 84/284 (29%), Positives = 132/284 (46%), Gaps = 40/284 (14%)

Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
            A  ++  K+ W      I R LG G  G V   + V    P A+K++    +E      
Sbjct: 24  EATAKEQAKKYW------ISRVLGSGATGTVLCAKRVSDGEPFAVKVV---DMEGMSEAD 74

Query: 65  QLRREMEIQSSLR--HPNILRLYGWF-HDDER-------IFLILEYAHRGELYRELRKH- 113
           + R + E+   L     +I++ +  F   D R       I L+L+YA+ G+L +E++   
Sbjct: 75  KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA 134

Query: 114 ---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
              R F E +A      +  A+ + H  H+IHRDIK  N+LL   G +K+GDFG+S    
Sbjct: 135 KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA 194

Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF 225
              S     T CGT  Y+APE+   K +    D ++LG+L YE L    PF+ E+ ++  
Sbjct: 195 ATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254

Query: 226 R------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                        SIS E + +++ LL  D  +R S  K++  P
Sbjct: 255 HKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  111 bits (280), Expect = 1e-29
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 35/261 (13%)

Query: 25  RPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRRE-------MEIQSSL 76
           R +GKG +G V LVR   + K  V         I+K  +++  RRE        ++ S L
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYV---------IKKLNLRNASRRERKAAEQEAQLLSQL 56

Query: 77  RHPNILRLY-GWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALA 133
           +HPNI+     W  +D  +++++ +   G+LY +L+  K +   E Q   +   +  AL 
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVEN 190
           Y HE H++HRD+K +N+ L     +K+GD G +    ++     T+ GT  Y++PE+  N
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-TFRSI-----------SAEAKHLISR 238
           K ++Y  D W LG   YE       F A+      +R I           S E   LI+ 
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236

Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
           +L K   KR S++ I+  P+I
Sbjct: 237 MLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  112 bits (280), Expect = 1e-29
 Identities = 80/255 (31%), Positives = 128/255 (50%), Gaps = 24/255 (9%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    P + + YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G     LR    F E Q AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 188

Query: 204 ILCYEFLYGAPP---------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRL 248
           I   E   G PP                   +    F   S   K  I   L KD S R 
Sbjct: 189 ITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF---SKPFKEFIDACLNKDPSFRP 245

Query: 249 SLQKIMEHPWIIKNA 263
           + +++++H +I+KNA
Sbjct: 246 TAKELLKHKFIVKNA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  112 bits (282), Expect = 2e-29
 Identities = 82/309 (26%), Positives = 130/309 (42%), Gaps = 71/309 (22%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSS 75
            L+D+EI   LG+G FG VY  R++++   VALK I+   + + + I     RE++I   
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63

Query: 76  LRHPNILRLYGWF---HDDER-----IFLILEY-AHRGELYRELRKHR-RFTEQQAATYI 125
           L+HPN++ L        D  +     ++++  Y  H  +L   L     + TE Q   Y+
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH--DLSGLLENPSVKLTESQIKCYM 121

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRS 171
             L   + Y HENH++HRDIK  N+L+D++G LKI DFG                     
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 172 KRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ--------- 221
           K   +  T  Y  PE++   + +  AVD W +G +  E     P  + +S          
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241

Query: 222 --------------------------------KDTFRSISAEAKHLISRLLVKDSSKRLS 249
                                           ++ F  +  E   L+S+LL  D  KRL+
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT 301

Query: 250 LQKIMEHPW 258
               +EHP+
Sbjct: 302 ASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  111 bits (280), Expect = 3e-29
 Identities = 67/269 (24%), Positives = 119/269 (44%), Gaps = 29/269 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D E    LG G  G V  V+ + +   +A K++      K  ++ Q+ RE++I    R 
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRS 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH-E 137
           P I+  YG F ++  I + +E+   G L R  +K      +       ++   L Y +  
Sbjct: 63  PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           + ++HRDIKP N+L++  G++K+ DFG S +   S   T  GT  Y++PE ++  ++   
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRS------------------------ISAEA 232
            D W+LGI   E   G  PF   +  D  +                            + 
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDL 242

Query: 233 KHLISRLLVKDSSKRLSLQKIME-HPWII 260
           +  +   L+KD ++R + Q++    P+I 
Sbjct: 243 RDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  111 bits (279), Expect = 3e-29
 Identities = 77/250 (30%), Positives = 123/250 (49%), Gaps = 18/250 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG VY   +  +K  VA+KII  E+ E  +I+  +++E+ + S    P I R YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYITRYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G    +L K     E   AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKGTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D+  D W+LG
Sbjct: 129 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG 188

Query: 204 ILCYEFLYGAPPFE------------AESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP                S        S   K  +   L KD   R + +
Sbjct: 189 ITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAK 248

Query: 252 KIMEHPWIIK 261
           ++++H +I +
Sbjct: 249 ELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  111 bits (279), Expect = 3e-29
 Identities = 76/267 (28%), Positives = 130/267 (48%), Gaps = 32/267 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY V    +   +A+K I + ++++ K   Q+  E++I      P I+  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDESKFN-QIIMELDILHKAVSPYIVDFYG 66

Query: 87  WFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIH 142
            F  +  +++ +EY   G   +LY          E        ++   L +  E H +IH
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVE----NKEHDY 195
           RD+KP N+L++  G++K+ DFG S   V S +K  T  G   Y+APE ++    N+   Y
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK--TNIGCQSYMAPERIKSGGPNQNPTY 184

Query: 196 AV--DNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISR 238
            V  D W+LG+   E   G  P+  E+  + F  +SA               +A+  +++
Sbjct: 185 TVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAK 244

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANP 265
            L K  ++R +  +++EHPW++K  N 
Sbjct: 245 CLNKIPNRRPTYAQLLEHPWLVKYKNA 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 4e-29
 Identities = 76/268 (28%), Positives = 124/268 (46%), Gaps = 25/268 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN 138
           ++ L   +   + + L+L   + G+L   +    +  F E++A  Y A +T  L   H  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYA 196
            +++RD+KPEN+LLD  G ++I D G +V+           GT+ Y+APE+V+N+ + ++
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFS 181

Query: 197 VDNWTLGILCYEFLYGAPPFEA---------------ESQKDTFRSISAEAKHLISRLLV 241
            D W LG L YE + G  PF                 E Q++     S  A+ +  +LL 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 242 KDSSKRLSLQK-----IMEHPWIIKNAN 264
           KD   RL  +      +  HP   + AN
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHP-FFRTAN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  111 bits (278), Expect = 5e-29
 Identities = 79/289 (27%), Positives = 135/289 (46%), Gaps = 58/289 (20%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L HPN
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE------QQAATYIASLTNALAY 134
           I++L    H + +++L+ E+     L+++L+K    +           +Y+  L   LA+
Sbjct: 61  IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVE 189
           CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE ++ 
Sbjct: 116 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLG 174

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRS------------------ 227
            K +  AVD W+LG +  E +     F  +S+ D     FR+                  
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234

Query: 228 ------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                             +  + + L+S++L  D +KR+S +  + HP+
Sbjct: 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  110 bits (277), Expect = 6e-29
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 32/261 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA        I +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVA--------IRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258

Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  111 bits (279), Expect = 6e-29
 Identities = 72/214 (33%), Positives = 105/214 (49%), Gaps = 9/214 (4%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+ +FE    +G+G +G VY  R+  S   VALK +  +  E+  I     RE+ +  +L
Sbjct: 5   SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN-ERDGIPISSLREITLLLNL 63

Query: 77  RHPNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALA 133
           RHPNI+ L         + IFL++EY  + +L   L      F+E Q    +  L   L 
Sbjct: 64  RHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQ 122

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPEMV-E 189
           Y HEN +IHRD+K  NLLL  +G LKI DFG +         M     TL Y APE++  
Sbjct: 123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
              +  A+D W +G +  E L   P    +S+ +
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  110 bits (277), Expect = 6e-29
 Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 41/277 (14%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH- 78
           D E+   LG+G +G V  +R V +   +A+K I +  +     Q Q R  M++  S+R  
Sbjct: 2   DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVN---SQEQKRLLMDLDISMRSV 57

Query: 79  --PNILRLYG-WFHD-DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALA 133
             P  +  YG  F + D  I + +      + Y+++        +     IA S+  AL 
Sbjct: 58  DCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117

Query: 134 YCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM-CGTLDYLAPEMV 188
           Y H    VIHRD+KP N+L++  G++K+ DFG S   V S +K  T+  G   Y+APE +
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPERI 175

Query: 189 ----ENKEHDYAVDNWTLGILCYEFLYGA-------PPFEAESQ----------KDTFRS 227
                 K +D   D W+LGI   E   G         PF+   Q           + F  
Sbjct: 176 NPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF-- 233

Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
            S E +  +++ L K+  +R +  ++++HP+   + +
Sbjct: 234 -SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  110 bits (276), Expect = 7e-29
 Identities = 79/255 (30%), Positives = 126/255 (49%), Gaps = 26/255 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH----PNIL 82
           +G+G FG VY  R+ ++    A+K + K++I K K    L     I  SL      P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            +   FH  +++  IL+  + G+L+  L +H  F+E++   Y   +   L + H   V++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNW 200
           RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++    +D + D +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWF 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLISRLLVKDSSK 246
           +LG + ++ L G  PF     KD                 S S E K L+  LL +D SK
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSK 240

Query: 247 RLSL-----QKIMEH 256
           RL       Q++ EH
Sbjct: 241 RLGCLGRGAQEVKEH 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  110 bits (276), Expect = 1e-28
 Identities = 81/300 (27%), Positives = 141/300 (47%), Gaps = 66/300 (22%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSS 75
           S+ ++E    + +G +G VY  R+ ++   VALK +  +++ E + I     RE+ I   
Sbjct: 3   SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSL--REINILLK 60

Query: 76  LRHPNILRL----YGWFHDDERIFLILEYAHRGELYRELR-----KHRRFTEQQAATYIA 126
           L+HPNI+ +     G   D   I++++EY     +  +L+       + F + +    + 
Sbjct: 61  LQHPNIVTVKEVVVGSNLDK--IYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLML 113

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-MCGTLDYL 183
            L + +A+ H+N ++HRD+K  NLLL++ G LKI DFG +    S  K +T +  TL Y 
Sbjct: 114 QLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR 173

Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FR------------ 226
           APE ++  KE+  A+D W++G +  E L   P F  +S+ D     F+            
Sbjct: 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPG 233

Query: 227 ---------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                      S+S     L++RLL  D +KR+S +  ++HP+ 
Sbjct: 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  109 bits (274), Expect = 1e-28
 Identities = 73/258 (28%), Positives = 128/258 (49%), Gaps = 24/258 (9%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G+ LG+G FGRVYL  +V++   +A K +    E  E  K    L  E+++  +L+H  I
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 82  LRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++ YG   D  ++ + + +EY   G +  +L+ +   TE     Y   +   ++Y H N 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEH 193
           ++HRDIK  N+L D  G +K+GDFG S        S +   ++ GT  +++PE++  + +
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 194 DYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFR------------SISAEAKHLISRLL 240
               D W+LG    E L   PP+ E E+    F+             IS  A+  +  + 
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIF 246

Query: 241 VKDSSKRLSLQKIMEHPW 258
           V ++  R S ++++ HP+
Sbjct: 247 V-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  109 bits (274), Expect = 1e-28
 Identities = 73/269 (27%), Positives = 130/269 (48%), Gaps = 39/269 (14%)

Query: 18  LQDFEIGRPLG--KGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ------HQLRRE 69
           L++ EI + L    GKFG+V ++     KH    K+  ++ I+           HQL ++
Sbjct: 13  LKNCEIVKKLKLIDGKFGKVSVL-----KHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKD 67

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
                   +PN ++LY      +   LI++Y   G+L+  L+K  + +E +    I  L 
Sbjct: 68  --------NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLV 119

Query: 130 NALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
            AL   H++++IH DIK EN+L D  + R+ + D+G   +         GTLDY +PE +
Sbjct: 120 EALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL-CKIIGTPSCYDGTLDYFSPEKI 178

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE--------------SQKDTF-RSISAEAK 233
           +   +D + D W +G+L YE L G  PF+ +               +K  F +++S  A 
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN 238

Query: 234 HLISRLLVKDSSKRL-SLQKIMEHPWIIK 261
             +  +L  + + RL +  +I++HP++  
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFLKI 267

Length = 267

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  109 bits (274), Expect = 2e-28
 Identities = 81/267 (30%), Positives = 131/267 (49%), Gaps = 32/267 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV------EIEILATCN 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G F+ D ++++++E+   G +    L   R  TE Q       +  AL Y H
Sbjct: 68  HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+LL  +G +K+ DFG S   V++  +R +  GT  ++APE+V     
Sbjct: 128 SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRS---ISAEAKH 234
           ++  +DY  D W+LGI   E     PP             A+S+  T       S E + 
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRD 247

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIK 261
            +   L K    R S  +++EHP++  
Sbjct: 248 FLKTALDKHPETRPSAAQLLEHPFVSS 274

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  109 bits (273), Expect = 2e-28
 Identities = 77/252 (30%), Positives = 129/252 (51%), Gaps = 18/252 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    P + + YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDSPYVTKYYG 69

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 70  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 188

Query: 204 ILCYEFLYGAPPF-EAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP  E    K  F            + S   K  +   L K+ S R + +
Sbjct: 189 ITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 248

Query: 252 KIMEHPWIIKNA 263
           ++++H +I++ A
Sbjct: 249 ELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  108 bits (272), Expect = 2e-28
 Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 7/206 (3%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L +F+I + +G+G+F  VY    +  + PVALK +   ++   K +    +E+++   L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALA 133
           HPN+++    F +D  + ++LE A  G+L + +    ++ R   E+    Y   L +A+ 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
           + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE +  
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF 216
             +++  D W+LG L YE      PF
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPF 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  108 bits (270), Expect = 5e-28
 Identities = 78/257 (30%), Positives = 128/257 (49%), Gaps = 26/257 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH----PNIL 82
           +G+G FG VY  R+ ++    A+K + K++I K K    L     I  SL      P I+
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            +   FH  +++  IL+  + G+L+  L +H  F+E +   Y A +   L + H   V++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNW 200
           RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++    +D + D +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWF 180

Query: 201 TLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLISRLLVKDSSK 246
           +LG + ++ L G  PF     KD                 S S E + L+  LL +D ++
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR 240

Query: 247 RLSL-----QKIMEHPW 258
           RL       Q++ EHP+
Sbjct: 241 RLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  106 bits (265), Expect = 2e-27
 Identities = 73/254 (28%), Positives = 122/254 (48%), Gaps = 22/254 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           LGKG FG VYLV++ ++     LK++ +  + +      ++   E Q  S L HP I++ 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67

Query: 85  YGWFHDDERIFLILEYAHRGEL---YRELRKH-RRFTEQQAATYIASLTNALAYCHENHV 140
           +  F + +   +I EY    +L     EL+   +  +E Q   +   L   + Y H+  +
Sbjct: 68  HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           +HRD+K +N+ L     LKIGDFG S   + S     T  GT  Y++PE ++++ +D   
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKS 186

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVKDSS 245
           D W+LG + YE    A  FE ++       I            S +   ++  +L KD S
Sbjct: 187 DIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPS 246

Query: 246 KRLSLQKIMEHPWI 259
            R S  +I+ +P+I
Sbjct: 247 LRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  106 bits (266), Expect = 2e-27
 Identities = 73/258 (28%), Positives = 124/258 (48%), Gaps = 27/258 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   +   +    A K + K++++K K       E  I + +    I+ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 87  WFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
            F     + L++   + G+L    Y    ++  F E +A  Y A + + L + H+  +I+
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           RD+KPEN+LLD++G ++I D G +V+    +SK     GT  ++APE+++ +E+D++VD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY 180

Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDS 244
           + LG+  YE +    PF A  +K   + +               S  +K     LL KD 
Sbjct: 181 FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP 240

Query: 245 SKRLSLQ-----KIMEHP 257
            KRL  +      +  HP
Sbjct: 241 EKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  106 bits (266), Expect = 3e-27
 Identities = 77/271 (28%), Positives = 132/271 (48%), Gaps = 36/271 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP 79
           +EI   +GKG +G+V+ V   ++    A+KI+  + I  + I  ++  E  I  +L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPI--HDIDEEIEAEYNILKALSDHP 75

Query: 80  NILRLYGWFH-----DDERIFLILEYAHRGELYR----ELRKHRRFTEQQAATYIASLTN 130
           N+++ YG ++     + ++++L+LE  + G +       L++  R  E   A  +     
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H N  IHRD+K  N+LL  EG +K+ DFG S Q   +R +R+T  GT  ++APE+
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 188 VE-----NKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRS-------------I 228
           +      +  +D   D W+LGI   E   G PP  +    +  F+               
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELW 255

Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           S E    I + L KD  KR ++  +++H +I
Sbjct: 256 SNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  105 bits (264), Expect = 4e-27
 Identities = 70/214 (32%), Positives = 113/214 (52%), Gaps = 9/214 (4%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G+G +G V   R  E+K  VA+K  FK+  E  +++    RE+++  +L+  N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQEN 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           I+ L   F    +++L+ EY  +   EL  E+        ++  +YI  L  A+ +CH+N
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKN 119

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            ++HRDIKPENLL+ H   LK+ DFG+    S  S +       T  Y +PE++    + 
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
            AVD W++G +  E   G P F  ES+ D   +I
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 5e-27
 Identities = 73/297 (24%), Positives = 123/297 (41%), Gaps = 70/297 (23%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E    +G+G +G VY  R++ +   VALK          K++  L  E    S+LR   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALK----------KVRVPLSEEGIPLSTLREIA 50

Query: 78  ---------HPNILRLYGWFH--DDER---IFLILEYAHRGELYRELRKH--RRFTEQQA 121
                    HPNI+RL    H    +R   + L+ E+  + +L   L K        +  
Sbjct: 51  LLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI 109

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-GT 179
              +  L   + + H + ++HRD+KP+N+L+  +G++KI DFG + + S     T    T
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVT 169

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------- 223
           L Y APE++    +   VD W++G +  E     P F   S+ D                
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229

Query: 224 ----------TFRS------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                     +F S            I  E   L+ ++L  +  KR+S  + ++HP+
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  105 bits (263), Expect = 7e-27
 Identities = 74/291 (25%), Positives = 135/291 (46%), Gaps = 59/291 (20%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D+     +G+G +G VY  R  ++   VA+K I  E  E+  +     RE+ +   L+HP
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-------RRFTEQQAATYIASLTNAL 132
           NI+ L      + R++LI E+     L  +L+K+       +    +   +Y+  +   +
Sbjct: 60  NIVCLQDVLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-M 187
            +CH   V+HRD+KP+NLL+D++G +K+ DFG    + +  R   H +  TL Y APE +
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVL 173

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-------------------------- 221
           + +  +   VD W++G +  E     P F  +S+                          
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 222 --KDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
             K+TF            +++  +   L+ ++L+ D +KR+S +K + HP+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  105 bits (262), Expect = 7e-27
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 24/261 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN 138
           ++ L   +   + + L+L   + G+L   +       F E +A  Y A +   L   H+ 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYA 196
            +++RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS 181

Query: 197 VDNWTLGILCYEFLYGAPPFE---------------AESQKDTFRSISAEAKHLISRLLV 241
            D W LG L YE + G  PF+                E Q++     S +A+ L   LL 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 242 KDSSKRL-----SLQKIMEHP 257
           KD  +RL       +++ EHP
Sbjct: 242 KDPKERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  107 bits (267), Expect = 8e-27
 Identities = 66/250 (26%), Positives = 118/250 (47%), Gaps = 50/250 (20%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G FG V L  +V++    A+K + K+ +        ++ E +I +   +  +++L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+   IHRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 145 IKPENLLLDHEGRLKIGDFG------W--------------------------------- 165
           IKP+N+L+D +G +K+ DFG      W                                 
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 166 ----SVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP 214
               +++ R+ +       H++ GT +Y+APE++  K +    D W++G++ +E L G P
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 215 PFEAESQKDT 224
           PF A +  +T
Sbjct: 247 PFLAPTPTET 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  106 bits (266), Expect = 1e-26
 Identities = 71/254 (27%), Positives = 121/254 (47%), Gaps = 50/254 (19%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   + LG G FG V L R+V++K   A+K + K+ +        ++ E +I +   +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++RLY  F D + ++ +++Y   G++   L +   F E  A  YIA LT A+   H+   
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG------WS---------------------------- 166
           IHRDIKP+N+L+D +G +K+ DFG      W+                            
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 167 ---------VQSRSKR-------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
                    ++ R+ R       H++ GT +Y+APE++    +    D W++G++ YE L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 211 YGAPPFEAESQKDT 224
            G PPF A++  +T
Sbjct: 243 VGQPPFLAQTPLET 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  104 bits (261), Expect = 1e-26
 Identities = 79/293 (26%), Positives = 135/293 (46%), Gaps = 59/293 (20%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +  +E    +G+G +G VY  R+  +   +ALK I  EQ E   +     RE+ +   ++
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQ 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA------ATYIASLTNA 131
           H NI+RL    H ++R++L+ EY     L  +L+KH   +   A       TY+  +   
Sbjct: 60  HGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114

Query: 132 LAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE 186
           +AYCH + V+HRD+KP+NLL+D     LK+ DFG    + +  R+  H +  TL Y APE
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPE 173

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------------------------ 221
            ++ ++ +   VD W++G +  E +   P F  +S+                        
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 222 ----KDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
               K  F             ++      L+S++L  D SKR++ +  +EH +
Sbjct: 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  104 bits (260), Expect = 1e-26
 Identities = 75/268 (27%), Positives = 134/268 (50%), Gaps = 32/268 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++     E+ +I+ ++     ++    H N
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 64

Query: 81  ILRLYGWFHD------DERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNAL 132
           I   YG F        D++++L++E+   G +   ++  K     E+  A     +   L
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
           ++ H++ VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++ 
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 184

Query: 190 NKE-----HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTF------------RSISAE 231
             E     +D+  D W+LGI   E   GAPP  +    +  F            +  S +
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244

Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            +  I   LVK+ S+R + +++M+HP+I
Sbjct: 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  103 bits (259), Expect = 2e-26
 Identities = 77/269 (28%), Positives = 131/269 (48%), Gaps = 34/269 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++   + E+ +I+ ++     ++    H N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM---LKKYSHHRN 74

Query: 81  ILRLYGWF-------HDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNA 131
           I   YG F       HDD+ ++L++E+   G +   ++  +     E   A     +   
Sbjct: 75  IATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV 188
           LA+ H + VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193

Query: 189 ENKE-----HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTF------------RSISA 230
              E     +DY  D W+LGI   E   GAPP  +    +  F            +  S 
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +    I   LVK+   R S +++++HP+I
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  103 bits (258), Expect = 2e-26
 Identities = 74/263 (28%), Positives = 121/263 (46%), Gaps = 27/263 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFE+ + +G G +G VY  R V +    A+K+I  E  E + +  Q   E+ +    +H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            NI+  +G +   +++++ +E+   G L          +E Q A         L Y H  
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM--VENK-E 192
             +HRDIK  N+LL   G +K+ DFG S Q   + +KR +  GT  ++APE+  VE K  
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 193 HDYAVDNWTLGILCYEFLYGAPP-----------------FEAESQKDTFRSISAEAKHL 235
           ++   D W +GI   E     PP                 F+    KD  +  S    H 
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMK-WSNSFHHF 244

Query: 236 ISRLLVKDSSKRLSLQKIMEHPW 258
           +   L K+  KR + +K+++HP+
Sbjct: 245 VKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  103 bits (258), Expect = 2e-26
 Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 16/206 (7%)

Query: 27  LGKGKFGRVYLVREVESKHP-VALKIIF-------KEQIEKYKIQHQLRREME-IQSSLR 77
           LG G FG VY VR+  +    +ALK I        K++ E+ K    +  E+  I+  LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 78  HPNILRLYGWFHDDERIFLILEY---AHRGELYRELR-KHRRFTEQQAATYIASLTNALA 133
           HPNI+R Y  F +++R++++++    A  GE +  L+ K +RFTE++       +  AL 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 134 YCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVEN 190
           Y H E  ++HRD+ P N++L  + ++ I DFG + Q +  SK  ++ GT+ Y  PE+V+N
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN 187

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPF 216
           + +    D W  G + Y+     PPF
Sbjct: 188 EPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  103 bits (257), Expect = 3e-26
 Identities = 68/263 (25%), Positives = 130/263 (49%), Gaps = 24/263 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +G+ LG+G FGRVYL  + ++   +A+K +    E  E  K  + L  E+++  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           H  I++ YG   D  +  + + +E+   G +  +L+ +   TE     Y   +   ++Y 
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDYLAPEMVE 189
           H N ++HRDIK  N+L D  G +K+GDFG S +      S +   ++ GT  +++PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFR------------SISAEAKHLI 236
            + +    D W++G    E L   PP+ E E+    F+             +S   +  +
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242

Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            R+ V ++  R S  +++ H ++
Sbjct: 243 KRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  103 bits (257), Expect = 5e-26
 Identities = 77/264 (29%), Positives = 123/264 (46%), Gaps = 25/264 (9%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E  I   +    ++ L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +    +  F EQ+A  Y A L   L       +++
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +VQ           GT+ Y+APE++ N+++ ++ D W
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185

Query: 201 TLGILCYEFLYGAPPFE---------------AESQKDTFRSISAEAKHLISRLLVKDSS 245
            LG L YE + G  PF                 E Q++     S +AK +   LL K+  
Sbjct: 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPK 245

Query: 246 KRLSLQ-----KIMEHPWIIKNAN 264
           +RL  +      + +HP I KN N
Sbjct: 246 ERLGCRGNGAAGVKQHP-IFKNIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  103 bits (258), Expect = 6e-26
 Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 53/299 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V  V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 2   DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  E        ++   L Y  E H
Sbjct: 60  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 198 DNWTLGILCYEFLYGAPPFEAESQK---------------------------DTFRSI-- 228
           D W+LG+   E   G  P      K                           D+ R +  
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 229 --------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 267
                               S E +  + + L K+  +R  L+++ +HP+I +      
Sbjct: 240 FELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  102 bits (256), Expect = 6e-26
 Identities = 78/264 (29%), Positives = 125/264 (47%), Gaps = 26/264 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN 138
           ++ L   +   + + L+L   + G+L   +    +  F E++A  Y A +   L   H  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++RD+KPEN+LLD  G ++I D G +V   +  S R  + GT+ Y+APE++ N+ +  
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAPEVLNNQRYTL 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQK-----------DTFRSISA----EAKHLISRLL 240
           + D W LG L YE + G  PF    +K           +T    SA    EAK +   LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240

Query: 241 VKDSSKRLSLQ-----KIMEHPWI 259
            KD  +RL  Q     ++  HP+ 
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  103 bits (257), Expect = 1e-25
 Identities = 66/212 (31%), Positives = 108/212 (50%), Gaps = 7/212 (3%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DFE    LG G  G V  V+   S   +A K+I  E   K  I++Q+ RE+++      
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNS 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I+  YG F+ D  I + +E+   G L + L++ +R  E+       ++   LAY  E 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 139 H-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           H ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +   
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182

Query: 197 VDNWTLGILCYEFL---YGAPPFEAESQKDTF 225
            D W++G+   E     Y  PP +A+  +  F
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  102 bits (255), Expect = 1e-25
 Identities = 71/284 (25%), Positives = 120/284 (42%), Gaps = 60/284 (21%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           LG+G +  VY  R   +   VALK I    +E      I     RE+ +   L+H NI+R
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62

Query: 84  LYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVI 141
           L+   H + ++ L+ EY  +  + Y +    R   +     ++   L   +A+CHEN V+
Sbjct: 63  LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122

Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPE-MVENKEHD 194
           HRD+KP+NLL++  G LK+ DFG +      V + S       TL Y AP+ ++ ++ + 
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAPDVLLGSRTYS 179

Query: 195 YAVDNWTLGILCYEFLYG----------------------------------------AP 214
            ++D W++G +  E + G                                         P
Sbjct: 180 TSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP 239

Query: 215 PFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            +  +  +  F         L+ RLL  +   R+S    ++HPW
Sbjct: 240 RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  101 bits (253), Expect = 3e-25
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 6/196 (3%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

Query: 201 TLGILCYEFLYGAPPF 216
           +LGI C E     PP 
Sbjct: 199 SLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  103 bits (258), Expect = 3e-25
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 21/219 (9%)

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRE----LRKHRRFTEQQAA 122
           R E+   ++  H  I++ +  F  D+++ LI+EY   G+L ++    L++H  F E +  
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMC 177
                +  AL   H   ++HRD+K  N+ L   G +K+GDFG+S Q     S     + C
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC 232

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------- 227
           GT  YLAPE+ E K +    D W+LG++ YE L    PF+  SQ++  +           
Sbjct: 233 GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292

Query: 228 --ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
             +S+  K L+  LL K+ + R + Q+++   ++   AN
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVAN 331

Length = 478

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  100 bits (251), Expect = 4e-25
 Identities = 84/272 (30%), Positives = 121/272 (44%), Gaps = 37/272 (13%)

Query: 18  LQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSS 75
           L+D  EIGR    G FG V  +    S   +A+K I     EK   Q +L  +++ +  S
Sbjct: 6   LKDLGEIGR----GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE--QKRLLMDLDVVMRS 59

Query: 76  LRHPNILRLYG-WFHD-DERIFLILEYAHRGELYR--ELRKHRRFTEQQAATYIASLTNA 131
              P I++ YG  F + D  I + L      + Y+           E+       +   A
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 132 LAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEM 187
           L Y  E   +IHRD+KP N+LLD  G +K+ DFG S   V S +K     G   Y+APE 
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPER 178

Query: 188 VENKEHD-YAV--DNWTLGILCYE-----FLYGA--PPFEAESQ----------KDTFRS 227
           ++    D Y V  D W+LGI  YE     F Y      F+  +Q              R 
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE 238

Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            S    + I+  L+KD SKR   ++++EHP+I
Sbjct: 239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  100 bits (252), Expect = 7e-25
 Identities = 85/307 (27%), Positives = 134/307 (43%), Gaps = 67/307 (21%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ +EI + LGKG +G V+   +  +K  VALK IF         Q   R  M +Q    
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 78  HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLT 129
           HPNI++L       +D+ I+L+ EY    +L+  +R       H+R+   Q       L 
Sbjct: 66  HPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ-------LL 117

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGTLDYLA--- 184
            AL Y H  +VIHRD+KP N+LL+ + R+K+ DFG   S+    +        DY+A   
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 185 ---PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------------------- 221
              PE ++ +  +   VD W++G +  E L G P F   S                    
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 222 -----------------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                   +     S +A  L+ +LLV + +KRL+ ++ +EHP+
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297

Query: 259 IIKNANP 265
           + +  NP
Sbjct: 298 VAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.6 bits (245), Expect = 2e-24
 Identities = 62/218 (28%), Positives = 113/218 (51%), Gaps = 11/218 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +G+ LG+G FG VYL  + ++   +A+K +    +  E  K  + L  E+++  +LR
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 78  HPNILRLYGWFHDDE--RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           H  I++ YG   D E  ++ + +EY   G +  +L+ +   TE     Y   +   ++Y 
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDYLAPEMVE 189
           H N ++HRDIK  N+L D  G +K+GDFG S +      S +   ++ GT  +++PE++ 
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFR 226
            + +    D W++     E L   PP+ E E+    F+
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  101 bits (254), Expect = 2e-24
 Identities = 57/180 (31%), Positives = 102/180 (56%), Gaps = 3/180 (1%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F I +P+ +G FG+VYL R+  +    A+K++ K  +    + HQ++ E +  +  
Sbjct: 2   SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           + P I+ LY        ++L++EY   G++   L  +  F E+ A  YI+ +  AL Y H
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            + +IHRD+KP+N+L+ +EG +K+ DFG S  + ++   M   L    P M + K +DY+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILT--TPSMAKPK-NDYS 178

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 99.5 bits (248), Expect = 2e-24
 Identities = 77/321 (23%), Positives = 130/321 (40%), Gaps = 80/321 (24%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--------------IQHQLRR 68
            G  LG+G +G+V    +  +   VA+K   K +I +                I     R
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E++I + ++H NI+ L   + + + I L+++     +L + + +  R TE Q    +  +
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQI 128

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--------VQSRSKRHTMCG-- 178
            N L   H+ + +HRD+ P N+ ++ +G  KI DFG +          + SK  TM    
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 179 -------TLDYLAPE--MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-------- 221
                  TL Y APE  M   K H  AVD W++G +  E L G P F  E++        
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHF-AVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247

Query: 222 -------------------------------KDTFRSISAEAKHLISRLLVKDSSKRLSL 250
                                          K  F + S +A  L+  LL  +  +R+S 
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 251 QKIMEHPWIIKNANPRGTCDI 271
           ++ ++H +   +  P   CD 
Sbjct: 308 KEALKHEYFKSDPLP---CDP 325

Length = 335

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 98.6 bits (246), Expect = 3e-24
 Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 29/276 (10%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D +K    L D E    +G G  G+VY +R  ++ H +A+K + +    K + +  L   
Sbjct: 6   DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDL 64

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIAS 127
             +  S   P I++ YG+F  D  +F+ +E         +L K  +    E        +
Sbjct: 65  DVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA 122

Query: 128 LTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           +  AL Y  E H VIHRD+KP N+LLD  G +K+ DFG S   V S++K  +  G   Y+
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-AGCAAYM 181

Query: 184 APEMVE----NKEHDYAVDNWTLGILCYEFLYGAPPFE-AESQKDTFRSI---------- 228
           APE ++    N ++D   D W+LGI   E   G  P++  +++ +    I          
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241

Query: 229 ----SAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
               S +    +   L KD  KR   +++++HP+I 
Sbjct: 242 NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 99.0 bits (246), Expect = 3e-24
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 7/211 (3%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 63

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 64  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 183

Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTF 225
           D W++G+   E   G    PP +A+  +  F
Sbjct: 184 DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 97.3 bits (242), Expect = 6e-24
 Identities = 72/265 (27%), Positives = 122/265 (46%), Gaps = 29/265 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           QD +    LG G  G VY    + ++  +A+K+I  +     ++Q Q+  E+EI      
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDS 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P I+  YG F  + RI +  E+   G L      +R+  E        ++   L Y    
Sbjct: 59  PYIIGFYGAFFVENRISICTEFMDGGSL----DVYRKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G++K+ DFG S Q   S   T  GT  Y+APE +  +++    
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDT--------FRSISAEAK-------------HLI 236
           D W+LGI   E   G  P+  + QK+          + I  E               H I
Sbjct: 175 DVWSLGISFMELALGRFPY-PQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIK 261
           ++ + K   +R + + +M+HP+I++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQ 258

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 82/270 (30%), Positives = 136/270 (50%), Gaps = 39/270 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E  L ++E+ + +G G+FG V+LV+   ++     K I    + K + + QL  E+ +  
Sbjct: 9   ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMR 67

Query: 75  SLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK-HRRF--TEQQAATYIA-SL 128
            L+H NI+R    F +  ++++++++E+   G+L R ++K ++ F   E+ A   I   L
Sbjct: 68  ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127

Query: 129 TNALAYCHE-------NHVIHRDIKPENLLLD----HEGRL-------------KIGDFG 164
            +ALAYCH          V+HRD+KP+N+ L     H G++             KIGDFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 165 WS--VQSRSKRHTMCGTLDYLAPEMV--ENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
            S  +   S  H+  GT  Y +PE++  E K +D   D W LG + YE   G  PF    
Sbjct: 188 LSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH--- 244

Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSL 250
           + + F  + +E K     L +K  SK L++
Sbjct: 245 KANNFSQLISELKRG-PDLPIKGKSKELNI 273

Length = 1021

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 96.7 bits (240), Expect = 2e-23
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 12/199 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +G G FG VY  R+V +   VA+K +    K+  EK++    + +E++    ++HPN 
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVKFLQRIKHPNS 87

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           +   G +  +   +L++EY   G     L  H++   E + A         LAY H +++
Sbjct: 88  IEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAV 197
           IHRDIK  N+LL   G++K+ DFG S    S  ++  GT  ++APE++   +  ++D  V
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG-SASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205

Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+LGI C E     PP 
Sbjct: 206 DVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 76/279 (27%), Positives = 126/279 (45%), Gaps = 49/279 (17%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V+  R  E+   VA+K  F E  +   I+    RE+ +   L+HPN++ L  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F    ++ L+ EY     L  EL K+ R   E      I     A+ +CH+++ IHRD+
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLN-ELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV 126

Query: 146 KPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC-GTLDYLAPEM-VENKEHDYAVDNWT 201
           KPEN+L+  +G++K+ DFG++  +      +T    T  Y APE+ V + ++   VD W 
Sbjct: 127 KPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186

Query: 202 LGILCYEFLYGAP------------------------------------------PFEAE 219
           +G +  E L G P                                          P   E
Sbjct: 187 IGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETRE 246

Query: 220 SQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
             +  F +IS+ A   +   L  D ++RLS ++++EHP+
Sbjct: 247 PLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.0 bits (239), Expect = 3e-23
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 25/262 (9%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +G G FG VY  R+V +   VA+K +    K+  EK++    + +E+     LRHPN 
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ---DIIKEVRFLQQLRHPNT 77

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           +   G +  +   +L++EY   G     L  H++   E + A         LAY H +  
Sbjct: 78  IEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAV 197
           IHRDIK  N+LL   G +K+ DFG S    S  ++  GT  ++APE++   +  ++D  V
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 198 DNWTLGILCYEFLYGAPPF-----------EAESQKDTFRSI--SAEAKHLISRLLVKDS 244
           D W+LGI C E     PP             A++   T  S   S   ++ +   L K  
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIP 255

Query: 245 SKRLSLQKIMEHPWIIKNANPR 266
             R S +++++H ++++   P 
Sbjct: 256 QDRPSSEELLKHRFVLRERPPT 277

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.0 bits (236), Expect = 3e-23
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 27/262 (10%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIF---KEQIEKYKIQHQLRREMEIQSSLRHPN 80
           G  LGKG +G VY          +A+K +       +   K   +L+ E+++  SL+H N
Sbjct: 5   GEVLGKGAYGTVYC-GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++  G   DD  I + +E+   G +   L +     E     Y   + + +AY H N V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG------WSVQSRSKRH---TMCGTLDYLAPEMVENK 191
           +HRDIK  N++L   G +K+ DFG      W     +  +   +M GT  ++APE++   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLIS 237
            +    D W++G   +E   G PP  +  +      I              SA A   ++
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
             L +D  +R S  +++ H ++
Sbjct: 244 SCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 4e-23
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 9/215 (4%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           + ++ ++G  +GKG+FG V L         VA+K +  +             E  + ++L
Sbjct: 4   NSKELKLGATIGKGEFGDVML--GDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTL 57

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAY 134
           RHPN+++L G       ++++ EY  +G L   LR   R   T  Q   +   +   + Y
Sbjct: 58  RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
             E + +HRD+   N+L+  +   K+ DFG + ++   + +    + + APE +  K+  
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFS 177

Query: 195 YAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
              D W+ GIL +E + +G  P+     KD    +
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 94.4 bits (235), Expect = 6e-23
 Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 50/279 (17%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V+  +  E+   VALK +  +  +   +     RE+ +   L+H NI+RLY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA-TYIASLTNALAYCHENHVIHRDI 145
             H D+++ L+ EY  + +L +         + +   +++  L   LA+CH ++V+HRD+
Sbjct: 67  VLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL 125

Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++  G LK+ DFG    + +  R     +  TL Y  P+ +   K +  ++D W
Sbjct: 126 KPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMW 184

Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI------------------------------- 228
           + G +  E    G P F      D  + I                               
Sbjct: 185 SAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATT 244

Query: 229 ---------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                    ++  + L+  LLV +  +R+S ++ ++HP+
Sbjct: 245 SLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 95.1 bits (237), Expect = 7e-23
 Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 66/294 (22%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++K  VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 86  -------GWFHDDERIFLILEY-AHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCH 136
                   +       +L+ E+  H  +L   L  K+ +FT  +    +  L N L Y H
Sbjct: 79  ICRTKATPYNRYKGSFYLVFEFCEH--DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCG---TLDYLAPEMVE 189
            N ++HRD+K  N+L+  +G LK+ DFG    +S+   SK +       TL Y  PE++ 
Sbjct: 137 RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 190 NKEHDY--AVDNWTLGILCYEFLYGAPPFEAESQK------------------------D 223
             E DY   +D W  G +  E    +P  +  +++                        +
Sbjct: 197 G-ERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255

Query: 224 TFRSI-------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            F+ +                      A  LI +LLV D +KR+     + H +
Sbjct: 256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 94.4 bits (235), Expect = 8e-23
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 25  RPLGKGKFGRVYLVR-EVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + LG+G FG+V L R +    +    VA+K +     E++  +    RE+EI  +L H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQH--RSDFEREIEILRTLDHEN 67

Query: 81  ILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
           I++  G         + LI+EY   G L   L++HR +   ++   + + +   + Y   
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGTLD-----YLAPEMVENK 191
              IHRD+   N+L++ E  +KI DFG + V    K +            + APE +   
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 192 EHDYAVDNWTLGILCYE-FLYGAP 214
           +   A D W+ G+  YE F YG P
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDP 211

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 93.9 bits (233), Expect = 1e-22
 Identities = 67/261 (25%), Positives = 120/261 (45%), Gaps = 27/261 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            D+E+ + +G G +G VY  R + +    A+KII  E  + + +   +++E+ +    +H
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            NI+  +G +   E++++ +EY   G L          +E Q A         LAY H  
Sbjct: 66  CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV---ENKE 192
             +HRDIK  N+LL   G +K+ DFG + +   + +KR +  GT  ++APE+    +N  
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 193 HDYAVDNWTLGILCYEFLYGAPP-----------------FEAESQKDTFRSISAEAKHL 235
           ++   D W +GI   E     PP                 F+    KD  +  S+   + 
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTK-WSSTFHNF 244

Query: 236 ISRLLVKDSSKRLSLQKIMEH 256
           +   L K+  KR + ++++ H
Sbjct: 245 VKISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 94.5 bits (235), Expect = 1e-22
 Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 53/282 (18%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +P+G G FG V   R+  +   VA+K I K       +  +  RE+++   LRH NI+ L
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKP-FSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 85  YGWF-HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
              F    E I+ + E     +L+R L   R   +Q    ++  +   L Y H   V+HR
Sbjct: 75  SDIFISPLEDIYFVTELLGT-DLHR-LLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHR 132

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDN 199
           D+KP N+L++    LKI DFG    +R +   M G   T  Y APE M+  +++D  VD 
Sbjct: 133 DLKPSNILINENCDLKICDFGL---ARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDI 189

Query: 200 WTLGILCYEFLYGAPPFEAESQ-------------------------------------- 221
           W+ G +  E L G P F  +                                        
Sbjct: 190 WSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKRE 249

Query: 222 ----KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                + F++    A  L+ ++LV D  KR+S  + + HP++
Sbjct: 250 PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 67/218 (30%), Positives = 112/218 (51%), Gaps = 7/218 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V   +  E+   VA+K  F E  +   ++    RE+ +   LRH N++ L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F   +R++L+ E+     L  +L K+     E +   Y+  +   + +CH +++IHRDI
Sbjct: 68  VFRRKKRLYLVFEFVDHTVL-DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDI 126

Query: 146 KPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-MCGTLDYLAPEM-VENKEHDYAVDNWT 201
           KPEN+L+   G +K+ DFG++  + +  + +T    T  Y APE+ V + ++  AVD W 
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWA 186

Query: 202 LGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRL 239
           +G L  E L G P F  +S  D    I     +LI R 
Sbjct: 187 VGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 67/292 (22%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLY 85
           +G+G +G+VY  R+  +   VALK    E +++  I     RE+ +   L     I+RL 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 86  GWFHDDER-----IFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNA 131
              H +E+     ++L+ EY     L  +L+K          R    +   +++  L   
Sbjct: 68  DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE 186
           +A+CH++ V+HRD+KP+NLL+D + G LKI D G    +S+  +S  H +  TL Y APE
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPE 181

Query: 187 MVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQ------------------------ 221
           ++    H    VD W++G +  E     P F  +S+                        
Sbjct: 182 VLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK 241

Query: 222 ---------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                +S E   L+ ++L  D +KR+S +  + HP+
Sbjct: 242 LRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 4e-22
 Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 60/286 (20%)

Query: 26  PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---YKIQHQLRREMEIQSSLRHPNIL 82
            LG+G +  VY  R   +   VALK I  E  E      I     RE  +   L+H NI+
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-----REASLLKDLKHANIV 66

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVI 141
            L+   H  + + L+ EY    +L + +              ++  L   LAYCH+  V+
Sbjct: 67  TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVL 125

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL+   G LK+ DFG     SV S++  + +  TL Y  P+ ++ + E+  +
Sbjct: 126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTS 184

Query: 197 VDNWTLGILCYEFLYGAPPF----EAESQ------------KDTFRSIS----------- 229
           +D W +G + YE   G P F    + E Q            ++T+  +S           
Sbjct: 185 LDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFP 244

Query: 230 -----------------AEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                               + L  + L  +  KR+S  + M+HP+
Sbjct: 245 FYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.8 bits (230), Expect = 4e-22
 Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 6/194 (3%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G FG VY      +   VA+K +     +  +    + +E++    L+HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +  +   +L++EY   G     L  H++   E + A         LAY H +++IHRDI
Sbjct: 89  CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNWTL 202
           K  N+LL   G++K+ DFG S    S  ++  GT  ++APE++   +  ++D  VD W+L
Sbjct: 148 KAGNILLTEPGQVKLADFG-SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSL 206

Query: 203 GILCYEFLYGAPPF 216
           GI C E     PP 
Sbjct: 207 GITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.7 bits (228), Expect = 5e-22
 Identities = 64/224 (28%), Positives = 94/224 (41%), Gaps = 21/224 (9%)

Query: 27  LGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG G FG   +VR  E          VA+K +  +++    I     +E  I  SL H N
Sbjct: 3   LGDGSFG---VVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHEN 57

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHEN 138
           ++RLYG       + ++ E A  G L   LRK     F       Y   + N + Y    
Sbjct: 58  LIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKE 192
             IHRD+   N+LL  + ++KIGDFG    +      + M   L     + APE +  + 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
             +A D W  G+  +E F YG  P+   S     + I  E + L
Sbjct: 177 FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 92.4 bits (229), Expect = 6e-22
 Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 26/224 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  V+  R   +++ VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 71

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-----FTEQQAATYIASLTNALAYCHENHVI 141
             H D+ + L+ EY     L ++L+++        +      ++  +   LAYCH   V+
Sbjct: 72  IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     SV +++  + +  TL Y  P+ ++ + E+   
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLL 240
           +D W +G + +E   G P F   + +D          HLI RLL
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDEL--------HLIFRLL 221

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 91.3 bits (227), Expect = 7e-22
 Identities = 58/222 (26%), Positives = 98/222 (44%), Gaps = 18/222 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++F + R LG G FG V+          VA+KI+  + + K   Q   ++E++    LRH
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRV-RVAIKILKSDDLLK---QQDFQKEVQALKRLRH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT-----YIAS-LTNAL 132
            +++ L+      E +++I E   +G L   LR      E Q         +A  +   +
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVASLIDMACQVAEGM 117

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT---LDYLAPEMVE 189
           AY  E + IHRD+   N+L+  +   K+ DFG +   +   +          + APE   
Sbjct: 118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISA 230
           +       D W+ GIL YE F YG  P+   +  + +  I+A
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 92.1 bits (229), Expect = 7e-22
 Identities = 73/302 (24%), Positives = 126/302 (41%), Gaps = 59/302 (19%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +  +  F+I   +G+G +G+VY  R+ ++   VALK +  +  EK        RE++I  
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILR 61

Query: 75  SLRHPNILRLYGWFHDD----------ERIFLILEYAHRGELYRELR-KHRRFTEQQAAT 123
            L H NI+ L     D              +L+ EY    +L   L      F+E    +
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKS 120

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGT 179
           ++  L   L YCH+ + +HRDIK  N+LL+++G++K+ DFG    ++ +          T
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 180 LDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQ----------------- 221
           L Y  PE++  +E +  A+D W+ G +  E     P F+A  +                 
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240

Query: 222 ------------------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                                   ++ F  I   A  L+  +L  D SKR + ++ +  P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300

Query: 258 WI 259
           W+
Sbjct: 301 WL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 91.2 bits (226), Expect = 1e-21
 Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 26/224 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  V+  R   +++ VALK I  E  E         RE+ +  +L+H NI+ L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI--REVSLLKNLKHANIVTLHD 70

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H +  + L+ EY     L  +L+++        +      ++  L   L+YCH+  ++
Sbjct: 71  IIHTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ +G LK+ DFG     SV +++  + +  TL Y  P+ ++ + E+   
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLL 240
           +D W +G + YE   G P F   + K        E  HLI RLL
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVK--------EELHLIFRLL 220

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 90.1 bits (224), Expect = 5e-21
 Identities = 68/299 (22%), Positives = 128/299 (42%), Gaps = 56/299 (18%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++    +G G +G V    +  S   VA+K I     +   +  +  RE++I    +H N
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPH-AFDVPTLAKRTLRELKILRHFKHDN 65

Query: 81  ILRLYGWFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +         D + ++++++     +L+  +   +  TE+    ++  L   L Y H
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTM-----CGTLDYLAPE-MV 188
             +VIHRD+KP NLL++ +  L+IGDFG    + S    H         T  Y APE ++
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 189 ENKEHDYAVDNWTLGILCYEFL---------------------YGAPPFEAESQ------ 221
              E+  A+D W++G +  E L                      G+P  E  ++      
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRV 244

Query: 222 ---------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                             F   S EA  L+S++L  D  +R+++++ ++HP++ +  +P
Sbjct: 245 RKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 90.0 bits (224), Expect = 7e-21
 Identities = 69/313 (22%), Positives = 129/313 (41%), Gaps = 63/313 (20%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + D ++   P+G G +G+V    + ++   VA+K +   F+  I      
Sbjct: 3   RQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI------ 56

Query: 64  HQLR--REMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   + H N++ L   F     +      +L+       +L   + K ++
Sbjct: 57  HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIV-KCQK 114

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            ++      +  +   L Y H   +IHRD+KP N+ ++ +  LKI DFG +  +  +   
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTG 174

Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPF------------------ 216
              T  Y APE++ N  H +  VD W++G +  E L G   F                  
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234

Query: 217 ---------EAESQK---------------DTFRSISAEAKHLISRLLVKDSSKRLSLQK 252
                     +ES +               + F   +  A  L+ ++LV D  KR++  +
Sbjct: 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAE 294

Query: 253 IMEHPWIIKNANP 265
            + HP++ +  +P
Sbjct: 295 ALAHPYLAEYHDP 307

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.9 bits (220), Expect = 8e-21
 Identities = 64/251 (25%), Positives = 117/251 (46%), Gaps = 20/251 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V  V+   +    A K + K++++K   +     E EI   +  P I+ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            F     + L++   + G+L   +     R    ++   Y A +T  + + H   +++RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNWTL 202
           +KPEN+LLD +G  ++ D G +V+ +  +      GT  Y+APE+++ + + Y VD + +
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAM 180

Query: 203 GILCYEFLYGAPPF----EAESQKDTFR------------SISAEAKHLISRLLVKDSSK 246
           G   YE + G  PF    E  ++++  R            + + E+K +    L K    
Sbjct: 181 GCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED 240

Query: 247 RLSLQKIMEHP 257
           RL  ++  + P
Sbjct: 241 RLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 89.0 bits (221), Expect = 8e-21
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 14/214 (6%)

Query: 21  FEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            E  + LG G FG VY    + E E  K PVA+K++ +E     K   ++  E  + +S+
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASV 66

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYC 135
            HP+++RL G      ++ LI +    G L   +R H+     Q    +   +   ++Y 
Sbjct: 67  DHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVEN 190
            E  ++HRD+   N+L+     +KI DFG +  +    K +   G    + ++A E + +
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185

Query: 191 KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
           + + +  D W+ G+  +E + +GA P+E     +
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE 219

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.0 bits (221), Expect = 1e-20
 Identities = 74/302 (24%), Positives = 123/302 (40%), Gaps = 69/302 (22%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +E+ + LG+G +G V   R  E+     VA+K I     +K   +  LR    ++    H
Sbjct: 2   YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61

Query: 79  PNILRLYGWFHDDERIFLILEYAHRG-ELYREL---------RKHRRFTEQQAATYIASL 128
            NI  LY    D + +F           LY EL         R  +  T+    ++I  +
Sbjct: 62  KNITCLY----DMDIVF---PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------VQSRSKRHTMCGTLD 181
              L Y H  +V+HRD+KP NLL++ +  LKI DFG +        ++         T  
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174

Query: 182 YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES---------------QKDTF 225
           Y APE M+  + +  A+D W++G +  E L   P F+ +                 ++T 
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234

Query: 226 RSI---------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
             I                           +  A  L+ +LL  D +KR+S+++ +EHP+
Sbjct: 235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294

Query: 259 II 260
           + 
Sbjct: 295 LA 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 87.8 bits (218), Expect = 1e-20
 Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)

Query: 27  LGKGKFGRV----YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG V    YL++  +    VA+K + +E I   K   +  RE  + + L HP I+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEV-EVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIV 59

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           RL G     E + L++E A  G L + L+K R             +   +AY    H +H
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVH 118

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGT--LDYLAPEMVENKEHDYA 196
           RD+   N+LL +  + KI DFG S      S   R T  G   L + APE +   +    
Sbjct: 119 RDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK 178

Query: 197 VDNWTLGILCYE-FLYGAPPF 216
            D W+ G+  +E F YGA P+
Sbjct: 179 SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.9 bits (213), Expect = 7e-20
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 12/218 (5%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           E   +D  +GR +G+G+FG VY    +     K  VA+K   K        +  L+ E  
Sbjct: 2   EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKT-CKNCTSPSVREKFLQ-EAY 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTN 130
           I     HP+I++L G   ++  +++++E A  GEL   L+ ++          Y   L+ 
Sbjct: 60  IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYLAPE 186
           ALAY      +HRDI   N+L+     +K+GDFG S  ++  S      G L   ++APE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 187 MVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
            +  +    A D W  G+  +E L  G  PF+     D
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 7e-20
 Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 23/223 (10%)

Query: 21  FEIGRPLGKGKFGRVYLVR--EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +EI   +G+G +GRVY  +    +     A+K    ++ +   I     RE+ +   L+H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 79  PNILRLYGWF--HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-IASLT----NA 131
            N++ L   F  H D+ ++L+ +YA   +L++ ++ HR+          + SL     N 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 132 LAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWSVQSRSKRHTMCG------TLD 181
           + Y H N V+HRD+KP N+L+       G +KIGD G +    +    +        T+ 
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180

Query: 182 YLAPEMVENKEHDY--AVDNWTLGILCYEFLYGAPPFEAESQK 222
           Y APE++    H Y  A+D W +G +  E L   P F+    K
Sbjct: 181 YRAPELLLGARH-YTKAIDIWAIGCIFAELLTLEPIFKGREAK 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 85.3 bits (211), Expect = 8e-20
 Identities = 52/193 (26%), Positives = 92/193 (47%), Gaps = 14/193 (7%)

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PN++ L+ +   ++ +FL+L++A  G+L+  + K     E+    + A +  AL   H  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++ RD+ P N+LLD  G +++  F  WS    S        + Y APE+    E   A 
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-YCAPEVGGISEETEAC 163

Query: 198 DNWTLGILCYEFLYGAPPFE-------AESQKDTFRSISAEAKHLISRLLVKDSSKRL-- 248
           D W+LG + +E L G    E         +  +    +S EA+ L+ +LL  + ++RL  
Sbjct: 164 DWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 249 ---SLQKIMEHPW 258
               ++ I  HP+
Sbjct: 224 GVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 9e-20
 Identities = 55/243 (22%), Positives = 101/243 (41%), Gaps = 35/243 (14%)

Query: 16  WSL--QDFEIGRPLGKGKFGRVY--LVREVESKH---PVALKIIF-----KEQIEKYKIQ 63
           W L  +   + R LG+G FG VY  L + V        VA+K +      +E+IE     
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN-- 58

Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---RF---- 116
                E  +       +++RL G     +   +++E   +G+L   LR  R         
Sbjct: 59  -----EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113

Query: 117 ---TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSR 170
              T Q+     A + + +AY      +HRD+   N ++  +  +KIGDFG +    ++ 
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173

Query: 171 SKRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRS 227
             R    G L   ++APE +++       D W+ G++ +E       P++  S ++  + 
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233

Query: 228 ISA 230
           +  
Sbjct: 234 VID 236

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.9 bits (212), Expect = 1e-19
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 8/201 (3%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E    LG+G +  VY  +   +   VALK+I  ++ E         RE  +   L+H N
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHAN 64

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENH 139
           I+ L+   H  E + L+ EY H  +L + + KH      +    ++  L   L+Y H+ +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY 123

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDY 195
           ++HRD+KP+NLL+   G LK+ DFG +       HT      TL Y  P+ ++ + E+  
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 196 AVDNWTLGILCYEFLYGAPPF 216
            +D W +G +  E + G   F
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 85.1 bits (210), Expect = 2e-19
 Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 26/224 (11%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY  R   + + VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 71

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H ++ + L+ EY     L ++L+++               ++  L   L YCH   V+
Sbjct: 72  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126

Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + ++   
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLL 240
           +D W +G + YE   G P F          S   E  H I R+L
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPG--------STVEEQLHFIFRIL 221

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 85.0 bits (210), Expect = 3e-19
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 8/199 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY      +   VALK+I  +  E   +     RE  +   L+H NI+ L+ 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHD 70

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H  E +  + EY H  +L + + +H           ++  L   LAY H  H++HRD+
Sbjct: 71  IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWT 201
           KP+NLL+ + G LK+ DFG +        T      TL Y  P+ ++   ++  A+D W 
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWG 189

Query: 202 LGILCYEFLYGAPPFEAES 220
            G +  E L G P F   S
Sbjct: 190 AGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 84.2 bits (208), Expect = 3e-19
 Identities = 65/238 (27%), Positives = 113/238 (47%), Gaps = 17/238 (7%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   +E K  VA+K I     E    +     E ++   L HP +++LYG
Sbjct: 12  IGSGQFGLVWLGYWLE-KRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R +F+++        +   +AY   ++VIHRD+
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+    ++    D W+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186

Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +   +I+A  +    RL  +      S+ ++M+H W
Sbjct: 187 FGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQ------SVYELMQHCW 238

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.7 bits (207), Expect = 3e-19
 Identities = 64/249 (25%), Positives = 99/249 (39%), Gaps = 32/249 (12%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
             +GKG FG VY    ++    VA+K          K +    +E EI     HPNI++L
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRK--FLQEAEILKQYDHPNIVKL 57

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     + I++++E    G L   LRK + R T ++           + Y    + IHR
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR 117

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLAPEMVENKEHDYAVD 198
           D+   N L+     LKI DFG S +     +T+   L      + APE +    +    D
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177

Query: 199 NWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS-------- 249
            W+ GIL +E F  G  P+   S + T   I              +S  R+         
Sbjct: 178 VWSYGILLWETFSLGDTPYPGMSNQQTRERI--------------ESGYRMPAPQLCPEE 223

Query: 250 LQKIMEHPW 258
           + ++M   W
Sbjct: 224 IYRLMLQCW 232

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 5e-19
 Identities = 64/265 (24%), Positives = 111/265 (41%), Gaps = 38/265 (14%)

Query: 27  LGKGKFGRVY------LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           LG G FG VY      ++        VA+K + K   ++ K +    +E  + S+  HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE--FLKEAHLMSNFNHPN 60

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-------TNALA 133
           I++L G    +E  ++I+E    G+L   LR  R          +  L            
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGR-----LKIGDFG-----WSVQSRSKRHTMCGTLDYL 183
           Y  + H IHRD+   N L+  +G      +KIGDFG     +      K       + ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSISAEAK--------- 233
           APE + + +     D W+ G+L +E L  G  P+ A + ++  + ++A  +         
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPD 240

Query: 234 ---HLISRLLVKDSSKRLSLQKIME 255
               L++    +D S+R +  +I E
Sbjct: 241 KIYQLMTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 83.1 bits (206), Expect = 9e-19
 Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 55/281 (19%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILR 83
           +G+G F  V   +  ++    A+K +     + +K   Q+    EIQ+  R   HPNILR
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 84  LYGWFHDDE--RIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHV 140
           L     D +  R+ L+ E      LY  ++  +R   E++  +Y+  L  +L + H N +
Sbjct: 63  LIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAV 197
            HRDIKPEN+L+  +  LK+ DFG    + S+        T  Y APE ++ +  +   +
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------------------- 228
           D W +G + +E L   P F   ++ D    I                             
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKK 240

Query: 229 -----------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                      SAE   L+ +LL  D  +R++ ++ + HP+
Sbjct: 241 GTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 73/297 (24%), Positives = 120/297 (40%), Gaps = 63/297 (21%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D E  RP+G G FG V+ V +      VALK +     +      ++ RE+++    +H 
Sbjct: 1   DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN-VFQNLVSCKRVFRELKMLCFFKHD 59

Query: 80  NILR--------LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           N+L             F +   I+++ E     +L++ +   +  +      ++  +   
Sbjct: 60  NVLSALDILQPPHIDPFEE---IYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRG 115

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCG---TLDYLAPEM 187
           L Y H   ++HRDIKP NLL++    LKI DFG + V+   +   M     T  Y APE+
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 188 VENKEHDY--AVDNWTLGILCYEFLYGAPPFEAES----------------QKDTFRSIS 229
           +    H Y  AVD W++G +  E L     F+A+S                 +    +  
Sbjct: 176 LMGSRH-YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234

Query: 230 A---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                       EA HL+ R+LV D  KR+S    + HP++
Sbjct: 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 83.0 bits (205), Expect = 2e-18
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 18/228 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + + + L  G  GRV++  +     PV LKI  K           L   M +Q+ + HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQN-VNHPS 118

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++R+           ++L + +  +LY  L ++ R     QA      +   L Y H   
Sbjct: 119 VIRMKDTLVSGAITCMVLPH-YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +IHRD+K EN+ ++   ++ IGD G + Q          + GT++  APE++   +++  
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSK 236

Query: 197 VDNWTLGILCYEFL-YGAPPFEAE--SQKDTFRSISAEAKHLISRLLV 241
            D W+ GI+ +E L Y +  FE    + ++  +S  +    +IS L V
Sbjct: 237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV 284

Length = 357

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 5/148 (3%)

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E  I  ++ HP+I++L G F  ++   LIL   ++ +LY  L   R            S+
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNIAICDILAIERSV 191

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
             A+ Y HEN +IHRDIK EN+ ++H G + +GDFG +      + +K +   GT+   A
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNA 251

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYG 212
           PE++    +  AVD W+ GI+ +E    
Sbjct: 252 PELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 81.3 bits (201), Expect = 4e-18
 Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 25  RPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           R LG+G FG+V+L     +     K  VA+K + KE       +    RE E+ ++ +H 
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTL-KETASN-DARKDFEREAELLTNFQHE 68

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--------------RRFTEQQA---A 122
           NI++ YG   + +   ++ EY   G+L + LR H                 T  Q    A
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTM 176
             IAS    + Y    H +HRD+   N L+ ++  +KIGDFG S  V +    R   HTM
Sbjct: 129 VQIAS---GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
              + ++ PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 186 L-PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 6e-18
 Identities = 71/274 (25%), Positives = 128/274 (46%), Gaps = 20/274 (7%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-QIEKYKIQHQ 65
           R++  K  W + D +   + +G G +G V    +  +   VA+K +++  Q E +    +
Sbjct: 3   RQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFA--KR 60

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRKHRRFTEQ 119
             RE+ +   ++H N++ L   F  D  +      +L++ +   G    +L KH + +E 
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSED 118

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVT 178

Query: 180 LDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----SAEAKH 234
             Y APE++ N  H    VD W++G +  E L G P F+     D    I       +K 
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238

Query: 235 LISRLLVKDSSKRL-SLQKIMEHPW--IIKNANP 265
            + +L  +D+   +  L +  +  +  ++ NANP
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANP 272

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  +   LG+G FG+V+L         + K  VA+K + KE  E  +   Q  RE E+ 
Sbjct: 5   RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQ--REAELL 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTE 118
           + L+H +I+R YG   +   + ++ EY   G+L R LR H                + T 
Sbjct: 62  TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG 178
            Q     + + + + Y    H +HRD+   N L+     +KIGDFG S    S  +   G
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 179 -----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                 + ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I+
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 7e-18
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 12/216 (5%)

Query: 23  IGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I + +G G+FG V   R          VA+K +     +K ++      E  I     HP
Sbjct: 8   IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD--FLTEASIMGQFDHP 65

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+RL G       + +I EY   G L + LR++  +FT  Q    +  + + + Y  E 
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCG--TLDYLAPEMVENKEH 193
           + +HRD+   N+L++     K+ DFG S +         T  G   + + APE +  ++ 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185

Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
             A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 81.6 bits (201), Expect = 8e-18
 Identities = 70/311 (22%), Positives = 127/311 (40%), Gaps = 59/311 (18%)

Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + + ++   P+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 3   RQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY 62

Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   ++H N++ L   F       +   ++L+      G     + K ++ +
Sbjct: 63  ----RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLS 116

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     I  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 117 DEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV 176

Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGA----------------------- 213
            T  Y APE++ N  H +  VD W++G +  E L G                        
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236

Query: 214 -------------------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                              P    +  K  FR  +  A  L+ ++LV DS KR+S  + +
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296

Query: 255 EHPWIIKNANP 265
            HP+  +  +P
Sbjct: 297 AHPYFSQYHDP 307

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.0 bits (197), Expect = 8e-18
 Identities = 58/196 (29%), Positives = 91/196 (46%), Gaps = 9/196 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V+    ++ K PVA+K   ++  ++ KI+     E  I     HPNI++L G
Sbjct: 3   LGKGNFGEVF-KGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIG 59

Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDI 145
                + I++++E    G+    LRK +     +Q   +       +AY    + IHRD+
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDL 119

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPEMVENKEHDYAVDNWT 201
              N L+     LKI DFG S Q     ++  G     + + APE +    +    D W+
Sbjct: 120 AARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWS 179

Query: 202 LGILCYE-FLYGAPPF 216
            GIL +E F  G  P+
Sbjct: 180 YGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.5 bits (198), Expect = 9e-18
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 25/228 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNI 81
           R LG+G FG+V+L  E  +  P   KI+   +  K      +    RE E+ ++L+H +I
Sbjct: 11  RELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASL 128
           ++ YG   + + + ++ EY   G+L + LR H                T+ Q       +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTMCGTLDY 182
              + Y    H +HRD+   N L+     +KIGDFG S  V S    R   HTM   + +
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 188

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           + PE +  ++     D W+LG++ +E F YG  P+   S  +    I+
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 80.1 bits (197), Expect = 1e-17
 Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 32/226 (14%)

Query: 19  QDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG+V+L     +   + K  VA+K +    +   K     +RE E+ 
Sbjct: 5   RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELL 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFT 117
           ++L+H +I++ YG   D + + ++ EY   G+L + LR H                    
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RS 171
             Q     + + + + Y    H +HRD+   N L+     +KIGDFG S  V S    R 
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181

Query: 172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
             HTM   + ++ PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 182 GGHTML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 79.2 bits (195), Expect = 2e-17
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 11/199 (5%)

Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + +  +S+  VA+KI+ K       ++ +L RE  +   L +P I+R+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
            G   + E   L++E A  G L + L+K++  TE+     +  ++  + Y  E + +HRD
Sbjct: 62  IG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT------LDYLAPEMVENKEHDYAVD 198
           +   N+LL  +   KI DFG S    +  +           + + APE +   +     D
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180

Query: 199 NWTLGILCYE-FLYGAPPF 216
            W+ G+L +E F YG  P+
Sbjct: 181 VWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 80.1 bits (197), Expect = 2e-17
 Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 26/220 (11%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           G  +G+G +G VY  +  + K      +   +QIE   I     RE+ +   L+HPN++ 
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDEKEYAL---KQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 84  LYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNAL 132
           L   F  H D +++L+ +YA   +L+  ++ HR         +       + +  + + +
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 133 AYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSRSKRHTMCGTLDY 182
            Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  +    +  T  Y
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181

Query: 183 LAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQ 221
            APE++    H   A+D W +G +  E L   P F    +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 67/252 (26%), Positives = 117/252 (46%), Gaps = 36/252 (14%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVRE--VESKHP-----VALKIIFKEQIEK 59
           E  ++ + E+S     +G+PLG+G FG+V +     ++   P     VA+K++  +  EK
Sbjct: 3   ELPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62

Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 63  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 120

Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  ++Q       + TY   +   + Y      IHRD+   N+L+     +KI
Sbjct: 121 EYSYDIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKI 178

Query: 161 GDFGWSVQSRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238

Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 239 PYPGIPVEELFK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 78.5 bits (193), Expect = 3e-17
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 9/209 (4%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+  R      PVA+K   +E +    ++ +  +E  I     HPNI+RL G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPP-DLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
                + I++++E    G+    LR    R   ++    + +    + Y    H IHRD+
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLAPEMVENKEHDYAVDNW 200
              N L+  +  LKI DFG S +     +   G +      + APE +    +    D W
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVW 180

Query: 201 TLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           + GIL +E F  GA P+   S + T  +I
Sbjct: 181 SFGILLWEAFSLGAVPYANLSNQQTREAI 209

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.8 bits (194), Expect = 3e-17
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 13/217 (5%)

Query: 23  IGRPLGKGKFGRVYLVR-EVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I + +G G+FG V   R ++  K   PVA+K +     EK +       E  I     HP
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + ++ EY   G L   LRKH  +FT  Q    +  + + + Y  + 
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S          +T  G    + + APE +  ++
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
              A D W+ GI+ +E + YG  P+   S +D  ++I
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 78.4 bits (193), Expect = 4e-17
 Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 11/212 (5%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V+L  +  ++  VA+K I     E    +     E ++   L HP +++L
Sbjct: 10  KELGSGQFGVVHL-GKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHR 143
           YG     + ++++ E+   G L   LR+ + + ++    +    +   + Y   N  IHR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDN 199
           D+   N L+   G +K+ DFG +       +T   G    + +  PE+    ++    D 
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 200 WTLGILCYE-FLYGAPPFEAESQKDTFRSISA 230
           W+ G+L +E F  G  PFE +S  +    IS 
Sbjct: 185 WSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 79.7 bits (196), Expect = 5e-17
 Identities = 68/245 (27%), Positives = 119/245 (48%), Gaps = 31/245 (12%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           + K  + + NR      + +++G  +G G FG VY    +++   VA+K + ++   +YK
Sbjct: 52  EEKMIDNDINRS---PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYK 106

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFH------DDERIFL--ILEYAHRGELYRELRKH 113
                 RE+ I  +L H NI+ L  +++      +++ IFL  ++E+  +  +++ ++ +
Sbjct: 107 -----NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHY 160

Query: 114 RRFTEQQ----AATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQ 168
            R            Y   L  ALAY H   + HRD+KP+NLL+D +   LK+ DFG +  
Sbjct: 161 ARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 169 ----SRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
                RS  + +C    Y APE M+    +   +D W+LG +  E + G P F  +S  D
Sbjct: 221 LLAGQRSVSY-ICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Query: 224 TFRSI 228
               I
Sbjct: 279 QLVRI 283

Length = 440

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 77.6 bits (191), Expect = 7e-17
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 11/217 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++   L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE 137
             +++LYG       I+++ EY   G L   LR+H +RF   Q       +   +AY   
Sbjct: 59  EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEH 193
              IHRD+   N L+D +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF 178

Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   +S
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 78.0 bits (192), Expect = 8e-17
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 15/199 (7%)

Query: 25  RPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           R LG+G FG+V L R       +   VA+K +  E    +     L++E+EI  +L H N
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHEN 67

Query: 81  ILRLYGWFHDD--ERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHE 137
           I++  G   +D    I LI+E+   G L   L R   +   +Q   Y   +   + Y   
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGTLD----YLAPEMVENK 191
              +HRD+   N+L++ E ++KIGDFG   ++++  + +T+   LD    + APE +   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS 187

Query: 192 EHDYAVDNWTLGILCYEFL 210
           +   A D W+ G+  YE L
Sbjct: 188 KFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 77.8 bits (192), Expect = 8e-17
 Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 32/232 (13%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLR 67
           EW L      +G+PLG+G FG+V     V   +P     VA+K++  +  EK      L 
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--LV 63

Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------R 115
            EME+   + +H NI+ L G    +  +++++EYA  G L   LR  R           R
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 116 FTEQQAATY-IASLTNALA----YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
             E+      + S    +A    +      IHRD+   N+L+  +  +KI DFG +    
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183

Query: 171 SK---RHTMCGTLDY--LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                R T  G L    +APE + ++ + +  D W+ G+L +E F  G  P+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 77.8 bits (191), Expect = 1e-16
 Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 30/222 (13%)

Query: 24  GRPLGKGKFGRVYLVREVESK--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G  +G+G +G VY  +  + K     ALK     QIE   I     RE+ +   L+HPN+
Sbjct: 6   GCKVGRGTYGHVYKAKRKDGKDDRDYALK-----QIEGTGISMSACREIALLRELKHPNV 60

Query: 82  LRLYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTN 130
           + L   F  H D +++L+ +YA   +L+  ++ HR         +       + +  + +
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSRSKRHTMCGTL 180
            + Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  +    +  T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 181 DYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQ 221
            Y APE++    H   A+D W +G +  E L   P F    +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 23/214 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K    +   Q+    ++E+ I  +L H NI+
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   +   + + LI+EY   G L   L KH+     Q   +   +   +AY H  H 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLHSQHY 128

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY------------LAPEMV 188
           IHRD+   N+LLD++  +KIGDFG +      +    G   Y             A E +
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
           +  +  YA D W+ G+  YE L      ++  +K
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 76.7 bits (189), Expect = 2e-16
 Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 21/215 (9%)

Query: 22  EIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSSLR 77
            + R LG G FG VY  L R  +    V L++  K   E    Q +    ME  I S   
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEALIMSKFN 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-------TN 130
           H NI+RL G   +    F++LE    G+L   LR++R   E+ ++  +  L         
Sbjct: 68  HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAK 127

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG--RL-KIGDFGWS---VQSRSKRHTMCGTL--DY 182
              Y  ENH IHRDI   N LL  +G  R+ KI DFG +    ++   R      L   +
Sbjct: 128 GCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           + PE   +       D W+ G+L +E F  G  P+
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.4 bits (191), Expect = 2e-16
 Identities = 74/311 (23%), Positives = 129/311 (41%), Gaps = 73/311 (23%)

Query: 21  FEIGR------PLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--RE 69
           FE+        P+G+G +G V   +  E+   VA+K I   F  +I+        R  RE
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDA------KRTLRE 54

Query: 70  MEIQSSLRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRRFTEQQAATY 124
           +++   L H N++ +        R     ++++ E     +L++ +R  +  ++     +
Sbjct: 55  IKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLD 181
           +  L   L Y H  +V+HRD+KP NLLL+    LKI DFG +  +  K   M     T  
Sbjct: 114 LYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173

Query: 182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEA------------------ESQK 222
           Y APE++ N  E+  A+D W++G +  E L   P F                    E   
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233

Query: 223 DTFRS------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
              R+                         +  A  L+ ++LV D SKR+++++ + HP+
Sbjct: 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293

Query: 259 IIK----NANP 265
           +      +  P
Sbjct: 294 LASLHDPSDEP 304

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 75.8 bits (186), Expect = 3e-16
 Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 13/207 (6%)

Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +  +      E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLA-----EASVM 53

Query: 74  SSLRHPNILRLYGWFHDDE-RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R          +   +  
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 114 AMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 173

Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPF 216
           K+     D W+ GIL +E + +G  P+
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.4 bits (185), Expect = 6e-16
 Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 33/230 (14%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR---REMEIQSSL 76
           +  +G+ LG+G+FG+V        K       +  + +++     +LR    E  +   +
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--------------------- 115
            HP++++LYG    D  + LI+EYA  G L   LR+ R+                     
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 116 ---FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----- 167
               T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI DFG S      
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
            S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.4 bits (185), Expect = 9e-16
 Identities = 63/244 (25%), Positives = 112/244 (45%), Gaps = 32/244 (13%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQ 65
           K E S     +G+PLG+G FG+V +   +  +   P     VA+K++  +  +K      
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD--LSD 63

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------- 114
           L  EME+   + +H NI+ L G    D  +++++EYA +G L   LR  R          
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT 123

Query: 115 -RFTEQQAA-----TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
            +  E+Q       +    +   + Y      IHRD+   N+L+  +  +KI DFG +  
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 169 SRS---KRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
             +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Query: 223 DTFR 226
           + F+
Sbjct: 244 ELFK 247

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 63/199 (31%), Positives = 97/199 (48%), Gaps = 17/199 (8%)

Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LGKG FG V L R    +  +   VA+K   K Q    +      RE+EI  SL+H NI+
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVK---KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 83  RLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G  +   R  + L++EY   G L   L+KHR R   ++   Y + +   + Y     
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR 128

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPEMVENKEH 193
            +HRD+   N+L++ E R+KIGDFG + V  + K +          + + APE +   + 
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 194 DYAVDNWTLGILCYE-FLY 211
             A D W+ G++ YE F Y
Sbjct: 189 SVASDVWSFGVVLYELFTY 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 1e-15
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 11/217 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +    + LG G+FG V+L  +   K  VA+K+I +  + +         E ++   L HP
Sbjct: 5   ELTFLKELGSGQFGVVHL-GKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           N+++LYG       IF++ EY   G L   LR+ + +   +      + +  A+ Y   N
Sbjct: 60  NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEHD 194
             IHRD+   N L+  +  +K+ DFG +      ++T   GT   + +  PE+ +     
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 195 YAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISA 230
              D W+ G+L +E F  G  P+E  S  +   S+SA
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 21/213 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
              IG+         V+L +   +   VA+K I  +   K  ++  L++E+     L+HP
Sbjct: 3   LTLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA----SLTNALAYC 135
           NIL     F  D  ++++      G     L+ H  F E      IA     + NAL Y 
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYI 117

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTM--------CGTLDYLAP 185
           H    IHR +K  ++LL  +G++ +    +SV      KR  +           L +L+P
Sbjct: 118 HSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 186 EMVENKEHDYAV--DNWTLGILCYEFLYGAPPF 216
           E+++     Y    D +++GI   E   G  PF
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 62/251 (24%), Positives = 112/251 (44%), Gaps = 26/251 (10%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---RREMEIQSSLRHPNILR 83
           LG+G+FG V+L +    +      ++  + ++K K ++     RRE+++   L H N++R
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE------ 137
           L G   + E  ++ILEY   G+L + LR  +   E+     +++    +A C +      
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST-KQKVALCTQIALGMD 131

Query: 138 ----NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMV 188
                  +HRD+   N L+  +  +K+     S    +      R+ +   L +LAPE V
Sbjct: 132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPEAV 190

Query: 189 ENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
           +  +     D W+ G+L +E F  G  PF   S ++    +  +A  L   L V +    
Sbjct: 191 QEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL--QAGKL--ELPVPEGCPS 246

Query: 248 LSLQKIMEHPW 258
             L K+M   W
Sbjct: 247 -RLYKLMTRCW 256

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 59/235 (25%), Positives = 95/235 (40%), Gaps = 35/235 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+   + E  R +G+G FGRV+  R       E    VA+K++ KE+     +Q   +RE
Sbjct: 1   EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASA-DMQADFQRE 58

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL- 128
             + +   HPNI++L G     + + L+ EY   G+L   LR      +   +   +S  
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 129 ---------------------TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                                   +AY  E   +HRD+   N L+     +KI DFG S 
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 168 QSRSKRHTMCGTLD-----YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
              S  +      D     ++ PE +    +    D W  G++ +E F YG  P+
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q ++I R +GKG  G VYL  +      VALK I ++  E   ++ +  RE +I + L 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASL---- 128
           HP I+ +Y    D + ++  + Y   G   + L K     E         T + +     
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYI-EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119

Query: 129 ---TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV---------------QSR 170
                 + Y H   V+HRD+KP+N+LL   G + I D+G ++               +  
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 171 SKRHTM------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
               +M       GT DY+APE +       + D + LG++ Y+ L  + P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 47/197 (23%), Positives = 83/197 (42%), Gaps = 16/197 (8%)

Query: 42  ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY--GWFHDDERIFLILE 99
            + H VA+K++  +  E+   + + RRE  + + L HPNI+ L   G       +F + E
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFE 59

Query: 100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEG 156
           Y     L   L         +    +  + +ALA  H   ++HRD+KP+N+++       
Sbjct: 60  YVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRP 119

Query: 157 RLKIGDFGWS----------VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILC 206
             K+ DFG            V + ++   + GT  Y APE +  +      D +  G++ 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 207 YEFLYGAPPFEAESQKD 223
            E L G    +  S  +
Sbjct: 180 LECLTGQRVVQGASVAE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 14/94 (14%)

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------- 228
           GT DYLAPE++  K H  AVD W LG+  +EFL G PPF  E+ +  F++I         
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601

Query: 229 -----SAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                S  A++ I  LL  D +KR  L+++ +HP
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.1 bits (179), Expect = 4e-15
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 13/214 (6%)

Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V+   L      +  VA+K +     EK +       E  I     H NI+R
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           L G     +   +I EY   G L + LR H   F+  Q    +  +   + Y  + + +H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           RD+   N+L++     K+ DFG S          +T  G    + + APE +  ++   A
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSA 190

Query: 197 VDNWTLGILCYEFL-YGAPPFEAESQKDTFRSIS 229
            D W+ GI+ +E + +G  P+   S  +  ++I+
Sbjct: 191 SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 17/224 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 1   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 59

Query: 75  SLRHPNILRLYGW---FHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              L + H + V+HRD+KP+N+L+   G++K+ DFG    +S Q      ++  TL Y A
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVTLWYRA 177

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           PE++    +   VD W++G +  E     P F   S  D    I
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 221

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 5e-15
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 15/212 (7%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSS 75
           +LQ   +G  +G+G+FG V        K  VA+K I      K  +  Q    E  + + 
Sbjct: 4   NLQKLTLGEIIGEGEFGAVLQGEYTGQK--VAVKNI------KCDVTAQAFLEETAVMTK 55

Query: 76  LRHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRRF--TEQQAATYIASLTNAL 132
           L H N++RL G   H+   +++++E   +G L   LR   R   +  Q   +   +   +
Sbjct: 56  LHHKNLVRLLGVILHNG--LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
            Y     ++HRD+   N+L+  +G  K+ DFG +             + + APE +++K+
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKK 173

Query: 193 HDYAVDNWTLGILCYE-FLYGAPPFEAESQKD 223
                D W+ G+L +E F YG  P+   S K+
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 72.6 bits (178), Expect = 5e-15
 Identities = 56/217 (25%), Positives = 96/217 (44%), Gaps = 23/217 (10%)

Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREME 71
           W ++  D  +   LG G++G VY    V  K+   VA+K + ++ +E      +  +E  
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVY--EGVWKKYSLTVAVKTLKEDTME----VEEFLKEAA 54

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-----FTEQQAATYIA 126
           +   ++HPN+++L G    +   ++I E+   G L   LR+  R           AT I+
Sbjct: 55  VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDY 182
           S   A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + +
Sbjct: 115 S---AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 171

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEF-LYGAPPFEA 218
            APE +   +     D W  G+L +E   YG  P+  
Sbjct: 172 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 72.5 bits (178), Expect = 6e-15
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 35/239 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           E  L        LG+G FG+VY   L    E     ++ I   ++  + K+Q + R+E E
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + S L+HPNI+ L G    ++   ++ EY   G+L+  L ++   ++  A +   ++ ++
Sbjct: 61  LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120

Query: 132 LA----------------YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--------- 166
           L                 Y   +H +HRD+   N L+     +KI DFG S         
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180

Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKD 223
            VQS+S        + ++ PE +   +     D W+ G++ +E F YG  P+   S ++
Sbjct: 181 RVQSKSLL-----PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.7 bits (178), Expect = 6e-15
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 38/237 (16%)

Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V +   +  + + P     VA+K++  +  EK      L  EME+   
Sbjct: 22  LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 79

Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   LR  R                + + 
Sbjct: 80  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 196

Query: 175 --TMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 73.0 bits (179), Expect = 6e-15
 Identities = 73/309 (23%), Positives = 126/309 (40%), Gaps = 70/309 (22%)

Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           RE+  K  W L + +   + +G G +G V    +  +   VA+K +   F+ +I      
Sbjct: 3   REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI----FA 58

Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHR--R 115
            +  RE+ +   ++H N++ L   F       + +  +L++ Y     +  +L+K     
Sbjct: 59  KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY-----MQTDLQKIMGHP 113

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            +E +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +R     
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL---ARHADAE 170

Query: 176 MCG---TLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--- 228
           M G   T  Y APE++ N  H +  VD W++G +  E L G   F+ +   D    I   
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230

Query: 229 ---------------------------------------SAEAKHLISRLLVKDSSKRLS 249
                                                  S +A  L+ ++L  D  KRL+
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT 290

Query: 250 LQKIMEHPW 258
             + +EHP+
Sbjct: 291 ATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.6 bits (175), Expect = 1e-14
 Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 12/222 (5%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E   +  ++ + LG G+FG V++     S   VA+K +   +     +Q  L  E  +  
Sbjct: 2   EIPRESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMK 56

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
           +L+H  ++RLY     +E I++I EY  +G L   L+     +    +   + A +   +
Sbjct: 57  TLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMV 188
           AY    + IHRD++  N+L+      KI DFG +        + R      + + APE +
Sbjct: 117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI 176

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSIS 229
                    D W+ GIL YE + YG  P+   S  D   ++ 
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 12/213 (5%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILR 83
           +G G +G VY  R+  S H VALK + + Q  +  +     RE+ +   L    HPNI+R
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 84  LY---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           L         D    + L + H  +    Y +         +     +      L + H 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDYLAPEMVENKEHDY 195
           N ++HRD+KPEN+L+   G++K+ DFG + + S     T +  TL Y APE++    +  
Sbjct: 127 NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYAT 186

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
            VD W++G +  E     P F   S+ D    I
Sbjct: 187 PVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 70/304 (23%), Positives = 129/304 (42%), Gaps = 76/304 (25%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ---LR--REMEIQ 73
             ++    +G+G +G V       +   VA+K     +I  +  +HQ    R  RE++I 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-----KISPF--EHQTFCQRTLREIKIL 57

Query: 74  SSLRHPNILRL--------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
              +H NI+ +        +  F+D   ++++ E     +LY+ ++  +  +      ++
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFND---VYIVQELMET-DLYKLIKT-QHLSNDHIQYFL 112

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD---- 181
             +   L Y H  +V+HRD+KP NLLL+    LKI DFG + +     H   G L     
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGFLTEYVA 171

Query: 182 ---YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----------------SQ 221
              Y APE M+ +K +  A+D W++G +  E L   P F  +                SQ
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231

Query: 222 KDTFRSISAEAKH--------------------------LISRLLVKDSSKRLSLQKIME 255
           +D    IS  A++                          L+ ++L  +  KR+++++ + 
Sbjct: 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291

Query: 256 HPWI 259
           HP++
Sbjct: 292 HPYL 295

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 72.1 bits (177), Expect = 2e-14
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 23/212 (10%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           RPLG G  G V+   + +    VA+K I     +  K      RE++I   L H NI+++
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDHDNIVKV 67

Query: 85  YGWF-------HDDERIFLILEYAHRGELY-----RELRKHRRFTEQQAATYIASLTNAL 132
           Y           +D      L   +  + Y       + +    +E+ A  ++  L   L
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 133 AYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
            Y H  +V+HRD+KP N+ ++ E   LKIGDFG +         K +   G +   Y +P
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSP 187

Query: 186 EMVENKEH-DYAVDNWTLGILCYEFLYGAPPF 216
            ++ +  +   A+D W  G +  E L G P F
Sbjct: 188 RLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLF 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 28/232 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           K E+      +G+PLG+G FG+V     Y + +      V + +   +     K    L 
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI 65

Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------R 115
            EME+   + +H NI+ L G    +  +++I+EYA +G L   LR  R           +
Sbjct: 66  SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITK 125

Query: 116 FTEQQAA-----TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV--- 167
             E+Q +     +    +   + Y      IHRD+   N+L+  +  +KI DFG +    
Sbjct: 126 VPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Query: 168 QSRSKRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                + T  G L   ++APE + ++ + +  D W+ GIL +E F  G  P+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 68/311 (21%), Positives = 126/311 (40%), Gaps = 59/311 (18%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQ 65
           R++  K  W + + ++   P+G G +G V    + ++     L++  K+    ++ I H 
Sbjct: 5   RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT----GLRVAVKKLSRPFQSIIHA 60

Query: 66  LR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
            R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++ T
Sbjct: 61  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLT 118

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           +      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +     
Sbjct: 119 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 178

Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEF---------------------LYGAPP 215
            T  Y APE++ N  H +  VD W++G +  E                      L G P 
Sbjct: 179 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238

Query: 216 FEAESQ---------------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
            E   +                      + F   +  A  L+ ++LV DS KR++  + +
Sbjct: 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298

Query: 255 EHPWIIKNANP 265
            H +  +  +P
Sbjct: 299 AHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 70.7 bits (173), Expect = 3e-14
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 15/215 (6%)

Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     EK +       E  I     HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69

Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           L G       + +I E+   G L   LR++  +FT  Q    +  +   + Y  E + +H
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVH 129

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  +   T   +L       + APE +  ++  
Sbjct: 130 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFT 189

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
            A D W+ GI+ +E + YG  P+   S +D   +I
Sbjct: 190 SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 46/197 (23%), Positives = 87/197 (44%), Gaps = 16/197 (8%)

Query: 21  FEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + I   L  G  G V++      E +  V +K +   +           RE++I  ++ H
Sbjct: 94  YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISH 145

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+ L   +     + +++   ++ +L+  + +      +QA T    L  ALAY H  
Sbjct: 146 RAIINLIHAYRWKSTVCMVMPK-YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR 204

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENKEH 193
            +IHRD+K EN+ LD      +GDFG + +        + +   GTL+  +PE++    +
Sbjct: 205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264

Query: 194 DYAVDNWTLGILCYEFL 210
               D W+ G++ +E  
Sbjct: 265 CAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 21/212 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   +GKG +G V    +  +   VA+K I  +  E      ++ RE+++   LRHP+
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 81  ILRLYGW--------FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           I+ +           F D   +F ++E     +L++ ++ +   T +    ++  L  AL
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELME----SDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------APE 186
            Y H  +V HRD+KP+N+L + + +LKI DFG +  + +   T     DY+      APE
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 187 MVENKEHDY--AVDNWTLGILCYEFLYGAPPF 216
           +  +    Y  A+D W++G +  E L G P F
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 28/228 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLRHPNILRL 84
           +G G FG+V L  E       A +++ KE         QL   +E++    L HPN+L+ 
Sbjct: 3   IGNGWFGKVLL-GEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHR--------RFTEQQAATYIASLTNALAYCH 136
            G   +     L+LE+   G+L   LR +R        +   Q+ A  +AS    L + H
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS---GLLWLH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LDYLAPEMVENK 191
           +   IH D+   N  L  +  +KIGD+G +++   + + +        L +LAPE+VE +
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 192 EHDYAVDN-------WTLGILCYE-FLYGAPPFEAESQKDTFRSISAE 231
             D    +       W+LG+  +E F     P+   S +   + +  E
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE 225

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 67.8 bits (166), Expect = 2e-13
 Identities = 54/199 (27%), Positives = 84/199 (42%), Gaps = 12/199 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LG G+FG V+      +  PVA+K +    ++          E +I   LRHP +++L
Sbjct: 12  RKLGAGQFGEVWEGLWNNTT-PVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQL 66

Query: 85  YGWFHDDERIFLILEYAHRGEL--YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           Y     +E I+++ E    G L  Y +    R     Q     A + + +AY    + IH
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEMVENKEHDYAVD 198
           RD+   N+L+      K+ DFG + V          G    + + APE           D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 199 NWTLGILCYEFL-YGAPPF 216
            W+ GIL  E + YG  P+
Sbjct: 187 VWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 6e-13
 Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 22/223 (9%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQIEKYKIQH 64
           + K E+   +   G+ LG G FG+V     VE      SK    +K+  K          
Sbjct: 27  DLKWEFPRNNLSFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSE 81

Query: 65  Q--LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQ 119
           +  L  E++I S L  H NI+ L G       I +I EY   G+L   LR+ R    T +
Sbjct: 82  REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE 141

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
              ++   +   +A+    + IHRD+   N+LL H   +KI DFG +  + + S      
Sbjct: 142 DLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG 201

Query: 178 GT---LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                + ++APE + N  + +  D W+ GIL +E F  G+ P+
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 27  LGKGKFGRVYL-VREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   V ++  K   VA+K++ K + EK  ++ ++ RE EI   L +P I+R+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEK-SVRDEMMREAEIMHQLDNPYIVRM 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G   + E + L++E A  G L + L  K    T       +  ++  + Y    + +HR
Sbjct: 61  IG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 144 DIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCG-TLDYLAPEMVENKEHDYAV 197
           D+   N+LL ++   KI DFG S       S  K  +     L + APE +  ++     
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRS 179

Query: 198 DNWTLGILCYE-FLYGAPPFE 217
           D W+ GI  +E F YG  P++
Sbjct: 180 DVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 16/214 (7%)

Query: 18  LQDFEIGRP--LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREME 71
           L++ E+ R   LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  
Sbjct: 4   LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEAL 61

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTN 130
           I +S+ HP+++RL G       I L+ +    G L   + +H+     Q    +   +  
Sbjct: 62  IMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAP 185
            + Y  E  ++HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A 
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180

Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEA 218
           E +  ++  +  D W+ G+  +E + +G  P++ 
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 23/217 (10%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEI 72
           S Q F+I   LG+G FG+V    + + K   A+KI+    + KY    KI+ Q   ++  
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKIEIQFMEKVRQ 184

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
                   ++++  +F ++     I+   +   L   + KH  F+ +  A  I     AL
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 133 AYCH-ENHVIHRDIKPENLLLDHEG----------------RLKIGDFGWSVQSRSKRHT 175
            Y H E H++H D+KPEN+L++                   R++I D G     R  R  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA 304

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG 212
           +  T  Y +PE+V      Y+ D W++G + YE   G
Sbjct: 305 IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.6 bits (157), Expect = 5e-12
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 14/209 (6%)

Query: 20  DFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    + E E  K PVA+K +   +    K   ++  E  + +S
Sbjct: 8   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMAS 65

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 66  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVE 189
             E  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 190 NKEHDYAVDNWTLGILCYEFL-YGAPPFE 217
           ++ + +  D W+ G+  +E + +G+ P++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 64.3 bits (156), Expect = 6e-12
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 24/220 (10%)

Query: 19  QDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +D +    +G+G FG+V   ++++   K   A+K++  ++            E+E+   L
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCKL 59

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQ 119
             HPNI+ L G   +   +++ +EYA  G L   LRK R                  T Q
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
           Q   + + +   + Y  E   IHRD+   N+L+      KI DFG S           G 
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGR 179

Query: 180 LD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           L   ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 63.5 bits (155), Expect = 8e-12
 Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 14/217 (6%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            ++ R LG G+FG V++     +    VA+K + K      +      +E +I   LRH 
Sbjct: 8   LKLERKLGAGQFGEVWM--GTWNGTTKVAVKTL-KPGTMSPE---AFLQEAQIMKKLRHD 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHE 137
            +++LY    ++E I+++ EY  +G L   L+    ++    Q     A +   +AY   
Sbjct: 62  KLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEH 193
            + IHRD+   N+L+      KI DFG +        + R      + + APE       
Sbjct: 122 RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF 181

Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W+ GIL  E   YG  P+   + ++    + 
Sbjct: 182 TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 23/225 (10%)

Query: 25  RPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           R LG+G FG VY  + + V    P   VA+K + +    + +I+     E  +       
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNEASVMKEFNCH 69

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT---------- 129
           +++RL G     +   +I+E   RG+L   LR  R   E        SL           
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLD--YLA 184
           + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R    G L   +++
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
           PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 35/178 (19%)

Query: 19  QDFEIGRPLGKGKFGRVYL------VREVESKHP----------VALKIIFKEQIEKYKI 62
           Q       LG+G+FG V+L          E              VA+K++  +  +  + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA- 121
                +E++I S L  PNI RL G    D  + +I+EY   G+L + L+KH   T   A 
Sbjct: 65  D--FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 122 -------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                        AT IAS    + Y    + +HRD+   N L+     +KI DFG S
Sbjct: 123 NSKSLSFSTLLYMATQIAS---GMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.4 bits (151), Expect = 2e-11
 Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 26/213 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR---EMEIQSSL-RHPNIL 82
           +G+G FG+V  ++    K  + +    K ++++Y  +   R    E+E+   L  HPNI+
Sbjct: 3   IGEGNFGQV--LKARIKKDGLRMDAAIK-RMKEYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIA 126
            L G       ++L +EYA  G L   LRK R                  + QQ   + A
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD--YLA 184
            +   + Y  +   IHRD+   N+L+      KI DFG S           G L   ++A
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 179

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
            E +    +    D W+ G+L +E +  G  P+
Sbjct: 180 IESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.0 bits (150), Expect = 2e-11
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 13/217 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++     +KH    K+  K              E  +  +L+H
Sbjct: 6   ESLKLEKKLGAGQFGEVWMA--TYNKHT---KVAVKTMKPGSMSVEAFLAEANVMKTLQH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASLTNALAYCH 136
             +++L+      E I++I E+  +G L   L+      +   +   + A +   +A+  
Sbjct: 61  DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKE 192
           + + IHRD++  N+L+      KI DFG +        + R      + + APE +    
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 179

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
                D W+ GIL  E + YG  P+   S  +  R++
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 28/222 (12%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNIL 82
           + +G G FG+V L  EV S +  A +++ KE      +Q Q++   E Q   SL+H N+L
Sbjct: 1   KEIGNGWFGKVIL-GEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRR--------FTEQQAATYIASLTNALAY 134
           +  G   +     L++E+   G+L   LR  R+         T Q+ A  IA     L +
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL---GLLH 115

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----LDYLAPEMVE 189
            H+N+ IH D+   N LL  +  +KIGD+G S     + + +        L ++APE+V+
Sbjct: 116 LHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVD 175

Query: 190 NKEHDYAV-------DNWTLGILCYE-FLYGAPPFEAESQKD 223
               +  V       + W+LG+  +E F  G+ P+   S + 
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.6 bits (149), Expect = 4e-11
 Identities = 56/241 (23%), Positives = 105/241 (43%), Gaps = 29/241 (12%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E +L        LG+ +FG+VY          E    VA+K + K++ E   ++ + + E
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAE-GPLREEFKHE 58

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL--------------RKHRR 115
             ++S L+HPNI+ L G    ++ + +I  Y    +L+  L               K  +
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 116 FTEQQAATY--IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRS 171
            T + A     +  +   + +   +HV+H+D+   N+L+  +  +KI D G    V +  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD 178

Query: 172 KRHTMCGTL---DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRS 227
               M  +L    +++PE +   +     D W+ G++ +E F YG  P+   S +D    
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238

Query: 228 I 228
           I
Sbjct: 239 I 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 60/202 (29%), Positives = 91/202 (45%), Gaps = 32/202 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQ--LRREMEIQSSLR 77
           F I R L  G  G V+     ES HP    +++ K       +     LRR       L 
Sbjct: 171 FAIHRALTPGSEGCVF-----ESSHPDYPQRVVVKAGWYASSVHEARLLRR-------LS 218

Query: 78  HPNILRLYGWFHDDERIF-----LILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNA 131
           HP +L L      D R+      L+L   +R +LY  L  + R     Q       L +A
Sbjct: 219 HPAVLALL-----DVRVVGGLTCLVLP-KYRSDLYTYLGARLRPLGLAQVTAVARQLLSA 272

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPE 186
           + Y H   +IHRDIK EN+L++    + +GDFG +  +R    T     + GT+D  APE
Sbjct: 273 IDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332

Query: 187 MVENKEHDYAVDNWTLGILCYE 208
           ++    +  +VD W+ G++ +E
Sbjct: 333 VLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 25  RPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           R +GKG FG VY   L+     K   A+K +   +I   +   Q  +E  I     HPN+
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 82  LRLYGWFHDDERIFLI-LEYAHRGELYRELRKHRRF-TEQQAATYIASLTNALAYCHENH 139
           L L G     E   L+ L Y   G+L   +R      T +    +   +   + Y     
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFG----------WSVQSRSKRHTMCGTLDYLAPEMVE 189
            +HRD+   N +LD    +K+ DFG          +SV   +        + ++A E ++
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH--NHTGAKL-PVKWMALESLQ 175

Query: 190 NKEHDYAVDNWTLGILCYEFLY-GAPPF 216
            ++     D W+ G+L +E +  GAPP+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 14/211 (6%)

Query: 19  QDFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
            +    + LG G FG V+    + E +S K PVA+K I  +     +   ++   M    
Sbjct: 7   TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMG 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALA 133
           SL H  I+RL G       + L+ + +  G L   +R+HR     Q+   +   +   + 
Sbjct: 65  SLDHAYIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMY 123

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC---GTLDYLAPEMV 188
           Y  E+ ++HR++   N+LL  +  ++I DFG +  +    K++        + ++A E +
Sbjct: 124 YLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEA 218
               + +  D W+ G+  +E + YGA P+  
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 59/227 (25%), Positives = 95/227 (41%), Gaps = 32/227 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVES--KHPVALKIIFKEQIEKYKIQHQLRR---E 69
           EW+  D +    +G+G FG+V   R  +   +   A+K     ++++Y  +   R    E
Sbjct: 5   EWN--DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIK-----RMKEYASKDDHRDFAGE 57

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------------- 114
           +E+   L  HPNI+ L G       ++L +EYA  G L   LRK R              
Sbjct: 58  LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 117

Query: 115 --RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
               + QQ   + A +   + Y  +   IHRD+   N+L+      KI DFG S      
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177

Query: 173 RHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
                G L   ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 48/229 (20%), Positives = 93/229 (40%), Gaps = 20/229 (8%)

Query: 46  PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DE--RIFLILEYA 101
            V ++   K       +      E++    +   NIL++YG+  D  D+  R+ LILEY 
Sbjct: 45  EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 102 HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKI 160
            RG L   L K +  + +            L   ++  +  ++++   + L+    +LKI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164

Query: 161 GDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEA 218
              G      S        + Y + +M+ +   E+    D ++LG++ +E   G  PFE 
Sbjct: 165 ICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224

Query: 219 ESQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIM 254
            + K+ +  I               E K ++      DS KR ++++I+
Sbjct: 225 LTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273

Length = 283

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 32/225 (14%)

Query: 30  GKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           G FGR++   L+ E   K         K+   + ++   L+    +   L H NIL +  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYG-LSHQNILPILH 75

Query: 87  -WFHDDERIFLILEYAHRGELYRELRK--------HRRFTEQQAATYIASLTNALAYCHE 137
               D E  F++  Y + G L   L++         +  + QQ       +   ++Y H+
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR----SKRHTMCGT----LDYLAPEMVE 189
             VIH+DI   N ++D E ++KI D   +  SR       H +       + ++A E + 
Sbjct: 136 RGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 190 NKEHDYAVDNWTLGILCYEF--LYGAP-----PFEAESQ-KDTFR 226
           NKE+  A D W+ G+L +E   L   P     PFE  +  KD +R
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 59.2 bits (143), Expect = 4e-10
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           EIGR  G      VYL R   +   V ++I   E   +  ++  L+ E+ +    RHPNI
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLK-ALQNEVVLSHFFRHPNI 61

Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL----TNALAYCHE 137
           +  +  F     +++I  +   G     L+ +  F E  +   I ++       L Y H+
Sbjct: 62  MTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQ 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHTMC--------GTLDYLAPEM 187
           N  IHR+IK  ++L+  +G + +      +S+    ++  +           L +L+PE+
Sbjct: 120 NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL 179

Query: 188 VENKEHDYAV--DNWTLGILCYEFLYGAPPFE 217
           +    + Y V  D +++GI   E   G  PF+
Sbjct: 180 LRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 62/307 (20%), Positives = 123/307 (40%), Gaps = 73/307 (23%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q    +      RE+ +  
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY----RELVLLK 75

Query: 75  SLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
            + H NI+ L   F       + + ++L++E      L + +  H     ++ +  +  +
Sbjct: 76  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI--HMELDHERMSYLLYQM 132

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAP 185
              + + H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y AP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTACTNFMMTPYVVTRYYRAP 191

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------- 228
           E++    +   VD W++G +  E + G+  F+     D +  +                 
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251

Query: 229 ------------------------------------SAEAKHLISRLLVKDSSKRLSLQK 252
                                               +++A+ L+S++LV D  KR+S+ +
Sbjct: 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDE 311

Query: 253 IMEHPWI 259
            + HP+I
Sbjct: 312 ALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 58.4 bits (141), Expect = 5e-10
 Identities = 60/252 (23%), Positives = 105/252 (41%), Gaps = 23/252 (9%)

Query: 23  IGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I R LG G+FG +    L    + + PVA+  +     +K   +     E        H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAEALTLGQFDHS 66

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+RL G       + ++ EY   G L   LRKH  +    Q    +  L + + Y  E 
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYL--APEMVENKEHD 194
             +H+ +    +L++ +   KI  F    + +S+    TM G    L  APE ++     
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSIS--------AEAKHLISRLLV---- 241
            A D W+ GI+ +E + YG  P+   S +D  +++             +L+ +L++    
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQ 246

Query: 242 KDSSKRLSLQKI 253
           K+  +R    +I
Sbjct: 247 KERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 69/328 (21%), Positives = 133/328 (40%), Gaps = 92/328 (28%)

Query: 13  KREWSLQDFEIG-------------RPLGKGKFGRVYLVREVESKHPVALKII---FKEQ 56
           KR+ +    EIG             +P+G G  G V    +   +  VA+K +   F+ Q
Sbjct: 5   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 64

Query: 57  IEKYKIQHQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYR 108
               +      RE+ +   + H NI+ L   F       + + +++++E   A+  ++ +
Sbjct: 65  THAKRAY----RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ 120

Query: 109 ELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
               H R +       +  +   + + H   +IHRD+KP N+++  +  LKI DFG +  
Sbjct: 121 MELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175

Query: 169 SRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGIL--------------------- 205
           + +         T  Y APE++    +   VD W++G +                     
Sbjct: 176 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235

Query: 206 ---------CYEFLYGAPP-------------------------FEAESQKDTFRSISAE 231
                    C EF+    P                         F A+S+ +  +  +++
Sbjct: 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQ 293

Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           A+ L+S++LV D+SKR+S+ + ++HP+I
Sbjct: 294 ARDLLSKMLVIDASKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 65/310 (20%), Positives = 128/310 (41%), Gaps = 79/310 (25%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q    +      RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY----RELVLMK 71

Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 126

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186

Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246

Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 304

Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 305 VDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.9 bits (137), Expect = 2e-09
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 26/177 (14%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVE-------------SKHPVALKIIFKEQIEKYK 61
           E+  Q   +   LG+G+FG V+L  E E                PV + +          
Sbjct: 1   EFPRQQLRLKEKLGEGQFGEVHLC-EAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT 59

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
            ++   +E++I S L++PNI+RL G    D+ + +I EY   G+L + L +    +    
Sbjct: 60  ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTH 119

Query: 122 ATYIASLTNA------------LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
           A  I S++ A            + Y    + +HRD+   N L+ +   +KI DFG S
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 2e-09
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 22/217 (10%)

Query: 21  FEIGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           F +GR LGKG+FG V    L  E  S   VA+K++  +      I+ +  RE        
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 78  HPNILRLYG---WFHDDERI---FLILEYAHRGELYRELRKHR------RFTEQQAATYI 125
           HPN+++L G         R+    +IL +   G+L+  L   R          Q    ++
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----L 180
             + + + Y    + IHRD+   N +L+    + + DFG S +  S  +   G      +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
            +LA E + +  +    D W  G+  +E +  G  P+
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.1 bits (135), Expect = 3e-09
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 29/167 (17%)

Query: 27  LGKGKFGRVYLVR--------------EVESKHP--VALKIIFKEQIEKYKIQHQLRREM 70
           LG+G+FG V+L                +V    P  VA+K++ +E   K   ++   +E+
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANK-NARNDFLKEI 70

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------RFTEQQ 120
           +I S L+ PNI+RL       + + +I EY   G+L + L +H                 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 121 AATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
              ++A+ + + + Y    + +HRD+   N L+     +KI DFG S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 49/210 (23%), Positives = 99/210 (47%), Gaps = 14/210 (6%)

Query: 25  RPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + LG G FG VY    + + E+ K PVA+K++ +E     K   ++  E  + + +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVL-RENTSP-KANKEILDEAYVMAGVGSPY 70

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           + RL G       + L+ +    G L   +R+++ R   Q    +   +   ++Y  E  
Sbjct: 71  VCRLLG-ICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGT--LDYLAPEMVENKEHD 194
           ++HRD+   N+L+     +KI DFG +       ++ H   G   + ++A E + ++   
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
           +  D W+ G+  +E + +GA P++    ++
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 13/211 (6%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V++         VA+K + +  +           E  +   L+HP ++RL
Sbjct: 12  KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRL 66

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIH 142
           Y      E I++I EY   G L   L+     + T  +     A +   +A+    + IH
Sbjct: 67  YAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      KI DFG +        + R      + + APE +         D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185

Query: 199 NWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
            W+ GIL  E + YG  P+   +  +  +++
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 5e-09
 Identities = 54/230 (23%), Positives = 97/230 (42%), Gaps = 54/230 (23%)

Query: 27  LGKGKFGRVYLVREVESKHP-----------------VALKIIFKEQIEKYKIQHQLRRE 69
           LG+G+FG V+L  EV +                    VA+KI+  +  +  +  +   +E
Sbjct: 13  LGEGQFGEVHLC-EVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR--NDFLKE 69

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ---------- 119
           ++I S L+ PNI+RL G   D++ + +I EY   G+L + L  H    ++          
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 120 --------QAATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
                    +  ++A  + + + Y    + +HRD+   N L+     +KI DFG S    
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 167 ------VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
                 +Q R+        + ++A E +   +   A D W  G+  +E L
Sbjct: 190 AGDYYRIQGRAVL-----PIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 5e-09
 Identities = 61/228 (26%), Positives = 106/228 (46%), Gaps = 29/228 (12%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +G G FG+V L+ E+ +   VA +++ KE       K Q++  ++ +    L+HPNIL+ 
Sbjct: 3   IGNGWFGKV-LLSEIYTDTGVA-RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 85  YGWFHDDERIFLILEYAHRGELYRELRK---HRRFTE----QQAATYIASLTNALAYCHE 137
            G   +     L+ EY   G+L   L +   HRR ++    Q+ A  IA+    + + H+
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA---GVTHMHK 117

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM------CGTLDYLAPEMVENK 191
           ++ +H D+   N  L  +  +K+GD+G    SR K   +      C  L +LAPE+V   
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGP-SRYKEDYIETEDDKCVPLRWLAPELVGEF 176

Query: 192 -------EHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAE 231
                  E     + W LG+  +E F   A P+   S ++    +  +
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 49/212 (23%), Positives = 87/212 (41%), Gaps = 34/212 (16%)

Query: 23  IGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-------IQ 73
           +G+ LG+G+FG V    + + +S   VA+K +        KI    R EME         
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM--------KIAICTRSEMEDFLSEAVCM 54

Query: 74  SSLRHPNILRLYG-WFHDDER-----IFLILEYAHRGELYRELRKHR------RFTEQQA 121
               HPN++RL G      E        +IL +   G+L+  L   R          Q  
Sbjct: 55  KEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML 114

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL- 180
             ++  + + + Y      IHRD+   N +L+    + + DFG S +  +  +   G + 
Sbjct: 115 VKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174

Query: 181 ----DYLAPEMVENKEHDYAVDNWTLGILCYE 208
                ++A E + ++ +    D W+ G+  +E
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 32/209 (15%)

Query: 25  RPLGKGKFGRVY--LVREVESKHP---VALKII-----FKEQIEKYKIQHQLRREMEIQS 74
           R LG+G FG VY    R++        VA+K +      +E+IE          E  +  
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-------FLNEASVMK 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE----------QQAATY 124
                +++RL G     +   +++E    G+L   LR  R   E          Q+    
Sbjct: 65  GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTL- 180
            A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R    G L 
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 181 -DYLAPEMVENKEHDYAVDNWTLGILCYE 208
             ++APE +++     + D W+ G++ +E
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWE 213

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 52/216 (24%), Positives = 94/216 (43%), Gaps = 23/216 (10%)

Query: 18  LQDFEIGRPLGKGKFGRVYL------VREVESKHPVALKIIFKEQ----IEKY-----KI 62
           L  F +   L  G FG++++        E E++  V      K +    I K      + 
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206

Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI---LEYAHRGELYRE-LRKHRRFTE 118
             QL  E+     L H NIL++      +   ++I    ++     +Y E      R   
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----H 174
           +Q    +  L  A+ Y H+  +IHRDIK EN+ L+ +G++ +GDFG ++    +R    +
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
              GT+   +PE++    +    D W+ G++  + L
Sbjct: 327 GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.8 bits (127), Expect = 5e-08
 Identities = 68/306 (22%), Positives = 121/306 (39%), Gaps = 84/306 (27%)

Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSSLRHPNIL 82
           +P+G G  G V    +  +   VA+K   K       + H  R  RE+ +   + H NI+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNII 78

Query: 83  RLYGWFHDDER------IFLILEY--AHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L   F   +       ++L++E   A+  ++ +    H R +       +  +   + +
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQMLCGIKH 133

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPEMV--- 188
            H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y APE++   
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYRAPEVILGM 192

Query: 189 ---EN----------------------KEHDYAVDNWT-----LGILCYEFL-------- 210
              EN                       +H   +D W      LG    EF+        
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGTPSDEFMSRLQPTVR 249

Query: 211 --------YGAPPFE---------AESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKI 253
                   Y    FE          +S+    +  +++A+ L+S++LV D  KR+S+   
Sbjct: 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHN-KLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 254 MEHPWI 259
           ++HP+I
Sbjct: 309 LQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 52.3 bits (125), Expect = 5e-08
 Identities = 50/217 (23%), Positives = 89/217 (41%), Gaps = 13/217 (5%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++         VA+K +    +           E +I   LRH
Sbjct: 6   ESLQLIKKLGNGQFGEVWM-GTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCH 136
             +++LY     +E I+++ EY  +G L   L+  + R           A +   +AY  
Sbjct: 61  DKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKE 192
             + IHRD++  N+L+      KI DFG +        + R      + + APE      
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 193 HDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRSI 228
                D W+ GIL  E +  G  P+   + ++    +
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 52.1 bits (125), Expect = 6e-08
 Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 21/210 (10%)

Query: 21  FEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            ++G+ LG+G+FG V    L ++  S+  VA+K + K  I  Y    +   E        
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59

Query: 78  HPNILRLYG---WFHDDERI---FLILEYAHRGELYRELRKHR------RFTEQQAATYI 125
           HPN+++L G        ++I    +IL +   G+L+  L   R      +   Q    ++
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL----- 180
             +   + Y    + IHRD+   N +L  +  + + DFG S +  S  +   G +     
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
            ++A E + ++ +    D W  G+  +E  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 36/148 (24%), Positives = 64/148 (43%), Gaps = 7/148 (4%)

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYI 125
           +E ++   LRH  +++LY     +E I+++ EY  +G L   L+    +     Q     
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMA 108

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD 181
           A + + +AY    + +HRD++  N+L+      K+ DFG +        + R      + 
Sbjct: 109 AQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 168

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEF 209
           + APE           D W+ GIL  E 
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 49/211 (23%), Positives = 85/211 (40%), Gaps = 17/211 (8%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++            K+  K       +     +E +I   LRH  ++ LY 
Sbjct: 14  LGQGCFGEVWM-----GTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 87  WFHDDERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I+++ E+  +G L   L+    K+ +    Q     A + + +AY    + IH
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYIERMNYIH 125

Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      KI DFG +        + R      + + APE           D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 199 NWTLGILCYEFLY-GAPPFEAESQKDTFRSI 228
            W+ GIL  E +  G  P+     ++    +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 46/229 (20%), Positives = 100/229 (43%), Gaps = 29/229 (12%)

Query: 27  LGKGKFGRVY----LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG+  FG++Y     +  ++    VA+K +  + I   +   + ++E  + + L HPNI+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 83  RLYGWFHDDERIFLILEYAHRGELY-----RELRKHRRFTEQQAATYIASLTN------- 130
            L G    ++ + ++ EY ++G+L+     R        +  +  T  +SL +       
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 131 -----ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT-----L 180
                 + Y   +  +H+D+   N+L+  +  +KI D G S +  S  +          +
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
            ++ PE +   +     D W+ G++ +E F +G  P+   S ++    +
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 33/257 (12%)

Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEK-----YKIQHQLRREMEIQSSLRHPN 80
           LG+G F  +Y  V  V+S   +         + K     ++          + S L H +
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALAYCHENH 139
           +++LYG    DE I ++ EY   G L   L + +          +A  L +AL Y  +  
Sbjct: 63  LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121

Query: 140 VIHRDIKPENLLLDHEGR-------LKIGDFGW--SVQSRSKRHTMCGTLDYLAPEMVEN 190
           ++H ++  +N+L+   G        +K+ D G   +V SR +R      + ++APE + N
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---RIPWIAPECIRN 178

Query: 191 --KEHDYAVDNWTLGILCYEFLYGAP-PFEA--ESQKDTF---RSI-----SAEAKHLIS 237
                  A D W+ G    E       P      S+K+ F   +        AE  +LI+
Sbjct: 179 GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELANLIN 238

Query: 238 RLLVKDSSKRLSLQKIM 254
           +    D +KR S + I+
Sbjct: 239 QCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 44/160 (27%), Positives = 70/160 (43%), Gaps = 32/160 (20%)

Query: 76  LRHPNILRLYGWFHDDERIFLILEY---AHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           L+HPNI++L G    ++  +LI EY    +  E+ R L   RR   ++ A  IA    AL
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERR---RKIAIGIAK---AL 793

Query: 133 AYCHEN---HVIHRDIKPENLLLD--HEGRLKIG-------DFGWSVQSRSKRHTMCGTL 180
            + H      V+  ++ PE +++D   E  L++        D    + S           
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA---------- 843

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
            Y+APE  E K+     D +  G++  E L G  P +AE 
Sbjct: 844 -YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882

Length = 968

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 30/146 (20%), Positives = 52/146 (35%), Gaps = 13/146 (8%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
             + L  G   RVYL+          LKI    +           RE+ I   L    + 
Sbjct: 2   SIKLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGA-----DREREVAILQLLARKGLP 54

Query: 83  --RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
             ++      D   +L++E+     L     + +    +Q A  +A L           +
Sbjct: 55  VPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLAELLAKLHQLPLLV----L 110

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS 166
            H D+ P N+L+D    L I D+ ++
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYA 136

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 43/185 (23%), Positives = 72/185 (38%), Gaps = 42/185 (22%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +  +   DF +G+ LG+G FG VY    V  +     K + K+  E Y         +EI
Sbjct: 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE-YG-------AVEI 177

Query: 73  --QSSLRH--PNILR--LYGWFH-----DDERIFLILEYAHRGELYRELRKHRRF----- 116
                +R   PN     +YG+        ++  +L+  Y     L  +L + + F     
Sbjct: 178 WMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA-DLMQSKEFPYNVE 236

Query: 117 -------------TEQQAA---TYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLK 159
                         E++     T +  +  AL   H   ++HRD+KP+N++     G  K
Sbjct: 237 PYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFK 296

Query: 160 IGDFG 164
           I D G
Sbjct: 297 IIDLG 301

Length = 566

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.8 bits (103), Expect = 4e-05
 Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 14/86 (16%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+  S R      L ++APE + +K
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL----PLKWMAPESIFDK 251

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPF 216
            +    D W+ G+L +E F  GA P+
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 18/32 (56%), Positives = 25/32 (78%)

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
           H   ++HRDIKPENLL+  +G++KI DFG +V
Sbjct: 326 HRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357

Length = 507

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 55/222 (24%), Positives = 93/222 (41%), Gaps = 37/222 (16%)

Query: 27  LGKGKFGRVY--LVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREME-------I 72
           LG+G F +++  + REV       K  V LK++ K            R   E       +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----------RNYSESFFEAASM 52

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNA 131
            S L H +++  YG     +   ++ EY   G L   L+K++          +A  L  A
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWA 112

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR--------LKIGDFGWSVQSRSKRHTMCGTLDYL 183
           L +  +  + H ++  +N+LL  E          +K+ D G S+    K   +   + ++
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-EILLERIPWV 171

Query: 184 APEMVENKEH-DYAVDNWTLGILCYE-FLYGAPPFEA-ESQK 222
            PE +EN ++   A D W+ G   +E F  G  P  A +SQK
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 42/86 (48%), Gaps = 14/86 (16%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+    R      L ++APE + +K
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL----PLKWMAPESIFDK 250

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPF 216
            +    D W+ G+L +E F  GA P+
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPY 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 34/212 (16%)

Query: 71  EIQSSLR---HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT------EQQA 121
           E  S +R   H +I+ LYG    D    ++ E+   G L  +L  HR+        + + 
Sbjct: 53  ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKFKV 110

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-------LKIGDFGWSVQSRSKRH 174
           A  +AS   AL+Y  +  ++H ++  +N+LL  EG        +K+ D G  +   S R 
Sbjct: 111 AKQLAS---ALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS-RQ 166

Query: 175 TMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLY-GAPPFEAE--SQKDTF----- 225
                + ++APE VE+ K    A D W+ G   +E  Y G  P + +  ++K+ F     
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226

Query: 226 RSISAEAKH---LISRLLVKDSSKRLSLQKIM 254
             ++   K    L++  +  D ++R   + IM
Sbjct: 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.6 bits (97), Expect = 2e-04
 Identities = 27/86 (31%), Positives = 42/86 (48%), Gaps = 14/86 (16%)

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSKRHTMCGTLDYLAPEMVENK 191
           IHRD+   N+LL     +KI DFG +         V+    R      L ++APE + ++
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL----PLKWMAPETIFDR 256

Query: 192 EHDYAVDNWTLGILCYE-FLYGAPPF 216
            +    D W+ G+L +E F  GA P+
Sbjct: 257 VYTIQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 8/83 (9%)

Query: 141 IHRDIKPENLLLDHEGRL-KIGDFGWSVQSRSKRHTMCG-----TLDYLAPEMVENKEHD 194
           IHRD+   N+LL H GR+ KI DFG +   R+  + +        + ++APE + N  + 
Sbjct: 236 IHRDLAARNILLTH-GRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYT 294

Query: 195 YAVDNWTLGILCYE-FLYGAPPF 216
           +  D W+ GIL +E F  G+ P+
Sbjct: 295 FESDVWSYGILLWEIFSLGSSPY 317

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.4 bits (94), Expect = 6e-04
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRL-KIGDFGWSVQ-SRSKRHTMCGT----LD 181
           + N + +    + +HRD+   N+L+  EG+L KI DFG +    R   +   G+    L 
Sbjct: 248 VANGMEFLASKNCVHRDLAARNVLI-CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLK 306

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           ++APE + N  +    D W+ GIL +E F  G  P+
Sbjct: 307 WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 35/166 (21%), Positives = 72/166 (43%), Gaps = 14/166 (8%)

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAAT 123
           L+ E+ +     HPNI+     F  D  ++++  +   G     +  H     +E   A 
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF--GWSVQSRSKRHTM----- 176
            +  +  AL Y H    +HR +K  ++L+  +G++ +       S+ +  +R  +     
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 177 ---CGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFE 217
                 L +L+PE+++   + +D   D +++GI   E   G  PF+
Sbjct: 166 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 36/143 (25%), Positives = 59/143 (41%), Gaps = 11/143 (7%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           N K E+   + + G+ LG G FG+V     + + + ++   VA+K++ K      + +  
Sbjct: 30  NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML-KASAHTDE-REA 87

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
           L  E++I S L +H NI+ L G       + +I EY   G+L   LRK            
Sbjct: 88  LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMAL 147

Query: 125 IASLTNALAY---CHENHVIHRD 144
                 +  Y     E   I  D
Sbjct: 148 PEISETSSDYKNITLEKKYIRSD 170

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 28/110 (25%), Positives = 48/110 (43%), Gaps = 8/110 (7%)

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTM 176
           ++   +   + +    + +HRD+   N+LL     +KI DFG +          SK  T 
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTF 225
              + ++APE + +  +    D W+ GIL +E F  G  P+       TF
Sbjct: 301 L-PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 37.0 bits (86), Expect = 0.004
 Identities = 26/93 (27%), Positives = 43/93 (46%), Gaps = 11/93 (11%)

Query: 131 ALAYCHEN----HVIHRDIKPENLLLDHEGRLKI-GDFGWSVQSRSKRHTMCGTLDYLAP 185
             A C +       +HR  K  N+LL  +G LK+ G   +    +S+         ++AP
Sbjct: 19  IWAVCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSRPDPY-----FMAP 73

Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFE 217
           E+++ + +    D ++LGI  YE L Y  P  E
Sbjct: 74  EVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	271
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
PRK12274	218	serine/threonine protein kinase; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.83
PRK10345	210	hypothetical protein; Provisional	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.74
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
KOG1243	690	consensus Protein kinase [General function predict	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.71
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.6
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.52
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.49
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.46
KOG3087	229	consensus Serine/threonine protein kinase [General	99.45
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.28
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.22
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.19
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.05
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.04
PRK09902	216	hypothetical protein; Provisional	99.01
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.85
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.72
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.53
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.38
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.28
PLN02876	822	acyl-CoA dehydrogenase	98.25
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.2
KOG2270	520	consensus Serine/threonine protein kinase involved	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.18
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.11
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.03
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.03
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.03
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.94
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.83
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.8
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.78
PRK05231	319	homoserine kinase; Provisional	97.75
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.73
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.59
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.45
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.41
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.39
PLN02236	344	choline kinase	97.36
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.36
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.11
PLN02756	418	S-methyl-5-thioribose kinase	97.09
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.09
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	97.08
PRK12396	409	5-methylribose kinase; Reviewed	97.06
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.94
PRK10593	297	hypothetical protein; Provisional	96.92
PTZ00384	383	choline kinase; Provisional	96.81
PRK11768	325	serine/threonine protein kinase; Provisional	96.25
PTZ00296	442	choline kinase; Provisional	96.24
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.03
PRK06148	1013	hypothetical protein; Provisional	95.9
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.47
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.17
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.17

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-56  Score=378.25  Aligned_cols=248  Identities=38%  Similarity=0.757  Sum_probs=232.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|...+.||+|||+.+|.+++..+|+.||+|++.+.........+++.+|+++.+.++||||++++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            56999999999999999999999999999999999988877788899999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Ccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~  175 (271)
                      |+|+.++|.+++++.+++++.+++.++.||+.|+.|||+++|+|||||..|++++.+.++||+|||++....   .....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~T  177 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKT  177 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccce
Confidence            999999999999999999999999999999999999999999999999999999999999999999996544   67788


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~~l~~~p  244 (271)
                      .+|||-|+|||+++....+..+||||+||++|.|+.|.+||+..+-.+..++           ++.++.+||.++|.+||
T Consensus       178 lCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P  257 (592)
T KOG0575|consen  178 LCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNP  257 (592)
T ss_pred             ecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCc
Confidence            8999999999999999999999999999999999999999998876666544           58999999999999999


Q ss_pred             cCCCCHHHHhcCCccccCCCCC
Q 024158          245 SKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       245 ~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      .+|||+++||.|+||++.-.|.
T Consensus       258 ~~Rpsl~~vL~h~Ff~~g~~p~  279 (592)
T KOG0575|consen  258 SERPSLDEVLDHPFFKSGFTPA  279 (592)
T ss_pred             ccCCCHHHHhcCHhhhCCCcCC
Confidence            9999999999999997764443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-56  Score=363.96  Aligned_cols=247  Identities=36%  Similarity=0.603  Sum_probs=219.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH----HHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ....|.+.+.||+|+||.|-+|..+++|+.||||++.++.....    ......++|+.+|+++.||+|++++++++..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            34557889999999999999999999999999999988765442    12344679999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---CCEEEeeecccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQS  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---~~~~L~dfg~~~~~  169 (271)
                      +.|+|+||++||.|.+.+-.++.+.++.-..++.|++.|+.|||+.||.||||||+|||+..+   ..+||+|||+++..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999998999999999999999999999999999999999999999776   67999999999887


Q ss_pred             c--CccccccccccccCCccccCCCC---CccchhhhHHHHHHHHHhCCCCCCCCCcch----------------hhccc
Q 024158          170 R--SKRHTMCGTLDYLAPEMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------TFRSI  228 (271)
Q Consensus       170 ~--~~~~~~~~~~~y~~pe~~~~~~~---~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------~~~~i  228 (271)
                      .  +.....+|||.|.|||.+.+...   ..+.|+|||||++|-+++|.+||+......                .|.++
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~I  409 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRI  409 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhh
Confidence            4  45677899999999999987653   347799999999999999999998655332                35568


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +.+..+||+.||..||++|||++++|+||||+..+
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            99999999999999999999999999999999665

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-55  Score=354.16  Aligned_cols=252  Identities=34%  Similarity=0.509  Sum_probs=224.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ...+.+++.+.++.||+|..|+||+|+++.+++-+|+|++....  ++...+++.+|+++++.++||||+.+|+.|..++
T Consensus        73 ~~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   73 DNGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             ccccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            34567779999999999999999999999999999999994332  3356788999999999999999999999999998


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       ...++||||++|||...+...+..++..+..++.++++||.|||+ ++|+||||||+|||+...|.+||||||.+....
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv  230 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV  230 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence             599999999999999999988889999999999999999999996 899999999999999999999999999885433


Q ss_pred             -CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----------------cchhhc-ccCHH
Q 024158          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-----------------QKDTFR-SISAE  231 (271)
Q Consensus       171 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~-----------------~~~~~~-~i~~~  231 (271)
                       +......||..|+|||.+.+..|+.++||||||+.++|++.|.-|+....                 ++.... ..+++
T Consensus       231 nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~e  310 (364)
T KOG0581|consen  231 NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPE  310 (364)
T ss_pred             hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHH
Confidence             34577889999999999999999999999999999999999999998751                 111122 26889


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      +++||..||.+||.+|||+.|+++|||+++...+.
T Consensus       311 f~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  311 FRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            99999999999999999999999999999886643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-53  Score=342.76  Aligned_cols=249  Identities=39%  Similarity=0.707  Sum_probs=232.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .....++|++++.||.|+||+||.++.+.+++.||+|++.+.........+..+.|..++.+++||.|+.++..|++.+.
T Consensus        20 ~~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   20 EMVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             ccCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            36789999999999999999999999999999999999999888777778889999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc---cc
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SR  170 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~---~~  170 (271)
                      +|+|+||+.||.|...|++.+.++++.+.-++..|+.||.|||++||+|||+||+|||+|.+|+++|+|||+++.   ..
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999999999999999989999999999999999999999999999999999999999999999999999953   33


Q ss_pred             CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------------cCHHHHHHHHH
Q 024158          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------------ISAEAKHLISR  238 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------------i~~~l~~li~~  238 (271)
                      ..+...+||+.|+|||++.+.+++...|-||||+++|+|++|.+||.+.+.....++            ++.+.++++++
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~  259 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKK  259 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHH
Confidence            456778999999999999999999999999999999999999999998886665443            58899999999


Q ss_pred             hcccCccCCC----CHHHHhcCCccccC
Q 024158          239 LLVKDSSKRL----SLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rp----s~~~il~~~~~~~~  262 (271)
                      +|..||++|.    .+++|.+||||...
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~i  287 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKGI  287 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCcccccC
Confidence            9999999995    89999999999875

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-53  Score=354.97  Aligned_cols=249  Identities=38%  Similarity=0.659  Sum_probs=229.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~   92 (271)
                      ..-..+||.+.+.||+|+|++|++|+++.+++.||+|++.+.-...+.-.+-+..|-..|..+ .||+|++++--|.++.
T Consensus        68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~  147 (604)
T KOG0592|consen   68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE  147 (604)
T ss_pred             ccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence            366789999999999999999999999999999999999998887777677777888888888 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+|+|+||+++|.|.++++..+.+++...+.++.+|+.||+|||++||+||||||+|||+|.+++++|.|||.++...+.
T Consensus       148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987432211


Q ss_pred             ----------------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc---------
Q 024158          173 ----------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------  227 (271)
Q Consensus       173 ----------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~---------  227 (271)
                                      .....||..|.+||.++....+..+|+|+|||++|+|+.|.+||.+......+++         
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence                            1336799999999999999999999999999999999999999999998888766         


Q ss_pred             --cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 --ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 --i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                        +|+.+++||+++|..||..|+++++|.+||||...
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V  344 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV  344 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence              48999999999999999999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-52  Score=324.11  Aligned_cols=247  Identities=42%  Similarity=0.751  Sum_probs=235.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ..+++|+.++.||.|+||.|.+++++.+|..+|+|++.+...-+-+..+-..+|..+|+.+.||.++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            88999999999999999999999999999999999999998888788888899999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      +||||.+||.|.+++++.+.+++..++.++.+|+.|++|||+++|++||+||+|||+|++|.+|+.|||+++.....+..
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T  200 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT  200 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~~l~~~p  244 (271)
                      .+|||.|+|||.+.+.++..+.|=|+||+++|+|+.|.+||...++-+..++           +++++++|++++|+.|-
T Consensus       201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~  280 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDL  280 (355)
T ss_pred             ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999999999999999999999888766655           48999999999999999


Q ss_pred             cCCC-----CHHHHhcCCccccC
Q 024158          245 SKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rp-----s~~~il~~~~~~~~  262 (271)
                      .+|.     -..+|..||||...
T Consensus       281 t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  281 TKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HhhhcCcCCCccccccCcccccc
Confidence            9994     67799999999865

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-52  Score=330.56  Aligned_cols=243  Identities=28%  Similarity=0.511  Sum_probs=214.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      |+.|+.+.++|+|+||+|++|+++.+|+-||||.|..+. +++...+-..+|++++++++|+|++.++++|......++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            578999999999999999999999999999999995543 3345566778999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      +|||+. ++.+.+.+.+ .++...+..++.|++.|+.|+|+++++||||||+||+++.+|.+||||||++.....   ..
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            999985 6767776643 589999999999999999999999999999999999999999999999999865443   33


Q ss_pred             ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-------------------------
Q 024158          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------------------------  227 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-------------------------  227 (271)
                      ..+..|-+|+|||.+.+ ..|....|||++||++.+|++|.+.|++..+-+++..                         
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            34567889999999998 6799999999999999999999999999888776533                         


Q ss_pred             -----------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 -----------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 -----------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                       ++.-+.++++.||..||++|+|.+|+|.||||...
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~  290 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF  290 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence                             24668899999999999999999999999999654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6e-51  Score=344.90  Aligned_cols=255  Identities=38%  Similarity=0.694  Sum_probs=228.8

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ........+++++|++.+.||+|+||.||+|++..+++.+++|++.............+.+|+.+++.++||||+++++.
T Consensus         7 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   86 (329)
T PTZ00263          7 FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCS   86 (329)
T ss_pred             eeccccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34446778899999999999999999999999999999999999977655444556778899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +..++..|++|||+.+++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         87 FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCce
Confidence            99999999999999999999999888889999999999999999999999999999999999999999999999999987


Q ss_pred             cccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHH
Q 024158          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLI  236 (271)
Q Consensus       168 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li  236 (271)
                      ..........|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .++..+.+++
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  246 (329)
T PTZ00263        167 KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLV  246 (329)
T ss_pred             EcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHH
Confidence            66555556678999999999999889999999999999999999999998766543322           2578999999


Q ss_pred             HHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          237 SRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+||..||.+||+     ++++++||||.+.
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            9999999999996     7999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-51  Score=333.15  Aligned_cols=249  Identities=36%  Similarity=0.691  Sum_probs=225.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..++|.+.+.||+|+|++||+|+++.++..||||.+.+..... +..+.+..|+.+|+.++||||+.+++++..++++|+
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~-k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK-KLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH-HHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            4689999999999999999999999999999999998876543 557788999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC------CCEEEeeeccccccc
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE------GRLKIGDFGWSVQSR  170 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~------~~~~L~dfg~~~~~~  170 (271)
                      |||||.||+|.+++++.+.+++..++..+.||+.|+++||+++|+||||||.|||++..      -.+||.|||++....
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999998899999999999999999999999999999999999999875      359999999986554


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc--------------cCHHHHH
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS--------------ISAEAKH  234 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~--------------i~~~l~~  234 (271)
                      ..  ....+|+|-|||||+.....|+.|+|+||+|+++|++++|..||...+..+.+..              ++..+.+
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~  246 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRE  246 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhh
Confidence            33  3556899999999999999999999999999999999999999998877766533              3566789


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      ++...+..+|..|.+..+-+.|++...++-.+
T Consensus       247 Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~  278 (429)
T KOG0595|consen  247 LLISLLQRNPKDRISFEDFFDHPFLAANPQDR  278 (429)
T ss_pred             hhhHHHhcCccccCchHHhhhhhhcccCcccc
Confidence            99999999999999999999999998876443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.9e-51  Score=342.27  Aligned_cols=249  Identities=39%  Similarity=0.648  Sum_probs=228.4

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .......||++++.||+|+||.||+|+.+.+|+.+|+|++.++..-......-++.|-.+|....++.||+++..|.+.+
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            34668899999999999999999999999999999999999988877777788888999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc--
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~--  170 (271)
                      ++||||||.+||++..+|.+.+.|+++.++.++.+++.|+..+|..|++|+||||+|+|||..|++||+|||++....  
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            999999999999999999998999999999999999999999999999999999999999999999999999872100  


Q ss_pred             ------------------------Cc----c--------------------ccccccccccCCccccCCCCCccchhhhH
Q 024158          171 ------------------------SK----R--------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTL  202 (271)
Q Consensus       171 ------------------------~~----~--------------------~~~~~~~~y~~pe~~~~~~~~~~~Di~sl  202 (271)
                                              ..    .                    ....|||.|+|||++.+..|+..+|-|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                    00    0                    01358999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCcchhhccc---------------CHHHHHHHHHhcccCccCCC---CHHHHhcCCccccC
Q 024158          203 GILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  262 (271)
Q Consensus       203 g~il~~l~~g~~p~~~~~~~~~~~~i---------------~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  262 (271)
                      |||+|||+.|.+||.+.++.+.+++|               ++++.+||.+||+ ||++|.   +++||..||||+..
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence            99999999999999999998887763               7999999999999 999998   69999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-50  Score=343.20  Aligned_cols=247  Identities=40%  Similarity=0.767  Sum_probs=222.2

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH--HHHHHHHHHHHHHHhhCC-CCceeceeeEEEeC
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQSSLR-HPNILRLYGWFHDD   91 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~   91 (271)
                      ....++|.+.+.||+|+||+|+++++..++..+|+|++.+.....  ......+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            467789999999999999999999999999999999876652221  134556778999999999 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecccccc-
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQS-  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~~~~~-  169 (271)
                      ..+|+||||+.||.|.+++.+.+.+++..+..++.||+.|+.|||++||+||||||+||+++.+ +++||+|||++... 
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999998889999999999999999999999999999999999999999 99999999999765 


Q ss_pred             --cCccccccccccccCCccccCCC-CC-ccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------cc-CHHHH
Q 024158          170 --RSKRHTMCGTLDYLAPEMVENKE-HD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SI-SAEAK  233 (271)
Q Consensus       170 --~~~~~~~~~~~~y~~pe~~~~~~-~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i-~~~l~  233 (271)
                        .......+|++.|+|||++.+.. |+ .++|+||+|++||.|++|..||...+......           .+ +++++
T Consensus       173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~  252 (370)
T KOG0583|consen  173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEAR  252 (370)
T ss_pred             CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHHH
Confidence              34566789999999999999877 86 68999999999999999999999866444432           24 88999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      +++.+||.++|.+|+|+.+|++||||++
T Consensus       253 ~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  253 SLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999998

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-50  Score=333.78  Aligned_cols=244  Identities=39%  Similarity=0.710  Sum_probs=219.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||+|++..+++.+++|++.............+.+|+.+++.++||||+++++++.+++.+|++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997655444445667889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~  178 (271)
                      ||+++++|.+++...+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...........|
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g  160 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG  160 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence            99999999999988888999999999999999999999999999999999999999999999999998665555555678


Q ss_pred             cccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCC
Q 024158          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKR  247 (271)
Q Consensus       179 ~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~R  247 (271)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..           ..+++.+.+++++||..||.+|
T Consensus       161 t~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  240 (291)
T cd05612         161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRR  240 (291)
T ss_pred             ChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHc
Confidence            99999999999888999999999999999999999999877654332           2357899999999999999999


Q ss_pred             CC-----HHHHhcCCccccC
Q 024158          248 LS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       248 ps-----~~~il~~~~~~~~  262 (271)
                      |+     ++++++||||+..
T Consensus       241 ~~~~~~~~~~~l~h~~~~~~  260 (291)
T cd05612         241 LGNMKNGADDVKNHRWFKSV  260 (291)
T ss_pred             cCCccCCHHHHhcCccccCC
Confidence            95     9999999999764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-51  Score=337.93  Aligned_cols=245  Identities=31%  Similarity=0.491  Sum_probs=218.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCC-e
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE-R   93 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~-~   93 (271)
                      .-+.+|.++++||.|.||.||+|+.+.+|+.||||.+++.....+ ..-. .+|+..|+++. ||||+++.+++.+++ .
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~n-LREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHH-HHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            457899999999999999999999999999999999977765533 2333 36888999998 999999999999888 9


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +|+|||+|+ .+|.++++.+ +.+++..++.++.||++||.|+|.+|+.|||+||+|||+.....+||+|||++....+.
T Consensus        85 L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   85 LYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             EeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            999999997 6999999874 57899999999999999999999999999999999999998899999999999665543


Q ss_pred             --cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc---------------------
Q 024158          173 --RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------------  228 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i---------------------  228 (271)
                        ...+..|-+|+|||++.. +-|+.+.|+|++||+++|+++-++.|.|...-+++.+|                     
T Consensus       164 pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~  243 (538)
T KOG0661|consen  164 PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASA  243 (538)
T ss_pred             CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHH
Confidence              345667889999998875 56899999999999999999999999999887776553                     


Q ss_pred             --------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          229 --------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       229 --------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                          ++++.++|.+|+.+||++|||++++|+|||||...
T Consensus       244 mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  244 MNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             hccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                                68899999999999999999999999999999763

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-49  Score=335.82  Aligned_cols=252  Identities=38%  Similarity=0.672  Sum_probs=224.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCC-ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      .....++.++|++.+.||+|+||.||+|++..++ ..+++|.+.............+.+|+.+++.++||||+++++++.
T Consensus        22 ~~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         22 KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             ccCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3446678899999999999999999999876655 689999997765544455667889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      .++.+|++|||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999999999988888999999999999999999999999999999999999999999999999998766


Q ss_pred             cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHH
Q 024158          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISR  238 (271)
Q Consensus       170 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~  238 (271)
                      ........|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...++....           ..+++++.+++++
T Consensus       182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  261 (340)
T PTZ00426        182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKK  261 (340)
T ss_pred             CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence            55555667899999999999888999999999999999999999999877654332           2258899999999


Q ss_pred             hcccCccCCC-----CHHHHhcCCccccC
Q 024158          239 LLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      ||..+|.+|+     +++++++||||.+.
T Consensus       262 ~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        262 LLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999995     99999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-51  Score=321.01  Aligned_cols=258  Identities=30%  Similarity=0.529  Sum_probs=221.4

Q ss_pred             CCchhhhhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc
Q 024158            1 MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN   80 (271)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~   80 (271)
                      |+....-..+-.+...++.+|+++++||+|+||+||+++...+|..+|.|.+..+..+. +..+.+..|+.+|++++|||
T Consensus         1 M~~~~~~~~~~~~~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~-k~rq~~v~Ei~lLkQL~HpN   79 (375)
T KOG0591|consen    1 MDKQSSAMMDFSPPQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDA-KARQDCVKEISLLKQLNHPN   79 (375)
T ss_pred             CCcccccccCCCCCcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccH-HHHHHHHHHHHHHHhcCCch
Confidence            44444445555567788999999999999999999999999999999999998665554 55788889999999999999


Q ss_pred             eeceee-E-EEeCCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCe
Q 024158           81 ILRLYG-W-FHDDERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHE--NH--VIHRDIKPENL  150 (271)
Q Consensus        81 i~~~~~-~-~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~--~~--i~H~dl~~~Ni  150 (271)
                      |+++++ . .++++.++++||+|++|+|...++.    .+.+++..+|.++.|++.||..+|+  ..  +.||||||.||
T Consensus        80 IVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNI  159 (375)
T KOG0591|consen   80 IVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANI  159 (375)
T ss_pred             HHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchhe
Confidence            999998 3 3444558999999999999999975    3458999999999999999999998  34  99999999999


Q ss_pred             eeCCCCCEEEeeecccccccCc---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc
Q 024158          151 LLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS  227 (271)
Q Consensus       151 li~~~~~~~L~dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~  227 (271)
                      +++.+|.+||+|||++......   .....|||.|++||.+.+.+|+.++||||+||++|+|+.-++||.+..-.+..++
T Consensus       160 Fl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K  239 (375)
T KOG0591|consen  160 FLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK  239 (375)
T ss_pred             EEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH
Confidence            9999999999999998665543   3567899999999999999999999999999999999999999998865555444


Q ss_pred             -------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          228 -------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       228 -------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                   ++.+++.+|..|+.+||+.||+.     +|++++.+.
T Consensus       240 I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~  284 (375)
T KOG0591|consen  240 IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS  284 (375)
T ss_pred             HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence                         36889999999999999999986     566655543

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-49  Score=333.06  Aligned_cols=244  Identities=34%  Similarity=0.594  Sum_probs=221.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||+|++..+++.+++|++.+...........+..|+.++..++|+||+++++++..++..|++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999998765554445667888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~  178 (271)
                      ||+++++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...........|
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g  160 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG  160 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence            99999999999988788999999999999999999999999999999999999999999999999998766555556678


Q ss_pred             cccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------------ccCHHHHHHHHHh
Q 024158          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------------SISAEAKHLISRL  239 (271)
Q Consensus       179 ~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------------~i~~~l~~li~~~  239 (271)
                      ++.|+|||.+.+..++.++|+||||+++|+|++|..||......+...                   .+++++.+++.+|
T Consensus       161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  240 (333)
T cd05600         161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKL  240 (333)
T ss_pred             CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHH
Confidence            999999999998899999999999999999999999998765433211                   3478999999999


Q ss_pred             cccCccCCCCHHHHhcCCccccC
Q 024158          240 LVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      |..+|++|||++++++||||.+.
T Consensus       241 l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         241 INDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hhChhhhcCCHHHHHhCcccCCC
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-50  Score=306.54  Aligned_cols=253  Identities=64%  Similarity=1.139  Sum_probs=235.3

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ......|.+++|.+.+.||.|-||.||+++.++++.-+++|++.++..........+++|+++.+.++||||.++++++.
T Consensus        13 ~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   13 SRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             cccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            34557899999999999999999999999999999999999999998888888899999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           90 DDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~--~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +....|+++||.+.|++...|.  ....+++.....++.|++.|+.|+|.++++||||+|+|+|++.+|.++++|||.+.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999999999998  45678999999999999999999999999999999999999999999999999986


Q ss_pred             cc-cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHH
Q 024158          168 QS-RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHL  235 (271)
Q Consensus       168 ~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~l  235 (271)
                      .. .......+||..|.|||...+..++...|+|++|+++|+++.|.+||......+..++           ++.+.+++
T Consensus       173 ~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dl  252 (281)
T KOG0580|consen  173 HAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADL  252 (281)
T ss_pred             ecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHH
Confidence            55 4556778999999999999999999999999999999999999999998876555443           68999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      |.+||.++|.+|.+..|++.|||++..
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHHhc
Confidence            999999999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-49  Score=306.49  Aligned_cols=245  Identities=30%  Similarity=0.529  Sum_probs=218.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|...++||+|.||.||+|++.++|+.||+|.++.....+ .......+|++.++.++|+||+.++++|...+...+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            47888999999999999999999999999999997765443 33456678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccc-
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-  176 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~-  176 (271)
                      ||++ .+|+..++.. ..++..++.+++.++++|++|||++.|.|||+||.|++++.+|.+||.|||++....+..... 
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            9997 6999999874 468999999999999999999999999999999999999999999999999997766554332 


Q ss_pred             --cccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc-------------------------
Q 024158          177 --CGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------------------  228 (271)
Q Consensus       177 --~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i-------------------------  228 (271)
                        .-|-+|+|||.+.|.. |....|+||.||++.||+-|.+.|.+.++-+++..+                         
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence              4688999999998764 888999999999999999999999998877775432                         


Q ss_pred             --------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          229 --------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       229 --------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                    ++++.+|+..|+..||.+|+|+.|+|+|+||...+.|
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence                          5778999999999999999999999999999987654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-49  Score=328.16  Aligned_cols=249  Identities=31%  Similarity=0.509  Sum_probs=218.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--Ce
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ER   93 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   93 (271)
                      .....|+.+++||+|.||.||+|++..+|+.||+|.+..+.... ....-..+||.+|++++||||+++.++..+.  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            34567999999999999999999999999999999997765443 4456677899999999999999999998776  68


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +|+|+|||+. +|.-++.. .-.+++.++.-++.||+.||.|||.+|+.|||||.+|||||.+|.+||+|||++......
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999985 99999977 347999999999999999999999999999999999999999999999999999754443


Q ss_pred             c----ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc--------------------
Q 024158          173 R----HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS--------------------  227 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~--------------------  227 (271)
                      .    .....|.+|+|||.+.|. .|+...|+||.|||+.||+.|+++|.+.+..+++.+                    
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            3    334568999999999986 489999999999999999999999999887766543                    


Q ss_pred             --------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          228 --------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       228 --------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                          ++....+|+..+|..||.+|.|+.++|.++||...+.+-
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~  410 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPC  410 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCC
Confidence                                378899999999999999999999999999996655443

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.9e-48  Score=327.75  Aligned_cols=238  Identities=39%  Similarity=0.652  Sum_probs=211.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|+||.||+|++..+|+.+++|++.+...........+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997765444444566778999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Ccccccccccc
Q 024158          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLD  181 (271)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~~  181 (271)
                      +|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++....   .......|++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~  160 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence            999999888889999999999999999999999999999999999999999999999999875432   22234568999


Q ss_pred             ccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCC--
Q 024158          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--  248 (271)
Q Consensus       182 y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rp--  248 (271)
                      |+|||.+.+..++.++|+||||+++|+|++|..||.........           ..+++++.+++.+||..||++||  
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05571         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCC
Confidence            99999999989999999999999999999999999776543322           34689999999999999999999  


Q ss_pred             ---CHHHHhcCCccccC
Q 024158          249 ---SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 ---s~~~il~~~~~~~~  262 (271)
                         ++.++++||||+..
T Consensus       241 ~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         241 GPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence               89999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-48  Score=317.33  Aligned_cols=255  Identities=30%  Similarity=0.495  Sum_probs=225.6

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ..+........+|++...||.|..++||+|+..-+++.|+||++..+.....  .+.+++|++.++.++||||+.++..|
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            3456677889999999999999999999999999999999999977766554  78999999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ..+..+|+||.+|.+||+.+.++..  ..+++..+..+++++++||.|||.+|.+|||+|+.||||+.+|.++|+|||.+
T Consensus        94 vv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvs  173 (516)
T KOG0582|consen   94 VVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVS  173 (516)
T ss_pred             EecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceee
Confidence            9999999999999999999999873  35899999999999999999999999999999999999999999999999976


Q ss_pred             ccccCc---c----ccccccccccCCcccc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc---------------
Q 024158          167 VQSRSK---R----HTMCGTLDYLAPEMVE--NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------  222 (271)
Q Consensus       167 ~~~~~~---~----~~~~~~~~y~~pe~~~--~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------------  222 (271)
                      ......   .    ....|++.|+|||.+.  -..|+.++||||||++..||++|..||....+.               
T Consensus       174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~  253 (516)
T KOG0582|consen  174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL  253 (516)
T ss_pred             eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc
Confidence            332221   1    3457899999999964  356899999999999999999999999765533               


Q ss_pred             ------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          223 ------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       223 ------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                            +...++++.++.++..||.+||.+|||++++|+|+||++.+.+
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence                  3344568899999999999999999999999999999998654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.9e-49  Score=334.86  Aligned_cols=243  Identities=34%  Similarity=0.600  Sum_probs=223.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      |++|.+.+.||+|+||.||+++.+++.+.||+|.+.+....+ +....+++|+++++.++||||+.++++|+...+.++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            578999999999999999999999999999999998876544 5678899999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc---
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~---  174 (271)
                      .||+.| +|..++...+.++++.+..++.+++.|+.|||+.+|.|+|+||.||+++.+|.+|+||||++.....++.   
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            999975 9999999999999999999999999999999999999999999999999999999999999988776654   


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------hcccCHHHHHHHHHhcccC
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------FRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------~~~i~~~l~~li~~~l~~~  243 (271)
                      ...|||.|+|||...+.+|+..+|+|||||++|+++.|++||-...-.+.           ..+++..+..+++.+|.+|
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kd  238 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKD  238 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcC
Confidence            34689999999999999999999999999999999999999965443333           3356899999999999999


Q ss_pred             ccCCCCHHHHhcCCccccC
Q 024158          244 SSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~  262 (271)
                      |.+|.|-.+++.|||.++.
T Consensus       239 P~~RltW~~Ll~HpF~k~~  257 (808)
T KOG0597|consen  239 PAQRLTWTDLLGHPFWKGK  257 (808)
T ss_pred             hhhcccHHHHhcChHHhhh
Confidence            9999999999999999876

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-49  Score=335.95  Aligned_cols=252  Identities=33%  Similarity=0.621  Sum_probs=228.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      -..+-|++.+.||.|+.|.|-+|++.+||+..|||++.+...-.......+.+|+.+++.+.|||+++++++++...++|
T Consensus         9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly   88 (786)
T KOG0588|consen    9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY   88 (786)
T ss_pred             ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence            34566888999999999999999999999999999997764333445677889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--cc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~  173 (271)
                      +|.||+++|.|.+++-+.+++++.++...++||+.|+.|||..+|+|+|+||+|+++|..+++||+|||.+.....  --
T Consensus        89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999999999999999989999999999999999999999999999999999999999999999999999854433  34


Q ss_pred             ccccccccccCCccccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcc
Q 024158          174 HTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLV  241 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~  241 (271)
                      ...+|+|.|.+||+..|.+|+ .++||||-|+|||.|++|++||+..+....+.           .|++++++|+.+||.
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~  248 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLD  248 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhc
Confidence            677999999999999999986 59999999999999999999999777655543           379999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                      .||..|.|.+||++|||+++....+.
T Consensus       249 VDp~~RiT~~eI~kHP~l~g~~~~~~  274 (786)
T KOG0588|consen  249 VDPSTRITTEEILKHPFLSGYTSLPS  274 (786)
T ss_pred             cCccccccHHHHhhCchhhcCCCCCh
Confidence            99999999999999999999976654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=320.08  Aligned_cols=244  Identities=32%  Similarity=0.586  Sum_probs=211.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC--eEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--RIF   95 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~~   95 (271)
                      ..++...+.||+|+||.||++.+.++|...+||.+.......   .+.+.+|++++++++||+|+++++.....+  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            456888999999999999999999999999999986653222   678999999999999999999999744444  699


Q ss_pred             EEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeecccccccC--
Q 024158           96 LILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~~~~--  171 (271)
                      +.|||+++|+|.+++.+.+ .+++..++.++.|+++||.|||++|++|+||||+|||++. ++.+||+|||.+.....  
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999876 7999999999999999999999999999999999999999 79999999998855442  


Q ss_pred             ----ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCC-Cc-------------chhhcccCHHH
Q 024158          172 ----KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAE-SQ-------------KDTFRSISAEA  232 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~-~~-------------~~~~~~i~~~l  232 (271)
                          ......||+.|+|||....+ ....++|||||||++.+|++|..||... ..             +.....++.++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence                23346799999999999854 3445999999999999999999999862 11             23344578999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ++|+.+|+..+|.+|||++++|+|||.++...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999988654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-47  Score=328.64  Aligned_cols=243  Identities=33%  Similarity=0.566  Sum_probs=212.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||+||+|++..+++.+|+|++.+...........+..|+.++..++|++|+++++.+.++..+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997765544455677888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~------  172 (271)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999987432210      


Q ss_pred             --------------------------------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          173 --------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       173 --------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                                                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~  240 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence                                            113468999999999999899999999999999999999999998766


Q ss_pred             cchhhc---------------ccCHHHHHHHHHhcccCcc---CCCCHHHHhcCCccccC
Q 024158          221 QKDTFR---------------SISAEAKHLISRLLVKDSS---KRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       221 ~~~~~~---------------~i~~~l~~li~~~l~~~p~---~Rps~~~il~~~~~~~~  262 (271)
                      ..+...               .+++++.+++.+|+. +|+   .||+++++++||||+..
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            543322               246889999999775 444   46899999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-48  Score=319.64  Aligned_cols=240  Identities=29%  Similarity=0.488  Sum_probs=206.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||+++++.++..+++|++....... .....+.+|+.+++.++|+||+++++++..++..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            47999999999999999999999999999999986543322 33456778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----~~  174 (271)
                      ||++++.+..+......+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99987666655544557899999999999999999999999999999999999999999999999998554321    22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------------------
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------------------  224 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------------------  224 (271)
                      ...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+.                              
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            34678899999999888899999999999999999999999976542211                              


Q ss_pred             -------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 -------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 -------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                   ...+++++.+++++||.+||++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence                         11257789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-47  Score=329.27  Aligned_cols=243  Identities=36%  Similarity=0.632  Sum_probs=214.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||+|++..+++.+|+|++.............+.+|+.+++.++|+||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            48999999999999999999999999999999997765444455567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~------  172 (271)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999988788999999999999999999999999999999999999999999999999987432111      


Q ss_pred             -----------------------------------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 024158          173 -----------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE  217 (271)
Q Consensus       173 -----------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  217 (271)
                                                         .....||+.|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~  240 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC  240 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence                                               012358999999999998889999999999999999999999998


Q ss_pred             CCCcchhhc---------------ccCHHHHHHHHHhcccCccCCCC---HHHHhcCCccccC
Q 024158          218 AESQKDTFR---------------SISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  262 (271)
Q Consensus       218 ~~~~~~~~~---------------~i~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  262 (271)
                      .....+...               .+++++.++|.+|+. +|.+|++   +++++.||||++.
T Consensus       241 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         241 SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            765433211               357899999999996 9999998   9999999999865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-47  Score=316.66  Aligned_cols=244  Identities=30%  Similarity=0.459  Sum_probs=212.9

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|++.+.||+|+||.||++.+..+++.+++|.+.+...........+.+|+.+++.++|++++++++.+..++..++++|
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999876655444444567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--cccc
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~~~  175 (271)
                      ++++++|...+...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++.....  ....
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998887542  3589999999999999999999999999999999999999999999999999865332  2234


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHHHHHHhc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKHLISRLL  240 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~li~~~l  240 (271)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......               ....+++++.+++.+||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  240 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL  240 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHh
Confidence            468999999999999999999999999999999999999998654321               12246889999999999


Q ss_pred             ccCccCCCC-----HHHHhcCCccccCC
Q 024158          241 VKDSSKRLS-----LQKIMEHPWIIKNA  263 (271)
Q Consensus       241 ~~~p~~Rps-----~~~il~~~~~~~~~  263 (271)
                      ..||++||+     ++++++||||+...
T Consensus       241 ~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         241 TKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             hcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            999999997     89999999998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-48  Score=329.18  Aligned_cols=243  Identities=37%  Similarity=0.688  Sum_probs=216.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||+|++..+++.+|+|++.+...........+..|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997765544445667888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc-----
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-----  173 (271)
                      ||+++++|.+++.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999887789999999999999999999999999999999999999999999999999885433221     


Q ss_pred             ---------------------------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc
Q 024158          174 ---------------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR  226 (271)
Q Consensus       174 ---------------------------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~  226 (271)
                                                 ....|++.|+|||.+.+..++.++|||||||++|+|++|..||..........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~  240 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN  240 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence                                       23468899999999999999999999999999999999999998766433221


Q ss_pred             ---------------ccCHHHHHHHHHhcccCccCCCC-HHHHhcCCccccC
Q 024158          227 ---------------SISAEAKHLISRLLVKDSSKRLS-LQKIMEHPWIIKN  262 (271)
Q Consensus       227 ---------------~i~~~l~~li~~~l~~~p~~Rps-~~~il~~~~~~~~  262 (271)
                                     .+++++.++|.+||. +|.+||+ ++++++||||++.
T Consensus       241 ~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         241 KIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence                           248999999999997 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.2e-47  Score=317.49  Aligned_cols=241  Identities=27%  Similarity=0.497  Sum_probs=206.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      .++++|++++.||+|+||.||+|++..++..+++|.+......  .....+.+|+++++.++|+||+++++++..++..+
T Consensus         2 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           2 GKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             CccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            4688999999999999999999999999999999998654322  12345678999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      +++|+++ ++|.+++... ..++...+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        80 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            9999997 4898888654 3578999999999999999999999999999999999999999999999998754332   


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------  225 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------  225 (271)
                      ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+....+..                         
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233467889999998875 45788999999999999999999999765432211                         


Q ss_pred             ----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 ----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 ----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                      ..+++++.+++++||.+||.+|||++|+++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence                            1246789999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-47  Score=313.49  Aligned_cols=253  Identities=39%  Similarity=0.639  Sum_probs=229.6

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .....+.+++|+++++||.|..|+||+|+...++..+|+|++.+...........++.|..+|+.++||.++.+|..++.
T Consensus        69 ~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   69 SKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             cCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            35577889999999999999999999999999999999999999988888888899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +...|++||||+||+|..+++++  +-+++..++.++..++-||+|||..||+.|||||+|||+..+|+++|+||+++..
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999999999999999875  4599999999999999999999999999999999999999999999999998621


Q ss_pred             cc----------------------------------C-c------------------------cccccccccccCCcccc
Q 024158          169 SR----------------------------------S-K------------------------RHTMCGTLDYLAPEMVE  189 (271)
Q Consensus       169 ~~----------------------------------~-~------------------------~~~~~~~~~y~~pe~~~  189 (271)
                      ..                                  . .                        .....||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            00                                  0 0                        01124677899999999


Q ss_pred             CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc-------------CHHHHHHHHHhcccCccCCCC----HHH
Q 024158          190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLS----LQK  252 (271)
Q Consensus       190 ~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i-------------~~~l~~li~~~l~~~p~~Rps----~~~  252 (271)
                      |...+.+.|=|+||+++|||+.|..||.+.+..+.+.++             +.++++||+++|.+||.+|..    +.+
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e  388 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE  388 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence            999999999999999999999999999999988887653             588999999999999999998    999


Q ss_pred             HhcCCccccCC
Q 024158          253 IMEHPWIIKNA  263 (271)
Q Consensus       253 il~~~~~~~~~  263 (271)
                      |.+||||++.+
T Consensus       389 IK~HpFF~gVn  399 (459)
T KOG0610|consen  389 IKRHPFFEGVN  399 (459)
T ss_pred             hhcCccccCCC
Confidence            99999999873

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-48  Score=310.28  Aligned_cols=249  Identities=31%  Similarity=0.492  Sum_probs=218.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~   94 (271)
                      +.+.|+.+.+|++|.||.||+|+++.+++-||+|.++.+. +.....-.-.+|+.++.+++||||+.+-.+....  +.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4567999999999999999999999999999999996654 3223333456899999999999999999987544  479


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc
Q 024158           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~  173 (271)
                      |+|||||+ -+|.+++..-+ +++..++.-++.|++.|++|||.+.|+|||+|++|+|+...|.+|++|||++....+..
T Consensus       153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99999997 49999998754 78999999999999999999999999999999999999999999999999998777663


Q ss_pred             ---ccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc---------------------
Q 024158          174 ---HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------------  228 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i---------------------  228 (271)
                         .....|.+|+|||.+.+.. |+.+.|+||+|||+.+|+++.+.|.+....+++.+|                     
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence               3446799999999998865 899999999999999999999999988877665442                     


Q ss_pred             ----------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCC
Q 024158          229 ----------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       229 ----------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                                            +.+..+|++.+|..||.+|.|++|.|+|+||...+.|.+
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~  372 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPID  372 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCC
Confidence                                  478899999999999999999999999999999876654

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-47  Score=320.99  Aligned_cols=236  Identities=37%  Similarity=0.620  Sum_probs=209.7

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||+|+||.||+|++..+++.+++|.+.............+..|+.+++.++||||+++++.+..++..|+++||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999765544444566778899999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccccccccccc
Q 024158          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYL  183 (271)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~~~~~~y~  183 (271)
                      .+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ......|++.|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~  160 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL  160 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence            99998878899999999999999999999999999999999999999999999999998854322   223456899999


Q ss_pred             CCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCC---C
Q 024158          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL---S  249 (271)
Q Consensus       184 ~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rp---s  249 (271)
                      |||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+||..||.+||   +
T Consensus       161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~  240 (312)
T cd05585         161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNG  240 (312)
T ss_pred             CHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence            999999989999999999999999999999999876544432           23678999999999999999997   5


Q ss_pred             HHHHhcCCccccC
Q 024158          250 LQKIMEHPWIIKN  262 (271)
Q Consensus       250 ~~~il~~~~~~~~  262 (271)
                      +.+++.||||.+.
T Consensus       241 ~~e~l~hp~~~~~  253 (312)
T cd05585         241 AQEIKNHPFFSQL  253 (312)
T ss_pred             HHHHHcCCCcCCC
Confidence            7999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.9e-47  Score=321.64  Aligned_cols=238  Identities=40%  Similarity=0.662  Sum_probs=211.2

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|+||.||++++..+|..+++|++.............+.+|+.+++.++||||+++++.+..++.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997765444444566778999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccccccccc
Q 024158          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLD  181 (271)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~~~~~~  181 (271)
                      +|..++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....   ......|++.
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~  160 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE  160 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence            9999998878899999999999999999999999999999999999999999999999998754322   1233468999


Q ss_pred             ccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCC--
Q 024158          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--  248 (271)
Q Consensus       182 y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rp--  248 (271)
                      |+|||.+.+..++.++|+||||+++|+|++|..||.........           ..+++++.+++.+||..||++|+  
T Consensus       161 y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (323)
T cd05595         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG  240 (323)
T ss_pred             cCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCC
Confidence            99999999889999999999999999999999999876544332           34689999999999999999998  


Q ss_pred             ---CHHHHhcCCccccC
Q 024158          249 ---SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 ---s~~~il~~~~~~~~  262 (271)
                         ++.++++||||.+.
T Consensus       241 ~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         241 GPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence               99999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.7e-47  Score=320.12  Aligned_cols=247  Identities=28%  Similarity=0.456  Sum_probs=215.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      +..++|++++.||+|+||.||++++..++..+++|.+.....  ......+.+|+++++.++|+||+++++++..++..+
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            567899999999999999999999999999999999865422  234567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeeccccccc-Ccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-~~~  173 (271)
                      ++|||+++++|.+++.....+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.... ...
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            9999999999999998878899999999999999999999986 69999999999999999999999999875433 223


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------------
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------------  224 (271)
                      ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.                             
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            345689999999999988899999999999999999999999964332111                             


Q ss_pred             ------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                                    ...+++++.+|+.+||..||++|||+.++++||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                                          0124688999999999999999999999999999987644

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=321.75  Aligned_cols=254  Identities=34%  Similarity=0.629  Sum_probs=217.5

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH-----------HHHHHHHHHHHHHhhCC
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-----------KIQHQLRREMEIQSSLR   77 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-----------~~~~~~~~e~~~l~~~~   77 (271)
                      .+.......++.|++.+.||+|.||.|-+|++..+++.||+|++.+......           ...+..++|+.+++++.
T Consensus        87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~  166 (576)
T KOG0585|consen   87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH  166 (576)
T ss_pred             ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence            3445566778999999999999999999999999999999999976544321           12468899999999999


Q ss_pred             CCceeceeeEEEeC--CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           78 HPNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        78 ~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      |+||++++++..+.  +.+|+|+|||..|.+.+.-.....++..+++.++.+++.||+|||.+||+||||||+|+|++.+
T Consensus       167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCC
Confidence            99999999999765  4699999999988886655443349999999999999999999999999999999999999999


Q ss_pred             CCEEEeeecccccccCc--------cccccccccccCCccccCCC---C-CccchhhhHHHHHHHHHhCCCCCCCCCcch
Q 024158          156 GRLKIGDFGWSVQSRSK--------RHTMCGTLDYLAPEMVENKE---H-DYAVDNWTLGILCYEFLYGAPPFEAESQKD  223 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~---~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~  223 (271)
                      |++||+|||.+......        .....|||.|+|||++.++.   + +.+.||||+|++||.|+.|+.||.+....+
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~  326 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE  326 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence            99999999988544221        12357999999999987733   2 458999999999999999999999877766


Q ss_pred             hhcc-------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          224 TFRS-------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       224 ~~~~-------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ...+             +.++++++|.+||.+||++|.++.+|..|||.-+.
T Consensus       327 l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  327 LFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            6554             36889999999999999999999999999999887

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.2e-47  Score=326.78  Aligned_cols=252  Identities=32%  Similarity=0.533  Sum_probs=217.7

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      .........++|++.+.||+|+||.||++++..++..+|+|++.+...........+.+|+.+++.++||||+++++++.
T Consensus        34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~  113 (370)
T cd05596          34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ  113 (370)
T ss_pred             hhccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            34456678899999999999999999999999999999999997655444444556778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      .++.+|+|+||+++++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999999999999876 45889999999999999999999999999999999999999999999999988544


Q ss_pred             cCc----cccccccccccCCccccCC----CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc---------------
Q 024158          170 RSK----RHTMCGTLDYLAPEMVENK----EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------  226 (271)
Q Consensus       170 ~~~----~~~~~~~~~y~~pe~~~~~----~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~---------------  226 (271)
                      ...    .....|++.|+|||.+.+.    .++.++|+||||+++|+|++|..||.+........               
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  272 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI  272 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcC
Confidence            322    2345689999999988653    37789999999999999999999998765432211               


Q ss_pred             ccCHHHHHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          227 SISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      .++.++.+++.+||..+|++  |+|++++++||||++.
T Consensus       273 ~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         273 EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             CCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            35899999999999999987  9999999999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.6e-47  Score=320.06  Aligned_cols=243  Identities=33%  Similarity=0.589  Sum_probs=213.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-CceeceeeEEEeCCeEEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +|++++.||+|+||.||+|++..+++.+|+|++.+...........+..|.+++..+.| ++++.+++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            68999999999999999999999999999999977654444445667788888988876 45888999998889999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Ccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~  175 (271)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999887789999999999999999999999999999999999999999999999999875322   22234


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p  244 (271)
                      ..|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+....+..           ..+++++.+++.+||.++|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP  240 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence            56899999999999989999999999999999999999999876654332           2368999999999999999


Q ss_pred             cCCCCH-----HHHhcCCccccC
Q 024158          245 SKRLSL-----QKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rps~-----~~il~~~~~~~~  262 (271)
                      .+|++.     +++++||||...
T Consensus       241 ~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         241 AKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHcCCCCCCCHHHHhcCCCcCCC
Confidence            999986     899999999864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.3e-47  Score=326.86  Aligned_cols=244  Identities=31%  Similarity=0.537  Sum_probs=212.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +.|++++.||+|+||+||+|++..+++.+|+|++.+...........+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999997765555455677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      ||+++++|.+++.....+++..+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999998878899999999999999999999999999999999999999999999999998632110       


Q ss_pred             -------------------------------------------ccccccccccccCCccccCCCCCccchhhhHHHHHHH
Q 024158          172 -------------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (271)
Q Consensus       172 -------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~  208 (271)
                                                                 ......||+.|+|||.+.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                       0012358899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCcchhh---------------cccCHHHHHHHHHhc--ccCccCCCCHHHHhcCCccccC
Q 024158          209 FLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLL--VKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       209 l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~~~l--~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      |++|..||......+..               ..+++++.+++.+|+  ..++..|+++++++.||||++.
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999999876543321               135789999999965  4556669999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-48  Score=328.43  Aligned_cols=244  Identities=32%  Similarity=0.562  Sum_probs=219.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|....+||+|+.|.||.++...+++.||+|.+.......   .+-+.+|+.+++..+|+||+.+++.+...+.+|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            45889999999999999999999999999999997766554   356789999999999999999999998889999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      ||++||+|.+.+... .+++.++..++..+++||.|||.+||+|+|||.+|||++.+|.+||+|||++.....   ....
T Consensus       350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            999999999998764 489999999999999999999999999999999999999999999999999855443   4566


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~  241 (271)
                      ..|||.|+|||......|..+.||||||++++||+.|.+||-...+...              ..++++++++|+.+||.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~  508 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLV  508 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhh
Confidence            7899999999999999999999999999999999999999975554433              34579999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      .|+++|+|+.++|+||||+...-+.
T Consensus       509 ~dv~~RasA~eLL~HpFl~~a~p~s  533 (550)
T KOG0578|consen  509 VDVEQRASAKELLEHPFLKMAKPES  533 (550)
T ss_pred             cchhcCCCHHHHhcChhhhhcCCHH
Confidence            9999999999999999996654443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.2e-47  Score=320.67  Aligned_cols=238  Identities=39%  Similarity=0.660  Sum_probs=211.1

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|+||.||++++..++..+|+|++.+...........+.+|+.+++.++||||+++++.+..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997765444445567788999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccccccccc
Q 024158          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLD  181 (271)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~~~~~~  181 (271)
                      +|..++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....   ......|++.
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~  160 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE  160 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence            9999998878899999999999999999999999999999999999999999999999998754322   2233468999


Q ss_pred             ccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCC--
Q 024158          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL--  248 (271)
Q Consensus       182 y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rp--  248 (271)
                      |+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+||.+||++|+  
T Consensus       161 y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  240 (328)
T cd05593         161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGG  240 (328)
T ss_pred             ccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence            99999999888999999999999999999999999876544432           23579999999999999999997  


Q ss_pred             ---CHHHHhcCCccccC
Q 024158          249 ---SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 ---s~~~il~~~~~~~~  262 (271)
                         ++.++++||||...
T Consensus       241 ~~~~~~~il~h~~~~~~  257 (328)
T cd05593         241 GPDDAKEIMRHSFFTGV  257 (328)
T ss_pred             CCCCHHHHhcCCCcCCC
Confidence               89999999999764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-47  Score=328.28  Aligned_cols=243  Identities=33%  Similarity=0.562  Sum_probs=213.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.++|+||+++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999997665444444567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      ||+++++|.+++...+.++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....       
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9999999999998877889999999999999999999999999999999999999999999999998632100       


Q ss_pred             ---------------------------------------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC
Q 024158          172 ---------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG  212 (271)
Q Consensus       172 ---------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g  212 (271)
                                                             ......|++.|+|||.+.+..++.++|+|||||++|+|++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G  240 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG  240 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence                                                   00123588999999999998999999999999999999999


Q ss_pred             CCCCCCCCcchhh---------------cccCHHHHHHHHHhcccCccCCC---CHHHHhcCCccccC
Q 024158          213 APPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  262 (271)
Q Consensus       213 ~~p~~~~~~~~~~---------------~~i~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  262 (271)
                      ..||......+..               ..+++++.+++.+|+ .+|.+|+   ++.++++||||+..
T Consensus       241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9999876643321               135789999999976 5999999   99999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-47  Score=327.10  Aligned_cols=243  Identities=33%  Similarity=0.578  Sum_probs=212.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||++++..+++.+++|++.+...........+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999997665444455677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~------  172 (271)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999988788999999999999999999999999999999999999999999999999987421100      


Q ss_pred             --------------------------------------------cccccccccccCCccccCCCCCccchhhhHHHHHHH
Q 024158          173 --------------------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (271)
Q Consensus       173 --------------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~  208 (271)
                                                                  .....||+.|+|||.+.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE  240 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence                                                        001358899999999998889999999999999999


Q ss_pred             HHhCCCCCCCCCcchhhc---------------ccCHHHHHHHHHhcccCccCC---CCHHHHhcCCccccC
Q 024158          209 FLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSKR---LSLQKIMEHPWIIKN  262 (271)
Q Consensus       209 l~~g~~p~~~~~~~~~~~---------------~i~~~l~~li~~~l~~~p~~R---ps~~~il~~~~~~~~  262 (271)
                      |++|..||......+...               .++.++.+++.+||. +|.+|   +|+.+++.||||...
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999998765433211               257889999999997 67765   599999999999853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=7.2e-47  Score=326.28  Aligned_cols=243  Identities=33%  Similarity=0.567  Sum_probs=213.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||+|++..+++.+++|++.+...........+.+|+.+++.++|+||+++++.+.+++.+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997765544455677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++.....       
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            9999999999998877889999999999999999999999999999999999999999999999998632100       


Q ss_pred             -------------------------------------------ccccccccccccCCccccCCCCCccchhhhHHHHHHH
Q 024158          172 -------------------------------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE  208 (271)
Q Consensus       172 -------------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~  208 (271)
                                                                 ......||+.|+|||.+.+..++.++|+|||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                       0012358899999999999899999999999999999


Q ss_pred             HHhCCCCCCCCCcchhh---------------cccCHHHHHHHHHhcccCccCCCC---HHHHhcCCccccC
Q 024158          209 FLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  262 (271)
Q Consensus       209 l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  262 (271)
                      |++|..||....+.+..               ..+++++.++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999876543321               235789999999986 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.2e-47  Score=316.22  Aligned_cols=245  Identities=28%  Similarity=0.450  Sum_probs=206.1

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +.++|++.+.||+|+||.||+|++..+++.+++|++.......  ....+.+|+.+++.++|+||+++++++..+...++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            4578999999999999999999999999999999986543221  12356679999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---c
Q 024158           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---K  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~  172 (271)
                      |+||++ ++|.+++... ..++...+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....   .
T Consensus        81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             EEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            999996 6887777653 4689999999999999999999999999999999999999999999999998754322   2


Q ss_pred             cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-h-------------------------
Q 024158          173 RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-F-------------------------  225 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-~-------------------------  225 (271)
                      .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+...... +                         
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            2334678899999988654 578899999999999999999999976432100 0                         


Q ss_pred             ----------------c--ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 ----------------R--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ----------------~--~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                      .  ..++++.+++++||..||++|||+.++++||||++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence                            0  12467889999999999999999999999999987643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-47  Score=319.25  Aligned_cols=238  Identities=37%  Similarity=0.652  Sum_probs=209.3

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|+++.+++.+++|++.+...........+..|..++... .||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4689999999999999999999999999776544444456667778887766 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875432   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .++.++.+++.+||..||++||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~  240 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLG  240 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            9999999998889999999999999999999999998776554332           35889999999999999999999


Q ss_pred             H------HHHhcCCccccC
Q 024158          250 L------QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~------~~il~~~~~~~~  262 (271)
                      +      ++++.||||+..
T Consensus       241 ~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         241 SLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCHHHHHcCCCcCCC
Confidence            8      999999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-46  Score=318.38  Aligned_cols=241  Identities=34%  Similarity=0.614  Sum_probs=209.3

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH---hhCCCCceeceeeEEEeCCeEEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ---SSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l---~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      |++++.||+|++|.||++++..+++.+++|++.+.........+.+..|.+++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999766544333445566665554   567899999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~  174 (271)
                      |||+++++|...+.. ..+++..++.++.||+.|+.|||+.|++|+||+|+||+++.++.++|+|||++....   ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS  159 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence            999999999988865 568999999999999999999999999999999999999999999999999875432   2233


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccC
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKD  243 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~  243 (271)
                      ...|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..           ..+++.+.+++.+||..|
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  239 (324)
T cd05589         160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRN  239 (324)
T ss_pred             ccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            456899999999999888999999999999999999999999877654432           236899999999999999


Q ss_pred             ccCCC-----CHHHHhcCCccccC
Q 024158          244 SSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       244 p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      |.+||     ++.++++||||.+.
T Consensus       240 P~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         240 PERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999     79999999999864

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=308.66  Aligned_cols=246  Identities=28%  Similarity=0.503  Sum_probs=215.0

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-----CCe
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-----DER   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   93 (271)
                      ..|..++.||.|++|.|+.+.++.+|+.||+|.+... +......+...+|+++++.++|+||+.+.+++..     .+.
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            3455579999999999999999999999999998543 2333456778899999999999999999999865     346


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--  171 (271)
                      +|+|+|+|+ .+|...++.++.|+.+.+..++.||+.|++|+|+.+++|||+||+|++++.++.+|++|||++.....  
T Consensus       101 vYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  101 VYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             eEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            999999995 79999999988899999999999999999999999999999999999999999999999999966532  


Q ss_pred             ---ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc--------------------
Q 024158          172 ---KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS--------------------  227 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~--------------------  227 (271)
                         ....+..|-+|.|||.+.+ ..|+...||||.||++.+|++|++.|.+.+...+++.                    
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence               2244567889999998865 5699999999999999999999999998876555432                    


Q ss_pred             ----------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          228 ----------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       228 ----------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                            .++.+.+|+++||..||.+|+|++|+|+|||+...-.|.
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence                                  268899999999999999999999999999999986554

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=317.81  Aligned_cols=242  Identities=30%  Similarity=0.505  Sum_probs=213.5

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCce-EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ....++..+..+...||+|+||+||++..  .|.. +++|++......... ...+.+|+.++++++||||++++|++.+
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            45667777888888899999999998885  4565 999999877666544 7899999999999999999999999988


Q ss_pred             CC-eEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeeeCCCC-CEEEeeecc
Q 024158           91 DE-RIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEG-RLKIGDFGW  165 (271)
Q Consensus        91 ~~-~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~-i~H~dl~~~Nili~~~~-~~~L~dfg~  165 (271)
                      +. ..++||||+++|+|.+++..  .+.+++..++.++.||+.||.|||+++ |+|+||||+|||++.++ ++||+|||+
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence            87 79999999999999999987  578999999999999999999999999 99999999999999998 999999999


Q ss_pred             cccccC---ccccccccccccCCcccc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cc
Q 024158          166 SVQSRS---KRHTMCGTLDYLAPEMVE--NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RS  227 (271)
Q Consensus       166 ~~~~~~---~~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~  227 (271)
                      +.....   ......||+.|+|||.+.  +..++.++||||||+++|+|++|..||......+..             ..
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~  270 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKE  270 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCcc
Confidence            965553   334468999999999999  668999999999999999999999999988763332             22


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .++.+..++.+|+..||.+||+..+|+..
T Consensus       271 ~~~~l~~l~~~CW~~dp~~RP~f~ei~~~  299 (362)
T KOG0192|consen  271 CPPHLSSLMERCWLVDPSRRPSFLEIVSR  299 (362)
T ss_pred             CCHHHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence            58899999999999999999999998764

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-46  Score=323.53  Aligned_cols=241  Identities=25%  Similarity=0.371  Sum_probs=208.1

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+..++|++++.||+|+||.||+|++..+++.+++|....         ..+.+|+++++.++||||+++++++..+...
T Consensus        88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            3556789999999999999999999999999999997421         2456899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      ++++|++. ++|..++.....++...++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....   
T Consensus       159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            99999996 68999988777899999999999999999999999999999999999999999999999999854322   


Q ss_pred             -ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------------------
Q 024158          172 -KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------------------  222 (271)
Q Consensus       172 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------------------  222 (271)
                       ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||......                            
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~  317 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA  317 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence             223457899999999999989999999999999999999998776432100                            


Q ss_pred             -------------------------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          223 -------------------------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       223 -------------------------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                               .....++.++.+++.+||..||.+|||++++|+||||+..+.|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence                                     0011246789999999999999999999999999999987554

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.7e-47  Score=321.37  Aligned_cols=243  Identities=32%  Similarity=0.582  Sum_probs=213.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|.+.+.||+|+||.||++++..+++.+++|++.............+.+|+.+++.++|++|+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998766544455677888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----  173 (271)
                      ||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  160 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS  160 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence            999999999999875 578999999999999999999999999999999999999999999999999985443221    


Q ss_pred             ccccccccccCCcccc------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc---------------ccCHHH
Q 024158          174 HTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEA  232 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~---------------~i~~~l  232 (271)
                      ....+++.|+|||.+.      +..++.++|+||||+++|+|++|..||..........               .+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (330)
T cd05601         161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDF  240 (330)
T ss_pred             ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHH
Confidence            2235789999999986      4557789999999999999999999997655432211               368899


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      .++++.||. +|.+|||+++++.||||++.
T Consensus       241 ~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         241 LDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             HHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            999999997 99999999999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-46  Score=316.86  Aligned_cols=243  Identities=33%  Similarity=0.577  Sum_probs=212.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +|++++.||+|+||.||+|++..++..+++|++.+..............+..++..+ .|++++.+++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            689999999999999999999999999999999776544444445566677777777 4789999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Ccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~  175 (271)
                      ||+++++|.+.+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....   .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            999999999999887789999999999999999999999999999999999999999999999999885432   22234


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p  244 (271)
                      ..|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+||.++|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p  240 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP  240 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCH
Confidence            56899999999999999999999999999999999999999877654433           2368999999999999999


Q ss_pred             cCCCCH-----HHHhcCCccccC
Q 024158          245 SKRLSL-----QKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rps~-----~~il~~~~~~~~  262 (271)
                      .+|+++     .++++||||+..
T Consensus       241 ~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         241 GKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             HhcCCCCCCCHHHHhcCCCcCCC
Confidence            999984     899999999864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-46  Score=322.80  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=215.6

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      .........++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+.
T Consensus        34 ~~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (370)
T cd05621          34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ  113 (370)
T ss_pred             HHHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            33456677889999999999999999999999999999999997654444444566788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      .++..|+||||+++++|.+++... .++...+..++.||+.||.+||++||+||||||+||+++.++.++|+|||++...
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         114 DDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence            999999999999999999999764 5889999999999999999999999999999999999999999999999998654


Q ss_pred             cCc----cccccccccccCCccccCCC----CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc---------------
Q 024158          170 RSK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------  226 (271)
Q Consensus       170 ~~~----~~~~~~~~~y~~pe~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~---------------  226 (271)
                      ...    .....||+.|+|||.+.+..    ++.++|+||+|+++|+|++|..||..........               
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  272 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV  272 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcc
Confidence            322    23456899999999987543    6789999999999999999999998765422211               


Q ss_pred             ccCHHHHHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          227 SISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      .+++.+.+++..||..++..  |+|++++++||||+..
T Consensus       273 ~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         273 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            25788999999999855543  8899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-46  Score=317.52  Aligned_cols=238  Identities=36%  Similarity=0.631  Sum_probs=209.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..+++.+++|++.+...........+..|.+++..+ +||+|+++++++..++.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4689999999999999999999999999776554444456667788888765 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|...+...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            9999999888889999999999999999999999999999999999999999999999999875432   2223446899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHHhcccCccCCC-
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISRLLVKDSSKRL-  248 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~~l~~~p~~Rp-  248 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+....           +++++.+++.+||.+||++|| 
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~  240 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLG  240 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence            99999999988899999999999999999999999988775554432           479999999999999999999 


Q ss_pred             ------CHHHHhcCCccccC
Q 024158          249 ------SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 ------s~~~il~~~~~~~~  262 (271)
                            +++++++||||...
T Consensus       241 ~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         241 CVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CCCCCCCHHHHhcCCccCCC
Confidence                  99999999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6.9e-47  Score=319.66  Aligned_cols=238  Identities=39%  Similarity=0.649  Sum_probs=210.5

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|+||.||++++..++..+++|++.+...........+..|+++++.++|+||+++++.+..++..|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999999999999999999997765544444566778999999999999999999999999999999999999


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      +|..++...+.+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            999999887889999999999999999999997 799999999999999999999999999875422   1223346899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCC-
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRL-  248 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rp-  248 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.........           ..+++++.+++.+||.+||++|+ 
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~  240 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLG  240 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCC
Confidence            999999999889999999999999999999999999876654332           23689999999999999999997 


Q ss_pred             ----CHHHHhcCCccccC
Q 024158          249 ----SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 ----s~~~il~~~~~~~~  262 (271)
                          ++.++++||||.+.
T Consensus       241 ~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         241 GGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCHHHHhcCCCcCCC
Confidence                99999999999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-46  Score=318.50  Aligned_cols=243  Identities=26%  Similarity=0.445  Sum_probs=205.9

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----CeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----ERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~   94 (271)
                      +|++.+.||+|+||.||+|++..++..+++|.+...... ......+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            599999999999999999999999999999998643222 22345678899999999999999999987543     258


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      |+++|+++ ++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......  
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999996 699999988778999999999999999999999999999999999999999999999999998543221  


Q ss_pred             ----cccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------
Q 024158          173 ----RHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------  224 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------  224 (271)
                          .....+++.|+|||.+.+  ..++.++|+||||+++|+|++|..||.+......                      
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                123468899999999865  5688899999999999999999999976442111                      


Q ss_pred             --------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 --------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 --------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                          +..+++++.+++.+||..+|++|||++++++||||+..+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence                                1235678899999999999999999999999999987543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.1e-46  Score=317.11  Aligned_cols=238  Identities=31%  Similarity=0.618  Sum_probs=208.2

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||++++..+++.+|+|++.+...........+..|..++..+ +||||+++++++...+.+|++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4689999999999999999999999999876555555566788899999888 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc---cCccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~---~~~~~~~~~~~  180 (271)
                      ++|..++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...   ........|++
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988788999999999999999999999999999999999999999999999999987542   22233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------------hhcccCHHHHHHHHHhc
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------------TFRSISAEAKHLISRLL  240 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------------~~~~i~~~l~~li~~~l  240 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+                    ....++.++.+++.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L  240 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999899999999999999999999999996422111                    11236788999999999


Q ss_pred             ccCccCCCC------HHHHhcCCccccC
Q 024158          241 VKDSSKRLS------LQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rps------~~~il~~~~~~~~  262 (271)
                      ..||.+|+|      ++++++||||...
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         241 NKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             ccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999997      7999999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-46  Score=316.63  Aligned_cols=245  Identities=38%  Similarity=0.707  Sum_probs=223.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   95 (271)
                      ....|++.+.||+|.||.||.|+.+.+|+.+|+|++.+...........+.+|+++++.+. |||++.+.++++....++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3456999999999999999999999999999999998887765556678999999999998 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC----CCEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~----~~~~L~dfg~~~~~~~  171 (271)
                      +|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|+|+||+|+++...    +.++++|||++.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999775 48999999999999999999999999999999999999643    4799999999976665


Q ss_pred             --ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc---------------chhhcccCHHHHH
Q 024158          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---------------KDTFRSISAEAKH  234 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~---------------~~~~~~i~~~l~~  234 (271)
                        .....+||+.|+|||.+...+++...|+||+|+++|.|++|..||.+.+.               ...|..++..+.+
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd  271 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKD  271 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHH
Confidence              45667899999999999999999999999999999999999999998874               3345567999999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++.+||..||.+|+|+.++|+|||++..
T Consensus       272 ~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  272 FIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999975

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.6e-46  Score=321.74  Aligned_cols=243  Identities=34%  Similarity=0.600  Sum_probs=213.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++++.||+|+||.||++++..+++.+++|++.............+..|+.++..++|++++++++.+..++.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997655444455677888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~------  172 (271)
                      ||+++++|.+++.+...++...+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            99999999999988788999999999999999999999999999999999999999999999999987432110      


Q ss_pred             --------------------------------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          173 --------------------------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       173 --------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                                                      .....||+.|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence                                            112468999999999999999999999999999999999999998776


Q ss_pred             cchhhc---------------ccCHHHHHHHHHhcccCccCCC---CHHHHhcCCccccC
Q 024158          221 QKDTFR---------------SISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  262 (271)
Q Consensus       221 ~~~~~~---------------~i~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  262 (271)
                      +.....               .+++++.+++.+|+ .+|.+|+   +++++++||||+..
T Consensus       241 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         241 PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            543321               15788999999987 4999998   58999999999874

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.6e-46  Score=314.89  Aligned_cols=238  Identities=30%  Similarity=0.589  Sum_probs=206.4

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh-CCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|+++.+|..+++|.+.+..............|..++.. .+|++++++++++..++.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            469999999999999999999999999977644332334556667777765 4899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|..++.....++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875322   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .++.++.+++.+||..||++||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~  240 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLG  240 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            9999999999999999999999999999999999998776544332           25789999999999999999999


Q ss_pred             H-HHHhcCCccccC
Q 024158          250 L-QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~-~~il~~~~~~~~  262 (271)
                      + +++++||||+..
T Consensus       241 ~~~~~~~h~~f~~~  254 (316)
T cd05620         241 VVGNIRGHPFFKTI  254 (316)
T ss_pred             ChHHHHcCCCcCCC
Confidence            8 589999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-46  Score=315.25  Aligned_cols=238  Identities=36%  Similarity=0.624  Sum_probs=210.1

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||++++..++..+++|++.+...........+..|..+++.+ +|+||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999876554444556677888888877 699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|...+.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875422   2223346889


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.........           ..+++++.+++.+||..||++|||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s  240 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLG  240 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCC
Confidence            999999999999999999999999999999999999876654432           236899999999999999999999


Q ss_pred             H-----HHHhcCCccccC
Q 024158          250 L-----QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~-----~~il~~~~~~~~  262 (271)
                      +     .++++||||+..
T Consensus       241 ~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         241 CLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCHHHHhcCCCcCCC
Confidence            9     999999999774

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-46  Score=315.09  Aligned_cols=247  Identities=29%  Similarity=0.463  Sum_probs=214.3

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      +..++|++.++||+|+||.||++.+..++..+++|.+.....  ......+.+|+++++.++|+||+++++++..++..+
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence            456899999999999999999999999999999998865422  233567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccccC-cc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~  173 (271)
                      ++|||+.+++|.+++...+.++...+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||++..... ..
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  159 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence            9999999999999998877899999999999999999999975 799999999999999999999999998754322 22


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------------------
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------------------  225 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------------------  225 (271)
                      ....++..|+|||.+.+..++.++|+||||+++|++++|..||......+..                            
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            3446888999999998888999999999999999999999998754321110                            


Q ss_pred             -----------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 -----------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 -----------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                                   ..++.++.+|+.+||..||++|||+++++.||||+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  307 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA  307 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence                                         014678999999999999999999999999999987643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-47  Score=326.26  Aligned_cols=248  Identities=36%  Similarity=0.628  Sum_probs=229.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   92 (271)
                      ..+.+++|++++.||.|+||+|+++..+.+++.+|||+++++.+-.....+.++.|.+++.... ||.++.++..+...+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4789999999999999999999999999999999999999998877778899999999988885 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc---c
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---S  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~---~  169 (271)
                      ++|+||||+.||++..+. ..+.+++..+..++..++.||.|||++||++||||.+|||+|.+|++||+|||+++.   .
T Consensus       443 ~l~fvmey~~Ggdm~~~~-~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI-HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             eEEEEEEecCCCcEEEEE-ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence            999999999999954444 346799999999999999999999999999999999999999999999999999954   3


Q ss_pred             cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHH
Q 024158          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISR  238 (271)
Q Consensus       170 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~  238 (271)
                      ...++..+|||.|+|||++.+..|+.+.|=|+|||+||+|+.|..||.+.+.++.+..           ++.+..+++++
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~  601 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR  601 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence            4567888999999999999999999999999999999999999999999998888765           48999999999


Q ss_pred             hcccCccCCC-C----HHHHhcCCccccC
Q 024158          239 LLVKDSSKRL-S----LQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rp-s----~~~il~~~~~~~~  262 (271)
                      +|.++|.+|. +    +++|..||||...
T Consensus       602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999 3    6999999999875

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.3e-46  Score=305.39  Aligned_cols=238  Identities=37%  Similarity=0.696  Sum_probs=210.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |++++.||+|+||+||++++..++..+++|++......... ......|+..+++++|+||+++++++...+..++++|+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            89999999999999999999999999999999777555433 23345599999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc---ccCcccccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMC  177 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~---~~~~~~~~~  177 (271)
                      +.+++|.+++...+.++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+..   .........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99889999998778899999999999999999999999999999999999999999999999999853   334445567


Q ss_pred             ccccccCCcccc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------------------cCHHHHHHHHH
Q 024158          178 GTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------------------ISAEAKHLISR  238 (271)
Q Consensus       178 ~~~~y~~pe~~~-~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------------------i~~~l~~li~~  238 (271)
                      +++.|.|||.+. +...+.++|+||||+++++|++|..||......+....                  .++++.+++.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            889999999998 78889999999999999999999999997732221110                  13799999999


Q ss_pred             hcccCccCCCCHHHHhcCCcc
Q 024158          239 LLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~  259 (271)
                      ||..||++|||+.++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=323.66  Aligned_cols=244  Identities=28%  Similarity=0.465  Sum_probs=217.9

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-C-----CceeceeeEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-H-----PNILRLYGWF   88 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~-----~~i~~~~~~~   88 (271)
                      +....+|.|++.||+|+||.|.+|.+.++++.||||+++...    ...++...|+.+|..++ |     -|++++++++
T Consensus       182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F  257 (586)
T KOG0667|consen  182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF  257 (586)
T ss_pred             ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence            344447999999999999999999999999999999995543    45677788999999996 3     4799999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC--CEEEeeec
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG--RLKIGDFG  164 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~--~~~L~dfg  164 (271)
                      .-.++.|+|+|..+ .+|.++++.++  .++...++.++.||+.+|..||..||+|+||||+|||+...+  .+|++|||
T Consensus       258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence            99999999999996 79999998764  589999999999999999999999999999999999996543  79999999


Q ss_pred             ccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc----------------
Q 024158          165 WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------  228 (271)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i----------------  228 (271)
                      .++........+..+..|+|||++.|.+|+.+.||||||||++||++|.++|.+....+++..|                
T Consensus       337 SSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  337 SSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            9998888888888999999999999999999999999999999999999999888776664331                


Q ss_pred             ----------------------------------------------------------CHHHHHHHHHhcccCccCCCCH
Q 024158          229 ----------------------------------------------------------SAEAKHLISRLLVKDSSKRLSL  250 (271)
Q Consensus       229 ----------------------------------------------------------~~~l~~li~~~l~~~p~~Rps~  250 (271)
                                                                                ...+.+++.+||..||.+|+|+
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence                                                                      2568899999999999999999


Q ss_pred             HHHhcCCccccCC
Q 024158          251 QKIMEHPWIIKNA  263 (271)
Q Consensus       251 ~~il~~~~~~~~~  263 (271)
                      .++|+||||....
T Consensus       497 ~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  497 AQALNHPFLTGTS  509 (586)
T ss_pred             HHHhcCccccccc
Confidence            9999999999553

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.6e-46  Score=318.25  Aligned_cols=252  Identities=31%  Similarity=0.541  Sum_probs=215.2

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ........++|++.+.||+|+||.||+++++.+++.+++|++.+...........+.+|..+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            44567778999999999999999999999999999999999976544444445667889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ++..|+||||+++++|.+++.. ..++...+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            9999999999999999999976 458899999999999999999999999999999999999999999999999985443


Q ss_pred             Cc----cccccccccccCCccccCCC----CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cc
Q 024158          171 SK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RS  227 (271)
Q Consensus       171 ~~----~~~~~~~~~y~~pe~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~  227 (271)
                      ..    .....||+.|+|||.+.+..    ++.++|+||||+++|+|++|..||...+.....               ..
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            21    23456899999999986533    678999999999999999999999876543221               13


Q ss_pred             cCHHHHHHHHHhcccCccC--CCCHHHHhcCCccccCC
Q 024158          228 ISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~~  263 (271)
                      +++++.+++..||..++.+  |++++++++||||++.+
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence            6889999999999844433  78999999999998753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.7e-46  Score=314.93  Aligned_cols=238  Identities=36%  Similarity=0.660  Sum_probs=205.7

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH-HHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||+||++++..+|+.+++|++.+...........+..+. .+++.++||||+++++.+..++..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4689999999999999999999999999766543333334444444 456889999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|..++...+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP  160 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223446899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+||..||.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (323)
T cd05575         161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLG  240 (323)
T ss_pred             hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCC
Confidence            999999999988999999999999999999999999876644332           236899999999999999999998


Q ss_pred             H----HHHhcCCccccC
Q 024158          250 L----QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~----~~il~~~~~~~~  262 (271)
                      +    .++++||||...
T Consensus       241 ~~~~~~~il~~~~~~~~  257 (323)
T cd05575         241 AKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             CCCCHHHHHcCCCcCCC
Confidence            7    699999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.3e-46  Score=312.98  Aligned_cols=238  Identities=34%  Similarity=0.613  Sum_probs=205.4

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh-CCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..+++.+|+|++................+..++.. .+||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            468999999999999999999999999977654333334445556666654 4899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|..++.....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999885432   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...           .+++++.+++.+||..+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~  240 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCC
Confidence            9999999998889999999999999999999999998776544332           25789999999999999999998


Q ss_pred             H-HHHhcCCccccC
Q 024158          250 L-QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~-~~il~~~~~~~~  262 (271)
                      + .++++||||...
T Consensus       241 ~~~~l~~h~~~~~~  254 (316)
T cd05592         241 VDGDIRQHPFFRGI  254 (316)
T ss_pred             ChHHHHcCcccCCC
Confidence            6 488999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.4e-46  Score=314.56  Aligned_cols=238  Identities=32%  Similarity=0.620  Sum_probs=206.5

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||++++..+++.+++|++.+...........+..|+.++.++ +||||+++++++..++.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876555445556677888888776 799999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|..++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9999999887889999999999999999999999999999999999999999999999999875422   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--------------------hhhcccCHHHHHHHHHhc
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------------DTFRSISAEAKHLISRLL  240 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--------------------~~~~~i~~~l~~li~~~l  240 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......                    .....++.++.+++++||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  240 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFL  240 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHh
Confidence            999999999999999999999999999999999999532111                    011235788999999999


Q ss_pred             ccCccCCCC------HHHHhcCCccccC
Q 024158          241 VKDSSKRLS------LQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rps------~~~il~~~~~~~~  262 (271)
                      ..||++||+      ++++++||||+..
T Consensus       241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         241 NKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             cCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999998      5899999999764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8e-46  Score=314.06  Aligned_cols=243  Identities=37%  Similarity=0.645  Sum_probs=208.4

Q ss_pred             ceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   94 (271)
                      +|++++.||+|+||.||++++.   .++..+++|++.+.... .....+.+..|+.+++.++ |++|+.+++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   46889999999765432 2334566778999999994 89999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      +++|||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....   
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            99999999999999998878899999999999999999999999999999999999999999999999998854322   


Q ss_pred             -ccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHH
Q 024158          172 -KRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKH  234 (271)
Q Consensus       172 -~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~  234 (271)
                       ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||.......               ....+++.+.+
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD  240 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence             222346899999999987654 7789999999999999999999996433211               11236889999


Q ss_pred             HHHHhcccCccCCC-----CHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      ++.+||..||++||     +++++++||||+..
T Consensus       241 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.6e-46  Score=312.69  Aligned_cols=239  Identities=38%  Similarity=0.685  Sum_probs=208.1

Q ss_pred             eeeecccCCceEEEEEEe---cCCceEEEEEechhhhhH-HHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           24 GRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      ++.||+|+||.||++++.   .+++.+++|++....... ......+.+|+.+++.++||||+++++.+..++.+|++||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   468899999997654322 2334567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~  176 (271)
                      |+++++|.+++...+.++...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....   .....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            999999999998888889999999999999999999999999999999999999999999999998754322   22335


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCcc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~  245 (271)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........           ..+++++.+++.+||.++|+
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  240 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPS  240 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHh
Confidence            6899999999999888899999999999999999999999876654332           23588999999999999999


Q ss_pred             CCC-----CHHHHhcCCccccC
Q 024158          246 KRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       246 ~Rp-----s~~~il~~~~~~~~  262 (271)
                      +||     +++++++||||...
T Consensus       241 ~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         241 SRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCC
Confidence            999     89999999999764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-45  Score=306.12  Aligned_cols=243  Identities=30%  Similarity=0.478  Sum_probs=212.3

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|++.+.||+|+||.||++.+..+++.+++|.+.............+.+|+.+++.++|++++++++.+..++..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48899999999999999999999999999999976555444444566789999999999999999999999899999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccc
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~  175 (271)
                      |+.+++|.+++...  ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG  160 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence            99999999888653  35899999999999999999999999999999999999999999999999988553322  233


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHHHhc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISRLL  240 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~~~l  240 (271)
                      ..+++.|+|||.+.+..++.++|+||+|+++|++++|..||.+......               ...++..+.+++.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05605         161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLL  240 (285)
T ss_pred             ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHc
Confidence            4678999999999988899999999999999999999999987543221               1246889999999999


Q ss_pred             ccCccCCC-----CHHHHhcCCccccC
Q 024158          241 VKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      ..||.+||     ++++++.||||.+.
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         241 TKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             cCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            99999999     89999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.5e-46  Score=311.69  Aligned_cols=238  Identities=32%  Similarity=0.613  Sum_probs=206.0

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh-CCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..+++.+|+|++................|..++.. .+||||+++++++..++.++++|||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999977643322334455566677765 4899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875422   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||+|+++|+|++|..||......+...           .++.++.+++.+||..+|++||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~  240 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLG  240 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCC
Confidence            9999999998889999999999999999999999998766544332           25788999999999999999999


Q ss_pred             HH-HHhcCCccccC
Q 024158          250 LQ-KIMEHPWIIKN  262 (271)
Q Consensus       250 ~~-~il~~~~~~~~  262 (271)
                      +. +++.||||...
T Consensus       241 ~~~~l~~h~~~~~~  254 (316)
T cd05619         241 VKGDIRQHPFFREI  254 (316)
T ss_pred             ChHHHHcCcccCCC
Confidence            96 99999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-47  Score=306.12  Aligned_cols=240  Identities=35%  Similarity=0.554  Sum_probs=208.5

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      .-.|...+.+|+|+||.||.++..++++.+|||..-.+..-       -.+|+++++.++||||+++.-++....     
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~   95 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEV   95 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence            34588999999999999999999999999999997444321       236889999999999999999885432     


Q ss_pred             eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecccc
Q 024158           93 RIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSV  167 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~~~  167 (271)
                      +..+|+||++ .+|.+.++.    +..++...++.+.+||++|+.|||+.||+||||||.|+|+|.+ |.+||||||.++
T Consensus        96 ~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   96 YLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            3567999997 699999974    4678999999999999999999999999999999999999987 899999999996


Q ss_pred             ccc--CccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------------
Q 024158          168 QSR--SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------  227 (271)
Q Consensus       168 ~~~--~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------------  227 (271)
                      ...  +....+..|-.|+|||.+.|. .|+.+.||||.||++.||+-|++.|.+.+..+++..                 
T Consensus       175 ~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  175 VLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             eeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence            544  444566788899999999875 599999999999999999999999999887666543                 


Q ss_pred             -----------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          228 -----------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       228 -----------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                             +++++.+|+.++|..+|.+|.++.+++.||||...-.|
T Consensus       255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                                   37999999999999999999999999999999987666

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-45  Score=305.01  Aligned_cols=236  Identities=30%  Similarity=0.471  Sum_probs=205.7

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||+|+||+||++++..+++.+++|.+.............+..|+.+++.++|++++++.+++..+...|++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999999999999999999776555444556778899999999999999999999999999999999999999


Q ss_pred             HHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccccccc
Q 024158          107 YRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGT  179 (271)
Q Consensus       107 ~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~~~~~  179 (271)
                      ...+..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+......   .....++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~  160 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT  160 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence            887743    346899999999999999999999999999999999999999999999999988543322   2334678


Q ss_pred             ccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHHHHHHhcccCc
Q 024158          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       180 ~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~li~~~l~~~p  244 (271)
                      +.|+|||.+.+..++.++|+||+|+++|+|++|..||.......               ....+++++.+++.+||..||
T Consensus       161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  240 (280)
T cd05608         161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDP  240 (280)
T ss_pred             cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCH
Confidence            99999999999999999999999999999999999997643211               112368899999999999999


Q ss_pred             cCCC-----CHHHHhcCCccccC
Q 024158          245 SKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rp-----s~~~il~~~~~~~~  262 (271)
                      ++||     +++++++||||+..
T Consensus       241 ~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         241 EKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             HHhcCCCCCCHHHHhcChhhhcC
Confidence            9999     88999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3e-45  Score=304.93  Aligned_cols=245  Identities=44%  Similarity=0.740  Sum_probs=220.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||++++..+++.+++|++.............+.+|++++++++|+||+++++++..++.+++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997665544455677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~  178 (271)
                      |++++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|.||+++.++.++|+|||++...........+
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  160 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG  160 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence            99999999999988888999999999999999999999999999999999999999999999999998766555556678


Q ss_pred             cccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCC
Q 024158          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKR  247 (271)
Q Consensus       179 ~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~R  247 (271)
                      ++.|++||.+.+...+.++|+||||+++++|++|..||.........           ..+++.+.+++.+||..+|.+|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R  240 (290)
T cd05580         161 TPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKR  240 (290)
T ss_pred             CccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHc
Confidence            89999999998888889999999999999999999999876643322           2357899999999999999999


Q ss_pred             C-----CHHHHhcCCccccCC
Q 024158          248 L-----SLQKIMEHPWIIKNA  263 (271)
Q Consensus       248 p-----s~~~il~~~~~~~~~  263 (271)
                      +     +++++++||||+...
T Consensus       241 ~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         241 LGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             cCcccCCHHHHHcCcccccCC
Confidence            9     999999999997753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-45  Score=310.72  Aligned_cols=243  Identities=33%  Similarity=0.586  Sum_probs=212.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +|.+.+.||+|+||.||+|++..+++.+|+|++.+...........+..|..++..+. |++++++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            5889999999999999999999999999999997765444444566777888888886 477888999999989999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      ||+++++|.+++.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            9999999999998878899999999999999999999999999999999999999999999999998754321   2234


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p  244 (271)
                      ..|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.......           ..+++++.+++.+||.++|
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p  240 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP  240 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCH
Confidence            46899999999999888999999999999999999999999877654332           2368899999999999999


Q ss_pred             cCCCC-----HHHHhcCCccccC
Q 024158          245 SKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+|++     .+++++||||+..
T Consensus       241 ~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         241 SKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             hhCCCCCCCCHHHHhcCcccCCC
Confidence            99997     5799999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-48  Score=297.31  Aligned_cols=243  Identities=33%  Similarity=0.632  Sum_probs=216.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|++.+.||.|+|+.|+++.+..+|..+++|++........ ..+++.+|+++-+.++||||+++.+.+.+....|+|+
T Consensus        11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            358899999999999999999999999999999977666554 5688999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC---CCCCEEEeeecccccccC--cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRS--KR  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~---~~~~~~L~dfg~~~~~~~--~~  173 (271)
                      |++.|+.|...+-...-.|+..+...+.||++++.|+|.+||+|+|++|+|+++-   +...+||+|||.+....+  ..
T Consensus        90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~  169 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAW  169 (355)
T ss_pred             ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcccc
Confidence            9999999976665545578899999999999999999999999999999999994   345799999999966553  33


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHHH
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISR  238 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~~  238 (271)
                      .+..|+|.|++||.+...+++..+|||+-|++||-|+.|.+||.+.+....               |..++++.++|+++
T Consensus       170 ~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvrr  249 (355)
T KOG0033|consen  170 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRR  249 (355)
T ss_pred             ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHH
Confidence            567899999999999999999999999999999999999999998655443               44578999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||..||.+|.|+.++|+|||+.+.
T Consensus       250 ML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  250 MLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999865

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-45  Score=310.75  Aligned_cols=238  Identities=31%  Similarity=0.596  Sum_probs=208.4

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..++..+++|++.+...........+.+|..++.++ +|++|+.+++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999876655555567788889888888 599999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|...+...+.+++..++.++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875422   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------------hhcccCHHHHHHHHHhccc
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------TFRSISAEAKHLISRLLVK  242 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------------~~~~i~~~l~~li~~~l~~  242 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||.......                  ....++..+.+++.+||..
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~  240 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNK  240 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcc
Confidence            9999999999999999999999999999999999996432211                  1123578899999999999


Q ss_pred             CccCCCC------HHHHhcCCccccC
Q 024158          243 DSSKRLS------LQKIMEHPWIIKN  262 (271)
Q Consensus       243 ~p~~Rps------~~~il~~~~~~~~  262 (271)
                      ||++|++      ++++++||||...
T Consensus       241 dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         241 DPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             CHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9999997      5799999999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=314.93  Aligned_cols=242  Identities=29%  Similarity=0.497  Sum_probs=220.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|..+..||+|+||.||+|.+..+++.||+|++..+....  ..+++++|+.++..++++||.++|+.+..+..++++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~d--eIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAED--EIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcch--hhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            45777899999999999999999999999999997765553  3678999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      |||.||++.++++.+..+.+..+.-++.+++.|+.|||..+.+|+|||+.||++..+|.++|+|||.+.+...   ....
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            9999999999999888779999999999999999999999999999999999999999999999999854432   3466


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------ccCHHHHHHHHHhcccC
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------SISAEAKHLISRLLVKD  243 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------~i~~~l~~li~~~l~~~  243 (271)
                      ..|||.|+|||+..+..|+.++||||||++.++|++|.+|+...++...+.            ..++.+++|+..||.+|
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKN  250 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcC
Confidence            789999999999998899999999999999999999999998777644433            35788999999999999


Q ss_pred             ccCCCCHHHHhcCCccccC
Q 024158          244 SSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~  262 (271)
                      |+.|||+.++|+|+|+++.
T Consensus       251 P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  251 PEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             cccCcCHHHHhhhHHHHhc
Confidence            9999999999999999983

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-47  Score=295.78  Aligned_cols=255  Identities=32%  Similarity=0.566  Sum_probs=221.4

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhC-CCCce
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSL-RHPNI   81 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~-~~~~i   81 (271)
                      ..+.....--.+.|.-.+.||+|..++|-++.++.+|..+++|++.....     ......+....|+.+++++ .||+|
T Consensus         6 lpd~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I   85 (411)
T KOG0599|consen    6 LPDKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI   85 (411)
T ss_pred             ccchhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE
Confidence            34444455567789999999999999999999999999999999853322     1234566677899999988 79999


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      +.+.++++.+...++|+|.|+.|.|.+++...-.+|+...+.++.|+++++.|||.++|+|+|+||+||+++.+.+++|+
T Consensus        86 I~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   86 IDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             EEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEe
Confidence            99999999999999999999999999999988899999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCc--cccccccccccCCcccc------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCc------------
Q 024158          162 DFGWSVQSRSK--RHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------------  221 (271)
Q Consensus       162 dfg~~~~~~~~--~~~~~~~~~y~~pe~~~------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~------------  221 (271)
                      |||+++.....  ....+|||+|+|||.+.      ...|+...|+|+.|+++|.|+.|.+||...-.            
T Consensus       166 DFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky  245 (411)
T KOG0599|consen  166 DFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY  245 (411)
T ss_pred             ccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence            99999765543  45679999999999874      34578899999999999999999999975432            


Q ss_pred             ---chhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          222 ---KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       222 ---~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                         ...|..++.+..+||++||+.||.+|.|++++|.||||++.
T Consensus       246 qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  246 QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence               23345578999999999999999999999999999999654

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.3e-45  Score=308.26  Aligned_cols=246  Identities=27%  Similarity=0.470  Sum_probs=209.0

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      +.++++|++.+.||+|+||.||++++..++..+++|.+.......  ....+.+|+.+++.++|+|++++++++..++..
T Consensus         2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            457789999999999999999999999999999999986543222  223566799999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      ++++||++ ++|.+++... ..++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          80 TLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             EEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            99999997 4888887654 45799999999999999999999999999999999999999999999999987543322 


Q ss_pred             --cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------
Q 024158          173 --RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------  224 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------  224 (271)
                        .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+..+.                         
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence              223456889999998865 4578899999999999999999999976543211                         


Q ss_pred             ----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 ----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 ----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                      ...+++++.+++.+||..||.+|||++++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence                            113577899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-45  Score=309.51  Aligned_cols=244  Identities=34%  Similarity=0.566  Sum_probs=208.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||++++..+++.+|+|++.+...........+.+|..++..++|++|+++++++..++.+|+|+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997654444445667888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----  173 (271)
                      ||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS  160 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence            99999999999976 4578999999999999999999999999999999999999999999999999875433221    


Q ss_pred             ccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------cccCHHH
Q 024158          174 HTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEA  232 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------~~i~~~l  232 (271)
                      ....|++.|+|||.+..     ..++.++|+||+|+++|+|++|..||......+..                ..++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  240 (331)
T cd05597         161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEA  240 (331)
T ss_pred             cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHH
Confidence            22458999999999863     34677999999999999999999999765433221                2368899


Q ss_pred             HHHHHHhcccCcc--CCCCHHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSS--KRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~--~Rps~~~il~~~~~~~~  262 (271)
                      ++++++||..+++  .|++++++++||||...
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         241 KDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            9999999865443  37899999999999764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-45  Score=313.23  Aligned_cols=246  Identities=25%  Similarity=0.455  Sum_probs=208.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------   91 (271)
                      .++|++++.||+|+||.||+|.+..++..+++|.+....... .....+.+|+.+++.++|+||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            478999999999999999999999999999999986543322 2345567899999999999999999887533      


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ...|++++++ +++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3478999998 5799888764 5689999999999999999999999999999999999999999999999999876655


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------  225 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------  225 (271)
                      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||......+..                         
T Consensus       171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07878         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK  250 (343)
T ss_pred             CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence            5556678999999999876 46788999999999999999999999764322111                         


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                       ...++.+.+++.+||..||.+|||+.++++||||.+...+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~  308 (343)
T cd07878         251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPE  308 (343)
T ss_pred             HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCc
Confidence                             12355688999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2e-45  Score=314.04  Aligned_cols=248  Identities=32%  Similarity=0.519  Sum_probs=208.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .....+.+|++++.||+|+||.||++++..+++.|++|++.....  ......+.+|+++++.++|+||+++++++..++
T Consensus        68 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         68 SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             CCCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            345567899999999999999999999999999999999854432  234567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+++++||+.+++|.+.    ...+...+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            99999999999888643    23567788899999999999999999999999999999999999999999988543322


Q ss_pred             ---cccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccC
Q 024158          173 ---RHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSIS  229 (271)
Q Consensus       173 ---~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~  229 (271)
                         .....|+..|+|||.+..     ...+.++||||||+++|+|++|..||......+.               ...++
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS  301 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence               234568999999998743     2234589999999999999999999974332211               22357


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      .++.++|.+||..||++|||+.++++||||.+...+.
T Consensus       302 ~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~  338 (353)
T PLN00034        302 REFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQ  338 (353)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCcccccCCccc
Confidence            8999999999999999999999999999999986554

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.5e-46  Score=312.44  Aligned_cols=238  Identities=35%  Similarity=0.676  Sum_probs=207.5

Q ss_pred             eeeecccCCceEEEEEEe---cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           24 GRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      ++.||+|+||.||++++.   .+|+.+++|++....... .....+..|+.++++++|+||+++++++..++.+|+|+||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            367999999999999863   578999999997654432 2234567789999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMC  177 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~~~  177 (271)
                      +++++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......   .....
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~  159 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC  159 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceeccc
Confidence            999999999988778999999999999999999999999999999999999999999999999987544322   23456


Q ss_pred             ccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccC
Q 024158          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       178 ~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~  246 (271)
                      |++.|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+||.+||.+
T Consensus       160 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~  239 (318)
T cd05582         160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPAN  239 (318)
T ss_pred             CChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhH
Confidence            889999999999888899999999999999999999999876644332           235889999999999999999


Q ss_pred             CCC-----HHHHhcCCccccC
Q 024158          247 RLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       247 Rps-----~~~il~~~~~~~~  262 (271)
                      |||     +++++.||||++.
T Consensus       240 R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         240 RLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             cCCCCCCCHHHHhCCCCcCCC
Confidence            999     7889999999764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.6e-45  Score=312.58  Aligned_cols=242  Identities=24%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC---
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE---   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   92 (271)
                      ...++|++.+.||+|+||.||++++..+|..+++|.+....... .....+.+|+.+++.++|+||+++++++...+   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            34689999999999999999999999999999999986543222 33456778999999999999999999886443   


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           93 ---RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        93 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                         .+|+++|+++ ++|...+..  .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               5799999997 477776643  4788999999999999999999999999999999999999999999999998543


Q ss_pred             cCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc---------------------
Q 024158          170 RSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------------  226 (271)
Q Consensus       170 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~---------------------  226 (271)
                      ...  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+.                     
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            322  234567889999999999899999999999999999999999998654322110                     


Q ss_pred             --------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          227 --------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       227 --------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                                      ..++++++++.+||..||++|||+.|+|+||||+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence                                            12467899999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.9e-46  Score=299.29  Aligned_cols=248  Identities=29%  Similarity=0.482  Sum_probs=215.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCC----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDE----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~----   92 (271)
                      +..|..+++||+|.||+||+|+.+.+|+.||+|.+.....+ +..-....+|+.+++.++|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            77899999999999999999999999999999998655432 223345678999999999999 999999998877    


Q ss_pred             --eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           93 --RIFLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        93 --~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                        ..++|+|+++ .+|..++....    .++...+..++.||+.||.|||++||+||||||.||++++.|.+||+|||++
T Consensus        89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              8999999996 69999997744    4777899999999999999999999999999999999999999999999998


Q ss_pred             ccccCc---cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc--------------
Q 024158          167 VQSRSK---RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------  228 (271)
Q Consensus       167 ~~~~~~---~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i--------------  228 (271)
                      ....-+   .....+|..|+|||.+.+. .|+...||||+||++.+|+++.+.|.+....+++..|              
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            544422   3445689999999999987 6899999999999999999999999887765554331              


Q ss_pred             ---------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCC
Q 024158          229 ---------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       229 ---------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                                                 .++..+++.+||+.+|.+|.|++.+|+||||+....+.+
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~  313 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS  313 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence                                       358999999999999999999999999999999866543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-46  Score=306.45  Aligned_cols=249  Identities=37%  Similarity=0.678  Sum_probs=230.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|.+.+.||.|.||.|-++.....|+.||||.+.++...+++..-.+++|+++++.++||||++++++|+..+.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            46999999999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--ccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTM  176 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~~~~  176 (271)
                      ||..+|.|.+++.+.+.|++.+++.++.||++|+.|||.++++|+|+|.+|||+|.++++||.|||++.....  .....
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTF  212 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTF  212 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999854443  34678


Q ss_pred             cccccccCCccccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc----------CHHHHHHHHHhcccCcc
Q 024158          177 CGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------SAEAKHLISRLLVKDSS  245 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i----------~~~l~~li~~~l~~~p~  245 (271)
                      +|+|-|.+||+.+|.+|. ...|.||||++||.|+.|..||++.+...+.++|          |....-||..||-.||+
T Consensus       213 CGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIRwmLmVNP~  292 (668)
T KOG0611|consen  213 CGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIRWMLMVNPE  292 (668)
T ss_pred             cCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHHHHHhcCcc
Confidence            999999999999999985 5899999999999999999999999988887765          67899999999999999


Q ss_pred             CCCCHHHHhcCCcccc-CCCCCC
Q 024158          246 KRLSLQKIMEHPWIIK-NANPRG  267 (271)
Q Consensus       246 ~Rps~~~il~~~~~~~-~~~~~~  267 (271)
                      .|.|+++|..|=|+.= .++|-+
T Consensus       293 RRATieDiAsHWWvNwgy~~~V~  315 (668)
T KOG0611|consen  293 RRATIEDIASHWWVNWGYNMPVI  315 (668)
T ss_pred             cchhHHHHhhhheeecccccccc
Confidence            9999999999988763 244433

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-45  Score=311.09  Aligned_cols=238  Identities=34%  Similarity=0.634  Sum_probs=205.1

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH-HHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||+||++++..+|+.+++|++.+...........+..|. .+++.++||||+++++.+..++..|++|||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4689999999999999999999999999765443333334444444 457789999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|..++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP  160 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence            9999999888889999999999999999999999999999999999999999999999999875422   2223456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .++..+.+++.+||..+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~  240 (325)
T cd05604         161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG  240 (325)
T ss_pred             hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCC
Confidence            9999999999899999999999999999999999998776544332           35788999999999999999997


Q ss_pred             H----HHHhcCCccccC
Q 024158          250 L----QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~----~~il~~~~~~~~  262 (271)
                      +    .++++||||...
T Consensus       241 ~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         241 AKEDFLEIQEHPFFESL  257 (325)
T ss_pred             CCCCHHHHhcCCCcCCC
Confidence            6    599999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-45  Score=315.55  Aligned_cols=242  Identities=28%  Similarity=0.452  Sum_probs=206.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----eE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----RI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~   94 (271)
                      +|++.+.||+|+||.||++.+..+++.+++|.+...... ......+.+|+.+++.++|+||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            588999999999999999999999999999998543222 223456788999999999999999999998766     78


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      |+++||+. ++|.+.+.....++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 688888877778999999999999999999999999999999999999999999999999988543322  


Q ss_pred             --cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------------------
Q 024158          173 --RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------------------  225 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------------------  225 (271)
                        .....+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+....+..                        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence              1233568889999998775 4788999999999999999999999765533221                        


Q ss_pred             -------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          226 -------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       226 -------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                         ...++++.+++.+||..||.+|||+.++++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                               12367889999999999999999999999999999854

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.7e-45  Score=321.91  Aligned_cols=241  Identities=27%  Similarity=0.466  Sum_probs=199.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC------CCceeceeeEEEe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR------HPNILRLYGWFHD   90 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~~~   90 (271)
                      ..++|++++.||+|+||+||+|.+..+++.||||++....    ........|+.+++.++      |.+++.+++++..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            4578999999999999999999999999999999985421    11223444555555554      4558888888865


Q ss_pred             C-CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCC------------
Q 024158           91 D-ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEG------------  156 (271)
Q Consensus        91 ~-~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~------------  156 (271)
                      + .++|++++++ +++|.+++.....+++..+..++.||+.||.|||+ .||+|+||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999998 57899999887789999999999999999999998 5999999999999998765            


Q ss_pred             ----CEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----
Q 024158          157 ----RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----  227 (271)
Q Consensus       157 ----~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----  227 (271)
                          .++|+|||.+...........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+....+.+..     
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             CCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence                49999999876655555566789999999999999999999999999999999999999976553221100     


Q ss_pred             ------------------------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          228 ------------------------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       228 ------------------------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                                                      -.+.+.+||.+||.+||.+|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence                                                            02456799999999999999999999999999


Q ss_pred             ccC
Q 024158          260 IKN  262 (271)
Q Consensus       260 ~~~  262 (271)
                      ++.
T Consensus       442 ~~~  444 (467)
T PTZ00284        442 LKY  444 (467)
T ss_pred             ccc
Confidence            986

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=7.6e-45  Score=304.05  Aligned_cols=247  Identities=28%  Similarity=0.477  Sum_probs=209.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ..++++|++++.||+|++|.||++++..++..+++|.+.......  ....+.+|+.+++.++|+||+++++++..++..
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            457889999999999999999999999999999999986443222  123466799999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--
Q 024158           95 FLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--  171 (271)
                      ++++||++ ++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....  
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            99999997 5898888653 4689999999999999999999999999999999999999999999999998754322  


Q ss_pred             -ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------
Q 024158          172 -KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------  224 (271)
Q Consensus       172 -~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------  224 (271)
                       ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+..+.                         
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence             12234568899999988654 477899999999999999999999976543211                         


Q ss_pred             ----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                      ...+++.+.++|.+||..||.+|||++++++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~  294 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE  294 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence                            1135778999999999999999999999999999987754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.5e-45  Score=303.22  Aligned_cols=239  Identities=27%  Similarity=0.463  Sum_probs=196.3

Q ss_pred             cceeeeeeecccCCceEEEEEEec-CCceEEEEEechhhhhHHHHHHHHHHHHHHHhh---CCCCceeceeeEEE-----
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS---LRHPNILRLYGWFH-----   89 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~---~~~~~i~~~~~~~~-----   89 (271)
                      ++|++++.||+|+||.||+|++.. ++..+++|.+........ ......+|+.+++.   ++||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999865 467899998865432221 11233345555544   47999999999875     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .+..+++++|+++ ++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            2456899999997 6999988753  358999999999999999999999999999999999999999999999999885


Q ss_pred             cccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------------
Q 024158          168 QSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------------  224 (271)
Q Consensus       168 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------------  224 (271)
                      ....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|.+||.+....+.                     
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            4332  23345678999999999888899999999999999999999999986543221                     


Q ss_pred             -----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 -----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 -----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                       ...+++.+.+++.+||..||++|||+.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             12356788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=296.64  Aligned_cols=241  Identities=28%  Similarity=0.536  Sum_probs=210.8

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh--HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ++|++.+.||+|++|.||.+.+..++..+++|.+......  .......+.+|+.++++++|+||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4699999999999999999999999999999998654322  22335678889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---  173 (271)
                      ++|++++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999887789999999999999999999999999999999999999999999999999875432211   


Q ss_pred             ---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHHHH
Q 024158          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHLIS  237 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~li~  237 (271)
                         ....++..|+|||.+.+..++.++|+||||+++|++++|..||........             ...++..+.+++.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  241 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLR  241 (263)
T ss_pred             ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHH
Confidence               223467889999999988899999999999999999999999976543322             2246899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCcc
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +||..+|++|||+.++++||||
T Consensus       242 ~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         242 RTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8e-45  Score=300.45  Aligned_cols=237  Identities=27%  Similarity=0.441  Sum_probs=203.1

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||+|+||.||+++.+.+|+.+++|.+.............+..|+++++.++||||+++++.+..+..++++|||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999999765443333344556789999999999999999999999999999999999999


Q ss_pred             HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--cccccccccc
Q 024158          107 YRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDY  182 (271)
Q Consensus       107 ~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~~~~~~~y  182 (271)
                      .+++...  ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......  .....+++.|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY  160 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence            9888653  35889999999999999999999999999999999999999999999999987544332  2234678899


Q ss_pred             cCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----hh------------hcccCHHHHHHHHHhcccCccC
Q 024158          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----DT------------FRSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       183 ~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----~~------------~~~i~~~l~~li~~~l~~~p~~  246 (271)
                      +|||.+.+..++.++|+||+|+++|+|++|..||......    +.            ...+++++.+++.+||.+||++
T Consensus       161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~  240 (277)
T cd05607         161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPED  240 (277)
T ss_pred             cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhh
Confidence            9999999888999999999999999999999999754321    11            1236899999999999999999


Q ss_pred             CCCH----HHHhcCCccccCC
Q 024158          247 RLSL----QKIMEHPWIIKNA  263 (271)
Q Consensus       247 Rps~----~~il~~~~~~~~~  263 (271)
                      ||++    ++++.||||+...
T Consensus       241 R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         241 RLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             CCCCccchhhhhcChhhcCCC
Confidence            9999    7788999998754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5e-45  Score=307.79  Aligned_cols=238  Identities=35%  Similarity=0.622  Sum_probs=204.2

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH-HHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..++..+++|++.+...........+..|. .+++.++|+||+++++.+...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999766544333334444444 467889999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|...+.....+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....   .......+++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP  160 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence            9999999887789999999999999999999999999999999999999999999999999875432   2223346889


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...           ..+.++.+++.+||..+|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (321)
T cd05603         161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLG  240 (321)
T ss_pred             ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCC
Confidence            9999999988889999999999999999999999998776443322           24678999999999999999997


Q ss_pred             H----HHHhcCCccccC
Q 024158          250 L----QKIMEHPWIIKN  262 (271)
Q Consensus       250 ~----~~il~~~~~~~~  262 (271)
                      .    .++++|+||...
T Consensus       241 ~~~~~~~~~~~~~~~~~  257 (321)
T cd05603         241 AKADFLEIKNHVFFSPI  257 (321)
T ss_pred             CCCCHHHHhCCCCcCCC
Confidence            5    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.4e-45  Score=308.12  Aligned_cols=238  Identities=35%  Similarity=0.661  Sum_probs=204.4

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHH-HHHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE-MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e-~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|+||.||+|++..++..+++|++.+...........+..+ ..+++.++|+||+++++.+..++..|++|||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999976544333323333333 4457888999999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|.+++.....++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....   .......|++
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  160 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP  160 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence            9999999887888999999999999999999999999999999999999999999999999875422   2233456899


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcccCccCCCC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      .|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++.+.+++.+||.++|.+||+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~  240 (325)
T cd05602         161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLG  240 (325)
T ss_pred             cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCC
Confidence            999999999989999999999999999999999999876644332           246899999999999999999998


Q ss_pred             HH----HHhcCCccccC
Q 024158          250 LQ----KIMEHPWIIKN  262 (271)
Q Consensus       250 ~~----~il~~~~~~~~  262 (271)
                      +.    ++++|+||...
T Consensus       241 ~~~~~~~i~~~~~~~~~  257 (325)
T cd05602         241 AKDDFMEIKNHIFFSPI  257 (325)
T ss_pred             CCCCHHHHhcCcccCCC
Confidence            76    89999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=303.67  Aligned_cols=248  Identities=38%  Similarity=0.647  Sum_probs=216.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++.+.||+|++|.||+|.+..+++.+++|.+.............+..|+..++.++|+||+++++.+..++..|+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47999999999999999999999999999999997765554445677889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---
Q 024158           99 EYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---  173 (271)
                      |++.+++|.+++...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999999764  468999999999999999999999999999999999999999999999999874322111   


Q ss_pred             -----------------------------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh
Q 024158          174 -----------------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (271)
Q Consensus       174 -----------------------------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  224 (271)
                                                   ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                         123467889999999988899999999999999999999999976654332


Q ss_pred             hc-------------ccCHHHHHHHHHhcccCccCCCC----HHHHhcCCccccCCCCC
Q 024158          225 FR-------------SISAEAKHLISRLLVKDSSKRLS----LQKIMEHPWIIKNANPR  266 (271)
Q Consensus       225 ~~-------------~i~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~~~~~~~  266 (271)
                      +.             .++.++.+++.+||..+|++|||    +++++.||||++..-+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~  299 (316)
T cd05574         241 FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWAL  299 (316)
T ss_pred             HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhh
Confidence            21             15889999999999999999999    99999999999875443

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.7e-44  Score=305.84  Aligned_cols=244  Identities=32%  Similarity=0.575  Sum_probs=208.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||+++++.+++.+++|++.+...........+.+|..++..++|++++++++.+..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999997654444444556788899999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----c
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----R  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----~  173 (271)
                      ||+++++|.+++.+ ...+++..+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||++......    .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~  160 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS  160 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence            99999999999977 457899999999999999999999999999999999999999999999999987543221    1


Q ss_pred             ccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------cccCHHH
Q 024158          174 HTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEA  232 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------~~i~~~l  232 (271)
                      ....|++.|+|||.+.     ...++.++|+||||+++|+|++|..||......+..                ..+++++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~  240 (332)
T cd05623         161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA  240 (332)
T ss_pred             cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHH
Confidence            2346899999999886     345788999999999999999999999866533221                2358899


Q ss_pred             HHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      .+++.+||..+++.  |++++++++||||+..
T Consensus       241 ~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             HHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99999999654444  6899999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1e-44  Score=317.29  Aligned_cols=239  Identities=26%  Similarity=0.457  Sum_probs=198.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ...+|++.+.||+|+||.||+|++..+++.+|+|.+....       ....+|+.+++.++|+||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            4568999999999999999999999999999999885432       1234688999999999999999876432     


Q ss_pred             ---CeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeee
Q 024158           92 ---ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDF  163 (271)
Q Consensus        92 ---~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~df  163 (271)
                         ..++++|||++ ++|.+++.    ....++...++.++.||+.||.|||++||+||||||+||+++.++ .++|+||
T Consensus       137 ~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               24779999997 57777664    345689999999999999999999999999999999999998765 6999999


Q ss_pred             cccccccC--ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------
Q 024158          164 GWSVQSRS--KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------  225 (271)
Q Consensus       164 g~~~~~~~--~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------  225 (271)
                      |++.....  ......+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||.+....+..               
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~  295 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL  295 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            99865432  22345678999999988764 5889999999999999999999999875432211               


Q ss_pred             -------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          226 -------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       226 -------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                               ...++++.+||.+||.+||.+|||+.+++.||||....
T Consensus       296 ~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             HHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                                     12467899999999999999999999999999998653

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-45  Score=310.90  Aligned_cols=236  Identities=36%  Similarity=0.622  Sum_probs=202.4

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC---CCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      ||+|+||+||+|++..+++.+++|++.+..............+..++...   +||+|+.+++.+...+.+|++|||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999765544333334444555666554   699999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTL  180 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~~~~~  180 (271)
                      ++|.+++.....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....   .......|++
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            9999999887889999999999999999999999999999999999999999999999999875432   2233456899


Q ss_pred             cccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------ccCHHHHHHHHHhcccCccCC
Q 024158          181 DYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------SISAEAKHLISRLLVKDSSKR  247 (271)
Q Consensus       181 ~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------~i~~~l~~li~~~l~~~p~~R  247 (271)
                      .|+|||.+.+. .++.++|+||||+++|+|++|..||......+...            .+++++.+++.+||.++|++|
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R  240 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHR  240 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHC
Confidence            99999998754 47889999999999999999999998766544322            258999999999999999999


Q ss_pred             C----CHHHHhcCCccccC
Q 024158          248 L----SLQKIMEHPWIIKN  262 (271)
Q Consensus       248 p----s~~~il~~~~~~~~  262 (271)
                      |    +++++++||||...
T Consensus       241 ~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         241 LGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCCHHHHhcCccccCC
Confidence            8    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2e-44  Score=299.24  Aligned_cols=243  Identities=30%  Similarity=0.483  Sum_probs=210.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|++.+.||+|+||.||++.+..+++.+++|.+.............+.+|+.+++.++|++++.+++.+..++..++++|
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999876554444444566789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccc
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~  175 (271)
                      |+++++|.+++...  ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  160 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG  160 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence            99999999988653  35899999999999999999999999999999999999999999999999987543322  223


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHHHHHHhc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKHLISRLL  240 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~li~~~l  240 (271)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......               ....+++++.+++.+||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05630         161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLL  240 (285)
T ss_pred             CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHh
Confidence            468899999999998889999999999999999999999998643211               11236889999999999


Q ss_pred             ccCccCCCC-----HHHHhcCCccccC
Q 024158          241 VKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      ..||.+|||     ++++++||||++.
T Consensus       241 ~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         241 CKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             hcCHHHccCCCCCchHHHHcChhhhcc
Confidence            999999999     8999999999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.6e-44  Score=305.89  Aligned_cols=244  Identities=33%  Similarity=0.548  Sum_probs=209.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||++++..+++.+++|++.+...........+.+|..++..++|++|+.+++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444444566788899999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----  173 (271)
                      ||+++++|.+++.. ...+++..+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.......    
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  160 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS  160 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence            99999999999987 4578999999999999999999999999999999999999999999999999885443221    


Q ss_pred             ccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHH
Q 024158          174 HTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEA  232 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l  232 (271)
                      ....|++.|+|||.+.+     ..++.++|+||+|+++|+|++|..||......+.                ...++.++
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~  240 (331)
T cd05624         161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEA  240 (331)
T ss_pred             ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHH
Confidence            23468999999998865     4577899999999999999999999976543222                12357899


Q ss_pred             HHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      .+++.+||...+++  |++++++++||||+..
T Consensus       241 ~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~  272 (331)
T cd05624         241 KDLIQRLICSRERRLGQNGIEDFKKHAFFEGI  272 (331)
T ss_pred             HHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence            99999999865544  5699999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.4e-44  Score=301.09  Aligned_cols=245  Identities=29%  Similarity=0.450  Sum_probs=212.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|+||.||++++..++..+++|.+.....  ......+.+|++++++++||||+++++.+..++.+++++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            479999999999999999999999999999999865422  233566888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecccccccC-ccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTM  176 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~~~~  176 (271)
                      ||+++++|.+++...+.++...+..++.|+++++.|||+ .+++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            999999999999887889999999999999999999997 5999999999999999999999999998744322 23345


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------------
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------------  225 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------------  225 (271)
                      .+++.|+|||.+.+..++.++|+||||++++++++|..||...+.....                               
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            6788999999998888889999999999999999999998643321110                               


Q ss_pred             ------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 ------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 ------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                        ..++.++.+++.+||..+|++|||+.+++.||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence                              1146789999999999999999999999999999987555

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.1e-44  Score=309.03  Aligned_cols=241  Identities=24%  Similarity=0.435  Sum_probs=204.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ..++|++.+.||+|+||.||++.+..+++.+++|++....... .....+.+|+.+++.++|+||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            4689999999999999999999999999999999986543222 2345677899999999999999999987543     


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       ..+|+|||+++ ++|...+..  .++...+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             35799999997 578777753  47889999999999999999999999999999999999999999999999986543


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc---------------------
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------------------  227 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~---------------------  227 (271)
                      ..  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+.+.+                     
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  257 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence            32  2345678999999999999999999999999999999999999976543221110                     


Q ss_pred             --------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          228 --------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       228 --------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                                      .+.+++++|.+||..||.+|||++++|+||||+.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence                                            1356889999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.7e-44  Score=299.95  Aligned_cols=238  Identities=28%  Similarity=0.468  Sum_probs=195.9

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHh---hCCCCceeceeeEEEe-----C
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS---SLRHPNILRLYGWFHD-----D   91 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~---~~~~~~i~~~~~~~~~-----~   91 (271)
                      +|++++.||+|++|.||+|++..+++.+++|.+........ ......+|+.+++   .++|+||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            58999999999999999999999999999999865422211 1122334444444   4579999999998754     2


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ...++++|+++ ++|.+++...  ..++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            45899999997 5898888763  34899999999999999999999999999999999999999999999999988544


Q ss_pred             cCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------
Q 024158          170 RSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------  224 (271)
Q Consensus       170 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------  224 (271)
                      ...  .....+++.|+|||.+.+..++.++|+||+|+++++|++|.+||......+.                       
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            322  2334578899999999988899999999999999999999999865433211                       


Q ss_pred             ---------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ---------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ---------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                     ...++..+.+++.+||.+||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                           12357788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.2e-44  Score=296.30  Aligned_cols=244  Identities=30%  Similarity=0.460  Sum_probs=212.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|+..+.||.|+||+||++.+..+++.+++|.+.............+.+|+++++.++|++++.+.+.+..++..++++|
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            37888999999999999999999999999999876554444445567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccc
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~  175 (271)
                      ++.+++|.+++...  ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999999888653  36899999999999999999999999999999999999999999999999987543322  233


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHHHHHHhc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKHLISRLL  240 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~li~~~l  240 (271)
                      ..++..|+|||.+.+..++.++|+||+|++++++++|..||.......               ....+++++.+++.+||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            468899999999988889999999999999999999999998654321               12346889999999999


Q ss_pred             ccCccCCCC-----HHHHhcCCccccCC
Q 024158          241 VKDSSKRLS-----LQKIMEHPWIIKNA  263 (271)
Q Consensus       241 ~~~p~~Rps-----~~~il~~~~~~~~~  263 (271)
                      ..+|++||+     +.+++.|+||...+
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999     88999999997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-44  Score=308.29  Aligned_cols=243  Identities=23%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   91 (271)
                      ...++|++.+.||+|+||.||++.+..+++.+++|.+....... .....+.+|+.+++.++|+||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            45689999999999999999999999999999999986543322 3345667899999999999999999987543    


Q ss_pred             --CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 --ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                        ...|++||+++ +++...+..  .++...+..++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              35799999997 477777753  4788999999999999999999999999999999999999999999999998654


Q ss_pred             cCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------------
Q 024158          170 RSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------------  225 (271)
Q Consensus       170 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------------  225 (271)
                      ...  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.+                      
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            332  23456789999999999888999999999999999999999999765421111                      


Q ss_pred             -------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          226 -------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       226 -------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                     ...+.++.+++.+||..||++|||+.++|+||||+..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                                           0124578899999999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.6e-44  Score=317.12  Aligned_cols=242  Identities=27%  Similarity=0.490  Sum_probs=210.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecC-CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ...|.+.+.||+|++|.||+|....+ +..+++|.+....   ......++.|+.+++.++||||+++++++..++..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            44599999999999999999998887 7888888764432   2334567789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           97 ILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ||||+++++|.+++..    ..++++..+..++.|++.||.+||++||+||||||+||+++.++.++|+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999988753    346899999999999999999999999999999999999999999999999998654322


Q ss_pred             -----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                           .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+..            ..+++++.++
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  302 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKAL  302 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHH
Confidence                 23346899999999999888999999999999999999999999876544332            2357899999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      |.+||.++|++|||+++++.|+|++..
T Consensus       303 i~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        303 LDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             HHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            999999999999999999999998643

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=5.7e-44  Score=296.31  Aligned_cols=240  Identities=29%  Similarity=0.533  Sum_probs=206.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||++++..+++.+++|++....... ...+.+.+|+.+++.++|+|++++++++.....+++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            47999999999999999999999999999999986543221 22345678999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~  175 (271)
                      ||+++++|..++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999988888877766679999999999999999999999999999999999999999999999999885443322   23


Q ss_pred             ccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------------------
Q 024158          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------------------  224 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------------------  224 (271)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+.                              
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            456788999999876 4578899999999999999999999976543211                              


Q ss_pred             ------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                  ...++..+.+++.+||.++|++|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence                        23457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.5e-44  Score=294.32  Aligned_cols=240  Identities=33%  Similarity=0.589  Sum_probs=214.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||.|++|.||++++..++..+++|++.+.........+.+.+|++.+++++|||++++++.+..+...++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999977655544556788999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMC  177 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~~~  177 (271)
                      ++.+++|.+.+....+++...+..++.|+++++.+||+.|++|+||+|+||+++.++.++|+|||.+......  .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~  160 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS  160 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence            9999999999987778999999999999999999999999999999999999999999999999987544332  23456


Q ss_pred             ccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc---c-----------hhhcccCHHHHHHHHHhcccC
Q 024158          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---K-----------DTFRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       178 ~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~---~-----------~~~~~i~~~l~~li~~~l~~~  243 (271)
                      ++..|+|||.+.+..++.++|+||+|+++|++++|..||.....   .           .....++.++.+++.+||..+
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  240 (258)
T cd05578         161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERD  240 (258)
T ss_pred             CChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCC
Confidence            78889999999888889999999999999999999999987653   1           112236799999999999999


Q ss_pred             ccCCCCH--HHHhcCCcc
Q 024158          244 SSKRLSL--QKIMEHPWI  259 (271)
Q Consensus       244 p~~Rps~--~~il~~~~~  259 (271)
                      |.+||+.  .++++||||
T Consensus       241 p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         241 PQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             hhHcCCccHHHHhcCCCC
Confidence            9999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.4e-44  Score=294.32  Aligned_cols=240  Identities=28%  Similarity=0.493  Sum_probs=207.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|++|.||++++..++..+++|.+.....  ......+.+|+.++++++|||++++++.+...+..++++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            478999999999999999999999999999999865422  223467888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-cccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMC  177 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~~~~~  177 (271)
                      ||+++++|..+    ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..... ......
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            99999888654    3468889999999999999999999999999999999999999999999998854332 233456


Q ss_pred             ccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-------hh-------------hcccCHHHHHHHH
Q 024158          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-------DT-------------FRSISAEAKHLIS  237 (271)
Q Consensus       178 ~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-------~~-------------~~~i~~~l~~li~  237 (271)
                      ++..|+|||.+.+..++.++|+||||+++|++++|..||......       ..             ...+++++.+++.
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT  234 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence            888999999999888999999999999999999999999653211       00             1236789999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +||..+|++||+++++++||||++...
T Consensus       235 ~~l~~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         235 QCMRKQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             HHhhCChhhCCCHHHHhcCcccccccC
Confidence            999999999999999999999987743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.6e-44  Score=316.92  Aligned_cols=251  Identities=30%  Similarity=0.481  Sum_probs=213.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ........++|++.+.||+|+||.||++++..+++.+|+|++....... .....+.+|+..+..++|++++++++.+..
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            3444455689999999999999999999999999999999987654433 335667889999999999999998877643


Q ss_pred             CC--------eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCE
Q 024158           91 DE--------RIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        91 ~~--------~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~  158 (271)
                      ..        .+++++||+++++|.+++..    ...+++..+..++.|++.+|.|||+.|++|+||||+||+++.++.+
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE
Confidence            22        37899999999999998864    2468999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------
Q 024158          159 KIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------  225 (271)
Q Consensus       159 ~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------  225 (271)
                      +|+|||++.....     ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......+..        
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~  262 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY  262 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            9999999754322     223456899999999999999999999999999999999999999876643332        


Q ss_pred             ----cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          226 ----RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       226 ----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                          ..+++++.+++.+||..+|.+|||+.++++|||++..
T Consensus       263 ~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        263 DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence                2368899999999999999999999999999998753

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-44  Score=294.99  Aligned_cols=242  Identities=33%  Similarity=0.526  Sum_probs=212.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||.|++|.||++++..++..+++|.+......  .....+.+|+++++.++|+|++++.+.+.++...|+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            4799999999999999999999999999999998654322  23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~  175 (271)
                      |++++++|.+++... .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999999765 7899999999999999999999999999999999999999999999999988554432   234


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cc-cCHHHHHHHHHhccc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RS-ISAEAKHLISRLLVK  242 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~-i~~~l~~li~~~l~~  242 (271)
                      ..+++.|+|||.+.+..++.++|+||||+++|++++|..||....+....            .. +++++.+++.+||..
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  237 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK  237 (274)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhC
Confidence            46778899999999888999999999999999999999999765433221            12 678899999999999


Q ss_pred             CccCCCCHHHHhcCCccccCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +|++|||++++++||||++..
T Consensus       238 ~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         238 DPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             ChhhCcCHHHHhhChhhcCCC
Confidence            999999999999999998854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-43  Score=289.51  Aligned_cols=239  Identities=32%  Similarity=0.523  Sum_probs=210.3

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|.+.+.||+|++|.+|++.+..++..+++|.+....... .....+.+|+.+++.++|+|++++++++..++.+++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            5899999999999999999999999999999986654433 345678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---c
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~  174 (271)
                      ++++++|.+++...  ..++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999764  568999999999999999999999999999999999999999999999999875433322   2


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||.........            ..++.++.+++.+|+..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTK  239 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccC
Confidence            345788899999999888999999999999999999999999876643322            13578999999999999


Q ss_pred             CccCCCCHHHHhcCCcc
Q 024158          243 DSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~  259 (271)
                      +|++||++.++++|||+
T Consensus       240 ~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         240 DYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CcccCcCHHHHhhCCCC
Confidence            99999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.8e-43  Score=296.21  Aligned_cols=244  Identities=31%  Similarity=0.565  Sum_probs=212.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|++|.||++.+..+++.+++|.+.............+.+|+.+++.++|+||+++++.+..++..++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987765444445567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      |++++++|.+++...+.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.....       
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            9999999999998878899999999999999999999999999999999999999999999999998742110       


Q ss_pred             -----------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc--------------
Q 024158          172 -----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------------  226 (271)
Q Consensus       172 -----------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~--------------  226 (271)
                                 ......++..|+|||.+.+..++.++|+||||+++|++++|..||.+....+...              
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE  240 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc
Confidence                       0011345778999999988889999999999999999999999998765443222              


Q ss_pred             ccCHHHHHHHHHhcccCccCCCC---HHHHhcCCccccC
Q 024158          227 SISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  262 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  262 (271)
                      .++.++.+++.+||.++|++||+   +.++++||||...
T Consensus       241 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            25788999999999999999997   7999999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.5e-44  Score=297.51  Aligned_cols=248  Identities=31%  Similarity=0.529  Sum_probs=211.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh--HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +|++.+.||+|++|.||+|.+..+++.+++|.+......  .......+..|+.+++.++|+|++++++++..++..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588999999999999999999999999999999665433  122345567899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---c
Q 024158           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~  173 (271)
                      +|++ +++|.+++.... .+++..+..++.||++||.+||++|++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM  159 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence            9999 789999998765 7999999999999999999999999999999999999999999999999988554332   2


Q ss_pred             ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------------
Q 024158          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------------  224 (271)
                      ....+++.|+|||.+.+ ..++.++|+||||++++++++|.++|......+.                            
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T cd07841         160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF  239 (298)
T ss_pred             cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence            22345678999998855 4568899999999999999999887765443221                            


Q ss_pred             -----------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCC
Q 024158          225 -----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       225 -----------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                                 ....+.++.+++.+||.++|++|||+.++++||||++.+.|-++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                       12246789999999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.9e-43  Score=288.82  Aligned_cols=239  Identities=29%  Similarity=0.552  Sum_probs=206.6

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-CCeEEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIFLIL   98 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~   98 (271)
                      +|++.+.||.|++|.||++++..+++.+++|.+....... ...+.+.+|+.+++.++|+|++++++.+.. +..+++++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5999999999999999999999999999999986654333 234567889999999999999999988764 44689999


Q ss_pred             eccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           99 EYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      |++++++|.+++...  ..+++.+++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999998763  4589999999999999999999999999999999999999999999999998754332   22


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhcc
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~  241 (271)
                      ....+++.|+|||.+.+..++.++|+||+|++++++++|..||...+.....            ..+++++.+++.+|+.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  239 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS  239 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhc
Confidence            2345788999999999988999999999999999999999999866543321            2357899999999999


Q ss_pred             cCccCCCCHHHHhcCCcc
Q 024158          242 KDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~  259 (271)
                      ++|++|||+.++++||||
T Consensus       240 ~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         240 KRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             cCcccCCCHHHHhcCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.4e-44  Score=292.55  Aligned_cols=240  Identities=30%  Similarity=0.527  Sum_probs=209.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh------HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE------KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      +|.+.+.||.|++|.||+|.+..++..+++|.+......      .......+.+|+.++++++|+|++++++++..++.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999999889999999988654322      12334678889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      .++++|++++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            9999999999999999988788999999999999999999999999999999999999999999999999987544321 


Q ss_pred             --------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHH
Q 024158          173 --------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEA  232 (271)
Q Consensus       173 --------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l  232 (271)
                              .....++..|+|||.+.+..++.++|+||+|+++++|++|..||........            ...++.++
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA  240 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHH
Confidence                    1123467889999999888888999999999999999999999986543222            12368999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      .+++.+||.++|.+||++.++++||||
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         241 IDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.9e-44  Score=296.04  Aligned_cols=245  Identities=20%  Similarity=0.251  Sum_probs=209.8

Q ss_pred             hhhhccCccccceeee--eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158            9 EDNRKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~--~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      +-.....++..+++..  ..||+|+++.||+++.  +|+.+++|.+...........+.+.+|+.++++++||||+++++
T Consensus         8 ~~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988          8 YINDIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             hcCcceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            3444555566666666  6789999999999986  78999999997765544455677889999999999999999999


Q ss_pred             EEEe----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEe
Q 024158           87 WFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        87 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      ++.+    ....++++||+++++|.+++...+.+++.....++.+++.|+.+||+. +++|+||+|+||+++.++.++|+
T Consensus        86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEc
Confidence            9866    346899999999999999998888899999999999999999999985 99999999999999999999999


Q ss_pred             eecccccccCccccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------
Q 024158          162 DFGWSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------  226 (271)
Q Consensus       162 dfg~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------  226 (271)
                      |||++...........+++.|+|||.+.+  ..++.++|+||||+++|+|++|..||......+...             
T Consensus       166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  245 (283)
T PHA02988        166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL  245 (283)
T ss_pred             ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC
Confidence            99998654444445567899999999976  678999999999999999999999998776543321             


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..++++.+++.+||..||++|||+.++++
T Consensus       246 ~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        246 DCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             cCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            25789999999999999999999999986

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.2e-44  Score=295.32  Aligned_cols=238  Identities=29%  Similarity=0.539  Sum_probs=202.4

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++++.||+|++|.||++++..++..+++|.+....... .....+.+|+.+++.++|+|++++++++..++.+++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            6899999999999999999999999999999986543222 233567789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---c
Q 024158          100 YAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (271)
Q Consensus       100 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~  173 (271)
                      +++ ++|.+++...   ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......   .
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5888887642   45899999999999999999999999999999999999999999999999987543322   1


Q ss_pred             ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch-----------------------------
Q 024158          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-----------------------------  223 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-----------------------------  223 (271)
                      ....+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+.....                             
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            223567889999988654 46889999999999999999999997543211                             


Q ss_pred             -----------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 -----------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 -----------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                 ....+++++.++|.+||..||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       012357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.4e-43  Score=295.88  Aligned_cols=243  Identities=29%  Similarity=0.499  Sum_probs=212.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++++.||+|++|.||++++..++..+++|.+.......   .+.+.+|+.+++.++|+|++++++++..++..+++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            378999999999999999999999999999999986543332   35577889999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      +||+++++|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence            999999999999865 45889999999999999999999999999999999999999999999999987543322   22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLL  240 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l  240 (271)
                      ...+++.|++||.+.+..++.++|+||+|+++|++++|..||....+...              ...++..+.+++.+||
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  253 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL  253 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHc
Confidence            34678889999999988889999999999999999999999976543221              2336788999999999


Q ss_pred             ccCccCCCCHHHHhcCCccccCCC
Q 024158          241 VKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ..+|++|||++++++||||++...
T Consensus       254 ~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         254 EMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             cCChhhCcCHHHHhcCchhccccc
Confidence            999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.5e-43  Score=290.82  Aligned_cols=239  Identities=31%  Similarity=0.514  Sum_probs=208.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||.|++|+||++....++..+++|++.......  ....+.+|+..++.++|+|++++++.+...+.+++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999988899999999986544333  4577889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc--
Q 024158           99 EYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~--  173 (271)
                      |++++++|.+++...   ..+++..+..++.|++.|+.+||+.|++|+|++|+||+++.++.++|+|||++.......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999763   358999999999999999999999999999999999999999999999999874433322  


Q ss_pred             -----ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------cccCH
Q 024158          174 -----HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------RSISA  230 (271)
Q Consensus       174 -----~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------~~i~~  230 (271)
                           ....++..|++||.+... .++.++|+||||+++++|++|..||.........                 ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence                 223578889999998776 6888999999999999999999999765432211                 24678


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      ++.+++.+||..+|++|||++++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-45  Score=307.15  Aligned_cols=245  Identities=28%  Similarity=0.541  Sum_probs=222.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe-EE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~   95 (271)
                      .+.+|.+++.+|.|+||.+++++++.++..+++|.+......... .+...+|+.++++++||||+.+.+.+.+++. .+
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            478999999999999999999999999999999999776555433 3478899999999999999999999999888 99


Q ss_pred             EEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           96 LILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      ++|+||+||++.+.+.+.+  .++++.+..++.|++.|+.|||+++|+|||||+.||++++++.++|+|||+++..... 
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            9999999999999998744  5899999999999999999999999999999999999999999999999999766654 


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------------cCHHHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------------ISAEAKHLISR  238 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------------i~~~l~~li~~  238 (271)
                        .....|||.|++||.+.+.+|..++|+|||||++|+|++-+++|...+......+            ++.+++.+|..
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~  240 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKS  240 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHH
Confidence              3567899999999999999999999999999999999999999998887666544            37899999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||.++|..||++.++|.+|..+..
T Consensus       241 ~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  241 MLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999999988743

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=303.43  Aligned_cols=250  Identities=36%  Similarity=0.683  Sum_probs=225.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .+=|++.+.||+|-|++|-++++.-+|+.||||++.+...++.. ...+.+|.+.++.++||||+++|++......+|+|
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            34589999999999999999999999999999999887776643 45677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee-CCCCCEEEeeeccccc--ccCcc
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL-DHEGRLKIGDFGWSVQ--SRSKR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili-~~~~~~~L~dfg~~~~--~~~~~  173 (271)
                      .|.-++|+|.+++-.+ ..++++.+..++.||+.|+.|||...++|+|+||+||++ .+-|-+||.|||++-.  +....
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL  175 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL  175 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchh
Confidence            9999999999999764 469999999999999999999999999999999999876 6678999999999843  33445


Q ss_pred             ccccccccccCCccccCCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHHhcc
Q 024158          174 HTMCGTLDYLAPEMVENKEHDY-AVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISRLLV  241 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~-~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~~l~  241 (271)
                      ...+|+..|.|||++.|..|+. +.||||||++||-|++|++||+..+..+.+..           ++.+.++||..||.
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLv  255 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLV  255 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHh
Confidence            6779999999999999999875 88999999999999999999998888777654           47999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                      .||++|.|+++|..++|+|-...+.+|
T Consensus       256 RdPkkRAslEeI~s~~Wlq~~D~~~sT  282 (864)
T KOG4717|consen  256 RDPKKRASLEEIVSTSWLQAGDRGLST  282 (864)
T ss_pred             cCchhhccHHHHhccccccCCCCCccc
Confidence            999999999999999999999888876

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=305.75  Aligned_cols=240  Identities=26%  Similarity=0.456  Sum_probs=210.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+++....++.++.||+|-||.||.+..+ ....+++|.++......    +.+.+|++++++++|++|+++++++..
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~  272 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTK  272 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEec
Confidence            4456667777899999999999999999974 34479999997765543    466799999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ++-+|||+|||+.|+|.++|+.  +..++..+.+.++.||++|++||++++++||||.+.|||++.+..+|++|||++..
T Consensus       273 ~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~  352 (468)
T KOG0197|consen  273 QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL  352 (468)
T ss_pred             CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence            8889999999999999999987  45789999999999999999999999999999999999999999999999999984


Q ss_pred             ccCccc----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhccc------------CHH
Q 024158          169 SRSKRH----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRSI------------SAE  231 (271)
Q Consensus       169 ~~~~~~----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i------------~~~  231 (271)
                      .....+    +..-+..|+|||++..+.++.+|||||||++|||++| |+.|+.+.+..+.++.+            |.+
T Consensus       353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~  432 (468)
T KOG0197|consen  353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDE  432 (468)
T ss_pred             cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHH
Confidence            443322    1222567999999999999999999999999999986 99999999988887654            899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+++..|+..+|++|||.+.+..
T Consensus       433 vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  433 VYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHHH
Confidence            999999999999999999997654

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-43  Score=294.59  Aligned_cols=241  Identities=29%  Similarity=0.495  Sum_probs=211.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ..+|++.+.||+|++|.||++++..++..+++|.+.......   ...+.+|+.+++.++|+|++++++.+..+...|+|
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            358999999999999999999999999999999986544332   35677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      +||+++++|.+++.. ..++..++..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  174 (296)
T cd06654          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (296)
T ss_pred             ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence            999999999999865 45899999999999999999999999999999999999999999999999987543322   22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLL  240 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l  240 (271)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+...              ...++..+.+++.+||
T Consensus       175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (296)
T cd06654         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL  254 (296)
T ss_pred             cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHC
Confidence            34678899999999888889999999999999999999999976554221              2346788999999999


Q ss_pred             ccCccCCCCHHHHhcCCccccC
Q 024158          241 VKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      .++|++|||+.+++.||||...
T Consensus       255 ~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         255 DMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             cCCcccCcCHHHHhhChhhhcc
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-43  Score=303.66  Aligned_cols=236  Identities=24%  Similarity=0.389  Sum_probs=198.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ....+|++++.||+|+||.||+|++..++..+++|+....         ....|+.+++.++|+||+++++++..++..+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            3456799999999999999999999999999999985332         1235788999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--c
Q 024158           96 LILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--K  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~  172 (271)
                      +++|++. ++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.....  .
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  212 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA  212 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence            9999996 588888765 45789999999999999999999999999999999999999999999999998854322  2


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCCcc------------------------hh---
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQK------------------------DT---  224 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~-~~~~~~------------------------~~---  224 (271)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|+++..++ ......                        ..   
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            33456899999999999989999999999999999999754443 221100                        00   


Q ss_pred             ---------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          225 ---------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       225 ---------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                                 ...++.++.++|.+||..||.+|||+.++|+||||++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                       0123566778999999999999999999999999986

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-43  Score=292.07  Aligned_cols=241  Identities=27%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ....++|++.+.||+|++|.||+|++..+++.+++|.+.....   .....+.+|+.+++.++|||++++++.+...+.+
T Consensus         5 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~   81 (267)
T cd06645           5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKL   81 (267)
T ss_pred             cCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEE
Confidence            3455789999999999999999999999999999999865432   2235677899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      ++++||+++++|.+++...+.+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             EEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            99999999999999998878899999999999999999999999999999999999999999999999998744332   


Q ss_pred             ccccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHH
Q 024158          172 KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEA  232 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l  232 (271)
                      ......+++.|+|||.+.   ...++.++|+||||+++|+|++|..||....+...                ...++..+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence            223446788999999874   45578899999999999999999999864432211                11356889


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                      .+++.+||..+|++|||++++++|||
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhcCCC
Confidence            99999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-43  Score=299.76  Aligned_cols=240  Identities=20%  Similarity=0.354  Sum_probs=200.8

Q ss_pred             eeeeeccc--CCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           23 IGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        23 ~~~~lg~g--~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      +++.||+|  ++++||++++..+|+.+++|.+....... .....+.+|+.+++.++||||+++++++..++..++|+||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            56789999  67899999999999999999986654332 3456788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158          101 AHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus       101 ~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      +++++|.+++...  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++++||+.......       
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999999653  4589999999999999999999999999999999999999999999999975422111       


Q ss_pred             ---ccccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------
Q 024158          172 ---KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------  224 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------  224 (271)
                         ......++..|+|||.+.+  ..++.++|+||||+++++|++|..||........                      
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               0112245667999999876  4588899999999999999999999964321110                      


Q ss_pred             -----------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 -----------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 -----------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                                         ...+++++.+++.+||..||++|||++++++||||++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                               112467899999999999999999999999999998753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.8e-44  Score=293.10  Aligned_cols=242  Identities=32%  Similarity=0.519  Sum_probs=210.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+......  .....+.+|+.+++.++|+|++++++.+..++.+++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            4788999999999999999999999999999998665433  33567788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecccccccCc-ccc
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-RHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-~~~  175 (271)
                      |++++++|.+++... ..++...+..++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            999989999999876 678999999999999999999999 99999999999999999999999999987443221 122


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----cchhh------------cc-cCHHHHHHHH
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-----QKDTF------------RS-ISAEAKHLIS  237 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~-----~~~~~------------~~-i~~~l~~li~  237 (271)
                      ..++..|+|||.+.+..++.++|+||||++++++++|..||....     ..+..            .. +++++.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  238 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN  238 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHH
Confidence            567888999999998889999999999999999999999986542     11111            11 5788999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||..+|++|||+.+++.||||++.
T Consensus       239 ~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         239 LCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.7e-43  Score=294.01  Aligned_cols=241  Identities=30%  Similarity=0.516  Sum_probs=211.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++.+.||.|++|.||++.+..+++.+++|.+......   ....+.+|+..++.++|+|++++++++..++.+++++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4699999999999999999999999999999998654332   2456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~  175 (271)
                      |++++++|..++.. ..+++.++..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   ...
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999998875 46899999999999999999999999999999999999999999999999987543322   223


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~  241 (271)
                      ..++..|+|||.+.+..++.++|+||||+++|++++|..||....+...              ...+++.+.+++.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  254 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE  254 (296)
T ss_pred             cCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhh
Confidence            4578899999999888889999999999999999999999987654221              23467899999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .+|.+|||+.+++.||||+...
T Consensus       255 ~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         255 MDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             cChhhCCCHHHHhhChHhhhcc
Confidence            9999999999999999998653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.2e-44  Score=296.42  Aligned_cols=238  Identities=26%  Similarity=0.531  Sum_probs=200.7

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||+|++..+|+.+++|.+....... .....+.+|+.+++.++|+|++++++++.+.+.+++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            5899999999999999999999999999999986543222 223456779999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccc
Q 024158          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~  175 (271)
                      |++ ++|.+++.. ...+++..++.++.||++|+.+||++|++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            997 588887764 456899999999999999999999999999999999999999999999999987543322   123


Q ss_pred             ccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCc-ch------------------------------
Q 024158          176 MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQ-KD------------------------------  223 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~------------------------------  223 (271)
                      ..+++.|+|||.+.+.. ++.++|+||||+++|+|++|..|+..... .+                              
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            45678899999887654 68899999999999999998888533221 10                              


Q ss_pred             ----------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 ----------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 ----------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                ....+++++.+++.+||..||.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence                      112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.7e-43  Score=288.78  Aligned_cols=243  Identities=35%  Similarity=0.550  Sum_probs=214.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||.|++|.+|++++..+++.+++|.+......  .....+.+|+..+..++|+|++++++++..++.+++++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            4799999999999999999999999999999998665432  34567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecccccccCccc---
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~---  174 (271)
                      |++++++|.+++.....++...++.++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999887889999999999999999999999 9999999999999999999999999998754433222   


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc---ch------------hhcc-cCHHHHHHHHH
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KD------------TFRS-ISAEAKHLISR  238 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~---~~------------~~~~-i~~~l~~li~~  238 (271)
                      ...++..|+|||.+.+..++.++|+||||+++|++++|..||.....   .+            .... ++..+.+++++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISA  238 (264)
T ss_pred             ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHH
Confidence            34567889999999888889999999999999999999999977641   11            1122 67889999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ||.++|++|||+.++++||||++..
T Consensus       239 ~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         239 CLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HccCChhhCCCHHHHHhCHHHHhcc
Confidence            9999999999999999999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.7e-43  Score=289.63  Aligned_cols=240  Identities=26%  Similarity=0.427  Sum_probs=206.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ....+|++.+.||+|+||.||++++..+++.+++|++......   ....+.+|+.+++.++|+|++++++.+..++.++
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            3456899999999999999999999999999999998644322   2345778999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      +++||+++++|.+++.....++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......   
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK  162 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc
Confidence            99999999999999987778999999999999999999999999999999999999999999999999988544322   


Q ss_pred             cccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHHH
Q 024158          173 RHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEAK  233 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l~  233 (271)
                      .....+++.|+|||.+.   ...++.++|+||+|+++++|++|..||....+...                ...++..+.
T Consensus       163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06646         163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH  242 (267)
T ss_pred             cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence            23345788999999874   34467899999999999999999999854432211                123578999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                      +++++||..+|++|||++++++|+|
T Consensus       243 ~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         243 NFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-43  Score=289.85  Aligned_cols=241  Identities=29%  Similarity=0.542  Sum_probs=208.5

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh---hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +|+..+.||+|++|.||++++..++..+++|++.....   ........+..|++.++.++|+|++++++++.+++.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            48888999999999999999999999999999864331   223346788899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~---  172 (271)
                      ++|++++++|.+++...+++++..+..++.|++.|+.+||++|++|+||+|+||+++.++ .++|+|||.+......   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998877899999999999999999999999999999999999998776 5999999987443321   


Q ss_pred             ----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------------hhcccCHHH
Q 024158          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------TFRSISAEA  232 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------~~~~i~~~l  232 (271)
                          .....++..|+|||.+.+..++.++|+||+|++++++++|..||.......                ....+++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL  240 (268)
T ss_pred             CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHH
Confidence                123356789999999988888999999999999999999999996543221                112357889


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                      .+++.+||..+|++|||+.++++||||+
T Consensus       241 ~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         241 RDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-43  Score=301.03  Aligned_cols=240  Identities=23%  Similarity=0.416  Sum_probs=198.4

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   87 (271)
                      +.+...+|++.+.||+|+||.||+|.+.     .++..||+|++......  .....+.+|+.++..+ +||||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            3566679999999999999999999752     34578999998643222  2345688899999999 89999999998


Q ss_pred             EEeC-CeEEEEEeccCCCchHHHHHhC-----------------------------------------------------
Q 024158           88 FHDD-ERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (271)
Q Consensus        88 ~~~~-~~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (271)
                      +... +.++++|||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (338)
T cd05102          80 CTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNP  159 (338)
T ss_pred             ecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCccccc
Confidence            7654 4589999999999999998652                                                     


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----ccccccc
Q 024158          114 ---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGT  179 (271)
Q Consensus       114 ---------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~  179 (271)
                               ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......     .....++
T Consensus       160 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         160 PQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             chhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                     23677888999999999999999999999999999999999999999999988543221     1122346


Q ss_pred             ccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh-------------hcccCHHHHHHHHHhcccCcc
Q 024158          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT-------------FRSISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       180 ~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~-------------~~~i~~~l~~li~~~l~~~p~  245 (271)
                      +.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.             ....++++.+++.+||..||.
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            78999999998889999999999999999996 9999987543221             123578999999999999999


Q ss_pred             CCCCHHHHhc
Q 024158          246 KRLSLQKIME  255 (271)
Q Consensus       246 ~Rps~~~il~  255 (271)
                      +|||+.++++
T Consensus       320 ~RPs~~el~~  329 (338)
T cd05102         320 ERPTFSALVE  329 (338)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-44  Score=307.58  Aligned_cols=238  Identities=24%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ...+|.+++.||+|+||.||++...  .++..+++|.+...        ....+|+.+++.++|+||+++++++......
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~  161 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV  161 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence            3457999999999999999999754  35678999987442        1235789999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      |++||++. ++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......  
T Consensus       162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            99999996 689998877778999999999999999999999999999999999999999999999999988543322  


Q ss_pred             ---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------
Q 024158          173 ---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------  224 (271)
Q Consensus       173 ---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------  224 (271)
                         .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+......                         
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence               1234689999999999998999999999999999999999999976432100                         


Q ss_pred             ---------------------h--cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 ---------------------F--RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 ---------------------~--~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                           +  ..++.+++++|.+||..||++|||+.++|.||||++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence                                 0  12356788999999999999999999999999998754

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.6e-43  Score=291.22  Aligned_cols=241  Identities=31%  Similarity=0.525  Sum_probs=207.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |++.+.||.|++|.||++++..++..+++|.+.....   .....+.+|+.+++.++|+|++++++.+..++..++++||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            6889999999999999999999999999999854332   2345678899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccccc
Q 024158          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (271)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~  176 (271)
                      +++++|..++.. ...+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999888765 45689999999999999999999999999999999999999999999999998744322   22334


Q ss_pred             cccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHH
Q 024158          177 CGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLIS  237 (271)
Q Consensus       177 ~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~  237 (271)
                      .+++.|+|||.+.     +..++.++|+||+|+++|+|++|..||......+.              ...++.++.+++.
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLK  243 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHH
Confidence            5788999999874     34567899999999999999999999976543222              1236789999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +||.++|.+||++++++.||||.....
T Consensus       244 ~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         244 KCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHccCChhhCcCHHHHhcCCCEeccCC
Confidence            999999999999999999999997643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.1e-43  Score=287.27  Aligned_cols=236  Identities=31%  Similarity=0.561  Sum_probs=208.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||+++...++..+++|.+.....     ...+.+|+.+++.++|+|++++++.+..+...|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            579999999999999999999988899999999855432     567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      |++++++|.+++.. ...+++..++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||++......   ..
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN  157 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence            99999999999975 456899999999999999999999999999999999999999999999999987544332   22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLL  240 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l  240 (271)
                      ...++..|+|||.+.+..++.++|+||+|+++++|++|..||.........              ..++.++.+++.+|+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (256)
T cd06612         158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCL  237 (256)
T ss_pred             cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHH
Confidence            345678899999998888999999999999999999999998765432221              135678999999999


Q ss_pred             ccCccCCCCHHHHhcCCcc
Q 024158          241 VKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~  259 (271)
                      ..+|++|||+.+++.||||
T Consensus       238 ~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         238 VKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hcChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-43  Score=287.12  Aligned_cols=237  Identities=31%  Similarity=0.513  Sum_probs=208.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++.+.||.|++|.||++++..+++.+++|++......   ....+.+|+.+++.++|+|++++++++..+..+|+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            5899999999999999999999999999999998654332   3567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      |++++++|.+++... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            999999999999775 67999999999999999999999999999999999999999999999999987543322   23


Q ss_pred             cccccccccCCccccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHHHHH
Q 024158          175 TMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEAKHL  235 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l~~l  235 (271)
                      ...++..|+|||.+.+.   .++.++|+||||+++++|++|..||....+...                ...++.++.++
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF  239 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHH
Confidence            34567889999998776   788899999999999999999999976553222                12346789999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCc
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~  258 (271)
                      +.+||..+|.+|||+.+++.|+|
T Consensus       240 i~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         240 IKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHcCCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.1e-43  Score=288.49  Aligned_cols=242  Identities=28%  Similarity=0.526  Sum_probs=206.0

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh--hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--CCeE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~   94 (271)
                      .+|++.+.||+|++|.||++.+..++..+++|.+.....  ........+.+|+.+++.++|+||+++++++..  +..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            479999999999999999999999999999999864422  222345678889999999999999999998865  3578


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      ++++|++++++|.+++.....++....+.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....   
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            99999999999999998877799999999999999999999999999999999999999999999999998753321   


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAKHL  235 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~~l  235 (271)
                         ......++..|+|||.+.+..++.++|+||+|+++|++++|..||.........             ..+++.+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence               112234678899999998888899999999999999999999999765433322             2246788899


Q ss_pred             HHHhcccCccCCCCHHHHhcCCcccc
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      + +|+..+|++||+++++++||||+.
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~~  266 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQL  266 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCccccC
Confidence            8 577789999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.7e-43  Score=291.43  Aligned_cols=239  Identities=34%  Similarity=0.561  Sum_probs=205.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||+|.+..+|..+++|++....... .....+.+|+.+++.++|+|++++++++..+...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            5899999999999999999999999999999987654322 334678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----cc
Q 024158          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----~~  174 (271)
                      ++ +++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......    ..
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 8999999865 456899999999999999999999999999999999999999999999999987544332    23


Q ss_pred             cccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------------------------
Q 024158          175 TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------------------  223 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------------------------  223 (271)
                      ...++..|+|||.+.+. .++.++|+||+|++++++++|.+||.+.....                              
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            34678899999988654 46889999999999999999988886543211                              


Q ss_pred             -----------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          224 -----------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       224 -----------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                                 .....+.++.+++++||..+|.+|||++++++||||-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence                       1123578899999999999999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4e-43  Score=288.32  Aligned_cols=239  Identities=28%  Similarity=0.469  Sum_probs=206.6

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh---hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +|++.+.||.|+||.||++.. .+++.+++|.+.....   ........+.+|+..++.++|+|++++++++.+++..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 5788999998864322   122345678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-----
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----  171 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----  171 (271)
                      ++|++++++|.+++.+...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....     
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            999999999999998877889999999999999999999999999999999999999999999999998754211     


Q ss_pred             ----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHH
Q 024158          172 ----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAK  233 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~  233 (271)
                          ......++..|+|||.+.+..++.++|+||||++++++++|..||.......              ....++.++.
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAI  239 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHH
Confidence                1123457888999999998888999999999999999999999997644322              1223578999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +++.+||.++|.+||++.+++.||||
T Consensus       240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         240 DFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.6e-43  Score=291.09  Aligned_cols=246  Identities=30%  Similarity=0.480  Sum_probs=209.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..+.|++++.||.|++|.||++++..++..+++|.+....   ......+.+|+.+++.++|+|++++++.+..++.+++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            3466999999999999999999999999999999986542   2335667889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      +|||+++++|...+.+ ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~  166 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR  166 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence            9999999999887754 456899999999999999999999999999999999999999999999999987543221   


Q ss_pred             cccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHH
Q 024158          173 RHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAK  233 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~  233 (271)
                      .....+++.|+|||.+.     ...++.++|+||||+++|+|++|..||........              ...++.++.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            23345778899999884     34467789999999999999999999976543221              123567899


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +++.+||..+|++||+++++++||||......
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  278 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLLEHPFVSSVTSN  278 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            99999999999999999999999999875443

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=292.85  Aligned_cols=243  Identities=32%  Similarity=0.529  Sum_probs=209.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++++.||.|++|.||++++..++..+++|.+....   ......+..|+.++++++|+|++++++.+..+...|+++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            46999999999999999999998899999999985432   233467788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccc
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~  174 (271)
                      |++++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   ...
T Consensus        82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            999999999998763 5689999999999999999999999999999999999999999999999998743322   223


Q ss_pred             cccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHH
Q 024158          175 TMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHL  235 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~l  235 (271)
                      ...+++.|++||.+.     ...++.++|+||||+++|++++|..||......+.              ...++.++.++
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDF  241 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHH
Confidence            345788899999875     34467799999999999999999999976553321              12357899999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +.+||..+|.+|||++++++||||.+...
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhcccch
Confidence            99999999999999999999999988643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-43  Score=288.12  Aligned_cols=236  Identities=41%  Similarity=0.698  Sum_probs=208.5

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||.|++|.||++++..++..+++|++.+.........+.+.+|+.+++.++|+|++++++.+.+++..++++|++++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            68999999999999999999999999766554444567888999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--cccccccccccC
Q 024158          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA  184 (271)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~~~~~~~y~~  184 (271)
                      .+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++......  .....+++.|++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~  160 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA  160 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence            999988778999999999999999999999999999999999999999999999999988554432  233467889999


Q ss_pred             CccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--cchhh-------------cccCHHHHHHHHHhcccCccCCCC
Q 024158          185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--QKDTF-------------RSISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       185 pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~--~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      ||.+.+..++.++|+||+|+++|++++|..||....  ..+..             ...++++.+++.+||..+|++||+
T Consensus       161 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~  240 (262)
T cd05572         161 PEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLG  240 (262)
T ss_pred             hhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcC
Confidence            999988888999999999999999999999997665  22211             124689999999999999999999


Q ss_pred             -----HHHHhcCCccccC
Q 024158          250 -----LQKIMEHPWIIKN  262 (271)
Q Consensus       250 -----~~~il~~~~~~~~  262 (271)
                           ++++++||||+..
T Consensus       241 ~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         241 NLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             CcccCHHHHhcChhhhCC
Confidence                 9999999999864

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-43  Score=308.09  Aligned_cols=235  Identities=25%  Similarity=0.372  Sum_probs=199.0

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ...+|.+.+.||+|+||.||++.+..++..+++|....         ....+|++++++++|+||+++++++..++..++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            35579999999999999999999999999999996321         234579999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      ++|++. ++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++......   
T Consensus       238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            999996 6888888653 46899999999999999999999999999999999999999999999999998543221   


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--------h-------------------
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------D-------------------  223 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--------~-------------------  223 (271)
                        .....||+.|+|||.+.+..++.++|+||||+++|+|++|..++......        +                   
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence              12346899999999999999999999999999999999876543221100        0                   


Q ss_pred             --------------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          224 --------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       224 --------------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                                ...+++..+.+||.+||..||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                      00123457899999999999999999999999999975

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.4e-43  Score=291.53  Aligned_cols=245  Identities=32%  Similarity=0.510  Sum_probs=212.8

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +.|+..+.||.|++|.||++.+..++..+++|.+......  .....+.+|+.+++.+.|+|++++++.+..+...++++
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            4688899999999999999999999999999998654322  33567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~  175 (271)
                      |++++++|.+++.. ..++...+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999999875 46889999999999999999999999999999999999999999999999987443322   223


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------hhcccCHHHHHHHHHhcccC
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------TFRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------~~~~i~~~l~~li~~~l~~~  243 (271)
                      ..++..|.|||.+.+...+.++|+||||+++|+|++|..||....+..            ....++..+.+++.+||..+
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccC
Confidence            356778999999988889999999999999999999999997654332            22235788999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCCCCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      |++||++++++.||||.+.....
T Consensus       241 p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06640         241 PSFRPTAKELLKHKFIVKNAKKT  263 (277)
T ss_pred             cccCcCHHHHHhChHhhhcchhh
Confidence            99999999999999999886643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.3e-43  Score=292.76  Aligned_cols=240  Identities=28%  Similarity=0.504  Sum_probs=205.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+....... ...+.+.+|+.+++.++|+|++++++++..++..++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999998899999999986544332 34556788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~  175 (271)
                      ||+++++|.++......+++..++.++.|++.++.|||+.|++|+|++|+||+++.++.++|+|||++......   ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99998888888776667899999999999999999999999999999999999999999999999987543222   223


Q ss_pred             ccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch-------------------------------
Q 024158          176 MCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------------------------------  223 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-------------------------------  223 (271)
                      ..++..|+|||.+.+. .++.++|+||||+++++|++|.+||......+                               
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            4567889999988754 46778999999999999999999886443211                               


Q ss_pred             -----------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 -----------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 -----------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                 ....++..+.+++.+||..+|++||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence                       112457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.4e-43  Score=288.13  Aligned_cols=240  Identities=30%  Similarity=0.516  Sum_probs=206.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-------HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-------KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      +|.+.+.||+|++|.||++++..+|+.+++|.+......       .....+.+..|+.+++.++|+|++++++++..++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588999999999999999999889999999988543221       1123456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..++++|++++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988778999999999999999999999999999999999999999999999999987543321


Q ss_pred             -----cccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcch-----------------hhccc
Q 024158          173 -----RHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKD-----------------TFRSI  228 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-----------------~~~~i  228 (271)
                           .....++..|+|||.+.+..  ++.++|+||||++++++++|..||.......                 ....+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence                 12235678899999987654  7889999999999999999999986443211                 11235


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +.++.+++.+|+.++|++|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            7899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-42  Score=284.30  Aligned_cols=239  Identities=32%  Similarity=0.555  Sum_probs=210.4

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++++.||.|++|.+|.+++..++..+++|.+....... .....+.+|+.++++++|+|++++++++.+++..++++|
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            6999999999999999999999999999999986554333 334567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---c
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~  174 (271)
                      |+++++|.+++...  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999764  458999999999999999999999999999999999999999999999999875443322   3


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|.|||.+.+..++.++|+||||+++++|++|..||......+..            ..++.++.+++.+||.+
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccc
Confidence            446788999999998888889999999999999999999999876554432            22578999999999999


Q ss_pred             CccCCCCHHHHhcCCcc
Q 024158          243 DSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~  259 (271)
                      +|++|||+.++++|||+
T Consensus       240 ~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         240 DPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CcccCCCHHHHhhCcCC
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=291.25  Aligned_cols=240  Identities=30%  Similarity=0.526  Sum_probs=206.0

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||+|.+..+++.+++|.+...... ......+.+|+++++.++|+|++++++++..++..++++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            4799999999999999999999999999999998654322 233567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----RH  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----~~  174 (271)
                      ||++++.+..+......++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......    ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99987666666665567899999999999999999999999999999999999999999999999987543332    22


Q ss_pred             cccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------------
Q 024158          175 TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------------  224 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------------  224 (271)
                      ...++..|+|||.+.+. .++.++|+||||++++++++|..||......+.                             
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            34567889999999887 788899999999999999999999875432110                             


Q ss_pred             --------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 --------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 --------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                    ...++.++.+++++||..+|++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence                          01237889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.7e-43  Score=285.46  Aligned_cols=239  Identities=30%  Similarity=0.573  Sum_probs=208.5

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.+|++++..++..+++|.+....... .....+.+|+.+++.++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            6999999999999999999999999999999986544332 234678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---c
Q 024158          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---H  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~  174 (271)
                      ++.+++|.+.+....  .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......   .
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999987643  57899999999999999999999999999999999999999999999999875433321   2


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|..||......+..            ..++.++.+++.+||..
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhC
Confidence            234678899999998888889999999999999999999999765443322            23578999999999999


Q ss_pred             CccCCCCHHHHhcCCcc
Q 024158          243 DSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~  259 (271)
                      +|.+||++.++++||||
T Consensus       240 ~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         240 NPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ChhhCcCHHHHhhCcCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.7e-43  Score=294.62  Aligned_cols=248  Identities=28%  Similarity=0.520  Sum_probs=214.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +.|.....||+|++|.||++.+..++..+++|.+.....   .....+.+|+..++.++|+|++++++.+..++..++++
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            345667889999999999999999999999999854332   23456788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      |++++++|.+++.. ..++...+..++.||+.++.+||++|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            99999999998865 4689999999999999999999999999999999999999999999999998743322   2233


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l~  241 (271)
                      ..+++.|+|||.+.+..++.++|+||+|++++++++|..||.........              ..++..+.+++.+|+.
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  257 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLV  257 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHcc
Confidence            45788999999998888999999999999999999999999765543221              1257889999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCCCCcC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPRGTCD  270 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~~~~~  270 (271)
                      .+|.+|||++++++||||.....|.+++.
T Consensus       258 ~~P~~Rpt~~~il~~~~~~~~~~~~~~~~  286 (292)
T cd06658         258 REPSQRATAQELLQHPFLKLAGPPSCIVP  286 (292)
T ss_pred             CChhHCcCHHHHhhChhhhccCCccccch
Confidence            99999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.1e-43  Score=291.39  Aligned_cols=245  Identities=28%  Similarity=0.482  Sum_probs=209.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .+|++++.||+|++|.||++++..++..+++|.+....  .......+.+|+.++++++|+|++++++.+..++.+++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999886432  2233467888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeeccccccc-Ccc
Q 024158           99 EYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-~~~  173 (271)
                      ||+++++|..++...   ..+++..+..++.+++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+.... ...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA  158 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence            999999999988763   368999999999999999999997 599999999999999999999999999875432 223


Q ss_pred             ccccccccccCCccccCCC------CCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHH
Q 024158          174 HTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEA  232 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~------~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l  232 (271)
                      ....+++.|+|||.+.+..      ++.++|+||||+++|++++|..||........               ...+++++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            3345778899999885543      47789999999999999999999965443221               12357889


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .+++.+||..+|++||++++++.||||.+...+
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999887654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-43  Score=290.84  Aligned_cols=249  Identities=27%  Similarity=0.454  Sum_probs=216.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++.++|++++.||+|++|+||++++..++..+++|++.....  ......+.+|+++++.++|+|++++++.+...+.++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            466899999999999999999999999999999998854322  234567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeeccccccc-Ccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SKR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-~~~  173 (271)
                      +++||+++++|.+++...+.++...+..++.+++.++.|||+ .|++|+||+|+||+++.++.++|+|||++.... ...
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            999999999999999887789999999999999999999997 589999999999999999999999999874432 222


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-----------hhh-------------cccC
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-----------DTF-------------RSIS  229 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-----------~~~-------------~~i~  229 (271)
                      ....++..|+|||.+.+..++.++|+||||++++++++|..||......           +..             ..++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3456788999999998888899999999999999999999999865432           000             1256


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      .++.+++.+|+.+||++|||++++++|+||.+.....
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~  276 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS  276 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence            7899999999999999999999999999998876543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-43  Score=285.62  Aligned_cols=238  Identities=35%  Similarity=0.607  Sum_probs=202.1

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHH-HHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      +.||+|++|.||+|.+..+++.+++|++.+..............+.. .....+|+|++++++.+..++.+|+++||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57999999999999999999999999986654333222333344443 34555899999999999999999999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccccccccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL  183 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~  183 (271)
                      ++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... .....+++.|+
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~  160 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKKFVGTPDYL  160 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-cccCCCCcCcc
Confidence            99999998877899999999999999999999999999999999999999999999999998754332 23345788899


Q ss_pred             CCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHHHhcccCccCCC
Q 024158          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSKRL  248 (271)
Q Consensus       184 ~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~~~l~~~p~~Rp  248 (271)
                      +||.+.+..++.++|+||+|++++++++|..||.........               ..+++++.+++.+||..+|++||
T Consensus       161 ~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~  240 (260)
T cd05611         161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL  240 (260)
T ss_pred             ChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHcc
Confidence            999998888889999999999999999999999776544322               13589999999999999999999


Q ss_pred             ---CHHHHhcCCccccCC
Q 024158          249 ---SLQKIMEHPWIIKNA  263 (271)
Q Consensus       249 ---s~~~il~~~~~~~~~  263 (271)
                         ++++++.||||.+..
T Consensus       241 ~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         241 GANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             CCCcHHHHHcChHhhcCC
Confidence               558999999998754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.7e-43  Score=321.41  Aligned_cols=253  Identities=30%  Similarity=0.536  Sum_probs=212.0

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-   90 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   90 (271)
                      ...++.+++|++++.||+|+||.||+|++..++..+++|.+....... .....+..|+.+++.++||||+++++++.. 
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de   84 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNK   84 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence            456777899999999999999999999999999999999987654333 335678889999999999999999998754 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCeeeCCC---
Q 024158           91 -DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN-------HVIHRDIKPENLLLDHE---  155 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~-------~i~H~dl~~~Nili~~~---  155 (271)
                       ...+|+||||+++++|.+++..    ...+++..++.++.||+.||.|||+.       +|+|+||+|+|||++.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence             4578999999999999999865    24689999999999999999999984       49999999999999642   


Q ss_pred             --------------CCEEEeeecccccccCc--cccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCC
Q 024158          156 --------------GRLKIGDFGWSVQSRSK--RHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFE  217 (271)
Q Consensus       156 --------------~~~~L~dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~  217 (271)
                                    +.++|+|||++......  .....+++.|+|||.+.+  ..++.++|||||||++|+|++|..||.
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                          34899999998554322  233468999999999864  347889999999999999999999997


Q ss_pred             CCCcchh------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          218 AESQKDT------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       218 ~~~~~~~------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .......            ....+.++.+||..||..+|.+|||+.++|.||||+....|
T Consensus       245 ~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        245 KANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             cCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            5543222            12347899999999999999999999999999999866544

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.3e-43  Score=293.96  Aligned_cols=248  Identities=32%  Similarity=0.477  Sum_probs=207.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~   94 (271)
                      .+.+|++.+.||+|++|.||++.+..+|+.+++|.+....... .......+|+.++++++|+|++++++++.+.  +..
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            5789999999999999999999999999999999986443221 1123455789999999999999999998654  468


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           95 FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      ++++|+++ ++|.+++.. ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999997 588888875 356899999999999999999999999999999999999999999999999988554432 


Q ss_pred             --cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------------------
Q 024158          173 --RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------------------  225 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------------------  225 (271)
                        .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+..+..                        
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence              122234678999998865 45788999999999999999999999755432221                        


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                       ..+++++.++|.+||.+||++|||+.+++.||||++.+.|.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~  300 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC  300 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence                             11478889999999999999999999999999999887763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.5e-43  Score=288.00  Aligned_cols=239  Identities=31%  Similarity=0.474  Sum_probs=206.0

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||+|+||+||+|.+..+|+.+++|.+.............+..|+.+++.++|+|++++++.+...+.+|+++||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999999999999999999765544434455667899999999999999999999999999999999999999


Q ss_pred             HHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--ccccccccccc
Q 024158          107 YRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDY  182 (271)
Q Consensus       107 ~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~~~~~~~~~y  182 (271)
                      .+++....  .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....  ......++..|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y  160 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY  160 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence            99997655  689999999999999999999999999999999999999999999999998754322  22234567889


Q ss_pred             cCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc---------------hhhcccCHHHHHHHHHhcccCccCC
Q 024158          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------DTFRSISAEAKHLISRLLVKDSSKR  247 (271)
Q Consensus       183 ~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------------~~~~~i~~~l~~li~~~l~~~p~~R  247 (271)
                      +|||.+.+..++.++|+||+|+++++|++|..||......               .....+++++.+++.+||..+|.+|
T Consensus       161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  240 (277)
T cd05577         161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKR  240 (277)
T ss_pred             CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHc
Confidence            9999998888899999999999999999999999765431               1112358899999999999999999


Q ss_pred             C-----CHHHHhcCCccccCCCC
Q 024158          248 L-----SLQKIMEHPWIIKNANP  265 (271)
Q Consensus       248 p-----s~~~il~~~~~~~~~~~  265 (271)
                      |     ++.+++.||||.+.+.+
T Consensus       241 ~~~~~~~~~~ll~h~~~~~~~~~  263 (277)
T cd05577         241 LGCRGGSADEVREHPLFKDLNWR  263 (277)
T ss_pred             cCCCcccHHHHHhChhhhcCChh
Confidence            9     88889999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.2e-43  Score=290.09  Aligned_cols=241  Identities=37%  Similarity=0.657  Sum_probs=213.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ++|.+.+.||+|++|.||++++..++..+++|++.+...........+..|..++++++ |+||+++++++..++..+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            57999999999999999999999999999999997765544455677888999999998 99999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----  173 (271)
                      ||++++++|.+++.....++...++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999888789999999999999999999999999999999999999999999999999874433221    


Q ss_pred             -------------------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------
Q 024158          174 -------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------  224 (271)
Q Consensus       174 -------------------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------  224 (271)
                                         ....++..|+|||...+..++.++|+||||++++++++|..||........          
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                               123457889999999888888999999999999999999999987654322          


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCH----HHHhcCCcc
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSL----QKIMEHPWI  259 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~----~~il~~~~~  259 (271)
                       ...+++.+.+++.+||..+|.+|||+    ++++.||||
T Consensus       241 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence             23357899999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-43  Score=291.19  Aligned_cols=241  Identities=30%  Similarity=0.505  Sum_probs=203.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~   94 (271)
                      +.++|++.+.||+|++|.||+|++..+++.+++|.+...... ......+.+|+.+++.++|+|++++++++...  ...
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999989999999998655433 22334566789999999999999999998877  789


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      |+++|+++ ++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999997 59999887643 5899999999999999999999999999999999999999999999999987543332 


Q ss_pred             --cccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------------------
Q 024158          173 --RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------------------  225 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------------------  225 (271)
                        .....+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||......+..                        
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence              22345678899999887654 678999999999999999999998754322111                        


Q ss_pred             -----------------cc--cCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 -----------------RS--ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 -----------------~~--i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                       ..  +++.+.++|++||..+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                             11  47789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.2e-42  Score=283.90  Aligned_cols=241  Identities=26%  Similarity=0.510  Sum_probs=205.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhh--hhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~   94 (271)
                      .+|++.+.||+|++|.||.+++..++..+++|.+....  .........+.+|+.++++++|+|++++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            58999999999999999999999999999999875332  12223456788899999999999999999988663  468


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      ++++|++++++|.+++.....++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998877789999999999999999999999999999999999999999999999998753221   


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHL  235 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~l  235 (271)
                         ......++..|+|||.+.+..++.++|+||||+++|++++|..||........             ...++..+.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDF  241 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHH
Confidence               12234577889999999888889999999999999999999999976543222             12356778999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccc
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                      +.+|+. +|++||++++++.|||+.
T Consensus       242 i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         242 LKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHhc-ChhhCCCHHHHhcCcccC
Confidence            999995 899999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.9e-42  Score=282.78  Aligned_cols=239  Identities=31%  Similarity=0.614  Sum_probs=209.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||++.+..++..+++|.+...... ....+.+.+|+.+++.++|+||++++++....+.+++++|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            589999999999999999999889999999998765443 3456788999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc------
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------  173 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~------  173 (271)
                      ++++++|.+++.....+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......      
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            99999999999887778999999999999999999999999999999999999999999999999875433221      


Q ss_pred             -ccccccccccCCccccCCC---CCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHH
Q 024158          174 -HTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKH  234 (271)
Q Consensus       174 -~~~~~~~~y~~pe~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~  234 (271)
                       ....+++.|+|||.+.+..   .+.++|+||||++++++++|..||........               ...+++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence             1245678999999998766   78899999999999999999999975532111               1124788999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCcc
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      ++.+||..+|++|||+.+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.8e-42  Score=281.48  Aligned_cols=239  Identities=33%  Similarity=0.574  Sum_probs=212.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv   97 (271)
                      +|++.+.||+|++|.||++.+..++..+++|++...... ....+.+.+|+..+++++|+|++++++.+...  +.++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998665433 24467888999999999999999999999888  889999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----  172 (271)
                      +|++++++|.+++.....+++..++.++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||.+......     
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999988778999999999999999999999999999999999999999999999999988554443     


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--------------cchhhcccCHHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISR  238 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~--------------~~~~~~~i~~~l~~li~~  238 (271)
                      .....++..|.|||.+.+...+.++|+||||++++++++|..||....              .......++..+.+++.+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  239 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRK  239 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHH
Confidence            234567889999999988889999999999999999999999997654              111223357899999999


Q ss_pred             hcccCccCCCCHHHHhcCCcc
Q 024158          239 LLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~  259 (271)
                      |+..+|++||++.+++.||||
T Consensus       240 ~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         240 CLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             hCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.6e-42  Score=283.34  Aligned_cols=240  Identities=30%  Similarity=0.506  Sum_probs=208.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh--HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +|+..+.||+|++|.||+|....++..+++|.+......  .....+.+.+|+.+++.++|+|++++++++..+..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            478889999999999999999889999999998654321  223456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~  175 (271)
                      +||+++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  160 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS  160 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence            999999999999988777899999999999999999999999999999999999999999999999987543322  234


Q ss_pred             ccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~li~~~l~  241 (271)
                      ..+++.|++||.+.... ++.++|+||||+++|++++|..||......+.             ...+++.+.+++.+||.
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  240 (258)
T cd06632         161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ  240 (258)
T ss_pred             cCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhh
Confidence            56788899999987766 88899999999999999999999976543222             12357889999999999


Q ss_pred             cCccCCCCHHHHhcCCcc
Q 024158          242 KDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~  259 (271)
                      .+|.+||++.+++.|||+
T Consensus       241 ~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         241 RDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.5e-43  Score=287.33  Aligned_cols=237  Identities=30%  Similarity=0.534  Sum_probs=201.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC------
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD------   91 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~------   91 (271)
                      +.|++.+.||+|+||.||++++..+++.+++|.+......    ...+..|+.+++.+ +|+|++++++++...      
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            5689999999999999999999999999999998654322    24567788888888 699999999998653      


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ..+|+++|++++++|.+++...  ..+++..+..++.|++.++.|||++|++|+|++|+||+++.++.++|+|||++...
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~  161 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  161 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence            4689999999999999999863  35899999999999999999999999999999999999999999999999998543


Q ss_pred             cC---ccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hccc
Q 024158          170 RS---KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSI  228 (271)
Q Consensus       170 ~~---~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i  228 (271)
                      ..   ......+++.|+|||.+.     ...++.++|+||+|+++|+|++|..||........             ...+
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW  241 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCc
Confidence            22   223456788999999886     33577899999999999999999999865432221             1235


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +.++.+++.+||..+|.+|||++++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            7899999999999999999999999999998

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.3e-42  Score=289.89  Aligned_cols=245  Identities=28%  Similarity=0.480  Sum_probs=209.8

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|++.+.||+|++|.||++++..+++.+++|.+.............+.+|+.+++.++|+|++++.+++..++..++++
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55999999999999999999998899999999986554444444567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccc
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~  177 (271)
                      ||+. +++.+++.. ...+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~~~  172 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSFV  172 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-CCcc
Confidence            9997 577777754 456899999999999999999999999999999999999999999999999987544322 3446


Q ss_pred             ccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHHHHHhcc
Q 024158          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       178 ~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~li~~~l~  241 (271)
                      +++.|+|||.+.   ...++.++|+||||+++|++++|..||........             ...++.++.+++.+||.
T Consensus       173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  252 (307)
T cd06607         173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ  252 (307)
T ss_pred             CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence            778899999874   35578899999999999999999999876543221             12357889999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .+|++||++.+++.||||++...+
T Consensus       253 ~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         253 KIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             CChhhCcCHHHHhcChhhcccCCc
Confidence            999999999999999999987644

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-42  Score=286.36  Aligned_cols=243  Identities=30%  Similarity=0.496  Sum_probs=210.7

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      -|++.+.||+|+||.||++.+..++..+++|.+......  .....+.+|+..++.++|+|++++++.+..+...++|+|
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            378899999999999999999889999999998544322  335678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~~  176 (271)
                      |+++++|.+++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++......   ....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            9999999999875 46899999999999999999999999999999999999999999999999987443321   2233


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHHHHHHHhcccCc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~~p  244 (271)
                      .++..|+|||.+.+...+.++|+||||++++++++|..||........            ...++.++.+++.+|+..+|
T Consensus       162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  241 (277)
T cd06641         162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP  241 (277)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            567889999999888888999999999999999999999976543322            22357899999999999999


Q ss_pred             cCCCCHHHHhcCCccccCCCC
Q 024158          245 SKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       245 ~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .+||++.+++.||||.+....
T Consensus       242 ~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         242 SFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             hhCcCHHHHHhCHHHhhhhhc
Confidence            999999999999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.6e-42  Score=281.80  Aligned_cols=239  Identities=33%  Similarity=0.505  Sum_probs=208.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||++.+..++..+++|.+....... .....+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            5899999999999999999999999999999987654433 335678899999999999999999999998899999999


Q ss_pred             ccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCc--cc
Q 024158          100 YAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK--RH  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~--~~  174 (271)
                      ++++++|.+++...  ..+++..+..++.+++.++.+||++|++|+||+|+||+++.++ .++|+|||.+......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999763  3589999999999999999999999999999999999998654 5899999988544332  22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~  242 (271)
                      ...++..|+|||.+.+..++.++|+||+|++++++++|..||........            ...+++++.+++.+||..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  239 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL  239 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccC
Confidence            34578899999999888888999999999999999999999976553222            123578999999999999


Q ss_pred             CccCCCCHHHHhcCCcc
Q 024158          243 DSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~  259 (271)
                      +|++|||+.+++.||||
T Consensus       240 ~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         240 DPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ChhhCCCHHHHhhCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-42  Score=288.44  Aligned_cols=238  Identities=30%  Similarity=0.539  Sum_probs=202.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++++.||.|++|.||+|++..++..+++|.+....... .....+.+|++++++++|+|++++++++..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            5899999999999999999999999999999986543222 233567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158          100 YAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      |+. ++|.+++..  ...+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 689888865  346899999999999999999999999999999999999999999999999987543321   22


Q ss_pred             cccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------------
Q 024158          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------------  224 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------------  224 (271)
                      ...+++.|+|||.+.+.. ++.++|+||||++++++++|..||......+.                             
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            234578899999887654 57789999999999999999999865432111                             


Q ss_pred             -----------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 -----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 -----------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                 ...+++++.++|.+||..||.+|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence                       12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=286.01  Aligned_cols=243  Identities=30%  Similarity=0.533  Sum_probs=208.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC---CCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~~~~~   95 (271)
                      +.|++++.||+|++|.||+|.+..++..+++|.+......  .....+.+|+.+++.++   |+|++++++++..+..++
T Consensus         1 ~~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           1 SLYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             ChhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            3588999999999999999999999999999998654322  23456778888888886   999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      +++|++++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        79 lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06917          79 IIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK  157 (277)
T ss_pred             EEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc
Confidence            99999999999999876 47899999999999999999999999999999999999999999999999987544332   


Q ss_pred             cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAKHLISR  238 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~~li~~  238 (271)
                      .....++..|+|||.+.++ .++.++|+||||+++|+|++|..||.........             ..++.++.+++.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (277)
T cd06917         158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA  237 (277)
T ss_pred             cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence            2234578889999988654 4688999999999999999999999765443221             1267899999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ||..+|++||++.+++.||||++...
T Consensus       238 ~l~~~p~~R~~~~~il~~~~~~~~~~  263 (277)
T cd06917         238 CLDEEPKERLSAEELLKSKWIKAHSK  263 (277)
T ss_pred             HcCCCcccCcCHHHHhhChHhhcccc
Confidence            99999999999999999999988654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2e-42  Score=286.38  Aligned_cols=238  Identities=31%  Similarity=0.501  Sum_probs=197.7

Q ss_pred             eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH---HHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM---EIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~---~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      .||+|+||.||++++..++..+++|.+.+.............++.   +++....|++++.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998665433222122222333   34444579999999999998899999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-cccccccccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLD  181 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~~~~~~~~~  181 (271)
                      +++|.+++.....+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++..... ......+++.
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  160 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence            999999998877899999999999999999999999999999999999999999999999998754332 2233468899


Q ss_pred             ccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHHHHHHhcccCccC
Q 024158          182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       182 y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~li~~~l~~~p~~  246 (271)
                      |+|||.+.+ ..++.++|+||+|+++++|++|..||.......              ....++.++.+++.+||..||.+
T Consensus       161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  240 (279)
T cd05633         161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSK  240 (279)
T ss_pred             ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHH
Confidence            999998864 557889999999999999999999997543211              11236789999999999999999


Q ss_pred             CC-----CHHHHhcCCccccCC
Q 024158          247 RL-----SLQKIMEHPWIIKNA  263 (271)
Q Consensus       247 Rp-----s~~~il~~~~~~~~~  263 (271)
                      ||     |+.++++||||+...
T Consensus       241 R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         241 RLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             hcCCCCCCHHHHHhCccccCCC
Confidence            99     699999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-42  Score=288.66  Aligned_cols=243  Identities=30%  Similarity=0.501  Sum_probs=210.1

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..++|++++.||+|+||.||++.+..++..+++|.+.....   ...+.+.+|+.+++.++|||++++++.+...+..|+
T Consensus        17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~l   93 (293)
T cd06647          17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWV   93 (293)
T ss_pred             chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEE
Confidence            35789999999999999999999988999999999854322   224567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---c
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~  173 (271)
                      |+||+++++|.+++.+ ..++...+..++.|++.++.+||++|++|+|++|+||+++.++.++|+|||++......   .
T Consensus        94 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~  172 (293)
T cd06647          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (293)
T ss_pred             EEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccc
Confidence            9999999999999876 45789999999999999999999999999999999999999999999999987433322   2


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHh
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRL  239 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~  239 (271)
                      ....+++.|++||.+.+..++.++|+||||+++|++++|..||........              ...++..+.+++.+|
T Consensus       173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (293)
T cd06647         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  252 (293)
T ss_pred             ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHH
Confidence            234577889999999888888999999999999999999999976543222              123578899999999


Q ss_pred             cccCccCCCCHHHHhcCCccccCC
Q 024158          240 LVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      |..+|++||++.+++.||||++..
T Consensus       253 l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         253 LEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             ccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=309.52  Aligned_cols=241  Identities=29%  Similarity=0.505  Sum_probs=212.5

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      +.|+..||.|+||.||++..+.++-..+.|++....   ...+.++.-|+.+|..++||+|+.+++.+.-++.++++.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            578999999999999999999999989999985433   34478889999999999999999999998888999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc---ccCccccc
Q 024158          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTM  176 (271)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~---~~~~~~~~  176 (271)
                      |+||-+...+-. ++.|.++++..++.|++.||.|||+++|+|+|||..|||++.+|.++|.|||.+..   ........
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF  190 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF  190 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence            999988777755 67899999999999999999999999999999999999999999999999998732   33455678


Q ss_pred             cccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHH
Q 024158          177 CGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLIS  237 (271)
Q Consensus       177 ~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~  237 (271)
                      .|||.|+|||+..     ..+|++++||||||++|.+|+.+.+|.....+-..+              ..++..+.+|+.
T Consensus       191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk  270 (1187)
T KOG0579|consen  191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK  270 (1187)
T ss_pred             cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence            9999999999775     467899999999999999999999998766554333              335788999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +||.+||+.||+++++|+||||+..+.
T Consensus       271 ~cL~Knp~~Rp~aaqll~Hpfv~~~~S  297 (1187)
T KOG0579|consen  271 RCLVKNPRNRPPAAQLLKHPFVQNAPS  297 (1187)
T ss_pred             HHHhcCCccCCCHHHHhhCcccccCCc
Confidence            999999999999999999999997653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-42  Score=287.49  Aligned_cols=241  Identities=29%  Similarity=0.494  Sum_probs=202.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      .++++|++.+.||+|++|.||++++..+++.+++|.+.......  ....+.+|+.+++.++|+||+++++++..++..+
T Consensus         2 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (291)
T cd07844           2 GKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLT   79 (291)
T ss_pred             CCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence            46789999999999999999999998899999999986543221  1233567999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      +|+||+. ++|.+++... ..++...+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        80 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             EEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            9999997 4999988764 46799999999999999999999999999999999999999999999999987443211  


Q ss_pred             -cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCc-chh-------------------------
Q 024158          173 -RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDT-------------------------  224 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~-------------------------  224 (271)
                       .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..... .+.                         
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence             122245778999998875 4578899999999999999999999965541 100                         


Q ss_pred             ----------------hcccC--HHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ----------------FRSIS--AEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ----------------~~~i~--~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                      ...++  .++.+++.+||.++|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                            01233  788899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.8e-42  Score=282.74  Aligned_cols=239  Identities=33%  Similarity=0.551  Sum_probs=207.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE--eCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv   97 (271)
                      +|++.+.||.|++|.||++.+..++..+++|.+....... .....+..|+.+++.++|+|++++++++.  .+...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            6899999999999999999999999999999986554333 33567788999999999999999999775  34568999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCH-----ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh-----~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +|++++++|.+++..    ...+++..++.++.||+.++.+||     +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999999865    356899999999999999999999     88999999999999999999999999998855


Q ss_pred             ccCcc---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHH
Q 024158          169 SRSKR---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAK  233 (271)
Q Consensus       169 ~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~  233 (271)
                      .....   ....+++.|+|||.+.+..++.++|+||||++++++++|..||........            ...++..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN  239 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHHH
Confidence            44322   234678899999999888889999999999999999999999987643222            223578999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +++.+||..+|++||++.+|++|||+
T Consensus       240 ~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         240 EVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-42  Score=288.22  Aligned_cols=239  Identities=23%  Similarity=0.402  Sum_probs=204.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +.+++|++.+.||+|++|.||++.....+     ..+++|.+.....  ......+.+|+..++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            46789999999999999999999876655     6799998854332  2335678899999999999999999999998


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC
Q 024158           91 DERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~  154 (271)
                      .+..++++||+++++|.+++...                ..++...++.++.|++.|+.+||++|++|+||+|+||+++.
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            88999999999999999999754                34788899999999999999999999999999999999999


Q ss_pred             CCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc--
Q 024158          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR--  226 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~--  226 (271)
                      ++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+...  
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI  239 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987543221     223345778999999988889999999999999999997 999998765544332  


Q ss_pred             ----------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 ----------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 ----------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                ..|.++.+++.+|+..+|.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                      357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.4e-43  Score=290.87  Aligned_cols=247  Identities=30%  Similarity=0.549  Sum_probs=213.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|.....||+|+||.||++.+..++..+++|.+......   ....+.+|+.+++.++|||++++++++..++..++++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            4456677899999999999999899999999998543322   2356778999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      |++++++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....   ....
T Consensus        98 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659          98 EFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             ecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99999999987765 5689999999999999999999999999999999999999999999999998743322   2233


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~  241 (271)
                      ..++..|+|||.+.+..++.++|+||+|+++++|++|..||......+.              ...++..+.+++.+||.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhc
Confidence            4578899999999888899999999999999999999999875543222              22467899999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCCCCc
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPRGTC  269 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~~~~  269 (271)
                      .+|++|||+++++.||||.+...|.+.+
T Consensus       257 ~~P~~Rps~~~ll~~~~~~~~~~~~~~~  284 (297)
T cd06659         257 REPQERATAQELLDHPFLLQTGLPECLV  284 (297)
T ss_pred             CCcccCcCHHHHhhChhhccCCCccccc
Confidence            9999999999999999999998877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-42  Score=285.29  Aligned_cols=244  Identities=26%  Similarity=0.438  Sum_probs=201.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHH-HHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ++|++++.||+|+||.||++++..+|+.+++|.+........  ...+..++. .++...|+|++++++++..++..|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            479999999999999999999999999999999866533222  223333444 46677899999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +|+++ ++|.+++..    ...+++..++.++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 688877754    23689999999999999999999997 9999999999999999999999999987543322


Q ss_pred             --cccccccccccCCccccC----CCCCccchhhhHHHHHHHHHhCCCCCCCCCc-chh-------------hcccCHHH
Q 024158          173 --RHTMCGTLDYLAPEMVEN----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDT-------------FRSISAEA  232 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~-------------~~~i~~~l  232 (271)
                        .....++..|+|||.+.+    ..++.++|+||+|+++|+|++|..||..... .+.             ...+|.++
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF  237 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHHH
Confidence              122457788999998865    3457899999999999999999999964321 111             12367899


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .+++.+||..+|++|||++++++||||++...+
T Consensus       238 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  270 (283)
T cd06617         238 QDFVNKCLKKNYKERPNYPELLQHPFFELHLSK  270 (283)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence            999999999999999999999999999998654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.3e-43  Score=291.70  Aligned_cols=245  Identities=30%  Similarity=0.486  Sum_probs=210.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|+.++.||+|++|.||++.+..++..+++|.+......  .....+.+|+.+++.++|+|++++++.+..+..+++|+
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            3577889999999999999999889999999998644322  23467889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~  175 (271)
                      ||+++++|.+++.. ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++.......   ..
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            99999999998865 568999999999999999999999999999999999999999999999999875433221   22


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHHHHHHHhcccC
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~~  243 (271)
                      ..++..|+|||.+.+..++.++|+||||++++++++|..|+....+...            ....+.++.+++.+|+..+
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD  240 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCC
Confidence            3567889999999988899999999999999999999999875443221            1235788999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCCCCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      |++|||+.+++.||||++..+..
T Consensus       241 p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         241 PRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             cccCcCHHHHHHhHHHHHHhhhH
Confidence            99999999999999998765543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2e-42  Score=291.45  Aligned_cols=230  Identities=29%  Similarity=0.552  Sum_probs=187.1

Q ss_pred             eeeecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--CCeEEEEEe
Q 024158           24 GRPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILE   99 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e   99 (271)
                      ..+||+|+||.||+|+++  .++..+++|.+......     ..+.+|+++++.++||||+++++++..  +...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999965  46788999998654322     345679999999999999999998854  456899999


Q ss_pred             ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----CCCCCEEEeeeccc
Q 024158          100 YAHRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS  166 (271)
Q Consensus       100 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----~~~~~~~L~dfg~~  166 (271)
                      +++ ++|.+++...         ..++...+..++.|++.||.|||+.|++|+||||+||++    +..+.++|+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            996 5888887532         248899999999999999999999999999999999999    45578999999998


Q ss_pred             ccccCc------cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------h------
Q 024158          167 VQSRSK------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------T------  224 (271)
Q Consensus       167 ~~~~~~------~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------~------  224 (271)
                      ......      .....+++.|+|||.+.+. .++.++|+||+|+++++|++|.+||.......         .      
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            543322      2234678899999998774 57889999999999999999999996433210         0      


Q ss_pred             ---------h---c-------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ---------F---R-------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ---------~---~-------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                               +   .                               ..+.++.+++.+||..||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                     0   0                               013467899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5e-42  Score=285.61  Aligned_cols=240  Identities=33%  Similarity=0.537  Sum_probs=201.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~----   91 (271)
                      -.++|.+.+.||+|++|.||++.+..+++.+++|++.....    ....+.+|+.+++++ +|+|++++++++...    
T Consensus        20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            46789999999999999999999999999999999854321    124556788888888 799999999998653    


Q ss_pred             -CeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           92 -ERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                       +.+++++||+++++|.+++..    ...+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~  175 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS  175 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence             358999999999999998853    356899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCc---cccccccccccCCccccCCC-----CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------
Q 024158          167 VQSRSK---RHTMCGTLDYLAPEMVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------  225 (271)
Q Consensus       167 ~~~~~~---~~~~~~~~~y~~pe~~~~~~-----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------  225 (271)
                      ......   .....++..|+|||.+....     ++.++|+||||+++|+|++|..||.........             
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  255 (291)
T cd06639         176 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLH  255 (291)
T ss_pred             hhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCc
Confidence            543321   22345788899999876432     578999999999999999999999765542221             


Q ss_pred             -cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          226 -RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       226 -~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                       .+++..+.+++.+||..+|++|||+.+++.||||+
T Consensus       256 ~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         256 PEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence             13457799999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.6e-42  Score=282.25  Aligned_cols=239  Identities=28%  Similarity=0.522  Sum_probs=205.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++.+.||+|+||.||++++..++..+++|.+.............+.+|+.+++.++|||++++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            46899999999999999999999999999999988654433444556778899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc
Q 024158           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~  173 (271)
                      +|++++++|.+++..    ...++...+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988853    3457899999999999999999999999999999999999999999999999875543322


Q ss_pred             ---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--h-------------hhcccCHHHHHH
Q 024158          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--D-------------TFRSISAEAKHL  235 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--~-------------~~~~i~~~l~~l  235 (271)
                         ....+++.|+|||.+.+..++.++|+||+|+++|++++|..||......  +             ....++..+.++
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLREL  240 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence               2345788899999998888899999999999999999999998654321  1             112356789999


Q ss_pred             HHHhcccCccCCCCHHHHhcC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+||..+|++|||+.++++.
T Consensus       241 i~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         241 VSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-42  Score=294.99  Aligned_cols=241  Identities=24%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      -.++|++.+.||+|++|.||++++..++..+++|.+....... .....+.+|+.+++.++|+|++++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4678999999999999999999999999999999986543222 2345567899999999999999999987543     


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       ...|+++|++. ++|.+.+...  ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             35799999996 5888888653  8899999999999999999999999999999999999999999999999986544


Q ss_pred             Ccc--ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------
Q 024158          171 SKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------  225 (271)
Q Consensus       171 ~~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------  225 (271)
                      ...  ....+++.|+|||.+.+..++.++|+||||+++++|++|..||...+....+                       
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            322  2345788899999999989999999999999999999999998754321110                       


Q ss_pred             -------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 -------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 -------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                                     ...++++.+++.+||..||++|||+.++|.||||.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~  316 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV  316 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence                                           012456889999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-42  Score=283.86  Aligned_cols=236  Identities=38%  Similarity=0.673  Sum_probs=207.6

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||.|++|.||++.+..+|+.+++|.+.............+.+|+.++++++|+|++++++.+..+...|+++|++++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999889999999999776554445667888999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----------ccc
Q 024158          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----------RHT  175 (271)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----------~~~  175 (271)
                      .+++.....+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++......           ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            999988778999999999999999999999999999999999999999999999999987443322           123


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------ccCHHHHHHHHHhccc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------SISAEAKHLISRLLVK  242 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------~i~~~l~~li~~~l~~  242 (271)
                      ..++..|++||...+...+.++|+||||++++++++|..||......+...             .++..+.+++.+||..
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  240 (265)
T cd05579         161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVP  240 (265)
T ss_pred             cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcC
Confidence            356788999999988888899999999999999999999997665443221             1388999999999999


Q ss_pred             CccCCCCH---HHHhcCCccccC
Q 024158          243 DSSKRLSL---QKIMEHPWIIKN  262 (271)
Q Consensus       243 ~p~~Rps~---~~il~~~~~~~~  262 (271)
                      +|++|||+   .++++||||.+.
T Consensus       241 ~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         241 DPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             CHhhcCCCccHHHHhcCccccCC
Confidence            99999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-42  Score=278.89  Aligned_cols=239  Identities=33%  Similarity=0.619  Sum_probs=211.9

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.+|++++..+++.+++|.+....... .....+.+|++++++++|++++++++++..++.+++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            5899999999999999999999899999999997665432 345788999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---ccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~~  176 (271)
                      ++++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999887889999999999999999999999999999999999999999999999999885544332   234


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhcccCc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~~p  244 (271)
                      .++..|+|||...+..++.++|+|++|++++++++|..||.........            ..++..+.+++.+||..+|
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  239 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDP  239 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCCh
Confidence            6788899999998888889999999999999999999998755432211            2357899999999999999


Q ss_pred             cCCCCHHHHhcCCcc
Q 024158          245 SKRLSLQKIMEHPWI  259 (271)
Q Consensus       245 ~~Rps~~~il~~~~~  259 (271)
                      ++|||+.+++.||||
T Consensus       240 ~~R~~~~~~l~~~~~  254 (254)
T cd06627         240 NLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhCcCHHHHhcCCCC
Confidence            999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.2e-42  Score=278.36  Aligned_cols=236  Identities=34%  Similarity=0.618  Sum_probs=209.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|.+.+.||+|++|.||++.+..++..+++|++.....   .....+.+|+..++.++|++++++++.+..++..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            68999999999999999999988999999999865443   345678889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc--ccc
Q 024158          100 YAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~--~~~  176 (271)
                      ++++++|.+++... ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99999999999875 578999999999999999999999999999999999999999999999999885554432  455


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhccc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l~~  242 (271)
                      .++..|+|||.+.+..++.++|+||||++++++++|..||...+.....              ..++.++.+++.+||..
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccC
Confidence            6788999999998888889999999999999999999999866322211              11378899999999999


Q ss_pred             CccCCCCHHHHhcCCc
Q 024158          243 DSSKRLSLQKIMEHPW  258 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~  258 (271)
                      +|++|||+.++++|||
T Consensus       238 ~p~~R~t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.7e-42  Score=285.28  Aligned_cols=239  Identities=28%  Similarity=0.459  Sum_probs=199.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ..+|++++.||+|++|.||+|.+..++..+++|.+.......  ....+.+|+.+++.++|+|++++++++..++..|++
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999999999999999985543221  123456789999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      +|++. +++.+++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....   ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 677776654 34578889999999999999999999999999999999999999999999998754322   22


Q ss_pred             ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hh---------------------------
Q 024158          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT---------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~---------------------------  224 (271)
                      ....+++.|+|||.+.+. .++.++|+||||++++++++|..||...... +.                           
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP  240 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccc
Confidence            334568889999998754 4778999999999999999999999754321 00                           


Q ss_pred             --------------hc--ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 --------------FR--SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 --------------~~--~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                    +.  ..+.++.+++.+|+..||.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                          00  015688999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.6e-42  Score=285.08  Aligned_cols=243  Identities=28%  Similarity=0.555  Sum_probs=209.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|...+.||+|++|.||++.+..++..+++|.+.....   ...+.+.+|+.+++.++|+|++++++++..++..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            56667899999999999999989999999998854322   224567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~  176 (271)
                      ++.+++|.+++.. ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   .....
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999987 6689999999999999999999999999999999999999999999999997643322   12234


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhccc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~~  242 (271)
                      .+++.|+|||.+.+..++.++|+||+|++++++++|..||....+...              ...++..+.+++.+||..
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHccc
Confidence            578899999999888899999999999999999999999876543221              112578999999999999


Q ss_pred             CccCCCCHHHHhcCCccccCCCCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      +|++|||+.++++||||.+...+.
T Consensus       256 ~p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         256 DPAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             ChhhCcCHHHHccCcccccCCCcc
Confidence            999999999999999999976654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-43  Score=298.55  Aligned_cols=249  Identities=36%  Similarity=0.641  Sum_probs=226.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ......+.|.+.+.||.|.|++|.++++.-++..||+|.+++...+.... ..+.+|++++..+.||||++++++.+...
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-QKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-HHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            34556788999999999999999999999999999999999888777554 44899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc--
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~--  170 (271)
                      .+|+||||+.++.+.+++.++..+.+..+..++.|+++|++|||+++|+|+|||++||+++.+.+++|+|||++....  
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999999999998888889999999999999999999999999999999999999999999999985544  


Q ss_pred             CccccccccccccCCccccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHHHHH
Q 024158          171 SKRHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHLISR  238 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~li~~  238 (271)
                      ......+|++.|.|||.+.+..++ .+.|+||+|+++|.|+.|.+||++.+-.+...+           ++-+..++|++
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk  288 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRK  288 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHHH
Confidence            445678999999999999998875 599999999999999999999998886655433           58899999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +|..+|.+|++++++++|.|..-.
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             hhccCccccCCHHHhhhhcccchh
Confidence            999999999999999999998644

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-42  Score=298.00  Aligned_cols=246  Identities=24%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCce
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNI   81 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i   81 (271)
                      .+....+.+..++|++.+.||+|+||.||+|++...+     ..|++|.+......  .....+.+|+++++.+ +|+||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nI  104 (374)
T cd05106          27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNI  104 (374)
T ss_pred             ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCce
Confidence            3445556677889999999999999999999865443     57999998654322  2245678899999999 89999


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhC------------------------------------------------
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKH------------------------------------------------  113 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------------------------------  113 (271)
                      +++++.+......+++|||+++++|.+++...                                                
T Consensus       105 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (374)
T cd05106         105 VNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM  184 (374)
T ss_pred             eeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence            99999999999999999999999999988542                                                


Q ss_pred             ----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158          114 ----------------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus       114 ----------------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                                            ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~  264 (374)
T cd05106         185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN  264 (374)
T ss_pred             CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence                                  1367888999999999999999999999999999999999999999999999854332


Q ss_pred             ccc-----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHHH
Q 024158          172 KRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAEA  232 (271)
Q Consensus       172 ~~~-----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~l  232 (271)
                      ...     ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........             ..+++++
T Consensus       265 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (374)
T cd05106         265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEI  344 (374)
T ss_pred             CcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHH
Confidence            211     1224567999999988889999999999999999997 99999765433211             1257999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .+++.+||..+|++|||+.++++
T Consensus       345 ~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         345 YSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.9e-42  Score=282.32  Aligned_cols=235  Identities=29%  Similarity=0.536  Sum_probs=198.9

Q ss_pred             ccceeeeeee--cccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh-CCCCceeceeeEEEeCCeE
Q 024158           18 LQDFEIGRPL--GKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        18 ~~~y~~~~~l--g~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~~~~~   94 (271)
                      .++|++.+.+  |+|+||.||+++++.++..+++|.+........        +...... .+|+|++++++.+..++.+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3567777776  999999999999999999999999865432221        1111111 2699999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCcc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~~  173 (271)
                      ++|+||+++++|.+++.....+++..+..++.|+++|+.+||+.|++|+||+|+||+++.++ .++|+|||.+...... 
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-  163 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-  163 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-
Confidence            99999999999999998877899999999999999999999999999999999999999988 9999999987544322 


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHHHHHHH
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAKHLISR  238 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~~li~~  238 (271)
                      ....++..|+|||.+.+..++.++|+||+|+++++|++|..||.......               ....+++.+.+++.+
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  243 (267)
T PHA03390        164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS  243 (267)
T ss_pred             ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH
Confidence            33467889999999998889999999999999999999999997543221               122368999999999


Q ss_pred             hcccCccCCCC-HHHHhcCCcccc
Q 024158          239 LLVKDSSKRLS-LQKIMEHPWIIK  261 (271)
Q Consensus       239 ~l~~~p~~Rps-~~~il~~~~~~~  261 (271)
                      ||+++|.+||+ ++++|+||||+.
T Consensus       244 ~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        244 MLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HhccChhhCCchHHHHhcCCcccC
Confidence            99999999995 699999999974

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.2e-42  Score=279.08  Aligned_cols=239  Identities=37%  Similarity=0.651  Sum_probs=210.6

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||++.+..++..+++|++....... .....+.+|++.++.++|+|++++.+.+..+...++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh-HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            6899999999999999999999999999999986654332 335677889999999999999999999999899999999


Q ss_pred             ccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158          100 YAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus       100 ~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      ++++++|.+.+...    ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999999763    56899999999999999999999999999999999999999999999999987543332   


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------ccCHHHHHHHHHhc
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------SISAEAKHLISRLL  240 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------~i~~~l~~li~~~l  240 (271)
                      .....+++.|+|||.+.+..++.++|+||+|++++++++|..||......+...            .++.++.+++.+||
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  239 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLL  239 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            233467888999999988889999999999999999999999997765433322            35789999999999


Q ss_pred             ccCccCCCCHHHHhcCCcc
Q 024158          241 VKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~  259 (271)
                      ..+|++|||+.++++||||
T Consensus       240 ~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         240 QKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCChhhCcCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.6e-42  Score=284.67  Aligned_cols=237  Identities=30%  Similarity=0.544  Sum_probs=202.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|+++++||.|++|.||++++..+|..+++|.+......  .....+.+|+.+++.++|+|++++++++...+..++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998654322  123456678999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---c
Q 024158          100 YAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (271)
Q Consensus       100 ~~~~~~L~~~l~~~---~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~  173 (271)
                      +++ ++|.+++...   ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   .
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            997 4888888653   35899999999999999999999999999999999999999999999999987543322   1


Q ss_pred             ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------------
Q 024158          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------------  225 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------------  225 (271)
                      ....++..|++||.+.+. .++.++|+||||++++++++|..||.+.+..+..                           
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            234467889999988664 4678999999999999999999999765533211                           


Q ss_pred             -------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 -------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 -------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                   ..++..+.+++.+|+..+|.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence                         1246788999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.9e-42  Score=283.63  Aligned_cols=243  Identities=33%  Similarity=0.499  Sum_probs=205.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFL   96 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~l   96 (271)
                      ++|...++||.|++|.||++.+..++..+++|.+......  .....+.+|+++++.++|+||+++++++...  ..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            4799999999999999999999999999999998654322  3356788899999999999999999988543  46899


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           97 ILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++||+++++|.+++..    ...++...+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  158 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS  158 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence            9999999999887753    345889999999999999999999999999999999999999999999999987543322


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc-----chhh------------------ccc
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-----KDTF------------------RSI  228 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-----~~~~------------------~~i  228 (271)
                       .....++..|++||.+.+..++.++|+||||+++|+|++|..||.....     .+..                  ..+
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd06621         159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW  238 (287)
T ss_pred             ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence             2234567889999999888899999999999999999999999976521     0100                  113


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ++.+.+++.+||..+|.+|||+.|+++||||++..
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            56899999999999999999999999999996653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.1e-42  Score=282.60  Aligned_cols=238  Identities=23%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ++..+|++.+.||+|+||.||++...   ..+..+++|.+......  .....+.+|+..++.++||||+++++++..++
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   79 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGN   79 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence            56788999999999999999999765   44678999998654322  23456888999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++||||+++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++++|||.+.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999999764 4689999999999999999999999999999999999999999999999997644321


Q ss_pred             cc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCCcchhh------------cccCHHHHH
Q 024158          172 KR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       172 ~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                      ..    ....++..|+|||.+.+..++.++|+||||+++|+++ +|..||......+..            ...|..+.+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            11    1223456899999999889999999999999999977 499999866544322            235789999


Q ss_pred             HHHHhcccCccCCCCHHHHhc
Q 024158          235 LISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++.+|+.++|.+|||+++|++
T Consensus       240 li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-42  Score=283.84  Aligned_cols=238  Identities=32%  Similarity=0.545  Sum_probs=201.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCC----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~----   92 (271)
                      .++|++.+.||+|++|.||+|++..+++.+++|++.....    ....+.+|+.+++++ .|+|++++++++....    
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            4789999999999999999999998999999999865432    235678899999998 6999999999986543    


Q ss_pred             --eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           93 --RIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        93 --~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                        .+++++|++++++|.+++..    ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~  160 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS  160 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence              58999999999999998865    346899999999999999999999999999999999999999999999999987


Q ss_pred             ccccC---ccccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------
Q 024158          167 VQSRS---KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------  225 (271)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------  225 (271)
                      .....   ......+++.|+|||.+..     ..++.++|+||||++++++++|..||.........             
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS  240 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc
Confidence            44322   2233457888999998753     23567899999999999999999999754432221             


Q ss_pred             -cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 -RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 -~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                       ..++.++.+++.+||..||++|||++++++|||+
T Consensus       241 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         241 PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence             1246789999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.1e-42  Score=284.85  Aligned_cols=239  Identities=30%  Similarity=0.514  Sum_probs=202.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEe-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD-----   90 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-----   90 (271)
                      -.+.|++.+.||.|+||.||++++..+++.+++|++....    .....+..++.+++++ +|+|++++++++..     
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            4578999999999999999999999999999999985532    2234577888888888 69999999998842     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           91 -DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                       +..+|++|||+++++|.+++...  ..+++..+..++.|++.++.|||+.|++|+|++|+||+++.++.++|+|||++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence             45789999999999999999763  357888899999999999999999999999999999999999999999999875


Q ss_pred             cccC---ccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hc
Q 024158          168 QSRS---KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FR  226 (271)
Q Consensus       168 ~~~~---~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~  226 (271)
                      ....   ......+++.|+|||.+.     ...++.++|+||||+++|+|++|..||....+...             ..
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  249 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK  249 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccc
Confidence            4332   223345788999999875     34577899999999999999999999965443221             12


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      .++.++.++|.+||..||.+||++.++++||||
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         250 KWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             ccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            368899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.7e-42  Score=287.56  Aligned_cols=238  Identities=24%  Similarity=0.392  Sum_probs=197.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec----------------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE----------------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP   79 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~   79 (271)
                      +..++|++.++||+|+||.||+|.+..                ++..+++|.+......  .....+.+|+.++.+++|+
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCC
Confidence            456799999999999999999997532                3446999998654322  2356788899999999999


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------------------RFTEQQAATYIASLTNALAYCHENHV  140 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i  140 (271)
                      ||+++++++...+..++++||+++++|.+++....                   .+++..++.++.||+.|+.+||+.|+
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999899999999999999999986421                   36778899999999999999999999


Q ss_pred             eecCCCCCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh--CC
Q 024158          141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GA  213 (271)
Q Consensus       141 ~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~--g~  213 (271)
                      +|+||+|+||+++.++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++|+|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999988543222     122334678999999988889999999999999999986  56


Q ss_pred             CCCCCCCcchhh-------------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          214 PPFEAESQKDTF-------------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       214 ~p~~~~~~~~~~-------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .||......+..                   ...++.+.+++.+|+..+|.+|||+++|..
T Consensus       240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            777765443322                   124688999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=5.6e-42  Score=285.71  Aligned_cols=243  Identities=29%  Similarity=0.520  Sum_probs=203.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++.+.||.|++|.||++++..+|+.+++|.+....... .....+.+|+++++.++|+|++++++++..++.+++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            478999999999999999999999999999999985543222 2345677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~~~~~--  172 (271)
                      +||++ ++|.+.+....  .++...++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||++......  
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            99996 58888776543  3578888999999999999999999999999999999985 457999999988543221  


Q ss_pred             -cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------------------
Q 024158          173 -RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------------  224 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------------------  224 (271)
                       .....+++.|+|||.+.+. .++.++|+||+|+++++|++|..||...+..+.                          
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYK  238 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhh
Confidence             1233467889999988664 578899999999999999999999965432111                          


Q ss_pred             --------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          225 --------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       225 --------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                    ...+++++.+++.+||..+|++||++.++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                          12357889999999999999999999999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.4e-42  Score=285.84  Aligned_cols=240  Identities=30%  Similarity=0.485  Sum_probs=199.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCe----
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDER----   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~----   93 (271)
                      ++|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+.+++.+. |+|++++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            47999999999999999999999999999999985543221 22356778999999995 5999999999877665    


Q ss_pred             -EEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeeccc
Q 024158           94 -IFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWS  166 (271)
Q Consensus        94 -~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~  166 (271)
                       .|+++||+++ +|.+++...     ..+++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||.+
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999985 888887542     35799999999999999999999999999999999999998 889999999987


Q ss_pred             ccccCc---cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------
Q 024158          167 VQSRSK---RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------  224 (271)
Q Consensus       167 ~~~~~~---~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------  224 (271)
                      ......   .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+....                  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            543221   122345788999998865 4568899999999999999999999975432211                  


Q ss_pred             ---------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          225 ---------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       225 ---------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                                           ...++.++.++|.+||.++|.+|||+++++.||||+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                 123678899999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-42  Score=294.18  Aligned_cols=246  Identities=26%  Similarity=0.455  Sum_probs=207.8

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe----CCeE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----DERI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~   94 (271)
                      .+|.+.+.||+|++|.||++++..++..+++|++...... ......+.+|+.+++.++|+||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            6899999999999999999999999999999998654322 2234566789999999999999999988753    3468


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc-
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-  173 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-  173 (271)
                      ++++||+. ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999996 6999999877789999999999999999999999999999999999999999999999999874432211 


Q ss_pred             ------ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch-----------------------
Q 024158          174 ------HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-----------------------  223 (271)
Q Consensus       174 ------~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-----------------------  223 (271)
                            ....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.......                       
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence                  23457888999998865 457889999999999999999999996543211                       


Q ss_pred             -------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          224 -------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       224 -------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                         .....+.++.++|.+||..+|++|||+++++.||||++.+.+-
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                               1123578899999999999999999999999999999876654

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.2e-42  Score=284.82  Aligned_cols=244  Identities=30%  Similarity=0.550  Sum_probs=212.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ....|++.+.||+|++|.||++.+..++..+++|++.....    ....+.+|+..++.++|+|++++++.+..++..++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34458999999999999999999988999999999865433    34567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      ++|++++++|.+++.... .++...+..++.|++.++.+||+.|++|+|++|+||+++.++.++|+|||++......   
T Consensus        93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614          93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            999999999999998866 8999999999999999999999999999999999999999999999999987433322   


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISR  238 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~  238 (271)
                      .....++..|+|||.+.+..++.++|+||||+++|++++|..||....+...              ...++.++.+++.+
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHH
Confidence            2233467889999999888889999999999999999999999876543221              11267889999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ||..+|.+|||+.++++|+||.+...
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhccCc
Confidence            99999999999999999999998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.2e-42  Score=297.35  Aligned_cols=244  Identities=25%  Similarity=0.423  Sum_probs=202.3

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEE-----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceece
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~   84 (271)
                      ...+.+..++|++.+.||+|+||.||+|.+     ..++..+++|++......  .....+.+|+++++.+ +||||+++
T Consensus        27 ~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l  104 (375)
T cd05104          27 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNL  104 (375)
T ss_pred             ccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeee
Confidence            344556667999999999999999999974     345678999998644322  2345678899999999 89999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC--------------------------------------------------
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHR--------------------------------------------------  114 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------  114 (271)
                      ++++..++..+++|||+++++|.+++....                                                  
T Consensus       105 ~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  184 (375)
T cd05104         105 LGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKAD  184 (375)
T ss_pred             eeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccc
Confidence            999999999999999999999999986421                                                  


Q ss_pred             -------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158          115 -------------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus       115 -------------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                                               .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         185 KRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             cccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence                                     3678889999999999999999999999999999999999999999999998544


Q ss_pred             cCccc-----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh-------------hcccCH
Q 024158          170 RSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT-------------FRSISA  230 (271)
Q Consensus       170 ~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~-------------~~~i~~  230 (271)
                      .....     ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||........             ....+.
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS  344 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence            32211     1234567999999999999999999999999999997 8889876543221             112478


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+||..||++|||+.++++.
T Consensus       345 ~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         345 EMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.5e-42  Score=312.72  Aligned_cols=239  Identities=26%  Similarity=0.447  Sum_probs=203.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++.+.||+|+||.||+|++..+++.+++|++...........+.+.+|+++++.++|||++++++++.+++..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999999999999999999765444444566788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           98 LEYAHRGELYRELRKH-----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-----------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      |||++|++|.+++...           ..++...++.++.||+.||.+||+.|++||||||+||+++.++.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988641           23566778999999999999999999999999999999999999999999988


Q ss_pred             ccccC---------------------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-
Q 024158          167 VQSRS---------------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-  224 (271)
Q Consensus       167 ~~~~~---------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-  224 (271)
                      .....                     ......||+.|+|||.+.+..++.++|+||||+++++|++|..||........ 
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            54310                     01123589999999999999999999999999999999999999976443221 


Q ss_pred             -------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 -------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 -------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                   ...+|+.+.+++.+||..||++||+..+.+..
T Consensus       241 ~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        241 YRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                         13468899999999999999999876665543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.5e-42  Score=280.52  Aligned_cols=238  Identities=21%  Similarity=0.384  Sum_probs=205.3

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++...+|.+.+.||+|++|.||++.+..++..+++|.+.....    ....+.+|+..++.++|+|++++++++..++.+
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   77 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence            5677889999999999999999999999999999999864432    245678899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..++...++.++.|+++++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999999999753  35899999999999999999999999999999999999999999999999987554332


Q ss_pred             cc----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 RH----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~~----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      ..    ....++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..            ..+|+++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            21    1223567999999988889999999999999999998 99998765543332            2357899999


Q ss_pred             HHHhcccCccCCCCHHHHhcC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+||..+|++|||+.++++.
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHH
Confidence            999999999999999999763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.7e-42  Score=288.87  Aligned_cols=240  Identities=24%  Similarity=0.392  Sum_probs=201.1

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCce--EEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      .+++++|++.+.||+|+||.||+|.+..++..  +++|.+...  ........+.+|+.++.++ +|+||+++++++..+
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            46788999999999999999999998877765  466665432  1223356778899999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           92 ERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      +.+|+++||+++++|.+++....                .++...++.++.|++.|+.+||++|++|+||+|+||+++.+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~  160 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  160 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence            99999999999999999997532                47889999999999999999999999999999999999999


Q ss_pred             CCEEEeeecccccccCcc--ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------
Q 024158          156 GRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------  225 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------  225 (271)
                      +.++|+|||++.......  .....+..|+|||.+.+..++.++|+||||++++++++ |..||......+..       
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             CcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            999999999875332211  11233567999999988888899999999999999998 99999765543322       


Q ss_pred             -----cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 -----RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 -----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                           ..+++++.+++.+||..+|++|||+++++.+
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 2257899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-42  Score=293.15  Aligned_cols=244  Identities=27%  Similarity=0.478  Sum_probs=210.3

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----eE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----RI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~   94 (271)
                      +|++.+.||+|++|.||+|++..++..+++|.+..... .....+.+.+|+..++.++|+||+++.+++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            68999999999999999999988999999999865432 2234567888999999999999999999987765     78


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      |+++++++ ++|.+++.+...+++..++.++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 589999988778999999999999999999999999999999999999999999999999988544332  


Q ss_pred             ----cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------
Q 024158          173 ----RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------  224 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------  224 (271)
                          .....+++.|+|||.+.+. .++.++|+||||+++++|++|..||......+.                       
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence                2234568889999999887 788899999999999999999999975543211                       


Q ss_pred             -------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 -------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 -------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                         ...++.++.+++.+||.++|++|||+++++.||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                               12257889999999999999999999999999999887655

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=284.82  Aligned_cols=237  Identities=31%  Similarity=0.566  Sum_probs=202.1

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |++.+.||.|++|.||++.+..+|..+++|++....... .....+.+|+..++.++|+|++++++++.+++..|+++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            678999999999999999999999999999986543222 2234567899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---cc
Q 024158          101 AHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HT  175 (271)
Q Consensus       101 ~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~  175 (271)
                      ++ ++|.+++....  .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+.......   ..
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            96 69999997755  68999999999999999999999999999999999999999999999999875433221   22


Q ss_pred             ccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch-------------------------------
Q 024158          176 MCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------------------------------  223 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-------------------------------  223 (271)
                      ..+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.......                               
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            3457889999988664 46889999999999999999999986543211                               


Q ss_pred             ---------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 ---------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 ---------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                               ....++.++.+++.+||.++|.+|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     112356889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.4e-41  Score=279.60  Aligned_cols=241  Identities=31%  Similarity=0.516  Sum_probs=202.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ...........||+|+||.||++++..++..+++|.+......   ....+.+|+.+++.++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            3445555667899999999999999899999999988654322   3457788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKH-RRF--TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l--~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~~~~  171 (271)
                      +++|++++++|.+++... ..+  +...+..++.|++.|+.+||++|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999999764 345  78888999999999999999999999999999999976 67999999998754322


Q ss_pred             ---ccccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEA  232 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l  232 (271)
                         ......+++.|+|||.+.+..  ++.++|+||+|+++|++++|..||.......              ....+++++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEA  241 (268)
T ss_pred             CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHH
Confidence               122345788999999986543  6789999999999999999999987543211              112357889


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      .+++.+||..+|++|||+.+++.||||
T Consensus       242 ~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         242 KNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-41  Score=288.09  Aligned_cols=247  Identities=30%  Similarity=0.490  Sum_probs=209.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-CCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~   95 (271)
                      ..++|++++.||.|++|.||++++..++..+++|.+.+..... .....+..|+.+++.++|||++++.+++.. .+..|
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            4568999999999999999999999999999999886543222 234567789999999999999999998865 55789


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      +++|+++ ++|.+++.. ..++...+..++.|+++|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        87 lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          87 FVTELLG-TDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             EEeehhc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            9999995 689888865 45788889999999999999999999999999999999999999999999988655544445


Q ss_pred             ccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--------------------------------
Q 024158          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------------------------  222 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--------------------------------  222 (271)
                      ..+++.|+|||.+.+ ..++.++|+||||++++++++|..||......                                
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQS  244 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhh
Confidence            567888999998766 56888999999999999999999999764421                                


Q ss_pred             ----------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          223 ----------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       223 ----------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                +....++.++.+++.+||..+|++|||+++++.||||++...|.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         245 LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence                      01123578899999999999999999999999999999887664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-42  Score=293.28  Aligned_cols=246  Identities=24%  Similarity=0.447  Sum_probs=209.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe---
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER---   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~---   93 (271)
                      ..++|++.+.||+|++|.||++++..++..+++|++....... .....+.+|+.+++.++|+|++++.+++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4678999999999999999999999999999999986543222 234566789999999999999999987765544   


Q ss_pred             ---EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           94 ---IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        94 ---~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                         .++++|+++ ++|.+++.. ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               899999994 699998876 568999999999999999999999999999999999999999999999999987665


Q ss_pred             CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------
Q 024158          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------  224 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------  224 (271)
                      .......++..|+|||.+.+ ..++.++|+||||++++++++|..||......+.                         
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07851         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR  249 (343)
T ss_pred             ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence            55555567888999998865 3577899999999999999999999975443211                         


Q ss_pred             -----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 -----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 -----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                       ...++.++.+++.+||.++|++|||+.+++.||||++...+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                             11247889999999999999999999999999999988665

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.7e-42  Score=281.26  Aligned_cols=238  Identities=30%  Similarity=0.540  Sum_probs=205.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++.+.||+|++|.||++++..++..+++|.+.............+.+|+.+++.++|+|++++++++..++..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46899999999999999999999999999999988665444444556788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      +|++++++|.+++..    ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    345899999999999999999999999999999999999999999999999987543322 


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--h-------------hhcccCHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--D-------------TFRSISAEAKHL  235 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--~-------------~~~~i~~~l~~l  235 (271)
                        .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+....  +             ....+++++.++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL  240 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHH
Confidence              22346788999999998888899999999999999999999999654321  1             112357899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+..+|++|||+.+|++
T Consensus       241 i~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         241 VNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHhcCCCcccCCCHHHHHH
Confidence            99999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-41  Score=290.04  Aligned_cols=246  Identities=24%  Similarity=0.434  Sum_probs=207.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ...+|.+.+.||+|+||.||++.+..++..+++|++....... .....+.+|+.++++++|+||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            3478999999999999999999999999999999986543222 2345677899999999999999999987543     


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       ...|++++++ +++|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             3478888888 5799888865 468999999999999999999999999999999999999999999999999987665


Q ss_pred             CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------------------
Q 024158          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------------------  225 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------------------  225 (271)
                      .......++..|+|||.+.+ ..++.++|+||||++++++++|..||.........                        
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (345)
T cd07877         172 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  251 (345)
T ss_pred             ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence            55555677889999998866 46788999999999999999999999754432210                        


Q ss_pred             ------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 ------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 ------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                        ...++++.++|.+||..+|.+|||+.++++||||++...|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                              0136778999999999999999999999999999987554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-41  Score=282.35  Aligned_cols=240  Identities=31%  Similarity=0.506  Sum_probs=200.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEE-----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH-----   89 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~-----   89 (271)
                      .-.++|++++.||+|++|.||++++..+++.+++|++.....    ....+..|+.+++.+ +|+|++++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            456789999999999999999999999999999998754321    124567788889888 6999999999874     


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           90 DDERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      .++.+++++||+++++|.+++..    ...+++..+..++.|++.++.+||+.+++|+|++|+||+++.++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~  170 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV  170 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence            34578999999999999988753    34588899999999999999999999999999999999999999999999998


Q ss_pred             cccccC---ccccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------
Q 024158          166 SVQSRS---KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------  225 (271)
Q Consensus       166 ~~~~~~---~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------  225 (271)
                      +.....   ......+++.|+|||.+..     ..++.++|+||+|+++|+|++|..||.........            
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (286)
T cd06638         171 SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH  250 (286)
T ss_pred             eeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCccc
Confidence            754332   2233457889999998753     44678999999999999999999998765432221            


Q ss_pred             --cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 --RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 --~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                        ...+.++.+++.+||..+|++|||+.++++|+||
T Consensus       251 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence              1136789999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-45  Score=286.57  Aligned_cols=238  Identities=29%  Similarity=0.507  Sum_probs=215.7

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |.++.+||+|+||.||++.++++|..+++|.+..+     ...+.+..|+.++++++.++++++|+.+.....+|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            78999999999999999999999999999998554     3356788999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccccc
Q 024158          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTM  176 (271)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~~~  176 (271)
                      |+.|++.+.+.. +++|+++++..++.+.+++|+|||...-+|||||..|||+..+|..||.|||.+-+..   ...+..
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence            999999999865 5789999999999999999999999999999999999999999999999999874433   355677


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhccc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l~~  242 (271)
                      .|||-|+|||.+..-.|+.++||||||++..+|+.|++||....+-..+              ..++.++.++++.||.+
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK  269 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIK  269 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcC
Confidence            8999999999999889999999999999999999999999876654432              23578899999999999


Q ss_pred             CccCCCCHHHHhcCCccccCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +|++|.++-++++|||+++.+
T Consensus       270 ~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  270 KPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             CHHHHHHHHHHhhhhhhcCCC
Confidence            999999999999999998764

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-43  Score=278.71  Aligned_cols=239  Identities=34%  Similarity=0.605  Sum_probs=203.6

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccC
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      .+.||+|+++.|..|....+|..|+||++.+.  .. .....+.+|..++..+ .|+||++++++|+++..+|+|||.|.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PG-HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC--Cc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            35689999999999999999999999999775  22 2345667788888888 59999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeeccccccc---------
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSR---------  170 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~~---------  170 (271)
                      ||+|...++..+-+++.++..+..+|+.||.+||++||+|+|+||+|||-...+   .+|||||++.....         
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999999999988999999999999999999999999999999999999997654   59999999862211         


Q ss_pred             -CccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------------
Q 024158          171 -SKRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------------  223 (271)
Q Consensus       171 -~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------------  223 (271)
                       +..-..+|+..|+|||...     ...|+.+.|+||||+++|-|++|.+||.+....+                     
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence             1112346778899999663     2448899999999999999999999998766421                     


Q ss_pred             ---------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          224 ---------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       224 ---------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                               .|..|+.+..++++.+|..++.+|.++.+++.|||++.....
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence                     123368999999999999999999999999999999987543

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-42  Score=287.98  Aligned_cols=239  Identities=27%  Similarity=0.503  Sum_probs=199.5

Q ss_pred             ceeeeeeecccCCceEEEEEEec--CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIF   95 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~   95 (271)
                      +|++.+.||+|++|.||+|.+..  ++..+++|.+.............+.+|+.+++.++|||++++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  8999999999764322222335567889999999999999999999888  7899


Q ss_pred             EEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC----CCCEEEeeeccc
Q 024158           96 LILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH----EGRLKIGDFGWS  166 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~----~~~~~L~dfg~~  166 (271)
                      +|+|+++ +++.+++...     ..++...++.++.|++.|+.+||+.|++|+||+|+||+++.    ++.++|+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999997 4777776532     25889999999999999999999999999999999999999    889999999987


Q ss_pred             ccccCc------cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------------
Q 024158          167 VQSRSK------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------  223 (271)
Q Consensus       167 ~~~~~~------~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------  223 (271)
                      ......      .....+++.|+|||.+.+. .++.++|+||||+++++|++|..||.+.....                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            543322      1233567889999988764 47889999999999999999999997554322                


Q ss_pred             ------------------h-----------h------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 ------------------T-----------F------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 ------------------~-----------~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                        .           .            ...+.++.+++.+||.+||++|||+.++++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                              0           0            0245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.9e-42  Score=278.56  Aligned_cols=239  Identities=29%  Similarity=0.592  Sum_probs=207.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|.+.+.||+|++|.||++....+|..+++|.+....... ...+.+.+|+.+++.++|+|++++++.+..++..++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            5899999999999999999999999999999986654332 234567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCcc---
Q 024158          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSKR---  173 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~~---  173 (271)
                      ++++++|.+++....  .+++..+..++.|+++++.+||+.+++|+|++|+||+++.++ .++|+|||.+.......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999997643  478999999999999999999999999999999999998886 46999999875443322   


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------ccCHHHHHHHHHhcc
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------SISAEAKHLISRLLV  241 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------~i~~~l~~li~~~l~  241 (271)
                      ....+++.|+|||.+.+..++.++|+||+|++++++++|..||......+...            .++.++.+++.+|+.
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFK  239 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhc
Confidence            22357888999999988888999999999999999999999998665433321            247889999999999


Q ss_pred             cCccCCCCHHHHhcCCcc
Q 024158          242 KDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~  259 (271)
                      .+|++|||+.+++.||||
T Consensus       240 ~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         240 VSPRDRPSITSILKRPFL  257 (257)
T ss_pred             cChhhCcCHHHHhhCCCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=8.8e-42  Score=284.31  Aligned_cols=241  Identities=29%  Similarity=0.528  Sum_probs=208.3

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      ...+||+|++|.||++....++..+++|.+....   ......+.+|+.+++.++|+|++++++.+..++..++++|+++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            3467999999999999999999999999974332   2234668889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccccccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGT  179 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~~~~~  179 (271)
                      +++|.+++.. ..+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......   .....++
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  179 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT  179 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence            9999988765 46899999999999999999999999999999999999999999999999987433221   2234578


Q ss_pred             ccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHHHHHHhcccCcc
Q 024158          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       180 ~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~li~~~l~~~p~  245 (271)
                      +.|++||.+.+..++.++|+||+|++++++++|..||.+....+              ....+++.+.+++.+||..+|.
T Consensus       180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~  259 (292)
T cd06657         180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA  259 (292)
T ss_pred             ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence            88999999988888899999999999999999999997654322              1223688999999999999999


Q ss_pred             CCCCHHHHhcCCccccCCCCCC
Q 024158          246 KRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       246 ~Rps~~~il~~~~~~~~~~~~~  267 (271)
                      +||++.++++||||.+...|.+
T Consensus       260 ~R~~~~~ll~~~~~~~~~~~~~  281 (292)
T cd06657         260 QRATAAELLKHPFLAKAGPPSC  281 (292)
T ss_pred             cCcCHHHHhcChHHhccCCCcc
Confidence            9999999999999999987665

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-41  Score=277.96  Aligned_cols=235  Identities=30%  Similarity=0.532  Sum_probs=204.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.||++++..++..+++|.+......  ...+.+.+|+.+++.++|+|++++++.+..++.+|+++|
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            689999999999999999999999999999998543322  335677789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158          100 YAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      |+++++|.+++..  ...++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......   ..
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            9999999998865  345789999999999999999999999999999999999999999999999987544322   22


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||.........            ..++..+.+++.+||..
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  238 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKR  238 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhC
Confidence            345788899999998888999999999999999999999999866533221            23578899999999999


Q ss_pred             CccCCCCHHHHhcC
Q 024158          243 DSSKRLSLQKIMEH  256 (271)
Q Consensus       243 ~p~~Rps~~~il~~  256 (271)
                      +|++|||+.+++.-
T Consensus       239 ~P~~Rp~~~~il~~  252 (255)
T cd08219         239 NPRSRPSATTILSR  252 (255)
T ss_pred             CcccCCCHHHHhhc
Confidence            99999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-41  Score=281.00  Aligned_cols=235  Identities=30%  Similarity=0.458  Sum_probs=196.0

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeC--CeEEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDD--ERIFLI   97 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~--~~~~lv   97 (271)
                      |++++.||+|++|.||++.+..++..+++|.+........ . .....|+..+.++. |+|++++++++.++  +..+++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-Q-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-h-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            7889999999999999999999999999999865432221 1 22345777777774 99999999999887  889999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc--c
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--H  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~--~  174 (271)
                      +|+++ ++|.+.+... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++. +.++|+|||.+.......  .
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence            99997 5888887653 46899999999999999999999999999999999999999 999999999885443221  2


Q ss_pred             cccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------------
Q 024158          175 TMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------------  224 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------------  224 (271)
                      ...++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+..+.                             
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            3456888999997654 4567899999999999999999999976543211                             


Q ss_pred             -----------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 -----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 -----------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                 ...++.++.+++.+||.++|++|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                       12357899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.6e-41  Score=284.22  Aligned_cols=241  Identities=26%  Similarity=0.461  Sum_probs=206.4

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |...+.||+|++|.||++++..++..+++|.+.............+.+|+.+++.++|+|++++++++......|+++||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66778899999999999999999999999998765444444456788899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccccc
Q 024158          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (271)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~  179 (271)
                      +. +++.+++.. ...+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+..... .....++
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-~~~~~~~  180 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-ANSFVGT  180 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-CCCcccc
Confidence            96 578777765 45689999999999999999999999999999999999999999999999998754322 2345678


Q ss_pred             ccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHHHHHhcccC
Q 024158          180 LDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       180 ~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~li~~~l~~~  243 (271)
                      ..|+|||.+.   +..++.++|+||||+++|+|++|..||........             ...++..+.+++.+||..+
T Consensus       181 ~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  260 (313)
T cd06633         181 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKI  260 (313)
T ss_pred             ccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCC
Confidence            8899999874   35578899999999999999999999876543221             1235678999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~  263 (271)
                      |.+||++.+++.||||....
T Consensus       261 P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         261 PQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             hhhCcCHHHHhcCcccCCCc
Confidence            99999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.8e-42  Score=290.20  Aligned_cols=246  Identities=27%  Similarity=0.469  Sum_probs=206.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~   92 (271)
                      ..+|++.+.||+|++|.||++++..++..+++|.+....... .....+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            357999999999999999999999999999999986542222 2234566899999999999999999987644     3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..|+++|+++ ++|.+++.....++...+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            4899999996 689999988788999999999999999999999999999999999999999999999999988554332


Q ss_pred             ---cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--------------------------
Q 024158          173 ---RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------------------  222 (271)
Q Consensus       173 ---~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--------------------------  222 (271)
                         .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||.+.+..                          
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA  241 (337)
T ss_pred             cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence               223456788999998865 45888999999999999999999999654210                          


Q ss_pred             ----------------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          223 ----------------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       223 ----------------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                      .....+++++.+++.+||.++|.+|||++++++||||.....+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             hHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence                            0112467889999999999999999999999999999875433

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-41  Score=289.29  Aligned_cols=244  Identities=25%  Similarity=0.457  Sum_probs=203.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~   92 (271)
                      .++|++.+.||+|++|.||++++..+|..|++|.+....  .......+.+|+.+++.++|+|++++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            368999999999999999999999999999999985422  223345677899999999999999999887544     3


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..|+++|+++ ++|.+.+.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            5799999996 588887754 56899999999999999999999999999999999999999999999999987543321


Q ss_pred             c------ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------------------
Q 024158          173 R------HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------------  223 (271)
Q Consensus       173 ~------~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------------  223 (271)
                      .      ....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.....                      
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            1      22356888999998654 567889999999999999999999996543111                      


Q ss_pred             --------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          224 --------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       224 --------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                          ....+++++.+++.+||..+|.+|||+.++++||||.+.-.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                                012346789999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-41  Score=277.11  Aligned_cols=234  Identities=21%  Similarity=0.413  Sum_probs=199.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +.++|++.+.||+|+||.||++..+ ++..+++|.+......    ...+.+|+.+++.++|||++++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            4678999999999999999999864 5567999987544322    2467789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc--
Q 024158           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~--  173 (271)
                      +|||+++++|.+++... ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999999999999753 458999999999999999999999999999999999999999999999999875433211  


Q ss_pred             --ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHHH
Q 024158          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLISR  238 (271)
Q Consensus       174 --~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~~  238 (271)
                        ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+...            ..+.++.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence              12234567999999988889999999999999999999 899998766544322            246789999999


Q ss_pred             hcccCccCCCCHHHHhc
Q 024158          239 LLVKDSSKRLSLQKIME  255 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~  255 (271)
                      |+..+|++|||++++++
T Consensus       237 c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         237 CWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=280.61  Aligned_cols=254  Identities=38%  Similarity=0.644  Sum_probs=231.4

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      +......+++++|..++.||.|.||+|-+|+.+.+++.+|+|++++...-....+.-...|-+.++..+||.+..+-..+
T Consensus       158 ~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  158 EAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             cccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            44566788999999999999999999999999999999999999888766555556666788999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ...+.+|+||||..||.|.-.+.+.+.++++..+.+...|+.||.|||+++|+.+|+|.+|.|+|++|++|+.|||+++.
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh
Confidence            99999999999999999999998888899999999999999999999999999999999999999999999999999955


Q ss_pred             ---ccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHH
Q 024158          169 ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKH  234 (271)
Q Consensus       169 ---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~  234 (271)
                         ........+|||.|+|||.+....|....|-|.+|+++|+|++|.+||...+....+           +.++++...
T Consensus       318 ~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAkt  397 (516)
T KOG0690|consen  318 EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKT  397 (516)
T ss_pred             cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHH
Confidence               345567789999999999999999999999999999999999999999877765553           457999999


Q ss_pred             HHHHhcccCccCCC-----CHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      |+..+|.+||.+|.     .+.+|.+|+||...
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v  430 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV  430 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence            99999999999998     78999999999764

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-41  Score=288.09  Aligned_cols=245  Identities=24%  Similarity=0.444  Sum_probs=207.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----   92 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   92 (271)
                      ..++|++++.||+|++|.||++.+..++..+++|.+..... .......+.+|+.+++.++|+||+++++++..+.    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            34669999999999999999999999999999999854322 2233456778999999999999999999886543    


Q ss_pred             --eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 --RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                        .+++++|++ +++|.+++.. ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999999 5799888865 568999999999999999999999999999999999999999999999999987665


Q ss_pred             CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------
Q 024158          171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------  224 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------  224 (271)
                      .......+++.|++||.+.+ ..++.++|+||||++++++++|..||........                         
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07880         170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK  249 (343)
T ss_pred             cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence            55555567889999998876 4578899999999999999999999975432111                         


Q ss_pred             -----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 -----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 -----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                       ...+++++.+++.+||..||.+|||+.+++.||||+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                             1235678999999999999999999999999999998633

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=288.95  Aligned_cols=247  Identities=27%  Similarity=0.457  Sum_probs=206.3

Q ss_pred             cceee-eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHH-----------HHHHHHHHHHHHhhCCCCceeceee
Q 024158           19 QDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-----------IQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        19 ~~y~~-~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-----------~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ++|.. .+.||+|++|.||++++..+++.+++|.+.........           ....+.+|+.+++.++|+|++++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            56654 56799999999999999999999999998554322100           1124678999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ++..++..++++|+++ ++|.+++.....++......++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~  166 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA  166 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence            9999999999999997 699999988778999999999999999999999999999999999999999999999999987


Q ss_pred             cccc-----------------CccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---
Q 024158          167 VQSR-----------------SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---  225 (271)
Q Consensus       167 ~~~~-----------------~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---  225 (271)
                      ....                 .......+++.|+|||.+.+.. ++.++|+||||+++++|++|..||......+..   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            4433                 1111234577899999887643 688999999999999999999999765432211   


Q ss_pred             ------------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          226 ------------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       226 ------------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                          ...+.++.+++.+||..+|++|||+++++.||||+..+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~~  323 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPC  323 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCCC
Confidence                                                12367889999999999999999999999999999887664

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.7e-42  Score=283.43  Aligned_cols=246  Identities=28%  Similarity=0.437  Sum_probs=204.1

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   95 (271)
                      ...+|...+.||+|+||.||++++..++..+++|.+......  .....+.+|+..+.++. |+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            456788899999999999999999999999999998654433  33456778888888886 999999999999888999


Q ss_pred             EEEeccCCCchHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           96 LILEYAHRGELYRELR-----KHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~-----~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +++|++. .++.++..     ....+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9999986 46655432     235689999999999999999999975 9999999999999999999999999987443


Q ss_pred             cCc--cccccccccccCCccccCC---CCCccchhhhHHHHHHHHHhCCCCCCCCCcc-----------------hhhcc
Q 024158          170 RSK--RHTMCGTLDYLAPEMVENK---EHDYAVDNWTLGILCYEFLYGAPPFEAESQK-----------------DTFRS  227 (271)
Q Consensus       170 ~~~--~~~~~~~~~y~~pe~~~~~---~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-----------------~~~~~  227 (271)
                      ...  .....+++.|+|||.+.+.   .++.++|+||+|+++|++++|..||......                 .....
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEERE  238 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCc
Confidence            221  2234578889999998766   5788999999999999999999998643210                 11123


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ++.++.+|+.+||.++|++|||+++++.||||++....
T Consensus       239 ~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         239 FSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            67889999999999999999999999999999886543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=282.12  Aligned_cols=237  Identities=32%  Similarity=0.558  Sum_probs=202.6

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeEEEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERIFLIL   98 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~   98 (271)
                      |++++.||+|++|.||++++..+++.+++|.+.... ........+.+|+.+++.++|+|++++++++...  +..++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999997654 2223345677899999999999999999999887  7899999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----c
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----R  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----~  173 (271)
                      |+++ ++|.+++... ..+++..++.++.|+++|+.+||+.|++|+||+|+||+++.++.++|+|||.+......    .
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            9997 5899888765 57899999999999999999999999999999999999999999999999987544332    2


Q ss_pred             ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------------
Q 024158          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------------  224 (271)
                      ....++..|+|||.+.+ ..++.++|+||||++++++++|..||........                            
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            23355778999998765 4578899999999999999999999875443211                            


Q ss_pred             -------------hcc-cCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 -------------FRS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 -------------~~~-i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                   ... .++++.+++.+||..+|.+||+++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         111 27889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-41  Score=276.31  Aligned_cols=233  Identities=45%  Similarity=0.727  Sum_probs=207.5

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||.|++|.||++.+..+++.+++|.+.............+..|+.+++.++|+|++++++.+..++..++++|++++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68999999999999888999999999776655444567788899999999999999999999999999999999988999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---ccccccccccc
Q 024158          107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYL  183 (271)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~~~~~~~~y~  183 (271)
                      .+++.....+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.++|+|||.+......   .....++..|+
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~  160 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL  160 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence            999988778999999999999999999999999999999999999999999999999987554332   34456788899


Q ss_pred             CCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------hcccCHHHHHHHHHhcccCccCCCCH--
Q 024158          184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------FRSISAEAKHLISRLLVKDSSKRLSL--  250 (271)
Q Consensus       184 ~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------~~~i~~~l~~li~~~l~~~p~~Rps~--  250 (271)
                      +||...+...+.++|+||||++++++++|..||........           ...++..+.+++.+||..+|++||++  
T Consensus       161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            99999888888999999999999999999999976654332           22348899999999999999999999  


Q ss_pred             -HHHhcCCcc
Q 024158          251 -QKIMEHPWI  259 (271)
Q Consensus       251 -~~il~~~~~  259 (271)
                       +++++||||
T Consensus       241 ~~~l~~~~~f  250 (250)
T cd05123         241 AEEIKAHPFF  250 (250)
T ss_pred             HHHHHhCCCC
Confidence             999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2e-41  Score=285.19  Aligned_cols=230  Identities=27%  Similarity=0.538  Sum_probs=185.8

Q ss_pred             eeeecccCCceEEEEEEec--CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE--eCCeEEEEEe
Q 024158           24 GRPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDERIFLILE   99 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~e   99 (271)
                      ..+||+|+||.||+|+...  ++..+++|.+......     ..+.+|+.+++.++|||++++++++.  .+...++++|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            3689999999999998653  5688999998554322     34668999999999999999999884  3567899999


Q ss_pred             ccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----CCCCCEEEeeeccc
Q 024158          100 YAHRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS  166 (271)
Q Consensus       100 ~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----~~~~~~~L~dfg~~  166 (271)
                      +++ ++|.+++...         ..+++..++.++.|++.||.+||+.|++|+||||+||++    +.++.++|+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            997 5887777421         247889999999999999999999999999999999999    45678999999998


Q ss_pred             ccccCc------cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------------
Q 024158          167 VQSRSK------RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------  223 (271)
Q Consensus       167 ~~~~~~------~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------  223 (271)
                      ......      .....+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            543322      1234578899999998764 47889999999999999999999986432110                


Q ss_pred             --------hh----------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 --------TF----------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 --------~~----------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                              .+                                  ...+..+.+++.+||..||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                    00                                  0123567889999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.3e-41  Score=275.74  Aligned_cols=237  Identities=29%  Similarity=0.523  Sum_probs=204.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++.+.||+|++|.||+|....+|..+++|.+.............+.+|+.++++++|++++++++.+..++..++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            68999999999999999999999899999999986544333344567889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           99 EYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      ||+++++|.+++..    ...++...++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......  
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~  161 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT  161 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence            99999999998864    245899999999999999999999999999999999999999999999999987543322  


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc--h-------------hhcccCHHHHHHH
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--D-------------TFRSISAEAKHLI  236 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~--~-------------~~~~i~~~l~~li  236 (271)
                       .....+++.|.|||.+.+..++.++|+||||+++|++++|..||......  +             ....++..+.+++
T Consensus       162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  241 (267)
T cd08224         162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLV  241 (267)
T ss_pred             ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHH
Confidence             23345788899999998888999999999999999999999998644311  0             0114567899999


Q ss_pred             HHhcccCccCCCCHHHHhc
Q 024158          237 SRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~  255 (271)
                      .+||.++|++|||+.+|++
T Consensus       242 ~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         242 SRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHcCCCcccCCCHHHHHH
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=304.36  Aligned_cols=240  Identities=27%  Similarity=0.452  Sum_probs=203.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeE-EEe---
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGW-FHD---   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~-~~~---   90 (271)
                      +.-.+++|.+.|.+|||+.||+|++...+..+|+|++...   ++...+.+++|+.++++++ |+|||.+++. ...   
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            3445678999999999999999999998899999998443   4466889999999999996 9999999993 221   


Q ss_pred             C---CeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCEEEeee
Q 024158           91 D---ERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        91 ~---~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      +   -.++|+||||.|+.|.++++.  ...|++.++++|+.|+++|+.+||...  |+|||||.+|||+..+|+.|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence            1   247899999999999999985  345999999999999999999999997  999999999999999999999999


Q ss_pred             cccccccCcc---c---------cccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc--
Q 024158          164 GWSVQSRSKR---H---------TMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--  226 (271)
Q Consensus       164 g~~~~~~~~~---~---------~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~--  226 (271)
                      |.+.......   .         ....|+.|++||.+.   +.+.+.|+|||+|||+||.||....||+......++.  
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~  270 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGN  270 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecc
Confidence            9874332211   1         124689999999764   6778999999999999999999999999875544432  


Q ss_pred             -------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          227 -------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       227 -------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                             +++..+.+||..||++||++||++.|++++-+
T Consensus       271 Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  271 YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                   46788999999999999999999999998744

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=299.75  Aligned_cols=240  Identities=28%  Similarity=0.494  Sum_probs=213.3

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |.-++.||+|+||-||.+++..+++.|+||.+..+.-.....+.++..|++++++++|||.+.+-+++..+...|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            66788999999999999999999999999999777665556678889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccccc
Q 024158          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (271)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~  179 (271)
                      |- ||..+++.-. +++.+..+..++.+.+.||.|||+.+.+|+|||..|||++..|.|||.|||.+.... +.....||
T Consensus       108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-PAnsFvGT  185 (948)
T KOG0577|consen  108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-PANSFVGT  185 (948)
T ss_pred             Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-chhcccCC
Confidence            95 6998988764 579999999999999999999999999999999999999999999999999874443 44567899


Q ss_pred             ccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHHHHHHHhcccC
Q 024158          180 LDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAKHLISRLLVKD  243 (271)
Q Consensus       180 ~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~l~~~  243 (271)
                      |.|+|||++.   .+.|+-+.||||||+++.+|+..++|....+.-..+             ..++..++.|+..||.+-
T Consensus       186 PywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKi  265 (948)
T KOG0577|consen  186 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI  265 (948)
T ss_pred             ccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhC
Confidence            9999999885   467999999999999999999999997654433222             336889999999999999


Q ss_pred             ccCCCCHHHHhcCCccccC
Q 024158          244 SSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~  262 (271)
                      |.+|||.+++|.|+|+.+-
T Consensus       266 pqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  266 PQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             cccCCcHHHHhhcchhccC
Confidence            9999999999999999864

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=275.60  Aligned_cols=240  Identities=26%  Similarity=0.533  Sum_probs=206.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhh--hhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--CeE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--ERI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~   94 (271)
                      .+|++.+.||+|++|.||++++..++..+++|.+....  .........+.+|+.++++++|+|++++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57999999999999999999999999999999875321  12234467888999999999999999999998654  468


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      ++++|++++++|.+++.....++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999999999999998777789999999999999999999999999999999999999999999999998854321   


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch-------------hhcccCHHHHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------------TFRSISAEAKHL  235 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-------------~~~~i~~~l~~l  235 (271)
                         ......++..|+|||.+.+..++.++|+||||++++++++|..||.......             ....+++++.++
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  241 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDF  241 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHH
Confidence               1123457888999999988888999999999999999999999997554222             233467899999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCcc
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +.+|+. +|..||++.++++|||+
T Consensus       242 i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         242 LKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHhc-CcccCccHHHHhcCCCC
Confidence            999998 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-41  Score=281.11  Aligned_cols=238  Identities=24%  Similarity=0.475  Sum_probs=203.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..++|.+.+.||+|++|.||+|....     ++..+++|.+......  .....+.+|+++++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            456789999999999999999998643     3678999998654332  235678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC
Q 024158           91 DERIFLILEYAHRGELYRELRKH--------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~  156 (271)
                      .+..++++|++++++|.+++...              ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            99999999999999999999753              2378889999999999999999999999999999999999999


Q ss_pred             CEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-----
Q 024158          157 RLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-----  225 (271)
Q Consensus       157 ~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-----  225 (271)
                      .++|+|||.+......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..     
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999987543221     122234678999999999999999999999999999998 99998765544322     


Q ss_pred             -------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          226 -------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       226 -------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                             ..++.++.+++.+||..+|++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         240 GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence                   235789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-41  Score=278.86  Aligned_cols=237  Identities=31%  Similarity=0.514  Sum_probs=197.9

Q ss_pred             eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHH---HHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL---RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~---~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      .||+|+||.||++++..+++.+++|.+.+............   ...++.++...|++++.+++.+..++.+++|+||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            47999999999999999999999999865433221111112   223345555689999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-cccccccccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLD  181 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~~~~~~~~~  181 (271)
                      +++|..++.....+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+..... ......++..
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  160 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG  160 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence            999999998777899999999999999999999999999999999999999999999999998754332 2234568899


Q ss_pred             ccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHHHHHHhcccCccC
Q 024158          182 YLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       182 y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~li~~~l~~~p~~  246 (271)
                      |+|||.+.++ .++.++|+||+|+++++|++|..||.......              ....+++++.+++.+||..+|.+
T Consensus       161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~  240 (278)
T cd05606         161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNR  240 (278)
T ss_pred             CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHh
Confidence            9999998754 57889999999999999999999997653211              11235789999999999999999


Q ss_pred             CC-----CHHHHhcCCccccC
Q 024158          247 RL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       247 Rp-----s~~~il~~~~~~~~  262 (271)
                      ||     ++.++++||||...
T Consensus       241 R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         241 RLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             ccCCCCCCHHHHHhCccccCC
Confidence            99     99999999999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.3e-41  Score=275.20  Aligned_cols=239  Identities=33%  Similarity=0.523  Sum_probs=208.6

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +|++.+.||+|++|.+|++++..++..+++|.+....... .....+.+|+.+++.++|+|++++.+++......++++|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            5899999999999999999999999999999987654333 334566788999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-ccc
Q 024158          100 YAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRH  174 (271)
Q Consensus       100 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~~~  174 (271)
                      ++++++|.+++..    ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~  159 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK  159 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCcc
Confidence            9999999999866    35689999999999999999999999999999999999999999999999998744332 223


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|+|||.+.+..++.++|+||||++++++++|..||...+.....            ..++.++.+++.+||..
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  239 (256)
T cd08530         160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQV  239 (256)
T ss_pred             cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCC
Confidence            345788999999998888889999999999999999999999876653322            12578899999999999


Q ss_pred             CccCCCCHHHHhcCCcc
Q 024158          243 DSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~  259 (271)
                      +|++|||+.+++.||++
T Consensus       240 ~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         240 KPKLRPNCDKILASPAV  256 (256)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.8e-41  Score=276.70  Aligned_cols=236  Identities=23%  Similarity=0.424  Sum_probs=201.9

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+..++|+++++||+|++|.||++.. .++..+++|.+.....    ..+.+.+|+.+++.++|+|++++++.+...+..
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI   76 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            56788999999999999999999986 4567799998754332    245778899999999999999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999999999653  45789999999999999999999999999999999999999999999999998544322


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      .    ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..++.++.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1    12234567999999988888999999999999999998 99999765543322            2357899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+..+|++|||++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-41  Score=279.78  Aligned_cols=239  Identities=19%  Similarity=0.361  Sum_probs=201.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEe----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      +.+.+|++.+.||+|+||.||+|...    .++..+++|.+.....  ......+.+|+.+++.++|+|++++++++..+
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            56789999999999999999999853    3567899999864322  23346788899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC
Q 024158           92 ERIFLILEYAHRGELYRELRKH-----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~  154 (271)
                      ...|++|||+++++|.+++...                 ..++...+..++.|++.|+.|||++|++|+||+|+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999998532                 23788889999999999999999999999999999999999


Q ss_pred             CCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh----
Q 024158          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT----  224 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~----  224 (271)
                      ++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++++|++ |..||.+......    
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~  239 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV  239 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999988543221     122334567999999988889999999999999999998 9989876544322    


Q ss_pred             --------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 --------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 --------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                              ...+++.+.+++.+|+.++|.+||++.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                    12358999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.4e-41  Score=283.69  Aligned_cols=242  Identities=26%  Similarity=0.458  Sum_probs=198.3

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC---
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE---   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---   92 (271)
                      -..++|++.+.||+|++|.||++++..++..+++|.+....... .......+|+.++++++|||++++++++...+   
T Consensus         9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (310)
T cd07865           9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPY   87 (310)
T ss_pred             chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence            35678999999999999999999999999999999985443221 12234567899999999999999999886543   


Q ss_pred             -----eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           93 -----RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        93 -----~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                           ..++++|+++ ++|.+++... ..+++..++.++.|+++|+.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        88 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          88 NRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             cCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence                 4599999996 5888887654 36899999999999999999999999999999999999999999999999987


Q ss_pred             ccccCcc-------ccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------
Q 024158          167 VQSRSKR-------HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------  226 (271)
Q Consensus       167 ~~~~~~~-------~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------  226 (271)
                      .......       ....++..|+|||.+.+.. ++.++|+||||+++++|++|..||..........            
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            4432211       1234677899999886653 6789999999999999999999987654321100            


Q ss_pred             -------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          227 -------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       227 -------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                                     ..++.+.++|.+||..||.+|||++++++||||
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                                           014567899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.1e-41  Score=280.49  Aligned_cols=237  Identities=25%  Similarity=0.484  Sum_probs=200.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEE-----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ++-.+|.+.+.||+|+||.||++..     ..++..+++|.+....   ......+.+|+.++++++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            4567899999999999999999985     2345668899885432   2335678889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC
Q 024158           91 DERIFLILEYAHRGELYRELRKHR-------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR  157 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~  157 (271)
                      .+.+++++|++++++|.+++...+             .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            999999999999999999997533             3899999999999999999999999999999999999999999


Q ss_pred             EEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------
Q 024158          158 LKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------  225 (271)
Q Consensus       158 ~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------  225 (271)
                      ++|+|||.+.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+..      
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999885433221     12234678999999988889999999999999999998 89998766543321      


Q ss_pred             ------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          226 ------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       226 ------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                            ..++.++.+++.+||.++|.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                  235789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.1e-41  Score=275.86  Aligned_cols=236  Identities=24%  Similarity=0.429  Sum_probs=200.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++.++|++.+.||+|++|.||+++... +..+++|.+......    ...+.+|+.+++.++||||+++++++...+..+
T Consensus         1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           1 IDPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             CChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            356789999999999999999998643 456999988654322    346788999999999999999999999888899


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc-
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-  173 (271)
                      +++|++.+++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999999999999764 468999999999999999999999999999999999999999999999999875433221 


Q ss_pred             ---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHH
Q 024158          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLIS  237 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~  237 (271)
                         ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+...            ..++.+.+++.
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY  235 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence               12234567999999988889999999999999999998 999997655433211            24788999999


Q ss_pred             HhcccCccCCCCHHHHhcC
Q 024158          238 RLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~  256 (271)
                      +||.++|.+||++.+++++
T Consensus       236 ~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         236 SCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHcCCCcccCCCHHHHHHh
Confidence            9999999999999999865

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-41  Score=287.92  Aligned_cols=242  Identities=25%  Similarity=0.444  Sum_probs=204.0

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC------
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE------   92 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------   92 (271)
                      .+|.+.+.||+|++|.||+|++..+|+.+++|.+....... .....+.+|+.+++.++|+||+++++++....      
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            58999999999999999999999999999999986543222 23455778999999999999999999886542      


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+++++|++. .+|....  ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        94 ~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             eEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            4699999996 4776665  246899999999999999999999999999999999999999999999999998665544


Q ss_pred             cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------------------
Q 024158          173 RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------------------  224 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------------------  224 (271)
                      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+......                           
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (342)
T cd07879         171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY  250 (342)
T ss_pred             CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHH
Confidence            445567888999998876 4578899999999999999999999986542111                           


Q ss_pred             ---------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ---------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ---------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                     ....++++.+++.+||..||.+||++++++.||||+....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         251 IKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                           1124677899999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-41  Score=279.20  Aligned_cols=247  Identities=21%  Similarity=0.367  Sum_probs=204.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      +++...+|++.+.||+|+||.||+|..+.     .+..+++|.+......  .....+.+|+..++.++|+||+++++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVV   78 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            35667899999999999999999987542     3557999987544322  2234567899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCE
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~  158 (271)
                      ..++..+++|||+++++|.+++...          ..++...+..++.|++.|+.+||++|++|+||+|+||+++.++.+
T Consensus        79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            9889999999999999999999652          234677889999999999999999999999999999999999999


Q ss_pred             EEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------
Q 024158          159 KIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------  226 (271)
Q Consensus       159 ~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------  226 (271)
                      +|+|||++.......     ....++..|+|||.+.+..++.++|+||||++++++++ |..||.+....+...      
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG  238 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999875332211     11234567999999988889999999999999999998 788987766444322      


Q ss_pred             ------ccCHHHHHHHHHhcccCccCCCCHHHHhc------CCccccC
Q 024158          227 ------SISAEAKHLISRLLVKDSSKRLSLQKIME------HPWIIKN  262 (271)
Q Consensus       227 ------~i~~~l~~li~~~l~~~p~~Rps~~~il~------~~~~~~~  262 (271)
                            ..++.+.+++.+||..+|++|||+.++++      ||||...
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~  286 (288)
T cd05061         239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV  286 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence                  34789999999999999999999999998      8988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-41  Score=288.15  Aligned_cols=244  Identities=26%  Similarity=0.444  Sum_probs=202.5

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------   91 (271)
                      .++|++.+.||.|++|.||+|.+..++..+++|.+.....   ...+.+.+|+.+++.++|+|++++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            3789999999999999999999999999999999855433   2345677899999999999999999776543      


Q ss_pred             --------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEee
Q 024158           92 --------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGD  162 (271)
Q Consensus        92 --------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~d  162 (271)
                              ...|+++|+++ ++|.+++.. ..+++..++.++.||++|+.+||+.|++|+||+|+||+++. ++.++|+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35799999997 589888865 46899999999999999999999999999999999999975 45789999


Q ss_pred             ecccccccCc------cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------
Q 024158          163 FGWSVQSRSK------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------  224 (271)
Q Consensus       163 fg~~~~~~~~------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------  224 (271)
                      ||.+......      .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||....+.+.           
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9987543221      122346778999998755 4577899999999999999999999975432111           


Q ss_pred             ------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          225 ------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       225 ------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                    ...++.++.+++.+||..||++|||+++++.||||+....|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~  310 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF  310 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence                                          123578899999999999999999999999999999776663

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-41  Score=278.28  Aligned_cols=240  Identities=20%  Similarity=0.357  Sum_probs=200.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      .+..++|++.+.||+|++|.||++.+..     ++..+++|.+......  .....+.+|+.+++.++|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4567789999999999999999988643     3567999988543222  23456788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      .++..++++|++++++|.+++...+          .++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence            9899999999999999999986522          257788999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh--------
Q 024158          160 IGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF--------  225 (271)
Q Consensus       160 L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~--------  225 (271)
                      |+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++|++++ |..||......+..        
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL  239 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence            99999875332211     12234678999999988889999999999999999998 78888766544332        


Q ss_pred             ----cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ----RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                          ...+..+.+++.+||..+|++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                2357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=273.93  Aligned_cols=235  Identities=24%  Similarity=0.454  Sum_probs=204.6

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+..++|++.+.||.|++|.||++..  .|+.+++|.+.....    ..+.+.+|+.+++.++|+|++++++++..+...
T Consensus         2 ~~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           2 AINSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             ccChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            35678999999999999999999986  478899999865433    346788899999999999999999999988899


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++....  .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999999997654  6899999999999999999999999999999999999999999999999988665443


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHHHh
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLISRL  239 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~~~  239 (271)
                      ......+..|.|||.+.+..++.++|+||||++++++++ |..||......+..            ...++++.+++.+|
T Consensus       156 ~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         156 QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence            333344567999999988888899999999999999997 99998766544322            23579999999999


Q ss_pred             cccCccCCCCHHHHhc
Q 024158          240 LVKDSSKRLSLQKIME  255 (271)
Q Consensus       240 l~~~p~~Rps~~~il~  255 (271)
                      |..+|++|||++++++
T Consensus       236 l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         236 WELDPAKRPTFKQLRE  251 (256)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=272.97  Aligned_cols=240  Identities=31%  Similarity=0.607  Sum_probs=203.7

Q ss_pred             ccccceeeee-eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEe---
Q 024158           16 WSLQDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD---   90 (271)
Q Consensus        16 ~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---   90 (271)
                      -..+||++.. .||-|-.|.|-.|.++.+|+.+|+|++.    +    ..+.++|.++--.. .|+||++++++++.   
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~----D----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~  129 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL----D----SPKARREVELHWMASGHPHIVSIIDVYENSYQ  129 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh----c----CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence            3556777654 5899999999999999999999999972    2    23455666554333 69999999999753   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeeec
Q 024158           91 -DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFG  164 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~dfg  164 (271)
                       ...+.+|||.++||.|.+.++..+  .+++.++..++.||..|+.|||+.+|+|||+||+|+|.+.   +..+||+|||
T Consensus       130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence             346889999999999999998865  4999999999999999999999999999999999999965   4579999999


Q ss_pred             ccccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc-------------------ch
Q 024158          165 WSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-------------------KD  223 (271)
Q Consensus       165 ~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-------------------~~  223 (271)
                      +++....  .....+-||.|.|||.+....|+...|+||+|+++|-|++|.+||-....                   ..
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            9977663  33455779999999999999999999999999999999999999965443                   23


Q ss_pred             hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          224 TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       224 ~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .|..++++..++|+.+|..+|.+|.|++++++|||+.+..
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            3455789999999999999999999999999999998874

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-41  Score=300.83  Aligned_cols=246  Identities=22%  Similarity=0.350  Sum_probs=192.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCC-ceEEEE--------------EechhhhhHHHHHHHHHHHHHHHhhCCCCce
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESK-HPVALK--------------IIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~vK--------------~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i   81 (271)
                      -.++|++++.||+|+||+||+|..+... ...+.|              .+.+...........+.+|+.+++.++|+||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998754432 222222              1111111222345567899999999999999


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~  156 (271)
                      +++++++...+..|++++++. ++|.+++...     .......++.++.||+.||.|||++||+|+||||+||+++.++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence            999999999999999999996 5777776542     1234677888999999999999999999999999999999999


Q ss_pred             CEEEeeecccccccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCCcc--hh-----
Q 024158          157 RLKIGDFGWSVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQK--DT-----  224 (271)
Q Consensus       157 ~~~L~dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p-~~~~~~~--~~-----  224 (271)
                      .++|+|||++......    .....|+..|+|||.+.+..++.++|||||||++|+|++|..+ +......  ..     
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            9999999998654332    2235689999999999999999999999999999999988754 3322100  00     


Q ss_pred             ------------------------------------h--cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 ------------------------------------F--RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 ------------------------------------~--~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                                          +  ..++.++.+++.+||..||.+|||+.|+|.||||....
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence                                                0  01356777889999999999999999999999998754

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-41  Score=274.07  Aligned_cols=236  Identities=23%  Similarity=0.383  Sum_probs=201.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++...+|++.+.||+|++|.||++.+. ++..+++|.+......    ...+.+|+.++++++|+|++++++++...+..
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            456678999999999999999999864 4577999998654322    34577899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++....  .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999998899999997643  6899999999999999999999999999999999999999999999999987544322


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      .    .....+..|+|||.+.+..++.++|+||||++++++++ |..||.+.......            ...++.+.++
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1    11122457999999988889999999999999999998 99999876654322            1247999999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+..+|++||++.++++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5e-41  Score=277.72  Aligned_cols=239  Identities=25%  Similarity=0.387  Sum_probs=201.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..++|++.+.||+|++|.||+|.+..     ++..+++|.+......  .....+..|+.+++.++|+||+++++++.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   80 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFE   80 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence            455789999999999999999999877     6788999987543322  224567789999999999999999999988


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEE
Q 024158           91 DERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKI  160 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L  160 (271)
                      .+..++++|++++++|.+++...+       .+++..++.++.||+.++.+||+++++|+||+|+||+++.++   .++|
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence            889999999999999999997643       478999999999999999999999999999999999998754   5999


Q ss_pred             eeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh---------
Q 024158          161 GDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF---------  225 (271)
Q Consensus       161 ~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~---------  225 (271)
                      +|||.+.......     .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..         
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999885442211     12223467999999988889999999999999999996 99999876544332         


Q ss_pred             ---cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ---RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ---~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                         ..++.++.+++.+|+..+|++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence               2357899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.5e-41  Score=279.43  Aligned_cols=238  Identities=25%  Similarity=0.483  Sum_probs=201.7

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ++.++|.+.+.||+|++|.||+++...     ++..+++|.+.....   .....+.+|+..+++++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            567899999999999999999998543     455688888754332   223567889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC
Q 024158           91 DERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~  154 (271)
                      ++..+++|||+++++|.+++....                .+++..++.++.||+.++.+||++|++|+||+|+||+++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997532                3789999999999999999999999999999999999999


Q ss_pred             CCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh---
Q 024158          155 EGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF---  225 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~---  225 (271)
                      ++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..   
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999885433221     22345678999999998889999999999999999998 99998765543322   


Q ss_pred             ---------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ---------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ---------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                               ...|..+.+++.+||.++|++|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                     2357899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.2e-41  Score=280.38  Aligned_cols=236  Identities=24%  Similarity=0.409  Sum_probs=197.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCc--eEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++|++.+.||.|+||.||+|....++.  .+++|.+....  .......+.+|+.++.++ +|||++++++++...+.++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            689999999999999999999877765  36777765321  223345678899999999 7999999999999988999


Q ss_pred             EEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           96 LILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      +++|++++++|.+++...+                .++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999996532                478899999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-----------
Q 024158          160 IGDFGWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-----------  225 (271)
Q Consensus       160 L~dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-----------  225 (271)
                      |+|||++......  ......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..           
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEK  239 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            9999987533221  111223457999999988889999999999999999997 99999776544322           


Q ss_pred             -cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 -RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 -~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                       ..++..+.+++.+||..+|.+|||++++++.
T Consensus       240 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         240 PRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             2357899999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-40  Score=281.13  Aligned_cols=244  Identities=26%  Similarity=0.481  Sum_probs=208.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|...+.||+|+||.||++++..++..+++|.+.............+.+|+++++.++|+|++++++++..+...++++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            34889999999999999999999999999999986554444445567888999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccc
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~  177 (271)
                      ||+. +++.+.+.. ...+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus       105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-~~~~~  182 (317)
T cd06635         105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-ANSFV  182 (317)
T ss_pred             eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-ccccc
Confidence            9997 477777754 45689999999999999999999999999999999999999999999999998754332 23446


Q ss_pred             ccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHHHHHHHhcc
Q 024158          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       178 ~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~l~  241 (271)
                      +++.|+|||.+.   .+.++.++|+||+|+++++|++|..||.........             ..+++.+.+++.+||.
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  262 (317)
T cd06635         183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ  262 (317)
T ss_pred             CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence            788899999874   456788999999999999999999998765432221             2357889999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      .+|.+||++.++++|+|+.....
T Consensus       263 ~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         263 KIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             CCcccCcCHHHHHhChhhhccCc
Confidence            99999999999999999976544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=274.37  Aligned_cols=230  Identities=25%  Similarity=0.477  Sum_probs=201.7

Q ss_pred             eeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEecc
Q 024158           25 RPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      +.||+|+||.||++.+...   +..+++|.+.......  ....+.+|+..++.++|+|++++++++.....+++++|++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4689999999999998866   8999999986654433  4577889999999999999999999999989999999999


Q ss_pred             CCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158          102 HRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus       102 ~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|.+++...         ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         67899999999999999999999999999999999999999999999999988554432


Q ss_pred             -----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHH
Q 024158          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                           .....+++.|+|||.+.+..++.++|+||+|++++++++ |..||......+..            ..+++++.+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYE  238 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHH
Confidence                 233456788999999988888999999999999999998 69999876544332            235799999


Q ss_pred             HHHHhcccCccCCCCHHHHhcC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+||..+|++|||+.+++++
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-42  Score=289.09  Aligned_cols=251  Identities=25%  Similarity=0.473  Sum_probs=204.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEe
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD   90 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~   90 (271)
                      .-..++...|++++.||+||.+.||+++.-.. ..+++|.+..... +......+.+|+..|.+++ |.+|++++++-..
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~  431 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT  431 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence            44567778899999999999999999996444 4455555533332 3366888999999999995 8999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++.+|+|||+-+ .+|..+|+.... ++...++.++.|++.++.++|..||+|.||||.|+++ ..|.+||+|||.+...
T Consensus       432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI  509 (677)
T KOG0596|consen  432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAI  509 (677)
T ss_pred             CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhccc
Confidence            999999999975 799999987543 4445888999999999999999999999999999999 6789999999998655


Q ss_pred             cCcc-----ccccccccccCCccccCCC-----------CCccchhhhHHHHHHHHHhCCCCCCCCC-cchh--------
Q 024158          170 RSKR-----HTMCGTLDYLAPEMVENKE-----------HDYAVDNWTLGILCYEFLYGAPPFEAES-QKDT--------  224 (271)
Q Consensus       170 ~~~~-----~~~~~~~~y~~pe~~~~~~-----------~~~~~Di~slg~il~~l~~g~~p~~~~~-~~~~--------  224 (271)
                      ...+     ...+||+-|++||.+....           .+.++|||||||+||+|+.|+.||.... ....        
T Consensus       510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~  589 (677)
T KOG0596|consen  510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN  589 (677)
T ss_pred             CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence            4432     4568999999999885322           4578999999999999999999996433 1111        


Q ss_pred             ----hccc--CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          225 ----FRSI--SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       225 ----~~~i--~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                          +..+  ..++.++++.||..||++|||+.++|.|||.+-...+.
T Consensus       590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~  637 (677)
T KOG0596|consen  590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV  637 (677)
T ss_pred             ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence                1112  24499999999999999999999999999999866553

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.5e-41  Score=281.89  Aligned_cols=243  Identities=29%  Similarity=0.537  Sum_probs=202.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC--
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--   92 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   92 (271)
                      ++..++|++.+.||+|++|.||++.+..+++.+++|.+....... .....+.+|+++++.++|||++++++++.+..  
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            456789999999999999999999999999999999986543221 22345678999999999999999999887654  


Q ss_pred             --------eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           93 --------RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        93 --------~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                              .+++++|++++ ++...+... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df  160 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF  160 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence                    79999999975 777777653 46899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCcc----ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------
Q 024158          164 GWSVQSRSKR----HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------  223 (271)
Q Consensus       164 g~~~~~~~~~----~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------  223 (271)
                      |.+.......    ....++..|+|||.+.+. .++.++|+||||+++++|++|.+||......+               
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9875433222    223457789999988654 46789999999999999999999986433211               


Q ss_pred             --------------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          224 --------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       224 --------------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                                ....+|+.+.+++.+||..+|.+|||++++++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                      122468999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=279.08  Aligned_cols=237  Identities=32%  Similarity=0.569  Sum_probs=203.5

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |++++.||+|++|.||++++..+++.+++|.+....... .....+.+|+.+++.++|++++++++++..++..++++|+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            678899999999999999998899999999986554332 3346777899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---ccc
Q 024158          101 AHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (271)
Q Consensus       101 ~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~~  176 (271)
                      +++ ++.+.+.. ...+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            974 88888766 3578999999999999999999999999999999999999999999999999875443322   223


Q ss_pred             cccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------------
Q 024158          177 CGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------------  224 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------------  224 (271)
                      .++..|.|||.+.+. .++.++|+||||++++++++|..||......+.                               
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            467789999998776 688899999999999999999999865443211                               


Q ss_pred             ----------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ----------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                ...++.++.+++.+||.++|.+||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                      12357889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-41  Score=278.18  Aligned_cols=232  Identities=33%  Similarity=0.595  Sum_probs=192.5

Q ss_pred             eeeeeecccCCceEEEEEEe----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           22 EIGRPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .+.+.||+|+||.||+|...    ..+..|+||.+....  .....+.+.++++.+++++||||+++++++...+..++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence            46789999999999999987    346779999995432  223367888999999999999999999999988889999


Q ss_pred             EeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           98 LEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      +|++++++|.+++...  ..+++..+..++.|++.||.|||+++++|++|++.||+++.++.+||+|||++......   
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999886  57899999999999999999999999999999999999999999999999988655221   


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLIS  237 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~  237 (271)
                        .........|+|||.+.+..++.++||||||+++|++++ |..||......+...            ..+..+.+++.
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence              122345678999999988889999999999999999999 789988766544322            25889999999


Q ss_pred             HhcccCccCCCCHHHHhc
Q 024158          238 RLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~  255 (271)
                      +||..+|++|||+.++++
T Consensus       240 ~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHT-SSGGGS--HHHHHH
T ss_pred             HHcCCChhhCcCHHHHHh
Confidence            999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=279.48  Aligned_cols=237  Identities=32%  Similarity=0.580  Sum_probs=204.0

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |++.+.||+|++|.||+++...+++.+++|.+.... ........+..|+.+++.++|++++++++++...+..++++|+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999997654 2223345677899999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---ccc
Q 024158          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTM  176 (271)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~~  176 (271)
                      ++ ++|.+++... ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......   ...
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            97 5999999876 578999999999999999999999999999999999999999999999999875443322   223


Q ss_pred             cccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------------------
Q 024158          177 CGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------------------  224 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------------------  224 (271)
                      ..+..|+|||.+.+. .++.++|+||||++++++++|..||......+.                               
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            456779999998766 788899999999999999999999876542211                               


Q ss_pred             ---------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ---------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ---------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                               ...++.++.+++.+||..+|++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                     11246789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.4e-41  Score=273.21  Aligned_cols=229  Identities=26%  Similarity=0.432  Sum_probs=194.5

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|+||.||++++..+++.+++|.+.....  ......+.+|+++++.++|+||+++++++...+..++++||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            468999999999999999999999998754322  233467888999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc-----cccc
Q 024158          105 ELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH-----TMCG  178 (271)
Q Consensus       105 ~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~-----~~~~  178 (271)
                      +|.+++... ..+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........     ....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            999999764 4589999999999999999999999999999999999999999999999998754332111     1122


Q ss_pred             cccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHHHhcccCcc
Q 024158          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       179 ~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~~p~  245 (271)
                      +..|+|||.+.++.++.++|+||||+++|++++ |..||.........            ...+.++.+++.+||..+|+
T Consensus       159 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  238 (252)
T cd05084         159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPG  238 (252)
T ss_pred             ceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChh
Confidence            456999999988889999999999999999997 88888755533221            23478999999999999999


Q ss_pred             CCCCHHHHhc
Q 024158          246 KRLSLQKIME  255 (271)
Q Consensus       246 ~Rps~~~il~  255 (271)
                      +|||+.++++
T Consensus       239 ~Rps~~~~~~  248 (252)
T cd05084         239 QRPSFSTVHQ  248 (252)
T ss_pred             hCcCHHHHHH
Confidence            9999999975

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8.9e-41  Score=273.05  Aligned_cols=234  Identities=24%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE-eCCe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDER   93 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~   93 (271)
                      -+++.+|++.+.||+|++|.||++..  .|..+++|.+....     ..+.+.+|+.+++.++|++++++++++. .++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            35678999999999999999999875  47889999985432     2346788999999999999999999754 4567


Q ss_pred             EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           94 IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      .++++|++++++|.+++....  .+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            899999999999999997643  478899999999999999999999999999999999999999999999998865544


Q ss_pred             ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHHH
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLISR  238 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~~  238 (271)
                      .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..+++.+.+++.+
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (256)
T cd05082         155 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ  234 (256)
T ss_pred             cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence            4444455678999999988889999999999999999997 99998765543332            2358899999999


Q ss_pred             hcccCccCCCCHHHHhc
Q 024158          239 LLVKDSSKRLSLQKIME  255 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~  255 (271)
                      |+..+|++|||+.++++
T Consensus       235 ~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         235 CWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HhcCChhhCcCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=276.75  Aligned_cols=237  Identities=28%  Similarity=0.488  Sum_probs=197.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC---CCCceeceeeEEEeCCe----
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDER----   93 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~i~~~~~~~~~~~~----   93 (271)
                      |++.+.||+|++|.||++++..++..+++|.+....... .....+.+|+.+++.+   .|+|++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            789999999999999999998889999999986543322 2223444566555544   69999999999987776    


Q ss_pred             -EEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           94 -IFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        94 -~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       .++++|+++ ++|.+++....  .+++..++.++.|++.||.+||+.|++|+|++|+||+++.++.++|+|||.+....
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             999999997 58988887643  48999999999999999999999999999999999999999999999999875433


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------  225 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------  225 (271)
                      ..  .....++..|+|||.+.+..++.++|+||+|+++++|++|.+||......+..                       
T Consensus       159 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07838         159 FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR  238 (287)
T ss_pred             CCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch
Confidence            22  22334678899999999888999999999999999999999998765432211                       


Q ss_pred             ---------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 ---------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 ---------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                     ..+++.+.+++.+||..||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         239 SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                           1245778899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=274.15  Aligned_cols=238  Identities=25%  Similarity=0.411  Sum_probs=201.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      +.++|++.+.||+|+||.||+|....+   ...+++|.+......  .....+..|+..++.++|+|++++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            457899999999999999999987654   457999988654322  234567789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .++++|++++++|.+++... ..++...++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999999764 46899999999999999999999999999999999999999999999999988654311


Q ss_pred             c-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHH
Q 024158          173 R-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       173 ~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                      .     ....+++.|+|||.+.+..++.++|+||||++++++++ |..||......+..            ...++.+.+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1     12234568999999998889999999999999999987 99998655533322            224789999


Q ss_pred             HHHHhcccCccCCCCHHHHhcC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+|+..+|++||++.+++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=312.97  Aligned_cols=249  Identities=35%  Similarity=0.576  Sum_probs=217.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ....+..||.+++.||+|+||.|.+++.+.+++.||+|++.+-..-.......|+.|-.++---+.+=|+.++-.|.+++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            34567889999999999999999999999999999999997765554455567777878887778888999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++|+||||++||+|..++.....++++-++.++..|+-||..||+.|++||||||+|||+|..|+++|.|||.+......
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999998555432


Q ss_pred             ----cccccccccccCCcccc----C-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------ccc
Q 024158          173 ----RHTMCGTLDYLAPEMVE----N-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSI  228 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~----~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i  228 (271)
                          .....|||.|++||++.    + +.|+..+|=||+|+++|+|+.|..||-....-+..               ..+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~V  308 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDV  308 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccccc
Confidence                34567999999999884    3 56889999999999999999999999644322221               227


Q ss_pred             CHHHHHHHHHhcccCccCCCC---HHHHhcCCccccC
Q 024158          229 SAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKN  262 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~~~  262 (271)
                      |+++.+||++.++ +|+.|..   ++++..||||.+.
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            8999999999997 6899998   9999999999876

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8e-41  Score=280.50  Aligned_cols=244  Identities=25%  Similarity=0.461  Sum_probs=203.2

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecC-------CceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      ....++...+|.+.+.||+|+||.||++++...       ...+++|.+......  .....+..|+.+++.+ +|+||+
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCCh--HHHHHHHHHHHHHHHhcCCCCEe
Confidence            345566668999999999999999999986432       346999998654322  2345677899999999 799999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      ++++++..++..|+++|++++++|.+++...+                .+++..++.++.|++.||.+||+.|++|+||+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  167 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA  167 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence            99999999999999999999999999997532                37889999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  220 (271)
                      |+||+++.++.++|+|||.+......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus       168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~  247 (307)
T cd05098         168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  247 (307)
T ss_pred             HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence            99999999999999999987543321     112234568999999988889999999999999999998 888887655


Q ss_pred             cchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          221 QKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       221 ~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..+..            ...+.++.+++.+||..+|++|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            43322            2357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=291.79  Aligned_cols=238  Identities=26%  Similarity=0.471  Sum_probs=213.6

Q ss_pred             hhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ++..++.+++-+.....+.-||+|++|-||+++.  .++.||||.+.          +.-..+|+.|++++|+||+.+.+
T Consensus       112 k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----------elkETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  112 KQQQEELWEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----------ELKETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hhhhhhhccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh----------hhhhhhHHHHHhccCcceeeEee
Confidence            3455677888888889999999999999999995  56889999861          12235789999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      +|...-.+|||||||..|-|.+.|+.++.+....+..+..+|+.++.|||.+.|+|+|||.-||||+.+..+||+|||.+
T Consensus       180 VCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS  259 (904)
T KOG4721|consen  180 VCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTS  259 (904)
T ss_pred             eecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             cccc--CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc-------------CHH
Q 024158          167 VQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAE  231 (271)
Q Consensus       167 ~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i-------------~~~  231 (271)
                      ....  +.....+||..|+|||.+.+.+.+.+.|||||||+||+|+||..||...+....+..+             |+.
T Consensus       260 ~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~G  339 (904)
T KOG4721|consen  260 KELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDG  339 (904)
T ss_pred             HhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchH
Confidence            5544  3445568999999999999999999999999999999999999999877766555432             788


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.-|++.||...|..|||+.+||.|
T Consensus       340 fklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  340 FKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             HHHHHHHHHhcCCCCCccHHHHHHH
Confidence            9999999999999999999999998

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-41  Score=285.75  Aligned_cols=245  Identities=32%  Similarity=0.523  Sum_probs=204.5

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC--Ce
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD--ER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~   93 (271)
                      ..++|++.+.||+|++|.||++.+..++..+++|.+....... .....+..|+.+++++ +|+||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4578999999999999999999998899999999885432222 2234566799999999 999999999988653  36


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      .++++|+++ ++|.+++... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... 
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            899999997 5999988765 7889999999999999999999999999999999999999999999999987543221 


Q ss_pred             -------cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------------
Q 024158          173 -------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------  224 (271)
Q Consensus       173 -------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------------  224 (271)
                             .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+.                    
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                   122356888999998765 4577899999999999999999999975432211                    


Q ss_pred             ----------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ----------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ----------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                            ...++.++.+++.+||..+|++|||+.++++||||++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                                  1225788999999999999999999999999999988743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=275.40  Aligned_cols=240  Identities=20%  Similarity=0.353  Sum_probs=202.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ++..++|++.+.||+|+||.||++.....+     ..+++|.+......  .....+.+++.+++.++|+|++++++++.
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            567789999999999999999999876544     78999998544322  23456778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      .+...++++|++++++|.+++....          .+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence            9999999999999999999986422          367889999999999999999999999999999999999999999


Q ss_pred             EeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh--------
Q 024158          160 IGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF--------  225 (271)
Q Consensus       160 L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~--------  225 (271)
                      |+|||++......     .....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+..        
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            9999987543221     122345678999999988889999999999999999998 99999766543322        


Q ss_pred             ----cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ----RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                          ...+.++.+++.+||..+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence                2357999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.3e-40  Score=273.18  Aligned_cols=236  Identities=21%  Similarity=0.394  Sum_probs=198.6

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+..++|++.++||+|++|.||++++..+ ..+++|.+......    ...+.+|+++++.++|+|++++++.+.+ ...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~   75 (262)
T cd05071           2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI   75 (262)
T ss_pred             CCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCc
Confidence            45668899999999999999999987655 45999998653332    2457889999999999999999998744 568


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999999999763  35789999999999999999999999999999999999999999999999988543322


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      .    ....++..|+|||...+..++.++|+||||+++|++++ |..||......+..            ..+++.+.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            2    12335667999999988889999999999999999998 88888766544332            2358999999


Q ss_pred             HHHhcccCccCCCCHHHHhcC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+|+.++|++|||+.++++.
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~  256 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAF  256 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHH
Confidence            999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5e-41  Score=275.17  Aligned_cols=236  Identities=23%  Similarity=0.416  Sum_probs=203.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ....+|++.+.||.|++|.||+|++.. +..+++|.+.....   .....+..|+.+++.++|+|++++++++...+..+
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   78 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY   78 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeE
Confidence            345689999999999999999999877 88999999865432   22456788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc
Q 024158           96 LILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~  173 (271)
                      +++|++++++|.+++...  ..++...+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999999999753  468999999999999999999999999999999999999999999999999885443221


Q ss_pred             ---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHH
Q 024158          174 ---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLIS  237 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~  237 (271)
                         ....++..|++||.+.+..++.++|+||||++++++++ |..||......+..            ...++.+.+++.
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence               12234567999999988889999999999999999998 89999876644332            235789999999


Q ss_pred             HhcccCccCCCCHHHHhc
Q 024158          238 RLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~  255 (271)
                      +|+..+|++|||+.++++
T Consensus       239 ~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         239 ECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHcCCCchhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-41  Score=273.63  Aligned_cols=235  Identities=23%  Similarity=0.426  Sum_probs=199.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +..+|++.+.||+|++|.||++++. ++..+++|.+......    ...+.+|+.+++.++|+|++++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            4567999999999999999999875 5678999998654332    2356779999999999999999999999899999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc-
Q 024158           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH-  174 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~-  174 (271)
                      ++|++++++|.+++... ..+++..++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999999999763 4689999999999999999999999999999999999999999999999998754332211 


Q ss_pred             ---cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHHH
Q 024158          175 ---TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLISR  238 (271)
Q Consensus       175 ---~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~~  238 (271)
                         ...++..|+|||.+.+..++.++|+||||+++|++++ |..||......+...            ..+.++.+++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS  236 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence               1122357999999998889999999999999999998 899997665443322            247899999999


Q ss_pred             hcccCccCCCCHHHHhcC
Q 024158          239 LLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~  256 (271)
                      ||..+|++|||+.++++.
T Consensus       237 cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         237 CWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HhcCChhhCcCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6e-41  Score=284.56  Aligned_cols=241  Identities=24%  Similarity=0.440  Sum_probs=198.3

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   87 (271)
                      +.+...+|++.+.||+|+||.||+|.+..     +++.+++|.+......  ...+.+..|+.++.++ +|+||++++++
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeee
Confidence            34555699999999999999999997543     3578999998643222  2345677899999999 79999999998


Q ss_pred             EEe-CCeEEEEEeccCCCchHHHHHhC-----------------------------------------------------
Q 024158           88 FHD-DERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (271)
Q Consensus        88 ~~~-~~~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (271)
                      +.. +..+++++||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            764 45688999999999999988542                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----cccccccc
Q 024158          114 --------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTL  180 (271)
Q Consensus       114 --------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~  180 (271)
                              ..+++..+..++.|++.|+.|||++||+|+||+|+||+++.++.++|+|||++......     .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    25788999999999999999999999999999999999999999999999988543221     12233466


Q ss_pred             cccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHHHHHHHHHhcccCccC
Q 024158          181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       181 ~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~l~~~p~~  246 (271)
                      .|+|||.+.+..++.++|+|||||+++++++ |..||.+....+..             ...++++.+++.+||..+|++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhh
Confidence            7999999999999999999999999999997 99999765432221             124788999999999999999


Q ss_pred             CCCHHHHhcC
Q 024158          247 RLSLQKIMEH  256 (271)
Q Consensus       247 Rps~~~il~~  256 (271)
                      ||++++++++
T Consensus       320 RPs~~ell~~  329 (337)
T cd05054         320 RPTFSELVEI  329 (337)
T ss_pred             CcCHHHHHHH
Confidence            9999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-40  Score=278.02  Aligned_cols=238  Identities=24%  Similarity=0.382  Sum_probs=201.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCC----------------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK----------------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP   79 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~   79 (271)
                      +..++|++++.||+|+||.||++.+...+                ..+++|.+......  .....+.+|+++++.++|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCC
Confidence            45689999999999999999999876644                45789998654332  3356788999999999999


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                      |++++++++..++..++++|++.+++|.+++....           .+++..++.++.|++.||.+||++|++|+||+|+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999899999999999999999997755           6899999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCCc
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQ  221 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~~~~  221 (271)
                      ||+++.++.++|+|||.+......     .....+++.|+|||.+.+..++.++|+||||+++|++++  +..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            999999999999999987543222     122345678999999988889999999999999999987  6778766544


Q ss_pred             chhhc-------------------ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          222 KDTFR-------------------SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       222 ~~~~~-------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .+.+.                   ..+.++.+++.+||..+|.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            33221                   23689999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.4e-41  Score=281.25  Aligned_cols=242  Identities=33%  Similarity=0.552  Sum_probs=198.3

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   91 (271)
                      -..++|++.+.||+|++|.||++++..++..+++|.+....... .......+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            34789999999999999999999999999999999985543222 1123456789999999999999999887443    


Q ss_pred             ----CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           92 ----ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        92 ----~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                          ..++++++|+. +++...+.. ...+++..+..++.|++++|.+||++|++|+||+|+||+++.++.++|+|||++
T Consensus        84 ~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          84 KRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             cccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence                34799999996 577777764 357999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCcc--------------ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------
Q 024158          167 VQSRSKR--------------HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------  224 (271)
Q Consensus       167 ~~~~~~~--------------~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------  224 (271)
                      .......              ....+++.|+|||.+.+. .++.++|+||||+++++|++|.+||.+......       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            4332211              112346779999987654 478899999999999999999999875443211       


Q ss_pred             ----------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          225 ----------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       225 ----------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                                        ...+++.+.+++.+||..+|.+|||+.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                              12245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.1e-40  Score=279.90  Aligned_cols=242  Identities=27%  Similarity=0.471  Sum_probs=205.7

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|+..+.||+|++|.||++++..++..+++|.+.............+.+|+.+++.++|+|++++++++..+...++++|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            48889999999999999999999999999999865433333445667789999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccc
Q 024158          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG  178 (271)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~  178 (271)
                      |+. +++.+.+.. ...++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++..... .....+
T Consensus        96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~~~~~~  173 (308)
T cd06634          96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANXFVG  173 (308)
T ss_pred             ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-cccccC
Confidence            997 588777754 45689999999999999999999999999999999999999999999999998754433 234467


Q ss_pred             cccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCHHHHHHHHHhccc
Q 024158          179 TLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       179 ~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~~l~~li~~~l~~  242 (271)
                      ++.|+|||.+.   ...++.++|+||||+++|++++|..||......+.             ...++..+.++|.+||.+
T Consensus       174 ~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  253 (308)
T cd06634         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK  253 (308)
T ss_pred             CccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhC
Confidence            88999999874   34577899999999999999999999865443221             123578899999999999


Q ss_pred             CccCCCCHHHHhcCCccccCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +|++||+++++++|||+.+..
T Consensus       254 ~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         254 IPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             CcccCCCHHHHhhCccccccC
Confidence            999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-40  Score=275.31  Aligned_cols=244  Identities=39%  Similarity=0.678  Sum_probs=205.7

Q ss_pred             ceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~   94 (271)
                      +|++.+.||.|++|.||++++.   .+|..+++|++...... .....+.+.+|+++++.+ +|++|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            5899999999999999999875   47899999998654332 223345677899999999 589999999999998999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      |+++|++++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            999999999999999988778899999999999999999999999999999999999999999999999987543321  


Q ss_pred             --cccccccccccCCccccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCcc----hh-----------hcccCHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQK----DT-----------FRSISAEAK  233 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----~~-----------~~~i~~~l~  233 (271)
                        .....++..|++||.+.+.  .++.++|+||+|+++|++++|..||......    ..           ...+++.+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK  240 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHH
Confidence              1234578889999998753  3667899999999999999999998643221    11           123578899


Q ss_pred             HHHHHhcccCccCCC-----CHHHHhcCCccccCC
Q 024158          234 HLISRLLVKDSSKRL-----SLQKIMEHPWIIKNA  263 (271)
Q Consensus       234 ~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~  263 (271)
                      +++.+||..+|++||     ++++++.||||++..
T Consensus       241 ~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            999999999999997     899999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-40  Score=277.97  Aligned_cols=243  Identities=25%  Similarity=0.476  Sum_probs=204.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ....+..++|++.+.||+|++|.||++.....+     ..+++|.+......  .....+.+|+.+++++ +|+|+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~   82 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLL   82 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            345677789999999999999999999876543     67999998654322  2345678899999999 799999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRK----------------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~----------------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      +++..++.+++++||+++++|..++..                ...+++..++.++.|++.|+.|||+.|++|+||+|+|
T Consensus        83 ~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            999999999999999999999999964                2357899999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcch
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  223 (271)
                      |+++.++.++|+|||.+.......     ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999885433221     11234567999999988889999999999999999997 999987665433


Q ss_pred             hhc------------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 TFR------------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 ~~~------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ...            ..+.++.+++.+|+..+|++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            322            246899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-40  Score=278.68  Aligned_cols=244  Identities=25%  Similarity=0.470  Sum_probs=204.5

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEe-------cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-------ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      .....+...+|.+.+.||+|+||.||+++..       .++..+++|.+.....  ......+.+|+.+++.+ +|+||+
T Consensus         7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~   84 (304)
T cd05101           7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNII   84 (304)
T ss_pred             CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCch
Confidence            3457788999999999999999999999753       2345799998864322  23356788899999999 899999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      ++++++......|+++||+++++|.+++...                ..++...+..++.|++.|+.|||++|++|+||+
T Consensus        85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk  164 (304)
T cd05101          85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA  164 (304)
T ss_pred             heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999999999999999999999999753                236788899999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  220 (271)
                      |+||+++.++.++|+|||.+......     .....+++.|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus       165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999988544321     122334567999999988889999999999999999997 788887665


Q ss_pred             cchhhc------------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          221 QKDTFR------------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       221 ~~~~~~------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..+...            ..+.++.+++.+||.++|++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            544332            247899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-40  Score=277.73  Aligned_cols=244  Identities=27%  Similarity=0.438  Sum_probs=205.1

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceec
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILR   83 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~   83 (271)
                      ....+.+..++|.+.+.||+|+||.||++...     .++..+++|.+......  .....+.+|+.+++++ +|+||++
T Consensus        26 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~  103 (302)
T cd05055          26 YDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVN  103 (302)
T ss_pred             ccccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcce
Confidence            33456788889999999999999999999752     34567999988654322  3346788999999999 7999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      +++++...+..++++||+.+++|.+++....  .+++.++..++.|++.++.|||++|++|+||+|+||+++.++.++|+
T Consensus       104 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         104 LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             EEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEEC
Confidence            9999999999999999999999999997643  38999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh----------
Q 024158          162 DFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF----------  225 (271)
Q Consensus       162 dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~----------  225 (271)
                      |||.+.......     ....++..|+|||.+.+..++.++|+||+|+++|++++ |..||.........          
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  263 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM  263 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence            999885433221     12234678999999998889999999999999999997 99998765533221          


Q ss_pred             ---cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          226 ---RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       226 ---~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                         ...++++.+++.+||.++|++|||+.+++.
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence               235789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2e-40  Score=276.73  Aligned_cols=250  Identities=27%  Similarity=0.477  Sum_probs=204.6

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEE
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH   89 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~   89 (271)
                      .....++.++|++.+.||+|++|.||++.+..++..+++|.+.......  ....+..++..+.+. +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~   84 (296)
T cd06618           7 GQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFI   84 (296)
T ss_pred             ceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeee
Confidence            3455778999999999999999999999998889999999986543222  123444555555555 5999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           90 DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .....|+++|+++ +++.+++.. ...+++..+..++.|++.++.|||+ .|++|+||+|+||+++.++.++|+|||.+.
T Consensus        85 ~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~  163 (296)
T cd06618          85 TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG  163 (296)
T ss_pred             cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence            9999999999986 577777765 3568999999999999999999997 599999999999999999999999999875


Q ss_pred             cccCc--cccccccccccCCccccCCC----CCccchhhhHHHHHHHHHhCCCCCCCCCcc-hh--------------hc
Q 024158          168 QSRSK--RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT--------------FR  226 (271)
Q Consensus       168 ~~~~~--~~~~~~~~~y~~pe~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~--------------~~  226 (271)
                      .....  .....+++.|+|||.+.+..    ++.++|+||||+++|+|++|..||...... +.              ..
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE  243 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCC
Confidence            43321  12234677899999987553    778999999999999999999999753221 11              11


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .++.++.+++.+||..+|++||++++++.||||+...
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence            2578899999999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-40  Score=275.17  Aligned_cols=252  Identities=19%  Similarity=0.334  Sum_probs=205.6

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCce----EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .++..+|++++.||+|+||.||+|++..++..    |++|.+......  .....+.+|+.+++.+.|+|++++++++..
T Consensus         3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45678999999999999999999998777763    789988544322  334677889999999999999999999865


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                       ...+++++++++++|.+++... ..+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence             4578899999999999999764 46899999999999999999999999999999999999999999999999987543


Q ss_pred             cCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hcccCHH
Q 024158          170 RSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSISAE  231 (271)
Q Consensus       170 ~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i~~~  231 (271)
                      ....     ....+++.|+|||...+..++.++|+||||+++|++++ |..||........            ....+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            3211     12234567999999988889999999999999999987 8999876543221            1224788


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCCcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD  270 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~  270 (271)
                      +.+++.+||..||++||++.++++ .+-.-...|...++
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~-~l~~~~~~~~~~~~  277 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD-EFSRMARDPSRFVV  277 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH-HHHHhhcCCcCeEe
Confidence            999999999999999999999994 44444444444443

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=290.48  Aligned_cols=242  Identities=24%  Similarity=0.449  Sum_probs=209.6

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      .....+++-.+...+..+||+|+||+||++++-  | .||||++.......+ ..+.|++|+..+++-+|.||+.+.|++
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhh
Confidence            344778888899999999999999999999863  3 499999987766654 689999999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ..+.. .+|+.+|+|.+|..+++.. ..+.....+.|+.|+++|+.|||.++|+|+|||..||++..+++|+|+|||++.
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEeccccee
Confidence            98886 9999999999999999764 368889999999999999999999999999999999999999999999999984


Q ss_pred             ccc-----CccccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc-----------
Q 024158          168 QSR-----SKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------  228 (271)
Q Consensus       168 ~~~-----~~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i-----------  228 (271)
                      ...     .......|..-|+|||+..   ..+|+.++|||+||+++|||++|..||......+.+..+           
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchh
Confidence            322     1223345677899999886   456899999999999999999999999955555544321           


Q ss_pred             -----CHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          229 -----SAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       229 -----~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                           ++++.+|+..|+.+++++||...+||.
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence                 679999999999999999999999988

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=280.65  Aligned_cols=240  Identities=20%  Similarity=0.345  Sum_probs=201.4

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCce----EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      +.+...+|++.+.||+|+||.||+|++..++..    +++|.+.....  ......+.+|+.+++.++|+||+++++++.
T Consensus         2 ~~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~   79 (316)
T cd05108           2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICL   79 (316)
T ss_pred             cccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence            356778999999999999999999997666654    89999854322  233467888999999999999999999987


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .+ ..+++++++.+++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          80 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             CC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence            64 578899999999999999774 3588999999999999999999999999999999999999999999999999864


Q ss_pred             ccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          169 SRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       169 ~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      .....     .....+..|++||.+.+..++.++|+||||+++|++++ |..||.+....+..            ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI  238 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence            43221     12233567999999999999999999999999999987 99999876543321            12367


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+|+..+|.+|||+.+++.+
T Consensus       239 ~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         239 DVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            89999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=283.91  Aligned_cols=233  Identities=27%  Similarity=0.456  Sum_probs=195.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-eEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-RIFLI   97 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~lv   97 (271)
                      ++|.-...||+|+||.||++.. .++..+|||++.......   ..++.+|+.++.+++|||+++++|+|.+.+ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            5677778999999999999986 445889999876544331   345999999999999999999999999988 59999


Q ss_pred             EeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           98 LEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENH---VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~---i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      +||++.|+|.+.+....  .++|..+.+|+.+++.||+|||...   |+|+|||++|||+|.+.++||+|||++..... 
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998754  8999999999999999999999864   99999999999999999999999999955543 


Q ss_pred             ccccc---cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----h------------------
Q 024158          172 KRHTM---CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----F------------------  225 (271)
Q Consensus       172 ~~~~~---~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----~------------------  225 (271)
                      .....   .||.+|++||+...+..+.++||||||++++++++|..+.+...+...     +                  
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            33222   789999999999999999999999999999999999987764321100     0                  


Q ss_pred             --cccC--HH---HHHHHHHhcccCccCCCCHHHHhc
Q 024158          226 --RSIS--AE---AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       226 --~~i~--~~---l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                        ...+  .+   +..+..+|+..+|+.||++.++.+
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence              1123  22   557777999999999999999754

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=261.57  Aligned_cols=241  Identities=28%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   91 (271)
                      .-.++-++|++.+.||+|||+-|++++...++..||+|.+.....+   ..+...+|+..-++++|||+++++++...+ 
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~---~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE---DIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH---HHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            3446778999999999999999999999999999999999766533   356788999999999999999988865333 


Q ss_pred             ----CeEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCEEEe
Q 024158           92 ----ERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        92 ----~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~~L~  161 (271)
                          ...|++++|...|+|.+.+...    ..+++.+++.++.++++||++||+..  ++|+||||.||++...+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence                3489999999999999998752    35899999999999999999999998  9999999999999999999999


Q ss_pred             eecccccccCcc------------ccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----
Q 024158          162 DFGWSVQSRSKR------------HTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----  222 (271)
Q Consensus       162 dfg~~~~~~~~~------------~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----  222 (271)
                      |||.+....-.-            -....|..|+|||.++-   ...+.++|||||||++|.|+.|..||+..-..    
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl  251 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL  251 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence            999874433111            12346888999999874   44678999999999999999999999643210    


Q ss_pred             ---------hhh--cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          223 ---------DTF--RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       223 ---------~~~--~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                               ...  ..++..+.++|+.||+.||.+||++.+++.+
T Consensus       252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                     000  1268999999999999999999999999874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-40  Score=287.31  Aligned_cols=243  Identities=23%  Similarity=0.395  Sum_probs=202.1

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceece
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRL   84 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~   84 (271)
                      .....+..++|++.+.||+|+||.||+|.+...     +..+++|++......  ...+.+.+|+.+++.+. ||||+++
T Consensus        29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l  106 (400)
T cd05105          29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNL  106 (400)
T ss_pred             CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            356677788999999999999999999986543     346999998654322  33467889999999996 9999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhC---------------------------------------------------
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKH---------------------------------------------------  113 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------  113 (271)
                      ++++...+..|++|||+++++|.+++...                                                   
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (400)
T cd05105         107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT  186 (400)
T ss_pred             EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence            99999999999999999999999888542                                                   


Q ss_pred             ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158          114 ---------------------------------------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus       114 ---------------------------------------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                                                                   ..+++..+..++.|++.|+.|||+.|++|+||+|+
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~  266 (400)
T cd05105         187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR  266 (400)
T ss_pred             ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence                                                         13677888999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcc
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~  222 (271)
                      ||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            999999999999999987543221     122345678999999988889999999999999999986 88998764432


Q ss_pred             hh-------------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          223 DT-------------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       223 ~~-------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..             ...++.++.+++.+||..+|++|||+.++.+
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            21             1236789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=270.99  Aligned_cols=228  Identities=25%  Similarity=0.391  Sum_probs=194.0

Q ss_pred             eeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEecc
Q 024158           25 RPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      ++||+|+||.||+|+....+   ..+++|.+......  .....+..|+++++.++|+|++++++++. .+.+++++|++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876655   78999998765443  33567888999999999999999999875 45689999999


Q ss_pred             CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc------
Q 024158          102 HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------  175 (271)
Q Consensus       102 ~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~------  175 (271)
                      ++++|.+++.....+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.........      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            99999999988778999999999999999999999999999999999999999999999999987544322211      


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hcccCHHHHHHHHHhccc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~  242 (271)
                      ..++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.            ...+++.+.+++.+||.+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  237 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKY  237 (257)
T ss_pred             ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcC
Confidence            122457999999998889999999999999999997 9999976654332            223578999999999999


Q ss_pred             CccCCCCHHHHhc
Q 024158          243 DSSKRLSLQKIME  255 (271)
Q Consensus       243 ~p~~Rps~~~il~  255 (271)
                      +|++|||+.++++
T Consensus       238 ~p~~Rp~~~~l~~  250 (257)
T cd05060         238 RPEDRPTFSELES  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-40  Score=275.09  Aligned_cols=237  Identities=25%  Similarity=0.467  Sum_probs=200.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEE-----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ++..+|++.++||+|+||.||+++.     ..++..+++|.+....   ......+.+|++.++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            5678899999999999999999964     2346678899875432   2334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           91 DERIFLILEYAHRGELYRELRKHR---------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      ....++++|++++++|.+++....               .+++..++.++.|++.|+.|||+.|++|+||+|+||+++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            899999999999999999987642               37889999999999999999999999999999999999999


Q ss_pred             CCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh-----
Q 024158          156 GRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT-----  224 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~-----  224 (271)
                      +.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||......+.     
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999875432211     12234678999999998889999999999999999998 9999866544322     


Q ss_pred             -------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 -------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 -------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                             ...+++.+.+++.+||..+|.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence                   1346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=7.3e-41  Score=277.48  Aligned_cols=240  Identities=20%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ++++.+|++.+.||.|+||.||++....+     +..+++|++......  .....+.+|..+++.++|+||+++++++.
T Consensus         1 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~   78 (283)
T cd05091           1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVT   78 (283)
T ss_pred             CCCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            35778899999999999999999987543     578999998654322  23466788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC
Q 024158           90 DDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD  153 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~  153 (271)
                      ..+..++++|++.+++|.+++...                ..++...+..++.|++.|+.+||++|++|+||||+||+++
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~  158 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF  158 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec
Confidence            989999999999999999998531                2478888999999999999999999999999999999999


Q ss_pred             CCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc-
Q 024158          154 HEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR-  226 (271)
Q Consensus       154 ~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~-  226 (271)
                      .++.++|+|||++.......     ....+++.|+|||.+.++.++.++|+||||+++++|++ |..||.+....+... 
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         159 DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999875432221     22334678999999988889999999999999999997 888887665443322 


Q ss_pred             -----------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 -----------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 -----------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                 ..+.++.+++.+|+..+|++||++.+|+..
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence                       257889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-40  Score=271.29  Aligned_cols=236  Identities=24%  Similarity=0.428  Sum_probs=202.3

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++..++|.+.+.||+|++|.||++... ++..+++|.+......    ...+.+|+.+++.++|+|++++++++......
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            467889999999999999999999964 5677999998654432    34678899999999999999999999888899


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..++...+..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999999999764  36899999999999999999999999999999999999999999999999987543321


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~l  235 (271)
                      .    .....+..|+|||.+.+..++.++|+||+|++++++++ |..||.+........            ..+.++.++
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            1    12234567999999998889999999999999999998 999998766543322            247899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+..+|++||+++++++
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHcccCcccCCCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=277.35  Aligned_cols=238  Identities=24%  Similarity=0.387  Sum_probs=197.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCC--------------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK--------------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~--------------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i   81 (271)
                      +..++|++.+.||+|+||.||+|++..++              ..+++|.+......  .....+.+|++++++++|+|+
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i   79 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNI   79 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCc
Confidence            34568999999999999999999875432              34899998654322  334568899999999999999


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHR------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      +++++++...+..+++|||+++++|.+++....            .+++..++.++.|++.|+.|||+.|++|+||+|+|
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N  159 (295)
T cd05097          80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN  159 (295)
T ss_pred             CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence            999999999999999999999999999986431            36888999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCCcc
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQK  222 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~~~~~  222 (271)
                      |+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++++|++  +..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999999875432211     12234668999999988889999999999999999987  66788765433


Q ss_pred             hhh-------------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          223 DTF-------------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       223 ~~~-------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +..                   ..+|+.+.+++.+|+..+|++|||+++|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            221                   124788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-40  Score=271.11  Aligned_cols=228  Identities=25%  Similarity=0.395  Sum_probs=192.8

Q ss_pred             eecccCCceEEEEEE--ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           26 PLGKGKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~--~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      .||+|+||.||+|..  ..++..+++|++..... .....+.+.+|+.+++.++|+|++++++++. .+..++++|++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            689999999999854  45788999999865432 2344577888999999999999999999875 4567999999999


Q ss_pred             CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc------cccc
Q 024158          104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTMC  177 (271)
Q Consensus       104 ~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~------~~~~  177 (271)
                      ++|.+++.....++...+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||.+.......      ....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            9999999887789999999999999999999999999999999999999999999999999875433221      1122


Q ss_pred             ccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hcccCHHHHHHHHHhcccCc
Q 024158          178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       178 ~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~~p  244 (271)
                      ++..|+|||.+.+..++.++|+||||+++|++++ |..||......+.            ...+++++.++|.+|+.+||
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p  239 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV  239 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCc
Confidence            3568999999988888899999999999999997 9999976543221            23468999999999999999


Q ss_pred             cCCCCHHHHhc
Q 024158          245 SKRLSLQKIME  255 (271)
Q Consensus       245 ~~Rps~~~il~  255 (271)
                      ++|||+++|.+
T Consensus       240 ~~Rp~~~~i~~  250 (257)
T cd05116         240 DERPGFAVVEL  250 (257)
T ss_pred             hhCcCHHHHHH
Confidence            99999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-40  Score=269.63  Aligned_cols=222  Identities=26%  Similarity=0.410  Sum_probs=189.8

Q ss_pred             cCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHH
Q 024158           30 GKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRE  109 (271)
Q Consensus        30 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  109 (271)
                      |.++.||++++..+++.+++|.+......        ..+...+....|||++++++++..++..++++|++++++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~--------~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY--------SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhh--------hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            88999999999999999999998654321        2233444455799999999999999999999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccccccccCCcccc
Q 024158          110 LRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE  189 (271)
Q Consensus       110 l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~  189 (271)
                      +.....+++..+..++.|+++|+.+||+.|++|+||+|+||+++.++.++++|||.+...........++..|+|||...
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccC
Confidence            98777899999999999999999999999999999999999999999999999998755544444455677899999998


Q ss_pred             CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-------hhhcccCHHHHHHHHHhcccCccCCCCH-----HHHhcCC
Q 024158          190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-------DTFRSISAEAKHLISRLLVKDSSKRLSL-----QKIMEHP  257 (271)
Q Consensus       190 ~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-------~~~~~i~~~l~~li~~~l~~~p~~Rps~-----~~il~~~  257 (271)
                      +..++.++|+||+|++++++++|..|+......       .....+++++.+++.+||..||++||++     ++++.||
T Consensus       156 ~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~  235 (237)
T cd05576         156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHP  235 (237)
T ss_pred             CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCC
Confidence            888889999999999999999999876543211       1223468899999999999999999985     9999999


Q ss_pred             cc
Q 024158          258 WI  259 (271)
Q Consensus       258 ~~  259 (271)
                      ||
T Consensus       236 ~~  237 (237)
T cd05576         236 FF  237 (237)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-40  Score=281.87  Aligned_cols=239  Identities=21%  Similarity=0.383  Sum_probs=197.5

Q ss_pred             eeeccc--CCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g--~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      ..||.|  ++++||++++..+|+.|++|++....... ...+.+.+|+.+++.++|+||+++++++..++..++++|++.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  88999999999999999999986554333 335788889999999999999999999999999999999999


Q ss_pred             CCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--------
Q 024158          103 RGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--------  172 (271)
Q Consensus       103 ~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--------  172 (271)
                      ++++.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++||+.+......        
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999999764  34899999999999999999999999999999999999999999999999754221110        


Q ss_pred             --cccccccccccCCccccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------
Q 024158          173 --RHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------  225 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------  225 (271)
                        .....++..|++||.+.+.  .++.++|+||+|+++++|++|..||.........                       
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              0111235569999998764  4678999999999999999999999754321110                       


Q ss_pred             -----------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 -----------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 -----------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                                         ...++.+.+++.+||..||++|||++++++||||.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                               113567899999999999999999999999999987644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-40  Score=270.65  Aligned_cols=238  Identities=23%  Similarity=0.389  Sum_probs=201.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      +..++|+..+.||+|++|.||+++...++.   .+++|.+......  .....+..|+.+++.++|+|++++.+++...+
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK   79 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence            566789999999999999999999876655   6899988554322  23466788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++++|++++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+|++|+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            999999999999999999763 5689999999999999999999999999999999999999999999999998754332


Q ss_pred             ccc------cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHH
Q 024158          172 KRH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEA  232 (271)
Q Consensus       172 ~~~------~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l  232 (271)
                      ...      ....+..|+|||.+.+..++.++|+||||+++|++++ |..||......+...            ..+.++
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            111      1122457999999988888999999999999999987 999997665443322            247899


Q ss_pred             HHHHHHhcccCccCCCCHHHHhc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .+++.+|+..+|++||++.++++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3e-40  Score=270.57  Aligned_cols=235  Identities=23%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++-.++|+++++||+|+||.||+|.. .++..+++|.+......    ...+.+|+.++++++|+|++++++++. .+..
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   75 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPI   75 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCc
Confidence            34567899999999999999999985 56788999998654433    246778999999999999999999874 4568


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++.+++|.+++...  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999999998653  36899999999999999999999999999999999999999999999999987543311


Q ss_pred             ----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                          .....++..|+|||.+.+..++.++|+||||++++++++ |..||......+..            ...+.++.++
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence                112234568999999998889999999999999999998 99999866544332            2257899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+..+|++|||++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.8e-40  Score=270.98  Aligned_cols=237  Identities=26%  Similarity=0.423  Sum_probs=200.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..++|++.+.||+|+||.||+|++..++.   .+++|.+......  .....+.+|+.+++.++||||+++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            46789999999999999999998765543   6999988654322  234678889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .++++|++++++|.+++... ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999764 46899999999999999999999999999999999999999999999999987543322


Q ss_pred             cc------cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHH
Q 024158          173 RH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAK  233 (271)
Q Consensus       173 ~~------~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~  233 (271)
                      ..      ....+..|++||.+.+..++.++|+||||++++++++ |..||......+..            ..+++.+.
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH  239 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence            11      1122457999999988889999999999999999886 99999766543221            23578999


Q ss_pred             HHHHHhcccCccCCCCHHHHhc
Q 024158          234 HLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +++.+|+.++|.+|||+.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-40  Score=270.82  Aligned_cols=235  Identities=23%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+..++|++.++||+|++|.||++... ++..+++|.+.......    ..+.+|+.++++++|++++++++++. .+..
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            456679999999999999999999864 56679999986544332    45788999999999999999999875 4568


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999999999753  35899999999999999999999999999999999999999999999999988543322


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~l  235 (271)
                      .    ....++..|+|||.+.+..++.++|+||||++++++++ |..||......+...            ..+..+.++
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL  235 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1    12234567999999988889999999999999999998 889997755433222            247899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+.++|++|||++++.+
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-40  Score=274.27  Aligned_cols=236  Identities=32%  Similarity=0.533  Sum_probs=199.0

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEEe
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      |++.+.||+|++|.||+|+...+++.+++|.+........  .....+|+..+++++ |+|++++++++..++..++++|
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            7889999999999999999988999999999865433211  223346788888998 9999999999999999999999


Q ss_pred             ccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--ccc
Q 024158          100 YAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~~  175 (271)
                      ++ +++|.+.+....  .+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+......  ...
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence            99 679998887654  6899999999999999999999999999999999999999999999999988544432  223


Q ss_pred             ccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------------
Q 024158          176 MCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------------  225 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------------  225 (271)
                      ..++..|+|||.+.+ ..++.++|+||||++++++++|.+||......+..                             
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            456788999998754 45788999999999999999999998655432211                             


Q ss_pred             ------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          226 ------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       226 ------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                                  ...+..+.+++.+||..+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                        1125789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.3e-40  Score=270.39  Aligned_cols=238  Identities=25%  Similarity=0.382  Sum_probs=201.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..++|++.+.||+|+||.||+|....++.   .+++|.+.....  ......+..|+.+++.++|||++++++++..++.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            56889999999999999999999887765   599999865422  2345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +++++|++++++|.+++... +.++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999999999763 46899999999999999999999999999999999999999999999999987433221


Q ss_pred             cc--c------ccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          173 RH--T------MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       173 ~~--~------~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ..  .      ...+..|+|||.+.+..++.++|+||||+++|++++ |..||......+..            ...|..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  239 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA  239 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence            11  1      112347999999988889999999999999999885 99999766543322            234788


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+|+.++|++||++++++..
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=279.81  Aligned_cols=252  Identities=33%  Similarity=0.499  Sum_probs=225.5

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      +...++.+.|+.-+.||.||||.||-|+-+.+|+-||+|.+.+.............+|-.++.++..+.|+.+-..++..
T Consensus       178 E~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTk  257 (591)
T KOG0986|consen  178 ELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETK  257 (591)
T ss_pred             HhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCC
Confidence            34678889999999999999999999999999999999999887777766677788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +.+|+|+..|.||+|.-.|-+.  +.+++..+..++.+|+.||++||+.+|+.||+||+|||+|..|+++|+|+|++...
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei  337 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI  337 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec
Confidence            9999999999999997777654  36899999999999999999999999999999999999999999999999999766


Q ss_pred             cCcc--ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHH
Q 024158          170 RSKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEA  232 (271)
Q Consensus       170 ~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l  232 (271)
                      ....  .+..||.+|+|||++.++.|+.+.|=|+|||++|+|+.|.-||...-....               ..+.++++
T Consensus       338 ~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea  417 (591)
T KOG0986|consen  338 PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA  417 (591)
T ss_pred             CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence            5543  345899999999999999999999999999999999999999975443222               23468999


Q ss_pred             HHHHHHhcccCccCCC-----CHHHHhcCCccccCC
Q 024158          233 KHLISRLLVKDSSKRL-----SLQKIMEHPWIIKNA  263 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~  263 (271)
                      .+|.+.+|.+||.+|.     .++++.+||||+..+
T Consensus       418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln  453 (591)
T KOG0986|consen  418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN  453 (591)
T ss_pred             HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence            9999999999999998     677999999999863

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.7e-40  Score=271.71  Aligned_cols=240  Identities=19%  Similarity=0.326  Sum_probs=199.0

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCce----EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      +.+..++|++.+.||+|+||.||++++..++..    +++|.+....  .......+..++..++.++|+||+++++++.
T Consensus         2 ~~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             CcCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            346778999999999999999999998777764    6777764322  1233456777888899999999999999875


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      . ...++++|++++++|.+++.. .+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        80 ~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          80 G-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             C-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            4 457889999999999999976 35689999999999999999999999999999999999999999999999998854


Q ss_pred             ccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          169 SRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       169 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      ....     .....++..|++||.+.+..++.++|+||||+++|++++ |..||.+..+....            ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTI  238 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCH
Confidence            3221     122345678999999988889999999999999999997 99999876543321            11367


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+|+..+|.+|||+.++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=287.74  Aligned_cols=243  Identities=26%  Similarity=0.448  Sum_probs=209.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCc---e-EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---P-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~-~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      .+++.-++-.+.++||+|+||.||++..+..+.   . ||+|....+..........+.+|+++++.++|+||++++|+.
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            455555666778999999999999998766532   3 899998764434445678899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ...+-+++|||+|.||+|.++|+..+ .++..+...++.+.+.||+|||+++++||||...|+|++.++.+|++|||++.
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999999999876 59999999999999999999999999999999999999999999999999986


Q ss_pred             cccCc--cc-cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhcc-------------cCH
Q 024158          168 QSRSK--RH-TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRS-------------ISA  230 (271)
Q Consensus       168 ~~~~~--~~-~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~-------------i~~  230 (271)
                      ....-  .. ....+.+|+|||.+..+.++.++||||+|+++||+++ |..||.+....+...+             .|.
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~  390 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPK  390 (474)
T ss_pred             CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHH
Confidence            55411  11 1234678999999999999999999999999999986 8899999887666544             378


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhc
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++..++.+|+..+|+.|||+.++.+
T Consensus       391 ~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  391 ELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHHhccCChhhccCHHHHHH
Confidence            8999999999999999999998865

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.2e-40  Score=273.65  Aligned_cols=238  Identities=25%  Similarity=0.417  Sum_probs=200.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..++|++.+.||+|+||.||++++..     ++..+++|.+......  .....+.+|+.+++.++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            456789999999999999999998743     6788999998654322  234668889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158           91 DERIFLILEYAHRGELYRELRKHR----------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~----------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                      +...++++|++++++|.+++....                      .+++..++.++.|++.+|.+||++|++|+||+|+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            889999999999999999996421                      3678889999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcc
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~  222 (271)
                      ||+++.++.++|+|||.+......     ......+..|+|||...+..++.++|+||||+++|+|++ |..||.+....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999987543221     122234567999999988889999999999999999997 88888766544


Q ss_pred             hhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          223 DTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       223 ~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +..            ...+.++.+++.+||..+|.+|||+.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         240 EVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            432            235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.1e-40  Score=275.99  Aligned_cols=244  Identities=24%  Similarity=0.450  Sum_probs=201.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEec-------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      +........+|.+.+.||+|++|.||++++..       ....+++|.+......  .....+..|+.+++.+ +|+||+
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv   81 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD--KDLADLISEMELMKLIGKHKNII   81 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCCh--HHHHHHHHHHHHHHhccCCCCee
Confidence            34456667899999999999999999998632       3456889987643222  3355678899999999 699999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      ++++++..++.+++++||+++++|.+++...                ..+++..+..++.|++.|+.+||++|++|+||+
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk  161 (314)
T cd05099          82 NLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA  161 (314)
T ss_pred             eEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence            9999999888999999999999999999653                247889999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  220 (271)
                      |+||+++.++.++|+|||.+......     .....++..|+|||.+.+..++.++|+||||+++|++++ |..||....
T Consensus       162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999988543321     111233467999999988889999999999999999998 888887665


Q ss_pred             cchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          221 QKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       221 ~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..+..            ...+.++.+++.+||..+|++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            43322            2346899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6.2e-40  Score=278.02  Aligned_cols=244  Identities=29%  Similarity=0.471  Sum_probs=201.4

Q ss_pred             ceeeeeeecccCCceEEEEEEecC--CceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC----C
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVES--KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD----E   92 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~----~   92 (271)
                      +|++.+.||+|+||.||++++..+  +..+++|.+.... ........+.+|+.+++++ .|+||+++++.....    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  8999999985432 2222345667789999998 599999999875432    4


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..|+++++++ ++|.+++.....++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5788999986 699999987788999999999999999999999999999999999999999999999999988543221


Q ss_pred             -------cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------------
Q 024158          173 -------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------  224 (271)
Q Consensus       173 -------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------------  224 (271)
                             .....+++.|+|||.+.+ ..++.++|+||+|++++++++|..||........                    
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence                   123457889999998765 4678899999999999999999999875432110                    


Q ss_pred             ----------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 ----------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 ----------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                            ....+..+.+++.+||..+|.+|||+.+++.|||+.+-..|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                                  11246789999999999999999999999999999865443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5e-40  Score=273.46  Aligned_cols=234  Identities=25%  Similarity=0.461  Sum_probs=197.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      +|++.+.||+|+||.||++.+...     ...+++|.+......  .....+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            588999999999999999987542     356888887544322  2346788899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 024158           95 FLILEYAHRGELYRELRKH------------------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Ni  150 (271)
                      ++++||+.+++|.+++...                        ..++...++.++.|++.++.+||+.|++|+||+|+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2377889999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh
Q 024158          151 LLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT  224 (271)
Q Consensus       151 li~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~  224 (271)
                      +++.++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++++|++ |..||.+..+.+.
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~  238 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL  238 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999987543221     122334668999999988889999999999999999998 9999987665443


Q ss_pred             h------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 F------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +            ..++.++.+++.+||.++|++||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         239 FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            2            235789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=8.2e-40  Score=271.89  Aligned_cols=243  Identities=39%  Similarity=0.687  Sum_probs=204.0

Q ss_pred             ceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~   94 (271)
                      +|++.+.||+|++|.||++++.   .++..+++|.+.+.... .......+.+|+.++..+ +|++++++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            5899999999999999999864   46788999998654332 223455677899999999 589999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc-
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-  173 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-  173 (271)
                      ++|+||+++++|.+++.....++...+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            9999999999999999877778999999999999999999999999999999999999999999999999875433221 


Q ss_pred             ---ccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcc----hh-----------hcccCHHHH
Q 024158          174 ---HTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQK----DT-----------FRSISAEAK  233 (271)
Q Consensus       174 ---~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~----~~-----------~~~i~~~l~  233 (271)
                         ....++..|++||.+.+..  .+.++|+||+|+++++|++|..||......    +.           ...++..+.
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  240 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEAR  240 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHHH
Confidence               2235788999999987655  678999999999999999999998643211    11           122578999


Q ss_pred             HHHHHhcccCccCCCC---HHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLS---LQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps---~~~il~~~~~~~~  262 (271)
                      +++.+||..+|++|||   +.++|+||||+..
T Consensus       241 ~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         241 DFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            9999999999999998   5778999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=5.3e-40  Score=268.29  Aligned_cols=233  Identities=26%  Similarity=0.482  Sum_probs=200.3

Q ss_pred             eeeeeeecccCCceEEEEEEecCC----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +++.+.||+|+||.||++++..++    ..+++|.+.......  ....+..|+..++.++|+|++++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            457889999999999999988766    889999986543321  35678889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc
Q 024158           97 ILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~  174 (271)
                      ++|++++++|.+++.....  +++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  89999999999999999999999999999999999999999999999998854443211


Q ss_pred             ----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHH
Q 024158          175 ----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLIS  237 (271)
Q Consensus       175 ----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~  237 (271)
                          ...+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+..            ..++.++.+++.
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLML  238 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence                1235688999999988889999999999999999997 88888765543332            225899999999


Q ss_pred             HhcccCccCCCCHHHHhc
Q 024158          238 RLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~  255 (271)
                      +|+..+|++|||+.++++
T Consensus       239 ~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      239 QCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHCcCChhhCcCHHHHHh
Confidence            999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-39  Score=269.89  Aligned_cols=234  Identities=26%  Similarity=0.425  Sum_probs=193.2

Q ss_pred             cce-eeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--C
Q 024158           19 QDF-EIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--D   91 (271)
Q Consensus        19 ~~y-~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   91 (271)
                      ++| ++++.||+|+||+||++.    ...++..+++|.+......  .....+.+|++.+++++|+|++++++++..  +
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            345 999999999999998765    3456788999998654321  234567789999999999999999998765  3


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ...+++||++++++|.+++... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            4689999999999999999764 589999999999999999999999999999999999999999999999998754332


Q ss_pred             cc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------h-------
Q 024158          172 KR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------T-------  224 (271)
Q Consensus       172 ~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~-------  224 (271)
                      ..      ....++..|+|||.+.+..++.++|+||||+++++|++|..|+......-              .       
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            21      11234567999999988888999999999999999999999875432110              0       


Q ss_pred             ------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                            ....+.++.+++.+|+.++|++|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                  1124689999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=248.50  Aligned_cols=244  Identities=26%  Similarity=0.525  Sum_probs=211.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +.+|+-.++||+|.+|+||++++.++++-|++|.+..+..+. .......+|+-+++.++|.||++++++...+..+.+|
T Consensus         1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlv   79 (292)
T KOG0662|consen    1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_pred             CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEe
Confidence            356777889999999999999999999999999986554332 3345667899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---
Q 024158           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---  173 (271)
                      +|+|+ .+|..+... ++.+..+..++++.|++.++.++|+.++.|+|+||.|.+|..+|.+||.|||++....-+-   
T Consensus        80 fe~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   80 FEFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            99996 688888765 5678999999999999999999999999999999999999999999999999986655443   


Q ss_pred             ccccccccccCCccccCCC-CCccchhhhHHHHHHHHH-hCCCCCCCCCcchhhccc-----------------------
Q 024158          174 HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI-----------------------  228 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~~~i-----------------------  228 (271)
                      +....|..|.||..+.+.. |+.+.|+||.||++.++. .|.+.|.+.+-.+++.+|                       
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            3345689999999998866 788999999999999998 578888887766665432                       


Q ss_pred             -----------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          229 -----------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       229 -----------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                       ...-+++++++|.-+|.+|.|+++.++||||...-
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                             35568999999999999999999999999998653

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=9.9e-40  Score=267.50  Aligned_cols=235  Identities=23%  Similarity=0.399  Sum_probs=196.9

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++..++|.+...||+|++|.||++.+..+ ..+++|.+......    ...+.+|+++++.++|++++++++++.. +..
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   75 (260)
T cd05069           2 EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPI   75 (260)
T ss_pred             cCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCc
Confidence            34567899999999999999999987554 45899987543322    3457789999999999999999998754 568


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +++||++.+++|.+++...  ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            9999999989999999763  34789999999999999999999999999999999999999999999999988543322


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      .    ....++..|+|||...+..++.++|+||||+++|++++ |..||......+..            ..++..+.++
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL  235 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence            1    12234667999999988889999999999999999998 89999876544322            2357899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+||.++|++||+++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHccCCcccCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-40  Score=270.24  Aligned_cols=235  Identities=20%  Similarity=0.358  Sum_probs=196.1

Q ss_pred             eeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe----
Q 024158           21 FEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER----   93 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----   93 (271)
                      |++.+.||+|+||.||+|....+   +..+++|.+....... .....+..|+..++.++|+|++++++++...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67889999999999999987654   4789999986543332 335678889999999999999999998865543    


Q ss_pred             --EEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           94 --IFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        94 --~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                        .++++||+++++|..++...      ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888542      2578999999999999999999999999999999999999999999999998


Q ss_pred             cccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cc
Q 024158          166 SVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RS  227 (271)
Q Consensus       166 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~  227 (271)
                      +.......     .....+..|++||.+.+..++.++|+||||+++|+|++ |..||......+..            ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPED  239 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence            75433221     11234567999999988889999999999999999998 88898766544332            23


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .++++.+++.+||..||++|||+.+++++
T Consensus       240 ~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         240 CLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            57899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7e-40  Score=277.93  Aligned_cols=243  Identities=25%  Similarity=0.474  Sum_probs=202.4

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecC-------CceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceec
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILR   83 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~   83 (271)
                      ..+++...+|++.+.||+|+||.||+|++...       +..+++|.+......  .....+.+|+.+++++ +|+||++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~   82 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIIN   82 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeee
Confidence            45666667899999999999999999986432       236899987643222  3356788899999999 7999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKP  147 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~  147 (271)
                      +++++..++..++++||+++++|.+++....                .++...+..++.|++.|+.+||++|++|+||+|
T Consensus        83 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          83 LLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            9999999889999999999999999997532                367888999999999999999999999999999


Q ss_pred             CCeeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCc
Q 024158          148 ENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQ  221 (271)
Q Consensus       148 ~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  221 (271)
                      +||+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999875433221     12233467999999999889999999999999999998 8888876654


Q ss_pred             chhhc------------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          222 KDTFR------------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       222 ~~~~~------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+...            ..+.++.+++.+|+..+|.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         243 EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            43322            247889999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.8e-41  Score=297.96  Aligned_cols=244  Identities=25%  Similarity=0.467  Sum_probs=214.9

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceec
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR   83 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~   83 (271)
                      .+.....++.++-+..+.||+|+||+||+++...-     ...|+||.++.....  ....+|++|+.++..++||||++
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVr  553 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVR  553 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEE
Confidence            35566778889999999999999999999985433     356999998665433  34789999999999999999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhC----------CC----CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKH----------RR----FTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~----l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      ++|+|.+++-.|+|+|||..|+|.++|...          .+    |+..+.+.++.||+.|+.||-++.++|+||...|
T Consensus       554 LlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  554 LLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             EEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            999999999999999999999999999632          12    8899999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccCcccccc-----ccccccCCccccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCCcch
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRSKRHTMC-----GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD  223 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~~~~~~~-----~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~  223 (271)
                      .||..+-.|||+|||+++..-+..+...     -+.+|+|||.+..+.++.+|||||+||+|||++ .|..||.+....+
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            9999999999999999977665554433     367999999999999999999999999999998 4999999999888


Q ss_pred             hhccc------------CHHHHHHHHHhcccCccCCCCHHHHh
Q 024158          224 TFRSI------------SAEAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       224 ~~~~i------------~~~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                      .++-+            |.++.+|+..|+..+|++|||+.||=
T Consensus       714 VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  714 VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            76543            89999999999999999999999873

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=7.7e-40  Score=267.54  Aligned_cols=228  Identities=25%  Similarity=0.470  Sum_probs=195.2

Q ss_pred             eeecccCCceEEEEEEec-CCc--eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEecc
Q 024158           25 RPLGKGKFGRVYLVREVE-SKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~-~~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      +.||+|++|.||++.+.. .+.  .+++|.+......  ...+.+.+|+..+++++|+|++++++.+.. ..+++++|++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            468999999999998765 333  5899998766543  446788899999999999999999999888 8899999999


Q ss_pred             CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc------
Q 024158          102 HRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------  173 (271)
Q Consensus       102 ~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~------  173 (271)
                      ++++|.+++....  .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......      
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997754  68999999999999999999999999999999999999999999999999875443311      


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHHHHHHHHHh
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAEAKHLISRL  239 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~  239 (271)
                      ....++..|+|||.+.+..++.++|+||||+++++|++ |..||......+..             ...|..+.+++.+|
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  237 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQC  237 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHH
Confidence            12345678999999988889999999999999999998 99999765544332             23578999999999


Q ss_pred             cccCccCCCCHHHHhc
Q 024158          240 LVKDSSKRLSLQKIME  255 (271)
Q Consensus       240 l~~~p~~Rps~~~il~  255 (271)
                      +..+|++|||+.++++
T Consensus       238 l~~~p~~Rps~~~~~~  253 (257)
T cd05040         238 WAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCcccCCCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.4e-40  Score=270.21  Aligned_cols=235  Identities=20%  Similarity=0.348  Sum_probs=193.9

Q ss_pred             eeeeeeecccCCceEEEEEEecCCc--eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC------C
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------E   92 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   92 (271)
                      |.+.+.||+|+||.||+++...++.  .+++|.+....... .....+..|+..++.++|+||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            4577899999999999999877765  58999886543222 3356778899999999999999999987432      2


Q ss_pred             eEEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           93 RIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ..++++||+.+++|.+++..      ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            46899999999999888742      134789999999999999999999999999999999999999999999999998


Q ss_pred             ccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------ccc
Q 024158          167 VQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSI  228 (271)
Q Consensus       167 ~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i  228 (271)
                      .......     ....+++.|++||.+.+..++.++|+||||+++|++++ |..||......+..            ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC  239 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            6543221     12234668999999998889999999999999999998 88999765543322            225


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +..+.+++.+||.++|++|||+.++++.
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         240 LDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=5.7e-40  Score=276.10  Aligned_cols=233  Identities=23%  Similarity=0.378  Sum_probs=193.5

Q ss_pred             CCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHHH
Q 024158           31 KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL  110 (271)
Q Consensus        31 ~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (271)
                      +.+.+|.++...+++.+++|++....... .....+.+|+..++.++|+||+++++++..++..++++||+++++|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            45667777777899999999987653333 34677899999999999999999999999999999999999999999999


Q ss_pred             HhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----------cccccc
Q 024158          111 RKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----------RHTMCG  178 (271)
Q Consensus       111 ~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----------~~~~~~  178 (271)
                      ...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+||+.+......          .....+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            763  45889999999999999999999999999999999999999999999999977433211          122345


Q ss_pred             cccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------------
Q 024158          179 TLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------------  225 (271)
Q Consensus       179 ~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------------  225 (271)
                      +..|+|||.+.+  ..++.++|+||+|++++++++|..||.........                               
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            678999999865  35788999999999999999999999754322110                               


Q ss_pred             --------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 --------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 --------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                    ..++.++.+++.+||..+|++|||++++|+||||++.-.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~  303 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR  303 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence                          012467889999999999999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.8e-40  Score=270.52  Aligned_cols=239  Identities=23%  Similarity=0.430  Sum_probs=201.7

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..++|++++.||+|+||.||+++.+.+     ...+++|.+.....  ......+.+|++++++++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            3457899999999999999999996543     46789998754332  2245678889999999999999999999988


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           91 DERIFLILEYAHRGELYRELRKHR---------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      .+..++++|++++++|.+++....         .+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            889999999999999999997655         68999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------
Q 024158          162 DFGWSVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------  224 (271)
Q Consensus       162 dfg~~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------  224 (271)
                      |||++......    .....+++.|+|||.+.+..++.++|+||||++++++++ |..||........            
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  239 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP  239 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence            99987533221    122345677999999988888899999999999999998 7888865443322            


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                       ....+..+.+++.+||..+|.+|||+.+++..
T Consensus       240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             22357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.4e-40  Score=267.32  Aligned_cols=232  Identities=24%  Similarity=0.437  Sum_probs=198.0

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      .+++|++.+.||+|+||.||++.  .++..+++|.+....     ....+.+|+.+++.++|+|++++++++..+ ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            56889999999999999999886  577889999985432     134677899999999999999999998664 4799


Q ss_pred             EEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc
Q 024158           97 ILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~  174 (271)
                      ++|++.+++|.+++....  .++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~  155 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD  155 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCC
Confidence            999999999999997643  478999999999999999999999999999999999999999999999998865443333


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hcccCHHHHHHHHHhcc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~  241 (271)
                      ....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+.            ...+++++.+++.+||.
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE  235 (254)
T ss_pred             CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence            3445678999999988889999999999999999997 9999976654332            12357899999999999


Q ss_pred             cCccCCCCHHHHhcC
Q 024158          242 KDSSKRLSLQKIMEH  256 (271)
Q Consensus       242 ~~p~~Rps~~~il~~  256 (271)
                      .+|++||+++++++.
T Consensus       236 ~~p~~Rp~~~~l~~~  250 (254)
T cd05083         236 TEPKKRPSFHKLREK  250 (254)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.5e-40  Score=271.64  Aligned_cols=236  Identities=26%  Similarity=0.410  Sum_probs=195.6

Q ss_pred             cceeeeeeecccCCceEEEEEE----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC--C
Q 024158           19 QDFEIGRPLGKGKFGRVYLVRE----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD--E   92 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~   92 (271)
                      .-|++++.||+|+||.||+++.    ..++..+++|.+.....  ......+.+|+++++.++|+|++++.+++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            4579999999999999999974    45688899999865432  23356788999999999999999999988765  5


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++++||+++++|.+++... ..+++..+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            689999999999999999764 3589999999999999999999999999999999999999999999999998754332


Q ss_pred             cc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-------------------------
Q 024158          172 KR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-------------------------  220 (271)
Q Consensus       172 ~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~-------------------------  220 (271)
                      ..      ....++..|+|||.+.+..++.++|+||||+++++++++..|.....                         
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE  241 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence            21      22345667999999988888999999999999999998766532110                         


Q ss_pred             --cchhhcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          221 --QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       221 --~~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                        .......++..+.+++.+||..+|++|||+.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence              011123357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.5e-39  Score=265.68  Aligned_cols=235  Identities=23%  Similarity=0.430  Sum_probs=199.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ...+|++.+.||+|++|.||++.+. ++..+++|.+......    ...+.+|+++++.+.|++++++++++......++
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            4578999999999999999999874 4678999998654433    2457789999999999999999999998889999


Q ss_pred             EEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc--
Q 024158           97 ILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~--  173 (271)
                      ++|++.+++|.+++... ..++++.++.++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999999998764 458999999999999999999999999999999999999999999999999875432221  


Q ss_pred             --ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHHH
Q 024158          174 --HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLISR  238 (271)
Q Consensus       174 --~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~~  238 (271)
                        .....+..|+|||.+.+..++.++|+||||+++|++++ |..||..........            ..+.++.+++.+
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH  236 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence              12234568999999988889999999999999999997 999997655433221            247889999999


Q ss_pred             hcccCccCCCCHHHHhcC
Q 024158          239 LLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~  256 (271)
                      ||..+|++|||+.++++.
T Consensus       237 ~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         237 CWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HcccChhhCCCHHHHHHh
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.8e-40  Score=269.84  Aligned_cols=239  Identities=29%  Similarity=0.501  Sum_probs=199.4

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh--HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +|.+.+.||+|++|.||++++...+..+++|+++.....  .......+..|+.+++.++|||++++++.+.+.+..+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            589999999999999999998887777777776432221  112234456788899999999999999999988999999


Q ss_pred             EeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           98 LEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      +||+++++|.+++..    ...+++..++.++.|++.|+.+||+.|++|+|++|+||+++. +.++|+|||.+...... 
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            999999999988853    346899999999999999999999999999999999999975 57999999987443222 


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAKHLISR  238 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~~li~~  238 (271)
                        .....+++.|+|||.+.+..++.++|+||+|++++++++|..||........            ...++.++.+++.+
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQS  239 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHH
Confidence              2234567889999999888888899999999999999999999975443221            12357899999999


Q ss_pred             hcccCccCCCCHHHHhcCCcc
Q 024158          239 LLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~  259 (271)
                      |+..+|++||++.++++||||
T Consensus       240 ~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         240 MLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-40  Score=278.30  Aligned_cols=241  Identities=24%  Similarity=0.447  Sum_probs=197.4

Q ss_pred             cCccccceeeeeeecccCCceEEEEEE-----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   87 (271)
                      +.+..++|++.+.||.|+||.||+|++     ..+++.+++|.+......  .....+.+|+.++..+ +|+||++++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            456677999999999999999999984     345788999998654322  2345678899999999 67999999998


Q ss_pred             EEeC-CeEEEEEeccCCCchHHHHHhC-----------------------------------------------------
Q 024158           88 FHDD-ERIFLILEYAHRGELYRELRKH-----------------------------------------------------  113 (271)
Q Consensus        88 ~~~~-~~~~lv~e~~~~~~L~~~l~~~-----------------------------------------------------  113 (271)
                      +... ...++++||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            7654 4679999999999999998642                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----cc
Q 024158          114 --------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RH  174 (271)
Q Consensus       114 --------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~  174 (271)
                                    ..+++..+..++.|+++|+.|||++|++|+||+|+||+++.++.++|+|||++......     ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          12577888999999999999999999999999999999999999999999987543221     11


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHHHHHHHHHhc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAEAKHLISRLL  240 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~l  240 (271)
                      ...++..|+|||.+.+..++.++|+||||+++|++++ |..||.........             ..+++++.+++.+|+
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl  319 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW  319 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHc
Confidence            2234567999999988889999999999999999996 99998765432111             124688999999999


Q ss_pred             ccCccCCCCHHHHhcC
Q 024158          241 VKDSSKRLSLQKIMEH  256 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~  256 (271)
                      ..+|++|||+.++++|
T Consensus       320 ~~~p~~Rps~~eil~~  335 (343)
T cd05103         320 HGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=267.98  Aligned_cols=238  Identities=22%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .++..+|++.+.||+|+||.||++..+.+|.    .+++|.+.....  ......+.+|+..++.++|+|++++++++..
T Consensus         3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            5678899999999999999999999877665    588888765433  2345678889999999999999999999877


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                       ...++++|++++++|.+++... ..+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence             7789999999999999999764 46899999999999999999999999999999999999999999999999987543


Q ss_pred             cCccc-----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhcc------------cCHH
Q 024158          170 RSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRS------------ISAE  231 (271)
Q Consensus       170 ~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~------------i~~~  231 (271)
                      .....     ...++..|++||.+....++.++|+||||++++++++ |..||......+....            .+.+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            32211     1223567999999988888999999999999999998 9999987665433221            3678


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+++.+|+..+|.+||++.++++
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=7.1e-40  Score=282.97  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=204.5

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCcee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNIL   82 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~   82 (271)
                      .....+.+...+|.+.+.||+|+||.||+|++.     ..+..+++|++.......  ....+..|+.++..+. |+||+
T Consensus        27 ~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~E~~~l~~l~~H~niv  104 (401)
T cd05107          27 PYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSS--EKQALMSELKIMSHLGPHLNIV  104 (401)
T ss_pred             CCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChh--HHHHHHHHHHHHHhcCCCCCeE
Confidence            344557888889999999999999999999853     345689999996543222  2356788999999997 99999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhCC------------------------------------------------
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKHR------------------------------------------------  114 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------  114 (271)
                      ++++.+..++..++|+||+++++|.+++...+                                                
T Consensus       105 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             EEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            99999999899999999999999999986431                                                


Q ss_pred             --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 024158          115 --------------------------------------------------RFTEQQAATYIASLTNALAYCHENHVIHRD  144 (271)
Q Consensus       115 --------------------------------------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~d  144 (271)
                                                                        .+++..++.++.|++.||.|||+.|++|+|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrd  264 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRD  264 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCccc
Confidence                                                              256677889999999999999999999999


Q ss_pred             CCCCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 024158          145 IKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEA  218 (271)
Q Consensus       145 l~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~  218 (271)
                      |+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||++++++++ |..||..
T Consensus       265 lkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         265 LAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             CCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999998543211     122345678999999998889999999999999999997 8889876


Q ss_pred             CCcchhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          219 ESQKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       219 ~~~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ....+..             ..++.++.+++.+|+.++|.+||++++|++.
T Consensus       345 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         345 LPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5433321             1257899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.7e-39  Score=264.93  Aligned_cols=235  Identities=21%  Similarity=0.397  Sum_probs=198.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++...+|++.++||+|++|.||++.. ..+..+++|.+.....    ....+.+|+.+++.++|+|++++++++.. ...
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            56778999999999999999999985 4566799998865322    24567889999999999999999999877 778


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++++|++++++|.+++...  ..++...+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999999999763  35788899999999999999999999999999999999999999999999987543321


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~l  235 (271)
                      .    ....++..|+|||.+.+..++.++|+||||++++++++ |..||......+..            ..++.++.++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            1    12234567999999988888999999999999999998 99999876543322            2357899999


Q ss_pred             HHHhcccCccCCCCHHHHhc
Q 024158          236 ISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+.++|++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHcccCcccCcCHHHHHH
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=290.34  Aligned_cols=235  Identities=33%  Similarity=0.550  Sum_probs=206.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      -.||.|.+|+||.+++..+...++||.+.....   +..+-+.+|+.+-+.++|.||++++|.+.+++++-+.||..+||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            358999999999999999999999999855432   34577899999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-CCCCEEEeeeccccccc---Ccccccc
Q 024158          105 ELYRELRKH-RRF--TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSR---SKRHTMC  177 (271)
Q Consensus       105 ~L~~~l~~~-~~l--~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-~~~~~~L~dfg~~~~~~---~~~~~~~  177 (271)
                      ||.+++... +++  ++..+..+.+||++||.|||++.|+|||||-+||++. -.|.+||+|||.++...   +-+....
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT  737 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT  737 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence            999999764 356  7888899999999999999999999999999999995 47899999999986544   3455678


Q ss_pred             ccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhcc
Q 024158          178 GTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       178 ~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~  241 (271)
                      ||..|+|||++..++  |..++|||||||++.+|+||++||-....++.              ...++.+.+.+|.+|+.
T Consensus       738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence            999999999998765  78899999999999999999999965443322              23457889999999999


Q ss_pred             cCccCCCCHHHHhcCCccccC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++|..|||+.++|..||+|.+
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999988

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-39  Score=271.25  Aligned_cols=236  Identities=22%  Similarity=0.367  Sum_probs=195.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEec----------------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVE----------------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i   81 (271)
                      .++|++.+.||+|+||.||++.+..                ++..+++|.+.....  ......+.+|+.+++.++|+|+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence            4679999999999999999986432                344689998864422  2335678899999999999999


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHR-----------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Ni  150 (271)
                      +++++++..++..++++|++++++|.+++....           .++...+..++.|++.|+.+||+.|++|+||+|+||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni  161 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC  161 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence            999999999999999999999999999987532           366778999999999999999999999999999999


Q ss_pred             eeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh--CCCCCCCCCcch
Q 024158          151 LLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY--GAPPFEAESQKD  223 (271)
Q Consensus       151 li~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~--g~~p~~~~~~~~  223 (271)
                      +++.++.++|+|||++.......     ....+++.|++||...++.++.++|+||||+++|+|++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999875432211     12233568999999888889999999999999999997  778887654333


Q ss_pred             hh-------------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          224 TF-------------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       224 ~~-------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..                   ...++.+.+++.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            21                   124689999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-41  Score=260.46  Aligned_cols=246  Identities=26%  Similarity=0.471  Sum_probs=203.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDER   93 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~   93 (271)
                      ..+.++.+.+..||+|+.|+|++++...+|...|||.+.......  ..+.+...+.++... +.|+|++.+++|..+..
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nke--e~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHH--HHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            345566778889999999999999999999999999986654332  244555556555544 58999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ++++||.|. ..++.++.+- +++++.-+-.+.-.+++||.||.++ |++|||+||+|||+|..|++||||||.+-...+
T Consensus       166 V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  166 VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence            999999995 5777777763 5688888889999999999999876 899999999999999999999999999843332


Q ss_pred             --ccccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hhh--------------cccCHH
Q 024158          172 --KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTF--------------RSISAE  231 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~~--------------~~i~~~  231 (271)
                        ......|.+.|+|||.+..   ..|+.++||||||+.+++|+||.-||.+...+ +.+              .+.++.
T Consensus       245 SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~  324 (391)
T KOG0983|consen  245 SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPD  324 (391)
T ss_pred             ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHH
Confidence              2345578899999998864   45889999999999999999999999885432 111              126899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +++++..||.+|+.+||.+.++|+|||+....
T Consensus       325 F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  325 FQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            99999999999999999999999999998763

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-39  Score=268.12  Aligned_cols=236  Identities=26%  Similarity=0.428  Sum_probs=194.1

Q ss_pred             ccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--D   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~   91 (271)
                      -++|++++.||+|+||.||++.    +..++..+++|.+.....   .....+.+|+++++.++|+|++++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            4689999999999999999987    456788999999865432   334677889999999999999999998653  3


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ..+++++||+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            4689999999999999999764 458999999999999999999999999999999999999999999999999885433


Q ss_pred             Cccc------cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------------
Q 024158          171 SKRH------TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------------  222 (271)
Q Consensus       171 ~~~~------~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------------  222 (271)
                      ....      ...++..|+|||.+.+..++.++|+||||+++++|++|..++......                      
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            2211      112334599999998888999999999999999999987665322110                      


Q ss_pred             ------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          223 ------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       223 ------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                            .....++.++.+++.+|+..+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                  0012357899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=267.53  Aligned_cols=230  Identities=25%  Similarity=0.402  Sum_probs=190.9

Q ss_pred             eeecccCCceEEEEEEecCCc--eEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEecc
Q 024158           25 RPLGKGKFGRVYLVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      +.||+|+||.||++++..++.  .+++|.+....  .......+.+|+.++.++ +|||++++++++...+.++++||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            368999999999999888775  46778775322  123345678899999999 7999999999999999999999999


Q ss_pred             CCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158          102 HRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus       102 ~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ++++|.+++...+                .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999997532                378899999999999999999999999999999999999999999999998


Q ss_pred             cccccCcc--ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          166 SVQSRSKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       166 ~~~~~~~~--~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      +.......  .....+..|+|||.+.+..++.++|+||||+++++|++ |..||......+..            ..++.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDD  238 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCCcCCH
Confidence            74322211  11223567999999988889999999999999999996 99999765433322            22568


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+|+..+|.+|||+.+++..
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         239 EVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             HHHHHHHHHcccChhhCCCHHHHHHH
Confidence            89999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-39  Score=263.00  Aligned_cols=228  Identities=27%  Similarity=0.409  Sum_probs=194.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      ++||.|++|.||++.+.. ++.+++|.+......  .....+.+|+.+++.++|+|++++++++...+..++++|++.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            468999999999999877 999999998654433  33567888999999999999999999999999999999999999


Q ss_pred             chHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc-----ccccc
Q 024158          105 ELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCG  178 (271)
Q Consensus       105 ~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~  178 (271)
                      +|.+++.. ...++...+..++.+++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......     .....
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999965 3467899999999999999999999999999999999999999999999999875443211     11223


Q ss_pred             cccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHHHhcccCcc
Q 024158          179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       179 ~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~~p~  245 (271)
                      +..|+|||.+.+..++.++|+||||++++++++ |..||.........            ...+.++.+++.+||..+|+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            556999999988889999999999999999998 88888765533221            23578999999999999999


Q ss_pred             CCCCHHHHhc
Q 024158          246 KRLSLQKIME  255 (271)
Q Consensus       246 ~Rps~~~il~  255 (271)
                      +|||++++++
T Consensus       238 ~Rp~~~ell~  247 (251)
T cd05041         238 NRPSFSEIYN  247 (251)
T ss_pred             hCcCHHHHHH
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-39  Score=295.73  Aligned_cols=150  Identities=33%  Similarity=0.628  Sum_probs=138.5

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      .+++|+++++||+|+||.||+|.+..+++.||+|++.............+..|+.++..++|+||+++++.+.....+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999976554444556778889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ||||+.+++|.+++.....+++..++.++.||+.||.|||.+||+|+||||+|||++.++.++|+|||++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls  151 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS  151 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence            9999999999999988778899999999999999999999999999999999999999999999999976

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-39  Score=263.61  Aligned_cols=228  Identities=25%  Similarity=0.392  Sum_probs=189.9

Q ss_pred             eecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           26 PLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      .||+|+||.||++...  ..+..+++|++.....  ....+.+.+|+.+++.++|+|++++++++. ....++++||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999998765  4456799999865432  234567889999999999999999999875 4578999999999


Q ss_pred             CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc------ccc
Q 024158          104 GELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTM  176 (271)
Q Consensus       104 ~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~------~~~  176 (271)
                      ++|.+++.. ...+++..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.......      ...
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999875 3468999999999999999999999999999999999999999999999999875332221      111


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHHHhcccC
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLISRLLVKD  243 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~~~l~~~  243 (271)
                      .++..|+|||.+.+..++.++|+||||+++|++++ |..||......+...            ..++++.+++.+|+..+
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~  238 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYK  238 (257)
T ss_pred             CCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            22467999999988888999999999999999996 999998765443321            24789999999999999


Q ss_pred             ccCCCCHHHHhcC
Q 024158          244 SSKRLSLQKIMEH  256 (271)
Q Consensus       244 p~~Rps~~~il~~  256 (271)
                      |++||++.+|++.
T Consensus       239 ~~~Rp~~~~i~~~  251 (257)
T cd05115         239 WEDRPNFAKVEER  251 (257)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-41  Score=271.07  Aligned_cols=245  Identities=25%  Similarity=0.458  Sum_probs=210.2

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC--CCc----eeceeeE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPN----ILRLYGW   87 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~----i~~~~~~   87 (271)
                      ..+-.++|.+++.+|+|.||.|-.+.+.+++..+|+|+++.  +.  +..+..+-|+..+.++.  .|+    ++++.++
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~--V~--kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w  159 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN--VD--KYREAALIEIEVLQKINESDPNGKFRCVQMRDW  159 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH--HH--HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence            34557889999999999999999999999999999999843  22  33456677889999883  232    6777788


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-----------
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-----------  154 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-----------  154 (271)
                      ++-.++.|+|+|.+ |.|+.+++.++.  +++...++.++.||++++.+||+.+++|.|+||+||++..           
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence            99999999999999 479999998754  6899999999999999999999999999999999999941           


Q ss_pred             ---------CCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh
Q 024158          155 ---------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF  225 (271)
Q Consensus       155 ---------~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~  225 (271)
                               ...++++|||.+.......+....|--|.|||++.+-+++..+||||+||||.|+++|...|+..+..+.+
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                     23599999999988887777778889999999999999999999999999999999999999887755422


Q ss_pred             ---ccc------------------------------------------------------CHHHHHHHHHhcccCccCCC
Q 024158          226 ---RSI------------------------------------------------------SAEAKHLISRLLVKDSSKRL  248 (271)
Q Consensus       226 ---~~i------------------------------------------------------~~~l~~li~~~l~~~p~~Rp  248 (271)
                         +.+                                                      ..+|.+|+++||..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence               110                                                      25689999999999999999


Q ss_pred             CHHHHhcCCccccCC
Q 024158          249 SLQKIMEHPWIIKNA  263 (271)
Q Consensus       249 s~~~il~~~~~~~~~  263 (271)
                      |+.|+|.||||....
T Consensus       399 Tl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  399 TLREALSHPFFARLT  413 (415)
T ss_pred             cHHHHhcCHHhhcCC
Confidence            999999999998754

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-39  Score=267.15  Aligned_cols=239  Identities=23%  Similarity=0.325  Sum_probs=200.5

Q ss_pred             CccccceeeeeeecccCCceEEEEEEec----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .++..+|++.+.||+|+||.||+|.+..    .+..+++|.+....  .......+.+|+.++++++|+|++++++++..
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3567899999999999999999999876    25778999875432  22345678889999999999999999998765


Q ss_pred             -CCeEEEEEeccCCCchHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           91 -DERIFLILEYAHRGELYRELRKH--------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~~--------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                       +...+++++++++++|.+++...        ..+++..++.++.|++.|+.|||+.+++|+||+|+||+++.++.++|+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence             46789999999989999998653        358899999999999999999999999999999999999999999999


Q ss_pred             eecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh----------
Q 024158          162 DFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF----------  225 (271)
Q Consensus       162 dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~----------  225 (271)
                      |||++.......     ....++..|+|||.+.+..++.++|+||||+++|++++ |..||....+.+..          
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            999985432211     12234567999999988889999999999999999998 99999765543322          


Q ss_pred             --cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          226 --RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       226 --~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                        ...|+++.+++.+|+..+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              234789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=284.77  Aligned_cols=245  Identities=27%  Similarity=0.473  Sum_probs=213.1

Q ss_pred             ccccce-eeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-
Q 024158           16 WSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-   92 (271)
Q Consensus        16 ~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   92 (271)
                      ..-++| +....||+|+|.+||+|.|..+|..||--.++.+... .+...+.+..|+.+|+.++|+||++++..+.+.. 
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            344555 6777899999999999999999999887766544332 3455788999999999999999999999997655 


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCeeeCC-CCCEEEeeeccccc
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--HVIHRDIKPENLLLDH-EGRLKIGDFGWSVQ  168 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~  168 (271)
                       ..-+|+|.+..|+|..++++.+..+...+..|+.||++||.|||++  .|+|||||.+||+|+. .|.+||+|+|++..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence             4788999999999999999999999999999999999999999999  5999999999999965 58999999999976


Q ss_pred             ccCcccc-ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-------------c-CHHHH
Q 024158          169 SRSKRHT-MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------------I-SAEAK  233 (271)
Q Consensus       169 ~~~~~~~-~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-------------i-~~~l~  233 (271)
                      ....... ..|||.|+|||.+- ..|+...||||||+++++|+|+.-||.-....-++.+             + .++++
T Consensus       196 ~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr  274 (632)
T KOG0584|consen  196 LRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVR  274 (632)
T ss_pred             hhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHH
Confidence            6654433 58999999999986 8899999999999999999999999987766555432             1 68999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||.+||.. ...|||+.++|.||||...
T Consensus       275 ~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  275 EFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            999999998 9999999999999999876

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=5.3e-41  Score=265.64  Aligned_cols=247  Identities=27%  Similarity=0.511  Sum_probs=204.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-C
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-D   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   91 (271)
                      .+..|++++.||+|.+|.||+|..++++.    .+|+|.++.....+ ......-+|+.+++.++|+|++.+..++.. +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            35679999999999999999996655543    68999886552221 233455689999999999999999999877 7


Q ss_pred             CeEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC----CCEEEee
Q 024158           92 ERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGD  162 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~----~~~~L~d  162 (271)
                      ..+++++||.+. +|...++-     .+.++...+.++++||+.|+.|||++-+.|||+||.|||+..+    |.+||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            889999999974 99999863     2468999999999999999999999999999999999999877    8999999


Q ss_pred             ecccccccCc------cccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------hc
Q 024158          163 FGWSVQSRSK------RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------FR  226 (271)
Q Consensus       163 fg~~~~~~~~------~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------~~  226 (271)
                      +|++......      ......|..|+|||.+.|.. |+.+.|+|+.||++.||++-.+.|.+....-.         +.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9998554432      23345688999999999865 88999999999999999999998876542211         11


Q ss_pred             cc------------------------------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          227 SI------------------------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       227 ~i------------------------------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                      +|                                                ++...+|+.+||..||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            10                                                455889999999999999999999999999


Q ss_pred             cccCCCC
Q 024158          259 IIKNANP  265 (271)
Q Consensus       259 ~~~~~~~  265 (271)
                      |..-+.|
T Consensus       340 F~~d~lp  346 (438)
T KOG0666|consen  340 FTEDPLP  346 (438)
T ss_pred             cccCCCC
Confidence            9998776

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-39  Score=268.39  Aligned_cols=237  Identities=24%  Similarity=0.404  Sum_probs=199.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEe----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREV----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--   90 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   90 (271)
                      +..+|++.+.||+|+||.||+++..    .++..+++|.+......  .....+.+|+..++.++|+|++++++++..  
T Consensus         2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            4568899999999999999999854    34788999998765443  345678899999999999999999999877  


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +...++++|++++++|.+++.... .++...+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            557899999999999999997654 5899999999999999999999999999999999999999999999999988554


Q ss_pred             cCcc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------------
Q 024158          170 RSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------  224 (271)
Q Consensus       170 ~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------------  224 (271)
                      ....      ....++..|++||...+..++.++|+||||+++++|++|..|+........                   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            4211      122334569999999888899999999999999999999998765322110                   


Q ss_pred             --------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 --------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 --------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                              ....+.++.+++.+||.++|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence                    0124678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-42  Score=266.34  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=214.5

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ...+.-...+.|.-+.+||+|.||+||+|+.+++|+.|++|.+.... +.+..-....+|+.++..++|+|++.++++|.
T Consensus         8 ~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen    8 MYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             ccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            34455567888999999999999999999999999999988763322 12223345568999999999999999998874


Q ss_pred             e--------CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEE
Q 024158           90 D--------DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        90 ~--------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L  160 (271)
                      .        ...+|+|+++|+ -+|.-++.+. ..+++..+..++.++++||.|+|+..|.|||+|+.|++|+.+|.++|
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilkl  165 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKL  165 (376)
T ss_pred             hccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEe
Confidence            3        235899999997 4999999775 57999999999999999999999999999999999999999999999


Q ss_pred             eeecccccccCc-cc------cccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc----
Q 024158          161 GDFGWSVQSRSK-RH------TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----  228 (271)
Q Consensus       161 ~dfg~~~~~~~~-~~------~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i----  228 (271)
                      .|||++...... ..      ....|..|++||.+.|. .+..+.|+|..||++.+|.++.+.+++.+..+++.-|    
T Consensus       166 ADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc  245 (376)
T KOG0669|consen  166 ADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC  245 (376)
T ss_pred             eccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh
Confidence            999998433221 11      12348899999999875 5889999999999999999999999988765553221    


Q ss_pred             ------------------------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          229 ------------------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       229 ------------------------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                                .++..+|+..+|..||.+|+.++++++|.||.+-++|.
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pq  325 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQ  325 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcch
Confidence                                                      35788999999999999999999999999999999986


Q ss_pred             C
Q 024158          267 G  267 (271)
Q Consensus       267 ~  267 (271)
                      +
T Consensus       326 a  326 (376)
T KOG0669|consen  326 A  326 (376)
T ss_pred             h
Confidence            5

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-41  Score=282.40  Aligned_cols=239  Identities=34%  Similarity=0.601  Sum_probs=212.0

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      .+.||+|.||+||-+++.++|+.||||++.+-.+.+.. ...+++|.++++++.||+|+.+-..++..+..++|||.+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence            46799999999999999999999999999887776643 4889999999999999999999999999999999999997 


Q ss_pred             CchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeecccccccCc--cccc
Q 024158          104 GELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRSK--RHTM  176 (271)
Q Consensus       104 ~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~~~~--~~~~  176 (271)
                      |+..+.+-.  .+.|++.....++.||+.||+|||-++|+|+|+||+||++....   .+||||||++......  ....
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV  726 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV  726 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence            466666643  35689999999999999999999999999999999999996543   7999999999776654  4556


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-------------cchhhcccCHHHHHHHHHhcccC
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-------------QKDTFRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~-------------~~~~~~~i~~~l~~li~~~l~~~  243 (271)
                      .|||.|+|||.+.+..|..+-|+||.|+++|--++|..||....             +..-|..++++..+||+.+|+..
T Consensus       727 VGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVk  806 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVK  806 (888)
T ss_pred             cCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHH
Confidence            89999999999999999999999999999999999999997543             23446678999999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~~  264 (271)
                      -.+|.|++..|.|||.|..+.
T Consensus       807 m~kRysvdk~lsh~Wlq~yq~  827 (888)
T KOG4236|consen  807 MRKRYSVDKSLSHPWLQDYQT  827 (888)
T ss_pred             HHHhcchHhhccchhhhcchH
Confidence            999999999999999998864

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-39  Score=264.73  Aligned_cols=238  Identities=26%  Similarity=0.449  Sum_probs=198.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      +...+|.+.+.||+|++|.||+|.+...   ...+++|.+.....  ....+.+.+|+.+++.++|+|++++++++.. +
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            4557799999999999999999987544   34689998855432  2334678889999999999999999998865 4


Q ss_pred             eEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++++|++++++|.+++.... .++...++.++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            5789999999999999997643 589999999999999999999999999999999999999999999999998754322


Q ss_pred             cc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHH
Q 024158          172 KR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       172 ~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                      ..    ....+++.|+|||.+.+..++.++|+||||++++++++ |..||......+..            ..++.++.+
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  239 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence            21    12223467999999988888999999999999999885 99999776543322            345899999


Q ss_pred             HHHHhcccCccCCCCHHHHhcC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+|+..+|++|||+.++++.
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.3e-39  Score=261.09  Aligned_cols=229  Identities=24%  Similarity=0.422  Sum_probs=193.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +.||+|++|.||++.. .++..+++|.+......  .....+.+|+.+++.++|+|++++++++...+..++++|+++++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            3689999999999985 47888999998654322  23446788999999999999999999999999999999999999


Q ss_pred             chHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----cccccc
Q 024158          105 ELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT  179 (271)
Q Consensus       105 ~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----~~~~~~  179 (271)
                      +|.+++... ..+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||++.......    ....++
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence            999998753 457899999999999999999999999999999999999999999999999875433221    112335


Q ss_pred             ccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hcccCHHHHHHHHHhcccCccC
Q 024158          180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       180 ~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~~p~~  246 (271)
                      ..|+|||.+.+..++.++|+||||+++|++++ |..||........            ...++.++.+++.+|+..+|++
T Consensus       158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (250)
T cd05085         158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPEN  237 (250)
T ss_pred             ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCccc
Confidence            67999999988889999999999999999998 9999976654322            1235799999999999999999


Q ss_pred             CCCHHHHhcC
Q 024158          247 RLSLQKIMEH  256 (271)
Q Consensus       247 Rps~~~il~~  256 (271)
                      |||+.++++.
T Consensus       238 Rp~~~~l~~~  247 (250)
T cd05085         238 RPKFSELQKE  247 (250)
T ss_pred             CCCHHHHHHH
Confidence            9999999753

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-41  Score=274.40  Aligned_cols=262  Identities=32%  Similarity=0.561  Sum_probs=234.4

Q ss_pred             CCchhhhhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CC
Q 024158            1 MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP   79 (271)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~   79 (271)
                      |.+++.........-++..||..+..||.|+||.|-++..+.+.+.+|||+++++..-.....+.-..|-++|.... -|
T Consensus       331 ~~~~~~~~~~~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kpp  410 (683)
T KOG0696|consen  331 MPTDSKFHNSSKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP  410 (683)
T ss_pred             CCCcccCCCCCcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCc
Confidence            45555555556666889999999999999999999999999999999999999887766666777777888887774 57


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      .+++++..+..-+.+|+||||+.||+|--.+++-+.+-+..+..++..|+-+|.+||++||+.||||.+|||++.+|++|
T Consensus       411 FL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiK  490 (683)
T KOG0696|consen  411 FLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIK  490 (683)
T ss_pred             hHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceE
Confidence            89999999999999999999999999999999888888999999999999999999999999999999999999999999


Q ss_pred             Eeeeccccc---ccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc---------
Q 024158          160 IGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------  227 (271)
Q Consensus       160 L~dfg~~~~---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~---------  227 (271)
                      |.|||.++.   ....+...+|||.|+|||+....+|..+.|-|++|++||+|+.|++||++.+..+.++.         
T Consensus       491 i~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP  570 (683)
T KOG0696|consen  491 IADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP  570 (683)
T ss_pred             eeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc
Confidence            999999854   33455678999999999999999999999999999999999999999999998887654         


Q ss_pred             --cCHHHHHHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          228 --ISAEAKHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       228 --i~~~l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                        ++.+..++.+..|.+.|.+|.-     -.+|.+||||...
T Consensus       571 KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  571 KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence              5899999999999999999983     4789999999875

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.1e-38  Score=262.56  Aligned_cols=237  Identities=28%  Similarity=0.518  Sum_probs=198.7

Q ss_pred             ceeeeeeecccCCceEEEEEEec-CCceEEEEEechhhh-------hHHHHHHHHHHHHHHHhh-CCCCceeceeeEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQI-------EKYKIQHQLRREMEIQSS-LRHPNILRLYGWFHD   90 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~-------~~~~~~~~~~~e~~~l~~-~~~~~i~~~~~~~~~   90 (271)
                      +|++.+.||+|++|.||++++.. .+..+++|.+.....       ........+.+|+.++.+ ++|+|++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            58899999999999999999887 678899998753221       222344566778887765 789999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           91 DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ++..++++||+++++|.+++..    ...++...++.++.|++.++.+||+ .|++|+||+|.||+++.++.++|+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3468999999999999999999996 6899999999999999999999999998


Q ss_pred             cccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCH
Q 024158          166 SVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISA  230 (271)
Q Consensus       166 ~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~  230 (271)
                      +......  .....++..|++||.+.+..++.++|+||||+++|++++|..||.........             ..+++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSE  240 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCH
Confidence            8544332  23445788899999999888999999999999999999999998765432211             13578


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+|+..||++||++.++.++
T Consensus       241 ~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         241 DVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            99999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.5e-39  Score=261.21  Aligned_cols=225  Identities=24%  Similarity=0.388  Sum_probs=187.7

Q ss_pred             eeecccCCceEEEEEEecCC----------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           25 RPLGKGKFGRVYLVREVESK----------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~----------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      +.||+|+||.||++.+..++          ..+++|.+......    ...+.+++.+++.++|+|++++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            46899999999999988776          34777776443211    4677889999999999999999999877 678


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-------CEEEeeeccc
Q 024158           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-------RLKIGDFGWS  166 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-------~~~L~dfg~~  166 (271)
                      ++++||+++++|.+++...+ .++...+..++.||+.||.|||++|++|+||+|+||+++.++       .++|+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 689999999999999999999999999999999999999887       7999999988


Q ss_pred             ccccCccccccccccccCCccccCC--CCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc----------ccCHHHH
Q 024158          167 VQSRSKRHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR----------SISAEAK  233 (271)
Q Consensus       167 ~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~----------~i~~~l~  233 (271)
                      ..... .....++..|+|||.+.+.  .++.++|+||||+++|++++ |..||..........          .....+.
T Consensus       156 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (259)
T cd05037         156 ITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDCAELA  234 (259)
T ss_pred             ccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCchHHH
Confidence            65443 2334456789999999876  68889999999999999998 577776654322111          1136899


Q ss_pred             HHHHHhcccCccCCCCHHHHhc
Q 024158          234 HLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +++.+||..+|.+|||+.++++
T Consensus       235 ~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         235 NLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-38  Score=263.02  Aligned_cols=228  Identities=23%  Similarity=0.342  Sum_probs=186.4

Q ss_pred             eeecccCCceEEEEEEecC------------------------CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc
Q 024158           25 RPLGKGKFGRVYLVREVES------------------------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN   80 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~------------------------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~   80 (271)
                      .+||+|+||.||++....+                        ...+++|.+.....   .....+.+++.+++.++|+|
T Consensus         1 ~~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CCcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCC
Confidence            3699999999999874322                        24588888754322   23456778889999999999


Q ss_pred             eeceeeEEEeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---
Q 024158           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---  156 (271)
Q Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---  156 (271)
                      |+++++++..+...++||||+++++|..++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++..+   
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999999999865 45689999999999999999999999999999999999997644   


Q ss_pred             ----CEEEeeecccccccCccccccccccccCCccccC-CCCCccchhhhHHHHHHHHH-hCCCCCCCCCcchhh-----
Q 024158          157 ----RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF-----  225 (271)
Q Consensus       157 ----~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~-----  225 (271)
                          .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++ +|..||....+.+..     
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  236 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK  236 (274)
T ss_pred             CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh
Confidence                3899999987443322 23356778999998865 45788999999999999985 799999766544321     


Q ss_pred             -----cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 -----RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 -----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                           ...++++.+++.+||..+|++|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence                 1235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=280.40  Aligned_cols=235  Identities=34%  Similarity=0.588  Sum_probs=205.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~   95 (271)
                      -.++|.+...+|.|+|+.+-.+.+..++..+++|++.+..       .+..+++.++... +|+|++++.+++.++.+.|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            4677899999999999999999999999999999996652       2234566555444 6999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee-CCCCCEEEeeecccccccCccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL-DHEGRLKIGDFGWSVQSRSKRH  174 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili-~~~~~~~L~dfg~~~~~~~~~~  174 (271)
                      +|||.+.++-+.+.+...+.++ .++..|+.+|+.++.+||++|++|||+||+|||+ +..++++|+|||.+........
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            9999999988888887655455 7888899999999999999999999999999999 5889999999999877776655


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hhh---------cccCHHHHHHHHHhcccCc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTF---------RSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~~---------~~i~~~l~~li~~~l~~~p  244 (271)
                      ..+-|..|.|||.+...+++.++|+||||++||+|++|..||...... +..         ..++.++++|++.||+.||
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP  551 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDP  551 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCCh
Confidence            556788899999999999999999999999999999999999876655 222         3368999999999999999


Q ss_pred             cCCCCHHHHhcCCcc
Q 024158          245 SKRLSLQKIMEHPWI  259 (271)
Q Consensus       245 ~~Rps~~~il~~~~~  259 (271)
                      .+||++.+++.||||
T Consensus       552 ~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  552 ALRLGADEIGAHPWF  566 (612)
T ss_pred             hhCcChhhhccCcch
Confidence            999999999999999

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.2e-39  Score=264.34  Aligned_cols=229  Identities=26%  Similarity=0.447  Sum_probs=191.5

Q ss_pred             eeecccCCceEEEEEEecCC------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           25 RPLGKGKFGRVYLVREVESK------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +.||+|++|.||+++.....      ..+++|.+......  .....+.+|+.+++.++|+||+++++++...+..++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            36899999999999876543      67899987543221  23456788999999999999999999999989999999


Q ss_pred             eccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-----CEEEeeeccc
Q 024158           99 EYAHRGELYRELRKH-------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWS  166 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-----~~~L~dfg~~  166 (271)
                      |++++++|.+++...       ..+++..++.++.|++.++.|||+++++|+||+|+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       2378899999999999999999999999999999999999887     8999999987


Q ss_pred             ccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchh------------hccc
Q 024158          167 VQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDT------------FRSI  228 (271)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~------------~~~i  228 (271)
                      ......     .....++..|+|||.+.++.++.++|+||||+++|+|++ |..||......+.            ...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENC  238 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCcccc
Confidence            543221     122344678999999998889999999999999999997 9999876543332            2246


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      |+.+.+++.+||.++|.+||+++++++
T Consensus       239 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         239 PDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             hHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            789999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.5e-39  Score=263.38  Aligned_cols=228  Identities=22%  Similarity=0.361  Sum_probs=187.5

Q ss_pred             eeecccCCceEEEEEEecCCce-------EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           25 RPLGKGKFGRVYLVREVESKHP-------VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~-------~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +.||+|+||.||++.+...+..       +++|.+....   ....+.+.++..+++.+.|+|++++++++..++..+++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            3689999999999998665443       7777764332   23345778899999999999999999999998899999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC--------EEEeeeccccc
Q 024158           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--------LKIGDFGWSVQ  168 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~--------~~L~dfg~~~~  168 (271)
                      |||+++++|.+++...+ .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.        ++++|||.+..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997643 5899999999999999999999999999999999999987764        69999998754


Q ss_pred             ccCccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCC-CCCCCCCcchhh----------cccCHHHHHHH
Q 024158          169 SRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTF----------RSISAEAKHLI  236 (271)
Q Consensus       169 ~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~-~p~~~~~~~~~~----------~~i~~~l~~li  236 (271)
                      ... .....++..|+|||.+.+. .++.++|+||||+++|++++|. .|+.........          ...+.++.+++
T Consensus       158 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (258)
T cd05078         158 VLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLI  236 (258)
T ss_pred             cCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHH
Confidence            433 2334567889999998764 4788999999999999999984 666554433221          12357899999


Q ss_pred             HHhcccCccCCCCHHHHhcC
Q 024158          237 SRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+||..+|++|||++++++.
T Consensus       237 ~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         237 NQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHhccChhhCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.7e-38  Score=260.50  Aligned_cols=228  Identities=22%  Similarity=0.361  Sum_probs=186.6

Q ss_pred             eeecccCCceEEEEEEec------------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           25 RPLGKGKFGRVYLVREVE------------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~------------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      +.||+|++|.||++....            ....+++|.+....   ......+.+++.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            468999999999997432            22358888875432   233456778899999999999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC-------EEEeeec
Q 024158           93 RIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-------LKIGDFG  164 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~-------~~L~dfg  164 (271)
                      ..++++|++++++|..++.. ...+++..++.++.||++|+.|||++|++|+||+|+||+++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            89999999999999888875 346899999999999999999999999999999999999987654       8999999


Q ss_pred             ccccccCccccccccccccCCcccc-CCCCCccchhhhHHHHHHHHH-hCCCCCCCCCcchhh----------cccCHHH
Q 024158          165 WSVQSRSKRHTMCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF----------RSISAEA  232 (271)
Q Consensus       165 ~~~~~~~~~~~~~~~~~y~~pe~~~-~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~----------~~i~~~l  232 (271)
                      .+...... ....++..|+|||.+. +..++.++|+||||+++|+|+ .|..|+......+..          ...+.++
T Consensus       158 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd05077         158 IPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKEL  236 (262)
T ss_pred             CCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHH
Confidence            87544322 2345678899999886 456888999999999999997 688888765432221          1135789


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+++.+||..||.+||++.+|+++
T Consensus       237 ~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         237 ADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-38  Score=266.58  Aligned_cols=240  Identities=21%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      +.++.++|++.+.||+|++|.||++++..++.    .+++|.+......  .....+.+|+.+++.++|+|++++++++.
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~   79 (303)
T cd05110           2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCL   79 (303)
T ss_pred             cccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence            35677899999999999999999999877776    4688877543322  22346788999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .. ..+++++++++++|.+++.... .++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          80 SP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             CC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence            54 4678999999999999987644 588999999999999999999999999999999999999999999999998854


Q ss_pred             ccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          169 SRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       169 ~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      ....     .....++..|++||.+.+..++.++|+||||+++|++++ |..||.+....+..            ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTI  238 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCH
Confidence            3321     112334668999999988889999999999999999986 88999765432211            12467


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+.+++.+|+..+|++||+++++++.
T Consensus       239 ~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         239 DVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            89999999999999999999998875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-41  Score=307.96  Aligned_cols=243  Identities=31%  Similarity=0.554  Sum_probs=213.2

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      +++-...||.|.||.||.|.+..+|+-.|+|.+.-.... .+....+.+|+.++..++|||+++++++--..+..++.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            356677899999999999999999999999998655444 4567788899999999999999999999988888999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-------
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-------  172 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-------  172 (271)
                      ||++|+|.+++..++-+++.....+..|++.|+.|||+.||+|+||||.||+++.+|.+|++|||.+......       
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            9999999999999888888888899999999999999999999999999999999999999999998443332       


Q ss_pred             cccccccccccCCccccCCC---CCccchhhhHHHHHHHHHhCCCCCCCCC-------------cchhhcccCHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAES-------------QKDTFRSISAEAKHLI  236 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~~-------------~~~~~~~i~~~l~~li  236 (271)
                      -....||+.|+|||.+.+..   ...++|||||||++.+|+||+.||...+             .++..++++++-++|+
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            24568999999999998654   4468999999999999999999996443             2344456899999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccCC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .+||..||++|+++.|+++|.|-+-..
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhcccccc
Confidence            999999999999999999999876543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.1e-38  Score=262.54  Aligned_cols=243  Identities=17%  Similarity=0.199  Sum_probs=189.4

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhH--HH------HHHHHHHHHHHHhhCCCCc
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEK--YK------IQHQLRREMEIQSSLRHPN   80 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~--~~------~~~~~~~e~~~l~~~~~~~   80 (271)
                      ...++.-++|++.+.||+|+||.||+|+...+   +..+++|.........  +.      .......+...+..+.|++
T Consensus         5 ~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~   84 (294)
T PHA02882          5 PLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLG   84 (294)
T ss_pred             eeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence            34456668999999999999999999998777   6677777643221110  00      0111223344556778999


Q ss_pred             eeceeeEEEeCC----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC
Q 024158           81 ILRLYGWFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG  156 (271)
Q Consensus        81 i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~  156 (271)
                      ++++++.+....    ..+++++.+. .++.+.+......+...+..++.|++.|+.+||+++++||||||+||+++.++
T Consensus        85 i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         85 IPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             CCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence            999998765543    3477788774 57777776655568888999999999999999999999999999999999999


Q ss_pred             CEEEeeecccccccC----------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--
Q 024158          157 RLKIGDFGWSVQSRS----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--  224 (271)
Q Consensus       157 ~~~L~dfg~~~~~~~----------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--  224 (271)
                      .++|+|||++.....          ......||+.|+|||.+.+..++.++|+||||+++++|++|..||.+......  
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999854321          11234689999999999999999999999999999999999999987632111  


Q ss_pred             -----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 -----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 -----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                       ....++++.++++.|+..+|++||+++++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                             1234788999999999999999999999975

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.9e-38  Score=258.16  Aligned_cols=230  Identities=22%  Similarity=0.371  Sum_probs=186.4

Q ss_pred             eeecccCCceEEEEEEec---CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE-eCCeEEEEEec
Q 024158           25 RPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-DDERIFLILEY  100 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e~  100 (271)
                      +.||+|+||.||+|....   .+..+++|.+....  .......+.+|+.+++.++|||++++++++. .++..++++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998654   34569999874322  2233567778999999999999999999765 45568999999


Q ss_pred             cCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-------
Q 024158          101 AHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-------  172 (271)
Q Consensus       101 ~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-------  172 (271)
                      +.+++|.+++... ..++...+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++......       
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999999764 34678888999999999999999999999999999999999999999999987543221       


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchh------------hcccCHHHHHHHHHh
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDT------------FRSISAEAKHLISRL  239 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~------------~~~i~~~l~~li~~~  239 (271)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++| .+||......+.            ...+++.+.+++.+|
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  238 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSC  238 (262)
T ss_pred             cccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHH
Confidence            1123346689999999888899999999999999999985 566654433221            123578999999999


Q ss_pred             cccCccCCCCHHHHhcC
Q 024158          240 LVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~  256 (271)
                      |.++|++||++.++++.
T Consensus       239 l~~~p~~Rp~~~~il~~  255 (262)
T cd05058         239 WHPKPEMRPTFSELVSR  255 (262)
T ss_pred             cCCChhhCCCHHHHHHH
Confidence            99999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.6e-38  Score=258.84  Aligned_cols=229  Identities=24%  Similarity=0.392  Sum_probs=183.9

Q ss_pred             eeecccCCceEEEEEEec--CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      +.||+|+||.||+|....  ....+++|.+.....  ......+.+|+..++.++|+||+++++.+.....+++++|+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            368999999999996433  345688887654322  2334567789999999999999999999998899999999999


Q ss_pred             CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----
Q 024158          103 RGELYRELRKHR-----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (271)
Q Consensus       103 ~~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----  172 (271)
                      +++|.+++....     ..++..+..++.||+.|+.|||++|++|+||+|+||+++.++.++|+|||++......     
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999997643     2467788999999999999999999999999999999999999999999987443221     


Q ss_pred             cccccccccccCCcccc-------CCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-----------------cc
Q 024158          173 RHTMCGTLDYLAPEMVE-------NKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-----------------RS  227 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-----------------~~  227 (271)
                      .....+++.|+|||.+.       ...++.++|+||||+++|+|++ |..||......+..                 ..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            12234567799999864       2346779999999999999998 78888765543221                 23


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +++.+.+++..|+ .||++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            5788889999998 599999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=276.61  Aligned_cols=256  Identities=39%  Similarity=0.634  Sum_probs=230.8

Q ss_pred             hhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      +........+++++.+++..||-||||.|-+++.+.....+|+|++++.-.-..+..+-+..|-.++..++.+.|+++|.
T Consensus       408 ~~~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYr  487 (732)
T KOG0614|consen  408 EDFAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYR  487 (732)
T ss_pred             HHHHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHH
Confidence            33455778899999999999999999999999977666679999998876666566667778889999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      -+.++.++|++||-|-||.|+..+...+.+.....+.++..+++|++|||++||+.||+||+|.+++.+|.+||.|||++
T Consensus       488 Tfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  488 TFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             HhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhH
Confidence            99999999999999999999999999899999999999999999999999999999999999999999999999999999


Q ss_pred             ccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHH
Q 024158          167 VQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAE  231 (271)
Q Consensus       167 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~  231 (271)
                      +....  .+-..+|||.|.|||+..+...+.+.|.|+||+++++|++|.+||++.++-...             ++|++.
T Consensus       568 Kki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~  647 (732)
T KOG0614|consen  568 KKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKT  647 (732)
T ss_pred             HHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchh
Confidence            76554  445678999999999999999999999999999999999999999988875442             456899


Q ss_pred             HHHHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          232 AKHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      ..+||.++...+|.+|.-     +.+|.+|.||...
T Consensus       648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            999999999999999984     8999999999876

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.8e-38  Score=257.54  Aligned_cols=228  Identities=23%  Similarity=0.368  Sum_probs=184.7

Q ss_pred             eeecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      +.||+|+||.||++...  .++..+++|.+......  .....+.+|+.+++.++|+|++++++.+.+....++++||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46899999999999754  34567999987554322  223467889999999999999999999988888999999999


Q ss_pred             CCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----
Q 024158          103 RGELYRELRKHR-----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (271)
Q Consensus       103 ~~~L~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----  172 (271)
                      +++|.+++....     .++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+......     
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999996532     3566788899999999999999999999999999999999999999999987543221     


Q ss_pred             cccccccccccCCccccCC-------CCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc-----------------c
Q 024158          173 RHTMCGTLDYLAPEMVENK-------EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR-----------------S  227 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~-------~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~-----------------~  227 (271)
                      .....++..|+|||.+.+.       .++.++|+||||+++|+|++ |..||......+...                 .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223456789999988542       34679999999999999996 999997655433211                 2


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .++.+.+++++|+ .+|++|||+++|..
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            4678899999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7.6e-38  Score=257.94  Aligned_cols=235  Identities=22%  Similarity=0.379  Sum_probs=192.5

Q ss_pred             eeeeeeecccCCceEEEEEEec---CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           21 FEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      |++.+.||+|++|.||+|....   ++..+++|.+....... ...+.+.+|+++++.++|||++++++++...+     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            6788999999999999998644   57889999986544333 33566788999999999999999999875432     


Q ss_pred             -eEEEEEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           93 -RIFLILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                       ..+++++++.+++|.+++...      ..++...+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247888999999998887432      1478899999999999999999999999999999999999999999999998


Q ss_pred             cccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cc
Q 024158          166 SVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RS  227 (271)
Q Consensus       166 ~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~  227 (271)
                      +......     .....+++.|++||.+.+..++.++|+||||+++|++++ |.+||......+..            ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  239 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPD  239 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCC
Confidence            7543221     112234567999999988888999999999999999998 88888766543321            12


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+..+.+++.+|+..+|++|||+.+++..
T Consensus       240 ~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         240 CLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            46899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-37  Score=250.05  Aligned_cols=227  Identities=44%  Similarity=0.810  Sum_probs=198.7

Q ss_pred             CCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHHH
Q 024158           31 KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL  110 (271)
Q Consensus        31 ~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  110 (271)
                      ++|.||+++...+++.+++|++........  .+.+.+|++.+++++|++++++++.+......++++|++++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999988999999999866544332  578889999999999999999999999989999999999988999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--ccccccccccccCCccc
Q 024158          111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMV  188 (271)
Q Consensus       111 ~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~~~~~~~~~y~~pe~~  188 (271)
                      .....++...++.++.+++.++.+||+.|++|+||+|.||+++.++.++|+|||.+.....  ......++..|++||.+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            8766689999999999999999999999999999999999999999999999998855444  33455678889999999


Q ss_pred             cCCCCCccchhhhHHHHHHHHHhCCCCCCCC-Ccchhhc--------------ccCHHHHHHHHHhcccCccCCCCHHHH
Q 024158          189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFR--------------SISAEAKHLISRLLVKDSSKRLSLQKI  253 (271)
Q Consensus       189 ~~~~~~~~~Di~slg~il~~l~~g~~p~~~~-~~~~~~~--------------~i~~~l~~li~~~l~~~p~~Rps~~~i  253 (271)
                      .+..++.++|+|++|++++++++|..||... .......              .++.++.+++.+|+..+|++||++.++
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            8888888999999999999999999999762 2221111              167899999999999999999999999


Q ss_pred             hcCCcc
Q 024158          254 MEHPWI  259 (271)
Q Consensus       254 l~~~~~  259 (271)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-37  Score=266.29  Aligned_cols=243  Identities=32%  Similarity=0.572  Sum_probs=212.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +-|..++.||-|+||+|.+++...+...||+|.+.+..+-......-++.|-.||..-+++-|++++-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            34888999999999999999999999999999997776665555666778889999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      +|++||++-++|-+-+-+.++.++.++..+..|+++.|..|++||||||+|||||.+|++||.|||++.-...       
T Consensus       709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            9999999999998877889999999999999999999999999999999999999999999999998721110       


Q ss_pred             --cc------------------------------------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCC
Q 024158          172 --KR------------------------------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA  213 (271)
Q Consensus       172 --~~------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~  213 (271)
                        ..                                    ....||+-|+|||++....++..+|-||.|++|++|+.|.
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence              00                                    1135789999999999999999999999999999999999


Q ss_pred             CCCCCCCcchhhc---------------ccCHHHHHHHHHhcccCccCCC---CHHHHhcCCccccC
Q 024158          214 PPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKN  262 (271)
Q Consensus       214 ~p~~~~~~~~~~~---------------~i~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~  262 (271)
                      +||-..++.+...               +++++..++|.++.. +++.|.   -.+++..||||+..
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence            9998887765533               258999999998765 688888   56679999999875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.3e-38  Score=242.41  Aligned_cols=237  Identities=29%  Similarity=0.554  Sum_probs=199.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCC--e
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE--R   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~--~   93 (271)
                      ...+|++++++|+|.+++||.++...+++.+++|++++-.      ...+.+|+.++..+. +|||+.++++..+..  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4567999999999999999999999999999999985532      467889999999996 999999999987654  5


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~  172 (271)
                      +.+++|+..+.+...+-   +.|+...+...+.+++.||.|||+.||.|+|+||+|+|||... .++|+|+|++...-+.
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            88999999876665544   5688999999999999999999999999999999999999764 7999999999665544


Q ss_pred             cc--cccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCC-CCCcchhhcc---------------------
Q 024158          173 RH--TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFE-AESQKDTFRS---------------------  227 (271)
Q Consensus       173 ~~--~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~-~~~~~~~~~~---------------------  227 (271)
                      ..  -...+-.|--||.+..- .|+.+-|+|||||++..|+..+.||. +.+..+++-+                     
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            33  23445667889988765 47889999999999999999888764 4555555432                     


Q ss_pred             ---------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 ---------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 ---------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                 .++++.+++.++|..|..+|+|+.+++.||||...
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                                       26999999999999999999999999999999754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=282.83  Aligned_cols=240  Identities=25%  Similarity=0.422  Sum_probs=207.3

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecC-Cc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVES-KH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ..+.-..-+..+.||+|.||.||.+..... |.    .|++|.+.+..  +.....++.+|..++++++||||++++|++
T Consensus       687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~  764 (1025)
T KOG1095|consen  687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVC  764 (1025)
T ss_pred             ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence            345566778899999999999999986543 32    38888875543  345578899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      .+.+.+++++|||++|+|..+|++.       ..|+..+++.++.|+++|+.||++++++||||...|.|++....+|+.
T Consensus       765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEc
Confidence            9999999999999999999999875       248999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCcccc-----ccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc---------
Q 024158          162 DFGWSVQSRSKRHT-----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR---------  226 (271)
Q Consensus       162 dfg~~~~~~~~~~~-----~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~---------  226 (271)
                      |||++.+.-...+.     ...+.+|+|||.+..+.++.++||||||++|||+++ |..||......+.+.         
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~  924 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLD  924 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccC
Confidence            99999743332221     234578999999999999999999999999999986 899999888766654         


Q ss_pred             ---ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          227 ---SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       227 ---~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                         .-|..+.+++..|+..+|++||++.+|++
T Consensus       925 ~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  925 PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence               23788999999999999999999999987

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.9e-37  Score=250.88  Aligned_cols=227  Identities=22%  Similarity=0.376  Sum_probs=181.0

Q ss_pred             eecccCCceEEEEEEecC--CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCC
Q 024158           26 PLGKGKFGRVYLVREVES--KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      .||+|+||.||+++...+  ...+++|.+.....  ....+.+.++...++.++|||++++++.+......|+++||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            689999999999975433  23466776644322  23356788889999999999999999999988899999999999


Q ss_pred             CchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-----ccc
Q 024158          104 GELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRH  174 (271)
Q Consensus       104 ~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----~~~  174 (271)
                      ++|.+++...    ..++...++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.....     ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            9999999763    2356677889999999999999999999999999999999999999999998743221     223


Q ss_pred             cccccccccCCccccC-------CCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-----------------cccC
Q 024158          175 TMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-----------------RSIS  229 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~-------~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-----------------~~i~  229 (271)
                      ...++..|+|||.+..       ..++.++|+||||+++|+|++ |..||......+..                 ..++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYS  239 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCc
Confidence            3456788999998743       234678999999999999986 57788654433221                 1247


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+.+++..|+ .+|++|||++++++
T Consensus       240 ~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         240 ERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            78899999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.2e-37  Score=274.54  Aligned_cols=244  Identities=18%  Similarity=0.273  Sum_probs=174.1

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecC----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE-
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW-   87 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~-   87 (271)
                      ...+..++|.+.+.||+|+||.||+|.+..+    +..+++|.+........     ... ..+ +...+.++..+... 
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~-e~l-~~~~~~~~~~~~~~~  198 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMN-ERV-RRACPNSCADFVYGF  198 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHH-HHH-HhhchhhHHHHHHhh
Confidence            4566889999999999999999999999888    89999998754321111     111 111 11111111111111 


Q ss_pred             -----EEeCCeEEEEEeccCCCchHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024158           88 -----FHDDERIFLILEYAHRGELYRELRKHRR--------------------FTEQQAATYIASLTNALAYCHENHVIH  142 (271)
Q Consensus        88 -----~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------l~~~~~~~i~~~l~~~l~~Lh~~~i~H  142 (271)
                           ...+..+++++||+++++|.+++.....                    .....+..++.||+.+|.|||++||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2355679999999999999998875321                    123346678999999999999999999


Q ss_pred             cCCCCCCeeeCC-CCCEEEeeecccccccC----ccccccccccccCCccccCCC----------------------CCc
Q 024158          143 RDIKPENLLLDH-EGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKE----------------------HDY  195 (271)
Q Consensus       143 ~dl~~~Nili~~-~~~~~L~dfg~~~~~~~----~~~~~~~~~~y~~pe~~~~~~----------------------~~~  195 (271)
                      +||||+|||++. ++.++|+|||++.....    ......+++.|+|||.+....                      ++.
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~  358 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD  358 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCC
Confidence            999999999986 57899999999864332    123456789999999664322                      234


Q ss_pred             cchhhhHHHHHHHHHhCCCCCCCCCc------------chhhc-------------------ccCHHHHHHHHHhcccCc
Q 024158          196 AVDNWTLGILCYEFLYGAPPFEAESQ------------KDTFR-------------------SISAEAKHLISRLLVKDS  244 (271)
Q Consensus       196 ~~Di~slg~il~~l~~g~~p~~~~~~------------~~~~~-------------------~i~~~l~~li~~~l~~~p  244 (271)
                      ++||||+||++|+|+++..++.....            ...+.                   .-+....+||.+||.+||
T Consensus       359 k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        359 RFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             CcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            56999999999999987665432110            00000                   012234589999999999


Q ss_pred             cCCCCHHHHhcCCccccCC
Q 024158          245 SKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       245 ~~Rps~~~il~~~~~~~~~  263 (271)
                      ++|||+.++|+||||++..
T Consensus       439 ~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        439 RQRISAKAALAHPYFDREG  457 (566)
T ss_pred             ccCCCHHHHhCCcCcCCCC
Confidence            9999999999999998754

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8e-38  Score=283.80  Aligned_cols=238  Identities=31%  Similarity=0.532  Sum_probs=192.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------   90 (271)
                      +.+|.++..||+||||.||+|+++-+|..||||++....  .......+.+|+..+.++.||||++++..+.+       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            467889999999999999999999999999999997665  34567888999999999999999998843310       


Q ss_pred             --------------------------------------------------------------------------------
Q 024158           91 --------------------------------------------------------------------------------   90 (271)
Q Consensus        91 --------------------------------------------------------------------------------   90 (271)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeEEEEEeccCCCchHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHh
Q 024158           91 ------------------------D--------ERIFLILEYAHRGELYRELRKHRRF-TEQQAATYIASLTNALAYCHE  137 (271)
Q Consensus        91 ------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~l-~~~~~~~i~~~l~~~l~~Lh~  137 (271)
                                              +        -.+|+-||||+...+.+++.++... .....+.++.+|++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                    0        1368899999876666766665433 478899999999999999999


Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccccccc---------------------CccccccccccccCCccccCCC---C
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---------------------SKRHTMCGTLDYLAPEMVENKE---H  193 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---------------------~~~~~~~~~~~y~~pe~~~~~~---~  193 (271)
                      .|++||||||.||+++.++.+||+|||++....                     ....+..||.-|+|||.+.+..   |
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999985411                     0112356888999999997655   8


Q ss_pred             CccchhhhHHHHHHHHHhCCCCCCC-CCcchhh---------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          194 DYAVDNWTLGILCYEFLYGAPPFEA-ESQKDTF---------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       194 ~~~~Di~slg~il~~l~~g~~p~~~-~~~~~~~---------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                      +.+.|+||||+++++|+.   ||.. ..+-..+               ..--+.-.++|..|+..||.+|||+.|+|.+.
T Consensus       796 n~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             cchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            999999999999999985   3431 1111111               11124568999999999999999999999999


Q ss_pred             ccc
Q 024158          258 WII  260 (271)
Q Consensus       258 ~~~  260 (271)
                      ||.
T Consensus       873 llp  875 (1351)
T KOG1035|consen  873 LLP  875 (1351)
T ss_pred             CCC
Confidence            987

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=263.31  Aligned_cols=242  Identities=24%  Similarity=0.405  Sum_probs=209.2

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ..+..++-.+...++++||+|.||.|.+|.- ..+..+|||.+.......  ...++..|+++|.+++||||+.++++|.
T Consensus       529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             CcchhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            3445556666778999999999999999985 347899999987665443  3578999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .++.+++++||++.|+|.+++.++  +.+......+++.||++|++||.+.+++|||+.+.|+|++.++++|++|||.+.
T Consensus       606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence            999999999999999999999886  334567778899999999999999999999999999999999999999999886


Q ss_pred             cccCccc-----cccccccccCCccccCCCCCccchhhhHHHHHHHHH--hCCCCCCCCCcchhhcc-------------
Q 024158          168 QSRSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL--YGAPPFEAESQKDTFRS-------------  227 (271)
Q Consensus       168 ~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~--~g~~p~~~~~~~~~~~~-------------  227 (271)
                      ..-+..+     ....+.+|+|+|.+..++++.++|+|++|+++|+++  +...||...++++..++             
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence            4443332     223478999999999999999999999999999975  68889998888776554             


Q ss_pred             ------cCHHHHHHHHHhcccCccCCCCHHHHh
Q 024158          228 ------ISAEAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       228 ------i~~~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                            -|..+.+++.+|+..+..+|||.+++-
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence                  278899999999999999999999984

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=248.62  Aligned_cols=255  Identities=31%  Similarity=0.597  Sum_probs=224.0

Q ss_pred             hhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      .........+.+++|++++.||+|++++|.+++.+++.+-|++|++++.........+..+.|-...... +||.++-++
T Consensus       238 m~g~~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  238 MDGIKISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             ccccccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence            3344567788999999999999999999999999999999999999998887777777777777776665 689999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ..+..+..+++|.||.+||+|-=.+++.+.|+++.++.+...|.-||.|||++||+.+|+|.+|+++|..|++||.|+|.
T Consensus       318 scfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  318 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             hhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence            99999999999999999999988888888999999999999999999999999999999999999999999999999999


Q ss_pred             ccc---ccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCC--Ccc-----hhh----------
Q 024158          166 SVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQK-----DTF----------  225 (271)
Q Consensus       166 ~~~---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~--~~~-----~~~----------  225 (271)
                      ++.   ....++..+|||.|.|||++.+..|..+.|-|+||+++++|+.|..||+-.  +..     +.+          
T Consensus       398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            854   445667889999999999999999999999999999999999999999632  211     111          


Q ss_pred             --cccCHHHHHHHHHhcccCccCCC------CHHHHhcCCcccc
Q 024158          226 --RSISAEAKHLISRLLVKDSSKRL------SLQKIMEHPWIIK  261 (271)
Q Consensus       226 --~~i~~~l~~li~~~l~~~p~~Rp------s~~~il~~~~~~~  261 (271)
                        +.++-....+++..|.+||.+|.      -..++..|+||..
T Consensus       478 iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  478 IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence              12456677899999999999997      5789999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=249.22  Aligned_cols=246  Identities=24%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-----C---Cceeceee
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----H---PNILRLYG   86 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~---~~i~~~~~   86 (271)
                      .++.++|.+.++||+|-|++||+|.+..+.+.||+|+.+....-    .+....||++|++++     +   .+|+++++
T Consensus        74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD  149 (590)
T KOG1290|consen   74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLD  149 (590)
T ss_pred             cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence            35568999999999999999999999999999999998655433    356678899998884     2   46999999


Q ss_pred             EEE----eCCeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCC----
Q 024158           87 WFH----DDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHE----  155 (271)
Q Consensus        87 ~~~----~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~----  155 (271)
                      .|.    .+.++|+|+|+.+ -+|..+|..  .+.++...+.+|+.|++.||.|||+. ||+|.||||+|||+..+    
T Consensus       150 ~FkhsGpNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~  228 (590)
T KOG1290|consen  150 HFKHSGPNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP  228 (590)
T ss_pred             cceecCCCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence            885    3558999999994 699999976  35799999999999999999999977 99999999999999400    


Q ss_pred             --------------------------------------------------------------------------------
Q 024158          156 --------------------------------------------------------------------------------  155 (271)
Q Consensus       156 --------------------------------------------------------------------------------  155 (271)
                                                                                                      
T Consensus       229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~  308 (590)
T KOG1290|consen  229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR  308 (590)
T ss_pred             hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 024158          156 --------------------------------------------------------------------------------  155 (271)
Q Consensus       156 --------------------------------------------------------------------------------  155 (271)
                                                                                                      
T Consensus       309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~  388 (590)
T KOG1290|consen  309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE  388 (590)
T ss_pred             CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence                                                                                            


Q ss_pred             --CCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------
Q 024158          156 --GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------  227 (271)
Q Consensus       156 --~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------  227 (271)
                        -++||.|||-++...........|-.|++||++.+..|+..+||||++|++|+|+||..+|........-+.      
T Consensus       389 ~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~  468 (590)
T KOG1290|consen  389 CDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL  468 (590)
T ss_pred             cceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence              012222333222222222222345679999999999999999999999999999999999986664332110      


Q ss_pred             -------------------------------------------------c----CHHHHHHHHHhcccCccCCCCHHHHh
Q 024158          228 -------------------------------------------------I----SAEAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       228 -------------------------------------------------i----~~~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                                                                       +    ..++.+|+.-||+.+|++|||+.+.|
T Consensus       469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl  548 (590)
T KOG1290|consen  469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL  548 (590)
T ss_pred             HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence                                                             0    36688999999999999999999999


Q ss_pred             cCCccccCCCC
Q 024158          255 EHPWIIKNANP  265 (271)
Q Consensus       255 ~~~~~~~~~~~  265 (271)
                      +|||+...+.|
T Consensus       549 ~hPwLn~~~~~  559 (590)
T KOG1290|consen  549 KHPWLNPVAGP  559 (590)
T ss_pred             cCccccCCCCC
Confidence            99999977664

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.5e-37  Score=260.66  Aligned_cols=243  Identities=27%  Similarity=0.453  Sum_probs=207.5

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC------CCceeceeeEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR------HPNILRLYGWF   88 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~------~~~i~~~~~~~   88 (271)
                      ++=-.+|.+....|.|-|++|..|++..-|..||||++.....-    ...=..|+++|+++.      .-|+++++..|
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F  503 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHF  503 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence            34456799999999999999999999999999999999554332    344567889999995      24789999988


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeec
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG  164 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg  164 (271)
                      ...+++|+|+|-.. .+|.+.|+..+   .|....+..++.|++-||..|-..|++|.||||+|||+... ..+||||||
T Consensus       504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence            88999999999986 69999998744   48889999999999999999999999999999999999765 469999999


Q ss_pred             ccccccCcc-ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc----------------
Q 024158          165 WSVQSRSKR-HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS----------------  227 (271)
Q Consensus       165 ~~~~~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~----------------  227 (271)
                      .+.....+. ..+..+--|.|||++.|.+|+...|+||.||+||+|++|+..|++.+..+++.-                
T Consensus       583 SA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  583 SASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            886555443 233445569999999999999999999999999999999999999988776531                


Q ss_pred             -------------------------------------------------------cCHHHHHHHHHhcccCccCCCCHHH
Q 024158          228 -------------------------------------------------------ISAEAKHLISRLLVKDSSKRLSLQK  252 (271)
Q Consensus       228 -------------------------------------------------------i~~~l~~li~~~l~~~p~~Rps~~~  252 (271)
                                                                             +-.++++|+..||..||.+|.|+.|
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence                                                                   0256899999999999999999999


Q ss_pred             HhcCCccccC
Q 024158          253 IMEHPWIIKN  262 (271)
Q Consensus       253 il~~~~~~~~  262 (271)
                      +|.||||+..
T Consensus       743 AL~HpFi~~k  752 (752)
T KOG0670|consen  743 ALKHPFITEK  752 (752)
T ss_pred             HhcCCcccCC
Confidence            9999999863

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-36  Score=254.62  Aligned_cols=231  Identities=26%  Similarity=0.444  Sum_probs=198.5

Q ss_pred             eeeeeeecccCCceEEEEEEecC----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVES----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ....++||+|.||.||.+....-    .-.||||.++.+-..  ...+.+..|..++++++||||++++|++.+ +-.|+
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            34566799999999999874322    345899999775433  336788999999999999999999999966 55899


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      |||.++.|.|..+++.++ .|+...+..++.||..|+.|||++.++||||...||++....-+||+|||++.........
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            999999999999998865 6899999999999999999999999999999999999999999999999999766654432


Q ss_pred             c----cccccccCCccccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCCcchhhccc------------CHHHHHHHHH
Q 024158          176 M----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISR  238 (271)
Q Consensus       176 ~----~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~~~i------------~~~l~~li~~  238 (271)
                      .    ..+..|+|||..+-..++.++|||-||+++|+++ .|..||.+....+.+-.+            |+.+..++.+
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmsk  627 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSK  627 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHH
Confidence            2    3356799999999999999999999999999987 599999998887776543            7999999999


Q ss_pred             hcccCccCCCCHHHHh
Q 024158          239 LLVKDSSKRLSLQKIM  254 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il  254 (271)
                      |+..+|.+||++.+|.
T Consensus       628 cWayeP~kRPrftei~  643 (974)
T KOG4257|consen  628 CWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HhccCcccCCcHHHHH
Confidence            9999999999887764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4e-35  Score=256.86  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=183.1

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEe----------------cCCceEEEEEechhhhhHH-H----------HHHHH
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREV----------------ESKHPVALKIIFKEQIEKY-K----------IQHQL   66 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~vK~~~~~~~~~~-~----------~~~~~   66 (271)
                      ..++.++|++.++||+|+||.||++...                ..++.|+||.+........ .          ..+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            4578999999999999999999998642                2356799999854322110 0          01122


Q ss_pred             HHHHHHHhhCCCCc-----eeceeeEEEe--------CCeEEEEEeccCCCchHHHHHhCC-------------------
Q 024158           67 RREMEIQSSLRHPN-----ILRLYGWFHD--------DERIFLILEYAHRGELYRELRKHR-------------------  114 (271)
Q Consensus        67 ~~e~~~l~~~~~~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~-------------------  114 (271)
                      ..|+.++.+++|.+     ++.+++++..        .+..++|+||+++++|.+++....                   
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            34566666666554     3566666543        346899999999999999886421                   


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----ccccccccccCC
Q 024158          115 -----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGTLDYLAP  185 (271)
Q Consensus       115 -----~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----~~~~~~~~y~~p  185 (271)
                           .+++..++.++.|++.++.+||+.+++|+||||+||+++.++.++|+|||++.......    ....+++.|++|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence                 23567788899999999999999999999999999999999999999999985433221    122347899999


Q ss_pred             ccccCCCC----------------------CccchhhhHHHHHHHHHhCCC-CCCCCC----------------------
Q 024158          186 EMVENKEH----------------------DYAVDNWTLGILCYEFLYGAP-PFEAES----------------------  220 (271)
Q Consensus       186 e~~~~~~~----------------------~~~~Di~slg~il~~l~~g~~-p~~~~~----------------------  220 (271)
                      |.+.....                      ....|+||+|+++++|+++.. |+....                      
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      124699999999999999875 554211                      


Q ss_pred             --cchhhcccCHHHHHHHHHhcccCc---cCCCCHHHHhcCCcccc
Q 024158          221 --QKDTFRSISAEAKHLISRLLVKDS---SKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       221 --~~~~~~~i~~~l~~li~~~l~~~p---~~Rps~~~il~~~~~~~  261 (271)
                        ....+...++...+++.+||.++|   .+|+|++|+|+||||..
T Consensus       460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence              011123457889999999999766   68999999999999953

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=261.36  Aligned_cols=242  Identities=33%  Similarity=0.559  Sum_probs=210.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEE-----eC
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH-----DD   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~-----~~   91 (271)
                      -.-|.+...||.|.+|.||+++.+.+++..++|+.......+    +.+..|..+++.. .|||++.+++++.     .+
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            345789999999999999999999999999999986654333    4567788888887 5899999999985     34


Q ss_pred             CeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +.+|+|||||.+||..++++.  +..+.++.+..++..++.|+.+||++.++|+|++-.||+++.++.+||+|||.+.+.
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl  173 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  173 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence            689999999999999999987  456899999999999999999999999999999999999999999999999998654


Q ss_pred             cC---ccccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cc
Q 024158          170 RS---KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RS  227 (271)
Q Consensus       170 ~~---~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~  227 (271)
                      ..   ......|||.|+|||+...     ..|+.++|+||||++..+|..|.+|+-...+-..+              .+
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~k  253 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKK  253 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhh
Confidence            43   4566789999999998864     34678999999999999999999998766654443              34


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ++.++.++|..||.+|-.+||+..++++|||+.+.+
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcchhhhccCCcccccc
Confidence            578899999999999999999999999999998665

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-36  Score=257.54  Aligned_cols=238  Identities=23%  Similarity=0.401  Sum_probs=207.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .++.+..+.....+||.|.||.||.+.+++-.-.++||.++.+..    .+..|..|..+++.++|||+++++++|..+-
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            344444556677889999999999999999999999999866554    4678899999999999999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      -+|||.|||..|+|.++|.+.  ..++...+++++.||.+|++||..++++|+||...|.|+..+..+|+.|||++....
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            899999999999999999863  246788899999999999999999999999999999999999999999999997776


Q ss_pred             Cccccc-cc---cccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHH
Q 024158          171 SKRHTM-CG---TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAK  233 (271)
Q Consensus       171 ~~~~~~-~~---~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~  233 (271)
                      ..++.. .|   ...|.|||.+....++.++|||+||++||++++ |.-||.+.+..+...            .-|+.+.
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVY  496 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVY  496 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHH
Confidence            655432 23   457999999999999999999999999999985 999999988654432            2489999


Q ss_pred             HHHHHhcccCccCCCCHHHHh
Q 024158          234 HLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il  254 (271)
                      +|+..|+.++|..||++++|-
T Consensus       497 eLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  497 ELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HHHHHHhcCCcccCccHHHHH
Confidence            999999999999999998874

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=262.60  Aligned_cols=201  Identities=33%  Similarity=0.526  Sum_probs=173.7

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC------e
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE------R   93 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~------~   93 (271)
                      -+.-.+.||.|+||.||+++++++|+.+|||.+......  +..+..-+|++++++++|+|||++.++-+...      .
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            345678899999999999999999999999999765533  33567789999999999999999999876544      4


Q ss_pred             EEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC--C--CEEEeeeccc
Q 024158           94 IFLILEYAHRGELYRELRK---HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--G--RLKIGDFGWS  166 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~--~--~~~L~dfg~~  166 (271)
                      ..++||||.+|+|...+++   ...|++.+++.++.++..|+.|||++||+||||||.||++-.+  |  ..||+|||.+
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            7899999999999999975   3469999999999999999999999999999999999999543  3  4899999999


Q ss_pred             ccccCcc--ccccccccccCCcccc-CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc
Q 024158          167 VQSRSKR--HTMCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK  222 (271)
Q Consensus       167 ~~~~~~~--~~~~~~~~y~~pe~~~-~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  222 (271)
                      +...+..  ....||+.|++||.+- ...|+...|.|||||++|+.+||..||-....+
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            7655544  4567999999999998 478889999999999999999999999765544

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=241.49  Aligned_cols=243  Identities=24%  Similarity=0.404  Sum_probs=209.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   91 (271)
                      .......+|.-++.+|.|.. .|..|-+.-.++++++|........ ....+...+|...+..+.|+|+++++.++.-. 
T Consensus        11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~   88 (369)
T KOG0665|consen   11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK   88 (369)
T ss_pred             cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence            34556678999999999999 7888888889999999998665333 23456778899999999999999999998533 


Q ss_pred             -----CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           92 -----ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        92 -----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                           ...|+|||+|. .+|...+..  .+..+.+.+++.|++.|+++||+.||+||||||+||++..++.+|++|||++
T Consensus        89 ~l~~~~e~y~v~e~m~-~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   89 TLEEFQEVYLVMELMD-ANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             cHHHHHhHHHHHHhhh-hHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence                 35899999997 699888873  4678899999999999999999999999999999999999999999999998


Q ss_pred             ccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc----------------
Q 024158          167 VQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------  228 (271)
Q Consensus       167 ~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i----------------  228 (271)
                      ......  ......+-.|.|||...+..+....||||+||++.+|+.|+..|.+.+.-+++.++                
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            554443  34456677899999999999999999999999999999999999988877776552                


Q ss_pred             -------------------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       229 -------------------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                                                           ...+++++.+||..+|++|.|++++|+||||+
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                                                 36689999999999999999999999999997

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=241.00  Aligned_cols=253  Identities=28%  Similarity=0.429  Sum_probs=202.4

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH-hhCCCCceeceeeEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWF   88 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~   88 (271)
                      +....+++-.+.+-+..||.|+||+|++..++.+|+..|||.+.....+  ....++..|.... +.-..|||++++|..
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~--keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE--KEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch--HHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            3455567777788889999999999999999999999999999665543  3345666666544 444689999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEee
Q 024158           89 HDDERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                      ..++..|++||.|+ .|+..+-+.     ...+++.-+-.+.--.+.||.||-+. .|+|||+||+|||++..|.+||||
T Consensus       133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD  211 (361)
T KOG1006|consen  133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD  211 (361)
T ss_pred             hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence            99999999999996 677655532     23578887888888888999999865 899999999999999999999999


Q ss_pred             ecccccccC--ccccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCc-chhh------------
Q 024158          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTF------------  225 (271)
Q Consensus       163 fg~~~~~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~------------  225 (271)
                      ||.+-+...  ......|...|+|||.+..  ..|+.++|+||||++|+++++|.-|+.+-.. -+++            
T Consensus       212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            998733222  1223356667999998864  3488999999999999999999999864321 1111            


Q ss_pred             -----cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 -----RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 -----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                           -.++..+..+|..||.+|-..||++.+++++||+...+..
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~  336 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE  336 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence                 1257889999999999999999999999999999877543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-36  Score=245.97  Aligned_cols=244  Identities=31%  Similarity=0.542  Sum_probs=206.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH----HHHHHHHHHHHHHhhCCCCceeceeeEEE-eCC
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEIQSSLRHPNILRLYGWFH-DDE   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~   92 (271)
                      -.+|-++..||+|||++||++.+...++.+|||+-.....+..    ...+-.-+|.++-+.++||.|+++|+++. +..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3568899999999999999999999999999999754433322    23344567889999999999999999986 455


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCeeeCCC---CCEEEeeecccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--HVIHRDIKPENLLLDHE---GRLKIGDFGWSV  167 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--~i~H~dl~~~Nili~~~---~~~~L~dfg~~~  167 (271)
                      .+|-|.|||+|.+|.=+|+.++.+++.++++|+.||+.||.||...  .|+|=||||.|||+-.+   |.+||.|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            7899999999999999999999999999999999999999999977  59999999999999543   679999999997


Q ss_pred             cccCcc----------ccccccccccCCccccCC----CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-hc------
Q 024158          168 QSRSKR----------HTMCGTLDYLAPEMVENK----EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-FR------  226 (271)
Q Consensus       168 ~~~~~~----------~~~~~~~~y~~pe~~~~~----~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-~~------  226 (271)
                      ......          +...||-+|+|||++.-+    ..+++.||||.|+++|..+.|..||......+. ++      
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            655433          335688999999999643    357899999999999999999999976553322 11      


Q ss_pred             ----------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          227 ----------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       227 ----------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                .++++..+||++||.+.-+.|..+.++..+|+|--
T Consensus       702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence                      15899999999999999999999999999999865

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=276.41  Aligned_cols=226  Identities=20%  Similarity=0.315  Sum_probs=184.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|...+.||+|+||.||+|++..++..|++|.+.......       ..+++.+++++||||+++++++...+..++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            34667788999999999999998999999999985432111       23478889999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH---ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh---~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      ||+++++|.+++..   +++..+..++.|+++|+.|||   +.+++|+|+||+||+++.++..++. ++...... ....
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-~~~~  837 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-TDTK  837 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-cCCC
Confidence            99999999999964   789999999999999999999   6699999999999999988887775 55432221 1122


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--h--------------------h-c------
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--T--------------------F-R------  226 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--~--------------------~-~------  226 (271)
                      ..+++.|+|||.+.+..++.++||||+|+++|+|++|..||.......  .                    . .      
T Consensus       838 ~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        838 CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             ccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            357889999999999899999999999999999999999985321100  0                    0 0      


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ....++.+++.+|+..+|++|||++++++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            011356788999999999999999999876

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=255.38  Aligned_cols=243  Identities=23%  Similarity=0.405  Sum_probs=209.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecC-C--ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVES-K--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~-~--~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++.++.+.||+|+||.|+++.++.- |  ..||||.+..+....  ...+|.+|..++.+++|+|++++|++..+ .-.-
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            4456788999999999999987764 2  458999987766554  57899999999999999999999999977 5678


Q ss_pred             EEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc
Q 024158           96 LILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~  173 (271)
                      +|+|.++.|||.+.|...  ..|-...+-.++.||+.|+.||.+++++|||+...|+++-....+||+|||+......+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999999999873  346778888899999999999999999999999999999989999999999986555443


Q ss_pred             ccc------cccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhccc------------CHHHHH
Q 024158          174 HTM------CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRSI------------SAEAKH  234 (271)
Q Consensus       174 ~~~------~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i------------~~~l~~  234 (271)
                      ..+      .....|+|||++.-..++.++|+|++|+++|||++ |..||.+....+.+++|            +..+.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~  346 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQ  346 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHH
Confidence            322      23567999999999999999999999999999985 89999999988888776            688999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ++..|+..+|..|||+.+|.+.-+....+.
T Consensus       347 imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  347 IMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             HHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence            999999999999999999987766665543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-36  Score=260.31  Aligned_cols=243  Identities=26%  Similarity=0.424  Sum_probs=214.6

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      -.++++.+...|.+.||.|.||+|++++.+..|   ..||||.++....+  +...+|..|+.++-+++||||+++.++.
T Consensus       622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            346788889999999999999999999988776   45999999776544  4568899999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ...+-..++.|||++|+|..+|..+ +.++..++..++..|+.|++||.+.|++||||...|||++.+-.+|++|||++.
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccccee
Confidence            9988899999999999999999764 579999999999999999999999999999999999999999999999999996


Q ss_pred             cccCcccc------ccccccccCCccccCCCCCccchhhhHHHHHHHHH-hCCCCCCCCCcchhhccc------------
Q 024158          168 QSRSKRHT------MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------  228 (271)
Q Consensus       168 ~~~~~~~~------~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~~~~i------------  228 (271)
                      ...+....      ..-+.+|.|||.+.-..++.++|+||+|+++||.+ .|..||......+.++.+            
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDC  859 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDC  859 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCC
Confidence            44332211      12257899999999999999999999999999976 699999999888887765            


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      |..|.+|+..|+++|=.+||...||..+
T Consensus       860 P~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  860 PAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             cHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            7889999999999999999999998764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=257.92  Aligned_cols=231  Identities=28%  Similarity=0.459  Sum_probs=188.2

Q ss_pred             eeecccCCce-EEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKGKFGR-VYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g~~~~-v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      +.+|.|+-|+ ||++.  ..|+.||||++-.      .....+++|+..++.. .||||+++++.-.+..+.|++.|.|.
T Consensus       515 eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGV--YEGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHcccCCCCcEEEEEe--eCCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4468888875 79888  5678999998733      2345678899999998 59999999999999999999999996


Q ss_pred             CCchHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CC--CEEEeeecccccccC--
Q 024158          103 RGELYRELRKH-RR---FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EG--RLKIGDFGWSVQSRS--  171 (271)
Q Consensus       103 ~~~L~~~l~~~-~~---l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~--~~~L~dfg~~~~~~~--  171 (271)
                       .+|.+++... ..   ......+.++.|+++|+.+||+.+|+||||||.||||+.   ++  .++|+|||+++....  
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence             6999999773 11   222556889999999999999999999999999999976   23  699999999954433  


Q ss_pred             ----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchhh--------ccc----CHHHHH
Q 024158          172 ----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTF--------RSI----SAEAKH  234 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~--------~~i----~~~l~~  234 (271)
                          ...+..||-+|.|||.+.......+.|||||||++|+.++| .+||...-..+..        ..+    ..++.+
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~eA~d  745 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCEAKD  745 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHHHHH
Confidence                23456789999999999988888899999999999998865 9999765433221        111    127899


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ||.+|+.++|..||++.++|.||||=...+
T Consensus       746 LI~~ml~~dP~~RPsa~~VL~HPlFW~~ek  775 (903)
T KOG1027|consen  746 LISRMLNPDPQLRPSATDVLNHPLFWDSEK  775 (903)
T ss_pred             HHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence            999999999999999999999999965443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.3e-33  Score=218.16  Aligned_cols=209  Identities=42%  Similarity=0.734  Sum_probs=186.8

Q ss_pred             ecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCch
Q 024158           27 LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL  106 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L  106 (271)
                      ||+|++|.||++....+++.+++|++.......  ....+.+|++.++.++|++++++++++......++++|++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986654332  346788999999999999999999999998999999999998999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeecccccccCc---ccccccccc
Q 024158          107 YRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK---RHTMCGTLD  181 (271)
Q Consensus       107 ~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~~~~~---~~~~~~~~~  181 (271)
                      .+++... ..++...+..++.+++.++.+||+.|++|+|++|.||+++. ++.++|+|||.+......   .....+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9999875 46899999999999999999999999999999999999999 899999999988555443   344567888


Q ss_pred             ccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          182 YLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       182 y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                      |.+||..... ..+.++|+|++|++++++                    ..+.+++..|+..+|++||+++++++++
T Consensus       159 ~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         159 YMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ccChhHhcccCCCCchhhhHHHHHHHHHH--------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            9999999877 788899999999999998                    7899999999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-36  Score=232.85  Aligned_cols=249  Identities=29%  Similarity=0.462  Sum_probs=206.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----Ce
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----ER   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   93 (271)
                      .|.+=.+.||-|+||+||.+.+-.+|+.+++|.+..-.. .-...+.+.+|++++..++|.|++..+++..-.     +.
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq-~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQ-NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHH-HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence            445556889999999999999999999999999854322 223456778899999999999999998886443     24


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR  173 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~  173 (271)
                      +|++.|.+. .+|...+-.-..|+.+.+.-.+.||+.+++|||+.||.|+||||.|.++..+..+||||||++.......
T Consensus       132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            788888885 6888877766789999999999999999999999999999999999999999999999999996655433


Q ss_pred             cc----ccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc--------------------
Q 024158          174 HT----MCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------------  228 (271)
Q Consensus       174 ~~----~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i--------------------  228 (271)
                      ..    ...|..|++||.+.|.. |+...||||.||++.+++..+..|....+-++++-|                    
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            32    34578899999998864 899999999999999999999999877766554321                    


Q ss_pred             -------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCCc
Q 024158          229 -------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC  269 (271)
Q Consensus       229 -------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  269 (271)
                                               ..+...++..+|.+||++|.+.++.+.|++..+.-.+-+.|
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~~sC  356 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRFHSC  356 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceeeeee
Confidence                                     35677899999999999999999999999988775554443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-32  Score=246.56  Aligned_cols=241  Identities=26%  Similarity=0.461  Sum_probs=202.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecC-------CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceece
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRL   84 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~   84 (271)
                      .+++.-++..+.+.||+|.||.|+++....-       ...+|||..+.....  ...+.+..|+.+++.+. |+|++.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            5566666667888999999999999874321       346899988665444  45688999999999995 9999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                      ++.+...+..+++.||+..|+|.+++...+                .++..+++.++.||+.|++||++++++|||+...
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999889999999999999999998755                3889999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccCccccc----c--ccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC-
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRSKRHTM----C--GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES-  220 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~~~~~~----~--~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~-  220 (271)
                      ||+++.+..+|++|||++..........    .  .+..|+|||.+....++.++||||+|++||++.+ |..||.+.. 
T Consensus       448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            9999999999999999996533322211    1  3556999999999999999999999999999986 899998754 


Q ss_pred             cchhhcc------------cCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          221 QKDTFRS------------ISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       221 ~~~~~~~------------i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..+..+.            -++++.++++.|+..+|++||+..++.+
T Consensus       528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            2222221            2789999999999999999999998865

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=238.44  Aligned_cols=202  Identities=31%  Similarity=0.543  Sum_probs=176.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHH-----HHHHHHHHHHHhhCC---CCceeceeeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI-----QHQLRREMEIQSSLR---HPNILRLYGW   87 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~-----~~~~~~e~~~l~~~~---~~~i~~~~~~   87 (271)
                      =++.+|..++.+|+|+||.|++|.+++++..|++|.+.+...--..+     .-.+--|++++..++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            35678999999999999999999999999999999997765432222     122345899999997   9999999999


Q ss_pred             EEeCCeEEEEEecc-CCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           88 FHDDERIFLILEYA-HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        88 ~~~~~~~~lv~e~~-~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      |++++++|+++|.. ++.+|.+++...+.+++.++..+++|++.++++||+.||+|||||-+|+.++.+|-++|+|||.+
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            99999999999975 45699999998889999999999999999999999999999999999999999999999999987


Q ss_pred             cc-ccCccccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCC
Q 024158          167 VQ-SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFE  217 (271)
Q Consensus       167 ~~-~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~  217 (271)
                      .. ...+.....||.+|.|||.+.|..| ...-|||+||+++|.++....||-
T Consensus       718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            44 3445567789999999999999887 457899999999999988888874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-35  Score=251.00  Aligned_cols=243  Identities=28%  Similarity=0.467  Sum_probs=214.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ..+|.++.++|+|.+|.||+++++.+++..++|+++..-   ......+++|+-+++.++|+||+.+++.+......+++
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            357999999999999999999999999999999995543   23456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~~  174 (271)
                      ||||++++|.+.-+-.+++++.++..+++..++++.|||+.|-.|||||-.||+++..|.++|.|||.+.+..   ....
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            9999999999988888899999999999999999999999999999999999999999999999999875443   3456


Q ss_pred             cccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------cccCHHHHHH
Q 024158          175 TMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEAKHL  235 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------~~i~~~l~~l  235 (271)
                      ...||+.|+|||...   .+.|...+|+|++|+...++..-++|.....+.+.+                .++++.+.+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            778999999999774   567889999999999999998877776544433222                2357889999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ++.+|.++|++||+++-+|.|||+.+.-
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccch
Confidence            9999999999999999999999998873

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-32  Score=222.83  Aligned_cols=229  Identities=27%  Similarity=0.447  Sum_probs=179.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHh--hCCCCceeceeeEEEeCC---
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS--SLRHPNILRLYGWFHDDE---   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~--~~~~~~i~~~~~~~~~~~---   92 (271)
                      ..+.++.+.||.|.||+||++++  .|+.||||+|....      .+.+.+|.++.+  .++|+||+.+++.-..++   
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            45578999999999999999995  67889999994432      234455555554  459999999998754332   


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCeeeCCCCCEEEeee
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--------~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                       .+|+|++|.+.|||.++|++ .+++.+..+.++..++.||.+||..        .|+|||||+.|||+.+++..-|.|+
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence             59999999999999999998 6799999999999999999999943        4999999999999999999999999


Q ss_pred             cccccccC-------ccccccccccccCCccccCCC----CC--ccchhhhHHHHHHHHHhC----------CCCCCCCC
Q 024158          164 GWSVQSRS-------KRHTMCGTLDYLAPEMVENKE----HD--YAVDNWTLGILCYEFLYG----------APPFEAES  220 (271)
Q Consensus       164 g~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~----~~--~~~Di~slg~il~~l~~g----------~~p~~~~~  220 (271)
                      |++.....       ..+...||.+|+|||.+....    +.  ..+||||||.++||++-.          .+||....
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            99854433       335578999999999996533    21  368999999999998732          45664433


Q ss_pred             cchh----hcc----------c---------CHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          221 QKDT----FRS----------I---------SAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       221 ~~~~----~~~----------i---------~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+.    .++          +         -..+.++++.|+..+|.-|.|+--|.+
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence            3221    111          1         145778899999999999998877654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-32  Score=226.06  Aligned_cols=229  Identities=24%  Similarity=0.392  Sum_probs=178.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH--hhCCCCceeceeeEEEeCC-
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRLYGWFHDDE-   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l--~~~~~~~i~~~~~~~~~~~-   92 (271)
                      +++...+++..||+|.||.||+|+.  +++.||||+|....      .+.+++|-.+.  -.++|+||+++++.-.... 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            3455567888999999999999984  56999999995543      33445444444  4568999999999876554 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCeeeCCCCCEEE
Q 024158           93 ---RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---------HVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        93 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~---------~i~H~dl~~~Nili~~~~~~~L  160 (271)
                         .+++|++|.+.|+|.++|.. ...++.....++..++.||+|||+.         +|+|||||..|||+..++...|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               79999999999999999987 4589999999999999999999954         4999999999999999999999


Q ss_pred             eeecccccccC-----ccccccccccccCCccccCCC-CC-----ccchhhhHHHHHHHHHhCCCCCC-CCCc-chh---
Q 024158          161 GDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKE-HD-----YAVDNWTLGILCYEFLYGAPPFE-AESQ-KDT---  224 (271)
Q Consensus       161 ~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~-~~-----~~~Di~slg~il~~l~~g~~p~~-~~~~-~~~---  224 (271)
                      +|||++.....     ......||.+|+|||.+-+.. ..     .+.||||+|.++|++++....+. +..+ .+.   
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            99999854432     233468999999999986533 21     37899999999999997654432 1111 111   


Q ss_pred             ------------h---------ccc---------CHHHHHHHHHhcccCccCCCCHHHH
Q 024158          225 ------------F---------RSI---------SAEAKHLISRLLVKDSSKRLSLQKI  253 (271)
Q Consensus       225 ------------~---------~~i---------~~~l~~li~~~l~~~p~~Rps~~~i  253 (271)
                                  .         ..+         ...+++.+..|++.||+.|.|+.=+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence                        0         001         3568899999999999999997643

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=3.3e-32  Score=204.37  Aligned_cols=202  Identities=28%  Similarity=0.418  Sum_probs=166.0

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~   92 (271)
                      .++...+..-+..||+|++|.|-+.++..+|.-.|+|.+.....+  +...++.+++.+..+. .+|.++.+++....+.
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            344455556677899999999999999999999999998665433  3345566677665555 6899999999999999


Q ss_pred             eEEEEEeccCCCchHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           93 RIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l----~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ..+++||.|. .||..+-    ..+...++..+-+++..++.|+.+||++ .++|||+||+|||++.+|++|+||||.+-
T Consensus       119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999996 5886554    4567789999999999999999999988 89999999999999999999999999873


Q ss_pred             cccC--ccccccccccccCCccccC----CCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024158          168 QSRS--KRHTMCGTLDYLAPEMVEN----KEHDYAVDNWTLGILCYEFLYGAPPFEA  218 (271)
Q Consensus       168 ~~~~--~~~~~~~~~~y~~pe~~~~----~~~~~~~Di~slg~il~~l~~g~~p~~~  218 (271)
                      ....  ......|...|+|||.++.    ..|+.++|+||||+.+++|+++..||..
T Consensus       198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            3222  1222456778999998863    4688999999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=9.9e-31  Score=209.00  Aligned_cols=196  Identities=42%  Similarity=0.785  Sum_probs=174.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      |.+.+.||+|+++.||++....+++.+++|.+......  .....+.+|+..++.++|++++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999888999999999765433  2356788899999999999999999999988899999999


Q ss_pred             cCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----cc
Q 024158          101 AHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HT  175 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----~~  175 (271)
                      +++++|.+++..... +++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+.......    ..
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            998899999987666 8999999999999999999999999999999999999999999999999886554432    44


Q ss_pred             ccccccccCCccc-cCCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024158          176 MCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEA  218 (271)
Q Consensus       176 ~~~~~~y~~pe~~-~~~~~~~~~Di~slg~il~~l~~g~~p~~~  218 (271)
                      ..++..|++||.+ ....++.++|+|+||++++++++|..||..
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            5677889999998 566677899999999999999999999976

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=3.4e-32  Score=223.42  Aligned_cols=244  Identities=25%  Similarity=0.460  Sum_probs=200.6

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEec---CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYG   86 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~   86 (271)
                      -+......+.|+++.+||+|.|++||++.+..   .++.+++|.+...+.     ...+.+|++++..++ +.||+.+.+
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchh
Confidence            34466777889999999999999999998877   788899999854332     245788999999995 799999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGW  165 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~  165 (271)
                      .+..+++..+|+||++.....++...   ++..++..++..++.||.++|.+||+|+||||+||+.... +.-.|+|||+
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence            99999999999999998888888755   6789999999999999999999999999999999999764 6899999998


Q ss_pred             ccccc---------C-------c------------------c-------------ccccccccccCCccccCCC-CCccc
Q 024158          166 SVQSR---------S-------K------------------R-------------HTMCGTLDYLAPEMVENKE-HDYAV  197 (271)
Q Consensus       166 ~~~~~---------~-------~------------------~-------------~~~~~~~~y~~pe~~~~~~-~~~~~  197 (271)
                      +....         .       .                  .             -...||++|.|||++...+ -+.+.
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            74100         0       0                  0             0134799999999998765 46789


Q ss_pred             hhhhHHHHHHHHHhCCCCCCCCCcc------------------------h--hhc-------------------------
Q 024158          198 DNWTLGILCYEFLYGAPPFEAESQK------------------------D--TFR-------------------------  226 (271)
Q Consensus       198 Di~slg~il~~l~~g~~p~~~~~~~------------------------~--~~~-------------------------  226 (271)
                      |+||.|+++..++++..||......                        .  .++                         
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999997422210                        0  000                         


Q ss_pred             ------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          227 ------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       227 ------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                  -.+..+.+++.+||..||.+|.|++++|.||||...
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~  387 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA  387 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence                        025578999999999999999999999999999854

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.4e-31  Score=232.74  Aligned_cols=232  Identities=23%  Similarity=0.412  Sum_probs=194.1

Q ss_pred             eeeeeeecccCCceEEEEEEecCCc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      .+-.+.||+|+||+||++...-.|+    +|++|++......  +...++.+|+-.+.+++|||++++++++.... +-+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            3456789999999999998665554    5788887544332  33577889999999999999999999997754 788


Q ss_pred             EEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           97 ILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      |++|+++|+|.++++.++ .+.....+.+..||++|+.|||.++++||||-..|||++....+|+.|||++.........
T Consensus       775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            899999999999998754 6888999999999999999999999999999999999999999999999998544432221


Q ss_pred             -----ccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhccc------------CHHHHHHHH
Q 024158          176 -----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRSI------------SAEAKHLIS  237 (271)
Q Consensus       176 -----~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~i------------~~~l~~li~  237 (271)
                           ..-.+.|+|-|.+....++.++||||+||++||++| |+.|+.+....+..+-+            +-++..++.
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence                 223567899999999999999999999999999985 99999988766654322            577899999


Q ss_pred             HhcccCccCCCCHHHHhc
Q 024158          238 RLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~  255 (271)
                      +||-.|++.||+++++..
T Consensus       935 kCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhccCcccCccHHHHHH
Confidence            999999999999988754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-30  Score=201.96  Aligned_cols=237  Identities=27%  Similarity=0.479  Sum_probs=186.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeE-EEeCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW-FHDDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~-~~~~~~~~lv   97 (271)
                      .|.|.+.+|+|-||.+-+|.++.++..+++|.+......    ..++.+|..---.+ .|.||+.-+++ |+..+.+.++
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            489999999999999999999999999999999776543    45566666544444 47899887775 4566788899


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-C-CCEEEeeecccccccCcccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-E-GRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~-~~~~L~dfg~~~~~~~~~~~  175 (271)
                      +|+++.|+|.+-+... .+-+..-..++.|+++|+.|+|+++++|||||.+||||-. + .++||||||.+...+.....
T Consensus       101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~  179 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY  179 (378)
T ss_pred             eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence            9999999999888653 3677888999999999999999999999999999999943 3 37999999998666655444


Q ss_pred             ccccccccCCccccC---CC--CCccchhhhHHHHHHHHHhCCCCCCCCCcc-------------------hhhcccCHH
Q 024158          176 MCGTLDYLAPEMVEN---KE--HDYAVDNWTLGILCYEFLYGAPPFEAESQK-------------------DTFRSISAE  231 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~---~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~-------------------~~~~~i~~~  231 (271)
                      .--...|.+||.+..   +.  ..+.+|+|.||++++..++|..||+.....                   ..++.+++.
T Consensus       180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~  259 (378)
T KOG1345|consen  180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEK  259 (378)
T ss_pred             hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHH
Confidence            444566888887642   22  467899999999999999999999743322                   222336889


Q ss_pred             HHHHHHHhcccCccCC---CCHHHHhcCCcccc
Q 024158          232 AKHLISRLLVKDSSKR---LSLQKIMEHPWIIK  261 (271)
Q Consensus       232 l~~li~~~l~~~p~~R---ps~~~il~~~~~~~  261 (271)
                      +..+.++-|.++++.|   .++.....--|...
T Consensus       260 a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~  292 (378)
T KOG1345|consen  260 ALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK  292 (378)
T ss_pred             HHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence            9999999999999999   45554444455443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.7e-30  Score=239.83  Aligned_cols=183  Identities=18%  Similarity=0.235  Sum_probs=138.8

Q ss_pred             CceeceeeEE-------EeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 024158           79 PNILRLYGWF-------HDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (271)
Q Consensus        79 ~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Ni  150 (271)
                      .||.++++.+       ...+.++.++|+++ ++|.+++.. ...++...++.++.||+.||.|||++||+|+||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            3566666655       12245677889885 699999975 34689999999999999999999999999999999999


Q ss_pred             eeCCCCCE-------------------EEeeecccccccC-------------------ccccccccccccCCccccCCC
Q 024158          151 LLDHEGRL-------------------KIGDFGWSVQSRS-------------------KRHTMCGTLDYLAPEMVENKE  192 (271)
Q Consensus       151 li~~~~~~-------------------~L~dfg~~~~~~~-------------------~~~~~~~~~~y~~pe~~~~~~  192 (271)
                      |++..+.+                   +++|||++.....                   ......+|+.|+|||.+.+..
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99665544                   4555554422110                   001134678899999999999


Q ss_pred             CCccchhhhHHHHHHHHHhCCCCCCCCCcc--hhh--------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          193 HDYAVDNWTLGILCYEFLYGAPPFEAESQK--DTF--------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       193 ~~~~~Di~slg~il~~l~~g~~p~~~~~~~--~~~--------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++.++|||||||++|+|++|.+|+......  ...        ..-.+....++.+||.++|.+|||+.++++||||.+.
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence            999999999999999999998887643210  000        0013456788999999999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=192.62  Aligned_cols=233  Identities=21%  Similarity=0.288  Sum_probs=189.5

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-CceeceeeEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWF   88 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~   88 (271)
                      .+.+..+..++|+++++||+|+||.+|++....+|+.||+|+=...     .....+..|.++.+.+++ .+|+.+..++
T Consensus         6 ~s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-----a~hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen    6 GSLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK-----AKHPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             cchhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc-----CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence            4556778899999999999999999999999999999999984222     123456667777787865 7889999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---CCEEEeeec
Q 024158           89 HDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFG  164 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---~~~~L~dfg  164 (271)
                      .+..+-.+||+.. |.||+++.+- .+.++...++.++.|++.-++|+|.++++|+||||+|+++.-+   ..+.|+|||
T Consensus        81 ~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFG  159 (341)
T KOG1163|consen   81 TEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFG  159 (341)
T ss_pred             cccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEecc
Confidence            8989999999999 5799999864 5678999999999999999999999999999999999999755   479999999


Q ss_pred             ccccccCcc----------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-------
Q 024158          165 WSVQSRSKR----------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------  227 (271)
Q Consensus       165 ~~~~~~~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-------  227 (271)
                      +++...+..          ....||.+|.+-..+.+.+-+.+.|+-|+|+++.++.-|.+||++.......++       
T Consensus       160 LaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  160 LAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             chhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence            995544322          234689999999988888888999999999999999999999998776544433       


Q ss_pred             ------------cCHHHHHHHHHhcccCccCCC
Q 024158          228 ------------ISAEAKHLISRLLVKDSSKRL  248 (271)
Q Consensus       228 ------------i~~~l~~li~~~l~~~p~~Rp  248 (271)
                                  .|.++.-.+.-|-..--++-|
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P  272 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP  272 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence                        366666666666443333444

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=4.4e-29  Score=203.61  Aligned_cols=237  Identities=20%  Similarity=0.261  Sum_probs=196.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +...+++....+.+|.||.||.+.+.+..     +.+.+|.++...  .+.....+..|.-.+....|||+.++.++..+
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            34455788888999999999999765442     346666653322  22446777888889999999999999998754


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           91 -DERIFLILEYAHRGELYRELRK--------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                       ...+.+++.+++-++|..++..        .+.++..++..++.|++.|+.|||+.|++|.||...|-+|+..-++||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             4578999999988999999972        2347888899999999999999999999999999999999999999999


Q ss_pred             eecccccccCccc-----cccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc---------
Q 024158          162 DFGWSVQSRSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR---------  226 (271)
Q Consensus       162 dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~---------  226 (271)
                      |=.++.+..+..+     ..-.+..|+++|.+....++..+|+||||+++|+|++ |+.|+...++.++-.         
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla  518 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA  518 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec
Confidence            9988866555433     2334678999999999999999999999999999986 899999888876632         


Q ss_pred             ---ccCHHHHHHHHHhcccCccCCCCHHHHh
Q 024158          227 ---SISAEAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       227 ---~i~~~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                         +-|.++..++.-|+...|++|||.+|+.
T Consensus       519 QP~NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  519 QPFNCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             CCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence               2389999999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=195.70  Aligned_cols=199  Identities=26%  Similarity=0.436  Sum_probs=173.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   94 (271)
                      +..-+|++.++||+|+||+++.+.+..++++||||.=...     .....++.|.+..+.+. .++|+.++-+..++.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            3445799999999999999999999999999999973222     22457788888888885 69999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-----CEEEeeeccccc
Q 024158           95 FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWSVQ  168 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-----~~~L~dfg~~~~  168 (271)
                      .+|+|.. |.||+++... ++.++...+..++.|++.-++++|++.++.|||||+|+||...+     .+.++|||.++.
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            9999999 5799999975 56899999999999999999999999999999999999997644     599999999976


Q ss_pred             ccCcc----------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          169 SRSKR----------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       169 ~~~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                      ..+..          ....||.+|++...+.+.+-+.+.|+-+||.++++++-|.+||++.-
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            55432          33578999999999999999999999999999999999999998755

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.9e-28  Score=187.31  Aligned_cols=148  Identities=22%  Similarity=0.251  Sum_probs=125.1

Q ss_pred             CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccccccc
Q 024158          104 GELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY  182 (271)
Q Consensus       104 ~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y  182 (271)
                      |+|.+++.. ...+++..++.++.|++.||.|||+.+      ||+||+++.++.+++  ||.+.......  ..+++.|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--~~g~~~y   70 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--SRVDPYF   70 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc--CCCcccc
Confidence            588999976 456999999999999999999999998      999999999999999  99875544332  2578999


Q ss_pred             cCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-h------------------cccCH--HHHHHHHHhcc
Q 024158          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-F------------------RSISA--EAKHLISRLLV  241 (271)
Q Consensus       183 ~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-~------------------~~i~~--~l~~li~~~l~  241 (271)
                      +|||.+.+..++.++||||||+++|+|++|..||........ .                  ..++.  ++.+++.+||.
T Consensus        71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~  150 (176)
T smart00750       71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS  150 (176)
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence            999999999999999999999999999999999975432111 0                  11223  69999999999


Q ss_pred             cCccCCCCHHHHhcCCcccc
Q 024158          242 KDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~  261 (271)
                      .+|++||++.++++|+|+..
T Consensus       151 ~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      151 RLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cccccccCHHHHHHHHHHHH
Confidence            99999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2e-26  Score=194.12  Aligned_cols=233  Identities=25%  Similarity=0.333  Sum_probs=186.5

Q ss_pred             ceeeeeeecccCCceEEEEEEecCC-ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC----CCceeceeeEE-EeCCe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR----HPNILRLYGWF-HDDER   93 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~i~~~~~~~-~~~~~   93 (271)
                      +|++.++||+|+||.||.|.+..++ ..+|+|.-........   ..+..|..++..+.    .+++..+++.+ ..+.+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999988775 5788887644322211   14556666666665    36899999998 57778


Q ss_pred             EEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-----CCEEEeeeccc
Q 024158           94 IFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----GRLKIGDFGWS  166 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-----~~~~L~dfg~~  166 (271)
                      .++||+.+ |.+|.++....  +.++...+..++.|++.+|+++|+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 57999988654  479999999999999999999999999999999999999865     36999999999


Q ss_pred             c--cccCc-----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------
Q 024158          167 V--QSRSK-----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------  227 (271)
Q Consensus       167 ~--~~~~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------  227 (271)
                      .  .....           .....||.+|+++.++.+.+.+.+.|+||+++++.++..|..||..........+      
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~  254 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR  254 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence            6  21110           1234489999999999999999999999999999999999999977664322111      


Q ss_pred             ----------cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          228 ----------ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       228 ----------i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                .+.++.++...+-..+...+|....+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence                      24677788877777888999988877554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=9.3e-28  Score=214.80  Aligned_cols=242  Identities=29%  Similarity=0.476  Sum_probs=196.9

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEech---hhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~---~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .-...+|.|++|.++.+......+.+..|.+..   ...........+..|.-+-..+.|++++..+....+.....-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            466778999999888888777777666665532   11122222333667777778889999887777666555555559


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-------
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-------  171 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-------  171 (271)
                      |||+. +|..++.....++..++-.++.|++.|+.|+|+.|+.|+|+|++|++++.+|.++++|||.+....-       
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~  479 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH  479 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence            99997 9999998877889999999999999999999999999999999999999999999999998743332       


Q ss_pred             ccccccccccccCCccccCCCCCc-cchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------------cccCH
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDY-AVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------------RSISA  230 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~-~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------------~~i~~  230 (271)
                      ...+..|+..|+|||.+.+..|+. ..|+||.|+++..|.+|+.||......+..                    ..+|.
T Consensus       480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~  559 (601)
T KOG0590|consen  480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR  559 (601)
T ss_pred             hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence            234567889999999999999876 689999999999999999999876655332                    22588


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +-+.+|.+||+.+|.+|.|+++|++.+||+....
T Consensus       560 ~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  560 ETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            9999999999999999999999999999998753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.94  E-value=3.7e-26  Score=185.21  Aligned_cols=226  Identities=25%  Similarity=0.398  Sum_probs=157.6

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC----------CceeceeeEEEe
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH----------PNILRLYGWFHD   90 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~----------~~i~~~~~~~~~   90 (271)
                      ......||.|+++.||.+.+.++|+.+++|++...........+.+++|.-....+.+          -.++-.++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            5677889999999999999999999999999976665555567777777766655432          233444444321


Q ss_pred             C------------C-----eEEEEEeccCCCchHHHHHh---C-CC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           91 D------------E-----RIFLILEYAHRGELYRELRK---H-RR---FTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        91 ~------------~-----~~~lv~e~~~~~~L~~~l~~---~-~~---l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      .            +     ..+++|+-+. ++|..++..   . ..   +.....+.+..|++..+++||..|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            1            1     2367888875 688777642   1 11   3344556677899999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCccccccccccccCCccccC--------CCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--------KEHDYAVDNWTLGILCYEFLYGAPPFEA  218 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slg~il~~l~~g~~p~~~  218 (271)
                      |+|++++++|.+.|+||+.....+........+..|.|||....        ..++.+.|.|+||+++|.++++..||..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            99999999999999999987666655444445677999996643        2467889999999999999999999986


Q ss_pred             CCcchh-------hcccCHHHHHHHHHhcccCccCC
Q 024158          219 ESQKDT-------FRSISAEAKHLISRLLVKDSSKR  247 (271)
Q Consensus       219 ~~~~~~-------~~~i~~~l~~li~~~l~~~p~~R  247 (271)
                      ..+...       ...+|..++.||..+|.++|.+|
T Consensus       253 ~~~~~~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCccccccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            553322       34689999999999999999987

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-27  Score=214.20  Aligned_cols=232  Identities=24%  Similarity=0.327  Sum_probs=183.6

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh--hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +|..++-||++.|=+|.++++.+ |. ++||+|.+...  +-.. ..+...+++ ...+++||++++.-+...+...|+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~-~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRP-FKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchH-HHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence            68999999999999999999754 43 99999966542  2112 222233444 5667899999999888888889999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----  172 (271)
                      .+|.. -+|.+.+..++.+..-+.+.+++||+.|+..+|+.||+|||||.+||||+..+++.|+||...+..--+     
T Consensus       100 Rqyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            99997 599999998888999999999999999999999999999999999999999999999999865321110     


Q ss_pred             c-c----cccccccccCCccccCCC-----------CCccchhhhHHHHHHHHH-hCCCCCCC-----------CCcchh
Q 024158          173 R-H----TMCGTLDYLAPEMVENKE-----------HDYAVDNWTLGILCYEFL-YGAPPFEA-----------ESQKDT  224 (271)
Q Consensus       173 ~-~----~~~~~~~y~~pe~~~~~~-----------~~~~~Di~slg~il~~l~-~g~~p~~~-----------~~~~~~  224 (271)
                      . .    .......|+|||.+....           ...+.||||+||+++||+ .|.+||..           ..+...
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            0 0    112234599999886422           457899999999999987 57888852           223444


Q ss_pred             hccc-CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 FRSI-SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 ~~~i-~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +++| ++.++.|+..|++.||.+|.|+++.|+.
T Consensus       259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            5555 4679999999999999999999999987

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=5.6e-25  Score=185.62  Aligned_cols=164  Identities=18%  Similarity=0.156  Sum_probs=125.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEec-CCceEEEEEechhhh--hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .-..+|++.+.||+|+||+||+|++.. ++..+++|.......  ........+.+|+++++.++|+++++.+..   .+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence            346779999999999999999999876 677789998653211  122335668999999999999998853322   24


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI-KPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl-~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..|++|||++|++|.. +..   ..   ...++.+++++|.+||+.||+|||| ||+||+++.++.++|+|||++.....
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            5799999999988863 211   11   1467889999999999999999999 99999999999999999999854332


Q ss_pred             cc-----------ccccccccccCCcccc
Q 024158          172 KR-----------HTMCGTLDYLAPEMVE  189 (271)
Q Consensus       172 ~~-----------~~~~~~~~y~~pe~~~  189 (271)
                      ..           ....+++.|++||.+.
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            21           1224567789999775

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1.6e-23  Score=175.91  Aligned_cols=239  Identities=40%  Similarity=0.662  Sum_probs=201.5

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC-ceeceeeEEEeCCeEEEEEe
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP-NILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~~~~lv~e   99 (271)
                      |.+...||.|+|+.||.+.+.   ..+++|.+.............+.+++..++.+.|+ +++.+.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            889999999999999999976   77899998776655544567888899999999988 79999999977777899999


Q ss_pred             ccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccC----
Q 024158          100 YAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRS----  171 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~----  171 (271)
                      ++.++++.+++....   .++......++.|++.++.++|+.|++|+|++|+||+++..+ .++++|||.+.....    
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777654   689999999999999999999999999999999999999988 799999998753332    


Q ss_pred             -----ccccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCc----chhhcc------------
Q 024158          172 -----KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS------------  227 (271)
Q Consensus       172 -----~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~----~~~~~~------------  227 (271)
                           ......++..|.+||...+   .......|+|++|+++++++.|..||.....    ......            
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2355678999999999987   5678899999999999999999999776653    111110            


Q ss_pred             cC--------HHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 IS--------AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 i~--------~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ..        ..+.+++..++..+|..|.+..+...+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            11        478999999999999999999999988666554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=7.8e-25  Score=172.53  Aligned_cols=177  Identities=12%  Similarity=0.158  Sum_probs=135.8

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHH------HHHHHHHHhhCCCCceeceeeE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~------~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ..+--++|++.+.||.|+||.||++..  ++..+++|++......++.....      +.+|++.+.++.|+++..+.++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            345568899999999999999999654  46789999997665555444333      5789999999999999999988


Q ss_pred             EEeC--------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           88 FHDD--------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        88 ~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      +...        +..+++|||++|.+|.++..    ++.    ....++..++..+|+.|++|+|++|+||+++++| ++
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence            6543        35789999999999977742    232    3456999999999999999999999999999988 99


Q ss_pred             EeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHH
Q 024158          160 IGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL  210 (271)
Q Consensus       160 L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~  210 (271)
                      |+|||...........         ........+..++|+|+||+++..+.
T Consensus       175 liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999976443221111         01223334557899999999887643

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=8.4e-24  Score=164.49  Aligned_cols=142  Identities=19%  Similarity=0.206  Sum_probs=110.8

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHH-----------------------HHHHHHHHHHHHhhCCCCc
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-----------------------IQHQLRREMEIQSSLRHPN   80 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~~~~~~   80 (271)
                      ...||+|++|.||+|.+. +|+.+|+|++..+......                       .......|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999986 8999999999654321100                       0123345889999998877


Q ss_pred             eeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCeeeCCCCCEE
Q 024158           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC-HENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L-h~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      +.....+... + .++||||++++++.........++...+..++.|++.++.++ |+.|++|+|+||+||+++ ++.++
T Consensus        81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            6544433222 2 389999999877765544456789999999999999999999 799999999999999998 57899


Q ss_pred             Eeeecccccc
Q 024158          160 IGDFGWSVQS  169 (271)
Q Consensus       160 L~dfg~~~~~  169 (271)
                      |+|||++...
T Consensus       158 LiDFG~a~~~  167 (190)
T cd05147         158 IIDVSQSVEH  167 (190)
T ss_pred             EEEccccccC
Confidence            9999988543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.7e-22  Score=156.51  Aligned_cols=143  Identities=17%  Similarity=0.169  Sum_probs=111.7

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhH-----------------------HHHHHHHHHHHHHHhhCCCC
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-----------------------YKIQHQLRREMEIQSSLRHP   79 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~~~~~   79 (271)
                      +.+.||+|++|.||+|.+. +|+.+++|++.......                       ......+..|.+.+.++.++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 89999999987642110                       01122345788999999888


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCE
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~  158 (271)
                      ++.....+....  .++||||++++++.........++......++.|++.++.++|. .|++|+||||+||+++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875555444332  48999999877554432233567888999999999999999999 9999999999999998 8899


Q ss_pred             EEeeecccccc
Q 024158          159 KIGDFGWSVQS  169 (271)
Q Consensus       159 ~L~dfg~~~~~  169 (271)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2e-24  Score=186.29  Aligned_cols=232  Identities=34%  Similarity=0.604  Sum_probs=192.7

Q ss_pred             ecccCCceEEEEEEec---CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEEeccC
Q 024158           27 LGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        27 lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      +|.|++|.|++++...   .+..+++|+..+......... -...+..++..++ ||.++.+...++.+...+++.++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            6899999999876432   366788888765544322211 3345667777776 9999999999999999999999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccccccccccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY  182 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y  182 (271)
                      ++.|...+.....+...........++-++.++|..|++|+|+|++||+++.+|++++.|||.++........ +|+.-|
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-cgt~ey  159 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-CGTYEY  159 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-ccchhh
Confidence            9999999888777788888888899999999999999999999999999999999999999998766655444 889999


Q ss_pred             cCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------cccCHHHHHHHHHhcccCccCCC-----CH
Q 024158          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------RSISAEAKHLISRLLVKDSSKRL-----SL  250 (271)
Q Consensus       183 ~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------~~i~~~l~~li~~~l~~~p~~Rp-----s~  250 (271)
                      +|||+.+  ....+.|-||+|+++++|++|..||.+......+       +.++..+++++..++..+|..|.     -+
T Consensus       160 mApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~  237 (612)
T KOG0603|consen  160 RAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGV  237 (612)
T ss_pred             hhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchh
Confidence            9999998  5667899999999999999999999983322222       34578899999999999999998     46


Q ss_pred             HHHhcCCccccC
Q 024158          251 QKIMEHPWIIKN  262 (271)
Q Consensus       251 ~~il~~~~~~~~  262 (271)
                      .++++|+||+..
T Consensus       238 ~eik~h~f~~~i  249 (612)
T KOG0603|consen  238 DEIKQHEFFQSI  249 (612)
T ss_pred             HHHhccchheee
Confidence            899999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.6e-23  Score=160.34  Aligned_cols=235  Identities=20%  Similarity=0.347  Sum_probs=188.2

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      -..+++++..+..+|.+.-.|+.|++++.+  ..+++|++....... +..+++.+|.-.++-+.||||.++++.+...-
T Consensus       184 ~~gid~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  184 YTGIDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             ccCcchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            344566777788899999999999999754  447788876654433 55678889999999999999999999999998


Q ss_pred             eEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCEEEe--eeccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIG--DFGWS  166 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~~L~--dfg~~  166 (271)
                      .+.++..||+-+||.+.+.....  ....++.+.+-+++.++.|||+..  |..--++...++||.+-..+|+  |--++
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfs  340 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFS  340 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceee
Confidence            99999999999999999987543  466788999999999999999884  4445688899999988766654  33222


Q ss_pred             ccccCccccccccccccCCccccCCCCC---ccchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCH
Q 024158          167 VQSRSKRHTMCGTLDYLAPEMVENKEHD---YAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISA  230 (271)
Q Consensus       167 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~---~~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~  230 (271)
                      .+.    .+...+|.|++||.+...+-+   .++|+|||++++|++.+...||....+-+-             ...+++
T Consensus       341 fqe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~  416 (448)
T KOG0195|consen  341 FQE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR  416 (448)
T ss_pred             eec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence            221    234557899999999876643   478999999999999999999987665432             233578


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHh
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                      .+..+++-|+..||.+||..+.|.
T Consensus       417 hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  417 HMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHHHhcCCCCcCCCcceeh
Confidence            899999999999999999987764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=5.7e-22  Score=181.84  Aligned_cols=240  Identities=23%  Similarity=0.295  Sum_probs=181.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ....++....|.|.+.||+|+||.||.|.+.. |+.+|+|+=+...........+++..++  -.+ -+.|+.+.....-
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~~-~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK--PQM-LPSIMHISSAHVF  765 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc--hhh-hcchHHHHHHHcc
Confidence            34556778889999999999999999999866 9999999976665554444444444443  111 2345555555555


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-------CCEEEeee
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-------GRLKIGDF  163 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-------~~~~L~df  163 (271)
                      .+.-++|++|.+-|+|.++++..+.+++.....+..|++..+++||..+|+||||||+|+|+...       .-++|+||
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf  845 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF  845 (974)
T ss_pred             CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence            56678999999999999999988889999999999999999999999999999999999999532       25999999


Q ss_pred             cccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCCcchhhccc-----CHHH
Q 024158          164 GWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI-----SAEA  232 (271)
Q Consensus       164 g~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~-~~~~~~~~~~~i-----~~~l  232 (271)
                      |.+.+..-     .....++|-.+-++|...|.+|+.+.|.|.|+.+++-|+.|+..- .....+....++     ...+
T Consensus       846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~~~W  925 (974)
T KOG1166|consen  846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKRDMW  925 (974)
T ss_pred             ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhHHHH
Confidence            98844332     334567788999999999999999999999999999999986532 111111111111     2446


Q ss_pred             HHHHHHhcccCccCCCCHHHHh
Q 024158          233 KHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il  254 (271)
                      .+++..+|..|...=|...++.
T Consensus       926 ~~~F~~lLN~~~~~~p~l~~lr  947 (974)
T KOG1166|consen  926 NKFFDLLLNPDCDTLPNLQELR  947 (974)
T ss_pred             HHHHHHHhCcCcccchhHHHHH
Confidence            6888889986666666665543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=3.9e-22  Score=180.57  Aligned_cols=207  Identities=32%  Similarity=0.575  Sum_probs=165.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      =.+|..++.|..|++|-||+++++.+..++++|+ .++..-       +++   ++.....|.++               
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li-------lRn---ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI-------LRN---ILTFAGNPFVV---------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcc-cccchh-------hhc---cccccCCccee---------------
Confidence            3679999999999999999999999999999954 222211       111   33333344433               


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC------
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS------  171 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~------  171 (271)
                            ++-...++.-++++.+.        +.+++|||+.||+|+|++|+|.+|+.-|++|+.|||+++...-      
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                  34444455545555443        6789999999999999999999999999999999998732110      


Q ss_pred             ------------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc------------
Q 024158          172 ------------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS------------  227 (271)
Q Consensus       172 ------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~------------  227 (271)
                                  .....+|||.|.|||+.....|....|=|++|+++|+++-|..||.+.++++.+..            
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d  281 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED  281 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC
Confidence                        11234789999999999999999999999999999999999999999998888754            


Q ss_pred             --cCHHHHHHHHHhcccCccCCC---CHHHHhcCCccccCCC
Q 024158          228 --ISAEAKHLISRLLVKDSSKRL---SLQKIMEHPWIIKNAN  264 (271)
Q Consensus       228 --i~~~l~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~~~  264 (271)
                        +++++++++.++|..+|..|.   ..-++..|+||+...-
T Consensus       282 ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw  323 (1205)
T KOG0606|consen  282 EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW  323 (1205)
T ss_pred             cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence              589999999999999999997   7889999999997643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=3.1e-21  Score=158.56  Aligned_cols=241  Identities=27%  Similarity=0.464  Sum_probs=170.5

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCc-----------------------------------eEEEEEec
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----------------------------------PVALKIIF   53 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----------------------------------~~~vK~~~   53 (271)
                      ++-....++..+|.+...||.|--+.||.+....+|.                                   +.++|.+-
T Consensus       147 ~~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMf  226 (598)
T KOG4158|consen  147 PNRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMF  226 (598)
T ss_pred             cchhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhc
Confidence            4455667888999999999999999999988655321                                   12333221


Q ss_pred             hhh--hhHHHHHHHHHHHHH------H--------Hhh--------CCCCceeceeeEEEe-------------------
Q 024158           54 KEQ--IEKYKIQHQLRREME------I--------QSS--------LRHPNILRLYGWFHD-------------------   90 (271)
Q Consensus        54 ~~~--~~~~~~~~~~~~e~~------~--------l~~--------~~~~~i~~~~~~~~~-------------------   90 (271)
                      .-.  .......+..-+|+.      .        .+.        -+||||+++..+|.+                   
T Consensus       227 N~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R  306 (598)
T KOG4158|consen  227 NFEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPAR  306 (598)
T ss_pred             ccccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccce
Confidence            000  011122222222210      0        011        259999999887633                   


Q ss_pred             --------CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC--CCC--CE
Q 024158           91 --------DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEG--RL  158 (271)
Q Consensus        91 --------~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~--~~~--~~  158 (271)
                              +.+.|+||..++ .+|..++-. ...+......++.|+++++.|||..|+.|+|+|.+||++.  +++  ++
T Consensus       307 ~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~L  384 (598)
T KOG4158|consen  307 WYPSGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQL  384 (598)
T ss_pred             ecccccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEE
Confidence                    346999999886 599999965 4467788889999999999999999999999999999994  333  68


Q ss_pred             EEeeecccccccC---------ccccccccccccCCccccCCCC------CccchhhhHHHHHHHHHhCCCCCCCCCc--
Q 024158          159 KIGDFGWSVQSRS---------KRHTMCGTLDYLAPEMVENKEH------DYAVDNWTLGILCYEFLYGAPPFEAESQ--  221 (271)
Q Consensus       159 ~L~dfg~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~------~~~~Di~slg~il~~l~~g~~p~~~~~~--  221 (271)
                      .++|||++.....         -.-..-|....+|||+.+.-+.      -.++|.|+.|.+.||+++...||-+...  
T Consensus       385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~  464 (598)
T KOG4158|consen  385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML  464 (598)
T ss_pred             EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence            8999998733221         1112345667899998864331      2489999999999999999999876221  


Q ss_pred             -------chh----hcccCHHHHHHHHHhcccCccCCCCHH
Q 024158          222 -------KDT----FRSISAEAKHLISRLLVKDSSKRLSLQ  251 (271)
Q Consensus       222 -------~~~----~~~i~~~l~~li~~~l~~~p~~Rps~~  251 (271)
                             +++    ....|+.+++++-.+|+.||.+|+|..
T Consensus       465 L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  465 LDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             echhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                   111    234689999999999999999999864

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=4.7e-20  Score=142.63  Aligned_cols=187  Identities=20%  Similarity=0.233  Sum_probs=136.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH-HHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..+...|++|+||+|+.+..  .+.+++.+.+........ .....+++|+++++++. +++++.++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34678899999999997663  677788777644332111 12235789999999996 4789999886    3469999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCeeeCCCCCEEEeeecccccccCccc---
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI-KPENLLLDHEGRLKIGDFGWSVQSRSKRH---  174 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl-~~~Nili~~~~~~~L~dfg~~~~~~~~~~---  174 (271)
                      +|+.|.+|...+..       ....++.++..++.++|+.|++|+|| +|+||+++.++.++|+|||++........   
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            99998888654322       12457789999999999999999999 79999999999999999999864443221   


Q ss_pred             -------------cccccccccCCccccCC-CCC-ccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          175 -------------TMCGTLDYLAPEMVENK-EHD-YAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       175 -------------~~~~~~~y~~pe~~~~~-~~~-~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                                   ....++.++.|+...-. ..+ .+.+-++-|+-+|.++|+..++.+..
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                         11235555555543322 233 35677799999999999998876543

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=4.9e-20  Score=148.06  Aligned_cols=144  Identities=20%  Similarity=0.230  Sum_probs=113.2

Q ss_pred             ceeeeeeecccCCceEEEEE-EecCCceEEEEEechhhhhH---------------------HHHHHHHHHHHHHHhhCC
Q 024158           20 DFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEK---------------------YKIQHQLRREMEIQSSLR   77 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~-~~~~~~~~~vK~~~~~~~~~---------------------~~~~~~~~~e~~~l~~~~   77 (271)
                      .|++.+.||.|++|.||+|. +..+|..+++|++.......                     ......+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58899999999999999998 66789999999986543210                     011234568999999987


Q ss_pred             CCc--eeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCeeeCC
Q 024158           78 HPN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPENLLLDH  154 (271)
Q Consensus        78 ~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~-i~H~dl~~~Nili~~  154 (271)
                      +.+  ++.++..    ...++|||++++.+|.........+....+..++.|++.++.+||+.| ++|+|++|+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  4444442    235899999998788766544455667778899999999999999999 99999999999998 


Q ss_pred             CCCEEEeeeccccc
Q 024158          155 EGRLKIGDFGWSVQ  168 (271)
Q Consensus       155 ~~~~~L~dfg~~~~  168 (271)
                      ++.++|+|||.+..
T Consensus       184 ~~~i~LiDFg~a~~  197 (237)
T smart00090      184 DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCEEEEEChhhhc
Confidence            88999999997654

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1.3e-19  Score=142.44  Aligned_cols=134  Identities=22%  Similarity=0.345  Sum_probs=104.8

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-----CCCceeceeeEEEeCC---e
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNILRLYGWFHDDE---R   93 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~---~   93 (271)
                      .-...||+|+++.||.  +..++.. +||++......   ..+.+.+|+.+++.+     .||||++++++++.+.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            4457899999999995  6666665 69988554322   245688999999999     5799999999998863   4


Q ss_pred             -EEEEEec--cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCeeeCCC----CCEEEeeec
Q 024158           94 -IFLILEY--AHRGELYRELRKHRRFTEQQAATYIASLTNAL-AYCHENHVIHRDIKPENLLLDHE----GRLKIGDFG  164 (271)
Q Consensus        94 -~~lv~e~--~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l-~~Lh~~~i~H~dl~~~Nili~~~----~~~~L~dfg  164 (271)
                       +.+|+|+  +.+++|.+++.+. .+++.  ...+.+++.++ .|||+.+|+|+||||+||+++..    +.++|+|++
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence             3378999  4478999999764 45555  35577777776 99999999999999999999753    379999954

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=4.2e-19  Score=140.88  Aligned_cols=138  Identities=19%  Similarity=0.285  Sum_probs=114.3

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++.||+|++|.||++..  +|..+++|.......     ........+.+|+.++..+.+++++.+..++...+..+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            35789999999999986  677899998654322     11122346778999999999999888777777777889999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      |+++|++|.+++.....    ....++.+++.++.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999999876432    7889999999999999999999999999999998 78999999998754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.79  E-value=6.1e-20  Score=155.89  Aligned_cols=164  Identities=25%  Similarity=0.447  Sum_probs=131.9

Q ss_pred             eEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++|+.|++|...+|.+|+.+.+   ..+....+.++.|++.++.|   +|..|+|++|.||+...++.++|.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            5899999999999999997543   46888899999999999999   99999999999999999999999999987433


Q ss_pred             cC---------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCC----------CCCcchhhcccC
Q 024158          170 RS---------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFE----------AESQKDTFRSIS  229 (271)
Q Consensus       170 ~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~----------~~~~~~~~~~i~  229 (271)
                      ..         ......||..|++||.+.+..|+.+.|||+||+++++++. =...+.          +.-++..+... 
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~~d~-  485 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFLQDY-  485 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHhhcC-
Confidence            32         3345678999999999999999999999999999999986 112221          22222222333 


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                      ++-..|+..++.+.|.+||++.+.-.|+|.+
T Consensus       486 p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  486 PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            3346899999999999999888777777643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=2.2e-18  Score=135.54  Aligned_cols=133  Identities=16%  Similarity=0.239  Sum_probs=107.6

Q ss_pred             eecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      .||+|++|.||++.  .++..+++|.......     +.......+.+|+++++.+.++++..+..++...+..+++||+
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            37999999999998  4678899998654322     1122346677899999999888766655555666677999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ++|++|.+++.....       .++.+++.++.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999988765321       7889999999999999999999999999998 88999999998744

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=1e-18  Score=150.62  Aligned_cols=184  Identities=26%  Similarity=0.421  Sum_probs=150.9

Q ss_pred             HhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCCe
Q 024158           73 QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHV-IHRDIKPENL  150 (271)
Q Consensus        73 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i-~H~dl~~~Ni  150 (271)
                      ++.+.|.|+.++++.+.++...++|.++|..|+|.+.+.. ...++.-....+..+|+.++.|||+..| +|+.+++.|-
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3567899999999999999999999999999999999987 4578888999999999999999999865 9999999999


Q ss_pred             eeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCC-------CCccchhhhHHHHHHHHHhCCCCCCC
Q 024158          151 LLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKE-------HDYAVDNWTLGILCYEFLYGAPPFEA  218 (271)
Q Consensus       151 li~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~-------~~~~~Di~slg~il~~l~~g~~p~~~  218 (271)
                      +++....+||.|||+......     .........-|.|||.+....       .+.+.|+||+|++++++++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999998744432     111122344589999886531       45679999999999999999999975


Q ss_pred             CCcchh----------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          219 ESQKDT----------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       219 ~~~~~~----------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ......                      ....++++..++.+|+..+|.+||+++++-..
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~  220 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK  220 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence            332211                      11346689999999999999999999998654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.78  E-value=2.1e-18  Score=135.47  Aligned_cols=138  Identities=22%  Similarity=0.300  Sum_probs=106.8

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH-------------------HHHHHHHHHHHHHhhCCCC--
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-------------------KIQHQLRREMEIQSSLRHP--   79 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-------------------~~~~~~~~e~~~l~~~~~~--   79 (271)
                      |.+.+.||+|++|.||++.. .+|+.++||++..+.....                   ........|...+..+.++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            88899999999999999987 4799999998754321100                   1122356788888888776  


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      .++.+++    ....+++|||+++++|......      .....++.+++.++.++|..|++|+||+|+||+++.++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            3444443    2345899999999888765431      34567889999999999999999999999999999999999


Q ss_pred             Eeeecccccc
Q 024158          160 IGDFGWSVQS  169 (271)
Q Consensus       160 L~dfg~~~~~  169 (271)
                      |+|||.+...
T Consensus       166 liDfg~~~~~  175 (198)
T cd05144         166 IIDWPQMVST  175 (198)
T ss_pred             EEECCccccC
Confidence            9999987443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1.5e-17  Score=149.24  Aligned_cols=138  Identities=17%  Similarity=0.228  Sum_probs=110.3

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhh-----hhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-----IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .|...+.||+|+||.||++....  ..+++|+.....     .........+.+|+++++.++|++++.+..+....+..
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            34567899999999999988643  344444432211     11222345678999999999999988877777777778


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +++|||+++++|.+++.        ....++.+++.++.+||+.|++|+|++|+||++ .++.++|+|||++..
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999998885        346789999999999999999999999999999 678999999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.74  E-value=2e-17  Score=128.69  Aligned_cols=139  Identities=22%  Similarity=0.332  Sum_probs=97.7

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHH---------------------HHHHHHHHHhhCCCCc-
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH---------------------QLRREMEIQSSLRHPN-   80 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~---------------------~~~~e~~~l~~~~~~~-   80 (271)
                      +.+.||+|++|.||+|.+. ++..+++|++............                     ....+...+..+.+.+ 
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            3578999999999999976 8999999998654322111111                     1134555555554332 


Q ss_pred             -eeceeeEEEeCCeEEEEEeccCCCchH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCC
Q 024158           81 -ILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGR  157 (271)
Q Consensus        81 -i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~  157 (271)
                       ++.+++.    ...++++|+++++.+. ..+.... .. ..+..++.+++.++.++|. .|++|+|++|+||+++ ++.
T Consensus        80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence             4445443    2368999999874332 1121111 11 6678899999999999999 9999999999999999 889


Q ss_pred             EEEeeecccccc
Q 024158          158 LKIGDFGWSVQS  169 (271)
Q Consensus       158 ~~L~dfg~~~~~  169 (271)
                      ++|+|||.+...
T Consensus       153 ~~liDfg~a~~~  164 (187)
T cd05119         153 VYIIDVPQAVEI  164 (187)
T ss_pred             EEEEECcccccc
Confidence            999999987443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.2e-19  Score=161.20  Aligned_cols=244  Identities=31%  Similarity=0.530  Sum_probs=198.1

Q ss_pred             cccceeeeeeecccCCceEEEEEEecC-CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   94 (271)
                      ....|.+.+.||+|+++.+-++....+ ...+++|.+.... ...........+..+-..+. |+|++.+++.....+..
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            367799999999999999988776444 3445566554332 11233445556777777776 99999999999999999


Q ss_pred             EEEEeccCCCchHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeeeCCCC-CEEEeeeccccccc
Q 024158           95 FLILEYAHRGELYREL-RKHR-RFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR  170 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l-~~~~-~l~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~  170 (271)
                      ++..++..++++.+.+ .... ..+.......+.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++....
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999998888 4443 5677788899999999999999 99999999999999999999 99999999985444


Q ss_pred             C-c-----cccccc-cccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcc----------------hhhc
Q 024158          171 S-K-----RHTMCG-TLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK----------------DTFR  226 (271)
Q Consensus       171 ~-~-----~~~~~~-~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------~~~~  226 (271)
                      . .     .....| ++.|.+||.+.+..+ ....|+||.|+++..+++|..|+......                ..+.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            3 1     233467 899999999988654 45789999999999999999998654432                2345


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      +++....+++.+++..+|..|.+.+++..++|+..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccccccccc
Confidence            57899999999999999999999999999999988

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.72  E-value=1.9e-16  Score=138.44  Aligned_cols=213  Identities=16%  Similarity=0.309  Sum_probs=163.3

Q ss_pred             EEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCC
Q 024158           37 LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRF  116 (271)
Q Consensus        37 ~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l  116 (271)
                      .+..+.++.++.|.+++....   .......+.++.++.++||+|+++++.++..+..|+|+|.+.  .|..++++   +
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---L  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---h
Confidence            355667888899998866544   334567788899999999999999999999999999999984  78888876   3


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc---ccccccccccCCccccCCC
Q 024158          117 TEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKE  192 (271)
Q Consensus       117 ~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~~~  192 (271)
                      +......-++||+.||.+|| +.+++|+|++...|+++..|.++|.+|.++.......   ........|..|+......
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            46677788899999999998 5689999999999999999999999999874433332   2222334466666554333


Q ss_pred             CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcccCHHHHHHHHHhcccCccCCCCHHHH-----hcCCcccc
Q 024158          193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKI-----MEHPWIIK  261 (271)
Q Consensus       193 ~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~i-----l~~~~~~~  261 (271)
                        ...|.|.||+++++++.|  ++...+.......+|+....+..+-+.-.+..||.....     +-|+||++
T Consensus       182 --~s~D~~~Lg~li~el~ng--~~~~~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n~~~~~~~~~~~~gff~n  251 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG--SLLTKTDLSNTGKIPKALIELYCKKLGATELKRPNKLRFILECRLLGGFFRN  251 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc--ccCcchhhhccCccchhHHHHHHHHhccccccccchhhHHHHHHhccccccc
Confidence              457999999999999999  555566666667788777877777777777777764333     33677765

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.71  E-value=2.2e-16  Score=127.14  Aligned_cols=137  Identities=18%  Similarity=0.237  Sum_probs=103.4

Q ss_pred             eeec-ccCCceEEEEEEecCCceEEEEEechhhh-----h-----HHHHHHHHHHHHHHHhhCCCCce--eceeeEEEeC
Q 024158           25 RPLG-KGKFGRVYLVREVESKHPVALKIIFKEQI-----E-----KYKIQHQLRREMEIQSSLRHPNI--LRLYGWFHDD   91 (271)
Q Consensus        25 ~~lg-~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~-----~~~~~~~~~~e~~~l~~~~~~~i--~~~~~~~~~~   91 (271)
                      ..|| .||.|++|.+..  .+..+++|.+.....     .     +......+.+|+.++..+.++++  +.++++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            3466 888888888875  367899998854321     0     11223567889999999988774  6677664332


Q ss_pred             C----eEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           92 E----RIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        92 ~----~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .    ..++|+|++++ .+|.+++.. ..++..    .+.+++.++.+||+.||+|+||+|.||+++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence            2    23599999986 689888865 345544    3568999999999999999999999999999999999999976


Q ss_pred             cc
Q 024158          167 VQ  168 (271)
Q Consensus       167 ~~  168 (271)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            44

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=3.2e-16  Score=117.21  Aligned_cols=131  Identities=24%  Similarity=0.289  Sum_probs=108.6

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC--CceeceeeEEEeCCeEEEEEec
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      +++.||+|.++.||++....  ..+++|.+.....     ...+..|...++.+++  .++++++.+....+..++++|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            56789999999999999744  7799999855432     3457778888888876  5888998888777889999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~---~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +++.++..+       +......++.+++.++..+|..   +++|+|++|.||++++.+.++++||+.+.
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            988777543       4566778889999999999985   79999999999999998999999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1.3e-15  Score=131.82  Aligned_cols=246  Identities=22%  Similarity=0.245  Sum_probs=189.3

Q ss_pred             cCccccceeeeeeecc--cCCceEEEEEE--ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEE
Q 024158           14 REWSLQDFEIGRPLGK--GKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWF   88 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~--g~~~~v~~~~~--~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   88 (271)
                      ..+.-+.+.+.+.+|.  |.+|.+|.+.-  ..++..+++|.-+............ .++....+++ .|++.++....+
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k-~~~~~s~~~i~~~~~~v~~~~~~  187 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRK-LREFLSHHKIDSHENPVRDSPAW  187 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccc-cchhhcccccCccccccccCccc
Confidence            3455566788999999  99999999887  7788999999843332211111111 2334444444 488999989999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCeeeCCC-CCEEEee
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN----ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGD  162 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~----~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~d  162 (271)
                      +..+..++-.|.|. .+|..+...- ..++...++..+.+..+    |+.++|+.+++|.|++|.||++..+ ...++.|
T Consensus       188 e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  188 EGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence            99999999999996 6887777653 34788999999999999    9999999999999999999999998 8899999


Q ss_pred             ecccccccCcc--------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCC--Ccchh--------
Q 024158          163 FGWSVQSRSKR--------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE--SQKDT--------  224 (271)
Q Consensus       163 fg~~~~~~~~~--------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~--~~~~~--------  224 (271)
                      ||+........        ....+...|++||... +.+....|+|++|.++.+...+..++...  ..+..        
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~  345 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL  345 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence            99875444322        1125677899999774 45567899999999999988877766554  33333        


Q ss_pred             --hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          225 --FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       225 --~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                        ....+.++...+..|++.+|..|++.+.++.+.++...
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence              33457778889999999999999999999999998743

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=2.6e-15  Score=121.21  Aligned_cols=188  Identities=19%  Similarity=0.367  Sum_probs=140.1

Q ss_pred             hhCCCCceeceeeEEEeCC-----eEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 024158           74 SSLRHPNILRLYGWFHDDE-----RIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN--HVIH  142 (271)
Q Consensus        74 ~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~--~i~H  142 (271)
                      -.+-|.|+++++.++.+..     ...++.|||..+++..+|++    ...++.....+++.||+.||.|||+.  .++|
T Consensus       122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih  201 (458)
T KOG1266|consen  122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH  201 (458)
T ss_pred             HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence            3345888999999886543     37888999999999999975    34688888999999999999999988  5999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeeccccccc-------CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCC
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWSVQSR-------SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP  215 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p  215 (271)
                      +++....|++..+|-+++..-.......       ..+....+.++|.+||.-.....+..+|||++|+...+|.-+..-
T Consensus       202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq  281 (458)
T KOG1266|consen  202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ  281 (458)
T ss_pred             CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence            9999999999998888876433221111       112334567889999977666677789999999999998866442


Q ss_pred             -CCCCC---cchhhcc----c-CHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          216 -FEAES---QKDTFRS----I-SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       216 -~~~~~---~~~~~~~----i-~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                       -.+..   ..+...+    + .+--+.++.+|+...|..||++.+++.||..-+
T Consensus       282 ~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  282 STNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             cCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence             11111   1111111    1 233468899999999999999999999997543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.1e-14  Score=126.24  Aligned_cols=248  Identities=19%  Similarity=0.214  Sum_probs=184.5

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEe-cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ..+...+|..+..||.|.|+.++.+... .++..|++|...............+...+.......|.+++.....+....
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            5677889999999999999999987755 678889999887766555444444443333333335888888888887878


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~~~~~~~  171 (271)
                      ..|+--|+|.++++...+.-...+....++.+..|++.++.++|+..++|.|++|+||++..+ +..++.||+......-
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~  419 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF  419 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence            888999999888887666444457888899999999999999999999999999999999886 7889999987753211


Q ss_pred             cccccccccccc--CCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------cccCHHHHHHHHHhcc
Q 024158          172 KRHTMCGTLDYL--APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------RSISAEAKHLISRLLV  241 (271)
Q Consensus       172 ~~~~~~~~~~y~--~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------~~i~~~l~~li~~~l~  241 (271)
                      .........++.  ++......++..+.|+++||.-+.+.+++...-........+        .....++..+.+.+..
T Consensus       420 ~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~  499 (524)
T KOG0601|consen  420 SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKVMIN  499 (524)
T ss_pred             ecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhhhcC
Confidence            111112223333  444444566778999999999999988887654433222221        1234778899999999


Q ss_pred             cCccCCCCHHHHhcCCcccc
Q 024158          242 KDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~  261 (271)
                      +++..||++.++..|+-|-+
T Consensus       500 ~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  500 PDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             Cccccchhhhhhcccchhhh
Confidence            99999999999988877654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.52  E-value=4.1e-15  Score=135.64  Aligned_cols=248  Identities=29%  Similarity=0.465  Sum_probs=189.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ....++.+.+.+.+++++.++.+.-..+|.....|+......-.....+....+-.+.-...+|.++....-+....-.+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            45667888889999999999999877778666666653321111111112221212222222344444333334455689


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-----
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----  170 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-----  170 (271)
                      +++++..+++|...++..+..+.+-.+.....+..+.++||...+.|+|++|.|+++..+++..+.+|+......     
T Consensus       881 L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            999999999999999987777888888888899999999999999999999999999999999999998321000     


Q ss_pred             ------------------------C-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc
Q 024158          171 ------------------------S-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ  221 (271)
Q Consensus       171 ------------------------~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  221 (271)
                                              .     ......+++.|.+||.+.+......+|.|+.|+++++.++|.+||...++
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                    0     01123468899999999999988899999999999999999999999998


Q ss_pred             chhhccc--------------CHHHHHHHHHhcccCccCCCCHH---HHhcCCccccCC
Q 024158          222 KDTFRSI--------------SAEAKHLISRLLVKDSSKRLSLQ---KIMEHPWIIKNA  263 (271)
Q Consensus       222 ~~~~~~i--------------~~~l~~li~~~l~~~p~~Rps~~---~il~~~~~~~~~  263 (271)
                      .+.++.+              +.+.++++...+..+|.+|..+.   ++..|+||+..+
T Consensus      1041 q~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1041 QQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred             hhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCC
Confidence            8887664              78899999999999999999887   999999999873

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.7e-13  Score=119.70  Aligned_cols=142  Identities=19%  Similarity=0.267  Sum_probs=95.6

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHH---------------------------H----------HHHHH
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---------------------------I----------QHQLR   67 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~---------------------------~----------~~~~~   67 (271)
                      +.||+|++|.||+|+. .+|+.||||+........-.                           .          .-++.
T Consensus       123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            6799999999999986 57999999997543211100                           0          01233


Q ss_pred             HHHHHHhhC----C-CCceeceeeEEEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q 024158           68 REMEIQSSL----R-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN-ALAYCHENHV  140 (271)
Q Consensus        68 ~e~~~l~~~----~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~-~l~~Lh~~~i  140 (271)
                      +|.+.+.++    + ++++.-.--+.......+++|||++|.+|.+..... ...   ....++..++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence            344444444    2 233222222222234569999999999998876532 112   23456666665 4788999999


Q ss_pred             eecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158          141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus       141 ~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      +|+|++|.||+++.++.++++|||.+....
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999874443

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=3.6e-13  Score=104.21  Aligned_cols=141  Identities=14%  Similarity=0.193  Sum_probs=100.6

Q ss_pred             eeeecccCCceEEEEEEec------CCceEEEEEechhhhh-----------------------HHHHHHHHHHHHHHHh
Q 024158           24 GRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQIE-----------------------KYKIQHQLRREMEIQS   74 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~   74 (271)
                      ...||.|.-+.||.|....      .+..+|+|++.....+                       ........+.|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998543      3578999987422110                       1112223447888888


Q ss_pred             hCCC--CceeceeeEEEeCCeEEEEEeccCCCchH-HHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCe
Q 024158           75 SLRH--PNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYC-HENHVIHRDIKPENL  150 (271)
Q Consensus        75 ~~~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~l~~~~~~~i~~~l~~~l~~L-h~~~i~H~dl~~~Ni  150 (271)
                      ++..  -.++.++.+    ..-++|||++++..+. ..+.. ..++.+....+..+++.++..| |+.|++|||+++.||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI  156 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM  156 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            8864  456666654    3458899999764332 22322 3455667778889999999998 899999999999999


Q ss_pred             eeCCCCCEEEeeeccccccc
Q 024158          151 LLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus       151 li~~~~~~~L~dfg~~~~~~  170 (271)
                      +++ ++.++|+|||.+....
T Consensus       157 L~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         157 LWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEE-CCcEEEEECCCceeCC
Confidence            996 5789999999775443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=1e-12  Score=98.61  Aligned_cols=136  Identities=18%  Similarity=0.245  Sum_probs=104.9

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhh-----HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      ..+++|+-+.++.+..  -|.++++|.-.+..+.     ..-......+|.+++++++...|.-++-+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3577899999998753  4556888875443332     23345566789999999987777666666667777889999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      |.+|..|.+.+...       ...++..+-..+.-||..||+|||++++||++..++ +.++|||++....
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            99998888888764       256677777889999999999999999999996554 9999999885433

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=7.8e-14  Score=123.37  Aligned_cols=144  Identities=19%  Similarity=0.306  Sum_probs=92.4

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH---------------------------H----HHHH-
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---------------------------Y----KIQH-   64 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---------------------------~----~~~~-   64 (271)
                      .+.+|+. +.||+|++|.||+|+...+|+.||||+..+.....                           .    ...+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3567777 89999999999999988779999999986542110                           0    0111 


Q ss_pred             -----HHHHHHHHHhhC----CCCceeceeeEEE-eCCeEEEEEeccCCCchHHH--HHhCC----CCCHHHHHHHHHHH
Q 024158           65 -----QLRREMEIQSSL----RHPNILRLYGWFH-DDERIFLILEYAHRGELYRE--LRKHR----RFTEQQAATYIASL  128 (271)
Q Consensus        65 -----~~~~e~~~l~~~----~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~--l~~~~----~l~~~~~~~i~~~l  128 (271)
                           ++.+|+..+.++    .+...+.+-.++. -....++||||+.|+++.+.  +...+    .+....+..+    
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~----  272 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF----  272 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH----
Confidence                 123333333333    2322222222222 23456899999999999764  22222    1222223333    


Q ss_pred             HHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeeccccc
Q 024158          129 TNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQ  168 (271)
Q Consensus       129 ~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~  168 (271)
                         +..+...|++|+|+||.||+++.+|    .++++|||....
T Consensus       273 ---~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~  313 (537)
T PRK04750        273 ---FTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS  313 (537)
T ss_pred             ---HHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence               3344568999999999999999988    999999998743

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.46  E-value=3.1e-13  Score=103.37  Aligned_cols=127  Identities=24%  Similarity=0.296  Sum_probs=92.1

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCeEEEEEeccC
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      ++.|+.|..+.+|++..  .+..+++|........    ......|...++.+.+.+ +++++....  ...++|||+++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            46788999999999885  3788999997544211    123456777777765444 345555432  33579999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCeeeCCCCCEEEeeecccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV-----IHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i-----~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      |.++...     ..   .....+.+++.++..||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        75 G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            8877543     01   123456789999999999985     9999999999998 6789999999753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.45  E-value=3.8e-12  Score=95.34  Aligned_cols=146  Identities=19%  Similarity=0.204  Sum_probs=110.4

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .+..+-+|+-+.|+++.  ..|+..+||.-....+     +..-......+|++.+.++.--+|.-..-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            56677899999999887  4678888886543333     3333456677899999998766666666566666677889


Q ss_pred             EeccCC-CchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeeccccccc
Q 024158           98 LEYAHR-GELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSR  170 (271)
Q Consensus        98 ~e~~~~-~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~~  170 (271)
                      |||.+| .++.+++....  .-.......++..|-+.+.-||..+++||||..+||++.+++   .+.|+|||++....
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~  167 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR  167 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence            999986 47888886532  223333478899999999999999999999999999997665   35899999985543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.31  E-value=7.8e-11  Score=101.03  Aligned_cols=206  Identities=17%  Similarity=0.199  Sum_probs=150.7

Q ss_pred             ceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE----eCCeEEEEEeccCC-CchH
Q 024158           33 GRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH----DDERIFLILEYAHR-GELY  107 (271)
Q Consensus        33 ~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~----~~~~~~lv~e~~~~-~~L~  107 (271)
                      .+.|++....+|..|++|+++-......   .....-.++.+++.|.|++++.+++.    .+..+++|++|.++ ++|.
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            5689999999999999999843332221   12233456778889999999999875    45579999999875 3666


Q ss_pred             HHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158          108 RELRK---------------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus       108 ~~l~~---------------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++-..               +...++..+|.++.||..||.++|+.|+.-+-+.+.+|+++.+.+++|+..|........
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            65532               223678999999999999999999999999999999999988888888877654222211


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc------chhhcccCHHHHHHHHHhcccCccC
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------KDTFRSISAEAKHLISRLLVKDSSK  246 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~------~~~~~~i~~~l~~li~~~l~~~p~~  246 (271)
                      .    +     +     .-.-..+.|.-.||.+++.|++|..=-...+.      ...-..++.++++++.-....++++
T Consensus       447 ~----~-----~-----~le~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~~~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  447 P----T-----E-----PLESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRITTTYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             C----C-----c-----chhHHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhhhhhhHHHHHHHHHHHhcCccc
Confidence            1    0     0     01122467999999999999999653222221      1122346889999999999888877


Q ss_pred             CCCHHHHhcC
Q 024158          247 RLSLQKIMEH  256 (271)
Q Consensus       247 Rps~~~il~~  256 (271)
                       -++.+++.+
T Consensus       513 -ksI~~llp~  521 (655)
T KOG3741|consen  513 -KSIQDLLPM  521 (655)
T ss_pred             -ccHHHHHHH
Confidence             788888765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.28  E-value=3.7e-11  Score=95.79  Aligned_cols=138  Identities=17%  Similarity=0.261  Sum_probs=99.7

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC--ceeceeeEEEeC---CeEEEEEe
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP--NILRLYGWFHDD---ERIFLILE   99 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~--~i~~~~~~~~~~---~~~~lv~e   99 (271)
                      +.|+.|..+.+|++... +|..+++|........  .....+..|.++++.+.+.  .+++++.+....   +..++++|
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            56889999999999864 3688999997544321  1234667888888888753  356777776553   26789999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE------------------------------------------  137 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~------------------------------------------  137 (271)
                      +++|.++.+.+.. ..++.+....++.+++.++..||+                                          
T Consensus        81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9998877665432 235556666666666666666662                                          


Q ss_pred             --------------CCceecCCCCCCeeeCC--CCCEEEeeeccc
Q 024158          138 --------------NHVIHRDIKPENLLLDH--EGRLKIGDFGWS  166 (271)
Q Consensus       138 --------------~~i~H~dl~~~Nili~~--~~~~~L~dfg~~  166 (271)
                                    ..++|+|+++.||+++.  ++.+.++||+.+
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~  204 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA  204 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence                          24799999999999998  567899999865

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.26  E-value=2.4e-12  Score=113.56  Aligned_cols=136  Identities=24%  Similarity=0.468  Sum_probs=109.1

Q ss_pred             HHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccccCcccc------------ccccccccCCccccCCCC
Q 024158          127 SLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------------MCGTLDYLAPEMVENKEH  193 (271)
Q Consensus       127 ~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~------------~~~~~~y~~pe~~~~~~~  193 (271)
                      +.+.|+.++|+. +++|++|.|++|.++..+.+||+.|+++.........            ..-...|.+||.+.....
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            334889999977 8999999999999999999999999987544432111            112456999999999888


Q ss_pred             CccchhhhHHHHHHHHH-hCCCCCCCCCcchh---------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDT---------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       194 ~~~~Di~slg~il~~l~-~g~~p~~~~~~~~~---------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                      ..++|+||+|++++.++ .|...+........               -.++|+++++-+.+++..++.-||++..++..|
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence            99999999999999988 55555543321111               135799999999999999999999999999999


Q ss_pred             ccccC
Q 024158          258 WIIKN  262 (271)
Q Consensus       258 ~~~~~  262 (271)
                      ||+..
T Consensus       267 ff~D~  271 (700)
T KOG2137|consen  267 FFSDP  271 (700)
T ss_pred             ccCCc
Confidence            99875

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.24  E-value=1.5e-10  Score=97.16  Aligned_cols=220  Identities=18%  Similarity=0.256  Sum_probs=148.2

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh-CCCCceec--------eeeEEEeCCe
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS-LRHPNILR--------LYGWFHDDER   93 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~-~~~~~i~~--------~~~~~~~~~~   93 (271)
                      ..+.||+|+-+.+|..-..  + -.+.|++...-....   .+   ....+.. -.||-+-.        +++- ..+.-
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~---aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~   84 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQ---AQ---KVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV   84 (637)
T ss_pred             CCccccCCccceeeecchh--h-chhheeecCCCchHH---HH---HHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence            3567899999999965422  2 245788865432221   11   1222222 24443222        1111 12223


Q ss_pred             EEEEEeccCCCchHHHH-------HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           94 IFLILEYAHRGELYREL-------RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l-------~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ..++|...++..-...+       +..+...++.+++++..|+.+...||..|.+-||++++|+|+..++.+.|.|-+..
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            77888887764322222       22234688999999999999999999999999999999999999999999987644


Q ss_pred             ccc--cCccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcc-------hh-------
Q 024158          167 VQS--RSKRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYG-APPFEAESQK-------DT-------  224 (271)
Q Consensus       167 ~~~--~~~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~-------~~-------  224 (271)
                      ...  ....-+..|.+.|+|||.-+     +..-+..+|.|.||+++++++.| .+||++....       +.       
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            222  12233456788999999665     34456789999999999998865 9999865421       10       


Q ss_pred             ------------------hcccCHHHHHHHHHhccc--CccCCCCHHH
Q 024158          225 ------------------FRSISAEAKHLISRLLVK--DSSKRLSLQK  252 (271)
Q Consensus       225 ------------------~~~i~~~l~~li~~~l~~--~p~~Rps~~~  252 (271)
                                        +.-+++.++.++.+|+..  ++.-|||++.
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence                              112589999999999874  3568998764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.22  E-value=3.3e-10  Score=87.40  Aligned_cols=128  Identities=21%  Similarity=0.330  Sum_probs=83.6

Q ss_pred             EEEEEEecCCceEEEEEechhhh-----------------------hHHHHHHHHHHHHHHHhhCCCC--ceeceeeEEE
Q 024158           35 VYLVREVESKHPVALKIIFKEQI-----------------------EKYKIQHQLRREMEIQSSLRHP--NILRLYGWFH   89 (271)
Q Consensus        35 v~~~~~~~~~~~~~vK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~~~~~--~i~~~~~~~~   89 (271)
                      ||.|.. .+|..+|+|++.....                       .........++|.+.|.++...  +++.++.+. 
T Consensus         2 Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    2 VYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             EEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            777775 5677899998642211                       1123455677899999999866  467776553 


Q ss_pred             eCCeEEEEEeccC--CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           90 DDERIFLILEYAH--RGELYRELRKHRRFTEQQAATYIASLTNALAY-CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        90 ~~~~~~lv~e~~~--~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~-Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                       .  -++||||++  |..+..+....  ++.+....++.+++..+.. +|..|++|||+++.||+++.+ .+.++|||.+
T Consensus        80 -~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa  153 (188)
T PF01163_consen   80 -R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA  153 (188)
T ss_dssp             -T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred             -C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence             2  379999998  65665544332  1234567788888885444 689999999999999999877 9999999977


Q ss_pred             cccc
Q 024158          167 VQSR  170 (271)
Q Consensus       167 ~~~~  170 (271)
                      ....
T Consensus       154 v~~~  157 (188)
T PF01163_consen  154 VDSS  157 (188)
T ss_dssp             EETT
T ss_pred             eecC
Confidence            5543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.19  E-value=6.4e-10  Score=90.79  Aligned_cols=131  Identities=15%  Similarity=0.043  Sum_probs=91.9

Q ss_pred             EEEEEEecCCceEEEEEechhhhhHH-H-------HHHHHHHHHHHHhhCCCCc--eeceeeEEEe-----CCeEEEEEe
Q 024158           35 VYLVREVESKHPVALKIIFKEQIEKY-K-------IQHQLRREMEIQSSLRHPN--ILRLYGWFHD-----DERIFLILE   99 (271)
Q Consensus        35 v~~~~~~~~~~~~~vK~~~~~~~~~~-~-------~~~~~~~e~~~l~~~~~~~--i~~~~~~~~~-----~~~~~lv~e   99 (271)
                      |.++.  -.|+.+.||.......... +       -...+.+|...+..+...+  ++.++.++..     ....++|+|
T Consensus        38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            55443  4677899997743321110 0       0113667777777775433  3445555543     234789999


Q ss_pred             ccCCC-chHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-------CCCEEEeeecccc
Q 024158          100 YAHRG-ELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------EGRLKIGDFGWSV  167 (271)
Q Consensus       100 ~~~~~-~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-------~~~~~L~dfg~~~  167 (271)
                      ++++. +|.+++..  ..+.+......++.+++..+..||..|++|+|++++||+++.       +..+.|+||+-+.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99875 78888864  234566778899999999999999999999999999999975       3579999998663

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=99.11  E-value=1.6e-09  Score=84.63  Aligned_cols=146  Identities=17%  Similarity=0.139  Sum_probs=95.8

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHH------HHHHHHHHhhCCC---Cc
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQSSLRH---PN   80 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~------~~~e~~~l~~~~~---~~   80 (271)
                      -+-...+.-++|.+.+.+-......|.++.  -+|..+++|.........++....      ..+.+..+.+++.   ..
T Consensus        22 ~~l~~~i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~   99 (229)
T PF06176_consen   22 LELGEKILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTE   99 (229)
T ss_pred             HHHHHHHHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccc
Confidence            334455677889999999998887777766  567889999975544333322221      1223333333322   22


Q ss_pred             eeceeeEEE-----eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           81 ILRLYGWFH-----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        81 i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      ...++-+..     -....++++||++|..|.+...    +++    .+...+.+++..||+.|++|||.+|.|++++.+
T Consensus       100 ~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  100 PADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             cccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence            333333222     1234678999999988866542    222    344667788999999999999999999999855


Q ss_pred             CCEEEeeeccc
Q 024158          156 GRLKIGDFGWS  166 (271)
Q Consensus       156 ~~~~L~dfg~~  166 (271)
                       .++++|++..
T Consensus       172 -~i~iID~~~k  181 (229)
T PF06176_consen  172 -GIRIIDTQGK  181 (229)
T ss_pred             -cEEEEECccc
Confidence             4999999743

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.05  E-value=2e-09  Score=85.87  Aligned_cols=135  Identities=21%  Similarity=0.341  Sum_probs=102.1

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhh-------------------hHHHHHHHHHHHHHHHhhCCCC--c
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-------------------EKYKIQHQLRREMEIQSSLRHP--N   80 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------------------~~~~~~~~~~~e~~~l~~~~~~--~   80 (271)
                      .+...||-|.-|.||.|.+. .|.++++|.-.....                   .-.-.....++|.+.|.++...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            36678999999999999975 688899997421111                   0012345567889999999765  6


Q ss_pred             eeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEE
Q 024158           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L  160 (271)
                      ++.++++    +.-.++||+.+|..|...-     +..+..-.++..|+.-+..+-..|++|||+++-||+++.+|.+.+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            8888865    3458999999986664432     234556677788888887777899999999999999999999999


Q ss_pred             eeeccc
Q 024158          161 GDFGWS  166 (271)
Q Consensus       161 ~dfg~~  166 (271)
                      +||-.+
T Consensus       244 IDwPQ~  249 (304)
T COG0478         244 IDWPQA  249 (304)
T ss_pred             EeCccc
Confidence            999644

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.04  E-value=3e-09  Score=83.93  Aligned_cols=104  Identities=21%  Similarity=0.303  Sum_probs=81.4

Q ss_pred             HHHHHHHHHHhhCCCC--ceeceeeEEEeC----CeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 024158           64 HQLRREMEIQSSLRHP--NILRLYGWFHDD----ERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH  136 (271)
Q Consensus        64 ~~~~~e~~~l~~~~~~--~i~~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh  136 (271)
                      ....+|...+..+...  .++.++.+....    ...++++|.+++. +|.+++.....++......++.+++..+..||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            3456666666666433  355666665542    2458899999874 89999987555777888999999999999999


Q ss_pred             hCCceecCCCCCCeeeCCCC---CEEEeeecccc
Q 024158          137 ENHVIHRDIKPENLLLDHEG---RLKIGDFGWSV  167 (271)
Q Consensus       137 ~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~  167 (271)
                      ..|++|+|+++.|||++.++   .+.|+||+-+.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            99999999999999999887   89999998653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=99.01  E-value=6.9e-09  Score=80.71  Aligned_cols=136  Identities=13%  Similarity=0.139  Sum_probs=95.6

Q ss_pred             cccCCceEEEEEEecCCceEEEEEechhhhhH---HHHHHHHHHHHHHHhhCCCCc--eeceeeEEEe-----CCeEEEE
Q 024158           28 GKGKFGRVYLVREVESKHPVALKIIFKEQIEK---YKIQHQLRREMEIQSSLRHPN--ILRLYGWFHD-----DERIFLI   97 (271)
Q Consensus        28 g~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---~~~~~~~~~e~~~l~~~~~~~--i~~~~~~~~~-----~~~~~lv   97 (271)
                      |+||-|.|+....  .|..+.+|.-.......   +--...+.+|...+..+...+  ++++. ++..     ....++|
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4688888887663  34468888753111111   112456777888887775332  45555 3321     1246888


Q ss_pred             EeccCC-CchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC--EEEeeeccc
Q 024158           98 LEYAHR-GELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWS  166 (271)
Q Consensus        98 ~e~~~~-~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~--~~L~dfg~~  166 (271)
                      +|-+++ .+|.+++...  .+.+......++.+++..+..||+.|+.|+|+.+.||+++.++.  +.++||.-+
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            887653 5898888663  24577778899999999999999999999999999999987777  999999744

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.85  E-value=7.4e-08  Score=76.24  Aligned_cols=141  Identities=17%  Similarity=0.166  Sum_probs=96.7

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---------------------HHHHHHHHHHHHHhhCCC--C
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---------------------KIQHQLRREMEIQSSLRH--P   79 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---------------------~~~~~~~~e~~~l~~~~~--~   79 (271)
                      +...|++|.-+.||+|.. .++..+++|++........                     ........|.+.|+++..  -
T Consensus        52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV  130 (268)
T COG1718          52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV  130 (268)
T ss_pred             eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence            344677888889999885 6788999999854433211                     122334456677777643  3


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCC
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGR  157 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~  157 (271)
                      .+++.+.+.    .-.++||+++.. .-.=.|+. -++..+....+..++++.+.-|-. .|++|+||+.-|||+. ++.
T Consensus       131 rvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~  204 (268)
T COG1718         131 RVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE  204 (268)
T ss_pred             CCCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence            455666553    347899998643 11111111 123344678888999999988877 8999999999999998 889


Q ss_pred             EEEeeeccccccc
Q 024158          158 LKIGDFGWSVQSR  170 (271)
Q Consensus       158 ~~L~dfg~~~~~~  170 (271)
                      +.++|++.+....
T Consensus       205 p~iID~~QaV~~~  217 (268)
T COG1718         205 PYIIDVSQAVTID  217 (268)
T ss_pred             EEEEECccccccC
Confidence            9999999775444

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.72  E-value=3e-07  Score=73.53  Aligned_cols=132  Identities=18%  Similarity=0.195  Sum_probs=81.5

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc--eeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~--i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      ..||+|..+.+|+.    .+..+++|...... .    .....+|.+.++.+..-+  +++++.+....+..+++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-D----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-C----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            56899999999973    25568899985432 1    234577888888775433  5778888877778899999998


Q ss_pred             CCc-hH--------------HHHH-------hC--CCCCHHHHHHHHH-----------HHHHH-HHHHH----hCCcee
Q 024158          103 RGE-LY--------------RELR-------KH--RRFTEQQAATYIA-----------SLTNA-LAYCH----ENHVIH  142 (271)
Q Consensus       103 ~~~-L~--------------~~l~-------~~--~~l~~~~~~~i~~-----------~l~~~-l~~Lh----~~~i~H  142 (271)
                      |.+ +.              ..+.       .-  ...+......-..           .+.+. ..+|.    ...++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            853 11              1111       10  0111111111000           11111 12222    124789


Q ss_pred             cCCCCCCeeeCCCCCEEEeeeccc
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      +|++|.||+++.++ +.++||+.+
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a  180 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDF  180 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhc
Confidence            99999999999888 999999865

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.72  E-value=2.1e-07  Score=87.39  Aligned_cols=201  Identities=20%  Similarity=0.206  Sum_probs=148.0

Q ss_pred             HHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE----EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 024158           63 QHQLRREMEIQSSLRHPNILRLYGWFHDDERIF----LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN  138 (271)
Q Consensus        63 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~----lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~  138 (271)
                      ......|+..+.+..|+|+..++.+..+.....    +..+++...++...++.-...+....+.+..++.+++.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344556778888889999999999886654433    3457788889999998877889999999999999999999999


Q ss_pred             CceecCCCCC---CeeeCCCCCEEEe--eecccccccCcccc--ccccccccCCccccCCCCCc--cchhhhHHHHHHHH
Q 024158          139 HVIHRDIKPE---NLLLDHEGRLKIG--DFGWSVQSRSKRHT--MCGTLDYLAPEMVENKEHDY--AVDNWTLGILCYEF  209 (271)
Q Consensus       139 ~i~H~dl~~~---Nili~~~~~~~L~--dfg~~~~~~~~~~~--~~~~~~y~~pe~~~~~~~~~--~~Di~slg~il~~l  209 (271)
                      ...|.-+..+   +.-++..+.+..+  ||+.+.........  ...+..+.++|......+..  ..|+|++|.....+
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~  385 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL  385 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence            7777666666   5555566666665  88776554443332  23455577777776655544  47999999999999


Q ss_pred             HhCCCCCC-CCCcchhhcccC-HHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          210 LYGAPPFE-AESQKDTFRSIS-AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       210 ~~g~~p~~-~~~~~~~~~~i~-~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ..|..+-. ...+...+.... .+..+.+.+|+..++++|+++.+++.|+|..-..
T Consensus       386 ~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  386 SQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            87765433 222333333322 3788999999999999999999999999987553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=2.3e-07  Score=82.16  Aligned_cols=139  Identities=21%  Similarity=0.282  Sum_probs=89.3

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhH---------------------------H----------HHHHHHH
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---------------------------Y----------KIQHQLR   67 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---------------------------~----------~~~~~~~   67 (271)
                      ..|+.++.|.||+|+.. +|+.||||+..++..+.                           .          ...-++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999974 59999999964332211                           0          0111233


Q ss_pred             HHHHHHhhCC-----CCceeceeeEEEeCCeEEEEEeccCCCchHHHH--HhCCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 024158           68 REMEIQSSLR-----HPNILRLYGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNA-LAYCHENH  139 (271)
Q Consensus        68 ~e~~~l~~~~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~l~~~~~~~i~~~l~~~-l~~Lh~~~  139 (271)
                      +|...+.+++     .+.+.-.--+.+-.+.-.++|||++|..+.+..  .. ...+...+.   ..++.+ +..+-..|
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia---~~~~~~f~~q~~~dg  285 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELA---ELLVRAFLRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHH---HHHHHHHHHHHHhcC
Confidence            3443333332     233322222233334568999999998888774  33 334433333   333332 44555689


Q ss_pred             ceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158          140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus       140 i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +.|+|.+|.||+++.+|.+.+.|||....
T Consensus       286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~  314 (517)
T COG0661         286 FFHADPHPGNILVRSDGRIVLLDFGIVGR  314 (517)
T ss_pred             ccccCCCccceEEecCCcEEEEcCcceec
Confidence            99999999999999999999999997633

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=7.9e-07  Score=78.67  Aligned_cols=142  Identities=13%  Similarity=0.175  Sum_probs=89.4

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhH--------------------------------------HHHHHHH
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--------------------------------------YKIQHQL   66 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--------------------------------------~~~~~~~   66 (271)
                      ..||.-+.|.||+|+.+. |+.|+||+=+++....                                      -....+.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            568999999999999755 9999999843221110                                      0112222


Q ss_pred             HHHHHHHhhCCCCc------eeceeeEEEeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024158           67 RREMEIQSSLRHPN------ILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENH  139 (271)
Q Consensus        67 ~~e~~~l~~~~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~  139 (271)
                      ++..+..+.+.|-+      |++++..+.  ....++|||++|..+.+.-.- ...++...+...+.+...  +.+=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence            33333333444433      555554432  346899999999877555422 133555544444444333  3334568


Q ss_pred             ceecCCCCCCeeeCC----CCCEEEeeecccccccC
Q 024158          140 VIHRDIKPENLLLDH----EGRLKIGDFGWSVQSRS  171 (271)
Q Consensus       140 i~H~dl~~~Nili~~----~~~~~L~dfg~~~~~~~  171 (271)
                      ++|+|-+|.||++++    ++.+.+.|+|+......
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999984    56899999998754443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.52  E-value=2e-06  Score=69.71  Aligned_cols=76  Identities=20%  Similarity=0.161  Sum_probs=50.2

Q ss_pred             eecccCC-ceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEEeccCC
Q 024158           26 PLGKGKF-GRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYAHR  103 (271)
Q Consensus        26 ~lg~g~~-~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~  103 (271)
                      .|..|.. +.||++..  .+..+++|......      ...+..|+++++.+. +--+++++.+...++..++||++++|
T Consensus         5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150           5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            3445555 78898864  34679999874432      123455666666663 23466778777666678999999988


Q ss_pred             CchHHH
Q 024158          104 GELYRE  109 (271)
Q Consensus       104 ~~L~~~  109 (271)
                      .++...
T Consensus        77 ~~l~~~   82 (244)
T cd05150          77 VPAAAL   82 (244)
T ss_pred             ccHhHh
Confidence            776543

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=1e-05  Score=64.82  Aligned_cols=78  Identities=26%  Similarity=0.300  Sum_probs=52.3

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC--ceeceeeEEE---eCCeEEEEE
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP--NILRLYGWFH---DDERIFLIL   98 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~--~i~~~~~~~~---~~~~~~lv~   98 (271)
                      ++.|+.|..+.+|++....  ..+++|.....     .....+..|..+++.+...  .+++++....   .....++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5678999999999998654  58999997554     1234455666666666432  3566666442   234578999


Q ss_pred             eccCCCchHH
Q 024158           99 EYAHRGELYR  108 (271)
Q Consensus        99 e~~~~~~L~~  108 (271)
                      ++++|.++..
T Consensus        75 ~~i~g~~~~~   84 (239)
T PF01636_consen   75 EYIPGRPLDD   84 (239)
T ss_dssp             EEESSEEHHH
T ss_pred             EEeccccccc
Confidence            9999877766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.38  E-value=1.3e-05  Score=62.06  Aligned_cols=95  Identities=24%  Similarity=0.315  Sum_probs=74.6

Q ss_pred             HHHHHHhhCCC-CceeceeeEEEeCCeEEEEEeccCCCchHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Q 024158           68 REMEIQSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYR---ELRKHRRFTEQQAATYIASLTNALAYCHEN---HV  140 (271)
Q Consensus        68 ~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~---~i  140 (271)
                      .|.-+++.+.+ +++++++|.|..    ..+.|+.+.+++..   .+......++..+..++.++++.+++|+..   .+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46677777765 699999999833    45788887655532   111222358999999999999999999873   57


Q ss_pred             eecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          141 IHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       141 ~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .-+|++++||.++.+++++++|.+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v  109 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDV  109 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhc
Confidence            88999999999999999999999865

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.28  E-value=7.8e-06  Score=61.54  Aligned_cols=128  Identities=20%  Similarity=0.229  Sum_probs=90.7

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCcee-ceeeEEEeCCeEEEEEec
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL-RLYGWFHDDERIFLILEY  100 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~-~~~~~~~~~~~~~lv~e~  100 (271)
                      ++.+.|+.|..|.||++..  .|..+++|+-..+     .....+..|.+++..+...++. +++.+..+    .+.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhh
Confidence            4567799999999999985  4568899985333     2246788899999988776654 45555433    345999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCCeeeCCCCCEEEeeecccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK-PENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~-~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ..|.+|.++....   .    ......+++...-|-..||-|+.|+ |..+++..++.+.|+||+.+.
T Consensus        94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            9988887766432   1    3344556666777888899999986 344444455699999998765

>PLN02876 acyl-CoA dehydrogenase

Probab=98.25  E-value=2.5e-05  Score=74.15  Aligned_cols=81  Identities=19%  Similarity=0.308  Sum_probs=55.8

Q ss_pred             eeeeecccCCceEEEEEEecCC--ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCc--eeceeeEEEeC---CeE
Q 024158           23 IGRPLGKGKFGRVYLVREVESK--HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPN--ILRLYGWFHDD---ERI   94 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~--~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~--i~~~~~~~~~~---~~~   94 (271)
                      .+..++.|.++.+|++.....+  ..+++|+........  ....+.+|.++++.+. |.+  +++++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            4677899999999998754332  468888864432211  1245678888888885 555  47777777554   468


Q ss_pred             EEEEeccCCCc
Q 024158           95 FLILEYAHRGE  105 (271)
Q Consensus        95 ~lv~e~~~~~~  105 (271)
                      |+|||+++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.20  E-value=6.2e-05  Score=58.69  Aligned_cols=131  Identities=22%  Similarity=0.357  Sum_probs=87.9

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhh-------------HHHHHHHHHHHHHHHhhCC------CCceece
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-------------KYKIQHQLRREMEIQSSLR------HPNILRL   84 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-------------~~~~~~~~~~e~~~l~~~~------~~~i~~~   84 (271)
                      ...||+|+.=.+|.  +. .....+||+.......             .....++..+|+.....+.      +.+|+++
T Consensus         6 ~~~i~~G~~R~cy~--HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--CC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35688898888883  32 3455789998766500             0012334444444444333      7889999


Q ss_pred             eeEEEeCCeEEEEEeccC------CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC--
Q 024158           85 YGWFHDDERIFLILEYAH------RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG--  156 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~--  156 (271)
                      +|+.+.+....+|+|.+.      ..+|.+++.++ .++. ...   ..+-+...+|-+.+|+.+|++|+||++...+  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            999999988999998753      24788888653 3554 333   3444556677888999999999999996543  


Q ss_pred             --CEEEee
Q 024158          157 --RLKIGD  162 (271)
Q Consensus       157 --~~~L~d  162 (271)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.19  E-value=2.7e-05  Score=65.43  Aligned_cols=144  Identities=22%  Similarity=0.261  Sum_probs=100.1

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----------------------HHHHHHHHHHHHHHHhhCCCC
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----------------------KYKIQHQLRREMEIQSSLRHP   79 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----------------------~~~~~~~~~~e~~~l~~~~~~   79 (271)
                      +-..|..|.-+.||.|.. .+|..+|||+++.+...                       +.........|++-|.++...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456678899999999874 67888999998543221                       112233345677778887766


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCeeeCCCCC
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGR  157 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~~~Nili~~~~~  157 (271)
                      +|+..--+...+  -.|||++++.- -..-.|+ .-.++...+..+-.+++..+.-|- ..+++|.||+--|+|+ .+|.
T Consensus       227 GIP~PePIlLk~--hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~  302 (520)
T KOG2270|consen  227 GIPCPEPILLKN--HVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK  302 (520)
T ss_pred             CCCCCCceeeec--ceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence            655444433332  37899998531 2222222 245788889999999999888885 5589999999999999 7789


Q ss_pred             EEEeeecccccccC
Q 024158          158 LKIGDFGWSVQSRS  171 (271)
Q Consensus       158 ~~L~dfg~~~~~~~  171 (271)
                      +.++|.+.+.....
T Consensus       303 lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  303 LYIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEEccccccCCC
Confidence            99999987654443

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.18  E-value=1.2e-05  Score=64.83  Aligned_cols=72  Identities=10%  Similarity=0.123  Sum_probs=43.8

Q ss_pred             eeecccCCc-eEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC---ceeceeeEEEeC---CeEEEE
Q 024158           25 RPLGKGKFG-RVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP---NILRLYGWFHDD---ERIFLI   97 (271)
Q Consensus        25 ~~lg~g~~~-~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~---~i~~~~~~~~~~---~~~~lv   97 (271)
                      ..|+.|+.. .||++     +..+++|......     ....+..|.+.++.+...   .++.++......   ...+++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l   72 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV   72 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence            457766665 58865     2458888764321     123577788888777532   345555544332   235889


Q ss_pred             EeccCCCch
Q 024158           98 LEYAHRGEL  106 (271)
Q Consensus        98 ~e~~~~~~L  106 (271)
                      |++++|.++
T Consensus        73 ~~~i~G~~l   81 (235)
T cd05155          73 YRWLEGETA   81 (235)
T ss_pred             EEeecCCCC
Confidence            999988665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.11  E-value=4.3e-05  Score=61.49  Aligned_cols=75  Identities=20%  Similarity=0.234  Sum_probs=45.2

Q ss_pred             eeeecccCCceEEEEEEec-CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCeEEEEEecc
Q 024158           24 GRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      ++.|..|-.+.+|++.... .+..+++|+.......    .-...+|..+++.+...+ .++++....  +  .+++||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~----~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL----IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc----eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            4667788888999987533 3578999987542111    112235666666664333 344444332  2  4799999


Q ss_pred             CCCch
Q 024158          102 HRGEL  106 (271)
Q Consensus       102 ~~~~L  106 (271)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            87655

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.03  E-value=7.8e-07  Score=78.84  Aligned_cols=236  Identities=18%  Similarity=0.145  Sum_probs=160.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERI   94 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~   94 (271)
                      -+..-|......+.++++++++.+...+.... .+.+...        ...+-++++|.+++||| .+..++-++.+...
T Consensus       239 Dk~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             CCccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence            34444566667788999999988765554433 5554222        23445789999999999 66666666666778


Q ss_pred             EEEEeccCCC-chHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRG-ELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~-~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++.++++.++ +....... .-.+-..+...+...-+..+.++|+.--+|+|    ||+... +..++.+|+........
T Consensus       310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence            9999999766 22221111 11234445556666667789999988667777    666644 67888899876554444


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHH-HHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAK-HLI  236 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~-~li  236 (271)
                        .....+++.+++||......+....|.|++|.-..++.-|.+|-.........             ....+... ++.
T Consensus       385 ~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~  464 (829)
T KOG0576|consen  385 MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFP  464 (829)
T ss_pred             cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccccCCCCCCCCccccchhhhcCcccccCCc
Confidence              45567899999999999999999999999998777777777765331110000             01111222 366


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ..|+...|..|+..-.++-|.+|.+-+..
T Consensus       465 ~~~~~g~P~~pkv~mgacfsKvfngCpl~  493 (829)
T KOG0576|consen  465 APCLNGLPPTPKVHMGACFSKVFNGCPLR  493 (829)
T ss_pred             ccccCCCCCCCcchhhHHHHHHhccCccc
Confidence            78899999999999999999999877654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.03  E-value=0.00013  Score=60.82  Aligned_cols=139  Identities=19%  Similarity=0.167  Sum_probs=78.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc--eeceeeE------EEeC
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGW------FHDD   91 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~--i~~~~~~------~~~~   91 (271)
                      +..-.+.+..|..+.+|++..  ++..+++|++...  .    ...+..|++++..+...+  +++++..      ...+
T Consensus        15 ~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~--~----~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~   86 (296)
T cd05153          15 ELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV--S----AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELA   86 (296)
T ss_pred             chhheecccCccccceEEEEe--CCCcEEEEEcCCC--C----hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeC
Confidence            333466777888889998864  3457999997541  1    123444555555553222  4444431      2334


Q ss_pred             CeEEEEEeccCCCchHH-----------HHH---h-CCCC----------CHHHH--H--------HHHHHHHHHHHHHH
Q 024158           92 ERIFLILEYAHRGELYR-----------ELR---K-HRRF----------TEQQA--A--------TYIASLTNALAYCH  136 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~-----------~l~---~-~~~l----------~~~~~--~--------~i~~~l~~~l~~Lh  136 (271)
                      +..++++++++|.++..           .+.   . ...+          .+...  .        .....+..++..+.
T Consensus        87 ~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  166 (296)
T cd05153          87 GKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQD  166 (296)
T ss_pred             CceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHH
Confidence            56789999998765421           110   0 0000          00000  0        01111223344443


Q ss_pred             h-------CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          137 E-------NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       137 ~-------~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .       .+++|+|++|.||+++.++.+.|+||+.+
T Consensus       167 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a  203 (296)
T cd05153         167 AFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA  203 (296)
T ss_pred             hhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence            2       37999999999999998877889999865

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.03  E-value=5.5e-06  Score=68.31  Aligned_cols=135  Identities=17%  Similarity=0.279  Sum_probs=95.2

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----------------HH--HHHHHHHHHHHHHhhCCCC--
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----------------KY--KIQHQLRREMEIQSSLRHP--   79 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----------------~~--~~~~~~~~e~~~l~~~~~~--   79 (271)
                      +.+...||-|.-+-+|.+-+ ..|.++++|.-.....+                 ++  ...-...+|.+.++.+...  
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            34667789999999999886 56888888863211111                 11  1123345677777777542  


Q ss_pred             ceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           80 NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                      -|+..+++    +.-++|||++.+.+|...-+-      ..+-.+...++..+--|-++|++|||++--||+++.++.++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            35566654    345889999988777554322      23456677788888889999999999999999999999999


Q ss_pred             Eeeeccc
Q 024158          160 IGDFGWS  166 (271)
Q Consensus       160 L~dfg~~  166 (271)
                      ++||-..
T Consensus       243 vIDFPQm  249 (465)
T KOG2268|consen  243 VIDFPQM  249 (465)
T ss_pred             EeechHh
Confidence            9999643

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.94  E-value=0.00017  Score=56.03  Aligned_cols=129  Identities=20%  Similarity=0.240  Sum_probs=86.8

Q ss_pred             ccceeeeeeecccCC-ceEEEEEEecCCceEEEEEech---hhh-------hH--------HHHHHHHHHHHHHHhhCC-
Q 024158           18 LQDFEIGRPLGKGKF-GRVYLVREVESKHPVALKIIFK---EQI-------EK--------YKIQHQLRREMEIQSSLR-   77 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~~vK~~~~---~~~-------~~--------~~~~~~~~~e~~~l~~~~-   77 (271)
                      ..+++.++.||.|.. |.||+++.  +|..||+|.+..   ...       ..        .....-+..|.+...+++ 
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            368999999999999 99999884  677999999311   100       00        012234556666655554 


Q ss_pred             --CCce--eceeeEEEeC------------------CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 024158           78 --HPNI--LRLYGWFHDD------------------ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC  135 (271)
Q Consensus        78 --~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~L  135 (271)
                        +.++  ++++++..-.                  -...||.||.+...         .++.    +-+.+|.+-+..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence              4455  8888886321                  02466777765422         2233    3345666678889


Q ss_pred             HhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       136 h~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      |..||+-+|+++.|..     .-+|+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc-----CCEEEecccC
Confidence            9999999999999998     5688999853

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.83  E-value=0.00012  Score=59.76  Aligned_cols=132  Identities=15%  Similarity=0.175  Sum_probs=73.6

Q ss_pred             eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce-eceeeEEEeCCeEEEEEeccCCC
Q 024158           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      .+..|-.+.+|++.  .++..+++|........-   .-...+|..+++.+...++ ++++...  .  .++|+||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL---GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc---cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            35567778899876  457789999864321110   0123556677777754333 4444443  2  26899999875


Q ss_pred             chHH--------------HHH---hCC----CCCHH-HHHHHHHHH---------HHHHHHHHh--------CCceecCC
Q 024158          105 ELYR--------------ELR---KHR----RFTEQ-QAATYIASL---------TNALAYCHE--------NHVIHRDI  145 (271)
Q Consensus       105 ~L~~--------------~l~---~~~----~l~~~-~~~~i~~~l---------~~~l~~Lh~--------~~i~H~dl  145 (271)
                      .+..              .+.   ...    +++.. .+.....++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5431              111   111    11211 111111111         112222221        24899999


Q ss_pred             CCCCeeeCCCCCEEEeeecccc
Q 024158          146 KPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       146 ~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +|.||+++.++ +.++||+.+.
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccC
Confidence            99999998876 7899998763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.80  E-value=0.0002  Score=60.01  Aligned_cols=75  Identities=23%  Similarity=0.214  Sum_probs=44.4

Q ss_pred             eeeecccCCceEEEEEEec------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCeEEE
Q 024158           24 GRPLGKGKFGRVYLVREVE------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERIFL   96 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~l   96 (271)
                      ++.+..|-.+.+|++....      .++.+++|+.......    .....+|.++++.+...+ .++++..+. +   ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL----LIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc----eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            4566677778899887533      2578999997553211    123345666666654333 345555543 2   35


Q ss_pred             EEeccCCCch
Q 024158           97 ILEYAHRGEL  106 (271)
Q Consensus        97 v~e~~~~~~L  106 (271)
                      |+++++|.++
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            7888877555

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.78  E-value=0.0013  Score=55.18  Aligned_cols=143  Identities=18%  Similarity=0.180  Sum_probs=78.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc--eeceeeE------E
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGW------F   88 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~--i~~~~~~------~   88 (271)
                      .++....+..++.|..+.+|++..  ++..+++|.+......     ..+..+.+++..+...+  +++++..      .
T Consensus        20 ~~~~~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~-----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        20 DLGELLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKA-----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             CCCCceeccccCCccccceEEEEe--CCCcEEEEEecCCCCH-----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            444455567778888889998874  3446889987442111     12233344444442211  4444432      1


Q ss_pred             EeCCeEEEEEeccCCCchH-----------HHH---Hh-CCCC-----------CHHHHH------------HHHHHHHH
Q 024158           89 HDDERIFLILEYAHRGELY-----------REL---RK-HRRF-----------TEQQAA------------TYIASLTN  130 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~-----------~~l---~~-~~~l-----------~~~~~~------------~i~~~l~~  130 (271)
                      ..++..++++++++|..+.           ..+   +. ...+           .+....            .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            2245678999999874331           111   10 0000           000000            00111223


Q ss_pred             HHHHHH-------hCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          131 ALAYCH-------ENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       131 ~l~~Lh-------~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .+.++.       ..+++|+|+++.||+++.++.+.++||+.+
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~  215 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA  215 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence            344443       258999999999999998887789999876

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.75  E-value=0.001  Score=56.09  Aligned_cols=30  Identities=27%  Similarity=0.399  Sum_probs=25.4

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .+++|+|+++.||+++.+...-++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            379999999999999866556899998763

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.73  E-value=0.0028  Score=54.87  Aligned_cols=80  Identities=19%  Similarity=0.201  Sum_probs=51.5

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhh---hH-HHHHHHHHHHHHHHhhCC---CCceeceeeEEEeCCeE
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EK-YKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERI   94 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~-~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~~~~   94 (271)
                      .-.+.||.|-++.||++.....++.++||.-.....   .. +...+....|.+.|+.+.   ..++++++.+.  .+..
T Consensus        29 ~~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~  106 (401)
T PRK09550         29 LTAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELA  106 (401)
T ss_pred             ceeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCC
Confidence            345789999999999999754335899998531110   10 122344555666666652   34577788763  3456


Q ss_pred             EEEEeccCC
Q 024158           95 FLILEYAHR  103 (271)
Q Consensus        95 ~lv~e~~~~  103 (271)
                      ++|||++++
T Consensus       107 ~lVME~L~~  115 (401)
T PRK09550        107 VTVMEDLSD  115 (401)
T ss_pred             EEEEecCCC
Confidence            899999875

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.59  E-value=0.0021  Score=54.68  Aligned_cols=76  Identities=17%  Similarity=0.193  Sum_probs=45.9

Q ss_pred             eecccCCceEEEEEEecCCceEEEEEechhhh----hHHHHHHHHHHHHHHHhhCC--CC-ceeceeeEEEeCCeEEEEE
Q 024158           26 PLGKGKFGRVYLVREVESKHPVALKIIFKEQI----EKYKIQHQLRREMEIQSSLR--HP-NILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        26 ~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~~e~~~l~~~~--~~-~i~~~~~~~~~~~~~~lv~   98 (271)
                      .||.|-.+.||++.+...++.++||.-..-..    +.+...+...-|...|+...  .| .+++++.+  +.+...++|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            57899999999999754346899997532211    11222334445566665543  23 45556554  444567889


Q ss_pred             eccCC
Q 024158           99 EYAHR  103 (271)
Q Consensus        99 e~~~~  103 (271)
                      |+.+.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            98753

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.45  E-value=0.0011  Score=55.97  Aligned_cols=106  Identities=18%  Similarity=0.244  Sum_probs=71.7

Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .+..+.|++|++. |+++...-.    -..+++.+++++.+..+.-+..+ ..-|+|+...||+|+ .|++.|+||-++.
T Consensus       296 de~~y~yl~~kdh-gt~is~ik~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         296 DETLYLYLHFKDH-GTPISIIKA----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             CCceEEEEEEecC-Cceeeeeec----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeee
Confidence            3445678888886 345533221    24678889999988888888766 799999999999999 9999999999875


Q ss_pred             cccCccccccccccccCCccccCCCCCccchhhhHH
Q 024158          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG  203 (271)
Q Consensus       168 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg  203 (271)
                      ...+..  ..-..++-.|-.+. +.-+.+-+||.+-
T Consensus       370 l~~~q~--~isy~rldhp~lF~-G~dd~QFeIYrlM  402 (488)
T COG5072         370 LSYSQG--IISYNRLDHPDLFN-GVDDYQFEIYRLM  402 (488)
T ss_pred             cccCCc--eeeccccCchhhhc-CccceeeeHHHHH
Confidence            322221  11122333444454 4446778888753

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.41  E-value=0.0019  Score=53.34  Aligned_cols=30  Identities=23%  Similarity=0.482  Sum_probs=24.5

Q ss_pred             CceecCCCCCCeeeCCCCC-EEEeeeccccc
Q 024158          139 HVIHRDIKPENLLLDHEGR-LKIGDFGWSVQ  168 (271)
Q Consensus       139 ~i~H~dl~~~Nili~~~~~-~~L~dfg~~~~  168 (271)
                      .++|+|+++.||+++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999987643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.39  E-value=0.00057  Score=60.01  Aligned_cols=147  Identities=15%  Similarity=0.208  Sum_probs=96.6

Q ss_pred             HHHHHHHHhhCCCCceeceeeEEEe-CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 024158           66 LRREMEIQSSLRHPNILRLYGWFHD-DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD  144 (271)
Q Consensus        66 ~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~d  144 (271)
                      +.-..++++.+.|++...++++-.. .+...+|+|++. .||++.+..+. +-.....                  +|+-
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~------------------~~~~   88 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL------------------AHGV   88 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc------------------cccc
Confidence            3445678888899999999988653 345788999995 69999987753 2111111                  3321


Q ss_pred             CCCCCeeeCCCCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh
Q 024158          145 IKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (271)
Q Consensus       145 l~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  224 (271)
                       .+-|++.       .+| .+....    ..                +...++|||++|.++.+++-|...+......+.
T Consensus        89 -~~~~~~~-------~td-~~~t~~----~~----------------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~  139 (725)
T KOG1093|consen   89 -LHLNIIY-------ITD-HFLTKY----PS----------------PIGPKSDVWSLGFIILELYLGISLEAELTESEY  139 (725)
T ss_pred             -ceehhhh-------ccc-cccccC----CC----------------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHH
Confidence             1222222       112 000000    00                011389999999999999988877765554433


Q ss_pred             hcc-----------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          225 FRS-----------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       225 ~~~-----------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      ...                       .+....++...|+...|..||...+..+++-|..
T Consensus       140 l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e  199 (725)
T KOG1093|consen  140 LEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE  199 (725)
T ss_pred             HHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence            322                       3677889999999999999999999999988764

>PLN02236 choline kinase

Probab=97.36  E-value=0.0023  Score=54.65  Aligned_cols=139  Identities=15%  Similarity=0.191  Sum_probs=77.1

Q ss_pred             eeeeeeecccCCceEEEEEEec----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce-eceeeEEEeCCeEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVE----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIF   95 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-~~~~~~~~~~~~~~   95 (271)
                      ..-+..+..|-...+|++....    .++.+++|+..... +  ...+ -.+|..+++.+...++ +++++.+.. +   
T Consensus        38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~--~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---  109 (344)
T PLN02236         38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-E--LFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---  109 (344)
T ss_pred             cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-C--eeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---
Confidence            4445566678888999986432    24689999885532 1  1111 2456666666654443 345555432 2   


Q ss_pred             EEEeccCCCchHHH----------H-------HhCC-C----C-CHHHHHHHHHHH-----------------HHHHHHH
Q 024158           96 LILEYAHRGELYRE----------L-------RKHR-R----F-TEQQAATYIASL-----------------TNALAYC  135 (271)
Q Consensus        96 lv~e~~~~~~L~~~----------l-------~~~~-~----l-~~~~~~~i~~~l-----------------~~~l~~L  135 (271)
                      .+.+|+++.++...          +       +... +    . ..+.+..+..++                 ...+..|
T Consensus       110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L  189 (344)
T PLN02236        110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL  189 (344)
T ss_pred             eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence            46888876554311          1       1100 0    1 122222222111                 1112222


Q ss_pred             ----H----hCCceecCCCCCCeeeCC-CCCEEEeeecccc
Q 024158          136 ----H----ENHVIHRDIKPENLLLDH-EGRLKIGDFGWSV  167 (271)
Q Consensus       136 ----h----~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~  167 (271)
                          .    ...++|+|+++.||+++. ++.+.++||+.+.
T Consensus       190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence                1    225899999999999986 4689999998763

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.36  E-value=0.0015  Score=55.52  Aligned_cols=27  Identities=37%  Similarity=0.673  Sum_probs=24.4

Q ss_pred             ceecCCCCCCeeeCC-CCCEEEeeeccc
Q 024158          140 VIHRDIKPENLLLDH-EGRLKIGDFGWS  166 (271)
Q Consensus       140 i~H~dl~~~Nili~~-~~~~~L~dfg~~  166 (271)
                      ++|+|+.+.||++++ ++.++++||+.+
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYa  211 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYG  211 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEccccc
Confidence            899999999999975 578999999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.006  Score=51.11  Aligned_cols=146  Identities=15%  Similarity=0.247  Sum_probs=81.5

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC--CceeceeeEEEeCC--eEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDE--RIFL   96 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~~--~~~l   96 (271)
                      -.+++.+..|-...+|...+.  ++.++++ ... ............+|...++.+..  --++..++++.++.  ..+.
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            344555544555556666543  7889999 322 11122234556677777777753  23444555555444  5699


Q ss_pred             EEeccCCCchHH------------------HHHh-------CCC-------CCHHHHHHHHHH--------------HHH
Q 024158           97 ILEYAHRGELYR------------------ELRK-------HRR-------FTEQQAATYIAS--------------LTN  130 (271)
Q Consensus        97 v~e~~~~~~L~~------------------~l~~-------~~~-------l~~~~~~~i~~~--------------l~~  130 (271)
                      ||++++|..+.+                  .|..       +.+       ....++.....+              ...
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            999998732221                  1110       000       001111111111              122


Q ss_pred             HHHHHHhC--------CceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158          131 ALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus       131 ~l~~Lh~~--------~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ...+|+.+        .++|||+++.|+++++++-+=++||+.+....
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            34555433        38999999999999999889999999874433

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.11  E-value=0.0051  Score=51.00  Aligned_cols=75  Identities=19%  Similarity=0.313  Sum_probs=44.6

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC---CCCceeceeeEEEeCCeEEEEE
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +-.+.++.|..+.+|.+.  .++..++||+-....      ...+..|..-|+.+   ..-.+++++.+....+..++++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll   91 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL   91 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence            445668889999999877  778889999975222      12344445444444   4566889999988777779999


Q ss_pred             eccCCC
Q 024158           99 EYAHRG  104 (271)
Q Consensus        99 e~~~~~  104 (271)
                      |+.+.+
T Consensus        92 e~l~~~   97 (288)
T PF03881_consen   92 EFLEMG   97 (288)
T ss_dssp             E-----
T ss_pred             EeecCC
Confidence            998754

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.09  E-value=0.0093  Score=51.70  Aligned_cols=77  Identities=12%  Similarity=0.109  Sum_probs=47.6

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhh----hHHHHHHHHHHHHHHHhhCC---CCceeceeeEEEeCCeEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI----EKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~~~~~   95 (271)
                      ..+.||.|..+.||++.+.  +..++||.-.....    +.+........|...|+...   ...+++++.++.+  ..+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence            4677899999999998863  45699998641111    00011222233344444443   3578888888764  357


Q ss_pred             EEEeccCC
Q 024158           96 LILEYAHR  103 (271)
Q Consensus        96 lv~e~~~~  103 (271)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999965

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.09  E-value=7e-05  Score=73.03  Aligned_cols=247  Identities=11%  Similarity=-0.020  Sum_probs=155.3

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh---HHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE---KYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ...+.+.+|++.=-++.+.++.--..+.+-++  +.+++.+.-..+   ++ ..+-...+...++...|+++.....-..
T Consensus      1223 kM~s~~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LseP-lkemll~e~de~~~~~h~~~~~~p~rI~ 1299 (2724)
T KOG1826|consen 1223 KMFSAMEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEP-LKEMLLSERDELREAKHYLTEVDPLRIP 1299 (2724)
T ss_pred             HHHHHhhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhH-HHHhhhhhhhhhhhhhceeeecccccCC
Confidence            44566777777766666665532222222222  455554322222   11 1122222333445567777665554443


Q ss_pred             e--CCeEEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---C--ceecCCCCCCeeeCCCCCE
Q 024158           90 D--DERIFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHEN---H--VIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        90 ~--~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~---~--i~H~dl~~~Nili~~~~~~  158 (271)
                      .  ....|..++++.+|.+.+.+-.+    +.+...-......+.+....-+|+.   |  -+|.++++.|.+|..+-++
T Consensus      1300 ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v 1379 (2724)
T KOG1826|consen 1300 PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNV 1379 (2724)
T ss_pred             CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcc
Confidence            2  22357788898899999988653    2233333333334435555555544   1  6889999999999999999


Q ss_pred             EEeeecccccccC---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCC--------CCCcchhhcc
Q 024158          159 KIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE--------AESQKDTFRS  227 (271)
Q Consensus       159 ~L~dfg~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~--------~~~~~~~~~~  227 (271)
                      ++.++|+.+....   ..+...+++-|+.|+..+.-.++.++|+|+.|+-+|....|..+|-        +.........
T Consensus      1380 ~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~s 1459 (2724)
T KOG1826|consen 1380 KLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFS 1459 (2724)
T ss_pred             cccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHHHHHHHcCccccccccc
Confidence            9999999873322   2344567788888988888888888999999999999888877652        2222222222


Q ss_pred             ----cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 ----ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 ----i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                          .|.+.-.....+|...-..||.-..++.-+.|--.
T Consensus      1460 Ie~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~~ 1498 (2724)
T KOG1826|consen 1460 IEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAVG 1498 (2724)
T ss_pred             ccccCCCcccHHHHHHHHHHhhhcchhhhhccccccccc
Confidence                25666666677777778899999999988877544

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=97.08  E-value=0.0055  Score=48.51  Aligned_cols=80  Identities=15%  Similarity=0.242  Sum_probs=55.5

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC---CCCceeceeeEEEeCCeEEE
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL---RHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~---~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +.+..+.+..|-....|.+.+  ...+++||+-..      .....+..|+.-|+.+   +.-.+++++.+..+.++.|+
T Consensus        17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n~~------~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl   88 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCNQR------EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL   88 (286)
T ss_pred             hhhcccccCCccccceeEeec--CCcceEEEecch------hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence            344556677777778887764  456788997422      2234555666666555   34568899999999999999


Q ss_pred             EEeccCCCchH
Q 024158           97 ILEYAHRGELY  107 (271)
Q Consensus        97 v~e~~~~~~L~  107 (271)
                      |+||.+.+.+.
T Consensus        89 Vle~L~~~~~d   99 (286)
T COG3001          89 VLEYLPTGPLD   99 (286)
T ss_pred             EEeeccCCCCC
Confidence            99999865553

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.06  E-value=0.015  Score=50.12  Aligned_cols=78  Identities=17%  Similarity=0.196  Sum_probs=48.2

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhh---hHHHHHHHHHHHHHHHhhCC--CC-ceeceeeEEEeCCeEEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLR--HP-NILRLYGWFHDDERIFL   96 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~~~~~~~e~~~l~~~~--~~-~i~~~~~~~~~~~~~~l   96 (271)
                      ..+.||.|-.+-||++.+...+..++||.-..-..   +.+...+...-|...|+...  .| ++++++.+  +.+...+
T Consensus        33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~  110 (409)
T PRK12396         33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCC  110 (409)
T ss_pred             eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhH
Confidence            36789999999999999744456799997532111   11223444555666666553  23 56666654  4444577


Q ss_pred             EEeccC
Q 024158           97 ILEYAH  102 (271)
Q Consensus        97 v~e~~~  102 (271)
                      |||+++
T Consensus       111 vMEdL~  116 (409)
T PRK12396        111 VMEDLS  116 (409)
T ss_pred             HHHhCc
Confidence            888874

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.94  E-value=0.028  Score=47.28  Aligned_cols=30  Identities=13%  Similarity=0.133  Sum_probs=27.1

Q ss_pred             CceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158          139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus       139 ~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +++|+|+.++||+++.++.+.++||+.+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK10593 hypothetical protein; Provisional

Probab=96.92  E-value=0.013  Score=48.97  Aligned_cols=106  Identities=11%  Similarity=0.048  Sum_probs=66.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC---CceeceeeEEEe---CCe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH---PNILRLYGWFHD---DER   93 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~---~~i~~~~~~~~~---~~~   93 (271)
                      .-.-...||.|..+.||....  .+..+++|..+.. ..    ...+..|...++.+..   -.++++++++..   .+.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~-~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSF-ST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhheeeecCCccceeEEEEEc--CCCCEEEEEeccc-cc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            344566799999999998863  2235777875321 01    2356677777777743   367888887754   356


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE  137 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~  137 (271)
                      .++|||++++.++.+.     ..+......+..++++++..||.
T Consensus        88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhC
Confidence            8999999998776431     11222333444455555555554

>PTZ00384 choline kinase; Provisional

Probab=96.81  E-value=0.0096  Score=51.50  Aligned_cols=28  Identities=21%  Similarity=0.195  Sum_probs=23.9

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ...+|.|+.+.||+.+ ++.++++||..+
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA  254 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFA  254 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEeccc
Confidence            4689999999999975 456999999876

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.25  E-value=0.24  Score=42.00  Aligned_cols=27  Identities=22%  Similarity=0.272  Sum_probs=23.0

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .+++|+|+.+.||+++ + .+.++||+.+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence            3689999999999995 4 5789999865

>PTZ00296 choline kinase; Provisional

Probab=96.24  E-value=0.062  Score=47.48  Aligned_cols=27  Identities=26%  Similarity=0.513  Sum_probs=23.3

Q ss_pred             CceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          139 HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       139 ~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .++|+|+-+.||+.+.+ .++|+||..+
T Consensus       285 VfCHNDl~~~NiL~~~~-~l~LIDfEYA  311 (442)
T PTZ00296        285 VFCHNDLQENNIINTNK-CLRLIDFEYS  311 (442)
T ss_pred             eEEeCCCCccceeecCC-CEEEEeeccc
Confidence            48999999999988654 4999999876

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.03  E-value=0.029  Score=44.34  Aligned_cols=84  Identities=24%  Similarity=0.329  Sum_probs=54.5

Q ss_pred             HHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--Ccee
Q 024158           65 QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--HVIH  142 (271)
Q Consensus        65 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--~i~H  142 (271)
                      -+..+.+++.++.  +|+++..  ..+-.+.++.|.|-....         +..    .+..-=++++.-.|+.  +..|
T Consensus       104 ~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i---------~~~----N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  104 LYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI---------NFS----NFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc---------chh----HHHHHhHHHHHHhhccCCCeec
Confidence            3456667766654  5666652  233457889998853211         010    1111113456777844  7999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeecc
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ||..|+|||-|..|.+||.|-+.
T Consensus       167 GD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  167 GDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCCChhheeecCCCCEEecChhh
Confidence            99999999999999999999764

The function of this family is unknown.

>PRK06148 hypothetical protein; Provisional

Probab=95.90  E-value=0.26  Score=48.32  Aligned_cols=29  Identities=38%  Similarity=0.634  Sum_probs=24.8

Q ss_pred             CCceecCCCCCCeeeCCCC--CEE-Eeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEG--RLK-IGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~--~~~-L~dfg~~  166 (271)
                      .+++|+|+++.||+++.++  .+. |+|||.+
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa  234 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDA  234 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccc
Confidence            4799999999999998875  555 9999976

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.47  E-value=0.037  Score=46.43  Aligned_cols=28  Identities=25%  Similarity=0.440  Sum_probs=24.6

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .+++|||+++.||+++. +.+.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            47899999999999987 67899999854

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.17  E-value=0.041  Score=45.23  Aligned_cols=43  Identities=30%  Similarity=0.471  Sum_probs=32.4

Q ss_pred             HHHHHHHHHHHHhC--CceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158          125 IASLTNALAYCHEN--HVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus       125 ~~~l~~~l~~Lh~~--~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +..+-.++...+..  -++|+|+.|+|++.+..+.++|+||..+.
T Consensus       138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            33444444444433  49999999999999998999999998763

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.17  E-value=0.088  Score=45.55  Aligned_cols=61  Identities=20%  Similarity=0.263  Sum_probs=42.3

Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCeeeCCC
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY-CHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~-Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      ..++-+|+.|.++..++.. ...+++....++.-.+.|+.. |--.+++|.|++|.||++...
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            4555568888899999876 334555555666555555443 344589999999999999543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	271
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-94
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-93
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-93
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-93
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-93
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-93
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-92
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-92
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-92
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-92
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-92
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-92
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-92
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-92
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-92
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-92
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-92
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-92
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-92
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-91
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-91
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-91
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-91
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-91
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-91
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-91
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-91
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-91
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-90
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-90
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-90
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-89
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-87
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-86
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-85
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-79
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-49
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-46
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-43
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-42
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-42
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-42
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-42
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-42
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-42
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-42
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-42
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-42
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		8e-42
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-42
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-42
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-41
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-41
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-41
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-41
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-41
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-41
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-41
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-41
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-41
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-41
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-41
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-41
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-41
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-41
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-41
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-41
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-41
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-41
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-41
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-41
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-41
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-41
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-41
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-41
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-41
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-41
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-40
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-40
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-40
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-40
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-40
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-40
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-40
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-40
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-40
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-40
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-40
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-40
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-40
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-40
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-40
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-40
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-40
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-40
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-40
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-40
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-40
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-40
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-40
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-40
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-40
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-40
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-40
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-40
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-40
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-40
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-40
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-40
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-40
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-40
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-40
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		9e-40
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-39
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-39
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-39
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-39
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-39
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-39
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-39
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-39
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-39
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-39
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-39
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-39
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-39
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-39
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-39
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-39
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-39
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-39
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-39
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-39
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-39
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-39
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-39
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-39
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-39
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-39
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-39
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-39
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-39
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-39
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-39
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-39
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-39
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-39
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-39
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-38
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-38
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-38
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-38
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-38
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-38
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-38
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-38
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-38
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-38
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-38
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-37
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-37
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-37
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-37
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-37
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-37
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-36
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-36
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-36
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-36
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-36
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-36
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-36
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-36
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-36
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-36
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-36
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-36
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-36
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-36
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-35
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-35
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-35
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-35
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-35
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-34
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-34
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-34
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-34
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-34
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-34
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-34
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-34
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-34
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-34
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-34
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-34
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-34
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-34
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-34
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-34
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-34
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-34
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-34
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-34
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-34
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		9e-34
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-33
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-33
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-33
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-33
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-33
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-33
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-33
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-33
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-33
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-33
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-33
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-33
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-33
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		9e-33
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-32
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-32
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-32
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-32
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-32
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		7e-32
3soa_A	444	Full-Length Human Camkii Length = 444		8e-32
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-31
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-31
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-31
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-31
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-31
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-31
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-31
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-31
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-31
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-30
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-30
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-30
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-29
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-29
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-29
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-29
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-29
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-29
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-29
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-29
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-29
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-29
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-29
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-29
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-29
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-29
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-29
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-29
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-29
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-29
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-29
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-29
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-29
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-29
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-29
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-29
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-29
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-29
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-29
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-29
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-29
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		6e-29
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-28
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-28
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-28
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-28
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-28
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-28
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-28
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-28
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-28
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-28
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-28
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-27
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-27
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-27
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-27
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-27
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-27
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-27
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-27
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-27
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-27
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-27
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-27
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-27
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-27
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-26
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-26
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-26
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-26
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-26
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-26
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-26
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-26
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-26
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-26
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-26
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-26
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-26
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-26
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-26
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-26
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-26
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-26
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-26
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-26
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-26
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-26
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-26
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-26
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-26
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-26
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-26
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-26
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-26
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-26
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-26
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-26
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-26
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-26
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-26
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-26
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-26
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-26
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-25
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-25
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-25
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-25
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-25
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-25
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-25
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-25
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-25
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-25
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-25
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-25
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-25
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-25
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-25
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-25
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-25
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-25
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-25
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-25
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-25
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-25
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-25
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-25
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-25
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-25
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-25
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-25
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-25
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-25
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-25
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-25
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-25
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-25
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-25
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-25
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-25
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-25
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-24
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-24
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-24
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-24
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-24
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-24
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-24
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-24
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-24
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-24
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-24
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-24
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-24
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-24
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-24
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-24
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-24
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-24
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-24
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-23
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-23
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-23
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-23
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-23
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-23
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-23
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-23
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-23
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-23
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-23
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-23
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-23
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-23
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-22
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-22
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-22
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-21
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-21
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-21
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-21
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-20
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-20
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-20
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-20
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-20
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-20
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-20
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-19
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-19
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-19
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-19
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-19
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		8e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-18
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-18
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-18
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-18
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-17
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-17
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-17
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-17
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-17
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		7e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		9e-17
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-17
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-16
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-16
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-16
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-16
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-16
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-16
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-16
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		2e-16
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-16
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-16
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		7e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		5e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		5e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-15
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		7e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-14
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-14
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-14
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-14
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-14
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-14
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-14
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-14
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-14
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-14
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-14
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		6e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		6e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-14
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		7e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		9e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		9e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-13
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-13
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-13
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-13
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-13
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		9e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-12
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-12
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-12
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-12
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-12
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-12
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-12
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-12
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-12
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-12
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-12
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-12
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		6e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		9e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		9e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-11
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		5e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-11
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		5e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		5e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		8e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-10
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-10
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-10
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		7e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		8e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  340 bits (872), Expect = 5e-94,   Method: Compositional matrix adjust.
 Identities = 161/272 (59%), Positives = 205/272 (75%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA RGE+Y+EL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  338 bits (868), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 161/273 (58%), Positives = 204/273 (74%), Gaps = 12/273 (4%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LI
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  338 bits (867), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 161/273 (58%), Positives = 204/273 (74%), Gaps = 12/273 (4%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 15  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 74
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM
Sbjct: 135 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LI
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 254
Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 255 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 287

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  337 bits (863), Expect = 6e-93,   Method: Compositional matrix adjust.
 Identities = 160/272 (58%), Positives = 203/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 241
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  336 bits (862), Expect = 7e-93,   Method: Compositional matrix adjust.
 Identities = 160/272 (58%), Positives = 203/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  336 bits (861), Expect = 9e-93,   Method: Compositional matrix adjust.
 Identities = 160/273 (58%), Positives = 203/273 (74%), Gaps = 12/273 (4%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           E+++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRR
Sbjct: 24  EESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 83
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 143
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEM 187
            NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM
Sbjct: 144 ANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLI 236
           +E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LI
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI 263
Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           SRLL  + S+R  L++++EHPWI  N++    C
Sbjct: 264 SRLLKHNPSQRPMLREVLEHPWITANSSKPSNC 296

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  335 bits (860), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 161/264 (60%), Positives = 201/264 (76%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  RF EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS             A+ LISRLL
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLL 245
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             ++S+RL+L +++EHPWI  N++
Sbjct: 246 KHNASQRLTLAEVLEHPWIKANSS 269

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  335 bits (860), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 160/271 (59%), Positives = 202/271 (74%), Gaps = 12/271 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISR 238
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISR
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           LL  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  335 bits (860), Expect = 1e-92,   Method: Compositional matrix adjust.
 Identities = 161/264 (60%), Positives = 201/264 (76%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DF+IGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  RF EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T+R IS             A+ LISRLL
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLL 245
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             ++S+RL+L +++EHPWI  N++
Sbjct: 246 KHNASQRLTLAEVLEHPWIKANSS 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  335 bits (858), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 159/272 (58%), Positives = 203/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI +FGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 180
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 240
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  335 bits (858), Expect = 2e-92,   Method: Compositional matrix adjust.
 Identities = 160/271 (59%), Positives = 201/271 (74%), Gaps = 12/271 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISR 238
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISR
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           LL  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  334 bits (857), Expect = 3e-92,   Method: Compositional matrix adjust.
 Identities = 160/271 (59%), Positives = 201/271 (74%), Gaps = 12/271 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 5   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 64
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 65  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E
Sbjct: 125 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 184
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISR 238
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISR
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 244
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           LL  + S+R  L++++EHPWI  N++    C
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  334 bits (856), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 159/272 (58%), Positives = 202/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 180
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 181 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 240
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 241 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 272

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  333 bits (855), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 159/272 (58%), Positives = 202/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PE +
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 184 EGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 244 RLLKHNPSQRPXLREVLEHPWITANSSKPSNC 275

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  333 bits (855), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 160/269 (59%), Positives = 199/269 (73%), Gaps = 12/269 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 241 VKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
             + S+R  L++++EHPWI  N++    C
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  333 bits (855), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 160/270 (59%), Positives = 200/270 (74%), Gaps = 12/270 (4%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           +KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+E
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           IQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NA
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVEN 190
           L+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E 
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEG 180
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRL 239
           + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRL
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRL 240
Query: 240 LVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           L  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LKHNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  333 bits (855), Expect = 5e-92,   Method: Compositional matrix adjust.
 Identities = 159/272 (58%), Positives = 203/272 (74%), Gaps = 12/272 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA RGE+Y+EL+K  +F EQ+ ATYI  L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  + GTLDYL PEM+
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMI 183
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 184 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 243
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           RLL  + S+R  L++++EHPWI  N++    C
Sbjct: 244 RLLKHNPSQRPMLREVLEHPWITANSSKPSNC 275

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  333 bits (854), Expect = 6e-92,   Method: Compositional matrix adjust.
 Identities = 159/267 (59%), Positives = 202/267 (75%), Gaps = 12/267 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 241
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           RLL  + S+R  L++++EHPWI  N++
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  333 bits (853), Expect = 9e-92,   Method: Compositional matrix adjust.
 Identities = 159/268 (59%), Positives = 199/268 (74%), Gaps = 12/268 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLLV 241
           HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 242 KDSSKRLSLQKIMEHPWIIKNANPRGTC 269
            + S+R  L++++EHPWI  N++    C
Sbjct: 243 HNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  332 bits (851), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 159/264 (60%), Positives = 199/264 (75%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 6   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 65
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 66  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 126 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 245
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 246 KHNPSQRPMLREVLEHPWITANSS 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  332 bits (850), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 158/267 (59%), Positives = 202/267 (75%), Gaps = 12/267 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI +FGWSV +  S+R T+CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 241
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           RLL  + S+R  L++++EHPWI  N++
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  332 bits (850), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 159/268 (59%), Positives = 198/268 (73%), Gaps = 12/268 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E + 
Sbjct: 123 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRM 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLLV 241
           HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL 
Sbjct: 183 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 242
Query: 242 KDSSKRLSLQKIMEHPWIIKNANPRGTC 269
            + S+R  L++++EHPWI  N++    C
Sbjct: 243 HNPSQRPMLREVLEHPWITANSSKPSNC 270

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  331 bits (849), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 159/264 (60%), Positives = 197/264 (74%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE  SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + +DT++ IS             A+ LISRLL
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSS 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  331 bits (849), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 159/264 (60%), Positives = 199/264 (75%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 1   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 60
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 61  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E +
Sbjct: 121 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 240
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 241 KHNPSQRPMLREVLEHPWITANSS 264

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  331 bits (849), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 158/268 (58%), Positives = 198/268 (73%), Gaps = 12/268 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRM 185
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLLV 241
           HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 242 KDSSKRLSLQKIMEHPWIIKNANPRGTC 269
            + S+R  L++++EHPWI  N++    C
Sbjct: 246 HNPSQRPMLREVLEHPWITANSSKPSNC 273

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  330 bits (847), Expect = 4e-91,   Method: Compositional matrix adjust.
 Identities = 158/267 (59%), Positives = 201/267 (75%), Gaps = 12/267 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           +++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMV 188
           NAL+YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMI 181
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLIS 237
           E + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LIS
Sbjct: 182 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 241
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           RLL  + S+R  L++++EHPWI  N++
Sbjct: 242 RLLKHNPSQRPMLREVLEHPWITANSS 268

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  330 bits (846), Expect = 5e-91,   Method: Compositional matrix adjust.
 Identities = 159/264 (60%), Positives = 198/264 (75%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV + S R T +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSS 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  330 bits (845), Expect = 6e-91,   Method: Compositional matrix adjust.
 Identities = 158/264 (59%), Positives = 198/264 (75%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSS 265

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  329 bits (843), Expect = 1e-90,   Method: Compositional matrix adjust.
 Identities = 158/264 (59%), Positives = 198/264 (75%), Gaps = 12/264 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 2   KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL
Sbjct: 62  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENK 191
           +YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E +
Sbjct: 122 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLL 240
            HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 241
Query: 241 VKDSSKRLSLQKIMEHPWIIKNAN 264
             + S+R  L++++EHPWI  N++
Sbjct: 242 KHNPSQRPMLREVLEHPWITANSS 265

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  328 bits (840), Expect = 3e-90,   Method: Compositional matrix adjust.
 Identities = 157/266 (59%), Positives = 198/266 (74%), Gaps = 12/266 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
            +KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   GKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWS  +  S+R T+ GTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIE 180
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISR 238
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISR
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           LL  + S+R  L++++EHPWI  N++
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSS 266

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  327 bits (838), Expect = 5e-90,   Method: Compositional matrix adjust.
 Identities = 157/263 (59%), Positives = 197/263 (74%), Gaps = 12/263 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R  +CGTLDYL PEM+E + 
Sbjct: 126 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRM 185
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLLV 241
           HD  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL 
Sbjct: 186 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 245
Query: 242 KDSSKRLSLQKIMEHPWIIKNAN 264
            + S+R  L++++EHPWI  N++
Sbjct: 246 HNPSQRPMLREVLEHPWITANSS 268

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  325 bits (834), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 156/262 (59%), Positives = 196/262 (74%), Gaps = 12/262 (4%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W+L+DFEIGRPLGKGKFG VYL RE + K  +ALK++FK Q+EK  ++HQLRRE+EIQS
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKRHTMCGTLDYLAPEMVENKEH 193
           CH   VIHRDIKPENLLL   G LKI DFGWSV +  S+R T+CGTLDYL PEM+E + H
Sbjct: 121 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS-----------AEAKHLISRLLVK 242
           D  VD W+LG+LCYEFL G PPFEA + ++T++ IS             A+ LISRLL  
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 240
Query: 243 DSSKRLSLQKIMEHPWIIKNAN 264
           + S+R  L++++EHPWI  N++
Sbjct: 241 NPSQRPMLREVLEHPWITANSS 262

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  316 bits (810), Expect = 8e-87,   Method: Compositional matrix adjust.
 Identities = 152/263 (57%), Positives = 196/263 (74%), Gaps = 12/263 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR++++ DF+IGRPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 9   KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L +AL
Sbjct: 69  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 128
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENK 191
            YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R  MCGTLDYL PEM+E K
Sbjct: 129 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLL 240
            HD  VD W  G+LCYEFL G PPF++ S  +T R I           S  +K LIS+LL
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 248
Query: 241 VKDSSKRLSLQKIMEHPWIIKNA 263
                +RL L+ +MEHPW+  N+
Sbjct: 249 RYHPPQRLPLKGVMEHPWVKANS 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  312 bits (800), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 151/263 (57%), Positives = 195/263 (74%), Gaps = 12/263 (4%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           KR++++ DF+I RPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRRE+EI
Sbjct: 8   KRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           QS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L +AL
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENK 191
            YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R  MCGTLDYL PEM+E K
Sbjct: 128 HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLL 240
            HD  VD W  G+LCYEFL G PPF++ S  +T R I           S  +K LIS+LL
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247
Query: 241 VKDSSKRLSLQKIMEHPWIIKNA 263
                +RL L+ +MEHPW+  N+
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKANS 270

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  290 bits (741), Expect = 7e-79,   Method: Compositional matrix adjust.
 Identities = 150/266 (56%), Positives = 188/266 (70%), Gaps = 12/266 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R +++ DFEIGRPLGKGKFG VYL RE +S   VALK++FK QIEK  ++HQLRRE
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           +EIQ+ L HPNILRLY +F+D  RI+LILEYA RGELY+EL+K   F EQ+ AT +  L 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELA 133
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMV 188
           +AL YCH   VIHRDIKPENLLL  +G LKI DFGWSV + S +R TMCGTLDYL PEM+
Sbjct: 134 DALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMI 193
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLIS 237
           E + H+  VD W +G+LCYE L G PPFE+ S  +T+R           S+   A+ LIS
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLIS 253
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNA 263
           +LL  + S+RL L ++  HPW+  N+
Sbjct: 254 KLLRHNPSERLPLAQVSAHPWVRANS 279

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  190 bits (483), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 150/261 (57%), Gaps = 16/261 (6%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           ++SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +I+RD+KPEN+LLD  G +KI DFG++       + +CGT DY+APE+V  K ++
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYN 181
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
            ++D W+ GIL YE L G  PF   +   T+  I           + + K L+SRL+ +D
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 244 SSKRL-----SLQKIMEHPWI 259
            S+RL       + +  HPW 
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWF 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 153/264 (57%), Gaps = 15/264 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++DF++G  LGKG F  VY    + +   VA+K+I K+ + K  +  +++ E++I   L+
Sbjct: 10  IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCH 136
           HP+IL LY +F D   ++L+LE  H GE+ R L+   + F+E +A  ++  +   + Y H
Sbjct: 70  HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEH 193
            + ++HRD+   NLLL     +KI DFG + Q +    K +T+CGT +Y++PE+     H
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
               D W+LG + Y  L G PPF+ ++ K+T   +           S EAK LI +LL +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 243 DSSKRLSLQKIMEHPWIIKNANPR 266
           + + RLSL  +++HP++ +N++ +
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTK 273

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  171 bits (433), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 96/259 (37%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  R LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  IQ ++
Sbjct: 41  LDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRIQQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  ++++LEYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 66  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 125 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 244
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 245 KDPKQRLGGGPSDAKEVMEHRFFL 268

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 8   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 67
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 68  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 127 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 246
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 247 KDPKQRLGGGPSDAKEVMEHRFFL 270

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 150/262 (57%), Gaps = 23/262 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSL 76
           FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I +  K     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           +  +I+RD+KPEN++L+H+G +K+ DFG    S+   +  HT CGT++Y+APE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH 198
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
           + AVD W+LG L Y+ L GAPPF  E++K T   I           + EA+ L+ +LL +
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 243 DSSKRLS-----LQKIMEHPWI 259
           +++ RL        ++  HP+ 
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFF 280

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 101/264 (38%), Positives = 154/264 (58%), Gaps = 21/264 (7%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I  K ++ H +     +Q++
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y 
Sbjct: 63  -RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKE 192
           H   V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ +
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV 241
           +  AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK 241
Query: 242 KDSSKRLS-----LQKIMEHPWII 260
           KD  +RL       +++MEH + +
Sbjct: 242 KDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 151/256 (58%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +A+ YCH+
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S       K  T CG+  Y APE+ + K++D 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ R LV +
Sbjct: 190 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 249
Query: 244 SSKRLSLQKIMEHPWI 259
             KR +L++IM+  WI
Sbjct: 250 PIKRGTLEQIMKDRWI 265

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 149/262 (56%), Gaps = 23/262 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEK-YKIQHQLRREMEIQSSL 76
           FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I +  K     + E  I   +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+A ++ AL + H
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           +  +I+RD+KPEN++L+H+G +K+ DFG    S+   +  H  CGT++Y+APE++    H
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGH 198
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
           + AVD W+LG L Y+ L GAPPF  E++K T   I           + EA+ L+ +LL +
Sbjct: 199 NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 243 DSSKRLS-----LQKIMEHPWI 259
           +++ RL        ++  HP+ 
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFF 280

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 153/256 (59%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPWI 259
            SKR +L++IM+  W+
Sbjct: 252 PSKRGTLEQIMKDRWM 267

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 153/256 (59%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPWI 259
            SKR +L++IM+  W+
Sbjct: 252 PSKRGTLEQIMKDRWM 267

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 26  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 84
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 85  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT +YLAPE++ +K ++ A
Sbjct: 145 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKA 204
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 264
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 265 KRFGNLKDGVNDIKNHKWF 283

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  166 bits (420), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 89/256 (34%), Positives = 149/256 (58%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 14  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ-KLFREVRIMKILN 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +A+ YCH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S       K    CG   Y APE+ + K++D 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ R LV +
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLN 252
Query: 244 SSKRLSLQKIMEHPWI 259
             KR +L++IM+  WI
Sbjct: 253 PIKRGTLEQIMKDRWI 268

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 153/256 (59%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA++II K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPWI 259
            SKR +L++IM+  W+
Sbjct: 252 PSKRGTLEQIMKDRWM 267

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG + + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P + +L   F D+  +++++EYA  GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 100 NFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  164 bits (416), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 92/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + +    T+CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  164 bits (415), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 151/256 (58%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG   Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPWI 259
            SKR +L++IM+  W+
Sbjct: 252 PSKRGTLEQIMKDRWM 267

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  164 bits (415), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  164 bits (415), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EYA  GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG + + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   G+++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 146/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + +G G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   G+++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +K+ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  163 bits (413), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+ +E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIXNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLPNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 89/261 (34%), Positives = 152/261 (58%), Gaps = 20/261 (7%)
Query: 18  LQDFEIG-----RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           + D  IG     + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I
Sbjct: 1   MADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRI 59
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
              L HPNI++L+     ++ ++L++EYA  GE++  L  H    E++A      + +A+
Sbjct: 60  MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAV 119
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVEN 190
            YCH+  ++HRD+K ENLLLD +  +KI DFG+S +    +K  T CG+  Y APE+ + 
Sbjct: 120 QYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 191 KEHDYA-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISR 238
           K++D   VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ +
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 239
Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
            L+ + SKR +L++IM+  W+
Sbjct: 240 FLILNPSKRGTLEQIMKDRWM 260

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 91
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 271
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 272 KRFGNLKNGVNDIKNHKWF 290

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 142/264 (53%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 20  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 75
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           V D W+ G+  Y  L GA PFE   +   FR                  IS E +HLISR
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D +KR+S+ +I  H W +KN
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLKN 279

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  163 bits (412), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 152/256 (59%), Gaps = 15/256 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA++II K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ-KLFREVRIMKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG+  Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKD----TFRS-------ISAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+      R        +S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPWI 259
            SKR +L++IM+  W+
Sbjct: 252 PSKRGTLEQIMKDRWM 267

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 147/259 (56%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAE----------SQKDTFRS-ISAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+          S K  F S  S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 152/261 (58%), Gaps = 22/261 (8%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 209 -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 267
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ 
Sbjct: 268 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 327
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL 240
           ++  AVD W LG++ YE + G  PF  +  +  F           R++  EAK L+S LL
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 387
Query: 241 VKDSSKRLS-----LQKIMEH 256
            KD  +RL       ++IM+H
Sbjct: 388 KKDPKQRLGGGSEDAKEIMQH 408

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 99/261 (37%), Positives = 152/261 (58%), Gaps = 22/261 (8%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 206 -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 264
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YLAPE++E+ 
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN 324
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL 240
           ++  AVD W LG++ YE + G  PF  +  +  F           R++  EAK L+S LL
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 384
Query: 241 VKDSSKRLS-----LQKIMEH 256
            KD  +RL       ++IM+H
Sbjct: 385 KKDPKQRLGGGSEDAKEIMQH 405

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 41  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 99
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 100 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 160 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 219
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 27  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 85
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 86  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 145
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 146 SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 205
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 265
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 266 KRFGNLKNGVNDIKNHKWF 284

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/264 (37%), Positives = 142/264 (53%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           V D W+ G+  Y  L GA PFE   +   FR                  IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/248 (35%), Positives = 149/248 (60%), Gaps = 22/248 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LVR+V   +S H  A+K++ K  +   K++ ++R +ME  I + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATL---KVRDRVRTKMERDILAD 86
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP +++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L   L + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S   +    K ++ CGT++Y+APE+V  + 
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLV 241
           H ++ D W+ G+L +E L G+ PF+ + +K+T   I           S EA+ L+  L  
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFK 266
Query: 242 KDSSKRLS 249
           ++ + RL 
Sbjct: 267 RNPANRLG 274

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 61  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 119
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 120 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 179
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 180 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 239
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  162 bits (410), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENL++D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIIISKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  162 bits (409), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 35  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 93
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 94  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 153
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 154 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 213
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 273
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 274 KRFGNLKNGVNDIKNHKWF 292

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 145/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L Y+   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  162 bits (409), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 91/259 (35%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  FE  + LG G FGRV LV+  E+ +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 33  LDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 91
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF E  A  Y A +     Y H
Sbjct: 92  NFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLH 151
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 152 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 211
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 271
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 272 KRFGNLKNGVNDIKNHKWF 290

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  161 bits (408), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 151/261 (57%), Gaps = 22/261 (8%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 66  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 124
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 125 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL 240
           ++  AVD W LG++ YE + G  PF  +  +  F           R++  EAK L+S LL
Sbjct: 185 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 244
Query: 241 VKDSSKRLS-----LQKIMEH 256
            KD  +RL       ++IM+H
Sbjct: 245 KKDPKQRLGGGSEDAKEIMQH 265

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 151/261 (57%), Gaps = 22/261 (8%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 67  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 126 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL 240
           ++  AVD W LG++ YE + G  PF  +  +  F           R++  EAK L+S LL
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 245
Query: 241 VKDSSKRLS-----LQKIMEH 256
            KD  +RL       ++IM+H
Sbjct: 246 KKDPKQRLGGGSEDAKEIMQH 266

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  161 bits (407), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAP ++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPAIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  160 bits (406), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 151/261 (57%), Gaps = 22/261 (8%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSS 75
           ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I  K ++ H L     +Q+S
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A + +AL Y 
Sbjct: 68  -RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 126
Query: 136 H-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENK 191
           H E +V++RD+K ENL+LD +G +KI DFG   +      TM   CGT +YLAPE++E+ 
Sbjct: 127 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL 240
           ++  AVD W LG++ YE + G  PF  +  +  F           R++  EAK L+S LL
Sbjct: 187 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 246
Query: 241 VKDSSKRLS-----LQKIMEH 256
            KD  +RL       ++IM+H
Sbjct: 247 KKDPKQRLGGGSEDAKEIMQH 267

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  160 bits (406), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           K        +  I  H W 
Sbjct: 279 KAFGNLKNGVNDIKNHKWF 297

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  160 bits (404), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 141/264 (53%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI  FG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           V D W+ G+  Y  L GA PFE   +   FR                  IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   +CGT + LAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEALAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 146/270 (54%), Gaps = 21/270 (7%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           N      + +FE  R LGKG FG+V L R  E+    A+K++ K+ I +         E 
Sbjct: 15  NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEK 74
Query: 71  EIQSSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
            I S  R HP + +L+  F   +R+F ++E+ + G+L   ++K RRF E +A  Y A + 
Sbjct: 75  RILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII 134
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPE 186
           +AL + H+  +I+RD+K +N+LLDHEG  K+ DFG     + +     T CGT DY+APE
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHL 235
           +++   +  AVD W +G+L YE L G  PFEAE++ D F +I             +A  +
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI 254
Query: 236 ISRLLVKDSSKRL-SLQK-----IMEHPWI 259
           +   + K+ + RL SL +     I+ HP+ 
Sbjct: 255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   + GT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 85/246 (34%), Positives = 142/246 (57%), Gaps = 15/246 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLR 77
            DF   + +GKG FG+V L R    +   A+K++ K+ I K K +  +  E  +   +++
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP ++ L+  F   ++++ +L+Y + GEL+  L++ R F E +A  Y A + +AL Y H 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            ++++RD+KPEN+LLD +G + + DFG    +++  S   T CGT +YLAPE++  + +D
Sbjct: 158 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKD 243
             VD W LG + YE LYG PPF + +  + +            +I+  A+HL+  LL KD
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 244 SSKRLS 249
            +KRL 
Sbjct: 278 RTKRLG 283

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/248 (34%), Positives = 148/248 (59%), Gaps = 22/248 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 83
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 144 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLV 241
           H  + D W+ G+L +E L G  PF+ + +K+T   I           S EA+ L+  L  
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 263
Query: 242 KDSSKRLS 249
           ++ + RL 
Sbjct: 264 RNPANRLG 271

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/248 (34%), Positives = 148/248 (59%), Gaps = 22/248 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLV 241
           H  + D W+ G+L +E L G  PF+ + +K+T   I           S EA+ L+  L  
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262
Query: 242 KDSSKRLS 249
           ++ + RL 
Sbjct: 263 RNPANRLG 270

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 97/264 (36%), Positives = 140/264 (53%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ +S   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++YCH   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI  FG+S  S   S+     GT  Y+APE++  KE+D  
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           V D W+ G+  Y  L GA PFE   +   FR                  IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 86/248 (34%), Positives = 148/248 (59%), Gaps = 22/248 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREME--IQSS 75
           FE+ + LG+G FG+V+LV+++   +++   A+K++ K  +   K++ ++R +ME  I   
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---KVRDRVRTKMERDILVE 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A L  AL + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKE 192
           H   +I+RD+KPEN+LLD EG +K+ DFG S +S     K ++ CGT++Y+APE+V  + 
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLV 241
           H  + D W+ G+L +E L G  PF+ + +K+T   I           S EA+ L+  L  
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFK 262
Query: 242 KDSSKRLS 249
           ++ + RL 
Sbjct: 263 RNPANRLG 270

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 84/255 (32%), Positives = 147/255 (57%), Gaps = 15/255 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 13  IGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ-KLFREVRIXKVLN 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L+ EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 72  HPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQ 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDY 195
             ++HRD+K ENLLLD +  +KI DFG+S +    +K    CG   Y APE+ + K++D 
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
             VD W+LG++ Y  + G+ PF+ ++ K+    +           S + ++L+ + L+ +
Sbjct: 192 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILN 251
Query: 244 SSKRLSLQKIMEHPW 258
            SKR +L++I +  W
Sbjct: 252 PSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 146/257 (56%), Gaps = 17/257 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + ++ + + +GKG F +V L R V +   VA+KII K Q+    +Q +L RE+ I   L 
Sbjct: 14  IGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQ-KLFREVRIMKILN 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L+     ++ ++L++EYA  GE++  L  H R  E++A      + +A+ YCH+
Sbjct: 73  HPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQ 132
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +++HRD+K ENLLLD +  +KI DFG+S      +K  T CG+  Y APE+ + K++D 
Sbjct: 133 KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSS--------- 245
             VD W+LG++ Y  + G+ PF+ ++ K+  R      K+ I   +  D           
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKE-LRERVLRGKYRIPFYMSTDCENLLKKLLVL 251
Query: 246 ---KRLSLQKIMEHPWI 259
              KR SL++IM+  W+
Sbjct: 252 NPIKRGSLEQIMKDRWM 268

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 90/259 (34%), Positives = 144/259 (55%), Gaps = 18/259 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K I+H L  E  I  ++
Sbjct: 40  LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLN-EKRILQAV 98
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
             P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A +     Y H
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
              +I+RD+KPENLL+D +G +++ DFG++ + + +   + GT +YLAPE++ +K ++ A
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGTPEYLAPEIILSKGYNKA 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSS 245
           VD W LG+L YE   G PPF A+     +  I           S++ K L+  LL  D +
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 246 KRL-----SLQKIMEHPWI 259
           KR       +  I  H W 
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  158 bits (400), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 96/264 (36%), Positives = 141/264 (53%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+ + +G G FG   L+R+ ++   VA+K I + +    KI   ++RE+    SLRHPN
Sbjct: 21  YELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHPN 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +++EYA  GEL+  +    RF+E +A  +   L + ++Y H   V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  KE+D  
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           V D W+ G+  Y  L GA PFE   +   FR                  IS E +HLISR
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D +KR+S+ +I  H W +KN
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKN 280

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  158 bits (399), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 140/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 273 DATKRLGCEEM 283

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 140/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 138/251 (54%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F  I             +A+ L+ +LLV 
Sbjct: 212 XKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 270 DATKRLGCEEM 280

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/259 (36%), Positives = 149/259 (57%), Gaps = 26/259 (10%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQI-EKYKIQHQLRREMEI 72
            +++FE+ + LG G +G+V+LVR++   ++    A+K++ K  I +K K     R E ++
Sbjct: 52  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 111
Query: 73  QSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +R  P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE +   Y+  +  A
Sbjct: 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 171
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKR-HTMCGTLDYLAPEM 187
           L + H+  +I+RDIK EN+LLD  G + + DFG S   V   ++R +  CGT++Y+AP++
Sbjct: 172 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 231
Query: 188 VENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SA 230
           V   +  HD AVD W+LG+L YE L GA PF  + +K++   I               SA
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291
Query: 231 EAKHLISRLLVKDSSKRLS 249
            AK LI RLL+KD  KRL 
Sbjct: 292 LAKDLIQRLLMKDPKKRLG 310

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 153 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 213 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 272
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 273 DATKRLGCEEM 283

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  157 bits (398), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 276
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 277 DATKRLGCEEM 287

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 270 DATKRLGCEEM 280

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 270 DATKRLGCEEM 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 155 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 215 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVL 274
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 275 DATKRLGCEEM 285

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 138/251 (54%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F  I             +A+ L+ +LLV 
Sbjct: 212 CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 129 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 189 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 248
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 249 DATKRLGCEEM 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 130 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 190 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 249
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 250 DATKRLGCEEM 260

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 248 DATKRLGCEEM 258

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 149 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 209 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 268
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 269 DATKRLGCEEM 279

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 144/267 (53%), Gaps = 21/267 (7%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 210
Query: 200 WTLGILCYEFLYGAPPFEAESQKD----------TF-----RSISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF   ++ D          TF     + +S  AK LI ++L    
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 270
Query: 245 SKRLSLQKIMEHPWIIKNANPRGTCDI 271
           S R+S +  ++H WI      + + D+
Sbjct: 271 SMRISARDALDHEWIQTYTKEQISVDV 297

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 127 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 187 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 246
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 247 DATKRLGCEEM 257

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 144/267 (53%), Gaps = 21/267 (7%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 233
Query: 200 WTLGILCYEFLYGAPPFEAESQKD----------TF-----RSISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF   ++ D          TF     + +S  AK LI ++L    
Sbjct: 234 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 293
Query: 245 SKRLSLQKIMEHPWIIKNANPRGTCDI 271
           S R+S +  ++H WI      + + D+
Sbjct: 294 SMRISARDALDHEWIQTYTKEQISVDV 320

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 144/267 (53%), Gaps = 21/267 (7%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-YDEKCDV 234
Query: 200 WTLGILCYEFLYGAPPFEAESQKD----------TF-----RSISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF   ++ D          TF     + +S  AK LI ++L    
Sbjct: 235 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 294
Query: 245 SKRLSLQKIMEHPWIIKNANPRGTCDI 271
           S R+S +  ++H WI      + + D+
Sbjct: 295 SMRISARDALDHEWIQTYTKEQISVDV 321

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 89/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 134 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 194 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 253
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 254 DATKRLGCEEM 264

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  156 bits (395), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 88/251 (35%), Positives = 139/251 (55%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  G L + +RK   F E     Y A + +AL Y H  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R ++  GT  Y++PE++  K  
Sbjct: 152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 212 SKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 271
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 272 DATKRLGCEEM 282

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/251 (35%), Positives = 138/251 (54%), Gaps = 16/251 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DF+ G+ LG+G F    L RE+ +    A+KI+ K  I K      + RE ++ S L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKR-HTMCGTLDYLAPEMVENKEH 193
            +IHRD+KPEN+LL+ +  ++I DFG     S +S+  R +   GT  Y++PE++  K  
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV 
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269
Query: 243 DSSKRLSLQKI 253
           D++KRL  +++
Sbjct: 270 DATKRLGCEEM 280

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 88/255 (34%), Positives = 140/255 (54%), Gaps = 21/255 (8%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI++L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 98  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 157
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 158 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDV 216
Query: 200 WTLGILCYEFLYGAPPFEAESQKD----------TF-----RSISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF   ++ D          TF     + +S  AK LI ++L    
Sbjct: 217 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVP 276
Query: 245 SKRLSLQKIMEHPWI 259
           S R+S +  ++H WI
Sbjct: 277 SMRISARDALDHEWI 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 139/256 (54%), Gaps = 14/256 (5%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIW 226
Query: 201 TLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS 249
           +LG + Y  L G PPFE    K+T+           R I+  A  LI R+L  D + R S
Sbjct: 227 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPS 286
Query: 250 LQKIMEHPWIIKNANP 265
           + +++   +      P
Sbjct: 287 VAELLTDEFFTSGYAP 302

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 86/250 (34%), Positives = 139/250 (55%), Gaps = 15/250 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+V L    +++  VALK I ++ ++K  +  ++ RE+     LRHP+I++LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
                  I +++EYA  GEL+  + + +R TE +   +   +  A+ YCH + ++HRD+K
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 147 PENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-VDNWTLG 203
           PENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +    VD W+ G
Sbjct: 136 PENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRLSLQK 252
           I+ Y  L G  PF+ E   + F+ +           S  A+ LI R++V D  +R+++Q+
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQE 255
Query: 253 IMEHPWIIKN 262
           I   PW   N
Sbjct: 256 IRRDPWFNVN 265

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 142/264 (53%), Gaps = 21/264 (7%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L ++  +    A+KII K  +        L  E+ +   L HPNI++L
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 69
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+   ++F+E  AA  +  + +   Y H+++++HRD
Sbjct: 70  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 129
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + R   +KI DFG S   +   K     GT  Y+APE++  K++D   D 
Sbjct: 130 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 188
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF  ++ ++  +                +S EAK L+  +L  + 
Sbjct: 189 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 248
Query: 245 SKRLSLQKIMEHPWIIKNANPRGT 268
           SKR+S ++ + HPWI+K  + + T
Sbjct: 249 SKRISAEEALNHPWIVKFCSQKHT 272

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 143/255 (56%), Gaps = 15/255 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 13  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 73  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 131
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
             VD W+ G++ Y  L    PF+ ES    F++I           S  A  LI R+L+ +
Sbjct: 192 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 251
Query: 244 SSKRLSLQKIMEHPW 258
              R+S+ +IM+  W
Sbjct: 252 PLNRISIHEIMQDDW 266

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 143/255 (56%), Gaps = 15/255 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 12  IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 72  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 130
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 190
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
             VD W+ G++ Y  L    PF+ ES    F++I           S  A  LI R+L+ +
Sbjct: 191 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 250
Query: 244 SSKRLSLQKIMEHPW 258
              R+S+ +IM+  W
Sbjct: 251 PLNRISIHEIMQDDW 265

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  154 bits (389), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 143/255 (56%), Gaps = 15/255 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 7   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 67  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 125
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
             VD W+ G++ Y  L    PF+ ES    F++I           S  A  LI R+L+ +
Sbjct: 186 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 245
Query: 244 SSKRLSLQKIMEHPW 258
              R+S+ +IM+  W
Sbjct: 246 PLNRISIHEIMQDDW 260

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 143/255 (56%), Gaps = 15/255 (5%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           + +++I + LG+G FG+V L     +   VALKII K+ + K  +Q ++ RE+     LR
Sbjct: 3   IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HP+I++LY      + I +++EYA   EL+  + +  + +EQ+A  +   + +A+ YCH 
Sbjct: 63  HPHIIKLYDVIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR 121
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           + ++HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +  
Sbjct: 122 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 181
Query: 196 A-VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
             VD W+ G++ Y  L    PF+ ES    F++I           S  A  LI R+L+ +
Sbjct: 182 PEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVN 241
Query: 244 SSKRLSLQKIMEHPW 258
              R+S+ +IM+  W
Sbjct: 242 PLNRISIHEIMQDDW 256

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  154 bits (389), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 89/267 (33%), Positives = 142/267 (53%), Gaps = 21/267 (7%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L HPNI +L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N ++HRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + +   ++I DFG S   ++  K     GT  Y+APE++    +D   D 
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT-YDEKCDV 210
Query: 200 WTLGILCYEFLYGAPPFEAESQKD----------TF-----RSISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF   ++ D          TF     + +S  AK LI + L    
Sbjct: 211 WSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVP 270
Query: 245 SKRLSLQKIMEHPWIIKNANPRGTCDI 271
           S R+S +  ++H WI      + + D+
Sbjct: 271 SXRISARDALDHEWIQTYTKEQISVDV 297

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 138/256 (53%), Gaps = 14/256 (5%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIW 226
Query: 201 TLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS 249
           +LG + Y  L G PPFE    K+T+           R I+  A  LI R+L  D + R S
Sbjct: 227 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPS 286
Query: 250 LQKIMEHPWIIKNANP 265
           + +++   +      P
Sbjct: 287 VAELLTDEFFTSGYAP 302

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 141/255 (55%), Gaps = 22/255 (8%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L R+  +    A+KII K  +       +L  E+ +   L HPNI++L
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHPNIMKL 101
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+    +F E  AA  I  + + + Y H+++++HRD
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRD 161
Query: 145 IKPENLLLDH---EGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+    +  +KI DFG S   +++ K     GT  Y+APE++  K++D   D 
Sbjct: 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEKCDV 220
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDS 244
           W++G++ +  L G PPF  ++ ++  R               ++S  AK LI ++L  DS
Sbjct: 221 WSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDS 280
Query: 245 SKRLSLQKIMEHPWI 259
            +R+S Q+ +EHPWI
Sbjct: 281 QRRISAQQALEHPWI 295

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 84/257 (32%), Positives = 139/257 (54%), Gaps = 21/257 (8%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G +G V L ++  +    A+KII K  +        L  E+ +   L HPNI++L
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKL 86
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           Y +F D    +L++E    GEL+ E+   ++F+E  AA  +  + +   Y H+++++HRD
Sbjct: 87  YEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRD 146
Query: 145 IKPENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDN 199
           +KPENLLL+ + R   +KI DFG S   +   K     GT  Y+APE++  K++D   D 
Sbjct: 147 LKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVL-RKKYDEKCDV 205
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDS 244
           W+ G++ Y  L G PPF  ++ ++  +                +S EAK L+  +L  + 
Sbjct: 206 WSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEP 265
Query: 245 SKRLSLQKIMEHPWIIK 261
           SKR+S ++ + HPWI+K
Sbjct: 266 SKRISAEEALNHPWIVK 282

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 138/256 (53%), Gaps = 14/256 (5%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 106
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 107 FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 166
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W
Sbjct: 167 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIW 226
Query: 201 TLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS 249
           +LG + Y  L G PPFE    K+T+           R I+  A  LI R+L  D + R S
Sbjct: 227 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPS 286
Query: 250 LQKIMEHPWIIKNANP 265
           + +++   +      P
Sbjct: 287 VAELLTDEFFTSGYAP 302

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  152 bits (385), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 138/256 (53%), Gaps = 14/256 (5%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           GR LGKG F + Y + ++++K   A K++ K  + K   + ++  E+ I  SL +P+++ 
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVG 90
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            +G+F DD+ ++++LE   R  L    ++ +  TE +A  ++      + Y H N VIHR
Sbjct: 91  FHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHR 150
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           D+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W
Sbjct: 151 DLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIW 210
Query: 201 TLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLS 249
           +LG + Y  L G PPFE    K+T+           R I+  A  LI R+L  D + R S
Sbjct: 211 SLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADPTLRPS 270
Query: 250 LQKIMEHPWIIKNANP 265
           + +++   +      P
Sbjct: 271 VAELLTDEFFTSGYAP 286

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 137/264 (51%), Gaps = 26/264 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++  + +G G FG   L+R+  +K  VA+K I +       I   ++RE+    SLRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLRHPN 77
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +I+EYA  GELY  +    RF+E +A  +   L + ++YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 141 IHRDIKPENLLLDHE--GRLKIGDFGWSVQS--RSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  +E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 197 V-DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
           + D W+ G+  Y  L GA PFE   +   +R                  IS E  HLISR
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKN 262
           + V D + R+S+ +I  H W +KN
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKN 281

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  151 bits (381), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 142/262 (54%), Gaps = 22/262 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSK 246
            G++ Y  L G PPF  +++ D                 R+IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 247 RLSLQKIMEHPWIIKNANPRGT 268
           R++  + +EHPWI K ++   T
Sbjct: 268 RITATQCLEHPWIQKYSSETPT 289

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 141/258 (54%), Gaps = 22/258 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSK 246
            G++ Y  L G PPF  +++ D                 R+IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 247 RLSLQKIMEHPWIIKNAN 264
           R++  + +EHPWI K ++
Sbjct: 268 RITATQCLEHPWIQKYSS 285

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 87/258 (33%), Positives = 141/258 (54%), Gaps = 22/258 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG FG V   ++  ++   A+K+I K    K K    + RE+E+   L HPNI++L+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H+++++HRD+K
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLK 148
Query: 147 PENLLLDHEGR---LKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PEN+LL+ + +   +KI DFG S   Q  +K     GT  Y+APE++    +D   D W+
Sbjct: 149 PENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWS 207
Query: 202 LGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSK 246
            G++ Y  L G PPF  +++ D                 R+IS +AK LI ++L    S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 247 RLSLQKIMEHPWIIKNAN 264
           R++  + +EHPWI K ++
Sbjct: 268 RITATQCLEHPWIQKYSS 285

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 133/242 (54%), Gaps = 14/242 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 264
Query: 253 IM 254
           ++
Sbjct: 265 LL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 133/242 (54%), Gaps = 14/242 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 208
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 209 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 268
Query: 253 IM 254
           ++
Sbjct: 269 LL 270

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 133/242 (54%), Gaps = 14/242 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++ T+CGT +Y+APE++  K H + VD W++G
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIG 204
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 205 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 264
Query: 253 IM 254
           ++
Sbjct: 265 LL 266

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 22/253 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSK 246
           +G++ Y  L G PPF  E+    F                 IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 247 RLSLQKIMEHPWI 259
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 22/253 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSK 246
           +G++ Y  L G PPF  E+    F                 IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 247 RLSLQKIMEHPWI 259
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  147 bits (372), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 84/253 (33%), Positives = 132/253 (52%), Gaps = 22/253 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I KE +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSK 246
           +G++ Y  L G PPF  E+    F                 IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 247 RLSLQKIMEHPWI 259
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  147 bits (371), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 95/275 (34%), Positives = 144/275 (52%), Gaps = 26/275 (9%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R+     FE+   LG+G    VY  ++  ++ P ALK++ K+ ++K KI   +R E
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL-KKTVDK-KI---VRTE 98
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + +   L HPNI++L   F     I L+LE    GEL+  + +   ++E+ AA  +  + 
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158
Query: 130 NALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            A+AY HEN ++HRD+KPENLL      +  LKI DFG S  V+ +    T+CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFRSI--------------- 228
           PE++    +   VD W++GI+ Y  L G  PF  E   +  FR I               
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           S  AK L+ +L+V D  KRL+  + ++HPW+   A
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  147 bits (371), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 132/242 (54%), Gaps = 14/242 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 226
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 227 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 286
Query: 253 IM 254
           ++
Sbjct: 287 LL 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  147 bits (371), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 132/242 (54%), Gaps = 14/242 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 229 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 288
Query: 253 IM 254
           ++
Sbjct: 289 LL 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  147 bits (370), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 151/291 (51%), Gaps = 34/291 (11%)
Query: 12  RKREWSLQD--FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK---------- 59
           RK+E  + +  F++ R LG G +G V L +E       A+K+I K Q +K          
Sbjct: 28  RKKEGKIGESYFKV-RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
            K   ++  E+ +  SL HPNI++L+  F D +  +L+ E+   GEL+ ++    +F E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL---KIGDFGWS--VQSRSKRH 174
            AA  +  + + + Y H+++++HRDIKPEN+LL+++  L   KI DFG S       K  
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206
Query: 175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------- 225
              GT  Y+APE+++ K+++   D W+ G++ Y  L G PPF  ++ +D           
Sbjct: 207 DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 226 ------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCD 270
                 ++IS EAK LI  +L  D +KR + ++ +   WI K AN     D
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD 316

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 134/253 (52%), Gaps = 14/253 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I  SL H +++  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
           +F D++ +F++LE   R  L    ++ +  TE +A  Y+  +     Y H N VIHRD+K
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++  K H + VD W++G
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG 202
Query: 204 ILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQK 252
            + Y  L G PPFE    K+T+           + I+  A  LI ++L  D + R ++ +
Sbjct: 203 CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINE 262
Query: 253 IMEHPWIIKNANP 265
           ++   +      P
Sbjct: 263 LLNDEFFTSGYIP 275

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  147 bits (370), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 135/268 (50%), Gaps = 23/268 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++  S LR
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR 212
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCH 136
           HP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   L + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 137 ENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEMVENKE 192
           EN+ +H D+KPEN++        LK+ DFG +     K+      GT ++ APE+ E K 
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------------ISAEAKHLIS 237
             Y  D W++G+L Y  L G  PF  E+  +T R+               IS + K  I 
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR 392
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           +LL+ D + R+++ + +EHPW+     P
Sbjct: 393 KLLLADPNTRMTIHQALEHPWLTPGNAP 420

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 83/253 (32%), Positives = 132/253 (52%), Gaps = 22/253 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V L  +  ++  VA+K I K+ +E    +  +  E+ +   ++HPNI+ L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDD 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +     ++LI++    GEL+  + +   +TE+ A+  I  + +A+ Y H+  ++HRD+K
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLK 143
Query: 147 PENLL---LDHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           PENLL   LD + ++ I DFG S      S   T CGT  Y+APE++  K +  AVD W+
Sbjct: 144 PENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWS 203
Query: 202 LGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSK 246
           +G++ Y  L G PPF  E+    F                 IS  AK  I  L+ KD  K
Sbjct: 204 IGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEK 263
Query: 247 RLSLQKIMEHPWI 259
           R + ++ ++HPWI
Sbjct: 264 RFTCEQALQHPWI 276

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 23/273 (8%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           K +  L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++ 
Sbjct: 45  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 101
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNA 131
            S LRHP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   
Sbjct: 102 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 161
Query: 132 LAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRHT--MCGTLDYLAPEM 187
           L + HEN+ +H D+KPEN++        LK+ DFG +     K+      GT ++ APE+
Sbjct: 162 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 221
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------------ISAEA 232
            E K   Y  D W++G+L Y  L G  PF  E+  +T R+               IS + 
Sbjct: 222 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 281
Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           K  I +LL+ D + R+++ + +EHPW+     P
Sbjct: 282 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 314

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 81/252 (32%), Positives = 130/252 (51%), Gaps = 14/252 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE++     RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY         F+++EY   GEL+  + KH R  E +A      + +A+ YCH + V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-V 197
           +HRD+KPEN+LLD     KI DFG S  +       T CG+ +Y APE++  + +    V
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISA-----------EAKHLISRLLVKDSSK 246
           D W+ G++ Y  L G  PF+ E     F+ I                 L+  +L  D  K
Sbjct: 193 DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 247 RLSLQKIMEHPW 258
           R +++ I EH W
Sbjct: 253 RATIKDIREHEW 264

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 143/256 (55%), Gaps = 16/256 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSL 76
           ++DFE+ + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 17  IEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 76
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG    ++   +K +  CGT DY+APE++  +++
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKY 196
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
           +++VD W+ G+L YE L G  PF  + +++ F SI             EAK L+ +L V+
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 256
Query: 243 DSSKRLSLQ-KIMEHP 257
           +  KRL ++  I +HP
Sbjct: 257 EPEKRLGVRGDIRQHP 272

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  144 bits (363), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 83/256 (32%), Positives = 130/256 (50%), Gaps = 22/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G F  V+LV++  +    ALK I K    +      L  E+ +   ++H NI+ L  
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +      +L+++    GEL+  + +   +TE+ A+  I  + +A+ Y HEN ++HRD+K
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLK 133
Query: 147 PENLLL---DHEGRLKIGDFGWS-VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTL 202
           PENLL    +   ++ I DFG S ++      T CGT  Y+APE++  K +  AVD W++
Sbjct: 134 PENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 203 GILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSKR 247
           G++ Y  L G PPF  E++   F                 IS  AK  I  LL KD ++R
Sbjct: 194 GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNER 253
Query: 248 LSLQKIMEHPWIIKNA 263
            + +K + HPWI  N 
Sbjct: 254 YTCEKALSHPWIDGNT 269

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 145/273 (53%), Gaps = 26/273 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE+ I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 138 NHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++APE+V  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE---------------AKHLI 236
                 D W++G++ Y  L GA PF  E++++T  +ISA                AK  I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI--IKNANPRG 267
            RLLVKD  +R+++ + +EH WI  I+  N RG
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 80/252 (31%), Positives = 129/252 (51%), Gaps = 14/252 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE++     RHP+
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY         F+++EY   GEL+  + KH R  E +A      + +A+ YCH + V
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMV 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-V 197
           +HRD+KPEN+LLD     KI DFG S  +         CG+ +Y APE++  + +    V
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISA-----------EAKHLISRLLVKDSSK 246
           D W+ G++ Y  L G  PF+ E     F+ I                 L+  +L  D  K
Sbjct: 193 DIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLK 252
Query: 247 RLSLQKIMEHPW 258
           R +++ I EH W
Sbjct: 253 RATIKDIREHEW 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 79/273 (28%), Positives = 143/273 (52%), Gaps = 30/273 (10%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A++++ KE +   +    ++ E  + + +
Sbjct: 50  GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++  ++
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 229
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------FRSISAEA 232
           + ++VD W LG+L +E + G  PF+     D                      RS+S +A
Sbjct: 230 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 289
Query: 233 KHLISRLLVKDSSKRL------SLQKIMEHPWI 259
             ++   L KD  +RL          I  HP+ 
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 142/256 (55%), Gaps = 16/256 (6%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSL 76
           ++DF + + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 16  IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG    ++   +K +  CGT DY+APE++  +++
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKY 195
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
           +++VD W+ G+L YE L G  PF  + +++ F SI             EAK L+ +L V+
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 243 DSSKRLSLQ-KIMEHP 257
           +  KRL ++  I +HP
Sbjct: 256 EPEKRLGVRGDIRQHP 271

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  142 bits (357), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 85/273 (31%), Positives = 144/273 (52%), Gaps = 26/273 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE+ I   +R
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 138 NHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++APE+V  +
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 207
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE---------------AKHLI 236
                 D W++G++ Y  L GA PF  E++++T  +ISA                AK  I
Sbjct: 208 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 267
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI--IKNANPRG 267
            RLLVKD  +R+ + + +EH WI  I+  N RG
Sbjct: 268 RRLLVKDPKRRMXIAQSLEHSWIKAIRRRNVRG 300

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 30/273 (10%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 18  GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 77
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 137
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 138 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 197
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------FRSISAEA 232
           + ++VD W LG+L +E + G  PF+     D                      RS+S +A
Sbjct: 198 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKA 257
Query: 233 KHLISRLLVKDSSKRL------SLQKIMEHPWI 259
             ++   L KD  +RL          I  HP+ 
Sbjct: 258 ASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF 290

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  141 bits (356), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 30/273 (10%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 3   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 122
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 123 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 182
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------FRSISAEA 232
           + ++VD W LG+L +E + G  PF+     D                      RS+S +A
Sbjct: 183 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 242
Query: 233 KHLISRLLVKDSSKRL------SLQKIMEHPWI 259
             ++   L KD  +RL          I  HP+ 
Sbjct: 243 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG GKF  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 80/273 (29%), Positives = 142/273 (52%), Gaps = 30/273 (10%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
            LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  + + +
Sbjct: 7   GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
             HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ AL Y 
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
           HE  +I+RD+K +N+LLD EG +K+ D+G   +      T    CGT +Y+APE++  ++
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED 186
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------FRSISAEA 232
           + ++VD W LG+L +E + G  PF+     D                      RS+S +A
Sbjct: 187 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKA 246
Query: 233 KHLISRLLVKDSSKRL------SLQKIMEHPWI 259
             ++   L KD  +RL          I  HP+ 
Sbjct: 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 131/250 (52%), Gaps = 14/250 (5%)
Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           +G  LG G FG+V + +   + H VA+KI+ +++I    +  ++RRE++     RHP+I+
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           +LY        IF+++EY   GEL+  + K+ R  E+++      + + + YCH + V+H
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA-VDN 199
           RD+KPEN+LLD     KI DFG S  +         CG+ +Y APE++  + +    VD 
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDI 199
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSKRL 248
           W+ G++ Y  L G  PF+ +     F+ I           +     L+  +L  D  KR 
Sbjct: 200 WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRA 259
Query: 249 SLQKIMEHPW 258
           +++ I EH W
Sbjct: 260 TIKDIREHEW 269

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 82/259 (31%), Positives = 131/259 (50%), Gaps = 22/259 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE    LG G F  V L  E  +    A+K I K+ ++    +  +  E+ +   ++H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGK--ESSIENEIAVLRKIKHEN 81
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ L   +     ++L+++    GEL+  + +   +TE+ A+T I  + +A+ Y H   +
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 141 IHRDIKPENLLL---DHEGRLKIGDFGWS-VQSRSK-RHTMCGTLDYLAPEMVENKEHDY 195
           +HRD+KPENLL    D E ++ I DFG S ++ +     T CGT  Y+APE++  K +  
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLL 240
           AVD W++G++ Y  L G PPF  E+    F                 IS  AK  I  L+
Sbjct: 202 AVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLM 261
Query: 241 VKDSSKRLSLQKIMEHPWI 259
            KD +KR + ++   HPWI
Sbjct: 262 EKDPNKRYTCEQAARHPWI 280

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  140 bits (353), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 137/269 (50%), Gaps = 25/269 (9%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M ++  ++  N      L DF     LGKG FG+V L     ++   A+KI+ K+ + + 
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 61  KIQHQLRREMEIQSSLRHPNIL-RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
                   E  + + L  P  L +L+  F   +R++ ++EY + G+L   +++  +F E 
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--- 176
           QA  Y A ++  L + H+  +I+RD+K +N++LD EG +KI DFG       K H M   
Sbjct: 121 QAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGM-----CKEHMMDGV 175
Query: 177 -----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--- 228
                CGT DY+APE++  + +  +VD W  G+L YE L G PPF+ E + + F+SI   
Sbjct: 176 TTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH 235
Query: 229 --------SAEAKHLISRLLVKDSSKRLS 249
                   S EA  +   L+ K  +KRL 
Sbjct: 236 NVSYPKSLSKEAVSICKGLMTKHPAKRLG 264

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 83/271 (30%), Positives = 144/271 (53%), Gaps = 25/271 (9%)
Query: 14  REWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           R+  ++D +E+G  LG G+F  V   R+  +    A K I K ++   +    + ++ RE
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   +RHPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + 
Sbjct: 66  VNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +     R+K+ DFG +  +++ ++   + GT +++
Sbjct: 126 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  E++++T  +ISA             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              AK  I RLLVKD  +R+ + + +EH WI
Sbjct: 246 SELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  140 bits (352), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 139/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT  ++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  139 bits (349), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V    ++ +    A KII  +++   +   +L RE  I   L+HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHP 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ +CH N 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           ++HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISR 238
              VD W  G++ Y  L G PPF  E Q   ++ I A               EAK LI++
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           +L  + +KR++  + ++HPWI + + 
Sbjct: 244 MLTINPAKRITASEALKHPWICQRST 269

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 140/286 (48%), Gaps = 28/286 (9%)
Query: 1   MDTKTAEREDNRKREWSLQ-------DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF 53
           M + T  ++  R  E+ +        ++++   LGKG F  V       +    A KII 
Sbjct: 4   MASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIIN 63
Query: 54  KEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH 113
            +++     Q +L RE  I   L+HPNI+RL+    ++   +L+ +    GEL+ ++   
Sbjct: 64  TKKLSARDFQ-KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 122
Query: 114 RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSR 170
             ++E  A+  I  +  ++AYCH N ++HR++KPENLLL  + +   +K+ DFG +++  
Sbjct: 123 EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182
Query: 171 SKR--HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
                H   GT  YL+PE+++   +   VD W  G++ Y  L G PPF  E Q   +  I
Sbjct: 183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI 242
Query: 229 SA---------------EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            A               EAK LI  +L  +  KR++  + ++ PWI
Sbjct: 243 KAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 139/266 (52%), Gaps = 22/266 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V    ++ +    A KII  +++   +   +L RE  I   L+HP
Sbjct: 5   EYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHP 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ +CH N 
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           ++HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++    +
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISR 238
              VD W  G++ Y  L G PPF  E Q   ++ I A               EAK LI++
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINK 243
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           +L  + +KR++  + ++HPWI + + 
Sbjct: 244 MLTINPAKRITASEALKHPWICQRST 269

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 146/273 (53%), Gaps = 32/273 (11%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSS 75
           Q + +   +G+G +G V +  +  ++   A K I   F E ++++K      +E+EI  S
Sbjct: 26  QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK------QEIEIMKS 79
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           L HPNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYC
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 139
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVEN 190
           H+ +V HRD+KPEN L      +  LK+ DFG + + +  +   T  GT  Y++P+++E 
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 199
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFR-------SISAEAKHL 235
             +    D W+ G++ Y  L G PPF A +  +        TF        ++S +A+ L
Sbjct: 200 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 258
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIK--NANPR 266
           I RLL K   +R++  + +EH W  K  +++PR
Sbjct: 259 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 291

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 88/273 (32%), Positives = 146/273 (53%), Gaps = 32/273 (11%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSS 75
           Q + +   +G+G +G V +  +  ++   A K I   F E ++++K      +E+EI  S
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK------QEIEIMKS 62
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           L HPNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYC
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVEN 190
           H+ +V HRD+KPEN L      +  LK+ DFG + + +  +   T  GT  Y++P+++E 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFR-------SISAEAKHL 235
             +    D W+ G++ Y  L G PPF A +  +        TF        ++S +A+ L
Sbjct: 183 L-YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIK--NANPR 266
           I RLL K   +R++  + +EH W  K  +++PR
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWFEKQLSSSPR 274

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 17  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 76
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 77  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 135
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 136 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 195
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 196 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 255
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 256 KALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 71  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 190 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 250 KALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA+KII K +      +       +  E+EI  
Sbjct: 10  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 69
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 70  KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 128
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 129 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 188
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 189 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 248
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 249 KALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 81/271 (29%), Positives = 144/271 (53%), Gaps = 25/271 (9%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + HPNI+ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I+A             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              AK  I +LLVK++ KRL++Q+ + HPWI
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 82/263 (31%), Positives = 138/263 (52%), Gaps = 24/263 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSLR 77
           ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPN++ L+  + +   + LI E    GEL+  L +    TE++A  ++  + N + Y H 
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 138 NHVIHRDIKPEN-LLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN +LLD    + R+KI DFG +  +   ++   + GT +++APE+V  +
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 192
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI 236
                 D W++G++ Y  L GA PF  +++++T               F + SA AK  I
Sbjct: 193 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 252
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  KR+++Q  ++HPWI
Sbjct: 253 RRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  137 bits (344), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 21/260 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISRL 239
             VD W  G++ Y  L G PPF  E Q   +  I A               EAK LI  +
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 240 LVKDSSKRLSLQKIMEHPWI 259
           L  +  KR++  + ++ PWI
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  137 bits (344), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 21/260 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 65  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 124
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISRL 239
             VD W  G++ Y  L G PPF  E Q   +  I A               EAK LI  +
Sbjct: 185 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 244
Query: 240 LVKDSSKRLSLQKIMEHPWI 259
           L  +  KR++  + ++ PWI
Sbjct: 245 LTVNPKKRITADQALKVPWI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  137 bits (344), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 21/260 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQHP 65
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N 
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
           ++HR++KPENLLL  + +   +K+ DFG +++       H   GT  YL+PE+++   + 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISRL 239
             VD W  G++ Y  L G PPF  E Q   +  I A               EAK LI  +
Sbjct: 186 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 245
Query: 240 LVKDSSKRLSLQKIMEHPWI 259
           L  +  KR++  + ++ PWI
Sbjct: 246 LTVNPKKRITADQALKVPWI 265

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 135/260 (51%), Gaps = 22/260 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +++   LGKG F  V    +V +    A KII  +++   +   +L RE  I   L+HPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSA-RDHQKLEREARICRLLKHPN 82
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+  V
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 141 IHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEHD 194
           +HRD+KPENLLL  +     +K+ DFG +++   ++       GT  YL+PE++    + 
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISRL 239
             VD W  G++ Y  L G PPF  E Q   ++ I A               EAK LI+++
Sbjct: 203 KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 262
Query: 240 LVKDSSKRLSLQKIMEHPWI 259
           L  + SKR++  + ++HPWI
Sbjct: 263 LTINPSKRITAAEALKHPWI 282

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/259 (31%), Positives = 138/259 (53%), Gaps = 20/259 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FEI R +GKG FG+V +V++ ++K   A+K + K++  +      + +E++I   L HP 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ L+  F D+E +F++++    G+L   L+++  F E+    +I  L  AL Y     +
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKE---HDY 195
           IHRD+KP+N+LLD  G + I DF  +  +   ++  TM GT  Y+APEM  +++   + +
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSF 196
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKD------TFRSI--------SAEAKHLISRLLV 241
           AVD W+LG+  YE L G  P+   S         TF +         S E   L+ +LL 
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 242 KDSSKRLS-LQKIMEHPWI 259
            +  +R S L  +   P++
Sbjct: 257 PNPDQRFSQLSDVQNFPYM 275

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA++II K +      +       +  E+EI  
Sbjct: 150 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 209
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 210 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 268
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 269 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 328
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 329 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 388
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 389 KALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  135 bits (340), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 138/269 (51%), Gaps = 30/269 (11%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-----QLRREMEIQS 74
           ++ + + LG G  G V L  E ++   VA++II K +      +       +  E+EI  
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
            L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ Y
Sbjct: 196 KLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM-- 187
            HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE+  
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 188 -VENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----SQKDTFRS------------ISA 230
            V    ++ AVD W+LG++ +  L G PPF       S KD   S            +S 
Sbjct: 315 SVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 374
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           +A  L+ +LLV D   R + ++ + HPW+
Sbjct: 375 KALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  135 bits (339), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 131/264 (49%), Gaps = 17/264 (6%)
Query: 3   TKTAEREDNR--KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEK 59
           T T  + DN   +    L DF     LGKG FG+V L     +    A+KI+ K+  I+ 
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++  +  +  +    + P + +L+  F   +R++ ++EY + G+L   +++  RF E 
Sbjct: 62  DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTM 176
            A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG    ++         
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXF 181
Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------- 228
           CGT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+SI        
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 241
Query: 229 ---SAEAKHLISRLLVKDSSKRLS 249
              S EA  +   L+ K   KRL 
Sbjct: 242 KSMSKEAVAICKGLMTKHPGKRLG 265

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  134 bits (337), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 23/253 (9%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG+V+   E  +   +A KII   +    K + +++ E+ + + L H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHANLIQLYD 153
Query: 87  WFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            F     I L++EY   GEL+ R + +    TE     ++  +   + + H+ +++H D+
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 146 KPENLLLDHEG--RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWT 201
           KPEN+L  +    ++KI DFG +   + R K     GT ++LAPE+V      +  D W+
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 202 LGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISRLLVKDSSK 246
           +G++ Y  L G  PF  ++  +T               F+ IS EAK  IS+LL+K+ S 
Sbjct: 274 VGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSW 333
Query: 247 RLSLQKIMEHPWI 259
           R+S  + ++HPW+
Sbjct: 334 RISASEALKHPWL 346

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 141/266 (53%), Gaps = 22/266 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++++   +GKG F  V    ++ + H  A KII  +++   +   +L RE  I   L+H 
Sbjct: 5   EYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSA-RDHQKLEREARICRLLKHS 63
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  A+ +CH+  
Sbjct: 64  NIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 123
Query: 140 VIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKEH 193
           V+HRD+KPENLLL  + +   +K+ DFG +++ +  +       GT  YL+PE++  + +
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLISR 238
              VD W  G++ Y  L G PPF  E Q   ++ I A               EAK+LI++
Sbjct: 184 GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQ 243
Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           +L  + +KR++  + ++HPW+ + + 
Sbjct: 244 MLTINPAKRITAHEALKHPWVCQRST 269

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 143/280 (51%), Gaps = 39/280 (13%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILR 83
           +PLG+G F         +S    A+KII K      +++   ++E+  ++    HPNI++
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           L+  FHD    FL++E  + GEL+  ++K + F+E +A+  +  L +A+++ H+  V+HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 144 DIKPENLLLDHEG---RLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           D+KPENLL   E     +KI DFG++           T C TL Y APE++    +D + 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESC 190
Query: 198 DNWTLGILCYEFLYGAPPFEAES----------------------QKDTFRSISAEAKHL 235
           D W+LG++ Y  L G  PF++                        + + ++++S EAK L
Sbjct: 191 DLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIK----NANPRGTCDI 271
           I  LL  D +KRL +  +  + W+      ++NP  T DI
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDI 290

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  133 bits (335), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 136/262 (51%), Gaps = 22/262 (8%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +++++   LGKG F  V    +V +    A  II  +++     Q +L RE  I   L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 139 HVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVENKE 192
            V+HR++KPENLLL  +     +K+ DFG +++   ++       GT  YL+PE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHLIS 237
           +   VD W  G++ Y  L G PPF  E Q   ++ I A               EAK LI+
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
           ++L  + SKR++  + ++HPWI
Sbjct: 250 KMLTINPSKRITAAEALKHPWI 271

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 129/258 (50%), Gaps = 16/258 (6%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ-IEKYKIQHQ 65
           +   NR R   L DF     LGKG FG+V L     +    A+KI+ K+  I+   ++  
Sbjct: 330 DNNGNRDR-MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT 388
Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           +  +  +    + P + +L+  F   +R++ ++EY + G+L   +++  RF E  A  Y 
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYA 448
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW---SVQSRSKRHTMCGTLDY 182
           A +   L +     +I+RD+K +N++LD EG +KI DFG    ++         CGT DY
Sbjct: 449 AEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDY 508
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAE 231
           +APE++  + +  +VD W  G+L YE L G  PFE E + + F+SI           S E
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 568
Query: 232 AKHLISRLLVKDSSKRLS 249
           A  +   L+ K   KRL 
Sbjct: 569 AVAICKGLMTKHPGKRLG 586

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 136/256 (53%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V L RE  S   VA+K++    + K + +  L  E+ I    +H N++ +Y 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   E +++++E+   G L  ++    R  E+Q AT   ++  ALAY H   VIHRDIK
Sbjct: 110 SYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR  + GT  ++APE++    +   VD W+LG
Sbjct: 169 SDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+ ++S     +               +S   +  + R+LV+D  +R +
Sbjct: 229 IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
Query: 250 LQKIMEHPWIIKNANP 265
            Q++++HP++++   P
Sbjct: 289 AQELLDHPFLLQTGLP 304

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  132 bits (332), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I+A             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
              AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 142/269 (52%), Gaps = 28/269 (10%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           D+++   LGKG F    +VR    K P    A KII  +++   +   +L RE  I   L
Sbjct: 32  DYQLFEELGKGAFS---VVRRCVKKTPTQEYAAKIINTKKLSA-RDHQKLEREARICRLL 87
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++ + H
Sbjct: 88  KHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIH 147
Query: 137 ENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRHT---MCGTLDYLAPEMVEN 190
           ++ ++HRD+KPENLLL  + +   +K+ DFG +++ + ++       GT  YL+PE++  
Sbjct: 148 QHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA---------------EAKHL 235
             +   VD W  G++ Y  L G PPF  E Q   ++ I A               EAK+L
Sbjct: 208 DPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 267
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           I+++L  + +KR++  + ++HPW+ + + 
Sbjct: 268 INQMLTINPAKRITADQALKHPWVCQRST 296

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  132 bits (331), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 80/281 (28%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I+A             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
              AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I++             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
              AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I++             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
              AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 145/281 (51%), Gaps = 25/281 (8%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRRE 69
           ++  ++DF +IG  LG G+F  V   RE  +    A K I K Q    +    + ++ RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + I   + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + 
Sbjct: 66  VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYL 183
           + + Y H   + H D+KPEN++L  +      +K+ DFG +  ++   +   + GT +++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE------------ 231
           APE+V  +      D W++G++ Y  L GA PF  +++++T  +I++             
Sbjct: 186 APEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT 245
Query: 232 ---AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
              AK  I +LLVK++ KRL++Q+ + HPWI    N +   
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMV 286

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  130 bits (326), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 132/262 (50%), Gaps = 26/262 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F   R LG G FG V+LV E  S     +K I K++ +      Q+  E+E+  SL HPN
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPN 81
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALAYCH 136
           I++++  F D   +++++E    GEL   +     + +  +E   A  +  + NALAY H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 137 ENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENK 191
             HV+H+D+KPEN+L         +KI DFG +   +S  H+    GT  Y+APE V  +
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKR 200
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAES-----QKDTF---------RSISAEAKHLIS 237
           +  +  D W+ G++ Y  L G  PF   S     QK T+         R ++ +A  L+ 
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLK 260
Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
           ++L KD  +R S  +++ H W 
Sbjct: 261 QMLTKDPERRPSAAQVLHHEWF 282

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  127 bits (318), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I + L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINAMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 25/260 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHL 235
             Y    D W++G+  YE L G  PF A+S   T+                 IS EAK+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 236 ISRLLVKDSSKRLSLQKIME 255
           I   L  D   RL    + E
Sbjct: 313 ICAFLT-DREVRLGRNGVEE 331

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 25/260 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHL 235
             Y    D W++G+  YE L G  PF A+S   T+                 IS EAK+L
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 236 ISRLLVKDSSKRLSLQKIME 255
           I   L  D   RL    + E
Sbjct: 308 ICAFLT-DREVRLGRNGVEE 326

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 25/260 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +I +    
Sbjct: 74  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P +++L+  F DD  +++++EY   G+L   L  +    E+ A  Y A +  AL   H  
Sbjct: 134 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEMVENKEHD 194
             IHRD+KP+N+LLD  G LK+ DFG  ++   +    C    GT DY++PE+++++  D
Sbjct: 193 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 252
Query: 195 --YA--VDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHL 235
             Y    D W++G+  YE L G  PF A+S   T+                 IS EAK+L
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 312
Query: 236 ISRLLVKDSSKRLSLQKIME 255
           I   L  D   RL    + E
Sbjct: 313 ICAFLT-DREVRLGRNGVEE 331

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 61
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 242 KILVENPSARITIPDIKKDRW 262

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 139/274 (50%), Gaps = 28/274 (10%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R  +   +D+++ + +G+G FG V LVR   S+   A+K++ K ++ K         E +
Sbjct: 68  RGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERD 127
Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD+ +++++EY   G+L   L  +    E+ A  Y A +  A
Sbjct: 128 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLA 186
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC----GTLDYLAPEM 187
           L   H   +IHRD+KP+N+LLD  G LK+ DFG  ++        C    GT DY++PE+
Sbjct: 187 LDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEV 246
Query: 188 VENKEHD--YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------------I 228
           ++++  D  Y    D W++G+  +E L G  PF A+S   T+                 I
Sbjct: 247 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEI 306
Query: 229 SAEAKHLISRLLVKDSSKRL---SLQKIMEHPWI 259
           S  AK+LI   L  D   RL    +++I +HP+ 
Sbjct: 307 SKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFF 339

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 128/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S                + ++ I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 138/269 (51%), Gaps = 39/269 (14%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E+   +G G +          +    A+KII K + +  +         EI+  LR   
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---------EIEILLRYGQ 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+  + ++T  + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 138 NHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
             V+HRD+KP N+L +D  G    ++I DFG++ Q R++     T C T +++APE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER 194
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISAE 231
           + +D A D W+LG+L Y  L G  PF A    DT                   + S+S  
Sbjct: 195 QGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWII 260
           AK L+S++L  D  +RL+   ++ HPWI+
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 85  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 263
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 264 AAELLKHPFLAKAGPP 279

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  125 bits (315), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 89  SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 148 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 207
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 208 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 267
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 268 AAELLKHPFLAKAGPP 283

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 94  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 153 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 212
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 213 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 272
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 273 AAELLKHPFLAKAGPP 288

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  125 bits (314), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 96  SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 155 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 214
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 215 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 274
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 275 AAELLKHPFLAKAGPP 290

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 139 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 198 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 257
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 258 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 317
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 318 AAELLKHPFLAKAGPP 333

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 136/268 (50%), Gaps = 32/268 (11%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KPEN+LL   ++   +K+GDFG ++Q   S        GT  ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRSISAE 231
           E+V+ + +   VD W  G++ +  L G  PF    ++                +  IS  
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES 262
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  125 bits (313), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 128/260 (49%), Gaps = 25/260 (9%)
Query: 21  FEIGRPLGKGKFGRVY-LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++I   LG G FG V+  V +   +  VA  I     ++KY +++    E+ I + L HP
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN----EISIMNQLHHP 108
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            ++ L+  F D   + LILE+   GEL+ R   +  + +E +   Y+      L + HE+
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 139 HVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMVENKEHD 194
            ++H DIKPEN++ + +    +KI DFG + +            T ++ APE+V+ +   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQ---------------KDTFRSISAEAKHLISRL 239
           +  D W +G+L Y  L G  PF  E                 +D F S+S EAK  I  L
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 240 LVKDSSKRLSLQKIMEHPWI 259
           L K+  KRL++   +EHPW+
Sbjct: 289 LQKEPRKRLTVHDALEHPWL 308

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 130/256 (50%), Gaps = 21/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +     S   VA+K   K  + K + +  L  E+ I    +H N++ +Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVK---KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q A    ++  AL+  H   VIHRDIK
Sbjct: 216 SYLVGDELWVVMEFLEGGALT-DIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL H+GR+K+ DFG+  Q      +R  + GT  ++APE++    +   VD W+LG
Sbjct: 275 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLG 334
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      + I              S   K  + RLLV+D ++R +
Sbjct: 335 IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT 394
Query: 250 LQKIMEHPWIIKNANP 265
             ++++HP++ K   P
Sbjct: 395 AAELLKHPFLAKAGPP 410

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 126/250 (50%), Gaps = 26/250 (10%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E ++  +   
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F DD  ++L+++Y   G+L   L K   R  E+ A  Y+A +  A+   H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMVENKE- 192
            H +HRDIKP+N+L+D  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 193 ----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEA 232
               +    D W+LG+  YE LYG  PF AES  +T+                  +S  A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 233 KHLISRLLVK 242
           K LI RL+  
Sbjct: 314 KDLIRRLICS 323

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 140/290 (48%), Gaps = 52/290 (17%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME-IQSSLRHPNILRLY 85
           LG+G + +V     +++    A+KII K+       + ++ RE+E +     + NIL L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHS---RSRVFREVETLYQCQGNKNILELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F DD R +L+ E    G +   ++K + F E++A+  +  +  AL + H   + HRD+
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDF----------GWSVQSRSKRHTMCGTLDYLAPEMVE--- 189
           KPEN+L +   +   +KI DF            +  +  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFT 197
Query: 190 --NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRS----- 227
                +D   D W+LG++ Y  L G PPF      D                F S     
Sbjct: 198 DQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 257
Query: 228 ----------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG 267
                     IS+EAK LIS+LLV+D+ +RLS  ++++HPW+   A  +G
Sbjct: 258 YEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKG 307

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 132/256 (51%), Gaps = 22/256 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G  G V +  E  +   VA+K   K  + K + +  L  E+ I     H N++ +Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +   + +++++E+   G L  ++  H R  E+Q AT   S+  AL+Y H   VIHRDIK
Sbjct: 110 SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 147 PENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
            +++LL  +GR+K+ DFG+  Q      KR  + GT  ++APE++    +   VD W+LG
Sbjct: 169 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLG 228
Query: 204 ILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLVKDSSKRLS 249
           I+  E + G PP+  E      R I              S+  +  +  +LV++ S+R +
Sbjct: 229 IMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRAT 288
Query: 250 LQKIMEHPWIIKNANP 265
            Q+++ HP+ +K A P
Sbjct: 289 AQELLGHPF-LKLAGP 303

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  124 bits (311), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G  G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  124 bits (311), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 137/269 (50%), Gaps = 39/269 (14%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           +E+   +G G +          +    A+KII K + +  +         EI+  LR   
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTE---------EIEILLRYGQ 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+  + ++T  + Y H 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA 134
Query: 138 NHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVEN 190
             V+HRD+KP N+L +D  G    ++I DFG++ Q R++     T C T +++APE++E 
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLER 194
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISAE 231
           + +D A D W+LG+L Y  L G  PF A    DT                   + S+S  
Sbjct: 195 QGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDT 253
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWII 260
           AK L+S+ L  D  +RL+   ++ HPWI+
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 118/211 (55%), Gaps = 27/211 (12%)
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L   + D + ++L+ E    GEL  ++ + + F+E++A+  + ++   + Y H
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 137 ENHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
              V+HRD+KP N+L +D  G    L+I DFG++ Q R++     T C T +++APE+++
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISA 230
            + +D   D W+LGIL Y  L G  PF A    DT                   + ++S 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSE 257
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
            AK L+S++L  D  +RL+ +++++HPW+ +
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 118/211 (55%), Gaps = 27/211 (12%)
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L   + D + ++L+ E    GEL  ++ + + F+E++A+  + ++   + Y H
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLH 138
Query: 137 ENHVIHRDIKPENLL-LDHEGR---LKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
              V+HRD+KP N+L +D  G    L+I DFG++ Q R++     T C T +++APE+++
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLK 198
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISA 230
            + +D   D W+LGIL Y  L G  PF A    DT                   + ++S 
Sbjct: 199 RQGYDEGCDIWSLGILLYTMLAGYTPF-ANGPSDTPEEILTRIGSGKFTLSGGNWNTVSE 257
Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
            AK L+S++L  D  +RL+ +++++HPW+ +
Sbjct: 258 TAKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 63
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 244 KILVENPSARITIPDIKKDRW 264

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEIXINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 125/250 (50%), Gaps = 26/250 (10%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E ++  +   
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   +  E  A  YI  +  A+   H+
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 193
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 194 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEA 232
                    D W+LG+  YE LYG  PF AES  +T+                  +S EA
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 313
Query: 233 KHLISRLLVK 242
           K LI RL+  
Sbjct: 314 KDLIQRLICS 323

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 125/250 (50%), Gaps = 26/250 (10%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +DFEI + +G+G FG V +V+   ++   A+KI+ K ++ K       R E ++  +   
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             I  L+  F D+  ++L+++Y   G+L   L K   +  E  A  YI  +  A+   H+
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ 209
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLAPEMVENKEH 193
            H +HRDIKP+N+LLD  G +++ DFG  ++       +     GT DY++PE+++  E 
Sbjct: 210 LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 194 DYA-----VDNWTLGILCYEFLYGAPPFEAESQKDTF----------------RSISAEA 232
                    D W+LG+  YE LYG  PF AES  +T+                  +S EA
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEA 329
Query: 233 KHLISRLLVK 242
           K LI RL+  
Sbjct: 330 KDLIQRLICS 339

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 134/264 (50%), Gaps = 33/264 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKI-------IFKEQIEKYKIQHQLRREMEIQSSLR-H 78
           +G+G    V       + H  A+KI       +  EQ+E+  ++   RRE  I   +  H
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEE--VREATRRETHILRQVAGH 159
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P+I+ L   +     +FL+ +   +GEL+  L +    +E++  + + SL  A+++ H N
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE------N 190
           +++HRD+KPEN+LLD   ++++ DFG+S  ++   K   +CGT  YLAPE+++      +
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHL 235
             +   VD W  G++ +  L G+PPF    Q    R I               S+  K L
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWI 259
           ISRLL  D   RL+ ++ ++HP+ 
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFF 363

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  121 bits (304), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  121 bits (303), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 22/261 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  +          +++E+ I   L 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLN 62
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 63  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + M GTL Y+APE+++ +E
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTF----RSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S          +K T+    + I +    L+ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 242
Query: 238 RLLVKDSSKRLSLQKIMEHPW 258
           ++LV++ S R+++  I +  W
Sbjct: 243 KILVENPSARITIPDIKKDRW 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 132/252 (52%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG+  LV+  E      +K I   ++   K + + RRE+ + ++++HPNI++   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRE 90
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRD 144
            F ++  ++++++Y   G+L++ +   +   F E Q   +   +  AL + H+  ++HRD
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150
Query: 145 IKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC-GTLDYLAPEMVENKEHDYAVDNWT 201
           IK +N+ L  +G +++GDFG +  + S  +    C GT  YL+PE+ ENK ++   D W 
Sbjct: 151 IKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 202 LGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRLLVKDSSKRLS 249
           LG + YE       FEA S K+    I            S + + L+S+L  ++   R S
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 250 LQKIMEHPWIIK 261
           +  I+E  +I K
Sbjct: 271 VNSILEKGFIAK 282

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 53/291 (18%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY 85
           LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H   + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDFG----------WSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           KPEN+L +H  +   +KI DFG           S  S  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 193 -----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRS----- 227
                +D   D W+LG++ Y  L G PPF      D                F S     
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 228 ----------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 268
                     IS  AK LIS+LLV+D+ +RLS  ++++HPW ++   P  T
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW-VQGCAPENT 307

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI- 228
           E+V     +++ +DY  D W+LGI   E     PP             A+S+  T     
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 141/278 (50%), Gaps = 33/278 (11%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R +  GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI- 228
           E+V     +++ +DY  D W+LGI   E     PP             A+S+  T     
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  119 bits (297), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 140/278 (50%), Gaps = 33/278 (11%)
Query: 14  REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRRE 69
           R+ + +DF EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E
Sbjct: 31  RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV------E 84
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASL 128
           ++I +S  HPNI++L   F+ +  +++++E+   G +    L   R  TE Q        
Sbjct: 85  IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQT 144
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAP 185
            +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S ++     +R    GT  ++AP
Sbjct: 145 LDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204
Query: 186 EMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI- 228
           E+V     +++ +DY  D W+LGI   E     PP             A+S+  T     
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS 264
Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
             S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 265 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 302

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 120/252 (47%), Gaps = 16/252 (6%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G    VYL  +      VA+K IF    EK +   +  RE+   S L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ +     +D+  +L++EY     L   +  H   +   A  +   + + + + H+  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +HRDIKP+N+L+D    LKI DFG     S  S ++ + + GT+ Y +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH 256
            D +++GI+ YE L G PPF  E+      ++S   KH      ++DS   ++     + 
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKH------IQDSVPNVTTDVRKDI 240
Query: 257 PWIIKNANPRGT 268
           P  + N   R T
Sbjct: 241 PQSLSNVILRAT 252

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  118 bits (296), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 130/261 (49%), Gaps = 32/261 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 23/205 (11%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K  ++CGT  YLAPE++E   +D 
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKH 234
              Y   VD W+ G++ Y  L G+PPF    Q    R I               S   K 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
           L+SR LV    KR + ++ + HP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLI 236
             +D + D ++LG + ++ L G  PF     KD                 S S E + L+
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 237 SRLLVKDSSKRLSL-----QKIMEHPWI 259
             LL +D ++RL       Q++ E P+ 
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 244
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 364
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLI 236
             +D + D ++LG + ++ L G  PF     KD                 S S E + L+
Sbjct: 365 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 424
Query: 237 SRLLVKDSSKRLSL-----QKIMEHPWI 259
             LL +D ++RL       Q++ E P+ 
Sbjct: 425 EGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K   +CGT  YLAPE++E   +D 
Sbjct: 130 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKH 234
              Y   VD W+ G++ Y  L G+PPF    Q    R I               S   K 
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 249
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
           L+SR LV    KR + ++ + HP+ 
Sbjct: 250 LVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 88/291 (30%), Positives = 139/291 (47%), Gaps = 53/291 (18%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLY 85
           LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    + H N+L L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
            +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H   + HRD+
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
Query: 146 KPENLLLDHEGR---LKIGDF----------GWSVQSRSKRHTMCGTLDYLAPEMVENKE 192
           KPEN+L +H  +   +KI DF            S  S  +  T CG+ +Y+APE+VE   
Sbjct: 138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFS 197
Query: 193 -----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRS----- 227
                +D   D W+LG++ Y  L G PPF      D                F S     
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257
Query: 228 ----------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT 268
                     IS  AK LIS+LLV+D+ +RLS  ++++HPW ++   P  T
Sbjct: 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW-VQGCAPENT 307

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLI 236
             +D + D ++LG + ++ L G  PF     KD                 S S E + L+
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 237 SRLLVKDSSKRLSL-----QKIMEHPWI 259
             LL +D ++RL       Q++ E P+ 
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 134/268 (50%), Gaps = 26/268 (9%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL----RREMEI 72
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I K K    L    R  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSL 245
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
            + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++  
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 365
Query: 192 -EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------------SISAEAKHLI 236
             +D + D ++LG + ++ L G  PF     KD                 S S E + L+
Sbjct: 366 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL 425
Query: 237 SRLLVKDSSKRLSL-----QKIMEHPWI 259
             LL +D ++RL       Q++ E P+ 
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 133/268 (49%), Gaps = 32/268 (11%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++AP
Sbjct: 145 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 204
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRSISAE 231
           E+V+ + +   VD W  G++ +  L G  PF    ++                +  IS  
Sbjct: 205 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES 264
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 265 AKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   +   H+
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEMVENKEHD- 194
            +++HRD+KPEN+LLD +  +K+ DFG+S Q     K   +CGT  YLAPE++E   +D 
Sbjct: 143 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 195 ---YA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKH 234
              Y   VD W+ G++ Y  L G+PPF    Q    R I               S   K 
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKD 262
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
           L+SR LV    KR + ++ + HP+ 
Sbjct: 263 LVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 133/268 (49%), Gaps = 32/268 (11%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ-----HQLRREMEIQSS 75
           +E+   +GKG F  V      E+    A+KI+    + K+          L+RE  I   
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIV---DVAKFTSSPGLSTEDLKREASICHM 82
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           L+HP+I+ L   +  D  ++++ E+    +L  E+ K       ++E  A+ Y+  +  A
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAP 185
           L YCH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++AP
Sbjct: 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAP 202
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRSISAE 231
           E+V+ + +   VD W  G++ +  L G  PF    ++                +  IS  
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES 262
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           AK L+ R+L+ D ++R+++ + + HPW+
Sbjct: 263 AKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 127/257 (49%), Gaps = 23/257 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           F++   LG+G +G VY     E+   VA+K     Q+       ++ +E+ I      P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQQCDSPH 85
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENH 139
           +++ YG +  +  +++++EY   G +   +R +++  TE + AT + S    L Y H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            IHRDIK  N+LL+ EG  K+ DFG + Q     +KR+ + GT  ++APE+++   ++  
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCV 205
Query: 197 VDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI---SAEAKHLISRLLVK 242
            D W+LGI   E   G PP+              +   TFR     S      + + LVK
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265
Query: 243 DSSKRLSLQKIMEHPWI 259
              +R +  ++++HP++
Sbjct: 266 SPEQRATATQLLQHPFV 282

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 130/261 (49%), Gaps = 32/261 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HR+IK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +   VD
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 260 EKRGSAKELIQHQF-LKIAKP 279

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 32/261 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 258
Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  116 bits (290), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 7/207 (3%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNAL 132
            HPN+++ Y  F +D  + ++LE A  G+L R +    ++ R   E+    Y   L +AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVE 189
            + H   V+HRDIKP N+ +   G +K+GD G      SK    H++ GT  Y++PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPF 216
              +++  D W+LG L YE      PF
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPF 236

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 32/261 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVD 199
Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 200 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDV 259
Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 260 EKRGSAKELIQHQF-LKIAKP 279

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  115 bits (289), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 32/261 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-----RHPNI 81
           +G+G  G VY   +V +   VA++        +  +Q Q ++E+ I   L     ++PNI
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           +     +   + +++++EY   G L  ++       E Q A        AL + H N VI
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           HRDIK +N+LL  +G +K+ DFG+  Q    +SKR  M GT  ++APE+V  K +   VD
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVD 198
Query: 199 NWTLGILCYEFLYGAPPFEAES--------------QKDTFRSISAEAKHLISRLLVKDS 244
            W+LGI+  E + G PP+  E+              +      +SA  +  ++R L  D 
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDV 258
Query: 245 SKRLSLQKIMEHPWIIKNANP 265
            KR S +++++H + +K A P
Sbjct: 259 EKRGSAKELLQHQF-LKIAKP 278

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  115 bits (288), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 250
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 251 RPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 245
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 246 RPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 189
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 249
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 250 RPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 250
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 251 RPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 70
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 71  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 130
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 131 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 190
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 191 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 250
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 251 RPTFEEIQNHPWMQDVLLPQETAEI 275

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 70  SGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 129
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 130 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 189
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 190 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 249
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 250 RPTFEEIQNHPWMQDVLLPQETAEI 274

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 68
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 69  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 128
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 129 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 188
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 189 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 248
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 249 RPTFEEIQNHPWMQDVLLPQETAEI 273

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWCLALRPSD 245
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 246 RPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 264
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 265 RPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 135/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S+E +HLI   L    S 
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSD 265
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 266 RPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 26  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 86  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 145
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 205
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 206 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 260 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  115 bits (287), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 94  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 153
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 274 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 125
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 126 CHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S E +HLI   L    S 
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSD 245
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 246 RPTFEEIQNHPWMQDVLLPQETAEI 270

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 141/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 258
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 259 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  114 bits (286), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 122/252 (48%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S      + + YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSSYVTKYYG 88
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G     LR    F E Q AT +  +   L Y H    IHRDIK
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRAGP-FDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 148 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG 207
Query: 204 ILCYEFLYGAPP------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP                +        +   K  I   L KD S R + +
Sbjct: 208 ITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTAK 267
Query: 252 KIMEHPWIIKNA 263
           ++++H +I+KN+
Sbjct: 268 ELLKHKFIVKNS 279

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 25  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 84
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 85  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 144
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 145 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S E +HLI   L    S 
Sbjct: 205 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSD 264
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 265 RPTFEEIQNHPWMQDVLLPQETAEI 289

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  114 bits (286), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 94  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 153
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 213
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 214 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 273
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 274 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 317

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 92
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 93  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 152
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 153 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 212
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S E +HLI   L    S 
Sbjct: 213 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSD 272
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 273 RPTFEEIQNHPWMQDVLLPQETAEI 297

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 134/265 (50%), Gaps = 14/265 (5%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSS 75
           +++G  LG G FG VY    V    PVA+K + K++I  + ++ +  R  ME+    + S
Sbjct: 26  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 85
Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAY 134
                ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ +
Sbjct: 86  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 145
Query: 135 CHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NK 191
           CH   V+HRDIK EN+L+D + G LK+ DFG     +   +T   GT  Y  PE +  ++
Sbjct: 146 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHR 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSK 246
            H  +   W+LGIL Y+ + G  PFE + +    +  FR  +S E +HLI   L    S 
Sbjct: 206 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWCLALRPSD 265
Query: 247 RLSLQKIMEHPWIIKNANPRGTCDI 271
           R + ++I  HPW+     P+ T +I
Sbjct: 266 RPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  114 bits (285), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 80  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 139
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 140 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 199
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 200 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 259
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 260 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 303

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 79  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 138
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 139 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 198
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 199 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQR 258
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 259 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 302

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  114 bits (285), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 140/284 (49%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 39  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 98
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 99  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 158
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 218
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 219 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 278
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 279 VSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 322

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 119/251 (47%), Gaps = 26/251 (10%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY  R++ ++  +A+K I  E+  +Y     L  E+ +   L+H NI++  G
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHR 143
            F ++  I + +E    G L   LR      +  EQ    Y   +   L Y H+N ++HR
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 144 DIKPENLLLD-HEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDY--AV 197
           DIK +N+L++ + G LKI DFG S           T  GTL Y+APE+++     Y  A 
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 206
Query: 198 DNWTLGILCYEFLYGAPPFE--AESQKDTFR------------SISAEAKHLISRLLVKD 243
           D W+LG    E   G PPF    E Q   F+            S+SAEAK  I +    D
Sbjct: 207 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 266
Query: 244 SSKRLSLQKIM 254
             KR     ++
Sbjct: 267 PDKRACANDLL 277

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  114 bits (284), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 135/267 (50%), Gaps = 31/267 (11%)
Query: 20  DFEIGRP-LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           D+++ +  LG G  G+V       +    ALK+++     + ++ H      +       
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH----WQASGGPHI 84
Query: 79  PNILRLYGWFHDDERIFLI-LEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYC 135
             IL +Y   H  +R  LI +E    GEL+  +  R  + FTE++AA  +  +  A+ + 
Sbjct: 85  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
           H +++ HRD+KPENLL    + +  LK+ DFG++ + +++   T C T  Y+APE++  +
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE 204
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISAEA 232
           ++D + D W+LG++ Y  L G PPF + + +                     +  +S +A
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 264
Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWI 259
           K LI  LL  D ++RL++ + M HPWI
Sbjct: 265 KQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  114 bits (284), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/251 (32%), Positives = 119/251 (47%), Gaps = 26/251 (10%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LGKG +G VY  R++ ++  +A+K I  E+  +Y     L  E+ +   L+H NI++  G
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEI-PERDSRY--SQPLHEEIALHKHLKHKNIVQYLG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCHENHVIHR 143
            F ++  I + +E    G L   LR      +  EQ    Y   +   L Y H+N ++HR
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 132
Query: 144 DIKPENLLLD-HEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEHDY--AV 197
           DIK +N+L++ + G LKI DFG S           T  GTL Y+APE+++     Y  A 
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAA 192
Query: 198 DNWTLGILCYEFLYGAPPFE--AESQKDTFR------------SISAEAKHLISRLLVKD 243
           D W+LG    E   G PPF    E Q   F+            S+SAEAK  I +    D
Sbjct: 193 DIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPD 252
Query: 244 SSKRLSLQKIM 254
             KR     ++
Sbjct: 253 PDKRACANDLL 263

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/267 (28%), Positives = 135/267 (50%), Gaps = 31/267 (11%)
Query: 20  DFEIGRP-LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           D+++ +  LG G  G+V       +    ALK+++     + ++ H      +       
Sbjct: 10  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHH----WQASGGPHI 65
Query: 79  PNILRLYGWFHDDERIFLI-LEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYC 135
             IL +Y   H  +R  LI +E    GEL+  +  R  + FTE++AA  +  +  A+ + 
Sbjct: 66  VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 125
Query: 136 HENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENK 191
           H +++ HRD+KPENLL    + +  LK+ DFG++ + +++   T C T  Y+APE++  +
Sbjct: 126 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPE 185
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------------FRSISAEA 232
           ++D + D W+LG++ Y  L G PPF + + +                     +  +S +A
Sbjct: 186 KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA 245
Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWI 259
           K LI  LL  D ++RL++ + M HPWI
Sbjct: 246 KQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 93  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 152 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 211
Query: 204 ILCYEFLYGAPP-FEAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP  E    K  F            + S   K  +   L K+ S R + +
Sbjct: 212 ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 271
Query: 252 KIMEHPWIIKNA 263
           ++++H +I++NA
Sbjct: 272 ELLKHKFILRNA 283

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/252 (30%), Positives = 126/252 (50%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D   D W+LG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 204 ILCYEFLYGAPPF-EAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP  E    K  F            + S   K  +   L K+ S R + +
Sbjct: 192 ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 251
Query: 252 KIMEHPWIIKNA 263
           ++++H +I++NA
Sbjct: 252 ELLKHKFILRNA 263

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/238 (31%), Positives = 120/238 (50%), Gaps = 14/238 (5%)
Query: 12  RKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           R +E  LQ  DFEI + +G+G F  V +V+  ++    A+KI+ K  + K       R E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASL 128
            ++  +     I +L+  F D+  ++L++EY   G+L   L K   R   + A  Y+A +
Sbjct: 112 RDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS----KRHTMCGTLDYLA 184
             A+   H    +HRDIKP+N+LLD  G +++ DFG  ++ R+    +     GT DYL+
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 185 PEMVENKEHDYA-------VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL 235
           PE+++               D W LG+  YE  YG  PF A+S  +T+  I    +HL
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 139/284 (48%), Gaps = 14/284 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY- 60
           D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  + 
Sbjct: 7   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 61  KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIFLILEYAHR-GELYRELRKHRR 115
           ++ +  R  ME+    + S     ++RL  WF   +   LILE      +L+  + +   
Sbjct: 67  ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRH 174
             E+ A ++   +  A+ +CH   V+HRDIK EN+L+D + G LK+ DFG     +   +
Sbjct: 127 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY 186
Query: 175 T-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTFRS- 227
           T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + G  PFE + +    +  FR  
Sbjct: 187 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 246
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +S E +HLI   L      R + ++I  HPW+     P+ T +I
Sbjct: 247 VSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLPQETAEI 290

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 132/265 (49%), Gaps = 32/265 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCD 66
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G ++ D ++++++E+   G +    L   R  TE Q       +  AL + H
Sbjct: 67  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 126
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+L+  EG +++ DFG S   +++  KR +  GT  ++APE+V     
Sbjct: 127 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI---SAEAKH 234
           ++  +DY  D W+LGI   E     PP             A+S   T  +    S E + 
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 246
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
            +   L K+   R S  +++EHP++
Sbjct: 247 FLKIALDKNPETRPSAAQLLEHPFV 271

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 263 ANP 265
             P
Sbjct: 292 TKP 294

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 132/265 (49%), Gaps = 32/265 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLR 77
           +EI   LG G FG+VY  +  E+    A K+I    +E++E Y +      E+EI ++  
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV------EIEILATCD 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HP I++L G ++ D ++++++E+   G +    L   R  TE Q       +  AL + H
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV----- 188
              +IHRD+K  N+L+  EG +++ DFG S   +++  KR +  GT  ++APE+V     
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI---SAEAKH 234
           ++  +DY  D W+LGI   E     PP             A+S   T  +    S E + 
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
            +   L K+   R S  +++EHP++
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFV 279

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  112 bits (280), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 263 ANP 265
             P
Sbjct: 293 TKP 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 137/270 (50%), Gaps = 29/270 (10%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S   T  GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFRSI----SAE 231
           +PE +    ++   D W+LG L YE     PPF A SQK+         FR I    S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
              +I+R+L      R S+++I+E+P I++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  112 bits (279), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 124/259 (47%), Gaps = 21/259 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 83
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 84  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 143
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 203
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------------SAEAKHLISRLL 240
           D W++G+   E   G  P  + S       +                 S E +  +++ L
Sbjct: 204 DIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL 263
Query: 241 VKDSSKRLSLQKIMEHPWI 259
           +K+ ++R  L+++M H +I
Sbjct: 264 IKNPAERADLKQLMVHAFI 282

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 27/265 (10%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------------ISAEAKH 234
           D W++G+   E   G  P      K+  R                         S E + 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 244
Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
            +++ L+K+ ++R  L+++M H +I
Sbjct: 245 FVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  111 bits (278), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 180
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 61
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 62  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 121
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 122 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 181
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 182 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 241
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 242 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 284

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 76
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 77  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 136
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 137 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 196
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 197 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 256
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 257 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 299

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 106
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 68
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 69  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 128
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 129 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 188
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 189 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 248
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 249 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 291

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 66
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 67  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 126
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 127 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 186
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 187 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 246
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 247 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 289

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 112
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 113 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 172
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 173 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 232
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 233 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 292
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 293 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 335

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 67
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 68  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 127
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 128 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 187
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 188 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 247
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 248 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  111 bits (278), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 146/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 182
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 183 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 242
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 243 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 285

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 263 ANP 265
             P
Sbjct: 292 TKP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 63
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 115
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 116 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 174
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 234
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 235 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 294
Query: 263 ANP 265
             P
Sbjct: 295 TKP 297

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 263 ANP 265
             P
Sbjct: 292 TKP 294

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 263 ANP 265
             P
Sbjct: 293 TKP 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 263 ANP 265
             P
Sbjct: 291 TKP 293

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 263 ANP 265
             P
Sbjct: 294 TKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 263 ANP 265
             P
Sbjct: 293 TKP 295

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 263 ANP 265
             P
Sbjct: 294 TKP 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 263 ANP 265
             P
Sbjct: 291 TKP 293

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 45/288 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--------------------- 56
           L  + +   +GKG +G V L          A+K++ K++                     
Sbjct: 12  LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 57  --IEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK 112
             I+      Q+ +E+ I   L HPN+++L     D  ++ ++++ E  ++G +  E+  
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPT 130
Query: 113 HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---S 169
            +  +E QA  Y   L   + Y H   +IHRDIKP NLL+  +G +KI DFG S +   S
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 170 RSKRHTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAE------- 219
            +      GT  ++APE +      +   A+D W +G+  Y F++G  PF  E       
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 220 ---SQKDTF---RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
              SQ   F     I+ + K LI+R+L K+   R+ + +I  HPW+ +
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 263 ANP 265
             P
Sbjct: 291 TKP 293

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 73  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D   D W+LG
Sbjct: 132 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 191
Query: 204 ILCYEFLYGAPPF-EAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP  E    K  F            + S   K  +   L K+ S R + +
Sbjct: 192 ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 251
Query: 252 KIMEHPWIIKNA 263
           ++++H +I++NA
Sbjct: 252 ELLKHKFILRNA 263

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 140/296 (47%), Gaps = 64/296 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                       + + L+S++L  D +KR+S +  + HP+
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 286

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  110 bits (276), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 125/252 (49%), Gaps = 18/252 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG V+   +  ++  VA+KII  +  E       +++E+ + S    P + + YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H    IHRDIK
Sbjct: 88  SYLKDTKLWIIMEYLGGGSAL-DLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL   G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D   D W+LG
Sbjct: 147 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLG 206
Query: 204 ILCYEFLYGAPPF-EAESQKDTF-----------RSISAEAKHLISRLLVKDSSKRLSLQ 251
           I   E   G PP  E    K  F            + S   K  +   L K+ S R + +
Sbjct: 207 ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAK 266
Query: 252 KIMEHPWIIKNA 263
           ++++H +I++NA
Sbjct: 267 ELLKHKFILRNA 278

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 138/303 (45%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+          + F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ--------DLKDFMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 263 ANP 265
             P
Sbjct: 291 TKP 293

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 128/261 (49%), Gaps = 16/261 (6%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ------IEKYKIQHQLRREMEI 72
           Q +    PLG G FG V+   + E    V +K I KE+      IE  K+  ++  E+ I
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL-GKVTLEIAI 82
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNA 131
            S + H NI+++   F +     L++E    G +L+  + +H R  E  A+     L +A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPE-MV 188
           + Y     +IHRDIK EN+++  +  +K+ DFG +      +  +T CGT++Y APE ++
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPF-----EAESQKDTFRSISAEAKHLISRLLVKD 243
            N      ++ W+LG+  Y  ++   PF       E+       +S E   L+S LL   
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPV 262
Query: 244 SSKRLSLQKIMEHPWIIKNAN 264
             +R +L+K++  PW+ +  N
Sbjct: 263 PERRTTLEKLVTDPWVTQPVN 283

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  110 bits (276), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 137/295 (46%), Gaps = 48/295 (16%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+C
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN- 190
           H + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE++   
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLGC 181
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA---------------- 230
           K +  AVD W+LG +  E +     F  +S+ D     FR++                  
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 241
Query: 231 --------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                               + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 242 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 296

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  110 bits (275), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 140/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 60
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 112
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 113 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 171
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 231
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 232 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 291
Query: 263 ANP 265
             P
Sbjct: 292 TKP 294

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 140/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KPENLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 263 ANP 265
             P
Sbjct: 294 TKP 296

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 136/270 (50%), Gaps = 29/270 (10%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S      GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYM 183
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFRSI----SAE 231
           +PE +    ++   D W+LG L YE     PPF A SQK+         FR I    S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
              +I+R+L      R S+++I+E+P I++
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE ++  K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 264 NP 265
            P
Sbjct: 292 KP 293

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 140/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 1   GMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 59
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 111
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 112 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYR 170
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 230
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 231 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 290
Query: 263 ANP 265
             P
Sbjct: 291 TKP 293

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 145/283 (51%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 60
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 61  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 120
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTM--CGT 179
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S       C T
Sbjct: 121 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYT 180
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 181 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 240
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 241 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 283

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 264 NP 265
            P
Sbjct: 292 KP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 264 NP 265
            P
Sbjct: 291 KP 292

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE ++  K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 238
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 239 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298
Query: 264 NP 265
            P
Sbjct: 299 KP 300

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 264 NP 265
            P
Sbjct: 291 KP 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 264 NP 265
            P
Sbjct: 291 KP 292

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 9   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 67
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 68  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 119
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 178
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 238
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 239 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 298
Query: 264 NP 265
            P
Sbjct: 299 KP 300

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 6   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 64
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 116
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 175
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 236 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 295
Query: 264 NP 265
            P
Sbjct: 296 KP 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 3   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 61
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 113
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRA 172
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 233 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 292
Query: 264 NP 265
            P
Sbjct: 293 KP 294

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 113/212 (53%), Gaps = 18/212 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           +D W++G +  E + GAP F   S+ D    I
Sbjct: 182 IDIWSVGCIFAEMVNGAPLFPGVSEADQLMRI 213

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  108 bits (271), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 127/261 (48%), Gaps = 24/261 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LG+G+FG V+   E  SK     K +  +  +    Q  +++E+ I +  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
            NIL L+  F   E + +I E+    +++  +        E++  +Y+  +  AL + H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 138 NHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSKRH--TMCGTLDYLAPEMVENKEH 193
           +++ H DI+PEN++        +KI +FG + Q +   +   +    +Y APE+ ++   
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQK---------------DTFRSISAEAKHLISR 238
             A D W+LG L Y  L G  PF AE+ +               + F+ IS EA   + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
           LLVK+   R++  + ++HPW+
Sbjct: 241 LLVKERKSRMTASEALQHPWL 261

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 83/301 (27%), Positives = 139/301 (46%), Gaps = 64/301 (21%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASLT 129
           PNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQLL 112
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAP 185
             LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y AP
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 171
Query: 186 EMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA---------- 230
           E++   K +  AVD W+LG +  E +     F  +S+ D     FR++            
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 231 --------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
                                     + + L+S++L  D +KR+S +  + HP+      
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
Query: 265 P 265
           P
Sbjct: 292 P 292

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/294 (26%), Positives = 136/294 (46%), Gaps = 48/294 (16%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN-K 191
            + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y APE++   K
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCK 178
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA----------------- 230
            +  AVD W+LG +  E +     F  +S+ D     FR++                   
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 231 -------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                              + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 123/255 (48%), Gaps = 17/255 (6%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 67
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 68  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 127
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-RHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   +  +   GT  Y++PE ++   +    
Sbjct: 128 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGTHYSVQS 187
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTFRS----------ISAEAKHLISRLLVKDS 244
           D W++G+   E   G    PP       D   +           S E +  +++ L+K+ 
Sbjct: 188 DIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNP 247
Query: 245 SKRLSLQKIMEHPWI 259
           ++R  L+++M H +I
Sbjct: 248 AERADLKQLMVHAFI 262

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 140/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              L++CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 264 NP 265
            P
Sbjct: 292 KP 293

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/275 (28%), Positives = 136/275 (49%), Gaps = 32/275 (11%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           FE+   +G G +G+VY  R V++    A+K++     E+ +I+ ++     ++    H N
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINM---LKKYSHHRN 82
Query: 81  ILRLYGWFHD------DERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNAL 132
           I   YG F        D++++L++E+   G +   ++  K     E+  A     +   L
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
           ++ H++ VIHRDIK +N+LL     +K+ DFG S Q   +  +R+T  GT  ++APE++ 
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 190 NKE-----HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTF------------RSISAE 231
             E     +D+  D W+LGI   E   GAPP  +    +  F            +  S +
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 262
Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
            +  I   LVK+ S+R + +++M+HP+I    N R
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNER 297

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 112/212 (52%), Gaps = 18/212 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           +D W++G +  E + G P F   S+ D    I
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 137/273 (50%), Gaps = 35/273 (12%)
Query: 19  QDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +D+E+   +G G +GR   +R + + K  V  ++ +    E  K    L  E+ +   L+
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK--QMLVSEVNLLRELK 63
Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIAS-LTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K    R++ +++    + + LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------MCGTL 180
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +   R   H         GT 
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA---RILNHDEDFAKEFVGTP 180
Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------TFRSI---- 228
            Y++PE +    ++   D W+LG L YE     PPF A SQK+         FR I    
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
           S E   +I+R+L      R S+++I+E+P I++
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 139/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VAL  I +   E   +     RE+ +   L 
Sbjct: 2   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 60
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 112
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 171
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 232 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 291
Query: 264 NP 265
            P
Sbjct: 292 KP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 139/302 (46%), Gaps = 64/302 (21%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VAL  I +   E   +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELN 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIASL 128
           HPNI++L    H + +++L+ E+ H+     +L+K   F +  A T         Y+  L
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKK---FMDASALTGIPLPLIKSYLFQL 111
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLA 184
              LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y A
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRA 170
Query: 185 PEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA--------- 230
           PE++   K +  AVD W+LG +  E +     F  +S+ D     FR++           
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 231 ---------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                                      + + L+S++L  D +KR+S +  + HP+     
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 264 NP 265
            P
Sbjct: 291 KP 292

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 140/303 (46%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+  +     +L+K   F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQ-----DLKK---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 263 ANP 265
             P
Sbjct: 294 TKP 296

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  107 bits (268), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 112/212 (52%), Gaps = 18/212 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+H NI++LY 
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-----QAATYIASLTNALAYCHENHVI 141
             H  +R+ L+ E+     L ++L+K     E       A +++  L N +AYCH+  V+
Sbjct: 68  VIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K++   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMGSKKYSTT 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           +D W++G +  E + G P F   S+ D    I
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+L+     +K+ DFG       S  S  +   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 125/268 (46%), Gaps = 16/268 (5%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREM 70
           + RE    ++ +G  LGKG FG V+    +  +  VA+K+I + ++  +  +   +   +
Sbjct: 24  KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 71  EIQ------SSLRHPNILRLYGWFHDDERIFLILEYAHRGE-LYRELRKHRRFTEQQAAT 123
           E+       +   HP ++RL  WF   E   L+LE     + L+  + +     E  +  
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRSKRHT-MCGTLD 181
           +   +  A+ +CH   V+HRDIK EN+L+D   G  K+ DFG       + +T   GT  
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203
Query: 182 YLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFE-----AESQKDTFRSISAEAKHL 235
           Y  PE +   + H      W+LGIL Y+ + G  PFE      E++      +S +   L
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCAL 263
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           I R L    S R SL++I+  PW+   A
Sbjct: 264 IRRCLAPKPSSRPSLEEILLDPWMQTPA 291

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  107 bits (267), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 61
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+    F +  A T         Y+  
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKD---FMDASALTGIPLPLIKSYLFQ 113
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 114 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 172
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 232
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 233 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 292
Query: 263 ANP 265
             P
Sbjct: 293 TKP 295

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  107 bits (266), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 100/192 (52%), Gaps = 6/192 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +GKG FG VY   +  +K  VA+KII  +  E       +++E+ + S    P I R +G
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
            +    ++++I+EY   G    +L K     E   AT +  +   L Y H    IHRDIK
Sbjct: 85  SYLKSTKLWIIMEYLGGGSAL-DLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 147 PENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLG 203
             N+LL  +G +K+ DFG + Q   ++ KR+   GT  ++APE+++   +D+  D W+LG
Sbjct: 144 AANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLG 203
Query: 204 ILCYEFLYGAPP 215
           I   E   G PP
Sbjct: 204 ITAIELAKGEPP 215

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 139/303 (45%), Gaps = 64/303 (21%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+++F+    +G+G +G VY  R   +   VALK I +   E   +     RE+ +   L
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKEL 62
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---------YIAS 127
            HPNI++L    H + +++L+ E+     L  +L+    F +  A T         Y+  
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEF-----LSMDLKD---FMDASALTGIPLPLIKSYLFQ 114
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYL 183
           L   LA+CH + V+HRD+KP+NLL++ EG +K+ DFG    + V  R+  H +  TL Y 
Sbjct: 115 LLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYR 173
Query: 184 APEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TFRSISA-------- 230
           APE++   K +  AVD W+LG +  E +     F  +S+ D     FR++          
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 233
Query: 231 ----------------------------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                                       + + L+S++L  D +KR+S +  + HP+    
Sbjct: 234 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 293
Query: 263 ANP 265
             P
Sbjct: 294 TKP 296

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 10/210 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + H
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 150
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGW------SVQSRSKRHTMCGTLDYLAPEMVEN 190
           +N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE    
Sbjct: 151 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              D   D ++LG + YE L G PPF  +S
Sbjct: 211 DSVDARSDVYSLGCVLYEVLTGEPPFTGDS 240

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 137/287 (47%), Gaps = 52/287 (18%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  ++ + +  VALK I +   E   I     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+CH++ ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +K++  +VD W
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIW 204
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRSISA------------------------------ 230
           ++G +  E + G P F   +  D    I +                              
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKK 264
Query: 231 -----------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
                      E   L+S +L  D +KR+S +  M HP+  K+ +P+
Sbjct: 265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDPQ 310

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 137/287 (47%), Gaps = 52/287 (18%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G VY  ++ + +  VALK I +   E   I     RE+ +   L HPNI+ L  
Sbjct: 29  VGEGTYGVVYKAKDSQGRI-VALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
             H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+CH++ ++HRD+
Sbjct: 87  VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDL 145
Query: 146 KPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNW 200
           KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +K++  +VD W
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIW 204
Query: 201 TLGILCYEFLYGAPPFEAESQKDTFRSISA------------------------------ 230
           ++G +  E + G P F   +  D    I +                              
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKK 264
Query: 231 -----------EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
                      E   L+S +L  D +KR+S +  M HP+  K+ +P+
Sbjct: 265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY-FKDLDPQ 310

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  104 bits (260), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 126
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 127 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 186
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 187 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 246
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 247 DIWSMGLSLVEMAVGRYPIPPPDAKE 272

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  104 bits (259), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 64
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKE 210

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  104 bits (259), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 4/206 (1%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 91
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 92  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 211
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 212 DIWSMGLSLVEMAVGRYPIPPPDAKE 237

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  103 bits (258), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 179 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 201 TLGILCYEFLYGAPPF 216
           +LGI C E     PP 
Sbjct: 238 SLGITCIELAERKPPL 253

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRHPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHR 143
            G +  +   +L++EY   G     L  H++   E + A         LAY H +++IHR
Sbjct: 81  RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHDYAVDNW 200
           D+K  N+LL   G +K+GDFG S    +  +   GT  ++APE++   +  ++D  VD W
Sbjct: 140 DVKAGNILLSEPGLVKLGDFG-SASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198
Query: 201 TLGILCYEFLYGAPPF 216
           +LGI C E     PP 
Sbjct: 199 SLGITCIELAERKPPL 214

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  103 bits (257), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 7/211 (3%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V  V+   S   +A K+I  E   K  I++Q+ RE+++      P
Sbjct: 17  DFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSP 74
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L++ +R  E+       ++   LAY  E H
Sbjct: 75  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y+APE ++   +    
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQGTHYSVQS 194
Query: 198 DNWTLGILCYEFLYG---APPFEAESQKDTF 225
           D W++G+   E   G    PP +A+  +  F
Sbjct: 195 DIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 140/283 (49%), Gaps = 40/283 (14%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK +        +   + RRE+E
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXL--------QDCPKARREVE 106
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + ++ E    GEL+  +  R  + FTE++A+  
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRH--TMCGT 179
             S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T
Sbjct: 167 XKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 226
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAES 220
             Y+APE++  +++D + D W+LG++ Y  L G PPF                   + E 
Sbjct: 227 PYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEF 286
Query: 221 QKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
               +  +S E K LI  LL  + ++R ++ +   HPWI ++ 
Sbjct: 287 PNPEWSEVSEEVKXLIRNLLKTEPTQRXTITEFXNHPWIXQST 329

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  103 bits (256), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 32/263 (12%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKE---QIEKYKIQHQLRREMEIQSSLRHPN 80
            + LG+GKF  V       +    A K + K    Q  + +I H++   +E+  S   P 
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAV-LELAKSC--PR 90
Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYR----ELRKHRRFTEQQAATYIASLTNALAYCH 136
           ++ L+  + +   I LILEYA  GE++     EL +    +E      I  +   + Y H
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE--MVSENDVIRLIKQILEGVYYLH 148
Query: 137 ENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENK 191
           +N+++H D+KP+N+LL      G +KI DFG S  +    +   + GT +YLAPE++   
Sbjct: 149 QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD 208
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------DTFRSISAEAKHLI 236
               A D W +GI+ Y  L    PF  E  +               +TF S+S  A   I
Sbjct: 209 PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268
Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
             LLVK+  KR + +  + H W+
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWL 291

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 128/296 (43%), Gaps = 42/296 (14%)
Query: 9   EDNRKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ED+    WS+   D+E+   +G G    V        K  VA+K I  E+ +      +L
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDEL 60
Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR--------KHRRFTE 118
            +E++  S   HPNI+  Y  F   + ++L+++    G +   ++        K     E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRS 171
              AT +  +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S         +R+
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 172 K-RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPF------------- 216
           K R T  GT  ++APE++E  + +D+  D W+ GI   E   GA P+             
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240
Query: 217 --------EAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
                        K+  +      + +IS  L KD  KR +  +++ H +  K  N
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  100 bits (250), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 130/301 (43%), Gaps = 68/301 (22%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRL 84
           +G+G +G V +  E +++   A+KI+ K +I +   K   +++ E+ +   L HPNI RL
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 85  YGWFHDDERIFLILEYAHRGELYREL---------------------------------- 110
           Y  + D++ I L++E  H G L  +L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 111 ----RKHRRFT--EQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGD 162
               R+   F   E+  +  +  + +AL Y H   + HRDIKPEN L   +    +K+ D
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVD 213
Query: 163 FGWSVQSRSKRH-------TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGA 213
           FG S +     +       T  GT  ++APE++      Y    D W+ G+L +  L GA
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
Query: 214 PPFEAESQKDT---------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            PF   +  DT               +  +S  A+ L+S LL ++  +R    + ++HPW
Sbjct: 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 259 I 259
           I
Sbjct: 334 I 334

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 124/245 (50%), Gaps = 14/245 (5%)
Query: 41  VESKHPVALKIIFKEQIEKY-KIQHQLRREMEI----QSSLRHPNILRLYGWFHDDERIF 95
           V    PVA+K + K++I  + ++ +  R  ME+    + S     ++RL  WF   +   
Sbjct: 73  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 132
Query: 96  LILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD- 153
           LILE      +L+  + +     E+ A ++   +  A+ +CH   V+HRDIK EN+L+D 
Sbjct: 133 LILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 192
Query: 154 HEGRLKIGDFGWSVQSRSKRHT-MCGTLDYLAPEMVE-NKEHDYAVDNWTLGILCYEFLY 211
           + G LK+ DFG     +   +T   GT  Y  PE +  ++ H  +   W+LGIL Y+ + 
Sbjct: 193 NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 252
Query: 212 GAPPFEAESQ----KDTFRS-ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           G  PFE + +    +  FR  +S+E +HLI   L    S R + ++I  HPW+     P+
Sbjct: 253 GDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 312
Query: 267 GTCDI 271
            T +I
Sbjct: 313 ETAEI 317

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 24/261 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 85  YGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +       F E +A  Y A +   L   H   +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++ D W
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 201 TLGILCYEFLYGAPPFEAESQK---------------DTFRSISAEAKHLISRLLVKDSS 245
            LG L YE + G  PF+   +K               +     S +A+ L S+LL KD +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429
Query: 246 KRL-----SLQKIMEHPWIIK 261
           +RL     S +++ EHP   K
Sbjct: 430 ERLGCRGGSAREVKEHPLFKK 450

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 99.8 bits (247), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 125/261 (47%), Gaps = 24/261 (9%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R LGKG FG V   +   +    A K + K++I+K K +     E +I   +    ++ L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 85  YGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
              +   + + L+L   + G+L   +       F E +A  Y A +   L   H   +++
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLAPEMVENKEHDYAVDNW 200
           RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+V+N+ + ++ D W
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369
Query: 201 TLGILCYEFLYGAPPFEAESQK---------------DTFRSISAEAKHLISRLLVKDSS 245
            LG L YE + G  PF+   +K               +     S +A+ L S+LL KD +
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPA 429
Query: 246 KRL-----SLQKIMEHPWIIK 261
           +RL     S +++ EHP   K
Sbjct: 430 ERLGCRGGSAREVKEHPLFKK 450

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +    +  +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFAFPQIKAHPW 267

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 42/286 (14%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           WS+   D+E+   +G G    V        K  VA+K I  E+ +      +L +E++  
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS--MDELLKEIQAM 62
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELR--------KHRRFTEQQAATYI 125
           S   HPNI+  Y  F   + ++L+++    G +   ++        K     E   AT +
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSK-RHTMC 177
             +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S         +R+K R T  
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 178 GTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPF-------------------- 216
           GT  ++APE++E  + +D+  D W+ GI   E   GA P+                    
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 217 -EAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
                 K+  +      + +IS  L KD  KR +  +++ H +  K
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
           +  +E+D++VD + LG+  YE +    PF A  +K   + +               S  +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 233 KHLISRLLVKDSSKRLSLQ 251
           K     LL KD  KRL  +
Sbjct: 421 KDFCEALLQKDPEKRLGFR 439

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
           +  +E+D++VD + LG+  YE +    PF A  +K   + +               S  +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 233 KHLISRLLVKDSSKRLSLQ 251
           K     LL KD  KRL  +
Sbjct: 421 KDFCEALLQKDPEKRLGFR 439

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
           +  +E+D++VD + LG+  YE +    PF A  +K   + +               S  +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 233 KHLISRLLVKDSSKRLSLQ 251
           K     LL KD  KRL  +
Sbjct: 421 KDFCEALLQKDPEKRLGFR 439

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 127/259 (49%), Gaps = 26/259 (10%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +W L DF   R LG+G FG V+  +   +    A K + K++++K K       E +I +
Sbjct: 185 DWFL-DF---RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIASLTN 130
            +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A + +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEM 187
            L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++APE+
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
           +  +E+D++VD + LG+  YE +    PF A  +K   + +               S  +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPAS 420
Query: 233 KHLISRLLVKDSSKRLSLQ 251
           K     LL KD  KRL  +
Sbjct: 421 KDFCEALLQKDPEKRLGFR 439

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 28  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 79
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 80  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 136
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 137 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 197 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 255
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 256 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 286

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 13  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 64
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 65  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 121
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 122 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 182 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 240
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 241 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 271

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 21  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 72
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 73  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 129
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 190 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 249 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 279

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 17  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 68
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 69  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 125
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 126 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 186 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 244
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 245 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 275

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 43  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 94
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 95  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 212 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 271 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 301

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +    +  +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFAFPQIKAHPW 267

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 267

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 21  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 72
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 73  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 129
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 130 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 190 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 248
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 249 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 279

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 267

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 10  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 61
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 62  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 118
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 119 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 179 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 237
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 238 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 268

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 14  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 65
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 66  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 122
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 123 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 183 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 241
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 242 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 272

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 88  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 139
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 140 --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 196
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 197 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 257 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 315
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 316 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 346

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 22  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 73
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 74  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 130
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 131 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 191 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 249
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 250 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 280

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 5/226 (2%)
Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +E    +G+G +G V   R  ++   VA+K  F E  +   ++    RE+++   L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKK-FLESDDDKMVKKIAMREIKLLKQL 81
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RH N++ L       +R +L+ E+     L            Q    Y+  + N + +CH
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPE-MVENKE 192
            +++IHRDIKPEN+L+   G +K+ DFG++    +          T  Y APE +V + +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK 201
Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISR 238
           +  AVD W +G L  E   G P F  +S  D    I     +LI R
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 45  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 96
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 97  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 153
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 154 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 214 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 272
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 273 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 303

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 43  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 94
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 95  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 151
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 212 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 270
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 271 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 301

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 37  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 88
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 89  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 145
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 146 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 206 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 264
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 265 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 295

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 267

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 128/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 47  TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 98
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 99  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 155
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 156 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215
Query: 171 SKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 216 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 274
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 275 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 305

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 125/273 (45%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + + +  K     
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK----- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D+  + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSYICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 267

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 5   TAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
           T  +  +R +E S  D ++   +G G FG VY  +  +S   VA+K + +++  ++K   
Sbjct: 9   TPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFK--- 60
Query: 65  QLRREMEIQSSLRHPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTE 118
              RE++I   L H NI+RL  +F+      D   + L+L+Y     +YR  R + R  +
Sbjct: 61  --NRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPE-TVYRVARHYSRAKQ 117
Query: 119 QQAATYIA----SLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS---VQSR 170
                Y+      L  +LAY H   + HRDIKP+NLLLD +   LK+ DFG +   V+  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 171 SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----TF 225
                +C    Y APE++    ++  ++D W+ G +  E L G P F  +S  D      
Sbjct: 178 PNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236
Query: 226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           + +    +  I  +    +       +I  HPW
Sbjct: 237 KVLGTPTREQIREM--NPNYTEFKFPQIKAHPW 267

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 94.0 bits (232), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +G VY   +  +   VA+K I  E  E+  +     RE+ +   L+H NI+ L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
             H + R+ LI EYA   +L + + K+   + +   +++  L N + +CH    +HRD+K
Sbjct: 101 VIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLK 159
Query: 147 PENLLL-----DHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEH-DYA 196
           P+NLLL          LKIGDFG    + +  R   H +  TL Y  PE++    H   +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTS 218
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           VD W++  +  E L   P F  +S+ D    I
Sbjct: 219 VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI 250

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 11/211 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G +  VY      +   VALK +  +  E         RE+ +   L+H NI+RLY 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYD 70
Query: 87  WFHDDERIFLILEYAHRG-ELY---RELRKHRRFTEQQAATYIA-SLTNALAYCHENHVI 141
             H + ++ L+ E+     + Y   R +    R  E     Y    L   LA+CHEN ++
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL 130
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAV 197
           HRD+KP+NLL++  G+LK+GDFG +       +T      TL Y AP+ ++ ++ +  ++
Sbjct: 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           D W+ G +  E + G P F   + ++  + I
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 6/221 (2%)
Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           +IG+ +G+G +G V+  R  ++   VA+K  F E  +   I+    RE+ +   L+HPN+
Sbjct: 7   KIGK-IGEGSYGVVFKCRNRDTGQIVAIK-KFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVI 141
           + L   F    R+ L+ EY     L+   R  R   E    +       A+ +CH+++ I
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAV 197
           HRD+KPEN+L+     +K+ DFG++               T  Y +PE +V + ++   V
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPV 184
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISR 238
           D W +G +  E L G P +  +S  D    I      LI R
Sbjct: 185 DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 73/242 (30%), Positives = 119/242 (49%), Gaps = 33/242 (13%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           D KT E     +RE +  + ++   +G G FG V+  + VES   VA+K + +++  ++K
Sbjct: 31  DGKTGE-----QREIAYTNCKV---IGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFK 79
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDD----ERIFL--ILEYAHRGELYRELRKHRR 115
                 RE++I   ++HPN++ L  +F+ +    + +FL  +LEY     +YR  R + +
Sbjct: 80  -----NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAK 133
Query: 116 FTEQQAAT----YIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWS---V 167
             +         Y+  L  +LAY H   + HRDIKP+NLLLD   G LK+ DFG +   +
Sbjct: 134 LKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
Query: 168 QSRSKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR 226
                   +C    Y APE++     +   +D W+ G +  E + G P F  ES  D   
Sbjct: 194 AGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252
Query: 227 SI 228
            I
Sbjct: 253 EI 254

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DFG S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 135/281 (48%), Gaps = 57/281 (20%)
Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 62
Query: 72  IQ-SSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATY 124
           +   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSKRHTMCGTLD 181
           + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++  ++        
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK-------- 174
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-------------------EAESQK 222
                      +D + D W+LG++ Y  L G PPF                   + E   
Sbjct: 175 -----------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 223
Query: 223 DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
             +  +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 112/228 (49%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DFG S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+   LG G FG V      ++   VA+K   +E   K + +  L  E++I   L HPN
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 74
Query: 81  ILRL------YGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNA 131
           ++              ++   L +EY   G+L + L +        E    T ++ +++A
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 134
Query: 132 LAYCHENHVIHRDIKPENLLLD-HEGRL--KIGDFGWSVQSRSKRHTMC----GTLDYLA 184
           L Y HEN +IHRD+KPEN++L     RL  KI D G++      +  +C    GTL YLA
Sbjct: 135 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTEFVGTLQYLA 192
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           PE++E K++   VD W+ G L +E + G  PF
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+   LG G FG V      ++   VA+K   +E   K + +  L  E++I   L HPN
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL--EIQIMKKLNHPN 73
Query: 81  ILRL------YGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNA 131
           ++              ++   L +EY   G+L + L +        E    T ++ +++A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 132 LAYCHENHVIHRDIKPENLLLD-HEGRL--KIGDFGWSVQSRSKRHTMC----GTLDYLA 184
           L Y HEN +IHRD+KPEN++L     RL  KI D G++      +  +C    GTL YLA
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA--KELDQGELCTEFVGTLQYLA 191
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           PE++E K++   VD W+ G L +E + G  PF
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 131/268 (48%), Gaps = 24/268 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEIQSSLRHP 79
           + +G  LG+G +G+V  V + E+    A+KI+ K+++ +    +  +++E+++   LRH 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 80  NILRLYGWFHDDER--IFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           N+++L    +++E+  +++++EY   G  E+   +   +RF   QA  Y   L + L Y 
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVEN 190
           H   ++H+DIKP NLLL   G LKI   G +       +     T  G+  +  PE+   
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEA-----------KHLIS 237
            +    + VD W+ G+  Y    G  PFE ++    F +I   +             L+ 
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLK 245
Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            +L  + +KR S+++I +H W  K   P
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 33/262 (12%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++ E+   +G+G FG V        K     K +  +QIE    +     E+   S + H
Sbjct: 9   KEIEVEEVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 61
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
           PNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY 
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 136 HENH---VIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E  
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGS 179
Query: 192 EHDYAVDNWTLGILCYEFL--------YGAPPFEA------ESQKDTFRSISAEAKHLIS 237
            +    D ++ GI+ +E +         G P F         ++    +++    + L++
Sbjct: 180 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 239
Query: 238 RLLVKDSSKRLSLQ---KIMEH 256
           R   KD S+R S++   KIM H
Sbjct: 240 RCWSKDPSQRPSMEEIVKIMTH 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/262 (27%), Positives = 120/262 (45%), Gaps = 33/262 (12%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           ++ E+   +G+G FG V        K     K +  +QIE    +     E+   S + H
Sbjct: 8   KEIEVEEVVGRGAFGVV-------CKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYC 135
           PNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY 
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 136 HENH---VIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E  
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGS 178
Query: 192 EHDYAVDNWTLGILCYEFL--------YGAPPFEA------ESQKDTFRSISAEAKHLIS 237
            +    D ++ GI+ +E +         G P F         ++    +++    + L++
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMT 238
Query: 238 RLLVKDSSKRLSLQ---KIMEH 256
           R   KD S+R S++   KIM H
Sbjct: 239 RCWSKDPSQRPSMEEIVKIMTH 260

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 24/228 (10%)
Query: 12  RKREWSLQDFEIG--RPLGKGKFGRVYLVREVESKHPVALKIIF-------KEQIEKYKI 62
           + R  +L D EI   + +GKG FG V+  R V+ K  VA+K +         E IEK++ 
Sbjct: 10  KSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQ- 68
Query: 63  QHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQA 121
             + +RE+ I S+L HPNI++LYG  H+  R  +++E+   G+LY R L K         
Sbjct: 69  --EFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 122 ATYIASLTNALAYCHENH--VIHRDIKPENLL---LDHEGRL--KIGDFGWSVQSRSKRH 174
              +  +   + Y    +  ++HRD++  N+    LD    +  K+ DF  S QS     
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVS 184
Query: 175 TMCGTLDYLAPEMVENKEHDYA--VDNWTLGILCYEFLYGAPPFEAES 220
            + G   ++APE +  +E  Y    D ++  ++ Y  L G  PF+  S
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK--IIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           G  LGKG FG+   V   E+   + +K  I F E+      Q    +E+++   L HPN+
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEET-----QRTFLKEVKVMRCLEHPNV 69
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHV 140
           L+  G  + D+R+  I EY   G L   ++    ++   Q  ++   + + +AY H  ++
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI 129
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS-----------------VQSRSKRHTMCGTLDYL 183
           IHRD+   N L+     + + DFG +                    R KR+T+ G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL 210
           APEM+  + +D  VD ++ GI+  E +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 105/224 (46%), Gaps = 11/224 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D  I   +G G FG V+  R       VA+KI+ ++     ++   LR E+ I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCH 136
           NI+   G       + ++ EY  RG LYR L K     +  E++  +    +   + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 137 ENH--VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENK 191
             +  ++HRD+K  NLL+D +  +K+ DFG S    S         GT +++APE++ ++
Sbjct: 155 NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL 235
             +   D ++ G++ +E      P+   +      ++  + K L
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 52/284 (18%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +P+G G +G V    +  +   VA+K +++   +      +  RE+ +   +RH N++ L
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGL 89
Query: 85  YGWFHDDERI------FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
              F  DE +      +L++ +   G    +L KH +  E +    +  +   L Y H  
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA 147
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAV 197
            +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T  Y APE++ N   +   V
Sbjct: 148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTV 207
Query: 198 DNWTLGILCYEFL---------------------YGAPPFE-----------------AE 219
           D W++G +  E +                      G PP E                  E
Sbjct: 208 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 267
Query: 220 SQKDTFRSI----SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            +K  F SI    S  A +L+ ++LV D+ +R++  + + HP+ 
Sbjct: 268 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G +  VY  +   + + VALK I  E  E         RE+ +   L+H NI+ L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLKHANIVTLHD 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNALAYCHENHVI 141
             H ++ + L+ EY     L ++L+++               ++  L   LAYCH   V+
Sbjct: 68  IIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVL 122
Query: 142 HRDIKPENLLLDHEGRLKIGDFGW----SVQSRSKRHTMCGTLDYLAPE-MVENKEHDYA 196
           HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + ++   
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYSTQ 181
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLL 240
           +D W +G + YE   G P F          S   E  H I R+L
Sbjct: 182 IDMWGVGCIFYEMATGRPLFPG--------STVEEQLHFIFRIL 217

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 11/224 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D  I   +G G FG V+  R       VA+KI+ ++     ++   LR E+ I   LRHP
Sbjct: 38  DLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLR-EVAIMKRLRHP 94
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLTNALAYCH 136
           NI+   G       + ++ EY  RG LYR L K     +  E++  +    +   + Y H
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 137 ENH--VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMCGTLDYLAPEMVENK 191
             +  ++HR++K  NLL+D +  +K+ DFG S    S      +  GT +++APE++ ++
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL 235
             +   D ++ G++ +E      P+   +      ++  + K L
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRL 258

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 42/274 (15%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR-EMEIQSSL 76
           + D E    +G G  G+V+ +R  ++ H +A+K     Q+ +   + + +R  M++   L
Sbjct: 24  INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK-----QMRRSGNKEENKRILMDLDVVL 78
Query: 77  RH---PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNA 131
           +    P I++ +G F  +  +F+ +E    G    +L+K  +    E+       ++  A
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 132 LAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEM 187
           L Y  E H VIHRD+KP N+LLD  G++K+ DFG S   V  ++K  +  G   Y+APE 
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPER 195
Query: 188 VE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------- 226
           ++       ++D   D W+LGI   E   G  P+  ++ K  F                 
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPPLLPGH 253
Query: 227 -SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              S + +  +   L KD  KR    K++EH +I
Sbjct: 254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EXSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 18/222 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           H NI+RL+   H D+++ L+ E+  +     +L+K+          +   +++  L   L
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMV 188
            +CH  +V+HRD+KP+NLL++  G LK+ DFG    + +  R     +  TL Y  P+++
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 189 EN-KEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              K +  ++D W+ G +  E    A P F      D  + I
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRI 215

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 117/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    ++T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 8/209 (3%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHPNILRL 84
           LG+G+F  VY  R+  +   VA+K I      + K  I     RE+++   L HPNI+ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
              F     I L+ ++                T      Y+      L Y H++ ++HRD
Sbjct: 78  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137
Query: 145 IKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDN 199
           +KP NLLLD  G LK+ DFG    +   +R+  H +  T  Y APE++   + +   VD 
Sbjct: 138 LKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMYGVGVDM 196
Query: 200 WTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           W +G +  E L   P    +S  D    I
Sbjct: 197 WAVGCILAELLLRVPFLPGDSDLDQLTRI 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 69  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 129 D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 245 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 304
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 305 PYPGIPVEELFK 316

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEK 59
           M + T + E  R+R       E+GR +G+G+FG V+    +  ++P +A+ I   +    
Sbjct: 26  MGSSTRDYEIQRER------IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 79
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++ +  +E        HP+I++L G   ++  +++I+E    GEL R   + R+++  
Sbjct: 80  DSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLD 137
Query: 120 QAAT--YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
            A+   Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 138 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 197
Query: 176 MCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
             G L   ++APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 113/236 (47%), Gaps = 16/236 (6%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEK 59
           M + T + E  R+R       E+GR +G+G+FG V+    +  ++P +A+ I   +    
Sbjct: 3   MGSSTRDYEIQRER------IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS 56
Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
             ++ +  +E        HP+I++L G   ++  +++I+E    GEL R   + R+++  
Sbjct: 57  DSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLD 114
Query: 120 QAAT--YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
            A+   Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 174
Query: 176 MCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
             G L   ++APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S     T     + GT  Y+APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL 207
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 208 RG-EITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 12  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 71
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 72  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 129
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 130 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 187
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 188 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 247
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 248 PYPGIPVEELFK 259

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 36  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 94  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 147
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S     T     + GT  Y+APE +
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL 207
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 208 RG-EITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 15  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 74
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 75  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 132
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 133 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 190
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 191 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 250
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 251 PYPGIPVEELFK 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 10  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 69
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 70  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 127
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 128 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLTARNVLVTENNVMKI 185
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 186 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 245
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 246 PYPGIPVEELFK 257

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 10/226 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRRE 69
            R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIAS 127
                   HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y   
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQ 499
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYL 183
           L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 32/239 (13%)
Query: 19  QDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG+V+L     +   + K  VA+K +    +   K     +RE E+ 
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELL 71
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFT 117
           ++L+H +I++ YG   D + + ++ EY   G+L + LR H                    
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RS 171
             Q     + + + + Y    H +HRD+   N L+     +KIGDFG S  V S    R 
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
             HTM   + ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I+
Sbjct: 192 GGHTML-PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 249

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 110/222 (49%), Gaps = 18/222 (8%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATYIASLTNAL 132
           H NI+RL+   H D+++ L+ E+  +     +L+K+          +   +++  L   L
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMV 188
            +CH  +V+HRD+KP+NLL++  G LK+ +FG    + +  R     +  TL Y  P+++
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 173
Query: 189 EN-KEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
              K +  ++D W+ G +  E    G P F      D  + I
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     ++I
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMRI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 140/302 (46%), Gaps = 66/302 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +   V +KI+  + ++K KI    +RE++I 
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKNKI----KREIKIL 85
Query: 74  SSLRH-PNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +LR  PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  
Sbjct: 86  ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILK 142
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE- 186
           AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE 
Sbjct: 143 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 202
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------ 216
           +V+ + +DY++D W+LG +    ++   PF                              
Sbjct: 203 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 262
Query: 217 -----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHP 257
                         S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP
Sbjct: 263 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 322
Query: 258 WI 259
           + 
Sbjct: 323 YF 324

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 10/226 (4%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRRE 69
            R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E
Sbjct: 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIAS 127
                   HP+I++L G   ++  +++I+E    GEL R   + R+F+   A+   Y   
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQ 499
Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTL--DYL 183
           L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM 559
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  E+
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 1   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ 60
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 61  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 118
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 178
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 179 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 107/255 (41%), Gaps = 17/255 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K +W L  +D  +G  +G+G FG V+  R       VA+K   +E +    ++ +  +E 
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPP-DLKAKFLQEA 163
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G     + I++++E    G+    LR    R   +     +    
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLA 184
             + Y      IHRD+   N L+  +  LKI DFG S +     +   G L      + A
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA 283
Query: 185 PEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKD 243
           PE +    +    D W+ GIL +E F  GA P+   S + T R    +   L    L  D
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-REFVEKGGRLPCPELCPD 342
Query: 244 SSKRLSLQKIMEHPW 258
           +  RL     ME  W
Sbjct: 343 AVFRL-----MEQCW 352

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 3   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 62
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 63  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 120
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 180
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 181 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 108/227 (47%), Gaps = 10/227 (4%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRR 68
             R  E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +
Sbjct: 4   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 63
Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIA 126
           E        HP+I++L G   ++  +++I+E    GEL R   + R+++   A+   Y  
Sbjct: 64  EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAY 121
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--Y 182
            L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +      G L   +
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 181
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           +APE +  +    A D W  G+  +E L +G  PF+     D    I
Sbjct: 182 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 28  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 87
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 147
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 148 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 207
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 208 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 10/216 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E        HP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT--YIASLTNALAYCHE 137
           +I++L G   ++  +++I+E    GEL R   + R+++   A+   Y   L+ ALAY   
Sbjct: 69  HIVKLIGVITENP-VWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD--YLAPEMVENKEH 193
              +HRDI   N+L+     +K+GDFG S  ++  +      G L   ++APE +  +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
             A D W  G+  +E L +G  PF+     D    I
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+ YA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 104/228 (45%), Gaps = 25/228 (10%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNI 81
           R LG+G FG+V+L  E  +  P   KI+   +  K      +    RE E+ ++L+H +I
Sbjct: 19  RELGEGAFGKVFLA-ECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASL 128
           ++ YG   + + + ++ EY   G+L + LR H                T+ Q       +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----RSKRHTMCGTLDY 182
              + Y    H +HRD+   N L+     +KIGDFG S  V S    R   HTM   + +
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML-PIRW 196
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           + PE +  ++     D W+LG++ +E F YG  P+   S  +    I+
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 38  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 97
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 157
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 158 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 217
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 218 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 261

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 33/286 (11%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           +D+K      N+  E    D E    LG+G +G V  +R V S   +A+K I        
Sbjct: 33  LDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA----TV 88
Query: 61  KIQHQLRREMEIQSSLRH---PNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHR 114
             Q Q R  M++  S+R    P  +  YG    +  +++ +E       + Y++ + K +
Sbjct: 89  NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQ 148
Query: 115 RFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSR 170
              E        S+  AL + H    VIHRD+KP N+L++  G++K+ DFG S   V S 
Sbjct: 149 TIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV 208
Query: 171 SKRHTMCGTLDYLAPEMV--ENKEHDYAV--DNWTLGILCYE-----FLYGA--PPF--- 216
           +K     G   Y+APE +  E  +  Y+V  D W+LGI   E     F Y +   PF   
Sbjct: 209 AKTID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 267
Query: 217 ----EAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
               E  S +      SAE     S+ L K+S +R +  ++M+HP+
Sbjct: 268 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 313

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 115/252 (45%), Gaps = 36/252 (14%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V +   V  +   P     VA+K++  +  EK
Sbjct: 23  ELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---- 114
                 L  EME+   + +H NI+ L G    D  +++I+ YA +G L   LR  R    
Sbjct: 83  D--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGM 140
Query: 115 -------RFTEQQ-------AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI 160
                  R  E+Q       + TY   L   + Y      IHRD+   N+L+     +KI
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
Query: 161 GDFGWSVQSRS---KRHTMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
            DFG +    +    + T  G L   ++APE + ++ + +  D W+ G+L +E F  G  
Sbjct: 199 ADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 258
Query: 215 PFEAESQKDTFR 226
           P+     ++ F+
Sbjct: 259 PYPGIPVEELFK 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 106/255 (41%), Gaps = 17/255 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K +W L  +D  +G  +G+G FG V+  R       VA+K   +E +    ++ +  +E 
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPP-DLKAKFLQEA 163
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G     + I++++E    G+    LR    R   +     +    
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAA 223
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL-----DYLA 184
             + Y      IHRD+   N L+  +  LKI DFG S +         G L      + A
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTA 283
Query: 185 PEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKD 243
           PE +    +    D W+ GIL +E F  GA P+   S + T R    +   L    L  D
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT-REFVEKGGRLPCPELCPD 342
Query: 244 SSKRLSLQKIMEHPW 258
           +  RL     ME  W
Sbjct: 343 AVFRL-----MEQCW 352

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G  +G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 30  GNKMGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 87
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 88  ELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA------NGIN 141
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S           + GT  Y+APE +
Sbjct: 142 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL 201
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 202 RG-EITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
             +   +D W+LG +  E L G P    E + D    +         +LL  D+SKR
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL--DASKR 328

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 109/237 (45%), Gaps = 17/237 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
             +   +D W+LG +  E L G P    E + D    +         +LL  D+SKR
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL--DASKR 328

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG +        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 125/311 (40%), Gaps = 59/311 (18%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 16  RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 75
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 76  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALS 129
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGA----------------------- 213
            T  Y APE++ N  H +  VD W++G +  E L G                        
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS 249
Query: 214 -------------------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                              PP   +     FR  +  A  L+ R+LV DS +R+S  + +
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 255 EHPWIIKNANP 265
            H +  +  +P
Sbjct: 310 AHAYFSQYHDP 320

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 26/230 (11%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRV---------YLVREVESKHPVALKIIFKEQIEKYKI 62
           ++++  + D+ I R L +GKF ++         Y +++ E       +   K   +K  I
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISI 83
Query: 63  QHQ---LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRG------ELYRELRKH 113
           + +    + E++I + +++   L   G   + + +++I EY          E +  L K+
Sbjct: 84  KSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 114 RR--FTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
                  Q     I S+ N+ +Y H E ++ HRD+KP N+L+D  GR+K+ DFG S    
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 171 SKRHTMC-GTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPF 216
            K+     GT +++ PE   N E  Y    VD W+LGI  Y   Y   PF
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 28/229 (12%)
Query: 27  LGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG+G F  V LV  +   H  ALK I+  EQ ++ + Q    RE ++     HPNILRL 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ----READMHRLFNHPNILRLV 92
Query: 86  GWFHDD----ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHE 137
            +   +       +L+L +  RG L+ E+     K    TE Q    +  +   L   H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS----RSKRHTMC--------GTLDYLAP 185
               HRD+KP N+LL  EG+  + D G   Q+       R  +          T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 186 EMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAE 231
           E+   + H   D   D W+LG + Y  ++G  P++   QK    +++ +
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ EY   G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG          +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 56/261 (21%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E S + + +G+ LG G FG V  V ++ES    ALK + ++   +YK      RE++I  
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD--PRYK-----NRELDIMK 55
Query: 75  SLRHPNILRLYGWFH-------------DDER-------------------------IFL 96
            L H NI++L  +F+             DD                           + +
Sbjct: 56  VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 97  ILEYA----HRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL 152
           I+EY     H+  L   +R  R       + YI  L  A+ + H   + HRDIKP+NLL+
Sbjct: 116 IMEYVPDTLHK-VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
Query: 153 DH-EGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCY 207
           +  +  LK+ DFG +   + S      +C    Y APE M+   E+  ++D W++G +  
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-YRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 208 EFLYGAPPFEAESQKDTFRSI 228
           E + G P F  E+  D    I
Sbjct: 234 ELILGKPLFSGETSIDQLVRI 254

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 125/311 (40%), Gaps = 59/311 (18%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 16  RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 75
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 76  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALS 129
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV 189
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGA----------------------- 213
            T  Y APE++ N  H +  VD W++G +  E L G                        
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS 249
Query: 214 -------------------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                              PP   +     FR  +  A  L+ R+LV DS +R+S  + +
Sbjct: 250 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 309
Query: 255 EHPWIIKNANP 265
            H +  +  +P
Sbjct: 310 AHAYFSQYHDP 320

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 6   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 61
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 62  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 120
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 121 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 180
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   ++  + +  D +  GI+ YE + G  P+   + +D
Sbjct: 181 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 220

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 111/230 (48%), Gaps = 13/230 (5%)
Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M+   A +++  +  W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA 230
Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFT 117
           +         E  + + LRH N+++L G   +++  ++++ EY  +G L   LR   R  
Sbjct: 231 Q-----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285
Query: 118 EQQAATYIASL--TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                    SL    A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345
Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
               + + APE +  K+     D W+ GIL +E + +G  P+     KD 
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 395

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDL 129
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +    RL          + +IM H W
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL------ASTHVYQIMNHCW 241

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/311 (23%), Positives = 125/311 (40%), Gaps = 59/311 (18%)
Query: 8   REDNRKREWSL-QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           R++  K  W + Q  +  RP+G G +G V    +   +  VA+K +   F+  I   +  
Sbjct: 8   RQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTY 67
Query: 64  HQLRREMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFT 117
               RE+ +   L+H N++ L   F       D   ++L+      G     + K +  +
Sbjct: 68  ----RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALS 121
Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
           ++     +  L   L Y H   +IHRD+KP N+ ++ +  L+I DFG + Q+  +     
Sbjct: 122 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV 181
Query: 178 GTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGA----------------------- 213
            T  Y APE++ N  H +  VD W++G +  E L G                        
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPS 241
Query: 214 -------------------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                              PP   +     FR  +  A  L+ R+LV DS +R+S  + +
Sbjct: 242 PEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEAL 301
Query: 255 EHPWIIKNANP 265
            H +  +  +P
Sbjct: 302 AHAYFSQYHDP 312

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 108/234 (46%), Gaps = 35/234 (14%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQH 64
           ED    ++  +  +  R LGKG FG V + R    +  +   VA+K          K+QH
Sbjct: 3   EDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQH 52
Query: 65  Q-------LRREMEIQSSLRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR- 114
                     RE+EI  SL+H NI++  G  +   R  + LI+E+   G L   L+KH+ 
Sbjct: 53  STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKE 112
Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKR 173
           R    +   Y + +   + Y      IHRD+   N+L+++E R+KIGDFG + V  + K 
Sbjct: 113 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172
Query: 174 HTMC-----GTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
                      + + APE +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 173 XXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 15  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 129
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 130 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +      L K       + +IM H W
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLASTHVYQIMNHCW 241

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQHQLRREMEIQSSLRHPNILRLY 85
           +G G FG+VY  R       VA+K    +  E   +    +R+E ++ + L+HPNI+ L 
Sbjct: 15  IGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH---VIH 142
           G    +  + L++E+A  G L R L   +R        +   +   + Y H+     +IH
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 143 RDIKPENLLL-------DHEGR-LKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEH 193
           RD+K  N+L+       D   + LKI DFG + +  R+ + +  G   ++APE++     
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMF 191
Query: 194 DYAVDNWTLGILCYEFLYGAPPF 216
               D W+ G+L +E L G  PF
Sbjct: 192 SKGSDVWSYGVLLWELLTGEVPF 214

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 18  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 133 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +      L K       + +IM H W
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLASTHVYQIMNHCW 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 11  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 70
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 130
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 131 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 190
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 191 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 234

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 98
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 99  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 218
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 74
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 75  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 134
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 135 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 194
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 195 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 230

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 70
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 130
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 35  IGSGQFGLVHLGYWL-NKDKVAIKTIKEGSMS----EDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 149
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 209
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +      L K       + +IM H W
Sbjct: 210 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLASTHVYQIMNHCW 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 66
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 67  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 126
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 127 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 186
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 222

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 72
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 73  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 132
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 133 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 192
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 193 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 228

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 71
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 72  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 131
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 132 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 191
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 192 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 227

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 65
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 66  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 125
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 126 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 185
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 221

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 73
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 74  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 133
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 134 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 193
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 194 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 229

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 110/230 (47%), Gaps = 13/230 (5%)
Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M    A +++  +  W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATA 58
Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFT 117
           +         E  + + LRH N+++L G   +++  ++++ EY  +G L   LR   R  
Sbjct: 59  Q-----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113
Query: 118 EQQAATYIASL--TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                    SL    A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173
Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
               + + APE +  K+     D W+ GIL +E + +G  P+     KD 
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/314 (23%), Positives = 130/314 (41%), Gaps = 59/314 (18%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-I 62
           T  R++  K  W + + ++   P+G G +G V    +V+S     LKI  K+    ++ I
Sbjct: 36  TFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKS----GLKIAVKKLSRPFQSI 91
Query: 63  QHQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHR 114
            H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K +
Sbjct: 92  IHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQ 149
Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH 174
           + T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +  
Sbjct: 150 KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 209
Query: 175 TMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEF---------------------LYG 212
               T  Y APE++ N  H +  VD W++G +  E                      L G
Sbjct: 210 GYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTG 269
Query: 213 APPFEAESQ---------------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQ 251
            PP    S+                      D F   +  A  L+ ++LV D+ KR++  
Sbjct: 270 TPPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITAS 329
Query: 252 KIMEHPWIIKNANP 265
           + + HP+  +  +P
Sbjct: 330 EALAHPYFSQYHDP 343

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 17/237 (7%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154
Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K++   F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +    +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRFYRAPEVILG 273
Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
             +   +D W+LG +  E L G P    E + D    +         +LL  D+SKR
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLL--DASKR 328

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 32/234 (13%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKR 173
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG +     +    K 
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
                 + ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 13  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +      L K       + +IM H W
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLASTHVYQIMNHCW 239

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E    +  I + +G G+FG V   R ++ SK  +++ I   +     K +     E  I
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASI 99
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPNI+RL G     + + ++ E    G L   LRKH  +FT  Q    +  + + 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S        +   T  G +   + +P
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E +  ++   A D W+ GI+ +E + YG  P+   S +D  +++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 39/261 (14%)
Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           M    A   D R R+  +  F++ R  G+G FG V L +E  +   VA+K +    I+  
Sbjct: 6   MSLNAAAAADERSRK-EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDP 60
Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFH-----DDERIFL--ILEYAHRGELYRELRKH 113
           + +++  + M+  + L HPNI++L  +F+     D   I+L  ++EY     L+R  R +
Sbjct: 61  RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNY 119
Query: 114 RRFTEQQAA-------TYIASLTNALAYCH--ENHVIHRDIKPENLLLDH-EGRLKIGDF 163
            R   +Q A        ++  L  ++   H    +V HRDIKP N+L++  +G LK+ DF
Sbjct: 120 YR---RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
Query: 164 GWSVQ---SRSKRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           G + +   S      +C    Y APE++  N+ +  AVD W++G +  E + G P F  +
Sbjct: 177 GSAKKLSPSEPNVAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235
Query: 220 SQKDTFRSISAEAKHLISRLL 240
           +        SA   H I R+L
Sbjct: 236 N--------SAGQLHEIVRVL 248

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 85
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 85
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 86  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 145
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 146 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 205
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 241

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 17/238 (7%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G G+FG V+L   + +K  VA+K I +  +     +     E E+   L HP +++LYG
Sbjct: 16  IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDI 145
              +   I L+ E+   G L   LR  R  F  +        +   +AY  E  VIHRD+
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEHDYAVDNWT 201
              N L+     +K+ DFG +      ++T   GT   + + +PE+     +    D W+
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 202 LGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            G+L +E F  G  P+E  S  +    IS   +      L K       + +IM H W
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------LYKPRLASTHVYQIMNHCW 242

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 73
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 74  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   ++  + +  D +  GI+ YE + G  P+   + +D
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 67
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 68  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 18  DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 73
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E +    IA  T   
Sbjct: 74  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 133 MDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   ++  + +  D +  GI+ YE + G  P+   + +D
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 12  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 24  GRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           G   G+G FG VY  +   +   VA+K +     I   +++ Q  +E+++ +  +H N++
Sbjct: 27  GNKXGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLV 84
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRK---------HRRFTEQQAATYIASLTNALA 133
            L G+  D + + L+  Y   G L   L           H R    Q A       N + 
Sbjct: 85  ELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAA------NGIN 138
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMV 188
           + HENH IHRDIK  N+LLD     KI DFG +  S           + GT  Y APE +
Sbjct: 139 FLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL 198
Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
              E     D ++ G++  E + G P  +
Sbjct: 199 RG-EITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMC----GTLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 27/212 (12%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+    +G G FG+V+     ++KH +  K    +++ KY    +  RE++  + L H 
Sbjct: 12  DFKEIELIGSGGFGQVF-----KAKHRIDGKTYVIKRV-KYN-NEKAEREVKALAKLDHV 64
Query: 80  NILRLYGWF----HDDER------------IFLILEYAHRGEL--YRELRKHRRFTEQQA 121
           NI+   G +    +D E             +F+ +E+  +G L  + E R+  +  +  A
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCGT 179
                 +T  + Y H   +I+RD+KP N+ L    ++KIGDFG   S+++  KR    GT
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLY 211
           L Y++PE + ++++   VD + LG++  E L+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 18  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 12  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 69  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 127
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 128 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 187
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--SVQSRSKRHTMCG----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG   ++      + M         + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 8   KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 65  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCG-----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG      ++  H +          + AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 183
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 98/231 (42%), Gaps = 18/231 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP------VALKIIFKEQIEKYKIQHQLRREMEI 72
           +D  +   LG G FG   +VR  E   P      VA+K +  + + + +      RE+  
Sbjct: 18  KDLRLLEKLGDGSFG---VVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
             SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   
Sbjct: 75  MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-WSVQSRSKRHTMCG-----TLDYLAP 185
           + Y      IHRD+   NLLL     +KIGDFG      ++  H +          + AP
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAP 193
Query: 186 EMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAKHL 235
           E ++ +   +A D W  G+  +E F YG  P+   +       I  E + L
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 244

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 11/236 (4%)
Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKY 60
           D   A RE  ++ + S    +I + +G G+FG V   R +V  K  + + I   +     
Sbjct: 14  DPNQAVREFAKEIDASC--IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTD 71
Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQ 119
           K +     E  I     HPNI+ L G     + + +I EY   G L   LRK+  RFT  
Sbjct: 72  KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI 131
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHT 175
           Q    +  + + + Y  +   +HRD+   N+L++     K+ DFG S        +   T
Sbjct: 132 QLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTT 191
Query: 176 MCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
             G +   + APE +  ++   A D W+ GI+ +E + YG  P+   S +D  ++I
Sbjct: 192 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 24  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 81
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 82  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 141
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 142 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 198
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 255

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 120/296 (40%), Gaps = 71/296 (23%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVMLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+ +EY   G LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 220 SQK----DTFRSISAE------------AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            ++       RS+S E             K +I  L+  D +KR   + ++   W+
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 68
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+KH+ R    +   Y + +   +
Sbjct: 69  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGM 128
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHR++   N+L+++E R+KIGDFG + V  + K +          + + APE
Sbjct: 129 EYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPE 188
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 224

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 25  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 82
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 83  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 142
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 143 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 199
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 256

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 74
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 134
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 191
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 21  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 78
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 79  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 138
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 139 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 195
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 252

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 129/293 (44%), Gaps = 50/293 (17%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+    +G G FG+V+     ++KH +  K     ++ KY    +  RE++  + L H 
Sbjct: 13  DFKEIELIGSGGFGQVF-----KAKHRIDGKTYVIRRV-KYN-NEKAEREVKALAKLDHV 65
Query: 80  NILRLYGWF------------------HDDER-----------IFLILEYAHRGEL--YR 108
           NI+   G +                  +D E            +F+ +E+  +G L  + 
Sbjct: 66  NIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI 125
Query: 109 ELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW--S 166
           E R+  +  +  A      +T  + Y H   +IHRD+KP N+ L    ++KIGDFG   S
Sbjct: 126 EKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTF 225
           +++  KR    GTL Y++PE + ++++   VD + LG++  E L+     FE        
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 245
Query: 226 RS------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA---NPRGTC 269
           R          + K L+ +LL K    R +  +I+    + K +   N R TC
Sbjct: 246 RDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERHTC 298

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 109/227 (48%), Gaps = 27/227 (11%)
Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R+R   L ++E G  +G+G +G VY  +  + K      +   +QIE   I     RE+ 
Sbjct: 15  RERVEDLFEYE-GCKVGRGTYGHVYKAKRKDGKDDKDYAL---KQIEGTGISMSACREIA 70
Query: 72  IQSSLRHPNILRLYGWF--HDDERIFLILEYAHRGELYRELRKHR---------RFTEQQ 120
           +   L+HPN++ L   F  H D +++L+ +YA   +L+  ++ HR         +     
Sbjct: 71  LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGM 129
Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDFGWS------VQSR 170
             + +  + + + Y H N V+HRD+KP N+L+  E    GR+KI D G++      ++  
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 171 SKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPF 216
           +    +  T  Y APE++    H   A+D W +G +  E L   P F
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 17/231 (7%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 20  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 75
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 76  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 133
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    
Sbjct: 134 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 193
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 9/224 (4%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +E      +I R +G G+FG V   R ++  K  VA+ I   +     K +     E  I
Sbjct: 38  KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASI 97
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
                HPN++ L G     + + +++E+   G L   LRKH  +FT  Q    +  +   
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAP 185
           + Y  +   +HRD+   N+L++     K+ DFG S          +T  G    + + AP
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAP 217
Query: 186 EMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           E ++ ++   A D W+ GI+ +E + YG  P+   S +D  ++I
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 261

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 9/217 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +I + +G G+FG V   R +V  K  + + I   +     K +     E  I     HP
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + +I EY   G L   LRK+  RFT  Q    +  + + + Y  + 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
              A D W+ GI+ +E + YG  P+   S +D  ++I
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 232

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 111/231 (48%), Gaps = 17/231 (7%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 19  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 74
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 75  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 132
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    
Sbjct: 133 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 192
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 193 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 9/217 (4%)
Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +I + +G G+FG V   R +V  K  + + I   +     K +     E  I     HP
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + +I EY   G L   LRK+  RFT  Q    +  + + + Y  + 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
              A D W+ GI+ +E + YG  P+   S +D  ++I
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           +++ +D +    +G+G +G V  +    S   +A+K I     EK + Q  +  ++ ++S
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77
Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRELRK--HRRFTEQQAATYIASLTN 130
           S   P I++ YG    +   ++ +E       + Y+ +         E+       +   
Sbjct: 78  S-DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVK 136
Query: 131 ALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPE 186
           AL +  EN  +IHRDIKP N+LLD  G +K+ DFG S   V S +K     G   Y+APE
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 195
Query: 187 MVE----NKEHDYAVDNWTLGILCYE-----FLY---------------GAPPFEAESQK 222
            ++     + +D   D W+LGI  YE     F Y               G PP  + S++
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEE 255
Query: 223 DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
              R  S    + ++  L KD SKR   +++++HP+I+
Sbjct: 256 ---REFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKM 130
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTE 118
           + +H NI+ L G    D  +++I+EYA +G L   L+  R                + + 
Sbjct: 131 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 247
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 178 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 238 PGAELLKKISSESARNYIQSLAQMP 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 22/210 (10%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-LRREMEIQSSLRHPNILRLY 85
           +G G FG VY   + +    VA+KI+  + ++    Q Q  R E+ +    RH NIL   
Sbjct: 44  IGSGSFGTVY---KGKWHGDVAVKIL--KVVDPTPEQFQAFRNEVAVLRKTRHVNILLFM 98
Query: 86  GWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
           G+   D  + ++ ++     LY+ L  +  +F   Q           + Y H  ++IHRD
Sbjct: 99  GYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRD 157
Query: 145 IKPENLLLDHEG-RLKIGDFG-------WSVQSRSKRHTMCGTLDYLAPEMV---ENKEH 193
           +K  N+ L HEG  +KIGDFG       WS   + ++ T  G++ ++APE++   +N   
Sbjct: 158 MKSNNIFL-HEGLTVKIGDFGLATVKSRWSGSQQVEQPT--GSVLWMAPEVIRMQDNNPF 214
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
            +  D ++ GI+ YE + G  P+   + +D
Sbjct: 215 SFQSDVYSYGIVLYELMTGELPYSHINNRD 244

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 13/215 (6%)
Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +         E  + 
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-----AFLAEASVM 53
Query: 74  SSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFTEQQAATYIASL--TN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R           SL    
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 114 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 173
Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
           K+     D W+ GIL +E + +G  P+     KD 
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMP 266

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 202 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 262 PGAELLKKISSESARNYIQSLAQMP 286

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 238 PGAELLKKISSESARNYIQSLAQMP 262

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 26  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 82
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 261 PGAELLKKISSESARNYIQSLAQMP 285

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 262 PGAELLKKISSESARNYIQSLAQMP 286

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 31/271 (11%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D E    LG+G +G V  +R V S   +A+K I +  +     Q Q R  M++  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNS---QEQKRLLMDLDI 58
Query: 75  SLRH---PNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHRRFTEQQAATYIASL 128
           S+R    P  +  YG    +  +++ +E       + Y++ + K +   E        S+
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 129 TNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL + H    VIHRD+KP N+L++  G++K+ DFG S  +     +    G   Y+AP
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 186 EMV--ENKEHDYAV--DNWTLGILCYE-----FLYGA--PPF-------EAESQKDTFRS 227
           E +  E  +  Y+V  D W+LGI   E     F Y +   PF       E  S +     
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK 238
Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
            SAE     S+ L K+S +R +  ++M+HP+
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 248 PGAELLKKISSESARNYIQSLAQMP 272

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 27  LGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQSS 75
           LGKG FG V + R    +  +   VA+K          K+QH          RE+EI  S
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVK----------KLQHSTEEHLRDFEREIEILKS 70
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNAL 132
           L+H NI++  G  +   R  + LI+EY   G L   L+ H  R    +   Y + +   +
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGM 130
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPE 186
            Y      IHRD+   N+L+++E R+KIGDFG + V  + K            + + APE
Sbjct: 131 EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 187 MVENKEHDYAVDNWTLGILCYE-FLY----GAPPFE 217
            +   +   A D W+ G++ YE F Y     +PP E
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 226

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E Y  Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLAQMP 266

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 118/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 17  TFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 73
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 131
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 132 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 191
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 192 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 251
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 252 PGAELLKKISSESARNYIQSLAQMP 276

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 63
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 220

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 8   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 62
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 63  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 122
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 219

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 58
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 27  LGKGKFGRVY--LVREVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           +G G+FG VY  +++    K   PVA+K +     EK ++      E  I     H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMGQFSHHNII 109
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVI 141
           RL G     + + +I EY   G L + LR K   F+  Q    +  +   + Y    + +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYLAPEMVENKEHDY 195
           HRD+   N+L++     K+ DFG S          +T  G    + + APE +  ++   
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 196 AVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSIS 229
           A D W+ GI+ +E + YG  P+   S  +  ++I+
Sbjct: 230 ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 78
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 109/237 (45%), Gaps = 38/237 (16%)
Query: 23  IGRPLGKGKFGRVYLVREV--ESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +G+PLG+G FG+V L   +  +   P     VA+K++  +  EK      L  EME+   
Sbjct: 32  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKM 89
Query: 76  L-RHPNILRLYGWFHDDERIFLILEYAHRGEL--YRELRK--------------HRRFTE 118
           + +H NI+ L G    D  +++I+EYA +G L  Y + R+                + + 
Sbjct: 90  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSS 149
Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH---- 174
           +   +    +   + Y      IHRD+   N+L+  +  +KI DFG    +R   H    
Sbjct: 150 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDIHHIDYY 206
Query: 175 --TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFR 226
             T  G L   ++APE + ++ + +  D W+ G+L +E F  G  P+     ++ F+
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 263

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 17/231 (7%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 12  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 67
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 68  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 125
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    
Sbjct: 126 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 185
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 186 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 9   KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 63
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 64  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC-GT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKF 183
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 220

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 4   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 59
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 60  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 118
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 119 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 179 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 15  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 69
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 70  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 129
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T   G+   + +  PE++   + 
Sbjct: 130 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 189
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 190 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 131
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 251
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 252 DIWSSCCMMLHMLNGCHPW 270

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 108/231 (46%), Gaps = 17/231 (7%)
Query: 4   KTAEREDNRKREWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           KT  R D+   +W + D +I  G+ +G G FG VY   + +    VA+K++        +
Sbjct: 20  KTLGRRDSSD-DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQ 75
Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           +Q   + E+ +    RH NIL   G +    ++ ++ ++     LY  L       E   
Sbjct: 76  LQ-AFKNEVGVLRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIK 133
Query: 122 ATYIASLT-NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---T 175
              IA  T   + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    
Sbjct: 134 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQ 193
Query: 176 MCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           + G++ ++APE++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 194 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 63  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 122 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 7   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 63  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 122 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 181
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 182 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 111/254 (43%), Gaps = 22/254 (8%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     E+ +   +   E  I     HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIR 79
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           L G   +   + ++ E+   G L   LR    +FT  Q    +  + + + Y  E   +H
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 139
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  S   T   +L       + APE +  ++  
Sbjct: 140 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRKFT 199
Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKI 253
            A D W+ GI+ +E + +G  P+   S +D   +I  + +      L        SL ++
Sbjct: 200 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR------LPPPPDCPTSLHQL 253
Query: 254 MEHPWII-KNANPR 266
           M   W   +NA PR
Sbjct: 254 MLDCWQKDRNARPR 267

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 106/220 (48%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-SVQSR-SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG  +V+SR S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K   K       I 
Sbjct: 3   TFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K  +
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 238 PGAELLKKISSESARNYIQSLAQMP 262

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 11/217 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 24  KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 78
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   LR+ R RF  QQ       +  A+ Y   
Sbjct: 79  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGT---LDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S        T   G+   + +  PE++   + 
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKF 198
Query: 194 DYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               D W  G+L +E +  G  P+E  +  +T   I+
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 111/254 (43%), Gaps = 22/254 (8%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G G+FG V    L    + +  VA+K +     E+ +   +   E  I     HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHPNIIR 81
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELR-KHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           L G   +   + ++ E+   G L   LR    +FT  Q    +  + + + Y  E   +H
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVH 141
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD------YLAPEMVENKEHD 194
           RD+   N+L++     K+ DFG S  ++  S   T   +L       + APE +  ++  
Sbjct: 142 RDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201
Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKI 253
            A D W+ GI+ +E + +G  P+   S +D   +I  + +      L        SL ++
Sbjct: 202 SASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYR------LPPPPDCPTSLHQL 255
Query: 254 MEHPWII-KNANPR 266
           M   W   +NA PR
Sbjct: 256 MLDCWQKDRNARPR 269

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S L H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 23  IGRPLGKGKFGRVYLVR-EVESKH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           I R +G G+FG V   R ++  K   PVA+K +     EK +       E  I     HP
Sbjct: 26  IERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 83
Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NI+ L G     + + ++ EY   G L   L+K+  +FT  Q    +  ++  + Y  + 
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDM 143
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLD--YLAPEMVENKE 192
             +HRD+   N+L++     K+ DFG S        +   T  G +   + APE +  ++
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
              A D W+ GI+ +E + YG  P+   + +D  +++
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAV 240

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 101/239 (42%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S L H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 13/215 (6%)
Query: 16  WSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W+L  ++ ++ + +GKG+FG V L     +K  VA+K I  +   +         E  + 
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-----AFLAEASVM 59
Query: 74  SSLRHPNILRLYGWFHDDER-IFLILEYAHRGELYRELRKHRRFTEQQAATYIASL--TN 130
           + LRH N+++L G   +++  ++++ EY  +G L   LR   R           SL    
Sbjct: 60  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 119
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
           A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  
Sbjct: 120 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALRE 179
Query: 191 KEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                  D W+ GIL +E + +G  P+     KD 
Sbjct: 180 AAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 214

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 117
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 238 DIWSSCCMMLHMLNGCHPW 256

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 137/305 (44%), Gaps = 44/305 (14%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  GT++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-------------ESQKDTFRSIS-AEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
           PF+               + +  F  I   + + ++   L +D  +R+S+ +++ HP++ 
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 261 KNANP 265
              +P
Sbjct: 326 IQTHP 330

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G FG V+ +++ ++    A+K   K ++E ++++     E+   + L  P I+ LYG
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRVE-----ELVACAGLSSPRIVPLYG 133
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 147 PENLLLDHEG-RLKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G R  + DFG ++        +S      + GT  ++APE+V  K  D  V
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 253
Query: 198 DNWTLGILCYEFLYGAPPF 216
           D W+   +    L G  P+
Sbjct: 254 DIWSSCCMMLHMLNGCHPW 272

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 12/210 (5%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++     S   VA+K +   +     +Q  L  E  +  +L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMKTLQHDKLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
               +E I++I EY  +G L   L+     +    +   + A +   +AY    + IHRD
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 135
Query: 145 IKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSIS 229
           + GIL YE + YG  P+   +  D   ++S
Sbjct: 196 SFGILLYEIVTYGKIPYPGRTNADVMTALS 225

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 76
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG-----TLD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I+
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 245

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 87
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI------------- 228
                          D W+LG + Y   YG  PF +  +Q     +I             
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 82
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG-----TLD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I+
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 251

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 137/305 (44%), Gaps = 44/305 (14%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  GT++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-------------ESQKDTFRSIS-AEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
           PF+               + +  F  I   + + ++   L +D  +R+S+ +++ HP++ 
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 261 KNANP 265
              +P
Sbjct: 326 IQTHP 330

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 119/296 (40%), Gaps = 71/296 (23%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVMLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+ +EY     LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231
Query: 220 SQK----DTFRSISAE------------AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            ++       RS+S E             K +I  L+  D +KR   + ++   W+
Sbjct: 232 MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 14  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 71
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 72  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 131 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 189
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI------------- 228
                          D W+LG + Y   YG  PF +  +Q     +I             
Sbjct: 190 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 249
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 250 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 286

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 29/229 (12%)
Query: 27  LGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI 81
           LG+G FG+V+L         + K  VA+K + KE  E  +     +RE E+ + L+H +I
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESAR--QDFQREAELLTMLQHQHI 105
Query: 82  LRLYGWFHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIA 126
           +R +G   +   + ++ EY   G+L R LR H                     Q     +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG-----TLD 181
            +   + Y    H +HRD+   N L+     +KIGDFG S    S  +   G      + 
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           ++ PE +  ++     D W+ G++ +E F YG  P+   S  +    I+
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 87
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 147 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI------------- 228
                          D W+LG + Y   YG  PF +  +Q     +I             
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 265
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 10  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 67
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 68  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 127 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI------------- 228
                          D W+LG + Y   YG  PF +  +Q     +I             
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 245
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 246 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 282

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
            E++I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 127 SLT--------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
           + T                +A+    + IHRD+   N+LL +    KIGDFG +    + 
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 173 RHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
            + +        + ++APE + +  +    D W+ GIL +E F  G  P+
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
            E++I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 127 SLT--------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
           + T                +A+    + IHRD+   N+LL +    KIGDFG +    + 
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 173 RHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
            + +        + ++APE + +  +    D W+ GIL +E F  G  P+
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 13/226 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR---EVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           RE       I + +G G  G V   R     +   PVA+K +     E+ +       E 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEA 101
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G         ++ EY   G L   LR H  +FT  Q    +  + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCG---TLDYL 183
             + Y  +   +HRD+   N+L+D     K+ DFG S          +T  G    + + 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           APE +  +    A D W+ G++ +E L YG  P+   + +D   S+
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/277 (22%), Positives = 128/277 (46%), Gaps = 36/277 (12%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+   
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQHS 68
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
             I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H++
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGNI-DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEH 193
            ++H D+KP N L+  +G LK+ DFG + Q +       + +  GT++Y+ PE +++   
Sbjct: 128 GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 194 D-----------YAVDNWTLGILCYEFLYGAPPFEA-ESQKDTFRSI------------- 228
                          D W+LG + Y   YG  PF+   +Q     +I             
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246
Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 16/220 (7%)
Query: 15  EWSLQDFEI--GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W + D +I  G+ +G G FG VY   + +    VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT-NA 131
               RH NIL   G +    ++ ++ ++     LY  L       E      IA  T   
Sbjct: 58  LRKTRHVNILLFMG-YSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRH---TMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG + +    S  H    + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 176
Query: 187 MV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
           ++   +   + +  D +  GI+ YE + G  P+   + +D
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 22/278 (7%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHPW-----IIKNANP 265
             + LL K SS+  R  +Q + + P      +   ANP
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 279

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + K       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMP 278

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 13/226 (5%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR---EVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           RE       I + +G G  G V   R     +   PVA+K +     E+ +       E 
Sbjct: 44  REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEA 101
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
            I     HPNI+RL G         ++ EY   G L   LR H  +FT  Q    +  + 
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVG 161
Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLD--YL 183
             + Y  +   +HRD+   N+L+D     K+ DFG S        +   T  G +   + 
Sbjct: 162 AGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT 221
Query: 184 APEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           APE +  +    A D W+ G++ +E L YG  P+   + +D   S+
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV 267

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 17  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 76
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 137 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 32  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 91
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 152 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 270

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 26  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 85
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 146 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 264

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 42  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 101
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 162 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 280

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 11/211 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           + LG G+FG V L +  + ++ VA+K+I +  +     + +  +E +    L HP +++ 
Sbjct: 14  KELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKF 68
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFTE-QQAATYIASLTNALAYCHENHVIHR 143
           YG    +  I+++ EY   G L   LR H +  E  Q       +   +A+   +  IHR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRH-TMCGT---LDYLAPEMVENKEHDYAVDN 199
           D+   N L+D +  +K+ DFG +      ++ +  GT   + + APE+    ++    D 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 200 WTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
           W  GIL +E F  G  P++  +  +    +S
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 10/212 (4%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           VD W++G +  E     P F   S+ D    I
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 52  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 111
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 172 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 290

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 10/212 (4%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           VD W++G +  E     P F   S+ D    I
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMP 268

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 10/212 (4%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLRHPNILRL 84
           +G G +G VY  R+  S H VALK +     E+      +R    ++   +  HPN++RL
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 85  Y---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
                    D  I + L + H  +    Y +         +     +      L + H N
Sbjct: 72  MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 131
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            ++HRD+KPEN+L+   G +K+ DFG +     +     +  TL Y APE++    +   
Sbjct: 132 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATP 191
Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           VD W++G +  E     P F   S+ D    I
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 223

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 43  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 102
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 163 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 281

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMP 272

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 59
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 60  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 117
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMP 262

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 5   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 61
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 62  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 119
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 120 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 179
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 180 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 239
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 240 PGAELLKKISSESARNYIQSLTQMP 264

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 125
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F++LE    G+L   LR+ R    Q ++  +  L  
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 4   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 60
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 118
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 239 PGAELLKKISSESARNYIQSLTQMP 263

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 4   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 60
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 61  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 118
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 119 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 179 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 238
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 239 PGAELLKKISSESARNYIQSLTQMP 263

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ +E+ + LGKG +G V+   +  +   VA+K IF         Q   R  M +     
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 78  HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA-SLTNALAY 134
           H NI+ L       +D  ++L+ +Y    +L+  +R +    E     Y+   L   + Y
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKY 124
Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLD---------- 181
            H   ++HRD+KP N+LL+ E  +K+ DFG S   V  R   + +  +++          
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 182 -----------YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
                      Y APE ++ + ++   +D W+LG +  E L G P F   S  +    I
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMP 273

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMP 271

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMP 273

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 71/296 (23%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ------LRREMEIQ 73
           DFE    LG+G FG+V   R        A+K          KI+H       +  E+ + 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIK----------KIRHTEEKLSTILSEVXLL 56
Query: 74  SSLRHPNILRLYG-WFH------------DDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
           +SL H  ++R Y  W                  +F+  EY     LY  +  H     QQ
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI--HSENLNQQ 114
Query: 121 AATY---IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------- 168
              Y      +  AL+Y H   +IHR++KP N+ +D    +KIGDFG +           
Sbjct: 115 RDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 169 --------SRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAE 219
                   S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y   PF   
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTG 231
Query: 220 SQK----DTFRSISAE------------AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            ++       RS+S E             K +I  L+  D +KR   + ++   W+
Sbjct: 232 XERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 84
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F+++E    G+L   LR+ R    Q ++  +  L  
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D     + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHY 155
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           IHRD+   N+LLD++  +KIGDFG +       +    R      + + APE ++  +  
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFY 215
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 216 YASDVWSFGVTLYELL 231

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 121/278 (43%), Gaps = 22/278 (7%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 30  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 86
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 144
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 204
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 235 LISRLLVKDSSK--RLSLQKIMEHPW-----IIKNANP 265
             + LL K SS+  R  +Q + + P      +   ANP
Sbjct: 265 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 302

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 18  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 74
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 132
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 192
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 252
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 253 PGAELLKKISSESARNYIQSLTQMP 277

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMP 278

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 19  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 75
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 76  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 133
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 134 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 193
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 194 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 253
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 254 PGAELLKKISSESARNYIQSLTQMP 278

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMP 271

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMP 273

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 26  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 82
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 83  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 141 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 201 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 260
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 261 PGAELLKKISSESARNYIQSLTQMP 285

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 30  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 86
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 87  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 144
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 145 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG 204
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 205 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 264
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 265 PGAELLKKISSESARNYIQSLTQMP 289

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMP 268

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 14  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 70
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 71  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 128
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 188
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 249 PGAELLKKISSESARNYIQSLTQMP 273

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMP 268

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 27  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 83
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 84  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 141
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 142 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 202 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 261
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 262 PGAELLKKISSESARNYIQSLTQMP 286

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 9   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 65
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 66  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 123
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 124 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 183
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 184 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 243
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 244 PGAELLKKISSESARNYIQSLTQMP 268

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 18  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 74
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 75  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 132
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 133 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 192
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 193 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 252
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 253 PGAELLKKISSESARNYIQSLTQMP 277

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 19/239 (7%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREME- 71
           +E   ++  + R LG G FG VY  +       P  L++  K   E    Q +L   ME 
Sbjct: 40  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEA 99
Query: 72  -IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL-- 128
            I S   H NI+R  G        F+++E    G+L   LR+ R    Q ++  +  L  
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 129 -----TNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWS---VQSRSKRHTMC 177
                     Y  ENH IHRDI   N LL   G     KIGDFG +    ++   R   C
Sbjct: 160 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 178 GTLD--YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAEAK 233
             L   ++ PE           D W+ G+L +E F  G  P+ ++S ++    +++  +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 278

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++ H VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DF  +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMP 272

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 13  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 69
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 70  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 127
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 128 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 187
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 188 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 247
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 248 PGAELLKKISSESARNYIQSLTQMP 272

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMP 271

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 6   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 62
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 63  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 120
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 121 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 180
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 181 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 240
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 241 PGAELLKKISSESARNYIQSLTQMP 265

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-----SSLRHPNI 81
           +G G +G VY  R+  S H VALK +             +    E+       +  HPN+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 82  LRLY---GWFHDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASLTNALAYC 135
           +RL         D  I + L + H  +    Y +         +     +      L + 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL 136
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDYLAPEMVENKEH 193
           H N ++HRD+KPEN+L+   G +K+ DFG + + S     T +  TL Y APE++    +
Sbjct: 137 HANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY 196
Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
              VD W++G +  E     P F   S+ D    I
Sbjct: 197 ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY+    +    VA+K + ++ +E      +  +E  +
Sbjct: 26  KWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 81
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---YIAS-L 128
              ++HPN+++L G    +   +++ EY   G L   LR+  R  E+  A    Y+A+ +
Sbjct: 82  MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR--EEVTAVVLLYMATQI 139
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLA 184
           ++A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + A
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 199
Query: 185 PEMVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           PE +         D W  G+L +E   YG  P+
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 12  TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 68
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 69  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 126
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +   
Sbjct: 127 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTG 186
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 187 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 246
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 247 PGAELLKKISSESARNYIQSLTQMP 271

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/305 (21%), Positives = 136/305 (44%), Gaps = 44/305 (14%)
Query: 1   MDTKTAEREDNRKREWSLQD--------FEIGRPLGKGKFGRVYLVREVESKHPVALKII 52
           MD+     +D+ K   S  +        + I + +G G   +V+ V   E K   A+K +
Sbjct: 30  MDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 53  FKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYAHRGELYREL 110
             E+ +   +    R E+   + L+     I+RLY +   D+ I++++E  +  +L   L
Sbjct: 89  NLEEADNQTLD-SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNI-DLNSWL 146
Query: 111 RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +K +     +  +Y  ++  A+   H++ ++H D+KP N L+  +G LK+ DFG + Q +
Sbjct: 147 KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQ 205
Query: 171 SK-----RHTMCGTLDYLAPEMVENKEHD-----------YAVDNWTLGILCYEFLYGAP 214
                  + +  G ++Y+ PE +++                  D W+LG + Y   YG  
Sbjct: 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 265
Query: 215 PFEA-------------ESQKDTFRSIS-AEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
           PF+               + +  F  I   + + ++   L +D  +R+S+ +++ HP++ 
Sbjct: 266 PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 261 KNANP 265
              +P
Sbjct: 326 IQTHP 330

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L R          ++  K    +    H   L++E+EI  +L H NI+
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G   +D    I LI+E+   G L   L K++ +   +Q   Y   +   + Y     
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 146
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKEH 193
            +HRD+   N+L++ E ++KIGDFG +  +++  +  T+    D    + APE +   + 
Sbjct: 147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKF 206
Query: 194 DYAVDNWTLGILCYEFL 210
             A D W+ G+  +E L
Sbjct: 207 YIASDVWSFGVTLHELL 223

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHSQHY 138
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR++   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 199 YASDVWSFGVTLYELL 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G+FG VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 6   WEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 61
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPES 181
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 12/218 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++ + LG G+FG V++     S   VA+K +   +     +Q  L  E  +  +L+H
Sbjct: 12  ESIKLVKKLGAGQFGEVWMGYYNNSTK-VAVKTL---KPGTMSVQAFLE-EANLMKTLQH 66
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCH 136
             ++RLY     +E I++I E+  +G L   L+     +    +   + A +   +AY  
Sbjct: 67  DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 126
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPEMVENKE 192
             + IHRD++  N+L+      KI DFG +        + R      + + APE +    
Sbjct: 127 RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGC 186
Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSIS 229
                + W+ GIL YE + YG  P+   +  D   ++S
Sbjct: 187 FTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALS 224

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 125/310 (40%), Gaps = 64/310 (20%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++EI   +G G +G V   R   +   VA+K I     +      +  RE++I    +H 
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHD 113
Query: 80  NILRL---------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           NI+ +         YG F   + ++++L+     +L++ +   +  T +    ++  L  
Sbjct: 114 NIIAIKDILRPTVPYGEF---KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-----MCGTLDYL 183
            L Y H   VIHRD+KP NLL++    LKIGDFG +  + +    H         T  Y 
Sbjct: 170 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFL-------------------------------- 210
           APE M+   E+  A+D W++G +  E L                                
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289
Query: 211 YGA----------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
            GA          PP +    +  +     +A  L+ R+L  + S R+S    + HP++ 
Sbjct: 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 349
Query: 261 KNANPRGTCD 270
           K  +P    D
Sbjct: 350 KYHDPDDEPD 359

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ--LRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K        QH+   ++E++I  +L H +I+
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEGMAYLHAQHY 138
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR++   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 199 YASDVWSFGVTLYELL 214

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH--QLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L R          ++  K    +    H   L++E+EI  +L H NI+
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 83  RLYGWFHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENH 139
           +  G   +D    I LI+E+   G L   L K++ +   +Q   Y   +   + Y     
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ 134
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----YLAPEMVENKEH 193
            +HRD+   N+L++ E ++KIGDFG +  +++  +  T+    D    + APE +   + 
Sbjct: 135 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKF 194
Query: 194 DYAVDNWTLGILCYEFL 210
             A D W+ G+  +E L
Sbjct: 195 YIASDVWSFGVTLHELL 211

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 69/309 (22%), Positives = 129/309 (41%), Gaps = 66/309 (21%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 79  PNILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
            NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVK 126
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTL 180
             H ++VIHRD+KP NLL++    LK+ DFG +                +S       T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 DYLAPE-MVENKEHDYAVDNWTLGIL---------------------------------- 205
            Y APE M+ + ++  A+D W+ G +                                  
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 206 ---CY------EFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH 256
              C       E++   P + A   +  F  ++ +   L+ R+LV D +KR++ ++ +EH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 PWIIKNANP 265
           P++    +P
Sbjct: 307 PYLQTYHDP 315

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 66/303 (21%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 79  PNILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
            NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVK 126
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTL 180
             H ++VIHRD+KP NLL++    LK+ DFG +                +S       T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 181 DYLAPE-MVENKEHDYAVDNWTLGIL---------------------------------- 205
            Y APE M+ + ++  A+D W+ G +                                  
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 206 ---CY------EFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH 256
              C       E++   P + A   +  F  ++ +   L+ R+LV D +KR++ ++ +EH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 PWI 259
           P++
Sbjct: 307 PYL 309

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAH---RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS 229
              E DY   +D W  G +  E    +P  +  +++     IS
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 13/216 (6%)
Query: 10  DNRKREWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           D    +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  
Sbjct: 4   DPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFL 59
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIA 126
           +E  +   ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 119
Query: 127 S-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LD 181
           + +++A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + 
Sbjct: 120 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 179
Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           + APE +   +     D W  G+L +E   YG  P+
Sbjct: 180 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 60
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 61  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 120
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 121 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I+E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 123
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 124 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 214

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 118/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I  + RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLAFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYLLSL 269
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 270 PHKNKVPWNRLFPNADSKA 288

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/245 (24%), Positives = 110/245 (44%), Gaps = 19/245 (7%)
Query: 1   MDTKTAEREDNRKREWS----LQDFEIGRPLGKGKFGRV---YLVREVESKHPVALKIIF 53
           +D  T E  +   RE++    +   +I + +G G+FG V   +L    + +  VA+K + 
Sbjct: 11  IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 70
Query: 54  KEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH 113
               EK +       E  I     HPN++ L G       + +I E+   G L   LR++
Sbjct: 71  SGYTEKQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 128
Query: 114 R-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSR 170
             +FT  Q    +  +   + Y  + + +HRD+   N+L++     K+ DFG S  ++  
Sbjct: 129 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 188
Query: 171 SKRHTMCGTLD------YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKD 223
           +   T    L       + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D
Sbjct: 189 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 248
Query: 224 TFRSI 228
              +I
Sbjct: 249 VINAI 253

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/309 (22%), Positives = 129/309 (41%), Gaps = 66/309 (21%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            DF++   LG+G +G V       +   VA+K I  E  +K     +  RE++I    +H
Sbjct: 11  SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFDKPLFALRTLREIKILKHFKH 68
Query: 79  PNILRLYGW-----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
            NI+ ++       F +   +++I E   + +L+R +   +  ++     +I     A+ 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAVK 126
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-------------VQSRSKRHTMCGTL 180
             H ++VIHRD+KP NLL++    LK+ DFG +                +S       T 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 181 DYLAPE-MVENKEHDYAVDNWTLGIL---------------------------------- 205
            Y APE M+ + ++  A+D W+ G +                                  
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 206 ---CY------EFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH 256
              C       E++   P + A   +  F  ++ +   L+ R+LV D +KR++ ++ +EH
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 257 PWIIKNANP 265
           P++    +P
Sbjct: 307 PYLQTYHDP 315

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 117/262 (44%), Gaps = 28/262 (10%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D EIGR    G F  VY   + E+   VA   +   ++ K + Q + + E E    L+HP
Sbjct: 31  DIEIGR----GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEXLKGLQHP 85
Query: 80  NILRLYGWFHDDER----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           NI+R Y  +    +    I L+ E    G L   L++ +    +   ++   +   L + 
Sbjct: 86  NIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFL 145
Query: 136 HENH--VIHRDIKPENLLLDH-EGRLKIGDFGWSVQSRSK-RHTMCGTLDYLAPEMVENK 191
           H     +IHRD+K +N+ +    G +KIGD G +   R+     + GT ++ APE  E K
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYEEK 205
Query: 192 EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSISA-------------EAKHLIS 237
            +D +VD +  G    E      P+ E ++    +R +++             E K +I 
Sbjct: 206 -YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
             + ++  +R S++ ++ H + 
Sbjct: 265 GCIRQNKDERYSIKDLLNHAFF 286

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 64/305 (20%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           ++EI   +G G +G V   R   +   VA+K I     +      +  RE++I    +H 
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHD 114
Query: 80  NILRL---------YGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           NI+ +         YG F   + ++++L+     +L++ +   +  T +    ++  L  
Sbjct: 115 NIIAIKDILRPTVPYGEF---KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLR 170
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT-----MCGTLDYL 183
            L Y H   VIHRD+KP NLL++    LKIGDFG +  + +    H         T  Y 
Sbjct: 171 GLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFL-------------------------------- 210
           APE M+   E+  A+D W++G +  E L                                
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 290
Query: 211 YGA----------PPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWII 260
            GA          PP +    +  +     +A  L+ R+L  + S R+S    + HP++ 
Sbjct: 291 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA 350
Query: 261 KNANP 265
           K  +P
Sbjct: 351 KYHDP 355

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAH---RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS 229
              E DY   +D W  G +  E    +P  +  +++     IS
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 86  -------GWFHDDERIFLILEYAH---RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 141
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 142 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 201
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS 229
              E DY   +D W  G +  E    +P  +  +++     IS
Sbjct: 202 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 101/223 (45%), Gaps = 25/223 (11%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY- 85
           +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L+H N++ L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 86  -------GWFHDDERIFLILEYAH---RGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
                   +      I+L+ ++      G L   L K   FT  +    +  L N L Y 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYI 140
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRH---TMCGTLDYLAPEMV 188
           H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL Y  PE++
Sbjct: 141 HRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELL 200
Query: 189 ENKEHDYA--VDNWTLGILCYEFLYGAPPFEAESQKDTFRSIS 229
              E DY   +D W  G +  E    +P  +  +++     IS
Sbjct: 201 LG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 86
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S E + L   + +K  +  LSL
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYLLSL 265
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 266 PHKNKVPWNRLFPNADSKA 284

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 21  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 76
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 77  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 136
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE 
Sbjct: 137 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 196
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 197 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 124
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 125 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 215

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 8   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 63
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 64  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE 
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K   E    +++   +RE+EI  +L H +I+
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHY 133
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR +   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 194 YASDVWSFGVTLYELL 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T   G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 11/196 (5%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNIL 82
           R LG+G FG+V L     +       +  K   E    +++   +RE+EI  +L H +I+
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 83  RLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           +  G   D  ++ + L++EY   G L   L +H      Q   +   +   +AY H  H 
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQQICEGMAYLHAQHY 132
Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTMCGTLDYLAPEMVENKEHD 194
           IHR +   N+LLD++  +KIGDFG +            R      + + APE ++  +  
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 195 YAVDNWTLGILCYEFL 210
           YA D W+ G+  YE L
Sbjct: 193 YASDVWSFGVTLYELL 208

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 117/265 (44%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D+G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ + + ++    A+K   K ++E ++ +     E+   + L  P I+ LYG
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 152
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 212
Query: 147 PENLLLDHEGR-LKIGDFGWSV--------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G    + DFG +V        +S      + GT  ++APE+V  +  D  V
Sbjct: 213 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV 272
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIME 255
           D W+   +    L G  P+    +      I++E   +     +  S   L+ Q I E
Sbjct: 273 DVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE---IPPSCAPLTAQAIQE 327

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 122
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 213

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 66
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 126
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S       +T        + + APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 127/292 (43%), Gaps = 56/292 (19%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I  + RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLAFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAE----------------SQKD---------------- 223
           ++D W++G +  E L   P F  +                SQ+D                
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 269
Query: 224 ----------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                      F +  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 270 PHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYDP 321

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/306 (24%), Positives = 133/306 (43%), Gaps = 62/306 (20%)
Query: 19  QDFEIG------RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           Q F++G      + +G+G +G V    +   K  VA+K I   + + Y  Q  LR E++I
Sbjct: 37  QPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTY-CQRTLR-EIQI 94
Query: 73  QSSLRHPNILRLYGWFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
               RH N++ +         +  R   I++     +LY+ L K ++ +      ++  +
Sbjct: 95  LLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK-LLKSQQLSNDHICYFLYQI 153
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDY 182
              L Y H  +V+HRD+KP NLL++    LKI DFG + +      HT        T  Y
Sbjct: 154 LRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWY 213
Query: 183 LAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE----------------SQKD-- 223
            APE M+ +K +  ++D W++G +  E L   P F  +                SQ+D  
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 273
Query: 224 ------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                    F    ++A  L+ R+L  + +KR+++++ + HP++
Sbjct: 274 CIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333
Query: 260 IKNANP 265
            +  +P
Sbjct: 334 EQYYDP 339

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           ++    +   VD W++G +  E     P F   S  D    I
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 13/210 (6%)
Query: 16  WSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  + 
Sbjct: 6   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 61
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTNA 131
             ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++A
Sbjct: 62  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-CGT---LDYLAPEM 187
           + Y  + + IHRD+   N L+     +K+ DFG S        T   G    + + APE 
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPES 181
Query: 188 VENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
           +   +     D W  G+L +E   YG  P+
Sbjct: 182 LAYNKFSIKSDVWAFGVLLWEIATYGMSPY 211

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           ++    +   VD W++G +  E     P F   S  D    I
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 127
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE
Sbjct: 128 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 101/222 (45%), Gaps = 13/222 (5%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQ---S 74
           Q +E    +G+G +G+V+  R++++    VALK + + Q  +  +     RE+ +     
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 75  SLRHPNILRLYGWF---HDDERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +  HPN++RL+        D    L L + H  +    Y +         +     +  L
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
              L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y APE
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 189
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           ++    +   VD W++G +  E     P F   S  D    I
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 231

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 104/242 (42%), Gaps = 33/242 (13%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR-- 67
           ++ K E+  ++  +G+ LG+G+FG+V        K       +  + +++     +LR  
Sbjct: 14  EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL 73
Query: 68  -REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----------- 115
             E  +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+           
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 116 -------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
                         T     ++   ++  + Y  E  ++HRD+   N+L+    ++KI D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 163 FGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
           FG S       S  KR      + ++A E + +  +    D W+ G+L +E +  G  P+
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 217 EA 218
Sbjct: 254 PG 255

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 96
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 155
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 156 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 215
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 216 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 275
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 276 PHKNKVPWNRLFPNADSKA 294

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 267
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 268 PHKNKVPWNRLFPNADSKA 286

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 39/264 (14%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G  G + + R +     VA+K I  E       + QL RE     S  HPN++R + 
Sbjct: 32  LGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRE-----SDEHPNVIRYFC 85
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASLTNALAYCHENHVIHRD 144
              D +  ++ +E        +E  + + F     +  T +   T+ LA+ H  +++HRD
Sbjct: 86  TEKDRQFQYIAIELC--AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD 143
Query: 145 IKPENLLL---DHEGRLK--IGDFGWSVQ------SRSKRHTMCGTLDYLAPEMV--ENK 191
           +KP N+L+   +  G++K  I DFG   +      S S+R  + GT  ++APEM+  + K
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203
Query: 192 EH-DYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRSISAE--------------AKHL 235
           E+  Y VD ++ G + Y  +  G+ PF    Q+     + A               A+ L
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263
Query: 236 ISRLLVKDSSKRLSLQKIMEHPWI 259
           I +++  D  KR S + +++HP+ 
Sbjct: 264 IEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 267
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 268 PHKNKVPWNRLFPNADSKA 286

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K   K       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI  FG +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+VY  R  +    VA+K + +E+ +  ++Q Q   E+E+ S   H N+LRL G
Sbjct: 46  LGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQ--TEVEMISMAVHRNLLRLRG 102
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-----IA-SLTNALAYCHEN-- 138
           +        L+  Y   G +   LR+  R   Q    +     IA      LAY H++  
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 139 -HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC---GTLDYLAPEMVENKEH 193
             +IHRD+K  N+LLD E    +GDFG + +      H      GT+ ++APE +   + 
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKS 220
Query: 194 DYAVDNWTLGILCYEFLYGAPPFE 217
               D +  G++  E + G   F+
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAFD 244

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 108
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 168 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 287
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 288 PHKNKVPWNRLFPNADSKA 306

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 93
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 272
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 273 PHKNKVPWNRLFPNADSKA 291

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 94
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 153
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 214 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 273
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 274 PHKNKVPWNRLFPNADSKA 292

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 85
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 144
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 205 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 264
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 265 PHKNKVPWNRLFPNADSKA 283

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 90
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 149
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 150 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 209
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 210 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 269
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 270 PHKNKVPWNRLFPNADSKA 288

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 86
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 145
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 206 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 265
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 266 PHKNKVPWNRLFPNADSKA 284

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 93
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 152
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 213 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 272
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 273 PHKNKVPWNRLFPNADSKA 291

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 20/238 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V+ + + ++    A+K   K ++E ++ +     E+   + L  P I+ LYG
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK---KVRLEVFRAE-----ELMACAGLTSPRIVPLYG 133
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIK 146
              +   + + +E    G L + +++     E +A  Y+      L Y H   ++H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVK 193
Query: 147 PENLLLDHEGR-LKIGDFGWSVQSRS--------KRHTMCGTLDYLAPEMVENKEHDYAV 197
            +N+LL  +G    + DFG +V  +             + GT  ++APE+V  +  D  V
Sbjct: 194 ADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV 253
Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIME 255
           D W+   +    L G  P+    +      I++E   +     +  S   L+ Q I E
Sbjct: 254 DVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVRE---IPPSCAPLTAQAIQE 308

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 267
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 268 PHKNKVPWNRLFPNADSKA 286

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y    +  RE++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY--XQRTLREIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 196 DVWSFGVLMWEAFSYGQKPY 215

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSL 267
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 268 PHKNKVPWNRLFPNADSKA 286

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 88
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 147
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 148 RDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 207
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 208 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKARNYLLSL 267
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 268 PHKNKVPWNRLFPNADSKA 286

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA+K I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 108
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   ++ +    +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 167
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 168 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 227
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 228 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 287
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 288 PHKNKVPWNRLFPNADSKA 306

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 269
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHR++   N L+     +K+ DFG S       +T        + + APE
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 175 TPELS------IIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSK 246
           ++    +D A+D W+LG +  E   G P F   ++ D    I        + +L +    
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 247 RLSLQKIMEHPWIIK 261
           R   +K+ +  W +K
Sbjct: 289 RKFFEKLPDGTWNLK 303

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + +  PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           V+ +++DY++D W+LG +    ++   PF
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 175 TPELS------IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 228
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSK 246
           ++    +D A+D W+LG +  E   G P F   ++ D    I        + +L +    
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288
Query: 247 RLSLQKIMEHPWIIK 261
           R   +K+ +  W +K
Sbjct: 289 RKFFEKLPDGTWNLK 303

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 71  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 130 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 189
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 190 DVWSFGVLMWEAFSYGQKPY 209

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 15/229 (6%)
Query: 13  KREWSLQDFEIGRPLGKGKFGRV---YLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
            +E  +   +I + +G G+FG V   +L    + +  VA+K +     EK +       E
Sbjct: 1   SKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSE 58
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASL 128
             I     HPN++ L G       + +I E+   G L   LR++  +FT  Q    +  +
Sbjct: 59  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 118
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLD----- 181
              + Y  + + +HR +   N+L++     K+ DFG S  ++  +   T    L      
Sbjct: 119 AAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 178
Query: 182 -YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
            + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D   +I
Sbjct: 179 RWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 83  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 201
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 202 DVWSFGVLMWEAFSYGQKPY 221

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 112/255 (43%), Gaps = 21/255 (8%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ--IEKYKIQHQLRREMEIQSSLRH 78
           +EI   +GKG FG+V    +   +  VA+KII  ++  + + +I+ +L   M    +   
Sbjct: 37  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 96
Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASL 128
             I+ L   F     + L+ E      LY  LR            R+F +Q     +   
Sbjct: 97  YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 155
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
           T  L+      +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE
Sbjct: 156 TPELS------IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXIQSRFYRSPE 209
Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSK 246
           ++    +D A+D W+LG +  E   G P F   ++ D    I        + +L +    
Sbjct: 210 VLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 269
Query: 247 RLSLQKIMEHPWIIK 261
           R   +K+ +  W +K
Sbjct: 270 RKFFEKLPDGTWNLK 284

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 73  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 192 DVWSFGVLMWEAFSYGQKPY 211

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 91  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 150 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 209
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 210 DVWSFGVLMWEAFSYGQKPY 229

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 212 DVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 93  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 152 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 211
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 212 DVWSFGVLMWEAFSYGQKPY 231

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)
Query: 25  RPLGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           + LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
           + G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HR
Sbjct: 77  MIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAV 197
           D+   N+LL  +   KI DFG S   R+  +           + + APE +   +     
Sbjct: 136 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 195
Query: 198 DNWTLGILCYE-FLYGAPPF 216
           D W+ G+L +E F YG  P+
Sbjct: 196 DVWSFGVLMWEAFSYGQKPY 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 8   EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 63
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 64  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 122
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 123 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 182
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF 225
             +    A D W   +  +E L +G  PF     KD  
Sbjct: 183 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           +G+G +G V    +  +K  VA++ I   + + Y  Q  LR E++I    RH NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTY-CQRTLR-EIKILLRFRHENIIGIND 92
Query: 87  WFH----DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
                  +  +   I++     +LY+ L K +  +      ++  +   L Y H  +V+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSANVLH 151
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-----MCGTLDYLAPE-MVENKEHDY 195
           RD+KP NLLL+    LKI DFG + V      HT        T  Y APE M+ +K +  
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----SAEAKHLISRLLVKDSSKRLSL 250
           ++D W++G +  E L   P F  +   D    I     S   + L   + +K  +  LSL
Sbjct: 212 SIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSL 271
Query: 251 QKIMEHPW--IIKNANPRG 267
               + PW  +  NA+ + 
Sbjct: 272 PHKNKVPWNRLFPNADSKA 290

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W ++  D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 308
Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIAS-LTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+ +R+        Y+A+ +++
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 368
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG----TLDYLAPE 186
           A+ Y  + + IHR++   N L+     +K+ DFG S       +T        + + APE
Sbjct: 369 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 187 MVENKEHDYAVDNWTLGILCYEF-LYGAPPF 216
            +   +     D W  G+L +E   YG  P+
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 459

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 17/265 (6%)
Query: 5   TAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
           T  R++  K  W + + ++   P+G G +G V    + ++   VA+K + +       I 
Sbjct: 7   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP---FQSII 63
Query: 64  HQLR--REMEIQSSLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRR 115
           H  R  RE+ +   ++H N++ L   F       +   ++L+      G     + K ++
Sbjct: 64  HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK 121
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
            T+      I  +   L Y H   +IHRD+KP NL ++ +  LKI D G +  +  +   
Sbjct: 122 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTG 181
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
              T  Y APE++ N  H +  VD W++G +  E L G   F      D  + I      
Sbjct: 182 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 241
Query: 235 LISRLLVKDSSK--RLSLQKIMEHP 257
             + LL K SS+  R  +Q + + P
Sbjct: 242 PGAELLKKISSESARNYIQSLTQMP 266

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 81
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 82  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 135
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           E +V+ +++DY++D W+LG +    ++   PF
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R+ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
           G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HRD+
Sbjct: 437 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 495
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAVDN 199
              N+LL  +   KI DFG S   R+  +           + + APE +   +     D 
Sbjct: 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 555
Query: 200 WTLGILCYE-FLYGAPPF 216
           W+ G+L +E F YG  P+
Sbjct: 556 WSFGVLMWEAFSYGQKPY 573

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 12  EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 67
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 68  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 186
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF 225
             +    A D W   +  +E L +G  PF     KD  
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 9/198 (4%)
Query: 27  LGKGKFGRVYL-VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LG G FG V     +++         I K +     ++ +L  E  +   L +P I+R+ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 86  GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDI 145
           G   + E   L++E A  G L + L+++R   ++     +  ++  + Y  E++ +HRD+
Sbjct: 438 G-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDL 496
Query: 146 KPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG------TLDYLAPEMVENKEHDYAVDN 199
              N+LL  +   KI DFG S   R+  +           + + APE +   +     D 
Sbjct: 497 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDV 556
Query: 200 WTLGILCYE-FLYGAPPF 216
           W+ G+L +E F YG  P+
Sbjct: 557 WSFGVLMWEAFSYGQKPY 574

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 22/234 (9%)
Query: 8   REDNRKREWSLQDFEIGRP-LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           ++D  K  W L    +    +G G +G V    +  S   VA+K +   F+ +I      
Sbjct: 12  KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FA 67
Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRK--HRR 115
            +  RE+ +   ++H N++ L   F     +      +L++ +     +  +L+K    +
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLK 122
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
           F+E++    +  +   L Y H   V+HRD+KP NL ++ +  LKI DFG +  + ++   
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
              T  Y APE++ +  H +  VD W++G +  E L G   F+ +   D    I
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 16/218 (7%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHP-----VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +D  + R LG+G FG VY    V + H      VA+K   K+     K   +   E  I 
Sbjct: 24  EDVVLNRILGEGFFGEVY--EGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIM 79
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
            +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +  A+
Sbjct: 80  KNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 138
Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT----LDYLAPEMV 188
           AY    + +HRDI   N+L+     +K+GDFG S     + +         + +++PE +
Sbjct: 139 AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESI 198
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTF 225
             +    A D W   +  +E L +G  PF     KD  
Sbjct: 199 NFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 81
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 82  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 135
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 136 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 195
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           E +V+ +++DY++D W+LG +    ++   PF
Sbjct: 196 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 227

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 82
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 83  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 136
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 137 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 196
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           E +V+ +++DY++D W+LG +    ++   PF
Sbjct: 197 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 228

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           V+ +++DY++D W+LG +    ++   PF
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCY-------EFLYG---------------------------- 212
           V+ +++DY++D W+LG +          F YG                            
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 213 --APPFEA----ESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
              P  EA     S+K   + ++A+ +HL+S        +LL  D  +RL+  + M HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 259 I 259
Sbjct: 318 F 318

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 134
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 135 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 194
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           E +V+ +++DY++D W+LG +    ++   PF
Sbjct: 195 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 226

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCY-------EFLYG---------------------------- 212
           V+ +++DY++D W+LG +          F YG                            
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 213 --APPFEA----ESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
              P  EA     S+K   + ++A+ +HL+S        +LL  D  +RL+  + M HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 259 I 259
Sbjct: 318 F 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 21/212 (9%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 101
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGE---LYRELRKHRRFTEQQAATYIASL 128
           +    PNI++L     D   +   LI EY +  +   LY  L      T+     YI  L
Sbjct: 102 NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTL------TDYDIRYYIYEL 155
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
             AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  P
Sbjct: 156 LKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 215
Query: 186 E-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           E +V+ +++DY++D W+LG +    ++   PF
Sbjct: 216 ELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPF 247

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG+VY  R  +    VA+K + +E+ +  ++Q Q   E+E+ S   H N+LRL G
Sbjct: 38  LGRGGFGKVYKGRLADGXL-VAVKRLKEERTQGGELQFQ--TEVEMISMAVHRNLLRLRG 94
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY-----IA-SLTNALAYCHEN-- 138
           +        L+  Y   G +   LR+  R   Q    +     IA      LAY H++  
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRE--RPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 139 -HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC---GTLDYLAPEMVENKEH 193
             +IHRD+K  N+LLD E    +GDFG + +      H      G + ++APE +   + 
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKS 212
Query: 194 DYAVDNWTLGILCYEFLYGAPPFE 217
               D +  G++  E + G   F+
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFD 236

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  QD +E+ R +G+GK+  V+    V +           + ++  K +   R    +Q
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI-----IKILKPVKKKKIKREIKILQ 80
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI++L     D   +   LI EY +  + ++ L  +   T+     YI  L  A
Sbjct: 81  NLXGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD-FKVL--YPTLTDYDIRYYIYELLKA 137
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 188 VENKEHDYAVDNWTLGILCY-------EFLYG---------------------------- 212
           V+ +++DY++D W+LG +          F YG                            
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 213 --APPFEA----ESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
              P  EA     S+K   + ++A+ +HL+S        +LL  D  +RL+  + M HP+
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 259 I 259
Sbjct: 318 F 318

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 61
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 62  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 122 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 181
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 182 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 22/234 (9%)
Query: 8   REDNRKREWSLQDFEIGRP-LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQ 63
           ++D  K  W L    +    +G G +G V    +  S   VA+K +   F+ +I      
Sbjct: 30  KQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI----FA 85
Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERI------FLILEYAHRGELYRELRK--HRR 115
            +  RE+ +   ++H N++ L   F     +      +L++ +     +  +L+K     
Sbjct: 86  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGME 140
Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
           F+E++    +  +   L Y H   V+HRD+KP NL ++ +  LKI DFG +  + ++   
Sbjct: 141 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 200
Query: 176 MCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
              T  Y APE++ +  H +  VD W++G +  E L G   F+ +   D    I
Sbjct: 201 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 254

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/301 (23%), Positives = 131/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +   VA      + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVA-----VKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+L+DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 70
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRK 190
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G +G VYL  +  ++  VA+K +   F++ I+  +I     RE+ I + L+   I+R
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI----LREITILNRLKSDYIIR 89
Query: 84  LYGWFHDDE-----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           LY     D+      ++++LE A   +L +  +     TE+   T + +L     + HE+
Sbjct: 90  LYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTLD---------------- 181
            +IHRD+KP N LL+ +  +K+ DFG +    S++ T +   L+                
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
Query: 182 --------YLAPEMVENKE-HDYAVDNWTLGILCYEFL 210
                   Y APE++  +E +  ++D W+ G +  E L
Sbjct: 209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 25  RPLGKGKFGRVY---LVREVESKHPVALK----IIFKEQIEKYKIQHQLRREMEIQSSLR 77
           R +GKG FG VY    + + +++   A+K    I   +Q+E +       RE  +   L 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFL------REGLLMRGLN 80
Query: 78  HPNILRLYGWFHDDERI-FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYC 135
           HPN+L L G     E +  ++L Y   G+L + +R   R  T +   ++   +   + Y 
Sbjct: 81  HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----------WSVQSRSKRHTMCGTLDYLAP 185
            E   +HRD+   N +LD    +K+ DFG          +SVQ    RH     + + A 
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQH--RHARL-PVKWTAL 197
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLY-GAPPF 216
           E ++        D W+ G+L +E L  GAPP+
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 27  LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  I +S+ HP+++
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHLV 103
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           RL G       I L+ +    G L   + +H+     Q    +   +   + Y  E  ++
Sbjct: 104 RLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 162
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A E +  ++  + 
Sbjct: 163 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 222
Query: 197 VDNWTLGILCYEFL-YGAPPFEA 218
            D W+ G+  +E + +G  P++ 
Sbjct: 223 SDVWSYGVTIWELMTFGGKPYDG 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + LG+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61
Query: 78  HPNILRLY-GWFHDD---------ERIFLILEYA-HRGELYRELRKHRRFTEQQAATY-- 124
           HP I+R +  W   +          +++L ++    R E  ++    R   E++  +   
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 125 --IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQ 168
                +  A+ + H   ++HRD+KP N+    +  +K+GDFG               +  
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 169 SRSKRHT-MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
               RHT   GT  Y++PE +    + + VD ++LG++ +E LY   PF  + ++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER 233

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 27  LGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
           LG G FG VY    V E E+ K PVA+KI+ +    K  ++     E  I +S+ HP+++
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE--FMDEALIMASMDHPHLV 80
Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           RL G       I L+ +    G L   + +H+     Q    +   +   + Y  E  ++
Sbjct: 81  RLLG-VCLSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 139
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENKEHDYA 196
           HRD+   N+L+     +KI DFG +  ++   K +   G    + ++A E +  ++  + 
Sbjct: 140 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ 199
Query: 197 VDNWTLGILCYEFL-YGAPPFEA 218
            D W+ G+  +E + +G  P++ 
Sbjct: 200 SDVWSYGVTIWELMTFGGKPYDG 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR------------ 114
            E++I S L +H NI+ L G       + +I EY   G+L   LR+ R            
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 115 ----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
               + + +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 171 SKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEA 218
           +  + +        + ++APE + +  +    D W+ GIL +E F  G  P+  
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 30  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 89
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRF 116
            E++I S L +H NI+ L G       + +I EY   G+L   LR+           R  
Sbjct: 90  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
             +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    +  + +
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 177 CG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                   + ++APE + +  +    D W+ GIL +E F  G  P+
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 255

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + R  + +  VA+K++ K+  EK   + ++ RE +I   L +P I+RL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIVRL 75
Query: 85  YGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     E + L++E A  G L++ L  K         A  +  ++  + Y  E + +HR
Sbjct: 76  IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 144 DIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           D+   N+LL +    KI DFG S          + R      L + APE +  ++     
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 194
Query: 198 DNWTLGILCYEFL-YGAPPFE 217
           D W+ G+  +E L YG  P++
Sbjct: 195 DVWSYGVTMWEALSYGQKPYK 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 20/226 (8%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 38  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 97
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRF 116
            E++I S L +H NI+ L G       + +I EY   G+L   LR+           R  
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
             +    + + +   +A+    + IHRD+   N+LL +    KIGDFG +    +  + +
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 177 CG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                   + ++APE + +  +    D W+ GIL +E F  G  P+
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 263

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/240 (22%), Positives = 104/240 (43%), Gaps = 25/240 (10%)
Query: 14  REWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +E SL        LG+ +FG+VY   L      +   A+ I   +   +  ++ + R E 
Sbjct: 21  KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEA 80
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT------- 123
            +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +         
Sbjct: 81  MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 140
Query: 124 ---------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-RSKR 173
                     +A +   + Y   +HV+H+D+   N+L+  +  +KI D G   +   +  
Sbjct: 141 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 200
Query: 174 HTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           + + G     + ++APE +   +     D W+ G++ +E F YG  P+   S +D    I
Sbjct: 201 YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI 260

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 105/243 (43%), Gaps = 25/243 (10%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            + +E SL        LG+ +FG+VY   L      +   A+ I   +   +  ++ + R
Sbjct: 1   GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT---- 123
            E  +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +      
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 124 ------------YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS-R 170
                        +A +   + Y   +HV+H+D+   N+L+  +  +KI D G   +   
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 171 SKRHTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTF 225
           +  + + G     + ++APE +   +     D W+ G++ +E F YG  P+   S +D  
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 226 RSI 228
             I
Sbjct: 241 EMI 243

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 83/155 (53%), Gaps = 13/155 (8%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQSSL 76
           ++EI   +G+G +G VYL  +  +   VA+K +   F++ I+  +I     RE+ I + L
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRI----LREITILNRL 84
Query: 77  RHPNILRLYGWFHDDE-----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +   I+RL+     ++      ++++LE A   +L +  +     TEQ   T + +L   
Sbjct: 85  KSDYIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLG 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
             + HE+ +IHRD+KP N LL+ +  +KI DFG +
Sbjct: 144 EKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 8   EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 65
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 66  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 185
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 186 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 242

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 117/269 (43%), Gaps = 27/269 (10%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D E    LG+G +G V   R V S    A+K I        + Q +L  +++I  
Sbjct: 30  EVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI--RATVNSQEQKRLLXDLDISX 87
Query: 75  -SLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRE-LRKHRRFTEQQAATYIASLTN 130
            ++  P  +  YG    +  +++  E       + Y++ + K +   E        S+  
Sbjct: 88  RTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 147
Query: 131 ALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           AL + H    VIHRD+KP N+L++  G++K  DFG S  +     +    G   Y APE 
Sbjct: 148 ALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPER 207
Query: 188 V--ENKEHDYAV--DNWTLGILCYE-----FLYGA--PPF-------EAESQKDTFRSIS 229
           +  E  +  Y+V  D W+LGI   E     F Y +   PF       E  S +      S
Sbjct: 208 INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 267
Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           AE     S+ L K+S +R +  ++ +HP+
Sbjct: 268 AEFVDFTSQCLKKNSKERPTYPELXQHPF 296

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 13  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 70
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 71  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 131 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 190
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 191 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 10  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 67
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 68  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 128 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 187
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 188 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 244

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 63
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 12  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 130 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 190 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 246

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           W L D      LG+G    V+  R  ++    A+K+     I   +      RE E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKK 63
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           L H NI++L+    +       LI+E+   G LY  L +        E +    +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 ALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            + +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLH 183
Query: 185 PEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPF 216
           P+M E         K++   VD W++G+  Y    G+ PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 37/245 (15%)
Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYK 61
           E E + K E+  ++ E G+ LG G FG+V     Y + +      VA+K++ KE+ +  +
Sbjct: 33  EYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSE 91
Query: 62  IQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQ 119
            +  L  E+++ + L  H NI+ L G       I+LI EY   G+L   LR  R +F+E 
Sbjct: 92  -REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 150
Query: 120 QA----------------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR 157
           +                         +   +   + +      +HRD+   N+L+ H   
Sbjct: 151 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV 210
Query: 158 LKIGDFGWS--VQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
           +KI DFG +  + S S    R      + ++APE +    +    D W+ GIL +E F  
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270
Query: 212 GAPPF 216
           G  P+
Sbjct: 271 GVNPY 275

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 76
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 41  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 98
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 159 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 218
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 219 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 275

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 31  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 88
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 89  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 148
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 149 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 208
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 209 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 268
Query: 221 QKDTFRSISAEAKHLIS 237
               F  +  E   ++S
Sbjct: 269 VDSKFYKMIKEGFRMLS 285

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 72
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 221 QKDTFRSISAEAKHLIS 237
               F  +  E   ++S
Sbjct: 253 VDSKFYKMIKEGFRMLS 269

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 26/220 (11%)
Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           W L D      LG+G    V+  R  ++    A+K+     I   +      RE E+   
Sbjct: 11  WLLSDI-----LGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKK 63
Query: 76  LRHPNILRLYGWFHDDER--IFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           L H NI++L+    +       LI+E+   G LY  L +        E +    +  +  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 131 ALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            + +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +   + GT +YL 
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLH 183
Query: 185 PEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPF 216
           P+M E         K++   VD W++G+  Y    G+ PF
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 33  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 90
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 91  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 150
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 151 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 210
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 211 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 270
Query: 221 QKDTFRSISAEAKHLIS 237
               F  +  E   ++S
Sbjct: 271 VDSKFYKMIKEGFRMLS 287

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 4/189 (2%)
Query: 35  VYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI 94
           VY   +   +  VALK+  +        + + +RE      L+ P+++ ++ +   D ++
Sbjct: 50  VYEAEDTVRERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQL 109
Query: 95  FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH 154
           ++     +  +L   LR+       +A   +  + +AL   H     HRD+KPEN+L+  
Sbjct: 110 YVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSA 169
Query: 155 EGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL 210
           +    + DFG +  +  ++ T      GTL Y APE        Y  D + L  + YE L
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECL 229
Query: 211 YGAPPFEAE 219
            G+PP++ +
Sbjct: 230 TGSPPYQGD 238

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 95
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 216 RHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275
Query: 221 QKDTFRSISAEAKHLIS 237
               F  +  E   ++S
Sbjct: 276 VDSKFYKMIKEGFRMLS 292

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/257 (23%), Positives = 107/257 (41%), Gaps = 32/257 (12%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V     Y + + ++   VA+K++  +       +  
Sbjct: 38  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREA 95
Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAAT 123
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R  F   + + 
Sbjct: 96  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 124 YIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            I                   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 215
Query: 167 VQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E F  G+ P+    
Sbjct: 216 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 275
Query: 221 QKDTFRSISAEAKHLIS 237
               F  +  E   ++S
Sbjct: 276 VDSKFYKMIKEGFRMLS 292

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++LR+    T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQ--TLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 9   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 66
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R            S
Sbjct: 67  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 186
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 187 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 243

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 63
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R   E        S
Sbjct: 64  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N  +  +  +KIGDFG +    ++   R 
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRK 183
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 184 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 240

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 10/194 (5%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 134
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 135 RDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQ 194
Query: 197 VDNWTLGILCYEFL 210
            D W+ G++ YE  
Sbjct: 195 SDVWSFGVVLYELF 208

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 103/237 (43%), Gaps = 25/237 (10%)
Query: 15  EWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHP---VALKIIFKEQIEKYKIQHQLR 67
           EW +  +   + R LG+G FG VY  + + V    P   VA+K + +    + +I+    
Sbjct: 19  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 76
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +       +++RL G     +   +I+E   RG+L   LR  R            S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 128 LT----------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
           L+          + +AY + N  +HRD+   N ++  +  +KIGDFG +    ++   R 
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI 228
              G L   +++PE +++       D W+ G++ +E    A  P++  S +   R +
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/235 (23%), Positives = 106/235 (45%), Gaps = 23/235 (9%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+     E
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FLNE 69
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE----------Q 119
             +       +++RL G     +   +++E    G+L   LR  R   E          Q
Sbjct: 70  ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 129
Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM 176
           +     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R   
Sbjct: 130 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG 189
Query: 177 CGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
            G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 190 KGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 244

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HRD+   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           LG G FG V   + R  + +  VA+K++ K+  EK   + ++ RE +I   L +P I+RL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTE-EMMREAQIMHQLDNPYIVRL 401
Query: 85  YGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHENHVIHR 143
            G     E + L++E A  G L++ L  K         A  +  ++  + Y  E + +HR
Sbjct: 402 IG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 144 DIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
           ++   N+LL +    KI DFG S          + R      L + APE +  ++     
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 198 DNWTLGILCYEFL-YGAPPFE 217
           D W+ G+  +E L YG  P++
Sbjct: 521 DVWSYGVTMWEALSYGQKPYK 541

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 15/225 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 7   KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 61
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 62  NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 120
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLA 184
              +A+  + + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 121 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 180
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           PE +         D W+ GIL  E + YG  P+   S  +  R++
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/296 (23%), Positives = 130/296 (43%), Gaps = 61/296 (20%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 66
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 67  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGW-----SV 167
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG      S 
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 168 QS--RSKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFLY-GAPPF- 216
           QS  R+  +   GT  + APE++E   +         ++D +++G + Y  L  G  PF 
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 217 -----EAESQKDTF----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                E+   +  F          RS+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 174 KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 228
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 229 NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 287
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
              +A+  + + IHRD++  N+L+      KI DFG +      R      + + APE +
Sbjct: 288 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA------RVGAKFPIKWTAPEAI 341
Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
                    D W+ GIL  E + YG  P+   S  +  R++
Sbjct: 342 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 382

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 10/194 (5%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 138 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 197
Query: 197 VDNWTLGILCYEFL 210
            D W+ G++ YE  
Sbjct: 198 SDVWSFGVVLYELF 211

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/314 (22%), Positives = 138/314 (43%), Gaps = 67/314 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 ---IIKNANPRGTC 269
              ++K+    G+ 
Sbjct: 324 FYTVVKDQARMGSS 337

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 85/194 (43%), Gaps = 10/194 (5%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 138
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG +            R      + + APE + +      
Sbjct: 139 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 198
Query: 197 VDNWTLGILCYEFL 210
            D W+ G++ YE  
Sbjct: 199 SDVWSFGVVLYELF 212

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 37  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 91
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 92  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 148
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 149 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 208
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 209 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 268
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 269 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 328
Query: 259 I 259
Sbjct: 329 F 329

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G++  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 15/225 (6%)
Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W +  +  ++ + LG G+FG V++     +KH    K+  K              E 
Sbjct: 180 KDAWEIPRESLKLEKKLGAGQFGEVWMA--TYNKH---TKVAVKTMKPGSMSVEAFLAEA 234
Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ--QAATYIASL 128
            +  +L+H  +++L+      E I++I E+  +G L   L+      +   +   + A +
Sbjct: 235 NVMKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLA 184
              +A+  + + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 353
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           PE +         D W+ GIL  E + YG  P+   S  +  R++
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 398

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/301 (22%), Positives = 131/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+    + +      + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 31  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 85
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 259 I 259
Sbjct: 323 F 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 31  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 85
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 86  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 142
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 259 I 259
Sbjct: 323 F 323

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 30  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 84
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 141
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 201
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 259 I 259
Sbjct: 322 F 322

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 132/301 (43%), Gaps = 64/301 (21%)
Query: 15  EWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           EW  QD +++ R LG+GK+  V+     E+ +    + +  + ++  K +   R    ++
Sbjct: 32  EWGNQDDYQLVRKLGRGKYSEVF-----EAINITNNEKVVVKILKPVKKKKIKREIKILE 86
Query: 74  SSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +    PNI+ L     D       L+ E+ +  + +++L  ++  T+     Y+  +  A
Sbjct: 87  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD-FKQL--YQTLTDYDIRFYMYEILKA 143
Query: 132 LAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-M 187
           L YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +  PE +
Sbjct: 144 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 203
Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPF------------------------------- 216
           V+ + +DY++D W+LG +    ++   PF                               
Sbjct: 204 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 263
Query: 217 ----------EAESQKDTFRSISAEAKHLIS--------RLLVKDSSKRLSLQKIMEHPW 258
                        S+K   R + +E +HL+S        +LL  D   RL+ ++ MEHP+
Sbjct: 264 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 323
Query: 259 I 259
Sbjct: 324 F 324

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 10/194 (5%)
Query: 27  LGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY 85
           LGKG FG V L R +    +  AL  + + Q      Q   +RE++I  +L    I++  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 86  GWFHDDER--IFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIH 142
           G  +   R  + L++EY   G L   L++HR R    +   Y + +   + Y      +H
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150
Query: 143 RDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMC-----GTLDYLAPEMVENKEHDYA 196
           RD+   N+L++ E  +KI DFG + +    K + +        + + APE + +      
Sbjct: 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210
Query: 197 VDNWTLGILCYEFL 210
            D W+ G++ YE  
Sbjct: 211 SDVWSFGVVLYELF 224

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G++  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +G G FG+VY  ++R+      VALK   +   E  +   +   E+E  S  RHP+++ L
Sbjct: 47  IGHGVFGKVYKGVLRD---GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFT-----EQQAATYIASLTNALAYCHENH 139
            G+  +   + LI +Y   G L R L      T     EQ+    I +    L Y H   
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA-ARGLHYLHTRA 159
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMVENKEHD 194
           +IHRD+K  N+LLD     KI DFG S +      T     + GTL Y+ PE        
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 195 YAVDNWTLGILCYEFL 210
              D ++ G++ +E L
Sbjct: 220 EKSDVYSFGVVLFEVL 235

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 89/196 (45%), Gaps = 19/196 (9%)
Query: 27  LGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           +G G FG+VY  ++R+      VALK   +   E  +   +   E+E  S  RHP+++ L
Sbjct: 47  IGHGVFGKVYKGVLRD---GAKVALK---RRTPESSQGIEEFETEIETLSFCRHPHLVSL 100
Query: 85  YGWFHDDERIFLILEYAHRGELYRELRKHRRFT-----EQQAATYIASLTNALAYCHENH 139
            G+  +   + LI +Y   G L R L      T     EQ+    I +    L Y H   
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA-ARGLHYLHTRA 159
Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-----MCGTLDYLAPEMVENKEHD 194
           +IHRD+K  N+LLD     KI DFG S +      T     + GTL Y+ PE        
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLT 219
Query: 195 YAVDNWTLGILCYEFL 210
              D ++ G++ +E L
Sbjct: 220 EKSDVYSFGVVLFEVL 235

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 12  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 69
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 70  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HR++   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 189
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 190 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 246

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/237 (23%), Positives = 107/237 (45%), Gaps = 25/237 (10%)
Query: 15  EW--SLQDFEIGRPLGKGKFGRVY--LVREV---ESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  S +   + R LG+G FG VY    R++   E++  VA+K + +    + +I+    
Sbjct: 11  EWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE--FL 68
Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE--------- 118
            E  +       +++RL G     +   +++E    G+L   LR  R   E         
Sbjct: 69  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 119 -QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRH 174
            Q+     A + + +AY +    +HR++   N ++ H+  +KIGDFG +    ++   R 
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK 188
Query: 175 TMCGTLD--YLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFRSI 228
              G L   ++APE +++     + D W+ G++ +E    A  P++  S +   + +
Sbjct: 189 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 27/241 (11%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 116 -----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-----W 165
                 T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG     +
Sbjct: 136 LYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIY 195
Query: 166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                 ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      + 
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255
Query: 225 F 225
           F
Sbjct: 256 F 256

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 37/237 (15%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+   + E  R +G+G FGRV+  R       E    VA+K++ +E      +Q   +RE
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE 100
Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT-------EQQAA 122
             + +   +PNI++L G     + + L+ EY   G+L   LR     T       +    
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 123 TYIAS-----------------LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
             ++S                 +   +AY  E   +HRD+   N L+     +KI DFG 
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 166 SVQSRSKRHTMCGTLD-----YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           S    S  +      D     ++ PE +    +    D W  G++ +E F YG  P+
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 97/241 (40%), Gaps = 33/241 (13%)
Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFK--EQIEKYKIQHQLR 67
           N K E+   + + G+ LG G FG+V         K    LK+  K  +       +  L 
Sbjct: 23  NEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM 82
Query: 68  REMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH------------- 113
            E++I S L +H NI+ L G       + +I EY   G+L   LR+              
Sbjct: 83  SELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 114 ----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
                     R    +    + + +   +A+    + IHRD+   N+LL +    KIGDF
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 164 GWSVQSRSKRHTMCG-----TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFE 217
           G +    +  + +        + ++APE + +  +    D W+ GIL +E F  G  P+ 
Sbjct: 203 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 262
Query: 218 A 218
Sbjct: 263 G 263

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 16/230 (6%)
Query: 14  REWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           +EW +  +  EIG  +GKG+FG+VY  R       VA+++I  E+  + +++   +RE+ 
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLK-AFKREVM 81
Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS-LTN 130
                RH N++   G       + +I        LY  +R  +   +      IA  +  
Sbjct: 82  AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-WSVQS-------RSKRHTMCGTLDY 182
            + Y H   ++H+D+K +N+  D+ G++ I DFG +S+           K     G L +
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200
Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEA 232
           LAPE++     D   D          F  G   +E  +++  F++  AEA
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 27/241 (11%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKD 135
Query: 116 -----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-----W 165
                 T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG     +
Sbjct: 136 LYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIY 195
Query: 166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                 ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      + 
Sbjct: 196 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 255
Query: 225 F 225
           F
Sbjct: 256 F 256

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 104/240 (43%), Gaps = 33/240 (13%)
Query: 17  SLQDFEIG------RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++  F++G      +PLG G  G V+   + +    VA+K I     +   ++H LR E+
Sbjct: 3   NIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALR-EI 59
Query: 71  EIQSSLRHPNILRLY--------------GWFHDDERIFLILEYAHRGELYRELRKHRRF 116
           +I   L H NI++++              G   +   ++++ EY         + +    
Sbjct: 60  KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPL 117
Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS----VQSRS 171
            E+ A  ++  L   L Y H  +V+HRD+KP NL ++ E   LKIGDFG +         
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 172 KRHTMCGTLD--YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI 228
           K H   G +   Y +P  ++    +  A+D W  G +  E L G   F    + +  + I
Sbjct: 178 KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 23  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 77
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 78  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 197 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 225

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/260 (23%), Positives = 109/260 (41%), Gaps = 31/260 (11%)
Query: 15  EWSLQDFEIGRPLGKGKFGRVY-LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           +W  + +EI   LG+G FGRV   V        VALKII  + +EKYK   +L   +  +
Sbjct: 29  DWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKII--KNVEKYKEAARLEINVLEK 86
Query: 74  SSLRHPN----ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE---QQAATYIA 126
            + + P+     ++++ WF  D    + + +   G    +  K   +      Q      
Sbjct: 87  INEKDPDNKNLCVQMFDWF--DYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAF 144
Query: 127 SLTNALAYCHENHVIHRDIKPENLLL---DHE----------------GRLKIGDFGWSV 167
            L  A+ + H+N + H D+KPEN+L    D+E                  +++ DFG + 
Sbjct: 145 QLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSAT 204
Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS 227
                  T+  T  Y APE++         D W++G + +E+  G   F+    ++    
Sbjct: 205 FDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAM 264
Query: 228 ISAEAKHLISRLLVKDSSKR 247
           +      + SR++ K   ++
Sbjct: 265 MERILGPIPSRMIRKTRKQK 284

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 22  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 76
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 77  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 196 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 224

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 131/310 (42%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 80
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 81  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 135
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM--CGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +    +    T  Y A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 196 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 255
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 256 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 313
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 314 VDEALQHPYI 323

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 29  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 83
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 84  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 203 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 231

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 30  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 84
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 85  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 204 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 232

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 103/243 (42%), Gaps = 29/243 (11%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKML--KEGATHSEHR 77
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKP 137
Query: 116 -------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
                   T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +  
Sbjct: 138 EDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 169 -----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
                   ++      L ++APE + ++ +    D W+ G+L +E F  GA P+      
Sbjct: 198 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 223 DTF 225
           + F
Sbjct: 258 EEF 260

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/310 (20%), Positives = 129/310 (41%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWFHDD------ERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F         + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD--YLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +        +   Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALK--ASQARDLLSKMLVIDASKRIS 311
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 312 VDEALQHPYI 321

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 27  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 82  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 127/292 (43%), Gaps = 57/292 (19%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 85  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWSVQ---- 168
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG   +    
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 169 ---SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPF----- 216
               R   +   GT  + APE++E    +    ++D +++G + Y  L  G  PF     
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 217 -EAESQKDTF----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
            E+   +  F          RS+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G +  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTF 225
             + F
Sbjct: 256 IDEEF 260

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 27  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 81
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 82  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 201 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 229

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 26  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 80
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 81  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 200 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 228

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/292 (23%), Positives = 127/292 (43%), Gaps = 57/292 (19%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 28  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 84
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 85  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 139
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWSVQ---- 168
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG   +    
Sbjct: 140 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 199
Query: 169 ---SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPF----- 216
               R   +   GT  + APE++E    +    ++D +++G + Y  L  G  PF     
Sbjct: 200 QXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 259
Query: 217 -EAESQKDTF----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
            E+   +  F          RS+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 260 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 21  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 76  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 223

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTF 225
             + F
Sbjct: 247 IDEEF 251

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 30/244 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+      +G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 19  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 76
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 77  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 116 --------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                    T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG + 
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 168 Q-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                    ++      L ++APE + ++ +    D W+ G+L +E F  GA P+     
Sbjct: 197 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 222 KDTF 225
            + F
Sbjct: 257 DEEF 260

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTF 225
             + F
Sbjct: 256 IDEEF 260

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G +  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 130/310 (41%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 312
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 313 VDEALQHPYI 322

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G +  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 31  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 85
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 86  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 205 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 233

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 130/310 (41%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 311
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 312 VDEALQHPYI 321

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 126/296 (42%), Gaps = 61/296 (20%)
Query: 15  EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E SL++  +  + LG G  G V      + + PVA+K +  +  +   ++ +L  E +  
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQGSFQGR-PVAVKRMLIDFCDIALMEIKLLTESD-- 66
Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ--------AATYI 125
               HPN++R Y     D  +++ LE  +     ++L + +  +++           + +
Sbjct: 67  ---DHPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK-------------IGDFGWS------ 166
             + + +A+ H   +IHRD+KP+N+L+    R               I DFG        
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 167 -VQSRSKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFLY-GAPPF- 216
               R   +   GT  + APE++E   +         ++D +++G + Y  L  G  PF 
Sbjct: 182 QXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 217 -----EAESQKDTF----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                E+   +  F          RS+ AEA  LIS+++  D  KR +  K++ HP
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 92/190 (48%), Gaps = 15/190 (7%)
Query: 21  FEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +E+   +  G  G +YL   R V  + PV LK +      + +      R+    + + H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGR-PVVLKGLVHSGDAEAQAMAMAERQF--LAEVVH 138
Query: 79  PNILRLYGWF-----HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           P+I++++ +      H D   ++++EY     L R   K ++    +A  Y+  +  AL+
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRS--KGQKLPVAEAIAYLLEILPALS 196
Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEH 193
           Y H   +++ D+KPEN++L  E +LK+ D G +V   +    + GT  + APE+V     
Sbjct: 197 YLHSIGLVYNDLKPENIMLTEE-QLKLIDLG-AVSRINSFGYLYGTPGFQAPEIVRTGP- 253
Query: 194 DYAVDNWTLG 203
             A D +T+G
Sbjct: 254 TVATDIYTVG 263

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 16  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 70
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHRD
Sbjct: 71  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 190 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 133/310 (42%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLY----------------GAPP-------- 215
           PE++    +   VD W++G     ++C++ L+                G P         
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQ 253
Query: 216 --------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
                                     F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 254 PTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 311
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 312 VDEALQHPYI 321

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----KIQHQLRREMEIQSSL 76
           F + R +G G FGRV L + +++K   A+K++    I+KY    KI+  + ++++     
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAY 134
            +  + + +G F   + + LI E      LY  + +  +  F  +    Y   +  AL Y
Sbjct: 95  NNNIV-KYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152
Query: 135 CHENHVIHRDIKPENLLLDH--------------EGR-----------LKIGDFGWSVQS 169
             +  + H D+KPEN+LLD               +G+           +K+ DFG +   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
                ++  T  Y APE++ N   D + D W+ G +  E   G+  F
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 55  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 112
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 232
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 233 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292
Query: 221 QKDTF 225
             + F
Sbjct: 293 IDEEF 297

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 75
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 76  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 221 QKDTF 225
             + F
Sbjct: 256 IDEEF 260

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 19/210 (9%)
Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           + +R   +  Q F+    LG G +G V+ VR  E     A+K   +        + + R+
Sbjct: 47  DPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVK---RSMSPFRGPKDRARK 103
Query: 69  EMEIQS---SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQ 120
             E+ S     +HP  +RL   + +   ++L  E          L++H         E Q
Sbjct: 104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGP-----SLQQHCEAWGASLPEAQ 158
Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCG 178
              Y+     ALA+ H   ++H D+KP N+ L   GR K+GDFG  V+  +        G
Sbjct: 159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEG 218
Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYE 208
              Y+APE+++   +  A D ++LG+   E
Sbjct: 219 DPRYMAPELLQGS-YGTAADVFSLGLTILE 247

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 126/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 116
Query: 75  SLRHPNILRLYGWFHDD------ERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F         + ++L++E   A+  ++ +    H R +       + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 171
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 349
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 350 VDDALQHPYI 359

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 130/310 (41%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 311
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 312 VDEALQHPYI 321

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G +  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 133/310 (42%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLY----------------GAPP-------- 215
           PE++    +   VD W++G     ++C++ L+                G P         
Sbjct: 188 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 216 --------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
                                     F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 248 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 305
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 306 VDEALQHPYI 315

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 133/310 (42%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 83
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 84  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 138
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 139 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 198
Query: 185 PEMVENKEHDYAVDNWTLG-----ILCYEFLY----------------GAPP-------- 215
           PE++    +   VD W++G     ++C++ L+                G P         
Sbjct: 199 PEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 258
Query: 216 --------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
                                     F A+S+ +  +  +++A+ L+S++LV D+SKR+S
Sbjct: 259 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLK--ASQARDLLSKMLVIDASKRIS 316
Query: 250 LQKIMEHPWI 259
           + + ++HP+I
Sbjct: 317 VDEALQHPYI 326

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 103/245 (42%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 77
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I+E+   G L   LR  R        
Sbjct: 78  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE 137
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 138 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 197
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 198 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 257
Query: 221 QKDTF 225
             + F
Sbjct: 258 IDEEF 262

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 20/218 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            D +    +G+G FG+V   R  +    +   I   ++            E+E+   L  
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQA 121
           HPNI+ L G       ++L +EYA  G L   LRK R                  + QQ 
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD 181
             + A +   + Y  +   IHRD+   N+L+      KI DFG S           G L 
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 182 --YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
             ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 232

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 85/218 (38%), Gaps = 20/218 (9%)
Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-R 77
            D +    +G+G FG+V   R  +    +   I   ++            E+E+   L  
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQA 121
           HPNI+ L G       ++L +EYA  G L   LRK R                  + QQ 
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD 181
             + A +   + Y  +   IHRD+   N+L+      KI DFG S           G L 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 182 --YLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPF 216
             ++A E +    +    D W+ G+L +E +  G  P+
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 116
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 171
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 349
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 350 VDDALQHPYI 359

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 312
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 313 VDDALQHPYI 322

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG +
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 167 VQ-----SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                     ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTF 225
             + F
Sbjct: 247 IDEEF 251

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 79
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 80  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 134
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 254
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 255 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 312
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 313 VDDALQHPYI 322

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 77
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 78  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 132
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 133 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 192
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 252
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 253 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 310
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 311 VDDALQHPYI 320

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 77  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 136 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 195
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 196 IYTHQSDVWSYGVTVWELMTFGSKPYDG 223

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 155 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 215 TKSDVWSFGVLLWELMTRGAPPY 237

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 71
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 126
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 304
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 305 VDDALQHPYI 314

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 305
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 306 VDDALQHPYI 315

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/308 (20%), Positives = 125/308 (40%), Gaps = 75/308 (24%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +   +  VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + +++++E   A+  ++ +    H R +       + 
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------- 228
           PE++    +   VD W++G +  E + G   F      D +  +                
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQ 253
Query: 229 -------------------------------------SAEAKHLISRLLVKDSSKRLSLQ 251
                                                +++A+ L+S++LV D+SKR+S+ 
Sbjct: 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD 313
Query: 252 KIMEHPWI 259
           + ++HP+I
Sbjct: 314 EALQHPYI 321

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 71
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 72  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 126
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 127 QMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 304
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 305 VDDALQHPYI 314

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 173
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 174 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 233
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 234 TKSDVWSFGVLLWELMTRGAPPY 256

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTF 225
             + F
Sbjct: 247 IDEEF 251

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 72
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 73  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 127
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 128 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 187
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 247
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 248 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 305
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 306 VDDALQHPYI 315

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/245 (22%), Positives = 102/245 (41%), Gaps = 31/245 (12%)
Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRV-----YLVREVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V     + + +  +   VA+K++  ++   +    
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHR 66
Query: 65  QLRREMEIQSSL-RHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR------- 115
            L  E++I   +  H N++ L G        + +I E+   G L   LR  R        
Sbjct: 67  ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 116 ---------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG-- 164
                     T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG  
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186
Query: 165 ---WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
              +      ++      L ++APE + ++ +    D W+ G+L +E F  GA P+    
Sbjct: 187 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 246
Query: 221 QKDTF 225
             + F
Sbjct: 247 IDEEF 251

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 174
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 175 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 234
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 235 TKSDVWSFGVLLWELMTRGAPPY 257

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPY 238

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++         VA+K +    +           E +I   L+H  +++LY 
Sbjct: 17  LGNGQFGEVWM-GTWNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQLYA 71
Query: 87  WFHDDERIFLILEYAHRGELYRELR--KHRRFTEQQAATYIASLTNALAYCHENHVIHRD 144
               +E I+++ EY ++G L   L+  + R           A +   +AY    + IHRD
Sbjct: 72  -VVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 130
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+ +    KI DFG +        + R      + + APE           D W
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 201 TLGILCYEFLY-GAPPFEAESQKDTFRSI 228
           + GIL  E +  G  P+   + ++    +
Sbjct: 191 SFGILLTELVTKGRVPYPGMNNREVLEQV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 147
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 148 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 207
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 208 TKSDVWSFGVLLWELMTRGAPPY 230

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/310 (20%), Positives = 127/310 (40%), Gaps = 79/310 (25%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA----KRAYRELVLMK 78
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEY--AHRGELYRELRKHRRFTEQQAATYIA 126
            + H NI+ L   F       + + ++L++E   A+  ++ +    H R +       + 
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLY 133
Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RHTMCGTLDYLA 184
            +   + + H   +IHRD+KP N+++  +  LKI DFG +  + +         T  Y A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEMVENKEHDYAVDNWTLGIL------------------------------CYEFLYGAP 214
           PE++    +   VD W++G +                              C EF+    
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 253
Query: 215 P-------------------------FEAESQKDTFRSISAEAKHLISRLLVKDSSKRLS 249
           P                         F A+S+ +  +  +++A+ L+S++LV D +KR+S
Sbjct: 254 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLK--ASQARDLLSKMLVIDPAKRIS 311
Query: 250 LQKIMEHPWI 259
           +   ++HP+I
Sbjct: 312 VDDALQHPYI 321

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 153
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 154 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 213
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 214 TKSDVWSFGVLLWELMTRGAPPY 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 152
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPY 235

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I++++EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEF 209
            W+ GIL  E 
Sbjct: 198 VWSFGILLTEL 208

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 210
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 211 TKSDVWSFGVLLWELMTRGAPPY 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 154
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 155 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 214
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 215 TKSDVWSFGVLLWELMTRGAPPY 237

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + Y      +
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 155
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 156 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT 215
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 216 TKSDVWSFGVLLWELMTRGAPPY 238

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 44/284 (15%)
Query: 25  RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL 84
           R L +G F  VY  ++V S    ALK +   + EK +   Q    M+  S   HPNI++ 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG--HPNIVQF 91
Query: 85  -----YGWFHDD--ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
                 G    D  +  FL+L    +G+L   L+K          T +            
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 138 NH-----VIHRDIKPENLLLDHEGRLKIGDFG------------WSVQSRS---KRHTMC 177
            H     +IHRD+K ENLLL ++G +K+ DFG            WS Q R+   +  T  
Sbjct: 152 MHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKH 234
            T  Y  PE+++   N       D W LG + Y   +   PFE  ++        +   H
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPH 271
Query: 235 ---------LISRLLVKDSSKRLSLQKI---MEHPWIIKNANPR 266
                    LI  +L  +  +RLS+ ++   ++     +N NP+
Sbjct: 272 DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 80  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 139 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 198
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 199 IYTHQSDVWSYGVTVWELMTFGSKPYDG 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/313 (20%), Positives = 126/313 (40%), Gaps = 73/313 (23%)
Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLRREMEIQS 74
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q        +  RE+ +  
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA----KRAYRELVLLK 76
Query: 75  SLRHPNILRLYGWF------HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
            + H NI+ L   F       + + ++L++E      L + +  H     ++ +  +  +
Sbjct: 77  CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI--HMELDHERMSYLLYQM 133
Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLAP 185
              + + H   +IHRD+KP N+++  +  LKI DFG + ++ S    M     T  Y AP
Sbjct: 134 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTASTNFMMTPYVVTRYYRAP 192
Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------- 228
           E++    +   VD W++G +  E + G+  F+     D +  +                 
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQP 252
Query: 229 ------------------------------------SAEAKHLISRLLVKDSSKRLSLQK 252
                                               +++A+ L+S++LV D  KR+S+ +
Sbjct: 253 TVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDE 312
Query: 253 IMEHPWIIKNANP 265
            + HP+I    +P
Sbjct: 313 ALRHPYITVWYDP 325

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 83/191 (43%), Gaps = 16/191 (8%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG+G FG V++     +   VA+K +    +          +E ++   LRH  +++LY 
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYA 80
Query: 87  WFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
               +E I++++EY  +G L      E+ K+ R    Q     A + + +AY    + +H
Sbjct: 81  -VVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERMNYVH 137
Query: 143 RDIKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVD 198
           RD++  N+L+      K+ DFG +        + R      + + APE           D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 199 NWTLGILCYEF 209
            W+ GIL  E 
Sbjct: 198 VWSFGILLTEL 208

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI++    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/209 (22%), Positives = 86/209 (41%), Gaps = 13/209 (6%)
Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG 86
           LG G+FG V++       +    K+  K   +          E  +   L+H  ++RLY 
Sbjct: 17  LGAGQFGEVWM-----GYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 71
Query: 87  WFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRD 144
                E I++I EY   G L   L+     + T  +     A +   +A+  E + IHR+
Sbjct: 72  -VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 145 IKPENLLLDHEGRLKIGDFGWSV----QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
           ++  N+L+      KI DFG +        + R      + + APE +         D W
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 201 TLGILCYEFL-YGAPPFEAESQKDTFRSI 228
           + GIL  E + +G  P+   +  +  +++
Sbjct: 191 SFGILLTEIVTHGRIPYPGMTNPEVIQNL 219

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 70/125 (56%), Gaps = 7/125 (5%)
Query: 96  LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH- 154
           L+ EY +  + +++L  ++  T+     Y+  L  AL YCH   ++HRD+KP N+++DH 
Sbjct: 112 LVFEYINNTD-FKQL--YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 168
Query: 155 EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLY 211
           + +L++ D+G +       + +    +  +  PE +V+ + +DY++D W+LG +    ++
Sbjct: 169 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 228
Query: 212 GAPPF 216
              PF
Sbjct: 229 RREPF 233

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 70  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDG 216

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 70/125 (56%), Gaps = 7/125 (5%)
Query: 96  LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH- 154
           L+ EY +  + +++L  ++  T+     Y+  L  AL YCH   ++HRD+KP N+++DH 
Sbjct: 117 LVFEYINNTD-FKQL--YQILTDFDIRFYMYELLKALDYCHSKGIMHRDVKPHNVMIDHQ 173
Query: 155 EGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLY 211
           + +L++ D+G +       + +    +  +  PE +V+ + +DY++D W+LG +    ++
Sbjct: 174 QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 233
Query: 212 GAPPF 216
              PF
Sbjct: 234 RREPF 238

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 76  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDG 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 82  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 141 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 200
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 201 IYTHQSDVWSYGVTVWELMTFGSKPYDG 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 78  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 137 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 196
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 197 IYTHQSDVWSYGVTVWELMTFGSKPYDG 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 86  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 145 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 204
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 205 IYTHQSDVWSYGVTVWELMTFGSKPYDG 232

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 79  NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 138 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 197
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 198 IYTHQSDVWSYGVTVWELMTFGSKPYDG 225

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 96/208 (46%), Gaps = 10/208 (4%)
Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y  
Sbjct: 101 NPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCG---TLDYLAPEMVENK 191
           +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + ++
Sbjct: 160 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 219
Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEA 218
            + +  D W+ G+  +E + +G+ P++ 
Sbjct: 220 IYTHQSDVWSYGVTVWELMTFGSKPYDG 247

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 15/203 (7%)
Query: 27  LGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR 83
           +G+G FG VY   L+     K   A+K +   +I       Q   E  I     HPN+L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 84  LYG-WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVI 141
           L G     +    ++L Y   G+L   +R      T +    +   +   + +      +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGT---LDYLAPEMVENKEHD 194
           HRD+   N +LD +  +K+ DFG +     K     H   G    + ++A E ++ ++  
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 274
Query: 195 YAVDNWTLGILCYEFLY-GAPPF 216
              D W+ G+L +E +  GAPP+
Sbjct: 275 TKSDVWSFGVLLWELMTRGAPPY 297
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	271
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-154
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-154
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-146
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-133
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-132
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-120
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-94
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-93
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-90
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-88
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-86
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-86
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-85
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-85
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-84
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-84
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-84
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-84
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-84
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-84
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-83
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-83
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-83
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-83
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-83
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-83
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-83
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-83
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-82
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-82
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-82
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-82
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-82
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-81
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-81
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-81
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-81
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-81
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-81
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-81
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-81
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-81
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-81
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-81
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-81
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-81
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-81
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-80
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-80
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-80
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-80
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-80
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-80
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-80
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-79
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-79
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-79
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-79
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-79
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-79
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-78
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-78
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-78
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-78
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-78
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-78
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-77
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-77
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-77
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-77
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-77
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-77
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-77
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-76
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-76
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-76
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-76
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-75
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-74
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-73
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-73
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-72
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-72
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-72
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-71
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-69
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-69
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-68
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-67
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-66
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-66
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-64
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-63
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-63
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-62
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-61
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-60
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-58
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-55
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-55
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-55
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-54
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-53
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-53
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-52
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-52
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-52
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-52
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-51
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-50
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-50
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-50
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-44
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-44
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-44
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-44
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-43
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-43
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-43
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-43
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-43
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-43
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-42
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-42
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-42
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-42
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-42
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-41
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-37
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-37
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-37
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-36
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-35
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-35
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-34
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-34
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-34
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-33
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-31
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-28
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-28
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-28
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-28
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-28
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-27
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-27
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-27
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-27
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-26
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-26
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-26
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-26
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-26
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-26
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-26
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-26
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-26
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-25
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-25
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-25
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-24
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-24
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-23
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-23
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-23
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-22
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-21
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-21
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-21
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-20
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-20
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-19
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-16
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	8e-04

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  429 bits (1106), Expect = e-154
 Identities = 158/271 (58%), Positives = 201/271 (74%), Gaps = 12/271 (4%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++KR+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+
Sbjct: 1   SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           EIQS LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L N
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVE 189
           AL+YCH   VIHRDIKPENLLL   G LKI DFGWSV + S +R  +CGTLDYL PEM+E
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIE 180

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISR 238
            + HD  VD W+LG+LCYEFL G PPFEA + ++T++ I           +  A+ LISR
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR 240

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTC 269
           LL  + S+R  L++++EHPWI  N++    C
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNC 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  429 bits (1105), Expect = e-154
 Identities = 153/269 (56%), Positives = 198/269 (73%), Gaps = 12/269 (4%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
            +  KR++++ DF+IGRPLGKGKFG VYL RE ++K  +ALK++FK Q+EK  ++HQLRR
Sbjct: 4   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+EIQS LRHPNILR+Y +FHD +RI+L+LE+A RGELY+EL+KH RF EQ++AT++  L
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL 123

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEM 187
            +AL YCHE  VIHRDIKPENLL+ ++G LKI DFGWSV + S +R TMCGTLDYL PEM
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEM 183

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLI 236
           +E K HD  VD W  G+LCYEFL G PPF++ S  +T R I           S  +K LI
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           S+LL     +RL L+ +MEHPW+  N+  
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRR 272

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  408 bits (1052), Expect = e-146
 Identities = 89/269 (33%), Positives = 153/269 (56%), Gaps = 15/269 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
                ++DF++G  LGKG F  VY    + +   VA+K+I K+ + K  +  +++ E++I
Sbjct: 5   CIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKI 64

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNA 131
              L+HP+IL LY +F D   ++L+LE  H GE+ R L+   + F+E +A  ++  +   
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITG 124

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMV 188
           + Y H + ++HRD+   NLLL     +KI DFG + Q +    K +T+CGT +Y++PE+ 
Sbjct: 125 MLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLIS 237
               H    D W+LG + Y  L G PPF+ ++ K+T   +           S EAK LI 
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           +LL ++ + RLSL  +++HP++ +N++ +
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRNSSTK 273

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  378 bits (973), Expect = e-133
 Identities = 80/277 (28%), Positives = 140/277 (50%), Gaps = 14/277 (5%)

Query: 4   KTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
              E  +      S + +  GR LGKG F + + + + ++K   A KI+ K  + K   +
Sbjct: 26  PAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR 85

Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
            ++  E+ I  SL H +++  +G+F D++ +F++LE   R  L    ++ +  TE +A  
Sbjct: 86  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTL 180
           Y+  +     Y H N VIHRD+K  NL L+ +  +KIGDFG + +      ++  +CGT 
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP 205

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------S 229
           +Y+APE++  K H + VD W++G + Y  L G PPFE    K+T+  I           +
Sbjct: 206 NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHIN 265

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
             A  LI ++L  D + R ++ +++   +      P 
Sbjct: 266 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  375 bits (965), Expect = e-132
 Identities = 79/268 (29%), Positives = 138/268 (51%), Gaps = 14/268 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
               S + +  GR LGKG F + + + + ++K   A KI+ K  + K   + ++  E+ I
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             SL H +++  +G+F D++ +F++LE   R  L    ++ +  TE +A  Y+  +    
Sbjct: 69  HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKRHTMCGTLDYLAPEMVE 189
            Y H N VIHRD+K  NL L+ +  +KIGDFG + +      ++  +CGT +Y+APE++ 
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISR 238
            K H + VD W++G + Y  L G PPFE    K+T+  I           +  A  LI +
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 248

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           +L  D + R ++ +++   +      P 
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPA 276

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  347 bits (891), Expect = e-120
 Identities = 69/318 (21%), Positives = 125/318 (39%), Gaps = 59/318 (18%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
                  +  ++++  + D+ I R L +GKF ++ L  +       ALK   K  +EK +
Sbjct: 14  SNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKR 71

Query: 62  --------------IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY 107
                              + E++I + +++   L   G   + + +++I EY     + 
Sbjct: 72  DFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131

Query: 108 RELRKH--------RRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPENLLLDHEGRL 158
           +                  Q     I S+ N+ +Y H E ++ HRD+KP N+L+D  GR+
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRV 191

Query: 159 KIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPP 215
           K+ DFG S      K     GT +++ PE   N+   +   VD W+LGI  Y   Y   P
Sbjct: 192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

Query: 216 FEAE-SQKDTFRSI------------------------------SAEAKHLISRLLVKDS 244
           F  + S  + F +I                              S E    +   L K+ 
Sbjct: 252 FSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP 311

Query: 245 SKRLSLQKIMEHPWIIKN 262
           ++R++ +  ++H W+   
Sbjct: 312 AERITSEDALKHEWLADT 329

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  285 bits (731), Expect = 1e-96
 Identities = 89/269 (33%), Positives = 143/269 (53%), Gaps = 22/269 (8%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           + R+   +DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE +
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           + S L HP  ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +A
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPE 186
           L Y H   +IHRD+KPEN+LL+ +  ++I DFG +        +++ ++  GT  Y++PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHL 235
           ++  K    + D W LG + Y+ + G PPF A ++   F+ I             +A+ L
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDL 262

Query: 236 ISRLLVKDSSKRL------SLQKIMEHPW 258
           + +LLV D++KRL          +  HP+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  280 bits (719), Expect = 3e-94
 Identities = 90/268 (33%), Positives = 144/268 (53%), Gaps = 16/268 (5%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + E   +    L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K     
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  I  ++  P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
            +     Y H   +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT + LAPE
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHL 235
           ++ +K ++ AVD W LG+L YE   G PPF A+     +  I           S++ K L
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268

Query: 236 ISRLLVKDSSKRLSLQK-----IMEHPW 258
           +  LL  D +KR    K     I  H W
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  277 bits (712), Expect = 1e-93
 Identities = 101/259 (38%), Positives = 150/259 (57%), Gaps = 16/259 (6%)

Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S 
Sbjct: 3   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y 
Sbjct: 63  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           H   +I+RD+KPEN+LLD  G +KI DFG++       +T+CGT DY+APE+V  K ++ 
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 182

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDS 244
           ++D W+ GIL YE L G  PF   +   T+  I           + + K L+SRL+ +D 
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 242

Query: 245 SKRL-----SLQKIMEHPW 258
           S+RL       + +  HPW
Sbjct: 243 SQRLGNLQNGTEDVKNHPW 261

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  268 bits (686), Expect = 8e-90
 Identities = 68/284 (23%), Positives = 115/284 (40%), Gaps = 40/284 (14%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +   + LG+G F  V LV  +   H  ALK I   + +    + + +RE ++     H
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNH 85

Query: 79  PNILRLYGWFHDDE----RIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTN 130
           PNILRL  +   +       +L+L +  RG L+ E+     K    TE Q    +  +  
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------------RHTMCG 178
            L   H     HRD+KP N+LL  EG+  + D G   Q+                     
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 179 TLDYLAPEMVENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQK-DTFRSI------ 228
           T+ Y APE+   + H   D   D W+LG + Y  ++G  P++   QK D+          
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265

Query: 229 -------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                  S+    L++ ++  D  +R  +  ++     ++   P
Sbjct: 266 IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  264 bits (677), Expect = 2e-88
 Identities = 62/279 (22%), Positives = 131/279 (46%), Gaps = 36/279 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+ 
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQ 85

Query: 79  PN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H
Sbjct: 86  HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENK 191
           ++ ++H D+KP N L+  +G LK+ DFG + Q     +   + +  GT++Y+ PE +++ 
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 192 -----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI----------- 228
                      +     D W+LG + Y   YG  PF +  +Q     +I           
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263

Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  257 bits (658), Expect = 4e-86
 Identities = 81/269 (30%), Positives = 133/269 (49%), Gaps = 14/269 (5%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
                  +  + +G  LG G FG+V +     + H VA+KI+ +++I    +  +++RE+
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           +     RHP+I++LY         F+++EY   GEL+  + KH R  E +A      + +
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEMV 188
           A+ YCH + V+HRD+KPEN+LLD     KI DFG S          T CG+ +Y APE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 189 ENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLI 236
             + +    VD W+ G++ Y  L G  PF+ E     F+ I           +     L+
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL 242

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
             +L  D  KR +++ I EH W  ++   
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  260 bits (666), Expect = 8e-86
 Identities = 79/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +   + +   FEI R +GKG FG+V +V++ ++K   A+K + K++  +      + +E+
Sbjct: 7   DENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL 66

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
           +I   L HP ++ L+  F D+E +F++++    G+L   L+++  F E+    +I  L  
Sbjct: 67  QIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM 126

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           AL Y     +IHRD+KP+N+LLD  G + I DF  +  +   ++  TM GT  Y+APEM 
Sbjct: 127 ALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMF 186

Query: 189 ENKE---HDYAVDNWTLGILCYEFLYGAPPFE---AESQKDTFRSI-----------SAE 231
            +++   + +AVD W+LG+  YE L G  P+    + S K+   +            S E
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246

Query: 232 AKHLISRLLVKDSSKRL-SLQKIMEHPW 258
              L+ +LL  +  +R   L  +   P+
Sbjct: 247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY 274

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  258 bits (660), Expect = 2e-85
 Identities = 62/279 (22%), Positives = 131/279 (46%), Gaps = 36/279 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+ 
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQ 66

Query: 79  PN--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H
Sbjct: 67  HSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-----SRSKRHTMCGTLDYLAPEMVENK 191
           ++ ++H D+KP N L+  +G LK+ DFG + Q     +   + +  GT++Y+ PE +++ 
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 192 -----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI----------- 228
                      +     D W+LG + Y   YG  PF +  +Q     +I           
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244

Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
               + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  254 bits (652), Expect = 4e-85
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 22/265 (8%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 HD-YAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLIS 237
                VD W+ GI+    L G  P++  S                  ++ I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKN 262
           ++LV++ S R+++  I +  W  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  252 bits (647), Expect = 3e-84
 Identities = 87/266 (32%), Positives = 142/266 (53%), Gaps = 22/266 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LGKG FG V   ++  ++   A+K+I K   +  K    + RE+E+   L H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++L+    D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPEN+LL+ +     +KI DFG S   Q  +K     GT  Y+APE V    +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
           D   D W+ G++ Y  L G PPF  +++ D  +               +IS +AK LI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           +L    S R++  + +EHPWI K ++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSS 285

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  253 bits (648), Expect = 3e-84
 Identities = 84/274 (30%), Positives = 134/274 (48%), Gaps = 22/274 (8%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           + +     + F     LG G F  V+LV++  +    ALK I K    +      L  E+
Sbjct: 1   SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEI 57

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +   ++H NI+ L   +      +L+++    GEL+  + +   +TE+ A+  I  + +
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117

Query: 131 ALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR-HTMCGTLDYLAPE 186
           A+ Y HEN ++HRD+KPENLL    +   ++ I DFG S   ++    T CGT  Y+APE
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPE 177

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAE 231
           ++  K +  AVD W++G++ Y  L G PPF  E++   F                 IS  
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISES 237

Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           AK  I  LL KD ++R + +K + HPWI  N   
Sbjct: 238 AKDFICHLLEKDPNERYTCEKALSHPWIDGNTAL 271

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  252 bits (646), Expect = 3e-84
 Identities = 83/266 (31%), Positives = 134/266 (50%), Gaps = 24/266 (9%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           Q + +   +G+G +G V +  +  ++   A K I K  +E      + ++E+EI  SL H
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD---RFKQEIEIMKSLDH 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RLY  F D+  I+L++E    GEL+  +   R F E  AA  +  + +A+AYCH+ 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +V HRD+KPEN L      +  LK+ DFG +   +      T  GT  Y++P+ V    +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLY 184

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
               D W+ G++ Y  L G PPF A +  +                  ++S +A+ LI R
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           LL K   +R++  + +EH W  K  +
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLS 270

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  252 bits (646), Expect = 4e-84
 Identities = 63/273 (23%), Positives = 116/273 (42%), Gaps = 34/273 (12%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             DF+    +G G FG+V+  +         +K +            +  RE++  + L 
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62

Query: 78  HPNILRLYGWFHDDE----------------RIFLILEYAHRGELYRELRKHR--RFTEQ 119
           H NI+   G +   +                 +F+ +E+  +G L + + K R  +  + 
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
            A      +T  + Y H   +I+RD+KP N+ L    ++KIGDFG    +++  KR    
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTFR------SISA 230
           GTL Y++PE + ++++   VD + LG++  E L+     FE        R          
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK 242

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           + K L+ +LL K    R +  +I+    + K +
Sbjct: 243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  253 bits (649), Expect = 5e-84
 Identities = 88/269 (32%), Positives = 148/269 (55%), Gaps = 15/269 (5%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
               +  + ++ + + +GKG F +V L R + +   VA+KII K Q+    +Q  L RE+
Sbjct: 7   CADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK-LFREV 65

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            I   L HPNI++L+     ++ ++LI+EYA  GE++  L  H R  E++A +    + +
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           A+ YCH+  ++HRD+K ENLLLD +  +KI DFG+S       K    CG   Y APE+ 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 189 ENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLI 236
           + K++D   VD W+LG++ Y  + G+ PF+ ++ K+    +           S + ++L+
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLL 245

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            R LV +  KR +L++IM+  WI      
Sbjct: 246 KRFLVLNPIKRGTLEQIMKDRWINAGHEE 274

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  253 bits (647), Expect = 9e-84
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 22/265 (8%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 63

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +   R        + MCGTL Y+APE+++ +E
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 HD-YAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLIS 237
                VD W+ GI+    L G  P++  S                  ++ I +    L+ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKN 262
           ++LV++ S R+++  I +  W  K 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKP 268

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  251 bits (644), Expect = 2e-83
 Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 14/285 (4%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
            D    +    +++E     +++G  LG G FG VY    V    PVA+K + K++I  +
Sbjct: 25  NDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 84

Query: 61  KI---QHQLRREMEIQSSLRH--PNILRLYGWFHDDERIFLILEYA-HRGELYRELRKHR 114
                  ++  E+ +   +      ++RL  WF   +   LILE      +L+  + +  
Sbjct: 85  GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG 144

Query: 115 RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS-VQSRSK 172
              E+ A ++   +  A+ +CH   V+HRDIK EN+L+D   G LK+ DFG   +   + 
Sbjct: 145 ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV 204

Query: 173 RHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQ--KDTFR--- 226
                GT  Y  PE +    +   +   W+LGIL Y+ + G  PFE + +  +       
Sbjct: 205 YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ 264

Query: 227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
            +S+E +HLI   L    S R + ++I  HPW+     P+ T +I
Sbjct: 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  253 bits (647), Expect = 2e-83
 Identities = 71/265 (26%), Positives = 134/265 (50%), Gaps = 18/265 (6%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +   + +G+G FG+  LV+  E      +K I   ++   K + + RRE+ + +++
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANM 80

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAY 134
           +HPNI++    F ++  ++++++Y   G+L++ +   +   F E Q   +   +  AL +
Sbjct: 81  KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENK 191
            H+  ++HRDIK +N+ L  +G +++GDFG +     +        GT  YL+PE+ ENK
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAKHLISRL 239
            ++   D W LG + YE       FEA S K+    I            S + + L+S+L
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260

Query: 240 LVKDSSKRLSLQKIMEHPWIIKNAN 264
             ++   R S+  I+E  +I K   
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIE 285

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  251 bits (643), Expect = 3e-83
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 16/276 (5%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-KIQH 64
                 + RE    ++ +G  LGKG FG V+    +  +  VA+K+I + ++  +  +  
Sbjct: 18  TPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD 77

Query: 65  QLRREMEIQ------SSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFT 117
            +   +E+       +   HP ++RL  WF   E   L+LE      +L+  + +     
Sbjct: 78  SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG 137

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWS-VQSRSKRHT 175
           E  +  +   +  A+ +CH   V+HRDIK EN+L+D   G  K+ DFG   +        
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD 197

Query: 176 MCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQ--KDTFR---SIS 229
             GT  Y  PE +   ++       W+LGIL Y+ + G  PFE + +  +        +S
Sbjct: 198 FDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            +   LI R L    S R SL++I+  PW+   A  
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  256 bits (655), Expect = 5e-83
 Identities = 88/273 (32%), Positives = 142/273 (52%), Gaps = 21/273 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             ++  R LGKG FG V L ++  +    A+K+I K Q+++   +  L RE+++   L H
Sbjct: 26  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++LY +F D    +L+ E    GEL+ E+   +RF+E  AA  I  + + + Y H+N
Sbjct: 86  PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HRD+KPENLLL     +  ++I DFG S   ++  K     GT  Y+APE V +  +
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTY 204

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISR 238
           D   D W+ G++ Y  L G PPF   ++ D  + +               S  AK LI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           +L    S R+S +  ++H WI      + + D+
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  251 bits (644), Expect = 8e-83
 Identities = 93/267 (34%), Positives = 136/267 (50%), Gaps = 26/267 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++  + +G G FG   L+R+  +K  VA+K I +       I   ++RE+    SLRHPN
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPN 77

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+R          + +I+EYA  GELY  +    RF+E +A  +   L + ++YCH   +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137

Query: 141 IHRDIKPENLLLDH--EGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHD-Y 195
            HRD+K EN LLD     RLKI DFG+S  S   S+  +  GT  Y+APE++  +E+D  
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------------ISAEAKHLISR 238
             D W+ G+  Y  L GA PFE   +   +R                  IS E  HLISR
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANP 265
           + V D + R+S+ +I  H W +KN   
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPA 284

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  255 bits (654), Expect = 8e-83
 Identities = 87/270 (32%), Positives = 143/270 (52%), Gaps = 22/270 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LGKG FG V   ++  ++   A+K+I K   +  K    + RE+E+   L H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDH 80

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++L+    D    +++ E    GEL+ E+ K +RF+E  AA  I  + + + Y H++
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPEN+LL   + +  +KI DFG S   +  +K     GT  Y+APE V    +
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTY 199

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
           D   D W+ G++ Y  L G PPF  +++ D  +               +IS +AK LI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANPRGT 268
           +L    S R++  + +EHPWI K ++   T
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPT 289

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  249 bits (637), Expect = 8e-83
 Identities = 78/265 (29%), Positives = 130/265 (49%), Gaps = 21/265 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+H
Sbjct: 6   DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HR++KPENLLL  +     +K+ DFG +  V      H   GT  YL+PE+++   +
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
              VD W  G++ Y  L G PPF  E Q   +                +++ EAK LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNA 263
           +L  +  KR++  + ++ PWI    
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRE 269

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  247 bits (634), Expect = 2e-82
 Identities = 78/264 (29%), Positives = 126/264 (47%), Gaps = 26/264 (9%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             F   R LG G FG V+LV E  S     +K I K++ +      Q+  E+E+  SL H
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDH 79

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELY----RELRKHRRFTEQQAATYIASLTNALAY 134
           PNI++++  F D   +++++E    GEL         + +  +E   A  +  + NALAY
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
            H  HV+H+D+KPEN+L         +KI DFG +   +S        GT  Y+APE V 
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VF 198

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHL 235
            ++  +  D W+ G++ Y  L G  PF   S ++  +                + +A  L
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDL 258

Query: 236 ISRLLVKDSSKRLSLQKIMEHPWI 259
           + ++L KD  +R S  +++ H W 
Sbjct: 259 LKQMLTKDPERRPSAAQVLHHEWF 282

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  250 bits (640), Expect = 3e-82
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 21/265 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            ++++   LGKG F  V       +    A KII  +++     Q +L RE  I   L+H
Sbjct: 29  DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ-KLEREARICRKLQH 87

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +L+ +    GEL+ ++     ++E  A+  I  +  ++AYCH N
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 139 HVIHRDIKPENLLLDHEG---RLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
            ++HR++KPENLLL  +     +K+ DFG ++        H   GT  YL+PE+++   +
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
              VD W  G++ Y  L G PPF  E Q   +                +++ EAK LI  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNA 263
           +L  +  KR++  + ++ PWI    
Sbjct: 268 MLTVNPKKRITADQALKVPWICNRE 292

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  248 bits (637), Expect = 3e-82
 Identities = 92/272 (33%), Positives = 151/272 (55%), Gaps = 23/272 (8%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQI-EKYKIQHQ 65
           +    +   + FE+ R LGKG +G+V+ VR+V   +     A+K++ K  I    K    
Sbjct: 8   NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
            + E  I   ++HP I+ L   F    +++LILEY   GEL+ +L +   F E  A  Y+
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A ++ AL + H+  +I+RD+KPEN++L+H+G +K+ DFG     +   +  HT CGT++Y
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEY 187

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAE 231
           +APE++    H+ AVD W+LG L Y+ L GAPPF  E++K T   I           + E
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQE 247

Query: 232 AKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
           A+ L+ +LL ++++ RL        ++  HP+
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  248 bits (634), Expect = 5e-82
 Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 53/289 (18%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             DFE    LG+G FG+V   R        A+K I   + +       +  E+ + +SL 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLN 60

Query: 78  HPNILRLYGWFHDDER-------------IFLILEYAHRGELYRELRKHRRFT-EQQAAT 123
           H  ++R Y  + +                +F+ +EY   G LY  +          +   
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----------------- 166
               +  AL+Y H   +IHRD+KP N+ +D    +KIGDFG +                 
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF 225
             S     +  GT  Y+A E+++   H +  +D ++LGI+ +E +Y  P      + +  
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238

Query: 226 RSI---------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           + +                   K +I  L+  D +KR   + ++   W+
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  250 bits (639), Expect = 6e-82
 Identities = 40/291 (13%), Positives = 79/291 (27%), Gaps = 52/291 (17%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-- 77
               G  LG+          + E+     + + +  +        Q++ E+     LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 78  -----------------------HPNILRLYGWFHDDE--RIFLILEYAHR------GEL 106
                                     ++R+     D      F +              L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                 H+             +   LA  H   ++H  ++P +++LD  G + +  F   
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253

Query: 167 VQSRSKRHTMCGTLDYLAPEMV-----------ENKEHDYAVDNWTLGILCYEFLYGAPP 215
           V+    R     +  +  PE+                  ++ D W LG++ Y       P
Sbjct: 254 VRD-GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 216 FEAESQKDTFR-------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              ++             +I    + L+   L      RL   + ME P  
Sbjct: 313 ITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  252 bits (645), Expect = 1e-81
 Identities = 79/272 (29%), Positives = 136/272 (50%), Gaps = 14/272 (5%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +        +  + +G  LG G FG+V + +   + H VA+KI+ +++I    +  ++R
Sbjct: 5   EKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR 64

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
           RE++     RHP+I++LY        IF+++EY   GEL+  + K+ R  E+++      
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQ 124

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAP 185
           + + + YCH + V+HRD+KPEN+LLD     KI DFG S          T CG+ +Y AP
Sbjct: 125 ILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184

Query: 186 EMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAK 233
           E++  + +    VD W+ G++ Y  L G  PF+ +     F+ I           +    
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244

Query: 234 HLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            L+  +L  D  KR +++ I EH W  ++   
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  247 bits (633), Expect = 1e-81
 Identities = 71/262 (27%), Positives = 128/262 (48%), Gaps = 14/262 (5%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI-----QHQLRREMEI 72
            Q +    PLG G FG V+   + E    V +K I KE++ +          ++  E+ I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNA 131
            S + H NI+++   F +     L++E    G +L+  + +H R  E  A+     L +A
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           + Y     +IHRDIK EN+++  +  +K+ DFG +  ++     +T CGT++Y APE++ 
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 190 NKEHD-YAVDNWTLGILCYEFLYGAPPFE--AESQKDTFR---SISAEAKHLISRLLVKD 243
              +    ++ W+LG+  Y  ++   PF    E+ +        +S E   L+S LL   
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPV 262

Query: 244 SSKRLSLQKIMEHPWIIKNANP 265
             +R +L+K++  PW+ +  N 
Sbjct: 263 PERRTTLEKLVTDPWVTQPVNL 284

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  249 bits (637), Expect = 2e-81
 Identities = 60/278 (21%), Positives = 128/278 (46%), Gaps = 36/278 (12%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I + +G G   +V+ V   E K   A+K +  E+ +   +    R E+   + L+  
Sbjct: 57  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLD-SYRNEIAYLNKLQQH 114

Query: 80  N--ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +  I+RLY +   D+ I++++E  +  +L   L+K +     +  +Y  ++  A+   H+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVENK- 191
           + ++H D+KP N L+  +G LK+ DFG +       +   + +  G ++Y+ PE +++  
Sbjct: 174 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 192 ----------EHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI------------ 228
                     +     D W+LG + Y   YG  PF +  +Q     +I            
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292

Query: 229 -SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
              + + ++   L +D  +R+S+ +++ HP++    +P
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  247 bits (633), Expect = 2e-81
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 16/268 (5%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           +   + + +  ++DF + + LGKG FG+V+L    ++    A+K + K+ +         
Sbjct: 5   KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64

Query: 67  RREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
             E  +   +  HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y 
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A +   L + H   +++RD+K +N+LLD +G +KI DFG     +   +K +T CGT DY
Sbjct: 125 AEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDY 184

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAE 231
           +APE++  ++++++VD W+ G+L YE L G  PF  + +++ F SI             E
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244

Query: 232 AKHLISRLLVKDSSKRL-SLQKIMEHPW 258
           AK L+ +L V++  KRL     I +HP 
Sbjct: 245 AKDLLVKLFVREPEKRLGVRGDIRQHPL 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  246 bits (630), Expect = 3e-81
 Identities = 76/271 (28%), Positives = 133/271 (49%), Gaps = 24/271 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSS 75
             ++IG  LG G+F  V   RE  +    A K I K       +   + ++ RE+ I   
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + H N++ L+  + +   + LILE    GEL+  L +    +E++A ++I  + + + Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 136 HENHVIHRDIKPENLLL----DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L         +K+ DFG +   +   +   + GT +++APE+V 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKH 234
            +      D W++G++ Y  L GA PF  +++++T                   S  AK 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            I +LLVK++ KRL++Q+ + HPWI    N 
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  250 bits (641), Expect = 3e-81
 Identities = 78/266 (29%), Positives = 137/266 (51%), Gaps = 22/266 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +++++   LGKG F  V    +V +    A  II  +++     Q +L RE  I   L+H
Sbjct: 11  EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ-KLEREARICRLLKH 69

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+RL+    ++   +LI +    GEL+ ++     ++E  A+  I  +  A+ +CH+ 
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSKR---HTMCGTLDYLAPEMVENKE 192
            V+HR++KPENLLL        +K+ DFG +++   ++       GT  YL+PE++    
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLIS 237
           +   VD W  G++ Y  L G PPF  E Q   ++               +++ EAK LI+
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNA 263
           ++L  + SKR++  + ++HPWI   +
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHRS 275

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  247 bits (632), Expect = 3e-81
 Identities = 76/315 (24%), Positives = 131/315 (41%), Gaps = 68/315 (21%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSL 76
           + + +   +G+G +G V +  E +++   A+KI+ K +I +   K   +++ E+ +   L
Sbjct: 26  KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRK------------------------ 112
            HPNI RLY  + D++ I L++E  H G L  +L                          
Sbjct: 86  HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145

Query: 113 ----------------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DH 154
                                E+  +  +  + +AL Y H   + HRDIKPEN L   + 
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205

Query: 155 EGRLKIGDFGWSVQSRSKR-------HTMCGTLDYLAPEMVENKEHDY--AVDNWTLGIL 205
              +K+ DFG S +             T  GT  ++APE++      Y    D W+ G+L
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 206 CYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLLVKDSSKRLSL 250
            +  L GA PF   +  DT                  +S  A+ L+S LL ++  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 251 QKIMEHPWIIKNANP 265
            + ++HPWI + ++ 
Sbjct: 326 MRALQHPWISQFSDK 340

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  245 bits (627), Expect = 3e-81
 Identities = 79/263 (30%), Positives = 137/263 (52%), Gaps = 24/263 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSSLR 77
           +E+G  LG G+F  V   R+  +    A K I K ++    +   + ++ RE+ I   +R
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           HPNI+ L+  F +   + LILE    GEL+  L +    TE +A  ++  + + + Y H 
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 138 NHVIHRDIKPENLLLDHE----GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENK 191
             + H D+KPEN++L  +     R+K+ DFG +   ++ ++   + GT +++APE+V  +
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE 186

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLI 236
                 D W++G++ Y  L GA PF  E++++T                 + S  AK  I
Sbjct: 187 PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFI 246

Query: 237 SRLLVKDSSKRLSLQKIMEHPWI 259
            RLLVKD  +R+++ + +EH WI
Sbjct: 247 RRLLVKDPKRRMTIAQSLEHSWI 269

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  246 bits (630), Expect = 4e-81
 Identities = 84/270 (31%), Positives = 145/270 (53%), Gaps = 23/270 (8%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQIEKYKIQHQLR 67
               +     FE+ + LG+G FG+V+LV+++         A+K++ K  ++         
Sbjct: 16  EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM 75

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E +I   + HP I++L+  F  + +++LIL++   G+L+  L K   FTE+    Y+A 
Sbjct: 76  -ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 134

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
           L  AL + H   +I+RD+KPEN+LLD EG +K+ DFG S   +    K ++ CGT++Y+A
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAK 233
           PE+V  + H  + D W+ G+L +E L G  PF+ + +K+T   I           S EA+
Sbjct: 195 PEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQ 254

Query: 234 HLISRLLVKDSSKRL-----SLQKIMEHPW 258
            L+  L  ++ + RL      +++I  H +
Sbjct: 255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  247 bits (634), Expect = 4e-81
 Identities = 87/276 (31%), Positives = 148/276 (53%), Gaps = 19/276 (6%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
            ++      +        DF   + +GKG FG+V L R    +   A+K++ K+ I K K
Sbjct: 21  PSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK 80

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            +  +  E  +   +++HP ++ L+  F   ++++ +L+Y + GEL+  L++ R F E +
Sbjct: 81  EEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR 140

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A + +AL Y H  ++++RD+KPEN+LLD +G + + DFG     ++  S   T C
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC 200

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------- 228
           GT +YLAPE++  + +D  VD W LG + YE LYG PPF + +  + + +I         
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 260

Query: 229 --SAEAKHLISRLLVKDSSKRL----SLQKIMEHPW 258
             +  A+HL+  LL KD +KRL       +I  H +
Sbjct: 261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  251 bits (643), Expect = 4e-81
 Identities = 87/266 (32%), Positives = 144/266 (54%), Gaps = 22/266 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + ++  + LG G +G V L R+  +    A+KII K  +       +L  E+ +   L H
Sbjct: 37  EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNS-KLLEEVAVLKLLDH 95

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI++LY +F D    +L++E    GEL+ E+    +F E  AA  I  + + + Y H++
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 139 HVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++HRD+KPENLLL   + +  +KI DFG S   +++ K     GT  Y+APE V  K++
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKY 214

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISR 238
           D   D W++G++ +  L G PPF  ++ ++  R +               S  AK LI +
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNAN 264
           +L  DS +R+S Q+ +EHPWI +  +
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCS 300

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  244 bits (626), Expect = 5e-81
 Identities = 76/291 (26%), Positives = 132/291 (45%), Gaps = 30/291 (10%)

Query: 3   TKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK- 61
           T+ A    +       +++E    LG+G    V       +    A+KII       +  
Sbjct: 1   TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 62  -----IQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR 115
                ++    +E++I   +  HPNI++L   +  +   FL+ +   +GEL+  L +   
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT 120

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKR 173
            +E++    + +L   +   H+ +++HRD+KPEN+LLD +  +K+ DFG+S Q     K 
Sbjct: 121 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180

Query: 174 HTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR- 226
             +CGT  YLAPE++E      +  +   VD W+ G++ Y  L G+PPF    Q    R 
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240

Query: 227 --------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                           S   K L+SR LV    KR + ++ + HP+  +  
Sbjct: 241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  247 bits (632), Expect = 5e-81
 Identities = 49/297 (16%), Positives = 82/297 (27%), Gaps = 54/297 (18%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +  ++  PL  G    V+LVR+VE     ALK+             +L       + L  
Sbjct: 62  RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121

Query: 79  PNILRLYGWFH--------------------------DDERIFLILEYAH------RGEL 106
            +                                         L++  A          L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                              A L    A      ++H    P+NL +  +GRL +GD    
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 167 VQSRSKRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQK-- 222
            +  ++       + Y   E +        +A++ W LG+  Y       PF   +    
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301

Query: 223 ------------------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
                              +   +    K LI R L  D  +RL   + ME P  ++
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  246 bits (630), Expect = 8e-81
 Identities = 77/271 (28%), Positives = 133/271 (49%), Gaps = 24/271 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFK---EQIEKYKIQHQLRREMEIQSS 75
             ++IG  LG G+F  V   RE  +    A K I K       +   + ++ RE+ I   
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HPNI+ L+  + +   + LILE    GEL+  L +    +E++A ++I  + + + Y 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131

Query: 136 HENHVIHRDIKPENLLL----DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L         +K+ DFG +   +   +   + GT +++APE+V 
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVN 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKH 234
            +      D W++G++ Y  L GA PF  +++++T                   S  AK 
Sbjct: 192 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            I +LLVK++ KRL++Q+ + HPWI      
Sbjct: 252 FIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  245 bits (628), Expect = 1e-80
 Identities = 97/261 (37%), Positives = 144/261 (55%), Gaps = 19/261 (7%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I           E  +  + 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMVENKEH 193
              V++RDIK ENL+LD +G +KI DFG     +   +   T CGT +YLAPE++E+ ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVK 242
             AVD W LG++ YE + G  PF  +  +  F  I           S EAK L++ LL K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242

Query: 243 DSSKRL-----SLQKIMEHPW 258
           D  +RL       +++MEH +
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRF 263

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  245 bits (627), Expect = 1e-80
 Identities = 87/259 (33%), Positives = 141/259 (54%), Gaps = 15/259 (5%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + I   LG+G FG+V L    +++  VALK I ++ ++K  +  ++ RE+     LRHP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I++LY        I +++EYA  GEL+  + + +R TE +   +   +  A+ YCH + +
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKEHD-YAV 197
           +HRD+KPENLLLD    +KI DFG S  +   +   T CG+ +Y APE++  K +    V
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEV 189

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDSSK 246
           D W+ GI+ Y  L G  PF+ E   + F+ +           S  A+ LI R++V D  +
Sbjct: 190 DVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQ 249

Query: 247 RLSLQKIMEHPWIIKNANP 265
           R+++Q+I   PW   N   
Sbjct: 250 RITIQEIRRDPWFNVNLPD 268

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  250 bits (640), Expect = 2e-80
 Identities = 86/277 (31%), Positives = 139/277 (50%), Gaps = 31/277 (11%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI----------QHQLRR 68
           + +   R LG G +G V L +E       A+K+I K Q +K +             ++  
Sbjct: 36  ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           E+ +  SL HPNI++L+  F D +  +L+ E+   GEL+ ++    +F E  AA  +  +
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155

Query: 129 TNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYL 183
            + + Y H+++++HRDIKPEN+LL   +    +KI DFG S       K     GT  Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SI 228
           APE V  K+++   D W+ G++ Y  L G PPF  ++ +D  +               +I
Sbjct: 216 APE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274

Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           S EAK LI  +L  D +KR + ++ +   WI K AN 
Sbjct: 275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  247 bits (632), Expect = 2e-80
 Identities = 81/273 (29%), Positives = 134/273 (49%), Gaps = 28/273 (10%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           R      +D+E+ + +G+G FG V LVR   ++   A+K++ K ++ K         E +
Sbjct: 62  RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           I +    P +++L+  F DD  +++++EY   G+L   +       E+ A  Y A +  A
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLA 180

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----HTMCGTLDYLAPEM 187
           L   H    IHRD+KP+N+LLD  G LK+ DFG  ++   +      T  GT DY++PE+
Sbjct: 181 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240

Query: 188 VENK----EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------- 228
           ++++     +    D W++G+  YE L G  PF A+S   T+  I               
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDI 300

Query: 229 SAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
           S EAK+LI   L  D   RL    +++I  H +
Sbjct: 301 SKEAKNLICAFL-TDREVRLGRNGVEEIKRHLF 332

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  244 bits (624), Expect = 3e-80
 Identities = 80/271 (29%), Positives = 134/271 (49%), Gaps = 24/271 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI---EKYKIQHQLRREMEIQSS 75
             ++ G  LG G+F  V   RE  +    A K I K +     +   +  + RE+ I   
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           ++HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 136 HENHVIHRDIKPENLLLDHE----GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVE 189
           H   + H D+KPEN++L        R+KI DFG +      ++   + GT +++APE+V 
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVN 190

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKH 234
            +      D W++G++ Y  L GA PF  +++++T                 + SA AK 
Sbjct: 191 YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            I RLLVKD  KR+++Q  ++HPWI      
Sbjct: 251 FIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  243 bits (623), Expect = 3e-80
 Identities = 86/277 (31%), Positives = 137/277 (49%), Gaps = 30/277 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
            ++ + + LG G  G V L  E ++   VA+KII K +       +      +  E+EI 
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ 
Sbjct: 70  KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128

Query: 134 YCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           Y HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE++
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188

Query: 189 ENKE---HDYAVDNWTLGILCYEFLYGAPPFEAES-QKDTFR---------------SIS 229
            +     ++ AVD W+LG++ +  L G PPF     Q                     +S
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 248

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
            +A  L+ +LLV D   R + ++ + HPW+      R
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  242 bits (619), Expect = 4e-80
 Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 27/273 (9%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +D+E+   +G G +GR   +R       +  K +    + +   +  L  E+ +   L+
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELK 63

Query: 78  HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNA 131
           HPNI+R Y    D  +  +++++EY   G+L   + K  +      E+     +  LT A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 132 LAYCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           L  CH      + V+HRD+KP N+ LD +  +K+GDFG +       S   T  GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAE 231
           +PE +    ++   D W+LG L YE     PPF A SQK+    I            S E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243

Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
              +I+R+L      R S+++I+E+P I+++ +
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  242 bits (619), Expect = 1e-79
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 24/267 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + + I   LG+G+FG V+   E  SK     K +  +  ++      +++E+ I +  RH
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARH 60

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHE 137
            NIL L+  F   E + +I E+    +++ R         E++  +Y+  +  AL + H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 138 NHVIHRDIKPENLLLDHE--GRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEH 193
           +++ H DI+PEN++        +KI +FG +   +       +    +Y APE+ ++   
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISR 238
             A D W+LG L Y  L G  PF AE+ +                    IS EA   + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 239 LLVKDSSKRLSLQKIMEHPWIIKNANP 265
           LLVK+   R++  + ++HPW+ +    
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIER 267

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  241 bits (618), Expect = 1e-79
 Identities = 71/268 (26%), Positives = 129/268 (48%), Gaps = 24/268 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSLRHP 79
           + +G  LG+G +G+V  V + E+    A+KI+ K+++ +    +  +++E+++   LRH 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 80  NILRLYGWFHDDER--IFLILEYAHRG--ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           N+++L    +++E+  +++++EY   G  E+   +   +RF   QA  Y   L + L Y 
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYL 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVEN 190
           H   ++H+DIKP NLLL   G LKI   G +             T  G+  +  PE+   
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185

Query: 191 KE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLIS 237
            +    + VD W+ G+  Y    G  PFE ++    F +I                 L+ 
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLK 245

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANP 265
            +L  + +KR S+++I +H W  K   P
Sbjct: 246 GMLEYEPAKRFSIRQIRQHSWFRKKHPP 273

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  243 bits (622), Expect = 1e-79
 Identities = 89/273 (32%), Positives = 142/273 (52%), Gaps = 21/273 (7%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
               N      + +FE  R LGKG FG+V L R  E+    A+K++ K+ I +       
Sbjct: 11  GIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT 70

Query: 67  RREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
             E  I   +  HP + +L+  F   +R+F ++E+ + G+L   ++K RRF E +A  Y 
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDY 182
           A + +AL + H+  +I+RD+K +N+LLDHEG  K+ DFG     + +     T CGT DY
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAE 231
           +APE+++   +  AVD W +G+L YE L G  PFEAE++ D F +I             +
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHED 250

Query: 232 AKHLISRLLVKDSSKRL------SLQKIMEHPW 258
           A  ++   + K+ + RL          I+ HP+
Sbjct: 251 ATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  244 bits (625), Expect = 3e-79
 Identities = 84/277 (30%), Positives = 138/277 (49%), Gaps = 30/277 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
            ++ + + LG G  G V L  E ++   VA++II K +       +      +  E+EI 
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
             L HP I+++  +F D E  +++LE    GEL+ ++  ++R  E     Y   +  A+ 
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253

Query: 134 YCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMV 188
           Y HEN +IHRD+KPEN+LL   + +  +KI DFG S  +   S   T+CGT  YLAPE++
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313

Query: 189 ENKEH---DYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSIS 229
            +      + AVD W+LG++ +  L G PPF     + +                +  +S
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
            +A  L+ +LLV D   R + ++ + HPW+      R
Sbjct: 374 EKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  242 bits (619), Expect = 4e-79
 Identities = 82/277 (29%), Positives = 132/277 (47%), Gaps = 20/277 (7%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +T +    +  +    L DF     LGKG FG+V L     +    A+KI+ K+ + +  
Sbjct: 3   NTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDD 62

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
                  E  +     + P + +L+  F   +R++ ++EY + G+L   +++  RF E  
Sbjct: 63  DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH 122

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG     +       T C
Sbjct: 123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC 182

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------- 228
           GT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+SI         
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK 242

Query: 229 --SAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
             S EA  +   L+ K   KRL       + I EH +
Sbjct: 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  240 bits (614), Expect = 4e-79
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 45/297 (15%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH---- 64
             +      L  + +   +GKG +G V L          A+K++ K+++ +         
Sbjct: 3   SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62

Query: 65  -------------------QLRREMEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHR 103
                              Q+ +E+ I   L HPN+++L     D  ++ ++++ E  ++
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
           G +  E+   +  +E QA  Y   L   + Y H   +IHRDIKP NLL+  +G +KI DF
Sbjct: 123 GPVM-EVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

Query: 164 GWSVQSRSKR---HTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFE 217
           G S + +          GT  ++APE +      +   A+D W +G+  Y F++G  PF 
Sbjct: 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241

Query: 218 AESQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
            E        I             + + K LI+R+L K+   R+ + +I  HPW+ +
Sbjct: 242 DERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  240 bits (615), Expect = 1e-78
 Identities = 91/275 (33%), Positives = 140/275 (50%), Gaps = 26/275 (9%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           D   R+     FE+   LG+G    VY  ++  ++ P ALK++     +K   +  +R E
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL-----KKTVDKKIVRTE 98

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
           + +   L HPNI++L   F     I L+LE    GEL+  + +   ++E+ AA  +  + 
Sbjct: 99  IGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL 158

Query: 130 NALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLA 184
            A+AY HEN ++HRD+KPENLL      +  LKI DFG S  V+ +    T+CGT  Y A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-SQKDTFR---------------SI 228
           PE++    +   VD W++GI+ Y  L G  PF  E   +  FR                +
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV 278

Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           S  AK L+ +L+V D  KRL+  + ++HPW+   A
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  240 bits (614), Expect = 1e-78
 Identities = 75/286 (26%), Positives = 140/286 (48%), Gaps = 33/286 (11%)

Query: 4   KTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ 63
            +  ++ +R        +E+   +G G +          +    A+KII K + +     
Sbjct: 7   HSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----- 61

Query: 64  HQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
                E+EI     +HPNI+ L   + D + ++++ E    GEL  ++ + + F+E++A+
Sbjct: 62  --PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWSVQSRSKRH---T 175
             + ++T  + Y H   V+HRD+KP N+L      +   ++I DFG++ Q R++     T
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF---EAESQKDTFR------ 226
            C T +++APE++E + +D A D W+LG+L Y  L G  PF     ++ ++         
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239

Query: 227 ---------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                    S+S  AK L+S++L  D  +RL+   ++ HPWI+   
Sbjct: 240 FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  241 bits (617), Expect = 2e-78
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 23/283 (8%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
           +  K   +    K+      ++I   LG G FG V+   E  +      K I        
Sbjct: 33  IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD- 91

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQ 119
             ++ ++ E+ I + L HP ++ L+  F D   + LILE+   GEL+ R   +  + +E 
Sbjct: 92  --KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHT 175
           +   Y+      L + HE+ ++H DIKPEN++ +      +KI DFG +           
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------- 226
              T ++ APE+V+ +   +  D W +G+L Y  L G  PF  E   +T +         
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF 269

Query: 227 ------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
                 S+S EAK  I  LL K+  KRL++   +EHPW+  + 
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  238 bits (610), Expect = 2e-78
 Identities = 56/306 (18%), Positives = 107/306 (34%), Gaps = 61/306 (19%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             + +   LG+G    V+  R  ++    A+K+       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 79  PNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALA 133
            NI++L+    +       LI+E+   G LY  L +        E +    +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 134 YCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 188 VE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------- 228
            E         K++   VD W++G+  Y    G+ PF         + +           
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 229 -----------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                              +++ +L  D  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 260 IKNANP 265
           I +   
Sbjct: 307 ILHRGN 312

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  240 bits (613), Expect = 4e-78
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQ 73
           Q ++    +G+G    V       + H  A+KI+          +  +++   RRE  I 
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153

Query: 74  SSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
             +  HP+I+ L   +     +FL+ +   +GEL+  L +    +E++  + + SL  A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPE---- 186
           ++ H N+++HRD+KPEN+LLD   ++++ DFG+S       K   +CGT  YLAPE    
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKC 273

Query: 187 --MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SIS 229
                +  +   VD W  G++ +  L G+PPF    Q    R                 S
Sbjct: 274 SMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS 333

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
           +  K LISRLL  D   RL+ ++ ++HP+  +
Sbjct: 334 STVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  239 bits (613), Expect = 5e-78
 Identities = 77/279 (27%), Positives = 139/279 (49%), Gaps = 25/279 (8%)

Query: 7   EREDNRKREWSLQDFEIGRP--LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH 64
            R    K+      + + +   LG G+FG+V+   E  +   +A KII    ++    + 
Sbjct: 75  HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KE 131

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAAT 123
           +++ E+ + + L H N+++LY  F     I L++EY   GEL+ R + +    TE     
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL 191

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHTMCGT 179
           ++  +   + + H+ +++H D+KPEN+L  +    ++KI DFG +   + R K     GT
Sbjct: 192 FMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------- 226
            ++LAPE+V      +  D W++G++ Y  L G  PF  ++  +T               
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE 311

Query: 227 --SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
              IS EAK  IS+LL+K+ S R+S  + ++HPW+  + 
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  237 bits (606), Expect = 2e-77
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 35/269 (13%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNIL 82
            +PLG+G F         +S    A+KII K            ++E+        HPNI+
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN------TQKEITALKLCEGHPNIV 69

Query: 83  RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIH 142
           +L+  FHD    FL++E  + GEL+  ++K + F+E +A+  +  L +A+++ H+  V+H
Sbjct: 70  KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129

Query: 143 RDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH---TMCGTLDYLAPEMVENKEHDYA 196
           RD+KPENLL   E     +KI DFG++           T C TL Y APE++    +D +
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQKDTFRS----------------------ISAEAKH 234
            D W+LG++ Y  L G  PF++  +  T  S                      +S EAK 
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKD 249

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           LI  LL  D +KRL +  +  + W+   +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  244 bits (624), Expect = 2e-77
 Identities = 80/271 (29%), Positives = 132/271 (48%), Gaps = 23/271 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G FG V+ V E  + +  A K +          +  +R+E++  S LRHP 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 215

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELY-RELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           ++ L+  F DD  + +I E+   GEL+ +   +H + +E +A  Y+  +   L + HEN+
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 140 VIHRDIKPENLLLDH--EGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
            +H D+KPEN++        LK+ DFG +     +       GT ++ APE+ E K   Y
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLL 240
             D W++G+L Y  L G  PF  E+  +T R                IS + K  I +LL
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395

Query: 241 VKDSSKRLSLQKIMEHPWIIKNANPRGTCDI 271
           + D + R+++ + +EHPW+     P     I
Sbjct: 396 LADPNTRMTIHQALEHPWLTPGNAPGRDSQI 426

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  240 bits (614), Expect = 2e-77
 Identities = 95/271 (35%), Positives = 144/271 (53%), Gaps = 20/271 (7%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
                K   ++ +FE  + LGKG FG+V LV+E  +    A+KI+ KE I          
Sbjct: 137 SLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL 196

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E  +  + RHP +  L   F   +R+  ++EYA+ GEL+  L + R F+E +A  Y A 
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 256

Query: 128 LTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYL 183
           + +AL Y H    V++RD+K ENL+LD +G +KI DFG     ++  +   T CGT +YL
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEA 232
           APE++E+ ++  AVD W LG++ YE + G  PF  +  +  F  I             EA
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376

Query: 233 KHLISRLLVKDSSKRL-----SLQKIMEHPW 258
           K L+S LL KD  +RL       ++IM+H +
Sbjct: 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  236 bits (603), Expect = 2e-77
 Identities = 60/262 (22%), Positives = 104/262 (39%), Gaps = 15/262 (5%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           +R   +  Q F+    LG G +G V+ VR  E     A+K              +L    
Sbjct: 49  SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLT 129
             +   +HP  +RL   + +   ++L  E      L +          E Q   Y+    
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTL 167

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPEM 187
            ALA+ H   ++H D+KP N+ L   GR K+GDFG  V+  +        G   Y+APE+
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAP-PFEAESQKDTFRSI---------SAEAKHLIS 237
           ++   +  A D ++LG+   E       P   E  +   +           S+E + ++ 
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLV 286

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
            +L  D   R + + ++  P +
Sbjct: 287 MMLEPDPKLRATAEALLALPVL 308

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  234 bits (600), Expect = 7e-77
 Identities = 68/268 (25%), Positives = 124/268 (46%), Gaps = 22/268 (8%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           +L +F I + +G+G+F  VY    +    PVALK +    +   K +    +E+++   L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNAL 132
            HPN+++ Y  F +D  + ++LE A  G+L R ++  ++      E+    Y   L +AL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVE 189
            + H   V+HRDIKP N+ +   G +K+GD G         +  H++ GT  Y++PE + 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----------KDTFRSI-----SAEAKH 234
              +++  D W+LG L YE      PF  +            +  +  +     S E + 
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKN 262
           L++  +  D  KR  +  + +    +  
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAKRMHA 297

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  238 bits (610), Expect = 9e-77
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 30/276 (10%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           ++     +DFEI + +G+G FG V +V+   +    A+KI+ K ++ K       R E +
Sbjct: 67  KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERD 126

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTN 130
           +  +     I  L+  F DD  ++L+++Y   G+L   L K   R  E+ A  Y+A +  
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYLAPE 186
           A+   H+ H +HRDIKP+N+L+D  G +++ DFG           +     GT DY++PE
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246

Query: 187 MVENKE-----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------- 228
           +++  E     +    D W+LG+  YE LYG  PF AES  +T+  I             
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV 306

Query: 229 ---SAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
              S  AK LI RL+      RL    ++   +HP+
Sbjct: 307 TDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPF 341

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  235 bits (601), Expect = 9e-77
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 24/265 (9%)

Query: 24  GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNIL 82
            + LG+GKF  V       +    A K + K +  +   + ++  E+ +    +  P ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVI 92

Query: 83  RLYGWFHDDERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTNALAYCHENHV 140
            L+  + +   I LILEYA  GE++           +E      I  +   + Y H+N++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152

Query: 141 IHRDIKPENLLL---DHEGRLKIGDFGWSV--QSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           +H D+KP+N+LL      G +KI DFG S       +   + GT +YLAPE++       
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITT 212

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKHLISRLL 240
           A D W +GI+ Y  L    PF  E  ++T+                S+S  A   I  LL
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272

Query: 241 VKDSSKRLSLQKIMEHPWIIKNANP 265
           VK+  KR + +  + H W+ +    
Sbjct: 273 VKNPEKRPTAEICLSHSWLQQWDFE 297

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  235 bits (602), Expect = 1e-76
 Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 26/270 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--EKYKIQHQLRREMEIQSSLRH 78
           +E+   +GKG F  V      E+    A+KI+   +           L+RE  I   L+H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYREL----RKHRRFTEQQAATYIASLTNALAY 134
           P+I+ L   +  D  ++++ E+    +L  E+         ++E  A+ Y+  +  AL Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145

Query: 135 CHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV 188
           CH+N++IHRD+KP  +LL   ++   +K+G FG ++Q   S        GT  ++APE+V
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVV 205

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK--------------DTFRSISAEAKH 234
           + + +   VD W  G++ +  L G  PF    ++                +  IS  AK 
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISESAKD 265

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
           L+ R+L+ D ++R+++ + + HPW+ +   
Sbjct: 266 LVRRMLMLDPAERITVYEALNHPWLKERDR 295

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  235 bits (602), Expect = 1e-76
 Identities = 79/276 (28%), Positives = 144/276 (52%), Gaps = 30/276 (10%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
                LQDF++ R +G+G + +V LVR  ++    A+K++ KE +   +    ++ E  +
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 73  -QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
            + +  HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ A  Y A ++ A
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLAPEMV 188
           L Y HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T CGT +Y+APE++
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 182

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPF---------EAESQKDTFRSI----------- 228
             +++ ++VD W LG+L +E + G  PF         +  ++   F+ I           
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242

Query: 229 SAEAKHLISRLLVKDSSKRL------SLQKIMEHPW 258
           S +A  ++   L KD  +RL          I  HP+
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  236 bits (604), Expect = 4e-76
 Identities = 78/281 (27%), Positives = 123/281 (43%), Gaps = 32/281 (11%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              ++      DFEI + +G+G F  V +V+  ++    A+KI+ K  + K       R 
Sbjct: 51  VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIAS 127
           E ++  +     I +L+  F D+  ++L++EY   G+L   L K   R   + A  Y+A 
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKRHTMCGTLDYL 183
           +  A+   H    +HRDIKP+N+LLD  G +++ DFG           +     GT DYL
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 184 APEMVENKE-------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------- 228
           +PE+++          +    D W LG+  YE  YG  PF A+S  +T+  I        
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290

Query: 229 --------SAEAKHLISRLLVKDSSKRL---SLQKIMEHPW 258
                     EA+  I RLL      RL          HP+
Sbjct: 291 LPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAGDFRTHPF 330

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  233 bits (597), Expect = 9e-76
 Identities = 97/283 (34%), Positives = 154/283 (54%), Gaps = 31/283 (10%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV---ALKIIFKEQI-EKYKI 62
                   +  +++FE+ + LG G +G+V+LVR++         A+K++ K  I +K K 
Sbjct: 42  ANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT 101

Query: 63  QHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
               R E ++ +   + P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE + 
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV 161

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKR-HTMC 177
             Y+  +  AL + H+  +I+RDIK EN+LLD  G + + DFG S   V   ++R +  C
Sbjct: 162 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221

Query: 178 GTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRSI--- 228
           GT++Y+AP++V   +  HD AVD W+LG+L YE L GA PF  + +K++     R I   
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281

Query: 229 --------SAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
                   SA AK LI RLL+KD  KRL        +I EH +
Sbjct: 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  234 bits (599), Expect = 1e-75
 Identities = 78/287 (27%), Positives = 145/287 (50%), Gaps = 30/287 (10%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +               LQDF++ R +G+G + +V LVR  ++    A++++ KE +   +
Sbjct: 35  EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE 94

Query: 62  IQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
               ++ E  + + +  HP ++ L+  F  + R+F ++EY + G+L   +++ R+  E+ 
Sbjct: 95  DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
           A  Y A ++ AL Y HE  +I+RD+K +N+LLD EG +K+ D+G     ++      T C
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC 214

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF---------EAESQKDTFRSI 228
           GT +Y+APE++  +++ ++VD W LG+L +E + G  PF         +  ++   F+ I
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274

Query: 229 -----------SAEAKHLISRLLVKDSSKRL------SLQKIMEHPW 258
                      S +A  ++   L KD  +RL          I  HP+
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  227 bits (581), Expect = 6e-74
 Identities = 85/295 (28%), Positives = 138/295 (46%), Gaps = 53/295 (17%)

Query: 19  QDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             +++    LG+G   RV     + +    A+KII K+      I+ ++ RE+E+    +
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ---PGHIRSRVFREVEMLYQCQ 68

Query: 78  -HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            H N+L L  +F +++R +L+ E    G +   + K R F E +A+  +  + +AL + H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 137 ENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR----------HTMCGTLDYL 183
              + HRD+KPEN+L +H  +   +KI DF      +              T CG+ +Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 184 APEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAE---------------SQKD 223
           APE+VE        +D   D W+LG++ Y  L G PPF                   Q  
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 224 TFRSI---------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
            F SI               S  AK LIS+LLV+D+ +RLS  ++++HPW+   A
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  237 bits (605), Expect = 1e-73
 Identities = 76/272 (27%), Positives = 133/272 (48%), Gaps = 24/272 (8%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQL--R 67
                 ++ DF + R +G+G FG VY  R+ ++    A+K + K++I+  +     L  R
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
             + + S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A 
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-HTMCGTLDYLAPE 186
           +   L + H   V++RD+KP N+LLD  G ++I D G +     K+ H   GT  Y+APE
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 360

Query: 187 MVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---FRSI-----------SAE 231
           +++    +D + D ++LG + ++ L G  PF     KD     R             S E
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 420

Query: 232 AKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
            + L+  LL +D ++RL       Q++ E P+
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  235 bits (600), Expect = 5e-73
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 20/278 (7%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
            +T +    +  +    L DF     LGKG FG+V L     +    A+KI+ K+ + + 
Sbjct: 323 ANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 382

Query: 61  KIQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ 119
                   E  +     + P + +L+  F   +R++ ++EY + G+L   +++  RF E 
Sbjct: 383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 442

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTM 176
            A  Y A +   L +     +I+RD+K +N++LD EG +KI DFG     +       T 
Sbjct: 443 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF 502

Query: 177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------- 228
           CGT DY+APE++  + +  +VD W  G+L YE L G  PFE E + + F+SI        
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 562

Query: 229 ---SAEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
              S EA  +   L+ K   KRL       + I EH +
Sbjct: 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  225 bits (575), Expect = 1e-72
 Identities = 73/276 (26%), Positives = 139/276 (50%), Gaps = 39/276 (14%)

Query: 19  QDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSL 76
            D+++ +  LG G  G+V       +    ALK+++           + R+E++    + 
Sbjct: 28  DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQAS 79

Query: 77  RHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLTN 130
             P+I+ +   + +       + +I+E    GEL+  +  R  + FTE++AA  +  +  
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQ-SRSKRHTMCGTLDYLAPE 186
           A+ + H +++ HRD+KPENLL   + +   LK+ DFG++ + +++   T C T  Y+APE
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPE 199

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------------S 227
           ++  +++D + D W+LG++ Y  L G PPF + + +                        
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
           +S +AK LI  LL  D ++RL++ + M HPWI ++ 
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  226 bits (577), Expect = 3e-72
 Identities = 76/278 (27%), Positives = 143/278 (51%), Gaps = 40/278 (14%)

Query: 18  LQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSS 75
           + D+++  + LG G  G+V  +    ++   ALK++            + RRE+E+   +
Sbjct: 60  IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRA 111

Query: 76  LRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAATYIASLT 129
            + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+  + S+ 
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKR--HTMCGTLDYLA 184
            A+ Y H  ++ HRD+KPENLL   +     LK+ DFG++ ++ S     T C T  Y+A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRS--- 227
           PE++  +++D + D W+LG++ Y  L G PPF +                    F +   
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 228 --ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
             +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  225 bits (576), Expect = 3e-72
 Identities = 56/303 (18%), Positives = 107/303 (35%), Gaps = 61/303 (20%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
             + +   LG+G    V+  R  ++    A+K+       +        RE E+   L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNH 66

Query: 79  PNILRLYGWFHDD--ERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALA 133
            NI++L+    +       LI+E+   G LY  L +        E +    +  +   + 
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 134 YCHENHVIHRDIKPENLLL----DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           +  EN ++HR+IKP N++     D +   K+ DFG +  ++   +  ++ GT +YL P+M
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186

Query: 188 VE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------- 228
            E         K++   VD W++G+  Y    G+ PF         + +           
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 229 -----------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                              +++ +L  D  K     +       
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 260 IKN 262
           I +
Sbjct: 307 ILH 309

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  227 bits (581), Expect = 2e-71
 Identities = 73/274 (26%), Positives = 127/274 (46%), Gaps = 27/274 (9%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
             +      F   R LG+G FG V+  +   +    A K + K++++K K       E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL----YRELRKHRRFTEQQAATYIAS 127
           I + +    I+ L   F     + L++   + G++    Y     +  F E +A  Y A 
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLA 184
           + + L + H+ ++I+RD+KPEN+LLD +G ++I D G +V+    ++K     GT  ++A
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMA 357

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRSI-----------S 229
           PE++  +E+D++VD + LG+  YE +    PF A  +K       + +           S
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417

Query: 230 AEAKHLISRLLVKDSSKRL-----SLQKIMEHPW 258
             +K     LL KD  KRL     S   +  HP 
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  215 bits (550), Expect = 1e-69
 Identities = 58/291 (19%), Positives = 115/291 (39%), Gaps = 48/291 (16%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + LG+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61

Query: 78  HPNILRLYGWFHDDER------------IFLILEYAHRGELYREL--RKHRRFTEQQAAT 123
           HP I+R +  + +               +++ ++   +  L   +  R      E+    
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 124 YIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---------------V 167
           +I   +  A+ + H   ++HRD+KP N+    +  +K+GDFG                 +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--- 224
            + ++     GT  Y++PE +    + + VD ++LG++ +E LY   PF  + ++     
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238

Query: 225 ----------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                     F         ++  +L     +R     I+E+        P
Sbjct: 239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  223 bits (570), Expect = 2e-69
 Identities = 77/271 (28%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
            ++  +   F   R LGKG FG V   +   +    A K + K++I+K K +     E +
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLT 129
           I   +    ++ L   +   + + L+L   + G+L   +    +  F E +A  Y A + 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--HTMCGTLDYLAPEM 187
             L   H   +++RD+KPEN+LLD  G ++I D G +V     +      GT+ Y+APE+
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEV 356

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----FRSI-----------SAEA 232
           V+N+ + ++ D W LG L YE + G  PF+   +K       R +           S +A
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416

Query: 233 KHLISRLLVKDSSKRL-----SLQKIMEHPW 258
           + L S+LL KD ++RL     S +++ EHP 
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  214 bits (547), Expect = 2e-68
 Identities = 68/285 (23%), Positives = 110/285 (38%), Gaps = 43/285 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP 79
             + R L +G F  VY  ++V S    ALK +   + EK +    + +E+     L  HP
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGHP 86

Query: 80  NILRLYGWFHDDER-------IFLILEYAHRGELYREL---RKHRRFTEQQAATYIASLT 129
           NI++        +         FL+L    +G+L   L         +            
Sbjct: 87  NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146

Query: 130 NALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFG------------WSVQSRSKRH- 174
            A+ + H     +IHRD+K ENLLL ++G +K+ DFG            WS Q R+    
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 175 --TMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----KDTF 225
             T   T  Y  PE+++   N       D W LG + Y   +   PFE  ++       +
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266

Query: 226 R-----SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                 +       LI  +L  +  +RLS+ +++     I  A  
Sbjct: 267 SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  219 bits (559), Expect = 4e-67
 Identities = 69/281 (24%), Positives = 115/281 (40%), Gaps = 32/281 (11%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +E+   LG G FG V      ++   VA+K   +E   K   + +   E++I   L HP
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQIMKKLNHP 72

Query: 80  NILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTN 130
           N++              ++   L +EY   G+L + L +        E    T ++ +++
Sbjct: 73  NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
           AL Y HEN +IHRD+KPEN++L         KI D G++  +          GTL YLAP
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAK 233
           E++E K++   VD W+ G L +E + G  PF    Q   +                    
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 234 HLISRLLVKDSSKRLSLQKIMEHPWI--IKNANP--RGTCD 270
            +    ++   +    +       W+  +   +   RGT  
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  206 bits (527), Expect = 4e-66
 Identities = 71/283 (25%), Positives = 131/283 (46%), Gaps = 57/283 (20%)

Query: 11  NRKREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
             K+   + D+++  + LG G  G+V  +    ++   ALK++              RRE
Sbjct: 9   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--------ARRE 60

Query: 70  MEI-QSSLRHPNILRLYGWFHD----DERIFLILEYAHRGELYREL--RKHRRFTEQQAA 122
           +E+   + + P+I+R+   + +     + + +++E    GEL+  +  R  + FTE++A+
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRSKRHTMCGT 179
             + S+  A+ Y H  ++ HRD+KPENLL   +     LK+ DFG               
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------- 165

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------F 225
               A E    +++D + D W+LG++ Y  L G PPF +                    F
Sbjct: 166 ---FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 226 RS-----ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA 263
            +     +S E K LI  LL  + ++R+++ + M HPWI+++ 
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  210 bits (537), Expect = 6e-66
 Identities = 67/293 (22%), Positives = 123/293 (41%), Gaps = 43/293 (14%)

Query: 2   DTKTAEREDNRKREWSLQ----DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI 57
            + + E++D  +    +      F     LG G  G +   R +     VA+K I  E  
Sbjct: 3   SSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF 61

Query: 58  EKYKIQHQLRREMEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRR 115
                     RE+++ + S  HPN++R +    D +  ++ +E      L   + +K   
Sbjct: 62  SF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFA 114

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----RLKIGDFGWSVQ-- 168
               +  T +   T+ LA+ H  +++HRD+KP N+L+         +  I DFG   +  
Sbjct: 115 HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174

Query: 169 ----SRSKRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
               S S+R  + GT  ++APEM+     +   Y VD ++ G + Y  +  G+ PF    
Sbjct: 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 221 QKDTF--------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           Q+                 +     A+ LI +++  D  KR S + +++HP+ 
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  202 bits (515), Expect = 3e-64
 Identities = 57/283 (20%), Positives = 101/283 (35%), Gaps = 40/283 (14%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
             +F     +G G+FG V+   +       A+K   K        Q+ LR         +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           H +++R +  + +D+ + +  EY + G L   + ++ R    F E +    +  +   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 134 YCHENHVIHRDIKPENLLLDHEGRL-------------------KIGDFGWSVQSRSKRH 174
           Y H   ++H DIKP N+ +                         KIGD G  V   S   
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG-HVTRISSPQ 188

Query: 175 TMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----- 228
              G   +LA E++ EN  H    D + L +         P        D +  I     
Sbjct: 189 VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RNGDQWHEIRQGRL 245

Query: 229 -------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
                  S E   L+  ++  D  +R S   +++H  ++  + 
Sbjct: 246 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  202 bits (515), Expect = 5e-63
 Identities = 43/287 (14%), Positives = 82/287 (28%), Gaps = 49/287 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
              G  LG+          + E+     + + +  +        Q++ E+     LR   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 78  ----------------------HPNILRLYGWFHDD--ERIFLILEYAHR------GELY 107
                                    ++R+     D      F +              L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 108 RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV 167
                H+             +   LA  H   ++H  ++P +++LD  G + +  F   V
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 168 QSRSKRHTMCGTL----DYLAPEMVENKEHD-----YAVDNWTLGILCYEFLYGAPPFEA 218
           +  +   +  G      +  A  M+   +H      +A D WTLG+  Y       P   
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 219 ESQKDTFR-------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
           ++             +I    + L+   L      RL   + ME P 
Sbjct: 320 DAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  202 bits (516), Expect = 8e-63
 Identities = 64/293 (21%), Positives = 115/293 (39%), Gaps = 60/293 (20%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLR 77
                 + LG G  G V   +      PVA+K +  +  +          E+++   S  
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDI------ALMEIKLLTESDD 67

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGEL-------YRELRKHRRFTEQQAATYIASLTN 130
           HPN++R Y     D  +++ LE      L              +   E    + +  + +
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEG-------------RLKIGDFGWSVQ-------SR 170
            +A+ H   +IHRD+KP+N+L+                 R+ I DFG   +        R
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 171 SKRHTMCGTLDYLAPEMVENKEH-------DYAVDNWTLGILCYEFL-YGAPPFEAESQK 222
           +  +   GT  + APE++E   +         ++D +++G + Y  L  G  PF  +  +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 223 DT----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           ++                 RS+ AEA  LIS+++  D  KR +  K++ HP  
Sbjct: 247 ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  197 bits (503), Expect = 6e-62
 Identities = 56/275 (20%), Positives = 106/275 (38%), Gaps = 31/275 (11%)

Query: 8   REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR 67
           +  + +    +        +G+G FG V+ +++ ++    A+K +        +++    
Sbjct: 47  KPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV--------RLEVFRV 98

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            E+   + L  P I+ LYG   +   + + +E    G L + +++     E +A  Y+  
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ 158

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQ--------SRSKRHTMCG 178
               L Y H   ++H D+K +N+LL  +G R  + DFG ++         S      + G
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218

Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFR- 226
           T  ++APE+V  K  D  VD W+   +    L G  P+            A         
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREI 278

Query: 227 --SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
             S +      I   L K+   R S  ++      
Sbjct: 279 PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  195 bits (498), Expect = 5e-61
 Identities = 44/283 (15%), Positives = 88/283 (31%), Gaps = 36/283 (12%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQ 63
           +   + +   +   +   LG+G F +VY        + ++K    LK+       ++ I 
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYI- 113

Query: 64  HQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-----FTE 118
               + ME          ++ Y          L+ E    G L   +  ++        +
Sbjct: 114 --GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLL-----------DHEGRLKIGDFGWSV 167
               ++   +   +   H+  +IH DIKP+N +L           D    L + D G S+
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 168 QSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK 222
             +     +     C T  +   EM+ NK  +Y +D + +    Y  L+G          
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 223 DTFRSISAEA-------KHLISRLLVKDSSKRLSLQKIMEHPW 258
           +                      +L       L    ++    
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  191 bits (488), Expect = 4e-60
 Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 24/266 (9%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F     +GKG FG V+   +  ++  VA+KII  E+ E  +I+  +++E+ + S    
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIE-DIQQEITVLSQCDS 79

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           P + + YG +  D ++++I+EY   G    +L +     E Q AT +  +   L Y H  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDY 195
             IHRDIK  N+LL   G +K+ DFG + Q   ++ KR+T  GT  ++APE+++   +D 
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRLL 240
             D W+LGI   E   G PP    S+    + +               S   K  +   L
Sbjct: 199 KADIWSLGITAIELARGEPPH---SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 255

Query: 241 VKDSSKRLSLQKIMEHPWIIKNANPR 266
            K+ S R + +++++H +I++NA   
Sbjct: 256 NKEPSFRPTAKELLKHKFILRNAKKT 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  185 bits (473), Expect = 5e-58
 Identities = 79/276 (28%), Positives = 125/276 (45%), Gaps = 26/276 (9%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
              D  + ++   +      LGKG +G VY  R++ ++  +A+K I +      +    L
Sbjct: 10  CESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PL 66

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---RFTEQQAAT 123
             E+ +   L+H NI++  G F ++  I + +E    G L   LR      +  EQ    
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQ---SRSKRHTMCGT 179
           Y   +   L Y H+N ++HRDIK +N+L++ + G LKI DFG S +         T  GT
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186

Query: 180 LDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFE--AESQKDTFR--------- 226
           L Y+APE+++     +  A D W+LG    E   G PPF    E Q   F+         
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE 246

Query: 227 ---SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
              S+SAEAK  I +    D  KR     ++   ++
Sbjct: 247 IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  179 bits (457), Expect = 1e-55
 Identities = 62/259 (23%), Positives = 116/259 (44%), Gaps = 24/259 (9%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL 82
               +G+G F  VY   + E+   VA   +   ++ K + Q + + E E+   L+HPNI+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPNIV 88

Query: 83  RLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           R Y  +       + I L+ E    G L   L++ +    +   ++   +   L + H  
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 139 H--VIHRDIKPENLLLDHE-GRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHD 194
              +IHRD+K +N+ +    G +KIGD G +     S    + GT +++APEM E K +D
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-YD 207

Query: 195 YAVDNWTLGILCYEFLYGAPPF-EAESQKDTFRSI-------------SAEAKHLISRLL 240
            +VD +  G+   E      P+ E ++    +R +               E K +I   +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267

Query: 241 VKDSSKRLSLQKIMEHPWI 259
            ++  +R S++ ++ H + 
Sbjct: 268 RQNKDERYSIKDLLNHAFF 286

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  180 bits (458), Expect = 1e-55
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 43/298 (14%)

Query: 9   EDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           ED+    WS+   D+E+   +G G    V        K  VA+K I  E+ +   +  +L
Sbjct: 3   EDSSALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT-SMD-EL 60

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELY--------RELRKHRRFTE 118
            +E++  S   HPNI+  Y  F   + ++L+++    G +         +   K     E
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------SR 170
              AT +  +   L Y H+N  IHRD+K  N+LL  +G ++I DFG S            
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 171 SKRHTMCGTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPF------------- 216
             R T  GT  ++APE M + + +D+  D W+ GI   E   GA P+             
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 217 --------EAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
                        K+  +      + +IS  L KD  KR +  +++ H +  + A  +
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF-FQKAKNK 297

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  178 bits (454), Expect = 4e-55
 Identities = 77/268 (28%), Positives = 130/268 (48%), Gaps = 30/268 (11%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
           + +     +G+G  G VY   +V +   VA++ +  ++Q +K  I      E+ +    +
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII----NEILVMRENK 75

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +PNI+     +   + +++++EY   G L  ++       E Q A        AL + H 
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHD 194
           N VIHRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAE-----------------SQKDTFRSISAEAKHLIS 237
             VD W+LGI+  E + G PP+  E                    +     SA  +  ++
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL---SAIFRDFLN 251

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           R L  D  KR S +++++H + +K A P
Sbjct: 252 RCLEMDVEKRGSAKELLQHQF-LKIAKP 278

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  177 bits (450), Expect = 3e-54
 Identities = 74/269 (27%), Positives = 135/269 (50%), Gaps = 29/269 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLR 77
              +    +G+G  G V L RE  S   VA+K++  ++Q  +  +      E+ I    +
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF----NEVVIMRDYQ 100

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N++ +Y  +   E +++++E+   G L  ++    R  E+Q AT   ++  ALAY H 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHD 194
             VIHRDIK +++LL  +GR+K+ DFG+  Q      KR ++ GT  ++APE++    + 
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAE-----------------SQKDTFRSISAEAKHLIS 237
             VD W+LGI+  E + G PP+ ++                          S   +  + 
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV---SPVLRDFLE 276

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           R+LV+D  +R + Q++++HP++++   P 
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGLPE 305

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  175 bits (446), Expect = 3e-53
 Identities = 68/262 (25%), Positives = 113/262 (43%), Gaps = 6/262 (2%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
              +    +  +  E    DFE    LG G  G V+ V    S   +A K+I  E     
Sbjct: 15  KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA- 73

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            I++Q+ RE+++      P I+  YG F+ D  I + +E+   G L + L+K  R  EQ 
Sbjct: 74  -IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 132

Query: 121 AATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCG 178
                 ++   L Y  E H ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  G
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 192

Query: 179 TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISA--EAKHLI 236
           T  Y++PE ++   +    D W++G+   E   G  P      K+         E     
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 237 SRLLVKDSSKRLSLQKIMEHPW 258
           +    +   + L+   +   P 
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPP 274

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  174 bits (443), Expect = 3e-53
 Identities = 68/285 (23%), Positives = 123/285 (43%), Gaps = 34/285 (11%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
             ++ +  + D E    +G G  G+V+ +R  ++ H +A+K + +   ++     ++  +
Sbjct: 16  GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE--ENKRILMD 73

Query: 70  MEI-QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +++   S   P I++ +G F  +  +F+ +E         + R      E+       ++
Sbjct: 74  LDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133

Query: 129 TNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             AL Y  E H VIHRD+KP N+LLD  G++K+ DFG S   V  ++K     G   Y+A
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD-RSAGCAAYMA 192

Query: 185 PEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAES------------------Q 221
           PE ++       ++D   D W+LGI   E   G  P++                      
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252

Query: 222 KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
              F   S + +  +   L KD  KR    K++EH +I +     
Sbjct: 253 HMGF---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  172 bits (438), Expect = 1e-52
 Identities = 69/270 (25%), Positives = 133/270 (49%), Gaps = 36/270 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-FKEQIEKYKIQHQLRREMEIQSSLRHP 79
           F++   LG+G +G VY     E+   VA+K +  +  +++      + +E+ I      P
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE------IIKEISIMQQCDSP 84

Query: 80  NILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           ++++ YG +  +  +++++EY   G   ++ R   +++  TE + AT + S    L Y H
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLH 142

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEH 193
               IHRDIK  N+LL+ EG  K+ DFG + Q   + +KR+T+ GT  ++APE+++   +
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAE-----------------SQKDTFRSISAEAKHLI 236
           +   D W+LGI   E   G PP+                     + + +   S      +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW---SDNFTDFV 259

Query: 237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
            + LVK   +R +  ++++HP+ +++A   
Sbjct: 260 KQCLVKSPEQRATATQLLQHPF-VRSAKGV 288

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  172 bits (437), Expect = 1e-52
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 37/276 (13%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +EI   LG G FG+VY  +  E+    A K+I  +  E+ +       E+EI ++  H
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILATCDH 75

Query: 79  PNILRLYGWFHDDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           P I++L G ++ D ++++++E+   G    +  EL +    TE Q       +  AL + 
Sbjct: 76  PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFL 133

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV---- 188
           H   +IHRD+K  N+L+  EG +++ DFG S +   +  KR +  GT  ++APE+V    
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET 193

Query: 189 -ENKEHDYAVDNWTLGILCYEFLYGAPPFEAE-----------------SQKDTFRSISA 230
            ++  +DY  D W+LGI   E     PP                          +   S 
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKW---SV 250

Query: 231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
           E +  +   L K+   R S  +++EHP+ + +    
Sbjct: 251 EFRDFLKIALDKNPETRPSAAQLLEHPF-VSSITSN 285

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  171 bits (436), Expect = 2e-52
 Identities = 69/280 (24%), Positives = 119/280 (42%), Gaps = 33/280 (11%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ- 73
           E    D E    LG+G +G V  +R V S   +A+K I      +   Q +L  +++I  
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISM 60

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYREL-RKHRRFTEQQAATYIASLTN 130
            ++  P  +  YG    +  +++ +E       + Y+++  K +   E        S+  
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 131 ALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWSVQ--SRSKRHTMCGTLDYLAPE- 186
           AL + H    VIHRD+KP N+L++  G++K+ DFG S        +    G   Y+APE 
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180

Query: 187 ---MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES-----------------QKDTFR 226
               +  K +    D W+LGI   E      P+++                     D F 
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF- 239

Query: 227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
             SAE     S+ L K+S +R +  ++M+HP+   + +  
Sbjct: 240 --SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  170 bits (434), Expect = 1e-51
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 39/288 (13%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           +    +  +++ +D +    +G+G +G V  +    S   +A+K I     EK   Q QL
Sbjct: 10  KISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQL 67

Query: 67  RREMEIQ-SSLRHPNILRLYGWFHDDERIFLILEYAHRG--ELYRELRK--HRRFTEQQA 121
             ++++   S   P I++ YG    +   ++ +E       + Y+ +         E+  
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127

Query: 122 ATYIASLTNALAYCHENH-VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMC 177
                +   AL +  EN  +IHRDIKP N+LLD  G +K+ DFG S   V S +K     
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA- 186

Query: 178 GTLDYLAPE----MVENKEHDYAVDNWTLGILCYEFLYGAPPFEA--------------- 218
           G   Y+APE        + +D   D W+LGI  YE   G  P+                 
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246

Query: 219 -----ESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK 261
                 S++  F   S    + ++  L KD SKR   +++++HP+I+ 
Sbjct: 247 PPQLSNSEEREF---SPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  168 bits (427), Expect = 2e-50
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 20/264 (7%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F   R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHE 137
           PN ++  G +  +   +L++EY   G     L  H++   E + A         LAY H 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV---ENKEHD 194
           +++IHRD+K  N+LL   G +K+GDFG +    +  ++  GT  ++APE++   +  ++D
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASI-MAPANSFVGTPYWMAPEVILAMDEGQYD 231

Query: 195 YAVDNWTLGILCYEFLYGAPPFE-----------AESQKDTFRSI--SAEAKHLISRLLV 241
             VD W+LGI C E     PP             A+++    +S   S   ++ +   L 
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291

Query: 242 KDSSKRLSLQKIMEHPWIIKNANP 265
           K    R + + +++H + +    P
Sbjct: 292 KIPQDRPTSEVLLKHRF-VLRERP 314

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  167 bits (425), Expect = 2e-50
 Identities = 82/304 (26%), Positives = 144/304 (47%), Gaps = 46/304 (15%)

Query: 1   MDTKTAEREDNRKREWSLQD----FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ 56
           M + +  R  +     +L+D    FE+   +G G +G+VY  R V++    A+K++    
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61

Query: 57  IEKYKIQHQLRREMEIQSSL-RHPNILRLYGWF------HDDERIFLILEYAHRG---EL 106
            E+ +I+    +E+ +      H NI   YG F        D++++L++E+   G   +L
Sbjct: 62  DEEEEIK----QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL 117

Query: 107 YRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
            +  +      E+  A     +   L++ H++ VIHRDIK +N+LL     +K+ DFG S
Sbjct: 118 IKNTKG-NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 167 VQ---SRSKRHTMCGTLDYLAPEMVENKEH-----DYAVDNWTLGILCYEFLYGAPPFEA 218
            Q   +  +R+T  GT  ++APE++   E+     D+  D W+LGI   E   GAPP   
Sbjct: 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-- 234

Query: 219 ESQKDTFRSI----------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN 262
                  R++                S + +  I   LVK+ S+R + +++M+HP+I   
Sbjct: 235 -CDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293

Query: 263 ANPR 266
            N R
Sbjct: 294 PNER 297

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  166 bits (421), Expect = 6e-50
 Identities = 56/330 (16%), Positives = 113/330 (34%), Gaps = 93/330 (28%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L DFE  + +G+G FG V+  +        A+K I     E  +   ++ RE++  + L 
Sbjct: 5   LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 62

Query: 78  HPNILRLYGWFHDDER-------------------------------------------- 93
           HP I+R +  + +                                               
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122

Query: 94  -IFLILEYAHRGELY-----------RELRKHRR---FTEQQAATYIAS-LTNALAYCHE 137
            +  +   + +  LY           ++    R      E     +I   +  A+ + H 
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS 182

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFG---------------WSVQSRSKRHTMCGTLDY 182
             ++HRD+KP N+    +  +K+GDFG                 + + +      GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSIS 229
           ++PE +    + + VD ++LG++ +E LY    F  + ++               F    
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKY 299

Query: 230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            +   ++  +L    ++R     I+E+   
Sbjct: 300 PQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  154 bits (390), Expect = 1e-44
 Identities = 43/213 (20%), Positives = 84/213 (39%), Gaps = 17/213 (7%)

Query: 20  DFEIGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            +E+   +GKG      V L R   +   V ++ I  E      +   L+ E+ +     
Sbjct: 26  CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLFN 84

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYC 135
           HPNI+     F  D  ++++  +   G     +  H      E   A  +  +  AL Y 
Sbjct: 85  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYI 144

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMC-------GTLDYLAP 185
           H    +HR +K  ++L+  +G++ +     ++       ++  +          L +L+P
Sbjct: 145 HHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 186 EMVENKEH--DYAVDNWTLGILCYEFLYGAPPF 216
           E+++      D   D +++GI   E   G  PF
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  151 bits (383), Expect = 2e-44
 Identities = 70/247 (28%), Positives = 114/247 (46%), Gaps = 20/247 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           ++I   LG G    VYL  +      VA+K IF    EK +   +  RE+   S L H N
Sbjct: 13  YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           I+ +     +D+  +L++EY     L   +  H   +   A  +   + + + + H+  +
Sbjct: 73  IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
           +HRDIKP+N+L+D    LKI DFG     S  S ++ + + GT+ Y +PE  + +  D  
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQ----------------KDTFRSISAEAKHLISRLL 240
            D +++GI+ YE L G PPF  E+                  D  + I     ++I R  
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRAT 252

Query: 241 VKDSSKR 247
            KD + R
Sbjct: 253 EKDKANR 259

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  150 bits (380), Expect = 5e-44
 Identities = 54/245 (22%), Positives = 106/245 (43%), Gaps = 18/245 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + + R +G+G  G VY   +   +  VALK++ +        + +++RE      L+ P+
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           ++ ++ +   D ++++ +   +  +L   LR+       +A   +  + +AL   H    
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155

Query: 141 IHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
            HRD+KPEN+L+  +    + DFG     + +  ++     GTL Y+APE        Y 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215

Query: 197 VDNWTLGILCYEFLYGAPPFEAESQ--------------KDTFRSISAEAKHLISRLLVK 242
            D + L  + YE L G+PP++ +                      I      +I+R + K
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAK 275

Query: 243 DSSKR 247
           +   R
Sbjct: 276 NPEDR 280

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  149 bits (379), Expect = 8e-44
 Identities = 55/213 (25%), Positives = 101/213 (47%), Gaps = 13/213 (6%)

Query: 15  EW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +      D  I   +G G FG V+  R       VA+KI+ ++     ++  +  RE+ I
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVN-EFLREVAI 87

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH---RRFTEQQAATYIASLT 129
              LRHPNI+   G       + ++ EY  RG LYR L K     +  E++  +    + 
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 130 NALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             + Y H  +  ++HR++K  NLL+D +  +K+ DFG S     +     +  GT +++A
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMA 207

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
           PE++ ++  +   D ++ G++ +E      P+ 
Sbjct: 208 PEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  148 bits (377), Expect = 2e-43
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 57/292 (19%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYKIQHQLRREMEIQ 73
           ++ +E    +G+G +G V+  R  ++   VA+K          I+K  +     RE+ + 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-----REIRML 56

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNAL 132
             L+HPN++ L   F    R+ L+ EY     +  EL +++R   E    +       A+
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAV 115

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEM-V 188
            +CH+++ IHRD+KPEN+L+     +K+ DFG++               T  Y +PE+ V
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLV 175

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------------- 223
            + ++   VD W +G +  E L G P +  +S  D                         
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235

Query: 224 -----------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                             F +IS  A  L+   L  D ++RL+ ++++ HP+
Sbjct: 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  148 bits (376), Expect = 4e-43
 Identities = 67/290 (23%), Positives = 116/290 (40%), Gaps = 51/290 (17%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S++ +E    +G+G +G V   R  ++   VA+K    E  +   ++    RE+++   L
Sbjct: 23  SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDKMVKKIAMREIKLLKQL 81

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
           RH N++ L       +R +L+ E+     +  +L         Q    Y+  + N + +C
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPEM-VEN 190
           H +++IHRDIKPEN+L+   G +K+ DFG     +         +  T  Y APE+ V +
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGD 199

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------------------- 223
            ++  AVD W +G L  E   G P F  +S  D                           
Sbjct: 200 VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 224 ---------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                           +  +S     L  + L  D  KR    +++ H +
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  148 bits (376), Expect = 5e-43
 Identities = 67/298 (22%), Positives = 112/298 (37%), Gaps = 67/298 (22%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-------IQHQLRRE 69
             + +E    LG+G+F  VY  R+  +   VA+K I      + K       +     RE
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-----RE 62

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-----RRFTEQQAATY 124
           +++   L HPNI+ L   F     I L+ ++     +  +L           T      Y
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAY 117

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTL 180
           +      L Y H++ ++HRD+KP NLLLD  G LK+ DFG    +   +R+  H +  T 
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TR 176

Query: 181 DYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------- 223
            Y APE +   + +   VD W +G +  E L   P    +S  D                
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236

Query: 224 -----------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                   F +   +   LI  L + +   R++  + ++  +
Sbjct: 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  148 bits (375), Expect = 5e-43
 Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 51/288 (17%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     LG+G +  VY  +   + + VALK I  E  E         RE+ +   L+
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI--REVSLLKDLK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI+ L+   H ++ + L+ EY  + +L + L              ++  L   LAYCH
Sbjct: 59  HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
              V+HRD+KP+NLL++  G LK+ DFG     S+ +++  + +  TL Y  P+ ++ + 
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------------------- 223
           ++   +D W +G + YE   G P F   + ++                            
Sbjct: 177 DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 224 -------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                            + ++   L+++LL  +   R+S +  M+HP+
Sbjct: 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  147 bits (373), Expect = 6e-43
 Identities = 64/288 (22%), Positives = 124/288 (43%), Gaps = 50/288 (17%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  +   +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELK 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI+RL+   H D+++ L+ E+  + +L +           +   +++  L   L +CH
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
             +V+HRD+KP+NLL++  G LK+ +FG    + +  R     +  TL Y  P+ +   K
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAK 177

Query: 192 EHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD--------------------------- 223
            +  ++D W+ G +  E    G P F      D                           
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 224 -------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                            ++A  + L+  LL  +  +R+S ++ ++HP+
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  148 bits (375), Expect = 6e-43
 Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 54/293 (18%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S+  +     LG+G +G VY   +  +   VA+K I  E  E+  +     RE+ +   L
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKEL 90

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +H NI+ L    H + R+ LI EYA   +L + + K+   + +   +++  L N + +CH
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149

Query: 137 ENHVIHRDIKPENLLLD-----HEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE- 186
               +HRD+KP+NLLL          LKIGDFG    + +  R   H +  TL Y  PE 
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEI 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------------- 224
           ++ ++ +  +VD W++  +  E L   P F  +S+ D                       
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL 268

Query: 225 -------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                 +  E   L++ +L  D  KR+S +  +EHP+
Sbjct: 269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (372), Expect = 6e-43
 Identities = 75/287 (26%), Positives = 132/287 (45%), Gaps = 50/287 (17%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     +G+G +G VY  +        ALK I  E+ E   I     RE+ I   L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEK-EDEGIPSTTIREISILKELK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCH 136
           H NI++LY   H  +R+ L+ E+  + +L + L           A +++  L N +AYCH
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVENK 191
           +  V+HRD+KP+NLL++ EG LKI DFG    + +  R   H +  TL Y AP+ ++ +K
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK 176

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------------------- 223
           ++   +D W++G +  E + G P F   S+ D                            
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236

Query: 224 ------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                         + +      L+S++L  D ++R++ ++ +EH +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (371), Expect = 8e-43
 Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 22/229 (9%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII----FKEQIEKYK 61
           +E   +R    +  + E  + +GKG FG V+  R V+ K  VA+K +     + + E  +
Sbjct: 6   SEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIE 65

Query: 62  IQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
              + +RE+ I S+L HPNI++LYG  H      +++E+   G+LY  L       +   
Sbjct: 66  KFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSV 123

Query: 122 ATYIAS-LTNALAYCHENH--VIHRDIKPENLLLDHEGR-----LKIGDFGWSVQSRSKR 173
              +   +   + Y    +  ++HRD++  N+ L           K+ DFG    S+   
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL---SQQSV 180

Query: 174 HTM---CGTLDYLAPEM--VENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
           H++    G   ++APE    E + +    D ++  ++ Y  L G  PF+
Sbjct: 181 HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  147 bits (372), Expect = 1e-42
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
            ++ E+   +G+G FG V   +       VA+K I  E   K         E+   S + 
Sbjct: 7   YKEIEVEEVVGRGAFGVVC--KAKWRAKDVAIKQIESESERK-----AFIVELRQLSRVN 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAY 134
           HPNI++LYG   +   + L++EYA  G LY  L        +T   A ++    +  +AY
Sbjct: 60  HPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117

Query: 135 CHE---NHVIHRDIKPENLLLDHEGR-LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
            H      +IHRD+KP NLLL   G  LKI DFG +   ++      G+  ++APE+ E 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEG 177

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFE 217
             +    D ++ GI+ +E +    PF+
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFD 204

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  146 bits (370), Expect = 2e-42
 Identities = 74/289 (25%), Positives = 134/289 (46%), Gaps = 51/289 (17%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            ++ ++    +G+G +G VY  ++ + +  VALK I  +  E   I     RE+ +   L
Sbjct: 19  LMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDA-EDEGIPSTAIREISLLKEL 76

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYC 135
            HPNI+ L    H +  + L+ E+  + +L + L +++    + Q   Y+  L   +A+C
Sbjct: 77  HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE-MVEN 190
           H++ ++HRD+KP+NLL++ +G LK+ DFG    + +  RS  H +  TL Y AP+ ++ +
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGS 194

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------------------- 223
           K++  +VD W++G +  E + G P F   +  D                           
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254

Query: 224 --------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                E   L+S +L  D +KR+S +  M HP+
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  145 bits (369), Expect = 2e-42
 Identities = 59/227 (25%), Positives = 99/227 (43%), Gaps = 27/227 (11%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
             R +   D   G  LGKG FG+   V   E+   + +K + +   E  +      +E++
Sbjct: 3   PHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR---TFLKEVK 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQA---ATYIAS 127
           +   L HPN+L+  G  + D+R+  I EY   G L   ++    ++   Q    A  IAS
Sbjct: 60  VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----------------VQSR 170
               +AY H  ++IHRD+   N L+     + + DFG +                    R
Sbjct: 120 ---GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
            KR+T+ G   ++APEM+  + +D  VD ++ GI+  E +       
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  145 bits (367), Expect = 6e-42
 Identities = 66/253 (26%), Positives = 113/253 (44%), Gaps = 27/253 (10%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 81  ILRLYGWFHDDERI----FLILEYAHRGELYRE-LRKHRRFTEQQAATYIASLTNALAYC 135
           I+ +Y     +       ++++EY   G   R+ +      T ++A   IA    AL + 
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYV-DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG--WSVQSRSKRHT----MCGTLDYLAPEMVE 189
           H+N +IHRD+KP N+++     +K+ DFG   ++       T    + GT  YL+PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---------------KDTFRSISAEAKH 234
               D   D ++LG + YE L G PPF  +S                      +SA+   
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 252

Query: 235 LISRLLVKDSSKR 247
           ++ + L K+   R
Sbjct: 253 VVLKALAKNPENR 265

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  144 bits (366), Expect = 8e-42
 Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 58/297 (19%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           S   F+    LG G +  VY      +   VALK +  +  E         RE+ +   L
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPST--AIREISLMKEL 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRG-----ELYRELRKHRRFTEQQAATYIASLTNA 131
           +H NI+RLY   H + ++ L+ E+         +        R         +   L   
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCGTLDYLAPE- 186
           LA+CHEN ++HRD+KP+NLL++  G+LK+GDFG    + +   +    +  TL Y AP+ 
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDV 179

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------------- 223
           ++ ++ +  ++D W+ G +  E + G P F   + ++                       
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 224 ----------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                 T   +       +  LL  +   RLS ++ + HPW
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  143 bits (362), Expect = 1e-41
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 16/213 (7%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE-QIEKYKIQHQLRREMEIQSSL 76
             +  +   +G G FG+VY  R       VA+K    +   +  +    +R+E ++ + L
Sbjct: 6   FAELTLEEIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPNI+ L G    +  + L++E+A  G L R L   +R        +   +   + Y H
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLH 122

Query: 137 ENH---VIHRDIKPENLLLDHEGR--------LKIGDFGWS-VQSRSKRHTMCGTLDYLA 184
           +     +IHRD+K  N+L+  +          LKI DFG +    R+ + +  G   ++A
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMA 182

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
           PE++         D W+ G+L +E L G  PF 
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  142 bits (359), Expect = 9e-41
 Identities = 59/289 (20%), Positives = 114/289 (39%), Gaps = 38/289 (13%)

Query: 1   MDTKTAEREDNRKREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
              + A +     +EW    +  EIG  +GKG+FG+VY          VA+++I  E+  
Sbjct: 13  SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVY---HGRWHGEVAIRLIDIERDN 69

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE 118
           + +++   +RE+      RH N++   G       + +I        LY  +R  +   +
Sbjct: 70  EDQLK-AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD 128

Query: 119 QQAATYIAS-LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSK 172
                 IA  +   + Y H   ++H+D+K +N+  D  G++ I DFG       +Q+  +
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187

Query: 173 RHTM---CGTLDYLAPEMV---------ENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
              +    G L +LAPE++         +        D + LG + YE      PF+ + 
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247

Query: 221 QKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH 256
            +                  +  E   ++      +  +R +  K+M+ 
Sbjct: 248 AEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  138 bits (349), Expect = 1e-39
 Identities = 38/220 (17%), Positives = 76/220 (34%), Gaps = 22/220 (10%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           N+      +       L +   G ++  +     + + +K++        K +     E 
Sbjct: 2   NKHSGIDFKQLNFLTKLNENHSGELW--KGRWQGNDIVVKVLKVRDWSTRKSR-DFNEEC 58

Query: 71  EIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR--FTEQQA---AT 123
                  HPN+L + G           LI  +   G LY  L +       + QA   A 
Sbjct: 59  PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118

Query: 124 YIASLTNALAYCH--ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT-MCGTL 180
            +A     +A+ H  E  +    +   ++++D +   +I          S +        
Sbjct: 119 DMAR---GMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV---KFSFQSPGRMYAP 172

Query: 181 DYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFE 217
            ++APE ++ K  D    + D W+  +L +E +    PF 
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  139 bits (352), Expect = 1e-37
 Identities = 52/238 (21%), Positives = 98/238 (41%), Gaps = 18/238 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVR-EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +E+   +  G  G +YL      +  PV LK +      +   Q     E +  + + HP
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA--QAMAMAERQFLAEVVHP 139

Query: 80  NILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAY 134
           +I++++        H D   ++++EY   G+  +  +  ++    +A  Y+  +  AL+Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYV-GGQSLKRSKG-QKLPVAEAIAYLLEILPALSY 197

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHD 194
            H   +++ D+KPEN++L  E +LK+ D G +V   +    + GT  + APE+V      
Sbjct: 198 LHSIGLVYNDLKPENIMLT-EEQLKLIDLG-AVSRINSFGYLYGTPGFQAPEIVRTGPTV 255

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----SISAEAKHLISRLLVKDSSKR 247
            A D +T+G          P                         L+ R +  D  +R
Sbjct: 256 -ATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQR 312

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (336), Expect = 1e-37
 Identities = 51/218 (23%), Positives = 96/218 (44%), Gaps = 16/218 (7%)

Query: 11  NRKREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           +   +W        +G+ +G G FG VY   + +    VA+K++        ++Q   + 
Sbjct: 14  DAADDWEIPDGQITVGQRIGSGSFGTVY---KGKWHGDVAVKMLNVTAPTPQQLQ-AFKN 69

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS- 127
           E+ +    RH NIL   G+     ++ ++ ++     LY  L       E +    IA  
Sbjct: 70  EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ 128

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-----VQSRSKRHTMCGTLDY 182
               + Y H   +IHRD+K  N+ L  +  +KIGDFG +          +   + G++ +
Sbjct: 129 TARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 183 LAPEMVENKEH---DYAVDNWTLGILCYEFLYGAPPFE 217
           +APE++  ++     +  D +  GI+ YE + G  P+ 
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  132 bits (334), Expect = 3e-37
 Identities = 64/294 (21%), Positives = 111/294 (37%), Gaps = 53/294 (18%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQS 74
           +   +E    +G G +G VY  R+  S H VALK +           +     RE+ +  
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 75  SLR---HPNILRLYGWFHDDE-----RIFLILEYAHRGEL--YRELRKHRRFTEQQAATY 124
            L    HPN++RL             ++ L+ E+  + +L  Y +         +     
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT-MCGTLDY 182
           +      L + H N ++HRD+KPEN+L+   G +K+ DFG + + S     T +  TL Y
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWY 185

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------- 223
            APE++    +   VD W++G +  E     P F   S+ D                   
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 245

Query: 224 -------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                  +      L+  +L  +  KR+S  + ++H +
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  131 bits (331), Expect = 2e-36
 Identities = 68/302 (22%), Positives = 119/302 (39%), Gaps = 62/302 (20%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +  +E    +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 73

Query: 77  RHPNILRLYGWFHDDER--------IFLILEYAHRGELYREL-RKHRRFTEQQAATYIAS 127
           +H N++ L                 I+L+ ++    +L   L     +FT  +    +  
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG----WSVQSRSKRHTMCG---TL 180
           L N L Y H N ++HRD+K  N+L+  +G LK+ DFG    +S+   S+ +       TL
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 181 DYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ------------------ 221
            Y  PE++   +++   +D W  G +  E    +P  +  ++                  
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 222 -----------------------KDTFRSI--SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
                                  KD  ++      A  LI +LLV D ++R+     + H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312

Query: 257 PW 258
            +
Sbjct: 313 DF 314

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  131 bits (332), Expect = 6e-36
 Identities = 78/293 (26%), Positives = 121/293 (41%), Gaps = 64/293 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +   + +G G FG VY  +  +S   VA+K + +++  K        RE++I   L H N
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-------RELQIMRKLDHCN 108

Query: 81  ILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS----LTN 130
           I+RL  +F+      D+  + L+L+Y     +YR  R + R  +     Y+      L  
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPE 186
           +LAY H   + HRDIKP+NLLLD +   LK+ DFG     V+       +C +  Y APE
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYYRAPE 226

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------- 228
            +    ++  ++D W+ G +  E L G P F  +S  D    I                 
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286

Query: 229 -----------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                    EA  L SRLL    + RL+  +   H +
Sbjct: 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  127 bits (320), Expect = 4e-35
 Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 36/226 (15%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSL 76
           +D  +   +GKG++G V+          VA+KI      + +       RE E+     L
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKSWF------RETELYNTVML 59

Query: 77  RHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
           RH NIL          H   +++LI  Y   G LY  L+             + S+ + L
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118

Query: 133 AYCHENH--------VIHRDIKPENLLLDHEGRLKIGDFGWSV-------QSRSKRHTMC 177
           A+ H           + HRD+K +N+L+   G+  I D G +V       Q     +   
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 178 GTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYGAPPFE 217
           GT  Y+APE+++        +    VD W  G++ +E         
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  127 bits (321), Expect = 4e-35
 Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 55/301 (18%)

Query: 9   EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLR 67
           +D   R  + Q +E    +G+G +G+V+  R++      VALK +  +   +  +     
Sbjct: 3   KDGLCR--ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTI 59

Query: 68  REMEIQSSLR---HPNILRLYGWFHDDE-----RIFLILEYAHRGEL--YRELRKHRRFT 117
           RE+ +   L    HPN++RL+            ++ L+ E+  + +L  Y +        
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHT- 175
            +     +  L   L + H + V+HRD+KP+N+L+   G++K+ DFG + + S     T 
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------ 223
           +  TL Y APE++    +   VD W++G +  E     P F   S  D            
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238

Query: 224 --------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                                         I    K L+ + L  + +KR+S    + HP
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298

Query: 258 W 258
           +
Sbjct: 299 Y 299

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  128 bits (324), Expect = 5e-35
 Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 65/293 (22%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +   + +G G FG V+  + VES   VA+K + +++  K        RE++I   ++HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQIMRIVKHPN 93

Query: 81  ILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS----LTN 130
           ++ L  +F+      D+  + L+LEY     +YR  R + +  +      I      L  
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 131 ALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFG---WSVQSRSKRHTMCGTLDYLAPE 186
           +LAY H   + HRDIKP+NLLLD   G LK+ DFG     +        +C +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPE 211

Query: 187 -MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------- 228
            +     +   +D W+ G +  E + G P F  ES  D    I                 
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP 271

Query: 229 -----------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPW 258
                                    +A  LISRLL    S RL+  + + HP+
Sbjct: 272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  125 bits (317), Expect = 2e-34
 Identities = 71/306 (23%), Positives = 134/306 (43%), Gaps = 66/306 (21%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++   EW  QD +++ R LG+GK+  V+    + +   V +KI+   + +K K      R
Sbjct: 26  ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK------R 79

Query: 69  EMEIQSSLR-HPNILRLYGWFHDDE--RIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           E++I  +LR  PNI+ L     D       L+ E+ +  +  +  +     T+     Y+
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYM 136

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS-VQSRSKRHTM-CGTLDY 182
             +  AL YCH   ++HRD+KP N+++DHE R L++ D+G +      + + +   +  +
Sbjct: 137 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 196

Query: 183 LAPE-MVENKEHDYAVDNWTLG-IL-------------------------------CYEF 209
             PE +V+ + +DY++D W+LG +L                                Y++
Sbjct: 197 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256

Query: 210 L-----------------YGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKRLSLQK 252
           +                 +    +E     +    +S EA   + +LL  D   RL+ ++
Sbjct: 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 316

Query: 253 IMEHPW 258
            MEHP+
Sbjct: 317 AMEHPY 322

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  123 bits (310), Expect = 8e-34
 Identities = 29/245 (11%), Positives = 60/245 (24%), Gaps = 44/245 (17%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +    G     + +   +      VAL  +  + +    +  +        S +  P 
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 81  ILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHV 140
           + R+    H      ++ E+   G L          +   A   + SL  A    H   V
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGV 150

Query: 141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNW 200
                 P  + +  +G + +                      +          +   D  
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA-----------------TMPDA-------NPQDDIR 186

Query: 201 TLGILCYEFLYGAPPFEAESQKDTF------------------RSISAEAKHLISRLLVK 242
            +G   Y  L    P      +                     R I  +   + +R +  
Sbjct: 187 GIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG 246

Query: 243 DSSKR 247
           D   R
Sbjct: 247 DGGIR 251

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  124 bits (313), Expect = 8e-34
 Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 36/227 (15%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SS 75
            +  ++ + +GKG++G V++ +       VA+K+ F  +   +       RE EI     
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTEEASWF------RETEIYQTVL 87

Query: 76  LRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +RH NIL              +++LI +Y   G LY  L+       +       S  + 
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSG 146

Query: 132 LAYCHE--------NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-------HTM 176
           L + H           + HRD+K +N+L+   G   I D G +V+  S         +T 
Sbjct: 147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR 206

Query: 177 CGTLDYLAPEM------VENKEHDYAVDNWTLGILCYEFLYGAPPFE 217
            GT  Y+ PE+        + +     D ++ G++ +E         
Sbjct: 207 VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  124 bits (313), Expect = 2e-33
 Identities = 65/265 (24%), Positives = 111/265 (41%), Gaps = 31/265 (11%)

Query: 1   MDTKTAEREDNRKREWSLQDFEI-GRPLGKGKFGRVYLVR--EVESKHPVALKIIFKEQI 57
           MD     +  +  RE     FE  G  +G+G +G VY  +  + +     ALK     QI
Sbjct: 3   MDYDFKVKLSSE-RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QI 56

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGWF--HDDERIFLILEYA--------HRGELY 107
           E   I     RE+ +   L+HPN++ L   F  H D +++L+ +YA              
Sbjct: 57  EGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRAS 116

Query: 108 RELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE----GRLKIGDF 163
           +  +K  +       + +  + + + Y H N V+HRD+KP N+L+  E    GR+KI D 
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 164 G----WSVQSRSKRHTMCG--TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPF 216
           G    ++   +          T  Y APE ++  + +  A+D W +G +  E L   P F
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 236

Query: 217 EAESQKDTFRSISAEAK-HLISRLL 240
               +     +     +   I  ++
Sbjct: 237 HCRQEDIKTSNPYHHDQLDRIFNVM 261

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  121 bits (306), Expect = 7e-33
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SS 75
            +   +   +GKG+FG V+  +       VA+KI    +   +       RE EI     
Sbjct: 41  ARTIVLQESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSW------FREAEIYQTVM 92

Query: 76  LRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           LRH NIL              +++L+ +Y   G L+  L ++   T +       S  + 
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASG 151

Query: 132 LAYCHENH--------VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM------- 176
           LA+ H           + HRD+K +N+L+   G   I D G +V+  S   T+       
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 211

Query: 177 CGTLDYLAPEMVEN------KEHDYAVDNWTLGILCYE 208
            GT  Y+APE++++       E     D + +G++ +E
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  121 bits (305), Expect = 9e-33
 Identities = 52/226 (23%), Positives = 96/226 (42%), Gaps = 35/226 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ--SSLR 77
             ++     +G+FG V+  + +     VA+KI   +       +   + E E+     ++
Sbjct: 25  PLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFPIQD------KQSWQNEYEVYSLPGMK 76

Query: 78  HPNILRLYGW----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           H NIL+  G        D  ++LI  +  +G L   L+ +   +  +      ++   LA
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLA 135

Query: 134 YCHEN----------HVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCG 178
           Y HE+           + HRDIK +N+LL +     I DFG ++     +S    H   G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195

Query: 179 TLDYLAPEMVE---NKEHDY--AVDNWTLGILCYEFLYGAPPFEAE 219
           T  Y+APE++E   N + D    +D + +G++ +E        +  
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  117 bits (294), Expect = 3e-31
 Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 45/230 (19%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           E SL   + ++   +G+G++G VY  +    + PVA+K+           +     E  I
Sbjct: 7   EPSLDLDNLKLLELIGRGRYGAVY--KGSLDERPVAVKVFSFAN------RQNFINEKNI 58

Query: 73  Q--SSLRHPNILRLYG-----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
                + H NI R                 L++EY   G L + L  H       +    
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLA 117

Query: 126 ASLTNALAYCHENH---------VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR--- 173
            S+T  LAY H            + HRD+   N+L+ ++G   I DFG S++    R   
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 174 --------HTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYE 208
                    +  GT+ Y+APE++E        +     VD + LG++ +E
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  117 bits (295), Expect = 5e-31
 Identities = 73/305 (23%), Positives = 122/305 (40%), Gaps = 73/305 (23%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLR--REMEIQSS 75
           +  F++ R  G+G FG V L +E  +   VA+K + ++   +       R  + M+  + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR------NRELQIMQDLAV 75

Query: 76  LRHPNILRLYGWFH-------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS- 127
           L HPNI++L  +F+        D  + +++EY     L+R  R + R         I   
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134

Query: 128 ---LTNALAYCHEN--HVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSKRHTM----C 177
              L  ++   H    +V HRDIKP N+L++   G LK+ DFG S +  S         C
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPSEPNVAYIC 193

Query: 178 GTLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------- 228
            +  Y APE +  N+ +  AVD W++G +  E + G P F  ++       I        
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 229 -----------------------------------SAEAKHLISRLLVKDSSKRLSLQKI 253
                                              + EA  L+S LL     +R+   + 
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 254 MEHPW 258
           + HP+
Sbjct: 313 LCHPY 317

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  111 bits (280), Expect = 1e-28
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 9/222 (4%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             + +D  +G  +G+G FG V+  R       VA+K   +E +        L+ E  I  
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQ-EARILK 167

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALA 133
              HPNI+RL G     + I++++E    G+    LR        +     +      + 
Sbjct: 168 QYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGME 227

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL-----APEMV 188
           Y      IHRD+   N L+  +  LKI DFG S +     +   G L  +     APE +
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287

Query: 189 ENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               +    D W+ GIL +E F  GA P+   S + T   + 
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  112 bits (283), Expect = 1e-28
 Identities = 49/238 (20%), Positives = 97/238 (40%), Gaps = 13/238 (5%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
            +  T         +W +   D  +   LG G++G VY     +    VA+K + ++ +E
Sbjct: 200 RNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 259

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--F 116
                 +  +E  +   ++HPN+++L G    +   ++I E+   G L   LR+  R   
Sbjct: 260 ----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSK 172
           +          +++A+ Y  + + IHR++   N L+     +K+ DFG S      + + 
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 375

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                  + + APE +   +     D W  G+L +E   YG  P+        +  + 
Sbjct: 376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  110 bits (278), Expect = 1e-28
 Identities = 72/326 (22%), Positives = 128/326 (39%), Gaps = 98/326 (30%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +G+ LG G FG V  V ++ES    ALK + ++   +YK      RE++I   L H N
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKN-----RELDIMKVLDHVN 61

Query: 81  ILRLYGWFH--------------------------------------DDERIFLILEYAH 102
           I++L  +F+                                       ++ + +I+EY  
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120

Query: 103 RGE-LYRELRKHRR----FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-G 156
             + L++ L+   R          + YI  L  A+ + H   + HRDIKP+NLL++ +  
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179

Query: 157 RLKIGDFGWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYG 212
            LK+ DFG S +             +  Y APE M+   E+  ++D W++G +  E + G
Sbjct: 180 TLKLCDFG-SAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 213 APPFEAESQ---------------KDTFRSIS-------------------------AEA 232
            P F  E+                K+    ++                         + A
Sbjct: 239 KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPW 258
             L+ ++L  +   R++  + M HP+
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPF 324

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  110 bits (276), Expect = 2e-28
 Identities = 66/298 (22%), Positives = 117/298 (39%), Gaps = 69/298 (23%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEIQ 73
           + +     +G G +G V    +  S   VA+K +   F+ +I         R  RE+ + 
Sbjct: 24  KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI------FAKRAYRELLLL 77

Query: 74  SSLRHPNILRLYGWFHDDER------IFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
             ++H N++ L   F            +L++ +    +L + +    +F+E++    +  
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQ 134

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYLA 184
           +   L Y H   V+HRD+KP NL ++ +  LKI DFG    +R     M G   T  Y A
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL---ARHADAEMTGYVVTRWYRA 191

Query: 185 PE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------------------- 223
           PE ++    ++  VD W++G +  E L G   F+ +   D                    
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 251

Query: 224 ----------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                  F   S +A  L+ ++L  D  KRL+  + + HP+ 
Sbjct: 252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 2e-28
 Identities = 48/220 (21%), Positives = 100/220 (45%), Gaps = 14/220 (6%)

Query: 20  DFEIGRPLGKGKFGRVY----LVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    +    + K PVA+K + +    K     ++  E  + +S
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 74  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDYLAPEMVE 189
             +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           ++ + +  D W+ G+  +E   +G+ P++     +    +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  109 bits (275), Expect = 4e-28
 Identities = 69/322 (21%), Positives = 128/322 (39%), Gaps = 74/322 (22%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIG------RPLGKGKFGRVYLVREVESKHPVALKII-- 52
           M +    R    ++E +   +E+       +P+G G +G V    +  +   VA+K +  
Sbjct: 1   MSSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR 60

Query: 53  -FKEQIEKYKIQHQLR--REMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHR 103
            F+ ++         R  RE+ +   +RH N++ L   F  DE        +L++ +   
Sbjct: 61  PFQSEL------FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT 114

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
            +L + ++ H +  E +    +  +   L Y H   +IHRD+KP NL ++ +  LKI DF
Sbjct: 115 -DLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172

Query: 164 GWSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAE 219
           G    +R     M G   T  Y APE ++    +   VD W++G +  E + G   F+  
Sbjct: 173 GL---ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229

Query: 220 SQKD------------------------------------------TFRSISAEAKHLIS 237
              D                                             + S  A +L+ 
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
           ++LV D+ +R++  + + HP+ 
Sbjct: 290 KMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  108 bits (271), Expect = 1e-27
 Identities = 67/304 (22%), Positives = 115/304 (37%), Gaps = 74/304 (24%)

Query: 19  QDFEIG------RPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR-- 67
             +E+        P+G G +G V    + ++   VA+K +   F+  I      H  R  
Sbjct: 23  TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII------HAKRTY 76

Query: 68  REMEIQSSLRHPNILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
           RE+ +   ++H N++ L           +   ++L+       +L   ++  ++ T+   
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVK-CQKLTDDHV 134

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG--- 178
              I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG    +R     M G   
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTADEMTGYVA 191

Query: 179 TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------------- 223
           T  Y APE M+    ++  VD W++G +  E L G   F      D              
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251

Query: 224 ----------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIME 255
                                        F   +  A  L+ ++LV DS KR++  + + 
Sbjct: 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311

Query: 256 HPWI 259
           H + 
Sbjct: 312 HAYF 315

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (269), Expect = 3e-27
 Identities = 51/241 (21%), Positives = 91/241 (37%), Gaps = 15/241 (6%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQI 57
           ++ +  +   +     S         +G+G FG VY   L+     K   A+K +    I
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-I 128

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR- 115
                  Q   E  I     HPN+L L G     +    ++L Y   G+L   +R     
Sbjct: 129 TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 188

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKR 173
            T +    +   +   + +      +HRD+   N +LD +  +K+ DFG +  +  +   
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248

Query: 174 HTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRS 227
                T   L     A E ++ ++     D W+ G+L +E    GAPP+   +  D    
Sbjct: 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

Query: 228 I 228
           +
Sbjct: 309 L 309

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  107 bits (270), Expect = 4e-27
 Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 39/238 (16%)

Query: 3   TKTAEREDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK 61
           +K          +W + D +EI   +G G +G V    +   K  VA+K I +   +   
Sbjct: 36  SKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLID 95

Query: 62  IQHQLRREMEIQSSLRHPNILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRF 116
            +  LR E+ I + L H +++++            + ++++LE A   +  +  R     
Sbjct: 96  CKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYL 153

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG------------ 164
           TE    T + +L   + Y H   ++HRD+KP N L++ +  +K+ DFG            
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 165 ---------------WSVQSRSKRHTMCG---TLDYLAPE-MVENKEHDYAVDNWTLG 203
                              +++ +  + G   T  Y APE ++  + +  A+D W++G
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (265), Expect = 6e-27
 Identities = 50/220 (22%), Positives = 101/220 (45%), Gaps = 14/220 (6%)

Query: 20  DFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +F+  + LG G FG VY    + E E  K PVA+K + +    K     ++  E  + +S
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 73

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAY 134
           + +P++ RL G       + LI +    G L   +R+H+     Q    +   +   + Y
Sbjct: 74  VDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 135 CHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDYLAPEMVE 189
             +  ++HRD+   N+L+     +KI DFG +  + +  K +   G    + ++A E + 
Sbjct: 133 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192

Query: 190 NKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           ++ + +  D W+ G+  +E   +G+ P++     +    +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  104 bits (262), Expect = 9e-27
 Identities = 51/241 (21%), Positives = 96/241 (39%), Gaps = 15/241 (6%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQI 57
           ++ +  +   +     S         +G+G FG VY   L+     K   A+K +     
Sbjct: 7   LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRIT 65

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR- 115
           +  ++  Q   E  I     HPN+L L G     +    ++L Y   G+L   +R     
Sbjct: 66  DIGEVS-QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN 124

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSR--- 170
            T +    +   +   + Y      +HRD+   N +LD +  +K+ DFG +  +  +   
Sbjct: 125 PTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184

Query: 171 SKRHTMCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRS 227
           S  +     L   ++A E ++ ++     D W+ G+L +E    GAPP+   +  D    
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244

Query: 228 I 228
           +
Sbjct: 245 L 245

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  104 bits (261), Expect = 1e-26
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 26/235 (11%)

Query: 12  RKREWSLQDFEI---GRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R +E  L    +    + LG G FG V     +  +    VA+KI+ K +     ++ +L
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDEL 65

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  +   L +P I+R+ G   + E   L++E A  G L + L+++R   ++     + 
Sbjct: 66  LAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 124

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY---- 182
            ++  + Y  E++ +HRD+   N+LL  +   KI DFG S      +        Y    
Sbjct: 125 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS------KALRADENYYKAQT 178

Query: 183 --------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                    APE +   +     D W+ G+L +E F YG  P+      +    +
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 233

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  104 bits (261), Expect = 1e-26
 Identities = 61/240 (25%), Positives = 94/240 (39%), Gaps = 14/240 (5%)

Query: 5   TAEREDNRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEK 59
           +A     +     +   D  +   LG G FG V              VA+K +  + + +
Sbjct: 2   SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61

Query: 60  YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTE 118
            +      RE+    SL H N++RLYG       + ++ E A  G L   LRKH+  F  
Sbjct: 62  PEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL 120

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTM 176
              + Y   +   + Y      IHRD+   NLLL     +KIGDFG    +      + M
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180

Query: 177 CGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSISAE 231
                    + APE ++ +   +A D W  G+  +E F YG  P+   +       I  E
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  107 bits (269), Expect = 1e-26
 Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 12/236 (5%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           +  T      R  E   +  E+GR +G+G+FG V+    +        VA+K       +
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
             + +    +E        HP+I++L G    +  +++I+E    GEL   L+  +    
Sbjct: 433 SVREK--FLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKFSLD 489

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT 175
                 Y   L+ ALAY      +HRDI   N+L+     +K+GDFG S  ++  +    
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 549

Query: 176 MCGTL--DYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
             G L   ++APE +  +    A D W  G+  +E  ++G  PF+     D    I
Sbjct: 550 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (261), Expect = 2e-26
 Identities = 57/254 (22%), Positives = 93/254 (36%), Gaps = 45/254 (17%)

Query: 11  NRKREWSLQDFEI-------GRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKY 60
           + + +  L+D  I       GR LGKG+FG V    L +E  S   VA+K++ K  I   
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIAS 66

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYG------WFHDDERIFLILEYAHRGELYRELRKHR 114
               +  RE        HP++ +L G               +IL +   G+L+  L   R
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126

Query: 115 ------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ 168
                     Q    ++  +   + Y    + IHRD+   N +L  +  + + DFG S  
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184

Query: 169 SRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAP 214
               R    G  DY             LA E + +  +    D W  G+  +E    G  
Sbjct: 185 ----RKIYSG--DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238

Query: 215 PFEAESQKDTFRSI 228
           P+      + +  +
Sbjct: 239 PYAGIENAEIYNYL 252

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  104 bits (261), Expect = 2e-26
 Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 74/311 (23%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALK-IIFKEQIEKYKIQHQLR--REMEIQSSLR 77
           +   +PLG G  G V+   + +    VA+K I+  +              RE++I   L 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ------SVKHALREIKIIRRLD 66

Query: 78  HPNILRLY--------------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
           H NI++++              G   +   ++++ EY    +L   L +     E+ A  
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARL 124

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFG---WSVQSRSKRHTMCG- 178
           ++  L   L Y H  +V+HRD+KP NL ++ E   LKIGDFG         S +  +   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 179 --TLDYLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------ 223
             T  Y +P  ++    +  A+D W  G +  E L G   F    + +            
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244

Query: 224 -----------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                                            IS EA   + ++L      RL+ ++ +
Sbjct: 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304

Query: 255 EHPWIIKNANP 265
            HP++   + P
Sbjct: 305 SHPYMSIYSFP 315

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  105 bits (265), Expect = 2e-26
 Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 16/237 (6%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           +E+ + +GKG FG+V    + +    VALK++  E+    +   Q   E+ I   LR   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQD 154

Query: 79  ----PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNAL 132
                N++ +   F     I +  E      LY  ++K+  + F+      +  S+   L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCL 213

Query: 133 AYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
              H+N +IH D+KPEN+LL  +GR  +K+ DFG S     + +T   +  Y APE++  
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILG 273

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
             +   +D W+LG +  E L G P    E + D    +  E   + S+ L+  S + 
Sbjct: 274 ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI-ELLGMPSQKLLDASKRA 329

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  104 bits (261), Expect = 3e-26
 Identities = 59/300 (19%), Positives = 105/300 (35%), Gaps = 64/300 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY------KIQHQLR--REMEI 72
           + + R +  G +G V    + E   PVA+K +F    +              R  RE+ +
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 73  QSSLRHPNILRLYGWFHDDER-----IFLILEYAHRGELYRELRKHRR-FTEQQAATYIA 126
            +   HPNIL L   F   E      ++L+ E     +L + +   R   + Q    ++ 
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYL 183
            +   L   HE  V+HRD+ P N+LL     + I DF  + +  +             Y 
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA-REDTADANKTHYVTHRWYR 200

Query: 184 APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------- 223
           APE +++ K     VD W+ G +  E       F   +  +                   
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260

Query: 224 ------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                      +    A  LI+++L  +  +R+S ++ + HP+ 
Sbjct: 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF 320

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  105 bits (264), Expect = 3e-26
 Identities = 61/309 (19%), Positives = 121/309 (39%), Gaps = 77/309 (24%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
           L+ ++  +P+G G  G V    +      VA+K +   F+ Q       H  R  RE+ +
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT------HAKRAYRELVL 114

Query: 73  QSSLRHPNILRLY------GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
              + H NI+ L           + + ++L++E      L + ++       ++ +  + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLY 171

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG---TLDYL 183
            +   + + H   +IHRD+KP N+++  +  LKI DFG + ++      M     T  Y 
Sbjct: 172 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMMTPYVVTRYYR 230

Query: 184 APEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------- 228
           APE++    +   VD W++G +  E +     F      D +  +               
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 229 --------------------------------------SAEAKHLISRLLVKDSSKRLSL 250
                                                 +++A+ L+S++LV D +KR+S+
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

Query: 251 QKIMEHPWI 259
              ++HP+I
Sbjct: 351 DDALQHPYI 359

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  103 bits (258), Expect = 4e-26
 Identities = 50/256 (19%), Positives = 96/256 (37%), Gaps = 35/256 (13%)

Query: 1   MDTKTAEREDNRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKE 55
           +  + +E   N+  +  +      +G+ LG+G+FG V    L +E  +   VA+K + K 
Sbjct: 14  LVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KL 72

Query: 56  QIEKYKIQHQLRREMEIQSSLRHPNILRLYG-----WFHDDERIFLILEYAHRGELYREL 110
                +   +   E        HPN++RL G           +  +IL +   G+L+  L
Sbjct: 73  DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132

Query: 111 RKHR------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG 164
              R          Q    ++  +   + Y    + +HRD+   N +L  +  + + DFG
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFG 192

Query: 165 WS--VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYG 212
            S  + S    R  R         +     A E + ++ +    D W  G+  +E    G
Sbjct: 193 LSKKIYSGDYYRQGRIAK------MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246

Query: 213 APPFEAESQKDTFRSI 228
             P+      + +  +
Sbjct: 247 MTPYPGVQNHEMYDYL 262

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  103 bits (260), Expect = 5e-26
 Identities = 66/305 (21%), Positives = 125/305 (40%), Gaps = 72/305 (23%)

Query: 19  QDFEIGR------PLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLR--R 68
           Q F++G        +G+G +G V    +  +K  VA+K I  F+ Q       +  R  R
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT------YCQRTLR 74

Query: 69  EMEIQSSLRHPNILRLYGWFH-----DDERIFLILEYAHRGELYRELRKHRRFTEQQAAT 123
           E++I    RH NI+ +            + ++++ +     +LY+ L+  +  +      
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICY 132

Query: 124 YIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL 183
           ++  +   L Y H  +V+HRD+KP NLLL+    LKI DFG +  +           +Y+
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 184 ------APE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------- 223
                 APE M+ +K +  ++D W++G +  E L   P F  +   D             
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252

Query: 224 -----------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIM 254
                                         F +  ++A  L+ ++L  +  KR+ +++ +
Sbjct: 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312

Query: 255 EHPWI 259
            HP++
Sbjct: 313 AHPYL 317

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (262), Expect = 5e-26
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 13/224 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   +   +   LG+G FG V++         VA+K +               +E ++
Sbjct: 178 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL----KPGTMSPEAFLQEAQV 232

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              LRH  +++LY     +E I+++ EY  +G L   L+          Q     A + +
Sbjct: 233 MKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----LAPE 186
            +AY    + +HRD++  N+L+      K+ DFG +       +T      +     APE
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 351

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                      D W+ GIL  E    G  P+     ++    + 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  103 bits (258), Expect = 6e-26
 Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 27/246 (10%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           +   A R     RE       I + +G G  G V    L    +   PVA+K +     E
Sbjct: 34  EPGRAGRSF--TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
           + +       E  I     HPNI+RL G         ++ EY   G L   LR H  +FT
Sbjct: 92  RQRRD--FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFT 149

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC 177
             Q    +  +   + Y  +   +HRD+   N+L+D     K+ DFG S      R    
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLS------RVLED 203

Query: 178 GTLDYL------------APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                             APE +  +    A D W+ G++ +E   YG  P+   + +D 
Sbjct: 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263

Query: 225 FRSISA 230
             S+  
Sbjct: 264 ISSVEE 269

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  105 bits (263), Expect = 6e-26
 Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 13/224 (5%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   +   +   LG+G FG V++         VA+K +               +E ++
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL----KPGTMSPEAFLQEAQV 315

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              LRH  +++LY    + E I+++ EY  +G L   L+          Q     A + +
Sbjct: 316 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----LAPE 186
            +AY    + +HRD++  N+L+      K+ DFG +       +T      +     APE
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 434

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                      D W+ GIL  E    G  P+     ++    + 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  103 bits (258), Expect = 9e-26
 Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 74/308 (24%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII--FKEQIEKYKIQHQLR--REMEIQ 73
             DF++   LG+G +G V       +   VA+K I  F + +        LR  RE++I 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL------FALRTLREIKIL 63

Query: 74  SSLRHPNILRLY-----GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
              +H NI+ ++       F +   +++I E     +L+R +   +  ++     +I   
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQT 121

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD------- 181
             A+   H ++VIHRD+KP NLL++    LK+ DFG +                      
Sbjct: 122 LRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 182 ------YLAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------- 223
                 Y APE M+ + ++  A+D W+ G +  E     P F     +            
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 224 --------------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQ 251
                                            F  ++ +   L+ R+LV D +KR++ +
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301

Query: 252 KIMEHPWI 259
           + +EHP++
Sbjct: 302 EALEHPYL 309

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  101 bits (255), Expect = 9e-26
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 17/228 (7%)

Query: 14  REWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
            E         R +GKG FG VY    + + +++   A+K +    I + +      RE 
Sbjct: 18  HERV--VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SR-ITEMQQVEAFLREG 73

Query: 71  EIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASL 128
            +   L HPN+L L G     +    ++L Y   G+L + +R  +R  T +   ++   +
Sbjct: 74  LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQV 133

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSR---SKRHTMCGTL--D 181
              + Y  E   +HRD+   N +LD    +K+ DFG +  +  R   S +      L   
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           + A E ++        D W+ G+L +E    GAPP+      D    +
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (256), Expect = 9e-26
 Identities = 50/218 (22%), Positives = 90/218 (41%), Gaps = 17/218 (7%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +    LGKG FG V L         +   VA+K +     ++   Q   +R
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQR 73

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E++I  +L    I++  G  +    + + L++EY   G L   L++HR R    +   Y 
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDY- 182
           + +   + Y      +HRD+   N+L++ E  +KI DFG +  +      + +       
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193

Query: 183 ---LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
               APE + +       D W+ G++ YE F Y     
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  101 bits (253), Expect = 1e-25
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 29/230 (12%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +   +    + +G G+FG V+L     +K  VA+K I +E       +     E E+
Sbjct: 2   KWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTI-REG---AMSEEDFIEEAEV 56

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
              L HP +++LYG   +   I L+ E+   G L   LR  R  F  +        +   
Sbjct: 57  MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---------VQSRSK---RHTMCGT 179
           +AY  E  VIHRD+   N L+     +K+ DFG +           + +K   +      
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---- 172

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
               +PE+     +    D W+ G+L +E F  G  P+E  S  +    I
Sbjct: 173 ----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  101 bits (253), Expect = 1e-25
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 27/231 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
             E   ++  + + LG G+FG V L +  + ++ VA+K+I KE       + +  +E + 
Sbjct: 2   HMELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMI-KEG---SMSEDEFFQEAQT 56

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNA 131
              L HP +++ YG    +  I+++ EY   G L   LR H +     Q       +   
Sbjct: 57  MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL-------- 183
           +A+   +  IHRD+   N L+D +  +K+ DFG    +R           Y+        
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDD-----QYVSSVGTKFP 168

Query: 184 ----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               APE+    ++    D W  GIL +E F  G  P++  +  +    +S
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  101 bits (255), Expect = 1e-25
 Identities = 54/243 (22%), Positives = 97/243 (39%), Gaps = 39/243 (16%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E + +   + R LG+G FG VY      V + E +  VA+K + +    + +I+     E
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FLNE 78

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
             +       +++RL G     +   +I+E   RG+L   LR  R            SL+
Sbjct: 79  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 138

Query: 130 NAL----------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT 179
             +          AY + N  +HRD+   N ++  +  +KIGDFG +      R      
Sbjct: 139 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYET- 191

Query: 180 LDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTF 225
            DY             ++PE +++       D W+ G++ +E       P++  S +   
Sbjct: 192 -DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250

Query: 226 RSI 228
           R +
Sbjct: 251 RFV 253

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (253), Expect = 2e-25
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 29/229 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
             ++  +  +  + LGKG FG V +      +  +   VA+K + +   E++       R
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEH--LRDFER 60

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E+EI  SL+H NI++  G  +      + LI+EY   G L   L+KH+ R    +   Y 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY--- 182
           + +   + Y      IHRD+   N+L+++E R+KIGDFG +      +        +   
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------KVLPQDKEFFKVK 174

Query: 183 ---------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                     APE +   +   A D W+ G++ YE F Y        ++
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  102 bits (257), Expect = 2e-25
 Identities = 60/238 (25%), Positives = 101/238 (42%), Gaps = 15/238 (6%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIE 58
           D      E    +E    +  I + +G G+FG V    L    + +  VA+K +     E
Sbjct: 30  DPTQTVHEF--AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE 87

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFT 117
           K +       E  I     HPNI+RL G     + + ++ EY   G L   LRKH  +FT
Sbjct: 88  KQRRD--FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 145

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS----VQSRSKR 173
             Q    +  + + + Y  +   +HRD+   N+L++     K+ DFG          +  
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205

Query: 174 HTMCGTLDYL--APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
            T  G +     +PE +  ++   A D W+ GI+ +E   YG  P+   S +D  +++
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV 263

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (253), Expect = 2e-25
 Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 28/229 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +  R LG+G FG+V L         +   VA+K +  E    +     L++
Sbjct: 15  PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKK 72

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYI 125
           E+EI  +L H NI++  G         I LI+E+   G L   L K++ +   +Q   Y 
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY--- 182
             +   + Y      +HRD+   N+L++ E ++KIGDFG +      +        Y   
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIETDKEYYTVK 186

Query: 183 ---------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQ 221
                     APE +   +   A D W+ G+  +E   Y        + 
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL 235

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  100 bits (250), Expect = 4e-25
 Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 13/223 (5%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +   D  +   LG G++G VY     +    VA+K + KE         +  +E  +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAV 62

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              ++HPN+++L G    +   ++I E+   G L   LR+  R   +          +++
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDY--LAPE 186
           A+ Y  + + IHRD+   N L+     +K+ DFG S  +   +              APE
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182

Query: 187 MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
            +   +     D W  G+L +E   YG  P+        +  +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  100 bits (251), Expect = 4e-25
 Identities = 51/227 (22%), Positives = 101/227 (44%), Gaps = 14/227 (6%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVY---LVREVES-KHPVALKIIFKEQIEKYKIQHQLRR 68
            R +   +    + LG G FG V+    + E ES K PV +K+I +++  + +    +  
Sbjct: 7   ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGR-QSFQAVTD 64

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIAS 127
            M    SL H +I+RL G       + L+ +Y   G L   +R+HR     Q    +   
Sbjct: 65  HMLAIGSLDHAHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGT---LDY 182
           +   + Y  E+ ++HR++   N+LL    ++++ DFG +  +    K+         + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
           +A E +   ++ +  D W+ G+  +E   +GA P+      +    +
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 99.6 bits (249), Expect = 5e-25
 Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 30/237 (12%)

Query: 11  NRKREWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQ 65
           +  R++ +Q    E+GR +G+G+FG V+    +        VA+K       +  + +  
Sbjct: 5   SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-- 62

Query: 66  LRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATY 124
             +E        HP+I++L G    +  +++I+E    GEL   L+  +          Y
Sbjct: 63  FLQEALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY 121

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY-- 182
              L+ ALAY      +HRDI   N+L+     +K+GDFG    SR    +      Y  
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDS-----TYYK 173

Query: 183 ----------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                     +APE +  +    A D W  G+  +E  ++G  PF+     D    I
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 5e-25
 Identities = 61/241 (25%), Positives = 103/241 (42%), Gaps = 29/241 (12%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQ 56
                +  ED    ++  +  +  + LGKG FG V +      +  +   VA+K + +  
Sbjct: 23  QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHS 81

Query: 57  IEKYKIQHQLRREMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHR 114
            E++       RE+EI  SL+H NI++  G  +      + LI+EY   G L   L+KH+
Sbjct: 82  TEEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK 139

Query: 115 -RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR 173
            R    +   Y + +   + Y      IHRD+   N+L+++E R+KIGDFG +      +
Sbjct: 140 ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT------K 193

Query: 174 HTMCGTLDY------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAES 220
                   Y             APE +   +   A D W+ G++ YE F Y        +
Sbjct: 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253

Query: 221 Q 221
           +
Sbjct: 254 E 254

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 99.6 bits (249), Expect = 5e-25
 Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 29/232 (12%)

Query: 13  KREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
              W +  +D    + LG G+FG V   +    ++ VA+K+I KE       + +   E 
Sbjct: 16  YGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG---SMSEDEFIEEA 70

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLT 129
           ++  +L H  +++LYG       IF+I EY   G L   LR+ R RF  QQ       + 
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 130

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------ 183
            A+ Y      +HRD+   N L++ +G +K+ DFG    SR          +Y       
Sbjct: 131 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD-----EYTSSVGSK 182

Query: 184 ------APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                  PE++   +     D W  G+L +E +  G  P+E  +  +T   I
Sbjct: 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 99.2 bits (248), Expect = 6e-25
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 27/242 (11%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M    A +++  +  W+L  ++ ++ + +GKG+FG V         + VA+K I K    
Sbjct: 1   MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI-KNDAT 57

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-- 115
                     E  + + LRH N+++L G    +   ++++ EY  +G L   LR   R  
Sbjct: 58  A----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                   +   +  A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173

Query: 176 -------MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRS 227
                          APE +  K+     D W+ GIL +E + +G  P+     KD    
Sbjct: 174 GKLPVKWT-------APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 226

Query: 228 IS 229
           + 
Sbjct: 227 VE 228

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 99.2 bits (248), Expect = 8e-25
 Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 42/252 (16%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQH 64
               +    +D  + R LG+G FG+V+L     +   + K  VA+K + K+     +   
Sbjct: 6   GIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKD- 63

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
             +RE E+ ++L+H +I++ YG   D + + ++ EY   G+L + LR H           
Sbjct: 64  -FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122

Query: 125 IASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-- 166
                  L                 Y    H +HRD+   N L+     +KIGDFG S  
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 167 VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
           V S    R   HTM      L      PE +  ++     D W+ G++ +E F YG  P+
Sbjct: 183 VYSTDYYRVGGHTM------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 217 EAESQKDTFRSI 228
              S  +    I
Sbjct: 237 FQLSNTEVIECI 248

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 99.7 bits (249), Expect = 9e-25
 Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 28/235 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
              +  +  +  R LG+G FG+V L         +   VA+K +  +   +++     ++
Sbjct: 25  PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG--WKQ 82

Query: 69  EMEIQSSLRHPNILRLYG--WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           E++I  +L H +I++  G         + L++EY   G L   L +H      Q   +  
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQ 141

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY---- 182
            +   +AY H  H IHRD+   N+LLD++  +KIGDFG +      +    G   Y    
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA------KAVPEGHEYYRVRE 195

Query: 183 --------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                    APE ++  +  YA D W+ G+  YE   +        ++      I
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  100 bits (251), Expect = 1e-24
 Identities = 56/242 (23%), Positives = 97/242 (40%), Gaps = 27/242 (11%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIEK-YKIQHQLRR-EMEIQ 73
           + + R LG G F  V+L +++ +   VA+KI+     + E  E   K+  ++   +   +
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 74  SSLRHPNILRLYGWF----HDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIAS 127
            S+   +IL+L   F     +   + ++ E      L   ++K  HR             
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQ 139

Query: 128 LTNALAYCH-ENHVIHRDIKPENLLLDHEGR------LKIGDFGWSVQSRSKRHTMCGTL 180
           L   L Y H    +IH DIKPEN+L++          +KI D G +            T 
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199

Query: 181 DYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL--ISR 238
           +Y +PE++         D W+   L +E + G   FE +         + +  H+  I  
Sbjct: 200 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY----TKDDDHIAQIIE 255

Query: 239 LL 240
           LL
Sbjct: 256 LL 257

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 58/244 (23%), Positives = 95/244 (38%), Gaps = 26/244 (10%)

Query: 2   DTKTAEREDNRKREWSLQDFEIGRPLGKGKFGRVYL----VREVESKHPVALKIIFKEQI 57
           D   A  +     E         + +G G+FG VY         + + PVA+K +     
Sbjct: 29  DPNQAVLKF--TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86

Query: 58  EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RF 116
           EK ++      E  I     H NI+RL G     + + +I EY   G L + LR+    F
Sbjct: 87  EKQRVD--FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF 144

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
           +  Q    +  +   + Y    + +HRD+   N+L++     K+ DFG S          
Sbjct: 145 SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA- 203

Query: 177 CGTLDY-----------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDT 224
                Y            APE +  ++   A D W+ GI+ +E   YG  P+   S  + 
Sbjct: 204 ----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

Query: 225 FRSI 228
            ++I
Sbjct: 260 MKAI 263

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 99.8 bits (249), Expect = 2e-24
 Identities = 65/332 (19%), Positives = 129/332 (38%), Gaps = 83/332 (25%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGR------PLGKGKFGRVYLVREVESKHPVALKII-- 52
           M +++    +    E     F + +      P+G G  G V    +   +  VA+K +  
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 53  -FKEQIEKYKIQHQLR--REMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHR 103
            F+ Q       H  R  RE+ +   + H NI+ L   F   +       +++++E    
Sbjct: 61  PFQNQT------HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD- 113

Query: 104 GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
             L + ++       ++ +  +  +   + + H   +IHRD+KP N+++  +  LKI DF
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 171

Query: 164 GWSVQSRSKRHTMCG---TLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES 220
           G + ++      M     T  Y APE++    +   VD W++G +  E + G   F    
Sbjct: 172 GLA-RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230

Query: 221 QKDTFRSI---------------------------------------------------- 228
             D +  +                                                    
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290

Query: 229 -SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
            +++A+ L+S++LV D+SKR+S+ + ++HP+I
Sbjct: 291 KASQARDLLSKMLVIDASKRISVDEALQHPYI 322

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (250), Expect = 2e-24
 Identities = 57/235 (24%), Positives = 107/235 (45%), Gaps = 13/235 (5%)

Query: 1   MDTKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE 58
           M+   A +++  +  W+L  ++ ++ + +GKG+FG V         + VA+K I K    
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVM--LGDYRGNKVAVKCI-KNDAT 229

Query: 59  KYKIQHQLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRR-- 115
                     E  + + LRH N+++L G    +   ++++ EY  +G L   LR   R  
Sbjct: 230 ----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 285

Query: 116 FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT 175
                   +   +  A+ Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T
Sbjct: 286 LGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 345

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
               + + APE +  K+     D W+ GIL +E + +G  P+     KD    + 
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 40/236 (16%)

Query: 20  DFEIGRPLGKGKFGRVYL-------VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           D      LG+G F +++              +  V LK++ K                 +
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASM 65

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
            S L H +++  YG     +   L+ E+   G L   L+K++              L  A
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA 125

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRL--------KIGDFGWS--VQSRSKRHTMCGTLD 181
           + +  EN +IH ++  +N+LL  E           K+ D G S  V  +          D
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK----------D 175

Query: 182 YL-------APE-MVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
            L        PE +   K  + A D W+ G   +E    G  P  A   +   +  
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 64/253 (25%), Positives = 105/253 (41%), Gaps = 51/253 (20%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
                 +D  +   LG+G FG+V+L     +   + K  VA+K + KE  E  +     +
Sbjct: 35  VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQD--FQ 91

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA------ 121
           RE E+ + L+H +I+R +G   +   + ++ EY   G+L R LR H    +  A      
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151

Query: 122 ------------ATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS 169
                       A+ +A+    + Y    H +HRD+   N L+     +KIGDFG    S
Sbjct: 152 PGPLGLGQLLAVASQVAA---GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG---MS 205

Query: 170 RSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           R    T     DY             + PE +  ++     D W+ G++ +E F YG  P
Sbjct: 206 RDIYST-----DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

Query: 216 FEAESQKDTFRSI 228
           +   S  +    I
Sbjct: 261 WYQLSNTEAIDCI 273

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 99.0 bits (247), Expect = 4e-24
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 18/239 (7%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP- 79
           +EI   +GKG FG+V    +   +  VA+KII  +  + +   +Q + E+ +   +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII--KNKKAF--LNQAQIEVRLLELMNKHD 111

Query: 80  -----NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNAL 132
                 I+ L   F     + L+ E      LY  LR       +      +   +  AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170

Query: 133 AYCHEN--HVIHRDIKPENLLLDHEGR--LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV 188
            +       +IH D+KPEN+LL +  R  +KI DFG S Q   + +    +  Y +PE++
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVL 230

Query: 189 ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVKDSSKR 247
               +D A+D W+LG +  E   G P F   ++ D    I  E   +    ++  + K 
Sbjct: 231 LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV-EVLGIPPAHILDQAPKA 288

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 96.5 bits (241), Expect = 7e-24
 Identities = 60/233 (25%), Positives = 96/233 (41%), Gaps = 30/233 (12%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVY---LVREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           ++ +   D  + R LG+G FG VY          K  VA+K   K+     K +     E
Sbjct: 6   QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK--FMSE 63

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASL 128
             I  +L HP+I++L G   ++E  ++I+E    GEL   L +++          Y   +
Sbjct: 64  AVIMKNLDHPHIVKLIG-IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI 122

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY------ 182
             A+AY    + +HRDI   N+L+     +K+GDFG    SR          DY      
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDE-----DYYKASVT 174

Query: 183 ------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                 ++PE +  +    A D W   +  +E   +G  PF     KD    +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL 227

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.5 bits (241), Expect = 9e-24
 Identities = 58/252 (23%), Positives = 104/252 (41%), Gaps = 45/252 (17%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + +E SL        LG+ +FG+VY          E    VA+K + K++ E   ++ + 
Sbjct: 2   KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEG-PLREEF 59

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
           R E  +++ L+HPN++ L G    D+ + +I  Y   G+L+  L      ++  +     
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 127 SLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---- 166
           ++ +AL                 Y   +HV+H+D+   N+L+  +  +KI D G      
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 167 ------VQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
                 +   S    R          APE +   +     D W+ G++ +E F YG  P+
Sbjct: 180 AADYYKLLGNSLLPIRWM--------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 217 EAESQKDTFRSI 228
              S +D    I
Sbjct: 232 CGYSNQDVVEMI 243

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 96.6 bits (241), Expect = 1e-23
 Identities = 65/240 (27%), Positives = 93/240 (38%), Gaps = 29/240 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +E   ++  + R LG G FG VY      +    S   VA+K + +   E+ ++     
Sbjct: 24  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FL 81

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-------- 119
            E  I S   H NI+R  G        F+++E    G+L   LR+ R    Q        
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 120 --QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH 174
               A  IA       Y  ENH IHRDI   N LL   G     KIGDFG +       +
Sbjct: 142 LLHVARDIAC---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY 198

Query: 175 TMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
              G    L      PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 199 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 97.1 bits (242), Expect = 1e-23
 Identities = 66/240 (27%), Positives = 93/240 (38%), Gaps = 29/240 (12%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLR 67
            +E   ++  + R LG G FG VY      +    S   VA+K + +   E+ ++     
Sbjct: 65  LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FL 122

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQ-------- 119
            E  I S   H NI+R  G        F++LE    G+L   LR+ R    Q        
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 120 --QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSKRH 174
               A  IA       Y  ENH IHRDI   N LL   G     KIGDFG +       +
Sbjct: 183 LLHVARDIAC---GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY 239

Query: 175 TMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
              G    L      PE           D W+ G+L +E F  G  P+ ++S ++    +
Sbjct: 240 YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 95.0 bits (237), Expect = 3e-23
 Identities = 56/234 (23%), Positives = 97/234 (41%), Gaps = 28/234 (11%)

Query: 14  REWSLQ--DFEIGR-PLGKGKFGRVY--LVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++  L+  +  I    LG G FG V   + R  + +  VA+K++ +   +      ++ R
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMR 59

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIAS 127
           E +I   L +P I+RL G     E + L++E A  G L++ L   R        A  +  
Sbjct: 60  EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY----- 182
           ++  + Y  E + +HRD+   N+LL +    KI DFG S      +        Y     
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS------KALGADDSYYTARSA 172

Query: 183 -------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSI 228
                   APE +  ++     D W+ G+  +E   YG  P++     +    I
Sbjct: 173 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 226

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.3 bits (240), Expect = 6e-23
 Identities = 51/240 (21%), Positives = 95/240 (39%), Gaps = 23/240 (9%)

Query: 3   TKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY 60
             +  ++   K  W +  +  ++ + LG G+FG V++         VA+K +        
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTM----KPGS 224

Query: 61  KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTE 118
                   E  +  +L+H  +++L+      E I++I E+  +G L   L+         
Sbjct: 225 MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL 283

Query: 119 QQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCG 178
            +   + A +   +A+  + + IHRD++  N+L+      KI DFG +       +T   
Sbjct: 284 PKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343

Query: 179 --------TLDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                   T    APE +         D W+ GIL  E   YG  P+   S  +  R++ 
Sbjct: 344 GAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 94.3 bits (235), Expect = 1e-22
 Identities = 62/233 (26%), Positives = 95/233 (40%), Gaps = 54/233 (23%)

Query: 22  EIGRPLGKGKFGRVYL-----VREVESKHPVALKII-----FKEQIEKYKIQHQLRREME 71
           + G+ LG G FG+V       + + ++   VA+K++       E+         L  E++
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-------LMSELK 101

Query: 72  IQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT- 129
           I S L +H NI+ L G       + +I EY   G+L   LR+  R  E   A  IA+ T 
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 130 -------------NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM 176
                          +A+    + IHRD+   N+LL +    KIGDFG +      R  M
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RDIM 215

Query: 177 CGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
                              +APE + +  +    D W+ GIL +E F  G  P
Sbjct: 216 ND--SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 21/246 (8%)

Query: 1   MDTKTAEREDNRKREWSLQDFEIGRP--------LGKGKFGRVY--LVREVESKHPVALK 50
           MDT   E   +   E   +   + R         LG G FG V   + R  + +  VA+K
Sbjct: 310 MDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIK 369

Query: 51  IIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL 110
           ++ +   +      ++ RE +I   L +P I+RL G     E + L++E A  G L++ L
Sbjct: 370 VLKQGTEKADT--EEMMREAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL 426

Query: 111 RKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--V 167
              R        A  +  ++  + Y  E + +HR++   N+LL +    KI DFG S  +
Sbjct: 427 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

Query: 168 QSRSKRHTMCGT----LDYLAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQK 222
            +    +T        L + APE +  ++     D W+ G+  +E   YG  P++     
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546

Query: 223 DTFRSI 228
           +    I
Sbjct: 547 EVMAFI 552

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 94.4 bits (235), Expect = 2e-22
 Identities = 55/241 (22%), Positives = 101/241 (41%), Gaps = 45/241 (18%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
             ++ I   +G+G +G VYL  +  ++  VA+K +   F++ I         R  RE+ I
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI------DCKRILREITI 78

Query: 73  QSSLRHPNILRLYGWF-----HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIAS 127
            + L+   I+RLY           + ++++LE A   +L +  +     TE+   T + +
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYN 137

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRSKR 173
           L     + HE+ +IHRD+KP N LL+ +  +K+ DFG                ++   + 
Sbjct: 138 LLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 174 HTMCGTLD-----------YLAPE-MVENKEHDYAVDNWTLG-ILCYEFLYGAPPFEAES 220
                 L            Y APE ++  + +  ++D W+ G I   E L        + 
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA-ELLNMLQSHINDP 256

Query: 221 Q 221
            
Sbjct: 257 T 257

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 91.9 bits (229), Expect = 3e-22
 Identities = 53/232 (22%), Positives = 90/232 (38%), Gaps = 31/232 (13%)

Query: 15  EWSL--QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           EW +  +  ++   LG G+FG V++         VA+K +     +          E  +
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL----KQGSMSPDAFLAEANL 61

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTN 130
              L+H  ++RLY      E I++I EY   G L   L+       T  +     A +  
Sbjct: 62  MKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYL------- 183
            +A+  E + IHRD++  N+L+      KI DFG    +R          +Y        
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL---ARLIEDN-----EYTAREGAKF 172

Query: 184 -----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPFEAESQKDTFRSIS 229
                APE +         D W+ GIL  E   +G  P+   +  +  +++ 
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 92.4 bits (230), Expect = 6e-22
 Identities = 59/262 (22%), Positives = 98/262 (37%), Gaps = 53/262 (20%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQH 64
                E+   + E  R +G+G FGRV+      +   E    VA+K++ KE+     +Q 
Sbjct: 38  KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASA-DMQA 95

Query: 65  QLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATY 124
             +RE  + +   +PNI++L G     + + L+ EY   G+L   LR     T    +  
Sbjct: 96  DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155

Query: 125 IASLTNAL------------------------AYCHENHVIHRDIKPENLLLDHEGRLKI 160
             S    +                        AY  E   +HRD+   N L+     +KI
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215

Query: 161 GDFGWSVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCY 207
            DFG    SR+         DY             + PE +    +    D W  G++ +
Sbjct: 216 ADFGL---SRNIYSA-----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 267

Query: 208 E-FLYGAPPFEAESQKDTFRSI 228
           E F YG  P+   + ++    +
Sbjct: 268 EIFSYGLQPYYGMAHEEVIYYV 289

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 91.2 bits (227), Expect = 1e-21
 Identities = 59/240 (24%), Positives = 90/240 (37%), Gaps = 32/240 (13%)

Query: 3   TKTAEREDNRKREWSL--QDFEIGRPLGKGKFGRVY--LVREVESKHPVALKIIFKEQIE 58
               +   +      L   D +    +G+G FG+V    +++   +   A+K + KE   
Sbjct: 7   HHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYAS 65

Query: 59  KYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFT 117
           K         E+E+   L  HPNI+ L G       ++L +EYA  G L   LRK R   
Sbjct: 66  K-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 118 EQQAATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIG 161
              A     S  + L                 Y  +   IHRD+   N+L+      KI 
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 162 DFGWSVQSRSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           DFG    SR +   +  T+  L     A E +    +    D W+ G+L +E    G  P
Sbjct: 185 DFGL---SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 91.1 bits (227), Expect = 1e-21
 Identities = 57/185 (30%), Positives = 89/185 (48%), Gaps = 28/185 (15%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQ---HQLRREMEIQSSL 76
           +F     LG+G FG+VY  R +     VA+K     ++++ + Q    Q + E+E+ S  
Sbjct: 31  NFSNKNILGRGGFGKVYKGR-LADGTLVAVK-----RLKEERTQGGELQFQTEVEMISMA 84

Query: 77  RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRF-------TEQQAATYIASL 128
            H N+LRL G+     ER+ L+  Y   G +   LR+             Q+ A   A  
Sbjct: 85  VHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR- 142

Query: 129 TNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRH---TMCGTLD 181
              LAY H++    +IHRD+K  N+LLD E    +GDFG + +      H    + GT+ 
Sbjct: 143 --GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200

Query: 182 YLAPE 186
           ++APE
Sbjct: 201 HIAPE 205

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 90.8 bits (226), Expect = 1e-21
 Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 48/239 (20%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+       G+ LG G FG+V       + + ++   VA+K++ K        +  L  E
Sbjct: 19  EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPS-AHLTEREALMSE 76

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +++ S L  H NI+ L G         +I EY   G+L   LR+ R        +     
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 129 TNAL------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
            + L                  A+    + IHRD+   N+LL H    KI DFG    +R
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL---AR 193

Query: 171 SKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
             ++                     +APE + N  + +  D W+ GI  +E F  G+ P
Sbjct: 194 DIKND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 90.4 bits (225), Expect = 2e-21
 Identities = 56/245 (22%), Positives = 99/245 (40%), Gaps = 53/245 (21%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           E+  ++  +G+ LG+G+FG+V       ++       VA+K++ KE          L  E
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASP-SELRDLLSE 76

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
             +   + HP++++LYG    D  + LI+EYA  G L   LR+ R+       +  +  +
Sbjct: 77  FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 130 NAL------------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
           ++L                         Y  E  ++HRD+   N+L+    ++KI DFG 
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196

Query: 166 SVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
           S      R       D              +A E + +  +    D W+ G+L +E    
Sbjct: 197 S------RDVYEE--DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248

Query: 212 GAPPF 216
           G  P+
Sbjct: 249 GGNPY 253

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 90.0 bits (224), Expect = 3e-21
 Identities = 54/232 (23%), Positives = 90/232 (38%), Gaps = 43/232 (18%)

Query: 20  DFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++G+PLG+G FG+V       + +  +   VA+K++ KE          L  E++I  
Sbjct: 28  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATH-SEHRALMSELKILI 85

Query: 75  SL-RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL 132
            +  H N++ L G        + +I+E+   G L   LR  R               + L
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 133 ----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQS----R 170
                            +      IHRD+   N+LL  +  +KI DFG +  +       
Sbjct: 146 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205

Query: 171 SKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FLYGAPPF 216
            K          L     APE + ++ +    D W+ G+L +E F  GA P+
Sbjct: 206 RKGDAR------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 251

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 90.1 bits (224), Expect = 5e-21
 Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 37/235 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-- 78
           F + R +G G FGRV L + +++K   A+K++    I+KY      + E +I   +++  
Sbjct: 37  FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV--RNIKKY--TRSAKIEADILKKIQNDD 92

Query: 79  ---PNILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALA 133
               NI++ +G F   + + LI E      LY  + ++    F  +    Y   +  AL 
Sbjct: 93  INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 134 YCHENHVIHRDIKPENLLLDHEG-------------------------RLKIGDFGWSVQ 168
           Y  +  + H D+KPEN+LLD                             +K+ DFG +  
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211

Query: 169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
                 ++  T  Y APE++ N   D + D W+ G +  E   G+  F      +
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 89.7 bits (223), Expect = 5e-21
 Identities = 59/257 (22%), Positives = 103/257 (40%), Gaps = 58/257 (22%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVY-------LVREVESKHPVALKII-----FKEQIEKYKI 62
           E+      +G+PLG+G FG+V           + +    VA+K++      K+  +    
Sbjct: 31  EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---- 86

Query: 63  QHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
              L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    + +
Sbjct: 87  ---LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143

Query: 122 ATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW 165
                     +                 Y      IHRD+   N+L+     +KI DFG 
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203

Query: 166 SVQSRSKRHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLY 211
              +R   +      DY             +APE + ++ + +  D W+ G+L +E F  
Sbjct: 204 ---ARDINNI-----DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255

Query: 212 GAPPFEAESQKDTFRSI 228
           G  P+     ++ F+ +
Sbjct: 256 GGSPYPGIPVEELFKLL 272

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 88.8 bits (221), Expect = 8e-21
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 19/180 (10%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
            +F+    +G G FG+VY    +     VALK    E  +  +   +   E+E  S  RH
Sbjct: 39  NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRH 94

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA------L 132
           P+++ L G+  +   + LI +Y   G L R L  +       + ++   L         L
Sbjct: 95  PHLVSLIGFCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGL 152

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT------MCGTLDYLAPE 186
            Y H   +IHRD+K  N+LLD     KI DFG S +      T        GTL Y+ PE
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVK-GTLGYIDPE 211

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 50/231 (21%), Positives = 93/231 (40%), Gaps = 33/231 (14%)

Query: 21  FEIGRPLGKGKFGRVYLVRE-VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI   LG+G FG+V    +    K  VALKII    + KY  +   R E+ +   ++  
Sbjct: 21  YEIVGNLGEGTFGKVVECLDHARGKSQVALKII--RNVGKY--REAARLEINVLKKIKEK 76

Query: 80  ------NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNA 131
                   + +  WF+    + +  E   +   +  L+++  + +           L +A
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 132 LAYCHENHVIHRDIKPENLLLDHEG-------------------RLKIGDFGWSVQSRSK 172
           L + HEN + H D+KPEN+L  +                      +++ DFG +      
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
             T+  T  Y  PE++         D W++G + +E+  G   F+    ++
Sbjct: 196 HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 88.0 bits (219), Expect = 1e-20
 Identities = 50/177 (28%), Positives = 78/177 (44%), Gaps = 27/177 (15%)

Query: 27  LGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE--MEIQ--SSLRHPNIL 82
           +G+G FG VY  +   +   VA+K +            +L+++   EI+  +  +H N++
Sbjct: 39  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDIT---TEELKQQFDQEIKVMAKCQHENLV 93

Query: 83  RLYGW-FHDDERIFLILEYAHRGELYRELRKHRRF------TEQQAATYIASLTNALAYC 135
            L G+    D+   L+  Y   G L   L               + A   A   N + + 
Sbjct: 94  ELLGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA---NGINFL 149

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHT----MCGTLDYLAPE 186
           HENH IHRDIK  N+LLD     KI DFG +   +  ++       + GT  Y+APE
Sbjct: 150 HENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV-GTTAYMAPE 205

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 48/231 (20%), Positives = 90/231 (38%), Gaps = 33/231 (14%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH-PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +EI   LG+G FG+V    + ++    VA+KI+  + +++Y      R E+++   L   
Sbjct: 16  YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV--KNVDRY--CEAARSEIQVLEHLNTT 71

Query: 80  ------NILRLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNA 131
                   +++  WF     I ++ E       Y  ++++    F           +  +
Sbjct: 72  DPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKS 130

Query: 132 LAYCHENHVIHRDIKPENLLLDHEG-------------------RLKIGDFGWSVQSRSK 172
           + + H N + H D+KPEN+L                         +K+ DFG +      
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH 190

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD 223
             T+  T  Y APE++         D W++G +  E+  G   F     K+
Sbjct: 191 HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 88.6 bits (220), Expect = 2e-20
 Identities = 60/258 (23%), Positives = 108/258 (41%), Gaps = 44/258 (17%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVY-------LVREVESKHPVALKIIFKEQIEK 59
           E  ++ K E+      +G+PLG+G FG+V           + +    VA+K++ K+   +
Sbjct: 69  ELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATE 127

Query: 60  YKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTE 118
            K    L  EME+   + +H NI+ L G    D  +++I+EYA +G L   LR  R    
Sbjct: 128 -KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186

Query: 119 QQAATYIASLTNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGD 162
           + +          +                 Y      IHRD+   N+L+     +KI D
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246

Query: 163 FGWS--VQS----RSKRHTMCGTLDYL-----APEMVENKEHDYAVDNWTLGILCYE-FL 210
           FG +  + +    +   +        L     APE + ++ + +  D W+ G+L +E F 
Sbjct: 247 FGLARDINNIDYYKKTTNGR------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

Query: 211 YGAPPFEAESQKDTFRSI 228
            G  P+     ++ F+ +
Sbjct: 301 LGGSPYPGIPVEELFKLL 318

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 87.7 bits (218), Expect = 3e-20
 Identities = 57/237 (24%), Positives = 87/237 (36%), Gaps = 53/237 (22%)

Query: 22  EIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           E G+ LG G FG+V       + +      VA+K++ KE+ +    +  L  E+++ + L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADS-SEREALMSELKMMTQL 105

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNAL--- 132
             H NI+ L G       I+LI EY   G+L   LR  R    +    Y           
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 133 --------------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK 172
                                +      +HRD+   N+L+ H   +KI DFG +      
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 173 RHTMCGTLDY-------------LAPEMVENKEHDYAVDNWTLGILCYE-FLYGAPP 215
           R  M                   +APE +    +    D W+ GIL +E F  G  P
Sbjct: 220 RDIMSD--SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 87.0 bits (216), Expect = 7e-20
 Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 43/245 (17%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII---FKEQIEKYKIQHQLR--REMEI 72
           L+ +E+ + LGKG +G V+   +  +   VA+K I   F+            R  RE+ I
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST------DAQRTFREIMI 61

Query: 73  QSSLR-HPNILRLYGWFH--DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLT 129
            + L  H NI+ L       +D  ++L+ +Y    +L+  +R             +  L 
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR-ANILEPVHKQYVVYQLI 119

Query: 130 NALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG--------------WSVQSRSKRHT 175
             + Y H   ++HRD+KP N+LL+ E  +K+ DFG                +        
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 176 MCGTLDYL----------APE-MVENKEHDYAVDNWTLG-ILCYEFLYGAPPFEAESQKD 223
                  L          APE ++ + ++   +D W+LG IL  E L G P F   S  +
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG-EILCGKPIFPGSSTMN 238

Query: 224 TFRSI 228
               I
Sbjct: 239 QLERI 243

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 85.9 bits (213), Expect = 2e-19
 Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 36/172 (20%)

Query: 22  EIGRPLGKGKFGRVY-------LVREVESKHPVALKII-----FKEQIEKYKIQHQLRRE 69
            +G+PLG+G FG+V           +      VA+K++      K+  +       L  E
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-------LISE 124

Query: 70  MEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           ME+   + +H NI+ L G    D  +++I+EYA +G L   L+  R    + +     + 
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 129 TNAL----------------AYCHENHVIHRDIKPENLLLDHEGRLKIGDFG 164
              L                 Y      IHRD+   N+L+  +  +KI DFG
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 82.3 bits (203), Expect = 3e-18
 Identities = 56/285 (19%), Positives = 98/285 (34%), Gaps = 73/285 (25%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--- 77
           + + R LG G F  V+L  +++ K  VA+K++  +  E Y        E+ +  S+R   
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV--KSAEHY--TETALDEIRLLKSVRNSD 94

Query: 78  --HPN---ILRLYGWFH----DDERIFLILEYA-HRGELYRELRKHRRFTEQQAATYIAS 127
              PN   +++L   F     +   I ++ E   H    +     ++          I  
Sbjct: 95  PNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 128 LTNALAYCH-ENHVIHRDIKPENLLL---------------------------------- 152
           +   L Y H +  +IH DIKPEN+LL                                  
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 153 ---------------DHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
                            + ++KI D G +            T  Y + E++    ++   
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL--ISRLL 240
           D W+   + +E   G   FE  S ++  R    +  H+  I  LL
Sbjct: 275 DIWSTACMAFELATGDYLFEPHSGEEYTR----DEDHIALIIELL 315

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 76.3 bits (188), Expect = 2e-16
 Identities = 43/179 (24%), Positives = 80/179 (44%), Gaps = 25/179 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           + +GR +G G FG +YL  ++ +   VA+K+      E  K +H QL  E +I   ++  
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQGG 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +     + +   +++E    G    +L     R+F+ +        + + + Y H
Sbjct: 65  VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 137 ENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLDY 182
             + IHRD+KP+N L+        + I DFG + +   +R+ +H        + GT  Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 76.6 bits (188), Expect = 4e-16
 Identities = 43/179 (24%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLR-H 78
           F +GR +G G FG +YL   +++   VA+K+      E  K +H QL  E +I   L+  
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQGG 62

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +  +  + +   L+++    G    +L     R+ + +        + N + + H
Sbjct: 63  TGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 137 ENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLDY 182
               +HRDIKP+N L+       ++ I DFG + +   + + +H        + GT  Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.3 bits (183), Expect = 9e-16
 Identities = 53/239 (22%), Positives = 95/239 (39%), Gaps = 31/239 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           +++GR +G+G FG ++    + +   VA+K       E  +    QLR E      L   
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGC 65

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I  +Y +  +     L+++    G    +L     R+F+ +  A     +   +   H
Sbjct: 66  TGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 137 ENHVIHRDIKPENLLL-----DHEGRLKIGDFGWSVQ---SRSKRH-------TMCGTLD 181
           E  +++RDIKP+N L+      +   + + DFG         +K+H        + GT  
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRSISAEAKHLIS 237
           Y++      +E     D   LG +   FL G+ P    +A + K  +  I  E K    
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEKKQSTP 241

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 73.6 bits (181), Expect = 2e-15
 Identities = 56/231 (24%), Positives = 98/231 (42%), Gaps = 30/231 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQH-QLRREMEIQSSLRH- 78
           F +G+ +G G FG + L + + +   VA+K+      E  K +  QL  E      L   
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKL------EPMKSRAPQLHLEYRFYKQLGSG 64

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCH 136
             I ++Y +    +   ++LE    G    +L     R F+ +        L + + Y H
Sbjct: 65  DGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLK-----IGDFGWSVQ---SRSKRH-------TMCGTLD 181
             ++I+RD+KPEN L+   G        I DF  + +     +K+H       ++ GT  
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP---FEAESQKDTFRSIS 229
           Y++      KE     D   LG +   FL G+ P    +A++ K+ ++ I 
Sbjct: 183 YMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.8 bits (171), Expect = 6e-14
 Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 26/165 (15%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-------- 72
           + +G+ +G G FG +YL          A  ++   ++E  +    L  E++         
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVV---KVEYQENG-PLFSELKFYQRVAKKD 94

Query: 73  -------QSSLRHPNILRLYGW----FHDDERIFLILEYAHRGELYRELRKHRRFTEQQA 121
                  +  L +  I   YG     F      F+++E     +L +   ++  F +   
Sbjct: 95  CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTV 153

Query: 122 ATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFG 164
                 + + L Y HEN  +H DIK  NLLL   +  ++ + D+G
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 67.6 bits (164), Expect = 3e-13
 Identities = 44/265 (16%), Positives = 82/265 (30%), Gaps = 60/265 (22%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKII-----FKEQIEKYKIQHQLRREME 71
             +  +    +G+G FG V+         PVA+KII             K   ++  E+ 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 72  IQSSL---------RHPNILRLYGWFH------------------------------DDE 92
           I   L         R    + L                                    D+
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 93  RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-VIHRDIKPENLL 151
           ++F++LE+   G    ++R  +  +   A + +  LT +LA    +    HRD+   N+L
Sbjct: 136 QLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVL 194

Query: 152 LDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY 211
           L      K+         +S     CG         V   ++  +       ++  +   
Sbjct: 195 LKKTSLKKLHYTL---NGKSSTIPSCGL-------QVSIIDYTLSRLERDGIVVFCDVSM 244

Query: 212 GAPPFEAES--QKDTFRSISAEAKH 234
               F  +   Q D +R +  E  +
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNN 269

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 67.1 bits (164), Expect = 4e-13
 Identities = 28/164 (17%), Positives = 64/164 (39%), Gaps = 21/164 (12%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKH--------PVALKI------IFKEQI--EKYKIQH 64
           +++     +   G +Y      +            +LK+      +F EQ   ++     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 65  QLRREMEIQSSLRHPNILRLYGW-FHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAA 122
           Q+ +  ++ S      I    G+  H D+  FL+L    R  +   ++      +E+   
Sbjct: 104 QVNKWKKLYS-TPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVL 162

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFG 164
                L +AL + HEN  +H ++  EN+ +  + + ++ +  +G
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.9 bits (161), Expect = 1e-12
 Identities = 36/198 (18%), Positives = 75/198 (37%), Gaps = 43/198 (21%)

Query: 21  FEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +++G P+G+G FG +YL        V S  P  +K+   +          L  E++    
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-------GPLFTELKFYQR 89

Query: 76  LRHPNILRLYGWFHDDE-----RIFLILEYAHRGELYREL--------------RKHRRF 116
              P  ++ +      +     + +    +   G+ YR +                 +RF
Sbjct: 90  AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149

Query: 117 TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQ---SRS 171
           + +        + + L Y HE+  +H DIK  NLLL+  +  ++ + D+G + +      
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

Query: 172 KRH-------TMCGTLDY 182
            +           GT+++
Sbjct: 210 HKAYAADPKRCHDGTIEF 227

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 3e-09
 Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 9/108 (8%)

Query: 20  DFEIGRPLGKGKFGRVYL-----VREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++G+PLG+G FG+V       + +  +   VA+K++ KE     + +  L  E++I  
Sbjct: 23  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHR-ALMSELKILI 80

Query: 75  SL-RHPNILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQ 120
            +  H N++ L G        + +I+E+   G L   LR  R      
Sbjct: 81  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.3 bits (107), Expect = 9e-06
 Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 17/188 (9%)

Query: 36  YLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHPNILRLYGWFHDDER 93
           YL  +     P   K     Q + Y   I   L+R ++  +S +          F +++ 
Sbjct: 117 YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSAS----SGFVEEKS 172

Query: 94  IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD 153
           +  + E     +LY++       T +    Y   +   + +      IHRD+   N+LL 
Sbjct: 173 LSDVEEEEAPEDLYKDF-----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 227

Query: 154 HEGRLKIGDFGWS---VQSRSKRHTMCGTLDY--LAPEMVENKEHDYAVDNWTLGILCYE 208
            +  +KI DFG +    +           L    +APE + ++ +    D W+ G+L +E
Sbjct: 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 287

Query: 209 -FLYGAPP 215
            F  GA P
Sbjct: 288 IFSLGASP 295

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 1e-04
 Identities = 35/218 (16%), Positives = 65/218 (29%), Gaps = 65/218 (29%)

Query: 37  LVREVESKHPVALKII------FKEQIEKYKIQHQLRREMEIQSSLRH--PNILR-LY-- 85
           L REV + +P  L II           + +K  +  +    I+SSL    P   R ++  
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDR 377

Query: 86  -GWFHDDERI----FLIL----EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
              F     I      ++      +    +  +L K     E+Q      S+        
Sbjct: 378 LSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-YSLVEKQPKESTISI-------- 428

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYA 196
               I+ ++K +   L++E  L               H            +V++      
Sbjct: 429 --PSIYLELKVK---LENEYAL---------------HRS----------IVDHYNIPKT 458

Query: 197 VDNWTLGILC-----YEFL-YGAPPFEAESQKDTFRSI 228
            D+  L         Y  + +     E   +   FR +
Sbjct: 459 FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMV 496

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 39.2 bits (91), Expect = 8e-04
 Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 20/159 (12%)

Query: 23  IGRPLGKGKFGRVYLVREVESKHPVALKI------IFKEQIEKYKIQHQLRREMEIQSSL 76
           IG+ +G+GK   V+     +      +K        FK+  EK          + I+S+ 
Sbjct: 94  IGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 152

Query: 77  R-HPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
                + +L G      +  E   +++E     EL        R   +     +  +   
Sbjct: 153 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEE 205

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR 170
           +A  +   ++H D+   N+L+  E  + I DF  SV+  
Sbjct: 206 VAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 243

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	271
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.76
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.41
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.07
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.9
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.86
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.32
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.01
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.0
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.59
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.58
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.53
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.52
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.48
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.36
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.23
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.2
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.98
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.27
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.86
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	94.87
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.29

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-63  Score=412.25  Aligned_cols=250  Identities=35%  Similarity=0.621  Sum_probs=226.6

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ......++|++.+.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+++++.++||||+++++++.+++
T Consensus        26 ~~~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           26 PRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             -CCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            34556789999999999999999999999999999999998776555455678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999965432 


Q ss_pred             ----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHH
Q 024158          172 ----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLI  236 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li  236 (271)
                          .....+||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+..           ..+++++++||
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli  265 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLV  265 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence                234568999999999999999999999999999999999999999987765543           34689999999


Q ss_pred             HHhcccCccCCCCHHH------HhcCCccccC
Q 024158          237 SRLLVKDSSKRLSLQK------IMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~------il~~~~~~~~  262 (271)
                      .+||.+||.+|||++|      |++||||+..
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            9999999999999987      6899999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-62  Score=401.79  Aligned_cols=245  Identities=35%  Similarity=0.655  Sum_probs=206.0

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      .+++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+++++.++||||+++++++.+++.+|+
T Consensus        11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i   90 (275)
T 3hyh_A           11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM   90 (275)
T ss_dssp             ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            46899999999999999999999999999999999987665555556778999999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--ccc
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--KRH  174 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--~~~  174 (271)
                      ||||+ +++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence            99999 579999998888999999999999999999999999999999999999999999999999999965433  234


Q ss_pred             cccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~~  242 (271)
                      ...||+.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+..           ..+++++.+||.+||.+
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~  249 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIV  249 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccC
Confidence            5689999999999998886 46999999999999999999999887654443           23689999999999999


Q ss_pred             CccCCCCHHHHhcCCccccC
Q 024158          243 DSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||++|||++|+++||||+..
T Consensus       250 dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          250 NPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             SGGGSCCHHHHHHCHHHHTT
T ss_pred             ChhHCcCHHHHHcCcccccC
Confidence            99999999999999999853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-62  Score=413.70  Aligned_cols=248  Identities=29%  Similarity=0.535  Sum_probs=217.7

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ..++++|++++.||+|+||+||+|+++.+|+.||||++.+..... ...+.+.+|++++++++||||+++++++.+++.+
T Consensus        20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   98 (350)
T 4b9d_A           20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSL   98 (350)
T ss_dssp             CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            456889999999999999999999999999999999997765544 3467889999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 FLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      |+|||||+|++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            9999999999999999754  35789999999999999999999999999999999999999999999999999665432


Q ss_pred             ---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------ccCHHHHHHHH
Q 024158          173 ---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------SISAEAKHLIS  237 (271)
Q Consensus       173 ---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------~i~~~l~~li~  237 (271)
                         ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+...            .+++++.+||.
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence               234579999999999999999999999999999999999999999877655432            36899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||.+||++|||++|+|+||||++..
T Consensus       259 ~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999998753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-62  Score=410.96  Aligned_cols=246  Identities=28%  Similarity=0.530  Sum_probs=221.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56999999999999999999999999999999997654333   345788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      |||++++|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....   ....
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999999987 5699999999999999999999999999999999999999999999999999865432   3456


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l~  241 (271)
                      .+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+              ..+++++.+||.+||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSC
T ss_pred             cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcC
Confidence            68999999999999999999999999999999999999999876654332              3468999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                      +||++|||++|+|+||||++...|.+.
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~p~~l  336 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGPPASI  336 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCGGGT
T ss_pred             CChhHCcCHHHHhcCHhhcCCCCCccc
Confidence            999999999999999999998766543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.7e-61  Score=394.07  Aligned_cols=243  Identities=24%  Similarity=0.459  Sum_probs=211.9

Q ss_pred             ccce-eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe----CC
Q 024158           18 LQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----DE   92 (271)
Q Consensus        18 ~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~   92 (271)
                      .++| ++.++||+|+||+||+|++..++..||+|++....... ...+.+.+|+.++++++||||+++++++..    ++
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            3455 78889999999999999999999999999997665444 335778999999999999999999999865    35


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCC-CCCEEEeeecccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDH-EGRLKIGDFGWSVQS  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~-~~~~~L~dfg~~~~~  169 (271)
                      .+|+|||||++++|.+++.+.+.+++..+..++.||+.||.|||++|  |+||||||+|||++. +|.+||+|||++...
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            68999999999999999998888999999999999999999999998  999999999999974 789999999999654


Q ss_pred             cC-ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHH
Q 024158          170 RS-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKH  234 (271)
Q Consensus       170 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~  234 (271)
                      .. .....+||+.|+|||.+.+ .++.++|||||||++|+|++|..||.+......              ....++++.+
T Consensus       183 ~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  261 (290)
T 3fpq_A          183 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKE  261 (290)
T ss_dssp             CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHH
T ss_pred             CCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHH
Confidence            33 3445689999999998864 699999999999999999999999976543222              2235789999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||.+||.+||++|||++|+|+||||++.
T Consensus       262 li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.1e-61  Score=412.01  Aligned_cols=248  Identities=28%  Similarity=0.523  Sum_probs=222.5

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|+++++||+|+||.||+|+++.+|+.||||++.......   .+.+.+|+.+++.++||||+++++++..++.+|+|
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            356999999999999999999999999999999997654332   34678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~  174 (271)
                      ||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....   ...
T Consensus       227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            999999999999976 4699999999999999999999999999999999999999999999999999865432   345


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLL  240 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l  240 (271)
                      ..+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....+.+              ..+++++.+||.+||
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L  385 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLL  385 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHS
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHc
Confidence            568999999999999999999999999999999999999999877654432              346899999999999


Q ss_pred             ccCccCCCCHHHHhcCCccccCCCCCCCc
Q 024158          241 VKDSSKRLSLQKIMEHPWIIKNANPRGTC  269 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~~~~~~~~~~~  269 (271)
                      .+||++|||++|+|+||||++...|.+.+
T Consensus       386 ~~dP~~R~ta~ell~Hp~~~~~~~p~~l~  414 (423)
T 4fie_A          386 VRDPAQRATAAELLKHPFLAKAGPPASIV  414 (423)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGGCCCGGGTG
T ss_pred             CCChhHCcCHHHHhcCHHhcCCCCCcccc
Confidence            99999999999999999999987665443

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-61  Score=400.34  Aligned_cols=248  Identities=34%  Similarity=0.651  Sum_probs=214.9

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+.++|++++.||+|+||+||+|++.   .+++.||+|++.+....... ...+.+|+.++++++||||+++++++.+
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~   97 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQT   97 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence            3456689999999999999999999874   46788999999765433211 2356789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ++.+|+|||||+|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus        98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A           98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999986432


Q ss_pred             ---CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHH
Q 024158          171 ---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLI  236 (271)
Q Consensus       171 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li  236 (271)
                         ......+||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+...           .+++++.+||
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence               23345689999999999999999999999999999999999999999877655543           3689999999


Q ss_pred             HHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          237 SRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+||.+||++|||     ++|+++||||+..
T Consensus       258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             HHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999998     5899999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-60  Score=399.23  Aligned_cols=244  Identities=25%  Similarity=0.411  Sum_probs=217.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..+.|++.++||+|+||.||+|+++.+|+.||||++..+...        .+|+.+++.++||||+++++++.+++.+|+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457899999999999999999999999999999999764322        368999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~~~---  172 (271)
                      |||||+|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||+|||++......   
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999888899999999999999999999999999999999999999887 6999999998654321   


Q ss_pred             -----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHH
Q 024158          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAK  233 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~  233 (271)
                           ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.              ...+++++.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence                 1234799999999999999999999999999999999999999987654322              234689999


Q ss_pred             HHHHHhcccCccCCCCHHHH-------------hcCCccccCCCCCCC
Q 024158          234 HLISRLLVKDSSKRLSLQKI-------------MEHPWIIKNANPRGT  268 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~i-------------l~~~~~~~~~~~~~~  268 (271)
                      ++|.+||.+||.+|||+.|+             |+|||+++...|++.
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~n  335 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRGN  335 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC-
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCCC
Confidence            99999999999999999998             679999999999873

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-57  Score=390.05  Aligned_cols=245  Identities=26%  Similarity=0.428  Sum_probs=214.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe------CC
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------DE   92 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~   92 (271)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+++++.++||||+++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            47999999999999999999999999999999997654333 335677899999999999999999998754      35


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .+|+|||||+ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... 
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7899999996 68999998888999999999999999999999999999999999999999999999999999864322 


Q ss_pred             ------ccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------------
Q 024158          172 ------KRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------------  226 (271)
Q Consensus       172 ------~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------------  226 (271)
                            .....+||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+..+++.                  
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence                  234568999999999988754 6889999999999999999999998766433321                  


Q ss_pred             ------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          227 ------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       227 ------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                              .+++++.+||.+||.+||.+|||++|+|+||||++...|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence                                    247889999999999999999999999999999987554

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-57  Score=376.11  Aligned_cols=246  Identities=22%  Similarity=0.404  Sum_probs=198.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++.....  ....+.+.+|+.++++++||||+++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            4689999999999999999999999999999999965442  233567889999999999999999999986544     


Q ss_pred             -------eEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEee
Q 024158           93 -------RIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        93 -------~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                             ++|++||||++++|.+++.....   .+...++.++.||++||.|||++||+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   37999999999999999987543   45567889999999999999999999999999999999999999999


Q ss_pred             ecccccccCc---------------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-h---
Q 024158          163 FGWSVQSRSK---------------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-D---  223 (271)
Q Consensus       163 fg~~~~~~~~---------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~---  223 (271)
                      ||++......               ....+||+.|+|||.+.+..++.++|||||||++|+|++   ||...... .   
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            9998543321               123469999999999999999999999999999999996   67543211 1   


Q ss_pred             ---------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCC
Q 024158          224 ---------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       224 ---------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                               .+...++.+.+||.+||.+||.+|||++|+++||||+...-|..+
T Consensus       239 ~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~~~  292 (299)
T 4g31_A          239 DVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKT  292 (299)
T ss_dssp             HHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC------
T ss_pred             HHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCCch
Confidence                     112235778899999999999999999999999999987665443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.9e-56  Score=399.57  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=221.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ....+++++|++++.||+|+||+||+|+++.+|+.||+|++.+......   ......+.++.+++.++||||+++++++
T Consensus       182 ~~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             TTCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             cCCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            3558899999999999999999999999999999999999977654332   2223334456778888999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .+.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999965


Q ss_pred             cc-CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHH
Q 024158          169 SR-SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEA  232 (271)
Q Consensus       169 ~~-~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l  232 (271)
                      .. ......+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||.+....+.              ...+++++
T Consensus       342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a  421 (689)
T 3v5w_A          342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  421 (689)
T ss_dssp             CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence            43 34456789999999999975 5789999999999999999999999976543221              23468999


Q ss_pred             HHHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+||.+||.+||.+|++     +++|++||||+..
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            99999999999999998     7999999999875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4e-56  Score=368.60  Aligned_cols=245  Identities=24%  Similarity=0.460  Sum_probs=211.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ...++.++|.+.+.||+|+||+||+|++.     .++..||||++....   ....+.+.+|++++++++||||++++++
T Consensus         7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~   83 (299)
T 4asz_A            7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGV   83 (299)
T ss_dssp             CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            34577889999999999999999999864     357889999996543   2335778999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKH-------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH  154 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~  154 (271)
                      +.+++.+|+|||||++|+|.+++...             ..+++.+++.++.|++.||.|||+++|+||||||+|||++.
T Consensus        84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~  163 (299)
T 4asz_A           84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE  163 (299)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECC
Confidence            99999999999999999999999753             35899999999999999999999999999999999999999


Q ss_pred             CCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc--
Q 024158          155 EGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR--  226 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~--  226 (271)
                      ++.+||+|||++......     .....||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+...  
T Consensus       164 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          164 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999998543322     223458999999999999999999999999999999998 899999877655432  


Q ss_pred             ----------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          227 ----------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       227 ----------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                .+|+++.+|+.+||..||++|||+++|  ++|+++.
T Consensus       244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence                      358999999999999999999999999  4566653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3e-55  Score=372.95  Aligned_cols=238  Identities=23%  Similarity=0.447  Sum_probs=202.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCe
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDER   93 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~   93 (271)
                      -++|++.+.||+|+||+||+|+++   .+++.||+|.+.+...     ...+.+|+++++.+ +||||+++++++..+++
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            367999999999999999999875   3578899999865432     23467899999988 69999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~~~~~~~~  172 (271)
                      +|+||||+++++|.+++.   .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++......
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999984   48999999999999999999999999999999999999876 79999999998533211


Q ss_pred             -------------------------------cccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          173 -------------------------------RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       173 -------------------------------~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                                                     ....+||+.|+|||.+.+.. ++.++||||+||++|+|++|..||....
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                           12346999999999998764 8889999999999999999999985433


Q ss_pred             cc------------------------------------------------------------------hhhcccCHHHHH
Q 024158          221 QK------------------------------------------------------------------DTFRSISAEAKH  234 (271)
Q Consensus       221 ~~------------------------------------------------------------------~~~~~i~~~l~~  234 (271)
                      ..                                                                  ..+..+++++.+
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            21                                                                  012346789999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ||++||..||++|||++|+|+||||+..+
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-55  Score=365.50  Aligned_cols=241  Identities=23%  Similarity=0.445  Sum_probs=203.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+++..+++++.++||+|+||+||+|+..   ..+|||+++...... ...+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  103 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK  103 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence            3456788899999999999999999999854   359999986544333 446789999999999999999999998755


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                       +.+|+|||||++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       104 -~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          104 -DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             -SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             -CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence             5689999999999999999764 57999999999999999999999999999999999999999999999999998643


Q ss_pred             cC-----ccccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------
Q 024158          170 RS-----KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------  224 (271)
Q Consensus       170 ~~-----~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------  224 (271)
                      ..     ......||+.|+|||++.+   ++++.++|||||||++|+|++|..||.+......                 
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  262 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKL  262 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTS
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccc
Confidence            32     2234579999999999864   4588999999999999999999999987654322                 


Q ss_pred             hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 ~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ...+|+++.+|+.+||..||++|||+.+|+++
T Consensus       263 ~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          263 YKNCPKAMKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             CTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            22357899999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-55  Score=367.35  Aligned_cols=244  Identities=23%  Similarity=0.393  Sum_probs=211.2

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceecee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      ....++..+++++.++||+|+||+||+|+..     .+++.||||++......  ...+.+.+|+.++++++||||++++
T Consensus        18 ~~~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~   95 (308)
T 4gt4_A           18 AKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLL   95 (308)
T ss_dssp             -CCCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            3456788999999999999999999999853     46788999999654322  2346789999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      +++.+++.+++|||||++|+|.++|...                ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~N  175 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRN  175 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccc
Confidence            9999999999999999999999999642                248999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcch
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  223 (271)
                      ||++.++.+||+|||++.....     ......||+.|+|||.+.++.++.++||||||+++|+|++ |..||.+.+..+
T Consensus       176 ILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          176 VLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             EEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             eEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999854332     2234578999999999999999999999999999999998 899998877655


Q ss_pred             hhc------------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 TFR------------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 ~~~------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ...            ..|+++.+++.+||..||++|||+.+|+++
T Consensus       256 ~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          256 VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            433            358999999999999999999999999875

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.1e-55  Score=367.90  Aligned_cols=241  Identities=23%  Similarity=0.435  Sum_probs=205.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ...++..+|.+.++||+|+||+||+|+..     .++..||||++....   ....+.+.+|++++++++||||++++++
T Consensus        35 ~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~  111 (329)
T 4aoj_A           35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGV  111 (329)
T ss_dssp             SCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            34567789999999999999999999854     468899999996543   2345779999999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKH---------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili  152 (271)
                      +.+++.+|+|||||++|+|.+++...               .++++.+++.++.|++.||.|||+++|+||||||+|||+
T Consensus       112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl  191 (329)
T 4aoj_A          112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV  191 (329)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence            99999999999999999999999753               248999999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc
Q 024158          153 DHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR  226 (271)
Q Consensus       153 ~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~  226 (271)
                      +.++.+||+|||++......     .....||+.|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus       192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            99999999999998643322     234568999999999999999999999999999999998 899998876554432


Q ss_pred             ------------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 ------------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 ------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                  .+|+++.+|+.+||..||++|||++||+++
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                        358999999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-54  Score=388.88  Aligned_cols=245  Identities=33%  Similarity=0.653  Sum_probs=219.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|+++.+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++.+++.+|++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~---~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh---hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999998664432   246778999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC--CCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~--~~~~L~dfg~~~~~~~~--  172 (271)
                      ||||+||+|.+++.. ...+++.++..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++......  
T Consensus       233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred             EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence            999999999999964 4579999999999999999999999999999999999999854  79999999999665433  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~  237 (271)
                      ....+||+.|+|||.+.+..++.++|||||||++|+|++|..||.+....+.+               ..+++++.+||.
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~  392 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  392 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHH
T ss_pred             eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            34567999999999999999999999999999999999999999877654432               346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +||.+||.+|||++|+|+||||+....|
T Consensus       393 ~~L~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          393 KLLLADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             HHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence            9999999999999999999999987554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.4e-53  Score=354.71  Aligned_cols=251  Identities=35%  Similarity=0.661  Sum_probs=223.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ......++|++++.||+|+||.||+|++..+|+.||+|++....... .....+.+|+++++.++||||+++++++..++
T Consensus         9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A            9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            34567889999999999999999999999999999999997765443 34567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc--
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR--  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~--  170 (271)
                      ..|+|||++++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....  
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999999999999888889999999999999999999999999999999999999999999999999985433  


Q ss_pred             CccccccccccccCCccccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHH
Q 024158          171 SKRHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISR  238 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~  238 (271)
                      .......||+.|+|||.+.+..++ .++|+||||+++|+|++|..||.+....+...           .+++++.+++.+
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKR  247 (328)
T ss_dssp             CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            233456789999999999888875 68999999999999999999999877655443           258999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ||..||.+|||++++++||||+....
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            99999999999999999999987643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-53  Score=353.78  Aligned_cols=248  Identities=40%  Similarity=0.717  Sum_probs=226.3

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+++++|++++.||+|+||.||+|++..+|+.+|+|++.+.........+.+.+|..+++.++||||+++++++.+.+.+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            36789999999999999999999999999999999999776544434456778899999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCccc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRH  174 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~  174 (271)
                      |+||||+++++|.+++.....+++..++.++.||+.||.+||++|++|+||||+||+++.+|.++|+|||++........
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~  161 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY  161 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBC
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCccc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999977766666


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccC
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKD  243 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~  243 (271)
                      ...||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .+++++.+++.+||..|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~d  241 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD  241 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSC
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccC
Confidence            7789999999999999999999999999999999999999998776544432           35899999999999999


Q ss_pred             ccCCC-----CHHHHhcCCccccC
Q 024158          244 SSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       244 p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      |.+||     +++++++||||+..
T Consensus       242 p~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          242 LSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHcCCCcCCCHHHHhcCccccCC
Confidence            99999     99999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.5e-54  Score=362.71  Aligned_cols=247  Identities=23%  Similarity=0.431  Sum_probs=211.1

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCC-----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-Cceeceee
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK-----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYG   86 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~   86 (271)
                      .+++..++|++.+.||+|+||+||+|++..++     +.||||.+......  ...+.+.+|++++.+++| |||+++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            45778899999999999999999999977654     57999998665433  335678999999999976 89999999


Q ss_pred             EEEeC-CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           87 WFHDD-ERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        87 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      ++... +.+++|||||++|+|.++|...                ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            98664 5689999999999999999752                248999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcch
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  223 (271)
                      ||++.++.+||+|||++......     .....||+.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999654322     233467899999999999999999999999999999998 999998765433


Q ss_pred             hh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC--Ccccc
Q 024158          224 TF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH--PWIIK  261 (271)
Q Consensus       224 ~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~--~~~~~  261 (271)
                      .+             ...++++.+++.+||..||++|||+.+|++|  .+++.
T Consensus       296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            22             2258999999999999999999999999987  44443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.6e-52  Score=354.02  Aligned_cols=247  Identities=39%  Similarity=0.653  Sum_probs=222.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      +++++|++++.||+|+||.||+|+++.+|+.+|+|++.+...........+.+|+.+++.++||||+++++++...+.+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            67899999999999999999999999999999999997765433334567788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Cc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SK  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~  172 (271)
                      +||||+++++|..++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++....   ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            999999999999999888889999999999999999999999999999999999999999999999999986432   23


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhcc
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLV  241 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l~  241 (271)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.++|.+||.
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~  241 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  241 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            34567899999999999999999999999999999999999999877655443           2368999999999999


Q ss_pred             cCccCCC-----CHHHHhcCCccccC
Q 024158          242 KDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      +||.+||     +++++++||||+..
T Consensus       242 ~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          242 KDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            9999999     99999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7.1e-53  Score=358.40  Aligned_cols=252  Identities=35%  Similarity=0.633  Sum_probs=218.5

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEE
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFH   89 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~   89 (271)
                      .....+.+++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++.
T Consensus        15 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~   94 (353)
T 3txo_A           15 NSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ   94 (353)
T ss_dssp             --------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             CCcCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence            344568889999999999999999999999999999999999876555545566778899999988 6999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ..+.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus        95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A           95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence            99999999999999999999988888999999999999999999999999999999999999999999999999998643


Q ss_pred             c---CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------cCHHHHHH
Q 024158          170 R---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------ISAEAKHL  235 (271)
Q Consensus       170 ~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------i~~~l~~l  235 (271)
                      .   ......+||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...+           +++++.++
T Consensus       175 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          175 ICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             CC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             ccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            2   233456789999999999988899999999999999999999999998876655433           58999999


Q ss_pred             HHHhcccCccCCCCH------HHHhcCCccccC
Q 024158          236 ISRLLVKDSSKRLSL------QKIMEHPWIIKN  262 (271)
Q Consensus       236 i~~~l~~~p~~Rps~------~~il~~~~~~~~  262 (271)
                      |.+||.+||.+||++      +++++||||+..
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999998      899999999864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-52  Score=354.57  Aligned_cols=250  Identities=35%  Similarity=0.637  Sum_probs=228.6

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .....+++|++++.||+|+||.||+|++..+|+.+++|++.+...........+.+|+.+++.++||||+++++++.+++
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            44578899999999999999999999999999999999997765544444567888999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999999777666


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcc
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLV  241 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~  241 (271)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+...           .+++++.++|.+||.
T Consensus       195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~  274 (350)
T 1rdq_E          195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ  274 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred             cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            667789999999999999999999999999999999999999998876554432           368999999999999


Q ss_pred             cCccCCCC-----HHHHhcCCccccC
Q 024158          242 KDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .||.+||+     ++++++||||+..
T Consensus       275 ~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          275 VDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             cCHHhccCCccCCHHHHHhCcCcCCC
Confidence            99999998     9999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.7e-52  Score=345.30  Aligned_cols=258  Identities=61%  Similarity=1.107  Sum_probs=228.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ...+.+++|++.+.||+|++|.||+|++..++..+++|++.............+.+|+.+++.++||||+++++++...+
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             -CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            45789999999999999999999999999999999999997766555555677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      ..++++|++++++|.+++.....++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999999999998878899999999999999999999999999999999999999999999999998754433 


Q ss_pred             ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhc
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLL  240 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l  240 (271)
                      ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+...           .+++++.+++.+||
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  242 (279)
T 3fdn_A          163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL  242 (279)
T ss_dssp             -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHC
T ss_pred             cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHh
Confidence            2344578999999999999889999999999999999999999998777554432           26899999999999


Q ss_pred             ccCccCCCCHHHHhcCCccccCCCCCCCcC
Q 024158          241 VKDSSKRLSLQKIMEHPWIIKNANPRGTCD  270 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~~~~~~~~~~~~  270 (271)
                      ..||.+|||++++++||||+......+.|.
T Consensus       243 ~~~p~~Rps~~e~l~h~~~~~~~~~~~~~~  272 (279)
T 3fdn_A          243 KHNPSQRPMLREVLEHPWITANSSKPSNCQ  272 (279)
T ss_dssp             CSSGGGSCCHHHHHHCHHHHHHCSSCCCC-
T ss_pred             ccChhhCCCHHHHhhCccccCCccCccccc
Confidence            999999999999999999999887777663

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.2e-52  Score=358.59  Aligned_cols=253  Identities=31%  Similarity=0.611  Sum_probs=218.2

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWF   88 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~   88 (271)
                      ......+.+++|++++.||+|+||.||+|+++.+++.+|+|++.+...........+..|..++.++ +||||+++++++
T Consensus        43 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~  122 (396)
T 4dc2_A           43 GKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF  122 (396)
T ss_dssp             ------CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             cccccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence            3445678899999999999999999999999999999999999877665555556677888888776 899999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ...+.+|+||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus       123 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999864


Q ss_pred             c---cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------------hh
Q 024158          169 S---RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------------TF  225 (271)
Q Consensus       169 ~---~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------------~~  225 (271)
                      .   .......+||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+                    ..
T Consensus       203 ~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  282 (396)
T 4dc2_A          203 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  282 (396)
T ss_dssp             CCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred             cccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence            2   234456689999999999999999999999999999999999999996432111                    11


Q ss_pred             cccCHHHHHHHHHhcccCccCCCCH------HHHhcCCccccC
Q 024158          226 RSISAEAKHLISRLLVKDSSKRLSL------QKIMEHPWIIKN  262 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~Rps~------~~il~~~~~~~~  262 (271)
                      ..+++++.++|.+||.+||.+||++      +++++||||+..
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            2368999999999999999999985      899999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.8e-52  Score=352.75  Aligned_cols=250  Identities=31%  Similarity=0.599  Sum_probs=220.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      ...++.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..+ +||||+++++++...
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            4567899999999999999999999999999999999999776543333345667788888776 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-  170 (271)
                      +.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++.... 
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            9999999999999999999887889999999999999999999999999999999999999999999999999986432 


Q ss_pred             --CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHH
Q 024158          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLIS  237 (271)
Q Consensus       171 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~  237 (271)
                        .......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...           .+++++.++|.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  250 (345)
T 1xjd_A          171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV  250 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence              23455678999999999999999999999999999999999999998877654433           36899999999


Q ss_pred             HhcccCccCCCCHH-HHhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQ-KIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~-~il~~~~~~~~  262 (271)
                      +||..||.+||++. ++++||||+..
T Consensus       251 ~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          251 KLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHhcCCHhHcCCChHHHHcCccccCC
Confidence            99999999999998 99999999865

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-52  Score=351.34  Aligned_cols=248  Identities=35%  Similarity=0.660  Sum_probs=220.3

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .....++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++..++.
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            34567899999999999999999999999999999999976654443334578899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--  171 (271)
                      .++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....  
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            99999999 579999998878899999999999999999999999999999999999999999999999999865433  


Q ss_pred             ccccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHh
Q 024158          172 KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRL  239 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~  239 (271)
                      ......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..........           .+++++.+++.+|
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  242 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRM  242 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTT
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHH
Confidence            2345678999999999988776 679999999999999999999998765444432           3589999999999


Q ss_pred             cccCccCCCCHHHHhcCCccccC
Q 024158          240 LVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      |..||.+|||++++++||||+..
T Consensus       243 L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          243 IVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             SCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             cCCChhHCcCHHHHHhChhhccC
Confidence            99999999999999999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.9e-52  Score=352.61  Aligned_cols=254  Identities=31%  Similarity=0.550  Sum_probs=220.4

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   87 (271)
                      .......+++++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|..++..+ +||+|++++++
T Consensus        10 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   89 (353)
T 2i0e_A           10 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC   89 (353)
T ss_dssp             ---------CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEE
T ss_pred             cCCCcCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEE
Confidence            34455678899999999999999999999999999999999999876544334456677889999887 79999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +...+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.
T Consensus        90 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~  169 (353)
T 2i0e_A           90 FQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  169 (353)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccc
Confidence            99999999999999999999999887889999999999999999999999999999999999999999999999999986


Q ss_pred             ccc---CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHH
Q 024158          168 QSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAK  233 (271)
Q Consensus       168 ~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~  233 (271)
                      ...   .......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...           .+++++.
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  249 (353)
T 2i0e_A          170 ENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV  249 (353)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             ccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            532   23455679999999999999999999999999999999999999998877655432           3689999


Q ss_pred             HHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      ++|.+||.+||.+||+     ++++++||||+..
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999999994     6999999999753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2e-51  Score=348.58  Aligned_cols=249  Identities=32%  Similarity=0.609  Sum_probs=221.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~   92 (271)
                      ..+.+++|++++.||+|+||.||+|+++.+++.+|+|++.+...........+.+|..+++.+ +||||+++++++..++
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            457889999999999999999999999999999999999877655555667788999999887 8999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc---
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~---  169 (271)
                      .+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...   
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999998642   


Q ss_pred             cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc---------hh-----------hcccC
Q 024158          170 RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------DT-----------FRSIS  229 (271)
Q Consensus       170 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------~~-----------~~~i~  229 (271)
                      ........||+.|+|||.+.+..++.++|+||||+++|+|++|..||......         ..           ...++
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s  243 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS  243 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence            22344567899999999999999999999999999999999999999753211         11           12368


Q ss_pred             HHHHHHHHHhcccCccCCCCH------HHHhcCCccccC
Q 024158          230 AEAKHLISRLLVKDSSKRLSL------QKIMEHPWIIKN  262 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~------~~il~~~~~~~~  262 (271)
                      +++.++|.+||..||.+||++      +++++||||+..
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            999999999999999999995      899999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=350.18  Aligned_cols=251  Identities=31%  Similarity=0.589  Sum_probs=223.7

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ....+.+++|++++.||+|+||.||+|++..+++.+|+|++.+...........+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            45778999999999999999999999999999999999999776554444567788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-  170 (271)
                      +..|+|+|++.+++|..++.....+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++.... 
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999999999999988889999999999999999999999999999999999999999999999999986543 


Q ss_pred             -CccccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHH
Q 024158          171 -SKRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEA  232 (271)
Q Consensus       171 -~~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l  232 (271)
                       .......||+.|+|||.+.+   ..++.++|+||||+++|+|++|..||........              ...+++++
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~  247 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEM  247 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHH
Confidence             33455679999999999874   4588899999999999999999999975433211              12368999


Q ss_pred             HHHHHHhcccCccCCCC-HHHHhcCCccccC
Q 024158          233 KHLISRLLVKDSSKRLS-LQKIMEHPWIIKN  262 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps-~~~il~~~~~~~~  262 (271)
                      .++|.+||.+||.+||+ ++++++||||+..
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            99999999999999998 9999999999865

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.8e-51  Score=340.30  Aligned_cols=244  Identities=30%  Similarity=0.492  Sum_probs=217.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..++|++.+.||+|+||.||+|++..+++.+++|++.......   .+.+.+|+.+++.++||||+++++++..++..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            4568999999999999999999999999999999986654433   3567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      ||||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  173 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccccc
Confidence            99999999999999874 689999999999999999999999999999999999999999999999998754432   23


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHh
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRL  239 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~  239 (271)
                      ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||........              ...+++.+.+++.+|
T Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHH
T ss_pred             CCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHH
Confidence            445789999999999999999999999999999999999999987654332              234789999999999


Q ss_pred             cccCccCCCCHHHHhcCCccccCCC
Q 024158          240 LVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      |..||.+|||++++++||||+....
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             ccCChhHCcCHHHHhhChhhcccCc
Confidence            9999999999999999999997643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.4e-51  Score=349.85  Aligned_cols=244  Identities=32%  Similarity=0.602  Sum_probs=217.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++|++.+.||+|+||.||+|+++.+|..+|+|++.+......   ...+.+.+|+.+++.++||||+++++++...+.+|
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            569999999999999999999999999999999976543211   12356889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~~~~  171 (271)
                      +|||++++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++    .++|+|||++.....
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~  171 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED  171 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence            9999999999999998878899999999999999999999999999999999999998776    799999999865443


Q ss_pred             --ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHH
Q 024158          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKH  234 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~  234 (271)
                        ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.               +..+++++.+
T Consensus       172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  251 (361)
T 2yab_A          172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD  251 (361)
T ss_dssp             TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence              23456789999999999998999999999999999999999999987664433               3456889999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||.+||.+||.+|||++++++||||+..
T Consensus       252 li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          252 FIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            9999999999999999999999999854

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.5e-51  Score=338.41  Aligned_cols=246  Identities=25%  Similarity=0.501  Sum_probs=208.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++..+++.+|+|++....... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            478999999999999999999999999999999997554332 3346778899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           98 LEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      ||++++ ++.+.+.. .+.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++.....   ..
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            999985 66555544 57899999999999999999999999999999999999999999999999999865432   23


Q ss_pred             ccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCC-CCCCcchh---------------------------
Q 024158          174 HTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPF-EAESQKDT---------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~-~~~~~~~~---------------------------  224 (271)
                      ....+|+.|+|||.+.+.. ++.++|+||||+++++|++|..|| .+....+.                           
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP  238 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccc
Confidence            4456799999999998766 789999999999999999887775 33322111                           


Q ss_pred             -------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 -------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 -------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                   ...+++++.+++.+||..||++|||++|+++||||++...|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~pP  292 (292)
T 3o0g_A          239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC---
T ss_pred             cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCCC
Confidence                         11357899999999999999999999999999999986543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7e-51  Score=336.43  Aligned_cols=254  Identities=59%  Similarity=1.070  Sum_probs=224.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .....+..++|++.+.||+|++|.||+|++..++..+++|++.............+.+|+.+++.++|+||+++++++..
T Consensus         6 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   85 (284)
T 2vgo_A            6 MPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD   85 (284)
T ss_dssp             ----CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc
Confidence            34567889999999999999999999999999999999999977654443345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ++..++++|++++++|.+++.....++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++....
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999989999999887889999999999999999999999999999999999999999999999999885443


Q ss_pred             C-ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHH
Q 024158          171 S-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISR  238 (271)
Q Consensus       171 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~  238 (271)
                      . ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+..           ..+++++.+++.+
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  245 (284)
T 2vgo_A          166 SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK  245 (284)
T ss_dssp             SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence            3 334457899999999999989999999999999999999999999876644332           3368999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ||..||.+|||++++++||||+....
T Consensus       246 ~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          246 LLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999987644

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.8e-50  Score=347.14  Aligned_cols=259  Identities=19%  Similarity=0.312  Sum_probs=221.4

Q ss_pred             hhhhhhhhccCccccceeeeeeeccc--CCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCcee
Q 024158            5 TAEREDNRKREWSLQDFEIGRPLGKG--KFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL   82 (271)
Q Consensus         5 ~~~~~~~~~~~~~~~~y~~~~~lg~g--~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~   82 (271)
                      |..-.+........++|++++.||+|  +||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+
T Consensus        11 ~~~~~~~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv   89 (389)
T 3gni_B           11 NLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIV   89 (389)
T ss_dssp             HSCCC--CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             hhhhhhhhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCC
Confidence            33344455556688999999999999  99999999999999999999997765443 4567888999999999999999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEE
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L  160 (271)
                      ++++++..++.+|+|||++++++|.+++...  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl  169 (389)
T 3gni_B           90 PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYL  169 (389)
T ss_dssp             CEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEE
T ss_pred             cEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE
Confidence            9999999999999999999999999999875  57999999999999999999999999999999999999999999999


Q ss_pred             eeeccccccc----------CccccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---
Q 024158          161 GDFGWSVQSR----------SKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---  225 (271)
Q Consensus       161 ~dfg~~~~~~----------~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---  225 (271)
                      +|||.+....          .......+++.|+|||.+.+  ..++.++||||||+++|+|++|..||.+....+..   
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  249 (389)
T 3gni_B          170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK  249 (389)
T ss_dssp             CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred             cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999863321          11223467889999999987  57889999999999999999999999765433221   


Q ss_pred             ------------------------------------------------------cccCHHHHHHHHHhcccCccCCCCHH
Q 024158          226 ------------------------------------------------------RSISAEAKHLISRLLVKDSSKRLSLQ  251 (271)
Q Consensus       226 ------------------------------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~  251 (271)
                                                                            ..+++++.+||.+||..||.+|||++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  329 (389)
T 3gni_B          250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS  329 (389)
T ss_dssp             --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence                                                                  23578899999999999999999999


Q ss_pred             HHhcCCccccCCC
Q 024158          252 KIMEHPWIIKNAN  264 (271)
Q Consensus       252 ~il~~~~~~~~~~  264 (271)
                      ++|+||||++...
T Consensus       330 ell~hp~f~~~~~  342 (389)
T 3gni_B          330 TLLNHSFFKQIKR  342 (389)
T ss_dssp             HHTTSGGGGGC--
T ss_pred             HHhcCHHHHHHhh
Confidence            9999999998643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-51  Score=343.61  Aligned_cols=244  Identities=29%  Similarity=0.529  Sum_probs=217.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|++..++..+++|.+.....    ....+.+|+.+++.++||||+++++++...+.++++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            5789999999999999999999999999999999865432    235678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC--CCCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~--~~~~~L~dfg~~~~~~~~--  172 (271)
                      ||++++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.  ++.++|+|||++......  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            9999999999999765 36999999999999999999999999999999999999987  789999999998654332  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.               +..+++++.+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHH
Confidence            2345689999999999988889999999999999999999999987665433               2357899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +||..||.+|||++++++||||++...+
T Consensus       240 ~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  267 (321)
T 1tki_A          240 RLLVKERKSRMTASEALQHPWLKQKIER  267 (321)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred             HHcCCChhHCcCHHHHhcChhhccCccc
Confidence            9999999999999999999999987443

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.1e-51  Score=354.83  Aligned_cols=244  Identities=32%  Similarity=0.598  Sum_probs=216.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|.+..+|+.+++|++....... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999997655433 3456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC---CCCCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~---~~~~~~L~dfg~~~~~~~~--  172 (271)
                      ||++.+++|.+.+.....+++..+..++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++......  
T Consensus        89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            99999999999999888899999999999999999999999999999999999998   4578999999998654433  


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHH
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI  236 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li  236 (271)
                       .....||+.|+|||.+.+..++.++||||||+++|+|++|.+||.+....+.               +..+++++.++|
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  248 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI  248 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence             2345789999999999998999999999999999999999999987664333               235689999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      .+||..||.+|||++++|+||||++.
T Consensus       249 ~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          249 NKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999999999754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=333.34  Aligned_cols=250  Identities=36%  Similarity=0.723  Sum_probs=197.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ..+++|++.+.||+|+||.||+|++..+++.+++|++.............+.+|+.+++.++||||+++++++...+..+
T Consensus         8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred             cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence            45789999999999999999999999999999999997655444334567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      +++|++++++|.+++... ..+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.....   
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999999875 5789999999999999999999999999999999999999999999999998855432   


Q ss_pred             ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHhc
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLL  240 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~l  240 (271)
                      ......+++.|+|||.+.+..++.++|+||||+++++|++|..||.........           ..++.++.+++.+||
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  247 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL  247 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHS
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHc
Confidence            223456889999999999888999999999999999999999999866543332           236899999999999


Q ss_pred             ccCccCCCCHHHHhcCCccccCCCC
Q 024158          241 VKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       241 ~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ..||.+|||++++++||||++....
T Consensus       248 ~~dp~~Rps~~~~l~h~~~~~~~~~  272 (278)
T 3cok_A          248 RRNPADRLSLSSVLDHPFMSRNSST  272 (278)
T ss_dssp             CSSGGGSCCHHHHTTSTTTC-----
T ss_pred             ccCHhhCCCHHHHhcCccccCCCCc
Confidence            9999999999999999999987544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8e-51  Score=357.50  Aligned_cols=252  Identities=31%  Similarity=0.616  Sum_probs=225.5

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .....+..++|++.+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++..
T Consensus         8 ~~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~   87 (476)
T 2y94_A            8 KHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST   87 (476)
T ss_dssp             -CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            44567889999999999999999999999999999999999977654443445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      .+..|+|+|++++++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999999999999888889999999999999999999999999999999999999999999999999986543


Q ss_pred             C--ccccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHH
Q 024158          171 S--KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLI  236 (271)
Q Consensus       171 ~--~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li  236 (271)
                      .  ......|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||..........           .+++++.+++
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          168 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL  247 (476)
T ss_dssp             TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred             ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence            3  2345678999999999988776 679999999999999999999998776544432           2589999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      .+||..||.+|||++++++||||++.
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.2e-51  Score=342.25  Aligned_cols=246  Identities=33%  Similarity=0.601  Sum_probs=217.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .++|++.+.||+|+||.||+|++..++..+++|++........   ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3579999999999999999999999999999999866533211   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeeccccccc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR  170 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~~~  170 (271)
                      ++|+|++++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998878899999999999999999999999999999999999998877    79999999985543


Q ss_pred             --CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHH
Q 024158          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAK  233 (271)
Q Consensus       171 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~  233 (271)
                        .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.               +..+++.+.
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (326)
T 2y0a_A          170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK  249 (326)
T ss_dssp             TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHH
Confidence              233445789999999999989999999999999999999999999987664433               234688999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +++.+||..||.+|||++++++||||+...
T Consensus       250 ~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            999999999999999999999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-51  Score=353.21  Aligned_cols=251  Identities=31%  Similarity=0.543  Sum_probs=220.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ........++|++++.||+|+||.||+|+++.+++.+|+|++.+...........+.+|..+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            34556788999999999999999999999999999999999976544333333457789999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ++.+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            9999999999999999999976 468999999999999999999999999999999999999999999999999986544


Q ss_pred             Cc----cccccccccccCCccccCCC----CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc---------------c
Q 024158          171 SK----RHTMCGTLDYLAPEMVENKE----HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------S  227 (271)
Q Consensus       171 ~~----~~~~~~~~~y~~pe~~~~~~----~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~---------------~  227 (271)
                      ..    .....||+.|+|||.+.+..    ++.++|+||||+++|+|++|..||.+....+...               .
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  299 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  299 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence            32    23567999999999998665    7789999999999999999999998776543322               3


Q ss_pred             cCHHHHHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          228 ISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      +++++.+||.+||..+|.+  ||++++|++||||+..
T Consensus       300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            6899999999999999988  9999999999999875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.2e-51  Score=341.80  Aligned_cols=243  Identities=32%  Similarity=0.604  Sum_probs=213.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++..+++.+++|++......  ...+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            57999999999999999999999999999999998654332  2245678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-----Cc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-----SK  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-----~~  172 (271)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....     ..
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            9999999999999887789999999999999999999999999999999999999999999999999985432     12


Q ss_pred             cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~li~  237 (271)
                      .....|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.......              .+..+++++.+++.
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHH
Confidence            234578999999999988775 678999999999999999999997655421              12457899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||..||.+|||++|+++||||++.
T Consensus       244 ~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          244 KILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHccCChhhCcCHHHHhhChhhccc
Confidence            9999999999999999999999865

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.2e-50  Score=344.49  Aligned_cols=243  Identities=31%  Similarity=0.615  Sum_probs=217.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|.+..++..+++|++....... ...+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            357999999999999999999999999999999997655443 3456788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~~~~--  172 (271)
                      ||++++++|.+.+.....+++..++.++.||+.||.|||++||+|+||||+||+++.++   .++|+|||++......  
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            99999999999998878899999999999999999999999999999999999998654   5999999998654432  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~  237 (271)
                      .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+.               +..+++++.++|.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  266 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  266 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHH
T ss_pred             cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            2345789999999999998999999999999999999999999987654322               3457899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCcccc
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      +||..||.+|||++++|+||||+.
T Consensus       267 ~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          267 SMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHcCCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999999975

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-50  Score=345.87  Aligned_cols=247  Identities=36%  Similarity=0.610  Sum_probs=208.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      .......++|++++.||+|+||.||++++..+++.||+|++.......    ..+.+|+.+++.++||||+++++++...
T Consensus        13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~   88 (361)
T 3uc3_A           13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTP   88 (361)
T ss_dssp             CCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence            345567789999999999999999999999999999999996654332    4577899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC--EEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~--~~L~dfg~~~~~  169 (271)
                      +.+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||++...
T Consensus        89 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           89 THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            999999999999999999988788999999999999999999999999999999999999987765  999999988532


Q ss_pred             c--CccccccccccccCCccccCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------cccC
Q 024158          170 R--SKRHTMCGTLDYLAPEMVENKEHDYA-VDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------RSIS  229 (271)
Q Consensus       170 ~--~~~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------~~i~  229 (271)
                      .  .......||+.|+|||.+.+..++.+ +|+||||+++|+|++|..||.........                 ..++
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          169 VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            2  23345578999999999988887655 89999999999999999999875542221                 1368


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +++.+||.+||..||.+|||++++++||||.+.
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999999775

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-50  Score=336.71  Aligned_cols=247  Identities=27%  Similarity=0.473  Sum_probs=212.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++..+|+.+++|++...... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            57899999999999999999999999999999998665433 34456778899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~  174 (271)
                      +|++++++|.+++...+.++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....   ...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99999999999988878899999999999999999999999999999999999999999999999999855432   223


Q ss_pred             cccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------------------
Q 024158          175 TMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------------------  225 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------------------  225 (271)
                      ...+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+..                            
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            4568899999999876 56789999999999999999999999876543321                            


Q ss_pred             --------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 --------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 --------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                    ..+++++.+++.+||..||.+|||++++++||||++....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence                          2467889999999999999999999999999999987544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.3e-50  Score=337.65  Aligned_cols=247  Identities=28%  Similarity=0.505  Sum_probs=209.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..--.++|++++.||+|+||.||+|++. +++.+|+|++...... ......+.+|+.+++.++||||+++++++..++.
T Consensus        16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            3445689999999999999999999984 6899999998654322 2334677899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .++|||+++ ++|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..... 
T Consensus        94 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           94 LTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            999999997 5888888764 4589999999999999999999999999999999999999999999999999865432 


Q ss_pred             --ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------
Q 024158          172 --KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------  225 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------  225 (271)
                        ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+..                       
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  252 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL  252 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence              2334567999999999876 45789999999999999999999999876544322                       


Q ss_pred             ------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          226 ------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       226 ------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                        ..+++++.+||.+||.+||.+|||++|+++||||++..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                              12467899999999999999999999999999999764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.3e-50  Score=346.69  Aligned_cols=250  Identities=35%  Similarity=0.633  Sum_probs=214.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHH-HhhCCCCceeceeeEEEeC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI-QSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~-l~~~~~~~i~~~~~~~~~~   91 (271)
                      ...++.++|++++.||+|+||.||+|+++.+++.+|+|++.+...........+..|..+ ++.++||||+++++++...
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            346788999999999999999999999999999999999987765544444555666665 5778999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-  170 (271)
                      +.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.... 
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            9999999999999999999888889999999999999999999999999999999999999999999999999986422 


Q ss_pred             --CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHH
Q 024158          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLIS  237 (271)
Q Consensus       171 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~  237 (271)
                        .......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...           .+++++.++|.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  271 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLE  271 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHH
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHH
Confidence              33455679999999999999999999999999999999999999998876555432           36899999999


Q ss_pred             HhcccCccCCCCH----HHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSL----QKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~----~~il~~~~~~~~  262 (271)
                      +||.+||.+||++    +++++||||+..
T Consensus       272 ~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          272 GLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             HHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             HHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            9999999999986    699999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7.9e-51  Score=356.46  Aligned_cols=250  Identities=38%  Similarity=0.635  Sum_probs=214.3

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ...+.+++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            34567899999999999999999999999999999999998765544455667788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeeccccccc-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-  170 (271)
                      .+|+||||+++++|.+++...+.+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++.... 
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            999999999999999999888889999999999999999999998 999999999999999999999999999985432 


Q ss_pred             --CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHH
Q 024158          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLIS  237 (271)
Q Consensus       171 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~  237 (271)
                        .......||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.++|.
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  381 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS  381 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence              2234567899999999999999999999999999999999999999887655443           236899999999


Q ss_pred             HhcccCccCCC-----CHHHHhcCCccccC
Q 024158          238 RLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      +||.+||.+||     |++++++||||+..
T Consensus       382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            99999999999     99999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.3e-50  Score=339.92  Aligned_cols=255  Identities=36%  Similarity=0.659  Sum_probs=211.9

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhhH-HHHHHHHHHHHHHHhhCCCCceec
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILR   83 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~   83 (271)
                      ........+..++|++.+.||+|+||.||+|++.   .+++.+++|++.+..... ......+.+|+.+++.++||||++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~   85 (327)
T 3a62_A            6 SVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD   85 (327)
T ss_dssp             -------CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCC
T ss_pred             ccCCCCCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccc
Confidence            3344567788999999999999999999999985   689999999997654322 233456778999999999999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      +++++..++.+|+|||++++++|.+++...+.++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df  165 (327)
T 3a62_A           86 LIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF  165 (327)
T ss_dssp             EEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred             eeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeC
Confidence            99999999999999999999999999988788999999999999999999999999999999999999999999999999


Q ss_pred             ccccccc---CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccC
Q 024158          164 GWSVQSR---SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SIS  229 (271)
Q Consensus       164 g~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~  229 (271)
                      |++....   .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+...           .++
T Consensus       166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~  245 (327)
T 3a62_A          166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLT  245 (327)
T ss_dssp             SCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSC
T ss_pred             CcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence            9885432   22344578999999999999999999999999999999999999998876554432           358


Q ss_pred             HHHHHHHHHhcccCccCCC-----CHHHHhcCCccccC
Q 024158          230 AEAKHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      +++.+++.+||..||.+||     +++++++||||+..
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999999999     89999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.5e-51  Score=338.33  Aligned_cols=231  Identities=23%  Similarity=0.355  Sum_probs=187.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC----eE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----RI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   94 (271)
                      .+|.+.++||+|+||+||+|++  +|+.||||++.......    .....|+..+.+++||||+++++++.+++    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            5799999999999999999986  68999999996543221    22345777778899999999999997653    58


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--------~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      |+|||||++++|.++++. ..++++.+..++.|++.||.|||++        +|+||||||+|||++.++++||+|||++
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999987 5689999999999999999999987        9999999999999999999999999998


Q ss_pred             ccccCc-------cccccccccccCCccccCC------CCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------
Q 024158          167 VQSRSK-------RHTMCGTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------  223 (271)
Q Consensus       167 ~~~~~~-------~~~~~~~~~y~~pe~~~~~------~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------  223 (271)
                      ......       .....||+.|+|||.+.+.      .++.++|||||||++|+|++|..|+......+          
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            544322       1234799999999998764      35678999999999999999977654322110          


Q ss_pred             -----hh---------cc---------cCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 -----TF---------RS---------ISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 -----~~---------~~---------i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                           ..         ..         .+..+.+|+.+||..||++|||+.+|++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                 00         00         12468899999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-50  Score=329.90  Aligned_cols=246  Identities=31%  Similarity=0.614  Sum_probs=219.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|.+..++..+++|++....... .....+.+|+.+++.++||||+++++++..++..+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            478999999999999999999999999999999997665443 3457788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC---EEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~---~~L~dfg~~~~~~~~--  172 (271)
                      +|++++++|.+.+.....+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.   ++|+|||.+......  
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            999999999999988888999999999999999999999999999999999999987655   999999998554433  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+..++.++|+||||+++++|++|..||.........               ..+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLID  243 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHH
Confidence            23457899999999999999999999999999999999999999776644332               346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +||.+||++|||++++++||||++...
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          244 SMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHcccChhhCCCHHHHhcCccccCChh
Confidence            999999999999999999999988643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-50  Score=336.54  Aligned_cols=248  Identities=29%  Similarity=0.558  Sum_probs=208.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH-----------------------HHHHHHHHHH
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-----------------------YKIQHQLRRE   69 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-----------------------~~~~~~~~~e   69 (271)
                      ...+.+++|++.+.||+|+||.||+|++..+++.+|+|++.......                       ....+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            44567899999999999999999999999999999999986554221                       1124568899


Q ss_pred             HHHHhhCCCCceeceeeEEEe--CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 024158           70 MEIQSSLRHPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKP  147 (271)
Q Consensus        70 ~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~  147 (271)
                      +.+++.++||||+++++++..  ++..++|||++++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  5689999999999999886543 5799999999999999999999999999999999


Q ss_pred             CCeeeCCCCCEEEeeecccccccCc---cccccccccccCCccccCCC---CCccchhhhHHHHHHHHHhCCCCCCCCCc
Q 024158          148 ENLLLDHEGRLKIGDFGWSVQSRSK---RHTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQ  221 (271)
Q Consensus       148 ~Nili~~~~~~~L~dfg~~~~~~~~---~~~~~~~~~y~~pe~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~~~  221 (271)
                      +||+++.++.++|+|||++......   .....+++.|+|||.+.+..   .+.++|+||||+++|+|++|..||.....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            9999999999999999998654332   23457899999999998765   36789999999999999999999987653


Q ss_pred             chh-------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          222 KDT-------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       222 ~~~-------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      ...             ...+++++.+++.+||..||++|||++++++||||++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            322             1246899999999999999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.1e-50  Score=332.86  Aligned_cols=255  Identities=31%  Similarity=0.600  Sum_probs=227.7

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      .......++|++.+.||+|+||.||++++..+++.+++|++...........+.+.+|+.+++.++|+||+++++++..+
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A            8 LVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             EEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            34556788999999999999999999999999999999999776555455567888999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc-
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-  170 (271)
                      +..++++|++++++|.+++.....+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.... 
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999999999999887889999999999999999999999999999999999999999999999999985533 


Q ss_pred             --CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------hcccCHHHHHHHH
Q 024158          171 --SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------FRSISAEAKHLIS  237 (271)
Q Consensus       171 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------~~~i~~~l~~li~  237 (271)
                        .......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+.           ...+++++.+++.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence              223345689999999999988899999999999999999999999987654332           2346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      +||..||.+|||++++++||||.....|.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHcccChhhCcCHHHHhhChheecCCcCC
Confidence            99999999999999999999999886654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2e-50  Score=340.57  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=207.3

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ......+++|++++.||+|+||.||+|++..+++.+++|++....... .....+.+|+.+++.++||||+++++++..+
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHN  105 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            446678899999999999999999999999999999999996554322 3355677899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-----CCCCEEEeeeccc
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-----HEGRLKIGDFGWS  166 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-----~~~~~~L~dfg~~  166 (271)
                      +.+++|||+++ ++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++     ..+.++|+|||++
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             CEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99999999997 59999999888899999999999999999999999999999999999994     4455999999998


Q ss_pred             cccc---CccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc----------------
Q 024158          167 VQSR---SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR----------------  226 (271)
Q Consensus       167 ~~~~---~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~----------------  226 (271)
                      ....   .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....+...                
T Consensus       185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred             cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhh
Confidence            5433   2233456799999999998754 7899999999999999999999998765433221                


Q ss_pred             -------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          227 -------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       227 -------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                               .+++++.+||.+||..||.+|||++++++||||++..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                                     1578999999999999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.4e-50  Score=334.03  Aligned_cols=242  Identities=30%  Similarity=0.555  Sum_probs=206.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++ .+++.+++|++....... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            47899999999999999999998 779999999986543322 2235677899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      +|++++ +|.+++... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....   ..
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            999974 999998764 5789999999999999999999999999999999999999999999999999854332   22


Q ss_pred             ccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------------
Q 024158          174 HTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------  224 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------------  224 (271)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+.                            
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            344679999999999764 578999999999999999999999976543221                            


Q ss_pred             ------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          225 ------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       225 ------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                  ...+++++.+++.+||..||++|||++++++||||++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        12468999999999999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-50  Score=330.48  Aligned_cols=252  Identities=32%  Similarity=0.614  Sum_probs=214.9

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ....+..++|++.+.||+|++|.||++++..+++.+++|++.............+.+|+..++.++||||+++++++...
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A            4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            35677889999999999999999999999999999999999766544434456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      +..++++|++++++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999999999998878899999999999999999999999999999999999999999999999998855433


Q ss_pred             c--cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHH
Q 024158          172 K--RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLIS  237 (271)
Q Consensus       172 ~--~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~  237 (271)
                      .  .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||..........           .+++++.+++.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  243 (276)
T 2h6d_A          164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLM  243 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHH
Confidence            2  234567899999999988765 579999999999999999999998766544332           35899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||..||.+|||++++++||||++..
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHccCChhhCCCHHHHHhChhhccCc
Confidence            99999999999999999999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.3e-50  Score=351.23  Aligned_cols=251  Identities=31%  Similarity=0.554  Sum_probs=219.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ....+..++|++++.||+|+||+||+|+++.+++.+|+|++.+...........+.+|..++..++||||+++++++.++
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            34467788999999999999999999999999999999999765443333334478899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      +.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            999999999999999999987 4679999999999999999999999999999999999999999999999999985443


Q ss_pred             Cc----cccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------
Q 024158          171 SK----RHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------  225 (271)
Q Consensus       171 ~~----~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------  225 (271)
                      ..    .....||+.|+|||.+.     ...++.++|+||||+++|+|++|..||.+....+..                
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            22    23357899999999986     456889999999999999999999999877654332                


Q ss_pred             cccCHHHHHHHHHhcccCccC--CCCHHHHhcCCccccC
Q 024158          226 RSISAEAKHLISRLLVKDSSK--RLSLQKIMEHPWIIKN  262 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~--Rps~~~il~~~~~~~~  262 (271)
                      ..+++++.+||++||..+|++  ||+++++++||||+..
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            236899999999999988888  9999999999999865

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.7e-50  Score=341.21  Aligned_cols=245  Identities=29%  Similarity=0.566  Sum_probs=213.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH--HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      -++|++.+.||+|+||.||+|++..+++.+|+|++........  ...+.+.+|+.+++.++||||+++++++..++.+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4679999999999999999999999999999999965443211  12467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC---EEEeeeccccc
Q 024158           96 LILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQ  168 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~---~~L~dfg~~~~  168 (271)
                      +|||++++++|.+.+...    ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998887542    35899999999999999999999999999999999999987654   99999999865


Q ss_pred             ccCc---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc--------------chhhcccCHH
Q 024158          169 SRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ--------------KDTFRSISAE  231 (271)
Q Consensus       169 ~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~--------------~~~~~~i~~~  231 (271)
                      ....   .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+...              ...+..++++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  262 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHISES  262 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccccCCHH
Confidence            4432   2345789999999999999999999999999999999999999976532              1223457899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +.++|.+||..||.+|||+.++++||||+..
T Consensus       263 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          263 AKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            9999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-50  Score=346.97  Aligned_cols=250  Identities=31%  Similarity=0.528  Sum_probs=219.3

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ....+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..++|++|+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34567789999999999999999999999999999999999775544433445678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      +.+|+||||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||+++.+++++|+|||++....
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            9999999999999999999874 479999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc----cccccccccccCCcccc-------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------
Q 024158          171 SK----RHTMCGTLDYLAPEMVE-------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------  225 (271)
Q Consensus       171 ~~----~~~~~~~~~y~~pe~~~-------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------  225 (271)
                      ..    .....||+.|+|||.+.       +..++.++|+||||+++|+|++|..||.+....+..              
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            32    23457899999999987       356889999999999999999999999877654332              


Q ss_pred             --cccCHHHHHHHHHhcccCccCC---CCHHHHhcCCccccC
Q 024158          226 --RSISAEAKHLISRLLVKDSSKR---LSLQKIMEHPWIIKN  262 (271)
Q Consensus       226 --~~i~~~l~~li~~~l~~~p~~R---ps~~~il~~~~~~~~  262 (271)
                        ..+++++.++|++||. +|.+|   |+++++++||||+..
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence              2468999999999999 99998   599999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.7e-49  Score=338.71  Aligned_cols=241  Identities=25%  Similarity=0.409  Sum_probs=211.9

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-----CCceeceeeEEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----HPNILRLYGWFH   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----~~~i~~~~~~~~   89 (271)
                      .+-.++|++++.||+|+||.||+|++..+++.+|+|++....    ........|+.+++.+.     |+||+++++++.
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~  106 (360)
T 3llt_A           31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM  106 (360)
T ss_dssp             CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred             eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence            344568999999999999999999999999999999986432    22345667888888886     999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-------------
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-------------  154 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-------------  154 (271)
                      ..+..++|||++ +++|.+++....  .++...++.++.||+.||.|||++|++|+||||+||+++.             
T Consensus       107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence            999999999999 789999998754  5899999999999999999999999999999999999975             


Q ss_pred             ------------CCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc
Q 024158          155 ------------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK  222 (271)
Q Consensus       155 ------------~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~  222 (271)
                                  ++.++|+|||++...........+|+.|+|||.+.+..++.++||||||+++|+|++|..||......
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  265 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHM  265 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHH
Confidence                        78899999999977666666778999999999999999999999999999999999999999876543


Q ss_pred             hhhcc---------------------------------------------------------cCHHHHHHHHHhcccCcc
Q 024158          223 DTFRS---------------------------------------------------------ISAEAKHLISRLLVKDSS  245 (271)
Q Consensus       223 ~~~~~---------------------------------------------------------i~~~l~~li~~~l~~~p~  245 (271)
                      +....                                                         .++.+.+|+.+||..||.
T Consensus       266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  345 (360)
T 3llt_A          266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPT  345 (360)
T ss_dssp             HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChh
Confidence            32211                                                         126788999999999999


Q ss_pred             CCCCHHHHhcCCccc
Q 024158          246 KRLSLQKIMEHPWII  260 (271)
Q Consensus       246 ~Rps~~~il~~~~~~  260 (271)
                      +|||++++|+||||+
T Consensus       346 ~Rpta~elL~hp~f~  360 (360)
T 3llt_A          346 LRPSPAELLKHKFLE  360 (360)
T ss_dssp             GSCCHHHHTTSGGGC
T ss_pred             hCCCHHHHhcCcccC
Confidence            999999999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.8e-49  Score=333.68  Aligned_cols=245  Identities=31%  Similarity=0.558  Sum_probs=217.1

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|+..+.||+|+||.||+|++..+|+.||||++.......   .+.+.+|+.+++.++|+||+++++++...+..++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4888899999999999999999899999999986554332   3567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTM  176 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~  176 (271)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   .....
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            9999999999875 5689999999999999999999999999999999999999999999999998754332   23445


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHHhccc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~~l~~  242 (271)
                      .||+.|+|||.+.+..++.++|+||||+++|+|++|..||......+.              ...+++++.+++.+||..
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCS
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccC
Confidence            789999999999999999999999999999999999999987654332              224689999999999999


Q ss_pred             CccCCCCHHHHhcCCccccCCCCCCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                      ||.+|||++++++||||++...|.+.
T Consensus       282 dp~~Rps~~ell~hp~~~~~~~~~~~  307 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQTGLPECL  307 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGCCCGGGG
T ss_pred             ChhhCcCHHHHhcChhhccCCCcccc
Confidence            99999999999999999988766543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=9.4e-50  Score=336.74  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=216.4

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      .........+++|++++.||+|+||.||+|++..+|+.+++|++....... .....+.+|+.+++.++||||+++++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~   93 (331)
T 4aaa_A           15 GTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVC   93 (331)
T ss_dssp             ----CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence            344456678999999999999999999999999999999999986554332 3456678899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ...+..++|||++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (331)
T 4aaa_A           94 KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART  173 (331)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             ecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCcee
Confidence            99999999999999888888887777899999999999999999999999999999999999999999999999999854


Q ss_pred             ccC---ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------
Q 024158          169 SRS---KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------  225 (271)
Q Consensus       169 ~~~---~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------  225 (271)
                      ...   ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||......+..                   
T Consensus       174 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          174 LAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            332   23445689999999999875 6788999999999999999999999876643321                   


Q ss_pred             -----------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          226 -----------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       226 -----------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                             ..+++++.+++.+||..||.+|||++++|+||||+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence                                   1358899999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.9e-50  Score=336.07  Aligned_cols=245  Identities=28%  Similarity=0.507  Sum_probs=197.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..++|++++.||+|+||.||+|++..+|+.+++|++......  .....+.+|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            357899999999999999999999999999999998654322  123467789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           97 ILEYAHRGELYRELRKH------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      |+|+++ ++|.+++...      ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999998 5999988653      358999999999999999999999999999999999999999999999999986543


Q ss_pred             C---ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------
Q 024158          171 S---KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------  225 (271)
Q Consensus       171 ~---~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------  225 (271)
                      .   ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+..                     
T Consensus       160 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (317)
T 2pmi_A          160 IPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL  239 (317)
T ss_dssp             SCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred             CCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhh
Confidence            2   22345689999999999764 5889999999999999999999999765533211                     


Q ss_pred             ------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 ------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                              ..+++++.+++.+||..||++|||++++++||||++...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                                    135789999999999999999999999999999998744

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-49  Score=342.58  Aligned_cols=246  Identities=28%  Similarity=0.467  Sum_probs=203.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCC--
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDE--   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~--   92 (271)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.+. |+||+++++++..++  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            4468999999999999999999999999999999998654322 234566778999999997 999999999997544  


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .+|+|||+++ ++|..++.. ..++...+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..... 
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            6899999997 699999976 5689999999999999999999999999999999999999999999999999854321 


Q ss_pred             -----------------------ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-
Q 024158          172 -----------------------KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-  226 (271)
Q Consensus       172 -----------------------~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-  226 (271)
                                             ......||+.|+|||.+.+ ..++.++|||||||++++|++|.+||.+....+.+. 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence                                   1223468999999999986 568999999999999999999999998766433221 


Q ss_pred             ---------------------------------------------------------ccCHHHHHHHHHhcccCccCCCC
Q 024158          227 ---------------------------------------------------------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       227 ---------------------------------------------------------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                                                                               ..++++.+|+.+||..||.+|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence                                                                     35788999999999999999999


Q ss_pred             HHHHhcCCccccCCC
Q 024158          250 LQKIMEHPWIIKNAN  264 (271)
Q Consensus       250 ~~~il~~~~~~~~~~  264 (271)
                      ++++|+||||+....
T Consensus       323 ~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          323 ANDALKHPFVSIFHN  337 (388)
T ss_dssp             HHHHTTSTTTTTTCC
T ss_pred             HHHHhCCHHHHHhcC
Confidence            999999999987643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-49  Score=335.20  Aligned_cols=240  Identities=34%  Similarity=0.630  Sum_probs=193.5

Q ss_pred             cceeee---eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeE
Q 024158           19 QDFEIG---RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERI   94 (271)
Q Consensus        19 ~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~   94 (271)
                      ++|++.   +.||+|+||.||+|++..+++.+|+|++....      .....+|+.+++.+. ||||+++++++.+++..
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            567775   78999999999999999999999999996542      245667899999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeecccccccC
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQSRS  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~~~  171 (271)
                      |+|||++++++|.+++...+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++   .++|+|||++.....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~  161 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP  161 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred             EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence            99999999999999999888899999999999999999999999999999999999998766   799999999864432


Q ss_pred             c---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------------hhhc
Q 024158          172 K---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------------DTFR  226 (271)
Q Consensus       172 ~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------------~~~~  226 (271)
                      .   .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......                      ..+.
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (325)
T 3kn6_A          162 DNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK  241 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHH
T ss_pred             CCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCccccc
Confidence            2   23456799999999999999999999999999999999999999764421                      1123


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      .+++++.+++.+||..||.+|||++++++||||++...
T Consensus       242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             TSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            47899999999999999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.9e-49  Score=334.29  Aligned_cols=252  Identities=31%  Similarity=0.625  Sum_probs=225.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .....++|++.+.||+|+||.||++++..+++.+++|++...........+.+.+|+.+++.++|+||+++++++..++.
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  115 (335)
T 2owb_A           36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF  115 (335)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            34567899999999999999999999999999999999977655555556788899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---  170 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---  170 (271)
                      .++++|++++++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++....   
T Consensus       116 ~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          116 VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             EEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999985433   


Q ss_pred             CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHHHh
Q 024158          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRL  239 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~~~  239 (271)
                      .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+..           ..+++++.+++.+|
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  275 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKM  275 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence            2234456899999999999988999999999999999999999999876544332           24689999999999


Q ss_pred             cccCccCCCCHHHHhcCCccccCCCC
Q 024158          240 LVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       240 l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      |..||.+|||++++++||||.....|
T Consensus       276 l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          276 LQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             TCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             ccCChhHCcCHHHHhcCccccCCCcc
Confidence            99999999999999999999987554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-49  Score=340.03  Aligned_cols=245  Identities=25%  Similarity=0.446  Sum_probs=209.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      .++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            46799999999999999999999999999999998654332 344567889999999999999999999987653     


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                       .+|+|+|++ +++|.+++.. ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence             469999999 6899999987 5689999999999999999999999999999999999999999999999999977666


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------  225 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------  225 (271)
                      ......+|+.|+|||.+.+ ..++.++|+||+||++++|++|..||.+....+.+                         
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            6666788999999999887 67899999999999999999999999876543221                         


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                       ...++++.+|+.+||..||.+|||++++|+||||+....+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                             2347889999999999999999999999999999987543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.7e-49  Score=325.74  Aligned_cols=241  Identities=34%  Similarity=0.636  Sum_probs=215.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|++..++..+++|.+.......   .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            467999999999999999999999999999999997654433   45688899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeecccccccC--c
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRS--K  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~~~--~  172 (271)
                      +|++++++|.+++...+.+++..++.++.|++.|+.+||++|++|+||+|+||++   +.++.++|+|||.+.....  .
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~  164 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM  164 (277)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred             EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence            9999999999999888889999999999999999999999999999999999999   7788999999999854332  3


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+. ++.++|+||||+++++|++|..||......+..               ..+++++.+++.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            3455789999999988654 888999999999999999999999876654332               246899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||..||.+|||+.++++||||++.
T Consensus       244 ~~l~~dp~~R~s~~~~l~h~~~~~~  268 (277)
T 3f3z_A          244 RLLTKSPKQRITSLQALEHEWFEKQ  268 (277)
T ss_dssp             HHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.5e-49  Score=354.58  Aligned_cols=250  Identities=31%  Similarity=0.481  Sum_probs=222.1

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ...+..++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+
T Consensus       178 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  257 (576)
T 2acx_A          178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD  257 (576)
T ss_dssp             TSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence            44578899999999999999999999999999999999997765544444566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      .+|+||||+++++|.+++....  .+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++....
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            9999999999999999997744  48999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHHHH
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAEAK  233 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~l~  233 (271)
                      ..  .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.......               ....+++++.
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~  417 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQAR  417 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHHH
Confidence            32  244579999999999999889999999999999999999999998754211               1133689999


Q ss_pred             HHHHHhcccCccCCC-----CHHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      ++|.+||.+||.+||     +++++++||||++.
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            999999999999999     89999999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-49  Score=330.78  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=203.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|+++++||+|+||+||+|++..+++.||||++.............+.+...+.+..+|+||+++++++.+++..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            37899999999999999999999999999999998655444333334444444555555999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--cc
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--RH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--~~  174 (271)
                      +|+++ ++|.+++... ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......  ..
T Consensus       136 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          136 TELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             EECCC-CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             EeccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence            99994 6888888763 46999999999999999999999999999999999999999999999999998554332  23


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc----------chhhcccCHHHHHHHHHhcccCc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----------KDTFRSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~----------~~~~~~i~~~l~~li~~~l~~~p  244 (271)
                      ...||+.|+|||.+.+ .++.++||||||+++|+|++|..|+.....          ......+++++.+++.+||.+||
T Consensus       215 ~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  293 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDP  293 (311)
T ss_dssp             CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSST
T ss_pred             ccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHHcCCCh
Confidence            4468999999998876 788999999999999999999776654332          22334578999999999999999


Q ss_pred             cCCCCHHHHhcCCcccc
Q 024158          245 SKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       245 ~~Rps~~~il~~~~~~~  261 (271)
                      ++|||++++++||||++
T Consensus       294 ~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          294 KLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TTSCCHHHHHTSGGGSC
T ss_pred             hhCcCHHHHHhCccccC
Confidence            99999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.3e-49  Score=324.16  Aligned_cols=246  Identities=31%  Similarity=0.593  Sum_probs=216.5

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|++|.||+|++..+++.+++|++.......  ..+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            478999999999999999999999999999999996554332  346788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-----c
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----K  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----~  172 (271)
                      +|++++++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.....     .
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99999899999998777899999999999999999999999999999999999999999999999998854321     2


Q ss_pred             cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..||.......              ....+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            234568999999999987775 678999999999999999999998655321              12457899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +||..||.+|||++++++||||++....
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          244 KILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHCCCCchhCCCHHHHhcCccccChhhc
Confidence            9999999999999999999999987543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.1e-49  Score=336.86  Aligned_cols=244  Identities=35%  Similarity=0.608  Sum_probs=203.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      -.++|++.+.||+|+||.||+|++..+++.|++|++....     ..+.+.+|+.++++++||||+++++++...+..++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            3466999999999999999999999999999999986542     23567789999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeeecccccccCc-
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~dfg~~~~~~~~-  172 (271)
                      ++|++++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.   ++.++|+|||++...... 
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            9999999999999988788999999999999999999999999999999999999975   789999999998654332 


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHHHHH
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEAKHL  235 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l~~l  235 (271)
                       .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.                +..++.++.++
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~l  285 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL  285 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHH
Confidence             2345689999999999998999999999999999999999999976554321                23478999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      |.+||..||++|||++++++||||+.....
T Consensus       286 i~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  315 (349)
T 2w4o_A          286 VRKLIVLDPKKRLTTFQALQHPWVTGKAAN  315 (349)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred             HHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence            999999999999999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-49  Score=339.34  Aligned_cols=243  Identities=31%  Similarity=0.562  Sum_probs=215.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++.+.||+|+||.||+|.+..+++.+++|++......   ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999999999999999998654322   235678999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC--CCCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~--~~~~~L~dfg~~~~~~~~--  172 (271)
                      ||++++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.  ++.++|+|||++......  
T Consensus       127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            99999999999997643 6899999999999999999999999999999999999974  467999999998654432  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~  237 (271)
                      .....+|+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.               +..+++++.++|.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  286 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  286 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHH
Confidence            2345789999999999999999999999999999999999999987664332               2347899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||..||.+|||++++++||||+...
T Consensus       287 ~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          287 NLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999999999999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-49  Score=334.07  Aligned_cols=245  Identities=31%  Similarity=0.571  Sum_probs=217.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .++|++.+.||+|+||.||+|++..+|..+++|++........   .....+.+|+.+++.++||||+++++++...+.+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4579999999999999999999999999999999866543211   1245688999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeeccccccc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR  170 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~~~  170 (271)
                      ++++|++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++    .++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999998878899999999999999999999999999999999999999887    79999999985544


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHH
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAK  233 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~  233 (271)
                      ..  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..               ..+++.+.
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAK  250 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHH
T ss_pred             ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHH
Confidence            32  23456899999999999999999999999999999999999999876544332               34688999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +++.+||..||.+|||++++++||||+..
T Consensus       251 ~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          251 DFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            99999999999999999999999999865

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-49  Score=326.84  Aligned_cols=242  Identities=32%  Similarity=0.587  Sum_probs=209.0

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ..++|++.+.||+|+||.||+|++..++..+++|++.......  ..+.+.+|+++++.++||||+++++++...+..++
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   97 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV--PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYI   97 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch--hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEE
Confidence            4478999999999999999999999999999999997654322  24678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeecccccc
Q 024158           97 ILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~  169 (271)
                      |+|++++++|.+++..    ...+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||++...
T Consensus        98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A           98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999998854    3679999999999999999999999999999999999999   44578999999998543


Q ss_pred             cC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHH
Q 024158          170 RS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAK  233 (271)
Q Consensus       170 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~  233 (271)
                      ..  ......+++.|+|||.+. ..++.++|+||||+++++|++|..||.+....+..              ..+++++.
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAV  256 (285)
T ss_dssp             ---------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHH
T ss_pred             CCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHH
Confidence            32  234456899999999875 56788999999999999999999999877644432              22589999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      +++.+||.+||.+|||++|+++||||++
T Consensus       257 ~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          257 DLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-49  Score=349.34  Aligned_cols=242  Identities=24%  Similarity=0.416  Sum_probs=205.2

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ..++|++++.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccCh-HHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3678999999999999999999999999999999997653332 4456788999999999999999999998654     


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       ..+|+||||+++ +|.+.+..  .+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             467999999974 67777643  48999999999999999999999999999999999999999999999999986544


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc--------------------
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------------  228 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i--------------------  228 (271)
                      ..  .....+|+.|+|||.+.+..++.++||||||+++++|++|..||.+.+..+++.++                    
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            32  34467899999999999999999999999999999999999999876643332111                    


Q ss_pred             ---------------------------------CHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          229 ---------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       229 ---------------------------------~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                       ++++.+||.+||..||++|||++|+|+||||+..
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                                             4678999999999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-49  Score=329.60  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=202.3

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH--HHHHHHHHHHHHHHhh---CCCCceeceeeEEE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK--YKIQHQLRREMEIQSS---LRHPNILRLYGWFH   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~~e~~~l~~---~~~~~i~~~~~~~~   89 (271)
                      .+-.++|++++.||+|+||.||+|++..+++.||+|++.......  ......+.+|+.+++.   ++||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            455789999999999999999999999999999999986432110  0001233345555444   46999999999997


Q ss_pred             eCC-----eEEEEEeccCCCchHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEee
Q 024158           90 DDE-----RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        90 ~~~-----~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                      ...     ..++++|+++ ++|.+++.....  +++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            755     5899999997 599999987543  89999999999999999999999999999999999999999999999


Q ss_pred             ecccccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------
Q 024158          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------  225 (271)
Q Consensus       163 fg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------  225 (271)
                      ||++.....  ......+|+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..               
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999854432  234457899999999999999999999999999999999999999776543322               


Q ss_pred             -----------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 -----------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 -----------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                             ..+++++.++|.+||.+||++|||++++|+||||++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence                                   236789999999999999999999999999999998654

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-50  Score=355.26  Aligned_cols=248  Identities=34%  Similarity=0.628  Sum_probs=219.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      .-.++|++.+.||+|+||.||+|++..+++.+|+|++.............+.+|+.+++.++||||+++++++...+.+|
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34568999999999999999999999999999999997654433334567889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeecccccccCc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~~~~  172 (271)
                      +|+|++.+++|.+.+...+.+++..++.++.||+.||.|||++|++|+||||+||++   +.++.++|+|||++......
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            999999999999999888889999999999999999999999999999999999999   46789999999998544332


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHL  235 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~l  235 (271)
                        .....||+.|+|||.+.+ .++.++||||||+++|+|++|.+||.+....+.               +..+++++.++
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  261 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL  261 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHH
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHH
Confidence              234578999999999876 688999999999999999999999987765433               34578999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      |.+||.++|.+|||++++|+||||++...
T Consensus       262 i~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          262 IRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            99999999999999999999999997654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.3e-49  Score=350.72  Aligned_cols=248  Identities=35%  Similarity=0.628  Sum_probs=217.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      -.++|++++.||+|+||.||+|++..+++.||+|++.+..... .....+.+|+.+++.++||||+++++++...+.+|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            3578999999999999999999999999999999997654332 224678899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC---CCCCEEEeeecccccccC--
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~---~~~~~~L~dfg~~~~~~~--  171 (271)
                      |+|++.+++|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||+++   .++.++|+|||++.....  
T Consensus        99 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            999999999999998878899999999999999999999999999999999999995   456799999999854433  


Q ss_pred             ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHH
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLI  236 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li  236 (271)
                      ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+....+.               +..+++++.++|
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  257 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI  257 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence            2344578999999999875 588999999999999999999999987665433               345689999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      .+||.+||.+|||+.++|+||||++.....
T Consensus       258 ~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          258 RKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             HHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             HHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            999999999999999999999999876544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.9e-49  Score=336.32  Aligned_cols=251  Identities=25%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-----   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   90 (271)
                      -.+++|++++.||+|+||.||+|++..+|+.+|+|++....... .....+.+|+.+++.++||||+++++++..     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            36789999999999999999999999999999999986554322 223456789999999999999999999876     


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           91 ---DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        91 ---~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                         .+..++|||++++ +|.+.+... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               4568999999974 777777653 57999999999999999999999999999999999999999999999999998


Q ss_pred             cccc-------CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-----------
Q 024158          167 VQSR-------SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-----------  227 (271)
Q Consensus       167 ~~~~-------~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-----------  227 (271)
                      ....       .......+++.|+|||.+.+ ..++.++||||||+++++|++|..||.+.........           
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            5432       12234467999999999876 4578999999999999999999999987664332211           


Q ss_pred             --------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCC
Q 024158          228 --------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       228 --------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                                                      .++++.+||.+||..||.+|||++|+|+||||+..+.|...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~  324 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL  324 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccc
Confidence                                            16779999999999999999999999999999998887653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.6e-49  Score=339.07  Aligned_cols=251  Identities=29%  Similarity=0.464  Sum_probs=220.2

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ......+..++|++++.||+|+||.||++++..++..+++|++.....  ......+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  101 (360)
T 3eqc_A           24 KQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFY  101 (360)
T ss_dssp             HHTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred             hhcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence            345667888999999999999999999999999999999999866432  234577889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .++..++|||++++++|.+++.....++...+..++.|++.+|.+||++ |++|+||+|+||+++.++.++|+|||++..
T Consensus       102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999999999999998878899999999999999999999996 999999999999999999999999998843


Q ss_pred             cc-CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------------
Q 024158          169 SR-SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------------  224 (271)
Q Consensus       169 ~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------------  224 (271)
                      .. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.                       
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          182 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             cccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            32 223445789999999999999999999999999999999999999976543221                       


Q ss_pred             --------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          225 --------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       225 --------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                      ...++.++.+|+.+||..||.+|||++++++||||++.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                            01257899999999999999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-49  Score=361.49  Aligned_cols=250  Identities=32%  Similarity=0.557  Sum_probs=221.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      ...+++++|++++.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +|++|+.+++++...
T Consensus       335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            4457889999999999999999999999999999999999876544444456677888888887 689999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc--
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS--  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~--  169 (271)
                      +.+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++...  
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999999998788999999999999999999999999999999999999999999999999998642  


Q ss_pred             -cCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHH
Q 024158          170 -RSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLIS  237 (271)
Q Consensus       170 -~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~  237 (271)
                       ........||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+...           .+++++.+||.
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  574 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK  574 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence             233445679999999999999999999999999999999999999999877655443           36899999999


Q ss_pred             HhcccCccCCCCH-----HHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSL-----QKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~-----~~il~~~~~~~~  262 (271)
                      +||.+||.+||++     ++|++||||+..
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             HHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            9999999999998     999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-49  Score=350.91  Aligned_cols=249  Identities=35%  Similarity=0.622  Sum_probs=216.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH----------HHHHHHHHHHHHHhhCCCCceecee
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY----------KIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      ...++|++++.||+|+||.||+|++..++..+|+|++.+......          ...+.+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            346789999999999999999999999999999999976543321          2346788999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEee
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGD  162 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~d  162 (271)
                      +++..++.+|+|||++++++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++   .++|+|
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999999999999998878899999999999999999999999999999999999998876   699999


Q ss_pred             ecccccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------h
Q 024158          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------F  225 (271)
Q Consensus       163 fg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~  225 (271)
                      ||++.....  ......||+.|+|||.+. ..++.++||||+|+++|+|++|..||.+....+.               +
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  271 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW  271 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence            999865433  234557899999999986 4688999999999999999999999988765443               2


Q ss_pred             cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ..+++++.++|.+||.+||.+|||++++|+||||++....
T Consensus       272 ~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            4578999999999999999999999999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-48  Score=324.15  Aligned_cols=255  Identities=29%  Similarity=0.511  Sum_probs=217.4

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhh------hhHHHHHHHHHHHHHHHhhCC-CCcee
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQ------IEKYKIQHQLRREMEIQSSLR-HPNIL   82 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~~e~~~l~~~~-~~~i~   82 (271)
                      ......--.++|++.+.||+|++|.||+|++..+++.+++|++....      .......+.+.+|+.+++++. ||||+
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A            8 GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             -------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             cccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            33444455789999999999999999999999999999999986543      112234567788999999995 99999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEee
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                      ++++++..++..++|+|++++++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999999999998878899999999999999999999999999999999999999999999999


Q ss_pred             ecccccccC--ccccccccccccCCcccc------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------
Q 024158          163 FGWSVQSRS--KRHTMCGTLDYLAPEMVE------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------  224 (271)
Q Consensus       163 fg~~~~~~~--~~~~~~~~~~y~~pe~~~------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------  224 (271)
                      ||.+.....  ......+++.|+|||.+.      ...++.++|+||||+++++|++|..||........          
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            998855432  234456899999999884      45678899999999999999999999976654332          


Q ss_pred             -----hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 -----FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 -----~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                           +..++.++.+++.+||..||.+|||++++++||||++...
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence                 2357899999999999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.3e-48  Score=322.32  Aligned_cols=245  Identities=24%  Similarity=0.447  Sum_probs=212.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe----C
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----D   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~   91 (271)
                      .....|++.+.||+|+||.||+|.+..++..+++|.+....... .....+.+|+.+++.++||||+++++++..    .
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence            34445899999999999999999999999999999997665443 346778899999999999999999998865    4


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeC-CCCCEEEeeeccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLD-HEGRLKIGDFGWSVQ  168 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~-~~~~~~L~dfg~~~~  168 (271)
                      ..+++|+|++++++|.+++...+.++...++.++.|++.||.+||+.|  ++|+||+|+||+++ .++.++|+|||++..
T Consensus       102 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          102 KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             ceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            568999999999999999998788999999999999999999999999  99999999999997 788999999999854


Q ss_pred             ccCc-cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHH
Q 024158          169 SRSK-RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAK  233 (271)
Q Consensus       169 ~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~  233 (271)
                      .... .....+++.|+|||.+. +.++.++|+||||+++++|++|..||........              ....++++.
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  260 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHH
Confidence            4433 33456899999999886 4588899999999999999999999987443222              223568999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +++.+||..||.+|||++++++||||++.
T Consensus       261 ~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          261 EIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            99999999999999999999999999864

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=336.19  Aligned_cols=246  Identities=28%  Similarity=0.490  Sum_probs=214.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH-----HHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY-----KIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .++|++.+.||+|+||.||+|++..+++.+++|++........     .....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4689999999999999999999999999999999976543211     12335667999999999999999999999999


Q ss_pred             eEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++++|++.++ +|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence            999999998666 9999999888899999999999999999999999999999999999999999999999999865433


Q ss_pred             c--cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchh-----hcccCHHHHHHHHHhcccC
Q 024158          172 K--RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----FRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       172 ~--~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----~~~i~~~l~~li~~~l~~~  243 (271)
                      .  .....||+.|+|||.+.+..+ +.++|+||||+++|+|++|..||........     ...+++++.+++.+||.+|
T Consensus       183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  262 (335)
T 3dls_A          183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPV  262 (335)
T ss_dssp             TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHHTCSS
T ss_pred             CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHHccCC
Confidence            2  334568999999999988876 7799999999999999999999976432211     2236899999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~  263 (271)
                      |++|||++++++||||++..
T Consensus       263 P~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          263 PERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             GGGSCCHHHHHHCTTTTCCC
T ss_pred             hhhCcCHHHHhcCccccCCc
Confidence            99999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.6e-49  Score=348.95  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=220.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..+..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            56788999999999999999999999999999999999977655444445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           94 IFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++...
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999999763    36899999999999999999999999999999999999999999999999998654


Q ss_pred             cCc---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----hh-----------hcccCHH
Q 024158          170 RSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----DT-----------FRSISAE  231 (271)
Q Consensus       170 ~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----~~-----------~~~i~~~  231 (271)
                      ...   .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||......    +.           ...++++
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~  419 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPA  419 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCHH
Confidence            332   23458999999999999999999999999999999999999999875321    11           1346899


Q ss_pred             HHHHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          232 AKHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      +.++|.+||.+||.+||+     ++++++||||+..
T Consensus       420 ~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            999999999999999995     5899999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.9e-49  Score=334.69  Aligned_cols=243  Identities=30%  Similarity=0.566  Sum_probs=213.4

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCC
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDE   92 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~   92 (271)
                      ++|++.+.||+|++|.||+|++..+|+.|+||++.....     ......+.+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999988999999999865431     1223456788899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      ..++||||+++++|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++..... 
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~  253 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG  253 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence            9999999999999999998877899999999999999999999999999999999999999999999999998854432 


Q ss_pred             -ccccccccccccCCccccC------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccC
Q 024158          172 -KRHTMCGTLDYLAPEMVEN------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSIS  229 (271)
Q Consensus       172 -~~~~~~~~~~y~~pe~~~~------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~  229 (271)
                       ......|++.|+|||.+.+      ..++.++|+||||+++|+|++|..||........               +..++
T Consensus       254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  333 (365)
T 2y7j_A          254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRS  333 (365)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSC
T ss_pred             cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence             3345678999999998863      3578899999999999999999999987654332               23467


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      +++.+++.+||..||.+|||++++++||||++
T Consensus       334 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          334 STVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            88999999999999999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=335.17  Aligned_cols=245  Identities=27%  Similarity=0.500  Sum_probs=205.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++..+++.+|+|++......  .....+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            47899999999999999999999999999999998654322  1122345789999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cc
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KR  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~  173 (271)
                      ||+++ ++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....   ..
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            99997 5998888764 4589999999999999999999999999999999999999999999999999854432   22


Q ss_pred             ccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------------
Q 024158          174 HTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------------  225 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------------  225 (271)
                      ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+..                           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTY  237 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHT
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccc
Confidence            34467999999999876 56789999999999999999999999876543321                           


Q ss_pred             --------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 --------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 --------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                    ..+++++.+|+.+||..||.+|||++|+|+||||+....+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          238 NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence                          1357889999999999999999999999999999987543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-49  Score=346.49  Aligned_cols=244  Identities=26%  Similarity=0.452  Sum_probs=196.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~   92 (271)
                      .++|++++.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++++...     .
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4789999999999999999999999999999999865432 234457788999999999999999999998433     5


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .+|+|+|+++ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..... 
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            6999999985 79999998888899999999999999999999999999999999999999999999999999855331 


Q ss_pred             -----------------------------ccccccccccccCCccc-cCCCCCccchhhhHHHHHHHHHh----------
Q 024158          172 -----------------------------KRHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLY----------  211 (271)
Q Consensus       172 -----------------------------~~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slg~il~~l~~----------  211 (271)
                                                   ......||+.|+|||.+ .+..++.++|||||||++|+|++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence                                         12234679999999976 45668999999999999999998          


Q ss_pred             -CCCCCCCCCc--------------------------------------------------------------chhhccc
Q 024158          212 -GAPPFEAESQ--------------------------------------------------------------KDTFRSI  228 (271)
Q Consensus       212 -g~~p~~~~~~--------------------------------------------------------------~~~~~~i  228 (271)
                       |.++|.+...                                                              ...+..+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6777765431                                                              0011234


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ++++.+||.+||..||.+|||++|+|+||||++..
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            88999999999999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.2e-49  Score=333.38  Aligned_cols=245  Identities=27%  Similarity=0.489  Sum_probs=215.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ..|++++.||+|+||.||+|++..+++.|++|++.............+.+|+.++++++||||+++++++..++..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            55999999999999999999999999999999997654444455678889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccc
Q 024158           99 EYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMC  177 (271)
Q Consensus        99 e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~  177 (271)
                      ||+. ++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-~~~~~  211 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFV  211 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCC
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC-CCccc
Confidence            9997 688888754 56799999999999999999999999999999999999999999999999999865443 34457


Q ss_pred             ccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------cccCHHHHHHHHHhcc
Q 024158          178 GTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       178 ~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i~~~l~~li~~~l~  241 (271)
                      |++.|+|||.+.   +..++.++||||||+++|+|++|..||......+..             ..+++.+.+++.+||.
T Consensus       212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  291 (348)
T 1u5q_A          212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ  291 (348)
T ss_dssp             SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred             CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            899999999985   567888999999999999999999999876543322             2368999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccCCCC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      .||.+|||++++++||||.+...+
T Consensus       292 ~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          292 KIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             SSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             cChhhCcCHHHHhhChhhhccCCc
Confidence            999999999999999999886544

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.9e-49  Score=338.06  Aligned_cols=245  Identities=24%  Similarity=0.439  Sum_probs=195.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------   91 (271)
                      .++|++++.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            37899999999999999999999999999999998654322 23456778999999999999999999998654      


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ...|+++|++ +++|.+++.. ..++...++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 5799998876 5799999999999999999999999999999999999999999999999999876665


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------  225 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------  225 (271)
                      ......+|+.|+|||.+.+ ..++.++||||||+++++|++|..||.+....+.+                         
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  264 (367)
T 2fst_X          185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  264 (367)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHH
T ss_pred             cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHH
Confidence            5566788999999999887 67889999999999999999999999876643221                         


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                       ...++++.+||.+||..||.+|||++++|+||||++...|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                             1246889999999999999999999999999999987554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-49  Score=335.70  Aligned_cols=248  Identities=30%  Similarity=0.537  Sum_probs=211.5

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh--HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE--KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      .++|++.+.||+|+||.||+|++..++..+++|++......  .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46799999999999999999999999999999999765432  2234578889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024158           96 LILEYAHRGELYRELRK----------------------------------------HRRFTEQQAATYIASLTNALAYC  135 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~----------------------------------------~~~l~~~~~~~i~~~l~~~l~~L  135 (271)
                      +|||++++++|.+++..                                        ...+++..++.++.|++.||.+|
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999999852                                        11236778889999999999999


Q ss_pred             HhCCceecCCCCCCeeeCCCC--CEEEeeecccccccC-------ccccccccccccCCccccC--CCCCccchhhhHHH
Q 024158          136 HENHVIHRDIKPENLLLDHEG--RLKIGDFGWSVQSRS-------KRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGI  204 (271)
Q Consensus       136 h~~~i~H~dl~~~Nili~~~~--~~~L~dfg~~~~~~~-------~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~  204 (271)
                      |++|++|+||+|+||+++.++  .++|+|||++.....       ......+++.|+|||.+.+  ..++.++||||||+
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  899999999854322       1234568999999999875  66888999999999


Q ss_pred             HHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          205 LCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       205 il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ++|+|++|..||.+....+..               ..+++++.++|.+||..||.+|||+.++++||||++....
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~  340 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK  340 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence            999999999999876654332               2368999999999999999999999999999999987654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-48  Score=324.98  Aligned_cols=249  Identities=27%  Similarity=0.452  Sum_probs=215.5

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..+-.++|++++.||+|+||.||++++..++..+++|++...........+.+.+|+.+++.++||||+++++++..++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            45556889999999999999999999999999999999866555555667788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      +|+|||++++++|.+++...+.+++..++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            9999999999999999998888999999999999999999999999999999999999999999999999998654322 


Q ss_pred             ---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------hcccCHHHH
Q 024158          173 ---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------FRSISAEAK  233 (271)
Q Consensus       173 ---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------~~~i~~~l~  233 (271)
                         .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+......                ...+|+.+.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence               2334689999999999999999999999999999999999999987664322                234789999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +++.+||.+||.+||+..+.+.+.|..-.
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            99999999999999966666666665443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.6e-50  Score=347.34  Aligned_cols=243  Identities=14%  Similarity=0.238  Sum_probs=204.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH---HHHhhCCCCceecee-------eE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM---EIQSSLRHPNILRLY-------GW   87 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~---~~l~~~~~~~i~~~~-------~~   87 (271)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...........+.+.+|+   +.++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            57899999999999999999999999999999999755443334457788898   556666899999988       66


Q ss_pred             EEeCC-----------------eEEEEEeccCCCchHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q 024158           88 FHDDE-----------------RIFLILEYAHRGELYRELRKHRRFTE-------QQAATYIASLTNALAYCHENHVIHR  143 (271)
Q Consensus        88 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~l~~-------~~~~~i~~~l~~~l~~Lh~~~i~H~  143 (271)
                      +...+                 ..|++||+++ ++|.+++...+.++.       ..++.++.||+.||.|||++||+|+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            66553                 2899999994 799999986444444       8888899999999999999999999


Q ss_pred             CCCCCCeeeCCCCCEEEeeecccccccCccccccccccccCCccccCC-----------CCCccchhhhHHHHHHHHHhC
Q 024158          144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK-----------EHDYAVDNWTLGILCYEFLYG  212 (271)
Q Consensus       144 dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~-----------~~~~~~Di~slg~il~~l~~g  212 (271)
                      ||||+||+++.++.++|+|||++...........| +.|+|||.+.+.           .++.++||||||+++|+|++|
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg  309 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA  309 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHC
Confidence            99999999999999999999999876665566677 999999999887           789999999999999999999


Q ss_pred             CCCCCCCCcchhh-------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          213 APPFEAESQKDTF-------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       213 ~~p~~~~~~~~~~-------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ..||.........       ..+++++.+++.+||..||.+|||+.++++||||++.
T Consensus       310 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          310 DLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             SCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             CCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            9999876544332       3578999999999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.1e-49  Score=325.50  Aligned_cols=244  Identities=33%  Similarity=0.620  Sum_probs=214.1

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++|++.+.||+|+||.||+|++..+++.+++|++........   ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            579999999999999999999999999999999866533211   12457889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~~~~  171 (271)
                      +++|++++++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++.++    .++|+|||.+.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998878899999999999999999999999999999999999998877    899999999855433


Q ss_pred             --ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHH
Q 024158          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKH  234 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~  234 (271)
                        ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+.               ...+++.+.+
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKD  244 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred             CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHH
Confidence              22344689999999999988999999999999999999999999987654433               2346889999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++.+||..||.+|||++++++||||+..
T Consensus       245 li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          245 FIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999875

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.3e-49  Score=327.12  Aligned_cols=244  Identities=34%  Similarity=0.609  Sum_probs=214.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      -.++|++.+.||+|+||.||+|++..+|+.+++|++......   ....+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            346899999999999999999999999999999999654322   23567889999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeecccccccCc-
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      ++|++++++|.+++...+.+++..++.++.|++.||.+||++|++|+||+|+||++   +.++.++|+|||++...... 
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  163 (304)
T 2jam_A           84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI  163 (304)
T ss_dssp             EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred             EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence            99999999999999887889999999999999999999999999999999999999   67889999999988544332 


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.               ...+++++.+++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            2344689999999999998999999999999999999999999987654332               2346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||..||.+|||++++++||||+...
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHcCCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.2e-49  Score=330.19  Aligned_cols=242  Identities=21%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      +++|++++.||+|+||.||+|++..+|+.||+|++......  ...+.+.+|+.++++++||||+++++++.+..     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            46899999999999999999999999999999999654422  23567889999999999999999999885543     


Q ss_pred             ----------------------------------------------------eEEEEEeccCCCchHHHHHhCCC---CC
Q 024158           93 ----------------------------------------------------RIFLILEYAHRGELYRELRKHRR---FT  117 (271)
Q Consensus        93 ----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---l~  117 (271)
                                                                          ..+++||++++++|.+++.....   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999987543   46


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---------------cccccccccc
Q 024158          118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---------------RHTMCGTLDY  182 (271)
Q Consensus       118 ~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---------------~~~~~~~~~y  182 (271)
                      ...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......               .....||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            6678999999999999999999999999999999999999999999998554332               2334689999


Q ss_pred             cCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCC----------cchhhcccCHHHHHHHHHhcccCccCCCCHHH
Q 024158          183 LAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAES----------QKDTFRSISAEAKHLISRLLVKDSSKRLSLQK  252 (271)
Q Consensus       183 ~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~----------~~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~  252 (271)
                      +|||.+.+..++.++|+||||+++|+|++|..|+....          ........++++.+++.+||.+||.+|||+++
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  322 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD  322 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence            99999999999999999999999999999877653211          11222345788999999999999999999999


Q ss_pred             HhcCCcccc
Q 024158          253 IMEHPWIIK  261 (271)
Q Consensus       253 il~~~~~~~  261 (271)
                      +++||||++
T Consensus       323 ~l~~~~f~~  331 (332)
T 3qd2_B          323 IIENAIFEN  331 (332)
T ss_dssp             HHHSTTCCC
T ss_pred             Hhhchhhhc
Confidence            999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-48  Score=339.86  Aligned_cols=248  Identities=27%  Similarity=0.459  Sum_probs=209.5

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD----   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~----   91 (271)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++|+||+++++++...    
T Consensus        23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            345789999999999999999999999999999999965432 334457788999999999999999999998766    


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                       +..|+|+|+++ ++|.+++.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~  180 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN  180 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence             56999999997 6999999988889999999999999999999999999999999999999999999999999985433


Q ss_pred             Cc-------------------------cccccccccccCCccc-cCCCCCccchhhhHHHHHHHHHhC-----------C
Q 024158          171 SK-------------------------RHTMCGTLDYLAPEMV-ENKEHDYAVDNWTLGILCYEFLYG-----------A  213 (271)
Q Consensus       171 ~~-------------------------~~~~~~~~~y~~pe~~-~~~~~~~~~Di~slg~il~~l~~g-----------~  213 (271)
                      ..                         .....+|+.|+|||.+ .+..++.++|||||||++|+|++|           .
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~  260 (432)
T 3n9x_A          181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF  260 (432)
T ss_dssp             ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred             ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence            21                         2445789999999986 556689999999999999999984           4


Q ss_pred             CCCCCCCc-----------------------------------------------------------chhhcccCHHHHH
Q 024158          214 PPFEAESQ-----------------------------------------------------------KDTFRSISAEAKH  234 (271)
Q Consensus       214 ~p~~~~~~-----------------------------------------------------------~~~~~~i~~~l~~  234 (271)
                      ++|.+...                                                           ......+++++.+
T Consensus       261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  340 (432)
T 3n9x_A          261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGIN  340 (432)
T ss_dssp             CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred             ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHH
Confidence            44444321                                                           0011346899999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ||.+||..||.+|||++++|+||||+....+
T Consensus       341 Ll~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          341 LLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            9999999999999999999999999987543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.3e-49  Score=329.05  Aligned_cols=243  Identities=34%  Similarity=0.623  Sum_probs=205.2

Q ss_pred             ccceeee-eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEE
Q 024158           18 LQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        18 ~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~   95 (271)
                      .++|++. +.||+|+||.||+|++..+++.+|+|++......   ....+.+|+.++.++ +||||+++++++..++.+|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3578986 7899999999999999999999999999654322   235677899999885 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC---EEEeeecccccccC-
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQSRS-  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~---~~L~dfg~~~~~~~-  171 (271)
                      +|||++++++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.   ++|+|||++..... 
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999988788999999999999999999999999999999999999988775   99999998754321 


Q ss_pred             ---------ccccccccccccCCccccC-----CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------
Q 024158          172 ---------KRHTMCGTLDYLAPEMVEN-----KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------  223 (271)
Q Consensus       172 ---------~~~~~~~~~~y~~pe~~~~-----~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------  223 (271)
                               ......|++.|+|||.+.+     ..++.++||||||+++|+|++|..||.+....+              
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                     1123458999999999875     457889999999999999999999998754221              


Q ss_pred             ----------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          224 ----------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       224 ----------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                      .+..+++++.+++.+||..||.+|||++++++||||++..
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence                            1234688999999999999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-48  Score=339.68  Aligned_cols=243  Identities=27%  Similarity=0.459  Sum_probs=209.7

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC------CCCceeceeeEEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL------RHPNILRLYGWFH   89 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~------~~~~i~~~~~~~~   89 (271)
                      ....+|++++.||+|+||.||+|++..+++.||+|++....    .....+.+|+++++.+      .|+||+.+++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            34567999999999999999999999999999999996543    2234555666666665      5779999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC--EEEeeecc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--LKIGDFGW  165 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~--~~L~dfg~  165 (271)
                      ..+..++++|+++ ++|.+++....  .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.  ++|+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999996 69999997754  4899999999999999999999999999999999999999887  99999999


Q ss_pred             cccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------------
Q 024158          166 SVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------------  226 (271)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------------  226 (271)
                      +...........+|+.|+|||.+.+..++.++||||||+++|+|++|.+||.+....+.+.                   
T Consensus       249 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~  328 (429)
T 3kvw_A          249 SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR  328 (429)
T ss_dssp             CEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred             ceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence            9777666667789999999999999999999999999999999999999998765432211                   


Q ss_pred             ---------------------------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          227 ---------------------------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       227 ---------------------------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                                                         ..++++.+||.+||..||.+|||++|+|+
T Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence                                                               12677899999999999999999999999


Q ss_pred             CCccccCC
Q 024158          256 HPWIIKNA  263 (271)
Q Consensus       256 ~~~~~~~~  263 (271)
                      ||||++..
T Consensus       409 Hpw~~~~~  416 (429)
T 3kvw_A          409 HPWLRRRL  416 (429)
T ss_dssp             STTTC---
T ss_pred             ChhhccCC
Confidence            99999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.2e-49  Score=348.55  Aligned_cols=242  Identities=35%  Similarity=0.660  Sum_probs=209.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||.||+|++..++..+|+|++.+..... .....+.+|+.+++.++||||+++++++...+.+|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46999999999999999999999999999999997654332 22456789999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---CCEEEeeecccccccC--cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRS--KR  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---~~~~L~dfg~~~~~~~--~~  173 (271)
                      ||+++++|.+.+.....+++..++.++.||+.||.|||++|++|+||||+||+++..   +.++|+|||++.....  ..
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~  195 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM  195 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCB
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccc
Confidence            999999999999887889999999999999999999999999999999999999764   4599999999855433  23


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHHH
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISR  238 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~~  238 (271)
                      ....||+.|+|||.+. ..++.++||||+|+++|+|++|..||.+....+.               +..+++++.++|.+
T Consensus       196 ~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  274 (494)
T 3lij_A          196 KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ  274 (494)
T ss_dssp             CCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHH
T ss_pred             cccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHH
Confidence            4457899999999885 5688999999999999999999999987765433               23478999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ||.+||.+|||++++|+||||++.
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.2e-48  Score=335.00  Aligned_cols=242  Identities=24%  Similarity=0.427  Sum_probs=208.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE----
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI----   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~----   94 (271)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            6899999999999999999999999999999999765433 24457788999999999999999999999876654    


Q ss_pred             --EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           95 --FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        95 --~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                        ++++|+++ ++|.+.+.  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  197 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  197 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC
Confidence              99999997 68888874  34899999999999999999999999999999999999999999999999999777666


Q ss_pred             cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------------------
Q 024158          173 RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------------------  225 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------------------  225 (271)
                      .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+..                          
T Consensus       198 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  277 (371)
T 4exu_A          198 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSY  277 (371)
T ss_dssp             --CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHH
T ss_pred             cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhh
Confidence            667788999999999987 67889999999999999999999999876533221                          


Q ss_pred             ----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 ----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                      ..+++++.+||.+||..||++|||++++|+||||+....
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          278 IQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                            235889999999999999999999999999999987644

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-49  Score=332.04  Aligned_cols=249  Identities=26%  Similarity=0.447  Sum_probs=215.4

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-   92 (271)
                      ...-.++|++.+.||+|+||.||+|++..+++.+++|++.............+.+|+.+++.++||||+++++++.... 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            3445678999999999999999999999999999999998766555566778899999999999999999999987644 


Q ss_pred             ---eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           93 ---RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        93 ---~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                         ..|+||||+++++|.+++...+.+++..++.++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence               35999999999999999988788999999999999999999999999999999999999999999999999998543


Q ss_pred             cCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------ccc
Q 024158          170 RSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSI  228 (271)
Q Consensus       170 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i  228 (271)
                      ...      .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..               ..+
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            322      22345899999999999999999999999999999999999999877654332               237


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++++.+++.+||..||.+||+..+++.|+|++..
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            8999999999999999999999999999999753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-48  Score=335.06  Aligned_cols=242  Identities=24%  Similarity=0.423  Sum_probs=202.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----   92 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----   92 (271)
                      ..++|++++.||+|+||.||+|++..+++.+|+|++...... ......+.+|+.+++.++||||+++++++...+    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            467899999999999999999999999999999999654333 234567889999999999999999999987654    


Q ss_pred             --eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 --RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 --~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                        ..|+|||+++ ++|.+.+.  ..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              7899999997 58888886  358999999999999999999999999999999999999999999999999986544


Q ss_pred             Cc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc---------------------
Q 024158          171 SK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS---------------------  227 (271)
Q Consensus       171 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~---------------------  227 (271)
                      ..  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.+....+.+..                     
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  258 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR  258 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence            32  2345789999999999999999999999999999999999999987654322111                     


Q ss_pred             --------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 --------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 --------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                      .++++.+||.+||..||.+|||++++|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          259 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                                            14678999999999999999999999999999864

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-48  Score=339.05  Aligned_cols=244  Identities=33%  Similarity=0.627  Sum_probs=204.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .++|++.+.||+|+||.||+|.+..+++.+|+|++.+....     .......+.+|+.++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            46899999999999999999999999999999999765432     11223457889999999999999999999754 5


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---CEEEeeecccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---RLKIGDFGWSVQS  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---~~~L~dfg~~~~~  169 (271)
                      ..++|||++++++|.+++...+.+++..++.++.|++.||.|||++|++|+||||+||+++.++   .++|+|||++...
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888899999999999999999999999999999999999997654   5999999998654


Q ss_pred             cCc--cccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------hhhccc
Q 024158          170 RSK--RHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------DTFRSI  228 (271)
Q Consensus       170 ~~~--~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------~~~~~i  228 (271)
                      ...  .....||+.|+|||.+.+   ..++.++|+||||+++|+|++|..||......                ..+..+
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  372 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  372 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhccc
Confidence            432  234578999999999864   56778999999999999999999999764432                222457


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++++.+++.+||..||.+|||++++++||||+..
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            8999999999999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.2e-48  Score=320.52  Aligned_cols=244  Identities=21%  Similarity=0.338  Sum_probs=206.6

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~l   96 (271)
                      .++|++.+.||+|+||.||+|++..+++.+++|++........ ....+.+|+..+..+ +||||+++++++..++..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4689999999999999999999999999999999876533332 245667888888888 89999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-----------------
Q 024158           97 ILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----------------  155 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-----------------  155 (271)
                      |+|++++++|.+++...    ..+++..++.++.||+.||.+||++|++|+||+|+||+++.+                 
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999999999764    568999999999999999999999999999999999999844                 


Q ss_pred             --CCEEEeeecccccccCccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------
Q 024158          156 --GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------  224 (271)
Q Consensus       156 --~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------  224 (271)
                        ..++|+|||.+...... ....+++.|+|||.+.+. .++.++||||||+++++|++|.+++........        
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP-QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPR  247 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS-CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCCC
T ss_pred             CceEEEEcccccccccCCc-cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCCC
Confidence              47999999988655443 334689999999999876 566799999999999999999887754432221        


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                       ...+++++.+++.+||..||.+|||+.++++||||+...
T Consensus       248 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          248 IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             234689999999999999999999999999999999754

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.6e-49  Score=332.76  Aligned_cols=239  Identities=32%  Similarity=0.594  Sum_probs=207.5

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~   95 (271)
                      -.++|++.+.||+|+||.||+|+++.+++.+|+|++.+....       ..+|+.++.++ +||||+++++++.+++..|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            356799999999999999999999999999999999765432       23466666666 7999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-C---CEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-G---RLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~---~~~L~dfg~~~~~~~  171 (271)
                      +|||++++++|.+.+...+.+++..+..++.||+.||.|||++|++|+||||+||++... +   .++|+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999999999888889999999999999999999999999999999999998543 3   599999999865432


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc---ch---------------hhcccCH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ---KD---------------TFRSISA  230 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~---~~---------------~~~~i~~  230 (271)
                         ......+|+.|+|||.+.+..++.++|+||||+++|+|++|..||.....   .+               .+..+++
T Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  252 (342)
T 2qr7_A          173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD  252 (342)
T ss_dssp             TTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCH
T ss_pred             CCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCH
Confidence               23445789999999999888888999999999999999999999986321   11               1245789


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++.++|.+||..||++|||++++++||||++.
T Consensus       253 ~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            99999999999999999999999999999753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=330.85  Aligned_cols=248  Identities=24%  Similarity=0.472  Sum_probs=208.8

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC--CceeceeeEEEeC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDD   91 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~   91 (271)
                      ..+..++|++++.||+|+||.||++.+ .++..+|+|++....... .....+.+|+.+++.++|  +||+++++++..+
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~   81 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD   81 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch-HHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence            356778899999999999999999997 568899999987654333 445778899999999986  9999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      +..++|||+. +++|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++.....
T Consensus        82 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           82 QYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             CEEEEEEeCC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            9999999954 689999999988899999999999999999999999999999999999996 67899999999865433


Q ss_pred             c-----cccccccccccCCccccC-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------
Q 024158          172 K-----RHTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------  223 (271)
Q Consensus       172 ~-----~~~~~~~~~y~~pe~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------  223 (271)
                      .     .....||+.|+|||.+.+           ..++.++||||||+++|+|++|..||.......            
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  239 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  239 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc
Confidence            2     234568999999999864           667889999999999999999999997643221            


Q ss_pred             --hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          224 --TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       224 --~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                        .....++++.+++.+||..||.+|||+.++++||||+....|
T Consensus       240 ~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          240 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence              112246889999999999999999999999999999876544

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.7e-48  Score=330.45  Aligned_cols=242  Identities=24%  Similarity=0.440  Sum_probs=210.3

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----Ce
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----ER   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~   93 (271)
                      ++|++++.||+|+||.||+|++..++..|++|++....  .......+.+|+++++.++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            58999999999999999999999999999999986533  223456788999999999999999999998654     36


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      .|+++|+++ ++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... 
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            899999997 599999976 56999999999999999999999999999999999999999999999999998544322 


Q ss_pred             -----cccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------
Q 024158          173 -----RHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------  225 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------  225 (271)
                           .....+|+.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+..                     
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence                 2334789999999987654 4889999999999999999999999876644332                     


Q ss_pred             ---------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 ---------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ---------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                           ..+++++.+|+.+||.+||.+|||++++|+||||++.-.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence                                 235789999999999999999999999999999998643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-48  Score=331.42  Aligned_cols=250  Identities=26%  Similarity=0.432  Sum_probs=206.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH--HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ...++|++.+.||+|+||.||+|++..+|+.+++|++........  .....+.+|+.+++.++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            456889999999999999999999999999999999965433221  223467789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .++|+|++++ +|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999999985 898888764 3689999999999999999999999999999999999999999999999999865432 


Q ss_pred             --ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------
Q 024158          172 --KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------  225 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------  225 (271)
                        ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.+....+..                       
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence              23345689999999998764 4788999999999999999999999876543221                       


Q ss_pred             ----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          226 ----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       226 ----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                      ..+++++.++|.+||..||.+|||++|+++||||++.+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                            33468999999999999999999999999999999875543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.8e-48  Score=334.09  Aligned_cols=242  Identities=31%  Similarity=0.610  Sum_probs=202.6

Q ss_pred             Cccccceeee-eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH-hhCCCCceeceeeEEEe--
Q 024158           15 EWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHD--   90 (271)
Q Consensus        15 ~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~--   90 (271)
                      ....++|.+. +.||+|+||.||++++..+++.||+|++...        ..+.+|+.++ +..+|+||+++++++..  
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3456788887 6899999999999999999999999998532        2345566665 55689999999999875  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeee
Q 024158           91 --DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDF  163 (271)
Q Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~df  163 (271)
                        .+.+|+||||+++++|.+++....  .+++..++.++.||+.||.|||+.||+|+||||+||+++.   ++.++|+||
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence              567899999999999999998743  5899999999999999999999999999999999999987   788999999


Q ss_pred             cccccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------------
Q 024158          164 GWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------------  223 (271)
Q Consensus       164 g~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------------  223 (271)
                      |++......  .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.......                  
T Consensus       209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             TTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            998654432  244578999999999999999999999999999999999999997654321                  


Q ss_pred             -hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          224 -TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       224 -~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                       .+..+++++.+||.+||..||.+|||++++++||||.+...
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence             12357899999999999999999999999999999987644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.1e-48  Score=333.40  Aligned_cols=238  Identities=31%  Similarity=0.598  Sum_probs=205.0

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEecc
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~  101 (271)
                      ...+.||+|+||.||+|++..+|..+++|++......   ..+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3367899999999999999999999999999764432   3467889999999999999999999999999999999999


Q ss_pred             CCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee--CCCCCEEEeeecccccccCc--cccc
Q 024158          102 HRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFGWSVQSRSK--RHTM  176 (271)
Q Consensus       102 ~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili--~~~~~~~L~dfg~~~~~~~~--~~~~  176 (271)
                      ++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++  +.++.++|+|||++......  ....
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~  248 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN  248 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence            999999988654 468999999999999999999999999999999999999  56678999999998654332  3345


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHHHHHhcc
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHLISRLLV  241 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~li~~~l~  241 (271)
                      .|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.               +..+++++.+||.+||.
T Consensus       249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~  328 (373)
T 2x4f_A          249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLI  328 (373)
T ss_dssp             CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSC
T ss_pred             cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcC
Confidence            689999999999988899999999999999999999999987665433               23478999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||.+|||++++++||||+..
T Consensus       329 ~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          329 KEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             SSGGGSCCHHHHHHSHHHHCH
T ss_pred             CChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.4e-48  Score=322.21  Aligned_cols=253  Identities=29%  Similarity=0.483  Sum_probs=213.0

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      +.........++|++++.||+|+||.||+|++..++..+++|++......   ....+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~   85 (302)
T 2j7t_A            9 EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYIVEIEILATCDHPYIVKLLGAY   85 (302)
T ss_dssp             -CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---HHHHHHHHHHHHhcCCCCCEeeeeeee
Confidence            33444455667899999999999999999999999999999998654332   245778899999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ..++..++++|++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  165 (302)
T 2j7t_A           86 YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA  165 (302)
T ss_dssp             ECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred             eeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence            999999999999999999998876 4679999999999999999999999999999999999999999999999999863


Q ss_pred             ccc---CccccccccccccCCccc-----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------h
Q 024158          168 QSR---SKRHTMCGTLDYLAPEMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------F  225 (271)
Q Consensus       168 ~~~---~~~~~~~~~~~y~~pe~~-----~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~  225 (271)
                      ...   .......+++.|+|||.+     .+..++.++|+||||+++|+|++|..||........              .
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  245 (302)
T 2j7t_A          166 KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTP  245 (302)
T ss_dssp             HHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred             cccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCc
Confidence            321   222345689999999988     366788899999999999999999999987654332              2


Q ss_pred             cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ..++.++.+++.+||..||.+|||++++++||||+....
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            346889999999999999999999999999999997653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.1e-48  Score=322.28  Aligned_cols=250  Identities=26%  Similarity=0.370  Sum_probs=202.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .++..++|++++.||+|+||.||+|++..+++.+|+|++....... .....+.++...++.++||||+++++++..++.
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~   80 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGD   80 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence            3577899999999999999999999999999999999996653332 334455566667888999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           94 IFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .++|+|+++ ++|.+++..    ...+++..++.++.|++.|+.+||++ |++|+||+|+||+++.++.++|+|||++..
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999999997 588777653    46799999999999999999999998 999999999999999999999999999854


Q ss_pred             ccCc--cccccccccccCCccc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hh-------------hccc
Q 024158          169 SRSK--RHTMCGTLDYLAPEMV----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT-------------FRSI  228 (271)
Q Consensus       169 ~~~~--~~~~~~~~~y~~pe~~----~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~-------------~~~i  228 (271)
                      ....  .....+++.|+|||.+    .+..++.++|+||||+++++|++|..||...... ..             ...+
T Consensus       160 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             ccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            4332  2334689999999996    4566888999999999999999999999753321 11             1246


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ++++.+++.+||..||.+|||++++++||||+.....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~  276 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK  276 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence            8999999999999999999999999999999865433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1e-48  Score=325.98  Aligned_cols=252  Identities=28%  Similarity=0.464  Sum_probs=192.5

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ..+..+..++|++.+.||+|++|.||++++..+++.+++|++......  .....+.+|+.+++.++||||+++++++..
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   84 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVV   84 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEES
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEee
Confidence            345677889999999999999999999999899999999998654322  235677889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEee
Q 024158           91 DERIFLILEYAHRGELYRELRK--------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~--------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                      .+..++++|++++++|.+++..        ...++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            9999999999999999999974        34589999999999999999999999999999999999999999999999


Q ss_pred             ecccccccCc--------cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------
Q 024158          163 FGWSVQSRSK--------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------  224 (271)
Q Consensus       163 fg~~~~~~~~--------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------  224 (271)
                      ||.+......        .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........         
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  244 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP  244 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSC
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCC
Confidence            9987443221        233468899999999875 5688899999999999999999999976543221         


Q ss_pred             ------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                  ...+++++.+++.+||..||.+|||++++++||||++...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence                        2346789999999999999999999999999999998654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-48  Score=321.72  Aligned_cols=246  Identities=30%  Similarity=0.502  Sum_probs=217.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      -..|++++.||+|+||.||+|++..+++.+++|++.......  ..+.+.+|+.+++.++|+||+++++++..++..+++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            456999999999999999999999999999999996654332  256788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~  174 (271)
                      +|++++++|.+++.. ..++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....   ...
T Consensus        99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            999999999999975 5689999999999999999999999999999999999999999999999999854433   233


Q ss_pred             cccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------hcccCHHHHHHHHHhccc
Q 024158          175 TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------FRSISAEAKHLISRLLVK  242 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------~~~i~~~l~~li~~~l~~  242 (271)
                      ...+++.|+|||.+.+..++.++|+||||+++++|++|..||........            ...++..+.+++.+||..
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCS
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCC
Confidence            45689999999999999999999999999999999999999987654332            234689999999999999


Q ss_pred             CccCCCCHHHHhcCCccccCCCCC
Q 024158          243 DSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       243 ~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      ||.+|||++++++||||.+.....
T Consensus       258 dp~~Rps~~~ll~~~~~~~~~~~~  281 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFILRNAKKT  281 (303)
T ss_dssp             SGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred             ChhhCcCHHHHhhChhhhcCCCcc
Confidence            999999999999999998775543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.8e-48  Score=326.05  Aligned_cols=247  Identities=23%  Similarity=0.421  Sum_probs=212.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEE-ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC------ceecee
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVRE-VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP------NILRLY   85 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~------~i~~~~   85 (271)
                      ...+-.++|++.+.||+|+||.||+|.+ ..+++.+++|++....    .....+.+|+.+++.++|+      ++++++
T Consensus         8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~   83 (339)
T 1z57_A            8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQML   83 (339)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred             cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence            4455668999999999999999999998 5578999999986432    2345667788888777654      599999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---------
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---------  154 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---------  154 (271)
                      +++...+..++|||++ +++|.+++....  .++...++.++.||+.||.|||++|++|+||+|+||+++.         
T Consensus        84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence            9999999999999999 689999998754  6899999999999999999999999999999999999987         


Q ss_pred             ----------CCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh
Q 024158          155 ----------EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (271)
Q Consensus       155 ----------~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  224 (271)
                                ++.++|+|||++...........+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                      6689999999997766666677889999999999999999999999999999999999999987654332


Q ss_pred             hcc-------------------------------------------------------cCHHHHHHHHHhcccCccCCCC
Q 024158          225 FRS-------------------------------------------------------ISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       225 ~~~-------------------------------------------------------i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      ...                                                       .++++.+++.+||..||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            211                                                       1467889999999999999999


Q ss_pred             HHHHhcCCccccCCC
Q 024158          250 LQKIMEHPWIIKNAN  264 (271)
Q Consensus       250 ~~~il~~~~~~~~~~  264 (271)
                      ++++++||||+....
T Consensus       323 ~~ell~hp~f~~~~~  337 (339)
T 1z57_A          323 LREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHTTSGGGGGGGC
T ss_pred             HHHHhcCHHHHHHhc
Confidence            999999999987543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-48  Score=335.16  Aligned_cols=243  Identities=21%  Similarity=0.255  Sum_probs=196.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHH---HHHHhhCCCCceecee-------eE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE---MEIQSSLRHPNILRLY-------GW   87 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e---~~~l~~~~~~~i~~~~-------~~   87 (271)
                      ..+|++.+.||+|+||.||+|++..+++.+|+|++.............+++|   ++.++. +|||+++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            4459999999999999999999999999999999987665455556677777   455555 799977744       45


Q ss_pred             EEeC-----------------CeEEEEEeccCCCchHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCceec
Q 024158           88 FHDD-----------------ERIFLILEYAHRGELYRELRKH-RRFTEQQA------ATYIASLTNALAYCHENHVIHR  143 (271)
Q Consensus        88 ~~~~-----------------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~------~~i~~~l~~~l~~Lh~~~i~H~  143 (271)
                      +...                 ..+|+||||++ ++|.+++... ..++...+      +.++.||+.||.|||++||+|+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr  218 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG  218 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence            5433                 34899999998 7999999863 34455555      6778999999999999999999


Q ss_pred             CCCCCCeeeCCCCCEEEeeecccccccCccccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCc
Q 024158          144 DIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPFEAESQ  221 (271)
Q Consensus       144 dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~~~~~~  221 (271)
                      ||||+||+++.++.++|+|||++...........+++.|+|||.+.+  ..++.++||||||+++|+|++|..||....+
T Consensus       219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~  298 (371)
T 3q60_A          219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP  298 (371)
T ss_dssp             TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred             cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence            99999999999999999999999776655545667799999999987  6789999999999999999999999987632


Q ss_pred             ch--------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          222 KD--------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       222 ~~--------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ..                    ....+++++.+++.+||..||++|||++++++||||++.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          299 GIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             ccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            21                    112468999999999999999999999999999999875

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.7e-48  Score=324.60  Aligned_cols=244  Identities=33%  Similarity=0.635  Sum_probs=207.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----HHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .++|++.+.||+|+||.||+|++..+++.|++|++......     .......+.+|+.+++.++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            36899999999999999999999999999999998655321     1122345788999999999999999999987655


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC---EEEeeecccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIGDFGWSVQS  169 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~---~~L~dfg~~~~~  169 (271)
                       .|+|+|++++++|.+++.....++...++.++.||+.||.+||++|++|+||+|+||+++.++.   ++|+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999988888999999999999999999999999999999999999987664   999999998654


Q ss_pred             cCcc--ccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------hhhccc
Q 024158          170 RSKR--HTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------DTFRSI  228 (271)
Q Consensus       170 ~~~~--~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------~~~~~i  228 (271)
                      ....  ....+++.|+|||.+.   ...++.++|+||||+++|+|++|..||......                ..+..+
T Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (322)
T 2ycf_A          168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV  247 (322)
T ss_dssp             CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTS
T ss_pred             ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhc
Confidence            4332  2346899999999874   456788999999999999999999999765432                112346


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ++++.+++.+||..||.+|||++++++||||+..
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            8999999999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=320.07  Aligned_cols=246  Identities=28%  Similarity=0.500  Sum_probs=210.0

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .....++|++.+.||+|+||.||+|++..+|+.+++|.+.....     ...+.+|+.+++.++||||+++++++..++.
T Consensus        24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   98 (314)
T 3com_A           24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD   98 (314)
T ss_dssp             ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            34456789999999999999999999999999999999865432     3457789999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .++++|++++++|.+++.. ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A           99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999999999999973 56799999999999999999999999999999999999999999999999999854432 


Q ss_pred             --ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHH
Q 024158          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHL  235 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~l  235 (271)
                        ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........              ...+++++.++
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  258 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDF  258 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHH
Confidence              23345688999999999998999999999999999999999999987654322              22368999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +.+||..||.+|||++++++||||+....
T Consensus       259 i~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          259 VKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            99999999999999999999999997653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=4.1e-48  Score=326.19  Aligned_cols=245  Identities=29%  Similarity=0.507  Sum_probs=211.0

Q ss_pred             cceeee-eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEE
Q 024158           19 QDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        19 ~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l   96 (271)
                      ++|.+. +.||+|+||.||+|++..+++.+|+|++....... .....+.+|+.+++.+. ||||+++++++...+..++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            457777 88999999999999999999999999987654332 22356778999999985 6999999999999999999


Q ss_pred             EEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeeecccccccC
Q 024158           97 ILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~dfg~~~~~~~  171 (271)
                      |+|++.+++|.+++...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.   ++.++|+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998653  57899999999999999999999999999999999999987   78999999999865443


Q ss_pred             c--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHH
Q 024158          172 K--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKH  234 (271)
Q Consensus       172 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~  234 (271)
                      .  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+.               ...+++.+.+
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD  266 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHH
Confidence            2  2345789999999999999999999999999999999999999987664433               2346899999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ++.+||..||.+|||++++++||||++...
T Consensus       267 li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          267 FIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             HHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            999999999999999999999999987643

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-48  Score=329.91  Aligned_cols=250  Identities=27%  Similarity=0.511  Sum_probs=216.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHH--------------HHHHHHHHHHHHhhCC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--------------IQHQLRREMEIQSSLR   77 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~--------------~~~~~~~e~~~l~~~~   77 (271)
                      ....+..++|++.+.||+|+||.||+|++  +++.|++|++.........              ....+.+|+.+++.++
T Consensus        24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            44556778999999999999999999998  8999999999765443211              1167889999999999


Q ss_pred             CCceeceeeEEEeCCeEEEEEeccCCCchHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCC
Q 024158           78 HPNILRLYGWFHDDERIFLILEYAHRGELYRE------LRK--HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPE  148 (271)
Q Consensus        78 ~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~  148 (271)
                      ||||+++++++..++..++|||++++++|.++      +..  ...+++..++.++.|++.||.+||+ .|++|+||+|+
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~  181 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS  181 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence            99999999999999999999999999999998      655  5679999999999999999999999 99999999999


Q ss_pred             CeeeCCCCCEEEeeeccccccc-CccccccccccccCCccccCC-CCCc-cchhhhHHHHHHHHHhCCCCCCCCCc-chh
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENK-EHDY-AVDNWTLGILCYEFLYGAPPFEAESQ-KDT  224 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~-~~~~~~~~~~~y~~pe~~~~~-~~~~-~~Di~slg~il~~l~~g~~p~~~~~~-~~~  224 (271)
                      ||+++.++.++|+|||.+.... .......+++.|+|||.+.+. .++. ++|+||||+++++|++|..||..... .+.
T Consensus       182 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          182 NILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             GEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             hEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            9999999999999999986533 234456789999999999887 5666 99999999999999999999987654 111


Q ss_pred             h------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 F------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 ~------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .                              ..+++++.+++.+||..||.+|||++++++||||+...
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            1                              34789999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-47  Score=318.57  Aligned_cols=239  Identities=24%  Similarity=0.396  Sum_probs=210.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ..+..++|++.+.||+|+||.||++.+..+++.+++|.+....   ....+.+.+|+.+++.++||||+++++++..++.
T Consensus         5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            4567899999999999999999999999999999999885432   2345778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .++|+|++++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            9999999999999999987 467999999999999999999999999999999999999999999999999998543322


Q ss_pred             c-----------------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------
Q 024158          173 R-----------------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------  224 (271)
Q Consensus       173 ~-----------------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------  224 (271)
                      .                 ....||+.|+|||.+.+..++.++||||||+++|+|++|..|+........           
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence            1                 134689999999999999999999999999999999999999876443322           


Q ss_pred             ---hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ---FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ---~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                         ...+++++.+++.+||..||.+|||++++++
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               1346788999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.6e-48  Score=322.10  Aligned_cols=251  Identities=26%  Similarity=0.472  Sum_probs=208.3

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ......+..++|++.+.||+|+||.||+|++  ++..+++|++....... ...+.+.+|+.++++++||||+++++++.
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            3445677889999999999999999999985  68889999987654433 34567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCEEEeeec
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRR---FTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFG  164 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~~L~dfg  164 (271)
                      ..+..++|+|++++++|.+++.....   +++..++.++.|++.||.+||++|  ++|+||||+||+++.++.++|+|||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg  184 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG  184 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence            99999999999999999999987543   899999999999999999999999  9999999999999999999999999


Q ss_pred             ccccccCc---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------ccc
Q 024158          165 WSVQSRSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSI  228 (271)
Q Consensus       165 ~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i  228 (271)
                      ++......   .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+..             ..+
T Consensus       185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 3p86_A          185 LSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL  264 (309)
T ss_dssp             -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             CCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            98543332   33457899999999999999999999999999999999999999877654432             246


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhc--CCccccCC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIME--HPWIIKNA  263 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~  263 (271)
                      ++++.+++.+||..+|.+|||++++++  .++++...
T Consensus       265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            899999999999999999999999998  56666543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-47  Score=322.32  Aligned_cols=240  Identities=27%  Similarity=0.528  Sum_probs=207.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEe--CC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD--DE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~   92 (271)
                      ...++|++.+.||+|+||.||+|++..+++.+++|++....      ...+.+|+.+++.++ |+||+++++++..  ..
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            34678999999999999999999999999999999986432      245778999999997 9999999999987  66


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeeccccccc-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR-  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~-  170 (271)
                      ..++++|++++++|.+++..   ++...++.++.||+.||.+||++|++|+||||+||+++.++ .++|+|||++.... 
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            79999999999999998854   88999999999999999999999999999999999999776 89999999985433 


Q ss_pred             -CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hh-----------------------
Q 024158          171 -SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT-----------------------  224 (271)
Q Consensus       171 -~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~-----------------------  224 (271)
                       .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...... +.                       
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccc
Confidence             23345578899999999987 66889999999999999999999998433211 00                       


Q ss_pred             -------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 -------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 -------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                               ...+++++.+||.+||.+||.+|||++++|+||||+....
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                     1116899999999999999999999999999999997653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=9.1e-48  Score=331.38  Aligned_cols=247  Identities=23%  Similarity=0.473  Sum_probs=207.6

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC--CCceeceeeEEEeCC
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPNILRLYGWFHDDE   92 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~   92 (271)
                      .+...+|++.+.||+|+||.||++.+.. +..+|||++....... .....+.+|+.+++.++  |+||+++++++..++
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~  129 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  129 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccH-HHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence            3445679999999999999999999754 8899999997654332 44677899999999997  499999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+|+|||+ .+++|.+++.....+++..++.++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++......
T Consensus       130 ~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          130 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             EEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             EEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            99999995 5689999999888899999999999999999999999999999999999995 589999999998654322


Q ss_pred             -----cccccccccccCCccccC-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hh-----------
Q 024158          173 -----RHTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DT-----------  224 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~-----------  224 (271)
                           .....||+.|+|||.+.+           ..++.++||||||+++|+|++|..||...... ..           
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~  287 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI  287 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC
Confidence                 234578999999999865           35788999999999999999999999865322 11           


Q ss_pred             --hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 --FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 --~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                        ....+.++.+++.+||..||.+|||+.++++||||+....+
T Consensus       288 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence              11236889999999999999999999999999999876544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9e-48  Score=330.83  Aligned_cols=239  Identities=28%  Similarity=0.475  Sum_probs=202.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-----
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-----   90 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   90 (271)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++..+...       ..+|+.+++.++|+||+++++++..     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            4567899999999999999999999999999999998554222       2368999999999999999999843     


Q ss_pred             ---------------------------------CCeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHH
Q 024158           91 ---------------------------------DERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALA  133 (271)
Q Consensus        91 ---------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~  133 (271)
                                                       +.+.++||||++ ++|.+.+.    ....+++..++.++.||+.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             345899999998 57766664    3567999999999999999999


Q ss_pred             HHHhCCceecCCCCCCeeeC-CCCCEEEeeeccccccc--CccccccccccccCCccccCCC-CCccchhhhHHHHHHHH
Q 024158          134 YCHENHVIHRDIKPENLLLD-HEGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEF  209 (271)
Q Consensus       134 ~Lh~~~i~H~dl~~~Nili~-~~~~~~L~dfg~~~~~~--~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l  209 (271)
                      |||++|++|+||||+||+++ .++.++|+|||++....  .......+++.|+|||.+.+.. ++.++|+||+|+++|+|
T Consensus       156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            99999999999999999997 67899999999986433  3334567899999999987754 89999999999999999


Q ss_pred             HhCCCCCCCCCcchhhc----------------------------------------ccCHHHHHHHHHhcccCccCCCC
Q 024158          210 LYGAPPFEAESQKDTFR----------------------------------------SISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       210 ~~g~~p~~~~~~~~~~~----------------------------------------~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      ++|..||.+....+.+.                                        .+++++.+|+.+||..||.+|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            99999998776443321                                        25788999999999999999999


Q ss_pred             HHHHhcCCccccC
Q 024158          250 LQKIMEHPWIIKN  262 (271)
Q Consensus       250 ~~~il~~~~~~~~  262 (271)
                      +.|+++||||+..
T Consensus       316 ~~e~l~hp~f~~~  328 (383)
T 3eb0_A          316 PYEAMAHPFFDHL  328 (383)
T ss_dssp             HHHHHTSGGGHHH
T ss_pred             HHHHhcCHHHHHH
Confidence            9999999999753

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.3e-48  Score=327.59  Aligned_cols=244  Identities=25%  Similarity=0.437  Sum_probs=208.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER----   93 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~----   93 (271)
                      .++|.+.+.||+|+||.||+|++..+|+.+++|++...... ......+.+|+.+++.++||||+++++++...+.    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            36899999999999999999999999999999999664433 3445678899999999999999999999977653    


Q ss_pred             --EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           94 --IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        94 --~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                        +|+++|+++ ++|.+++..  .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999997 688887743  589999999999999999999999999999999999999999999999999876665


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------------  224 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------------------  224 (271)
                      ......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||.+....+.                          
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence            5566678999999999877 6788899999999999999999999987553221                          


Q ss_pred             ----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 ----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 ----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                      ...+++++.+++.+||..||.+|||++++++||||+....+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence                            12458899999999999999999999999999999976543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.8e-48  Score=318.49  Aligned_cols=249  Identities=30%  Similarity=0.522  Sum_probs=214.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--CCe
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DER   93 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~   93 (271)
                      -..++|++++.||+|+||.||++++..+++.+++|.+....... ...+.+.+|+.+++.++||||+++++++..  ++.
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT   81 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence            35789999999999999999999999999999999997654433 345778899999999999999999998754  568


Q ss_pred             EEEEEeccCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCeeeCCCCCEEEeeec
Q 024158           94 IFLILEYAHRGELYRELRKH----RRFTEQQAATYIASLTNALAYCHENH-----VIHRDIKPENLLLDHEGRLKIGDFG  164 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~~l~~~l~~Lh~~~-----i~H~dl~~~Nili~~~~~~~L~dfg  164 (271)
                      .++++|++++++|.+++...    ..+++..++.++.|++.||.+||+.|     ++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999989999999753    34899999999999999999999999     9999999999999999999999999


Q ss_pred             ccccccCcc---ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccC
Q 024158          165 WSVQSRSKR---HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSIS  229 (271)
Q Consensus       165 ~~~~~~~~~---~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~  229 (271)
                      .+.......   ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||......+..            ..++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  241 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS  241 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTTSC
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcccC
Confidence            885543322   2346789999999999988999999999999999999999999877654332            2368


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +++.+++.+||..||.+|||++++++|+|+.....+
T Consensus       242 ~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          242 DELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            999999999999999999999999999999876544

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.1e-48  Score=318.93  Aligned_cols=247  Identities=34%  Similarity=0.620  Sum_probs=214.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      .-.++|++++.||+|++|.||+|++..+++.+++|++....... .....+.+|+.++++++||||+++++++...+..+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            33578999999999999999999999999999999996654332 22457788999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---CCEEEeeecccccccCc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---~~~~L~dfg~~~~~~~~  172 (271)
                      +++|++++++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++.+   +.++|+|||++......
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            999999999999999877789999999999999999999999999999999999999764   46999999988554332


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hcccCHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FRSISAEAKHL  235 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~~i~~~l~~l  235 (271)
                        .....+++.|+|||.+.+ .++.++|+||||+++++|++|..||......+.               +..+++++.++
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          178 TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             SSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             CccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence              233457889999998865 488899999999999999999999987654332               23468999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      +.+||..||.+|||++++++||||++...
T Consensus       257 i~~~l~~dp~~Rps~~ell~hp~~~~~~~  285 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred             HHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence            99999999999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-47  Score=319.41  Aligned_cols=246  Identities=27%  Similarity=0.534  Sum_probs=209.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH-HHHHHHHHHHHHHHhhCCCCceeceeeEEE--eCCeE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILRLYGWFH--DDERI   94 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~   94 (271)
                      .++|++.+.||+|+||.||++++..++..+++|++....... ......+.+|+.+++.++|+||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            578999999999999999999999999999999997654332 234567889999999999999999999984  45578


Q ss_pred             EEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           95 FLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      ++++|++++ .|.+++..  ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        84 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           84 YMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             EEEEECCSE-EHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             EEEehhccC-CHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            999999985 47777765  35689999999999999999999999999999999999999999999999999854332 


Q ss_pred             ----ccccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHH
Q 024158          172 ----KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKH  234 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~  234 (271)
                          ......+++.|+|||.+.+..  .+.++|+||||+++|+|++|..||......+..           ..+++++.+
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~  242 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD  242 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHH
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHH
Confidence                223446899999999997654  367999999999999999999999876654432           236899999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      ++.+||..||.+|||++++++||||++...
T Consensus       243 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             HHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            999999999999999999999999998744

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.7e-48  Score=331.59  Aligned_cols=240  Identities=23%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC--------CCceeceeeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--------HPNILRLYGWF   88 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--------~~~i~~~~~~~   88 (271)
                      -.++|++.+.||+|+||.||+|++..+++.||+|++....    .....+.+|+.+++.++        |+||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            3478999999999999999999999999999999996542    23456778888888885        78899999998


Q ss_pred             E----eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCC-----
Q 024158           89 H----DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEG-----  156 (271)
Q Consensus        89 ~----~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~-----  156 (271)
                      .    ....+++|||+++ ++|.+.+...  ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            7    4567999999995 5666666543  4699999999999999999999998 999999999999998775     


Q ss_pred             --------------------------------------------CEEEeeecccccccCccccccccccccCCccccCCC
Q 024158          157 --------------------------------------------RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKE  192 (271)
Q Consensus       157 --------------------------------------------~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~  192 (271)
                                                                  .++|+|||.+...........+|+.|+|||.+.+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence                                                        799999999977666666678899999999999999


Q ss_pred             CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------------------------------------
Q 024158          193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------------------------------------  225 (271)
Q Consensus       193 ~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------------------------------------  225 (271)
                      ++.++||||||+++|+|++|..||.+....+..                                               
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            999999999999999999999999765432110                                               


Q ss_pred             ------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 ------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 ------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                  ...++++.+||.+||..||.+|||++++|+||||+.
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                        112456889999999999999999999999999973

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.4e-47  Score=328.10  Aligned_cols=243  Identities=29%  Similarity=0.419  Sum_probs=207.3

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CC-----ceeceeeEEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HP-----NILRLYGWFH   89 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~-----~i~~~~~~~~   89 (271)
                      .-.++|++.+.||+|+||.||+|++..+++.||+|++....    .....+..|+.+++.+. |+     +++.+++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            34678999999999999999999999999999999996432    23455666777777664 34     5999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCeeeC--CCCCEEEeee
Q 024158           90 DDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCH--ENHVIHRDIKPENLLLD--HEGRLKIGDF  163 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh--~~~i~H~dl~~~Nili~--~~~~~~L~df  163 (271)
                      ..+..++|||+++ ++|.+++...  ..+++..++.++.|++.||.+||  +.||+|+||||+||+++  .++.++|+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999999997 5999999775  45899999999999999999999  57999999999999995  4678999999


Q ss_pred             cccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhccc---------------
Q 024158          164 GWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------  228 (271)
Q Consensus       164 g~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i---------------  228 (271)
                      |++...........+|+.|+|||.+.+..++.++||||||+++|+|++|..||.+....+....+               
T Consensus       206 G~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          206 GSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             TTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            99977766666778999999999999999999999999999999999999999876543322110               


Q ss_pred             ------------------------------------------------------------CHHHHHHHHHhcccCccCCC
Q 024158          229 ------------------------------------------------------------SAEAKHLISRLLVKDSSKRL  248 (271)
Q Consensus       229 ------------------------------------------------------------~~~l~~li~~~l~~~p~~Rp  248 (271)
                                                                                  .+++.+||.+||..||.+||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                                                                        03789999999999999999


Q ss_pred             CHHHHhcCCccccCC
Q 024158          249 SLQKIMEHPWIIKNA  263 (271)
Q Consensus       249 s~~~il~~~~~~~~~  263 (271)
                      |++|+|+||||++..
T Consensus       366 ta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          366 QPYYALQHSFFKKTA  380 (382)
T ss_dssp             CHHHHTTSGGGCC--
T ss_pred             CHHHHhcCcccccCC
Confidence            999999999999865

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-47  Score=327.49  Aligned_cols=252  Identities=23%  Similarity=0.387  Sum_probs=206.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhh--------hHHHHHHHHHHHHHHHhhCCCCceece
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--------EKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      ....-.++|++.+.||+|+||.||+|.+. ++..+|+|++.....        ......+.+.+|+.+++.++||||+++
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   94 (362)
T 3pg1_A           16 ELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL   94 (362)
T ss_dssp             HHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred             HHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence            34445689999999999999999999975 499999999854322        223445788999999999999999999


Q ss_pred             eeEEEe-----CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCE
Q 024158           85 YGWFHD-----DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~  158 (271)
                      ++++..     ....|+|+|+++ ++|.+.+... ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.+
T Consensus        95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  173 (362)
T 3pg1_A           95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI  173 (362)
T ss_dssp             SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred             eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence            999843     336899999997 6888888764 468999999999999999999999999999999999999999999


Q ss_pred             EEeeecccccccC--ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------
Q 024158          159 KIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------  225 (271)
Q Consensus       159 ~L~dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------  225 (271)
                      +|+|||++.....  ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+..          
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999999854332  3344568899999999877 66889999999999999999999999876533322          


Q ss_pred             ---------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          226 ---------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       226 ---------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                       ..+++.+.+++.+||..||.+|||++++++||||+....|.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  327 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL  327 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence                                             12478899999999999999999999999999999886554

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-47  Score=320.30  Aligned_cols=248  Identities=29%  Similarity=0.515  Sum_probs=208.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEe-
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHD-   90 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-   90 (271)
                      ......++|++.+.||+|+||.||+|++..+++.+++|++......    ...+.+|+.+++++ +||||+++++++.. 
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            3444567899999999999999999999999999999998654322    24677889999998 79999999999976 


Q ss_pred             -----CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           91 -----DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        91 -----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                           .+..++|+|++++++|.+++...  ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df  173 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF  173 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence                 46799999999989999999864  46899999999999999999999999999999999999999999999999


Q ss_pred             cccccccC---ccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------
Q 024158          164 GWSVQSRS---KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------  225 (271)
Q Consensus       164 g~~~~~~~---~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------  225 (271)
                      |++.....   ......+++.|+|||.+.     +..++.++|+||||+++|+|++|..||.........          
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  253 (326)
T 2x7f_A          174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  253 (326)
T ss_dssp             TTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred             cCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc
Confidence            98855432   233456899999999987     456888999999999999999999999876543332          


Q ss_pred             ---cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 ---RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 ---~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                         ..+++.+.++|.+||..||.+|||++++++||||++.+.
T Consensus       254 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence               236899999999999999999999999999999998654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.8e-47  Score=323.27  Aligned_cols=245  Identities=27%  Similarity=0.455  Sum_probs=210.1

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ..++|++.+.||+|+||.||+|++..+|+.+++|++....  .......+.+|+.+++.++||||+++++++...     
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            4578999999999999999999999999999999986432  223456778899999999999999999987654     


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ...++++|+++ ++|.+++.. ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            67899999997 699999876 5689999999999999999999999999999999999999999999999999854332


Q ss_pred             c-------------cccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------
Q 024158          172 K-------------RHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------  223 (271)
Q Consensus       172 ~-------------~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------  223 (271)
                      .             .....|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+              
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            1             122467899999998765 678889999999999999999999998754221              


Q ss_pred             -----------------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          224 -----------------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       224 -----------------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                                   ....+++++.+++.+||..||.+|||++++++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence                                         113568999999999999999999999999999999987554

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-48  Score=328.90  Aligned_cols=250  Identities=38%  Similarity=0.664  Sum_probs=211.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhC-CCCceeceeeE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSL-RHPNILRLYGW   87 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~   87 (271)
                      ...+..++|++.+.||+|+||.||++++.   .+++.+|+|++...... .......+.+|+++++.+ .|+||++++++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  127 (355)
T 1vzo_A           48 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA  127 (355)
T ss_dssp             CCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred             cccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEE
Confidence            34566789999999999999999999984   47999999998654321 111123456788888888 69999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      +..++.+++||||+++++|.+++.....++...++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus       128 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          128 FQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999999999887889999999999999999999999999999999999999999999999999885


Q ss_pred             cccC----ccccccccccccCCccccCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------hc
Q 024158          168 QSRS----KRHTMCGTLDYLAPEMVENK--EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------FR  226 (271)
Q Consensus       168 ~~~~----~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------~~  226 (271)
                      ....    ......||+.|+|||.+.+.  .++.++||||||+++|+|++|..||........               ..
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  287 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  287 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence            4322    22345689999999999863  467899999999999999999999975432211               23


Q ss_pred             ccCHHHHHHHHHhcccCccCCC-----CHHHHhcCCccccC
Q 024158          227 SISAEAKHLISRLLVKDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      .++..+.++|.+||..||.+||     |++++++||||++.
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            4688999999999999999999     99999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=319.48  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=205.2

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE-----
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH-----   89 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   89 (271)
                      ..-.++|++++.||+|++|.||+|++..+++.+++|++....   ....+.+.+|+.+++.++||||+++++++.     
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   83 (320)
T 2i6l_A            7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ   83 (320)
T ss_dssp             EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred             CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence            344578999999999999999999999999999999986543   234567889999999999999999999873     


Q ss_pred             ---------eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-CCCCEE
Q 024158           90 ---------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLK  159 (271)
Q Consensus        90 ---------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-~~~~~~  159 (271)
                               ..+..++++|+++ ++|.+++.. ..++...++.++.|++.||.+||++|++|+||+|+||+++ .++.++
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence                     3467899999997 699999975 5689999999999999999999999999999999999997 467999


Q ss_pred             EeeecccccccC------ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------
Q 024158          160 IGDFGWSVQSRS------KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------  224 (271)
Q Consensus       160 L~dfg~~~~~~~------~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------  224 (271)
                      |+|||++.....      ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....+.        
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999865432      2233456888999998865 6788899999999999999999999987654322        


Q ss_pred             ---------------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          225 ---------------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       225 ---------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                       ...+++++.+++.+||..||.+|||++++++||||+....|.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence                                             124689999999999999999999999999999999887664

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.7e-48  Score=328.07  Aligned_cols=250  Identities=26%  Similarity=0.429  Sum_probs=197.7

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ......+++|++.+.||+|+||.||+|++..++..+|+|++..+....    ....++++.++.++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            334567889999999999999999999999999999999985543222    2345667778888999999999998654


Q ss_pred             C-------eEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCeeeCC-CCC
Q 024158           92 E-------RIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCH--ENHVIHRDIKPENLLLDH-EGR  157 (271)
Q Consensus        92 ~-------~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~Lh--~~~i~H~dl~~~Nili~~-~~~  157 (271)
                      +       ..+++|||+++ +|...+.    ....++...++.++.|++.|+.+||  +.|++|+||||+||+++. ++.
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence            3       28999999985 5544443    4567899999999999999999999  999999999999999997 889


Q ss_pred             EEEeeecccccccC--ccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-------
Q 024158          158 LKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------  227 (271)
Q Consensus       158 ~~L~dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-------  227 (271)
                      ++|+|||++.....  ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........       
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  250 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC  250 (360)
T ss_dssp             EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence            99999999865443  233456899999999987654 78999999999999999999999987765433221       


Q ss_pred             ------------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          228 ------------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       228 ------------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                                          .++++.+|+.+||..||.+|||+.++|+||||++...+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                                357899999999999999999999999999999875543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=6e-47  Score=321.90  Aligned_cols=246  Identities=24%  Similarity=0.457  Sum_probs=210.4

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCC-ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc------eece
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN------ILRL   84 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~------i~~~   84 (271)
                      ....+-.++|++.+.||+|+||.||+|++..++ ..+++|++....    .....+.+|+.+++.++|++      ++.+
T Consensus        12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A           12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            445566789999999999999999999998877 689999986532    23456677888888876544      8999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----------
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----------  152 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----------  152 (271)
                      ++++...+..+++||+++ +++.+.+...  ..+++..++.++.||+.||.|||++|++|+||||+||++          
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred             eeeeeeCCeEEEEEeccC-CChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence            999999999999999995 6777777654  368999999999999999999999999999999999999          


Q ss_pred             ---------CCCCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch
Q 024158          153 ---------DHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD  223 (271)
Q Consensus       153 ---------~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~  223 (271)
                               +.++.++|+|||++...........+|+.|+|||.+.+..++.++|+||||+++|+|++|..||......+
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                     56789999999999776666667789999999999999999999999999999999999999998766433


Q ss_pred             hhcc-------------------------------------------------------cCHHHHHHHHHhcccCccCCC
Q 024158          224 TFRS-------------------------------------------------------ISAEAKHLISRLLVKDSSKRL  248 (271)
Q Consensus       224 ~~~~-------------------------------------------------------i~~~l~~li~~~l~~~p~~Rp  248 (271)
                      ....                                                       .+.++.+|+.+||..||.+||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            2111                                                       134788999999999999999


Q ss_pred             CHHHHhcCCccccC
Q 024158          249 SLQKIMEHPWIIKN  262 (271)
Q Consensus       249 s~~~il~~~~~~~~  262 (271)
                      |++++++||||++.
T Consensus       327 t~~e~l~hp~f~~~  340 (355)
T 2eu9_A          327 TLAEALLHPFFAGL  340 (355)
T ss_dssp             CHHHHTTSGGGGGC
T ss_pred             CHHHHhcChhhcCC
Confidence            99999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-47  Score=319.29  Aligned_cols=242  Identities=24%  Similarity=0.386  Sum_probs=206.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC--
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--   92 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   92 (271)
                      .+.-++|++.+.||+|+||.||+|++..+++.||+|++........  .+.+.+|+.+++.++||||+++++++....  
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            3556789999999999999999999999999999999976543322  456678999999999999999999987655  


Q ss_pred             eEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----CCCCCEEEeeecc
Q 024158           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGW  165 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----~~~~~~~L~dfg~  165 (271)
                      ..++|||++++++|.+++....   .+++..++.++.|++.||.|||++|++|+||||+||++    +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            7899999999999999998643   38999999999999999999999999999999999999    7777899999999


Q ss_pred             cccccCc--cccccccccccCCcccc--------CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------
Q 024158          166 SVQSRSK--RHTMCGTLDYLAPEMVE--------NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------  224 (271)
Q Consensus       166 ~~~~~~~--~~~~~~~~~y~~pe~~~--------~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------  224 (271)
                      +......  .....+++.|+|||.+.        +..++.++||||||+++|+|++|..||........           
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            8654332  23456899999999886        56788999999999999999999999964332111           


Q ss_pred             -----------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          225 -----------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       225 -----------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                                                   ...+++.+.+++.+||..||++|||++|+++||-
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence                                         1123568999999999999999999999999973

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-47  Score=320.06  Aligned_cols=254  Identities=23%  Similarity=0.374  Sum_probs=195.6

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceece
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      .+......+..++|++.+.||+|+||.||+|++..++.   .+++|++....... ...+.+.+|+.+++.++||||+++
T Consensus        12 ~~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~   90 (323)
T 3qup_A           12 KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKL   90 (323)
T ss_dssp             ----CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             HHHhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehh
Confidence            34455566778899999999999999999999887765   79999997654333 335778899999999999999999


Q ss_pred             eeEEEeCCeE------EEEEeccCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee
Q 024158           85 YGWFHDDERI------FLILEYAHRGELYRELRKHR------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (271)
Q Consensus        85 ~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili  152 (271)
                      ++++...+..      ++++|++.+++|.+++....      .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus        91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli  170 (323)
T 3qup_A           91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML  170 (323)
T ss_dssp             CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE
Confidence            9999876654      99999999999999996532      58999999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-
Q 024158          153 DHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-  225 (271)
Q Consensus       153 ~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-  225 (271)
                      +.++.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+.. 
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999999985443221     23345778999999999999999999999999999999 99999877655443 


Q ss_pred             -----------cccCHHHHHHHHHhcccCccCCCC-------HHHHhcCCccccC
Q 024158          226 -----------RSISAEAKHLISRLLVKDSSKRLS-------LQKIMEHPWIIKN  262 (271)
Q Consensus       226 -----------~~i~~~l~~li~~~l~~~p~~Rps-------~~~il~~~~~~~~  262 (271)
                                 ..+++++.+++.+||..||.+|||       ++++++|||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          251 YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence                       236899999999999999999999       8999999999876

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.8e-47  Score=318.31  Aligned_cols=246  Identities=26%  Similarity=0.437  Sum_probs=205.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEe-cCCceEEEEEechhhhhHHHHHHHHHHHHHHHh---hCCCCceeceeeEEE----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREV-ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS---SLRHPNILRLYGWFH----   89 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~---~~~~~~i~~~~~~~~----   89 (271)
                      .++|++.+.||+|+||.||+|++. .+++.+++|++........ ....+.+|+.+++   .++||||+++++++.    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            478999999999999999999985 6788999999865432211 1122334555544   458999999999987    


Q ss_pred             -eCCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           90 -DDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        90 -~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                       .....++++|+++ ++|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             4567899999997 69999998743  4899999999999999999999999999999999999999999999999998


Q ss_pred             ccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------------
Q 024158          167 VQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------------  224 (271)
Q Consensus       167 ~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------------  224 (271)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+.                    
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            54432  23345689999999999999999999999999999999999999986553221                    


Q ss_pred             ------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 ------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 ------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                        ...+++++.+++.+||..||.+|||++++++||||++....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~  306 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC  306 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence                              13468899999999999999999999999999999987543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.2e-46  Score=322.23  Aligned_cols=241  Identities=26%  Similarity=0.473  Sum_probs=209.2

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEec-------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ..+..++|++.+.||+|+||.||+|++..       ++..+++|++.....  ......+.+|+.+++.+ +||||++++
T Consensus        76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~  153 (370)
T 2psq_A           76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLL  153 (370)
T ss_dssp             TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred             ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            45677899999999999999999999753       455799999966532  24467788999999999 899999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      +++...+.+|+|+||+++++|.+++...+                .+++..++.++.||+.||.|||++|++|+||||+|
T Consensus       154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  233 (370)
T 2psq_A          154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN  233 (370)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence            99999999999999999999999998643                47899999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcch
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKD  223 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~  223 (271)
                      |+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999998643322     233456788999999999999999999999999999998 999998766544


Q ss_pred             hh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 TF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 ~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..            ..+++++.+++.+||..+|.+|||+.+++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33            2357899999999999999999999999874

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.7e-47  Score=325.62  Aligned_cols=246  Identities=23%  Similarity=0.407  Sum_probs=207.4

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-----------CCcee
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----------HPNIL   82 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----------~~~i~   82 (271)
                      ..+..++|++.+.||+|+||.||+|++..+++.+|+|++.....    ....+.+|+.+++.+.           |+||+
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~   89 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHIL   89 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhccccchHH
Confidence            44567899999999999999999999999999999999965432    2345667777777775           78999


Q ss_pred             ceeeEEEeCC----eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCC-
Q 024158           83 RLYGWFHDDE----RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDH-  154 (271)
Q Consensus        83 ~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~-  154 (271)
                      ++++++...+    .+++++|++ +++|.+++...  ..++...++.++.||+.||.+||++ |++|+||||+||+++. 
T Consensus        90 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           90 KLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             CCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEE
T ss_pred             HHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEecc
Confidence            9999987654    789999999 68999999763  4589999999999999999999998 9999999999999953 


Q ss_pred             -----CCCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----
Q 024158          155 -----EGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----  224 (271)
Q Consensus       155 -----~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----  224 (271)
                           .+.++|+|||++...........+|+.|+|||.+.+..++.++||||||+++|+|++|..||........     
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence                 3479999999997766666667889999999999999999999999999999999999999986542110     


Q ss_pred             ------------------------------------------------------hcccCHHHHHHHHHhcccCccCCCCH
Q 024158          225 ------------------------------------------------------FRSISAEAKHLISRLLVKDSSKRLSL  250 (271)
Q Consensus       225 ------------------------------------------------------~~~i~~~l~~li~~~l~~~p~~Rps~  250 (271)
                                                                            ...+++++.+||.+||..||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence                                                                  01235788999999999999999999


Q ss_pred             HHHhcCCccccCCC
Q 024158          251 QKIMEHPWIIKNAN  264 (271)
Q Consensus       251 ~~il~~~~~~~~~~  264 (271)
                      +++++||||++...
T Consensus       329 ~ell~hp~f~~~~~  342 (373)
T 1q8y_A          329 GGLVNHPWLKDTLG  342 (373)
T ss_dssp             HHHHTCGGGTTCTT
T ss_pred             HHHhhChhhhcccC
Confidence            99999999998743

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.1e-46  Score=312.37  Aligned_cols=243  Identities=22%  Similarity=0.401  Sum_probs=203.6

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .....+++|++.+.||+|+||.||++++..+++.+++|++...........+.+.+|+.+++.++||||+++++++..++
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 2h34_A           28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG  107 (309)
T ss_dssp             ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence            34566899999999999999999999999999999999997766555566688899999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..++++|++++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            99999999999999999988788999999999999999999999999999999999999999999999999987544332


Q ss_pred             ----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHHH
Q 024158          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAKH  234 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~~  234 (271)
                          .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......              ....+|+++.+
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence                234468899999999999889999999999999999999999998655321              22347899999


Q ss_pred             HHHHhcccCccCCC-CHHHHhc
Q 024158          235 LISRLLVKDSSKRL-SLQKIME  255 (271)
Q Consensus       235 li~~~l~~~p~~Rp-s~~~il~  255 (271)
                      ++.+||..||.+|| |++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 7777765

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-47  Score=326.19  Aligned_cols=243  Identities=31%  Similarity=0.475  Sum_probs=201.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .......+|++.+.||+|+||.||+|++..++. +++|.+......       ..+|+.+++.++|+||+++++++...+
T Consensus        34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~  105 (394)
T 4e7w_A           34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNG  105 (394)
T ss_dssp             SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred             CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecC
Confidence            445566789999999999999999999877766 778877443211       236889999999999999999986543


Q ss_pred             ------eEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-CCCCEEEe
Q 024158           93 ------RIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIG  161 (271)
Q Consensus        93 ------~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-~~~~~~L~  161 (271)
                            ..++||||+++ ++...+.    ....++...++.++.||+.||.|||++|++|+||||+||+++ .++.++|+
T Consensus       106 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             SSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEe
Confidence                  38899999985 5444432    246799999999999999999999999999999999999998 78999999


Q ss_pred             eeccccccc--CccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc------------
Q 024158          162 DFGWSVQSR--SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR------------  226 (271)
Q Consensus       162 dfg~~~~~~--~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~------------  226 (271)
                      |||++....  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||.+....+.+.            
T Consensus       185 DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          185 DFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             CCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             eCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999985532  333456789999999998765 58899999999999999999999998766432211            


Q ss_pred             ----------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          227 ----------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       227 ----------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                                  .+++++.+|+.+||.+||.+|||+.++++||||+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence                                        26789999999999999999999999999999997643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.8e-47  Score=310.16  Aligned_cols=241  Identities=23%  Similarity=0.400  Sum_probs=209.9

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..+.++.++|++.+.||+|+||.||++++. ++..+++|++.......    +.+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~   76 (269)
T 4hcu_A            2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLE   76 (269)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CccEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3456778899999999999999999999975 57789999997655443    457889999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++..+++||++++++|.+++... ..++...++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV  156 (269)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred             CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence            99999999999999999999764 46899999999999999999999999999999999999999999999999998644


Q ss_pred             cCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHH
Q 024158          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEA  232 (271)
Q Consensus       170 ~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l  232 (271)
                      ...    .....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+...            ..++++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV  236 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             cccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHH
Confidence            332    233455778999999998899999999999999999999 999998776554432            258999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+++.+||..+|.+|||+.+++++
T Consensus       237 ~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          237 YQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999975

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=328.68  Aligned_cols=244  Identities=28%  Similarity=0.541  Sum_probs=192.6

Q ss_pred             ccceeee-eeecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--CC
Q 024158           18 LQDFEIG-RPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DE   92 (271)
Q Consensus        18 ~~~y~~~-~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~   92 (271)
                      .+.|.+. ++||+|+||.||+|++.  .++..||+|++......     ..+.+|+.+++.++||||+++++++..  +.
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            3557774 47999999999999965  57899999999654433     346789999999999999999999954  67


Q ss_pred             eEEEEEeccCCCchHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----CCCCCEE
Q 024158           93 RIFLILEYAHRGELYRELRKH---------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLK  159 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~---------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----~~~~~~~  159 (271)
                      ..|+|+||++ ++|.+++...         ..+++..++.++.||+.||.|||++||+|+||||+||++    +.++.++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            8999999997 5888887532         148999999999999999999999999999999999999    6778999


Q ss_pred             EeeecccccccC------ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcc---------h
Q 024158          160 IGDFGWSVQSRS------KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------D  223 (271)
Q Consensus       160 L~dfg~~~~~~~------~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------~  223 (271)
                      |+|||++.....      ......||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+....         +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999865432      22345789999999999875 4888999999999999999999999754431         0


Q ss_pred             h---------------hc----------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHh
Q 024158          224 T---------------FR----------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIM  254 (271)
Q Consensus       224 ~---------------~~----------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il  254 (271)
                      .               +.                                  ..++++.+||.+||..||.+|||++|+|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0               00                                  0167889999999999999999999999


Q ss_pred             cCCccccCCCCCC
Q 024158          255 EHPWIIKNANPRG  267 (271)
Q Consensus       255 ~~~~~~~~~~~~~  267 (271)
                      +||||++.+.|..
T Consensus       333 ~hp~f~~~~~~~~  345 (405)
T 3rgf_A          333 QDPYFLEDPLPTS  345 (405)
T ss_dssp             TSGGGTSSSCCCS
T ss_pred             cChhhccCCCCcc
Confidence            9999998766543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.8e-47  Score=313.24  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=209.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ...+...+|.....||+|+||.||+|++..++..+++|.+.....   ...+.+.+|+.+++.++||||+++++++...+
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   92 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG   92 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence            334455556666699999999999999999999999999865432   23467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-CCCEEEeeeccccc
Q 024158           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-EGRLKIGDFGWSVQ  168 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-~~~~~L~dfg~~~~  168 (271)
                      ..++++|++++++|.+++....   .+++..++.++.|++.||.+||++|++|+||+|+||+++. ++.++|+|||.+..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence            9999999999999999997642   4678999999999999999999999999999999999987 88999999999855


Q ss_pred             ccC---ccccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccC
Q 024158          169 SRS---KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSIS  229 (271)
Q Consensus       169 ~~~---~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~  229 (271)
                      ...   ......+++.|+|||.+.+..  ++.++|+||||+++|+|++|..||.......              ....++
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS  252 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence            432   233456899999999987654  7889999999999999999999997543221              123468


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      +++.+++.+||..||++|||++++++||||+.....
T Consensus       253 ~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  288 (295)
T 2clq_A          253 AEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK  288 (295)
T ss_dssp             HHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence            999999999999999999999999999999977544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-46  Score=318.69  Aligned_cols=243  Identities=29%  Similarity=0.560  Sum_probs=185.3

Q ss_pred             cCccccceeeee-eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--
Q 024158           14 REWSLQDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--   90 (271)
Q Consensus        14 ~~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--   90 (271)
                      ...-.++|++++ .||+|+||.||+|++..+++.||+|++.....       ...+....++.++|+|++++++++..  
T Consensus        23 ~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            344567899976 59999999999999999999999999855321       11223344667799999999999876  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---CCEEEeee
Q 024158           91 --DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---GRLKIGDF  163 (271)
Q Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---~~~~L~df  163 (271)
                        +...++||||+++++|.+++....  .+++..++.++.||+.||.|||++|++|+||+|+||+++.+   +.++|+||
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence              456899999999999999998753  69999999999999999999999999999999999999764   45999999


Q ss_pred             cccccccC-ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------
Q 024158          164 GWSVQSRS-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------  224 (271)
Q Consensus       164 g~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------  224 (271)
                      |++..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........                  
T Consensus       176 g~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (336)
T 3fhr_A          176 GFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP  255 (336)
T ss_dssp             TTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred             ccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence            99865443 23445679999999999888889999999999999999999999966543221                  


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                       +..+++++.+++.+||..||.+|||++++++||||++..
T Consensus       256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence             135689999999999999999999999999999998763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-46  Score=314.69  Aligned_cols=255  Identities=23%  Similarity=0.437  Sum_probs=208.9

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC--CCceeceee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPNILRLYG   86 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~   86 (271)
                      ...+...+..++|++.+.||+|+||.||++++. ++..+++|++....... .....+.+|+.++++++  |+||+++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEE
Confidence            344556677889999999999999999999984 58899999986544332 34577889999999997  599999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ++..++..+++||+ .+++|.+++.....++...++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||++
T Consensus        96 ~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~  173 (313)
T 3cek_A           96 YEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA  173 (313)
T ss_dssp             EEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             EeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence            99999999999995 4689999999888899999999999999999999999999999999999996 489999999998


Q ss_pred             ccccCc-----cccccccccccCCccccC-----------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcch-------
Q 024158          167 VQSRSK-----RHTMCGTLDYLAPEMVEN-----------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-------  223 (271)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~~pe~~~~-----------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-------  223 (271)
                      ......     .....+++.|+|||.+.+           ..++.++|+||||+++|+|++|..||.......       
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence            654332     234468999999999875           467889999999999999999999997654221       


Q ss_pred             -------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCC
Q 024158          224 -------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       224 -------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                             .....++++.+++.+||..||.+|||++++++||||+....|.+
T Consensus       254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~~  304 (313)
T 3cek_A          254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN  304 (313)
T ss_dssp             CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-----
T ss_pred             hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCchh
Confidence                   11224789999999999999999999999999999998866543

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-47  Score=321.40  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=214.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCC--CCceeceeeE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLR--HPNILRLYGW   87 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~--~~~i~~~~~~   87 (271)
                      ....-.++|++.+.||+|+||.||+|++..+++.+++|++........   .....+.+|+.+++.++  |+|+++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            344557789999999999999999999999999999999976543221   11234556888888886  5999999999


Q ss_pred             EEeCCeEEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-CCCCEEEeeecc
Q 024158           88 FHDDERIFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDFGW  165 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-~~~~~~L~dfg~  165 (271)
                      +..++..++++|++.+ ++|.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++ .++.++|+|||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            9999999999999975 79999998888899999999999999999999999999999999999998 678999999999


Q ss_pred             cccccCc-cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcc-----hhhcccCHHHHHHHHH
Q 024158          166 SVQSRSK-RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQK-----DTFRSISAEAKHLISR  238 (271)
Q Consensus       166 ~~~~~~~-~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~-----~~~~~i~~~l~~li~~  238 (271)
                      +...... .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||......     .....+++++.+++.+
T Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li~~  276 (320)
T 3a99_A          197 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW  276 (320)
T ss_dssp             CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHH
T ss_pred             ccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHHHHHH
Confidence            8554432 334568999999999987765 67899999999999999999999754321     1123578999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                      ||..||.+|||++++++||||++...+.
T Consensus       277 ~l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          277 CLALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             HccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            9999999999999999999999886553

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=315.82  Aligned_cols=242  Identities=25%  Similarity=0.383  Sum_probs=209.2

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCce---EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP---VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~---~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ..++..++|++.+.||+|+||.||++++..++..   +++|++......  .....+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  120 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVT  120 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            4567788999999999999999999999866654   999999654322  33567889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .++..++|||++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999999999764 5799999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccC
Q 024158          169 SRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SIS  229 (271)
Q Consensus       169 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~  229 (271)
                      ....      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+...            .++
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            4332      122345678999999998889999999999999999998 999998776554432            358


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +++.+++.+||..||.+|||+.++++.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=323.02  Aligned_cols=248  Identities=25%  Similarity=0.368  Sum_probs=210.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEE-----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ...++..++|++.+.||+|+||.||+|+     +..++..||+|++......  .....+.+|+.+++.++||||+++++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~  141 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIG  141 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3456778999999999999999999999     5557788999998643222  33456788999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC---
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG---  156 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~---  156 (271)
                      ++...+..++|||++++++|.+++...+       .+++..++.++.||+.||.|||++||+||||||+||+++.++   
T Consensus       142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~  221 (367)
T 3l9p_A          142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR  221 (367)
T ss_dssp             EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTC
T ss_pred             EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCc
Confidence            9999889999999999999999997642       489999999999999999999999999999999999998555   


Q ss_pred             CEEEeeeccccccc-----CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-----
Q 024158          157 RLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-----  225 (271)
Q Consensus       157 ~~~L~dfg~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-----  225 (271)
                      .++|+|||++....     .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+..     
T Consensus       222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             eEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            59999999985321     22334567889999999998999999999999999999998 99999877654443     


Q ss_pred             -------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 -------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 -------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                             ..+++++.+++.+||..+|.+|||+++++++.++..
T Consensus       302 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence                   236899999999999999999999999999876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-46  Score=316.40  Aligned_cols=250  Identities=28%  Similarity=0.436  Sum_probs=193.3

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHH-HHHhhCCCCceeceeeEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM-EIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~   88 (271)
                      ....+.+..++|++++.||+|+||.||+|.+..+|+.+++|++....... . ...+..++ .+++.++||||+++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~h~niv~~~~~~   90 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-E-QKQLLMDLDVVMRSSDCPYIVQFYGAL   90 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-H-HHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-H-HHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence            34566788899999999999999999999999999999999996543222 2 23344444 478888999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEee
Q 024158           89 HDDERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGD  162 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~d  162 (271)
                      ..++..++++|+++ ++|.+++..     ...++...+..++.|++.|+.+||+. |++|+||+|+||+++.++.++|+|
T Consensus        91 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           91 FREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECC
T ss_pred             EeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEcc
Confidence            99999999999997 488888763     46789999999999999999999999 999999999999999999999999


Q ss_pred             ecccccccCc--cccccccccccCCccc----cCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-h------------
Q 024158          163 FGWSVQSRSK--RHTMCGTLDYLAPEMV----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-D------------  223 (271)
Q Consensus       163 fg~~~~~~~~--~~~~~~~~~y~~pe~~----~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~------------  223 (271)
                      ||++......  .....+++.|+|||.+    .+..++.++|+||||+++|+|++|..||...... +            
T Consensus       170 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3aln_A          170 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQ  249 (327)
T ss_dssp             CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCC
T ss_pred             CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCC
Confidence            9998554332  2234689999999998    4566889999999999999999999999763321 1            


Q ss_pred             ----hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          224 ----TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       224 ----~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                          ....+++++.+++.+||..||.+|||+.++++||||.+.
T Consensus       250 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence                112468999999999999999999999999999999865

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2e-46  Score=326.02  Aligned_cols=240  Identities=30%  Similarity=0.460  Sum_probs=201.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----   91 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----   91 (271)
                      ...+|++.+.||+|+||.||+|++..+|+.||||++.....       ...+|+++++.++|+||+++++++...     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            34579999999999999999999999999999999855321       223689999999999999999988532     


Q ss_pred             -CeEEEEEeccCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecc
Q 024158           92 -ERIFLILEYAHRGELYRELR----KHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGW  165 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~  165 (271)
                       .++++|+||+++ ++.+.+.    ....+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence             247799999974 6766654    24679999999999999999999999999999999999999965 5689999999


Q ss_pred             ccccc--CccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------------
Q 024158          166 SVQSR--SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------------  225 (271)
Q Consensus       166 ~~~~~--~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------------  225 (271)
                      +....  .......+++.|+|||.+.+. .++.++|||||||++|+|++|..||.+....+.+                 
T Consensus       204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          204 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             CEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             hhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            86433  233445789999999998765 6889999999999999999999999876533221                 


Q ss_pred             -----------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          226 -----------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       226 -----------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                             ..+++++.+||.+||..||.+|||+.++++||||++...
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence                                   134789999999999999999999999999999987643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-46  Score=314.05  Aligned_cols=245  Identities=25%  Similarity=0.458  Sum_probs=212.7

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceece
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      ......+..++|++.+.||+|+||.||+|.+.     .++..+++|++.....  ....+.+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~   91 (314)
T 2ivs_A           14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKL   91 (314)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeE
Confidence            34566778899999999999999999999874     4558899999965432  2345778899999999999999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCc
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHRR------------------------FTEQQAATYIASLTNALAYCHENHV  140 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------l~~~~~~~i~~~l~~~l~~Lh~~~i  140 (271)
                      ++++..++..++++|++++++|.+++.....                        +++..++.++.||+.||.+||++|+
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  171 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL  171 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999986443                        8999999999999999999999999


Q ss_pred             eecCCCCCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCC
Q 024158          141 IHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAP  214 (271)
Q Consensus       141 ~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~  214 (271)
                      +|+||+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999998544322     233456788999999998889999999999999999999 999


Q ss_pred             CCCCCCcchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          215 PFEAESQKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       215 p~~~~~~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ||.+.......            ..+++++.+++.+||..||.+|||+++++++
T Consensus       252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99877654433            2368999999999999999999999999875

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.1e-46  Score=309.45  Aligned_cols=239  Identities=27%  Similarity=0.482  Sum_probs=199.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------   90 (271)
                      .++|++++.||+|+||.||+|++..+++.+++|++....    .....+.+|+.+++.++||||+++++++.+       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            368999999999999999999999999999999985432    335678899999999999999999998754       


Q ss_pred             ------CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           91 ------DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        91 ------~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                            .+..|+++|++++++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  45789999999999999999864 35788999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-----------------ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCC-c---
Q 024158          164 GWSVQSRS-----------------KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAES-Q---  221 (271)
Q Consensus       164 g~~~~~~~-----------------~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~-~---  221 (271)
                      |.+.....                 ......+++.|+|||.+.+. .++.++|+||||+++|+|++   ||.... .   
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            98854331                 12334678999999999765 68899999999999999998   443211 1   


Q ss_pred             ------------chhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          222 ------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       222 ------------~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                  .......++.+.+++.+||..||.+|||++++++||||+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence                        111223567899999999999999999999999999998653

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-46  Score=306.89  Aligned_cols=238  Identities=23%  Similarity=0.393  Sum_probs=208.5

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .++..++|++.+.||+|+||.||++++. ++..+++|++.......    +.+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   77 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYP   77 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence            4678899999999999999999999764 67779999997655443    457889999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .+++||++++++|.+++... ..+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999999999774 45999999999999999999999999999999999999999999999999988544332


Q ss_pred             c----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHH
Q 024158          173 R----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHL  235 (271)
Q Consensus       173 ~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~l  235 (271)
                      .    ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+...            ..++++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence            2    23345677999999988889999999999999999998 999998766544422            258999999


Q ss_pred             HHHhcccCccCCCCHHHHhcC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+||..+|.+|||+.+++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-46  Score=309.42  Aligned_cols=242  Identities=24%  Similarity=0.406  Sum_probs=208.5

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ....+.+..++|++++.||+|+||.||++++. ++..+++|++.......    +.+.+|+.+++.++|+||+++++++.
T Consensus        15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             -CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            34566788889999999999999999999874 67789999997654443    45788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .++..+++||++++++|.+++.. ...+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||++..
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            99999999999999999999976 45799999999999999999999999999999999999999999999999999864


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~  231 (271)
                      ....    .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+...            ..++.
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK  249 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHH
Confidence            4332    223345778999999998889999999999999999998 999998776544432            24899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..+|.+|||+++++++
T Consensus       250 l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          250 VYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999976

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.4e-46  Score=306.05  Aligned_cols=246  Identities=25%  Similarity=0.434  Sum_probs=209.8

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHH----HHHHHHHHHHHhhCCCCceec
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI----QHQLRREMEIQSSLRHPNILR   83 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~----~~~~~~e~~~l~~~~~~~i~~   83 (271)
                      ........+..++|++.+.||+|+||.||+|++..+++.+++|++..........    .+.+.+|+.+++.++||||++
T Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   87 (287)
T 4f0f_A            8 FPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVK   87 (287)
T ss_dssp             ----CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCC
T ss_pred             CcchhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchh
Confidence            3445566788899999999999999999999999999999999986544332211    267889999999999999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCC---
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGR---  157 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~---  157 (271)
                      +++++....  ++++|++++++|.+.+... ..+++..++.++.|++.|+.+||+.|  ++|+||+|+||+++.++.   
T Consensus        88 ~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~  165 (287)
T 4f0f_A           88 LYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAP  165 (287)
T ss_dssp             EEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCS
T ss_pred             hheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCc
Confidence            999986655  6899999999998888654 47899999999999999999999999  999999999999988776   


Q ss_pred             --EEEeeecccccccCccccccccccccCCcccc--CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------
Q 024158          158 --LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE--NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------  224 (271)
Q Consensus       158 --~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~--~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------  224 (271)
                        ++|+|||++...........+++.|+|||.+.  ...++.++|+||||+++|+|++|..||........         
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  245 (287)
T 4f0f_A          166 VCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE  245 (287)
T ss_dssp             CCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHS
T ss_pred             eeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhcc
Confidence              99999999977666666678999999999984  44567899999999999999999999986553322         


Q ss_pred             ------hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ------FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                            ...+++++.+++.+||..||.+|||++++++
T Consensus       246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence                  2346899999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-46  Score=320.82  Aligned_cols=246  Identities=24%  Similarity=0.452  Sum_probs=210.1

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEE-----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      .....+++..++|++.+.||+|+||.||+|+     +..+++.|++|++......  ...+.+.+|++++.++ +||||+
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCccee
Confidence            3445667888999999999999999999998     5556789999999664332  3356788999999999 789999


Q ss_pred             ceeeEEEeCC-eEEEEEeccCCCchHHHHHhCCC----------------------------------------------
Q 024158           83 RLYGWFHDDE-RIFLILEYAHRGELYRELRKHRR----------------------------------------------  115 (271)
Q Consensus        83 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------  115 (271)
                      ++++++...+ ..++++||+++++|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            9999987755 48999999999999999976432                                              


Q ss_pred             --------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158          116 --------------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus       116 --------------------l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                                          +++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                                899999999999999999999999999999999999999999999999998643322   


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAEAKHLI  236 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~l~~li  236 (271)
                        .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..             ..+++++.+++
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence              223456888999999998899999999999999999998 99999876643322             23688999999


Q ss_pred             HHhcccCccCCCCHHHHhcC
Q 024158          237 SRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+||..||.+|||++++++|
T Consensus       330 ~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHH
Confidence            99999999999999999976

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.3e-46  Score=306.21  Aligned_cols=239  Identities=26%  Similarity=0.464  Sum_probs=197.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhH-HHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEK-YKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ++..++|++.+.||+|+||.||++++  ++..+++|++....... ....+.+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            56789999999999999999999996  48889999986654332 2335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCeeeCC--------CCCEEEee
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH---VIHRDIKPENLLLDH--------EGRLKIGD  162 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~---i~H~dl~~~Nili~~--------~~~~~L~d  162 (271)
                      .++++|++++++|.+++.. +.+++..++.++.|++.|+.+||++|   ++|+||+|+||+++.        ++.++|+|
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999999864 57999999999999999999999999   899999999999986        67899999


Q ss_pred             ecccccccC-ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------ccc
Q 024158          163 FGWSVQSRS-KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------RSI  228 (271)
Q Consensus       163 fg~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------~~i  228 (271)
                      ||.+..... ......+++.|+|||.+.+..++.++|+||||+++++|++|..||.+.......             ..+
T Consensus       160 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (271)
T 3dtc_A          160 FGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC  239 (271)
T ss_dssp             CCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTC
T ss_pred             CCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCccc
Confidence            999854332 233457899999999999888999999999999999999999999876643332             346


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++++.+++.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            8999999999999999999999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-46  Score=323.24  Aligned_cols=241  Identities=24%  Similarity=0.404  Sum_probs=210.1

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .+.+..++|++.+.||+|+||.||+|++..++..||+|++.....  ......+.+|+++++.++||||+++++++..++
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            456677899999999999999999999998999999999865422  233467889999999999999999999999888


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++|||++++++|.+++... ..++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            999999999999999999764 4689999999999999999999999999999999999999999999999999865433


Q ss_pred             cc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHH
Q 024158          172 KR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAK  233 (271)
Q Consensus       172 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~  233 (271)
                      ..     ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ...|+++.
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  345 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVF  345 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            22     12234678999999998889999999999999999998 99999876654332            23588999


Q ss_pred             HHHHHhcccCccCCCCHHHHhc
Q 024158          234 HLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +++.+||..||.+|||++++++
T Consensus       346 ~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          346 RLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCchhCcCHHHHHH
Confidence            9999999999999999999975

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=311.13  Aligned_cols=249  Identities=26%  Similarity=0.439  Sum_probs=197.0

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ......+++|++++.||+|+||.||+|++..+++.+++|++....... ...+.+.++..+++.++||||+++++++..+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~   96 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITN   96 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence            345677899999999999999999999999999999999997654332 2334555666778888999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +..+++||++ ++.+..+... ...+++..++.++.|++.||.+||++ |++|+||+|+||+++.++.++|+|||++...
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            9999999999 4566666654 46799999999999999999999996 9999999999999999999999999988543


Q ss_pred             cC--ccccccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-hhh--------------cc
Q 024158          170 RS--KRHTMCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-DTF--------------RS  227 (271)
Q Consensus       170 ~~--~~~~~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-~~~--------------~~  227 (271)
                      ..  ......+++.|+|||.+.     +..++.++|+||||+++|+|++|..||...... +..              ..
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence            32  223446899999999984     456788999999999999999999999864321 111              23


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +++++.+++.+||..||.+|||++++++||||++.
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            68999999999999999999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=315.46  Aligned_cols=243  Identities=24%  Similarity=0.390  Sum_probs=210.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ....+..++|++.+.||+|+||.||+|++.     .++..+++|++.....  ......+.+|+.+++.++||||+++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~  117 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLG  117 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            345778899999999999999999999987     3458899999976532  234567899999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKH------------------------RRFTEQQAATYIASLTNALAYCHENHVIH  142 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H  142 (271)
                      ++..++..++||||+++++|.+++...                        ..+++..++.++.||+.||.+||++|++|
T Consensus       118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            999999999999999999999999763                        46899999999999999999999999999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCC
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPF  216 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~  216 (271)
                      +||+|+||+++.++.++|+|||++.....     ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999998854321     2234467889999999998889999999999999999998 99999


Q ss_pred             CCCCcchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          217 EAESQKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       217 ~~~~~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+....+..            ..+++++.+++.+||..||.+|||+.+++++
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            877654432            2368999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.4e-46  Score=318.44  Aligned_cols=243  Identities=25%  Similarity=0.471  Sum_probs=211.4

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCC-------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceec
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILR   83 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~   83 (271)
                      ..+++..++|++.+.||+|+||.||+|++..++       ..+++|++.....  ......+.+|+++++.+ +||||++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~  139 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIIN  139 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhh
Confidence            345667789999999999999999999976443       5799999866532  23457788999999999 8999999


Q ss_pred             eeeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 024158           84 LYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKP  147 (271)
Q Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~  147 (271)
                      +++++..++..++|||++++++|.+++....                .+++..++.++.||+.||.+||+.|++|+||||
T Consensus       140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            9999999999999999999999999998743                489999999999999999999999999999999


Q ss_pred             CCeeeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCc
Q 024158          148 ENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQ  221 (271)
Q Consensus       148 ~Nili~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~  221 (271)
                      +||+++.++.++|+|||++.....     ......+++.|+|||.+.+..++.++||||||+++++|++ |..||.....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999864432     2233456788999999999999999999999999999998 9999987765


Q ss_pred             chhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          222 KDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       222 ~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+..            ..+++++.+++.+||..||.+|||+++++++
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4433            2368999999999999999999999999976

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-45  Score=306.32  Aligned_cols=243  Identities=29%  Similarity=0.511  Sum_probs=201.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ....+++|++.+.||+|+||.||+|.+..+|..+++|++.............+.+|+.+++.++|+||+++++++..++.
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            44567899999999999999999999999999999999976544444556788899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           94 IFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      .++++|++++++|.+++..    ...++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            9999999999999999864    456899999999999999999999999999999999999999999999999987543


Q ss_pred             cCc---cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---------------hhcccCHH
Q 024158          170 RSK---RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---------------TFRSISAE  231 (271)
Q Consensus       170 ~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---------------~~~~i~~~  231 (271)
                      ...   .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.....               ....++++
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            322   234468899999999999899999999999999999999999997543211               11346899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..||.+|||+++++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.9e-45  Score=305.70  Aligned_cols=238  Identities=20%  Similarity=0.273  Sum_probs=205.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      ...+..++|++.+.||+|++|.||+|++..+++.+++|++......     ..+.+|+..++.+ +|++++.+++++..+
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   78 (298)
T 1csn_A            4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEG   78 (298)
T ss_dssp             --CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEET
T ss_pred             cCcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCC
Confidence            4456678899999999999999999999999999999998544322     3467788999998 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC-----EEEeeecc
Q 024158           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-----LKIGDFGW  165 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~-----~~L~dfg~  165 (271)
                      ...++++|++ +++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.     ++|+|||+
T Consensus        79 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           79 LHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             ceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999999999 78999999874 46999999999999999999999999999999999999987765     99999999


Q ss_pred             cccccCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch------------
Q 024158          166 SVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD------------  223 (271)
Q Consensus       166 ~~~~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~------------  223 (271)
                      +......          .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......            
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            8543322          234568999999999999999999999999999999999999998754221            


Q ss_pred             -------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 -------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 -------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                             ....+|+++.+++.+||..||.+|||++++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                   112468999999999999999999999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=316.13  Aligned_cols=252  Identities=29%  Similarity=0.521  Sum_probs=202.7

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhC----CCCceecee
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSL----RHPNILRLY   85 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~----~~~~i~~~~   85 (271)
                      ..+.-.++|++.+.||+|+||.||+|++..+++.+++|++........   .....+.+|+.+++++    +|+||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            344556789999999999999999999999999999999966543321   1223455688888887    899999999


Q ss_pred             eEEEeCCeEEEEEec-cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC-CCCCEEEeee
Q 024158           86 GWFHDDERIFLILEY-AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD-HEGRLKIGDF  163 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~-~~~~~~L~df  163 (271)
                      +++...+..++++|+ +.+++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++ .++.++|+||
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999988899999998 78899999998878899999999999999999999999999999999999999 7889999999


Q ss_pred             cccccccC-ccccccccccccCCccccCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCcc-----hhhcccCHHHHHHH
Q 024158          164 GWSVQSRS-KRHTMCGTLDYLAPEMVENKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQK-----DTFRSISAEAKHLI  236 (271)
Q Consensus       164 g~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slg~il~~l~~g~~p~~~~~~~-----~~~~~i~~~l~~li  236 (271)
                      |++..... ......+++.|+|||.+.+..+. .++|+||||+++|+|++|..||......     .....++.++.+++
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li  264 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPDCCALI  264 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccCCHHHHHHH
Confidence            99855433 33445689999999999877664 4899999999999999999999754321     11234789999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                      .+||..||++|||++++++||||+....
T Consensus       265 ~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          265 RRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             HHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             HHHccCChhhCcCHHHHhcChhhcCchh
Confidence            9999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.5e-46  Score=310.94  Aligned_cols=246  Identities=25%  Similarity=0.421  Sum_probs=212.5

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEE-----ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVRE-----VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      .......+..++|++.+.||+|+||.||+|.+     ..++..+++|++......  ...+.+.+|+.+++++ +||||+
T Consensus        13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~   90 (313)
T 1t46_A           13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIV   90 (313)
T ss_dssp             CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCee
Confidence            34556677789999999999999999999985     456788999999765332  3356788999999999 899999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKHR------------------RFTEQQAATYIASLTNALAYCHENHVIHRD  144 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~d  144 (271)
                      ++++++..++..++++|++++++|.+++....                  .+++..++.++.|++.||.+||++|++|+|
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  170 (313)
T 1t46_A           91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD  170 (313)
T ss_dssp             CEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             eEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            99999999999999999999999999997643                  389999999999999999999999999999


Q ss_pred             CCCCCeeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 024158          145 IKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEA  218 (271)
Q Consensus       145 l~~~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~  218 (271)
                      |+|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||..
T Consensus       171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            99999999999999999999986544322     23345778999999998899999999999999999998 9999987


Q ss_pred             CCcchhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          219 ESQKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       219 ~~~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .......             ..+++++.+++.+||..||.+|||+++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            6543321             2368999999999999999999999999875

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.8e-46  Score=305.19  Aligned_cols=242  Identities=25%  Similarity=0.425  Sum_probs=199.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ...++..++|++.+.||+|+||.||+|++..+   +..+++|.+.....  ....+.+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            34567789999999999999999999998654   45699999865432  23456788999999999999999999997


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      . ++..++|||++++++|.+++...+ .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus        86 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           86 T-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            4 466899999999999999998654 68999999999999999999999999999999999999999999999999985


Q ss_pred             cccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          168 QSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       168 ~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      .....    .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..            ..+++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            54332    223345778999999998889999999999999999996 99999876654432            24689


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++.+++.+||..||.+|||+.+++++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-46  Score=315.19  Aligned_cols=246  Identities=25%  Similarity=0.390  Sum_probs=208.6

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceece
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~   84 (271)
                      +..+++..++|++.+.||+|+||.||+|++.     .++..+++|++.....  ......+.+|+.+++.+ +||||+++
T Consensus        37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            3456777899999999999999999999973     3567899999965432  23356788999999999 89999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCce
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHR-----------------------RFTEQQAATYIASLTNALAYCHENHVI  141 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~  141 (271)
                      ++++..++..++|||++++++|.+++....                       .+++..++.++.||+.||.+||++|++
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  194 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV  194 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            999999999999999999999999997643                       278999999999999999999999999


Q ss_pred             ecCCCCCCeeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCC
Q 024158          142 HRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPP  215 (271)
Q Consensus       142 H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p  215 (271)
                      |+||+|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999985443221     23346778999999998899999999999999999998 9999


Q ss_pred             CCCCCcchhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          216 FEAESQKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       216 ~~~~~~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                      |.+.......             ..+++++.+++.+||..||.+|||+.+++++-.
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            9876543321             235899999999999999999999999998743

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.5e-46  Score=306.72  Aligned_cols=241  Identities=22%  Similarity=0.384  Sum_probs=212.6

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ..+++..++|++.+.||+|+||.||+|.+..++..+++|.+..+..    ..+.+.+|+.+++.++||||+++++++..+
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   81 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   81 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            4667788999999999999999999999999999999999965432    245678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +..++|+|++++++|.+++...  ..+++..++.++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999999999863  35899999999999999999999999999999999999999999999999998654


Q ss_pred             cCcc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHH
Q 024158          170 RSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l  232 (271)
                      ....    ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||.........            ..+++++
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence            4322    22345778999999998899999999999999999999 99999876654432            2368999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+++.+||..||.+|||++++++.
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHHH
Confidence            999999999999999999999863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.2e-46  Score=312.83  Aligned_cols=246  Identities=24%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCceE--EEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV--ALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~--~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      .......+..++|++.+.||+|+||.||+|++..++..+  ++|.+....  .......+.+|+.+++++ +||||++++
T Consensus        15 ~~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~   92 (327)
T 1fvr_A           15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLL   92 (327)
T ss_dssp             -CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             CCcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhc
Confidence            334455688899999999999999999999999998865  899886432  223356788999999999 899999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPEN  149 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~N  149 (271)
                      +++...+..+++||++++++|.+++...+                .+++..++.++.||+.||.+||++|++|+||+|+|
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N  172 (327)
T 1fvr_A           93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN  172 (327)
T ss_dssp             EEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             eeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence            99999999999999999999999997654                68999999999999999999999999999999999


Q ss_pred             eeeCCCCCEEEeeecccccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-
Q 024158          150 LLLDHEGRLKIGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-  225 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-  225 (271)
                      |+++.++.++|+|||++.....  ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+.. 
T Consensus       173 Il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~  252 (327)
T 1fvr_A          173 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE  252 (327)
T ss_dssp             EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred             EEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH
Confidence            9999999999999998854332  2233456788999999988888999999999999999998 99999877654332 


Q ss_pred             -----------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 -----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 -----------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                 ..+++++.+++.+||..+|.+|||+++++++
T Consensus       253 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          253 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                       2358999999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.9e-46  Score=309.02  Aligned_cols=241  Identities=24%  Similarity=0.417  Sum_probs=202.7

Q ss_pred             hccCccccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ....+..++|++++.||+|+||.||+|+    +..+++.+++|++....   ....+.+.+|+.+++.++||||++++++
T Consensus         3 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   79 (295)
T 3ugc_A            3 DPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGV   79 (295)
T ss_dssp             ---CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4567888999999999999999999998    66789999999986543   2335678899999999999999999999


Q ss_pred             EEeC--CeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeec
Q 024158           88 FHDD--ERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFG  164 (271)
Q Consensus        88 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg  164 (271)
                      +...  ...++|||++++++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus        80 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           80 CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             ECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            8543  45899999999999999998754 48999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc----------------
Q 024158          165 WSVQSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK----------------  222 (271)
Q Consensus       165 ~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~----------------  222 (271)
                      ++......      .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+......                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            98554322      12334667799999999999999999999999999999999988643211                


Q ss_pred             ------------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          223 ------------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       223 ------------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                  .....+++++.+++.+||..||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                        011236899999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-45  Score=302.51  Aligned_cols=238  Identities=17%  Similarity=0.296  Sum_probs=207.3

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-   91 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-   91 (271)
                      ...+..++|++.+.||+|+||.||+|++.  +..+++|++....... ...+.+.+|+.+++.++||||+++++++... 
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            46788999999999999999999999974  8889999997654333 3356788999999999999999999999876 


Q ss_pred             -CeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           92 -ERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        92 -~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                       +..++++|++++++|.+++....  .+++..++.++.|++.||.|||++|  ++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             77899999999999999998755  4899999999999999999999999  999999999999999999999999876


Q ss_pred             ccccCccccccccccccCCccccCCCCCc---cchhhhHHHHHHHHHhCCCCCCCCCcchh-------------hcccCH
Q 024158          167 VQSRSKRHTMCGTLDYLAPEMVENKEHDY---AVDNWTLGILCYEFLYGAPPFEAESQKDT-------------FRSISA  230 (271)
Q Consensus       167 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~---~~Di~slg~il~~l~~g~~p~~~~~~~~~-------------~~~i~~  230 (271)
                      ....  .....+++.|+|||.+.+..++.   ++|+||||+++|+|++|..||......+.             ...+++
T Consensus       161 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          161 FSFQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             CTTS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             eeec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence            4422  23456789999999998765544   79999999999999999999987664433             234689


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhc
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++.+++.+||..||.+|||++++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.1e-45  Score=312.16  Aligned_cols=246  Identities=26%  Similarity=0.479  Sum_probs=210.4

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEe-------cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCc
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREV-------ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPN   80 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~   80 (271)
                      .......+..++|++.+.||+|+||.||+|++.       .++..+++|++.....  ......+.+|+.+++.+ +|||
T Consensus        25 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~  102 (334)
T 2pvf_A           25 PEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKN  102 (334)
T ss_dssp             CCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCC
Confidence            344556667799999999999999999999975       4577899999965432  23456788999999999 8999


Q ss_pred             eeceeeEEEeCCeEEEEEeccCCCchHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 024158           81 ILRLYGWFHDDERIFLILEYAHRGELYRELRKHR----------------RFTEQQAATYIASLTNALAYCHENHVIHRD  144 (271)
Q Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~d  144 (271)
                      |+++++++...+..++|+|++++++|.+++....                .+++..++.++.||+.||.+||++|++|+|
T Consensus       103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D  182 (334)
T 2pvf_A          103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD  182 (334)
T ss_dssp             BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence            9999999999999999999999999999998643                389999999999999999999999999999


Q ss_pred             CCCCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCC
Q 024158          145 IKPENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEA  218 (271)
Q Consensus       145 l~~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~  218 (271)
                      |+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            9999999999999999999998544332     223456788999999988889999999999999999998 9999987


Q ss_pred             CCcchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          219 ESQKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       219 ~~~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ....+..            ..+++++.+++.+||..+|.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          263 IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             CCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6654332            2368999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-45  Score=322.03  Aligned_cols=238  Identities=23%  Similarity=0.432  Sum_probs=206.4

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+.+..++|++.+.||+|+||.||++..  .++.||||++....     ..+.+.+|+.++++++||||+++++++..
T Consensus       185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~  257 (450)
T 1k9a_A          185 RSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVE  257 (450)
T ss_dssp             HTTCBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             ccccccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEc
Confidence            345678899999999999999999999986  47899999996643     23568899999999999999999999876


Q ss_pred             CC-eEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           91 DE-RIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        91 ~~-~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      .+ ..++|||++++++|.+++...+  .++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.
T Consensus       258 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~  337 (450)
T 1k9a_A          258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  337 (450)
T ss_dssp             TTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcc
Confidence            65 7999999999999999998754  37999999999999999999999999999999999999999999999999987


Q ss_pred             cccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHH
Q 024158          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       168 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                      ..........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ...|+++.+
T Consensus       338 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  417 (450)
T 1k9a_A          338 EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD  417 (450)
T ss_dssp             ECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            55544444567889999999999999999999999999999998 99999876654433            235899999


Q ss_pred             HHHHhcccCccCCCCHHHHhc
Q 024158          235 LISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++.+||..||.+|||+.++++
T Consensus       418 li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-45  Score=310.52  Aligned_cols=234  Identities=21%  Similarity=0.290  Sum_probs=203.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~   94 (271)
                      +..++|++.+.||+|+||.||+|++..+++.||+|++......     ..+.+|+.+++.+ +|+||+++++++..++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3457899999999999999999999999999999998654322     3577899999999 899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC-----EEEeeeccccc
Q 024158           95 FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR-----LKIGDFGWSVQ  168 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~-----~~L~dfg~~~~  168 (271)
                      ++|||++ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.     ++|+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 7899999986 367999999999999999999999999999999999999998887     99999999864


Q ss_pred             ccCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---cc--------
Q 024158          169 SRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---RS--------  227 (271)
Q Consensus       169 ~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---~~--------  227 (271)
                      ....          .....||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+....+..   ..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            3322          13457899999999999999999999999999999999999999875443221   11        


Q ss_pred             -------cCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          228 -------ISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       228 -------i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                             ..+++.+++..||..+|.+||+++++.+
T Consensus       240 ~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          240 PIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             CHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence                   1239999999999999999999998886

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-45  Score=301.69  Aligned_cols=238  Identities=23%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      +.++.++|++.+.||+|+||.||++++. ++..+++|++.......    +.+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4567889999999999999999999975 67889999997654432    467889999999999999999999999899


Q ss_pred             EEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           94 IFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      .++++|++++++|.+++... ..++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999999999875 46899999999999999999999999999999999999999999999999998654322


Q ss_pred             ----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHH
Q 024158          173 ----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHL  235 (271)
Q Consensus       173 ----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~l  235 (271)
                          .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+...            ..++++.++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence                223456778999999998889999999999999999999 899998766544322            258899999


Q ss_pred             HHHhcccCccCCCCHHHHhcC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+||..||.+|||+++++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.3e-45  Score=307.40  Aligned_cols=248  Identities=18%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEec---CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceece
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      +.......+..++|++.+.||+|+||.||+|.+..   ++..+++|.+....... ...+.+.+|+.+++.++||||+++
T Consensus        23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~  101 (313)
T 3brb_A           23 QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRL  101 (313)
T ss_dssp             -CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hhhHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeee
Confidence            34445556777899999999999999999998766   45579999986654333 345678899999999999999999


Q ss_pred             eeEEEeCC-----eEEEEEeccCCCchHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC
Q 024158           85 YGWFHDDE-----RIFLILEYAHRGELYRELRK------HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD  153 (271)
Q Consensus        85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~  153 (271)
                      ++++...+     ..++++|++++++|.+++..      ...+++..++.++.|++.||.+||++|++|+||+|+||+++
T Consensus       102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~  181 (313)
T 3brb_A          102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR  181 (313)
T ss_dssp             CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred             eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence            99987654     35999999999999999842      34689999999999999999999999999999999999999


Q ss_pred             CCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh--
Q 024158          154 HEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF--  225 (271)
Q Consensus       154 ~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~--  225 (271)
                      .++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..  
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  261 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY  261 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence            9999999999998544322     223346778999999999999999999999999999999 88999876654432  


Q ss_pred             ----------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ----------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                ..+++++.+++.+||..||.+|||+.+++++
T Consensus       262 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                      2368999999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8e-46  Score=305.20  Aligned_cols=242  Identities=23%  Similarity=0.417  Sum_probs=199.1

Q ss_pred             hhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      +........+..++|++.+.||+|++|.||++.+  +|+.+++|++....     ..+.+.+|+.+++.++||||+++++
T Consensus         9 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~   81 (278)
T 1byg_A            9 DEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLG   81 (278)
T ss_dssp             ------CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEE
T ss_pred             hhhhhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3444555678899999999999999999999986  48899999986542     2456888999999999999999999


Q ss_pred             EEEeC-CeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           87 WFHDD-ERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        87 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      ++... +..++++|++++++|.+++....  .++...++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+||
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Df  161 (278)
T 1byg_A           82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDF  161 (278)
T ss_dssp             EECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeec
Confidence            87554 47899999999899999997643  3899999999999999999999999999999999999999999999999


Q ss_pred             cccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCH
Q 024158          164 GWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISA  230 (271)
Q Consensus       164 g~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~  230 (271)
                      |++...........+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+..            ..+++
T Consensus       162 g~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          162 GLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP  241 (278)
T ss_dssp             CC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred             cccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence            998766555555677889999999988889999999999999999998 99999876544332            23589


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhc
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++.+++.+||..||.+|||+.++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHH
Confidence            9999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=9.4e-46  Score=311.15  Aligned_cols=243  Identities=23%  Similarity=0.332  Sum_probs=201.0

Q ss_pred             hhhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceecee
Q 024158            6 AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus         6 ~~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      .......+..+..++|++.+.||+|+||.||+|++.  ++.||+|++......    ......|+.++++++||||++++
T Consensus        11 ~~~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~   84 (322)
T 3soc_A           11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFI   84 (322)
T ss_dssp             ---CCCCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             ccccCccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhc
Confidence            344456677788899999999999999999999864  789999999654322    23445688899999999999999


Q ss_pred             eEEEeCC----eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCee
Q 024158           86 GWFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN----------HVIHRDIKPENLL  151 (271)
Q Consensus        86 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~----------~i~H~dl~~~Nil  151 (271)
                      +++....    .+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.          |++|+||||+||+
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nil  163 (322)
T 3soc_A           85 GAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL  163 (322)
T ss_dssp             EEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEE
T ss_pred             ceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEE
Confidence            9997743    47999999999999999977 4589999999999999999999999          9999999999999


Q ss_pred             eCCCCCEEEeeecccccccC-----ccccccccccccCCccccCC-----CCCccchhhhHHHHHHHHHhCCCCCCCCCc
Q 024158          152 LDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENK-----EHDYAVDNWTLGILCYEFLYGAPPFEAESQ  221 (271)
Q Consensus       152 i~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~-----~~~~~~Di~slg~il~~l~~g~~p~~~~~~  221 (271)
                      ++.++.++|+|||++.....     ......+|+.|+|||.+.+.     .++.++||||||+++|+|++|..||.+...
T Consensus       164 l~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          164 LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             ECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             ECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            99999999999999854332     22335689999999999863     455678999999999999999999976443


Q ss_pred             chhhc----------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          222 KDTFR----------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       222 ~~~~~----------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .....                                  ..++++.+++.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            21100                                  01345999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.8e-45  Score=305.07  Aligned_cols=243  Identities=23%  Similarity=0.372  Sum_probs=205.3

Q ss_pred             hhccCccccceeeee-eecccCCceEEEEE--EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           11 NRKREWSLQDFEIGR-PLGKGKFGRVYLVR--EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~-~lg~g~~~~v~~~~--~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      .....+..++|++.+ .||+|+||.||++.  ...+++.+++|++....... ...+.+.+|+.+++.++||||++++++
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~   86 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGI   86 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C-HHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH-HHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            344566778999999 99999999999994  45668899999997654322 345778899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      + ..+..++++|++++++|.+++...+.++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        87 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           87 C-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             E-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             E-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            8 567789999999999999999988889999999999999999999999999999999999999999999999999985


Q ss_pred             cccCcc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------ccc
Q 024158          168 QSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSI  228 (271)
Q Consensus       168 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i  228 (271)
                      ......      ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  245 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGC  245 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCC
Confidence            543322      12345688999999988888899999999999999998 99999876654332            346


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ++++.+++.+||..||.+|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            899999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.7e-46  Score=306.18  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=204.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCc-------eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKH-------PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-------~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ..+..++|++.+.||+|+||.||+|++..+++       .+++|++......   ..+.+.+|+.+++.++||||+++++
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~   79 (289)
T 4fvq_A            3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYG   79 (289)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred             EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            35678899999999999999999999988874       6999998654433   2467889999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC--------
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHRR-FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR--------  157 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~--------  157 (271)
                      ++..++..++|||++++++|.+++...+. ++...++.++.|++.||.+||++|++|+||||+||+++.++.        
T Consensus        80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           80 VCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             EECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             EEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999999999987554 899999999999999999999999999999999999998886        


Q ss_pred             EEEeeecccccccCccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchhh----------
Q 024158          158 LKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTF----------  225 (271)
Q Consensus       158 ~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~----------  225 (271)
                      ++|+|||.+...... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++| .+|+.........          
T Consensus       160 ~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          160 IKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP  238 (289)
T ss_dssp             EEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             eeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCC
Confidence            999999988554333 33457889999999987 6688999999999999999995 5555544332221          


Q ss_pred             cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ...++++.+++.+||..||.+|||+++++++
T Consensus       239 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2357889999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-45  Score=310.56  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             hhhccCccccceeeeeeecccCCceEEEEE-----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceece
Q 024158           10 DNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus        10 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~-----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      -.....+..++|++.+.||+|+||.||+|+     +..++..+++|.+......  .....+.+|+.+++.++||||+++
T Consensus        21 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~   98 (327)
T 2yfx_A           21 ISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRC   98 (327)
T ss_dssp             GGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeE
Confidence            345567888999999999999999999999     5567889999998643322  334578889999999999999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---  154 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---  154 (271)
                      ++++...+..++|||++++++|.+++....       .++...++.++.|++.||.+||++|++|+||+|+||+++.   
T Consensus        99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~  178 (327)
T 2yfx_A           99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP  178 (327)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred             EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence            999999889999999999999999998753       4899999999999999999999999999999999999984   


Q ss_pred             CCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh---
Q 024158          155 EGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF---  225 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~---  225 (271)
                      +..++|+|||++.....     ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..   
T Consensus       179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  258 (327)
T 2yfx_A          179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV  258 (327)
T ss_dssp             TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence            44699999998753221     2233456889999999988889999999999999999998 99999876644332   


Q ss_pred             ---------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 ---------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 ---------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                               ..+++.+.+++.+||..||.+|||+++++++.|+..
T Consensus       259 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence                     246899999999999999999999999999987643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-45  Score=308.98  Aligned_cols=244  Identities=20%  Similarity=0.345  Sum_probs=210.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceecee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      ...+.+..++|++.+.||+|+||.||+|++.     .++..+++|.+......  .....+.+|+.+++.++|+||++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            4455677789999999999999999999876     35788999998654322  3345788999999999999999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      +++..++..+++||++++++|.+++...          ..+++..++.++.|++.||.+||++|++|+||+|+||+++.+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTT
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCC
Confidence            9999999999999999999999999752          356899999999999999999999999999999999999999


Q ss_pred             CCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh----
Q 024158          156 GRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF----  225 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~----  225 (271)
                      +.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..    
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  254 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM  254 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence            99999999998544322     123345788999999998889999999999999999999 89999876654332    


Q ss_pred             --------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 --------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 --------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                              ..+++++.+++.+||..||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence                    3468999999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-45  Score=308.68  Aligned_cols=243  Identities=24%  Similarity=0.439  Sum_probs=207.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ....+..++|++.+.||+|+||.||+|++.     .+++.+++|++......  .....+.+|+.+++.+ +||||++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            345677889999999999999999999853     46788999999765332  3356788999999999 689999999


Q ss_pred             eEEEeCC-eEEEEEeccCCCchHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158           86 GWFHDDE-RIFLILEYAHRGELYRELRKHRR----------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus        86 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                      +++...+ .+++++|++++++|.+++.....                +++..++.++.|++.||.+||+.|++|+||+|+
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~  177 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  177 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            9987654 58999999999999999987543                899999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcc
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQK  222 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~  222 (271)
                      ||+++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            999999999999999998654322     123456788999999998899999999999999999998 99999876543


Q ss_pred             hh-------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          223 DT-------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       223 ~~-------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..             ...+++++.+++.+||..||.+|||++++++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            22             12368999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.7e-45  Score=315.43  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=200.5

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      -..++..++|++.+.||+|+||.||+|++.   .++..+++|++.....  ......+.+|+.++++++||||+++++++
T Consensus        38 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             TSCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            345677889999999999999999999877   4677899999865432  23456788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            99999999999999999999998753 68999999999999999999999999999999999999999999999999985


Q ss_pred             cccCcc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------cc
Q 024158          168 QSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SI  228 (271)
Q Consensus       168 ~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i  228 (271)
                      ......      ....+++.|+|||.+.+..++.++||||||+++|++++ |..||......+...            ..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~  275 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC  275 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTC
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            443221      12234678999999998899999999999999999997 999998766544332            35


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.++.+++.+||..||.+|||++++++
T Consensus       276 ~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          276 PAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             BHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            789999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.3e-45  Score=309.43  Aligned_cols=242  Identities=19%  Similarity=0.337  Sum_probs=200.5

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceE----EEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV----ALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ....++.++|++.+.||+|+||.||+|++..+++.+    ++|.+....  .......+.+|+.++++++||||++++++
T Consensus         8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   85 (327)
T 3poz_A            8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             SSEECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEE
T ss_pred             HHhhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            345678899999999999999999999988887765    777664332  22335678899999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      +..+. .+++++++.+++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        86 ~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             EecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcce
Confidence            98755 78899999999999999874 56899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------ccc
Q 024158          167 VQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSI  228 (271)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i  228 (271)
                      ......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..            ...
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccC
Confidence            543322     123345778999999999999999999999999999999 99999876654432            225


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.++.+++.+||..+|.+|||+.+++++
T Consensus       245 ~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          245 TIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            7899999999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.8e-45  Score=309.31  Aligned_cols=238  Identities=25%  Similarity=0.359  Sum_probs=205.0

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ...++|++.+.||+|+||.||+|++ .++..+++|.+......   ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3568899999999999999999996 57899999998654322   2467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           96 LILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      +|+|++++++|.+++....    .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999996543    489999999999999999999999999999999999999999999999999854332


Q ss_pred             c-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------
Q 024158          172 K-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------  225 (271)
Q Consensus       172 ~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------  225 (271)
                      .     .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....+.+..                     
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            1     22345789999999998888999999999999999999999999765432211                     


Q ss_pred             -------cccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          226 -------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       226 -------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                             ...+.++.+++.+||..||++|||+.+++++-
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence                   11356799999999999999999999999763

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.5e-45  Score=304.20  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=206.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-------
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-------   90 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-------   90 (271)
                      .++|++++.||+|+||.||+|++..+++.+++|.+....       ..+.+|+.+++.++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            468999999999999999999999999999999986543       245678999999999999999998854       


Q ss_pred             ---------CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEE
Q 024158           91 ---------DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLK  159 (271)
Q Consensus        91 ---------~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~  159 (271)
                               ...++++||++++++|.+++...  ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     44589999999999999999753  5789999999999999999999999999999999999999999999


Q ss_pred             EeeecccccccC--ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc-------hhhcccCH
Q 024158          160 IGDFGWSVQSRS--KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK-------DTFRSISA  230 (271)
Q Consensus       160 L~dfg~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~-------~~~~~i~~  230 (271)
                      |+|||++.....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+......       .....+++
T Consensus       163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK  242 (284)
T ss_dssp             ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCTTSCH
T ss_pred             ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccccCCH
Confidence            999998754433  233456899999999999999999999999999999999999887432210       11234689


Q ss_pred             HHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          231 EAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       231 ~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      ++.+++.+||..||.+|||+.+++++.+.-+....
T Consensus       243 ~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          243 KEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            99999999999999999999999999887766443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-45  Score=305.97  Aligned_cols=243  Identities=26%  Similarity=0.381  Sum_probs=203.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      .....+...+|++.+.||+|+||.||+|+    +..+++.+++|++......  .....+.+|+.+++.++|+||+++++
T Consensus        13 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~   90 (302)
T 4e5w_A           13 VDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKG   90 (302)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCeeeeee
Confidence            44556677889999999999999999999    6778999999999654322  23467889999999999999999999


Q ss_pred             EEEeC--CeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           87 WFHDD--ERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        87 ~~~~~--~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      ++...  ...++++|++++++|.+++.. ...++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Df  170 (302)
T 4e5w_A           91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF  170 (302)
T ss_dssp             EEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcc
Confidence            99876  668999999999999999955 457999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc----------------
Q 024158          164 GWSVQSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ----------------  221 (271)
Q Consensus       164 g~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~----------------  221 (271)
                      |++......      .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+.....                
T Consensus       171 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 4e5w_A          171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT  250 (302)
T ss_dssp             TTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred             cccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence            998554432      2334567789999999988899999999999999999999887542210                


Q ss_pred             -----------chhhcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          222 -----------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       222 -----------~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                 ......+++++.+++.+||..||.+|||++++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence                       0011236899999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=309.76  Aligned_cols=243  Identities=19%  Similarity=0.282  Sum_probs=198.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEec---CCceEEEEEechhhhhHHH--------HHHHHHHHHHHHhhCCCCce
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVE---SKHPVALKIIFKEQIEKYK--------IQHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~~~~~~--------~~~~~~~e~~~l~~~~~~~i   81 (271)
                      ...+..++|++.+.||+|+||.||+|++..   ++..+++|++.........        ....+.+++..++.++|+||
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni  110 (345)
T 2v62_A           31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI  110 (345)
T ss_dssp             EECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred             eccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence            344566789999999999999999999987   7889999998654321111        12235577888999999999


Q ss_pred             eceeeEEEe----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-
Q 024158           82 LRLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-  156 (271)
Q Consensus        82 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-  156 (271)
                      +++++++..    ....|++||++ +++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++ 
T Consensus       111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             ceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            999999987    67899999999 889999998877899999999999999999999999999999999999998877 


Q ss_pred             -CEEEeeecccccccCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-
Q 024158          157 -RLKIGDFGWSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-  224 (271)
Q Consensus       157 -~~~L~dfg~~~~~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-  224 (271)
                       .++|+|||++......          .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ 
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             9999999998543221          1344689999999999999999999999999999999999999965321111 


Q ss_pred             h---------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 F---------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 ~---------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .                     ..+++++.+++.+||..||++|||++++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            0                     0567899999999999999999999999874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-45  Score=300.82  Aligned_cols=242  Identities=24%  Similarity=0.354  Sum_probs=207.7

Q ss_pred             ccCccccceeeee-eecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           13 KREWSLQDFEIGR-PLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~-~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ...+..++|.+.+ .||+|+||.||+|.+.  .++..+++|++....  .....+.+.+|+.+++.++||||+++++++ 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-   79 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-   79 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence            4567788999998 9999999999999853  467889999997643  224467788999999999999999999998 


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      ..+..++++|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            556799999999999999999653 4689999999999999999999999999999999999999999999999999855


Q ss_pred             ccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccC
Q 024158          169 SRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSIS  229 (271)
Q Consensus       169 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~  229 (271)
                      ....      .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence            4322      123345788999999988889999999999999999998 99999876654332            3468


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                      +++.+++.+||..+|.+|||+.+++++.
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999999873

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.1e-45  Score=309.16  Aligned_cols=243  Identities=24%  Similarity=0.415  Sum_probs=209.0

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCc-----eEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ...++..++|++.+.||+|+||.||+|.+..++.     .+++|.+......  .....+.+|+.+++.+ +||||++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~  116 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLL  116 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEE
Confidence            3567778999999999999999999999877664     6999998654322  3356788999999999 899999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCee
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKH--------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLL  151 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nil  151 (271)
                      +++..++..++|||++++++|.+++...              ..++...++.++.|++.||.+||+.|++|+||+|+||+
T Consensus       117 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9999999999999999999999999652              35799999999999999999999999999999999999


Q ss_pred             eCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh
Q 024158          152 LDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF  225 (271)
Q Consensus       152 i~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~  225 (271)
                      ++.++.++|+|||++......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+.......
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            999999999999998543322     123345778999999998889999999999999999998 99999876543322


Q ss_pred             -------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 -------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 -------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                   ...++++.+++.+||..||.+|||+.+++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence                         2258999999999999999999999999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=305.39  Aligned_cols=242  Identities=24%  Similarity=0.372  Sum_probs=203.6

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCC----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ..++..++|++.+.||+|+||.||+|.+..++    ..+++|++......  .....+.+|+.+++.++||||+++++++
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~  115 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVI  115 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            34677889999999999999999999987654    35999998654322  3356788999999999999999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      ...+..++|||++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.
T Consensus       116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999999999764 579999999999999999999999999999999999999999999999999985


Q ss_pred             cccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------ccc
Q 024158          168 QSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSI  228 (271)
Q Consensus       168 ~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i  228 (271)
                      .....      .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            54322      122345778999999998899999999999999999998 99999876544332            235


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ++++.+++.+||..+|.+|||+.+++++
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7999999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=9.7e-46  Score=311.46  Aligned_cols=241  Identities=19%  Similarity=0.329  Sum_probs=203.1

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCce----EEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHP----VALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF   88 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   88 (271)
                      ...++.++|++++.||+|+||.||+|++..++..    +++|.+......  .....+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A            7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            3567889999999999999999999999888877    666666433211  1124566788999999999999999988


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      . ++..++|+|++.+++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  163 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD  163 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccc
Confidence            6 45689999999999999999774 478999999999999999999999999999999999999999999999999986


Q ss_pred             cccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccC
Q 024158          168 QSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SIS  229 (271)
Q Consensus       168 ~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~  229 (271)
                      .....     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+...            ..+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (325)
T 3kex_A          164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT  243 (325)
T ss_dssp             GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred             ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence            54322     233456778999999998899999999999999999999 999998766544322            247


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .++.+++.+||..||.+|||+.+++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=297.84  Aligned_cols=246  Identities=22%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceecee
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      -.+-........|++.+.||+|+||.||+|++..++.   .+++|.+....  .....+.+.+|+.+++.++||||++++
T Consensus        11 ~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~   88 (298)
T 3pls_A           11 VKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALI   88 (298)
T ss_dssp             TGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            3333444455567788999999999999999766555   79999986533  224467788999999999999999999


Q ss_pred             eEEEeCCeE-EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           86 GWFHDDERI-FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        86 ~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      +++...+.. ++++|++.+++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+||
T Consensus        89 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A           89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             EEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcC
Confidence            999766654 999999999999999987 456899999999999999999999999999999999999999999999999


Q ss_pred             cccccccC-------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchhh----------
Q 024158          164 GWSVQSRS-------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTF----------  225 (271)
Q Consensus       164 g~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~----------  225 (271)
                      |++.....       ......+++.|+|||.+.+..++.++|+||||+++|+|++| .+||......+..          
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP  248 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC
Confidence            99854322       22334568899999999999999999999999999999995 5555544443332          


Q ss_pred             --cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 --RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 --~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                        ..+++++.+++.+||..||.+|||++++++.
T Consensus       249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence              2358899999999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.3e-44  Score=309.10  Aligned_cols=241  Identities=18%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHH--------HHHHHHHHHHHhhCCCCce
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKI--------QHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~--------~~~~~~e~~~l~~~~~~~i   81 (271)
                      ....++|++.+.||+|+||.||+|.+..+     ++.+++|++..........        ......++..++.++|+||
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i  110 (364)
T 3op5_A           31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV  110 (364)
T ss_dssp             CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred             ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence            34556999999999999999999998765     5889999986553221111        1123345567788899999


Q ss_pred             eceeeEEEeC----CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC--C
Q 024158           82 LRLYGWFHDD----ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--H  154 (271)
Q Consensus        82 ~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~--~  154 (271)
                      +++++++...    ...++|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++  .
T Consensus       111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            9999998764    4589999999 89999999875 5799999999999999999999999999999999999998  7


Q ss_pred             CCCEEEeeecccccccCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh
Q 024158          155 EGRLKIGDFGWSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (271)
Q Consensus       155 ~~~~~L~dfg~~~~~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  224 (271)
                      ++.++|+|||++......          .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999998543221          1234489999999999999999999999999999999999999986432211


Q ss_pred             h----------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 F----------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 ~----------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .                      ..+|+++.+++..|+..+|.+|||++++++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            0                      3458999999999999999999999998863

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5e-45  Score=323.27  Aligned_cols=241  Identities=22%  Similarity=0.389  Sum_probs=211.5

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ..+++...+|++.+.||+|+||.||+|++..++..|++|.+......    .+.+.+|+.++++++||||+++++++...
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            34567788999999999999999999999999999999999765433    35688999999999999999999999998


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +..++|||++++++|.+++...  ..++...++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++...
T Consensus       289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            9999999999999999999863  45899999999999999999999999999999999999999999999999998654


Q ss_pred             cCcc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHH
Q 024158          170 RSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l  232 (271)
                      ....    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..+++++
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  448 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  448 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            3321    23345678999999998889999999999999999998 99999877654432            2357999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+++.+||..||.+|||+.++++.
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~~  472 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQA  472 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCcChhHCcCHHHHHHH
Confidence            999999999999999999999863

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.6e-44  Score=297.94  Aligned_cols=241  Identities=26%  Similarity=0.379  Sum_probs=204.6

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ...+..++|++.+.||+|+||.||+|++...   +..+++|.+......  ...+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            4567789999999999999999999986653   345999998765322  33567889999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      . +..++++|++++++|.+++... ..++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus        84 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 E-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            5 4568999999999999999764 4589999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ....    .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+..            ..+++.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPV  242 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHH
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHH
Confidence            4332    223456778999999988889999999999999999998 99999765544332            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..||.+|||+.+++++
T Consensus       243 l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          243 LYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCchhCcCHHHHHHH
Confidence            9999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.3e-44  Score=299.65  Aligned_cols=227  Identities=29%  Similarity=0.604  Sum_probs=191.3

Q ss_pred             cCccccceeee-eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH-hhCCCCceeceeeEEEe-
Q 024158           14 REWSLQDFEIG-RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHD-   90 (271)
Q Consensus        14 ~~~~~~~y~~~-~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~-   90 (271)
                      .....++|.+. +.||+|+||.||+|.+..+++.||+|++...        ....+|+.++ +..+||||+++++++.. 
T Consensus        12 ~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~   83 (299)
T 3m2w_A           12 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL   83 (299)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             ccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence            34567889888 7799999999999999999999999998542        2345666666 66689999999999876 


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEee
Q 024158           91 ---DERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGD  162 (271)
Q Consensus        91 ---~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~d  162 (271)
                         ....++|||++++++|.+++....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.   ++.++|+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence               677999999999999999998754  6999999999999999999999999999999999999998   78899999


Q ss_pred             ecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------
Q 024158          163 FGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------  224 (271)
Q Consensus       163 fg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------  224 (271)
                      ||++....                   +..++.++|+||||+++|+|++|..||........                  
T Consensus       164 fg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (299)
T 3m2w_A          164 FGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  224 (299)
T ss_dssp             CTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHH
T ss_pred             cccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCch
Confidence            99874322                   23467789999999999999999999965443221                  


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCC
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                       +..+++++.+++.+||..||.+|||++++++||||++......
T Consensus       225 ~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~  268 (299)
T 3m2w_A          225 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  268 (299)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCC
T ss_pred             hcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCC
Confidence             1346899999999999999999999999999999988754443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1e-44  Score=300.35  Aligned_cols=243  Identities=23%  Similarity=0.473  Sum_probs=196.1

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      .......++..++|++.+.||+|+||.||++++.   ..+++|++...... ....+.+.+|+.+++.++|+||++++++
T Consensus        13 ~~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           13 RDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             -----CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CCCCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            3455677888999999999999999999999854   35999998655433 3446778899999999999999999996


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      . .....++++|++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           89 S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             E-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             c-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceec
Confidence            5 45668999999999999999965 356899999999999999999999999999999999999999999999999988


Q ss_pred             ccccC-----ccccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------
Q 024158          167 VQSRS-----KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------  224 (271)
Q Consensus       167 ~~~~~-----~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------  224 (271)
                      .....     ......+++.|+|||.+.   +..++.++||||||+++|+|++|..||......+.              
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCT
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcch
Confidence            54332     223346899999999986   56678899999999999999999999987554322              


Q ss_pred             ---hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ---FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ---~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                         ...+++++.+++.+||..+|.+|||++++++
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence               1246899999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=305.55  Aligned_cols=242  Identities=19%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceE----EEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPV----ALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~----~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      ....+..++|++++.||+|+||.||+|++..+++.+    ++|.+......  .....+.+|+.+++.++||||++++++
T Consensus         8 ~~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (327)
T 3lzb_A            8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGI   85 (327)
T ss_dssp             CCEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSC--CCHHHHHHHHHHHTTCCBTTBCCCCEE
T ss_pred             hhcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCH--HHHHHHHHHHHHHHhCCCCCeeEEEEE
Confidence            345677899999999999999999999998888876    55555332211  234678889999999999999999999


Q ss_pred             EEeCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           88 FHDDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      +..+. .+++++++.+++|.+++... ..++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++
T Consensus        86 ~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           86 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             EESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             EecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            98755 78899999999999999774 56899999999999999999999999999999999999999999999999998


Q ss_pred             ccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------ccc
Q 024158          167 VQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSI  228 (271)
Q Consensus       167 ~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i  228 (271)
                      ......     .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..            ..+
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            543322     223345778999999999999999999999999999999 99999876654432            235


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.++.+++.+||..||.+|||+.++++.
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=302.33  Aligned_cols=241  Identities=27%  Similarity=0.425  Sum_probs=202.0

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe---
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD---   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---   90 (271)
                      ..+..++|++.+.||+|+||.||++++..+++.+++|++....   ....+.+.+|+.+++.++||||+++++++..   
T Consensus        24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  100 (317)
T 2buj_A           24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG  100 (317)
T ss_dssp             EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred             EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence            3456788999999999999999999999999999999985532   2335678899999999999999999999862   


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           91 -DERIFLILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                       ....++++|++.+++|.+++..    ...+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus       101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence             3478999999999999999975    45799999999999999999999999999999999999999999999999998


Q ss_pred             cccccCcc------------ccccccccccCCccccCCC---CCccchhhhHHHHHHHHHhCCCCCCCCCcc--------
Q 024158          166 SVQSRSKR------------HTMCGTLDYLAPEMVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQK--------  222 (271)
Q Consensus       166 ~~~~~~~~------------~~~~~~~~y~~pe~~~~~~---~~~~~Di~slg~il~~l~~g~~p~~~~~~~--------  222 (271)
                      +.......            ....+++.|+|||.+.+..   ++.++|+||||+++|+|++|..||......        
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            75432211            1234689999999987654   678999999999999999999998542110        


Q ss_pred             ------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          223 ------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       223 ------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                            .....+++++.+++.+||..||.+|||+++++++-
T Consensus       261 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence                  01124689999999999999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=300.44  Aligned_cols=241  Identities=29%  Similarity=0.486  Sum_probs=199.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .++.++|++.+.||+|+||.||++++  .++.+++|.+....     ..+.+.+|+.++++++||||+++++++.+  ..
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~   74 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PV   74 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TT
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Cc
Confidence            46788999999999999999999986  47889999985432     24567889999999999999999998763  47


Q ss_pred             EEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCeeeCCCCC-EEEeeecccc
Q 024158           95 FLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHE---NHVIHRDIKPENLLLDHEGR-LKIGDFGWSV  167 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~---~~i~H~dl~~~Nili~~~~~-~~L~dfg~~~  167 (271)
                      ++||||+++++|.+++....   .++...++.++.|++.||.|||+   +|++|+||+|+||+++.++. ++|+|||++.
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~  154 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC  154 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred             EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence            89999999999999998754   37899999999999999999999   89999999999999988886 7999999987


Q ss_pred             cccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------hhcccCHHHH
Q 024158          168 QSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------TFRSISAEAK  233 (271)
Q Consensus       168 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------~~~~i~~~l~  233 (271)
                      ..........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.......              ....+++.+.
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (307)
T 2eva_A          155 DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE  234 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHH
T ss_pred             ccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHH
Confidence            65555555678999999999999899999999999999999999999997543221              1234789999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcC-----CccccCCC
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEH-----PWIIKNAN  264 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~-----~~~~~~~~  264 (271)
                      +++.+||..||.+|||+++++++     +++.....
T Consensus       235 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          235 SLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence            99999999999999999999984     55554443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-44  Score=298.02  Aligned_cols=238  Identities=22%  Similarity=0.389  Sum_probs=205.7

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ..+++..++|++++.||+|+||.||+|++. ++..+++|.+......    .+.+.+|+.+++.++||||+++++++.. 
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   79 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-
Confidence            456777899999999999999999999964 6778999998665433    3567889999999999999999999864 


Q ss_pred             CeEEEEEeccCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +..++++|++++++|.+++....  .++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            56899999999999999997543  6899999999999999999999999999999999999999999999999998654


Q ss_pred             cCcc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHH
Q 024158          170 RSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l  232 (271)
                      ....    ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||.+....+..            ..+++++
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL  239 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHH
Confidence            4322    23345778999999988889999999999999999998 99999876654432            2468999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .+++.+||..+|.+|||++++++
T Consensus       240 ~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          240 YQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhccChhhCCCHHHHHH
Confidence            99999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.7e-45  Score=308.68  Aligned_cols=243  Identities=24%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ......++|++.+.||+|+||.||+|++ .+++.+|+|++.......  ....+.+|+.+++.++||||+++++++..++
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            3445678899999999999999999985 468999999986543221  1235788999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           93 RIFLILEYAHRGELYRELRKHR----RFTEQQAATYIASLTNALAYCHEN---HVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~~l~~~l~~Lh~~---~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ..++++|++++++|.+++....    .+++..++.++.|++.||.+||+.   |++|+||+|+||+++.++.++|+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  180 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL  180 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred             ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence            9999999999999999998643    489999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc-----------------chh
Q 024158          166 SVQSRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-----------------KDT  224 (271)
Q Consensus       166 ~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-----------------~~~  224 (271)
                      +......    .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||.....                 ...
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  260 (326)
T 3uim_A          181 AKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK  260 (326)
T ss_dssp             CEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred             ccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence            8543322    2334589999999999888899999999999999999999999952110                 000


Q ss_pred             -------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCc
Q 024158          225 -------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPW  258 (271)
Q Consensus       225 -------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~  258 (271)
                                   ....+.++.+++.+||..||.+|||+.+++++-.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                         0112478999999999999999999999998854

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4e-44  Score=297.30  Aligned_cols=232  Identities=20%  Similarity=0.323  Sum_probs=195.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE-EeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF-HDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~l   96 (271)
                      .++|++.+.||+|+||.||+|++..+++.+++|++......     ..+.+|+.+++.++|++++..+..+ ..++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            46899999999999999999999999999999986543322     3467889999999887766655544 67778899


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeecccccccCc
Q 024158           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++|++ +++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++   +.++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 7899999985 4579999999999999999999999999999999999999   78899999999998544332


Q ss_pred             ----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------
Q 024158          173 ----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------  224 (271)
Q Consensus       173 ----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------  224 (271)
                                .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........                  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence                      2245689999999999999999999999999999999999999987543221                  


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                       ...+|+++.+++.+||..||++|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             1345899999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-44  Score=305.31  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=206.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      .....++.++|++++.||+|+||.||+|+    +..++..+++|++.....   ...+.+.+|+.+++.++|+||+++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~   91 (327)
T 3lxl_A           15 QDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRG   91 (327)
T ss_dssp             --CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEE
Confidence            34456788999999999999999999999    567899999999865432   33467889999999999999999999


Q ss_pred             EEE--eCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           87 WFH--DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        87 ~~~--~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                      ++.  ..+..++|+|++++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df  171 (327)
T 3lxl_A           92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF  171 (327)
T ss_dssp             EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred             EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence            886  45678999999999999999976 346999999999999999999999999999999999999999999999999


Q ss_pred             cccccccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------
Q 024158          164 GWSVQSRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------  223 (271)
Q Consensus       164 g~~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------  223 (271)
                      |.+......      .....+++.|+|||.+.+..++.++|+||||+++++|++|..||.......              
T Consensus       172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            998654322      223456778999999988888999999999999999999999986443211              


Q ss_pred             -------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          224 -------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       224 -------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                   ....+++++.+++.+||..||.+|||+++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                         112358999999999999999999999999654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.3e-44  Score=297.63  Aligned_cols=244  Identities=20%  Similarity=0.334  Sum_probs=201.4

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeE
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGW   87 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   87 (271)
                      .....-...+|++.+.||+|+||.||+|++..++   ..+++|.+....  .......+.+|+.++++++||||++++++
T Consensus        17 ~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (298)
T 3f66_A           17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGI   94 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             heecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence            3344555677999999999999999999865443   358899886532  22345778899999999999999999998


Q ss_pred             EE-eCCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           88 FH-DDERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        88 ~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      +. .++..++++|++++++|.+++.. ...++...++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus        95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A           95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence            64 45678999999999999999976 34689999999999999999999999999999999999999999999999999


Q ss_pred             cccccCc-------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------
Q 024158          166 SVQSRSK-------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------  225 (271)
Q Consensus       166 ~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------  225 (271)
                      +......       .....+++.|+|||.+.+..++.++|+||||+++++|++ +.+||......+..            
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP  254 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC
Confidence            8543322       223456788999999998899999999999999999999 66677665543332            


Q ss_pred             cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ..+++++.+++.+||..+|.+|||+.++++.
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2358999999999999999999999999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2e-44  Score=316.36  Aligned_cols=239  Identities=22%  Similarity=0.399  Sum_probs=207.4

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+++..++|++.+.||+|+||.||+|.+. ++..||||++......    .+.+.+|+.+++.++||||+++++++. 
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-  253 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-  253 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-
Confidence            3456778889999999999999999999974 5778999999765432    457889999999999999999999986 


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .+..++|||++++++|.+++...  ..++...++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus       254 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            56789999999999999999753  3689999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~  231 (271)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+...            .+|++
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  413 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  413 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4332    223345778999999998899999999999999999998 999998776554432            35899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+++.+||..||.+|||++++++
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999976

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=304.25  Aligned_cols=241  Identities=25%  Similarity=0.383  Sum_probs=188.0

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEE--
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFH--   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~--   89 (271)
                      ..++.-.+|++.+.||+|+||.||++++..+++.|++|++.....   .....+.+|+.+++++. ||||+++++++.  
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            445556689999999999999999999999999999999855432   33467788999999996 999999999984  


Q ss_pred             ------eCCeEEEEEeccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeCCCCCE
Q 024158           90 ------DDERIFLILEYAHRGELYRELRK---HRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLDHEGRL  158 (271)
Q Consensus        90 ------~~~~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~~~~~~  158 (271)
                            ....+++++|+++ ++|.+++..   ...+++..++.++.||+.||.|||+.|  ++|+||+|+||+++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3345899999996 699888865   456999999999999999999999999  9999999999999999999


Q ss_pred             EEeeecccccccCcc---------------ccccccccccCCccc---cCCCCCccchhhhHHHHHHHHHhCCCCCCCCC
Q 024158          159 KIGDFGWSVQSRSKR---------------HTMCGTLDYLAPEMV---ENKEHDYAVDNWTLGILCYEFLYGAPPFEAES  220 (271)
Q Consensus       159 ~L~dfg~~~~~~~~~---------------~~~~~~~~y~~pe~~---~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~  220 (271)
                      +|+|||++.......               ....+++.|+|||.+   .+..++.++||||||+++|+|++|..||....
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~  257 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA  257 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence            999999985543321               134588999999998   56678889999999999999999999997655


Q ss_pred             cchhh---------cccCHHHHHHHHHhcccCccCCCCHHHHhcCC
Q 024158          221 QKDTF---------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHP  257 (271)
Q Consensus       221 ~~~~~---------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~  257 (271)
                      .....         ...+..+.+++.+||..||.+|||+++++++-
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             --------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            43332         23467899999999999999999999999874

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.1e-44  Score=300.15  Aligned_cols=242  Identities=23%  Similarity=0.383  Sum_probs=197.3

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecC-Cc--eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVES-KH--PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-~~--~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ..+..++|++.+.||+|+||.||+|++... +.  .+++|++...........+.+.+|+.+++.++||||+++++++..
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            456778999999999999999999986543 33  589999876654444556788999999999999999999999877


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +. .++++|++++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            55 88999999999999999764 56899999999999999999999999999999999999999999999999998554


Q ss_pred             cCcc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccC
Q 024158          170 RSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSIS  229 (271)
Q Consensus       170 ~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~  229 (271)
                      ....      ....+++.|+|||.+.+..++.++|+||||+++++|++ |..||......+..             ..++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            3322      23346778999999988888999999999999999999 99999876644332             2468


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +++.+++.+||..||.+|||+.+++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999973

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-45  Score=331.44  Aligned_cols=247  Identities=27%  Similarity=0.410  Sum_probs=204.5

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe---
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD---   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---   90 (271)
                      .....++|++.+.||+|+||.||+|++..+|+.||+|++....  .......+.+|+.+++.++||||+++++++..   
T Consensus         9 pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~   86 (676)
T 3qa8_A            9 PTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQK   86 (676)
T ss_dssp             --------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCC
T ss_pred             CCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccc
Confidence            3456689999999999999999999999999999999986542  22345678899999999999999999998755   


Q ss_pred             ---CCeEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCC---EEEe
Q 024158           91 ---DERIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGR---LKIG  161 (271)
Q Consensus        91 ---~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~---~~L~  161 (271)
                         ++..++||||+++++|.+++....   .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.   ++|+
T Consensus        87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence               667899999999999999998743   5899999999999999999999999999999999999987765   9999


Q ss_pred             eecccccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch----------------
Q 024158          162 DFGWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD----------------  223 (271)
Q Consensus       162 dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~----------------  223 (271)
                      |||.+......  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.....                
T Consensus       167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            99998654432  344578999999999999999999999999999999999999996532111                


Q ss_pred             -------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          224 -------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       224 -------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                         ....+++.+.+++.+||.+||.+|||++++++||||+..
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l  304 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL  304 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence                               112257889999999999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1e-43  Score=294.87  Aligned_cols=233  Identities=20%  Similarity=0.318  Sum_probs=198.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEE-EeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWF-HDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-~~~~~~~l   96 (271)
                      .++|++.+.||+|+||.||+|++..+++.+++|++......     ..+.+|+.+++.++|++++..+..+ ..++..++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            47899999999999999999999999999999998654322     3477899999999987765555544 66778899


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC---CCCCEEEeeecccccccCc
Q 024158           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~---~~~~~~L~dfg~~~~~~~~  172 (271)
                      ++|++ +++|.+++.. ...+++..++.++.|++.||.+||++|++|+||+|+||+++   .++.++|+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99999 7899999974 45799999999999999999999999999999999999994   7889999999998543332


Q ss_pred             ----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch---h---------------
Q 024158          173 ----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD---T---------------  224 (271)
Q Consensus       173 ----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~---~---------------  224 (271)
                                .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......   .               
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence                      234568999999999999999999999999999999999999998743221   1               


Q ss_pred             -hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 -FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 -~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                       ...+|+++.+++.+||..||.+|||++++++.
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  274 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL  274 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence             13468999999999999999999999998764

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=313.00  Aligned_cols=240  Identities=24%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC--
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE--   92 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--   92 (271)
                      .+..++|++.+.||+|+||.||+|++..+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++...+  
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            455678999999999999999999999999999999997654332  2456678999999999999999999988755  


Q ss_pred             eEEEEEeccCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee----CCCCCEEEeeecc
Q 024158           93 RIFLILEYAHRGELYRELRKHR---RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL----DHEGRLKIGDFGW  165 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili----~~~~~~~L~dfg~  165 (271)
                      ..++||||+++++|.+++....   .+++..++.++.||+.||.|||++|++|+||||+||++    +.++.++|+|||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            7899999999999999997643   38999999999999999999999999999999999999    6777899999999


Q ss_pred             cccccCc--cccccccccccCCccccC--------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------
Q 024158          166 SVQSRSK--RHTMCGTLDYLAPEMVEN--------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------  224 (271)
Q Consensus       166 ~~~~~~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------  224 (271)
                      +......  .....|++.|+|||.+.+        ..++.++|+||||+++|+|++|..||........           
T Consensus       163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            8654332  234568999999998865        4567799999999999999999999964332110           


Q ss_pred             -----------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          225 -----------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       225 -----------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                                   ...+++.+.+++.+||..||++|||+++++++
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                                         01245788999999999999999999998543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-44  Score=297.94  Aligned_cols=232  Identities=26%  Similarity=0.434  Sum_probs=190.5

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh--CCCCceeceeeEEEe--
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS--LRHPNILRLYGWFHD--   90 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~--~~~~~i~~~~~~~~~--   90 (271)
                      .+..++|++.+.||+|+||.||++++  +++.+|+|++.....      ..+..|.+++..  ++||||+++++++..  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            45678999999999999999999986  689999999865432      223344455444  799999999998654  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCeeeCCCCCEEE
Q 024158           91 --DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH--------ENHVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh--------~~~i~H~dl~~~Nili~~~~~~~L  160 (271)
                        ....++++|++++++|.++++. ..+++..++.++.|++.||.|||        +.|++|+||||+||+++.++.++|
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3468999999999999999965 56899999999999999999999        999999999999999999999999


Q ss_pred             eeecccccccCc-------cccccccccccCCccccCC------CCCccchhhhHHHHHHHHHhC----------CCCCC
Q 024158          161 GDFGWSVQSRSK-------RHTMCGTLDYLAPEMVENK------EHDYAVDNWTLGILCYEFLYG----------APPFE  217 (271)
Q Consensus       161 ~dfg~~~~~~~~-------~~~~~~~~~y~~pe~~~~~------~~~~~~Di~slg~il~~l~~g----------~~p~~  217 (271)
                      +|||++......       .....||+.|+|||.+.+.      .++.++||||||+++|+|++|          ..||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998543322       2234789999999999876      344689999999999999999          88886


Q ss_pred             CCCcchh----h-------------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          218 AESQKDT----F-------------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       218 ~~~~~~~----~-------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .......    .                   ...++++.+++.+||..||.+|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            5432211    0                   113478999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=305.81  Aligned_cols=231  Identities=18%  Similarity=0.288  Sum_probs=197.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEec--------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceec-----
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVE--------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILR-----   83 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~-----   83 (271)
                      ..++|++.+.||+|+||.||+|++..        .++.+|+|++...        ..+.+|+.+++.++|||+++     
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhh
Confidence            35799999999999999999999987        4889999998653        34667888999999988877     


Q ss_pred             ----------eeeEEEe-CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCe
Q 024158           84 ----------LYGWFHD-DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENL  150 (271)
Q Consensus        84 ----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Ni  150 (271)
                                +++++.. ++..++|||++ +++|.+++...  ..+++..++.++.||+.||.|||++|++|+||+|+||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  190 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI  190 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGE
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence                      6777765 67899999999 89999999875  6799999999999999999999999999999999999


Q ss_pred             eeCCCC--CEEEeeecccccccCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCC
Q 024158          151 LLDHEG--RLKIGDFGWSVQSRSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEA  218 (271)
Q Consensus       151 li~~~~--~~~L~dfg~~~~~~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~  218 (271)
                      +++.++  .++|+|||++......          .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999988  8999999998543321          1334789999999999998999999999999999999999999987


Q ss_pred             CCc-chhh---------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          219 ESQ-KDTF---------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       219 ~~~-~~~~---------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ... ....                     ..+++++.+++.+||..||.+|||++++++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            641 1110                     1358999999999999999999999999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-44  Score=311.59  Aligned_cols=238  Identities=26%  Similarity=0.427  Sum_probs=191.9

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERI   94 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~   94 (271)
                      +.-.+|.+.+.||+|+||+|+. +...+++.||||++......      .+.+|+.+++.+ +||||+++++++...+..
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            3445599999999999999763 44578999999998654433      245788999998 799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-----CCEEEeeeccccc
Q 024158           95 FLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-----GRLKIGDFGWSVQ  168 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-----~~~~L~dfg~~~~  168 (271)
                      |++||+++ ++|.+++.... .++...++.++.||+.||.|||++||+|+||||+||+++.+     ..++|+|||++..
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             EEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            99999997 69999997643 45556678999999999999999999999999999999532     2588999999855


Q ss_pred             ccC------ccccccccccccCCcccc---CCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------
Q 024158          169 SRS------KRHTMCGTLDYLAPEMVE---NKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------  225 (271)
Q Consensus       169 ~~~------~~~~~~~~~~y~~pe~~~---~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------  225 (271)
                      ...      ......||+.|+|||.+.   ...++.++||||||+++|+|++ |..||.........             
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~  252 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP  252 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc
Confidence            432      223456899999999997   3556779999999999999999 89998654432221             


Q ss_pred             -cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 -RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 -~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                       ...+..+.++|.+||..||.+|||++++++||||..
T Consensus       253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          253 EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence             112466899999999999999999999999999974

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.9e-44  Score=300.15  Aligned_cols=237  Identities=27%  Similarity=0.427  Sum_probs=199.9

Q ss_pred             ccccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      +....|++++.||+|+||.||++.    +..+++.+++|++.....  ......+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            333445999999999999998775    445788999999976532  23457788999999999999999999999874


Q ss_pred             --CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 --ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 --~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                        ..+++|||++++++|.+++... .+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence              6789999999999999999774 4899999999999999999999999999999999999999999999999998654


Q ss_pred             cCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcc---------------------
Q 024158          170 RSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQK---------------------  222 (271)
Q Consensus       170 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~---------------------  222 (271)
                      ...      .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......                     
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            432      22345677899999999888899999999999999999999998754321                     


Q ss_pred             ------hhhcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          223 ------DTFRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       223 ------~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                            .....+++++.+++.+||..||.+|||++++++
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                  111236899999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-44  Score=300.90  Aligned_cols=244  Identities=25%  Similarity=0.414  Sum_probs=203.2

Q ss_pred             hhhhccCccccceeeeeeecccCCceEEEEE----EecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceece
Q 024158            9 EDNRKREWSLQDFEIGRPLGKGKFGRVYLVR----EVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRL   84 (271)
Q Consensus         9 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~----~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~   84 (271)
                      .+.....+..++|++++.||+|+||.||+++    +..+++.+++|++.....   ...+.+.+|+.+++.++|+||+++
T Consensus        31 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~  107 (326)
T 2w1i_A           31 EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKY  107 (326)
T ss_dssp             ------CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeE
Confidence            3445667888999999999999999999998    567899999999865432   335678899999999999999999


Q ss_pred             eeEEEeCC--eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEe
Q 024158           85 YGWFHDDE--RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIG  161 (271)
Q Consensus        85 ~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~  161 (271)
                      ++++...+  ..++|+|++++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus       108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             EEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             EEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEe
Confidence            99886543  689999999999999999875 458999999999999999999999999999999999999999999999


Q ss_pred             eecccccccCcc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc--------------
Q 024158          162 DFGWSVQSRSKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ--------------  221 (271)
Q Consensus       162 dfg~~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~--------------  221 (271)
                      |||++.......      ....++..|+|||.+.+..++.++|+||||+++++|++|..|+.....              
T Consensus       188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            999986543322      223456779999999888889999999999999999999988764310              


Q ss_pred             --------------chhhcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          222 --------------KDTFRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       222 --------------~~~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                    ......+++++.+++.+||..||.+|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence                          0011246899999999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5e-44  Score=313.65  Aligned_cols=244  Identities=21%  Similarity=0.386  Sum_probs=205.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+++..++|++.+.||+|+||.||++.+.. +..+|+|++......    .+.+.+|+.++++++||||+++++++..
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~  250 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE  250 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34566778899999999999999999999854 466999999765433    2467899999999999999999999866


Q ss_pred             CCeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                       +..++|||++++++|.+++..  ...++...++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus       251 -~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          251 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             -CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence             678999999999999999974  35689999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..+|++
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  409 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  409 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4322    223345778999999998899999999999999999999 99999877654433            235889


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC--Cccc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH--PWII  260 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~--~~~~  260 (271)
                      +.+++.+||..||++|||++++++.  .++.
T Consensus       410 l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          410 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            9999999999999999999999874  5554

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-43  Score=309.96  Aligned_cols=240  Identities=28%  Similarity=0.430  Sum_probs=189.9

Q ss_pred             cCccccce-eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           14 REWSLQDF-EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        14 ~~~~~~~y-~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      .+..++++ .+.+.||+|+||+||.+ ...+|+.||||++..+.      .+.+.+|+.+++.+ +||||+++++++..+
T Consensus         9 ~~~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   81 (434)
T 2rio_A            9 FEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTD   81 (434)
T ss_dssp             CSCSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             hhhhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence            34444554 55688999999999865 45789999999986543      23456788888876 899999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC---------
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRF-------TEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE---------  155 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l-------~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~---------  155 (271)
                      +..|+|+|+++ ++|.+++......       +...++.++.||+.||.|||++||+|+||||+||+++.+         
T Consensus        82 ~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           82 RFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             SEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             CeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccccc
Confidence            99999999996 6999999865432       223457799999999999999999999999999999754         


Q ss_pred             ----CCEEEeeecccccccCcc-------ccccccccccCCccccC-------CCCCccchhhhHHHHHHHHHh-CCCCC
Q 024158          156 ----GRLKIGDFGWSVQSRSKR-------HTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLY-GAPPF  216 (271)
Q Consensus       156 ----~~~~L~dfg~~~~~~~~~-------~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slg~il~~l~~-g~~p~  216 (271)
                          +.++|+|||++.......       ....||+.|+|||.+.+       ..++.++||||||+++|+|++ |..||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                479999999986544321       23468999999999975       567889999999999999998 99999


Q ss_pred             CCCCcchh----------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          217 EAESQKDT----------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       217 ~~~~~~~~----------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                      ........                ...+++++.+++.+||..||.+|||+.++++||||..
T Consensus       241 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          241 GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             CSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             CCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            76533211                0123588999999999999999999999999999964

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.5e-44  Score=312.16  Aligned_cols=244  Identities=17%  Similarity=0.221  Sum_probs=196.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-Cce---------ecee-
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNI---------LRLY-   85 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i---------~~~~-   85 (271)
                      ....|+..+.||+|+||.||+|++..+|+.||||++...........+.+++|+.+++.+.| ++.         +... 
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            34568899999999999999999999999999999875444444446778899999999976 211         1111 


Q ss_pred             -----------eEEEe-----CCeEEEEEeccCCCchHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024158           86 -----------GWFHD-----DERIFLILEYAHRGELYRELRK-------HRRFTEQQAATYIASLTNALAYCHENHVIH  142 (271)
Q Consensus        86 -----------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H  142 (271)
                                 .++..     ...++++++.+. ++|.+++..       ...+++..++.++.|++.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                       11111     124678888874 799988841       234778899999999999999999999999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeecccccccCccccccccccccCCccc----------cCCCCCccchhhhHHHHHHHHHhC
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMV----------ENKEHDYAVDNWTLGILCYEFLYG  212 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~----------~~~~~~~~~Di~slg~il~~l~~g  212 (271)
                      |||||+||+++.++.++|+|||++...........| +.|+|||.+          .+..++.++||||||+++|+|++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg  313 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA  313 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHC
Confidence            999999999999999999999998766665666677 999999999          555678899999999999999999


Q ss_pred             CCCCCCCCcchhh-------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          213 APPFEAESQKDTF-------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       213 ~~p~~~~~~~~~~-------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      ..||......+..       ..+|+++.+++.+||..||++|||+.++++||||++.
T Consensus       314 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          314 DLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             SCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999876554332       3479999999999999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=303.16  Aligned_cols=236  Identities=18%  Similarity=0.306  Sum_probs=194.8

Q ss_pred             cCccccceeeeeeecccCCceEEEE-----EEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC---CCceecee
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLV-----REVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRLY   85 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~-----~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~   85 (271)
                      ..+..++|++.+.||+|+||.||+|     .+..+++.+|+|++.....      ..+..+.++++.+.   |++++.++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            3455678999999999999999999     4677899999999865432      23455666666665   89999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC------
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRK-----HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH------  154 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~------  154 (271)
                      +++..++..|+||||+++++|.+++..     ...+++..++.++.||+.||.|||++||+||||||+||+++.      
T Consensus       134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred             eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence            999999999999999999999999974     456999999999999999999999999999999999999998      


Q ss_pred             -----CCCEEEeeeccccccc-----CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh
Q 024158          155 -----EGRLKIGDFGWSVQSR-----SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT  224 (271)
Q Consensus       155 -----~~~~~L~dfg~~~~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~  224 (271)
                           ++.++|+|||++....     .......||+.|+|||.+.+..++.++||||||+++|+|++|..||........
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  293 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC  293 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce
Confidence                 8999999999985432     223445689999999999999999999999999999999999999865433211


Q ss_pred             -----hc--ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 -----FR--SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 -----~~--~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                           ..  ..++.+.+++..||..+|.+|++..+.+.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence                 11  13678999999999999999976554444

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-43  Score=294.17  Aligned_cols=233  Identities=26%  Similarity=0.414  Sum_probs=197.0

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhh-hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      |...+.||+|+||.||+|.+  ++..+++|++..... ......+.+.+|+.+++.++||||+++++++..++..++++|
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            44458999999999999985  688999999865322 222345678899999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc----
Q 024158          100 YAHRGELYRELRK---HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK----  172 (271)
Q Consensus       100 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~----  172 (271)
                      ++++++|.+++..   ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......    
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999974   346899999999999999999999999999999999999999999999999988543322    


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------------------
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------------------  226 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------------------  226 (271)
                       .....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||......+...                         
T Consensus       191 ~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDAD  269 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCC
T ss_pred             cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccc
Confidence             233468999999998865 47889999999999999999999998655432211                         


Q ss_pred             -ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 -SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 -~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                       ..+..+.+++.+||..+|.+|||+.+++++
T Consensus       270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             124678999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.1e-44  Score=300.49  Aligned_cols=247  Identities=23%  Similarity=0.370  Sum_probs=191.4

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-   90 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-   90 (271)
                      ....+.+++|++.+.||+|+||.||+++.  +++.||+|++.......    .....++..+..++|+||+++++.+.. 
T Consensus         6 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            6 SEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             ---CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             cCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh----HHHHHHHHHHHhccCcchhhheeccccc
Confidence            44678899999999999999999999975  78999999986543222    122344445566899999999986542 


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCeeeCCCCC
Q 024158           91 ----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN---------HVIHRDIKPENLLLDHEGR  157 (271)
Q Consensus        91 ----~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~---------~i~H~dl~~~Nili~~~~~  157 (271)
                          ...+++||||+++++|.+++... ..++..++.++.|++.||.|||+.         |++|+||||+||+++.++.
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence                23679999999999999999774 458999999999999999999999         9999999999999999999


Q ss_pred             EEEeeecccccccCc-----------cccccccccccCCccccC-------CCCCccchhhhHHHHHHHHHhCCCCCCCC
Q 024158          158 LKIGDFGWSVQSRSK-----------RHTMCGTLDYLAPEMVEN-------KEHDYAVDNWTLGILCYEFLYGAPPFEAE  219 (271)
Q Consensus       158 ~~L~dfg~~~~~~~~-----------~~~~~~~~~y~~pe~~~~-------~~~~~~~Di~slg~il~~l~~g~~p~~~~  219 (271)
                      ++|+|||++......           .....||+.|+|||.+.+       ..++.++||||||+++|+|++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            999999998543321           123468999999999987       34567899999999999999996665332


Q ss_pred             Ccchhh---------------------------c----------ccCHHHHHHHHHhcccCccCCCCHHHH------hcC
Q 024158          220 SQKDTF---------------------------R----------SISAEAKHLISRLLVKDSSKRLSLQKI------MEH  256 (271)
Q Consensus       220 ~~~~~~---------------------------~----------~i~~~l~~li~~~l~~~p~~Rps~~~i------l~~  256 (271)
                      ......                           .          ..++++.++|.+||..||.+|||++++      +-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            211100                           0          023479999999999999999999999      456


Q ss_pred             CccccCCCC
Q 024158          257 PWIIKNANP  265 (271)
Q Consensus       257 ~~~~~~~~~  265 (271)
                      +|-+++..+
T Consensus       319 ~~~~~~~~~  327 (336)
T 3g2f_A          319 IWERNKSVS  327 (336)
T ss_dssp             CCCC-----
T ss_pred             HHHhcccCC
Confidence            777766443

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=303.19  Aligned_cols=238  Identities=21%  Similarity=0.347  Sum_probs=193.9

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-CC
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DE   92 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   92 (271)
                      ....|++.+.||+|+||.||+|+...++   ..+++|.+.....  ......+.+|+.++++++||||+++++++.. ++
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  164 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG  164 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC
Confidence            3446889999999999999999876543   4589998854322  2345778899999999999999999998654 55


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++|+||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            789999999999999999764 4589999999999999999999999999999999999999999999999999854322


Q ss_pred             c-------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          172 K-------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       172 ~-------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      .       .....+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||......+..            ..++++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  324 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            1       123456778999999999999999999999999999999 78888765543322            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..||++|||+.+++++
T Consensus       325 l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-43  Score=295.58  Aligned_cols=233  Identities=23%  Similarity=0.411  Sum_probs=190.6

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHh--hCCCCceeceeeEEEeC-
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS--SLRHPNILRLYGWFHDD-   91 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~--~~~~~~i~~~~~~~~~~-   91 (271)
                      ....++|++.+.||+|+||.||++++.  ++.+|+|++......      ....+..++.  .++|+||+++++++... 
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            344578999999999999999999864  899999998544321      2233344444  44899999999999877 


Q ss_pred             ---CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCeeeCCCCCEEE
Q 024158           92 ---ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN--------HVIHRDIKPENLLLDHEGRLKI  160 (271)
Q Consensus        92 ---~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~--------~i~H~dl~~~Nili~~~~~~~L  160 (271)
                         ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.        |++|+||||+||+++.++.++|
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence               689999999999999999976 4689999999999999999999999        9999999999999999999999


Q ss_pred             eeecccccccCcc-------ccccccccccCCccccCCCCCcc------chhhhHHHHHHHHHhC----------CCCCC
Q 024158          161 GDFGWSVQSRSKR-------HTMCGTLDYLAPEMVENKEHDYA------VDNWTLGILCYEFLYG----------APPFE  217 (271)
Q Consensus       161 ~dfg~~~~~~~~~-------~~~~~~~~y~~pe~~~~~~~~~~------~Di~slg~il~~l~~g----------~~p~~  217 (271)
                      +|||++.......       ....||+.|+|||.+.+......      +||||||+++|+|++|          ..||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            9999985433221       24468999999999987766655      9999999999999999          66765


Q ss_pred             CCCcchh-----------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          218 AESQKDT-----------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       218 ~~~~~~~-----------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .......                       ....++++.+++.+||..||.+|||+++++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            4332111                       01245779999999999999999999999976

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-42  Score=306.45  Aligned_cols=234  Identities=21%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-CceeceeeEEEeCCeE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERI   94 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~   94 (271)
                      ...++|++.+.||+|+||.||+|++..+++.||||++......     ..+..|+.+++.+.| +++..+..++...+..
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999987654332     246788899999987 5666677777788889


Q ss_pred             EEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee---CCCCCEEEeeeccccccc
Q 024158           95 FLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili---~~~~~~~L~dfg~~~~~~  170 (271)
                      ++|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||+   +.++.++|+|||++....
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 7899999985 4679999999999999999999999999999999999999   578899999999985543


Q ss_pred             Ccc----------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------
Q 024158          171 SKR----------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------  224 (271)
Q Consensus       171 ~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------  224 (271)
                      ...          ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+......                
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            322          245789999999999999999999999999999999999999987554211                


Q ss_pred             ---hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ---FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ---~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                         ...++.++.+++..||..+|++||+++++++
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence               1446899999999999999999999998876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3e-43  Score=319.78  Aligned_cols=237  Identities=23%  Similarity=0.387  Sum_probs=200.2

Q ss_pred             cccceeee-eeecccCCceEEEEEE--ecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           17 SLQDFEIG-RPLGKGKFGRVYLVRE--VESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        17 ~~~~y~~~-~~lg~g~~~~v~~~~~--~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      ....+.+. +.||+|+||.||+|.+  ..+++.+|||++....... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus       366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  443 (635)
T 4fl3_A          366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ES  443 (635)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            33445544 4799999999999954  4567889999997654332 335678899999999999999999999865 55


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-  172 (271)
                      .++|||++++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++...... 
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            8999999999999999998888999999999999999999999999999999999999999999999999998544322 


Q ss_pred             -----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHH
Q 024158          173 -----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKH  234 (271)
Q Consensus       173 -----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~  234 (271)
                           .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..+++++.+
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  603 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD  603 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence                 122345678999999999999999999999999999998 99999887655433            235899999


Q ss_pred             HHHHhcccCccCCCCHHHHhc
Q 024158          235 LISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~  255 (271)
                      +|.+||..||++|||++++++
T Consensus       604 li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          604 LMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-43  Score=314.55  Aligned_cols=244  Identities=21%  Similarity=0.386  Sum_probs=209.3

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      ...+++..++|++.+.||+|+||.||++.+.. +..|+||++......    .+.+.+|+++++.++|+||+++++++.+
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~  333 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE  333 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            34566778899999999999999999999854 466999999765433    2467899999999999999999999866


Q ss_pred             CCeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                       +..|+||||+.+++|.+++..  ...+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..
T Consensus       334 -~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          334 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             -SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             -ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence             678999999999999999975  35689999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ....    .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..++.+
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  492 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES  492 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            4322    223345778999999998899999999999999999999 99999877654433            235889


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC--Cccc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH--PWII  260 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~--~~~~  260 (271)
                      +.++|.+||..||++|||++++++.  .+|.
T Consensus       493 l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          493 LHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            9999999999999999999999875  4443

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.4e-43  Score=315.64  Aligned_cols=238  Identities=23%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             Cccccceeeee-eecccCCceEEEEEEec--CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           15 EWSLQDFEIGR-PLGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        15 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      .+...++.+.+ .||+|+||.||+|.+..  ++..||||++......  ...+.+.+|+++++.++||||+++++++.. 
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-  407 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-  407 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence            34455667666 89999999999998753  5667999999764322  234678899999999999999999999876 


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      +..++|||++++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus       408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            5699999999999999999754 468999999999999999999999999999999999999999999999999986543


Q ss_pred             Ccc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          171 SKR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       171 ~~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ...      ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..++++
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  567 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  567 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            221      12234678999999998999999999999999999998 99999887655443            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+++.+||..+|.+|||++++++
T Consensus       568 l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          568 LYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999854

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.7e-44  Score=299.14  Aligned_cols=245  Identities=23%  Similarity=0.381  Sum_probs=204.0

Q ss_pred             hhhhhhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158            7 EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus         7 ~~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ........++..++|++.+.||+|+||.||++++..   .+++|++....... .....+.+|+.+++.++|+||+++++
T Consensus        21 ~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~   96 (319)
T 2y4i_B           21 TSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMG   96 (319)
T ss_dssp             -CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCE
T ss_pred             cccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            334557788899999999999999999999998743   59999986543221 12345667899999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ++...+..++++|++++++|.+++...+ .+++..++.++.|++.||.+||++|++|+||+|+||+++ ++.++|+|||+
T Consensus        97 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B           97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             EEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             EEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999999999998754 689999999999999999999999999999999999998 67999999998


Q ss_pred             ccccc--------CccccccccccccCCccccC---------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---
Q 024158          166 SVQSR--------SKRHTMCGTLDYLAPEMVEN---------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---  225 (271)
Q Consensus       166 ~~~~~--------~~~~~~~~~~~y~~pe~~~~---------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---  225 (271)
                      +....        .......+++.|+|||.+.+         ..++.++|+||||+++|+|++|..||.........   
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            64322        12233457899999999864         34678999999999999999999999876654332   


Q ss_pred             ----------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ----------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ----------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                ..++.++.+++.+||..||.+|||++++++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence                      1367899999999999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.2e-42  Score=283.63  Aligned_cols=214  Identities=14%  Similarity=0.130  Sum_probs=188.2

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      +-.++|++.+.||+|+||.||+|++..+++.|++|++.............+.+|+..+..++|+||+++++++..++..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999998765554555678889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      +||||+++++|.+++..+  ....++..++.|++.||.|||++|++|+||||+||+++.+|.++|++++           
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999999999653  4667789999999999999999999999999999999999999997443           


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh------------------hcccCHHHHHHHH
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT------------------FRSISAEAKHLIS  237 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~------------------~~~i~~~l~~li~  237 (271)
                            |++       +++.++|+||||+++|+|++|..||.+....+.                  ...+++++.+++.
T Consensus       175 ------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  241 (286)
T 3uqc_A          175 ------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA  241 (286)
T ss_dssp             ------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHH
T ss_pred             ------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHH
Confidence                  323       367899999999999999999999987665331                  1347899999999


Q ss_pred             HhcccCccCCCCHHHHhcC
Q 024158          238 RLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~  256 (271)
                      +||.+||++| |++++++.
T Consensus       242 ~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          242 RSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHCTTSSCC-CHHHHHHH
T ss_pred             HHcccCCccC-CHHHHHHH
Confidence            9999999999 99999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.9e-42  Score=314.34  Aligned_cols=241  Identities=24%  Similarity=0.421  Sum_probs=203.8

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecC---CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVES---KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      ...+..++|++.+.||+|+||.||+|++..+   +..+++|.+.....  ......+.+|+.+++.++||||+++++++.
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3456678899999999999999999998654   45699998865432  234567889999999999999999999985


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                       ++..++|||++++++|.+++...+ .+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence             456899999999999999998654 689999999999999999999999999999999999999999999999999865


Q ss_pred             ccCcc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          169 SRSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       169 ~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      .....    ....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+....+..            ..++++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  620 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  620 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHH
Confidence            43322    22345778999999998899999999999999999996 99999876654432            235799


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..||.+|||+.++++.
T Consensus       621 l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          621 LYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999863

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.2e-42  Score=291.58  Aligned_cols=230  Identities=25%  Similarity=0.403  Sum_probs=192.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhh--CCCCceeceeeEEEeCC---
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS--LRHPNILRLYGWFHDDE---   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~--~~~~~i~~~~~~~~~~~---   92 (271)
                      .++|++.+.||+|+||.||++++  +++.+++|++....      ...+.+|.+++..  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            46899999999999999999986  58999999986543      2345567777776  78999999999998775   


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCeeeCCCCCEEEeee
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH--------ENHVIHRDIKPENLLLDHEGRLKIGDF  163 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh--------~~~i~H~dl~~~Nili~~~~~~~L~df  163 (271)
                       ..++++|++++++|.+++.. ..+++..++.++.|++.||.+||        +.|++|+||+|+||+++.++.++|+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             79999999999999999976 46899999999999999999999        899999999999999999999999999


Q ss_pred             cccccccCc-------cccccccccccCCccccCCC------CCccchhhhHHHHHHHHHhC----------CCCCCCCC
Q 024158          164 GWSVQSRSK-------RHTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYG----------APPFEAES  220 (271)
Q Consensus       164 g~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~------~~~~~Di~slg~il~~l~~g----------~~p~~~~~  220 (271)
                      |++......       .....+++.|+|||.+.+..      ++.++|+||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            998544332       23446899999999997653      23689999999999999999          77886543


Q ss_pred             cch-----hh---------c---------ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          221 QKD-----TF---------R---------SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       221 ~~~-----~~---------~---------~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      ...     ..         .         ..+..+.+++.+||..||.+|||+++++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            211     00         0         123579999999999999999999999976

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-42  Score=317.63  Aligned_cols=239  Identities=22%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEec-CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVE-SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .+-.++|++.+.||+|+||.||++.+.. +++.|++|++.....  ......+.+|+.+++.++||||+++++++...+.
T Consensus        76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred             CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence            3445899999999999999999999976 789999999865332  2345677899999999999999999999987655


Q ss_pred             -----EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           94 -----IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        94 -----~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                           .|+||||+++++|.+++..  .+++..++.++.||+.+|.|||++||+|+||||+||+++.+ .++|+|||++..
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999988755  68999999999999999999999999999999999999875 899999999865


Q ss_pred             ccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcch-----hhcccCHHHHHHHHHhcccC
Q 024158          169 SRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKD-----TFRSISAEAKHLISRLLVKD  243 (271)
Q Consensus       169 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~-----~~~~i~~~l~~li~~~l~~~  243 (271)
                      .... ....||+.|+|||.+.+.. +.++||||||+++++|++|..||.+.....     .....++.+.++|.+||.+|
T Consensus       231 ~~~~-~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  308 (681)
T 2pzi_A          231 INSF-GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPD  308 (681)
T ss_dssp             TTCC-SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTCSS
T ss_pred             cccC-CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhccCC
Confidence            5443 4557899999999987654 789999999999999999998876543221     12235788999999999999


Q ss_pred             ccCCCCHHHHhcCCccc
Q 024158          244 SSKRLSLQKIMEHPWII  260 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~  260 (271)
                      |.+||+..+.+.++|+.
T Consensus       309 P~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          309 PRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             GGGSCSSHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHHH
Confidence            99999999999988874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-44  Score=304.15  Aligned_cols=235  Identities=20%  Similarity=0.285  Sum_probs=189.4

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----HHHHHHHHHHHHHHHhhCC---------CCc
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----KYKIQHQLRREMEIQSSLR---------HPN   80 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~---------~~~   80 (271)
                      .+..++|++.+.||+|+||.||+|++  +|+.||+|++......     .....+.+.+|+.+++.++         |+|
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~n   93 (336)
T 2vuw_A           16 CLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEG   93 (336)
T ss_dssp             HSCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCC
T ss_pred             hcccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCc
Confidence            35578999999999999999999997  7899999999765321     1112345667777777764         777


Q ss_pred             eeceeeEEE------------------------------eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHH
Q 024158           81 ILRLYGWFH------------------------------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN  130 (271)
Q Consensus        81 i~~~~~~~~------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~  130 (271)
                      ++++.+++.                              .++..|+||||++++++.+.+.+ ..+++..++.++.||+.
T Consensus        94 iv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           94 FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             BCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHH
T ss_pred             hhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHH
Confidence            777766542                              26789999999988877666644 56899999999999999


Q ss_pred             HHHHHH-hCCceecCCCCCCeeeCCCC--------------------CEEEeeecccccccCccccccccccccCCcccc
Q 024158          131 ALAYCH-ENHVIHRDIKPENLLLDHEG--------------------RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE  189 (271)
Q Consensus       131 ~l~~Lh-~~~i~H~dl~~~Nili~~~~--------------------~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~  189 (271)
                      ||.||| ++||+||||||+|||++.++                    .++|+|||++......  ...||+.|+|||.+.
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGC
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhc
Confidence            999999 99999999999999999887                    8999999998655433  347899999999998


Q ss_pred             CCCCCccchhhhHHHH-HHHHHhCCCCCCCC-------------------CcchhhcccCHHHHHHHHHhcccCccCCCC
Q 024158          190 NKEHDYAVDNWTLGIL-CYEFLYGAPPFEAE-------------------SQKDTFRSISAEAKHLISRLLVKDSSKRLS  249 (271)
Q Consensus       190 ~~~~~~~~Di~slg~i-l~~l~~g~~p~~~~-------------------~~~~~~~~i~~~l~~li~~~l~~~p~~Rps  249 (271)
                      +.. +.++||||++.+ .++++.|..||...                   ........+++++.+||++||..|     |
T Consensus       251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s  324 (336)
T 2vuw_A          251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S  324 (336)
T ss_dssp             CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S
T ss_pred             CCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C
Confidence            766 889999998777 56677888888531                   111223357899999999999976     9


Q ss_pred             HHHHh-cCCccc
Q 024158          250 LQKIM-EHPWII  260 (271)
Q Consensus       250 ~~~il-~~~~~~  260 (271)
                      ++|+| +||||+
T Consensus       325 a~e~l~~Hp~f~  336 (336)
T 2vuw_A          325 ATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHCGGGC
T ss_pred             HHHHHhcCCCcC
Confidence            99999 999996

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2e-34  Score=258.51  Aligned_cols=184  Identities=13%  Similarity=0.111  Sum_probs=133.9

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhh-------hHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeCCeEEE
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-------EKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~~~~~l   96 (271)
                      ...+.|+.+....++....|+.+++|++.++..       ..+...+.+.+|+++|+++ .|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345566777677777778899999999965421       2334567899999999999 69999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---c
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---R  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~  173 (271)
                      ||||++|++|.+++...++++..   .++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......   .
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999988888765   47899999999999999999999999999999999999999998654332   3


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG  212 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g  212 (271)
                      ...+||+.|++||.+.+. +...+|+|++|++++.+.++
T Consensus       397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred             cCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence            445789999999998654 56679999999988776544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.7e-27  Score=212.40  Aligned_cols=182  Identities=17%  Similarity=0.172  Sum_probs=142.4

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhh-----hHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-----EKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ..+.||+|+||.||++.  ..+..+++|.......     ......+.+.+|++++++++||||+.+..++...+..|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  5678899998644322     2223356689999999999999999666666677778999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcc----
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR----  173 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~----  173 (271)
                      |||+++++|.+++..        +..++.|++++|.|||++||+|+||||+||+++.  .++|+|||++.......    
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999999976        5689999999999999999999999999999998  99999999997655432    


Q ss_pred             ------ccccccccccCCccccC--CCCCccchhhhHHHHHHHHHhCCCCC
Q 024158          174 ------HTMCGTLDYLAPEMVEN--KEHDYAVDNWTLGILCYEFLYGAPPF  216 (271)
Q Consensus       174 ------~~~~~~~~y~~pe~~~~--~~~~~~~Di~slg~il~~l~~g~~p~  216 (271)
                            ....||+.|+|||.+..  ..|+...|+|+..+-..+-..+..+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                  24578999999999976  55777889999887777766655544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=5.4e-25  Score=181.03  Aligned_cols=130  Identities=22%  Similarity=0.246  Sum_probs=107.1

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHH---------------HHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---------------KIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      +.||+|++|.||+|++ .+|+.+|+|++........               .....+.+|+.+++.++  | +++.+++.
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            9999999999999999 8899999999864432111               23567889999999999  5 66666654


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV  167 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~  167 (271)
                      . +..|+||||+++++|.+ +..      .....++.|++.|+.+||+.|++|+||||+||+++ ++.++|+|||++.
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~  240 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV  240 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred             c-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence            4 45699999999999988 422      23557999999999999999999999999999999 9999999999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=2.3e-21  Score=157.42  Aligned_cols=140  Identities=19%  Similarity=0.266  Sum_probs=108.4

Q ss_pred             eeeeeeecccCCceEEEEEEecCCce--EEEEEechhhhh---------------------HHHHHHHHHHHHHHHhhCC
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIE---------------------KYKIQHQLRREMEIQSSLR   77 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~--~~vK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~~~   77 (271)
                      |.+.+.||+|+||.||+|.+..+|..  +|||++......                     .......+.+|+..+..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78999999999999999998788999  999987543211                     1122346778999999998


Q ss_pred             CCce--eceeeEEEeCCeEEEEEeccCC-C----chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCC
Q 024158           78 HPNI--LRLYGWFHDDERIFLILEYAHR-G----ELYRELRKHRRFTEQQAATYIASLTNALAYCH-ENHVIHRDIKPEN  149 (271)
Q Consensus        78 ~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh-~~~i~H~dl~~~N  149 (271)
                      |+++  +.++..    +..++||||+++ +    +|.+....   .+...+..++.|++.++.+|| +.|++|+||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            7754  444432    346899999942 3    66665433   234567899999999999999 9999999999999


Q ss_pred             eeeCCCCCEEEeeecccccc
Q 024158          150 LLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus       150 ili~~~~~~~L~dfg~~~~~  169 (271)
                      ||++.  .++|+|||++...
T Consensus       202 ILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEESS--SEEECCCTTCEET
T ss_pred             EEEcC--cEEEEECcccccC
Confidence            99988  9999999988543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.76  E-value=1.7e-18  Score=146.55  Aligned_cols=139  Identities=17%  Similarity=0.187  Sum_probs=100.5

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh-----------------HH--HHHHHHHHHHHHHhhCCCCce
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE-----------------KY--KIQHQLRREMEIQSSLRHPNI   81 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-----------------~~--~~~~~~~~e~~~l~~~~~~~i   81 (271)
                      |.+.+.||.|++|.||+|.+ .+|+.+|||++......                 .+  ........|...+.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            88999999999999999997 57999999987532110                 00  111123456677777755544


Q ss_pred             eceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-----
Q 024158           82 LRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-----  156 (271)
Q Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-----  156 (271)
                      ....-+... . .++||||++|.+|..+..      .+....++.|++.+|.+||+.|++||||||.|||++.++     
T Consensus       176 ~vp~p~~~~-~-~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS-R-HTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE-T-TEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc-C-ceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            322222222 2 379999999888865432      123567889999999999999999999999999998776     


Q ss_pred             -----CEEEeeeccccc
Q 024158          157 -----RLKIGDFGWSVQ  168 (271)
Q Consensus       157 -----~~~L~dfg~~~~  168 (271)
                           .+.++||+.+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                 389999997644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=1.8e-13  Score=110.88  Aligned_cols=140  Identities=15%  Similarity=0.141  Sum_probs=109.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~   95 (271)
                      .+.+|++...++.|+.+.||++..  .+..+++|+........   ...+.+|.++++.+. +..++++++++...+..|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            456799999999999999999874  36789999986532111   124677888887774 567889999998888999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE--------------------------------------  137 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~--------------------------------------  137 (271)
                      ++||+++|.+|.+.+.     +......++.++..++..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999989877632     122345778899999999998                                      


Q ss_pred             ---------------------CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 ---------------------NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ---------------------~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                                           ..++|+|++|.||+++.++.+.|+||+.+
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                 44899999999999987655679999854

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.41  E-value=1.6e-12  Score=105.03  Aligned_cols=139  Identities=14%  Similarity=0.122  Sum_probs=99.5

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc--eeceeeEEEe
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYGWFHD   90 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~--i~~~~~~~~~   90 (271)
                      .....+.+|.+....+.|..+.||++.. .+|..+++|+.....      ...+..|...++.+.+.+  +++++.+...
T Consensus        14 ~l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~   86 (264)
T 1nd4_A           14 AWVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTE   86 (264)
T ss_dssp             GGTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred             HHHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccC
Confidence            3344466777765555677799999864 567789999975431      134556777777764433  6678888888


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH-------------------------------  139 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~-------------------------------  139 (271)
                      ++..+++||+++|.++.  ..   ..+   ...++.+++..+..||+..                               
T Consensus        87 ~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (264)
T 1nd4_A           87 AGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL  158 (264)
T ss_dssp             SSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred             CCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence            78899999999988884  21   112   2356677777777777643                               


Q ss_pred             ---------------------------ceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          140 ---------------------------VIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       140 ---------------------------i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                                                 ++|+|++|.||+++.++.+.|+||+.+
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a  212 (264)
T 1nd4_A          159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL  212 (264)
T ss_dssp             CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred             hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence                                       999999999999987666679999865

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=3.9e-11  Score=101.63  Aligned_cols=142  Identities=15%  Similarity=0.276  Sum_probs=104.8

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEec--hhhhhHHHHHHHHHHHHHHHhhCCC--CceeceeeEEEeC---C
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIF--KEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGWFHDD---E   92 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~--~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~~~~~---~   92 (271)
                      ....++.|+.|.++.+|++...  +..+++|+..  .....  .....+.+|..+++.+..  ..+++++.++.+.   +
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g  114 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG  114 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred             CCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence            3446778999999999998853  4678999875  33211  113466778888888864  4578888888766   4


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE-----------------------------------  137 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~-----------------------------------  137 (271)
                      ..++|||+++|..+.+..  -..++......++.+++..|..||+                                   
T Consensus       115 ~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          115 RAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             SCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             CeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            589999999987774421  1346788889999999999999997                                   


Q ss_pred             -----------------------CCceecCCCCCCeeeCCCCC--EEEeeecccc
Q 024158          138 -----------------------NHVIHRDIKPENLLLDHEGR--LKIGDFGWSV  167 (271)
Q Consensus       138 -----------------------~~i~H~dl~~~Nili~~~~~--~~L~dfg~~~  167 (271)
                                             .+++|+|+++.||+++.++.  +.++||+.+.
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence                                   36999999999999987753  6899999763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.07  E-value=1.8e-10  Score=95.37  Aligned_cols=180  Identities=18%  Similarity=0.165  Sum_probs=117.0

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCc--eeceeeEEEeCC---eEEEE
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPN--ILRLYGWFHDDE---RIFLI   97 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~--i~~~~~~~~~~~---~~~lv   97 (271)
                      ++.++.|..+.+|++.     ..+++|+....     .....+.+|.+.++.+. +..  ++.++......+   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4558899999999753     56999986433     22456778888887773 332  445555443333   35889


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE----------------------------------------  137 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~----------------------------------------  137 (271)
                      |++++|.++.....  ..++.++...++.+++..+..||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865432  246777888888888888888885                                        


Q ss_pred             ------------------CCceecCCCCCCeeeCC--CCCEEEeeecccccccCccccccccccc---cCCcccc-----
Q 024158          138 ------------------NHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSKRHTMCGTLDY---LAPEMVE-----  189 (271)
Q Consensus       138 ------------------~~i~H~dl~~~Nili~~--~~~~~L~dfg~~~~~~~~~~~~~~~~~y---~~pe~~~-----  189 (271)
                                        ..++|+|++|.||+++.  ++.+.++||+.+......... ......   ..|+...     
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCHHHHHHHHHH
Confidence                              13799999999999988  456889999976432211100 000000   1111100     


Q ss_pred             -CCC--------CCccchhhhHHHHHHHHHhCCCCC
Q 024158          190 -NKE--------HDYAVDNWTLGILCYEFLYGAPPF  216 (271)
Q Consensus       190 -~~~--------~~~~~Di~slg~il~~l~~g~~p~  216 (271)
                       +..        .....+.|+++.+++.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             000        112368899999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.90  E-value=4e-08  Score=81.26  Aligned_cols=133  Identities=17%  Similarity=0.153  Sum_probs=91.7

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC---ceeceeeEEE-eCCeEEEEEe
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP---NILRLYGWFH-DDERIFLILE   99 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~---~i~~~~~~~~-~~~~~~lv~e   99 (271)
                      +..++.|..+.+|++     +..+++|+....     .....+..|.++++.+.+.   .++.++.++. ..+..+++|+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            455788888899987     577999985321     2345678899999888642   3667777764 4456789999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-----------------------------------------  138 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-----------------------------------------  138 (271)
                      +++|.++.+..-  ..++......++.++...+..||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999888866321  1234445555555555555555532                                         


Q ss_pred             -------------------CceecCCCCCCeeeCC---CCC-EEEeeeccccc
Q 024158          139 -------------------HVIHRDIKPENLLLDH---EGR-LKIGDFGWSVQ  168 (271)
Q Consensus       139 -------------------~i~H~dl~~~Nili~~---~~~-~~L~dfg~~~~  168 (271)
                                         .++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   355 57999987643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.86  E-value=8.6e-08  Score=77.61  Aligned_cols=130  Identities=16%  Similarity=0.163  Sum_probs=91.1

Q ss_pred             ecccCCc-eEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEEEEeccCCC
Q 024158           27 LGKGKFG-RVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFLILEYAHRG  104 (271)
Q Consensus        27 lg~g~~~-~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~  104 (271)
                      +..|..+ .||+......+..+++|+-....      ...+..|...++.+. +--+++++.++..++..++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence            3344444 68988877778889999864332      345667777777664 334788899998889999999999988


Q ss_pred             chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 024158          105 ELYRELRKHRRFTEQQAATYIASLTNALAYCHEN----------------------------------------------  138 (271)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~----------------------------------------------  138 (271)
                      ++.+.....    ......+..++...+..||..                                              
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            877665432    122234445555555555521                                              


Q ss_pred             ------------CceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          139 ------------HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       139 ------------~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                                  .++|+|+++.||+++.++.+-|+||+.+
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a  221 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV  221 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence                        1789999999999988777779999865

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.36  E-value=9.4e-06  Score=62.59  Aligned_cols=136  Identities=18%  Similarity=0.125  Sum_probs=92.7

Q ss_pred             CchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccccccc
Q 024158          104 GELYRELRK-HRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLD  181 (271)
Q Consensus       104 ~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~  181 (271)
                      .+|.+.|.. +.+++++++|.++.|.+.++..+-. +.-...=+.|..|++..+|.+.+.+ ..+.         .....
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------~~~~~  102 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------AGEPP  102 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------ccccC
Confidence            589999976 5689999999999999999888732 1112233456889999999888763 1100         11234


Q ss_pred             ccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcccCHHHHHHHHHhccc-------------------
Q 024158          182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHLISRLLVK-------------------  242 (271)
Q Consensus       182 y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~i~~~l~~li~~~l~~-------------------  242 (271)
                      +.|||... ...+.+.-|||||+++|.-+--..      +.+.-..+++.|.+||..|..-                   
T Consensus       103 ~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL------~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~  175 (229)
T 2yle_A          103 PVAGKLGY-SQCMETEVIESLGIIIYKALDYGL------KENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLG  175 (229)
T ss_dssp             ----CCSS-SSSCHHHHHHHHHHHHHHHHTTTC------CTTEEECCCHHHHHHHHHHTTCCC-----------------
T ss_pred             CCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC------CcccchhhCHHHHHHHHHHHhcccccccccccccccccccc
Confidence            66777653 344568899999999999874332      3344557999999999999865                   


Q ss_pred             ------CccCCCCHHHHhcC
Q 024158          243 ------DSSKRLSLQKIMEH  256 (271)
Q Consensus       243 ------~p~~Rps~~~il~~  256 (271)
                            .+..|+++++||+.
T Consensus       176 d~~~~~~~~~~~sl~~Vi~~  195 (229)
T 2yle_A          176 DEDEKRKISAIRSYRDVMKL  195 (229)
T ss_dssp             ---CCSCCCCCCSHHHHHHH
T ss_pred             cccccccccCcCCHHHHHHH
Confidence                  24688899999864

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.34  E-value=3.9e-06  Score=71.77  Aligned_cols=81  Identities=14%  Similarity=0.092  Sum_probs=47.5

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhh-hHH---HHHHHHHHHHHHHhhCCC---CceeceeeEEEeCCeE
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI-EKY---KIQHQLRREMEIQSSLRH---PNILRLYGWFHDDERI   94 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~---~~~~~~~~e~~~l~~~~~---~~i~~~~~~~~~~~~~   94 (271)
                      ..++.||.|..+.||++....++..+++|....... ...   ........|.+.++.+..   ..++.++.+  +.+..
T Consensus        33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~  110 (397)
T 2olc_A           33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMA  110 (397)
T ss_dssp             CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTT
T ss_pred             eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCcc
Confidence            346789999999999997666678899998643211 000   011234556666665532   345566654  33446


Q ss_pred             EEEEeccCCC
Q 024158           95 FLILEYAHRG  104 (271)
Q Consensus        95 ~lv~e~~~~~  104 (271)
                      ++|||++++.
T Consensus       111 ~lvmE~l~g~  120 (397)
T 2olc_A          111 VTVMEDLSHL  120 (397)
T ss_dssp             EEEECCCTTS
T ss_pred             EEEEEeCCCc
Confidence            8999999763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.33  E-value=1.3e-06  Score=73.64  Aligned_cols=84  Identities=7%  Similarity=0.103  Sum_probs=52.6

Q ss_pred             eeeeeee-cccCCceEEEEEEe--c----CCceEEEEEechhh---hhHHHHHHHHHHHHHHHhhCC---CCceeceeeE
Q 024158           21 FEIGRPL-GKGKFGRVYLVREV--E----SKHPVALKIIFKEQ---IEKYKIQHQLRREMEIQSSLR---HPNILRLYGW   87 (271)
Q Consensus        21 y~~~~~l-g~g~~~~v~~~~~~--~----~~~~~~vK~~~~~~---~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~   87 (271)
                      ....+.| +.|..+.+|++...  .    ++..+++|......   ...   ...+..|...++.+.   .-.+++++.+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            3445677 88888999988753  1    25679999875432   100   123445555555553   2346778877


Q ss_pred             EEeC---CeEEEEEeccCCCchH
Q 024158           88 FHDD---ERIFLILEYAHRGELY  107 (271)
Q Consensus        88 ~~~~---~~~~lv~e~~~~~~L~  107 (271)
                      ..+.   +..+++||+++|.++.
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCCC
T ss_pred             ccCCCccCCceEEEEecCCCChh
Confidence            6554   3568999999876543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.32  E-value=1.4e-05  Score=66.58  Aligned_cols=29  Identities=21%  Similarity=0.272  Sum_probs=26.5

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .+++|+|+++.||+++.++.+.++||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence            57999999999999988889999999865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=0.00013  Score=60.24  Aligned_cols=77  Identities=21%  Similarity=0.307  Sum_probs=57.5

Q ss_pred             eeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC---CCceeceeeEEEeCCeEEEEE
Q 024158           22 EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        22 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      .-++.|+.|..+.+|++..  ++..+++|+.....      ...+..|.+.++.+.   ...+++++.+....+..++||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3457789999999999874  56789999875432      234566666666663   356888998888888899999


Q ss_pred             eccCCCch
Q 024158           99 EYAHRGEL  106 (271)
Q Consensus        99 e~~~~~~L  106 (271)
                      |++++.++
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99987654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.01  E-value=1.3e-05  Score=65.77  Aligned_cols=71  Identities=13%  Similarity=0.027  Sum_probs=41.7

Q ss_pred             eeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce-eceeeEEEeCCeEEEEEecc-
Q 024158           24 GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYA-  101 (271)
Q Consensus        24 ~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-~~~~~~~~~~~~~~lv~e~~-  101 (271)
                      ++.|+.|..+.+|++      ..+++|+.......    .-....|...++.+...++ ++++.+  ..+.-++++|++ 
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~   90 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA   90 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence            788989999999998      56999998543211    0111234444444432222 455554  333347899999 


Q ss_pred             CCCch
Q 024158          102 HRGEL  106 (271)
Q Consensus       102 ~~~~L  106 (271)
                      ++.++
T Consensus        91 ~g~~l   95 (301)
T 3dxq_A           91 GAQTM   95 (301)
T ss_dssp             TCEEC
T ss_pred             CCccC
Confidence            66544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.00  E-value=4.4e-05  Score=65.76  Aligned_cols=32  Identities=16%  Similarity=0.349  Sum_probs=27.2

Q ss_pred             HhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158          136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus       136 h~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +...++|||+++.||+++.++ +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            355799999999999998876 99999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.59  E-value=0.00028  Score=58.58  Aligned_cols=30  Identities=33%  Similarity=0.412  Sum_probs=26.0

Q ss_pred             CCceecCCCCCCeeeCCC----CCEEEeeecccc
Q 024158          138 NHVIHRDIKPENLLLDHE----GRLKIGDFGWSV  167 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~----~~~~L~dfg~~~  167 (271)
                      ..++|||+++.||+++.+    +.+.++||+.+.
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~  216 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK  216 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence            469999999999999874    679999998763

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.58  E-value=0.00041  Score=57.20  Aligned_cols=141  Identities=13%  Similarity=0.116  Sum_probs=73.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCC--ceeceeeE------EEe
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP--NILRLYGW------FHD   90 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~--~i~~~~~~------~~~   90 (271)
                      +...-++.|+.|..+.+|++...  +..+++|.......     ...+..|..+++.+...  .+++++..      ...
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES--SCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CcceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            34445667888888999998753  33688999865211     11223344444433211  13333321      123


Q ss_pred             CCeEEEEEeccCCCchH-----------HH---HHh-CCC--------CC---HHHHHH------------HHHHHHHHH
Q 024158           91 DERIFLILEYAHRGELY-----------RE---LRK-HRR--------FT---EQQAAT------------YIASLTNAL  132 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~-----------~~---l~~-~~~--------l~---~~~~~~------------i~~~l~~~l  132 (271)
                      ++..++++++++|..+.           ..   ++. ...        ..   +.....            +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            45678999999875431           11   111 000        01   111000            001133344


Q ss_pred             HHHHh-------CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          133 AYCHE-------NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       133 ~~Lh~-------~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ..+..       .+++|+|+++.||+++.++.+.++||+.+
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a  215 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA  215 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence            44442       36999999999999987766689999866

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.0015  Score=53.04  Aligned_cols=81  Identities=17%  Similarity=0.210  Sum_probs=53.7

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC---CceeceeeEEEeCCe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH---PNILRLYGWFHDDER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~---~~i~~~~~~~~~~~~   93 (271)
                      ......-++.+|.|..+.||++.. .+|+.+++|+........   ...+..|.+.|+.+..   --+++++.+  +.  
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--   84 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--   84 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--
Confidence            345667788999999999999885 678999999865432221   1245667777776642   234555554  22  


Q ss_pred             EEEEEeccCCCc
Q 024158           94 IFLILEYAHRGE  105 (271)
Q Consensus        94 ~~lv~e~~~~~~  105 (271)
                      .+++||+..+..
T Consensus        85 ~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 RTLAMEWVDERP   96 (288)
T ss_dssp             TEEEEECCCCCC
T ss_pred             ceEEEEeecccC
Confidence            367889886543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.53  E-value=0.00028  Score=59.77  Aligned_cols=139  Identities=18%  Similarity=0.215  Sum_probs=77.7

Q ss_pred             cceeeeeeecccCCceEEEEEEec-------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEe
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHD   90 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~   90 (271)
                      +... ++.|..|-.+.+|++....       ++..+++|+.......    .....+|.++++.+...+ .+++++.+.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~----~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG----VDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC----HHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch----HHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            4444 4567788888999988642       3578999997432111    233446767666664222 3566665432


Q ss_pred             CCeEEEEEeccCCCchH--------------HHHH---hC-----CCCC--HHHHHHHHHHHHH----------------
Q 024158           91 DERIFLILEYAHRGELY--------------RELR---KH-----RRFT--EQQAATYIASLTN----------------  130 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~--------------~~l~---~~-----~~l~--~~~~~~i~~~l~~----------------  130 (271)
                          .+|+||++|.+|.              ..+.   ..     +...  +.++..+..++-.                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                2889999875442              1111   11     1122  2444444443321                


Q ss_pred             ---HHHHH----HhC----CceecCCCCCCeeeCCC----CCEEEeeeccc
Q 024158          131 ---ALAYC----HEN----HVIHRDIKPENLLLDHE----GRLKIGDFGWS  166 (271)
Q Consensus       131 ---~l~~L----h~~----~i~H~dl~~~Nili~~~----~~~~L~dfg~~  166 (271)
                         .+..|    ...    .++|+|+.+.||+++.+    +.+.++||..+
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence               12333    222    59999999999999876    68999999876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.52  E-value=0.00023  Score=61.46  Aligned_cols=74  Identities=23%  Similarity=0.261  Sum_probs=45.3

Q ss_pred             eeeeecccCCceEEEEEEec-------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCeE
Q 024158           23 IGRPLGKGKFGRVYLVREVE-------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDERI   94 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~-------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~   94 (271)
                      -++.|+.|..+.+|++....       ++..+++|+......     ...+..|..+++.+...+ .+++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            45678888889999997642       357899999843211     012234666666553333 356666543  2  


Q ss_pred             EEEEeccCCCc
Q 024158           95 FLILEYAHRGE  105 (271)
Q Consensus        95 ~lv~e~~~~~~  105 (271)
                      .++++|++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            37899987633

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.48  E-value=0.0012  Score=54.49  Aligned_cols=75  Identities=16%  Similarity=0.235  Sum_probs=42.8

Q ss_pred             eeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC--CceeceeeE-----EEeCCeEEEE
Q 024158           25 RPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH--PNILRLYGW-----FHDDERIFLI   97 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~--~~i~~~~~~-----~~~~~~~~lv   97 (271)
                      ..++ |..+.+|++.. .+|+.+++|.........    ..+..|...++.+..  -.+++++..     ...++..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4466 77888998764 356689999986432221    223344444444421  123444432     2234567889


Q ss_pred             EeccCCCc
Q 024158           98 LEYAHRGE  105 (271)
Q Consensus        98 ~e~~~~~~  105 (271)
                      +++++|.+
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998644

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.36  E-value=0.0028  Score=52.83  Aligned_cols=29  Identities=28%  Similarity=0.368  Sum_probs=26.1

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      ..++|+|+++.||+++.++.+.++||+.+
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~  234 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEP  234 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSC
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCC
Confidence            36999999999999998888999999865

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.23  E-value=0.001  Score=56.09  Aligned_cols=75  Identities=17%  Similarity=0.097  Sum_probs=40.8

Q ss_pred             eeeeecccCCceEEEEEEec--------CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCe
Q 024158           23 IGRPLGKGKFGRVYLVREVE--------SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDER   93 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~   93 (271)
                      .+..|+.|....+|++....        .+..+++|+.......-    .....|...++.+...+ ++++++..  .+ 
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-  109 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----YNTISEFEVYKTMSKYKIAPQLLNTF--NG-  109 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----SCHHHHHHHHHHHHHTTSSCCEEEEE--TT-
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----ecHHHHHHHHHHHHhcCCCCceEEec--CC-
Confidence            45677888889999988643        13679999875432110    01234555555543222 44666543  22 


Q ss_pred             EEEEEeccCCCc
Q 024158           94 IFLILEYAHRGE  105 (271)
Q Consensus        94 ~~lv~e~~~~~~  105 (271)
                       ++++++++|.+
T Consensus       110 -~~v~e~i~G~~  120 (369)
T 3c5i_A          110 -GRIEEWLYGDP  120 (369)
T ss_dssp             -EEEEECCCSEE
T ss_pred             -cEEEEEecCCc
Confidence             67899998754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.98  E-value=0.0029  Score=54.99  Aligned_cols=76  Identities=18%  Similarity=0.178  Sum_probs=45.3

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCce-eceeeEEEeCCeEEEEEecc
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNI-LRLYGWFHDDERIFLILEYA  101 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-~~~~~~~~~~~~~~lv~e~~  101 (271)
                      -++.|+.|-.+.+|++.....+..+++|+.......-    -....|..+++.+...++ +++++.+ . +  ..|+||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~-~-~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFF-T-N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEE-T-T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEe-C-C--eEEEEee
Confidence            3567888888999998864445789999874421110    011356666766654443 5666665 2 2  2499999


Q ss_pred             CCCch
Q 024158          102 HRGEL  106 (271)
Q Consensus       102 ~~~~L  106 (271)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            86443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.27  E-value=0.0065  Score=52.16  Aligned_cols=27  Identities=26%  Similarity=0.576  Sum_probs=24.6

Q ss_pred             CceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          139 HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       139 ~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .++|+|+.+.||+ +.++.+.++||..+
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a  289 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYS  289 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTC
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccC
Confidence            4899999999999 77889999999977

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.86  E-value=0.035  Score=47.27  Aligned_cols=27  Identities=33%  Similarity=0.564  Sum_probs=23.7

Q ss_pred             ceecCCCCCCeee------CCCCCEEEeeeccc
Q 024158          140 VIHRDIKPENLLL------DHEGRLKIGDFGWS  166 (271)
Q Consensus       140 i~H~dl~~~Nili------~~~~~~~L~dfg~~  166 (271)
                      ++|+|+.+.||++      +.++.+.++||.++
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya  278 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYS  278 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTC
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhc
Confidence            7899999999999      34567999999977

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=94.87  E-value=0.14  Score=39.27  Aligned_cols=115  Identities=11%  Similarity=0.117  Sum_probs=75.2

Q ss_pred             CCCceeceeeEEEeCCeEEEEEeccCCC-chHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           77 RHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      .+|++++. .+-.+++.+.+.++.-+.. +... +   +.++....++++.+|+....+++  .-+|--++|+|++++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCC
Confidence            46887766 5666777777777665422 3333 3   33688999999999998774443  34677899999999999


Q ss_pred             CCEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCC
Q 024158          156 GRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFE  217 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~  217 (271)
                      +.+++.--|.-.              -++|.     ..+...-+-..=+++..+++++..|.
T Consensus       116 ~~p~i~~RGik~--------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQN--------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETT--------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCcc--------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999998665321              12221     12222333455567777788776653

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.29  E-value=0.43  Score=36.72  Aligned_cols=82  Identities=12%  Similarity=0.091  Sum_probs=59.3

Q ss_pred             CCCceeceeeEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHH-HHHhCCceecCCCCCCeeeCCC
Q 024158           77 RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA-YCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        77 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~-~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      .||++  .-.+-.+++.+.+.++.-++..-...+   +.++....++++.+|+.... ++  ..-+|--++|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            46777  444446777777777765443333344   34688999999999888666 44  345677899999999999


Q ss_pred             CCEEEeeecc
Q 024158          156 GRLKIGDFGW  165 (271)
Q Consensus       156 ~~~~L~dfg~  165 (271)
                      +.+++.-.|.
T Consensus       121 ~~p~i~hRGi  130 (219)
T 4ano_A          121 LEPFFLHVGV  130 (219)
T ss_dssp             CCEEESCCEE
T ss_pred             CcEEEEEcCC
Confidence            9999987664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	271
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-96
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-78
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-77
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-77
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-76
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-76
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-76
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-75
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-74
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-73
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-73
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-73
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-72
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-71
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-70
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-70
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-69
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-67
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-66
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-65
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	7e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-64
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-64
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-61
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-59
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-58
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-57
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-57
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-57
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-56
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-55
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-55
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-55
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-55
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-54
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-53
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-51
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-48
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-35
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-06
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  280 bits (717), Expect = 9e-96
 Identities = 157/263 (59%), Positives = 198/263 (75%), Gaps = 12/263 (4%)

Query: 14  REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ 73
           R+W+L+DFEIGRPLGKGKFG VYL RE +SK  +ALK++FK Q+EK  ++HQLRRE+EIQ
Sbjct: 1   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S LRHPNILRLYG+FHD  R++LILEYA  G +YREL+K  +F EQ+ ATYI  L NAL+
Sbjct: 61  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-KRHTMCGTLDYLAPEMVENKE 192
           YCH   VIHRDIKPENLLL   G LKI DFGWSV + S +R T+CGTLDYL PEM+E + 
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLV 241
           HD  VD W+LG+LCYEFL G PPFEA + ++T++ I           +  A+ LISRLL 
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240

Query: 242 KDSSKRLSLQKIMEHPWIIKNAN 264
            + S+R  L++++EHPWI  N++
Sbjct: 241 HNPSQRPMLREVLEHPWITANSS 263

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 4e-78
 Identities = 86/258 (33%), Positives = 140/258 (54%), Gaps = 16/258 (6%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DF+ G+ LG+G F  V L RE+ +    A+KI+ K  I K      + RE ++ S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
             ++LY  F DDE+++  L YA  GEL + +RK   F E     Y A + +AL Y H   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKEHD 194
           +IHRD+KPEN+LL+ +  ++I DFG +        +++ ++  GT  Y++PE++  K   
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKD 243
            + D W LG + Y+ + G PPF A ++   F+ I             +A+ L+ +LLV D
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 248

Query: 244 SSKRLSLQKIMEHPWIIK 261
           ++KRL  +++  +  +  
Sbjct: 249 ATKRLGCEEMEGYGPLKA 266

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  236 bits (602), Expect = 1e-77
 Identities = 66/263 (25%), Positives = 117/263 (44%), Gaps = 17/263 (6%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + F   R +G G FG VY  R+V +   VA+K +     +  +    + +E+     LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PN ++  G +  +   +L++EY             +   E + A         LAY H +
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVE---NKEHDY 195
           ++IHRD+K  N+LL   G +K+GDFG +    +  ++  GT  ++APE++      ++D 
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSA-SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 193

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------SAEAKHLISRLLVK 242
            VD W+LGI C E     PP    +       I             S   ++ +   L K
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253

Query: 243 DSSKRLSLQKIMEHPWIIKNANP 265
               R + + +++H ++++   P
Sbjct: 254 IPQDRPTSEVLLKHRFVLRERPP 276

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (597), Expect = 2e-77
 Identities = 77/265 (29%), Positives = 128/265 (48%), Gaps = 22/265 (8%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++D+++ + LG+G +G V L     ++  VA+KI+  ++         +++E+ I   L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLN 61

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H N+++ YG   +    +L LEY   GEL+  +       E  A  +   L   + Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKE 192
             + HRDIKPENLLLD    LKI DFG +            + MCGTL Y+APE+++ +E
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 193 -HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLIS 237
            H   VD W+ GI+    L G  P++  S                  ++ I +    L+ 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 238 RLLVKDSSKRLSLQKIMEHPWIIKN 262
           ++LV++ S R+++  I +  W  K 
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKP 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (593), Expect = 1e-76
 Identities = 75/279 (26%), Positives = 137/279 (49%), Gaps = 27/279 (9%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++  R+ + +D +EI   LG G FG+VY  +  E+    A K+I  +  E+ +       
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMV 58

Query: 69  EMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIAS 127
           E++I +S  HPNI++L   F+ +  +++++E+   G +   +    R  TE Q       
Sbjct: 59  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 118

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS---VQSRSKRHTMCGTLDYLA 184
             +AL Y H+N +IHRD+K  N+L   +G +K+ DFG S    ++  +R +  GT  ++A
Sbjct: 119 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178

Query: 185 PEMV-----ENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------- 228
           PE+V     +++ +DY  D W+LGI   E     PP    +       I           
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 229 ---SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN 264
              S+  K  + + L K+   R +  ++++HP++  ++N
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  233 bits (594), Expect = 2e-76
 Identities = 101/260 (38%), Positives = 150/260 (57%), Gaps = 16/260 (6%)

Query: 16  WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSS 75
           +SLQDF+I R LG G FGRV+L+R   +    A+K++ KE + + K       E  + S 
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60

Query: 76  LRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           + HP I+R++G F D ++IF+I++Y   GEL+  LRK +RF    A  Y A +  AL Y 
Sbjct: 61  VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDY 195
           H   +I+RD+KPEN+LLD  G +KI DFG++       +T+CGT DY+APE+V  K ++ 
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHLISRLLVKDS 244
           ++D W+ GIL YE L G  PF   +   T+  I           + + K L+SRL+ +D 
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240

Query: 245 SKRL-----SLQKIMEHPWI 259
           S+RL       + +  HPW 
Sbjct: 241 SQRLGNLQNGTEDVKNHPWF 260

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  232 bits (593), Expect = 7e-76
 Identities = 80/273 (29%), Positives = 137/273 (50%), Gaps = 23/273 (8%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           K +  L  ++I   LG G FG V+ V E  + +  A K +          +  +R+E++ 
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 76

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNA 131
            S LRHP ++ L+  F DD  + +I E+   GEL+ ++  +H + +E +A  Y+  +   
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 132 LAYCHENHVIHRDIKPENLLL--DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEM 187
           L + HEN+ +H D+KPEN++        LK+ DFG +  +  +       GT ++ APE+
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 188 VENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEA 232
            E K   Y  D W++G+L Y  L G  PF  E+  +T R++               S + 
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256

Query: 233 KHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
           K  I +LL+ D + R+++ + +EHPW+     P
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 4e-75
 Identities = 77/264 (29%), Positives = 130/264 (49%), Gaps = 22/264 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           + +     +G+G  G VY   +V +   VA++ +  +Q  K   +  +  E+ +    ++
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           PNI+     +   + +++++EY   G L  ++       E Q A        AL + H N
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVENKEHDY 195
            VIHRDIK +N+LL  +G +K+ DFG+  Q    +SKR TM GT  ++APE+V  K +  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------SAEAKHLISRLLV 241
            VD W+LGI+  E + G PP+  E+       I              SA  +  ++R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 242 KDSSKRLSLQKIMEHPWIIKNANP 265
            D  KR S +++++H + +K A P
Sbjct: 256 MDVEKRGSAKELLQHQF-LKIAKP 278

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  226 bits (577), Expect = 5e-74
 Identities = 83/268 (30%), Positives = 136/268 (50%), Gaps = 22/268 (8%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           ++ E     ++    LG G F  V L  +  ++  VA+K I K+ +E    +  +  E+ 
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIA 59

Query: 72  IQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           +   ++HPNI+ L   +     ++LI++    GEL+  + +   +TE+ A+  I  + +A
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDA 119

Query: 132 LAYCHENHVIHRDIKPENLLL---DHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPE 186
           + Y H+  ++HRD+KPENLL    D + ++ I DFG S      S   T CGT  Y+APE
Sbjct: 120 VKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE 179

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAE 231
           ++  K +  AVD W++G++ Y  L G PPF  E+    F  I               S  
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 239

Query: 232 AKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           AK  I  L+ KD  KR + ++ ++HPWI
Sbjct: 240 AKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 1e-73
 Identities = 76/258 (29%), Positives = 142/258 (55%), Gaps = 16/258 (6%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK-IQHQLRREMEIQSSL 76
           ++DF + + LGKG FG+V+L    ++    A+K + K+ +     ++  +  +  +  + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
            HP +  ++  F   E +F ++EY + G+L   ++   +F   +A  Y A +   L + H
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS---RSKRHTMCGTLDYLAPEMVENKEH 193
              +++RD+K +N+LLD +G +KI DFG   ++    +K +T CGT DY+APE++  +++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVK 242
           +++VD W+ G+L YE L G  PF  + +++ F           R +  EAK L+ +L V+
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240

Query: 243 DSSKRLSL-QKIMEHPWI 259
           +  KRL +   I +HP  
Sbjct: 241 EPEKRLGVRGDIRQHPLF 258

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  226 bits (577), Expect = 2e-73
 Identities = 73/262 (27%), Positives = 121/262 (46%), Gaps = 23/262 (8%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
              ++I   LG G FG V+   E  +      K I          ++ ++ E+ I + L 
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 84

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCH 136
           HP ++ L+  F D   + LILE+   GEL+  +     + +E +   Y+      L + H
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 137 ENHVIHRDIKPENLLLD--HEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVENKE 192
           E+ ++H DIKPEN++ +      +KI DFG +  +           T ++ APE+V+ + 
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLIS 237
             +  D W +G+L Y  L G  PF  E   +T +++               S EAK  I 
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK 264

Query: 238 RLLVKDSSKRLSLQKIMEHPWI 259
            LL K+  KRL++   +EHPW+
Sbjct: 265 NLLQKEPRKRLTVHDALEHPWL 286

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (568), Expect = 4e-73
 Identities = 77/266 (28%), Positives = 125/266 (46%), Gaps = 27/266 (10%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           D+E+   +G G +GR   +R       +  K +    + + + Q  L  E+ +   L+HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 63

Query: 80  NILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRR----FTEQQAATYIASLTNALA 133
           NI+R Y    D  +  +++++EY   G+L   + K  +      E+     +  LT AL 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 134 YCHE-----NHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAP 185
            CH      + V+HRD+KP N+ LD +  +K+GDFG +       S      GT  Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------SAEAK 233
           E +    ++   D W+LG L YE     PPF A SQK+    I            S E  
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELN 243

Query: 234 HLISRLLVKDSSKRLSLQKIMEHPWI 259
            +I+R+L      R S+++I+E+P I
Sbjct: 244 EIITRMLNLKDYHRPSVEEILENPLI 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (564), Expect = 7e-72
 Identities = 70/266 (26%), Positives = 124/266 (46%), Gaps = 24/266 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            + I   LG+G+FG V+   E  SK     K +  +  +    Q  +++E+ I +  RH 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHR 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHEN 138
           NIL L+  F   E + +I E+    +++  +        E++  +Y+  +  AL + H +
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 139 HVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSR--SKRHTMCGTLDYLAPEMVENKEHD 194
           ++ H DI+PEN++        +KI +FG + Q +       +    +Y APE+ ++    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 195 YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHLISRL 239
            A D W+LG L Y  L G  PF AE+ +    +I               S EA   + RL
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 240 LVKDSSKRLSLQKIMEHPWIIKNANP 265
           LVK+   R++  + ++HPW+ +    
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER 267

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  218 bits (557), Expect = 2e-71
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 30/271 (11%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY------KIQHQLRREMEI 72
           +++E    LG+G    V       +    A+KII       +      +++    +E++I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 73  QSSLR-HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +  HPNI++L   +  +   FL+ +   +GEL+  L +    +E++    + +L   
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           +   H+ +++HRD+KPEN+LLD +  +K+ DFG+S  +    K   +CGT  YLAPE++E
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 190 NKE------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------- 228
                    +   VD W+ G++ Y  L G+PPF    Q    R I               
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 229 SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
           S   K L+SR LV    KR + ++ + HP+ 
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  218 bits (556), Expect = 4e-70
 Identities = 76/267 (28%), Positives = 134/267 (50%), Gaps = 24/267 (8%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRRE---MEIQ 73
           ++ DF + R +G+G FG VY  R+ ++    A+K + K++I+  + +     E   + + 
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALA 133
           S+   P I+ +   FH  +++  IL+  + G+L+  L +H  F+E     Y A +   L 
Sbjct: 62  STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVE-NK 191
           + H   V++RD+KP N+LLD  G ++I D G +   S+ K H   GT  Y+APE+++   
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 192 EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLIS 237
            +D + D ++LG + ++ L G  PF     KD                 S S E + L+ 
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 238 RLLVKDSSKRLSL-----QKIMEHPWI 259
            LL +D ++RL       Q++ E P+ 
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (553), Expect = 4e-70
 Identities = 99/262 (37%), Positives = 147/262 (56%), Gaps = 19/262 (7%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
           ++ DF+  + LGKG FG+V LVRE  +    A+KI+ KE I           E  +  + 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           RHP +  L   F   +R+  ++EYA+ GEL+  L + R FTE++A  Y A + +AL Y H
Sbjct: 63  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVENKEH 193
              V++RDIK ENL+LD +G +KI DFG   +  S   TM   CGT +YLAPE++E+ ++
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLISRLLVK 242
             AVD W LG++ YE + G  PF  +  +  F           R++S EAK L++ LL K
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242

Query: 243 DSSKRLS-----LQKIMEHPWI 259
           D  +RL       +++MEH + 
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFF 264

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  216 bits (551), Expect = 1e-69
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)

Query: 7   EREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           + E   +    L  F+  + LG G FGRV LV+  ES +  A+KI+ K+++ K K     
Sbjct: 29  KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIA 126
             E  I  ++  P +++L   F D+  +++++EY   GE++  LR+  RF+E  A  Y A
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148

Query: 127 SLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPE 186
            +     Y H   +I+RD+KPENLL+D +G +++ DFG++ + + +  T+CGT + LAPE
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE 208

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-----------SAEAKHL 235
           ++ +K ++ AVD W LG+L YE   G PPF A+     +  I           S++ K L
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268

Query: 236 ISRLLVKDSSKRL-----SLQKIMEHPWI 259
           +  LL  D +KR       +  I  H W 
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 4e-69
 Identities = 61/261 (23%), Positives = 113/261 (43%), Gaps = 24/261 (9%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
            +    +G+G F  VY   + E+   VA   +   ++ K + Q + + E E+   L+HPN
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ-RFKEEAEMLKGLQHPN 69

Query: 81  ILRLYGWFHD----DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           I+R Y  +       + I L+ E    G L   L++ +    +   ++   +   L + H
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 137 ENH--VIHRDIKPENLLLDHE-GRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENKE 192
                +IHRD+K +N+ +    G +KIGD G +   R S    + GT +++APEM E K 
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK- 188

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISR 238
           +D +VD +  G+   E      P+                       +    E K +I  
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 248

Query: 239 LLVKDSSKRLSLQKIMEHPWI 259
            + ++  +R S++ ++ H + 
Sbjct: 249 CIRQNKDERYSIKDLLNHAFF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (534), Expect = 1e-67
 Identities = 80/264 (30%), Positives = 137/264 (51%), Gaps = 24/264 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK---IQHQLRREMEIQSSL 76
            ++ G  LG G+F  V   RE  +    A K I K + +  +    +  + RE+ I   +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 77  RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           +HPN++ L+  + +   + LILE    GEL+  L +    TE++A  ++  + N + Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 137 ENHVIHRDIKPENLLLDHEG----RLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVEN 190
              + H D+KPEN++L        R+KI DFG +  +   ++   + GT +++APE+V  
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY 190

Query: 191 KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SAEAKHL 235
           +      D W++G++ Y  L GA PF  +++++T  ++               SA AK  
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250

Query: 236 ISRLLVKDSSKRLSLQKIMEHPWI 259
           I RLLVKD  KR+++Q  ++HPWI
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWI 274

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 3e-67
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 4/206 (1%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           DFE    LG G  G V+ V    S   +A K+I  E     +  +Q+ RE+++      P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR--NQIIRELQVLHECNSP 64

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I+  YG F+ D  I + +E+   G L + L+K  R  EQ       ++   L Y  E H
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 140 -VIHRDIKPENLLLDHEGRLKIGDFGWSVQ-SRSKRHTMCGTLDYLAPEMVENKEHDYAV 197
            ++HRD+KP N+L++  G +K+ DFG S Q   S  ++  GT  Y++PE ++   +    
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 198 DNWTLGILCYEFLYGAPPFEAESQKD 223
           D W++G+   E   G  P      K+
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKE 210

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 2e-66
 Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 14/266 (5%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSL 76
            +++G  LG G FG VY    V    PVA+K + K++I  +       ++  E+ +   +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64

Query: 77  R--HPNILRLYGWFHDDERIFLILEYAH-RGELYRELRKHRRFTEQQAATYIASLTNALA 133
                 ++RL  WF   +   LILE      +L+  + +     E+ A ++   +  A+ 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124

Query: 134 YCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSR-SKRHTMCGTLDYLAPEMVENK 191
           +CH   V+HRDIK EN+L+D   G LK+ DFG     + +      GT  Y  PE +   
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184

Query: 192 E-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----SISAEAKHLISRLLVKDSS 245
             H  +   W+LGIL Y+ + G  PFE + +    +      +S+E +HLI   L    S
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244

Query: 246 KRLSLQKIMEHPWIIKNANPRGTCDI 271
            R + ++I  HPW+     P+ T +I
Sbjct: 245 DRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  202 bits (514), Expect = 6e-65
 Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 25/265 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +E+G  LG G    V+L R++     VA+K++  +         + RRE +  ++L HP
Sbjct: 8   RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 67

Query: 80  NILRLYGWFHDDE----RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
            I+ +Y     +       ++++EY     L   +      T ++A   IA    AL + 
Sbjct: 68  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFG------WSVQSRSKRHTMCGTLDYLAPEMVE 189
           H+N +IHRD+KP N+++     +K+ DFG       S  S ++   + GT  YL+PE   
Sbjct: 128 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 187

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR---------------SISAEAKH 234
               D   D ++LG + YE L G PPF  +S                      +SA+   
Sbjct: 188 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDA 247

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
           ++ + L K+   R      M    +
Sbjct: 248 VVLKALAKNPENRYQTAAEMRADLV 272

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 7e-65
 Identities = 57/280 (20%), Positives = 115/280 (41%), Gaps = 33/280 (11%)

Query: 15  EWSLQ--DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEI 72
           +W +      +G+ +G G FG VY  +       VA+K++        ++Q   + E+ +
Sbjct: 2   DWEIPDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQ-AFKNEVGV 57

Query: 73  QSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNA 131
               RH NIL   G +    ++ ++ ++     LY  L     +F   +           
Sbjct: 58  LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPE 186
           + Y H   +IHRD+K  N+ L  +  +KIGDFG +          +   + G++ ++APE
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176

Query: 187 MVENKE---HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------- 228
           ++  ++   + +  D +  GI+ YE + G  P+   + +D    +               
Sbjct: 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS 236

Query: 229 --SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR 266
                 K L++  L K   +R    +I+    ++  + P+
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-64
 Identities = 57/258 (22%), Positives = 112/258 (43%), Gaps = 23/258 (8%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
             ++++ ++ + +GKG+FG V L       + VA+K I  +   +         E  + +
Sbjct: 3   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVMT 55

Query: 75  SLRHPNILRLYGWFHDDE-RIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNA 131
            LRH N+++L G   +++  ++++ EY  +G L   LR   R          +   +  A
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENK 191
           + Y   N+ +HRD+   N+L+  +   K+ DFG + ++ S + T    + + APE +  K
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREK 175

Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISR 238
           +     D W+ GIL +E   +G  P+     KD    +                  ++  
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN 235

Query: 239 LLVKDSSKRLSLQKIMEH 256
               D++ R S  ++ E 
Sbjct: 236 CWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 4e-64
 Identities = 75/285 (26%), Positives = 142/285 (49%), Gaps = 40/285 (14%)

Query: 13  KREWSLQDFEI-GRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREME 71
           K+   + D+++  + LG G  G+V  +    ++   ALK++        +   + RRE+E
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVE 56

Query: 72  IQSSL-RHPNILRLYGWFHD----DERIFLILEYAHRGELYRELRKH--RRFTEQQAATY 124
           +     + P+I+R+   + +     + + +++E    GEL+  ++    + FTE++A+  
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 125 IASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWS--VQSRSKRHTMCGT 179
           + S+  A+ Y H  ++ HRD+KPENLL         LK+ DFG++    S +   T C T
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 180 LDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------- 224
             Y+APE++  +++D + D W+LG++ Y  L G PPF +                     
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236

Query: 225 ----FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
               +  +S E K LI  LL  + ++R+++ + M HPWI+++   
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 281

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-61
 Identities = 66/283 (23%), Positives = 103/283 (36%), Gaps = 45/283 (15%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYK--IQHQLRREMEIQSSLRHP 79
           E    LG+G+F  VY  R+  +   VA+K I      + K  I     RE+++   L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
           NI+ L   F     I L+ ++                T      Y+      L Y H++ 
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 140 VIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM---CGTLDYLAPEMVEN-KEHDY 195
           ++HRD+KP NLLLD  G LK+ DFG +    S          T  Y APE++   + +  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 196 AVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------------------- 228
            VD W +G +  E L   P    +S  D    I                           
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 229 ------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                         +   LI  L + +   R++  + ++  + 
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 5e-61
 Identities = 57/256 (22%), Positives = 107/256 (41%), Gaps = 23/256 (8%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH 78
           +D    + LG G+FG V   +    ++ VA+K+I +  +     + +   E ++  +L H
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSH 58

Query: 79  PNILRLYGWFHDDERIFLILEYAHRGELYREL-RKHRRFTEQQAATYIASLTNALAYCHE 137
             +++LYG       IF+I EY   G L   L     RF  QQ       +  A+ Y   
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEMVENKEH 193
              +HRD+   N L++ +G +K+ DFG S       +T        + +  PE++   + 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 194 DYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISRLL 240
               D W  G+L +E    G  P+E  +  +T   I            S +   ++    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238

Query: 241 VKDSSKRLSLQKIMEH 256
            + + +R + + ++ +
Sbjct: 239 HEKADERPTFKILLSN 254

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 1e-59
 Identities = 95/274 (34%), Positives = 149/274 (54%), Gaps = 31/274 (11%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQI-EKYKIQHQLRREMEI 72
            +++FE+ + LG G +G+V+LVR++         A+K++ K  I +K K     R E ++
Sbjct: 22  GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV 81

Query: 73  QSSLRH-PNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
              +R  P ++ L+  F  + ++ LIL+Y + GEL+  L +  RFTE +   Y+  +  A
Sbjct: 82  LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT----MCGTLDYLAPEM 187
           L + H+  +I+RDIK EN+LLD  G + + DFG S +  +         CGT++Y+AP++
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 188 VENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI---------------SA 230
           V   +  HD AVD W+LG+L YE L GA PF  + +K++   I               SA
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261

Query: 231 EAKHLISRLLVKDSSKRLSL-----QKIMEHPWI 259
            AK LI RLL+KD  KRL        +I EH + 
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  187 bits (476), Expect = 6e-59
 Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 34/284 (11%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIEKYKIQHQL 66
               +E  +   +I + +G G+FG V         + +  VA+K +     EK +     
Sbjct: 17  REFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDF 74

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL-YRELRKHRRFTEQQAATYI 125
             E  I     HPN++ L G       + +I E+   G L     +   +FT  Q    +
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ--------SRSKRHTMC 177
             +   + Y  + + +HRD+   N+L++     K+ DFG S          + +      
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI-------- 228
             + + APE ++ ++   A D W+ GI+ +E + YG  P+   + +D   +I        
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254

Query: 229 ----SAEAKHLISRLLVKDSSKRLS-------LQKIMEHPWIIK 261
                +    L+     KD + R         L K++ +P  +K
Sbjct: 255 PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-58
 Identities = 58/264 (21%), Positives = 96/264 (36%), Gaps = 25/264 (9%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQ 73
             +D  +   LG G FG V              VA+K +  + + + +      RE+   
Sbjct: 6   GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASLTNAL 132
            SL H N++RLYG       + ++ E A  G L   LRKH+  F     + Y   +   +
Sbjct: 66  HSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLAPE 186
            Y      IHRD+   NLLL     +KIGDFG              +        + APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 187 MVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI-------------SAEA 232
            ++ +   +A D W  G+  +E   YG  P+   +       I               + 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244

Query: 233 KHLISRLLVKDSSKRLSLQKIMEH 256
            +++ +        R +   + + 
Sbjct: 245 YNVMVQCWAHKPEDRPTFVALRDF 268

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 3e-58
 Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 60/308 (19%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
            +  +E    +G+G FG V+  R  ++   VALK +  E  EK        RE++I   L
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLL 66

Query: 77  RHPNILRLYGWFHDDE--------RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASL 128
           +H N++ L                 I+L+ ++              +FT  +    +  L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-------HTMCGTLD 181
            N L Y H N ++HRD+K  N+L+  +G LK+ DFG +      +            TL 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 182 YLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------ 228
           Y  PE++   +++   +D W  G +  E    +P  +  +++     I            
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 229 -------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                                             A  LI +LLV D ++R+     + H 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 258 WIIKNANP 265
           +   +  P
Sbjct: 307 FFWSDPMP 314

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 3e-58
 Identities = 54/255 (21%), Positives = 100/255 (39%), Gaps = 23/255 (9%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
           +    + +G G+FG V+L     +K  VA+K I +  + +         E E+   L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNALAYCHEN 138
            +++LYG   +   I L+ E+   G L      +   F  +        +   +AY  E 
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM----CGTLDYLAPEMVENKEHD 194
            VIHRD+   N L+     +K+ DFG +      ++T        + + +PE+     + 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 195 YAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISRLLV 241
              D W+ G+L +E    G  P+E  S  +    I            S     +++    
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 242 KDSSKRLSLQKIMEH 256
           +    R +  +++  
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-58
 Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 46/293 (15%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +++F+    +G+G +G VY  R   +   VALK I  +   +  +     RE+ +   L 
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELN 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALAYCH 136
           HPNI++L    H + +++L+ E+ H+  + + +             +Y+  L   LA+CH
Sbjct: 60  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 137 ENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMV-ENKE 192
            + V+HRD+KP+NLL++ EG +K+ DFG +               TL Y APE++   K 
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 193 HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------------------ 228
           +  AVD W+LG +  E +     F  +S+ D    I                        
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 229 ----------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                             + + L+S++L  D +KR+S +  + HP+      P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 1e-57
 Identities = 56/270 (20%), Positives = 109/270 (40%), Gaps = 30/270 (11%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           ++  +L+D    + LG G FG V     +  +    VA+KI+  E  +   ++ +L  E 
Sbjct: 5   RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEA 59

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
            +   L +P I+R+ G    +    L++E A  G L + L+++R   ++     +  ++ 
Sbjct: 60  NVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS------VQSRSKRHTMCGTLDYLA 184
            + Y  E++ +HRD+   N+LL  +   KI DFG S            +      + + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAE 231
           PE +   +     D W+ G+L +E   YG  P+      +    +              E
Sbjct: 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE 238

Query: 232 AKHLISRLLVKDSSKRLSLQKI---MEHPW 258
              L++     D   R     +   + + +
Sbjct: 239 MYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  183 bits (465), Expect = 2e-57
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 46/286 (16%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           ++ +     +G+G +G VY  +        ALK I  E+ ++  I     RE+ I   L+
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI++LY   H  +R+ L+ E+  +                 A +++  L N +AYCH+
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV---QSRSKRHTMCGTLDYLAPEMVENKE-H 193
             V+HRD+KP+NLL++ EG LKI DFG +        K      TL Y AP+++   + +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 194 DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------------------- 228
              +D W++G +  E + G P F   S+ D    I                         
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 229 ---------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                L+S++L  D ++R++ ++ +EH + 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-57
 Identities = 64/299 (21%), Positives = 108/299 (36%), Gaps = 50/299 (16%)

Query: 6   AEREDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKY 60
            E E + K E+  ++ E G+ LG G FG+V                VA+K++ ++     
Sbjct: 24  REYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83

Query: 61  KIQHQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR---- 115
           +    L  E+++ + L  H NI+ L G       I+LI EY   G+L   LR  R     
Sbjct: 84  R--EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSE 141

Query: 116 -------------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG 156
                               T +    +   +   + +      +HRD+   N+L+ H  
Sbjct: 142 DEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK 201

Query: 157 RLKIGDFGWS-----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL- 210
            +KI DFG +       +   R      + ++APE +    +    D W+ GIL +E   
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261

Query: 211 YGAPPFEAESQKDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
            G  P+        F  +             + E   ++      DS KR S   +   
Sbjct: 262 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 5e-57
 Identities = 54/264 (20%), Positives = 101/264 (38%), Gaps = 27/264 (10%)

Query: 13  KREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           + EW    +  ++   LG G+FG V++         VA+K + +  +           E 
Sbjct: 5   EDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEA 59

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR--RFTEQQAATYIASL 128
            +   L+H  ++RLY     +  I++I EY   G L   L+     + T  +     A +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
              +A+  E + IHRD++  N+L+      KI DFG +        + R      + + A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAE 231
           PE +         D W+ GIL  E + +G  P+   +  +  +++              E
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE 238

Query: 232 AKHLISRLLVKDSSKRLSLQKIME 255
              L+     +    R +   +  
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRS 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 5e-57
 Identities = 50/270 (18%), Positives = 101/270 (37%), Gaps = 29/270 (10%)

Query: 13  KREW--SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREM 70
           K  W    +   +   LG+G FG V++     +   VA+K +    +          +E 
Sbjct: 9   KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEA 63

Query: 71  EIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGEL--YRELRKHRRFTEQQAATYIASL 128
           ++   LRH  +++LY    ++  I+++ EY  +G L  + +    +     Q     A +
Sbjct: 64  QVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLA 184
            + +AY    + +HRD++  N+L+      K+ DFG +        + R      + + A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAE 231
           PE           D W+ GIL  E    G  P+     ++    +               
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 242

Query: 232 AKHLISRLLVKDSSKRLSLQKIME--HPWI 259
              L+ +   K+  +R + + +      + 
Sbjct: 243 LHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (461), Expect = 1e-56
 Identities = 61/292 (20%), Positives = 116/292 (39%), Gaps = 49/292 (16%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLR--REMEIQ 73
           + Q +E    +G+G +G+V+  R++++    VALK +  +  E+      +R    +   
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 74  SSLRHPNILRLYGWFHDDE-----RIFLILEYAHRGEL-YRELRKHRRFTEQQAATYIAS 127
            +  HPN++RL+            ++ L+ E+  +    Y +         +     +  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 128 LTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAP 185
           L   L + H + V+HRD+KP+N+L+   G++K+ DFG +     +    ++  TL Y AP
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 186 EMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------------- 228
           E++    +   VD W++G +  E     P F   S  D    I                 
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 229 ---------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                    K L+ + L  + +KR+S    + HP+ 
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-56
 Identities = 57/272 (20%), Positives = 101/272 (37%), Gaps = 32/272 (11%)

Query: 17  SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL 76
              D +    +G+G FG+V   R  +    +   I   ++            E+E+   L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 77  -RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQ 119
             HPNI+ L G       ++L +EYA  G L   LRK                    + Q
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 120 QAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMC 177
           Q   + A +   + Y  +   IHRD+   N+L+      KI DFG S   +   K+    
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 178 GTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI-------- 228
             + ++A E +    +    D W+ G+L +E +  G  P+   +  + +  +        
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247

Query: 229 ----SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
                 E   L+ +   +   +R S  +I+  
Sbjct: 248 PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 4e-56
 Identities = 69/302 (22%), Positives = 127/302 (42%), Gaps = 53/302 (17%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R++  K  W ++  +   +P+G G +G V    +  +   VA+K +++    +     + 
Sbjct: 6   RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRA 64

Query: 67  RREMEIQSSLRHPNILRLYGWFHDDER------IFLILEYAHRGELYRELRKHRRFTEQQ 120
            RE+ +   +RH N++ L   F  DE        +L++ +   G    +L KH +  E +
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDR 122

Query: 121 AATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTL 180
               +  +   L Y H   +IHRD+KP NL ++ +  LKI DFG + Q+ S+      T 
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

Query: 181 DYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI----------- 228
            Y APE++ N   +   VD W++G +  E + G   F+     D  + I           
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 229 -------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHP 257
                                          S  A +L+ ++LV D+ +R++  + + HP
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302

Query: 258 WI 259
           + 
Sbjct: 303 YF 304

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 2e-55
 Identities = 63/299 (21%), Positives = 117/299 (39%), Gaps = 58/299 (19%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           +     +G+G +G V    +  +K  VA+K I   + + Y    +  RE++I    RH N
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFRHEN 67

Query: 81  ILRLYGWFHDD-----ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYC 135
           I+ +            + ++L+      G    +L K +  +      ++  +   L Y 
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 136 HENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKR------HTMCGTLDYLAPEMVE 189
           H  +V+HRD+KP NLLL+    LKI DFG +  +               T  Y APE++ 
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 190 NKEHD-YAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI-------------------- 228
           N +    ++D W++G +  E L   P F  +   D    I                    
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245

Query: 229 ----------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                                  ++A  L+ ++L  +  KR+ +++ + HP++ +  +P
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 3e-55
 Identities = 73/299 (24%), Positives = 117/299 (39%), Gaps = 60/299 (20%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
            +   + +G G FG VY  +  +S   VA+K + +++  K        RE++I   L H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHC 73

Query: 80  NILRLYGWFH------DDERIFLILEYAHRG---ELYRELRKHRRFTEQQAATYIASLTN 130
           NI+RL  +F+      D+  + L+L+Y             R  +         Y+  L  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDYLAP-E 186
           +LAY H   + HRDIKP+NLLLD +   LK+ DFG +  +       +   +  Y AP  
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------------ 228
           +    ++  ++D W+ G +  E L G P F  +S  D    I                  
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 229 ----------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                                   EA  L SRLL    + RL+  +   H +  +  +P
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (449), Expect = 5e-55
 Identities = 55/260 (21%), Positives = 103/260 (39%), Gaps = 23/260 (8%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
           E    D  +   LG G++G VY     +    VA+K + ++ +E      +  +E  +  
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMK 68

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR--FTEQQAATYIASLTNAL 132
            ++HPN+++L G    +   ++I E+   G L   LR+  R   +          +++A+
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS-VQSRSKRHTMCGT---LDYLAPEMV 188
            Y  + + IHRD+   N L+     +K+ DFG S + +        G    + + APE +
Sbjct: 129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFR------------SISAEAKHL 235
              +     D W  G+L +E   YG  P+        +                 +   L
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248

Query: 236 ISRLLVKDSSKRLSLQKIME 255
           +      + S R S  +I +
Sbjct: 249 MRACWQWNPSDRPSFAEIHQ 268

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 8e-55
 Identities = 66/306 (21%), Positives = 120/306 (39%), Gaps = 49/306 (16%)

Query: 8   REDNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQL 66
           R++  K  W + + ++   P+G G +G V    + ++   VA+K + +        + + 
Sbjct: 6   RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RT 64

Query: 67  RREMEIQSSLRHPNILRLYGWFHDD----ERIFLILEYAHRGELYRELRKHRRFTEQQAA 122
            RE+ +   ++H N++ L   F       E   + L     G     + K ++ T+    
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ 124

Query: 123 TYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDY 182
             I  +   L Y H   +IHRD+KP NL ++ +  LKI DFG +  +  +      T  Y
Sbjct: 125 FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWY 184

Query: 183 LAPE-MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI------------- 228
            APE M+    ++  VD W++G +  E L G   F      D  + I             
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 229 -----------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWI 259
                                        +  A  L+ ++LV DS KR++  + + H + 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

Query: 260 IKNANP 265
            +  +P
Sbjct: 305 AQYHDP 310

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-55
 Identities = 63/293 (21%), Positives = 122/293 (41%), Gaps = 46/293 (15%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           +Q +E    +G+G +G V+  +  E+   VALK +  +  ++  +     RE+ +   L+
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           H NI+RL+   H D+++ L+ E+  +         +     +   +++  L   L +CH 
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ---SRSKRHTMCGTLDYLAPEMVEN-KEH 193
            +V+HRD+KP+NLL++  G LK+ +FG +               TL Y  P+++   K +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 194 DYAVDNWTLGILCYEFLYG-APPFEAESQKDTFRSI------------------------ 228
             ++D W+ G +  E      P F      D  + I                        
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 229 ----------------SAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP 265
                           +A  + L+  LL  +  +R+S ++ ++HP+      P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-54
 Identities = 42/267 (15%), Positives = 100/267 (37%), Gaps = 20/267 (7%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKE--QIEKYKIQHQLRREMEIQSSLR 77
           +F+  + LG G FG VY    +     V + +  KE  +    K   ++  E  + +S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69

Query: 78  HPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE 137
           +P++ RL G         +         L            Q    +   +   + Y  +
Sbjct: 70  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 138 NHVIHRDIKPENLLLDHEGRLKIGDFGWSV-----QSRSKRHTMCGTLDYLAPEMVENKE 192
             ++HRD+   N+L+     +KI DFG +      +           + ++A E + ++ 
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189

Query: 193 HDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISRL 239
           + +  D W+ G+  +E + +G+ P++     +    +            + +   ++ + 
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 240 LVKDSSKRLSLQKIMEHPWIIKNANPR 266
            + D+  R   ++++     +     R
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQR 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-54
 Identities = 61/273 (22%), Positives = 109/273 (39%), Gaps = 32/273 (11%)

Query: 12  RKREWSLQDFEIGRPLGKGKFGRVYLV--REVESKHPVALKIIFKEQIEKYKIQHQLRRE 69
           ++    + D E+G     G FG V     R  + +  VA+K++ +   +      ++ RE
Sbjct: 6   KRDNLLIADIELGC----GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMRE 59

Query: 70  MEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-RFTEQQAATYIASL 128
            +I   L +P I+RL G    +  + L++E A  G L++ L   R        A  +  +
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ------SRSKRHTMCGTLDY 182
           +  + Y  E + +HRD+   N+LL +    KI DFG S          + R      L +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 183 LAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------S 229
            APE +  ++     D W+ G+  +E L YG  P++     +    I             
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP 238

Query: 230 AEAKHLISRLLVKDSSKRLS---LQKIMEHPWI 259
            E   L+S   +     R     +++ M   + 
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 7e-53
 Identities = 60/261 (22%), Positives = 108/261 (41%), Gaps = 20/261 (7%)

Query: 15  EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP-VALKIIFKEQIEKYKIQHQLRREMEIQ 73
           E   +  E+GR +G+G+FG V+    +  ++P +A+ I   +      ++ +  +E    
Sbjct: 3   EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62

Query: 74  SSLRHPNILRLYGWFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNAL 132
               HP+I++L G   ++  +++I+E    GEL      +           Y   L+ AL
Sbjct: 63  RQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121

Query: 133 AYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ----SRSKRHTMCGTLDYLAPEMV 188
           AY      +HRDI   N+L+     +K+GDFG S      +  K       + ++APE +
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 189 ENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHL 235
             +    A D W  G+  +E L +G  PF+     D    I                  L
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL 241

Query: 236 ISRLLVKDSSKRLSLQKIMEH 256
           +++    D S+R    ++   
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  170 bits (431), Expect = 5e-52
 Identities = 67/306 (21%), Positives = 131/306 (42%), Gaps = 66/306 (21%)

Query: 10  DNRKREWSLQD-FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRR 68
           ++   EW  QD +++ R LG+GK+  V+    + +   V +KI+   + +      +++R
Sbjct: 25  ESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK------KIKR 78

Query: 69  EMEIQSSLR-HPNILRLYGWFHD--DERIFLILEYAHRGELYRELRKHRRFTEQQAATYI 125
           E++I  +LR  PNI+ L     D       L+ E+ +  +     + ++  T+     Y+
Sbjct: 79  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFK---QLYQTLTDYDIRFYM 135

Query: 126 ASLTNALAYCHENHVIHRDIKPENLLLDHEGR-LKIGDFGWS--VQSRSKRHTMCGTLDY 182
             +  AL YCH   ++HRD+KP N+++DHE R L++ D+G +       + +    +  +
Sbjct: 136 YEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195

Query: 183 LAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAES--------------------- 220
             PE++ + + +DY++D W+LG +    ++   PF                         
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 221 ----------------------------QKDTFRSISAEAKHLISRLLVKDSSKRLSLQK 252
                                         +    +S EA   + +LL  D   RL+ ++
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 253 IMEHPW 258
            MEHP+
Sbjct: 316 AMEHPY 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 1e-51
 Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 45/288 (15%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQ 65
           + K E+       G+ LG G FG+V         + ++   VA+K++        +    
Sbjct: 15  DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EA 72

Query: 66  LRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR---------- 114
           L  E+++ S L  H NI+ L G         +I EY   G+L   LR+ R          
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 115 --------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                       +   ++   +   +A+    + IHRD+   N+LL H    KI DFG +
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192

Query: 167 VQSRSKRHTM-----CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
              ++  + +        + ++APE + N  + +  D W+ GI  +E    G+ P+    
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 221 QKDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIME 255
               F  +              AE   ++      D  KR + ++I++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  168 bits (427), Expect = 1e-51
 Identities = 47/286 (16%), Positives = 98/286 (34%), Gaps = 41/286 (14%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
           + +GR +G G FG +YL  ++ +   VA+K+   +         QL  E +I   ++   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63

Query: 81  ILRLYGW-FHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            +    W   + +   +++E              R+F+ +        + + + Y H  +
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 140 VIHRDIKPENLL---LDHEGRLKIGDFGWSVQSRS----------KRHTMCGTLDYLAPE 186
            IHRD+KP+N L         + I DFG + + R           +   + GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 187 MVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------RS 227
                E     D  +LG +   F  G+ P++                           + 
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 228 ISAEAKHLISRLLVKDSSKRLS---LQKIMEHPWIIKNANPRGTCD 270
             +E    ++         +     L+++  + +  +  +     D
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-51
 Identities = 58/270 (21%), Positives = 105/270 (38%), Gaps = 33/270 (12%)

Query: 19  QDFEIGRPLGKGKFGRVYLVREVES----KHPVALKIIFKEQIEKYKIQHQLRREMEIQS 74
                 + +G G+FG VY      S    + PVA+K +     EK ++      E  I  
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIMG 64

Query: 75  SLRHPNILRLYGWFHDDERIFLILEYAHRG-ELYRELRKHRRFTEQQAATYIASLTNALA 133
              H NI+RL G     + + +I EY   G        K   F+  Q    +  +   + 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 134 YCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSV------QSRSKRHTMCGTLDYLAPEM 187
           Y    + +HRD+   N+L++     K+ DFG S       ++          + + APE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 188 VENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKH 234
           +  ++   A D W+ GI+ +E + YG  P+   S  +  ++I             +    
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 235 LISRLLVKDSSKRLS-------LQKIMEHP 257
           L+ +   ++ ++R         L K++  P
Sbjct: 245 LMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 3e-51
 Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 49/290 (16%)

Query: 13  KREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLR 67
             E+   + E  R +G+G FGRV+  R       E    VA+K++ +E      +Q   +
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQ 64

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRR------------ 115
           RE  + +   +PNI++L G     + + L+ EY   G+L   LR                
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 116 ------------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDF 163
                        +  +       +   +AY  E   +HRD+   N L+     +KI DF
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 184

Query: 164 GWSVQSRSKRH-----TMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFE 217
           G S    S  +          + ++ PE +    +    D W  G++ +E   YG  P+ 
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244

Query: 218 AESQKDTFRSI------------SAEAKHLISRLLVKDSSKRLSLQKIME 255
             + ++    +              E  +L+     K  + R S   I  
Sbjct: 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-50
 Identities = 61/288 (21%), Positives = 120/288 (41%), Gaps = 44/288 (15%)

Query: 11  NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-------PVALKIIFKEQIEKYKIQ 63
           + + E       +G+PLG+G FG+V L   +            VA+K++  +  EK    
Sbjct: 5   DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--L 62

Query: 64  HQLRREMEIQSSL-RHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHR-------- 114
             L  EME+   + +H NI+ L G    D  +++I+EYA +G L   L+  R        
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 122

Query: 115 --------RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS 166
                   + + +   +    +   + Y      IHRD+   N+L+  +  +KI DFG +
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 167 -----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAES 220
                +    K       + ++APE + ++ + +  D W+ G+L +E    G  P+    
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242

Query: 221 QKDTFRSI------------SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
            ++ F+ +            + E   ++        S+R + ++++E 
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-48
 Identities = 54/277 (19%), Positives = 105/277 (37%), Gaps = 37/277 (13%)

Query: 15  EW--SLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQHQLR 67
           EW  + +   + R LG+G FG VY        + E +  VA+K + +    + +I+    
Sbjct: 14  EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE--FL 71

Query: 68  REMEIQSSLRHPNILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRF----------T 117
            E  +       +++RL G     +   +I+E   RG+L   LR  R            +
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 118 EQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW-----SVQSRSK 172
             +       + + +AY + N  +HRD+   N ++  +  +KIGDFG            K
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191

Query: 173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI--- 228
                  + +++PE +++       D W+ G++ +E       P++  S +   R +   
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251

Query: 229 ---------SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
                          L+      +   R S  +I+  
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 4e-48
 Identities = 57/309 (18%), Positives = 116/309 (37%), Gaps = 65/309 (21%)

Query: 18  LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR 77
           L+ ++  +P+G G  G V    +      VA+K + +    +     +  RE+ +   + 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVN 74

Query: 78  HPNILRLYGWFH------DDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNA 131
           H NI+ L   F       + + ++L++E                   ++ +  +  +   
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCG 131

Query: 132 LAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS--VQSRSKRHTMCGTLDYLAPEMVE 189
           + + H   +IHRD+KP N+++  +  LKI DFG +    +         T  Y APE++ 
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 190 NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSI--------------------- 228
              +   VD W++G +  E +     F      D +  +                     
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251

Query: 229 --------------------------------SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
                                           +++A+ L+S++LV D +KR+S+   ++H
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311

Query: 257 PWIIKNANP 265
           P+I    +P
Sbjct: 312 PYINVWYDP 320

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (401), Expect = 6e-48
 Identities = 49/257 (19%), Positives = 94/257 (36%), Gaps = 26/257 (10%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-P 79
           +++GR +G+G FG ++    + +   VA+K   +          QLR E      L    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61

Query: 80  NILRLYGWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH 139
            I  +Y +  +     L+++              R+F+ +  A     +   +   HE  
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121

Query: 140 VIHRDIKPENLLLD-----HEGRLKIGDFGWSVQSRS----------KRHTMCGTLDYLA 184
           +++RDIKP+N L+      +   + + DFG     R           ++  + GT  Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 185 PEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---FRSISAEAKHLISRLLV 241
                 +E     D   LG +   FL G+ P++          +  I  + +    R L 
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241

Query: 242 KDSSKRLSLQKIMEHPW 258
               +     K M +  
Sbjct: 242 AGFPE--EFYKYMHYAR 256

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-47
 Identities = 48/258 (18%), Positives = 96/258 (37%), Gaps = 27/258 (10%)

Query: 24  GRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN 80
              +G+G FG VY    +++       A+K + +  I       Q   E  I     HPN
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89

Query: 81  ILRLYG-WFHDDERIFLILEYAHRGELYR-ELRKHRRFTEQQAATYIASLTNALAYCHEN 138
           +L L G     +    ++L Y   G+L      +    T +    +   +   + +    
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149

Query: 139 HVIHRDIKPENLLLDHEGRLKIGDFGWS-------VQSRSKRHTMCGTLDYLAPEMVENK 191
             +HRD+   N +LD +  +K+ DFG +         S   +      + ++A E ++ +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 192 EHDYAVDNWTLGILCYEFL-YGAPPFEAESQKDTFRSI------------SAEAKHLISR 238
           +     D W+ G+L +E +  GAPP+   +  D    +                  ++ +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269

Query: 239 LLVKDSSKRLSLQKIMEH 256
                +  R S  +++  
Sbjct: 270 CWHPKAEMRPSFSELVSR 287

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 1e-44
 Identities = 56/288 (19%), Positives = 108/288 (37%), Gaps = 42/288 (14%)

Query: 10  DNRKREWSLQDFEIGRPLGKGKFGRVYLVR-----EVESKHPVALKIIFKEQIEKYKIQH 64
           D  K E+     ++G+PLG+G FG+V         +  +   VA+K++ +      + + 
Sbjct: 4   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRA 62

Query: 65  QLRREMEIQSSLRHPNILRLYG-WFHDDERIFLILEYAHRGELYRELRKHRR-------- 115
            +     +     H N++ L G        + +I+E+   G L   LR  R         
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 116 --------FTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWS- 166
                    T +    Y   +   + +      IHRD+   N+LL  +  +KI DFG + 
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182

Query: 167 ----VQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQ 221
                    ++      L ++APE + ++ +    D W+ G+L +E     A P+     
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 222 KDTFRSI-------------SAEAKHLISRLLVKDSSKRLSLQKIMEH 256
            + F                + E    +      + S+R +  +++EH
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 3e-43
 Identities = 49/293 (16%), Positives = 98/293 (33%), Gaps = 63/293 (21%)

Query: 20  DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHP 79
              +   +GKG+FG V+  +       VA+KI    +   +  +     E+     LRH 
Sbjct: 4   TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHE 57

Query: 80  NILRLYGWFHDDE----RIFLILEYAHRGELYRELRKHR-------RFTEQQAATYIASL 128
           NIL      + D     +++L+ +Y   G L+  L ++        +     A+      
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117

Query: 129 TNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTM-------CGTLD 181
              +    +  + HRD+K +N+L+   G   I D G +V+  S   T+        GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 182 YLAPEMVENKEH------DYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR--------- 226
           Y+APE++++  +          D + +G++ +E                           
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 227 ------------------------SISAEAKHLISRLLVKDSSKRLSLQKIME 255
                                           ++      + + RL+  +I +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (320), Expect = 3e-35
 Identities = 47/234 (20%), Positives = 90/234 (38%), Gaps = 19/234 (8%)

Query: 21  FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ------- 73
           + + R LG G F  V+L +++ +   VA+KI+  +++     + +++    +        
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 74  SSLRHPNILRLYGWFHDDERIFLIL-----EYAHRGELYRELRKHRRFTEQQAATYIASL 128
            S+   +IL+L   F+      + +               +  +HR             L
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 129 TNALAYCHENH-VIHRDIKPENLLLDHEG------RLKIGDFGWSVQSRSKRHTMCGTLD 181
              L Y H    +IH DIKPEN+L++         ++KI D G +            T +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 182 YLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRSISAEAKHL 235
           Y +PE++         D W+   L +E + G   FE +      +     A+ +
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 44.6 bits (104), Expect = 6e-06
 Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 1/85 (1%)

Query: 176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-RSISAEAKH 234
           +   L  L   ++ N ++     N    +     L   P  +  ++K  F +  + E   
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306

Query: 235 LISRLLVKDSSKRLSLQKIMEHPWI 259
            +S +L  D  KR     ++ HPW+
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.5 bits (221), Expect = 2e-22
 Identities = 28/193 (14%), Positives = 61/193 (31%), Gaps = 20/193 (10%)

Query: 22  EIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQ-------LRREMEIQS 74
            IG+ +G+GK   V+     E      +K          K++ +               +
Sbjct: 3   AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61

Query: 75  SLRHPNILRLYG----WFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTN 130
                 + +L G      +  E   +++E            +  R   +     +  +  
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILE 114

Query: 131 ALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVEN 190
            +A  +   ++H D+   N+L+  EG + I DF  SV+   +        D        +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

Query: 191 KEHDYAVDNWTLG 203
           + +    D  +  
Sbjct: 174 RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	271
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.33
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.26
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.26

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-63  Score=404.51  Aligned_cols=249  Identities=63%  Similarity=1.127  Sum_probs=228.2

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      +.|++++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++.
T Consensus         1 r~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   80 (263)
T d2j4za1           1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   80 (263)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE
Confidence            46889999999999999999999999999999999999987665555556778899999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-c
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-K  172 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-~  172 (271)
                      +|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999865543 3


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcc
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLV  241 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~  241 (271)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+...           .+++++.+||.+||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  240 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK  240 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTC
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHcc
Confidence            445679999999999999999999999999999999999999999877655543           358999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||++|||++|+|+||||+.+
T Consensus       241 ~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         241 HNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             SSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999865

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-61  Score=392.24  Aligned_cols=243  Identities=32%  Similarity=0.602  Sum_probs=214.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.......  ..+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            468999999999999999999999999999999996654332  245688999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-----c
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-----K  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----~  172 (271)
                      |||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....     .
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999864322     2


Q ss_pred             cccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~  237 (271)
                      .....||+.|+|||.+.+..+ +.++|||||||++|+|++|..||........              +..+++++.+|+.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            344579999999999988876 5689999999999999999999976553322              2457999999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||.+||++|||++|+|+||||++.
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999853

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.7e-60  Score=394.65  Aligned_cols=247  Identities=40%  Similarity=0.718  Sum_probs=228.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      +++++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus         1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   80 (316)
T d1fota_           1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   80 (316)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeee
Confidence            57899999999999999999999999999999999998766555455677889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccc
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHT  175 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~  175 (271)
                      +||||++|++|..++.....++...++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus        81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999887777777


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcccCc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVKDS  244 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~~p  244 (271)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+...           .+++++.+++.+||.+||
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp  240 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL  240 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCT
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCH
Confidence            899999999999999999999999999999999999999998877654433           368999999999999999


Q ss_pred             cCCC-----CHHHHhcCCccccC
Q 024158          245 SKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       245 ~~Rp-----s~~~il~~~~~~~~  262 (271)
                      .+|+     |++++++||||++.
T Consensus       241 ~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         241 SQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HhccccchhhHHHHHcCcccccC
Confidence            9996     99999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-60  Score=388.37  Aligned_cols=240  Identities=30%  Similarity=0.511  Sum_probs=216.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      ++|++++.||+|+||+||+|++..+|+.||+|++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            46999999999999999999999999999999997654433   356889999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      ||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....   ....
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999998876 4699999999999999999999999999999999999999999999999999865432   3345


Q ss_pred             ccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHHHHhcc
Q 024158          176 MCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLISRLLV  241 (271)
Q Consensus       176 ~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li~~~l~  241 (271)
                      ..||+.|+|||.+.+..++.++|||||||++|+|++|..||.+....+..              ..+++++++||.+||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  255 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD  255 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTC
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHcc
Confidence            67999999999999999999999999999999999999999876644332              3468999999999999


Q ss_pred             cCccCCCCHHHHhcCCccccC
Q 024158          242 KDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +||.+|||++|+|+||||+..
T Consensus       256 ~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         256 MDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGC
T ss_pred             CChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-60  Score=391.21  Aligned_cols=249  Identities=35%  Similarity=0.623  Sum_probs=222.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDER   93 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   93 (271)
                      .....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+++.
T Consensus         3 ~~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~   82 (288)
T d1uu3a_           3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK   82 (288)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred             CCCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence            34456789999999999999999999999999999999987665544456778999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--  171 (271)
                      +|+||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....  
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999999999999888999999999999999999999999999999999999999999999999999865432  


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-----------cccCHHHHHHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-----------RSISAEAKHLIS  237 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-----------~~i~~~l~~li~  237 (271)
                         ......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+..           ..+++++.+||+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  242 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE  242 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence               223457999999999999999999999999999999999999999987655443           346899999999


Q ss_pred             HhcccCccCCCCHHH------HhcCCccccC
Q 024158          238 RLLVKDSSKRLSLQK------IMEHPWIIKN  262 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~------il~~~~~~~~  262 (271)
                      +||.+||.+|||++|      +++||||+..
T Consensus       243 ~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         243 KLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             TTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999987      6899999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-59  Score=392.43  Aligned_cols=248  Identities=39%  Similarity=0.647  Sum_probs=226.1

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      .+++++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+++.+
T Consensus         1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            36889999999999999999999999999999999999877654444467788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      |+||||+++++|.+++...+.++++.++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....   
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            99999999999999999988999999999999999999999999999999999999999999999999999865432   


Q ss_pred             ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhc
Q 024158          172 KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLL  240 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l  240 (271)
                      .....+||+.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+..+...           .+++++.+||++||
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L  240 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL  240 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence            3345679999999999999999999999999999999999999999887655433           46899999999999


Q ss_pred             ccCccCCCC-----HHHHhcCCccccC
Q 024158          241 VKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       241 ~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+||.+|++     ++++++||||++.
T Consensus       241 ~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         241 KKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             cCCchhhcccccccHHHHHcCcccccC
Confidence            999999995     8999999999764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-59  Score=389.14  Aligned_cols=245  Identities=27%  Similarity=0.460  Sum_probs=220.5

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            49999999999999999999999999999999977665555667788999999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCcccccccc
Q 024158          100 YAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSKRHTMCGT  179 (271)
Q Consensus       100 ~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~~~~~~~  179 (271)
                      ||.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....||
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-~~~~~GT  174 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-ANSFVGT  174 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-BCCCCSC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC-CCccccC
Confidence            999999988887778899999999999999999999999999999999999999999999999999865443 3456799


Q ss_pred             ccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-------------ccCHHHHHHHHHhcccC
Q 024158          180 LDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-------------SISAEAKHLISRLLVKD  243 (271)
Q Consensus       180 ~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-------------~i~~~l~~li~~~l~~~  243 (271)
                      +.|+|||++.+   ..++.++|||||||++|+|++|..||.+....+.+.             .+++++.+||.+||.+|
T Consensus       175 ~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~d  254 (309)
T d1u5ra_         175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI  254 (309)
T ss_dssp             GGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSS
T ss_pred             ccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCC
Confidence            99999999864   458889999999999999999999998776554332             35899999999999999


Q ss_pred             ccCCCCHHHHhcCCccccCCCC
Q 024158          244 SSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       244 p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      |.+|||++++|+||||++...+
T Consensus       255 P~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         255 PQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             GGGSCCHHHHTTCHHHHSCCCT
T ss_pred             hhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999876544

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-59  Score=393.28  Aligned_cols=250  Identities=35%  Similarity=0.637  Sum_probs=229.9

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      .....+++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+++.++||||+++++++...+
T Consensus        35 ~~~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCCCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            34566899999999999999999999999999999999998766555455677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..++|+|++.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999999887777


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhcc
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLV  241 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~  241 (271)
                      .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+......           .+++++.++|++||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~  274 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQ  274 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSC
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhh
Confidence            777889999999999999999999999999999999999999999877655433           368999999999999


Q ss_pred             cCccCCC-----CHHHHhcCCccccC
Q 024158          242 KDSSKRL-----SLQKIMEHPWIIKN  262 (271)
Q Consensus       242 ~~p~~Rp-----s~~~il~~~~~~~~  262 (271)
                      +||.+|+     |++++++||||+..
T Consensus       275 ~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         275 VDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             hCHHhccccccccHHHHHcCccccCC
Confidence            9999995     99999999999865

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-59  Score=392.84  Aligned_cols=246  Identities=30%  Similarity=0.475  Sum_probs=217.2

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeE
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERI   94 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   94 (271)
                      ++.-++|++++.||+|+||+||+|++..+|+.||+|++......  .....+.+|+.+++.++||||+++++++.+++.+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45677999999999999999999999999999999999765322  2346788999999999999999999999999999


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCeeeCCCCCEEEeeeccccccc-Cc
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHEN-HVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR-SK  172 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~-~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~-~~  172 (271)
                      |+||||+++++|.+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+|||++.+|.+||+|||++.... ..
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  159 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  159 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred             EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence            99999999999999998888899999999999999999999975 99999999999999999999999999986433 33


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------------
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------------  224 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------------  224 (271)
                      .....||+.|+|||.+.+..++.++||||+||++|+|++|..||.+....+.                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            4456899999999999999999999999999999999999999976542211                            


Q ss_pred             ---------------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          225 ---------------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       225 ---------------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                                                 ...+++++.+|+.+||..||.+|||++|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                                       00146899999999999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-59  Score=383.84  Aligned_cols=241  Identities=29%  Similarity=0.526  Sum_probs=214.0

Q ss_pred             ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEe
Q 024158           20 DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILE   99 (271)
Q Consensus        20 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   99 (271)
                      .|++++.||+|+||+||+|++..+|..+|+|++.......   .+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            5899999999999999999999999999999996643322   4567889999999999999999999999999999999


Q ss_pred             ccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccc
Q 024158          100 YAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHT  175 (271)
Q Consensus       100 ~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~  175 (271)
                      |+++++|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ....
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            9999999999765 46799999999999999999999999999999999999999999999999999854332   2345


Q ss_pred             ccccccccCCcccc-----CCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------cccCHHHHHHH
Q 024158          176 MCGTLDYLAPEMVE-----NKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------RSISAEAKHLI  236 (271)
Q Consensus       176 ~~~~~~y~~pe~~~-----~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------~~i~~~l~~li  236 (271)
                      ..||+.|+|||.+.     +..++.++|||||||++|+|++|..||.+....+..              ..+++++.+||
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li  249 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFL  249 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            67899999999984     455788999999999999999999999887655442              24689999999


Q ss_pred             HHhcccCccCCCCHHHHhcCCccccCC
Q 024158          237 SRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       237 ~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      .+||.+||++|||++|+++||||+...
T Consensus       250 ~~~L~~dp~~R~t~~ell~hp~~~~~~  276 (288)
T d2jfla1         250 KKCLEKNVDARWTTSQLLQHPFVTVDS  276 (288)
T ss_dssp             HHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999999999998643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-59  Score=386.16  Aligned_cols=243  Identities=33%  Similarity=0.634  Sum_probs=203.2

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLIL   98 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   98 (271)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++.+......  ...+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            459999999999999999999999999999999976654432  356788999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC---CCCCEEEeeecccccccC--cc
Q 024158           99 EYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD---HEGRLKIGDFGWSVQSRS--KR  173 (271)
Q Consensus        99 e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~---~~~~~~L~dfg~~~~~~~--~~  173 (271)
                      |||+|++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||++.   .++.++|+|||++.....  ..
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~  166 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL  166 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCee
Confidence            9999999999999888899999999999999999999999999999999999995   468999999999865433  33


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHHH
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLISR  238 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~~  238 (271)
                      ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+....+..               ..+|+++.+||.+
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  246 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH  246 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence            4567999999999999999999999999999999999999999876644332               3478999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccccCC
Q 024158          239 LLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ||.+||++|||++|+++||||++..
T Consensus       247 ~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         247 LMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             HccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999998653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=375.15  Aligned_cols=238  Identities=24%  Similarity=0.467  Sum_probs=209.7

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe----CCeEEE
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD----DERIFL   96 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~----~~~~~l   96 (271)
                      |++.++||+|+||+||+|++..++..||+|.+....... ...+.+.+|++++++++||||+++++++..    ++.+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            478889999999999999999999999999997765443 335678899999999999999999999865    356899


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCeeeC-CCCCEEEeeecccccccC-c
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENH--VIHRDIKPENLLLD-HEGRLKIGDFGWSVQSRS-K  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~--i~H~dl~~~Nili~-~~~~~~L~dfg~~~~~~~-~  172 (271)
                      ||||+++++|.+++.+...+++..++.++.||++||.|||++|  |+||||||+|||++ .++.+||+|||++..... .
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~  169 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF  169 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc
Confidence            9999999999999998888999999999999999999999998  99999999999996 478999999999965443 3


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLISR  238 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li~~  238 (271)
                      .....||+.|+|||.+.+ .++.++|||||||++|+|++|..||........              ....++++.++|.+
T Consensus       170 ~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~  248 (270)
T d1t4ha_         170 AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG  248 (270)
T ss_dssp             BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHH
T ss_pred             cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHH
Confidence            445689999999998865 589999999999999999999999976543322              12358999999999


Q ss_pred             hcccCccCCCCHHHHhcCCccc
Q 024158          239 LLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~~~~~  260 (271)
                      ||.+||++|||++|+|+|||||
T Consensus       249 ~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         249 CIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999997

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-59  Score=379.49  Aligned_cols=241  Identities=31%  Similarity=0.532  Sum_probs=204.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe--CCeEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD--DERIF   95 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~   95 (271)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++....... ...+.+.+|++++++++||||+++++++.+  ++.+|
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            478999999999999999999999999999999997765543 335678899999999999999999998854  45689


Q ss_pred             EEEeccCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158           96 LILEYAHRGELYRELRK----HRRFTEQQAATYIASLTNALAYCHENH-----VIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~~l~~~l~~Lh~~~-----i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      +|||||++++|.+++..    ...+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            99999999999999864    457999999999999999999999976     999999999999999999999999998


Q ss_pred             ccccC---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh------------cccCHH
Q 024158          167 VQSRS---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       167 ~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      .....   ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+..+..            ..++++
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            65432   234567899999999999999999999999999999999999999887655443            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcCCcc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEHPWI  259 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~~~~  259 (271)
                      +.+|+.+||.+||.+|||++|+|+|||+
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            9999999999999999999999999996

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.3e-58  Score=388.48  Aligned_cols=247  Identities=32%  Similarity=0.644  Sum_probs=220.1

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ..+++|++++.||+|+||.||+|+++.+|+.||||++......   ..+.+.+|+.++++++||||+++++++.+++.+|
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   99 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV   99 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3467999999999999999999999999999999999665432   2467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC--CCCEEEeeecccccccCc
Q 024158           96 LILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH--EGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~--~~~~~L~dfg~~~~~~~~  172 (271)
                      +|||||++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.  ++.+||+|||++......
T Consensus       100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            99999999999999954 457999999999999999999999999999999999999964  578999999998654433


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHL  235 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~l  235 (271)
                        .....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+               ..+++++.+|
T Consensus       180 ~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence              33467899999999999999999999999999999999999999877654443               3468999999


Q ss_pred             HHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          236 ISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       236 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                      |.+||.+||++|||++|+|+||||+....+
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            999999999999999999999999987544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=381.74  Aligned_cols=245  Identities=33%  Similarity=0.602  Sum_probs=217.9

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+......   ...+.+.+|+.++++++||||+++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            459999999999999999999999999999999966543221   13467889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC----CEEEeeeccccccc-
Q 024158           96 LILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG----RLKIGDFGWSVQSR-  170 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~----~~~L~dfg~~~~~~-  170 (271)
                      +|||||++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++    .++|+|||++.... 
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~  169 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  169 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence            9999999999999998888899999999999999999999999999999999999998776    59999999986543 


Q ss_pred             -CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHH
Q 024158          171 -SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKH  234 (271)
Q Consensus       171 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~  234 (271)
                       .......+++.|+|||.+.+..++.++||||+|+++|+|++|..||.+.+..+..               ..+|+++++
T Consensus       170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  249 (293)
T d1jksa_         170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKD  249 (293)
T ss_dssp             SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred             CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHH
Confidence             3344567899999999999999999999999999999999999999877654432               346889999


Q ss_pred             HHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          235 LISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       235 li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      ||.+||.+||.+|||++|+++||||+...
T Consensus       250 li~~~L~~dP~~R~s~~eil~hp~~~~~~  278 (293)
T d1jksa_         250 FIRRLLVKDPKKRMTIQDSLQHPWIKPKD  278 (293)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.1e-58  Score=385.13  Aligned_cols=243  Identities=30%  Similarity=0.554  Sum_probs=217.3

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||.||+|++..+|+.||+|++......   ....+.+|+.++++++||||+++++++.+++.+|+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            46799999999999999999999999999999998665432   235678899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeC--CCCCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLD--HEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~--~~~~~~L~dfg~~~~~~~~--  172 (271)
                      ||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++  .++.++|+|||++......  
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            9999999999887654 4699999999999999999999999999999999999997  5689999999998665433  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~  237 (271)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+.+               ..+++++.+||.
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            34467899999999999999999999999999999999999999877654432               346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||.+||.+|||++|+|+||||+...
T Consensus       265 ~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         265 NLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCc
Confidence            99999999999999999999998753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.7e-57  Score=385.35  Aligned_cols=247  Identities=30%  Similarity=0.512  Sum_probs=216.7

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHH---HHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKI---QHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      +++++|++.+.||+|+||.||+|++..+|+.||+|++.+........   .....+++++++.++||||+++++++..++
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            46889999999999999999999999999999999997665443322   223334577888889999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC-
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS-  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~-  171 (271)
                      .+|+||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.+|.+||+|||++..... 
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999999999999888899999999999999999999999999999999999999999999999999865443 


Q ss_pred             ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh--------------hcccCHHHHHHH
Q 024158          172 KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT--------------FRSISAEAKHLI  236 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~--------------~~~i~~~l~~li  236 (271)
                      ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+.              ...+++++.+||
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  240 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLL  240 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHH
Confidence            3455679999999999975 4689999999999999999999999987553322              134789999999


Q ss_pred             HHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          237 SRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       237 ~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      .+||.+||.+|||     ++++++||||+..
T Consensus       241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            9999999999999     7999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2e-57  Score=371.36  Aligned_cols=245  Identities=30%  Similarity=0.526  Sum_probs=217.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh------HHHHHHHHHHHHHHHhhCC-CCceeceeeEEEe
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE------KYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD   90 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~   90 (271)
                      .++|++.+.||+|+||+||+|++..+|+.+|||++.+....      .....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999999999999999998665322      1234556889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      ++..|+||||+++++|.+++.....+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999888889999999999999999999999999999999999999999999999999986544


Q ss_pred             C--ccccccccccccCCccccC------CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cc
Q 024158          171 S--KRHTMCGTLDYLAPEMVEN------KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RS  227 (271)
Q Consensus       171 ~--~~~~~~~~~~y~~pe~~~~------~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~  227 (271)
                      .  ......||+.|.|||.+.+      ..++.++|+||+|+++|+|++|..||.+.+.....               ..
T Consensus       162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (277)
T d1phka_         162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDD  241 (277)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGG
T ss_pred             CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            3  3345678999999998853      34678999999999999999999999887754432               24


Q ss_pred             cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKN  262 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~  262 (271)
                      +|+++.+|+.+||.+||.+|||++|+|+||||++.
T Consensus       242 ~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         242 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            68999999999999999999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-57  Score=378.62  Aligned_cols=245  Identities=31%  Similarity=0.611  Sum_probs=218.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHH-hhCCCCceeceeeEEEeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQ-SSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l-~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +++|++.+.||+|+||+||+|+++.+|+.||||++.++..........+..|..++ +.++||||+++++++.+++..|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            46899999999999999999999999999999999876544333345555666655 47899999999999999999999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc---Ccc
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR---SKR  173 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~---~~~  173 (271)
                      ||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+|||++.+++++|+|||++....   ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999986433   233


Q ss_pred             ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------ccCHHHHHHHHHhccc
Q 024158          174 HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------SISAEAKHLISRLLVK  242 (271)
Q Consensus       174 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------~i~~~l~~li~~~l~~  242 (271)
                      ....||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+...           .+++++.+||++||.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCS
T ss_pred             cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhccc
Confidence            44678999999999999999999999999999999999999999877665543           3589999999999999


Q ss_pred             CccCCCCHH-HHhcCCccccC
Q 024158          243 DSSKRLSLQ-KIMEHPWIIKN  262 (271)
Q Consensus       243 ~p~~Rps~~-~il~~~~~~~~  262 (271)
                      ||.+|||+. ++++||||++.
T Consensus       241 dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         241 EPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             SGGGSBTTBSCGGGSGGGTTC
T ss_pred             CCCCCcCHHHHHHhCchhccC
Confidence            999999996 89999999864

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-57  Score=377.82  Aligned_cols=242  Identities=29%  Similarity=0.538  Sum_probs=216.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||+||+|+++.+|+.||+|++......    ...+.+|+++++.++||||+++++++.+++.+|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            67899999999999999999999999999999999765433    24577899999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC--CCEEEeeecccccccCc--
Q 024158           98 LEYAHRGELYRELRKHR-RFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE--GRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~--~~~~L~dfg~~~~~~~~--  172 (271)
                      ||||+|++|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.+  +.++|+|||++......  
T Consensus        80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            99999999999998754 79999999999999999999999999999999999999854  48999999998654433  


Q ss_pred             cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHHHHHH
Q 024158          173 RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAKHLIS  237 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~~li~  237 (271)
                      .....+++.|+|||...+..++.++|||||||++|+|++|..||...+..+..               ..+++++.+||.
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  239 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVD  239 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHH
Confidence            34456899999999999999999999999999999999999999887654432               346899999999


Q ss_pred             HhcccCccCCCCHHHHhcCCccccCC
Q 024158          238 RLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                      +||.+||.+|||++|+++||||++..
T Consensus       240 ~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         240 RLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             TTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHccCChhHCcCHHHHhcCHhhccCc
Confidence            99999999999999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=370.25  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=209.8

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH--HHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEec
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY--KIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEY  100 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~  100 (271)
                      .++.||+|+||+||+|++..+|+.||||++........  ...+.+.+|+.+++.++||||+++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            46889999999999999999999999999966543321  2245688999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---cccccc
Q 024158          101 AHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRHTMC  177 (271)
Q Consensus       101 ~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~~~~  177 (271)
                      +.++++..+......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||.+.....   ......
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~  161 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV  161 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence            99877777777677899999999999999999999999999999999999999999999999999865443   233457


Q ss_pred             ccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------------
Q 024158          178 GTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------------  225 (271)
Q Consensus       178 ~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------------  225 (271)
                      ||+.|+|||.+.+. .++.++||||+||++|+|++|.+||.+....+.+                               
T Consensus       162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (299)
T d1ua2a_         162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP  241 (299)
T ss_dssp             CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred             cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence            89999999998755 5788999999999999999999999876543322                               


Q ss_pred             --------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCCCc
Q 024158          226 --------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRGTC  269 (271)
Q Consensus       226 --------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~  269 (271)
                              ..+++++.+||.+||..||++|||++|+|+||||+..+.|--.+
T Consensus       242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~  293 (299)
T d1ua2a_         242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGC  293 (299)
T ss_dssp             CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSS
T ss_pred             CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCC
Confidence                    23578999999999999999999999999999999887665443

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-55  Score=365.79  Aligned_cols=246  Identities=29%  Similarity=0.542  Sum_probs=209.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +.+|++++.||+|+||+||+|++..+|+.||+|++....... .....+.+|+.++++++||||+++++++.+++.+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            468999999999999999999999999999999996654332 3356788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---c
Q 024158           98 LEYAHRGELYRELR-K-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---K  172 (271)
Q Consensus        98 ~e~~~~~~L~~~l~-~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~  172 (271)
                      ||++.+ ++..++. . ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+.....   .
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            999975 5544443 3 45699999999999999999999999999999999999999999999999999854432   3


Q ss_pred             cccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------------------
Q 024158          173 RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------------------  225 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------------------  225 (271)
                      .....||+.|+|||.+.... ++.++|+||+|+++|+|++|..||.+.+..+.+                          
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccc
Confidence            34457899999999887766 477999999999999999999999876543321                          


Q ss_pred             --------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 --------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 --------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                    ..+++++.+|+++||.+||.+|||++|+|+||||++...|
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence                          1246889999999999999999999999999999988766

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-57  Score=368.90  Aligned_cols=250  Identities=30%  Similarity=0.537  Sum_probs=214.0

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHH---HHHHHHHHHHHHHhhCC--CCceeceeeEEEeCCe
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKY---KIQHQLRREMEIQSSLR--HPNILRLYGWFHDDER   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~---~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~   93 (271)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+......   .....+.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999976543321   11223557889999886  8999999999999999


Q ss_pred             EEEEEeccCC-CchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC-CCEEEeeecccccccC
Q 024158           94 IFLILEYAHR-GELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE-GRLKIGDFGWSVQSRS  171 (271)
Q Consensus        94 ~~lv~e~~~~-~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~-~~~~L~dfg~~~~~~~  171 (271)
                      .|+|||++.+ +++.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++.....
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~  163 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD  163 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence            9999999975 5888888887889999999999999999999999999999999999999854 7899999999865433


Q ss_pred             -ccccccccccccCCccccCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCc-----chhhcccCHHHHHHHHHhcccCc
Q 024158          172 -KRHTMCGTLDYLAPEMVENKEH-DYAVDNWTLGILCYEFLYGAPPFEAESQ-----KDTFRSISAEAKHLISRLLVKDS  244 (271)
Q Consensus       172 -~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slg~il~~l~~g~~p~~~~~~-----~~~~~~i~~~l~~li~~~l~~~p  244 (271)
                       ......||+.|+|||.+.+..+ +.++||||+||++|+|++|..||.....     ......+|+++.+||.+||.+||
T Consensus       164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dp  243 (273)
T d1xwsa_         164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRP  243 (273)
T ss_dssp             SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHTCSSG
T ss_pred             ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHccCCH
Confidence             3345679999999999987775 5678999999999999999999986432     11234579999999999999999


Q ss_pred             cCCCCHHHHhcCCccccCCCCCCC
Q 024158          245 SKRLSLQKIMEHPWIIKNANPRGT  268 (271)
Q Consensus       245 ~~Rps~~~il~~~~~~~~~~~~~~  268 (271)
                      .+|||++|+++||||++...|+.+
T Consensus       244 ~~R~s~~eil~hp~~~~~~~p~e~  267 (273)
T d1xwsa_         244 SDRPTFEEIQNHPWMQDVLLPQET  267 (273)
T ss_dssp             GGSCCHHHHHTSGGGSSCCCHHHH
T ss_pred             hHCcCHHHHhcCHhhCCCCCCCCc
Confidence            999999999999999987666543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=367.90  Aligned_cols=241  Identities=30%  Similarity=0.605  Sum_probs=207.0

Q ss_pred             Cccccceeeee-eecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHh-hCCCCceeceeeEEEe--
Q 024158           15 EWSLQDFEIGR-PLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQS-SLRHPNILRLYGWFHD--   90 (271)
Q Consensus        15 ~~~~~~y~~~~-~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~--   90 (271)
                      ...+++|.+++ .||+|+||.||+|++..+++.||||++...        ..+.+|+.++. ..+||||+++++++.+  
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            34468999986 599999999999999999999999998542        23556787754 5589999999999865  


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeee
Q 024158           91 --DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDF  163 (271)
Q Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~df  163 (271)
                        +..+|+|||||+||+|.+++...  ..+++.+++.++.||+.||.|||++||+||||||+||+++.   .+.++|+||
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccc
Confidence              46789999999999999999763  46999999999999999999999999999999999999975   457999999


Q ss_pred             ccccccc--CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------
Q 024158          164 GWSVQSR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------  224 (271)
Q Consensus       164 g~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------  224 (271)
                      |++....  .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.+......                 
T Consensus       159 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         159 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             TTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            9985433  334456799999999999999999999999999999999999999976543221                 


Q ss_pred             --hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          225 --FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       225 --~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                        +..+++++.+||.+||.+||++|||++|+++||||++..
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence              234689999999999999999999999999999998654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.2e-55  Score=359.23  Aligned_cols=242  Identities=29%  Similarity=0.510  Sum_probs=208.1

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||+||+|+++ +|+.||||++....... .....+.+|+.++++++||||+++++.+..++..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999984 78999999996654332 2346788999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---ccc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---KRH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---~~~  174 (271)
                      ++++.++.+..+....+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+.....   ...
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            99998777777767678899999999999999999999999999999999999999999999999999854332   234


Q ss_pred             cccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh----------------------------
Q 024158          175 TMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF----------------------------  225 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~----------------------------  225 (271)
                      ...+++.|.|||.+.+. .++.++|+||||+++++|++|..||.+....+.+                            
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            44688999999998765 4688999999999999999999999766543321                            


Q ss_pred             ------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCcccc
Q 024158          226 ------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIK  261 (271)
Q Consensus       226 ------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~  261 (271)
                                  ..+++++.+|+++||.+||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                        224789999999999999999999999999999985

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-54  Score=354.63  Aligned_cols=242  Identities=27%  Similarity=0.467  Sum_probs=207.5

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC----eE
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----RI   94 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~   94 (271)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+++++.++||||+++++++...+    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            56999999999999999999999999999999998776666666778999999999999999999999987643    48


Q ss_pred             EEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC---
Q 024158           95 FLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS---  171 (271)
Q Consensus        95 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~---  171 (271)
                      |+||||++|++|.+++...+.+++.+++.++.||+.||.|||++|++||||||+||+++.++..+++|||.+.....   
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            99999999999999998888899999999999999999999999999999999999999999999999998743322   


Q ss_pred             ---ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cccCHHHH
Q 024158          172 ---KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RSISAEAK  233 (271)
Q Consensus       172 ---~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~i~~~l~  233 (271)
                         ......||+.|+|||.+.+..++.++||||||+++|+|++|.+||.+.+..+..               ..+|+++.
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~  246 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLD  246 (277)
T ss_dssp             ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHH
T ss_pred             cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHH
Confidence               223456899999999999999999999999999999999999999877654332               34789999


Q ss_pred             HHHHHhcccCccCCCCHHHHhcCCccc
Q 024158          234 HLISRLLVKDSSKRLSLQKIMEHPWII  260 (271)
Q Consensus       234 ~li~~~l~~~p~~Rps~~~il~~~~~~  260 (271)
                      ++|.+||.+||.+||+..+.+.|+|.+
T Consensus       247 ~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         247 AVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            999999999999999555555566653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-54  Score=355.13  Aligned_cols=240  Identities=21%  Similarity=0.356  Sum_probs=209.9

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ..+++..++|++.+.||+|+||+||+|++..+++.||||++..+...    .+.+.+|++++++++||||+++++++.++
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            45677889999999999999999999999999999999999765433    34688999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +.++++|||+++|+|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999999999764  46899999999999999999999999999999999999999999999999998654


Q ss_pred             cCcc----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCC-CCCCcchhh------------cccCHHH
Q 024158          170 RSKR----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPF-EAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~-~~~~~~~~~------------~~i~~~l  232 (271)
                      ....    ....+++.|+|||.+.+..++.++||||||+++|+|++|..|+ .+....+..            ..+|+++
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  245 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  245 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence            4332    2234688999999999999999999999999999999966655 444332221            2368999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhc
Q 024158          233 KHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      .+|+.+||..||++|||++++++
T Consensus       246 ~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         246 YELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHH
Confidence            99999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-54  Score=358.31  Aligned_cols=250  Identities=24%  Similarity=0.420  Sum_probs=210.0

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe------
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------   90 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   90 (271)
                      ..++|+++++||+|+||+||+|++..+|+.||||++..+.... .....+.+|+.++++++|+|++++++++..      
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            3689999999999999999999999999999999986654332 234567789999999999999999998754      


Q ss_pred             --CCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 --DERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 --~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                        ++..|+++|+++++.+.........+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence              346899999998766666656567899999999999999999999999999999999999999999999999999843


Q ss_pred             cc-------CccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhcc-------------
Q 024158          169 SR-------SKRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFRS-------------  227 (271)
Q Consensus       169 ~~-------~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~~-------------  227 (271)
                      ..       .......||+.|+|||.+.+. .++.++||||+|+++++|++|..||.+.+.......             
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            33       222335689999999998765 688999999999999999999999987654333211             


Q ss_pred             ------------------------------cCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCCC
Q 024158          228 ------------------------------ISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPRG  267 (271)
Q Consensus       228 ------------------------------i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  267 (271)
                                                    .++++.+||.+||.+||++|||++|+|+||||+..+.|.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~  316 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD  316 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCC
Confidence                                          2577889999999999999999999999999998888764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=360.41  Aligned_cols=243  Identities=26%  Similarity=0.449  Sum_probs=209.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----   92 (271)
                      -++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+++++.++||||+++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSH-HHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcCh-HHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            468999999999999999999999999999999997654333 44677889999999999999999999997654     


Q ss_pred             -eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 -RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 -~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                       .+|+|||++ +.+|..+.+. ..+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+.....
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence             479999999 4678777765 5799999999999999999999999999999999999999999999999999988877


Q ss_pred             ccccccccccccCCccccCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------------------------
Q 024158          172 KRHTMCGTLDYLAPEMVENK-EHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------------------------  225 (271)
Q Consensus       172 ~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------------------------  225 (271)
                      ......+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+.+                         
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence            77788899999999998764 4688999999999999999999999876533221                         


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                       ..+++++.+||.+||..||.+|||++|+|+||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                             23478999999999999999999999999999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=353.34  Aligned_cols=239  Identities=23%  Similarity=0.441  Sum_probs=203.2

Q ss_pred             ccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           13 KREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        13 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ++++..++|++.+.||+|+||+||+|+..   ..||||++....... ...+.+.+|+.++++++||||+++++++.+ +
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~   76 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P   76 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence            46778899999999999999999999753   359999986554333 345788999999999999999999998754 5


Q ss_pred             eEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      .+++||||+++++|.+++... ..+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            689999999999999999764 5699999999999999999999999999999999999999999999999999854432


Q ss_pred             -----ccccccccccccCCccccC---CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh-----------------hc
Q 024158          172 -----KRHTMCGTLDYLAPEMVEN---KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT-----------------FR  226 (271)
Q Consensus       172 -----~~~~~~~~~~y~~pe~~~~---~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~-----------------~~  226 (271)
                           ......||+.|+|||.+.+   ..++.++||||||+++|+|++|..||.+......                 ..
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence                 2234578999999999864   3478899999999999999999999987654332                 12


Q ss_pred             ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          227 SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       227 ~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+|+++.+++.+||..||++|||+++|+++
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            357899999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-53  Score=349.43  Aligned_cols=246  Identities=24%  Similarity=0.450  Sum_probs=214.0

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   97 (271)
                      +++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            57999999999999999999999999999999999665433 24467888999999999999999999999999999999


Q ss_pred             EeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---cc
Q 024158           98 LEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---RH  174 (271)
Q Consensus        98 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---~~  174 (271)
                      ++++.++++..++...+.+++..++.++.|++.||+|||++||+|+||||+||+++.++.++|+|||.+......   ..
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            999999999998888888999999999999999999999999999999999999999999999999998654432   23


Q ss_pred             cccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCc-chh----------------------------
Q 024158          175 TMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDT----------------------------  224 (271)
Q Consensus       175 ~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~----------------------------  224 (271)
                      ...+++.|.|||.+.+.. ++.++||||+||++++|++|..||..... .+.                            
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            345678899999887665 68899999999999999999988643222 111                            


Q ss_pred             ------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCC
Q 024158          225 ------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNAN  264 (271)
Q Consensus       225 ------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  264 (271)
                                  ...+++++.+|+.+||.+||++|||++|+|+||||++.-.
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                        1124789999999999999999999999999999987643

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-54  Score=357.48  Aligned_cols=244  Identities=25%  Similarity=0.429  Sum_probs=201.8

Q ss_pred             cceeeeeeecccCCceEEEEEEecC-CceEEEEEechhhhhHHHHHHHHHHHHHHH---hhCCCCceeceeeEEEe----
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVES-KHPVALKIIFKEQIEKYKIQHQLRREMEIQ---SSLRHPNILRLYGWFHD----   90 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l---~~~~~~~i~~~~~~~~~----   90 (271)
                      ++|++++.||+|+||+||+|++.++ ++.||||++........ ....+.+|+.++   +..+||||+++++++..    
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            6899999999999999999999776 56789999865433221 112233455544   45589999999999853    


Q ss_pred             -CCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 -DERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 -~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                       ....++++|+++++.+...... ...+++..++.++.|++.||.|||++||+||||||+|||++..+.++|+|||++..
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             3468999999987666544433 45689999999999999999999999999999999999999999999999999754


Q ss_pred             cc--CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------------
Q 024158          169 SR--SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------------  225 (271)
Q Consensus       169 ~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------------  225 (271)
                      ..  .......||+.|+|||.+.+..++.++||||+||++|+|++|..||.+.+..+.+                     
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            43  3335667899999999999999999999999999999999999999876543321                     


Q ss_pred             -----------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          226 -----------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       226 -----------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                       ..+++++.+||.+||.+||++|||++|+|+||||++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence                             23578999999999999999999999999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-53  Score=352.50  Aligned_cols=241  Identities=23%  Similarity=0.386  Sum_probs=201.0

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCc---eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKH---PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~---~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .++..++|++.+.||+|+||+||+|+++.+++   .++||.+......  ...+.+.+|++++++++||||+++++++..
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            45778999999999999999999999877765   4788887554332  335678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++..++|||||++++|.+++... +.+++.+++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++...
T Consensus        99 ~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_          99 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999999999988774 56899999999999999999999999999999999999999999999999998543


Q ss_pred             cCcc--------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------cc
Q 024158          170 RSKR--------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SI  228 (271)
Q Consensus       170 ~~~~--------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i  228 (271)
                      ....        ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+...            .+
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            3221        12356889999999999999999999999999999997 899998776654432            35


Q ss_pred             CHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          229 SAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       229 ~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      |+++.+++.+||..||++|||+.++++.
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            8999999999999999999999998875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-53  Score=357.49  Aligned_cols=243  Identities=26%  Similarity=0.406  Sum_probs=207.3

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCc-----eEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKH-----PVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ..+++..++|++.+.||+|+||+||+|++..+++     .|++|.+......  .....+.+|+.++.++ +||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~  107 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLL  107 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEE
Confidence            3455677899999999999999999999877654     5889988654322  3346788899999888 899999999


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHR-----------------------RFTEQQAATYIASLTNALAYCHENHVIH  142 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H  142 (271)
                      +++..++..|+|||||++|+|.+++...+                       .+++..++.++.|++.||.|||++||+|
T Consensus       108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH  187 (325)
T d1rjba_         108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  187 (325)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            99999999999999999999999997532                       3789999999999999999999999999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCC
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPF  216 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~  216 (271)
                      |||||+||+++.++.+||+|||++.......     ....+|+.|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence            9999999999999999999999986544322     23457899999999999999999999999999999997 89999


Q ss_pred             CCCCcchhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          217 EAESQKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       217 ~~~~~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+....+.+             ..+|+++.+||.+||..||++|||++||++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            876654332             2358999999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=346.53  Aligned_cols=236  Identities=23%  Similarity=0.413  Sum_probs=198.8

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEE
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIF   95 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   95 (271)
                      ++-++|++++.||+|+||.||+|++. ++..||||++.......    +.+.+|++++++++||||+++++++..++.++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            34578999999999999999999974 67789999997654433    46889999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc--
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK--  172 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~--  172 (271)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++......  
T Consensus        77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999999999998764 56899999999999999999999999999999999999999999999999998554322  


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhcc------------cCHHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRS------------ISAEAKHLIS  237 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~------------i~~~l~~li~  237 (271)
                        .....||+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....            .++++.+++.
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence              233567899999999999999999999999999999998 5666766554444322            4799999999


Q ss_pred             HhcccCccCCCCHHHHhcC
Q 024158          238 RLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~  256 (271)
                      +||.+||++|||+++|+++
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-54  Score=349.36  Aligned_cols=245  Identities=22%  Similarity=0.376  Sum_probs=208.9

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +..+++..++|++.+.||+|+||.||+|+++ ++..||||++......    .+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~   79 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ   79 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence            3456677899999999999999999999974 6788999999765433    2468899999999999999999998755


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                       +..++||||+++++|.+++...  ..+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus        80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence             5579999999999999987543  3689999999999999999999999999999999999999999999999999865


Q ss_pred             ccCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchhh------------cccCHH
Q 024158          169 SRSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       169 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ....    .....+++.|+|||.+.+..++.++||||||+++|+|++| .+|+......+..            ..++++
T Consensus       159 ~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~  238 (272)
T d1qpca_         159 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEE  238 (272)
T ss_dssp             CSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHH
Confidence            4332    2345678899999999988899999999999999999985 5555554433322            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc--CCcccc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME--HPWIIK  261 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~--~~~~~~  261 (271)
                      +.+|+.+||..||++|||++++++  ++||..
T Consensus       239 l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999999998  788853

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=349.23  Aligned_cols=234  Identities=24%  Similarity=0.397  Sum_probs=198.5

Q ss_pred             eeecccCCceEEEEEEe--cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEEEEeccC
Q 024158           25 RPLGKGKFGRVYLVREV--ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFLILEYAH  102 (271)
Q Consensus        25 ~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~  102 (271)
                      +.||+|+||+||+|...  .+++.||||++...... ....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            46999999999999754  35678999999665433 2445778999999999999999999999865 45789999999


Q ss_pred             CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc------cccc
Q 024158          103 RGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK------RHTM  176 (271)
Q Consensus       103 ~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~------~~~~  176 (271)
                      +++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++......      ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999998888999999999999999999999999999999999999999999999999998643322      1234


Q ss_pred             cccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHHHHHHHHhcccC
Q 024158          177 CGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEAKHLISRLLVKD  243 (271)
Q Consensus       177 ~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l~~li~~~l~~~  243 (271)
                      .||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+..            ..+|+++.+|+.+||..|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~d  250 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYD  250 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence            67899999999999999999999999999999997 89999877654432            235899999999999999


Q ss_pred             ccCCCCHHHH---hcCCccc
Q 024158          244 SSKRLSLQKI---MEHPWII  260 (271)
Q Consensus       244 p~~Rps~~~i---l~~~~~~  260 (271)
                      |.+|||+++|   |+++|++
T Consensus       251 p~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         251 VENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TTTSCCHHHHHHHHHHHHHH
T ss_pred             HhHCcCHHHHHHHhhCHHhh
Confidence            9999999998   4566653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=343.06  Aligned_cols=235  Identities=24%  Similarity=0.427  Sum_probs=208.6

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCCeEEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l   96 (271)
                      +-++|++++.||+|+||+||+|++ .++..||||++.++....    +.+.+|+.++++++||||+++++++.+++.+++
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i   76 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   76 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence            457899999999999999999997 478889999997755443    468899999999999999999999999999999


Q ss_pred             EEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc---
Q 024158           97 ILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK---  172 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~---  172 (271)
                      ||||+++++|..++.. ...+++..++.++.|+++||.|||++||+|+||+|+||+++.++.+||+|||++......   
T Consensus        77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            9999999999998765 356899999999999999999999999999999999999999999999999998543322   


Q ss_pred             -cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhcc------------cCHHHHHHHHH
Q 024158          173 -RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFRS------------ISAEAKHLISR  238 (271)
Q Consensus       173 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~~------------i~~~l~~li~~  238 (271)
                       .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+...+            .++++.+|+.+
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  236 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  236 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence             223567899999999999999999999999999999997 8999998876655433            47899999999


Q ss_pred             hcccCccCCCCHHHHhcC
Q 024158          239 LLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       239 ~l~~~p~~Rps~~~il~~  256 (271)
                      ||+.||++|||+++|++|
T Consensus       237 cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         237 CWHEKADERPTFKILLSN  254 (258)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHH
Confidence            999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=346.54  Aligned_cols=243  Identities=24%  Similarity=0.350  Sum_probs=207.6

Q ss_pred             Cccccceeeeee-ecccCCceEEEEEEec--CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           15 EWSLQDFEIGRP-LGKGKFGRVYLVREVE--SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        15 ~~~~~~y~~~~~-lg~g~~~~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      .++.++|.+.+. ||+|+||+||+|.++.  ++..||||++......  ...+.+.+|++++++++||||+++++++.. 
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-   80 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-   80 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCH--HHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence            456678999885 9999999999997654  3557999998654322  345678999999999999999999999865 


Q ss_pred             CeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           92 ERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      +.+|+||||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            4689999999999999998653 579999999999999999999999999999999999999999999999999986543


Q ss_pred             Cc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          171 SK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       171 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ..      .....+|+.|+|||.+.++.++.++||||||+++|+|++ |..||.+....+..            ..+|++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~  240 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  240 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence            22      223467899999999998899999999999999999997 89999877654432            236899


Q ss_pred             HHHHHHHhcccCccCCCCHHHH---hcCCccc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKI---MEHPWII  260 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~i---l~~~~~~  260 (271)
                      +.+|+.+||..||++|||+.+|   |+++|+.
T Consensus       241 l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         241 LYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999888   6778875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=354.82  Aligned_cols=247  Identities=24%  Similarity=0.405  Sum_probs=209.8

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC-----C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD-----E   92 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~   92 (271)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+..... ...+.+.+|+.+++.++|+|++++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            368999999999999999999999999999999997654433 3356788999999999999999999998533     2


Q ss_pred             eEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc
Q 024158           93 RIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK  172 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~  172 (271)
                      ..+++++++.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||.+......
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~  174 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE  174 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred             ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence            33455566668899999965 56999999999999999999999999999999999999999999999999999877777


Q ss_pred             cccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------------------
Q 024158          173 RHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------------------  224 (271)
Q Consensus       173 ~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------------------  224 (271)
                      .....|++.|+|||...+.. ++.++|+||||+++|+|++|..||.+.+....                           
T Consensus       175 ~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  254 (348)
T d2gfsa1         175 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY  254 (348)
T ss_dssp             GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHH
T ss_pred             cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhh
Confidence            77788999999999877654 57899999999999999999999976553221                           


Q ss_pred             ---------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCCC
Q 024158          225 ---------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANPR  266 (271)
Q Consensus       225 ---------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  266 (271)
                                     ...+++++.+||.+||..||.+|||++|+|+||||++...+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             HTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             hhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence                           123578999999999999999999999999999999875543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=349.83  Aligned_cols=243  Identities=26%  Similarity=0.448  Sum_probs=203.7

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC-----e
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE-----R   93 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~   93 (271)
                      .+|+++++||+|+||+||+|++..+|+.||||++.+...  ....+.+.+|+.+++.++|||++++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            469999999999999999999999999999999965442  234567889999999999999999999986643     3


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC--
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS--  171 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~--  171 (271)
                      +|++++. .+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....  
T Consensus        86 ~~l~~~~-~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          86 VYLVTHL-MGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEEEEC-CCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEee-cCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            5666555 47899999976 4699999999999999999999999999999999999999999999999999854332  


Q ss_pred             ----ccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------------------
Q 024158          172 ----KRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------------------  224 (271)
Q Consensus       172 ----~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------------------  224 (271)
                          ......|++.|+|||.+.. ..++.++|+||+|+++++|++|..||......+.                      
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence                2344568999999999854 4568899999999999999999999987653222                      


Q ss_pred             --------------------hcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          225 --------------------FRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       225 --------------------~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                          ...+++++.+|+.+||..||.+|||++|+|+||||++...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                                12346789999999999999999999999999999976543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=352.05  Aligned_cols=240  Identities=30%  Similarity=0.443  Sum_probs=201.6

Q ss_pred             cceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC------C
Q 024158           19 QDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD------E   92 (271)
Q Consensus        19 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~   92 (271)
                      -+|+.++.||+|+||+||+|++..+|+.||||++..+...       ..+|++++++++|+||+++++++...      .
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            3799999999999999999999999999999999654322       24689999999999999999998543      3


Q ss_pred             eEEEEEeccCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeeccccc
Q 024158           93 RIFLILEYAHRGELYREL---RKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQ  168 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l---~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~  168 (271)
                      ++|+||||++++.+..+.   .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus        93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence            579999999864333332   3345799999999999999999999999999999999999999775 899999999855


Q ss_pred             cc--CccccccccccccCCccccC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhh--------------------
Q 024158          169 SR--SKRHTMCGTLDYLAPEMVEN-KEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF--------------------  225 (271)
Q Consensus       169 ~~--~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~--------------------  225 (271)
                      ..  .......|++.|+|||.+.+ ..++.++||||+||++|+|++|..||......+.+                    
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             ccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            43  33445678999999998875 46899999999999999999999999766543321                    


Q ss_pred             --------------------cccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCCCC
Q 024158          226 --------------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNANP  265 (271)
Q Consensus       226 --------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  265 (271)
                                          ..+++++.+||.+||..||++|||+.|+|+||||++..++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                                1257899999999999999999999999999999876443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=351.88  Aligned_cols=249  Identities=38%  Similarity=0.680  Sum_probs=214.2

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEe---cCCceEEEEEechhhhh-HHHHHHHHHHHHHHHhhCCC-CceeceeeEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREV---ESKHPVALKIIFKEQIE-KYKIQHQLRREMEIQSSLRH-PNILRLYGWF   88 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~~vK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~   88 (271)
                      ..+.+++|++++.||+|+||+||+|++.   .+|+.||+|++.+.... .....+.+.+|+.++++++| |||+++++++
T Consensus        19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            3467899999999999999999999874   46889999998654321 11224567789999999977 8999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           89 HDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      .+.+.+++++|++.+++|.+++...+.+++..+..++.||+.|+.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999854


Q ss_pred             ccC----ccccccccccccCCccccCCC--CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh---------------cc
Q 024158          169 SRS----KRHTMCGTLDYLAPEMVENKE--HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF---------------RS  227 (271)
Q Consensus       169 ~~~----~~~~~~~~~~y~~pe~~~~~~--~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~---------------~~  227 (271)
                      ...    ......|++.|++||.+.+..  ++.++|||||||++|+|++|..||.+....+..               ..
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            332    234457899999999987643  677999999999999999999999876543331               24


Q ss_pred             cCHHHHHHHHHhcccCccCCCC-----HHHHhcCCccccC
Q 024158          228 ISAEAKHLISRLLVKDSSKRLS-----LQKIMEHPWIIKN  262 (271)
Q Consensus       228 i~~~l~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~  262 (271)
                      +++++.+|+.+||.+||++|||     ++|+++||||++.
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            6899999999999999999994     8999999999874

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=342.55  Aligned_cols=246  Identities=20%  Similarity=0.364  Sum_probs=206.2

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeC
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDD   91 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   91 (271)
                      ..++++.++|++.+.||+|+||+||+|++..+ ..||||++.......    +.+.+|+.++++++|+||+++++++.+ 
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-   83 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-   83 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence            45677889999999999999999999998654 569999997655432    568899999999999999999999855 


Q ss_pred             CeEEEEEeccCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           92 ERIFLILEYAHRGELYRELRK--HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      +..++||||+++|+|..++..  .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence            557899999999999988864  356999999999999999999999999999999999999999999999999998644


Q ss_pred             cCc----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCCcchhh------------cccCHHH
Q 024158          170 RSK----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p-~~~~~~~~~~------------~~i~~~l  232 (271)
                      ...    .....+|+.|+|||.+.++.++.++||||||+++|+|++|..| +......+.+            ..+++++
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l  243 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL  243 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHH
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHH
Confidence            322    2335688999999999999999999999999999999986554 4444433222            2368999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhc--CCccccCC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIME--HPWIIKNA  263 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~  263 (271)
                      .+++.+||..||++|||+++|++  ++||....
T Consensus       244 ~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         244 HDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            99999999999999999999998  88987664

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=345.57  Aligned_cols=238  Identities=26%  Similarity=0.527  Sum_probs=204.3

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEe--CCe
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHD--DER   93 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--~~~   93 (271)
                      +.++|++++.||+|+||+||+|++..+|+.||+|++....      .+.+.+|+.+++.+. ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            5578999999999999999999999999999999986543      245678999999985 9999999999874  356


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCC-CEEEeeeccccccc--
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEG-RLKIGDFGWSVQSR--  170 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~-~~~L~dfg~~~~~~--  170 (271)
                      .++|||++++++|....   +.+++..++.++.||+.||.|||++||+|+||||+|||++.++ .++|+|||++....  
T Consensus       107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999999987654   4689999999999999999999999999999999999998765 69999999985543  


Q ss_pred             CccccccccccccCCccccCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCcch--------------------------
Q 024158          171 SKRHTMCGTLDYLAPEMVENKE-HDYAVDNWTLGILCYEFLYGAPPFEAESQKD--------------------------  223 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slg~il~~l~~g~~p~~~~~~~~--------------------------  223 (271)
                      .......+|+.|+|||.+.+.. ++.++|+||+|++++++++|..||.......                          
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  263 (328)
T d3bqca1         184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  263 (328)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence            3345567899999999987654 7889999999999999999999986543211                          


Q ss_pred             -----------------------hhcccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          224 -----------------------TFRSISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       224 -----------------------~~~~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                             ....+++++.+||++||.+||.+|||++|+|+||||+...
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~  326 (328)
T d3bqca1         264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  326 (328)
T ss_dssp             CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred             CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence                                   0112578999999999999999999999999999998754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=339.77  Aligned_cols=236  Identities=24%  Similarity=0.432  Sum_probs=199.7

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-CC
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DE   92 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   92 (271)
                      +++++++|++.+.||+|+||.||+|+.  .|..||||+++++.     ..+.+.+|+.++++++||||+++++++.+ .+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            578999999999999999999999997  47889999996543     23568899999999999999999998854 45


Q ss_pred             eEEEEEeccCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccccc
Q 024158           93 RIFLILEYAHRGELYRELRKH--RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSR  170 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~  170 (271)
                      .+|+||||+++++|.+++...  ..+++..++.++.||+.|+.|||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence            689999999999999999653  358999999999999999999999999999999999999999999999999998776


Q ss_pred             CccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhhc------------ccCHHHHHHHH
Q 024158          171 SKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTFR------------SISAEAKHLIS  237 (271)
Q Consensus       171 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~~------------~i~~~l~~li~  237 (271)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+...            .+++++.++++
T Consensus       155 ~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~  234 (262)
T d1byga_         155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK  234 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHH
T ss_pred             CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            66666778999999999998999999999999999999997 788888766554432            25799999999


Q ss_pred             HhcccCccCCCCHHHHhcC
Q 024158          238 RLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~  256 (271)
                      +||..||.+|||+.+++++
T Consensus       235 ~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         235 NCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcccCHhHCcCHHHHHHH
Confidence            9999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-52  Score=351.47  Aligned_cols=242  Identities=24%  Similarity=0.394  Sum_probs=200.4

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe------C
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD------D   91 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~   91 (271)
                      +++|++++.||+|+||+||+|++..+|+.||||++.+..... .....+.+|+.++++++||||+++++++..      .
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~-~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCH-HHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            478999999999999999999999999999999997665443 345678899999999999999999999853      3


Q ss_pred             CeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           92 ERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..+|+||||+.+ ++.+.+.  ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++++|||.+.....
T Consensus        95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence            679999999975 5555553  4589999999999999999999999999999999999999999999999998754443


Q ss_pred             --ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchhhc-----------------------
Q 024158          172 --KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDTFR-----------------------  226 (271)
Q Consensus       172 --~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~~-----------------------  226 (271)
                        ......+|+.|+|||.+.+..++.++||||+||++++|++|..||.+.+......                       
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence              3344568999999999999999999999999999999999999997665332211                       


Q ss_pred             ------------------------------ccCHHHHHHHHHhcccCccCCCCHHHHhcCCccccCC
Q 024158          227 ------------------------------SISAEAKHLISRLLVKDSSKRLSLQKIMEHPWIIKNA  263 (271)
Q Consensus       227 ------------------------------~i~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~~~~  263 (271)
                                                    ..++++.+||++||..||++|||++|+|+||||+...
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                                          1257789999999999999999999999999999754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=337.97  Aligned_cols=240  Identities=25%  Similarity=0.421  Sum_probs=198.5

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      +++..++|++.+.||+|+||.||+|++..++   ..+++|.+.....  ....+.+.+|+.++++++||||+++++++. 
T Consensus         2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-   78 (273)
T d1mp8a_           2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-   78 (273)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            5667789999999999999999999986653   4588888754432  234567889999999999999999999985 


Q ss_pred             CCeEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence            4678999999999999998765 457899999999999999999999999999999999999999999999999998653


Q ss_pred             cC----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHHH
Q 024158          170 RS----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAEA  232 (271)
Q Consensus       170 ~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~l  232 (271)
                      ..    ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+..            ..+|+++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  238 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            32    2234457899999999999999999999999999999987 89999877665443            2368999


Q ss_pred             HHHHHHhcccCccCCCCHHHHhcC
Q 024158          233 KHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      .+||.+||..||++|||+++|+++
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=336.71  Aligned_cols=240  Identities=23%  Similarity=0.353  Sum_probs=199.6

Q ss_pred             cCccccceeeeeeecccCCceEEEEEEecCC----ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEE
Q 024158           14 REWSLQDFEIGRPLGKGKFGRVYLVREVESK----HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFH   89 (271)
Q Consensus        14 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   89 (271)
                      .++..++|++.+.||+|+||.||+|....++    ..||||.+......  .....+.+|+.++++++||||+++++++.
T Consensus         2 ~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            3567789999999999999999999987655    46999998654433  23456889999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeeccccc
Q 024158           90 DDERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQ  168 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~  168 (271)
                      +.+..++++|++.++++.+.+... ..+++..+..++.|++.|+.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999999999888664 5799999999999999999999999999999999999999999999999999854


Q ss_pred             ccCc------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCC-CCCCCcchhh------------cccC
Q 024158          169 SRSK------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPP-FEAESQKDTF------------RSIS  229 (271)
Q Consensus       169 ~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p-~~~~~~~~~~------------~~i~  229 (271)
                      ....      .....||+.|+|||.+.++.++.++||||||+++|+|+++..| +......+..            ..+|
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  239 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence            3321      2234578999999999999999999999999999999986555 4444333222            2358


Q ss_pred             HHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          230 AEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       230 ~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +++.+++.+||..||++|||+.+|++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=335.66  Aligned_cols=239  Identities=23%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             ccccceeeeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC
Q 024158           16 WSLQDFEIGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE   92 (271)
Q Consensus        16 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   92 (271)
                      ++.++|++.+.||+|+||.||+|+...+.   ..||||++.+.........+.+.+|+.++++++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            45689999999999999999999865443   3689999977665555667789999999999999999999999966 4


Q ss_pred             eEEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccC
Q 024158           93 RIFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRS  171 (271)
Q Consensus        93 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~  171 (271)
                      ..++|+||++++++.+.+.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999999999887765 45699999999999999999999999999999999999999999999999999865433


Q ss_pred             cc------ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh-------------cccCHH
Q 024158          172 KR------HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF-------------RSISAE  231 (271)
Q Consensus       172 ~~------~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~-------------~~i~~~  231 (271)
                      ..      ....++..|+|||.+.+..++.++||||||+++|+|++ |.+||.+.+..+..             ..+|++
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            21      22346788999999999999999999999999999997 89999876654432             336899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhc
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      +.+|+.+||.+||++|||+++|++
T Consensus       244 l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999974

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=339.19  Aligned_cols=245  Identities=23%  Similarity=0.368  Sum_probs=206.2

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCce--EEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceeceeeEEEeC
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKHP--VALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLYGWFHDD   91 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~--~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~   91 (271)
                      .+++++|++.+.||+|+||.||+|+++.+|..  ++||.+....  .....+.+.+|+++++++ +||||+++++++..+
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            46889999999999999999999999988875  5667664322  223356789999999998 799999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCC
Q 024158           92 ERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHE  155 (271)
Q Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~  155 (271)
                      +..++||||+++|+|.+++...                ..+++..+..++.||+.|+.|||++|++||||||+|||++.+
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN  163 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence            9999999999999999999653                468999999999999999999999999999999999999999


Q ss_pred             CCEEEeeecccccccCc--cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCC-CCCCCCCcchhh-------
Q 024158          156 GRLKIGDFGWSVQSRSK--RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPFEAESQKDTF-------  225 (271)
Q Consensus       156 ~~~~L~dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~-~p~~~~~~~~~~-------  225 (271)
                      +.+||+|||++......  .....+|..|+|||.+.++.++.++||||||+++|+|++|. +||...+..+..       
T Consensus       164 ~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             CceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            99999999998543332  23446789999999999999999999999999999999865 577766654442       


Q ss_pred             -----cccCHHHHHHHHHhcccCccCCCCHHHHhcC--Ccccc
Q 024158          226 -----RSISAEAKHLISRLLVKDSSKRLSLQKIMEH--PWIIK  261 (271)
Q Consensus       226 -----~~i~~~l~~li~~~l~~~p~~Rps~~~il~~--~~~~~  261 (271)
                           ..+++++.+||.+||..||++|||+++++++  .++++
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                 2368999999999999999999999999987  44443

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=337.23  Aligned_cols=239  Identities=20%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             CccccceeeeeeecccCCceEEEEEEecCCc----eEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe
Q 024158           15 EWSLQDFEIGRPLGKGKFGRVYLVREVESKH----PVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD   90 (271)
Q Consensus        15 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   90 (271)
                      .++-.+|++++.||+|+||+||+|++..+|+    .||+|.+......  ...+.+.+|+.++++++||||+++++++.+
T Consensus         5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   82 (317)
T d1xkka_           5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLT   82 (317)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3456789999999999999999999988876    4777777543222  235678999999999999999999999977


Q ss_pred             CCeEEEEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccc
Q 024158           91 DERIFLILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQS  169 (271)
Q Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~  169 (271)
                      ++ .+++++++.+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus        83 ~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          83 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             CC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            54 67778888889998888764 57999999999999999999999999999999999999999999999999998554


Q ss_pred             cCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCCcchhh------------cccCHH
Q 024158          170 RSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAESQKDTF------------RSISAE  231 (271)
Q Consensus       170 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~~~~~~------------~~i~~~  231 (271)
                      ...     .....||+.|+|||.+.++.++.++||||||+++|+|++ |.+||.+....+..            ..++++
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~  241 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  241 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            322     223457899999999999999999999999999999998 89999877654432            235899


Q ss_pred             HHHHHHHhcccCccCCCCHHHHhcC
Q 024158          232 AKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       232 l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +.+++.+||..||.+|||+.+|++|
T Consensus       242 ~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         242 VYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-50  Score=333.81  Aligned_cols=242  Identities=24%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYG   86 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~   86 (271)
                      ...++-.++|++.+.||+|+||+||+|+...     ++..||||++......  .....+.+|++++++++|||++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCccccee
Confidence            3455667899999999999999999999753     4578999998765433  33567899999999999999999999


Q ss_pred             EEEeCCeEEEEEeccCCCchHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 024158           87 WFHDDERIFLILEYAHRGELYRELRKHR------------------------RFTEQQAATYIASLTNALAYCHENHVIH  142 (271)
Q Consensus        87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H  142 (271)
                      ++...+..++++|++++++|.+++....                        .+++..++.++.|++.||.|||++|++|
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH  163 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  163 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence            9999999999999999999999996422                        3789999999999999999999999999


Q ss_pred             cCCCCCCeeeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCC-CCC
Q 024158          143 RDIKPENLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGA-PPF  216 (271)
Q Consensus       143 ~dl~~~Nili~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~-~p~  216 (271)
                      |||||+||+++.++.+||+|||++.....     ......+++.|+|||.+.+..++.++||||||+++|+|++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999853322     223456788999999999999999999999999999999885 678


Q ss_pred             CCCCcchhh------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          217 EAESQKDTF------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       217 ~~~~~~~~~------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ......+..            ..+|+++.+++.+||..+|++|||+.||++
T Consensus       244 ~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            777655443            236899999999999999999999999964

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=333.81  Aligned_cols=243  Identities=24%  Similarity=0.473  Sum_probs=203.8

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEecCC-------ceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCcee
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREVESK-------HPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNIL   82 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-------~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~   82 (271)
                      +..+++..++|.+.+.||+|+||.||+|+...++       ..||||++..+....  ....+.+|...+.++ +||||+
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~e~~~l~~~~~HpnIv   82 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNII   82 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHH--HHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChH--HHHHHHHHHHHHHHhcCCCeEE
Confidence            3446677899999999999999999999976654       369999997655333  345677788778777 899999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      ++++++.+++..++||||+++|+|.+++...                ..+++..++.++.||+.||.|||+.|++|||||
T Consensus        83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence            9999999999999999999999999999754                248999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  220 (271)
                      |+|||++.++.+||+|||++......     .....+++.|+|||.+.++.++.++||||||+++|+|++ |.+||....
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999999999999999998544322     234567899999999999999999999999999999997 788888766


Q ss_pred             cchhhc------------ccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          221 QKDTFR------------SISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       221 ~~~~~~------------~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..+...            .+++++.+|+.+||.+||.+|||+.||++
T Consensus       243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            554432            35899999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=334.17  Aligned_cols=252  Identities=20%  Similarity=0.323  Sum_probs=215.3

Q ss_pred             hhhhhccCccccceeeeeeecccCCceEEEEEEec-----CCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCcee
Q 024158            8 REDNRKREWSLQDFEIGRPLGKGKFGRVYLVREVE-----SKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNIL   82 (271)
Q Consensus         8 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~   82 (271)
                      .+....+++.-++|++.+.||+|+||.||+|.+..     ++..||||++......  .....+.+|+.++++++||||+
T Consensus         9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv   86 (308)
T d1p4oa_           9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVV   86 (308)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBC
T ss_pred             CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEe
Confidence            33445567788999999999999999999998753     3578999999765433  3356788999999999999999


Q ss_pred             ceeeEEEeCCeEEEEEeccCCCchHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeee
Q 024158           83 RLYGWFHDDERIFLILEYAHRGELYRELRKH----------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLL  152 (271)
Q Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili  152 (271)
                      ++++++..++..++|+|++++|+|.+++...          ..++...+..++.|++.||.|||+++|+||||||+|||+
T Consensus        87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV  166 (308)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred             eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence            9999999999999999999999999988632          246889999999999999999999999999999999999


Q ss_pred             CCCCCEEEeeecccccccCc-----cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcchhhc
Q 024158          153 DHEGRLKIGDFGWSVQSRSK-----RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQKDTFR  226 (271)
Q Consensus       153 ~~~~~~~L~dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~~~~~  226 (271)
                      +.++++||+|||++......     .....+++.|+|||.+.++.++.++|+||||+++|+|++| ..||.+....+...
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99999999999998544322     2233578999999999999999999999999999999988 57887766554433


Q ss_pred             ------------ccCHHHHHHHHHhcccCccCCCCHHHHhc------CCcccc
Q 024158          227 ------------SISAEAKHLISRLLVKDSSKRLSLQKIME------HPWIIK  261 (271)
Q Consensus       227 ------------~i~~~l~~li~~~l~~~p~~Rps~~~il~------~~~~~~  261 (271)
                                  .+++++.+++.+||..+|++|||+++|++      +|+|++
T Consensus       247 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         247 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence                        35789999999999999999999999998      677765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-50  Score=332.18  Aligned_cols=243  Identities=23%  Similarity=0.425  Sum_probs=194.9

Q ss_pred             hccCccccceeeeeeecccCCceEEEEEEecC-----CceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceecee
Q 024158           12 RKREWSLQDFEIGRPLGKGKFGRVYLVREVES-----KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRLY   85 (271)
Q Consensus        12 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~   85 (271)
                      ..+++..++|++.+.||+|+||.||+|++...     ++.||||++.......  ..+.+.++...+.++ .|+||+.++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEee
Confidence            44567778999999999999999999997654     4679999986544332  245566666666665 688999999


Q ss_pred             eEEEeC-CeEEEEEeccCCCchHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 024158           86 GWFHDD-ERIFLILEYAHRGELYRELRKH----------------RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPE  148 (271)
Q Consensus        86 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~  148 (271)
                      +++... +.++++||||++++|.+++...                ..+++..++.++.||+.||.|||++||+||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            987654 4689999999999999999653                24789999999999999999999999999999999


Q ss_pred             CeeeCCCCCEEEeeecccccccC-----ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhC-CCCCCCCCcc
Q 024158          149 NLLLDHEGRLKIGDFGWSVQSRS-----KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYG-APPFEAESQK  222 (271)
Q Consensus       149 Nili~~~~~~~L~dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g-~~p~~~~~~~  222 (271)
                      |||++.++.+||+|||++.....     ......||+.|+|||.+.+..++.++||||||+++|+|++| .+||.+....
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999854332     22345689999999999999999999999999999999986 5678765543


Q ss_pred             hhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          223 DTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       223 ~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                      +..             ..+++++.+++.+||..||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            322             2368999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=329.15  Aligned_cols=243  Identities=25%  Similarity=0.433  Sum_probs=208.7

Q ss_pred             hhccCccccceeeeeeecccCCceEEEEEEe-----cCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhC-CCCceece
Q 024158           11 NRKREWSLQDFEIGRPLGKGKFGRVYLVREV-----ESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSL-RHPNILRL   84 (271)
Q Consensus        11 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~   84 (271)
                      ...+++.-++|++.+.||+|+||.||+|+..     .+++.||||++......  .....+.+|+.+++++ +||||+++
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEE
Confidence            3456667799999999999999999999863     45678999999765433  3356788999999998 69999999


Q ss_pred             eeEEEeCCeEEEEEeccCCCchHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 024158           85 YGWFHDDERIFLILEYAHRGELYRELRKHR------------------RFTEQQAATYIASLTNALAYCHENHVIHRDIK  146 (271)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~  146 (271)
                      ++++.+++..+++||||++++|.+++....                  .+++..++.++.||+.|+.|||++|++|||||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLK  172 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA  172 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccc
Confidence            999999999999999999999999997533                  48999999999999999999999999999999


Q ss_pred             CCCeeeCCCCCEEEeeecccccccCcc-----ccccccccccCCccccCCCCCccchhhhHHHHHHHHHh-CCCCCCCCC
Q 024158          147 PENLLLDHEGRLKIGDFGWSVQSRSKR-----HTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLY-GAPPFEAES  220 (271)
Q Consensus       147 ~~Nili~~~~~~~L~dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~-g~~p~~~~~  220 (271)
                      |+||+++.++.++++|||.+.......     ....+|+.|+|||.+.++.++.++||||||+++|+|++ |.+||....
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999986543322     23467899999999999999999999999999999998 666676655


Q ss_pred             cchhh-------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          221 QKDTF-------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       221 ~~~~~-------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                      ..+.+             ..+++++.+||.+||.+||++|||+++|++
T Consensus       253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            54332             235899999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-48  Score=319.39  Aligned_cols=232  Identities=19%  Similarity=0.335  Sum_probs=193.9

Q ss_pred             eeeeecccCCceEEEEEEecCC---ceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEe-CCeEEEEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESK---HPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHD-DERIFLIL   98 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~   98 (271)
                      ..+.||+|+||+||+|++..++   ..+|||++....  .......+.+|++++++++||||+++++++.. ++..++||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4678999999999999976643   358999986432  23446789999999999999999999999765 46899999


Q ss_pred             eccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecccccccCc-----
Q 024158           99 EYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGWSVQSRSK-----  172 (271)
Q Consensus        99 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~~~~~~~~-----  172 (271)
                      |||++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......     
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999998764 45788899999999999999999999999999999999999999999999998543322     


Q ss_pred             --cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCc-chhh------------cccCHHHHHHHH
Q 024158          173 --RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQ-KDTF------------RSISAEAKHLIS  237 (271)
Q Consensus       173 --~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~-~~~~------------~~i~~~l~~li~  237 (271)
                        .....||+.|+|||.+.+..++.++||||||+++|+|++|..||..... .+..            ..+++++.+|+.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence              1234578999999999999999999999999999999997777654322 1111            235889999999


Q ss_pred             HhcccCccCCCCHHHHhcC
Q 024158          238 RLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       238 ~~l~~~p~~Rps~~~il~~  256 (271)
                      +||..||++|||+.||+++
T Consensus       269 ~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4e-48  Score=320.35  Aligned_cols=243  Identities=19%  Similarity=0.293  Sum_probs=199.3

Q ss_pred             cccc-ceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEEeCCe
Q 024158           16 WSLQ-DFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFHDDER   93 (271)
Q Consensus        16 ~~~~-~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~   93 (271)
                      ++++ +|++++.||+|+||.||+|++..+|+.||||++......     ..+..|+++++.++|++ |+.+..++..++.
T Consensus         3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            3443 699999999999999999999999999999997654322     34678999999998766 5556666778888


Q ss_pred             EEEEEeccCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC---CCCEEEeeecccccc
Q 024158           94 IFLILEYAHRGELYRELRK-HRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH---EGRLKIGDFGWSVQS  169 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~---~~~~~L~dfg~~~~~  169 (271)
                      .++|||+++ +++...+.. .+.++...+..++.|++.||.|||++||+||||||+||+++.   +..++|+|||++...
T Consensus        78 ~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            999999996 566665544 567999999999999999999999999999999999999864   457999999998543


Q ss_pred             cCc----------cccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------
Q 024158          170 RSK----------RHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------  224 (271)
Q Consensus       170 ~~~----------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------  224 (271)
                      ...          .....||+.|+|||.+.+..++.++||||||+++|+|++|..||......+.               
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            321          2334689999999999999999999999999999999999999976543222               


Q ss_pred             ----hcccCHHHHHHHHHhcccCccCCCCHH---HHhcCCccccCCC
Q 024158          225 ----FRSISAEAKHLISRLLVKDSSKRLSLQ---KIMEHPWIIKNAN  264 (271)
Q Consensus       225 ----~~~i~~~l~~li~~~l~~~p~~Rps~~---~il~~~~~~~~~~  264 (271)
                          ...+|+++.+++..|+..+|.+||+++   ++|+++|.+++-.
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence                234689999999999999999999987   5578887765533

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-46  Score=310.58  Aligned_cols=233  Identities=20%  Similarity=0.286  Sum_probs=199.8

Q ss_pred             cccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCC-CceeceeeEEEeCCeEE
Q 024158           17 SLQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRH-PNILRLYGWFHDDERIF   95 (271)
Q Consensus        17 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~   95 (271)
                      ..++|++.+.||+|+||+||+|++..+|+.+|||++......     ..+++|++.++.+.| +|++.+++++..+...+
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            457899999999999999999999999999999998554322     345678888888875 89999999999999999


Q ss_pred             EEEeccCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCC-----CCCEEEeeecccccc
Q 024158           96 LILEYAHRGELYRELRKH-RRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDH-----EGRLKIGDFGWSVQS  169 (271)
Q Consensus        96 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~-----~~~~~L~dfg~~~~~  169 (271)
                      +|||++ +++|.+++... ..++...+..++.|++.+|.+||++||+||||||+||+++.     ++.++|+|||++...
T Consensus        78 ~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          78 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999999 57999988764 47999999999999999999999999999999999999974     568999999998543


Q ss_pred             cC----------ccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh---------------
Q 024158          170 RS----------KRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT---------------  224 (271)
Q Consensus       170 ~~----------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~---------------  224 (271)
                      ..          ......||+.|+|||.+.+..++.++|+||||+++|+|++|..||.+......               
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            22          12234689999999999999999999999999999999999999986543211               


Q ss_pred             ----hcccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 ----FRSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 ----~~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                          ...+|+++.+++..|+..+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence                1347899999999999999999998877654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-47  Score=313.34  Aligned_cols=232  Identities=22%  Similarity=0.339  Sum_probs=187.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCceeceeeEEEeCC----e
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPNILRLYGWFHDDE----R   93 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~   93 (271)
                      ..+|.+.++||+|+||.||+|+.  +|+.||||++..+....    .....|+..+..++||||+++++++..++    .
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~   75 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ   75 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence            46899999999999999999984  68999999996543221    22335666777889999999999987654    5


Q ss_pred             EEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           94 IFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHE--------NHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~--------~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      +|+||||+++++|.+++++ ..+++..++.++.|++.|+.+||+        +||+||||||+|||++.++.+||+|||+
T Consensus        76 ~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          76 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            8999999999999999987 468999999999999999999996        5999999999999999999999999998


Q ss_pred             cccccC-------ccccccccccccCCccccCCC------CCccchhhhHHHHHHHHHhCCCCCCCCCcchhh-------
Q 024158          166 SVQSRS-------KRHTMCGTLDYLAPEMVENKE------HDYAVDNWTLGILCYEFLYGAPPFEAESQKDTF-------  225 (271)
Q Consensus       166 ~~~~~~-------~~~~~~~~~~y~~pe~~~~~~------~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~~-------  225 (271)
                      +.....       ......||+.|+|||.+.+..      ++.++||||||+++|+|++|..|+......+..       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            854332       123457899999999987543      566899999999999999998876432211100       


Q ss_pred             ---------------------c-----ccCHHHHHHHHHhcccCccCCCCHHHHhcC
Q 024158          226 ---------------------R-----SISAEAKHLISRLLVKDSSKRLSLQKIMEH  256 (271)
Q Consensus       226 ---------------------~-----~i~~~l~~li~~~l~~~p~~Rps~~~il~~  256 (271)
                                           .     ..+..+.+++.+||..||++|||+.||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence                                 0     012458999999999999999999999763

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-45  Score=313.08  Aligned_cols=244  Identities=23%  Similarity=0.424  Sum_probs=195.2

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-----------CCceeceee
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-----------HPNILRLYG   86 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-----------~~~i~~~~~   86 (271)
                      -++|++++.||+|+||+||+|++..+|+.||||++.++...    .+...+|+.+++.+.           |+||+++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~   87 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   87 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence            35699999999999999999999999999999999765432    345566777776664           578999998


Q ss_pred             EEEe--CCeEEEEEeccCCC-chHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCeeeCCCC----
Q 024158           87 WFHD--DERIFLILEYAHRG-ELYRELR--KHRRFTEQQAATYIASLTNALAYCHE-NHVIHRDIKPENLLLDHEG----  156 (271)
Q Consensus        87 ~~~~--~~~~~lv~e~~~~~-~L~~~l~--~~~~l~~~~~~~i~~~l~~~l~~Lh~-~~i~H~dl~~~Nili~~~~----  156 (271)
                      ++..  ....++++.++... .......  ....+++..+..++.|++.|+.+||+ .||+||||||+|||++.++    
T Consensus        88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence            8754  34556666655433 3333332  23568999999999999999999998 8999999999999998665    


Q ss_pred             --CEEEeeecccccccCccccccccccccCCccccCCCCCccchhhhHHHHHHHHHhCCCCCCCCCcchh----------
Q 024158          157 --RLKIGDFGWSVQSRSKRHTMCGTLDYLAPEMVENKEHDYAVDNWTLGILCYEFLYGAPPFEAESQKDT----------  224 (271)
Q Consensus       157 --~~~L~dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slg~il~~l~~g~~p~~~~~~~~~----------  224 (271)
                        .++++|||.+...........+++.|+|||.+.+..++.++|+||+|+++++|++|..||........          
T Consensus       168 ~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             cceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence              39999999997777777778899999999999999999999999999999999999999975432100          


Q ss_pred             -----------h--------------------------------------cccCHHHHHHHHHhcccCccCCCCHHHHhc
Q 024158          225 -----------F--------------------------------------RSISAEAKHLISRLLVKDSSKRLSLQKIME  255 (271)
Q Consensus       225 -----------~--------------------------------------~~i~~~l~~li~~~l~~~p~~Rps~~~il~  255 (271)
                                 .                                      ...++++.+||.+||.+||.+|||++|+|+
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       0                                      012577999999999999999999999999


Q ss_pred             CCccccCCCC
Q 024158          256 HPWIIKNANP  265 (271)
Q Consensus       256 ~~~~~~~~~~  265 (271)
                      ||||+....+
T Consensus       328 Hp~f~~~~~~  337 (362)
T d1q8ya_         328 HPWLKDTLGM  337 (362)
T ss_dssp             CGGGTTCTTC
T ss_pred             CcccCCCCCc
Confidence            9999966433

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=7.1e-26  Score=174.07  Aligned_cols=167  Identities=19%  Similarity=0.214  Sum_probs=120.4

Q ss_pred             eeeeeeecccCCceEEEEEEecCCceEEEEEechhhhh---------------HHHHHHHHHHHHHHHhhCCCCceecee
Q 024158           21 FEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIE---------------KYKIQHQLRREMEIQSSLRHPNILRLY   85 (271)
Q Consensus        21 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~---------------~~~~~~~~~~e~~~l~~~~~~~i~~~~   85 (271)
                      +.+.++||+|+||+||+|++ .+|+.+|||++......               ..........|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            46789999999999999997 57899999987532211               111234455688889999999998887


Q ss_pred             eEEEeCCeEEEEEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCeeeCCCCCEEEeeecc
Q 024158           86 GWFHDDERIFLILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCHENHVIHRDIKPENLLLDHEGRLKIGDFGW  165 (271)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh~~~i~H~dl~~~Nili~~~~~~~L~dfg~  165 (271)
                      ++.  .  .+++||++++..+..       ++...+..++.|++.++.+||++|++|+||||+|||++++ .++|+|||.
T Consensus        81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            653  2  378999998755432       3445567899999999999999999999999999999865 589999998


Q ss_pred             cccccCccccccccccccCCc-----cccCCCCCccchhhhHHHH
Q 024158          166 SVQSRSKRHTMCGTLDYLAPE-----MVENKEHDYAVDNWTLGIL  205 (271)
Q Consensus       166 ~~~~~~~~~~~~~~~~y~~pe-----~~~~~~~~~~~Di~slg~i  205 (271)
                      +.....+...     .|....     .+....|+.++|+||+.--
T Consensus       149 a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         149 SVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             cccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            8554433211     111110     1123557788999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=1.4e-07  Score=74.03  Aligned_cols=139  Identities=14%  Similarity=0.143  Sum_probs=89.7

Q ss_pred             ccceeeeeeecccCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC-CCceeceeeEEEeCCeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR-HPNILRLYGWFHDDERIFL   96 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~l   96 (271)
                      ++.|++++..+.++.+.||++.  .++..+++|..........   ..+.+|...++.+. +--+++++.+...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccch---hhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4577888876666667899876  5667788998755433221   23445566655553 3336788888888889999


Q ss_pred             EEeccCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 024158           97 ILEYAHRGELYRELRKHRRFTEQQAATYIASLTNALAYCH----------------------------------------  136 (271)
Q Consensus        97 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~~l~~~l~~Lh----------------------------------------  136 (271)
                      ||++.+|.++.+......  ..   ..++.++...+..||                                        
T Consensus        88 v~~~l~G~~~~~~~~~~~--~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ--SP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS--CH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccccc--cH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            999999877755432211  11   112222222223232                                        


Q ss_pred             -------------hC------CceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          137 -------------EN------HVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       137 -------------~~------~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                                   ..      .++|+|++|.||+++.++.+.|+||+.+
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a  211 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence                         11      2799999999999987766779999855

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.31  E-value=1.7e-06  Score=71.90  Aligned_cols=81  Identities=14%  Similarity=0.095  Sum_probs=46.4

Q ss_pred             eeeeecccCCceEEEEEEecCCceEEEEEechhhh--h--HHHHHHHHHHHHHHHhhCC---CCceeceeeEEEeCCeEE
Q 024158           23 IGRPLGKGKFGRVYLVREVESKHPVALKIIFKEQI--E--KYKIQHQLRREMEIQSSLR---HPNILRLYGWFHDDERIF   95 (271)
Q Consensus        23 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~--~~~~~~~~~~e~~~l~~~~---~~~i~~~~~~~~~~~~~~   95 (271)
                      ..+.||.|..+.||++.+..+++.+++|.......  .  .+........|...++.+.   ...+++++.+  +++..+
T Consensus        30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~  107 (392)
T d2pula1          30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  107 (392)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             eEEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence            35678999999999999877788999997532110  0  0011122334555555442   2346666654  344457


Q ss_pred             EEEeccCCCc
Q 024158           96 LILEYAHRGE  105 (271)
Q Consensus        96 lv~e~~~~~~  105 (271)
                      ++||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999987644

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.23  E-value=8.5e-06  Score=63.13  Aligned_cols=78  Identities=14%  Similarity=0.142  Sum_probs=49.8

Q ss_pred             eeeeeeecccC-CceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCC--CCceeceeeEEEeCCeEEEE
Q 024158           21 FEIGRPLGKGK-FGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLR--HPNILRLYGWFHDDERIFLI   97 (271)
Q Consensus        21 y~~~~~lg~g~-~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~i~~~~~~~~~~~~~~lv   97 (271)
                      ++.. .+..|. -+.||++.. .++..+++|........      .+..|...++.+.  .-.+++++.+..+++..+++
T Consensus        13 ~~~~-~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v   84 (255)
T d1nd4a_          13 YDWA-QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   84 (255)
T ss_dssp             CEEE-ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CceE-EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence            4443 334444 467898874 45777899987544322      2344555555442  23367788888888889999


Q ss_pred             EeccCCCch
Q 024158           98 LEYAHRGEL  106 (271)
Q Consensus        98 ~e~~~~~~L  106 (271)
                      |++++|.++
T Consensus        85 ~~~i~G~~~   93 (255)
T d1nd4a_          85 LGEVPGQDL   93 (255)
T ss_dssp             EECCSSEET
T ss_pred             EEeeecccc
Confidence            999987655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.33  E-value=0.0004  Score=57.21  Aligned_cols=79  Identities=25%  Similarity=0.326  Sum_probs=47.9

Q ss_pred             ccceeeeeeecccCCceEEEEEEecC-------CceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc-eeceeeEEE
Q 024158           18 LQDFEIGRPLGKGKFGRVYLVREVES-------KHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN-ILRLYGWFH   89 (271)
Q Consensus        18 ~~~y~~~~~lg~g~~~~v~~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~   89 (271)
                      .++.++ +.|+.|-...+|++.....       +..++++++....  ..   ....+|..+++.+...+ .+++++++.
T Consensus        42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~---idr~~E~~i~~~ls~~gl~Pkll~~~~  115 (395)
T d1nw1a_          42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TE---SHLVAESVIFTLLSERHLGPKLYGIFS  115 (395)
T ss_dssp             GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CH---HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred             ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hh---hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence            344444 6788899999999986532       4568888875221  11   12335666666554333 456777653


Q ss_pred             eCCeEEEEEeccCCCch
Q 024158           90 DDERIFLILEYAHRGEL  106 (271)
Q Consensus        90 ~~~~~~lv~e~~~~~~L  106 (271)
                      +    ..|+||++|.++
T Consensus       116 ~----g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G----GRLEEYIPSRPL  128 (395)
T ss_dssp             T----EEEECCCCEEEC
T ss_pred             C----ceEEEEeccccC
Confidence            2    578899876443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.26  E-value=0.0014  Score=51.89  Aligned_cols=29  Identities=24%  Similarity=0.337  Sum_probs=25.9

Q ss_pred             CCceecCCCCCCeeeCCCCCEEEeeeccc
Q 024158          138 NHVIHRDIKPENLLLDHEGRLKIGDFGWS  166 (271)
Q Consensus       138 ~~i~H~dl~~~Nili~~~~~~~L~dfg~~  166 (271)
                      .|++|+|+.++||+++.+...-++||+.+
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~  211 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFA  211 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred             cccccCCcchhhhhcccccceeEeccccc
Confidence            37999999999999998877789999976

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.26  E-value=0.00071  Score=54.06  Aligned_cols=70  Identities=14%  Similarity=0.180  Sum_probs=41.3

Q ss_pred             cCCceEEEEEEecCCceEEEEEechhhhhHHHHHHHHHHHHHHHhhCCCCc--eeceee-----EEEeCCeEEEEEeccC
Q 024158           30 GKFGRVYLVREVESKHPVALKIIFKEQIEKYKIQHQLRREMEIQSSLRHPN--ILRLYG-----WFHDDERIFLILEYAH  102 (271)
Q Consensus        30 g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~--i~~~~~-----~~~~~~~~~lv~e~~~  102 (271)
                      +.-..||++.. ++|..+++|+........    ..+..|...+..+...+  ++..+.     ....++..+.++++.+
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            33468999885 678999999986543222    33455565555553221  111111     2234567888999987


Q ss_pred             CC
Q 024158          103 RG  104 (271)
Q Consensus       103 ~~  104 (271)
                      |.
T Consensus       108 G~  109 (325)
T d1zyla1         108 GR  109 (325)
T ss_dssp             CE
T ss_pred             Cc
Confidence            53